EPISODE TRANSCRIPT: Nelson Repenning

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I’m Naji Gehchan, your host, joined today by Nelson Repenning, Faculty Director of the MIT Leadership Center and the School of Management Distinguished Professor of System Dynamics and Organization Studies at the MIT Sloan School of Management.

Nelson’s early work focused on understanding the inability of organizations to leverage well-established tools and practices. He has worked extensively with organizations trying to develop new capabilities in both manufacturing and new product development. Nelson has also studied the failure to use safety practices that often lead to industrial accidents and has helped investigate several major incidents. This line of research has been recognized with several awards, including best paper recognition from both California Management Review and the Journal of Product Innovation Management.

Building on his earlier work, Nelson now focuses on developing the theory and practice of dynamic work design, a new approach to designing work that is both effective and engaging. I personally have extensively learned from and benefited from this work, including dynamic management systems, a method for ensuring that day-to-day work is tightly linked to the strategic objectives of the firm.

Nelson, I am really so excited to see you here and have you with me today, especially with the launch of your new book, There’s Got to Be a Better Way.

Nelson Repenning:
It’s a pleasure to be here. I know you and I have been trying to get together for quite a while, but thank you for having me.

Naji Gehchan:
So Nelson, before we dig into the book and your research, can you tell us a little bit more about your personal journey and ultimately how you became such a central voice in shaping organizational work?

Nelson Repenning:
Well, that’s a very kind construal. So I came to MIT on my 23rd birthday not really knowing what I wanted to do other than I thought I wanted to be an academic when I grew up. I’ve never left, as it turns out, so it was a good decision. I thought I was going to be here four or five years — that was 35 years ago.

What really defined my trajectory is that when I first got here, most people in my department were developing tools. I thought I was pretty good at math, but I realized quickly there was a whole level I wasn’t even aware of. Many of my fellow PhD students were far more sophisticated than I was, and I worried I wasn’t going to be able to compete.

Around that time, John Sterman — my thesis advisor and later my colleague — and I came across what I still think is a heretical question: do people actually use these tools we spend so much time developing? As I dug into it, I realized this wasn’t just about system dynamics — it applied to management tools broadly, whether from books, HBR articles, or elsewhere.

The answer turned out to be: at best, maybe — and often not at all. That question has driven my work ever since. I’ve focused on tools that actually have good evidence that they work, because it makes for better research design. That question opened a million doors into broader organizational phenomena.

Like most good things in life, it was mostly luck — I stumbled onto a topic that grabbed me personally. Every day I see new variants of the same phenomenon. It’s been the gift that keeps on giving.

Naji Gehchan:
Thank you for sharing that. Let’s go deeper into the work. Your research has always been about helping people do meaningful work in better ways. What is the core human problem you’re trying to solve with dynamic work design, and what ultimately inspired you to write this book?

Nelson Repenning:
I’d describe my career in two phases: a diagnostic phase and a solution phase. The diagnostic phase showed that people struggle to use new tools because they’re trapped in daily firefighting — a very familiar setting for managers.

We open the book with a quote from a former student:
“I know my organization is in trouble. When I show up Monday morning, I make a list of important things to do. I work my ass off all week. On Friday afternoon, I check my list — and I’ve got nothing done.”

Many people resonate with that. You walk in with great intentions, then a customer is mad, equipment breaks, something doesn’t arrive — and suddenly your whole week is gone. You never get to strategy, new tools, or future thinking.

The diagnosis boils down to what I call the capability trap. Fixing short-term problems gives fast, clear feedback — our brains love that. Preventing problems or building capability gives slow, ambiguous feedback — and so we avoid it. That asymmetry drives firefighting.

Early in my career, I’d present this and people would say, “That’s exactly my organization.” Then they’d ask, “What do we do about it?” And I didn’t have a good answer.

This book is the answer. Most organizational processes assume we can predict the future — budgeting is a great example. We create budgets assuming forecasts are accurate, then the world changes and we spend the year working around the budget. All of this happens with good intentions, but the workarounds create complex, brittle systems.

So the book offers design principles for operating in a dynamic, unpredictable world. When organizations apply them, the gains can be shockingly large. You get both productivity and more engaging work.

Naji Gehchan:
I’m smiling because it feels like daily life — especially in healthcare. Many of my listeners work in pharma, hospitals, and health systems. Firefighting is the norm, and we often feel healthcare is “different.” Does dynamic work design apply there?

Nelson Repenning:
This question always comes up. Everyone thinks their industry is unique — and it is, to a degree. But the common denominator is people. The work only applies to organizations with humans in them — wonderfully flawed humans with good intentions.

We deliberately use principles instead of best practices. Best practices rarely transfer cleanly. Even companies across the street from each other in the same industry can’t copy-paste success.

If you understand the principles, you can adapt practices to your own culture. That’s the goal.

There’s a famous NEJM article titled “Keep the Toyota Crap Out of My Hospital.” I get the argument — patients aren’t cars. But with adaptation, lessons from manufacturing can absolutely improve hospitals. We’ve seen big wins in patient flow, ICU stays, and drug development — but never by copying blindly.

Naji Gehchan:
Yes, and I can attest that it works across industries. You outline five principles in the book. Can you walk us through them, and highlight one especially relevant for healthcare leaders?

Nelson Repenning:
The first principle is solve the right problem. Be an intuitive scientist — clarify the real problem before jumping to solutions.

Second is structure for discovery — design work so people learn the right lessons. Poor incentives and fragmented roles often teach the wrong lessons.

Third is connect the human chain — ensure problems reach the best person to solve them quickly.

Fourth is regulate for flow — manage how much work is in the system.

Fifth is visual management.

If I had to pick one, it’s regulate for flow. Most organizations take on far too much work. When leaders rank-order priorities and enforce focus — real flow emerges.

Instead of killing pet projects, we rank them. Most never rise in priority — and eventually disappear naturally.

Balancing workload unlocks massive gains across patients, drugs, invoices — everything.

Naji Gehchan:
Another thing I took from your classes is that small, well-designed changes can transform systems far more than top-down initiatives. Can you share a story that crystallizes this?

Nelson Repenning:
Large organizations often use what I call the “T-shirt and coffee mug” change model — slogans, consultants, binders. I’ve never seen it produce meaningful change. It breeds cynicism.

The alternative is dynamic work design: pick one critical process, identify one real problem, go see the work, fix it fast, then expand outward.

Senior leaders are often shocked when they actually watch work happen. They find low-hanging fruit immediately. Small experiments limit risk, accelerate learning, and — most importantly — model the right behavior.

When leaders get their hands dirty, it sends a powerful signal. And once results appear, momentum builds quickly.

Naji Gehchan:
If a leader listening today wants to start Monday morning, what should they do?

Nelson Repenning:
Ask: what is the biggest collective pain in our ass? Not external shocks — internal, recurring problems. Projects always late. Enrollment always slow. Systems never work the first time.

Go see the work. Talk to the people doing it. Pick one problem and solve it hands-on.

You’ll know you’re succeeding when your team tells you, “We’ve got this — you can leave.”

Naji Gehchan:
I can attest to that — from drug development to decision-making structures, small changes had outsized impact on getting therapies to patients.

Nelson Repenning:
And as an MIT professor, I’m obligated to mention AI. We’ve seen cases where AI inserted surgically — after understanding the work — cut processes from 60 days to four hours. AI should solve real problems, not be applied everywhere blindly.

Naji Gehchan:
I love that perspective. Now, quick reactions. Leadership.

Nelson Repenning:
Leadership development needs a revolution. We shouldn’t copy hot leaders — we should develop who we are meant to be. Effective leadership development requires a mirror, not a model.

Naji Gehchan:
A3?

Nelson Repenning:
A powerful structured problem-solving tool — but more importantly, A3 thinking changes how you approach complexity.

Naji Gehchan:
Biking?

Nelson Repenning:
I’m an avid cyclist — it keeps me grounded.

Naji Gehchan:
Spread love in organizations?

Nelson Repenning:
We spend most of our lives at work. Loving your work, colleagues, and community makes everything better. I’m all for it.

Naji Gehchan:
Any final word for leaders?

Nelson Repenning:
Don’t be the “what part of 17% don’t you understand?” manager. Targets without support kill learning. If someone brings you a problem, they’ve done you a favor. Leadership is about developing people, not deflecting responsibility.

Naji Gehchan:
Thank you so much, Nelson. It’s always a pleasure.

Nelson Repenning:
My pleasure. Thanks for having me.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Giovanni Abbadessa

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji your host, joined today by Giovanni Abbadessa is a Medical Oncologist and PhD with 23 years drug development experience across academia, small biotech, and pharma. He is a passionate, hands-on, and entrepreneurial leader specializing in oncology, hematology, and rare disease pre-clinical and clinical (Phase 1-3) development. Giovanni has worked on the development of nearly 30 clinical and as many preclinical experimental drugs across eight classes of agents. Currently, as Chief Medical Officer at ModeX Therapeutics, Giovanni guides strategy and execution of a variety of clinical programs in oncology and infectious diseases. Before that Giovanni held a series of senior leadership roles at Sanofi, ArQule, and Ziopharm Oncology. Giovanni serves on several for profit and non profit boards. He spent his post-doctoral fellowship at Temple Fox Chase Cancer Center in Philadelphia, and began his Oncology and Physician career in Italy.

Giovanni Abbadessa: Nice to be on your podcast, Naji. Thank you for having me.

Naji Gehchan: I’d love to start first with your personal story. What drove you to medicine, then shifting into biotech and pharma?

Giovanni Abbadessa: That’s a long story. So I grew up in Naples, south of Italy, and it’s an amazing place. If you live there, you have to learn how to survive a little bit, but on the other end, there’s beauty, natural beauty, architectural beauty, human beauty everywhere, and you learn a lot. From life there. So my father was a professor of hematology, oncohematology at the university, at one of the two universities in Naples, and then became chair of a hematology department. So I didn’t want to go into medicine. At the end of high school, there was a little bit of pressure in, at least to try and taking the test and see if I could access. And I actually passed with very good ranking and entered a school. There were, I think, 1,200 people who tried, and 250 spots. And so I said, okay. I was actually always interested in understanding mechanisms and solving problems and physiology of the human body. So I said, okay, I’ll give it a try. And the first, in Italy, you have six years of med school. The first year was chemistry, biochemistry, stats. It was hard. But then there was an English exam, which I passed very well, which motivated me. And then I became more passionate about the biology and about, especially when you go into clinical subjects. So in Italy, you do the first three years, it’s all basic sciences. And the next three years is clinical sciences. So once I finished the first three years, I didn’t want to be in the same university as my father was teaching. So I switched to the other university so that I would not be with his friends, professors. Now, something very important happened. I wanted to do interventional, be an interventional cardiologist. I like cardiology, the mechanisms and so on. But I wanted to try what it means. So I found through an introduction the way to go to spend a month in Milan in a new hospital where they were pretty much ahead in interventional cardiology. And if I remember correctly, I was booked to go there in August, to spend my August there. But I was volunteering, I volunteered for years with a nonprofit organization in Naples, which was founded by a missionary who’s also a priest, who’s also a theologist, who also writes books with famous Italian writers, who’s also friends with Mother Teresa and Muhammad Yunus, the Nobel Prize for Peace, I believe. He invented the concept of the microcredit. And so together with him and Mother Teresa, he opened a number of missions in East India, West India, and then Africa, and then South America. So I took a trip with the organization that I was helping in Naples, and we spent a month in India touring and checking the projects in West India, South of Indore, and Tamil Nadu, and lepers changing their bandages, and then orphans. And that thing, that experience had a deep impact on me. We were not going there as tourists, we were going there to learn and do. And I remember still today when we arrived, another great human lesson, life lesson. We were like a dozen of us, with the founder of the nonprofit, we were on the bus entering for the first time a lepers village, which our organization was sustaining. But these lepers were encouraged to work because the concept was always, we provide funds, but the people who benefit of the funds have to work and have to do things and deserve to be helped and want to be helped. That was a very important piece. You have to want to be helped. And when we are entering the village, the founder told us very seriously, “Guys, you’re gonna see people that are clearly worth nothing. They cannot have a life outside of here because in India they’re segregated, discriminated. They lose their limbs, their face. It’s horrible. They’re poor. Probably what you pay in university fees is their entire years of life. You’re also gonna see people who are horrible monsters, who look like monsters and scary. Do not dare treating them as inferior. Do not dare showing them that you’re scared or disgusted.” That would be horrible of you to do. It would be shameful of you to do. So we arrived in the village and we get down the bus and 60 or so lepers come surrounding us. And it was like in a zombie movie, very scary. But we took very seriously the promise of being welcoming and try and smile. And well, within half hour we were dancing with them, hugging them. And they were showing us very proudly the work that they were doing. It was such a lesson. There were two villages. One with lepers were still sick and receiving drugs and they were taking care of animals and growing plants and food. And the other village, once they get cured, of course the limbs don’t grow back. So they stay in the village. Society will not accept them, but in the other village they were making saris. They were making cloths and sheets with machines that our organization provides. And now those villages were profitable. They were actually selling food and cloths and tissues to the surrounding villages. So it was a great example of how social entrepreneurship can help. But the most moving moment was when they asked us to get on our knees and give us the Indian blessing. And picture yourself, I mean, this is all happened in a span of maybe four or five hours. You arrive with a mindset and you find yourself on your knees getting blessed by these people. We were crying, I couldn’t stop crying. And I went back with a different understanding of respect of people, of the impact you can actually have, how much you get when you give. It really had a profound impact. So when I came back to Italy, I went to this hospital. I went first afternoon, first day in this cardiology, interventional cardiology department, where they let me enter the surgery room. I saw a doctor who was playing with a joystick in the heart of a patient. The patient was awake, but nobody was talking with the patient. He was really looking at the screen and doing his thing and then get out. And that was it. And I thought, oh my God, this is, there’s no human interaction. I don’t know. The only human interaction is a little bit at the beginning and in the end. I felt I didn’t study so much and do all this for that. I wanted to be more involved with the patient with psychology. So I went, my contact there was in the oncology department and I asked them, look, I really cannot be another day in this place, but I booked a month, an apartment, everything. Can I stay in the oncology department? After all, you do internal medicine. You see everything with patients. I can help out and see what it is. And I really liked it. I really liked it because in oncology, well, at the time it was 2000 and, no, this was 99, 1999, very few drugs approved for oncology patients, chemo’s toxic, but the relation and the connection with the patient and their family was totally different than what I had seen at the cardiology department. Of course, we need cardiologists to survive and then do a very important job. But the connection with the family, with the patient, the concept that some patients will survive, many won’t. And that type of, it’s almost a spiritual connection with the patient and the family at the end of their life. And also how valuable is each month, each day that you can give to somebody and how they can spend those days, how well or bad, depending on what you can do. That was gratifying as being with a leper who will never have their limb grown back. And so I came back to Naples and I said, okay, I think this is what I want to do. So once I decided I wanted to be an oncologist, I could no longer stay in Naples because my father is one of the most well-known oncologist there. And I wanted to be on my own. And so I asked the hospital in Milan if they could take me back. I was still in med school at the time. So what I did is I did my exams in Naples and then every time I had a break, I would spend a month in Milan at the hospital, then come back to Naples to study, get exams. I think it was in my fourth year of med school. So then in 2001, I joined the hospital and I became an investigator on clinical trials while I was entering my fellowship. That was another really, really interesting experience. It’s a very modern hospital. At the time they had 600 beds, an ER. And I volunteered to do night shifts because I thought it was, well, after the second year, of course, because I thought it was a learning experience. And the night shift, it was only an internist, me, a surgeon, an anesthesiologist, and a cardiologist on the whole 600 beds. And then there were people in the ER, but every time they had to hospitalise a patient from the ER, it was the four of us. So you can imagine how intense it was. I was fortunate to be an investigator on four experimental drugs, phase one, phase two, phase three, the registration trial with cetoximab for colorectal cancer. I was the top enroller in the world in the phase two sorafinib trial in liver cancer, and actually the only one with partial responses in that study, which then led Bayer to decide to move forward with developing sorafinib in phase three. They asked me to come as an advisor. I was very fortunate. Well, because I cared of the patients, and so the results were probably better than in other places, and so they asked how to help understanding how to develop the drug. So then I wanted to learn basic science, and I used another one of my summer, 2004, to come to Philadelphia in a lab and see what the lab life was like, because in Italy I was just doing clinic, 8, 15 a.m. to 7, 30 p.m. every day with a 20-minute break for lunch. I think we were 25 oncologists. We were doing, at the time, 15,000 visits. It was absurd the amount of work we had. So I wanted to experience basic research. I came to Philadelphia, spent a month in a lab. I found it interesting, fascinating, and also oncology was becoming more and more targeted and biological. And 2001 is when Gleevec, the first targeted therapy, was approved, right? So we were, and now there were mouse models with human tumors transplanted, xenografts, and so on. So it became very interesting. So I applied for a project, for a grant. Actually, the Milan Hospital helped me with some support, and I was able to then come back in April 5, 2005. I came back to Philadelphia with the idea of staying there maybe six months and do some basic research project. What I proposed was to do multi-gene therapy in a human model of liver cancers transplanted in a mouse. Soon I realized that it would take much longer than six months. The lab where I ended up, they didn’t even have an animal facility. They didn’t have the rotors to centrifuge the cells and extract the virus. They had nothing. I said, “Why did you bring me here?” Because you’re a smart, Southern Italian physician, and I know you people are smart, so you’re gonna find a way to do it. (both laughing) So there was nothing. But what happened is I wanted to make use of my trip again. And also I met a girl that I really liked, who is now my wife. And so I wanted to stay. And so I’ve always been social, as a good Southern Italian should be. And so one night at the pizza restaurant, I meet an associate professor from Heidelberg, Germany, who was doing research gene therapy in cardiology at another university in Philadelphia. And so I asked him, “Hey, look, I don’t have, I cannot do much experiments in the lab where I am. Can I come and help you for free and learn how to do gene therapy?” So he said, “Yes, sure, come.” So that’s where I learned how to get mice, work with them, how to cultivate the cells, how to centrifuge, extract viruses and so on. And then we made an agree. Then at the lunch, I met, I think it was from Syria, another investigator at my same university who had an animal facility for neurology. So I asked him, “Hey, can we collaborate and I rent a room from your animal facility and I turn it into a BL2 room?” (laughing) – That’s amazing. – BL3? I can’t remember anymore. Basically, when you do gene therapy, what I had to do in this room, I had to set up a 24-hour life cycle. I had to order mice cages, which I just went online and ordered them on the Charles River website. Then I had to order a hood, a laminar flow hood, and I had to set up a laminar flow in the room so that whenever you use viruses under the hood, it aspirates out anything that can fly out. So I did that. I ordered the mice. I started my experiments. And thanks to the other university who helped me making the genes. And these experiments actually were working. We were injecting the mice with these genes and the tumors were disappearing. Then I set up a model of ovarian cancer. And at the same time, I was once a week going to Fox Chase to still stay in the clinic.

Giovanni Abbadessa: So there was a very learning, again, a very good learning. I enrolled in this PhD in genetics. But after two and a half years, I said, okay, I wanna go to patients. I wanna help patients, not mice. And I tried to go back to Italy. But getting a proper job as an oncologist in Italy revealed to be quite, not only, well, I had a couple of offers, but the salaries were, I should have, I would have had to share the apartment with someone. It was, at this point, I had already six years of med school, four years in the hospital as an oncologist, three years as a PhD. And also it was hard to bring my girlfriend, now wife, to Italy with me. ‘Cause she’s not European. And so I decided to look for a job here in the US. And I got a couple of offers. One that I like more because it was in Boston. I wanted to stay in a city. And so I came to Zio from oncology in Boston at the end of 2007. – And the rest is history. – You asked me, how did you became? – I love it. – That’s just the beginning. – Yeah, so thanks for this incredible story and sharing it. So let me go to another question, actually, for how the beginning continues, right? You’ve worked across academia and you started in this biotech, but you also worked in big pharma. So thinking about this, how has those movements between these different environments shaped your leadership and shaped who you are and how you think about science? – Well, I think you need to add a third sector, which is the nonprofit volunteering. Because if you’re talking about shaping behavior and leadership style, the volunteering work, I tell everyone, plays a big role there. Of course, with the nonprofit, after going to India, I also went to Albania and did a lot more work in Italy. But here, when I came in Boston, 2007, 2008, at that time, there were problems in Italy. There was trash in the streets. The prime minister was a very smart guy, but he liked girls. And so he was caught a few times with girls in different places. So the reputation was not super professional for Italians, right? And a few times people told me, Italy’s just good for pizza and why not to work with them? And I said, well, no, I actually know very, very good doctors and a lot of good professionals there. So I’ve started an organization here in Boston with the help of a few friends to promote Italian professionalism and bring Italian professionals together and organize cultural events in English for everyone in the Boston area. And convincing volunteers to do things, to get together, to spend time, especially if they’re professionals with busy lives, that takes a different angle than telling somebody at your workplace that they have to do something because they’re paid to do it. And so you learn a lot about bringing people together, understanding what everybody likes and what everybody knows how to do and try to leverage what everybody likes to do more while they also contribute in other ways. So that was very important. The other, so it was then what happened in 2011, I was fortunate to be accepted to the Harvard Business School Leadership Training. What they do is they offer the entire semester, leadership semester, the training that they do during the MBAs, they offer it for executive education in a full week. You have to sleep there. It’s, you start at eight, you finish at midnight. For a whole week, it’s groups of eight in the dorms. And that was another changing experience, right? ‘Cause a physician, a scientist, you’re not trained in leadership. I had some natural things that came from the experiences in Italy, in the nonprofit, but having them objectively demonstrated how useful these are and the behavior, how behavior impacts behavior, that was fundamental, but also understanding more the business and team building and so on. I had no idea of these things, not in an organic way. So that really changed. It’s like turning on a light in a dark place, it was for me. And then in 2014, as I was working on clinical trials at this point at RQ, right? What happened is I was working on phase one, two, and three at RQ, we had a phase three study, which in 2014, the phase three study, unfortunately, the second phase three study was negative. So RQ had to restructure. The same year, I started the school for Italian children in Boston, not because I wanted it, but because families asked, and I didn’t want really to do it. But, and so I tried to have somebody else do it and we were just helping. It was not at the quality that people wanted. So we had to become independent and rent a place. And today that school has 180 children every Saturday morning. We only teach Italian full immersion, no English spoken, and we have 180 children and a dozen adults. And that’s another, of course we reimbursed the teachers, we pay the rent, but a lot of this is volunteering. And we have a team of volunteers. The teachers themselves are partially volunteers. So that’s another, I’ve been doing this for now, I don’t know, 15 years with, or more, with the nonprofit. Nonprofit and volunteering really helps you shaping leadership traits and understanding people, groups, communities, behaviors. And the other aspects, things that happened in those years that really shaped was that the first biotech, Zyfram Oncology, 2007, you remember, there was a financial crisis. So the company, we had three drugs in the clinic, but we went from, I think $3 a share to less than a dollar a share, we were delisted by NASDAQ. Leadership was failing to guide the company. The company went from 50 people to 15 in no matter of a summer, but it was not just that. It was hard to see a guide. And that was a real teaching. The head of the fish determines how the rest of the fish smells. And even if you had three drugs, molecules in the clinic, which actually were given good data, I decided to leave the company because of the leadership. Then I went to Arq. And at Arq, we brought seven drugs to the clinic in 80 years. And at Arq, the phase three with the metinib failed in 2014. But the CEO was a very strong, well, strong, compassionate and human person. Yes, he became very nervous at that time. We did have to restructure and lose 70% of the people. And we, differently than at Zyfarm, we didn’t have at that point drugs that were giving good signals yet, but I stayed because of the leadership. The board made me head of the labs also. So I was already a head of clinical development, but the board made me, I was only in the older board meetings for the last few years. The board made me also head of basically basic research besides the medical affair, investigative response study and clinical development. And that was an important transition because once I took over the labs, I finally was able to bring together preclinical and clinical. Another learning is that even in small environments, small biotechs, silos happen and matter. Clinical didn’t know what preclinical was doing and preclinical wouldn’t care, wouldn’t want the clinical to know and vice versa. Once I had them all together, I had started to order pizza. And the impact that pizza can have on teams is actually taught at the Harvard Business School. At Harvard Business School, they taught us how sharing food brings people together because you’re putting your hands and you’re putting your mouth something from a common place, a common plate, a common. So I thought, okay, let’s do this. I’m Neapolitan, pizza, sharing, let’s do it. And I started having every other week, a team meeting with all the preclinical and clinical people, very few at that point, we were eight, with pizza. And going around the room and asking everyone, I knew what everybody was doing, but I asked them so that everybody else could know what they were doing. And this started connecting people on a totally different level. That allowed us to understand better the clinical assets, but also that we had in the lab something that actually my manager had trashed and the leadership decided not to advance, a BTK inhibitor. So we did experiments a little bit in secret, quite a lot in secret actually, to characterize better the molecule. And once we had the data, I said, look, I understand why you guys trashed it, but you didn’t see the real activity of this molecule and why it works this way. Allow me to do some animal study. So we didn’t have much money. So I called an Italian guy at Ohio State, Carlo Croce. I said, Carlo, we’d interact in Philadelphia, you had already left, but look, I’m cashless, we’re a small biotech and I have a molecule that I think could work. You have a beautiful model of chronic lymphatic leukemia in animals, can I please bring the drug and we try it? So we negotiated. I went to Columbus, Ohio, spent a nice time, very nice, he’s a very nice guy. And we did the experiment, it worked. We wiped out CLL from these mice with no significant toxicity. So then at that point, John Bird, who was the head of the leukemia program there, the same guy who was heading development of ibrutinib, baccalabrutinib, other BTK inhibitors for CLL, he said, you should bring this thing forward. So we did more animal experiments, more, oh, we published quite a bit. And finally I was able to bring this thing to the clinic in a phase one study, which then was, gave positive data and was the reason why Arcula was acquired by Merck. So a lot of learnings, resilience, bringing people together. It’s all because of the pizza. (laughing) – I love it. I have a section you will love when I say the words. But look, you’re a big believer. I know we discussed about this. And I relate to several things you’ve said. Like I’ve been a humanitarian, it shaped your leadership in a different way. Managing and leading folks who are volunteers in tough situations is certainly life lessons. But you’re also a big believer in collaboration and human connection. You talk about pizza here. What you’ve done also in the nonprofit world, whether it’s the school, the professional organization of Italians, what do you think really make collaboration effective? If you look at it from purely our industry, like drug development, what would make it effective? And where do you see the biggest gaps, for example, today?

Giovanni Abbadessa: I think it’s like the same thing that another learning came from, geez, I think in the ’70s and then in the ’90s, there were active negotiations which the US was involved with between Palestinians and Arabs and Israel. And they were able to move forward at the time because the concept was, okay, let’s look at what really everybody wants. What do you want? What does the other one want? And the point is not to try to, when you collaborate is not to try to ask for 100 so you can get 50. The point is to understand what does the other party want? It may not be 100, it may be something different. Oh, maybe that’s not a big deal. I can give that. And this is what I really want. So I think collaborations are proficus when people really put on the table, what is it they want? What is it they need? And then you find complementarity. If you want, if there’s no compatibility between what you want, then no money and no benefit will make a fruitful collaboration. You have to start from what you really need and want and of course trust. And the people, as I always say to my team, drugs do not develop drugs. People develop drugs. – I love it. I love this. (laughs) That’s so true. – It’s true. I’ve seen bad people ruining good drugs and I’ve seen decent drug moving forward because the people were really, really good. And today we’re no longer in the environment that was 50 years ago where a single person could really make a huge difference. Everything in research today requires teamwork. So it has to be the people. – It has to be the people. – You have to start from the people.

Naji Gehchan: Certainly. I’m gonna now give you a word, Giovanni, and I would love your first reaction to it. The first one is leadership.

Giovanni Abbadessa: Yeah. Well, you have to give the example. You have to give the example. You have to be compassionate. You have to be humble. You have to be hungry and you have to be a people person. I like a lot an author named Patrick Lencioni. He wrote the finest functions of a team, but especially the ideal team player. And I think it’s totally true. Good leader should be humble because otherwise you don’t see when you’re making a mistake. If you don’t, anyone could give you a good idea. And if you’re not humble, you’re gonna miss it. You need to be passionate. You need to be hungry. You need to have a drive. If you wanna be a leader, of course. If you feel that you have something else to contribute. And then you have to be a people person. That’s the third important point. – What about innovation?

Giovanni Abbadessa: Innovation comes with failure. Come with failure and self-confidence and be confident enough that you can try things that don’t work. You’re never gonna innovate if you don’t fail. You have to fail and you have to accept failure and you have to accept failure and learn of course from failure. So you have to accept productive criticism and try. And you need to be resilient. – Yes. The third one that I wrote before we chatted was pizza. (both laughing) So what’s your reaction to pizza? – I love it. (both laughing) Well, first of all, let me tell you, pizza was not invented in New York. (both laughing)

Giovanni Abbadessa: Well, I went to this Neapolitan place where it says they invented margarita pizza. Is that like a myth or is it true? – Well, no, no. That’s a brandy in Naples. – In Naples, yeah. – They invented the margarita, not the pizza. So the pizza was, of course, before the Romans without tomatoes. Sorry, the Roman time without tomatoes was more focaccia. Not like the focaccia in general, which is thick but more flat. And then with the tomatoes, pizza with tomato became something. It was a, you know, pizza and pasta are relatively cheap. And so it became a privileged food in South of Italy, especially which was poorer after the so-called unification in 1860. And pizza margarita was invented by this pizza place, which is still open and still, as you know, active. When the queen of Italy came to visit Naples and the flag of Italy was green, white, and red. And so what he did is he did the pizza with the green is the basil, white is the mozzarella, and red is tomato. And the queen was named Margarita. It was Queen Margarita. So he says, “Queen, I made a pizza for you. We’re gonna call it Pizza Margarita.” Everybody loved it also because they were using tomatoes from the Vesuvius Mountain and mozzarella di bufala, which is… – Oh yeah, it’s very different. – So the ingredients were particularly good. They didn’t have them in Turin, where they were sadly coming from. And so the queen loved it and it became a thing. Yeah, there’s different ways of making pizza, of course, many different ways. And throughout Italy, you will find very different ways. In Rome, it’s harder. In Tuscany, it’s thin. For me, the pizza is the Neapolitan pizza, which is soft and thin in the middle with a thick crust. You need to use a different type of flour. You need to cook it very quickly, 60 seconds maximum. You have to be careful not to let it burn. It’s an art. There’s only a few places, for example, in Boston, where they make it well. – Giovanni, I’m anxious now about our pizza evening we’re having together and the pizza I promised to prepare. – Well, yeah. And then, you know, the other thing I learned over these years, that food really brings, I think food and medicine bring people together. I became very good friends with a Lebanese couple, Armenian Lebanese couple here in Boston. He’s an amazing pizza maker. I would have never thought. And so we have fun making pizza together. In fact, we took a trip to Italy and we went to Pepe & Grani, which has been voted for years as the best pizza place in the world. We spent a week in the Naples area and we booked three nights at this pizza place to have pizza three times. – I have to go now there. – Yes, you should. You should. – The fourth word, and last one, is spread love and organizations. – Spread love and organizations. – And organizations. – Oh, and organization. Well, we go back to the people component. Look, we spent, I always tell people, never hire somebody that you wouldn’t like to have dinner with. We spend 80% of our time at work. You have to have a nice and good reminder. I interviewed at so many places, a couple of times when I was looking for a move. When I found organizations where you could feel that they could stab you in the back anytime, that people were competing against each other, not with each other, I just stopped talking with them. I don’t wanna be in that environment. When I was in the hospital in Milan, in those particular years, the culture was that if I didn’t know that a paper came out, people would actually highlight, oh, you don’t know that you’re deaf. Oh, you don’t know that paper. Oh, oh, you don’t know this thing. And they would never tell you where to find the paper so that you could read it because they were competing against each other. I don’t like that. I’d rather have a place where we collaborate and grow together, where if my team members do well, that actually speaks well of me. I don’t have to try to control my team members so that I always look better than them. No, to lead is not to always show that you’re the best one in the room. You’re the one who can bring people together and get the best out of everyone. You need to help people to give their best. If you try to be the best one and suppress their ideas, you’re not leading, you’re doing things on your own. This is not golf, it’s soccer. – Giovanni, any final word of wisdom for healthcare leaders around the world? – Yeah, well, look, well, wisdom, I don’t know. What wisdom can I bring? Unfortunately, too young to have enough wisdom, but I can tell what I see. What I see is, you know, my colleague, Elias Zerouni, he wrote an interesting book, “Disease Knows No Politics.” I think that’s really important. As I was saying, medicine and food bring people together. We really need to, well, first of all, the society needs to try to understand each other and again, go and understand what does each other want and try to see how hard it is to give up something. But in science, it is particularly true. And the relation between science and medicine and the rest of the world, it is absolutely fundamental. Scientists don’t take leadership trainings and/or communication trainings, right? But today, communication is a lot, more than before. And so I think scientists, I believe they need to learn how to communicate in a modern way so that everyone can understand what they’re saying. Until, I believe until the ’60s, the Christian masses were saved in Latin until they changed the rules. The concept was, and also legal documents in Italy were, some legal documents were in Latin. The concept was people should not understand, people should just follow, but that doesn’t work. That doesn’t work. You need people to understand, to believe. And the same is for science. And if people, and if scientists say things in a way that people can’t understand them, well, people are the ones who vote. People are the ones who choose who decides what to do with our science in the end. And so I think scientists need to go back and become a little bit more humble and be able to spread messages in a way that people can understand so that people can understand what they’re voting for. – Well, thank you so much, Giovanni, for being with me today. We could spend hours. We’ll talk more over a pizza. – We will. – We will over a pizza. Thanks again for being with me today. It was a real pleasure. – Thank you. – Thanks for listening to the show. For more episodes, make sure to subscribe to spreadloveio.com or whatever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time. story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Basil Upton

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji your host, joined today by a dear friend Dr. Basil Upton. Basil is a purpose driven transformational and servant leader dedicated to helping others reach their potential. He is entering his 24th year with Eli Lilly and Company where he is an executive business director. His teams have consistently exceeded performance expectations for numerous years. Basil’s work accomplishments include business director of the year, Elite coach, Platinum Performer, and recipient of several Coaching Awards. In the summer of 2024, Basil graduated from Marymount University with a doctoral degree in Educational Leadership and Organizational Innovation. He studied how a supervisor’s leadership style affects the engagement of pharmaceutical sales professionals during periods of varied sales performance.

Basil Upton: This is an honor, Dr. Gehchan. I’ve waited a long time for this. This has been a, I guess the, the, the journey of spread love in organizations is, is finally coming all the way full circle.

This is great. Oh

Naji Gehchan: man.

Basil Upton: Thanks for this

Naji Gehchan: opportunity. Certainly. Full circle, sir. Um, I’m excited for you to be here and, uh. For those who, uh, don’t know, you were behind the idea of taking spread love all the concept that I had into like something bigger and it became a podcast. So I, I owe you that. I’m really excited to have you here.

Basil Upton: I I, I’ll never forget that, uh, that day, uh, you know, I think it was the, uh, middle to end stages of, uh, the pandemic. And like many people during the pandemic, I listened to a, a, a zillion podcasts and was listening to one on innovation and, and following, um, following the talents that you have and, and taking the special gifts that you have and, and doing something with it.

And I got thinking, I’m like. Should have listened to this. I just, I just, I think I had texted you and said, Hey, let’s catch up. And I’m sure you came on and thought, you know, we were gonna talk about something work related and, and we just started brainstorming and, and then this came about. And then to see what you’ve done with it.

I’m pretty proud of you.

Naji Gehchan: Thanks. Yeah. Well, it’s, it’s been, it’s been an incredible, uh, journey now, four years, who would’ve said, yeah, it’s been 162 episodes and four years. It’s, it’s crazy.

Basil Upton: Yeah.

Naji Gehchan: But today is about you, but I’d love first to start with a question you, I’m sure you enjoy and like about you, your personal story. What drove you to healthcare, to pharma and, and now like after several years of experience, you, you’ve done a doctorate in leadership and organizational innovation.

Tell me, tell me a little bit more about you.

Basil Upton: Sure. Yeah. So I’ll, I’ll hit on my, uh, personal story and professional story. Um, but first, uh, I, I have to do a disclaimer at the request of my employer, uh, you know, for fair balance here. So anything that I’m talking about, you know, the contents and views, uh, expressed here are my own.

And do you not represent the views of my employer, Eli Lilly Company. So now we have the legal part out of the way, uh, and, and can jump into this. Um, you know, if I’m looking at, at, at the story, um, an hour to, you know, just kind of sum it up in one sentence, I’d say, you know, I’m just a kid from Maine and I, I’d love to, you know, go and trademark that.

But there’s a, a, a company in Maine that’s actually already done that. It’s, uh, catalyst for change. And first off, and I guess another disclaimer, I’m not involved with this company. I have no financial interest in this company, but it’s, it’s a cool group in, in Maine, and they make, uh, you know, uh, shirts and hats and, and things with, uh, sayings like just a kid from Maine.

And I’m like, that is, that is me. And I, and I think it’s neat how that group. Uh, ties into your podcast as servant leadership because this group, uh, donates, um. Money from every sale to the Maine Children’s Cancer Program and, uh, a suicide prevention program in Maine. So it’s, it’s really cool, uh, how that comes together.

So, yeah, long story short, just a kid from Maine, um, I, I was raised, uh, you know, by my maternal grandparents in down East Main, in fact. My wife and I live in the house that, uh, I grew up in for and for the earliest parts of, of my wife. Um, my, my name, my first name, uh, comes from my grandfather. My maternal grandfather I was mentioning.

He was, uh, he was actually a World War II hero. Um, he served in the European theater in World War ii. And was awarded two bronze stars, uh, for bravery. Uh, he and my grandmother really instilled the values that I have, especially for, for hard work. Um, no excuses, no complaining, uh, and it, and it shaped me to become the person that, uh, that I am.

I, I wish everybody could have a grandmother, like, like I had, who was. It was truly so caring and, and really exemplified to me what unconditional love is. So very blessed, um, that way to have had those two in my life. And as we go through the, the personal story, the professional story, you, you’ll, you’ll hear more about my grandmother, uh, coming into this.

Um, my wife and I have been married for three, four years. Uh, we’ve known each other, uh, all our lives and, and. It’s funny, we talked about the grandparents part, the grandparents that I mentioned, and her grandparents actually built a hunting camp together, uh, back in the sixties. So when I say my wife and I have known each other all our lives, we really have all our lives and grew up about a mile away from, from each other.

Uh, we’re blessed with two wonderful, uh, adult children. Uh. Just, uh, gifted individuals, uh, doing great, uh, with their lives and have two amazing, wonderful, uh, grandchildren, um, as, as well, you know, and in my free time when seriously I’m not geeking out over, uh, trying to uncover the latest trends and, and leadership and, and how I could, you know, build a better mouse trap and being a leader.

Um, I love being outdoors. Love, uh, fishing. Um, any type of freshwater fishing, uh, I’ll be involved in. And, and we still live here, like I said, in in Maine, which is one of the best parts in the world to live if, uh, if you like to do those things. Yeah, yeah,

Naji Gehchan: it certainly is. And so what, what, what drove you, what drove you to pharma?

Like how did you end up in pharma and then. You know, we will certainly delve more into the leadership aspect of it. Mm-hmm. Why, why the healthcare industry?

Basil Upton: Yeah. I, uh, I started off, um, in, in, when I was in college, uh, undergraduate degree in, in psychology. So I wanted to help people, I wanted to be involved in, in that.

Um, you know, as I mentioned, my, my grandmother was a, a driving force in my education. My uncle and my cousin, uh, were already, uh, medical doctors. And so her assumption to me was, guess what? You’re, you’re gonna be a doctor too. And when it came to, uh, blood, for example, or just, you know, what it, what it’s like, and then being involved with, with being a medical doctor, that wasn’t what was best for me.

So I said, well, Graham, I, I’ll be a psychologist instead. Uh, you know, I’ll still be able to be in healthcare and, and help people. And she’s like, okay, yep, that’s, that’s good. So, went on and, uh, got a degree master’s degree in, in counseling and, um, was a, a psychotherapist for, uh, a number of years. Um, and you know, after I finished my, my master’s degree, I decided, well, you know, I’m going to take a little break.

Um, so I told my grandmother, you know, Hey, I’m, I’m gonna pause, you know, this pursuit of becoming a doctor. And she was, she was, let’s just say, upset, um, with me, still loving, that’s what unconditional love is, but upset and, uh, you know, said, okay, but you, you’ve gotta promise me. You, you need to become a doctor one day.

And I said, yes, I promise. And so I, I worked, you know, thinking I was gonna become a, a clinical psychologist and found that, um, it just, I, I wasn’t, it wasn’t where my passion was. I, um, I don’t know. I, I just eventually, uh, came to understand that there were other things that I was more interested in, in healthcare, um, from a, a more of a business standpoint.

And so I was really struggling with my career, figuring out what, what am I going to do? And so my wife said, well, you know, based on, uh, you know, what you do as, um, you know, as a therapist and, and being a halfway decent active listener. You know, why aren’t you go into pharma? Why don’t you go into, uh, uh, pharmaceutical sales?

I’m like, I dunno if that’s for me. And she’s like, yeah, I think you could, you should, you should do that. Give it a try. So I begrudgingly tried, um, decided to come to Lily. Um, and fortunate enough that they took a chance on me, you know, like I said, you know, nearly 24 years ago. And, um. Was able to go in and, and start selling in primary care sales for neuroscience.

So having worked in, in mental health, um, it was a, a good transition in working in, in Lily’s neuroscience portfolio. So at that time, you know, I was able to, to really combine it and put that into, uh, into work. And that’s, that’s the story of really how did I, I get to, uh, pharmaceuticals and, and healthcare at Lilly.

Naji Gehchan: Well, thanks, thanks for sharing, uh, this part of your life. Um, and truly, you know, you wanted to be a doctor. You promised that and you are now. So, and that’s, that’s part of also a piece of you that always inspired me. Uh, I remember when we first started discussing about you, thinking about it, and then you went, you did it, uh, successfully.

So I’m intrigued because it’s leadership and you said like you geek on leadership and it’s a good trends. Um, and you’ve been in different part of the organization, led teams throughout different, uh, places. Is there kind of like a leadership experience or trade or something specific throughout that intrigued you to a level where you’re like, okay, I’m gonna study it.

I’ve gotta do a doctorate of leadership and organizational innovation. Like what, what really triggered that inside you?

Basil Upton: Uh, it’s a, it’s an innate curiosity. Always, always wondering, you know, what could, how could we tweak something? How could we change something to be able to bring out the best in people?

Um, and then how do we, how do we replicate it? And then the more you’re replicating it, how do we take it? And then improve it even more. And so for, for me, the, the leadership aspect of it was being able to dig deeper and, and better understand the, the theories that are out there, the, um, the history, be behind the theories, how they were developed, and then the innovation part, you know, the balance between risk and reward.

Deciding what are you going to, to take a chance on changing? What are the, what would be the impact of the changes that, that you make? Who’s going to benefit? Who will benefit, uh, the most from it, the stakeholder analysis that that goes into it? Um, it was very, there were a lot similarities in that to the, uh, to being a Lean Six Sigma black belt.

Uh, at Lilly. So you’re able to dig into the analysis of what are the, the soft skills that you’re changing. And I know one of your, your, your former guests talks about, um, how there aren’t really soft skills and, and, uh, renamed those and it was an amazing podcast. Uh, but that’s, that kind of sums it up and, and ties it together there.

Yeah.

Naji Gehchan: Yeah. And you know, one of the things, as you were, you were saying about, you know, being Six Sigma soft skills, et cetera. And, um, yeah, we, we talked in one of the episodes about calling them smart skills instead of

mm-hmm.

Naji Gehchan: Of self. Mm-hmm. Um, but, you know, you’re, you’ve, you’re a servant leader. I know it, it’s not just you saying it.

Uh, and really part of what you’ve done. And I would love to go more into, uh, your research actually that you worked through, uh, the past years. Uh, and dissertation. Uh, there, there’s always this piece where. If you are more analytical data driven, six Sigma type of leader than the softest software we don’t care about.

But we, we discussed about this quite a bit where you and I do not believe in that like we believe mm-hmm. In the end. So yeah, tell me a little bit more about your thinking about that and also part of your research, I’m sure touches this too.

Basil Upton: Yeah, absolutely. Uh, so the research I did was. You know, it was entitled, you know, leading for Sustained Success, um, how, uh, a supervisor’s leadership style affects employee engagement in pharmaceutical sales professionals.

And I, and I wanted to look specifically at periods of varied sales performance. So if you look at any type of, of industry, regardless if it’s sales or not, they’re ups and downs and are leaders consistent. The, do their employees want them to be consistent? What are they looking for? So it started as a, as a very big question, and I set up the, the study was, was qualitative.

Um, and, you know, it was a, a phenomenological approach. So, you know, you always want to do research that hopefully someone will come after you and say, Hey, this looks neat. Let’s take it and try to replicate it. Or let’s do it in a different style such as quantitative. So hopefully, you know, someone will hear this and, and do that.

But it’s, it’s, it’s wondering, you know. Can the concept of leadership really start to be seen as, as the science aspect versus the art aspect of it. And as you started digging in, there were, um, three research questions that kind of drove, uh, the study. And the first one was, you know, what type of leadership styles or behaviors are most common?

During each period of varied sales performance, uh, according to, or, or, you know, perceived by pharmaceutical sales professionals. And, and the first thing that really was an aha was when I say, Hey, what’s your leadership style? If you say that to somebody, a lot of times you’re gonna hear about what are the behaviors they have and demonstrate as a leader.

But you don’t always hear, Hey, I’m a servant leader. I’m a transformational leader. Actually, I’m a transactional leader. And so in digging through this, there, there was a a lot of misunderstanding. And during the, the, the interviews I did with the subjects, I found that there was only one whose leader had told them specifically, Hey, I am a transformational leader.

All the others like. Based on, I don’t know what type of leadership style my leader has. They could tell me the behaviors, but they couldn’t tell me a specific style. Now, is that a big deal? Is it, is it monumental? Probably not, but, but to me, I think there needs to be a central foundation that you adopt as a leader.

That is your North star. And it doesn’t mean that you can’t adapt the behaviors you have as a leader to the individual, each individual that works with you. I mean, as a servant leader, you get to know who your, who your people are, what motivates them, what do they love, and you don’t change to, to different styles based on.

You, you don’t have to change your foundation based on that. So that was, um, the first research question and one of the interesting things that, that kind of popped up as, as we were going through it and then looking at how to changes in a, in the supervisor’s leadership style or behaviors, uh, affect pharmaceutical sales professionals engagement.

When the performance varies. The third research question was, um, which leadership style or behaviors provide positive engagement when sales performance does and and doesn’t meet sales quota? Then I actually had a, an unexpected result. So sometimes when, when you’re doing research, um, things just pop out that you, that you didn’t expect.

And I did have a, a interview question, not a research question, but an interview question where I said, Hey, are there any factors beyond your supervisor’s leadership style or behaviors that affect your engagement? Um, during periods when you are and are not meeting quota? I’ll go back to some of the other findings here, but this just really stood out and a a, a majority of the participants said, yeah, you know, my, my level, the level of teamwork I have with my coworkers and sometimes my direct, uh, partner, uh, really influence my engagement sometimes even more than, than what my supervisor does.

And so when, when you look through the, the study that I did, you know, some of the things you would say, Hey, yeah, uh, okay, that makes sense. I’m not shocked by, by some of what you’re sharing there, but to take it a step deeper and say, all right, well, what are we doing? We already know this. So we we’re learning that and we know that there’s this, uh, incredible, um, effect on engagement based on, you know, the relationship you have with your coworkers, the collaboration.

But how, how much do we actually do with that? You know, hey, if, if someone has a problem. Two people, coworkers aren’t working well together. Yeah, we, we have these great plans that we’ll put together, but how much are we taking advantage of the fact that we know this is variable that we can influence? How much time are we training our leaders?

How much time are we spending with coworkers to, to teach them how to really, truly be great teammates? How to great partners. From, from a business standpoint as well as just a relational standpoint. And do we do that consistently over time? Yeah, we could say, yeah, we had a workshop on that when they went through training or we did a, a, a one hour workshop at a meeting.

But truly is, is that enough? Is that really what’s going to take a advantage, give us an advantage for our people and make them more engaged? I think we could do better. I think we could all do a lot better there.

Naji Gehchan: Yeah, I, and you, I, I love this one. Uh, uh, because it’s basically also taking it as a leader once you develop those skills to ensure that you create an environment where people know how to collaborate and love collaborating and enjoys being with one another.

Right? Like, it, it’s also as a like, for you as a teammate and for you as a leader to create those environments, right? Because it’s. A lot in leadership. I’m not, I’m not sure if you’ve seen that also in your research. I’d be intrigued, but you know, I, I believe a lot in the ecosystem you build and as a leader around you, right?

For, for your people to thrive and how you build this culture and this environment for everyone to be at their best. So what was it, did you touch on some of those aspects or have you seen this in the research, especially on this engagement part? In the ups and downs.

Basil Upton: Yeah, so I saw, we looked, I looked more into that aspect of it in the relationship between the supervisor, uh, and the, uh, sales representative.

And you know, as I said with the first research question. The, the sales professionals weren’t really sure what the leader’s style was. They could describe the behaviors, but what their actual style was and then what drove them, what was, you know, the foundation of it, you know, they weren’t sure. Um, believe it or not, when the sales fluctuated, so do the behaviors.

And some the surprise. Yeah, total surprise. And sometimes it worked out well. Sometimes the changes, uh, produced worse engagement. So the, you know, factors that were really driving, you know, the, the positive results, the positive engagements related around active listening, uh, empathy. So EQ was a, a definite part.

And then, um, being able to, uh, roll up your shirt sleeves and get in there with your people and work together to make the change. It’s, it reminded me of the, the old. Leadership saying that you hear where leaders tell their people, don’t come to me with problems, come to me with solutions. Those were the, the type of behaviors that led to negative engagement.

But the leaders that said, come to me with your problems. Let’s sit down together and try to find out a solution that led to positive engagement. Um, I, I think that the recognition that was there. Uh, is is extremely important to, to drive the engagement, recognition of those that are overcoming the barriers that are dealing with circumstances that are outside of their control.

Environments change, uh, and the, you know, when the environment changes, it doesn’t mean you as a professional. Are not working as hard, or your skills aren’t as sharp or you’re not as, uh, committed. Um, most of those times people are, are working even harder to try and, uh, overcome that. So that recognition, the acknowledgement, strong eq, uh, especially active listening and uh, empathy really were some of the things that, uh, that, that, that, you know, drove the level of engagement that the sales professionals were feeling.

Naji Gehchan: So based on what you, after your research, your journey, your amazing experience across, um, different, different jobs and even the psychology piece. I, I, that’s, I always learn from, uh, something new about you when I meet with you, man. Uh, but really across all of those, is there an advice. You would give your younger self as you started being like first time manager, first time leading a team?

Basil Upton: Oh yeah. We could, we could, uh, a whole lot and I would say, uh, base will sit down. We have a lot to talk about. Uh, you know, when I was first trained in leadership, um. And, and when I first became a, a supervisor, uh, at Lilly, you know, I was, you know, cautioned to, to not, um, I would say get too close to people.

So it was the true traditional transactional style of leadership. And now where am I at the, in my opinion, the opposite end of that spectrum as a servant leader. So I would say, uh, here’s why. Servant leadership is the, the, uh, way to, to, uh, pursue, um, your style. This is the approach that needs to be your, your North star.

Um, that

the, the ability to. Help people outside of their job is a gift to, to understand the, the, the power that, uh, uh, an employer has, the effect that it has on their employees’ lives outside of work is tremendous. The amount of time they spend at work, the, the, the effect it has on, on someone’s, um. Physical and emotional wellbeing.

It’s, it’s a, it’s an incredible responsibility and to be first and foremost, so much aware of that. And I, I take it to, to be similar to what you had to do when you graduated from Medi Medical School and took the Hippocratic Oath. Do you know, first, do you no harm? Uh, that is what I would definitely tell my, tell myself if I had the opportunity to go back and, and start all over again, and then go back to some of the, the people I first manage and apologize for, I’m being a very good leader.

Yeah,

Naji Gehchan: yeah. No, but what, what you said is, uh, you know, I think a lot about it. Um. You said something really powerful that few managers as we start, think of right, the impact that you have on people’s lives. Mm-hmm. You know, not only growing them professionally, but as you, as you very well stated, it’s, it’s beyond that, right?

Like, how do they live in interaction they have with you? Are it tremendous responsibility? Are they depressed? Are they happy? Yeah. Do they feel better? Like at some point, you and I discussed this, but like having this framework in your head, like every, I want every interaction to be, to end up in a way where people feel good about themselves, even if it’s a very tough, crucial conversation about performance.

Basil Upton: Mm-hmm.

Naji Gehchan: Right. So I, I love how you framed it because yeah, we have a huge responsibility as managers. Of people, and we all lived different managers, right? Mm-hmm. And so their impact on ourselves. So I’m fascinated, like how we don’t sometimes think about it, like, yeah, like if I suffered from this, I shouldn’t probably replicate it.

Basil Upton: Yeah. There needs to be a very, uh, serious conversation for anybody when they begin, uh, their journey in leadership. Around the, the impact that they are going to have and how powerful that is. It doesn’t matter where you are, what industry, what level, but when you get into that, you need to, you need to be prepared and accept that responsibility.

You need to have, uh, a great system around you. To keep you grounded. You know, when we look at eq, um, I was, I was attending a, a, a talk the other day about, um, leadership and, and the presenter talked, was, was discussing EQ and said, you know, as a leader you need to be open to feedback. And, and I, I, I completely agree, you need to be open to feedback, but more importantly, you need to seek out.

Feedback, seek out diverse feedback. Don’t go to the people that you know are, are, know you well and will, um, that, that you see things similarly. It’s not going to be helpful for you and it’s not gonna be helpful for, for your people. So you, you absolutely need to get that feedback loop in there. Very strong.

Naji Gehchan: Yes. Yes. It, you’re touching so many different things you’re both passionate about, right? Like taking feedback, it’s humility also of accepting it. Mm-hmm. Acting on it, the diversity in those feedback. Certainly. I, I’m gonna go to a section you know very well where I’m gonna give you a word and I want to reaction to it.

Absolutely. And the first one we’ve been discussing quite a bit, but I always love to start with this. It’s leadership.

Basil Upton: Okay. So for, for me, when you, when I first hear leadership, I, I default to what’s the definition of leadership and then, um, you know, through, through the program, um, one of the authors of.

Our, our most impactful textbooks was, um, Peter North House. And, you know, based on, on what I learned there, I, I see the definition as influencing others through, uh, kindness, empathy, um, candor and accountability to achieve results. You know, I think he would boil it down probably more basic, where it’s, you know, could almost be influencing others to achieve results.

Another great definition of leadership I heard from, uh, an amazing leader I worked for once was, uh, leadership is love with discipline. That sound familiar?

Naji Gehchan: Oh, man.

Basil Upton: Yeah. Love with discipline. But again, it’s interesting if you were to sit down with 10 different people and ask them what’s your definition of leadership?

Just how different the responses, uh, could be. Is that good? Is that bad? I don’t know. Maybe, but, uh, I would say. You know, look at, you know, do you have actually a, a definition of it? You know it when you see it, but can you define it and to have that definition? So I think, I think people forget that with servant leaders, that there still is accountability.

Uh, you call it a discipline, um, that needs to be there. But you want to create an environment where people are, are okay. When that difficult or crucial conversation comes up, they’re okay with it. The best of the best will be looking for it. Um, but for you as a leader, you, you, you have to do a lot of work to make sure your team is ready for that and want to do that.

But yeah, when, when you say, all right, what comes to mind when you say leadership? I, I default to, to the definition and, um, yeah. You, you, your, uh, your definition stuck with me. Oh, thanks. Yeah, a few changes, but discipline, you

Naji Gehchan: should,

Basil Upton: it’s your style. It’s, it’s direct, it’s, it’s simple, but effective. I love it.

Naji Gehchan: Oh, thanks. That means a lot. The second one is performance

Basil Upton: performers or performance?

Naji Gehchan: Uh, performance.

Basil Upton: Performance, I think. Wow, that’s a, I wasn’t anticipating that one. You, you there. So performance. Performance is, is the discipline. It is the accountability. It, it’s your scorecard. Um, I think you people could say, Hey, you know what, I, I’m not a competitive person, but you still want to do the best in, in aspects of your life, I would hope.

So performance, um, you know, it certainly is, is something that it varies. I’d have to say that based on my research, uh, and you need to be prepared for the changes that come with changes in performance. I

Naji Gehchan: What about Nexus?

Basil Upton: Nexus. Love that one. A lot of people aren’t as in tune. So some, in some ways that’s an inside joke.

But, um, yeah, nexus that, uh, catalyst for change that comes in and the, uh, pinnacle of where greatness is. Absolutely. Tell me again, old friend, you got me again?

Naji Gehchan: Oh, yeah, yeah. That was like for the listeners. That was the name of our team.

Basil Upton: Yeah.

Naji Gehchan: Part of, uh, the last one is Spread Love and Organizations.

Basil Upton: Yeah.

I’m gonna, I’m gonna, I think I’m gonna stump you on on, or surprise you on, on this one. And, and for me, spread love in organizations is challenging the status quo. It is, you know, if we look at how do you, how do you know, how do you, how would you measure if there is love in your organization? My bias, employee engagement.

Is it, is it important? No, it’s crucial. It’s critical. It’s a lifeblood. You, you have to have the love there. So if it’s so important, then why the heck? Isn’t it a performance measurement, a KPI for companies? You know, we’re, you know, if, if you’re giving your quarterly earnings report to Wall Street, you’re talking about, you know, uh, what those earnings are, why aren’t you also saying, and guess what?

Here’s our employee engagement. I don’t care. It doesn’t have to be a company that’s on Wall Street. It could be any business, any nonprofit, any organization out there if they were to publish what their employee engagement score is. How would that impact the performance of the company? I have, again, I think it would dramatically increase it.

You know, you’re shopping for any type of of service and you can see what the employee engagement score is, where are you going to go? And I would just, I would love to see, um, finally some. Quantitative data that shows or more, uh, in, in a way that people will finally act on that shows here’s the company’s employee engagement score, here is their performance.

Because we, we talk a lot about, um, the importance of employee engagement, but where do the things like training people, uh, training leaders continually on eq, collaboration skills, uh, all of those things that affect it, where do they appear in the, in the shuffle of what’s getting done at the company and where the company spends their time?

It’s not, I think a lot of times it is just not there because people are saying, well, I know that if I pull this lever, I’m gonna see this change in performance. Whether it’s it, it could be in any situation. But so for me to spread love in organizations right now in this world, it is to challenge the status quo because there’s not enough of it out there.

Am I right or am I wrong?

Naji Gehchan: Man, I’m biased. So, you know, so you know which side I will take. Uh, I love it and I love how you’re framing it. Any final word of wisdom? Uh, basically for healthcare leaders around the world?

Basil Upton: Yeah, I, I would challenge I of the leaders you’ve had, so over. About what a 160 or so leaders that you’ve had on your podcast to honestly go back and seek feedback.

How have you spread love in your organization since you’ve been a guest on NA’s show? How have you taken. Your future leaders, your talent pipeline sat down with them and said, let’s talk about spreading love in an organization. What does that mean? Uh, I, I remember, you know, one of the, the things you, you said to our, our leadership team when we were discussing, uh, diversity, equity, and inclusion.

You said, we need to get to the point where DEI is in our DNA well. Spread love in organizations concept needs to be in the curriculum for future leaders. And if everyone on your, uh, uh, any, every one of your guests, all of us were to go back and say, okay, gimme feedback. How am I doing this? How can I get better doing it?

We’d get wonderful, innovative ideas from incredible people that would drive the engagement. And guess what? Help more customers, help more patients, help the people that that we serve every day, because that’s what we do. We serve others. Those are my final thoughts, my friend.

Naji Gehchan: Well, my friend, thank you so much for being with me today.

I, um, I more than enjoyed it. I miss working with you, but who knows what the future holds.

Basil Upton: You never know. Things keep coming full circle.

Naji Gehchan: Thanks again for being with me today, so it was a great chat.

Basil Upton: Thank you Dr. Naji Gehchan. Appreciate you.

Naji Gehchan: Thanks for listening to the show. For more episodes, make sure to subscribe to spread love io.com or whatever you listen to podcasts.

Let’s inspire a change together and make a positive impact in healthcare. One story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Rania Abou Samra

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

This is a special episode, the second of a series in partnership with Biosciences Lebanese International Network – BioLink.  

I’m Naji your host, joined today by Rania Abou Samra Vice President and Head of Innovation and Research & Development at Nestlé Middle East and North Africa. With over 20 years of experience in Nutrition and R&D, Rania has a strong technical and scientific background that drives innovation forward. Prior to her current role, she assumed the position of Global Head of Product & Technology Development for Nestlé Health Science, following her tenure as Vice President of Research and Development at the Vital Proteins business. Rania’s professional journey includes her previous roles as Global Director of Science and Technology at Nestlé Health Science and Global R&D Lead for Consumer Care. Across various Nestlé research centers, she has lent her expertise to diverse sectors as well as her entrepreneurial spirit, translating scientific and technical insights into breakthrough innovations for both patients and consumers.

She earned both her Bachelor’s and Master’s degrees in Nutrition and Dietetics from the American University of Beirut, followed by a PhD in Obesity and Nutrition from the University of Toronto.

Rania aligns her mission with her passion to advance nutrition and positively impact lives through science. Her unwavering commitment to making the benefits of nutrition accessible to all remains a driving force in her personal and professional pursuits.

Great to have you Rania!

Rania Abou Samra: Thank you. Thank you for hosting me, uh, Naji. I’m really excited to be on your amazing podcast and looking forward to a wonderful discussion.

Naji Gehchan: Uh, great. I’d love first, uh, to hear more about your personal story, what’s behind the story of who you are today?

Rania Abou Samra: Uh, sure. Happy to share. So my story started in, in Lebanon. Um, I am, uh, I’m originally Lebanese like you, uh, and, uh, I, uh, I grew up in a, in a small town in, uh, in a little bit north of Lebanon. And, uh, ever since I was a kid, I was really fascinated by everything, biology and chemistry. And, um, I do recall, um, when I decided early on in my life that I wanted to study nutrition, which is, uh, a passion of mine and still remains a passion of mine.

It was really with this, with this, uh, very, uh, noble, um, goal is to help, you know, uh, fight malnutrition in the world. Um, started off that way. I did my studies in nutrition and at some point I started going into research and um, and I discovered that actually malnutrition is not the only problem that the world is suffering from it’s obesity and diabetes.

So that led me to doing a PhD on appetite regulation, studying gut hormones, uh, and uh, one of them was GLP one. And looking at its effect on, on weight loss, um, in obese, uh, and diabetic, uh, populations. Um, after that I was actually adamant that I’m gonna go into an academic career and then all of a sudden I had the, one of the biggest food companies, food and beverage companies in the world reach out to me and say, would you like to come work for us?

I hesitated a little bit. I remember my supervisor telling me, you know what, you can always come back, go try it out for a couple of years, and you can always come back to academia. Here we are 20 years later, still working at Nestle, uh, and did not regret it, not once. Um, moving around at Nestle. Different roles, always in innovation and r and d, um, and uh, going into different categories.

Loving the reach that Nestle has and the capabilities to be able to innovate. Um, and the fact that they do sponsor a lot of research, um, is, is, is such a, makes it such an exciting company. And, uh, and as well the fact that you, you get to really go around geographically and, you know, um, experience the different cultures around the world because you, because of the, of the breadth of the company.

Naji Gehchan: Thanks Ranya for sharing. I, I, I love this mission. You said you started because you wanted to fight malnutrition in the worked. So if I, if I go there, how do you make sure these days you connect through your mission, your purpose, your leadership, uh, with, with your teams to ensure that actually in your daily work, this is happening?

Rania Abou Samra: Yeah, absolutely. I, I, I’m still a nutritionist at heart, uh, and I, I never forget this, uh, what in everything I do. So whenever, whenever we’re looking at innovation and regardless of any category, um, nutrition is always the first question I ask. Um, and, and it all depends on who we are catering to, but in certain areas of the world, actually, we do make a, we, we are able to make an impact because, um, first of all, um, the, the reach.

That, that a company like Nestle and its products has, um, if you do make a fortification on a product in a certain market where there are major nutritional deficiencies, um, and you know for a fact that your product is consumed by, let’s say, 90% of the population, then you know that you’re creating, you know, an impact through that amazing reach.

Um, you know, I and I, and I think that I consider myself very lucky because I’m able to actually see that impact through the work that I do. But making sure that I put nutrition first and insisting that, you know, uh, ev all the innovations that we do should be nutrition and science-based.

Naji Gehchan: So this connection, I, I love it.

You know, like, and you’ve been able to connect obviously your, your deep science expertise on nutrition and then improving people’s lives. And several times we think about, and, you know, several of the. Uh, the guests I host are really focused on medicines, on, uh, on bio technologies. Uh, you know, when you talk about nutrition, we don’t immediately potentially connect it with, you know, proving labs, which is very wrong actually, because you, you do it and it’s, it’s the startup, all of it.

Yeah. So how do you make sure that actually science and this improvement of your life of are always connected and truly reaches, uh, and transform, uh, lives in meaningful ways?

Rania Abou Samra: I think, I think at the end of the day, um, what we’re doing is, to your point, we’re not, we’re not in the business of doing drugs.

Uh, so we’re not basically trying to heal, uh, or, or trying to recover from a disease. What we focus on is prevention. How are we able to prevent that someone goes into a situation where they need the drugs? Right. Um, and, and by focusing on the deficiencies and, and, you know, deficiencies do not have to always only be with populations that are malnourished, right?

So you have people that are, are obese, overweight, but they do have significant, uh, micronutrient deficiencies because the quality of their diet is very, very poor. Right. So at the end of the day, by knowing your consumer, but also knowing what are the gaps that consumer has, um, then, you know, whatever innovation you do is not only gonna taste good because I know we are in the business of making confectionery and, and, and coffee and, and we’re, we’re pleasurable experiences to consumers.

But also, how can I. Get to that sweet spot where I’m not only making them, you know, enjoy what they’re consuming, but it’s also making them feel better in terms of avoiding them to have to get to a situation where, you know, they get to a deficient, uh, state. Um, so, so it’s always. Tricky because, you know, sometimes in certain categories you’re not gonna be able to fortify, let’s say a bar, a confectionary bar.

But you can always, uh, work on talking about what is the appropriate portion size, you know, how much, what is, what is basically eating, uh, uh, enjoying it, but, but being, being mindful of how much you’re eating so that you’re not creating excessive calories. Um, and also with that, coming with other products.

That would contribute to that, you know, pleasurable experience. So it’s not just about, you know, confectionary, it’s also about are you, are you drinking, um, a, a beverage that has enough protein for you? What other functional ingredients can you put in there to help you make you feel better? Um, and, and, uh, and then you combine the two together, make sure that they taste good so that people can, you know, enjoy it at the same time.

Naji Gehchan: So I, I have to ask you this question. You’ve done a PhD in obesity, uh, and nutrition. It’s the era of, you know, GLP ones and, and all the, all the change around it. And you’re, you talked about, which I truly believe in, is all this preventative. Care and preventive medicine, uh, and starts with kids. Um, and then like there’s all those discussions these days about protein based, uh, diets.

Yeah. Uh, there’s, uh, all, finally we’re talking about the ultra processed food and the mega ultra processed food like I I any like generalistic thoughts about all this era we’re moving towards, especially if you think like, what’s, what’s next for, uh, for us as a humans in this field?

Rania Abou Samra: Yeah, I mean, I think, I think you cannot, um, escape mentioning, you know, the GLP one analogs when you talk about obesity these days.

Right. The two topics come together and, uh, I, I think, I think the, the GLP one analogs are a great solution to help people that have morbidities and comorbidities, right? So, so it is a way to, to, to prolong, you know, the, the, the health span. Um, however. No, no drug comes without side effects. Maybe I’m overgeneralizing, but you know, even when you combine the, what, the current solution, which is a really good solution, the side effects are quite strong, meaning you have, uh, a huge, uh, loss of muscle.

Uh, you tend to also, um, have, uh, uh, side effects on your skin, your hair, your nails. Uh, you have GI side effects. You’re dehydrated because people spend a long time not consuming anything. So, so from that perspective, I think where we as a food company could come in and help is by providing solutions to accompany the people who will be taking the GLP one analogs.

Because the, it, it, it’s hard to escape it. You know, I, I was a dietician for a while. I was seeing patients who were obese and, and I can tell you, they were always asking me about, is there a magic bullet? Is there a pill? Is there something I can just take? Because I really don’t want to be on a diet for a long time.

So, you know, from a behavioral perspective, you know, we’re, we’re just lazy. You know, we don’t want to make an effort and think about everything we eat because food gives us pleasure. So the minute food becomes un, you know, a source of, of anxiety, then it’s an issue. Right? So, so I, I, I do believe that, you know, we need to combine the reality of the fact that these GLP one analogs are gonna be available.

They’re gonna be cheaper and everybody’s gonna take them. But we as nutritionists as a food company, we have actually a responsibility to make sure that we provide products to make sure these people are losing weight, but losing weight safely. And they are not losing on their health while they’re losing the weight.

So, so, so that’s basically it. I mean, I, I know that wasn’t probably the answer you’re expecting ’cause you’re, but, but to be honest. This is, I mean, I, I’m in a, I’m in a region right now where everybody is taking GLP one analog and it’s available, easily accessible to everyone. So we need to make, basically face the three reality and say, how can we play a role there?

Naji Gehchan: Yeah. And it’s, uh, I, I love how you’re framing it, you know, sometimes, and there’s more and more research, uh, as you said about. Um, you know, obesity as itself linked to sometimes like it’s a disease, right? Like, and more and more we’re seeing like how, uh, how we can, um, how we can help, uh, patients and yeah, it feels like there is a before and after.

Yeah. Those drugs and obesity is by itself linked to many risk factor. Like, you know, like it’s a risk factor to many diseases. So, so it’s great to hear like how you’re thinking about how to combine through innovation. And help patients who are on GLP ones. ’cause Yeah, I feel. Yeah, we can’t escape it anymore for, for some parts of the regions.

No. Uh, if I pivot now to, um, your leadership, uh, through, um, through, through all your career, you’ve done it in different roles, in different parts of the world. You’re in Switzerland, you, us now you’re in, uh, leading Middle East and we’re talking, you’re in Dubai. Um, and, and you come from Lebanon. You started with that, like coming from, um, from the north part of, uh, this small country.

Uh, how did all this kind of shape your leadership style and how you lead today?

Rania Abou Samra: Um. I tell you, it’s not easy, you know, it’s not easy for a Lebanese girl, um, to, to, you know, coming from a culture that you’re probably familiar with where, um, and we were talking about that earlier, it’s all very emotional.

You’re, everybody expresses themselves very openly and then you get sometimes into cultures where. You should not express your feelings that it’s frowned upon if you are venting. Um, so you, you tend to start working on yourself to adapt and become, not necessarily not who you are, but, but, but really make sure that you’re mindful of the people around you.

Um, so, so in a way, you know, I try to remain true to who I am. The Lebanese person who can express themselves and, and, and show emotions, not, not. Not shy away from that, but you know, in a way like, like make sure they’re framed. There’s an occasion for it. So, so, you know, I, I speak about specifically emotions because that’s, that’s a very Lebanese thing.

And, um, and I mean, we have, we have a lot of, um, amazing attributes culture wise, where, you know, we’re very good negotiators, we’re extremely resilient. Um, and, and we, we tend, we tend to not give up easily. Right. Um, and I guess it’s because of, of, you know, first of all, living through different wars, uh, being able to manage.

Chaos, chaos, not getting lost easily. Because, because, uh, you know, we, we did not grow up in a place where everything was clearly, uh, signaled, outlined, and you knew how to find your way. So these are like amazing positive attributes that you can bring in on the table, but at the same time, you kind of have to manage the whole expressing yourself too much emotional, et cetera, to, to adapt to certain cultures.

So it’s kind of a balancing act. And at the same time, opening up to learning from these cultures. A lot of things, learning how to be on time. And this is not something that, you know, our culture is, is known for, you know, um, that, that delivering on, on the promise and not overpromising when, and not able, being able to deliver, uh, being very organized.

Um, and so and so, and. Planning for the future. Uh, you know, I, I may, I might be probably over stereotyping here and, and Naji, please correct me if I’m wrong, but you know, you know, coming from a culture where you, you grow up where you don’t know if you’re gonna live, uh, next month or next year because of you’re in a situation in a war or economic situation is so volatile.

People tend to want to live day by day. Um, not plan too much for the distant future. You know, that’s, that’s always a good learning for me. That actually, no, you know, it’s better if you, if you do plan for the future and it, it makes you a better person and less anxious. Um, so, so, you know, lots of great learning going through, but I can tell you, um, you know, it, it, it all depends on how adaptable you are.

Um, you know, uh, you, it doesn’t mean you have to lose your identity completely. As a Lebanese, you can always keep that identity. You can always take it out when, when the time is, is right, when you’re either surrounded with Lebanese or you feel like it’s a safe space, but you know, you have to adapt to other cultures because at the end of the day, what’s the use of leaving Lebanon?

Traveling around the world, if you don’t learn anything and you hold onto the Lebanese culture and say, that’s it, that’s the only way, and that’s who I am. So right now, if you ask me, Rana, are you Lebanese? I tell you, I don’t know if I’m Lebanese anymore. Uh, but I’m not necessarily Swiss or American. So I’m, I would say I’m just this global citizen that is, has pieces of Switzerland, pieces of the US that I learned along the way.

And then, yes, my DNA is Lebanese. I actually ha sh. Even prove that through 23 and me testing.

Naji Gehchan: I love it. I, I obviously relate to so many different things you said, you know, I always, uh, even remember my dad always saying, you know, every day is a bonus, you know, to what, what you’re saying, like, planning for tomorrow.

Uh, and sometimes you go the opposite way. Actually, my reaction was like, oh, I need to be organized. I need to exactly what you said and you learn doing it. But certainly, uh, you know, now I, I feel like not Lebanese planning my weekends and what I want to do over the next three months. So there is some downsides.

I think all my Lebanese friends are, think we are now crazy.

Um, yeah. Another part you talked about trying, in the very beginning of your sentence, you said a little girl from Lebanon. You’ve been also remarkably leading. Um, not only senior executive positions, but also a path in science, which is also, I know, and not only Lebanon, across the world actually, we still see all those, uh, unfortunate, uh, biases, right?

Where women in leadership is still not where it needs to be. Uh, and women in stem, uh, are still not where it needs to be. You know, even if there is some advances, sometimes we feel we go forward. Then 10 steps backwards. So, uh, what is, who aspire? Like how, how, how, what would you say? To girls, women, I’m biased.

I have two daughters, uh, you know, looking into the future and, and those young women, especially in stem, who aspire to lead with both excellence and heart.

Rania Abou Samra: I think, um, I think the bias, unfortunately, NJI starts from kindergarten. You know, I, I, um, I remember, you know, um, my, I have, I have a niece, she’s, uh, two years old, and, um, you know, and she was still not exposed to kindergarten or any, any of that, you know, I remember I, I wanted to get her a gift and my brother tells me, you know, she loves cars.

Soccer balls. I’m like, oh my God, this is amazing. So I get her horse ball and cars and you know, I’m very excited, you know, and then the minute she starts kindergarten, she comes back, she wants to wear pink, she wants to carry a bag, she wants to put nail polish. And my brother’s like, what happened? I mean, I mean the, the nothing against pink and nail polish, but, but I do believe that society has a big role to play on in terms of, um, brainwashing young women at a very young age.

Into what they, they are to become. And, and I’ll, I’ll get to the stem in one minute, but honestly this is my personal observation. When I go to buy a gift for a little girl, there’s the girl section in the toy store, and I’m sure Naji, you’ve lived it with two girls. Yeah. I mean, you have ironing boards, baby vacuum cleaners, strollers with dolls.

It you, you, it’s very hard to find stem toys. Yeah. In the play, in the, in the girls. Section. All right. Yeah, no, but why, so my question is why, you know, who, how is it that we are programming these little girls from like kindergarten with the toys they receive on their birthdays? Even if we as parents say, no, I want them to be gender neutral on this, and I don’t want any brainwashing, and I’m gonna only give them puzzles and stem toys and rockets to build.

But, but you know, the minute they get to school, the minute they’re hanging out, it’s society that is impacting and that’s very sad. You know what I mean? Yeah. I can tell you when I was growing up. In school, we had, um, I was, I was in a, in, there was, in our school, there was the math section, the experimental science section, and the literary section.

Um, that’s, that’s basically a little bit French, uh, school system, the way, what we have in Lebanon. So I, I actually went to the experimental sciences because I, my passion was biology and chemistry since I was a girl and we were three girls out of a class of 25. The math section had zero girls.

Naji Gehchan: Yeah.

Rania Abou Samra: And then all the girls went to literary and you were considered like the, the exception, um, to, to the rule.

You know what I mean? Like Yeah. You know, it’s so, so you have to have so much resilience to be in a class where all the boys are around you and you’re only three girls. It takes a lot. So, so I’m not trying to say, oh my God, I had a lot. I’m saying how hard is it if you are an introverted girl, a shy girl?

To survive and then eventually, because you’re in this experimental path, end up going into STEM in university. Right. Um. It’s very hard. So, so, you know, you, you, you kind of have to do an extra fight and you kind of have to build your seminal, um, to resist to it. And, um, you know, I mean, I ended up being the president of the class and, um, it was a funny ongoing joke that, that Rania is a, is not, is really a boy, not a girl, but when Oh wow.

Naji Gehchan: You know.

Rania Abou Samra: Um, but, but, but, but it’s, it’s just, it takes a lot of grits, likes a lot of gut to survive in these environments. Right. Um, and then when we went to university. It was a little bit more balanced, but in nutrition, um, every, there were all girls and like two boys, so it was, it felt good actually to have the imbalance.

But you know, like nursing, these are two disciplines where girls are more than boys, but it’s still in stem. And I thought that was, that was really nice. Um, after the, afterwards I went to do my dietetic internship at the hospital and I was, uh, a dietician there and I remember, um, crossing path with the, with the surgery fellows, and there were around 10.

Men, uh, studying surgery. And there was one girl and, uh, they, the joke was that she was, uh, actually a boy, not a girl, because how could she survive doing surgery as a fellow, being a girl? Apparently it’s not a girl’s thing. Hmm. But you know, I mean, all this is a little bit of a psychological, uh, brainwash, you know what I mean?

Yeah. And unless you’re extremely stubborn and you really know what you want, if you’re having any self-doubt, you’ll drop off. That line. You know what I mean?

Naji Gehchan: Yeah. Um, and, and unfortunately it’s, it’s still here. Like I’ve experienced it.

Yep.

All of it with my young daughter still now, you know, like even clothing, like I went and had a.

Yeah. Big

argument with this story because like all their closeting is they, they, I couldn’t find anything in the girl’s section with astronauts. And my girl like was, you know, like my daughter was like four years and this is what she wanted. They’re like, no, it’s only four boys. It’s like, what? What? Yeah.

Ands the same, like, she went to a robotics summer camp. She was the only girl, you know, so it’s unfortunately, uh, it’s so true. Yeah. It’s hard even today for, for them and hard for us as parents to ensure that they’re not, you know, the society doesn’t shape them in ways that Exactly. They shouldn’t be shaped.

Rania Abou Samra: Yeah. I mean, I think in keeping to encourage them, but also making sure that they have mentors outside, like role models, you know what I mean? That they could look up and say, you know what? You can do it. You can do it. You know, just, just because you’re the only girl. Yeah.

Naji Gehchan: Yeah. Don’t

Rania Abou Samra: worry about it. You can

Naji Gehchan: do it.

Uh, they, they will, they will listen to this episode right now. Oh my God.

Rania Abou Samra: I’d love to talk to them. I’d love to, for sure. For sure, for sure.

Naji Gehchan: Great. Well, uh, I, I’m gonna now give you a word and I would love your first reaction to it. The first one is leadership.

Rania Abou Samra: So my first reaction, what comes to my mind when I, when you say leadership? Okay. For me, leadership, leadership is about, um, resilience is about, um, a group and team basically empowering your team to get to where you wanna go. Um, leadership is about fairness. It’s about, um, making sure, um, you know, you’re, you’re not putting yourself before others.

Um, leadership is about remaining humble and continuing to learn, um, and always being open to learn and admitting that you’ve made a mistake and, and being okay, um, with it. Um. Yeah. Leadership is showing walking the talk, basically being the example, being the role model and showing things the way they are being transparent.

Naji Gehchan: What about innovation?

Rania Abou Samra: Oh, innovation, agility. Being fast, failing fast. You know, for me, innovation and failing fast go hand in hand because I can tell you, and I’ve had a loss of experiences, there’s no glory in innovation without many, many failures behind it. So if, if you wanna do any innovation, you gotta be very ready to prepare to fail many, many times before getting there.

If you’re lucky, you might get there the first time, but you haven’t learned anything and it I, for me, it’s a lucky strike. Which, which makes the second innovation, you need to do a tough one because you didn’t learn. Um, but honestly, uh, these days, um, if you wanna, if you wanna innovate properly, uh, first you have to know your consumer, your patient, but, but also you have to be very agile.

But you have to be ready to launch things that are at 60% and then iterate and not seek perfection. Um, basically perfection is the enemy of innovation.

Naji Gehchan: What about Biolink?

Rania Abou Samra: Biolink is a breath of fresh air. Najee Biolink for me, came at the right time, you know, um, I was, I was in New Jersey, I was working, um, at Nestle Health Science, and I was starting to have these, I was, uh, you know, as you were discussing existentialist questions about why, what am I doing to pay back?

To my country. I left, I was 24. I continued my studies abroad. I worked abroad. But besides going back on vacation and helping family and friends, what have I done? To advance my country. And, uh, and honestly, the, when, when I remember when Francois reached out to me to join Biolink, it was exactly the right time.

I was ready. I was thinking, how can I pay back? And it was really the right forum for me to be, to be there and be part of this amazing, um, team of individuals that are really all behind one goal, one mission. Um, and, and that is to basically revive Lebanon. Bring back, bring Lum back on, its two feet. Um, and, and, you know, um, I think the healthcare angle is, is the best one because we do have amazing talent in healthcare.

Uh, you’re one of them najee. And, you know, by leveraging the amazing talent that we have, uh. Together. I think we can definitely help Lebanon a lot. Um, and it, and then, you know, it’s, uh, for me it’s, it’s creating this forum for us and, and I’m sure we all have that deep in our hearts. We want to give back.

And we didn’t know how, you know, we didn’t wanna do charity. We really wanted to do something where it’s more sustainable, where you give them the tools and then it grows. Um. No, I’m, I’m, you know, I’m very excited about Biolink. Love it.

Naji Gehchan: I, uh, I am too. And what better angle than healthcare and, and then connecting with incredible leaders like, like you and many others.

The last, uh, the last word is spread love in organizations.

Rania Abou Samra: First of all, I love the title. You know? Um, every time I tell someone, oh, there’s this podcast you have to hear, you have to listen to. It’s called Spread Love. The minute you say Spread Love, of course, afterwards they ask, what’s io? But the minute you say Spread love. There’s an instant smile because, you know, it, it creates a very, um, how do you call reaction, natural reaction to, um, the, this positive vibe.

You know what I mean? So, so I think, I think honestly, you’re, um, first of all, you nailed it with the title spot on, and second of all, I love the fact that you’re also focusing on healthcare with it. You know, um, because to be honest, this is our expertise. This is our domain. This is what we know, and you’re totally leveraging that, um, and your network to spread love.

Right. Um, and, and you know, I don’t need to tell you about how health is, is at the center of everything we do and also as humanity, you know what I mean? We’re not gonna get anywhere without help if we’re not healthy, right? So, um, so it also touches upon that, um. So, um, I, I, I love your podcast. I’m, I’m spreading the word

thanks, right.

Start seeing weird people connecting from Mena. That would be me, you know, telling everybody, you know, that you have to listen to this, you know, podcast. That’s amazing. So, yeah.

Naji Gehchan: Oh, thanks. Right. Any final word of wisdom for, uh, healthcare leaders around the world?

Rania Abou Samra: I think, um. I think to, you know, today, the healthcare, um, you know, when, when you say healthcare, um, a lot pharma comes to mind right away, right?

And, and, uh, you know, maybe it’s too idealistic and, uh, but, but I think at the end of the day, whoever works in healthcare should think about how can we advance humanity versus advance the stocks of the company. You know what I mean? Because, uh, because, because to be honest, there’s no use of us, um, creating solutions that a lot of people can’t afford to, you know, can’t afford, basically.

Period. And they can’t make use of, so why are we, why are we working on it as human beings? You know what I mean? Like, if we can’t have, give the, give them access to it, what’s the point? I get it. We wanna make money, but, but then why work in healthcare? Go go work in banking, go become a lawyer. Nothing against bankers and lawyers, but, but, you know, because, because I mean, I remember I went into nutrition, I went to health because I felt like I want to, you know, do better for the people, for the humans, people who study medicine, they have, you know, the, the oath, right?

People. So when you, the minute you’re in healthcare, you’re in the business of making people’s lives better. So are you really making people’s lives better? Are you making people’s pockets, some people’s pockets better? I know I’m sounding very on an evening on Tuesday sounding to your topic, but, um, basically that’s, that’s just my thought.

Naji Gehchan: Thanks for these thoughts and leaving us with this big question, how can we advance humanity and are we really making lives better? I, I love it As a question to keep in mind, thank you so much Rania again for being with me today. You’re welcome.

Rania Abou Samra: Thank you. I truly enjoyed it. Thanks, Naji.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Charlene Son Rigby

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

This episode is in partnership with the Termeer Foundation, a nonprofit organization working to vibrantly connect and empower the world of healthcare innovators until every patient has a cure.

I am Naji your host, joined today by Charlene Son Rigby, Chief Executive Officer of Global Genes. Charlene has spent her career building organizations at the intersection of data, technology, and life sciences. Charlene led the merger between Global Genes and RARE-X, a health technology nonprofit. She was previously Chief Business Officer at Fabric Genomics and held executive roles at enterprise software and genomics companies, including Oracle and Doubletwist. She started her career in neuroscience research at Roche. When Charlene’s daughter was diagnosed with a rare genetic disease, she co-founded the STXBP1 Foundation. She is committed to finding a cure for her daughter’s disorder. Charlene’s unplanned connection between her personal life and profession has helped push forward the search for a cure for her daughter and kids like her, and given her work deeper meaning. Charlene is a Termeer Scholar. She holds a B.A. in Human Biology from Stanford University and an M.B.A. from the Haas School of Business at U.C. Berkeley.

Charlene Son Rigby: Thanks so much for having me, Naji.

Naji Gehchan: I’d love first to hear more about your personal story and how it links with the really important and impactful work you are doing today.

Charlene Son Rigby: Yeah, so I am a parent of a now 11-year-old who has a rare, rare neurodevelopmental disorder called STX BP one, and my daughter. So my daughter was born in 2013, and. A few months after she was born, she started experiencing delays and we kept hoping that these were just, uh, temporary and she was going to, she was going to norm.

But it became pretty obvious after she was six or seven months old that, you know, she was. Not, um, moving toward kind of typical development. And so we pushed really hard with her pediatrician and we were able to get to, uh, a geneticist at University of California, San Francisco. So we live in San Francisco and they, that started for us a three year journey to try to find out what was going on with my daughter.

So we went through, you know, something like. 27 different tests. We were finally approved for, uh, genomic sequencing, whole exome sequencing. And that gave us an answer that she had a mutation in this gene that was involved in communication between neurons. Um, so it was a really difficult answer, and I think that no, no parent or patient wants to get this type of answer and.

At the same time, it was very, very, an important piece of information because it gave us a door, it gave us a key to, you know, what we could possibly do next for, you know, for my daughter. And so. We were given a couple of scientific papers by the geneticist and a printout of a Facebook group, and after a few months, I finally got the courage to join the Facebook group, and we found five other families and started a foundation for, for St.

Xb P one. Really our goal was to accelerate research and kickstart therapies. We were really quite lucky because even though it was a very, very small disorder, so at the time there were 200 kids who had been diagnosed. There was a lot of basic and translational research that had defined what S Tx BP one did.

In, you know, in the, in the body. And so we were able to really leverage that and start to, you know, build the strategy around how we would accelerate therapies. And so that’s how I got into the rare disease space. Not as a technologist, but as a a, a patient and a pa, a care a care.

Naji Gehchan: Thank you so much, uh, for sharing this, uh, this story.

So from, from that moment to now working, uh, as a CEO at Global Genes, can you tell us a little bit more about your work and where this stands, uh, currently?

Charlene Son Rigby: Yeah. Yeah. I. Got very, very passionate about this idea around how we can accelerate work across rare diseases when we were working on my daughter’s disorder.

So we started. With very little, frankly, in terms of, in terms of the pieces that were needed to, you know, start to develop therapies and accelerate therapies. And so we, um, we started to develop things like data assets, and I was realizing that those are things that. You really could create a much more leverageable infrastructure for, to work across rare diseases.

And, you know, since my background is in data analytics and in the, you know, basically generating insights out of data, it was very natural for me to, to focus on that part of the problem. And so I ended up leaving industry and moving over to a nonprofit called Rare X that was building a cross disorder.

Pro research program to collect data across rare diseases and do it in a way that enabled patients to really be the drivers of that research. So we partner, um, very closely with patient advocacy organizations to do that in, in that data collection. And then a year and a half after I joined that organization, we merged it, as you said in the introduction, we merged.

Rare X with a larger organization called Global Genes. Global Genes has been in the nonprofit space for over 16 years, focused on enabling and empowering rare disease patients and advocates. And so with bringing together those two organizations, we now have, uh, services and offerings around support, education, as well as research.

Naji Gehchan: This is really crucial, especially in this space, obviously, where there’s less resources. So it’s really meaningful for all the patients. I’m also, I also work within the rare disease space. I’d love to get your thoughts about really the biggest challenges for rare diseases currently, as you think from a research standpoint and discovering new medicine like there is this.

Uh, really big technologies that we’re seeing with, uh, genes, genes editing, gene therapy, cell therapy, et cetera, that can help. Um, so there is the hope and there are the challenges being faced with those rare diseases. So I’d love to hear your thoughts as you’ve been heavily involved and, and advocating for patients.

Charlene Son Rigby: Yeah. As you said, this is a really exciting time. Yeah. Uh, as, as hard as the path in rare disease is, it’s also a really promising time. All of these genetic therapies, these therapies that have the potential to be disease modifying, you know, precision therapies, you know, um, even these, these approaches that are much more.

Scalable around repurposed drugs, like identify, identifying, promising, repurposed drugs that, you know, has the, the potential to really change the rare disease landscape. The, the challenge, you know, one, a major challenge that I see is that for a lot of rare diseases, the drive. To develop therapies for that specific rare disease really comes from the patients and there are very few patients, and so we have this kind of, if you will, financial gap where.

There are a number of companies that are making medicines for rare disease and have committed, you know, that they, that they have an emphasis on rare disease or an emphasis for part of their portfolio on rare disease, you know? But right now, because of the. Cost to develop those, uh, medicines, to get them all the way through a, an approval process out onto, you know, um, out onto the market.

There’s a real challenge in terms of making that. Uh, economic argument, especially early in the process where that disorder, you know, might not have a lot of kind of the fundamental research that that needs to happen in order to, um, if you will call it de-risked. So what we see, and frankly, part of the reason why we merged Global Genes and Rare X is because we see this.

I, I’ll say, frankly, really exciting phenomenon of what we’re calling the next generation advocate, and it’s patients who are taking it upon themselves to kickstart research, you know, in their disease. And the, you know, the, I’ll say that, you know, we have done this in my daughter’s disorder in terms of doing this kick-starting, you know, but I’ll also say that.

You know, we, in our founding board, we had a couple of people, myself and another person who had, you know, some, some biology background. You know, when, when I was, of course, when I was studying genetics in, in, um, 19 Forgotten, as my father says, we were still talking about Mendel and Peas. You know, it was very, very different from today.

But you know, a lot of patients are, you know, have, don’t have a biology background. They might not have a business background. They’re coming from whatever background they came from, and yet they have such urgency. Around needing to have, you know, something that is going to truly be impactful for, you know, them, for their, you know, family member for their community.

And it’s that passion and activation that is really kickstarting, you know, therapeutic development in so many of these rare diseases. So. It is a huge challenge because there is a, um, you know, a knowledge gap that you know is that, that advocates are working as hard as possible to try to address, and also to build that ecosystem of partners in terms of, you know, folks who do understand those processes or who have brought drugs to market.

Um, you know, and, and need to be part of that ecosystem to make that, you know, ultimately successful.

Naji Gehchan: I love how you framed it. Next generation advocates, you said. Mm-hmm. So can, can you tell us a little bit more, or if you have an example where, um, where, where you had this impact? And ultimately the, the research gets started, as you said, and the spark of research gets started.

Charlene Son Rigby: Yeah. I’m gonna use a very old example and then I can talk about a newer one because one of the, I, I read breath from Salt a, a year or so ago, and I was just so struck because. It was hard to believe that the Cystic Fibrosis Foundation started, you know, 90 years before they had an approved therapy. And, you know, the, the commitment of that community and those families and, you know, the amount of money that they raised, the, the researchers that they got involved, you know, the.

The, the, I mean, literal creation of an industry around, around cystic fibrosis was just truly impressive. And so I think that that’s a success story, but it’s also a 90 year success story. And so if we fast forward to where we are today with, you know, all of these new therapeutic approaches and are. Much clearer understanding of the genetic underpinnings of many of these diseases because, you know, 80% of rare diseases do have a genetic cause.

So we, we now have the ability to kind of shrink this problem. Right. And. Um, I’ll just give a an another example in the neurodevelopmental disorder space, um, which is the type of disorder that my daughter has. If you look at, um, if you look at Angelman syndrome, so you know that’s, that’s a, a disease that, you know, where advocates have really come in and.

Really driven, um, the development of therapeutic pipelines and even have, you know, started, um, you know, started. Biotech companies to, you know, drive forward the, the, the development of therapies. And, you know, one of those therapies is, you know, currently in clinical trials, you know, for, for an A SO, uh, for an antisense oligonucleotide therapy.

And what I. You know, think about today is, you know, Angelman also has been, you know, the first case reports, I think were in the mid 1960s. And, um, so what I see that is happening now is this timeline is being shrunk. Like we have diseases where the first patient reports were, you know, five years ago and already there are therapies that are, you know, being developed.

You know, there, there are oftentimes in. Academic settings, you know, and now you know, this, the n of one or N of few is, uh, a possibility for is, is a possible, uh, um, kind of modality for or strategy for some of these diseases. But it really is a, a, a changing time.

Naji Gehchan: So as you, as you look forward for the next years, and you talked about how time is getting, uh, luckily shorter.

Mm-hmm. Um, and. You know, the involvement of patients, as you said, they, they, uh, I interviewed a prior, um, patient also with a rare disease who’s a scientist actually, and built his own biotech company exactly as you shared to, um, to figure out a solution, uh, to his disease. Um, and. He advanced through IND and, and so it’s, it’s really, uh, those great stories.

So look, looking forward with all the technologies also being developed, um, in, um, within the genetic world, what are you most excited about?

Charlene Son Rigby: There are so many things. I think that the, the, the, this is probably gonna be a, a, an answer that right now isn’t. In favor from a market standpoint. But I am really excited about platform approaches because the, the issue around economics right now is that we, we, we do, we still have pretty bespoke processes, you know, to get a, a, a therapy from, you know, in discovery all the way through the regulatory process.

And so. Um, I, I think that in order to really unlock the potential around the ultra rare, the very rare and the ultra rare. And the vanishingly rare diseases, we need to have platform approaches that, you know, we can, we can apply. And, and so there’s technology in terms of, you know, the, you know, those approaches.

But then there’s also a piece of it that is regulatory. And I do think that we’re st there’s a recognition and that needs to happen. And you know, also some, you know, efforts including like the BGTC. That is a joint effort, uh, a, a public-private partnership that includes the NIH and the FDA to really build some of those, you know, critical pieces around the regulatory.

Naji Gehchan: So I would love now to give you, um, a word and get your reaction.

Charlene Son Rigby: Okay.

Naji Gehchan: Whatever. First come to mind. So the first one is leadership.

Charlene Son Rigby: I am hesitating because we are, we are actually, I’ll, I’ll give you an answer, but I wanted to insert that. Global Genes has started a leadership, uh, uh, virtual series this year called the Oh, I love

Naji Gehchan: it.

Charlene Son Rigby: Change. Yeah. And we just had our second, our second installation yesterday and. So, and, and the one of the speakers showed a word cloud around, around, you know, feelings around leadership.

And so

the word that I’m going to use is not one that was on the word cloud. Um, uh, I, I’m, I’m gonna say standing tall, not one word, but two words.

Naji Gehchan: I wanna hear more about this and the cloud.

Charlene Son Rigby: So, standing tall, the reason that I, I thought about that is that one of the things that I think is important about leadership is to really know, know what you’re grounded in, and be able to stand tall, take a stance. On what you think is important, the that, that is, I think a core aspect of leadership.

Naji Gehchan: So the second word is rare diseases. Hope.

The third one is re foundation.

Charlene Son Rigby: Uh, impressive and amazing. Are I, I can’t pick between the two.

Naji Gehchan: The last one is spread love and organizations

Charlene Son Rigby: inspire, inspiring.

Naji Gehchan: Any final word of whi uh, wisdom Charlene for leaders around the world.

Charlene Son Rigby: I know that right now times are, there’s a lot of change happening and in the environment, but I think that really focusing on what matters and standing tall in that is really important in these times.

Naji Gehchan: This is such an important charge for all of us, uh, as we move forward in healthcare leaders, whether we’re in drug development, biotech, pharma, nonprofit, patient advocacy. Um, you’re, it’s, it’s really an important point you’re making and I thank you so much for being with me today. And. For the impactful work you’re doing for several patients, uh, around the world.

Um, and I’m as hopeful as you that we, uh, we will advance therapies to, uh, help the help patients like your daughter and, uh, cure those diseases at some point. Thanks again for being with me today, Geraldine.

Charlene Son Rigby: Thank you so much.

Naji Gehchan: Thanks for listening to the show. More episodes in partnership with Termeer Institue can be found on spreadloveio.com.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Sekhar Naik

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji your host, joined today by Sekhar Naik a serial entrepreneur, business leader, aviation enthusiast, long-distance runner, and above all a community builder who believes in the innate power of authentic people-to-people connections. As the founder of MResult, Sekhar has built a foundation of ethical and empathetic commercial growth by serving as a trusted advisor to a select group of respected global brands. Sekhar is also a co-founder and investor in a variety of startups, providing them with both mentoring as well as financial support. In his commitment to pay it forward he is a major donor of YMCA Naik Family Branch in Mystic, Connecticut. Sekhar is committed to academic partnerships that explore leading edge innovation and investments in cutting edge technologies around Gen AI and Biotechnology companies.

Sekhar Naik: Naji. Thank you. So, so thank you so much for having me in your show. I’m, uh, really excited, uh, to talk more.

Naji Gehchan: Yeah, I am too. And I, I actually would love to start with your personal story from your early childhood in India to successfully being now a global, uh, leader. Uh, in, in your field, tell us a little bit more about your inspiring journey.

Sekhar Naik: Ji You know, it’s gonna be long story. We’ll have to kinda do like two podcast sessions, but, you know, I’ll try to be brief Now. One thing I think, you know, when it kinda comes to entrepreneurship and, uh, and, uh, you know, I guess, uh, success, at least for me, I think it’s all being able to kind of communicate storytelling is a very, very.

Powerful, uh, way of kinda communicating. And I think, uh, you know, uh, this is one thing that, uh, probably differentiates us as humans, you know, so, uh, humans forever, kind of even going back to 40, 50,000 years, they were storytellers. So, uh, so maybe what I’ll, uh, uh, my life story again is, is a story, is a, is my story.

Um, so, um, as, as you said, you know, again, I started off, uh, in India, grew up in India. Mostly in, uh, in, in South India. And, uh, you know, around, uh, 20 or 21 year when I was 20 or 21-year-old, I, I moved to, uh, Mumbai, which is obviously one of the biggest cities in India. So, uh, it was a major change for me, kind of coming in from a small town to kind going into this, uh, huge, massive city.

But then, you know, there are so many opportunities in Mumbai and, and you know, you, if you have the, if you actually have the, the, the drive and the hustle. The ability to embarrass yourself, you know, you can really try new things. And so, uh, uh, uh, surprisingly, you know, I got a gig in, uh, as a, as a, uh, the term would be like market breaker.

The, the right in India, the term would be jobber, but it’s really a market maker. And the, at the Bombay Stock Exchange, I was a 21-year-old kid, didn’t really know much, but it was a, it was a very exciting ti time for me, you know, uh, to, uh, to work in, uh, the stock markets, in, in finance. I was there for about, uh, two and a half years or so, and then I, uh, and I, uh, you know, I wanted to kinda move, uh, abroad and, uh, a, a good place to kinda go is, is Dubai, which is, which is, uh, a lot different than the Dubai of today.

We are talking about Dubai of 30 years back. It just started, just started actually like happening in Dubai at that point of time. And so I was in Dubai in, uh, again, in finance for around, uh, uh, for about three years or so. Um, I came to America to do my MBA. I came, uh, here at, uh, to study at University of Del.

I did my MBA in, uh, finance and in it and, uh, moved on into technology, you know, since then.

Naji Gehchan: So, shaker, thanks for sharing this, and I know you as you shared, uh, and we discussed last time. Um, I’d love to to to get more into your upbringing and those moves that you’ve done. You know, you talked about a small city.

In India to moving to, uh, to a larger one, but then Dubai than the us. You really lived across different geographies, uh, and eventually founded end result, uh, that, that became now really a super successful company. How did your early experiences and your really life experiences shape your values? Around ethical and empathetic growth in business?

Sekhar Naik: You know, I think in some ways probably, uh, I would, you know, in some ways I think my dad was a very, uh, principled person. So, uh, you know, I mean, I guess I was. A little bit of more of a wheeler dealer. And so my dad would probably kind of, you know, in some ways kind of look down because he never really kind of liked wheeling dealing.

And, but then, you know, so in India, you know, back then, uh, you know, some of those, uh, businesses, they’re very sort of like cutthroat, you know, when you kinda do business there. I think, uh, to me, I think in, in some ways it sort of like the ethical and, uh, empathic part. Probably gonna happen later in the life, especially once I kinda came to America, probably in some ways because, uh, you know, I think this is again, you know, uh, a great thing about, about America is, and of course you can actually have success in, uh, in any part of the world, in any country where people are, you can actually have success.

But I think, uh, the, what, at least this is from my perception, uh, Naji, you know, so one thing that, uh, differentiates in America, the success is really you, you can kind of do, you can actually kinda succeed within sort of like the ethical and the legal framework. You can really succeed. You don’t need to kind of, you know, so, uh, so in many places you would have to kinda have like really good connections.

There is like, uh, nepotism. There is actually, uh, sort of like corruption and things like that behind the scenes, you know, play to play. What I kind of found was in, in America, you know, certainly, like, I think, uh, a lot of it is around like innovation. A lot of it is around, uh, doing things right, you know, within the framework in some ways.

Um, you know, so, uh, to me, I think in some ways I probably kind of got into that in my, as I kind of got older and as I actually started appreciating what America has to offer, I probably, you know, uh, I probably kinda held on more and more to that and as, as I had like more, uh, success. I felt, you know, I have a, I have a, uh, higher responsibility, you know, to have empathy, you know, so, um, and now again, you know, I mean, I, I I do not judge people.

I’m not judgmental in some ways. Uh, you know, um, uh, humans by nature are selfish. Now, that said, you know, as you have, as you see more and more success, uh, you know, uh, you now have, you’re not like resource constrained. You don’t have as much insecurity. That might actually kind get you to be less selfish in some ways.

The more you have, potentially the less selfish you actually gonna become. You know, of course, you know, there are other stories of people having tremendous amount of wealth and kind of continue on, but that’s kind of a different, uh, I think, you know, obviously people sometimes do selfish things because they wanna be powerful versus they are, you know, they actually think that they don’t have, you know, two different, two different angles.

Right. Yeah. Now, the, the other part also kind of going back to the entrepreneurial, uh, journey, I think in some ways, uh, you know, uh, my dad’s story was a little bit of an inspiration to me. My dad was a, uh, my dad, my father was a very, uh, smart guy. He had, he had, uh, two engineering degrees, both in mechanical engineering and textile engineering.

And he, uh. He, you know, worked on, uh, worked on some major jobs, uh, you know, kind of, sort of like setting up these, uh, textile factories, running them, you know, employing thousands of, uh, people at the, at, uh, you know, and, and these were, some of them were like sort of like, uh, semi government type of, uh, you know, like, uh, you know, organizations.

But then, uh, what happened was, uh, in our textile industry in India, uh, and, and maybe even globally here in the US too, uh, you know, is, uh, went through like major periods of, uh, of recession. And so when that would actually happen, my dad, you know, would still be working, but would not gonna get paid for like years probably.

And so, um, uh, you know, I think that is kind of maybe one influence in my life, uh, when I felt, you know, what, uh, you know, hard work. That’s not necessarily like, you know, translate to success. You also need to really kind of pick and figure out how are you gonna apply that hard work. So, uh, to me that was more around, you know, I want to be responsible for my own destiny rather than actually, uh, someone else, uh, being responsible as in like, if you’re working for, uh, uh, for, for an organization now, you know, you have somebody else who actually, uh, in some ways, you know, your, your, you know, your destiny is like tied to that.

So perhaps that’s probably the reason why. I always wanted to start my own, uh, company, and perhaps that is a reason why I always wanted to start different, uh, businesses, perhaps, you know,

Naji Gehchan: ticker. I, I love you. You said pick where you put your hard work.

Sekhar Naik: Yes.

Naji Gehchan: And, and I, I really love, love this sentence. Can we go more about this?

Because you’re, you’re an entrepreneur by heart. You’ve built several companies. How did you pick where to put your hard work? Was it a kind of. You know, because I talk with a lot of leaders, some of it is planned. Some of it is just, you know, I, I don’t like to call it luck. ’cause I think like you kind of look for your luck in some, in some, I’d love, like how did you pick it?

Sekhar Naik: You know, I mean, it’s a, uh, it’s a great question because, you know, these days when I look at it, I don’t, I don’t even think about it, right? Because it’s actually, I’m kind of going through the process. I’m, I’m, I’m, you know, sort of like experiencing the success. But, you know, your question actually sort of like, uh.

Got me thinking, uh, uh, very briefly, and I remembered probably long time back before all of my success. Uh, you know, maybe I may have had some framework. I think vaguely, I kinda remember having some sort of like a framework on, on, you know, this very exact question, right. Very exact question. So, uh, you know, uh, you know, I guess like the thought process back then, you know, again, I don’t remember it really well because this is probably, you know, like a 25-year-old, uh, story probably.

You know, I probably, uh, I would’ve said like, you know, what do I kinda want in life? So, um, uh, you know, I think like for me back then, kind of, kind of growing up in a constrained environment, you know, I think financial success was kind of pretty big for me back then, you know, back then, uh, just for, for most of the people, right?

I mean, especially if, you know, if you, uh, if you didn’t kind of grow with a lot of money, I think financial success is kind really important, especially like, you know, if you, uh, had, uh. Sort of like, uh, you know, especially like, you know, if you, uh, family financial issues and things like that, right. So it’s, it’s kinda important.

So, uh, that was clearly in my metric. The other thing was that I wanted to sort of like, uh, you know, uh, be in control of my own destiny in some ways. Yeah. So that, that freedom to be able to kinda do stuff. When it comes to passion, you know, I don’t know if I, uh, I, I suppose, uh, you know, I don’t know because I also gonna believe in, uh, of course, you know, we all have like our natural passion, but I also gonna be believe in taking on any subject and sort of like building passion to that.

So, for example, you know, if, if, you know, I’ve never actually kind of gotten into teaching, but you know, if I were to basically, uh, get into teaching, I think I would be a passionate teacher. I mean, which again, one of the, you, you did mention earlier on in your podcast that I’m a pilot, you know, I, I am a commercially related pilot.

This is relatively a, a new, uh, uh, activity that I kinda do. I mean, I don’t, though I’m commercially related, I do not fly people commercially, as in, I don’t, uh, you know, I don’t kinda work as a pilot for an airline. Now that said, you know, again, I do it really well. Built passion to it, you know, as in like, you know, you know, I want kind of really fly well, I want to kind of learn.

So I’ve always kinda had that mindset. But kind going back to, uh, you know, the, the, the, the drivers, you know, for me, I think back then, originally it was more around, Hey, you know, whatever I’m gonna do, will it actually kinda make sure I, I have a good living, you know, kinda given, given, you know. Uh, uh, given basically some of the ins, uh, financial insecurities that I actually had early on in my, in my life, that is kinda very important.

It was also, uh, important that, uh, that I was able to chose what I want to do. And so maybe that probably might be the reason why I decided to kind of strike on, uh, the entrepreneurial path. Now, uh, come to think of it, you know, I have taken risks there, not just the risks. Not just a financial risk, you know, I mean, again, I’m a, I, I came in here as an immigrant into this country.

Um, you know, so I was working, uh, for a large, large, very large, uh, you know, pharmaceutical company as a, as a consultant, uh, slash contractor. Uh, they really liked me. They offered me, this is early on, they offered me a full-time job at, you know, at a, at a man, at a, you know, this is a, at a director level position, good pay, but the best of all.

Know, my, my green card would’ve been a, a very easy process. And, uh, you know, though it was very tempting. I, uh, made a call and I thanked them for that offer and I said, look, I want to really kind of, you know, set up my own company. I know I did not have a green card at the time, but you know, that is my initial dream.

So I did not, uh, take on, uh, you know, the path of, uh, working, uh, you know, as a director for this very large, uh, you know, pharmaceutical company. So, I mean, I did take. I suppose in some ways, you know, I mean, I, I didn’t look at it that way, but I think I actually, uh, made a choice, you know, made a choice based on, you know, what I thought I wanted and, uh, I’m glad it actually worked out.

Naji Gehchan: So, you know, taking risks, the drivers that, that got you there. I wanna now go into this company you built from. Uh, one person you

Sekhar Naik: Yeah.

Naji Gehchan: Starting with pharma? Yes. Uh, to now a thousand people, uh, company. So tell us a little bit what OL does and how you do it differently. And I would love to understand more because I know.

You are, you’re really passionate about this people to people connection. So I’d love to hear from you, how do you keep that now in a company of a thousand people with your people, do you have rituals, practices to make sure that the people to people connection remains?

Sekhar Naik: So, you know, at the core end result is a, is a, is a technology consulting company.

You know, so, uh, you know, I, I, so now that said. There, there are many technology consulting companies like, uh, you know, like Accenture, Deloitte, IBM, uh, you name it, cognizant. These are all very big companies. Uh, you know what, uh, uh, I guess in some ways what, uh, distinguishes end result is, you know, we are a large company, thousand plus people we work with.

Uh, we work on complex projects just like all these other large companies. Now that said, we are a very agile company and because of our size we are able to be agile. We are also very passionate. In some ways the company’s an extension of my personality, so you know, whatever we do, we do really, really well.

So that’s kind of probably why now EM result doesn’t have any salespeople at all. That’s probably the reason why EM result grew from a one person company to a thousand people company without any salespeople. It’s purely word of mouth. And, uh, in terms of. The actual work. We really do. We do a lot of work.

We started off, uh, you know, doing work around like data, you know, building, uh, data marts, you know, building reporting systems, building dashboards, and, uh, eventually kinda moved into, uh, analytics and then, uh, you know, as. The whole landscape progressed. I mean, if you remember Naji, you know, so, uh, you know, there was this whole move into cloud.

You know, we kind of became pretty good at, at the cloud deployment and cloud projects. And then, you know, you remember the time when it all became big data, you know, there was actually like really, really very big. And then digital became a big thing. So we, thankfully for us, we started off with a data company and you know, we were able to kind of morph, you know, sort of like morph into, into this larger and larger offerings because our landscape kind of moved, you know, more into that direction.

So around 2018 or so, uh, we had opportunities to kind of start working on AI ml. And so since then we have, we have built some very good expertise in the AI ml space. So, but at the core, uh, you know, end result really helps our clients, um, solve business problems or become more efficient by using technology, leveraging technology and, uh, leveraging and, and, and getting their operations better.

You know, that the code, that’s kinda what we do. And then I think, uh, going back to, uh, the other question on how do we, you know, continue to kind of really maintain the culture, uh, now, uh, sometimes I think, uh, uh, now this is again probably as an entrepreneur, so things are not necessarily linear. You know, I started m result in 2004 and you know, com company kind of, you know, early on I, I made a couple of, uh, I had a couple of stumbles.

Then at some point, you know, the company maybe, probably I’d say maybe about 20 10, 20 11, it became a stable company. So till about 2017, you know, it was a very stable company. But then, uh, you know, I, I kinda call around 20.

So I started seeing

started.

About how AI ML could profoundly change, you know, how we work, you know, what actually happens. And to me, in my mind, uh, suddenly I was, I was, you know, what will actually happen to all the people who have been working at M Result? They’ve been here for a long time. And then I started looking at the organization.

I realized, you know, in some ways we were like amplified, you know, we were a 14-year-old organization, but we are very atrophied. So, um, now that was, I think in some ways there was actually like a, the, you know, if I had kinda pat myself on the back, um, there is something I think I should pat myself because not only did I recognize that we had a amplified, not only did we recognize that we need to really like change, I had to convince people, convince organization.

I think we were probably close to, uh, I would say maybe about 400 hundred employees at the time, which is still, you know, significant and to kinda convince people basically that. We are a new company. We are a different company. So that’s kinda hard, right? Because people in some ways are like, you know, they’re kind of seeing it all.

They’re like, what do you mean it’s a new company? You know? Right. Cultural change is actually kinda harder in Midway. It’s very hard. So, uh, the best way that what I did was, you know, I mean, I, I, I, I had a genuine story and I was very convinced that this was a story and this is where we need to kinda go.

And I started actually really, you know, doing town halls, kind of meeting people, being, uh, open about it, asking for people for, uh, for their comments, their feedback, making investments. You know, we moved on to like a much larger office because you had to also do like all those, uh, optics as well, you know, because it’s very hard to kind of change in the middle of the process.

So we had this. We, I, you know, we made substantial investments into, into better, nicer office and, uh, better infrastructure and all of that stuff, you know, bringing in the right people. So that started paying off and people, you know, started seeing end result just themselves and say, wow, you know, this is a different company.

You know, then where we were like two years back. And to me, I think that that was a very, um, in some ways, uh, it, it is actually very, very. Very gratifying, you know, because, uh, this is some, I think it’s obviously it’s a cool thing, cool thing to kinda start a company from one person to a larger company. But it is very gratifying to recognize and, uh, say hey, you know, gee, wow, uh, I built a good company, but it is gonna amplify it and I gotta kinda change that.

And being able to change that, you know, that’s kind of hard actually, you know, in some ways. Right. Course. So that is of, uh, I think that is a cool thing. Yeah.

Naji Gehchan: Of course. Well, thanks for sharing this and yeah, congrats for you to be able, you know, not only to pivot, but to pivot, as you said, listening to people, convincing, people taking your time with you on this journey.

And basically here you are, seven years after.

Sekhar Naik: Yes.

Naji Gehchan: This pivot made you grow even more and you’re, you’re now absolutely

Sekhar Naik: helping. Absolutely. And now, you know, now I think in, uh, some ways, you know, again, we are, uh, we are in some ways like a, a fairly, uh, there, I don’t believe there are many companies our size with the over a thousand employees, you know, that’s gonna controlled, basically not controlled by a private equity or a group of partners or a publicly trade company, COE.

We are privately held. So, you know, pretty much I, we don’t have any external investors at all. It’s pretty much a homegrown company and, uh, and, you know, we work on these cutting edge problems with these, uh, very large companies. Uh, it is very gratifying. And so that’s kind of why today, you know, what kinda kept, keeps me going is, you know, I have this, uh, this, this tremendous, uh, sense of gratitude that I kinda made it.

And, you know, I feel now I have. I have, uh, you know, like greater responsibilities. You know, I think, uh, you know, as they say in Spiderman, you know, of course in, in, in any culture, right? You know, uh, not that I have great power, but you know, now you have, when with greater success gonna come, greater responsibility.

I’m gonna come, you know, change the, change the phrase, you know, with great power’s gonna come. Like, you know, I think it says great power comes great responsibilities. You know, I, I would say like, you know, with great, I think the same thing, you know, with great, uh, success. Comes greater responsibility. So I feel now, hey, you know, I, uh, I am, uh, you know, I’m very fortunate to kinda get to this point and, uh, it would be a shame now to kinda continue to kinda keep going and building and doing better.

And, uh, and, and, uh, you know, doing more.

Naji Gehchan: So Shehar, I know you’re also passionate, uh, by doing more on helping others, the community startups, you’ve invested, you mentor quite a bit of people, so I’m, I’m intrigued what traits. Do you look for, uh, in those people beyond, you know, the usual things of qualifications, like the company insights, et cetera, what, what do you look for really in the people and the leader you invest in?

Sekhar Naik: So, uh, yeah, I guess, you know, you mentioned two things, right? You mentioned basically building community and then kind of building companies and, you know, as, as you get, you know, kinda gotten older now. So as you kinda get older, you kinda become. Know, you, you, you, you start actually, uh, using your life experience and start kind of feeling people in some ways, right?

So if I am actually gonna be, uh, uh, doing, you know, helping out the community, you know, we still, you know, uh, I and my wife, we still support a number of nonprofits. So, uh, you know, what I kinda see there would be like, you know, do they have, uh, the, the passion, you know, are they, are they, are they actually in some ways.

People who are like giving, you know, are they actually willing to kinda serve other people? Do they have the passion? Are they like genuine people? Yeah. So that is what I would kinda look at, uh, if I’m gonna be supporting a nonprofit or, you know, building a community or, you know, something like that. Yeah.

On the other hand, um, you know, if I’m actually, uh, investing in a company or if I’m actually kinda co-founding, uh, you know, another company I would kinda look for, you know, like one of the key traits I look for is, uh, is this person open-minded? Open-minded because, you know, even the best business model doesn’t kind, make, doesn’t really like, make mean anything because business models kinda keep changing.

So the, the, so the, so the, the ideal entrepreneur, the most successful entrepreneur is the one who’s able to see things on the wall and being able to kind of pivot. Yeah. So, uh, and then I try to, uh, you know, look, look for that. You know, are they, are they, are they open? You know, how do they understand? How do they see the world?

Do they feel they know a lot because if they feel they know a lot, you know, that’s, to me, like in some ways that’s sort of like a red flag for me at least. Again, you know, I’m not kind of saying it may not kind of work for other people at least kind of, for me that is sort of like a red flag basically because uh, uh, you know, entrepreneur, being an entrepreneur is a very humbling thing.

The smartest entrepreneurs have failed many, many times, you know, so, uh, you gotta kinda have that humidity probably. Yeah.

Naji Gehchan: I love those, uh, shaker. So now I’m gonna move to a part where I’m gonna give you a word and I would love your first reaction to it.

Sekhar Naik: Okay. Yeah.

Naji Gehchan: The first one is leadership.

Sekhar Naik: I mean, uh, my reaction to that is it, to me it’s actually almost in some ways like a, a natural thing.

You know? I don’t know if I really kinda go back. I don’t even actually kind of, uh, read, uh, you know, of course I have an MBA degree. I’ve kind of, you know, studied things a lot. To me when it kinda comes to asset, you know, maybe my reaction would be when we talk about leadership, my instant reaction was people.

That is my instant reaction. If I had to kind of come back and say a reaction. When you said leadership, I said like people. That’s kinda what I had in my head.

Naji Gehchan: Love it. Second one is gen ai. I have to ask this, man, it’s so trendy

Sekhar Naik: when you say gen ai. You know, my uh, first reaction would be possibilities.

That’s the first reaction. Right. Second reaction would be changes.

Naji Gehchan: Oh, so, well, I have to double click on that because I know like you’ve, you’re big and this is kind of the core of what you do. Cutting edge tech, like gen AI and other things. Yes. What are, like, as you, as you look forward, what excites you most?

What are the opportunities you think? ’cause you, you used really two great words, right? Possibilities and changes.

Sekhar Naik: Yes.

Naji Gehchan: Uh, how, how do you see the world in 10 years and what are the possibilities that you see coming? For us

Sekhar Naik: at least, what the way I see the world is. You know, I know this is probably a contrarian view, you know, maybe not many people because I think there is a lot of, uh, you know, people are actually obviously like kind of concerned about all the changes kind of going on.

You know, I kinda see this, uh, slightly differently. I, you know, I’m a contrarian. In some ways. I see humanity getting better and better, or like they’re be becoming smarter and smarter because I think by nature, humans, many humans, not everybody, many humans are competitive. So now gen ai. You know, with, with, you know, more and more gen ai, you know, for humans to stay relevant, they had to be smarter.

They had to kind of, you know, learn more. They had to kinda leverage an AI to, you know, they had to leverage an AI to kinda get better themselves because again, gen AI exists at for only one purpose, which is actually for the purpose of humanity. So I kinda see the upside of it, you know, I mean, at least as an entrepreneur for fellow entrepreneurs or other people who are.

Who are act, who are like hungry. Yeah. Who are hungry. I can, you know, again, there are different people in the world and I see everybody as like a hungry person, but that may not be true now in the world. Right. But when I kinda see, uh, the world as made up of people like me, I think it’s a great thing. I think, uh, you know, uh, through gen ai you can, you can actually kind of become expert in many, many things.

You can become expert, you know, as long as you are, if you have the curiosity and if you have the passion, and if you actually have. You know, unending quest for knowledge. You know, uh, gen AI is, is great.

Naji Gehchan: Hunger, passion, curiosity. And then with gen ai, I think that it’s a great mix, you know, to, to think of and keep on building on.

It’s so, it’s so true, right? Like these days, the amplification that we can have on the knowledge and the ease of access.

Sekhar Naik: Precisely. Precisely. You know, as long as you’re hungry, you know, I mean, if you’re not hungry, then you know, you become a consumer.

Naji Gehchan: Yeah.

Sekhar Naik: Which is not a bad thing. I’m not being judgmental, you know, which is not a bad thing.

Yeah.

Naji Gehchan: Yeah. So the

Sekhar Naik: third word, once you become a, once you become a consumer, then you know, you, you can still, you still have a life, but at the point of time, you know, you’re not like, you’re just kinda consuming stuff, just living. I don’t wanna say living the life, but it becomes more passive at the point of time.

You know, it’s technology, TikTok and all of those things. I mean, or like even, you know, I mean, to an extent, I guess. I suppose. So if you’re a consumer, let’s say for a an hour, for a two, for three, that’s kind of great. But then if you become a perpetual consumer your whole day, you know, you’re sleeping and you’re kind of consuming, right?

And not necessarily like producing, then, uh, you know, I don’t know, can you still be a human? You know?

Naji Gehchan: Yeah. I,

Sekhar Naik: big question. I’m not, I’m not being judgmental Naji. I just wanna make it very clear.

Naji Gehchan: No, no. And it’s, it’s your

Sekhar Naik: Yeah,

Naji Gehchan: of course. And it, it is your point on being active. And I think it’s kind of like one of those traits with your passions where you’re always active to do impact, to do good.

And this is kind of the difference between passive and uh, and active. Right? And it’s, it’s a great framework to think of. Uh, the third one is flying.

Sekhar Naik: Yes.

Naji Gehchan: What’s your reaction to that

Sekhar Naik: flying joy. You know, joy.

Naji Gehchan: Well, I know you fly, you also do boats and like, so it’s a lot of passions. You do marathons too.

Sekhar Naik: True, true, true, true. So, you know, marathons was a huge thing around the health, basically. You know, because I have had, uh, in the past, you know, like, uh, going back to like about, you know, maybe till about like 20 years back.

Or maybe till about 18 years back, I always kind struggled with the, with the, with being overweight, you know, overweight to some ways, even to being obese. So once I kind took up running, I think that started changing. And, uh, I was very, very fortunate that I did like multiple marathons. I’ve done the Boston, sorry, I’ve done the New York Marathon, I’ve done the Philadelphia Marathon.

I did a bunch of other half marathons. Uh, so that really kind of changed my life. It also kinda gave me a lot of energy, right? Because many people are aspirational, um, they want to do stuff, but you know, I’ve kind of seen this, this is kind of firsthand, you know, from me. Um, you know, I guess 20 years back or 25 years back, or I wanted to do stuff and I may not have been able to do it because I didn’t have energy.

So taking care of yourself, you know, uh, running or other activities, uh, basically it’s really kinda gives you energy and that’s kinda really important because you need to kinda have energy, uh, for everything else. For everything else. And so, uh, now that’s, it got into flying around two and a half, three years back.

Uh, you know, I, I would say probably like part of pandemic. I never was passionate about flying, but once I started like really flying, it’s this, this was a phenomenal activity. And I was also, also, you know, what, uh, America offers, you know, there are so many of these like airports, you know, small, big airports and the whole infrastructure, the whole ecosystem.

I really, truly, truly want to, uh, uh, you know, like take advantage of that. So flying is a great activity now, boarding, uh, I live in, uh, mystic, Connecticut, and, uh, beautiful shoreline. And, uh, I got into it about, uh, I guess around 13, 14 years back and, you know, kind, uh, use it as a challenge to kind get better and better and, uh, yeah, you know, it’s, it’s, it’s a, it’s a, it’s really truly a fun activity doing boring.

Naji Gehchan: I love it. Uh, the last one is spread love in organizations.

Sekhar Naik: You know, I think ultimately that’s kind of where we are, right? You know, there has to be, going back to the scarcity, going back to, uh, a change of mindset. I mean, I guess it’s with, with scarcity, you know, you are selfish at some point of time initially, but at some point of time, once you are, once you’re full, once you’re satisfied.

At the point of time, you know, I think the best way to kind of go about, at least to me is to, uh, really make the world a better place. So spread love is really that, you know, it embodies, you know, the concept of what can we kinda give back and what would that be to making the world a better place. I mean, Naji again, you’re a very successful, uh, you know, uh, researcher, pharmaceutical executive, you know, but you know, you’re taking time to kinda do this, you know, and this is basically in some ways your way of.

Making the world a better place.

Naji Gehchan: Oh, thank you. Thank you, Shehar. It means a lot. And I’d love, uh, a final word of wisdom for healthcare leaders like you and myself, uh, around the world.

Sekhar Naik: You know, I think again, ultimately, of course, you know, we exist in a commercial ecosystem. We need to, uh, build successful companies.

But, uh, I think ultimately for humans, you know, it’s all about, uh. Uh, having a, uh, long, uh, and happy life. So he, healthcare really would, uh, is, is really a, a key, key component to that. And, and in some ways, uh, I end all the healthcare leaders are, uh, are in some ways, you know, uh, in some ways in our own little ways, responsible for making all of us, you know, live better and live longer.

Naji Gehchan: Certainly this is why we do what we do and why we’re so passionate about it. And I, I really wanna thank you so much, Sekhar, for taking the time and being with me today. It was great chat. Thank you

Sekhar Naik: Naji. Thank you so much.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Vanessa Almendro Navarro

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji your host, joined today by Vanessa Almendro Navarro, a life sciences executive who builds at the intersection of innovation, AI-enabled R&D, and commercialization. As Vice President and Head of Science & Technology Innovation at Danaher, she leads enterprise innovation and operating-model modernization across a global portfolio. She designed and scaled the Danaher Beacon distributed R&D program with leading academic partners, launched the Danaher Nexus intrapreneurship pipeline, established the Danaher Antibody Capability Center, and created the Danaher Summits to connect operating companies with top domain expertise. Previously, Vanessa co-founded and led the Brain Tumor Investment Fund; served as Head of Strategy & External Innovation at Eisai and Head of Strategy & Operations at Repertoire Immune Medicines; and held scientific and commercial roles at Vertex. Earlier in her career, she was a research fellow at Dana-Farber Cancer Institute/Harvard Medical School. She holds a PhD in Biochemistry & Molecular Biology (University of Barcelona) and an Executive MBA (MIT). She serves on the boards of the Brain Tumor Investment Fund and MIT Sandbox and is a member of the ARM CEO Advisory Council.

01:30
Vanessa Almendro Navarro: Thank you so much. I’m really honored to be here. I’d love to start first with your personal story. What drove you to healthcare where you’ve been having an inspiring career and really a profound impact on people? Sure. Let me share with you the story. And my story actually starts when I was nine years old, very, very young age. And I found my father one day.

01:57
crying in front of my grandparents’ picture. My grandparents died of cancer when my dad was very young, actually. He was 22 or 23 years old. And that image of my father crying to my grandparents’ pictures really um ignited something inside myself. And later in my still young age,

02:26
Vanessa Almendro Navarro: When I started understanding what cancer was, I kind of somehow decided I wanted to do something with my life where I could help others so that they should not be crying in front of their parents’ pictures. So um fast forward, um again, I’m from Spain, from Barcelona. I was the first person in my family going to college. And um during my uh young teenager age,

02:53
The drive was still there. wanted to do to impact. wanted to deliver, you know, something with my professional career that would be helping others. And as I was, you know, going through college, I became a biologist and then I did my PhD as well in molecular biology and cancer. Unfortunately, in my family, there were appearing many more cases of cancer. So, you know, personally,

03:21
It’s been something that has been very close to my heart and my goal as a professional scientist and um now working on the business side of things. As I was evolving my career and I was working in research as well, was um at some point became the head for translational research in uh one of the largest hospitals in Barcelona.

03:49
And that was another point in my life where I felt I had to do something better, more. I had to be faster. Just being in academia, when you are working in a hospital and you are seeing the patients every single day, starts building on you this sense of urgencies. We need to deliver impact. Patients cannot wait. So um I decided to come to the U.S. I went to Dana Farber.

04:18
And I was still, of course, my lapiness pain. I was still in academia, but at Dana-Farber, where I ended up spending six years, every single day where I was going to have lunch in the cafeteria with all my colleagues, I had to pass in front of the pediatric oncology department. That’s in the third floor at Dana-Farber. Again, those first 10 years of my life as a faculty working in academia, I was exposed to patients.

04:46
waiting for solutions. And that was something honestly that at a given point in my life, I could not handle anymore. And I decided to go to industry to continue to learn how do you really go from a good idea to develop a product that can go to the patient’s side and actually deliver that impact I was looking for. um I went to industry. left my…

05:12
career as an investigator, as a faculty, and I had to start over with no industry experience. It was an incredible opportunity. I got to join Vertex Pharmaceuticals, where I was doing research in new target discovery for the oncology portfolio, then transitioning to become a group leader to run a drug development program. But again, um as a scientist, was now working finally in drug development, but I was in the earlier stage of drug development.

05:42
new target discovery and, and, know, lead identification. There was still so much that I didn’t understood about clinical trials. How do you set up a clinical trial to get to the right end point so that you can have the right marketing materials to properly, you know, um, you know, be able to, to distribute those treatments to the right patient populations. How do we think about commercial viability of a drug or a treatment or, know,

06:11
an indication that was something I had honestly, very limited exposure and idea. And again, that, that was this lack of understanding was something that was like, it ignited me another, um, how to put it ignited this, um, desire to keep learning more. were still steps about going from an idea to a product I did not understood.

06:40
So I decided then to transition from research to the commercial department. That was the time as well where I decided to do an MBA at MIT and build that gap into this business acumen and that understanding from the financial perspective that I was lacking at that time. And then from there, honestly, I’ve been then transitioning in my career in roles that have been

07:04
always sitting at the intersection between innovation and commercialization, always trying to find opportunities to go from a good idea to a good product. And at the end, again, just to summarize, it’s always about trying to deliver on patient impact. And it’s not enough to just have a good idea. You need to be able to see it through and develop actually a solution that will impact human health. And that’s really it.

07:32
the, the, inspires me to continue to, to be doing what I do every single day. Well, thank you so much Vanessa for this inspiring story and moving. think several of us have moved to keep on growing our impact and you’re certainly are delivering it. And your, how you’re ending is actually a great segue for my first question, because you’ve built program and we are one of the few who builds program to foster collaboration and

08:00
entrepreneurship and intrapreneurship somehow. So how do you ensure that innovation is really staying, uh not just gutting edge innovation as we hear it, but exactly what you said, deeply connected to patients and societal impact.

08:18
Vanessa Almendro Navarro: uh It’s important, or the way I think about it, it’s always important to understand what is the problem that you are trying to solve. If there is a problem that needs to be solved, there is always the opportunity to develop a solution for that problem. And I said there is always a solution because one of my principles, it’s always um

08:46
don’t tell me no, tell me how. There is always an opportunity to do something and approach the problems. We might fail from a technical perspective, know, science is complicated and very often fails, but there is always an opportunity for us to try and to move forward. So when it comes into innovation, again, it’s important that there is always a problem that needs to be solved and to solve that problem, we might need to really

09:15
go into the wild to develop a novel technology and try to discover something new. But importantly, sometimes there might be simple, elegant solutions that just deliver impact. And I think this is also critically important when we think about developing treatments and just delivering solutions for human health. um Because a challenge that we’ve seen for the past uh five

09:43
to 10 years is that there has been a boom of therapeutic modalities that can be used today to uh virtually treat every single molecule, every single condition, if you think about it. But we lack still the ability to be able to advance these potential solutions to cure as many diseases as we can today, right?

10:11
So it’s important that we don’t as a, you know, as an industry that we continue to invest in trying to match short existing technologies rather than jumping into the next new shiny thing. I do believe that with the right focus, we might be able to really uncover that some existing, maybe less attractive or new technologies can actually deliver a lot of impact. And that’s as well a mindset of

10:41
you know, being pragmatic and always focusing um on solving a problem that, you know, I applied consistently through the innovation programs that I’ve been running.

10:55
So at the intersection of AI, R &D, commercialization, AI is a big topic these days. I would love to get your views since you’re really close to those collaborations and making sure they get, as you’re saying, improved and not only the shiny things, but rather the other technologies to get a patient impact. Really thinking forward for the next five, 10 years, what excites you most about what’s ahead of us? What really excites me, m

11:25
is that uh we are, I think we are very lucky, um honestly, to be living in the time that we are living despite all the existing challenges from a microeconomic and geopolitical situation. We are living in the time where data, artificial intelligence, analytics,

11:49
technology, biotechnology and robotics are really converging into what is going to be an innovation revolution. And what really excites me is how that next future is going to look like. And it’s not going to be a future where we can just continue to do incremental innovation. We have the opportunity today to really rewrite and rethink and redesign how the next, you know,

12:17
hospitals in the future are going to look like at the intersection, as I mentioned before, of robotics, artificial intelligence, data, a different way to manage and monitor health and actually deliver uh treatments for diseases. It’s going to change the way that we think about experimentation. We are going to move towards data first, in silico first, and wet lab as a way for us to validate.

12:45
versus the way that we discover most of the things that we do today that is experimentally right. So I think that for me, what’s exciting is the fact that optionality is going to expand because of the fact of what I just mentioned, this ability to really interrogate biology and, you know, accelerate the adding the cycle so that we can test many more hypotheses faster. So that’s extremely exciting. The cautionary tale though, is that within all this hype, we need to be of course realistic.

13:15
into what are the problems and the solutions that will be truly solved and delivered with the opportunities that we have in front of us and what is hype and a little bit of an emerging maturing aspirational scenario that is going to take a little bit more time to be developed. Is AI automation going to help us to develop many more drugs?

13:42
faster indeed one day, still we need to streamline the way that we get clinical validation of those therapeutic modalities before we can even develop many more of these modalities, right? So I think that there’s gonna be as well this opportunity to ensure that we um tap into what can help us to deliver impact now.

14:10
versus what’s going to require still a much more maturity before we can really deliver impact on, let’s say on AI driven, fully drug development programs, just to speak on an example. Yeah. So I want to double click on that, I fully with you on this acceleration of drug discovery, how we apply AI, and really AI as a tool across all our value chain.

14:36
But that’s something I’d love your thoughts on, which is the clinical side, right? Like discovering all those targets, even being able to drug the undruggable targets now are happening. But then to your questions and what you said on biology, you know, like we are humbled every time we’ve put a molecule or, you know, a technology into humans and how this will work out. So how do you think about this step of first in a human to getting a drug approved?

15:05
through this new AI lens. And did I hear you correctly? Like we will have a lot of new modalities or new targets, but the tough piece will be this bottleneck of making sure that they are clinically relevant and getting to patients’ hands. Yes, exactly. So to be a little bit more concrete, let me pick on a specific example. Let’s think, for example, about how

15:32
we can use, I don’t know, like machine learning algorithms, excuse me, to, um and data analytics in general, just to understand how to optimize sequences, let’s say for gene editing technologies, right? So that’s one modality right now that is extremely important. And we are seeing um more and more what’s the promise that gene editing technologies can deliver. um

16:00
still when we think about gene editing, um the amount of tools, the enzymes, CRISPR-Cas9, base editors, you name it, prime editors, there are many modalities today of editors we can use on DNA, on RNA, that are potentially um able to provide cures to many diseases, but yet we have not

16:27
figure out what’s the opportunity or what are the, how to develop these racks in a way that is, um is going to be safe and for what indications. Some of these assets still, some of these racks are still like clinical validation. That’s the point I’m trying to make. So that’s an example with gene editing technologies. Again, products that we can, there are many AI tools that can be used to understand, know, safety, efficacy, potential.

16:57
you know, toxicity of target effects. So that’s, that’s an area where, we have been using this, type of tools. Another area that it’s important as well, where actually we are seeing an amazing um opportunity is in ligand discovery, right? And everything that alpha fold, bolts models and all these, you know, protein modeling tools have been helping us to understand into how to target proteins.

17:26
and how to design ligands in a much more efficient and faster way and really to expand our ability to understand the chemical space. So that has been an incredible opportunity for us at the front end of the drug discovery. Yet we still, for example, are missing the ability to build that lab in a loop, quick iteration model so that we can validate those virtual hits to continue to advance the drug development programs, right?

17:56
So I think that’s an important consideration at the front end. Then when it comes into your question about the patients, and then even if we are able to sort all these problems and get to the right molecules, something that is more and more important is understanding what is the patient population that is truly going to benefit from your treatment so that we decrease.

18:22
the failure rates that we’ve seen in the past with very promising therapeutic modalities that just failed clinical trials because they were not hitting the right patient population. we know that this has happened in the past in many situations. We know that our understanding of eligible patient populations, our ability to discover um

18:51
and understanding patient pathophysiology and drivers of uh response to these treatments is going to help us to then accelerate, tailor an increased probability of success of these potentially, you know, curative treatments. So when I think about AI to your point before, AI is really an enabler on the full uh cycle of drug discovery from, you know, finding your target, discover your molecule.

19:19
thinking about clinical trial design for patient, you know, again, eligibility, um even at the end, if you will, into commercialization of that particular treatment. But the clinical component, I think it’s gonna be crucial. We are evolving towards, and we are seeing this more and more and more, uh in the possibility for us today to change the way that we think about population health.

19:46
and then trying to figure out how you narrow into treating one patient towards let’s understand first what’s um the right treatment for individual patients and let’s use that patient population, um individualized data to understand larger um patient diseases. So I think that we are changing that paradigm and that’s an opportunity where AI hopefully is gonna help us to do that.

20:15
Certainly, you know, like the field as we’ve been discussing, right, like the field of AI as an enabler. I love this word, how you use that, right? And in different steps of drug development from early to late will be impacting us for better health is really exciting. I want to go, you know, go back to your story, right? Like from early childhood to uh bench science.

20:44
at DNA Farber and now Global Innovation. Is there kind of a guiding principle that really shaped the way you lead and inspire others through your story? um Yes, I would say that um something I have learned from my career that now I try to inspire to my team and my colleagues and my peers, it’s never give up.

21:15
I mean, you know, I was, um as I mentioned before, I went from Spain, from Barcelona, the first person in my family actually going to college, studying biology in a country where at that time there were very limited career opportunities, but I was determined. I wanted to become a biologist. I wanted to go out there. I wanted to do research in oncology. um And then when the opportunity came to come to the U.S.,

21:43
And by the way, I barely speak any English at the time. So I basically came to the U S and had to learn a language. I was not speaking. Um, I never gave up. It’s like, that’s not going to stop me. I’m going to go to the not far. Where this is a great opportunity. Then going to industry, starting over, you know, never give up. will figure it out. That’s, that’s the theme I consistently use with my, with my team. Um, then transitioning careers, starting over again, moving into commercial where I had really limited.

22:13
understanding on marketing and commercial. I did not give up. I continued to push because again, there is always, I like to think about our careers as every moment, the lows and the highs are just a point in time, know, uh a bottom, uh a challenging moment in your professional career. Things sometimes don’t go well.

22:39
It’s just that a moment at some point it’s going to get well. So just keep going. Don’t give up. Keep pushing forward. So why I’m sharing this with you, I’m sharing this with you because as you know, being now working more on business strategy, mostly right, I’m on the other side. I’m actually a scientist by training. I spend many, many years of my career on the bench and I know how frustrating it is when you know that, you know, five to 10 % and that’s for the lucky ones of experiments ever worked.

23:09
um As a bench scientist, you know that you are going to need to try over and over and over again until something works. So that’s point number one. Then you start adding, you know, let me put it this way, probability of success of every single tiny little step from advancing an idea to actually a product. And most of the time you are going to fail. Our jobs, our careers are extremely challenging. We need to build that resilience. It’s always don’t give up, keep going.

23:38
And we will figure it out. And I, that’s the theme I consistently use with, again, with my team, with my colleagues is my personal philosophy. I will figure it out. This is so powerful. We will figure it out. And it’s certainly a story of resilience throughout your life and the journey. And, know, sometimes I think of it the same, very close to what you said, you know, every time we know how to do a job, just…

24:06
are curious enough to go and do something we’ve never done before, but we’ll figure it out. We’ll learn and we grow and we’ll figure it out. I love that. And this is a testament for your great leadership. And talking about this, I’m now going to go to giving you a word and I would love your first reaction to it. And the first one is leadership.

24:27
humble.

24:30
I want to learn more about this because again, you have a phenomenal journey through academia, biotech, pharma, global enterprise, small, large. Has your leadership definition or the different cultures and scales and organization evolved over time? Significantly, yes. um

24:56
When I said humble to leadership is precisely because um as a leader, when I started my career, very, you know, at a very early age, I was like group leader already in the hospital clinic in Barcelona. I was very immature. I was very green. And I thought that leadership was something that candidly it was not. So as I was, you know,

25:26
experiencing my leadership through the different teams. I was running at the hospital with scientists, medical students, then transitioning coming to the US, going to work at Dana Farmer, then transitioning to industry to biotech. I’ve seen, I’ve had to experience different type of teams that I was managing at the time. And that made me to realize that your leadership style cannot be just one. You need to adapt to…

25:56
to the different cultures, the different styles, the different industry settings. And um it took me time to realize that um it’s important that we all adapt as leaders. We are not always right. And it’s really, when I say humble, we need to admit when we are wrong. And it’s a good thing to ask for forgiveness when you make a mistake with your team members.

26:23
And this is something that I’ve learned over the years. And I become really humble to say that it doesn’t really matter where you sit in an organization. No one succeeds because of our individual, let’s say skills. Everything we do is with teams. It doesn’t matter where you sit. doesn’t matter your title, your position. You are another team member and you need to reflect that within your leadership.

26:50
And it’s important to recognize when you have been wrong. And I’ve been wrong many times and I’ve done many mistakes as a manager, but uh I’ve learned how to embrace and admit those mistakes so I can become a better leader in the future. Right. So that’s a little bit, you know, my, my journey, my story. And um unfortunately, I would love to see many more leaders becoming a little bit more humble in, in understanding that.

27:20
We, everyone is always trying to do their best and we need to be able to support. We need to be able to enhance. Of course, we are gonna always be trying to aspire for more and challenge our teams to deliver more, better, faster, because patients are waiting. that sense of urgency is something I’m never going to lose because of the personal story I mentioned before. But it’s really important that leaders recognize when we are wrong.

27:48
and admit that, and if we need to ask for forgiveness, I make a mistake, I’m sorry, we should be doing that. And that’s the way I like to move forward with any team that I manage.

28:01
The second word is impact.

28:05
Patience. The third one is sandbox. Innovation. I’m very traditional, I can see that. And the last one is spread love and organizations.

28:24
Yes, I don’t know why, but philanthropic came to my head. It spread love and organizations, I guess, related to the other big passion of mine that is supporting the National Rintomor Society. Do you want to tell us more about it? Sure, happy to do that. So when I was actually doing my MBA at MIT and I was working at Vertex Pharmaceuticals,

28:49
A very good colleague of mine was the CSO of the National Brain Tumor Society. And he reached out to me and said, listen, Vanessa, the National Brain Tumor Society is thinking about launching potentially a philanthropic investment fund because we want to make sure that we continue to help in advancing ideas from the academic setting to commercialization so that we can deliver more solutions for patients with brain cancer.

29:18
So I got engaged into working with, David Arons is the CEO of the National Brain Tumor Society, Kirk Tanner, who was at CSO at that time and the full organization. And we built this proposal for the board about creating a philanthropic fund to invest in brain cancer enterprises to support seed investments and serious brain cancer companies.

29:47
and make sure that with this investment vehicle, we could connect the work that the National Green Tumor Society is doing today as an advocacy association, supporting with grants, academic institutions, and then build an investment opportunity to take that early research from those academic institutions and be able to support them to create new companies and advance towards commercialization.

30:14
So that was an incredible um experience when I started working with the National Brain Tumor Society in building this, you know, the Brain Tumor Investment Fund. Because brain cancer, as many other cancers, I mean, this is just one of them. There is a huge unmet medical need. And unfortunately, the investment community

30:40
has been traditionally very reluctant to invest too much capital in this disease just because we know it’s challenging, it’s very complicated. But when there is a challenge, we saw an opportunity and the opportunity is that today we understand the molecular subtypes of oh brain cancer. There are technologies today that are allowing us to approach brain cancer very differently. We are seeing in

31:09
incredible progress of CAR-Ts, know, cell therapies providing long lasting uh responses in patients that had no other option. They were destined to really not have any opportunity. And on top of that as well, we are seeing an incredible progress in liquid biopsies and being able today to infer brain biology through, you know, a blood test, which is opening the possibility as well for early diagnosis.

31:39
diagnosis in the future. So with the Brain Tumor Society, what we are trying to do is to continue to inspire the ecosystem. We are a very small organization. We do very, you know, small investments, but it’s all about enhancing the ecosystem, building that momentum and making sure that the rest of the investor community can see what we are doing and they can start also understanding that this is, there is an opportunity today to invest in these enterprises.

32:09
cancer today, brain cancer today, it’s much more attainable than it was 10 years ago with the new technology. So we should continue to invest and help here. Well, thank you for doing that. It’s certainly an area of incredible high on met need and many of us have seen friends or touched by this and it’s great to see those breakthrough advancements and hopefully we will be able to cure one day those cancers. That’s why.

32:38
We do what we do. Any final word of wisdom, Vanessa, for healthcare leaders around the world?

32:48
Um, well, I would say that.

32:55
As healthcare leaders working on innovation, we are very fortunate to be living in the time that we are living today. And I think it’s up to us to really embrace this opportunity and ensure that we rethink and redesign the way that we want to develop treatments and healthcare solutions in the future, considering the tools that we have today.

33:25
It’s up to us. The opportunities are there. The technologies are there. We just need to be able to ensure that we as leaders are focused, that we try to decrease, you know, bureaucracy and administrative barriers. Patients are not waiting. They need solutions, that we are decisive, that we invest with conviction when we know that there is a solution that can

33:53
you know, deliver an impact for a patient. And importantly as well that as society is changing, that we as leaders as well change, the noble generations that are gonna become the leaders of the future, they are different. Society is changing. We as leaders need to change. This humble leadership really understanding that we are just one more piece of the game. We are just one more team player.

34:19
It’s a philosophy on leadership that I think organizations are gonna need more and more and more in the future. Especially um the last thing I want to mention as well as we recognize that we cannot solve for these big problems alone. Everything has to be through collaboration. And again, we are just one more piece in the puzzle. that would be my, you know, um maybe, you know. m

34:44
final note of inspiration for other leaders to think about, you know, what’s all the good and impact that we could deliver if we modernize our way of, you know, um managing teams and running organizations. So that’s it from me. Well, thank you so much, Vanessa. It’s inspiring and really great to us. I always talk about love and discipline. You kind of touch on both between focus and carrying leadership. And I love your framing. Embrace the opportunity of living today.

35:14
because patients cannot wait and really uh great chatting with you and thanks for being with me today. Thank you so much, Nagy. This was fantastic and thank you so much for inviting me. Thanks for listening to the show. For more episodes, make sure to subscribe to spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare one story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Rose Saïa

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji your host, for a special episode today touching health through food. I am excited to be joined by Rose Saia Executive Director of Centre Street Food Pantry. Rose joined Centre Street in 2019 as a part-time Pantry Manager. When the pandemic began, she pivoted the operation to a new program and distribution model to address the exponential increase in food insecurity. She became Executive Director in 2021. Prior to joining Centre Street, she was Pantry Director for Open Table, a Metrowest regional grocery and meals agency. Her experience in nonprofit organizations includes being a member of the board of directors and marketing chair for The Capital Network and WEST (Women Entrepreneurs in Science and Technology) and as a CEO coach for women leading high growth businesses at The Commonwealth Institute. Her professional career is anchored in high technology where she was a leader of technical, product marketing and business development teams for startups and global providers. She was the CEO and co-founder of a network security consulting and product company that was acquired by Juniper Networks. Rose is also a published writer and professional true-life storyteller who has appeared on local stages and on the national television series, “Stories from the Stage.”

01:50
Rose, you’re a storyteller. I love how you tell stories and how much I learn from you and the way you tell these stories. So would you tell us your story and how you came to now lead a food relief agency?

Rose Saïa: Of course. think one of the things that I’ll mention to the audience is that my storytelling skills really were sharpened as a result of becoming a

02:18
competitor in Moth, the Moth competitions. People may know the Moth as the Moth Radio Hour, which is a nationally broadcast show that features uh impromptu stories told by people just like you and I. uh And the way they get those stories is they go from different stages in the country and just you put your name in a bag and you get called and then you stand up in front of people you don’t know and tell these uh really intimate

02:48
sometimes, you know, points of your life. And I was invited by somebody to do a local story on a local stage. And I had never really listened to the moth. And somebody said, well, you know, maybe you should think about that. And so the moth, you know, when you asked me to tell my story, really looks for a very compact kind of story. And, you know, it’s all driven around.

03:15
you and what was transformative for you. So I think in answering your question, one thing I can say that I was able to dive into through the moth was the fact that I grew up in Boston. I grew up in a very gritty neighborhood in Boston, South Boston, known as Southie, um at a time when um it was working class. due to the circumstances in my specific family, I was food insecure from the time I was about five.

03:45
until probably the age of 20. And of course, didn’t really recognize it as that. That’s sort of an insight that came later. But I was in a family where my mom suffered from mental illness. had dissociative disorder, anxiety and depression, and my dad was affiliated with the mafia. So there was a lot of chaos. I was homeless a couple of times.

04:14
I was stalked by the FBI and the mafia as a little kid. But the overarching theme of my childhood was my mother trying to be sure we had food, housing, heat, lights, and how that was a secret, which is an interesting backdrop to the world today. There was a lot of shame. My mother had a lot of pride.

04:43
And there’s a specific story actually on the Moth Radio Hour uh that I told about in fourth grade how a teacher saw that and what that teacher did about it. um that’s a very quick synopsis, I think, but probably one that sets us up for some more questions. Well, thank you. Thank you, Rose, again for sharing this part of your story and delving in it actually.

05:13
As you’re saying, like the second part of the question is for me, how does, how did this kind of shaped your purpose and the way you lead today? I know how passionate you are in a center street food pantry where I had really the privilege to be working closely with you as a board member. How does the story shaped your leadership and how you’re serving today in the pantry?

05:42
I mean, absolutely, it’s a foundation for the work that I do at a very practical level. You know, I have a way, a relatable way to interact with those that we serve, either as understanding the perspective of the young, child, and that might be in that family, but even more important, the perspective of those who are relying on Center Street as part of their safety net for food.

06:11
And that doesn’t come up. Often, you know many people who’ve many of the clients who come to Center Street don’t really know my background, but I think when you. Have had that experience. You have a shorthand that you can conduct with that person. You know a comment, a bit of encouragement, a way to listen that that creates a bond of trust. Quite honestly, so there’s that dimension of it and leadership and. m

06:40
that allows me to also hear very carefully what are these people experiencing? It’s not just my recollection of it, but it allows me to soak in and really understand what’s happening with these people today and what do we as an organization need to consider and do to respond to them. And I think that’s the ultimate goal when you’re in a service.

07:06
organization that you really want to understand those you’re serving and be responsive to them. So I think, you know, an example I can give you of that and how it played out in Center Street is that when the pandemic hit, we had a very small market and people could choose what they wanted. And then after the pandemic within a week, nobody could go inside. And so we pivoted, we were outdoors, we were getting our groceries, but very quickly after that, um

07:34
I created what I called a programmatic model to give out food, which was really looking at the food that people needed for their families so they could go home and make meals. Not here’s 10 things in a bag. Good luck with that. And I know from when I was a kid, there wasn’t a Center Street. My mom went to a state agency and brought home a bag of five very different things and said, how is this food?

08:01
How do I, how do I’m going to feed you with this? You know, a can of shortening, a jar of peanut butter, bag of flour. So the leadership I think I’ve brought is under, is constantly trying to take a pulse on what is going to be the most helpful to these clients. Not just, you know, not just because of my interactions with them and hearing them and hearing about their family sizes, but also taking in the feedback of organizations who also support them like local hospitals, Newton-Wesley hospitals, other agencies.

08:31
So the result of that is that Center Street has various programs that all coalesce, groceries, fresh produce, kids club, personal care items, that give families core elements of what they need that are healthy and nutritious so they can go home, make meals, and have enough food for their families. I think that was another dimension I wanted to address. It is not equitable or dignified.

09:01
to give somebody with seven people in their family a box of pasta, and you give somebody who’s a senior a box of pasta. So, know, allocation wise. So really trying to instill that kind of approach, again, starting with my own experience of what it was like, but also then really being able to build upon that, to listen and craft a programmatic approach that was dignified.

09:29
based upon what the clients need, based upon what we’re hearing in the community that these people need today. Yeah. Yeah. You brought up two words that are obviously very close to your heart and the heart of what is done at the pantry, equity, dignity. And really, I remember, you know, joining and trying to help when all those programs and COVID happened. I…

09:56
you know, before going and I want to go into the food insecurity more specifically, uh but what key learnings you really transformed a pantry and we can go into also the numbers of pre-COVID, post-COVID. But when you think about this time and shifting operations, looking back, is there specific moments of leadership or specific lessons on leadership during crisis and

10:26
And really how you took the community into resilience that you can think of and that we can teach us now. You know, I think, um, I’ll answer that and then explain. I think you need a moment of, we can do this. I can do this when everything says you cannot. Everything says it’s not the same. Um, I certainly know coming out of high technology.

10:56
that high technology has always been a field of constant innovation, constant take a problem and make it, find a way to have a better solution, right? Even when it doesn’t seem like that’s going to be possible. And I was part of a team actually that started delivery of full motion video to people before YouTube, right? I mean, just things that seemed you can’t do that. there’s, there’s that, I came out of that, that you can always do that. So I think when the pandemic hit and

11:26
You know, I remember it vividly. It was a Tuesday when the governor had the shutdown and we were in a service. And, you know, I spoke to our board chair at that point and she said, well, what are we going to do? And I said, we’re going to go outside and we’re going to do this. We can do this. And I think it’s that belief in what doesn’t seem possible is possible. If you think about it, it’s problem solving and it’s faith in those around you. I did not do that alone.

11:57
Right? We lost our whole volunteer team though. So there weren’t a lot of us. So it was really thinking about, who can stand with us at this time? What are the resources we have and how do we best use them? And, you know, there were people from the board and there were people, you know, we thought about how people could come in and pack bags and who were there. And I think that is a nice segue to think about, you know, what is it that makes somebody in my position, you know, leading a food relief agency successful?

12:25
It is the belief in those you do not know that they’re going to bring their best selves and align with you to create something really quite amazing. You know, we are a volunteer run organization. We rely on 60 to 75 people every Tuesday, a stable of 150 people a month. There’s 300 names in our database. You know, one of the great challenges and rewards of my position.

12:55
is leaning heavily on the talents and the commitment of those people. And I think to do this, you have to have a picture of how do you get them all to orchestrate? Somebody who came to Center Street once said it looked like a symphony, right? Everybody knew their part. Everybody was able to interact, right? And I think it’s that approach. I think that’s what makes food relief different than any other social services organization. We are

13:24
I am very dependent and grateful for the people who come in and aware that they are skilled people in their own right. But that day, what they really want to do is pack produce or unload produce or be part of something that is meaningful. I didn’t give you any stats on the food insecurity, but certainly being able to share how are we able to make that happen. How do we make that happen today?

13:54
That’s how we do it. Yeah. know, like, obviously I’ve seen, as you’re saying, the magic of the symphony, right? And people getting together to serve and make an impact. But let’s go on the numbers, as you’re saying, because, you know, even for me, when I discovered Ida Newton, as many would know, when I discovered the pantry, I never even

14:23
imagine that there is food insecurity in my community and the neighborhood we live in. Even though I discussed with my daughter, because as you know, like I brought them a couple of times, they were, they never even would have imagined this. But yet, still in each community, unfortunately, people face this. So I’m bringing it through this lens, because I know, and we discussed it quite a bit, like food insecurity feels like a social issue. It’s not

14:53
in our neighborhoods. But the numbers are here and it exists. And unfortunately, I’ll let you go through those numbers are quite striking and increasing as you keep reminding us, unfortunately, every week. So tell us about this, like from a community lens, how many the explosion number we’ve been seeing over the past few years, but also taking it at a more

15:22
state level, national level, and global perspective that you always keep on reminding us that it’s what we see at the pantry is a reflection of the global state of the world. That is a really great way to segue into this because I shared with you that I always take a look at the Boston Globe every day because and I read the New York Times and those are very difficult things to do because I learned that

15:50
If I read about it at a national level, I will see it at the pantry in 10 to 14 days. And I think that was played out quite strikingly when the war began between Russia and Ukraine. within two weeks, there was a woman standing on the corner and this truly a little boy was hiding behind her coat. And she was new and she had walked there. She had taken the T and when we

16:20
talked to her about the groceries she wanted. She kept insisting, only fresh food, only fresh food. She just stood tall, really clear in her speaking. And then I brought her what we have is our Kids Club Bag Program, which is a bag that has extra breakfast and lunch foods for kids that they like. She took one look inside, and of course the little boy was now coming out from behind the coat and looking in the bag and he was smiling and she gave it back. She said, only fresh food.

16:50
So I went back and I got, we had strawberries, we had bananas, so I got more of that. And that’s when she finally smiled and said, we have been hiding in a subway in Ukraine for almost two weeks and all we had to eat was things out of cans. This is what I want today. So I see that over and over again, whether it be immigrants, whether it be…

17:16
a housing crisis or prices going up, you know, that’s just the reality of what’s happening. I think at a local level, sociologically, we all know that we always think the problem is in another neighborhood. That’s just a common thing. And I regularly hear from people in Newton, I don’t understand. How can there be food insecurity in Newton? And, you know, it is a community that is…

17:43
You know, of course it has a number of people who are not food insecure, but it speaks to the constant state of food insecurity in our country. Senior citizens are chronically food insecure because they are on fixed incomes and housing prices have increased and the contributions for those housing prices, whether it be, um you know, through rent control or heat assistance have been squeezed. uh We don’t have rent control.

18:11
Of course, prices have gone up, and if people can’t own their own homes, that, and taxes go up. Senior citizens, that was the majority of who used to visit Center Street before the pandemic were senior citizens. Now let’s move the pendulum. Now it’s families with children. 65 % of those who visit Center Street are families with children because uh wages have not kept up, fuel prices have increased, housing prices have increased.

18:41
And this isn’t about what it used to be. It’s not just, well, I can’t make my check last for three or four days until my next check comes in. We are now a regular part of the safety net that families use to augment the food they need so their children are not hungry. That’s even with school meals, because there’s just not enough money for food. And a stark statistic I read from the USDA in 2023,

19:11
is that of the people who are getting snapped in this country, 42 million nationally, 1 million in the state of Massachusetts, something like 80 % of them include families with children, and those include senior families with children. So a chronic issue that is now blown up is that this is not news. News, news. We are a country, we are a local community.

19:40
that has people who are chronically struggling to put enough food on the table. And while the numbers are different in Newton, the reported numbers for food insecurity take into account those on fixed incomes, those on disability incomes, those who are reporting to be at the federal poverty level, which let’s put that in perspective, is somewhere between 24 and say $40,000 a year of income.

20:06
I’m gonna pause and let that soak in for those who live in communities like Newton, like how do you get by? So the food insecurity rate in Newton is probably rated between five and 6 % of the population, which by the way is 89,000 people. That’s still a lot of people. Then you go to another community that we serve like Waltham where it’s 10 % out of 65,000. So you can start to see the thousands aggregating here, right? But that’s not taking into account the people who…

20:35
don’t end up in that statistic. Those are people who are earning just above that, 50, $60,000 or two people earning 75 or $80,000, right? Which is not a lot of money anymore for a family of four. It is not taking into account those who are episodically hit by a healthcare issue, their own injury or health issue that has them not work. And I will say that the issues that most affect

21:05
food insecurity outside of the reported statistics are health related emergencies. Absolutely. I cannot tell you how many people have said to me, I’m here today because my mother has cancer. I can’t work as much. My sister’s trying to help. We’ve got five kids between us. We’re trying to help my mom with cancer. Health crisis is probably a key determinant of food insecurity.

21:35
whether for the people experiencing the health crisis or those trying to support them. And that’s where there’s a great intersection between health outcomes, getting health care to people and hunger. Yeah. Yeah. And it’s, you know, as we talked about it, I was, you know, in the beginning saying how through food it’s certainly, and this is what we try to do at our pantry, right? Like trying to bring

22:02
healthy options, as you said, and healthy meals for people. uh But this is another point where it touches food insecurity. The health crisis touching it, and at the end of the day, obviously the food touches your health, and it’s kind of a full circle, unfortunately. And really, you said 42 million food insecure in the US by statistics, without counting a little bit more. That’s just striking.

22:32
number. We’re in the 11 % of the population, basically. One in six. It’s hard for people to wrap their heads around that. Again, in Massachusetts, due to truly what Massachusetts has done, which is to provide two meals a day for children and a number of other things that have tried to keep our citizens healthy and well, it is not enough to personalize those numbers here.

22:59
in eastern massachusetts you know amidst affluent communities and people who are doing extremely well we are surrounded by people who are not doing extremely well and they are those people driving lifts and it done you know working retail jobs at starbucks oh and they’re they’re they’re dentalists hygienist assistants they’re in the hospitals i had somebody horrified and argue with me once when i said look i see people getting out of their cars in scrubs

23:28
to pick up food and that person said, that is impossible. Nobody in the medical community could possibly be coming to a food pantry. said, well, I don’t think they were dressed up for Halloween. I think there’s that and I think the piece people don’t understand is food equals health, not just because we want to provide medically tailored food for those in need. Of course at the pantry, we provide low salt, 30 foods, 35 % of what we distribute is fresh.

23:57
produce. We’re providing a variety of whole grain fresh bread. There are medically tailored kinds of things and initiatives related to food equaling better health. But that’s skipping over the basics, which is that the fact that people are struggling to have enough food on the table is a health crisis. It’s not about just being diabetic or high blood pressure or the things that, you know,

24:26
many organizations are looking at to try and provide better food because we know that if you do not give children the basic foundation of healthy food, they are going to be health compromised. And never mind the opportunities they don’t get, they’re cognitively compromised. So I think this synergy between health and food and what I would love to see

24:52
are more initiatives like the one I see at New York Wellesley Hospital where people are now asked, know, do you have enough food at home? Are you able to get the healthy food you have at home? And the next step, quite honestly, is a partnership between the food relief organizations and those groups. You know, you’re talking to someone who’s leading an incredible community-supported food relief organization that touches six

25:20
communities in greater Boston. do that through the generosity of individuals primarily. We don’t receive any state funds. We don’t receive any city funds. We don’t have any broad partnerships. We’re working out of tiny little rooms and of church. right, but to really transform this, we need partnerships. All of us need ways to get the food to people in places where they are. And they need to start to see, in my opinion, that that’s part of their mission.

25:50
That’s my wish. If I were to look to try and broaden the reach here, hospitals, medical community centers, they prescribe medicine. What if you’re here, you’re talking to somebody who says, I’m really struggling. You want to hand them a list of resources, you want to hand them a bag of food or a $25 gift card from the market. I just think we as a nation, we as local communities, there are a lot of really well-intentioned people.

26:20
there needs to be this kind of transformative moment here uh in those kinds of partnerships and other approaches like free grocery stores for people who qualify. Right. uh So, you know, know I’ve drifted a bit maybe from your original question, but you’re trying to look at where do we go from here? How do we make, how do we help? Right. And really looking at health, you know, more than any other basic human need, you know, my line is we need to provide basic.

26:50
human needs to people. That’s food, that’s housing, that’s healthcare. You give those three things, you have a population of people who can work and thrive, reach their potential, but reach their potential and contribute in a way to the better life for all of us. So I think there’s a real synergy there that I think is

27:18
people are trying to move forward, we’re all sort of in our silos about, and my hope would be that we can make some progress. Yeah. It’s actually a great segue to a question I was thinking of, taking it from here, as you said, what do we do next? How can we help? How can listeners help? And really when you think about the stories that stay with you.

27:47
from the families, the volunteers, the community, what gives you hope about the future of addressing food insecurity in our community and even more largely? I’m so glad you asked because sometimes I swim in a sea of sadness um at times because it is. uh Yet, I don’t feel sad. And the reason I don’t

28:15
feel sad is first and foremost, those who visit us for food are the most resilient, upbeat, capable people I think I’ve ever seen. And they are uh truly an example of how you transform hardship into hope, the way they live their lives, the way they share their gratitude with the volunteers. that’s just extraordinary. It’s a privilege to be able to talk with them and have their trust.

28:45
The other hopeful piece is I am in a situation where I am working alongside people like you and hundreds of others who give their time, give of themselves to make that difference and are concerned for people they don’t know but are willing to put in the work to make that difference. Not everybody can do that, right? Then there are those who donate financially to support our work and we direct

29:14
98 % of the funds we get into programs that deliver food and we transform their money into food at a rate that’s more effective than someone just handing us food. So, you without that financial support, we could not go further. Then if you keep going up the chain, there are people in organizations, whether they be the hospitals, the social service agencies, the state government, who are trying to bring us together, who are trying to put systemic changes in place.

29:44
For the first time ever, there’s a coalition, uh Make Hunger History in Massachusetts. There’s an office for food security, both at the city level and the city of Austin and the state level. It’s hard though, right? Because while we’re doing the work, it’s hard to then pop up and create the framework of changes. And it’s extremely hard when at a very high level, the federal government isn’t collaborating with us on that. In fact, it’s creating…

30:14
circumstances that are sabotaging it. So I think I’m hopeful that the core DNA of our humanity is to want to help those who are around us. all want to know. It’s just, we are, you know, it’s the moving train thing. If we saw someone in front of a moving train, nine out of 10 people will push that person out of the way. We are people, our humanity is to help. That’s so positive.

30:44
We need to find ways to channel that, that create both local and broad change. So I am hopeful because we all, doesn’t matter where you’re from in this country. I just heard people from Elliott County, Kentucky saying, I just want to feed my family. You could go around, you could ask people from any race, any culture, any religion, any part of this country, what is the core tenant of their success and dignity as a human? And they will say,

31:13
I just want to feed my family. And that is what mobilizes us. So I’m optimistic. I’m optimistic that this moment in time will pass, that we will get better at it, that good people will always be drawn to help. And let me be clear here. People in this country are dealing with hunger. It’s not starvation at the level you see in famine. Because people don’t…

31:42
People think hunger and they think starvation. Hunger here means people are skipping meals so their kids eat. They are not getting enough food on the table so that the kid doesn’t walk away hungry or they’re not hungry. Hunger means they’re not getting access to the nutritious food that they need, not just want, but need to be healthy so they’re not dealing with doctor visits, dentist visits. uh

32:12
That’s hunger, and that’s real, and that’s here. So, I’m just profoundly grateful that there are people who support Center Street, who support their local organizations, and those who are in positions of more influence than me, who are at state and government levels to try, and in hospitals, to make broad sweeping changes. So that’s my hope.

32:41
That’s my optimism.

32:44
So Rose, I’ll give you now a word and I would love your first reaction to it. So the first one is leadership. Well, we admire our leaders, don’t we? I I think about leadership being an essential piece of uh an essential quality for change. think that’s what I would say. You need leadership to transform something. You need leadership for change.

33:12
We discussed a lot about this. My second word is hunger.

33:22
Yeah, that immediately touched me as a child, right? And I will say that for me, hunger created a level of resilience. It created… um

33:40
a belief in myself and learning how to live with it all the time and overcome it. I’ll just share very quickly, when I was in high school, I was on a lot of sports teams and I went to uh a private high school in Milton um and the girls would go out afterwards for pizza and I could never join. And I always said it was because I had to get home and I had a long commute, all that was true. I didn’t have a dollar.

34:09
to contribute, right? And I maintained that, you know, and I never thought of myself as lesser than, I just couldn’t do that. And I was going to overcome that. I was still going to go home, do my homework and be one of them. So there’s a certain resilience that comes with hunger. It’s unfortunate and not always the outcome, right? But that’s just my little, little story.

34:39
What about Center Street? You know, it’s a Center Street is a sounds crazy, but it’s a joyous place. um You know, here we are this dealing with this onslaught of need, especially in this day. um And we’ve created this m convivial collaborative community that of people who genuinely enjoy coming in, get right to work. um

35:09
and offer that and more. uh And I’ll share with you that there’s a volunteer who’s with us right now who was a volunteer pre-pandemic. He used to walk around the pantry and help people get their groceries. And he’s not a young man. Many volunteers are retired. are ah very fit, though. I’ve often said, boy, don’t put me next to that person. You’re going to put me to shame. uh

35:37
And he walked up to me and he volunteers regularly and he’s volunteered regularly. He’s great rapport with clients. When he heard about what was happening this week with Snap, he took me aside. He said, I know you can’t tell me exactly what’s going, what we’re going to do differently. I’m sure we’re going to get that message. I just want you to know you want to open another day. I will be there all day. You want to open at night? I will come at night. You can rely. I am here, right? That’s just crazy good. And I just said,

36:06
Thank you. mean, I’m often overwhelmed by the generosity and the good naturedness of everyone. um So yeah, that’s Center Street. uh It’s really a remarkable organization that regularly, by the way, deals with very extreme circumstances, right? We’re weather dependent. know, people are sometimes outside bringing groceries to people at the curb when it’s 20 degrees, when it’s raining. You know, we have tents that we have to pop.

36:35
water off of and it falls down people’s backs and everybody’s laughing, you know, we, we, and, we are all, you know, with, just a little bit of guidance from me in the very early days, interacting with respect and kindness to all who come, you know, the fact that last week we had cotton candy to give out to the children because a volunteer has a cotton candy machine and they came in to do that. It brings a level of, um,

37:06
Again, dignity. You’re not coming to a food pantry. One of the clients even said to me, she told her daughter when they were out of milk, don’t worry, mommy’s going to go and get milk today. She’s going shopping. We’re shopping. And the fact that those parents could bring home a cotton candy cone to their kids, they didn’t go to the food pantry. And then they did. So there’s this sort great feeling here of

37:35
of how do we interact with our clients? And our volunteers exemplify that every single time. One of the tweaks I introduced, by the way, is if people are wondering is never ask somebody, are they here for the food pantry? If somebody asks you for something, never say no reflexively. Always say, how can I help you today? What more can I get you today? And if they ask for something, then say, let me see what I can do about that. Because these are people that are constantly having to

38:05
negotiate things, their healthcare premiums, whatever it is. To be welcomed with, me see what I can do for you, or is there something else you need, or how are you today, or isn’t it great? Just keep it at that level so they feel like this is a safe place. They can ask for something. And the ask is simple. Can I have wheat bread instead of white bread, or do you have any more of that? And to hear, let me see what I can do. Let me go.

38:35
It doesn’t mean you can accommodate everyone or that we’re having special favors. uh People know that. The act of being heard, acknowledged. brings this humanity. No, we don’t do that. And now I think an extension of that, which I’ll share with you, about is we had a situation and we have situations at times when we just have more people than we can serve. We are just truly out of food.

39:05
And so we have this breakfast bag program, which came to me out of clients. ah And we give, if we are out, we always make sure we have eggs, cheese, milk, and fresh sliced bread. We can hand that back to people who we don’t have a full complement of groceries for. It doesn’t count against them coming in to get groceries. And that not only gives them dinner, but breakfast the next morning. Because sometimes there actually is no food at home.

39:34
And it came to me when somebody saw that we had some leftover bagels one night and we didn’t have any more. And she said, do you, can I have those? I said, of course you can have those. She said, well, if you have some eggs, I can make egg sandwiches for my children tonight. So I think, you know, the fact that we go that little extra so that, you know, again, that goes back to something I said very early in the podcast, you know, listening to what people need right now and being aware that there are people who are going home to nothing.

40:04
It just is. So we’ve got that stop cap. And that’s another piece of dignity. Not know we’re out of food, but I don’t have a full complement of groceries, but I do have this. Is that going to be helpful to you? And nine times out of 10 it is. So I’m just grateful we can do that. And that’s because we get donations, right? can, we, you know, we, we do get the eggs from the food bank at no cost. do, you know, but get other things, but we need to buy that bread.

40:34
um But that’s a bet for somebody who isn’t able to go home with any food at all that night. And as you started, it’s a special place, joyous place, I think what you said, from certainly the households who come to volunteers, to the board, you, our staff, and also certainly donors who make

41:03
all of this also possible. So thanks, Rose, how you’ve been leading and bringing those pieces, really like tying up from your story and how you think about this to now serving people with dignity and equity. The last word I always ask my guests is spread love in organizations. What’s your reaction to this?

41:32
such a great way to refocus the purpose of organizations. We all get caught uh in nonprofit, particularly on the mission. We all meet the mission. But coming out of the corporate world, that would just seem like a complete contrary thing to say. And I will tell you that when I had my software company, uh we partnered with nonprofit organizations to help them.

42:02
I think the idea of spreading the love is spreading our humanity. Let’s not forget that as part of what we intellectually are here to do. I think we emotionally package up that feeling of love. Because what is it? It’s love for one another. It’s love for ourselves to be able to step up and acknowledge maybe the parts of all of us. My story is somewhat unique as I’ve learned, but…

42:30
many people have had hardship in their early lives in different ways, whether they come from countries that they dealt with it. And you have to have a certain amount of love for yourself to own that. And when you own it, it allows you to move forward and in a positive way. So I think that’s a fabulous thing because we don’t think about love and we so many hours, you know, and I think, you know, um

43:00
You know, I think when you see people who are very good at what they do, they love it. Yeah. Right. They love it. And so I think back to the leadership thing, leadership probably has a lot of love in it. It does. It certainly does.

43:21
Any final words of wisdom, Rose, for leaders around the world? Don’t give up. It’s hard. Just don’t. You know, I will tell you that I thought I was joining Center Street, I’d only be there a couple of years, and I would retire. I didn’t really think about what that meant.

43:46
And now I realize that for some leaders, there’s a purpose. And it’s okay if that purpose is more of your life than you thought, right? These are times when it would be easy and understandable to just give up. No. People, need you. Every leader in every way, whether it’s a small meals agency to a government position,

44:16
We are small ripples in a big pond and together the large impact will be, it’s going to make a difference. Just visualize it. We’re all throwing that pebble in the pond. And the more of us who do that, the better we will all be. So don’t give up. Well, thank you so much, Rose, for this very inspiring discussion we’ve had and for all you do locally and

44:45
beyond, I should say. Thanks again for joining me today. Thank you very much.

44:53
Thanks for listening to the show. For more episodes, make sure to subscribe to spreadloveio.com or whatever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare one story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Alain Eudaric & Jean Noël Pellegrin

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

00:04
Welcome to Spread Love and Organizations, the healthcare leadership podcast where we explore leadership with purpose. I’m Nagy, your host, and I have the pleasure today to be sitting with two leaders who’ve spent decades navigating one of the world’s most complex industries, my industry, biotech and pharma. Jean-Noël Pellegrain and Alain Eudaric aren’t just strategists or deal makers, they’re connectors of purpose, people, and innovation.

00:32
It is really great to have you both with me today. You’ve earned the reputation of a strategist across borders, advising biopharma leaders on growth, integration and innovation across markets. Before launching idea pathways and shaping decisions from the consulting side, what first drew you into the space? Thanks, Nadjian. Thank you for having me. I’m delighted to be here. So what first drew me in?

00:59
Honestly, I did not set out thinking and end up advising biotech and pharma companies around the world. My background is in engineering and I’ve always been fascinated by how things work, especially when it comes to complex and cutting edge systems. But what really hooked me into the biopharma space was seeing how people, science and business come together in this industry. There was a time in my career where I worked first for global life sciences instrumentation company.

01:28
and then for global pharma services organization. I’ve been part of incredibly smart teams trying to bring real innovation to life. But I also saw how often great ideas struggled, not because of the science, but because of misalignment between strategy, execution, and what the market actually needed. That disconnect really stuck with me. And that experience is actually the one that shaped everything I’ve done since.

01:55
I founded Idea Pathways to help biotech and pharma teams navigate that complexity. Whether it’s building strategy, scaling across geographies, working through a deal, or unlocking value that gets stuck in silos, I found that most challenges come down to two things, clarity and follow through. Thanks so much, Alain, for this. can only agree that it’s a need. And I’m sure, Jean-Louis, you’ll go through this too later on with your book.

02:25
But you’ve spent two decades, John-O-Well, shaping biopharma deeds from the inside, building valuation models, structuring transactions, and guiding M &A or business development decisions at Sanofi and beyond. But before the spreadsheets and strategic negotiations, what really first brought you into this work? Thanks, Neji, and thank you for having me. I started my career at ENY in Paris before stepping into CFO roles.

02:55
across diverse companies like Renault, IBM. But it has been my 19 years at Sanofi where I really found my passion for unlocking value in life sciences. What excites me most in working is working side by side with engineers and scientists to build forecasts and business cases that bring innovative ideas.

03:22
close to reality, this is what we want to do. At Sanofi, I’ve been deeply involved in hundreds of licensing deals, partnerships and M &A projects, always fully embedded in the project teams and collectively driving forward. So this international cross-functional collaborations across multiple therapeutic areas.

03:52
have been eye-opening. I have seen how finance is not just about numbers, it’s about shaping decisions. Projects can get a swift no if the value is not there. And that puts a real responsibility on us to work closely with R &D, commercial, business development teams to thoroughly evaluate every opportunity. That’s where we

04:22
can have a real value be unlocked for a project. I love this. You you said something bringing innovation into reality. I think this is what we do here in pharma and biotech and ultimately bringing life changing innovations for patients into uh reality. and I first connected while working with entrepreneurs, helping them really shape kind of their venture, navigate the leap.

04:51
from science to strategy to seeing this, what John Well said, like this opportunity, getting it to patients. Were there a moment in those conversations or collaborations that sparked the idea for this great book, The Thriving Biopharma Business? Definitely. You know, early on, I spent a lot of time, as said, coaching biotech startups and listening to many pitches from scientific entrepreneurs.

05:18
And what stood out was how often the feedback I gave circled back to similar core themes. Those included clearly defining the company purpose, understanding the problems that they were solving and for whom, articulating why their solution made sense in the current market, and demonstrating a sustainable business model with strong financials and investment plans. It also involved explaining their unique position against their competition.

05:48
showing why their team was the right one to make it happen. And after a while, I found myself looking for a book I could confidently recommend to these founders. Something practical, something insightful, something tailored to their unique challenges. However, surprisingly, I could not find a resource that really hit the market in that respect. So that’s when we started thinking maybe we should write that book. And I share that idea with Jean-Noël at the time, was equally passionate about helping biotech leaders thrive.

06:18
So together we decided to take that leap and put those real world lessons into a practical guide, which is that book. So next step for us was to find the right publishing partner. And we are fortunate that Teller and Francis at the time quickly saw the value in our proposal. And their support gave us the confidence, the platform turned those insights into the thriving biopharma business, which is really a book directly born from the frontline of biotech entrepreneurship.

06:48
We wrote it for leaders who want a practical guide to building and growing companies in this space. It’s packed with real world examples, frameworks, and lessons learned from the field.

07:00
And it is a great book for those in the industry, as you shared. And Jean-Noel, you have also a full-time job, like Alain, writing a book is never a small undertaking, especially when you’re trying to do this in an industry complex like biopharma and really spanning from strategy, finance, leadership. How did you and Adab decide to take this on together?

07:30
And what made this collaboration kind of blank? Yes, in fact, what Alain described really resonated with me. While he was hearing similar themes around purpose, market fit, business models, also uh on my side, the challenges on the finance and deal making side. I know the types of how many talented scientists

07:59
struggled to frame their innovations in terms of value creation, investor expectations, or deal structures. These gaps often created barriers to growth, even when the science was solid. That’s when it clicked for us by combining Alan’s deep strategy and operational insight with my experience in finance, valuation, and

08:29
deal making in a big pharma context. We could offer a more complete picture. Our skills completed each other perfectly. Together, we decided to turn our shared observations into a practical guide that helps biotech leaders move beyond just the science and build companies that can attract investment and scale effectively.

08:58
And this collaboration allowed us to bring different but equally essential perspectives to the book, ensuring it speaks directly to the diverse challenges biotech entrepreneurs face every day. So I love that because it’s already kind of cross-collaboration on the different really capabilities, expertise that you both bring.

09:23
I’d love now to go and dig a little bit more into the insights of the book and what you’re sharing. So one of the things is those strategic pivots that can really define companies future. And we see it quite a bit in, uh in bio pharma early beginning. Can you walk us through one that stands out and leadership mindset that really turned uncertainty that we live daily in this industry into momentum? Sure.

09:51
One strategic pivot that stood out for me really in Bio Pharma is Moderna’s bold decision to focus entirely on mRNA vaccines during the COVID-19 pandemic. It’s an example that people know well. At a time when mRNA was still an emerging and somewhat unproven technology, CEO Stephane Bancel and his leadership team leaned into relentless curiosity.

10:18
and took really calculated risk to rapidly develop a vaccine that would reshape global health. And this pivot perfectly illustrated a key theme from chapter four in our book, The Thriving Biopharma Business. Great outcomes demand more than science. You need the ability to set strategy in a disciplined way while remaining flexible. You need to provide a clear vision. And finally, you need decisive leaders.

10:46
That’s how you turn uncertainty into opportunity. Instead of simply reacting, Moderna’s leadership was able to follow a clear MRNA roadmap with careful market priorities. They stayed nimble and struck a balance between bold innovation and solid planning in my view. I believe that greatly helped them move fast, make a real impact, and build lasting value for the company.

11:14
That’s a great example. And certainly you’re ending on value creation, right? For the company, for the society, for shareholders and all stakeholders basically. And really like the valuation in pharma and biotech is a complex piece. So Jean-Noel, you’re one of the experts on those things. Can you share with us a little bit your thoughts on value creation in our industry? Yes. In fact, with experience, you can see that your point about

11:44
valuations, transcending pure financials, particularly insightful. I would like to illustrate it with two stories, two acquisition stories. The first was um with a mid-stage biopharma company. They had this exciting therapeutic that has been on the market for about three years, but it was still, you know, in a critical critical

12:13
uh commercial ramp up where you know every quarter matters and the sales team is building a momentum and valuable experience. The temptation for as an acquiring company is to come in and start aligning all the processes, integrating all systems and to just standardize everything from day one. But we realized that

12:43
In this case, if we disrupted their commercial momentum, we would essentially be destroying the very value we paid for. So our leadership team made a very uh conscious decision to give their commercial organization significant autonomy. They maintained their sales structure and preserved their go-to market approach.

13:11
So we made sure the team felt valued and included rather than lost in a very large organization like a big firm. So we had to resist the urge to standardize. So it was a restraint, a restraint in preserving their commercial operations, which proved essential to maintain their operational performance and at the same time reach our financial targets.

13:40
after the deal closed. So this case was, I have another case where with a small startup with maybe 15 people, they had a breakthrough technology at a very early development. This was a completely different challenge dealing with a brilliant team of scientists. So there was no way to roll them into our process heavy.

14:10
standard big pharma approach. So it would simply have killed the innovation potential there were building. So in fact, here again, our leadership had to resist the urge to integrate everything immediately. So we preserved the innovation ecosystem they had built while ensuring adequate, albeit

14:39
minimal corporate requirements. This took real emotional intelligence, pragmatic judgment, I would say, on the part of the executive team. So in both these situations, the financial models look great on paper, but the real value creation came down to the leadership team having the business instinct to hold back.

15:10
know where, when to preserve and protect the key value drivers and when to align with the broader corporate goals. These are really great framings actually as we think about those like from what makes sense on paper you’re bringing it back to something that is very close to my heart which is leadership, the instinct to make sure that things are well integrated you even said the urge

15:38
resist the urge to integrate immediately. So all those, all those pieces comes back to the beauty of what we do, right? Like it’s people, it’s humans and how we interact and think about these problems. And if I go a step backwards, before you get into those MNAs or or deeds and partnerships between pharma, biotechs, the pitches themselves, like how do they pitch to you? How do they tell you the story? Does storytelling even play a role?

16:08
in a data and science driven industry. So I’m intrigued, and I’ve seen several of those. Is there like a most unforgettable pitch that you’ve witnessed and how did it connect with decision makers at a human level to make the deal? So, Nadjia, I’m really glad you asked this question. This is something I’m really passionate about. You literally stumbled upon one of my soapboxes.

16:36
The ability to tell stories and pitch is so important that we opened the thriving biofarm business with a section titled, The Importance of Stories Over Data. And we even dedicate an entire chapter, chapter six, to helping leaders craft strong pitches that speak to their audiences. In there, we cover how to structure a pitch, we consider cultural context, when to submit questions, how to leave a lasting uh impression.

17:04
And as you said, in bioforma, a great pitch is not just about what you know, it’s about helping others believe in what is possible. The most effective pitches I’ve seen or witnessed combine three elements in my view, logic, emotion, and trust. And those need to be packaged into a coherent and compelling package. This is something we illustrate in detail at the beginning of our book. And while logic is the default language of science,

17:33
using clinical trial results, technical analysis, emotions do connect us on a more universal level, often through inspirational patient stories. And trust is built through credible references, key opinion leaders, and a clear articulation of the unmet needs and potential impact. And to come back to your original question, maybe one of the most memorable examples I’ve seen was

18:00
vertex pharmaceutical during the lead up to Trikafta. The clinical results there was strong. It was a therapy that could benefit about 90 % of people with cystic fibrosis. They were tackling genetics for the first time at an incredible scale. But what made that pitch resonate with me at the time was how they brought the science to life through the voice of patients and families. In one widely shared story, for instance,

18:30
You saw a mother of a 10-year-old patient that described what the treatment meant to her. She said it lifted a weight she had been carrying since her son’s diagnosis. For the first time, she could picture him growing up with healthy lungs. And that moment really stayed with me. When you pair a story like that with solid data and a clear market need, the message does tick. And it worked.

18:56
Trikafta became a commercial success. It drove significant revenue growth for the company. It reshaped expectations in rare disease drug development. But it started with a pitch that made people care and believe before they even had time to analyze the numbers. Yeah, I certainly relate to that. I’m now in the rare disease space. And really, when you hear those powerful story of patients.

19:24
and how those drugs can transform their lives, make you wake up every morning, but also make the story more compelling, but with data, as you said, and a clear unmet medical need. I’m going to now move to a place where I’ll give you a word and I would love for you to react to it. The first one is leadership. So maybe I take the lead on this one.

19:53
Leadership for me is integrative leadership. And by that, mean a leadership style that brings together diverse perspectives across science, across regulatory, across commercial functions, geographies, and more. It’s really about connecting the dots across disciplines and teams to create real alignment and fuel innovation. In the Thriving Biopharm of Business, we emphasize how this approach can really unlock values for companies.

20:21
Leaders who create open collaborations between R &D, regulatory, commercial, and external stakeholders build the kind of ecosystem where complex challenges are addressed from multiple angles. And that alignment speeds up decision making, it avoids duplication, it drives innovation that delivers for patients. This approach becomes especially powerful in my view during complex strategic decisions. In the book, for instance, we explore

20:50
In the case of Roche, a 2022 partnership with SmallBioTech to develop a new cancer treatment targeting tough-to-treat mutations. And we noticed that the deal threw four key lenses, financial, market, competition, and operations. In the case of financials, we need to ask whether the structure of the deal generates sufficient value. How does it compare to other options with similar risk?

21:17
Does it reflect the funding environment that most biopharmacompanies face in practice today? From a market perspective, we need to evaluate how attractive this particular segment is, how challenging market access might be, how complex the regulatory landscape might be, and whether the opportunity really fits the company’s capabilities. On the competition side, it’s all about how the deal leverage differentiated and unique companies’ strengths.

21:45
how it secures freedom to operate from an IP perspective, how it positions the therapy to stand out within a crowded and fast-moving field. Operationally, the review considers access to the right expertise something critical nowadays, whether manufacturing capabilities will be available in a timely fashion, and whether the supply chain can hold up under pressure. That kind of resilience to disruption is something the industry has paid, as you know, closer attention to since the pandemic.

22:15
And by looking at those four dimensions across, this is the kind of integrative analysis, integrative leadership that brings clarity to complex partnerships and help companies move forward with confidence and speed, even in high stakes, high uncertainty environments. I love this concept of integrative leadership. I’m sure Jean-Noel, you can also bring another lens to it, an additional lens to it as you guys complement one another. uh

22:44
I’ll let you react to it too. Yeah, okay. In fact, integrative leadership can also be viewed in the context of a transaction of a partnership. Imagine when experts on both sides, they do not share, only share data, but they build a genuine understanding and trust. It’s very rewarding for both cases. So when you get

23:11
both functional teams working together openly on both sides, you create a solid foundation that allows for creative problem solving and flexibility. uh They can make or break a deal beyond financial terms or legal frameworks that we have for any transaction. And also, this is important, uh

23:39
when you are in a context across borders, when you have cultural nuances that come into play. So for example, I remember an acquisition with a biotech company where from the very first meeting, you could tell that the sales side team was prepared to collaborate and not just prepared to defend their company.

24:08
So they had done incredible preparation, but not just from the standard data or material point of view, but also detailed document proactively addressing most of our concerns as a buyer. So whenever we needed clarification, they were extremely responsive and promptly organized meetings with their, of course, the relevant experts. So in fact, in this

24:37
experience, what really stood out for me was their open mindset and their exceptional cross-functional approach, in particular from regulatory affairs, lead scientists, commercial strategy. So in this area, it wasn’t just buyers versus sellers. It was problem solvers talking to problem solvers. And this was very, very

25:07
helpful. This quality of exchanges was essential to closing the deal in a very timely manner because the acquired products represented a new therapeutic field for us and we needed a better understanding of operational aspects and specific risks. So their communication approach and collaborative framework helped build trust and enable our team

25:36
to complete successfully all the due diligence tasks within a very short, demanding two, three week timeframe. So one reason why integrative leadership allows for such performance is that generates a generally open environment where both sides foster a partnership mentality.

26:06
other than a purely transactional one. So in this transaction example, just described, the process went in fact, mostly than we would have expected. And we created a mutual goodwill and we were positioned for a successful company integration, post acquisition. And so for me,

26:32
uh I would say that integrative leadership is a mindset that can prove decisive in many other contexts. Like when you, for example, other transactions, when you are co-developing a combined product that requires another company’s support, for example. Yeah. And this is really an incredible example and way of thinking of things. And I certainly

27:01
see it working here and beyond, right? Because you said something super powerful instead of being one against the other is how can we partner to solve the same problem that both companies are solving? One needs a partner, needs funding, the other is trying to bring this asset to market. So it’s great examples. The second word I would love a reaction to is entrepreneurs. Yeah, we can see that.

27:29
And in my experience, we consider that biotech entrepreneurs, they should act as savvy business builders, not just scientists, but also business builders. Alongside great science, in fact, investors who expect a clear business model, a solid market plan, and a smart financing path.

27:58
So start-up entrepreneurs, we succeed in our today’s very uncertain environment. They blend strong business skills with scientific innovation.

28:14
What about resilience? So I guess I’ll take that one on. So I actually have the perfect answer for this, you know, and there is something that has anchored me during turbulent times. And it’s actually a poem, believe it or not. It’s titled If by Rudolf Kipling. It is 32 lines of resilience, humility and focus under pressure.

28:40
And my father gave it to me in France when I was a kid growing up in Paris. And it’s really encouraged me ever since. Well, Alain, I need to add that on the page, actually. So I’ll have to read it and translate it and add it on the page. I love it. The last word I always ask uh my guests is spread love in organizations. Give me a reaction to

29:09
So for this, it’s better to clearly articulate the value proposition that your technology or lead asset uh to better attract investor interest. They need a clear, compelling narrative that demonstrates the scientific promise, but also the commercial viability.

29:37
We will do it because that will be the conclusion. So on that I will ask you question about final word of wisdom for leaders. on spread love and organizations, can you react on… Because you talk a lot about leadership, how you tell the story, the working together.

30:00
So can perhaps start over with integrative leadership. Like Spread Love and Organization, it’s about integrative leadership and partnering with one another. Maybe I should start first because otherwise it’d be back to the… so that we can have a dynamic. Okay. And so the last two sentences… The last sentences are for you two. So I’ll the question, a final word of wisdom. And can do it. Okay. Do you to react to Spread Love or do take

30:29
I think it’s not worth to answer. So I’m spread love and organizations. You have an idea? Improvise it. Improvise it. Okay. The final word is spread love and organizations. Thank you, Nadhi, for mentioning this. I think this is one of the passions, the underlying passions that’s pretty much central in the industry.

30:57
for many entrepreneurs and many executives in BioDek. And that’s actually something we acknowledge in the beginning of the book. And I would like again, take the opportunity to on behalf of both of us to thank all those leaders in the industry for their passion for sharing that love and for their commitment to making the world a better place and developing new therapies. So that to me is a given building block for the industry. A hundred percent. This is why we wake up every morning and

31:26
Thanks for shining those great cases in your book. Any final word of wisdom, Don Noel and Alain, for healthcare leaders around the world? I would say clearly articulate the value proposition your technology or leadership set will bring to attract investor interest. they seek, investors seek clear, compelling narratives.

31:54
that demonstrate both scientific promise and commercial viability.

32:02
Now, thing I do hope listeners take away from today’s discussion is the vital role of relentless curiosity in driving innovation. now, combining that with strong storytelling capabilities, financial savanness, and calculated risk-taking can really unlock value in the industry. These are insights we explore deeply in our upcoming book, The Thriving Biofarm Business. So stay tuned for more insight there.

32:33
These are great charges and bits of wisdoms for us to think of as leaders in healthcare. Thank you both, Alain and Jean-Noel, for being with me today. Thanks for listening to the show. For more episodes, make sure to subscribe to spreadloveio.com or whatever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare. One story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Benjamin Hadida

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. I am joined today Benjamin Hadida co-founder of Exeliom Biosciences, a clinical-stage biotech company founded in 2016 in France, winner of the Biotech Summit Pitch this year. With experience spanning investment banking, venture capital, regulatory affairs, biotech operations, and applied research, Benjamin brings a multidisciplinary perspective to biotech innovation. He holds master’s degrees in Management from ESSEC Business School, and Molecular and Cellular Biology from Sorbonne. Under his leadership, Exeliom has raised $29 million to develop EXL01, a groundbreaking microbiome-based immunomodulator targeting the innate immune system. This first-in-class therapy is now in Phase 2 trials for Immuno-oncology, Inflammatory Bowel Diseases and Infectious Diseases.

I’d love first to hear more about your personal story before we go into the biotech world. What brought you to found and lead now Excellium?

Benjamin Hadida: Really it was the willingness to create my dream job and I was not able to find it. There’s a lot of biotech activities in France but not so many biotech companies developing actual novel drugs and the number of options were very limited.

But the science is excellent with all these academic institutions creating a lot of new opportunities there. So the idea was just okay let’s meet an excellent scientific team and create the dream job. I love that and kind of like how did you land into knowing that health care, biotech is kind of your dream and what you want to do in your life? So yeah it’s a good question because at the start I had a very generalist background.

I did the preparatory schools in France and then went to ESSEC business school where I was mostly studying corporate finance. But then I was trying to find an area where I could apply this knowledge and I was immediately attracted by the health care because there was something more to it. We were talking about life and death, about ethical issues and I had this opportunity to discover the field through an innovation therapeutic share at ESSEC business school and then I went to Amgen and definitely I fell in love with the complexity of this field.

So from generalistic to you’ve worked in pharma, you’ve worked in venture capital and now really building the company since it’s been nine years on your anniversary. So tell us more about this journey and how it started and I’m sure it’s a roller coaster of a journey as any biotech. Can you tell us a little bit more about your key learning as you’ve been building this venture? To be honest it’s better not to know everything before you start especially as you’re developing a first-in-class modality.

I mean it’s already a first-in-class but it’s also a novel modality so there were so many question marks and to be honest I tried to present it to the people I met. So first of all my co-founders but also my first investors. I tried to convince them that because you know it would be the first time for me that I would do these things I would do better than anyone else because I would give it everything but while keeping the openness you know because my starting point was I don’t know anything so I would go talk to as many people who were supposed to know and then practice my best judgment to make the next decision and little by little we start building this project and the organization around it but really it was tailor-made.

We were not applying any recipe and you know very early on we decided not to have any C-level in the company for instance because we would not have the resources, we didn’t know exactly where we would go with this project, there was no regulatory roadmap, there was nothing written for us. So first decision was to to be completely virtual, no C-level, the experienced people would be outside of the company, they would also evolve with the project and within the company we would have only super project managers basically with no particular experience in drug development but the willingness to learn and this is how we started and I guess this is the reason why we’re able to do what we did. We basically took an academic program with a few slides some great publications but in terms of project just a few slides and we took it to a candidate that is now in phase two that has been seen by many agencies including the FDA and it was really because we were the first one to do what we did and it was the first time as well for us.

It was some kind of a combination of both that made it a success I guess. This is an incredible story and now congrats you’re in phase two, you’re pretty advanced, you have enough runway, you managed to raise 29 million through the years in Europe which is not something simple I would say. What is kind of your biggest learning if you have to pick one? What is the biggest learning for others who are now starting their companies and going into from pre-clin IND or those early stages to becoming clinical stage companies? Yeah the biggest learning is always I ask the question and that’s a question that you should ask almost every day it’s what does the program need and not what do you need or what does your company need but what does the program need because at the end of the day when you look at the valuation even of the company you’re not going to value the people or the many pre-clinical programs that you have especially in this economy the only thing that are valued are the clinical stage assets so our key question was what our lead program needs to be in the clinic as fast as possible in a valuable way and you know to kind of identify what has value and what doesn’t have value and it’s complicated because you know when you are in love with your science with your innovation you see value in a lot of things even in your manufacturing unit because you think it’s unique and you need know-how and so on but before I started this company I had this experience in another biotech company where I was not the co-founder I was just a simple employee and I could see what you know what happens when a biotech falls and at the end of the day what the investor and the financial people will look at and the way you know they put numbers on things and this is very rude and crude and there are not that many things at the end of the day that have value for these guys so to keep your eyes on what do I value and be focused on that seems easy and obvious but that’s not.

Yeah I agree it’s not and it’s I think related to that there are many aspects right like when you’re focusing on what the program needs to bring this innovation and help patients you need to create a culture within the teams and the leaders you bring on and you work with to be able to transcend one’s self-interest and egos and literally work on what’s best for the assets you have to bring it to patients so I think it’s not an easy question but if you manage to do it it talks a lot I think on how you the culture you created. And you know one of the key aspects for that was I know it sounds a bit counterintuitive but in the way we build the company the scientific co-founders they were extremely involved but they were not employees of the companies so they were active consultant or board members but they were outside of the company and our deal from the beginning was that my job would be at some point to tell them things that they won’t like because I would defend the program and at some point the program interest might deviate from their scientific vision or interest and this is something that is not easy as well you know initially we were funded with a major focus in IBD this is where our co-founders came from and at some point we made this prioritization to go to oncology and you know it was massively accepted because and with the support of the co-founders because we set the rules right from the start and they all understood that it was what was best for the program so at some point it’s exactly what you say you you isolate the program and the program has its own interest vision and road map and that’s a great example you know as building companies I’ve had this experience even with startups I just had an idea like kudos to you having those tough conversations in the beginning usually we try to say that you know like we’ll start who knows what it goes and then you know you have tougher conversations later but it’s not the ideal case by learning is also like having those tough conversations in the beginning is crucial for the success of the company and and you’re showing it here tell me more now we’ve mentioned that but tell me briefly about the science what’s what do you do what’s novel in your approach I’ve heard your pitch obviously so I’m a little bit biased but tell me from your lens about your science yeah maybe I can I can I can I can tell about it the way it really started and that’s really interesting because it’s a bit the opposite roadmap of the conventional drug development normally you have a target identify that has some scientific rational you design something to eat that target and you go for it right in our case it’s all started with clinical observations is so just physicians trying to understand why some patients were responding to immunotherapy and why those were not responding and one of our co-founders are is one of the pioneers in trying to get this understanding by looking at the gut microbiome was one of the first to do that and barely early on with not the tools that we have today but the tools that we had 20 years ago he identified a signal which was a particular gut bacteria and then took it to the lab and identify with our other co-founders that in fact this bacteria had a lot of specificities in terms of properties and really it’s only 20 years later that we had the breakthrough where we understood the mechanism of action where it’s while we’re in phase two that we really were able to identify the target that we eat and the cells that we eat and so on with this bacteria so in terms of modality it looks simple we only basically have this master cell bank with one strain a specific strain that we selected from this good bacterial species that is called bacterium prosnitzi we grew it we freeze dried put it in a capsule that is designed to release it in the lower part of the intestine and and then we use it really as an immunomodulator and what we’ve identified in fact this bacteria is carrying on its membrane a specific structure that binds to not two which is an innate immune receptor that is particularly fine it found in macrophages and monocytes yellow itself basically that are particularly present around the intestine so this is really interesting in terms of delivery and when when the bacteria binds to not two or this component binds to not two it acts as a super agonist of not two and activates not two in a very specific way that then makes the the whole system more able to respond to immunotherapy so if you’re in the IBD setting that would be NTTNF if you’re in oncology that would be the immune checkpoint inhibitor and what is very interesting is that not two there’s a lot of rationale in these different therapeutic areas because that’s an immunomodulator that can take macrophages either to an anti-inflammatory phenotype or pro-inflammatory phenotype and this is very context driven so at the beginning we thought we were developing an anti-inflammatory drug based on this bacteria because in the inflammatory setting the effect that you drive is an anti-inflammatory effect but in fact this is not an anti-inflammatory drug that’s just an immunomodulator that activates macrophages so that they do what they’re supposed to do in the context they are so in the context of checkpoint inhibitors in oncology the effect is completely the opposite and you boost the macrophages so that they will help you respond better to immunotherapy and so that’s why now we’ve got phase two trials both in oncology and in Crohn’s disease with the same candidate. This is great and so tell me more I’m intrigued about you know like obviously I’m in immunology too so there is this immunomodulation you’re talking based on the contact so how do you see yourself as a company and as this drug develops is it an add-on it’s an enhancer sometimes for whatever immunological treatment you would have? That’s exactly our vision for this product you know you need to know your product and what it can and cannot do and this is really an add-on positioning it will enhance the response of checkpoint inhibitors the objective is to have more patients responding to these treatments when you combine to it so actually our flagship trial in gastric cancer it’s in first line gastric cancer in combination with chemotherapy and nivolumab and we have a control group where they only take chemotherapy and nivolumab and yeah the idea is really to have more patients responding with the presence of the bacteria and in the context of immunology in Crohn’s disease we are either in monotherapy for the patients that you know where anti-TNF are too toxic for them and there is a major need for these patients because there is just nothing that is given to them if the patient or the physician think that the anti-TNF is too toxic or it can be as an add-on to anti-TNF but definitely the vision is we see that as a boost we helped the immune system to be in a better state for the patients to respond to these treatments we do not really see it as a shock treatment or monotherapy doesn’t make sense to us and this is this is awesome you talked about like you kind of shaping the way it’s true like this was a lot of ideas about microbrome I’m really like it’s great you guys are in phase two and getting there but what is currently you see as your biggest challenge or barrier for you to get to the next stage of getting this to market it’s um I mean if we’re successful with our current trials um I mean either in in oncology or in IBD the next step will require a partnership with the pharma and our biggest challenge right now is to get the pharma on board to educate the pharma regarding this microbiome-based therapies they I mean they had they had been in the past a frenzy regarding microbiome with a number of company raising a lot of money and they did not execute well and we just need to educate pharma to basically they know that already but based on positive data that would be generating to explain that you know there are a million ways to do something and we’re doing right with this very control and defined candidate with an identified target and mechanism with also the right application because you know maybe the companies before us they expected a bit too much from this type of modalities and they did not position it well and most of the time they developed it as a monotherapy in inflammatory settings and it was maybe too much to ask we’re really convinced that what you can expect from these therapies is a long-term effect their strength is their safety profile not their potency but their other strength is to activate the immune system in a non-suppressive way in a different way something that was not done before and as we all know in the immuno setting you need different angles different strategy to combine to have the best effect and we cannot ignore the microbiome components the people I talked to in the pharma world they know that they they are very interested in the microbiome science they just don’t see yet a modality they don’t see yet the the conversion into a product so this is what we need to bring to them show them that in phase two we de-risk the regulatory the manufacturing now the the efficacy and this is not rocket science I mean it already exists when you look at the BCG vaccines on these type of things we’re not that far away in fact the people that evaluate our dossier the FDA are the exact same people that evaluate vaccines because this is the same type of manufacturing it’s just that you do not attenuate the strain because the strain here is good for you but the rest is uh is very similar so it’s not that surprising in a way that’s that’s great and really best of luck with uh with that and again the opportunity you have is you will have data as you said and this is kind of yeah exactly what we live and breathe for summer 2026 and final readout in 27 so uh yeah awesome it’s coming awesome uh I’m gonna now give you a word and I would love your first reaction to it the first word is leadership it’s uh put yourself behind the others not in front of that what about entrepreneurship don’t get any ideas just uh just discover it your way don’t try to to have other people explain it for you microbiome it’s uh for me it’s uh it’s it’s um the other space I mean it’s a the other space discovery uh and it’s fascinating spread love and organizations you cannot you cannot be successful without love any final word of wisdom for healthcare leaders around the world yeah just keep your uh your mind open uh don’t get stuck into uh uh to what the the financial people ask you to do well thank you so much again for being with me today and this great thank you so much thank you so much Najee it was nice talking to you thanks for listening to the show more episodes summarizing the boston biotech summit are available on spreadloveio.com or on your preferred podcast app make sure to follow us let’s inspire change together and make a positive impact in healthcare one story at a time

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Fernando Vieira

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

This episode is in partnership with the Termeer Foundation, a nonprofit organization working to vibrantly connect and empower the world of healthcare innovators until every patient has a cure.

I am Naji your host, joined today by Fernando Vieira, a healthcare executive with over 20 years of dedication to advancing ALS research and treatment development at the ALS Therapy Development Institute (ALS TDI), an non-profit biotech company. Fernando has progressed through various leadership roles at ALS TDI, culminating in his current positions as Chief Executive Officer and Chief Scientific Officer. He leads a team of over 25 researchers, overseeing target discovery, drug discovery, biomarker development, and translational ALS research. Having lost his closest friend to ALS, Fernando is deeply committed to translating scientific discoveries into clinical applications that benefit people with ALS. Fernando is a recognized leader in ALS research, affirmed by his roles on the Research Committee of ALS ONE and the International Alliance of ALS/MND Associations Research Directors Forum. He holds multiple patents for novel therapeutic approaches and has contributed to publications in multiple high impact journals such as Nature Communications, Nature Genetics, and Science Translational Medicine. Fernando earned a degree in biological engineering from the University of Florida and his MD from Harvard Medical School. Outside of his professional life, He is a dedicated father to a high school-aged son in Newton. He actively participates in his son’s activities with a local Scouting America troop. In his free time, he enjoys running, hiking, and playing basketball.

Fernando, it’s great to have you on my show and seeing you today.

Fernando Vieira: Thank you, Naji. It’s great to be here and great to speak with you and your audience.

Naji Gehchan: I’d love first to hear more about your personal story and how it links with the important work you are doing today in your non-profit biotech.

Fernando Vieira: Yeah, it’s where to begin, trying to think. I guess I’ll start really young. Going back or thinking back to my childhood, I guess the first job I imagined ever having wasn’t really a job. I imagined being an inventor. I think I always wanted to find ways to solve problems for people that hadn’t yet been addressed yet. Then as I went through high school, I got really interested in biology. I really enjoyed my AP biology course loads and started to think, okay, well, maybe I’ll go into clinical medicine. I pivoted off of that idea of becoming an inventor and more problem-solving very practically in a clinical setting. I never really got off of that completely. When I went through undergrad, I chose to go into biological engineering instead of just a basic biology major because I liked the idea of solving problems still. Then I found myself drawn into laboratory settings and joined a vascular surgery lab at the University of Florida and really ended up loving that. Ultimately, I ended up in the space between undergraduate and medical school. I ended up engaged with the ALS Therapy Development Institute or at the time it was called the Foundation, which was actually founded by a Newton family when one of their family members at the age of 29 had been diagnosed with ALS. I was really drawn to this effort to marshal resources to find treatments for him, to solve problems for him and other people with ALS. So I joined this group and this group was, it was made of kind of a motley crew of people who were trying to solve problems for their family members or some patients themselves were working at this organization. And they had set up a lab and it was a really early stage program. And I thought, Oh, well, maybe I can be helpful here. And, um, and I was drawn to all of these folks and their, their resilience in the face of, of this tragic diagnosis, ALS, for people who don’t know, um, ALS is a neurodegenerative disease that results in the loss of motor neurons in your brain and in your spinal cord, and ultimately results in, in complete paralysis. Um, it’s gradual over time. And there are really no effective treatments for the vast majority of people with ALS today still. And so I was drawn to all of these people and their stories. And I became best friends with one of my colleagues. We became roommates in fact. Um, and he was there because it was in his family for some cases of ALS, it’s directly hereditary and his mother had the disease. When I met him, his grandmother had died of the disease and he didn’t know if he was a mutation carrier himself. And so I stayed involved, uh, with the organization all through, uh, my medical training. And then, uh, at the end of medical school, he was diagnosed with ALS himself. And I watched his progression. Um, it was incredibly rapid. The guy who used to kick my butt on the tennis court, um, nine months later he had passed away. And so, um, I couldn’t imagine, um, becoming a practicing neurologist without something to give a person like Sean, uh, my friend. And so, um, I threw myself full time into, uh, drug discovery and drug development here at our our nonprofit biotech, the ALS therapy development Institute. Um, and it’s been an incredible journey since. Well, thank you, Fernando, for sharing this. And yeah, it’s, uh, as you said, it’s a devastating disease that’s still up to today has no, has no effective therapy or cure. So I’m, I’m intrigued if you can tell us a little bit more about your work because you have patents, you have advancements. So I’d love to know more about what you do, uh, on a daily basis and how you’re advancing research for this disease. Yeah, I’m happy to. So we’re a unique organization. We are a nonprofit, um, but we’re a brick and mortar research lab. Uh, we’re located here in Watertown, Massachusetts, and we have a research team with, uh, three different groups. There is a cell biology team. There is an in vivo pharmacology team. And then we have a clinical team that runs a natural history study slash translational research program that collects data from people with ALS while also collecting samples to generate omics data. And so our research program is very well integrated where we’re, uh, leveraging that natural history study and those omics to, um, prioritize therapeutic targets. We also leverage the reagents, the cell samples that we can collect from those people for our cell biology program, where we build assay systems to validate therapeutic targets and to screen drugs. And then when we’re screening drugs and we find something that has some potential, we have a large, like robust in vivo pharmacology team that can do lead optimization and really validation in an in vivo setting. And so we’re this nonprofit discovery engine where if we discover and invent or help somebody else validate their therapeutic, we either, you know, file for IP ourselves and we kind of spin that forward into the for-profit space for others to pick up and move that into clinical development. And that’s the model. Um, we have, um, some, you know, projects that have moved forward in that way that we’re excited about, but we’re always churning because we understand ALS is really, really complex. There’s a reason we have this natural history study. ALS is not one disease, right? Like cancer as well. These are, uh, complex disorders that we call the same thing that can actually be quite different. And so we know it’s going to take multiple treatments to ultimately address every ALS patient’s needs. And so we’re going to keep at it in this sort of engine. This is great. So I’m really intrigued in this, in this model you just, uh, discussed, right? Like being a non-profit and then building IP and doing a for-profit company. Uh, it’s really fascinating model. Um, and I feel like it’s at the core of how it was founded and this is like one of the values you have. So can you speak a little bit more about why non-profit and, and your view about research in a non-profit based versus biotech, uh, that, you know, like we all know, uh, probably more, I would say than a non-profit biotech. So I’m really interested in your view about this and how you’re leading this. Uh, yeah, I, I think for a disease like ALS, right. Where, um, there’s a lot still unknown and you know that it’s going to be a long haul. There’s a lot of value in building really an infrastructure where you maintain institutional knowledge and you can build over time focused on a specific problem, like in this case, ALS. And so if you’re in many biotech settings, you often are inventing incredible technologies and you’re finding the best path to solving problems quickly. Right. And you’re not necessarily worried about a specific disease. You’re finding the, the, the lock that fits your key, I guess. Like, so we’re, we’re focused on ALS specifically. We’re never going to pivot off of that. And so we get to build over time and learn and, and, uh, remain focused. And I think that’s really it. It’s maintaining sort of the mission and that critical focus on the one disease and not pivoting because you may have a quicker path to maybe a lucrative exit, which I don’t have a problem with that. I don’t have a problem with, with, uh, solving problems and people earning dollars, but for a disease like ALS, I think, uh, our model, uh, makes a lot of sense. Yeah, it certainly does. And, and as you were sharing, I like how you framed it like this, this, this focus, it can provide you a focus on the disease. And especially with diseases like this, where it’s between, you know, immunology symptoms are different. Like we still don’t really know it’s a multi by your framing is correct, right? Like I’m, I’m an autoimmune now that I was in cancer before it’s all, we talk about one type of disease where actually it’s really kind of a spectrum of diseases we just consolidated, but to get to this cure, potentially it might be one patient at a time with different modalities. Yeah. I think we, we, we might have cures, but it’s unlikely we will have a cure, right. Uh, for a disease like ALS and these other conditions. So as you think through it, and you’ve been building research for now a couple of decades, uh, on this disease, what are, where are today some of the specific challenges in this field, uh, and within the nonprofit, uh, nonprofit towards your end? I think, um, in the ALS space, um, a really big challenge is as we start to understand that ALS is more than one condition and you’ll need more than one therapeutic, you start getting to patient subsets that are really quite small. Like you go from a disease that’s an orphan disease, that’s rare to a disease where you have maybe ultra rare. And the, the same challenges in sort of economics of developing, uh, therapeutic for a broad population apply for these ultra rare populations. So it’s, um, trying to find the most expeditious way and efficient way to get really profoundly effective treatments to these smaller populations while also keeping an eye on how those insights could apply to the broader ALS population and, um, um, navigating the, the ecosystem that we’re in to get the most solutions to the most people as effectively as possible. Um, that’s, that’s probably our biggest challenge, right? You might have a therapeutic program that will, that has potential to profoundly affect 20 people living with the disease today. You have a responsibility to develop that and help those people. Um, but you also have to keep the bigger picture in mind. So that’s hard. Um, specifically the nonprofit space, there are definitely, um, major advantages, um, that we, um, you’re not working in specific tranches of funding. You can go out and raise capital for, uh, projects, um, over time. And it gives you a chance to build, uh, knowledge and expertise and develop assets. Um, at the same time, um, the, uh, available funds are not, uh, they’re, they’re, they’re, uh, uh, the pot of, of resources available is smaller in the nonprofit space. So you really do have to always be grinding, um, to keep, uh, these research programs going. So as you think about the next 10 years, let’s say like the next decade, uh, what are you most excited about, uh, as you’re looking ahead really in medicine, in medicines and in the therapies and innovation that you’re seeing today? I was thinking about this recently because, you know, we’ve been at this for a while and I look, I remember back to when I came into the space two decades ago, that version of me would be so jealous of the opportunities we have now, right. Of the new insights that we have into this disease. Um, we might’ve been blissfully unaware, right. That, that the disease was as complex as it is, but, uh, it’s so much better illuminated. Now we were looking in a, in just, uh, a black box in a dark room. And now thanks to various omics technologies, uh, we can really, uh, begin to tease, um, different patient subsets and better therapeutic targets and really go higher upstream, which gives us an opportunity to maybe make a bigger impact. We have a proof of concept, right? So, um, uh, there are rare mutations in a gene called, uh, superoxide dismutase or SOD1, which are responsible for about 2% of all ALS cases. And recently there was an approval of an antisense oligonucleotide, an ASO, um, that suppresses expression of that. It’s called Tofersen by Biogen and Ionis. And that is making a big difference in those people with ALS. Um, and we’re learning from that, that, uh, earlier intervention seems to have a big impact. So I think we have this proof of concept with drug types that didn’t exist years ago and with, uh, better ability to elucidate good targets that we can really make a difference in people with ALS. So it’s just doing that hard work. It’s continuing to, to do the lift, to be able to address that for everybody. And I’m sure you get this question and you kind of like, but I have to ask it, right? Like as you’re looking into targets, obviously one of the biggest questions we constantly get, you know, in healthcare as healthcare leaders is, are you using AI? Right. So I don’t want to get into like just the AI, but I’m sure you have some, because you talked about omics, obviously this is kind of like your business model, uh, and finding not only targets, but specific modalities therapeutically to be able to hit them. I’m sure you have some cool case that you can bring here to kind of really talk use cases versus just generic AI. So I don’t want to put you on the spot, but I’m like, as you were speaking, I’m like, Oh, I’m sure you have some cool examples. There are so many different use cases for AI. Like AI means so many different things. And, and, um, there are some applications that are quite mature. So, um, I’ll, I’m going to veer, veer for a moment away from target discovery into, um, disease, um, symptom measurement. So in ALS, one of the challenges is the heterogeneity of how it presents and a person might have onset in their arm or their leg, or another person might have their voice affected first. And it’s very, very variable in how, um, it progresses, which makes it actually hard to measure if a drug is having a benefit in clinical trials. Um, that’s typically done using, um, you know, subjective surveys, uh, something called the ALS functional rating scale. And, and so one of the elements of our natural history study, uh, which we’ve been running since 2014 has been capturing digital data. So we use actigraphy or accelerometers on people’s wrists and ankles, and we captured digital voice samples. And, um, so back in 2018, 2019, we were working with Google to apply machine learning and artificial intelligence to extract that signal, to measure, um, symptom decline using these digital technologies. And I think, you know, that will provide ultimately, if we can get these into the clinic and clinical testing, more sensitivity to detect therapeutics that are working, maybe in, uh, subsets of responders and really understand the disease that way. So that’s like a very near term application of AI and machine learning. On the other hand, um, applying AI for target discovery, it’s, it’s really exciting to see sort of a big tech’s interest in applying these tools on dataset resources, like the ones that we’ve generated here at ALS TDI and our partners at answer ALS that we’ve kind of joined our large data sets together, um, to really mine them for the most promising targets. It’s early days. Um, sometimes you wonder if we have enough data yet to really parse these things through. Like one of my, I have this, um, experiment in mind, um, to test for the, uh, the effectiveness of the technologies. Don’t tell the tech, uh, don’t tell the model about the genes that we know are important in familial ALS and ask, does it find them? And if it does, then you feel confident in what else it finds. And that might help you, uh, have a little bit more certainty that you should start, um, to explore and prioritize what’s, what’s bubbling out of these AIs. And so we’re, um, we have a number of irons in the fire with partners. We’re not developing the models ourselves. We won’t reinvent those wheels. There are folks out there who are much better at that than we are, uh, but we find partners to help us out. These are great examples. Thank you for sharing those. And I love it because it’s like from target finding to actual clinical practice, as you’re saying, and potential new endpoints, you know, with digital biomarkers, uh, for therapies, uh, I’m going to give you now a word, uh, and I would love to get first things that come to your mind. The first one is leadership. Servant. Uh, I think, um, when you’re really, really young and actually this, I see this in, in my son’s scout troop, when you’re young, you think that, um, leadership positions are kind of an award or like a prize to attain, uh, similar to like winning a race. So you, you’re, I, it’s not like that. Um, uh, leadership roles are, are service roles and, um, you’re just in a different position and you have a different vantage point and you have different responsibilities in the organization, but, um, you are serving your team, uh, in the same way, uh, the, and, and the mission in the same way each one of them are serving the mission. And, and I think that, um, a lot of, you can demonstrate leadership many, many different ways, but, um, the first is be helpful to your team. What about rare diseases? Complex. Um, we’ve, it’s a little bit of a theme that we’ve talked about, but I think, um, when you get into rare diseases, you do start to think, oh, they’re, they’re one thing like, uh, ALS one disease. It’s not, it gets rare, becomes ultra rare, very, very quickly. Um, and each person’s experience with those diseases can vary a lot and you really need to, um, engage with your community, um, to learn about their lived experience and what you need to deliver for them. Tremere foundation. Uh, support. It’s, um, so I’ve, I’ve, I’ve had the honor of being a Tremere fellow. I actually, yesterday was my final day as a 2024, uh, in my active portion of the 2024 Tremere fellowship. Um, it’s a fantastic program that brings together, uh, um, their, the Tremere foundation, uh, has a Tremere fellowship program where they bring together a group every year of first time CEOs and founders. And it’s, it can be out of the for-profit space, but also nonprofit spaces as well. And you go through this incredible year of programming, um, where you’re really supported, um, by the foundation from these fantastic mentors who have really done so many of the things that we’re trying to do, maybe different disease spaces, but, uh, they’ve been impactful and you, you have a chance to really, uh, learn from them even more though, you become really close to your, uh, uh, the members of your cohort and being a CEO can feel lonely at times. Um, and having other folks, uh, to exchange ideas and, uh, talk about your challenges and solutions, um, is incredible. And, uh, I am grateful. Well, and congrats for graduating. I don’t know if you guys say it that way, but I know it’s a really impactful work this foundation is doing. So congrats for your recent graduation. Uh, the last one is spread love and organizations. Um, I, I think, um, so I, speaking of Tremere foundation, um, I was two, two days ago, uh, they were hosting the, um, celebrating the 2025 cohort. And there was a wonderful talk by, um, a pharma exec, a lot, a lot of different domains. His name was, uh, Rod Cotton. And he was speaking about leadership and he was talking about, um, humanity, like, like, um, meeting people where they are. And, um, I think that’s critical to being part of any organization, being part of something that’s like bigger than yourself is spreading love to the people around you and, and, um, and really basking when it’s reflected back to it’s, um, for the problems that we’re trying to address in the life sciences sector. Um, you, um, you want, they, they can be really challenging and, um, emotionally, um, taxing and having people around you who are warm and kind of sharing that back, uh, keeps you going. Any final word of wisdom, uh, Fernando, for healthcare leaders around the world? Um, think about the people that you’re trying to serve, um, and that same token, um, uh, meet them where they are, um, understand their needs. And sometimes, um, we, when you become sort of an expert in a domain, um, um, you think you have the answers, um, but, uh, those conversations can be really illuminating. Um, and that’s one of the other advantages of being part of a non-profit is we’re so connected to our community. So for those who don’t have that advantage, um, go and create that community. Oh, this is great final words. Think about the people you are trying to serve. Thank you for all that you’re bringing to, uh, the ALS community through your work for research and biotech and science. Uh, it’s been a real pleasure and honor to have you with me today, Fernando. Thanks again. Thank you, Najee. Thanks for listening to the show. More episodes in partnership with Termeer Foundation can be found on spreadloveio.com. Make sure to subscribe to Spread Love and Organizations or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare. One story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Dimitrios Skaltsas

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

This episode is in partnership with MIT Club of Boston BioSummit. I am Naji your host, joined today by Dimitrios Skaltsas, CEO and co-founder of Intelligencia AI. Founded in 2017, Intelligencia AI leads the way in leveraging proprietary data, biomedical expertise and artificial intelligence with its patented technology to address significant challenges in the pharmaceutical industry. Intelligencia AI has been recognized in Inc. 5000 and as one of the Top 100 Healthcare Technology Companies. In 2021, the company completed its Series A funding and was named one of Forbes’s Top AI Companies to Watch. Before tapping into his entrepreneurial spirit and co-founding Intelligencia AI, Dimitrios spent over a decade in various leadership roles within the healthcare and life sciences sectors. Dimitrios holds an MBA from INSEAD and a law degree from University College London (UCL) and the University of Athens.

Dimitrios Skaltsas: Uh, great to be here. Thanks for having me. Well.

Naji Gehchan: Same here. I’d love first to hear more about your personal story from law to business, to AI in healthcare. What’s in between the lines of this inspiring journey?

Dimitrios Skaltsas: Oh, uh, for sure it has not been a linear journey, um, starting from where I am now. I’m, I’m an immigrant.

I have been in the states since 2013. Um, and I have been fortunate, like, you know, being at the right place at the right time to find fertile ground and grow my ideas and, uh, and create intelligentsia. Um. At the same time, you know, if I go back to my roots, I, you know, I often refer to ODI like Ulysses and you know, the guy who was away from home for 20 years and he was always trying to go back.

Um, yeah, thinking of. Ulysses and, and love. Um, you know, my journey, uh, has also been linking me back to Greece in some ways. So I founded the company in the US and, and most of our, uh, partners and customers are in, in the us. Uh, at the same time, much of the r and d. If you think of biologists and software engineers and data scientists and so on and so forth, they’re locate actually increase, and that’s my way of bringing something back and giving something back to my country.

Naji Gehchan: Um, this is great. I love how you’re framing it also from really as you said, your roots. And we discussed a little bit, uh, the linkage, uh, and going back. Um, so you, you did start studying increase before you, uh, immigrated and it was law. And then now it’s like one of the most, you know, hot topics of AI and in healthcare, which is another also like super intriguing, uh, space.

I imagine for you as you, uh, crack down AI in this space, how, how, how did you make these different pivots in your career?

Dimitrios Skaltsas: Yeah, it’s a bit crazy as you think of it, like going originally from, from load to actually pushing the boundaries of, uh, of AI within, uh, live sciences r and d, uh, identity, the commercial side of it.

Um, again, tying to, um, this podcast here. It is about love. Like, and, and I’ll tie it also to my roots. Uh, I grew up in a family where, uh, you know, I received a lot of love and I, I, I saw also love being expressed in some ways through, um. Healthcare and life science, like, um, one of my parents, uh, used to be a medical doctor so often I, you know, I could, uh, I could see how, you know, patients would, uh.

You know, who would send us wine and cheese and, and, and, and, and flowers and, and, and all those gesture of, uh, you know, saying thank you, um, for becoming healthier. And, um, and uh, also it was a family where, you know, I, I felt my parents were always giving both to me and my siblings, but also to the brother family, to friends around us and so on and so forth.

Um. And also families that, as most of the families were, uh, actually hit at times by, um, you know, medical, uh, malaise and we had people pass away. So that kind of, um, shaped my values system. Um. Now when I decided to what I want to study, I was thinking much more about, uh, you know, how have impact at the social or more broadly public level.

So that’s how I went into law. Not necessarily want to become a lawyer, but more want to have broader impact through how we live, how we regulate our lives, our societies, um. It was interesting, but I, I was also a bit, um, priceless, I would say. Um, and yeah, and then I, I, I made a thing at engineering, uh, which I never crashed from.

Um, electrical and computer, um, electrical engineer, computer science, um. And, and then, uh, you know, consulting somehow showed up. Like, I think I was in one of those people in their early twenties who at some point was not sure what to do with their lives. Uh, and, um, yeah, and the door of management consulting, um, opened up for me.

I, I joined McKinsey where I stayed for several years and. Um, yeah. Yeah. There I experiment again with public and social sector, along with many other industries. But ultimately I experiment also with healthcare. So when I joined, um, I told ’em I wanted to healthcare and public sector, and I, I tried both and at some point I work in life sciences and.

And, and I loved it. Uh, I loved the, the caliber of the people like, you know, very well educated, uh, very well spoken and dialectic in their approach. Um, I loved the, the, the concept of building, like, you know, bringing innovation to, to patients. Um, and. Yeah. At the same time, everything else that I was trying, uh, was leaving me a bit disillusioned, like, you know, with the speed of how things worked in, in other sectors and so on and so forth.

Um, so more and more I trained myself into life. Science was a hard path. You know, if you don’t have the life science academic background, uh, it’s a very. Deep, uh, shield climb, and I was worried about that. Um, but yeah, I guess I, I like the talent and it has helped me. I’m not, I’m not as deep as people like you in in world we two, but that has helped me by definition, create a broader kind of bird side view almost in the space.

Um, and, and that’s one of my strengths.

Naji Gehchan: Yeah. And, and here you are now, you are impacting, uh, you’re impacting healthcare, uh, through one of the most hype topic ai, but you’ve done it before it became a thing. So I, I would love here to learn more about what intelligent Gena AI actually does. Uh, and I, uh, I’ve been following your work.

Uh, so give us a pitch of what you do and then we can discuss a little bit more how you’re helping r and d in the biotech and pharma world.

Dimitrios Skaltsas: Yeah, so let me, let me actually. Lay the bridge to exactly what we do. And, and, and I also, um, built on the, on the love theme. I’ll keep building on it. So when I was at consulting at some point, um, McKinsey was experimenting with big data and ai.

That was back in 2015, 16, so relatively early days. And at that point I had realized for myself that one, I love technology. So I love building, I love creating, uh, I love innovation and doing things differently. Um, and that’s where I got an opportunity in, in New York to enter this new domain and build something specifically for r and d, both track discovery and development.

So that was my, my eventual preach to AI and, and data science. Um. And, and that has actually led to intelligentsia. Ai. Um, so one of the recurring themes of my work back in the day, and obviously these days, has been r and d productivity. So ever since I remember myself in the space, like since, you know, uh, two thousand nine thousand ten, um, RT productivity has been declining.

Um. And one of the, one of the key themes that you see, especially with larger companies, is that in a way it’s still r and d is a lot about portfolio management, portfolio strategy. You make bets, uh. On, on multiple tracks, on multiple programs at any given time. And you have to make decisions on which things to advance, what things to accelerate, uh, what programs sometimes to decelerate or, you know, trials that you discontinue and so on and so forth.

And, and people typically do an ENPV risk, astic, NPV analysis on this. Um. But my experience was consistently underwhelming in the sense that when it comes to risk, which is at the core, at the heart of drug discovery and drug development, like we all make bets and big bets, and that’s why those bets are rewarded through IP and and protected prices and so on and so forth.

But when you make these bets and you think about risk. There is not necessarily much science going into this. Uh, so I haven’t, I hadn’t seen very robust frameworks of how to define the risk. Um. Uh, I was working a lot in due diligences and m and a and portfolio strategy and commercial strategy as well.

And, and every time we’re going through the exercise, you know, we’re relying on historical benchmarks and obviously calling experts and, and creating something semi quantitative. But even at that times, often, you know, the, the people who say CRA here in the room actually would come in and apply their own, um.

Intuition, their own judgment and, and often almost throw out of the window, even this semi quant analysis. Um, so yeah, when I was exposed to more AI and other science applications, I thought that could be, uh, one of the holy trails, the space that can be addressed in a more appropriate way, um, through these emerging technologies and.

And that was the initial bet on intelligence. And that is the core of what we still do. We’re the first company to apply, uh, productized, uh, approach on addressing proba or assessing probability of success with machine learning, with predictive modeling, uh, we take a host of, um. Features or aspects into account?

Uh, we have a patent technology. Uh, we have accuracy that has been prospectively validated for several years. Um, obviously we’re not a hundred percent accurate and we’ll never be. Uh, but I do trust that we. Provide a very good, robust, consistent triangulation method, uh, for decision makers out there. And that’s why we are being trusted by, uh, a lot of the large pharma.

Like we’re working now with more than 10 of the top 20 parts, pharma, uh, and also with the host of Meat Cup, Liz. Less often with smaller biotech. Uh, both because of our business model, which is mostly software as a service. So it’s, you know, carrying access to a product that, that tends better to, you know, larger portfolios.

Um,

but also, you know, if you’re a biotech, you kind of live and die. Hmm. By your, based on your decisions of development track, right, exactly. You have to maximize it times for these, uh, one or two drugs, uh, more than decide on how to calibrate your portfolio. Yeah,

Naji Gehchan: yeah. So in your, in your work and your help, obviously, like this is an ultimate important, uh, problem to solve for, you know, probability of technical su uh, success of the trial decision making between different prioritization.

So your work is a cross portfolio, or, or how do you optimize actually the PTS because. There is the, uh, probability of success there is. I’m sure you’re faced with several questions on efficiency of the trial’s, productivity, the length of enrollment, and then like all the execution of the trial. Like I’d love to understand what is the main focus you’re doing, uh, through your patented technology, uh, and what are you thinking for next steps of improvement, uh, of drug development?

Dimitrios Skaltsas: Yeah. So we took, uh, a more high level, more strategic approach where we say, okay, let’s try in this to define probability of technical and regulatory. Well, let’s, uh, let’s train a model where the objective function is with this program. Actually receive FDA approval down the line, be. Nine years from now or be, you know, nine months from now, depending on which phase, uh, the program is.

Um, and then we gathered a lot of historical data and we create, we engineered features and, and we train models that could apply pattern recognition. Stronger partner organism, what with humans apply with more data than what we typically humans have. And, and, and differentiate problems between more likely to succeed, less likely to succeed, right?

And apply a specific probability. So that’s how we started. And then over time what we did is we have been, uh, become stronger also in the phase transition. Probably this, which is more of the. Technical success and also providing visibility into the underlying drivers that will help people also be more, um, prescriptive if you.

Interact with like, how can I improve my probability of success at the asset level by changing things that I can change? Not your question. Uh, we are, how are we planning to expand the one is more sensitivity, more what ifs, scenario planning, like invest more into the prescriptive part of the equation.

Like how can you. Prove probability of success at the asset level and at the program level. Um, the other thing is more broadly, if you think about portfolio strategy, um, one expansion has been ongoing in terms of therapeutic carriers, like we started oncology, then we move to immunology, inflammation, CNS, now metabolics, cardiovascular, renal.

But we still haven’t covered everything out there like. For instance, we’re going after Infectious Disease Index and so on and so forth. The other one is, um, geographic expansion. We started with the US FDA, we cover a lot of, uh, EMA. We are venturing out China, which has become increasingly relevant for innovation.

Um. The other thing is functionality wise, you know, we realized at some point we, we were forced to create a very clean, high quality summary level clinical development data set. Which, if you ask me, I think it, it, it’s likely to be the best, uh, exists right now in the space. ’cause we’re trying to. Feed the algorithms in a very proper way to solve these, uh, specific problems.

Right on this crown, our sponsors, school, our partners, our customers have all. Quite often been pushing us on developing more things, more functionalities. So now for instance, we have been developing, uh, something around target product profiles. Uh, we have been developing some functionalities on, you know, more broadly, track development insights and, and executive level landscapes.

Um. We have been, um, exploring more broadly NPV analysis. So we’re not the experts ’cause we don’t bring all the elements there, but that’s, that’s how we expect. Typically we get feedback from, uh, or gently push from, uh, one of our, um, customers. We test it with others and if there is need. If there’s market for that and if we think we can be best in class in what we do, then we venture into that.

Naji Gehchan: Well, one of the things, Dimitrius, as you were giving, why you started the company, uh, I, I wanna understand also and get your view as you have built now the company is, you said like some folks. We’ll throw out even the semi quant analysis and go with their gut and, and we hear it, right? Like I’m in drug development for a while now.

Like we all say, like there’s an art to it, there is science to it. There is different aspects that we look, but there is this human decision making that several of us actually enjoy and like, so I’m interested during this journey. There’s, I’m sure a piece of change management that you help the companies.

Get to as you bring a more data driven approach that is based o out of the models. Do you have any examples? ’cause I’ve seen several times, as you said, like all the data would show something, but then someone still believes that our intuition is stronger than data. Like how, how do you manage the art of data with the scientific and medical intuition?

Dimitrios Skaltsas: I’ll, um, I’ll address this in two ways. I’ll go in two directions. The first one is that when we started, you know, one of our values is humility, like being grounded, but still, when we started having a powerful tool in your hands, like ai, um. Sometimes we felt, oh, we we’re getting it right. Like no, uh, we’re getting more right than everyone else.

And sometimes there is also a validating this, but there has been a mindset shift, like the more you work with the people on the ground, the more you realize you ought to be a decision support tool. Like your, my role, our technology’s role is provide insights. For people like you to make better decisions, like, um, apply your own intuition or run the dialogue internally in, in a more data driven way, so.

With that in mind, um, the way we quite often work with our users is even large companies often don’t necessarily have a specific, um. Uh, process around p you will see that the ownership, uh, is, is quite different from one company to the other. You’ll see that workflows, uh, they may not even exist or when they exist, they, they run a different way.

Uh, what I have seen work. Increasingly well our process where it’s a mix of one, they, they’re cross al like it’s. There, there are multiple people coming together to, to actually inform those decisions, even if ultimately it’s one person making those decisions. But there are multiple people involved in the process, often owned by like the recommendation owned by the program managers, but not necessarily.

Um, and then it’s typically a mix of historical benchmarks. And I’ve seen again, companies that use not none or rely on papers. White papers or external papers, commands that use three or four historical benchmarks. You see all the, all the spectrum there. But typically there is some baselining that can be done with historical benchmark.

This base line is informed then triangulated by what we do, um, more. Data achievement, more smart approach. And then there’s a dialogue where either it can be done around some heuristics. Some companies have heuristic or create heuristics where they say, you know, we’ll use those heuristics to apply, uh, or to, yeah, to apply our own infusion and, and, um, change the pt, the PTS or PTs, up or down.

Um. Or sometimes, you know, we help inform those heuristics because we have our own drivers who have the explainability so that people can go inside the system and say, oh, you know, it’s, uh, 25% and it’s driven by this, this, and that. Actually, we do not believe that, you know, these drivers should have that much influence because we know our track better and we think that, yeah, the MA has not been, um.

Validated so far, but, uh, we know a bit better because we have some more data. So this should not be a minus two, it should be a plus three. Right? Uh, so that’s, that’s how it works. And then still people, yeah, people actually will apply. Sometimes still people will, uh, have the tendency to throw this out of the window, but listen less.

I, I see the. See the industry is more and more hungry on, it has always been hungry on data, but it’s more and more hungry on, you know, systematic approaches. And the more we get validated on this specific niche, for instance, the more the, there’s word of mouth. It’s like, okay, you know, we can do it is a bit more systematic.

But always people will ultimate rely on their own intuition. You’ll never get away from that. And, uh, I’m not sure that. We should, like ultimately, you know, there are decision makers and, and people who have honed their skill, uh, in a way that our machines, I think we’re still far away from.

Naji Gehchan: And I know how you framed it, right?

Like providing insights to make better decisions, like keeping, uh, there, there is still a place for intuition and art in all those, uh, models. Like, because it’s, uh, being smarter in the way we do our decisions rather than anything else. And, and I know you’re, we’re, we’re talking about art. I know you are.

You love art, you paint, and I would love to, uh, you know, like open, uh, my last questions about. Painting the Greek countryside, this is how you spend most of your time. How, how do these passions influence your leadership and your, your personal decision making?

Dimitrios Skaltsas: Yeah. Uh, I’ve never thought about how they influence my leadership.

Uh uh, yeah. If I start with painting, I love painting. I love drawing. Uh, like these days I will, uh. You know, when I do paint or show half the time, I will be painting. People I know, uh, and often write because, because, you know, you, you focus on someone. If I start focusing on painting you, then it feels like you start to know the other person better.

Like you, you start connecting emotionally with them and, and trying of unpeeling their own personality, their own characters, their own emotion. So I love that part. And there are half the times I’m just throwing. Colors on, on big canvases, and it’s more of the art that I would do when I was seven or eight years old, like abstract art, uh, which is very creative because it’s open-ended.

Uh, the one makes me focus a lot. The other one, um, it’s very open-ended and maybe that, that that’s the linkage to leadership. Like I think.

At least in my case, but it applies more broadly, uh, leadership of a function of a company, of a team, of anything is, is it’s both about having the ability to, you know, take a few steps back and, you know, uh, look at the broader picture in a more relaxed way. Ideally, uh, and, and do some idea generation, um, and, and also at the same time be able to connect with the people, understand the people you are working with, um, inspire, get inspired.

That’s, that goes both ways, uh, and, and go also sometimes into the details, like the things. Um, and I do less and less of the latter, which is relaxing to me, like avoiding sometimes going the details. But building a company quite often, you, you, you still a little bit a plumber, uh. I remember like we’re now in the eighth year, we’re about a hundred people strong and definitely we have a very strong, nice, mature, in many ways, leadership team, but sometimes still things will, you know.

Fall and or be orphan like, you know, something new will come up and no one is responsible. And you have to, you have to be the ultimate protector to come in. Like the person will go in, solve it and make sure next time, you know, there’s a better way for this to be done. Um. Yeah,

Naji Gehchan: I love it. Uh, what is the first word that comes to mind when you hear the word, uh, leadership?

Actually,

Dimitrios Skaltsas: uh, what I often tell to, to my team members is. Like, for instance, we had a person who, who got promoted now, and, and I recall in our discussion, the first thing I told him is, you know, this is about being servant leader. This means that you have more responsibilities over our team members now and external world, uh, than before.

It doesn’t mean that you ask more people from more things from them. It means that. People will expect more from you and I’ll expect more from you. Um, I think it’s, it ties back to responsibility in my mind. Leadership is, uh. Being able to take responsibility, enjoy it ideally. So I think people who thrive in leaders’ roles are people who enjoy responsibility in building, but also even when you don’t enjoy, and there are times where, you know, responsibility can’t fall quite heavy on our shoulders.

Um, you know, you, you’ll bear with it. You’ll make sacrifices. Um. It’s, yeah, that’s, that’s what I think about leaders taking responsibility, conserving others.

Naji Gehchan: What about, um, the first thing comes to mind when you hear clinical trials,

Dimitrios Skaltsas: uh. Uh, expensive and a, and a blessing because often people outside our space, outside our industry, uh, don’t realize why.

You know, we have to run these very well regulated, uh, again, long and expensive, uh, process. Um, I think it’s a blessing that, you know, our societies have come up with this process where we ultimately protect, uh, the patients, uh, what translates, or, you know, what applies well and preclinical. Settings quite often doesn’t translate as expected into human biology.

So I think it’s really good that we have this gated approach. Um, I do think there are many opportunities to get faster, better, stronger, um, and, and we see it happening. Like I think COVID was. It was very interesting in helping us see that there can be different part times of, you know, accelerating innovation.

Um, uh, yeah. I, I think it will be, and I’m glad that it will be eventually, um, really, really long process until we get there. And because it means, uh, you know, pe it still stays well regulated and people don’t take. Too many experiments. I think we ought to experiment and learn and apply technology. That’s what we do.

Um, uh, you know, you have to test things first and, and then things,

Naji Gehchan: well, talking about technology, the third word is ai. Poof.

Dimitrios Skaltsas: You know, it’s in our name, so we cannot escape it. And it’s in our technology. I mean, that’s. In many ways that’s, that’s what we stand for. Um, okay, let me see. It’s an opportunity, it’s a huge opportunity for humanity, for life sciences, for all of us.

Even the person who live. Um, it can, it can help generate a lot of efficiencies, a lot of productivity, uh, unlock our minds and how we do things. It’s risk is, um, it can be a major risk again to. Humanity. I think if, you know, we, um, we don’t apply some appropriate frameworks and ethics and, uh, and discipline into how we do ai.

Um, and that’s long term. I think also in the medium short term, it’s risky in the sense that, uh, you know, we get more and more. Familiarize with those technologies and if we don’t, if we’re not careful enough, they can mislead us like special generative ai. It still hallucinates. I know. You know, it gets better and better and better.

Specialist CP five that was just released. I play a bit with it. It does hallucinate less than the past, but it does hallucinate and, and I see myself where I use a lot of same AI in my, my daily life. Sometimes I forget to apply limits. I, I get too comfortable with it, uh, until I have a reality awakening or that whoa, uh.

Yeah, I think it’s, overall, I think it’s, it’s a blessing. Like most technologies, it can be very, uh, it can be very risky if not applied, of course, in the proper way.

Naji Gehchan: Yeah. Goes back as, as you said, like any technology to the ethics. Integrity and how you use it. Uh, and if you’re using it for good, but it’s, uh, I love how you started it.

It, it is an opportunity for humanity, uh, as several of the advances in life sciences too, uh, that, that are blessing. But if well used the last word is, uh, spread love and organizations.

Dimitrios Skaltsas: It, it is what inspired me to, to come to the podcast. Um.

I think it’s about caring, which again, is one of our values. Um, it’s how you we care about,

about the people and about the organization. And I would say it. It’s different by the context, by the by,

by the level of maturity or by the states are Wes. The organization needs, uh, love for me was very different when we’re. A couple of people in the organization. I was in love with the idea. I was in love with the concept. Uh, and everything was frozen, by the way ’cause we didn’t have too much responsibilities back then.

And then it was different when we were 10 or 15 people. Then I had a very strong instinct of, um. Being in a crew, like almost in a wolf pack. Uh, and I, and I felt this, this love over, over, not necessarily what we do, but over the team. I’m like, you know, we, we need to succeed. We need to protect each other.

We need to take care of each other and grow together. And it’s different now that we a hundred people where, um,

it’s.

Speaker 3: You

Dimitrios Skaltsas: know, it’s a lot of caring for the people, obviously the people that we started with, but also more of the newcomers, but in a different way. ’cause I don’t even know them. Some of them personally, like I know them by never having to. But it’s more about making sure, you know, they have the appropriate career paths and they can grow and they can get opportunities, and they can have a quality of life that fits them, so on and so forth.

Uh, but in a more impersonal level. And it’s also care obviously about the, the customers and what we deliver. So we’re getting closer and closer by the years with our actual users because. You, you know, our work is such that when I think of impact, I’m like, you know, there is this broad impact in the space where we can make this help make the space more product more efficient, so ultimately get better drugs patients faster.

But in our daily reality, we interact with our. Users and much of the energy, much of the reward, the emotional reward we get is by, you know, how we help our users. Uh. Have a better life, like be more productive, their work, be smarter in their work, have better outcomes, and so on and so forth. Um, and caring about the organization as well, like, uh, shareholders.

Uh, I would compete. It’s, it’s a more multifaceted love, I would say, but practical, I think love. Always to be practical, like expressed in, uh, through our contact, through our actions, uh, and, uh, typically translation to care.

Naji Gehchan: Uh, that’s, that’s a great definition, uh, about caring leadership and, uh, love in organizations.

Any final word of wisdom, uh, Demetrius for healthcare leaders around the world.

Dimitrios Skaltsas: I was, I was listening to some other podcast, um, you had, and I was always inspired by that part. Uh, I thought, before I call, the one word that came in my mind is prevention, which is not what we do. It’s very different. But I’m like, if I think about healthcare and life sciences.

I think the world would be a better place if we collectively exercise, invest more in prevention, in how we avoid having to take certain drugs, um, get, go to the hospital, see our, um, see physician or ZP, so on so forth. Like if. It goes back again to where I started. Again, my roots like more of the social public sector, but like if you can incentivize people, society, uh, and, and educate.

People in society and create the right mechanism. Systems, we’re in process where, you know, we can eat better, we can sleep better, we can uh, we can go to our GP earlier and, and make exams and test ourselves and, and yeah, avoid getting, uh, sick, um, to the extent that’s possible, right? It’s in many cases will not be possible, but yeah, eventually.

Naji Gehchan: Well, I feel there’s a new venture that might be building up, uh, for prevention. I’m, I’m all in for it with you. Well, thank you so much again. Thank you so much for being with me today. It was, uh, a great chat and, uh, again, a huge, uh, kudos to all that you’re building and you’re doing to help, um, all of the pharma and biotech world, uh, bring innovations to patients faster.

There is certainly a lot to be done still in the healthcare world. So thank you for much for all that you do,

Dimitrios Skaltsas: Azi. Thank you. Uh, pleasure connect with you and thanks for, you know, creating these, uh. Podcast and, and ground for, for this type of discussion.

Naji Gehchan: Thank you. Thanks for listening to the show. More episodes.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: John P Bamforth

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I am Naji your host, joined today by John Bamforth for the launch of his book: Race to Innovation. John grew up in Wigan, England and studied at the University of Bath and Aston University, earning a phd in neuropharmacology. He joined Eli Lilly in 1989, building global brands and leading diverse teams after moving to the U.S. in 2001. Most recently he completed 6 years with Eshelman Innovation at UNC-Chapel Hill, helping turn breakthrough ideas into real-world patient solutions. I had the pleasure to know John for years now and he was my very first guest on the show 4 years ago!

John P Bamforth: Great to be back. Naji.

Naji Gehchan: Uh, well, I certainly recommend folks to listen to your story on our first episode, John. Uh, but why don’t you share with us again, through the lens of the past four years and a little bit of the craziness, uh, in the, in the word and how the word changed since the last episode we recorded during the pandemic.

Actually, uh, can you tell us a little bit more like a brief story about who you are and where you are today?

John P Bamforth: Yeah, sure. Um, well, Naji, you know me well, um. I, uh, had 30 years, as you say, at Lilly and then moved to the, moved back to academia, which was quite, quite a journey in itself. Um, and moved back to early stage science, right?

So we were in the institute and I literally just finished the six year stint there. You know, we were developing early stage therapeutics. Um, so very different to my role at Lilly and, and also digital health companies. So. That was a great experience. Uh, um, a great experience for six years working back within, you know, we were, we were embedded in the number one school of pharmacy in the country.

Um, and, you know, it was, it, you know, it was really, um, so about the time that we last talked, I mean, it was, it was around that point in time that, uh, everything happened with George Floyd, um, and, uh, and his murder. That caused Roy, who’s the co-author of the book, Roy as well, and I, to pause a little bit, um, there was a lot of, as we all remember, there was a lot of back and forth at that time around, uh, race and, and everything associated with race and, and a lot of reflection.

And Roy and my reflection was, you know, this is a community, the African American community that, that, uh, we know. Um, to a degree. I mean, I’m, at the end of the day, I’m still a Brit right at heart. Uh, and so I, I was still in my learning journey about the African American experience here in the us but you know, that we knew enough that, you know, the African American community has a really rich history in innovation entrepreneurship that in some cases not many people know.

And so, um, we, we decided to, to dig in, uh, to, to do a little bit more research. And, uh, out of that came the book, right? And, uh. The books got dives deep into the African American community, but we believe this is a story that applies to many un underrepresented communities. In the US We always say, including white, rural America.

Um, this is not about the color of your skin. This is about marginalized communities. And I think, and you and I have this global experience, I think this has application outside the US as well.

Naji Gehchan: Yeah, it certainly does. And you know, I loved how you frame it between your incredible journey career that you had, your roots as you also shared last time, and you said you’re bit by heart.

Um, and also what has happened, uh, through the last, through the last year is it’s kind of culminated, it seems in this book. Right. So tell us more about trace to innovation.

John P Bamforth: Yeah. So, um, you know, we di I think, as I say, we took. Um, the research was really to understand the history of innovation within the Afri African American community, um, which is a long and storied history, pulling out individual stories, you know, uh, uh, Madam CJ Walker is a great example because it has a, a connection for, for us in Indianapolis as well.

’cause she, that’s where she ended up with her business. You know, the first African American female millionaire. In the US and then we interviewed a whole host of current day innovators and, and entrepreneurs and told their story in the book and, and we came out with five domains that we think are important, encouraging communities like the African-American community.

’cause our high level premise, this is not a de and i book. This is a business book. Okay. The premise of the book is. If we encourage these types of communities and support these types of communities to innovate and become entrepreneurs, there is a benefit to all of us. This is not a zero sum game, so the majority doesn’t lose.

If we encourage these communities to innovate, we all win, and I think that’s probably the most important message from the book. And there’s a lot of debate right now in the US and frankly outside the US as well, is that. There’s a lot of discussion about immigration. There’s a lot of discussion about, um, different communities and, and some of the, some of the concepts are, you know, people, these people are coming to take our jobs.

Our bias is completely different in the book. Our belief is completely different. We believe both from a community perspective and economically, that if we encourage innovation, entrepreneurship in these communities, it benefits all of us.

Naji Gehchan: So, John, let’s start, uh, and I want to go there, uh, because it’s, it’s a key out output that you have, um, about all thriving together. So I wanna go there, but before that, can you define how you’re thinking about innovation in the book? Like, it’s a word obviously, that everyone uses, like think of, et cetera, but how, how do you define innovation?

John P Bamforth: Yeah, it’s a great question. You know, my, my friend innovation is, uh, probably a little simple. Um, you know, for me, and it, it goes probably back to, to our days at Lilly, you know, innovation to me are, are novel solutions to, you know, uh, really challenging problems. Um, that’s one of the benefits, um, of, um, the joys of diverse thinking, particularly on teams, right?

I mean, you and I had the pleasure of working together at Lilly on some very diverse teams. Um, global teams, you know, the, our work together on, on Seattle back in the day, you know, we had people from all over the world on that team, right? We had people from Japan, we had people from Portugal, we had people from, when I say those countries, you’re thinking of the people I know.

Exactly. Because we all knew. We all knew who I’m talking about. It’s all about people. It’s all about people. But those teams, um, we didn’t pull those teams together. Because we wanted, you know, different countries and different, you know, colored skin. We pulled together those teams for the talent, right? We, we pulled in the most talented people we could find from around the world to enable our success.

And when we got that team together, and, and you and I know that team still talks today, we’re, I think the, we’re talking about like 2003, 2004. That team still talks today, like almost daily, right? Almost daily. I’m texting those same people like usually every week in some way, shape or form. And the reason that team is so tight is the quality of innovation and, and business acumen that that team brought to the table.

’cause everybody had a different view, right? Every had a different lens on the problems we were dealing with. Everybody had different, uh, ideas of how we could solve those problems. That was respected within the team, right? We’d argue sometimes and, and have all those arguments, but nonetheless, the, and, and it delivered amazing outcomes, right?

And I think that’s the richness that we’re trying to pull out with the book is, look, we’ve got, you know, one of the first principles we talk about in the book is, um, uh, recognized potential. So, so believe there is potential in every individual that comes in front of you, no matter what their background is.

Assume potential is the way we describe it, assume potential. And there are some great examples in the book of, of, of individuals that we’ve talked about in that frame. But if you go in there with that mentality of no matter what background that person comes from, African-American, whatever, Lebanese, um, assume potential, assume that they’re gonna bring value to the table.

It’s just gonna, it may represent itself in a bit of a different way, right.

Naji Gehchan: Yeah, certainly. And I can of course attest to all those stories with Cialis and, but you know, John, like, as you were talking about it, which is very true, and we kept being a tight community either growing within the company or now, like that’s very spread.

You know, as I joined was my first job in the, you know, in corporate it, it, it felt so natural. As I grew in roles and leadership, I realized that it’s not actually, you have to be intentional about it and have those core beliefs in humanity, basically. And so, so you’ve done it, like you’ve done it through a leading career.

You’ve done it also, uh, through leading innovation in academic ways. Like is there, is there a formula? Like can you get people believe in that and do it? Because we discussed several times the scarcity of this, so I’m, I’m, I’m sure within your book it’s kind of a recipe for those aspiring to do that, but in a word where potentially we’re seeing more, you know, like people fearing one another rather than embracing our differences to thrive together.

Like what is your message of hope and how to do that?

John P Bamforth: I, I actually don’t think it’s very hard to do. I just think it’s not done very often. Um, and, you know, uh, we’ve probably talked about it before, we may even talked about it in the last podcast, but, you know, I’m a great believer in, uh, what Daniel Pink describes in this book drive because I think it’s the essence of building this, the sort of culture that we’re talking about.

And, you know, he talks really about three things. He talks about, you know, humans, humans like to learn, they like to feel like they’re growing, right? And so asking people in a team, you know, what is the, what is the big audacious goal for themselves as individuals? What, what is the, what are they trying to achieve in life?

You know, it’s surprising how few times people are asked that question, right? What do you, what do you wanna do with your life? Right? So that knowledge piece is important. Um, the other thing he talks about is autonomy. So the feeling that you’re in control of what you’re doing within your job and that you, people trust you to go do the right thing.

Again, it’s, that’s an infrequent thing. You know, people, everybody talks about micromanagers and our whole nine yards, right? So many times people don’t trust their employees to, to do the right thing. So autonomy’s really important. And then this, the last piece that Daniel talks about in the book is, is that purpose piece, right?

That vision of something. You know, when we were doing Cialis, you know, we had, we won’t go into the details, but you know, we had a audacious goal that we all bought into and nobody believed outside the team that it could be done, but we did. We believed it could be done and we achieved it and surprised everybody that that knew us, that we would that, but we believed that we could do it as a team, we’re like, okay, they don’t think we can do it.

We do. We’re gonna go do it. Right? And sure enough, we built, you know, the number one brand in the category. That’s what we wanted to do. No, we believe we could do it, but we did. And that, you know, that that purpose piece bonded us together and we had a ton of fun with it as we were doing it right.

Naji Gehchan: Yeah.

Yeah. And, and you know, like I, I, obviously we talked about this and I, I thought a lot about it. O of course the purpose is so important, but I would go back also to what you started with. It had like, purpose, you know, as I thought about it, and basically when we discussed me studying this podcast four years ago, and the name of Spread Love, right?

In organizations you have the purpose, the vision, the, the values. They need to be here and need to be aligned. And, and then what you just said about trust, like for me that was the piece I think that you led and that a lot of us now leaders aspire to lead teams that way. Where you build this genuine care of a community here together to achieve this bigger purpose and, and you’re mixing it with diversity.

Obviously, as you said, that was one of your core beliefs since the beginning. Um, that, that made a difference, right? Like this genuine care for one another. And it’s funny, like this is why we stay connected, right? Like we generally believe that we can achieve something big, but we generally believe that we can do it together.

Yeah. And there’s a place for all of us and you know, like we care for one another and this is why we keep on calling one another. Actually,

John P Bamforth: no, I, it’s funny ’cause uh, you know, I’ve got a copy of the book. Um. So, you know, this came out with a dialogue with Roy and I, right? So, hey, this is really interesting.

We should do some research here. Maybe we should write a book. Oh, that’s a good idea. Maybe we should write, have you ever written a book? No, I’ve never written a book. I do that. I have no idea. I have no idea how we write a book. But let’s, why don’t we go try, right, let, so again, I’m going back to this vision police, like how are we gonna do it?

I don’t know. But we, we will work it out, right? We’ll work it out. There’s a, there, there are three. The reason I hold up the book, there are, um, there are three contributing authors in here. There’s a, you can see it, but there are three, three faces in the book here, three contributors. And it was really interesting how those three individuals came in, came, became part of the project.

Um, Maya, uh, Maya Fitzgerald, um, is a pharm d student at the school. She, she, uh, connected with me on LinkedIn. Before she even came to the school and she said, I’ve read about the institute. It seems really cool. I’ve done some work in biotech already. Are there any, are there any roles that I can do within the institute?

And, uh, she’s Maya’s a bundle of energy. In fact, she’s, she’s already had two internships at Accompany You, and I know quite well you leading company, but Maya, Maya did a lot of the early research, a lot of the kind of bench research on the book. As soon as she arrived at the school and got super excited about the whole thing, dove in and has been part of the project all the way through.

Um, Ashley Thomas, um, uh, we hired from the School of Medicine. Um, she was an individual that, um, in the, when we first hired her, I think all the jobs she’d had to this point, she’d just been kind of just do the job. If we don’t need to know who you are, just do the job. And when she came to the institute, we slowly but surely pulled out.

We, you know, we asked in one of the early conversations, I said to her, ’cause she told me a few things about her, but she was still a little reticent to share too much. And Ashley’s African American, um, her stories in the book as well as being a contributor, but she had a interest in, um, gardening. She had turned around the lives of her grandparents by getting them onto health.

They were both dying from chronic illnesses and she’d given up college to go support them and help. She thought she was gonna help them through a passage to a, a premature death. But when she got there, she realized what was going on. They were eating highly processed food, poor food. They were in a, essentially in a, in a food desert.

She completely changed their diet. Oh, wow. And got them onto a healthy path and then went back to college. Wow. And so that, that drove a real interest in this, this frame of healthy eating, gardening, et cetera. Lo and behold, she tells me in one of the first dialogues, well, actually I have an online, I have an online presence.

Um, I’m, I’m the mocha gardener and I’m just about to publish a book on gardening. I’m like, what? What? Um, and so, you know, we tell her story in the book, but we, we pulled her onto the team, right? She comes from the community. She had a passion for what we were talking about. And so she came onto the team.

And then finally, Ruben Blackwell, who’s, uh, an amazing leader from, uh, from the African American community here in North Carolina runs a, um, a whole system in Rocky Mount. Rocky Mount in North Carolina was a tobacco. Town. Um, and then when, when tobacco, uh, the tobacco industry became less profitable, what Ruben always says is All the white folks left and left us all we had.

Right. And so it’s a, a very, um, uh, a very black town in North Carolina. Ruben runs, um, a federally qualified health center and some entrepreneurial, uh, activities in, in Rocky Mountain. And Reuben has a long history. Uh, we going all the way back to Martin Luther King. So having somebody like Reuben who has the history, uh, of, you know, the struggle Yeah.

Of the African American community, having him advises on the book has been super valuable. His story’s in the book too. Um, so, so, you know that, that team, long-winded answer, but that team has come to, came together with this, again, going back to what we talked about with this vision of what we were trying to do with the book, which is change the frame of how people think.

About people with different backgrounds. Right?

Naji Gehchan: Yeah. And, and I wanna go back to that. ’cause one of, uh, as you said, one of the key takeaways, uh, you’re, you’re really framing in the book is those difference can help us make a difference, not just in how we all live together, but in how we all thrive together.

So can you tell us, can you tell us a little bit more about, about how you view this?

John P Bamforth: Yeah. Uh, again. One is this openness to, uh, believing that everybody who walks into the room brings value, right? Brings value to the dialogue. But it’s also this frame of, um, you know, a lot of these communities and I, and I, I, we like to talk about rural white America.

As an, as an unrepresented community, because it, first of all, ’cause it is, you know, we did, we’ve done a lot of work with the institute up in Western North Carolina, up in Asheville, um, because we were doing some innovation work, uh, in the opioid space and, you know, the, the epicenter of the opioid crisis in North Carolina is up in Appalachia, up in, up in Asheville.

And they had the, the best insights into that problem. We built a, we built a very successful digital health company to solve some of the problems associated with opioid overdose that was built from the insights of that community. Right? So it’s just a great example of saying, look, the, these communities bring insights to problems that others don’t.

The majority probably haven’t had the experience, like nobody in route, nobody. People in Raleigh have experienced the opioid crisis than Western North Carolina. So surprise, surprise, because they’re dealing with that problem every day. They have the best insights to solve the problem, right? So go. All you are doing is you wander in there, is you’re pulling out those insights, those, those solutions that they already kinda know, right?

And you’re helping them bring it forward. So that frame, frame of thriving is, you know, let’s listen to people. Right. Let, let’s assume good. Uh, let’s assume potential, and let’s assume that by working together we can solve some of the most intractable problems that we have in our society. Um, it’s just a different frame on how to go about engaging with people.

Naji Gehchan: Yeah. That’s a beautiful charge, I think for all of us, uh, to just. Assume those things, assume good, assume potential, and working together to solve big, complex problems. Uh, but I have to ask you, jb, why and how you wrote this book.

John P Bamforth: Um, the why, uh, first of all, there’s a, there’s a, there’s certainly an African American lens on this.

You know, the, the, I’ve spent 24 years here in the US now still learning about. The African American experience here in the US which is, is, is has some interesting history. In fact, we’re off to, um, we’re off to Tulsa next week to, to Greenwood to launch, launch the book. And, you know, to launch, it’s a privilege to launch the book down there.

’cause Greenwood has a rich history, right? It was Black Wall Street. We use, we, we use that example in the book to say, look at the speed of growth. Entrepreneurship that happened in Greenwood as it grew, unfortunately, to the point where people didn’t like the speed of growth, right? There were, that’s why it was burnt to the ground, because of the speed, um, and the, the scale of success that, that was happening in Greenwood.

But, um, highlighting for me the, the, the African American experience. Just as an example, right? Just an example of what’s possible and, you know, tell some of the untold stories around what, you know, the contribution that the African American communities made. ’cause it, you know, I, I’m, I’m blessed to have a lot of friends in that community and certainly at this point in time, it’s probably easier for me to tell that story and it is for that, um, ’cause a strange English guy can go talk about these things where sometimes they may not be able to talk about it.

Right. But then to say, okay, that’s just an example, but let’s now open the aperture to say, how about if you apply, apply this idea of the potential of these communities to the US as a whole, to all of these communities that we’ve talked about. And then even the globe, right? There’s too much, you know, we all, we’re all looking at these conflicts going on around the world, you know, in your home country, in, you know, in the Middle East, in Ukraine.

You name it. Right? Um, you’ve gotta find a way of being counterbalance to that, right? To say, you know, you can look at your enemy and assume they are your enemy. Or you can look at somebody and say, again, assume potential, assume that you could maybe have a different relationship with that individual, right?

And, and I, I think we want. The book to be a, you know, a counterbalance to a lot of the negativity that surround that surrounds us right now.

Naji Gehchan: And we, we certainly need that. We certainly need that, and I’m looking forward to reading it. Uh, John, you, I, I, it’s hard to like segue into this next section, but I’ll do it.

Um, you know, this one where I’ll give you a word and you’re gonna give me a reaction. Uh, two words are the same. So we will, you know, we’ll see if it changed within four years. The first one is leadership.

John P Bamforth: Um. Again, the, the, the word that springs to mind is opportunity.

Naji Gehchan: What about, you talked about innovation. I have to bring this, uh, trendy word these days. Ai,

John P Bamforth: um, you know, again, it’s scary ’cause it’s the same words coming to mind. Opportunity, um, you know, um. Risk benefit is the other phrase that springs to mind. I mean, the, the upside is almost endless, but you’ve already seen it be used in, in less than positive ways.

So endless opportunity, but plenty of risk.

Naji Gehchan: Yeah. Yeah. And I love how like, you’re, you’re framing it. I’ve been thinking about, um, about this, right? Like as a. A tool. And unfortunately like, you know, you have so many tools that can be used for good or for bad and destruction. So it goes back to people, right?

And the culture you build, you build. So what about humanity?

John P Bamforth: Um, good question. Beauty is the, is the word that springs to mind. Um, you know, we see a lot of things in the press these days, but my lived experience of humanity is very different. If I think about the, you know, I think about this week alone, you know, I came back from the UK after being over there for a month and I spent the week meeting people right.

For a variety of different reasons. Um. I think every one of those experiences has been a, a really positive one. So in my mind, you know, I think there’s so much negativity when you, you pick up these things these days and look at social media and everything else. The reality is different. Humanity is very, the, the reality of dealing, talking to people every day is a completely different experience to the one you believe to be the truth when you, when you’re looking at the phone.

Right?

Naji Gehchan: Yes. Yeah. The last one, you know, is spread love in organizations.

John P Bamforth: Yeah. Well, you and I know, um, from our, uh, shared experience and we talked about one of our favorite teams earlier. Um, you know, I, I think about the, you know, I’m thinking about one particular friend right now, um, who, who’s, uh, stepson, um, in the last six weeks, um, had a.

An accident in a, around a, a lake in Indiana and passed and died, um, way too young. And uh, obviously the family’s really struggling with that right now. And, and I think the only thing, um, you can do in that situation is support. And I think, you know, for me, that’s a work, you know, this is somebody who used to work for me, right?

Uh, back in the day, back at Lilly. Um, but, uh, you know, for me, the relationship I have with that individual is, has always been very deep. And, you know, you, this is the time where you’ve gotta step up for somebody, um, because they, that’s the family that’s in real need right now. And, and I, I think being there for people in those times is super important, right?

Naji Gehchan: Yeah. Yeah. And you’ve always demonstrated that, you know, and this is part of. Love and being here for one another when it’s needed, and it goes beyond the job. And I can attest to that, John, you know, like how you’ve, you’ve been here with me and you know, I’m, I’m here with you. And it’s certainly something we, um, we all aspire to be as leaders, uh, being here for one another.

Any final word of wisdom, uh, John for leaders around the world?

John P Bamforth: Yeah, so I’d say, you know, um. I would hope people get a chance to read the book. Um, and, and the reason why is I hope people, um, take a moment to think about the world and think about different communities in the world in a bit of a different way.

Now, there is way too much tension, uh, wrapped up in the us, wrapped up in other parts of the world. There’s, there’s a lot of real value. By being open to people that aren’t, that don’t look like you, um, you know, working in global organizations, you get that all the time. Um, and, uh, you know, you, we were, I think, blessed to have those global experiences to, to know somebody from, from the Lebanon, to know somebody from Italy, to know somebody from Japan, and, you know, to come live in the us You know, you and I are both immigrants.

To live in the US for a period of time and know, come to know the United States as a, you know, the beauty of the United States, which we see a lot of negativity around that going on right now. You know, that’s the United States or the, the, the US experience has been a great one for me and I’m blessed to have had that.

Um, but we, we’ve gotta be open to every community and not just leap to negativity.

Naji Gehchan: Well, thank you, uh, so much, John, for being again with me on uh, on this show and being with me today. Uh, we will certainly have your book on this podcast, on the web, uh, on the website, uh, for many listeners to, uh, to read it.

It’s been great to reconnect here on the show and, uh, thanks again.

John P Bamforth: Pleasure.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Francois Nader & Khalil Barrage

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose. This is a special episode, the first of a series in partnership with Biosciences Lebanese International Network – BioLink. This New York-based non-profit is on a mission to build a global community of professionals in biosciences of Lebanese origin, like me, and it turns out, there’s quite a few of us. Most interestingly, it has set a bold vision, which is to catalyze a life sciences ecosystem in Lebanon by working with local talent and academic centers, with the support of the Lebanese diaspora community. This is an ambitious goal, but BioLink.org’s founders Dr. Francois Nader and Khalil Barrage are some of the most accomplished people in the industry, and if anyone can pull it off, they can. I’m thrilled to have them with me today! Francois is a pharma veteran who sits on the board of several biopharma companies. He is chairman of GEn1E Lifesciences, and a board director of Moderna and Ring Therapeutics, as as a senior advisor to Blackstone Life Sciences. Francois became known within the industry, when he took the helm of NPS Pharma in 2006. The company was then on the verge of insolvency. Francois turned it around and sold it less than a decade later for more than $5 billion to Shire. Khalil is a managing director at The Invus Group, a New York-based global investment firm. He established the Public Equity Group which invests in emerging innovative biotech companies, and co-manages private biotech investments, making Invus one of the most active investors in biotech, according to PitchBook. Khalil also sits on the board of several biotech companies, including ElevateBio, Sensorion, Onxeo, Protagenic Therapeutics, and Orthobond. Great to have you Francois and Khalil! I’d love first to hear more about your personal storis, how did you end up in the healthcare world and being incredible leaders in biotech?

Francois Nader: , I can, , I can start. , first and foremost, thank you for in, , inviting us to be here, , today. , really a pleasure and thank you for your many contributions to, , , biopharma, but also to our community. My story is not, , very different from many of the Lebanese in the diaspora. , born and raised in Lebanon.

Went to the, , French, , faculty, St. Joseph, and then because of the Civil War, , we left Lebanon back in the early eighties. , and very quickly from, . Clinical medicine to, , r and d and commercial. , and my first mandate was in France. I, , was involved with the pastor vaccine, which is the vaccine business of the Pastor Institute.

And, . Quickly became the head of international there. it was a terrific experience. Very different from being a clinical physician. , we then moved to, , to Montreal, , for family reasons. , and then from Montreal, I, , I moved to, , Kansas City, , where I joined. The executive team of Mary Merl Dell back then, , north America, in the capacity of head of medical Affairs and, , global head economics and outcomes research and, , many, many mergers.

Later we became eventists. And, , at that point I decided to switch career one more time and joined a venture capital firm, care capital in, , Princeton, New Jersey for a couple of years. And, , from then went to lead, , NPS Pharma, which was a very interesting journey in the rare disease. , that, , took us, , from a company that was in challenged to say the least, , to having, , two products approved globally, , in the rare disease space, , with no other treatments approved for either or.

And then, , my phone rang and, , shatter. Made us an offer that we could not refuse, and we, and the company was acquired back in 2015. Since then, , I, , I really divide my time between, , serving on board and I was lucky enough to have, , eight exits in the last eight years. , successive and successful exit.

But the other part of my life, , is to give back, to give back to Lebanon through, , either direct activities from our, , family foundation, justso Foundation, or through organizations like A TFL. And I serve also on the board of, , of LAU. , along this journey, I met my, , friend. And partner in crime, Halil.

And, , the idea of Biolink was born. And I would say the rest is history. Naji Gehchan: Thank you much, , FOWA for sharing your inspiring story. , what about you, Halil? And then we’ll go into Biolink story.

Khalil Barrage: , , thank you very much Najee, for having us, and, , it’s a real pleasure, , to be on your podcast and, , thank you for all your contributions to, to our industry and to our community as .

, I’m, I, I, I’m, I was born in, , Lebanon and I, . Graduated in, , 1987 from a UB. , and, , in 1987, , the situation was really, . , bad in Lebanon and I had no choice but, , to leave the country. I came to New York and I started, , I was offered my first job, , with the Ian group where I started my investment career.

And that’s where I learned the trait of investing. And in 2003. , I wanted to have more of an entrepreneurial career and I left to join the Invis group where, , I joined to set up it’s, , as a partner to set up its public equity activity. And that was, , the. As, as we all know though, in 2003 was the end of the sequencing of the human genome and the beginning of the, , biotech revolution and the burst of precision medicine and all this innovation that we’re seeing.

And, , Invis is a, , we’re managing the asset of a European family office, we have the luxury of having permanent capital and investing for the long term. And that’s where my, , journey started and investing in biotech. , , we, , today we’re one of the largest investors in this space. I also co-manage our private investment activity, which started in 2014 when we saw a lot of this innovation.

That, , we’re seeing in, in the biotech space. , , and we felt like we needed to, to be, , exposed to this innovation. And actually, Moderna was our first investment, , in 2014. . , the rest is history. , I met Francois, actually, , my partner in crime, , through one of the investments that we had. He was the chair of Acceleron, , which was a very successful exit.

We were one of the largest investors in Acceleron. And, , and that’s how we met. And, , and this whole journey started and, , subsequently the idea of Biolink was born. And, , we’re very excited to be part of it, both of us. Naji Gehchan: Thanks, , Jil for sharing your journey. And it’s, , as we discussed also several times, it’s these journeys of, , resilience of grit and really built on purpose.

, I know both of you are in this industry, not by coincidence, but really to, . To bring innovations for patients, , as we all do in in the biotech field. you both mentioned Biolink and how it started and the idea that came to mind. tell us a little bit more, how did you come up with this idea, , and how all this journey started?

Francois Nader: There is a certain synchronicity and, , I cannot say it coincidence, I could say that it was meant to be. , as unfortunately we all recall, , the port explosion, which, , which triggered, , quite a bit of, , pain and suffering in Lebanon at the same time. , it also triggered a lot of goodwill, , from the diaspora.

Trying to do, to use every mean, , to help and give back. And this is where, , Halil and I, through our different channels, , were committed to help Lebanon, , through providing medicines and medical supplies and equipments that were badly needed. And, , we went. On, , a journey to look for donors. And, , it, it became very clear that, , many of the, , donors, , that were, , willing to help, , came from Lebanese origin.

, which, , is not surprising in a way, but what was surprising, the more we were looking, the more we find. People like Halil and I, , who are in the life science industry and willing to help. And one thing leading to another, , Halil and I were just talking, and I vividly remember is Sunday morning where we were on the phone and brainstorming and the idea came up as to.

It came up as a question, is there an organization that could really coalesce, , all these Lebanese talents in the life science industry? And quickly we came to the conclusion that such an organization, interestingly enough, does not exist. And then we came up with the idea, why don’t we create one.

And, , I started dabbling with names and the name Biosciences, , Lebanese International Network was born. And the idea of creating Biolink, , which is Bioscience Lebanese International Network, , , was also. It was one of those, as I said, serendipity, but also synchronicity because J and I had the same idea at the same time and we were talking to each other. it did not take long for us to say, , let’s do it. And, , we, , then incorporated, , , the organization as 5 0 1 C3 in, in New York, and we started building it. , and we can talk, , more about, , our strategy in building it and, , our objectives, but to, and I will pass on the, the microphone to Halil, but really we had one immediate, .

Objective and one dream. The immediate objective was certainly to, and this is why we called it network, is to identify and put, , all these colleagues. , together, , find a way where we can create a community of, , executives, , from, , Lebanese descent who either work in or with the life science industry. that was the immediate goal. But hail and I had a, a vision, a dream, , which, which was, and is how can we create a life science ecosystem in Lebanon? That was frankly the give back, contribute back to our country that drove most everything we did. And il, you take it from here. Khalil Barraje: , it’s really, . It’s exactly how Francois described it.

It was, , we knew we had, we were aligned when, , when I invested in, , in Acceleron, I knew, , we had, , I, I always bet on, on great management teams and great boards, the first thing I do is I look who’s the board and, . When I saw Francois and his track record and, , and , there was a lot of, , meeting of the minds even in that investment.

And it’s exactly how he described it. When, when, , the explosion happened, , we were both trying to see how we can send some, , much needed medicine to Lebanon and through that, , discovery. We found that there is an incredible network of, , of Lebanese, , executive in the industry. And, , and it wasn’t surprising in hindsight because, , we have great academic institutions in Lebanon, like a UB and USG and where Francois graduated, I graduated from A-U-B-L-A-U.

. , , and because of the war, , this talent basically is not, didn’t have the opportunity to stay locally and work locally, and they immigrated. we, in, in parallel, I was also on the board of, , life at that point, and I was in charge of the nurture, , , , vertical basically that, , provide scholarships, , to, , Lebanese students, , in Lebanon and abroad.

And. I was always very uncomfortable, , that all the scholarships were going to, to business majors, and we saw what happened in the, , banking industry and, and I pushed very hard to broaden the scholarship to to other industries because I was always of the belief that. Lebanon of tomorrow is gonna, or the economy of the Lebanon of tomorrow is gonna be different from what happened in the past.

, when Francois and I started talking about Biolink, we both had this same idea that first, what if we put this network together? And, , and create a sense of, , community and, , and in the future, hopefully one day we can use this, , network to help, , catalyze, or we use the word, put the blueprint of a, , life science economy.

In Lebanon, , given we know what’s happening in Lebanon today, , all the institutions are pretty much, , the government has ran out of resources and, and , , there was a lot of corruption and. A lot of help will be needed. And our thought was, what if we can put this, , , , this network together, working in partnership with the academic institution to potentially one day, , , create help, , and, and create.

, , new sectors or new industries in on our beloved Lebanon. And, , if the, if the situation is, is, , conducive to having, , creating jobs, , and, and, and if there is peace one day, , then there wouldn’t be a need for this talent to immigrate and stay local. And that’s how Biolink was born.

And, , and it’s incredible how much we find, , appeal, , to this proposition. Like you Naji, who, , you were, we were grateful and really honored to have you part of this organization and, . As it appealed to you, this proposition. we’re finding it, it is appealing to a lot of, , our, , our community who is in this industry.

Naji Gehchan: Thank you both and , the honor is all mine. And as you said, it’s , those encounters, the common values and unfortunately it started with an event, , just for the listeners who don’t know, but the Beirut explosions you both talked about was the third. Biggest explosion in the world, , non-nuclear, , that unfortunately, , accounted for several deaths in, in Lebanon and more than 7,000 wounded.

, from there you had this vision, you had this dream. , you started encountering several, , like us in this industry from Lebanese origins. , tell us a little bit more about how many do you estimate we are, , and how are you making sure that you’re convincing them to join this, , this noble purpose?

We have.

Francois Nader: , that’s the million dollar question about how many, , we are. , what I can tell you though is the more you look, the more you find it, it has been an amazing journey, , because, , , with, , with folks with a name that sounds Lebanese, it’s easy because you can detect that they could possibly be from, from Lebanon, but.

Many of our colleagues have, have, , different last names that are don’t sound Lebanese or, , through, , marriage or, , Americanization of, of their last name. , you cannot trace them, but yet. , they’re there and I cannot tell you how many precisely, but what I can tell you is, , the strategy we adopted was to first and foremost.

Once we incorporated the Biolink was to, , , recruit, attract a top-notch, , board. And, , we were very gratified by, , how, how quickly and, , we were able to build the board, but also very gratified. By the amazing talent, , that we were able to attract. Actually, it’s not Hal, it is the concept of Biolink and answering probably your second question.

It, it’s pretty also very interesting that, , when we talk about Biolink. , , far I can, I can say with no exception, people listen and are very interested and, , the, the board is playing, , the role of magnet, if you will. , because remember, it’s a network and, , we want to ensure that, , our, , our membership, .

Is, , is working together. also it’s very important, especially in the context of Lebanon, to remind your listeners that, , biolink is apolitical. , and secular. , , we are, and it’s by membership only and by invitation only. it’s, it’s a very selective, , approach, , by design. , but yet we’re open to, , it’s a global organization.

We have now a, , a, , chapter in, , in Boston, chapter in New York, chapter in the Bay Area, and I will be heading to London in, . In April, , to hopefully inaugurate a London chapter. And, , we start having, , members in Lebanon. We have board members, , from Lebanon, Bernard, and Mui. And, , recently Dr.

Kamal Bader joined us as our first member in Lebanon. , , the organization is expanding and, . It’s attracting various, various backgrounds. All of them share the lay same love for Lebanon and, , their contribution, , to the life science industry. Naji Gehchan: What has been your biggest surprise, Jil, as you started to expand the network and build, , the objectives?

Khalil Barrage: I think our biggest surprise was the, . The breadth of this, , the network and, and, , , the, the how, how, , like Francois said, the more we looked. The more we find it’s, it’s, it’s incredible. Like, and then the highest places, , in our industry, this, like we, we, we suspected, but , there are a lot of Lebanese organizations like Lab Net and other, other organizations.

, and there is of course also, , a lot of medical associations because there are a lot of doctors. . That are, that graduated from those, , top tier academic institutions. And we honestly, we, we thought that there’s are a lot of us out there, but we didn’t realize how many are, are there, , and the quality, not just like quantity in terms of like in the, in the highest, , positions and really in the leadership of a lot of, because we focused, we wanted, , we wanted to be, .

Differentiated from, , from, , other organization. We were focused on executives in the industry. that, that was, , that continued to surprise us. And, , , the other, the other surprise I think is even. , , the members that we’re attracting that are not actually, that were not born in Lebanon .

, that have, , that are from Lebanese descent, how committed they are and how excited to be part of this organization. , there is really an energy that. Francois and I are, , , we’re thrilled to see it. , but, , , no matter, , how far you are, , there is this connectivity back to the, to the, to the, to the, to to the home country, which has been really, .

Incredibly rewarding to both of us. , which gives us, , the, the, it’s not easy to build an organization like that, ? And Francois has been an incredible chair. Not surprising. , is, , one thing, , for sure is both of us will not go into anything if we don’t wanna. See, we we’re not gonna see through, , , to its success.

But, , it takes a lot of work to get that. And, , and, , I’m, I’m really, , thrilled to be francois’s partner in this endeavor, but it’s incredible the amount of, , excitement we sense in the community for this. Organization, which keeps us going really.

Naji Gehchan: I can certainly attest to that. I, I saw, I feel the energy and I’m, , really grateful you both founded this. I’m excited for what’s ahead for Biolink as, , as it keeps growing and bringing. The impact of a network, , and also this longer term vision of, , life sciences ecosystem, , in, in our home country.

, I, I’m gonna now move to a section that is different where I’m gonna give you a word and I would love your first reaction to it. , the first word is leadership. And I’ll start with you, Francois.

Francois Nader: Outcome.

Khalil Barrage: Vision. Naji Gehchan: Vision, great. The second one is Lebanon

Francois Nader: Opportunities.

Khalil Barrage: , very dear to my heart.

Naji Gehchan: What about Biolink Khalil Barraje: Dream?

I would say Dream Naji Gehchan: two. And the last one is spread love in organizations.

Francois Nader: We need it most. We need it today more than ever.

Khalil Barrage: It is an essential recipe for success.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Francois Nader: , I, , certainly don’t. Want to give any lesson to anyone because, , leaders, , across, , different verticals and different, different domains are, are doing absolutely amazing things. Probably what I learned the hard way is, , two things. One is, , leaders, , probably show most leadership. During a crisis, , this is where, , your teams, your stakeholders, look at you and, , and expect you to lead. my probably comment or suggestion is, please lead, especially if you don’t have a clue where you’re going, which happens. But, , they, . Everyone around you expect you to lead. Corollary to this is, , in my opinion, the single most important, , attribute of a leader is personal credibility. , whatever you do, , make sure you do not, , lose that.

It’s very difficult to build. It takes time. It’s, it can be lost in a nanosecond. , and that is what, , makes the difference between terrific leaders and leaders.

Khalil Barrage: Look, I, , I couldn’t agree, , more with Francois. , I would add also, look, this is a tough business. . , , , you need to have grit and, , and really in any situation you get in or any opportunity you have to be there for the long term, ? Because what we do is not easy. , biology is difficult, .

, always surround yourself. Make sure that all the stakeholders are the right stakeholders, whether it’s the board, whether it’s the investors, , and, , and your reputation is everything, right? Because you’re the example to the rest of your organization. And, , that’s a, . Prerequisites as Francois was actually, , and continues to be a leader and a a, , an operator and he has a very long list of success.

I’m an investor, , and I. Those are the, the qualities and those are the characteristic I look for when I, when I invest. And that’s why I invested in Acceleron when, when he was the chair and another, , colleague of ours on the board, Habib Daley, who was also, , , the, the CEO who Francois recruited to Acceleron, but.

That’s the first thing I look for, right? Like integrity, honesty, and track record of, of success. , , and God knows, . How many ups and downs accelerant went through before the, , , before the, the, the ultimate, , success, which was one of the biggest exits in biotech that I’ve ever had in my portfolio.

, , yeah, it’s, it’s a long-term game and there are no shortcuts. There’s one thing you can bet on in this industry, like. It’s easy to have shortcuts, right? Because, , it’s, there’s a lot of excitements and you can cut the corners in decisions, but everything will come back to bite you. , , doing it the right way, , surrounding yourself with the right people, the right capital.

, that enable long-term success is really a, a, a prerequisite.

Naji Gehchan: , thank you both. These are incredible words of wisdom for all of us leading in, , the biotech world. , it’s been really a pleasure and honor to have you both with me today. Thanks again for joining me.

Francois Nader: Thank you very much for inviting us, Naji, and, , great job with your podcast and, , the influence.

You’re having a great positive influence you’re having. thank you for that.

Khalil Barrage: Thank you Naji, and , good luck with your new role, , Kyverna, and, , we’re all rooting for you. Naji Gehchan: Thank you tha thanks again both of you. Thanks for listening to the show. More episodes in partnership with biolink.org can be found on our respective websites.

Make sure to subscribe to spread love io.com or whatever you listen to your podcasts. Let’s inspire, change together and make a positive impact in healthcare. One story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Catharine Smith

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

I’m Naji your host, excited to be joined today by Catharine Smith, who serves as inaugural Executive Director of the term Foundation, which carries on the bold legacy of former Genzyme, CEO, uh, Henry Term.

The foundation understands that bringing new treatments to patients is grueling work with a low probability of success, and believes we can improve these odds by positively impacting the human variables in healthcare. By supporting biotech leaders, they seek to increase the probability of creating cures and solving healthcare’s greatest challenges.

Prior to this, Catherine served as the CEO of the Clinton Health Matters Initiative at the Clinton Foundation, where she led a team focused on stigma reduction and overdose prevention related to the opioid epidemic. Before that role, Catherine was the executive director of the Harvard Center for Primary Care.

Where she led business development strategy and operations for a think tank focused on improving value-based patient-centered care. She holds an MBA from MIT and a graduate degree in social science research from the University of Chicago. Catherine, it’s really great to see you again and have you with me today.

Thanks, NJI. It’s awesome to be here. I’d love for us to hear more about your personal story, what’s, uh, behind your journey in the nonprofit world and specifically focused on healthcare.

Catharine Smith: Yeah, I’m, I’m happy to answer that. You know, I’ve had kind of an, an interesting shift in my life. So I started out, I mean, you mentioned that I have, uh, my first master’s is in social science research, and I, I really started out more in the kind of like social movement, social activism space, looking at the intersection of social movements in the international political economy.

But I moved back to the United States, finished my master’s in the early two thousands, and. I started really thinking about what the biggest challenges that I saw socially in the United States and where I wanted to get involved and where I really wanted to start my career. And if I, if I go backwards a little bit.

You know, I grew up in Missouri with a single mom without health insurance, and so really grow. Growing up I thought healthcare is just one of these things that wealthy people access. It’s not something for everybody. And then when I moved back to Chicago, and again, I’m, I’m sort of in that mindset of like human rights and social activism.

I started meeting a group of people in Chicago who are really sort of. At, at the time, pioneering this idea of healthcare as a human right. It’s been around for a really long time, but this was a new idea for me, and I was, I was blown away by it. I think now I’m, I’m kind of like, oh, that’s really silly.

How did I not know that? But coming from the sort of more blue collar background that I had, I never really thought about healthcare as this thing that, that anyone could access, that really anyone should access. And so started my career in healthcare, in health research and really started on this journey of how do you actually achieve health here as a human, right?

There’s so many cool entities working across the globe thinking about, you know, sustainable development goals and how do we get to universal health coverage? But at the time I didn’t know any of that, and so really was looking at these different bright spot models over the last 10 or 15 years of how do you achieve this goal of universal health coverage of healthcare as a human right.

While also supporting the workforce that delivers that healthcare while also making sure that it’s really patient-centered and, um, approaches different people in different ways that there’s a health equity focus. And so I started out really more in the delivery space, working primarily with physicians.

In the hospital medicine space, the primary care space, um, the community medicine space, looking at those bright spot models. And then a couple of years ago, um, got a call from a brand new foundation called the Tamir Foundation, which was really working more in the biotech space. And I thought, wow, if, if we’re really thinking about.

Bright spot models for achieving universal health coverage. What better way than looking at these cutting edge science and technological breakthroughs to really be a lever for change to make the world healthier? I mean, this is really the biotech social contract. This is what biotech is trying to do.

But for me, again, coming from this. System space. I was like, wow, how cool could this be? Right? So really shifted two or three years ago into this mindset of how do we use breakthroughs in science and breakthroughs in technology to breakthrough some of the complexity in the global and US healthcare system to make healthcare better for everybody.

Naji Gehchan: Thank you so much for, for sharing part of your story, uh, and also how you’re thinking throughout, uh, the, the past years. Uh, so as you said, you moved from being in the care place delivery. To now biotech, uh, and also you did some vertical specific and some, uh, crisis or diseases. So I’m interested along the way you’ve really do always supporting and solving complex problems with this idea of bringing healthcare as a human right.

Which I certainly believe in. Um, what has been your biggest learning throughout this journey and those different verticals, if you want to call them that way?

Catharine Smith: Yeah, so I, I would say overarching and, and this ties into the work that we’re doing at the Premier Foundation, overarching, is the power of an individual leader or a group of leaders to affect systemic change.

And, and I, again, I think this isn’t a, a surprise when I really think about. My initial focus on social movements and how much social movements have, have impacted us sort of socially and politically, um, and economically over, over the last century. Um, but I really started thinking about this when I was working at the Society of Hospital Medicine.

Which at the time was kind of in the scale up phase, but still working very closely with the founders and the idea with those founders, with the founders of Society of Hospital Medicine were, you know, there’s this tremendous shift in the way care is delivered in the hospital, and there have been so many tremendous changes in.

The hospital setting in terms of technology, care delivery, disease management. Um, and that was leading to a lot of challenges really in patient care in the hospital. And so this hospital medicine movement or the movement of, you know, physicians, nurses, and PAs working in the hospital who are really focused on that environment, um, provided an opportunity and really the founders of the hospital medicine movement took that opportunity to say, how do we actually improve the care?

For patients in the hospital and they thought about that in a lot of different ways. Um, but the thing that I think was the most interesting is how they deployed leaders. So, you know, when hospital medicine was born, sort of in the 1990s as a term. There was an acknowledgement across healthcare that we weren’t really training physicians as leaders.

And so they were one of the first organizations to say, how do we train our hospitalists not just to provide care, it’s really important, but to lead the care delivery. So they trained hospitalists as managers, as CEOs. They trained hospitalists as quality improvement experts. Um, they developed sort of a hub and spoke model for quality improvement where they trained mentors and leaders across the globe to then train other hos.

Hospitalists, I’m sorry, across the United States to then train other hospitals. Hospitalists across the United States to disseminate innovation through those hospitals. And I was like, wow, this is really, you know, there’s all kinds of things in the clinical care delivery and the education and the CME and the advocacy and what’s happening in dc that’s critical.

But what really fascinated me was how hospitalists as a movement honed in on the need to train leaders. And so that’s really followed through. And how I thought about primary care and how the Clinton Foundation was thinking about really shifting the narrative in the substance use crisis. And it is at the core of what we’re trying to do at the term year foundation with biotech leaders.

Naji Gehchan: So that’s a great segue for you to tell us a little bit more about the term foundation and the philosophy. You, uh, you.

Catharine Smith: Yeah. So, you know, for, for people listening who knew Henry Tamir? I did not meet Henry, but I feel like I know Henry through the people that worked with him, um, at Bio, at the Fed, at Genzyme in his life, um, in starting many, many, uh, companies.

You know, Henry, there were a lot of things that defined Henry, but I think the founders of the Tamir Foundation were really honed in on a couple of things. One, that he was a patient centered. Leader, his why was around patient impact. So it’s no surprise that he was really focused in the rare disease space.

And the other piece was he was a mentor. So there’s lots and lots of really cool stories about how Henry would take calls and really transformed, transformed careers, transformed ecosystems, companies, uh, therapeutic areas because he was mentoring leaders. And so that was the spark of the TRA foundation.

And so for me coming into it, I was the, um, brought in as the inaugural executive director and the first full-time employee to work with the founders, people who knew Henry Henry’s wife and several people who had worked with Henry or Henry had mentored. And so I’m coming in and I’m thinking. Okay. We have this really complex health healthcare system globally, especially in the United States.

If you really look at our high level metrics, we are not killing it in healthcare. Our life expectancy has been going down since pre COVID. We spend a ton of money, so I’m always thinking, what are these levers for change to make care better and more sustainable? Right? Because what we have now is, is care that’s really great in certain areas, but not great across the board.

We have health equity issues. We have cost issues, right? So what if we looked at biotech as this like really key lever to provide better therapeutics, better diagnostics, better patient journey, makes it life easier for physicians and nurses and PAs and care delivery teams. And what if we thought about leadership like Henry, right?

What if we thought about, you know. Our responsibility to solve big problems, leveraging our passion for patient care to move the needle forward. And so with the foundation, we, we said, what if we start with founders with early stage CEOs? Because we know that, um, early stage companies have tremend. Power.

It kind of feels like they don’t, right? Because there’s a lot of them and it’s really hard to get the company off the ground to get the science off the ground. But there’s a lot of power in entrepreneurship. There’s a lot of power in founding a company. Um, and there’s certainly a lot of potential for impact.

So what we’ve done is really think about this kind of, um. Social movement of biotech leaders. We really started with first time CEOs of people who want to change healthcare, wanna change society primarily through impacting patients. So we’ve recruited a group of healthcare leaders, of biotech leaders who are laser focused on patient impact, and then we provide them really lifetime support.

Sports by talking to them, by looking at what best practices are in leadership development, how do we take those people from wherever they are to where they want to go, which is patient impact? ’cause we all have the same why through providing them mentoring and professional development, training and coaching.

Um, and so we’re about, as a, as an organization with staff, we’re about four years old. So that’s been our kind of four year journey, like focusing on that why around Henry and patient impact and then around building this. Movement, social movement of patient-centered biotech leaders.

Naji Gehchan: And I’m excited. Uh, we can share.

I think today we will be bringing amazing biotech founders and, uh, some, some of their stories, uh, through Spread lab io and the partnership we will be building, uh, with, uh, with you, Katherine, and the foundation. Um, I, I know one of the key aspects that you work on, and you said it several times. Uh, leadership, uh, and how it’s defined as I was going through, uh, what what you do and what the foundation has been really, uh, doing strongly with a big belief is what you call human variable.

Um, so can you help us understand how you think about it and how have you been supporting those early phase biotech leaders through their journeys?

Catharine Smith: Yeah, happy to do that. So, you know, as our founders, the initial concept that our founders and our founding board had, I’ve heard this from Belinda Tamir and from John Meno, who’s the founding CEO of Alnylam, um, Alan Waltz, who’s another one of our co-founders.

I hear from them and, and I love this spark for the foundation, this idea that. You know, when we think about starting a biotech and we think about the biotech ecosystem, there’s really tremendous science. There’s tremendous breakthroughs in science. There’s a lot of capital around, even though sometimes it feels like there’s a not, um, the part, all of that needs to be moved forward.

And it’s complex. But the part that it has the most opportunity are the people, right? It’s the people involved in all of those processes, and there’s never enough. Leadership support for those individuals. So we know that, especially ’cause we’re working with early stage first time CEOs, everything is new for us, right?

Um, and for the community that we serve. And we also know that it’s a really lonely journey, right? So when I think about the. This resources we provide, I’ll, I’ll start with network. Um, which sounds like, I think when people think about network, they think about what’s the largest number of people that I can have in my network so that I can look at my LinkedIn or I can pick up the phone.

But when we think about network, we think about the deliberate, deliberate curation of a table of people. Could be a large table of people. That you call when you’re having your worst day that you call when your pitch deck needs to be refined, when you are having some sort of challenge in the lab or challenge in the clinic, right?

So multi-layered people with values that match with yours, because that’s really important. And for us, our value is really around patient-centeredness, um, and leveraging this. Science and the business as tools to support patients, right? So we look for those that values aligned network and really curating that group of people who can help a biotech leader or A CEO get to the next step, get to what they’re identifying as success.

So we do network curation in a lot of different ways. Um, we have a group of the most amazing mentors on the planet. Um, most of whom were either former CEOs or their board members, or they have really deep expertise in biotech. We have a group of advisors who are subject matter experts in anything from, um, clinical trials to hr, to finance.

And then, um, you know, we have the peer network, right? Which we actually hear from our first time CEOs that that peer network is the most valuable. I think I mentioned being A CEO, um, is really lonely. It’s a lonely path. You’re kind of, you’re stuck between a lot of different priorities in a lot of different groups of people and they really need each other and they lean on each other.

And then in terms of more like concrete resources, we look at the, the sort of training element of our programs in two ways, if you will. One of it, one of them is leadership development skills, and those are those leadership development skills that I saw developed in hospital medicine that I just saw, uh, developed in the physician as leader courses at Harvard Medical School.

In the, in the leadership skills that we were developing with primary care leaders across the us, across the globe. Those are those leadership skills that we need to navigate change to lead teams to fundraise. And then the other side are really technical skills. And those technical skills tend to vary.

So when we recruit a cohort, we have conversations with them, we find out their needs, and we sort of make those, um, technical skills a little more bespoke depending on the year, depending on where the cohort is hanging out. We bring in cohorts between seed and series A, um, but then in the lifetime of a fellow, they could be anywhere up through B Series B-C-D-I-P-O, right?

So those needs change. We have regular conversations with people to bring in technical expertise depending on the life cycle of that company. Um, so we really try to sort of put our footprint on what we think is really important for leadership, but also let our cohorts, let the CEOs that we’re supporting or the biotech leaders that we’re supporting also define what they need so that it’s really blended of need and sort of market best practices.

Naji Gehchan: This sounds really super strong and appealing for any first time ceo, so I don’t know how you, uh, how you do this selection and who are the lucky ones who get in. Uh, but it’s, uh, it’s really an amazing, uh, program and support system as you start into biotech. And I love how you talk about biotech being a lever to change care, you know, like.

Not, not many would think about it that way, but I certainly agree with how you’re framing it. Uh, so as you’re putting all this together and you’ve been having several cohorts, uh, I think through the past four years, um, in our current world, which is. Constantly changing. Sometimes we feel to the better as the science evolves.

Sometimes with policy, we might feel it in a different way. Where, where do you see the most exciting parts and the future of biotech as you’re really at the heart of the beginning of those, uh, revolutions, you’re, you’re leading.

Catharine Smith: Yeah, I mean there are so many ways that I could answer this, so I’ll just kind of try to be as concise as possible.

I think, I think like everybody, you know, we work with a lot of, um, patient advocate advocacy groups in the rare disease disease space. So I think just watching from micro to macro advancements in the rare disease space, I mean, it’s. I am not even sure that I have words to explain the impact that that has on children and families.

So I think there’s sort of actual changes that have happened, you know, from Genzyme with Gaucher disease to what we’ve seen with cystic fibrosis, um, today, you know, but really that potential, that new gene therapies, new therapies will come to. Really, hopefully cure children with rare disease and individuals with rare disease and treat other, um, rare disease symptoms.

So I think, like I could talk a lot about how, how wonderful it is to work with the different patient advocacy groups and different startups in the rare disease space. So I think that is. Always really exciting. It’s, you know, cord Henry, it’s core to Genzyme. Um, it’s not exclusively what we do, but we certainly have a rare disease bias because of the passion that lives within that community and the passion that still extends from the Genzyme community.

You know, I think you mentioned policy and I think. One of the things that I’ve observed in the biotech space in particular, obviously there’s a ton of federal funding in the biotech space, and federal funding is like, you know, it’s, it’s subjected to the whims of what’s happening in dc, right? It’s subjected to the whims of politics across the United States.

There’s also a lot of private sector money in biotech, obviously, that gives biotech, again, the ability to be a tremendous lever for change. And we see a lot of investments happen and we know, especially with vc, um, people are looking to make money and that’s fine. That’s the game that we’re playing. And there is also an opportunity to really think about health equity.

And so one of the things that I’m really excited about is. All of the energy and passion around women’s health that I’ve seen over the past six or eight months. I know some of that came from some of the, the, um, statements and policy out of dc but honestly, there’s still a lot of excitement. You know, that you look at the biotech, sisterhood, right?

Biotech, CEO, sisterhood, um, a group of women CEOs across the United States, and there’s such tremendous energy for that. But if you also just look at the different, um, VCs, different labs that are really thinking about women’s health and if we really think about health equity and what’s happening in particular in the United States, but across the globe with disproportionate impact of disease on certain communities, I think you could look at a lot of different communities, but you look at women and we’re a huge percentage of population, right?

Um, and so I am really excited to see how the private sector across the board really rallies around. Unmet need in that space. I mean, there’s no better definition of unmet need, um, than looking at women’s health right now. So I’m really excited to see what happens in that space too.

Naji Gehchan: Certainly a, a lot to be done.

I’m, I’m with you. Like the excitement of the work ahead and also what started is really important and there’s still, there’s still a lot to be done, which is exciting actually, because we can, we can solve for it together. Um, I’m gonna now give you a word and I would love your first reaction to it. The first one is leadership.

Catharine Smith: Yeah, my first reaction to that is responsibility. Um, it’s one of our values at the Premier Foundation. It’s one of my personal values. I think the biggest sign of a leader, and, and I would note like leaders can be anybody, right? They can be. First year corporate interns, they can be high school students. I mean, leadership is not about title, it’s about ethos.

Right. And I think the first sign of a leader is that they take responsibility for the change that they wanna see. That could be having a less toxic team culture. It could be, you know, curing rare disease. It could be scientific breakthroughs, it could be running for office, right? And I think taking the responsibility for the change that you wanna see.

Is so critical, like we just won’t move forward as a society no matter what. Move forward is like a little subjective, but whatever move forward looks like for somebody we can’t do if we don’t take responsibility for that. Um, so that’s the first word that comes to mind.

Naji Gehchan: What about biotech?

Catharine Smith: Oh, you know, I really think I’ve, I’ve been listening to, um, Peter Ksky in particular talk about the biotech social contract.

Again, a new concept to me being relatively new to biotech and really been thinking about how he frames that. I think I mentioned sort of biotech as a lever for change. I, because I come from a more health systems approach, I really do think about this unbelievably complex ecosystem of hospitals, community-based care payers, the government, um, investors, biotech rights labs, and.

We need serious change in healthcare in this country. I think anybody who’s received any sort of healthcare, whether it’s for something relatively simple or complex, knows how terrible that process can be for a patient. Um, and think about how much better the process would be if. The diagnostics and the therapeutics were more streamlined.

If they were more accessible, if they were affordable, if they were easy to deliver, if the side effects were minimal. Think about how much biotech could play a role in the broader, broader healthcare system in solving some of the problems. Even honestly with. With clinician burnout, which is a huge issue.

The, the, the departure of clinicians from the health system is a little concerning. It’s one of my biggest concerns. Right? But what if we made the delivery of care a lot easier, a lot more streamlined? And so I just, I think I, when I think about biotech, I know people tend to think about disease and science.

I tend to think about this big ecosystem and what biotech’s role is, what the responsibility of biotech is for. Thinking about how it makes the system better. In providing better care for everybody. Um, obviously that taps into unmet need, which is a big part of the contract that biotech has with the globe, but it, it unmet need is small groups.

It’s big groups, right? It’s public health, it’s individual disease. Um, so I think it’s just really thinking about the potential for biotech to change the world through, through science.

Naji Gehchan: We talked about systems, so the word is system dynamics.

Catharine Smith: Yeah.

Naji Gehchan: Yeah.

Catharine Smith: I mean, of course I think like you, I’m thinking of one of these big Nelson repenting, like, yeah, yeah, yeah, yeah, yeah.

Um, I think system dynamics, I think it’s an, it’s an interesting way of thinking about the world because it’s so. You know, it’s easy for us to get into this kind of, I, I’m always annoyed with how people can get very binary about all different types of things, when in reality it’s a complex system. And if instead of thinking yes or no, if we think, what if I jump in at a point in this big factory, right?

And Nelson rep Pennings dynamics look like a big factory. What if I jump in at a point in the factory and try to make this piece better, it’s gonna have disproportionate impact. We don’t know what that’s gonna look like. What if I find a group of people that think like me and we jump in at different places in the factory and try to make the whole factory better, right?

These are the opportunities that we have, um, when we think more systems wide and, and take responsibility for the change that we wanna make.

Naji Gehchan: Totally. The last one is spread love in organizations.

Catharine Smith: Yeah. Okay. So what really, what really interested me about you and about this podcast is, you know, um, aside from thinking about the, the healthcare system as a whole, you know, uh.

I’ve been working for a long time, right. I’ve been working for a long time and I, I, I think my first job when was when I was 11, um, off the books and have been doing a lot of off the books and on the books, working basically since I was a teenager and I’ve worked in some amazing places. Um, you know, I’ve worked in some amazing places and I’ve worked in some toxic places, and at the end of the day, um, most of us spend a lot of times, a lot of time within the, within the containment of our organization, of our employer, um, of our school, right.

And. There are so many really cool ways to run those organizations, to run those institutions, companies, and schools. And I think really your framing around spreading love, letting that be a point of orientation is so cool. I mean, I think that’s super core. It’s core to like management philosophy. It’s core to, you know, setting organizational vision.

I think I mentioned before just about biotech. We don’t do anything without the people. And I think a lot of organizations, they do kind of lose sight of the people, right? For a whole, for a lot of reasons, some of which are really good reasons. But the people, and making sure that the people have that, um, meaningful connection and are oriented around love is, and kindness is really critical.

Um, there’s no way we can get through the hard stuff if we don’t do that. So I love that you have this podcast and that you’re talking with people who have that same point of orientation.

Naji Gehchan: Thank you so much for your words. And, uh, yeah, it’s a, it’s a journey as you said, and certainly we deeply believe in it as you are also doing with, uh, with the leaders and founders you have, uh, in the foundation.

Uh, any final word of wisdom, uh, Katherine for leaders in healthcare?

Catharine Smith: I think, you know, two things that I’ve been thinking about a lot, and this is, this is a little bit for my friends, more in the care delivery space right now because that work is so, so hard. Um, and that’s just like, keep going and figure out.

What your point of light and point of why is, um, because we need you and that’s the people in the care delivery space specifically. We need you and ask for partnership. I think within the biotech space, I have some conversations with some people in the space that are, um. You know, crossing over between care delivery and biotech.

I think there’s a lot of opportunities to sort of refresh some of the challenges that are happening in the care delivery space through those partnerships. But, um, you know, and I think for everyone it’s think of, think of big problems that you wanna solve and let that be your point of inspiration. It drains us all.

It drains me too. Um, but it’s really exciting to think about some of these big challenges in healthcare, whether they’re due to the policy that we’re seeing now, or whether it’s just the natural eeb ebb and flow and complexity of human health. Um, but to find those big problems that you want to get involved in and, and find your humans who will solve them with you.

Naji Gehchan: I love that, and it’s certainly exciting. Uh, thank you so much, Catherine. We can, uh, talk for hours, uh, and I’m really, uh, grateful for your time today, all the impactful work you’re doing in the healthcare and, and in the biotech, uh, field. I look forward to meeting actually several of, uh, the founders you have and fellows you have at the, the foundation soon on future episodes.

Uh, so thanks again. It, it was a great pleasure to have you with me today.

Catharine Smith: Thank you so much. Thank you for you and thank you for the work that you’re doing as well.

Naji Gehchan: Thanks for listening to the show. For more episodes, make sure to subscribe to spread love io.com or whatever you listen to your podcasts.

Let’s inspire, change together and make a positive impact in healthcare one story at a time.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Selin Kurnaz

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

Naji Gehchan: I’m Naji your host. Joined today by Selin Kurnaz CEO and co-founder of Massive Bio, a health tech company, improving access to cancer clinical trials through AI and data driven solutions.

Seline holds a PhD in mechanical engineering. And brings over a decade of experience in life sciences, strategy and operations. Inspired by Higher Families Cancer Journey, Celine launched massive bio in 2015 to make cutting edge treatments more accessible, particularly in underserved communities. Under her leadership, the company has onboarded over 160,000 patients and built a global network of sites, partners, and advocates.

Sine is also a recognized voice for women in tech and digital health innovation. It is so great, uh, to see you again sine and have you with me today.

Selin Kurnaz: Thank you so much, Najee, for having me. It’s a wonderful opportunity to talk to you today.

Naji Gehchan: I had love to first, uh, hear more about your personal story and how it links to this, uh, great inspiring work you’re doing.

Selin Kurnaz: Yeah, so frankly in my personal story, I was not that kind of a kid on a lemonade stand, and I’m going to be the entrepreneur of all time. So the story has started with a much more well structured and planned story, you know, for those. Of us that has been grow up in outside the United States. You know, if you’re smart, you need to go into science, and then if you go into science, there’s a certain level of, uh, career paths that you have to follow.

So my story was in that one. You know, I, I studied engineering and go into a traditional route of working in a large and respected company. But while I was going through that, you know, I became exposed to private equity and the world of investment and I very much liked that. Uh, and then I was in process of opening up my own growth equity fund and investing companies at different growth stages.

And it was a very well planned, very well articulated career path, and that was also very much supported to my upbringing and everything that my family thought. That I have a job and that job is delivering, uh, its purpose with the financial freedom and so on and so forth. But then once the family hit with the world, uh, of cancer, everything has changed because historically, I was just trying to think this is going to be like a sighting in addition to my job.

Because coming to United States, going to PhD, going into that layers in the private equity. It took so much effort, so much, you know, resilience and I had a very well articulated plan, but then, uh, taking that entire plan, putting it aside, was absolutely very crazy thought for me. And I said, okay, let me try to do this thing as a, you know, a hobby or a side job, try to fix certain things.

But at, you know, six months after I have recognized that I was significantly underestimating the amount of work, the amount of stamina, the amount of everything that you need to do to change even a minute thing in the world of healthcare. And after I get that enlightening moment, then I said, okay, this is not going to be a hobby or a part-time job.

Then I have to put my everything into helping cancer patient to get access to clinical trials or anything beyond that. Then I left my job, uh, at Ernst and Young, which I was very close to being a partner, uh, and, uh, basically dedicated myself to the ma massive bio and the mission of Massive Bio. I don’t regret a second, but I have to admit that I was significantly underestimated the amount of, uh, challenge and the resilience that is required to build these kind of businesses.

Naji Gehchan: Well, thank you so much. Same for, for sharing this part of your journey. So I’m now intrigued, you’re open for another question, uh, about all the challenges. It’s quite a leap from engineering to healthcare health back and all the complexities of clinical trial. So I’d love to hear a little bit more about the challenges, how you’re applying your problem solving skills you’ve probably had as an engineer.

And, and maybe your leadership aspect into this, ’cause you’re such a human centered, uh, leader and what you’re doing is impacting patient at a really individual level of the toughest moments of their journey and stories. So I’d love to hear the hurdles, but also how you’re applying and transitioning and you transition to that word.

Selin Kurnaz: Yeah. So I think one of the things that I’m a big advocate is that, you know, clinical operations right now mostly done by people who has particular experience in how to execute clinical operations. But I think there are different disciplines, like engineering needs to be integrated, uh, in order to be able to work with, uh, clinical operations.

Because in the world of clinical operations. We’re not really changing the clinical trial itself, but we are changing the enablers to make that clinical trial successful. And for that purpose, you need to be, of course, knowledgeable about the clinical trial process, but you still need to. You know, have other disciplines and the involvement of those disciplines in order to solve the patient recruitment problem to the uh, clinical.

Trial, and those are very systematic approach problems that you may not necessarily find in the DNA of clinical operations in the DNA of clinical operations. Everything has to be in the FDA regulatory framework, and there’s a lot of complex processes that needs to be distilled. That creates the, uh, efficacy, uh, and the efficiency for the patient to have that safe environment, to have that drug and go into the next day in their journey.

And that requires a very nuanced subject matter expertise for the field. But patient recruitment, you have to find a patient, you have to prescreen the patient. You have to do the last mile of that patient that’s not necessarily in that regulatory framework, and that is much less scripted, which means you need to innovation driven mindset in order to be able to solve those large scale problems with very articulated, automated and scalable manner.

That’s what I am trying to play in advocacy, and I’m trying to marry engineering with clinical operations because I see that the patient recruitment problem in the world of oncology is a problem that has been there for very, very long years. It’s not that massive buy has invented that problem, and frankly, it is not even the top 20 pharma, uh, companies has invented that problem.

That problem was always there for decades. But what I’m trying to do is that I’m trying to bring a differentiated approach to solve a good old problem, maybe in a way that people haven’t thought before. And I also want that problem solving methodologies to not only potentially adapt just for patient recruitment, every aspect of the patient journey that can be used to further accelerate an advancement of the drug development process.

Because there is an individual patient clinical outcome improvement. But at the same time, we also wanted to go into the population level, learning from the previous journey of those patients and applying these, uh, you know, insights and learnings for the future, uh, drug development of the patients that, so that those patients can get less impacted for some of the things that the previous patients has been impact.

Naji Gehchan: This is, this is really impactful and meaningful, obviously for patients and, and at massive bio, uh, you guys have been leveraging, uh, AI before it was, or it became a thing right now. Yeah, it

Selin Kurnaz: was before Sexy and a thing and uh, we were using that. Yeah.

Naji Gehchan: Yeah. So you’re using it and really to solve, as you said, like one of the oldest and probably one of the most complex problems, which is clinical trial access.

Uh, and, uh, and enrollment, uh, and really we know in oncology, but also in other diseases several times, the clinical trial is the best option for patients to get the most novel therapies. And sometimes patients unfortunately don’t know that. Uh, and, and you’ve been solving for that 160,000 patients, uh, as I said in the beginning.

So can you tell us a little bit more what you’re doing differently? And how you’re thinking about it. I heard you say about the patient journey and trying to solve for it. I’m hearing also some predictability work for you to be able for the future patients, not to live what the, the first patients are living.

But tell us a little bit more from a tangible, how, how are you doing a tangible difference for patients? ’cause I know you do.

Selin Kurnaz: Sure, sure. So let me give you the more like the foundationally, how we are different. Then I’m also going to focus more on the AI aspect and how that AI is actually creating the outcomes for the patients.

So in terms of the differences, first and foremost, we are oncology and hematology dedicated company. So we are not. In different disease types. We are the people in the world of cancer. Unfortunately, cancer is so difficult and challenging, and I think you cannot serve to multiple masters at this point in time.

We only serve to one master, and that master is very difficult to, you know, unbundle because cancer is always very strong, unfortunately, uh, relative to the humankind. So that’s one. And then the second thing is that we’re looking at this thing at global scale because there’s a lot of companies, you know, trying to do this thing at a US level, some section of the us, which is important, but in order to be able to create real impact.

You need to be in the world of the top 20 pharma because they have fairly large scale clinical trials that impacts very large amount of patients. And in order to be able to get into the map of these guys, you absolutely need to work globally. The second aspect is that. You know when a pharma companies are looking for these inclusion, exclusion criteria, they’re looking at very, you know, particular patient populations, like patients that they look for first line, second line and above.

And the way how you find a first line patient is very different. Then how you find a patient from, you know, second line and above. You know, if it’s a first line osm, small cell lung cancer, you need to go into a pulmonologist. But if it’s a second line and above, you can go to the good old medical oncologist.

So you should have that flexibility and adaptability to work with different patient acquisition channels. Because if you’re a company just working with certain EMR integrations, you’re very limited. With the set of those, and then it’s very impossible almost to get back and then go into the direct to patient.

So you need to have that flexibility. And thirdly, which I’m also also going to consolidate with the artificial intelligence, you need to do this thing for the entire steps in the value chain because there are three different. Sections in the patient enrollment value chain. There is a patient identification.

There is the in the middle master pre screening, and then the third bucket is a last mile concierge enrollment. These are the each three pieces of the puzzle. If you do not do a good job in any of them, the deal is off. The challenge is to be. Equally successful in three of them, where each of them is more like a noble price level, difficulty, uh, problems, and you, it’s, it’s hard to get everything in order.

In terms of the ai, there are three layers of AI that we use. The first one is this master per screening. What that means is the following, when you wanted to get prescreen for a clinical trial, it takes about 25 minutes. In order for manually a nurse to prescreen you for a single trial with your medical records or any of the detailed clinical information that you have, given that we have 14,000 active recruiting and with some information, even 19,000 active recruiting oncology clinical trials@clinicaltrials.gov, that equates to 8.09 months.

For a patient to get pre-screened for all these trials, and if you are a patient at a very rapidly, uh, you know, progressing, uh, you know, subtype of cancer, that is completely unacceptable. So that 8.09 months need to be reduced to days, if not minutes. And that’s what we are trying to do to use the artificial intelligence.

To structure the medical information of the patient, to structure the molecular diagnostic testing of the information, plus to structure all the inclusion exclusion criteria that we receive@clinicaltrust.gov. And if we have protocols from pharma, wonderful. We also integrate that so that we do that mass matchmaking at scale to reduce the amount of time, maybe by 99%.

So that we can get to that patient real time, that these are the options for you to participate. So that’s kind of one application. And what is in it for the patient? The patient sits down in their living room, they don’t lose time, they don’t lose money, and they have a peace of mind to understand what is the right trial further.

So that they can activate their clinical trial enrollment process by being their own advocate. You know, because you, of course, you work collaboratively to a physician, but 50% of the physicians don’t even talk about a clinical trial. Maybe intentionally, not intentionally, you know, they don’t have the time in a lot of the cases.

But as a patient you can activate that process by yourself, which is like very important for me. And when you activate that massive bio is become your complimentary nature of, for you to operationalize that activation. The second part is this. Cancer patient’s journey. There has to be some level of prediction in that cancer patient journey.

You know, if you’re a multiple myeloma patient, the progression takes a lot of time and you really need to predict when is going to be the next progression in that patient’s journey. When the next M spike value is going to come to a level that I can predict that you are going to be a, um, uh, you are going to have the progression and how to.

You know, engage with the patient based on their clinical journey and what is the best time to intervene for a clinical trial because it’s not about, you have multiple myeloma and there is like thousands of clinical trials for multiple myeloma. Are you at the right timing in your disease stage and your clinical criteria?

And that’s where AI helps for us to identify that perfect timings to intervene and work with the patient. So that’s the kind of the second aspect of the leverage intelligence. The third aspect. There is also a lot of supply chain work that we do in the, in the last mile. We do a lot of patient engagement.

We do a lot of provider engagement. We develop these, all these applications with different chat bots that they basically sometimes work with agentic ai in order to be able to engage, you know, if you’re a patient, you have to be able to understand how many clinical trials often that you have. When is the next pre, because there are three outcomes.

Of the clinical trial journey, you are either fully eligible to at least one trial, which is wonderful. And then you moved into this last mile process. The second one is that you may be fully ineligible. You may be very late stage in the game that we have to look for other, uh, options for that patient.

And then the third option, which is typically the 80% of the patients, they’re in the middle. They’re not ineligible, but they’re not fully eligible either. So they are partially eligible, which we call those patients, are the patients in the virtual wait list. What that means is that they, that patient’s medical information needs to be received, and after receiving those medical information at certain intervals, then we determine if the eligibility has been insured or not insured.

And in that journey, those patients has to be engaged. You know, having in applications use of artificial intelligence that automates and scale that patient engagement, having an application that activates the physician for pre-screening their patients for referral to another site. Those are all the beauty of ai.

So that an individual patient can activate themself, an individual physician can activate themselves so that we are not restricted by the structural issues of the healthcare ecosystem. And that’s where AI can support. But keep in mind that in, in the world of healthcare, as you are also the master on this, just AI is not helpful.

AI needs to be integrated. The workflow and it needs to be invisible. And then AI also needs to be supported with these high value added customer services. So for example, in our last mile services, we refer the patient to a site and set up the uh, screening appointment. You know, yes, there is some kind of component that runs in the background, but there’s still an interaction that is needed.

If the clinical research coordinator at site doesn’t open the phone, I need to have a nurse that calls that, uh, you know, clinical research coordinator to convince that that appointment needs to be received two days from now as opposed to 23 days from now. And that customer support and high value added service has also needs to be integrated in the world of healthcare to have a really material impact how this AI needs to be felt in the daily life of humankind.

Naji Gehchan: Yeah, and this is, well, it’s incredible what, what you’re doing and what you’re, uh, solving for. Um, and I love how you’re bringing it. You know, we always use, like, use cases, et cetera, for AI are more important than all the, you know, hype around the terms. Uh, but really here you’re going again from the core of what will you do and your mission of improving those patient journeys.

And making sure patients get the best treatment options. And if it’s a clinical trial, it’s through clinical trials for you. Uh, and you’re solving each part of them, you know, like those last examples you gave. It’s real issues, you know, like today to even set an appointment. So really using the best tools for you to be able to.

Prescreen to select to get the patient in front of their, uh, sites. Uh, and, and, um, and investigators are really, really great to, to be able to do it. Uh, so I’d love now to, you know, go, go back on things you touched in the beginning, building the company, you know, from an idea to now having. Hundreds of thousands of patients impacted.

Your company grew. I think you’re more than 80 people in the company,

Selin Kurnaz: right? We’re 88 people working in 17 countries.

Naji Gehchan: Wow. And so tell me how, how did this go? How did you scale your vision and how do you keep it now and keep your people grounded? In this mission, you believed in the, when you started the company, now that it is grown to 88 people?

Selin Kurnaz: Well, I think the first thing is resilience because if there are hundred words that I hear on a given day, 99 of them is no. So if I basically run my life with nos, I had to shut down the company in two weeks. So this is a very, uh, challenging journey and you need to be uber resilient to, uh, move forward the next day assuming nothing has happened in the previous day and you haven’t punched in the face.

So that is very, very important. The second thing is that. Uh, you need to have the right co-founders and the right team because, you know, although you know I’ve been talking to you in here, I won’t be talking to you in here if this level of success has not been generated with all the people that I have.

So you need to believe in it. And you have to make sure that the other people around you has to believe in it. And I think there’s an easy way to solve that because you can talk everything you know, and then say, I believe in it. I believe in it. But if you are not the hardest working in the team to do it by yourself, to show it, to work on it, to sweat on it, people are not going to believe in you.

Or people are not going to believe in just the words. So you have to also show it, you know, if something is very difficult, put yourself into that very difficult situation. So when the team sees that, you know, you as the founder at 2:00 AM trying to fix something, then people respects you and they start to do as well.

So you cannot do this thing, uh, in my famous uh, word, which you cannot do this thing in your fingertips. You have to really immerse yourself into the situation. And then the third thing is that you need to have early adapters from a customer standpoint, uh, as well as ecosystem standpoint because you can kill yourself.

But if nobody is adapting, then uh, that’s also very challenging. And keep in mind that convincing this large pharma for these new approaches is monumentally difficult. Uh, ’cause their process is very long. Uh, they always look for very quantifiable metrics to say, uh, because they, they get a lot of options, so they have to filter out which option is the right option, not option, but there is nothing in the world that has become a, you know, a sensation, not in an overnight sensation, but even a sustainable sensation.

Without having certain level of infrastructure and investment, especially in the world of healthcare, this doesn’t happen overnight. So finding those people that believe in it and working with those people are significantly important. You know, I have all these people in these fairly large pharma companies.

I know who to call. I know who to cry in front. You know, I know who to to, you know, like fight this thing for me because these people know that. It requires time, investment and a lot of challenging days, and you need to have people in on the pharma side that’s an advocate of you internally and championing your company inside pharma.

Uh, because, and I’m think, uh, basically thinking that those champions are probably getting a lot of inertia and resistance even internally. Uh, to fight for this, uh, stuff, but the, those forward looking people are bringing the field forward. Yes. And you need to have some of them.

Naji Gehchan: Yeah. Yeah. And, and a hundred percent.

And you know, when, what you’re saying about fighting crying, uh, again, I think you’re grounded. Uh, and as of those folks in biotech and pharma, we’re all grounded because, and we do this and we fight because we wanna. Better health for patients and, and trying to fix the health equity issues that we face. I, I, I wanna move now to, um, giving you a word, and I would love your first reaction to it.

I, I feel I know the first reaction to the first word, but I’m gonna try it still. The first one is leadership.

Selin Kurnaz: Very important.

Naji Gehchan: What about clinical trials?

Selin Kurnaz: My heart, I guess right now.

Naji Gehchan: Uh, women in health tech,

Selin Kurnaz: uh, challenging.

Naji Gehchan: Oh, I wanna know more now.

Selin Kurnaz: Yeah, because the thing is that. Even if you’re in the United States, which is one of the world’s most, um, forward-looking, uh, countries, uh, and one of the most wealthiest countries, um, you still get, uh, gender biases, uh, especially for in the women, uh, in healthcare because everyone wants to see the women in healthcare in junior positions.

But there are not a lot of people that want to see women in healthcare in senior positions and the very significant decision making level. And, uh, that is problematic ’cause you actually have more resistance. The more move up that you go when you are more junior, when you have less decision making power, people don’t see you as a threat and you don’t get a lot of, you know, resistance ocean level.

But then the more that you go up, the more decision making power that you have, the more you become a potential threat to the mankind. Then, uh, you start to get a lot of reactions and, and sometimes you get reactions that you don’t even know where that reaction is coming from, but then you started to peel that.

But no matter how, the difficult is, I always try not to take it personally. So, because if you take it personally, it’ll go nowhere. I try to take it, not to take it personally and try to digest it. But not dwell on it too much. Uh, and also, you know, like, understand the aspect is that life is not fair and, um, I’m not, you know, seeking for fairness in life, but I am seeking for success in the unfairness of life.

So that’s what I’m trying to do.

Naji Gehchan: Oh, I love this framing. And we, we certainly. Moved forward, but not enough. I’m, I’m a hundred percent with you. And, um, yeah, it’s, uh, it, it’s good to see where we, how far we’ve went, but it’s a journey and we can, we can see, we can go backwards, but there’s still a lot to go forward for, so For sure.

The, the last one is spread love in organizations.

Selin Kurnaz: Well, I think that spreading love should be, uh, the, the Democratic and that law has to be spread to every level, to every person. It needs to be a true meritocracy in that sense. Uh, and as a founder, I honestly don’t believe in titles, frankly. So, you know, like to me, the most junior person. The most inexperienced person is literally the same as me, the most senior and the flashiest title in the organization.

It’s all about sharing the same mission. Uh, and, you know, titles and all that stuff comes with time and all that stuff. You know, if you’re 21, it’s not your mistake. You are just starting. So the important thing is that do you have the business chemistry with that other person? Do you share the common mission and can you compliment each other?

You know, I have my skillset, the other person has their own skillset. Can you kind of, uh, basically bring that harmony together to create the best outcome? And you know, if you look at, in my organization, you know, we are very flat. You know, we don’t have like, oh, you can’t talk to the CEO at in this time, that time this restrictions and all that stuff.

It’s just like. You know, everyone has my, you know, cell phone number. They can call anytime, any hour for any issue. Uh, we are very open.

Naji Gehchan: I love this view of organizations and how you’re framing it. Uh, any final word of wisdom, Celine, for healthcare leaders around the world? Well,

Selin Kurnaz: I’m going to steal from what I’ve said, you know, resilience is key. Uh, being invisible in the world of healthcare, if you try to, you know, impose a particular innovation and change.

Uh, get ready for capital missile location because the way how the healthcare dollars are spent are not necessarily the places where the actual outcomes are generated. And fourth, enjoy the right. So I think, uh, no matter how complicated and challenging and, uh, everything it is, I think the way how I look at it, uh, when I wake up in the morning.

You know, is my family healthy? Uh, is the team intact? That’s it. So other than that, I don’t have a lot of, you know, uh, objective functions for today.

Naji Gehchan: Oh, well, so it’s a great reminder, uh, and you started with resilience. It’s a great reminder also how to keep ourself grounded, uh, as, as leaders, especially, uh, again, you’re, you’re super humble.

In the way you’re doing, but what, what your company did, when we talk about hundreds of thousands of patients who, uh, are now doing better, thanks to the work you’ve done and your partnership with, uh, a lot of people in the ecosystem, because I also see you as a connector between. All those people trying to serve patients, you’re the one actually doing it from the beginning to the last mile, as you call it.

Uh, so thank you again for being with me today. It’s been, uh, a pleasure to talk again with you and, uh, thanks for all your work you do with Massify and all your team.

Selin Kurnaz: Thank you so much Naji, for having you. This was a wonderful, uh, podcast and I definitely look forward to speaking you in the future ones as well.

Naji Gehchan: Thanks for listening to the show. For more episodes, make sure to subscribe to spreadloveio.com or whatever you listen to your podcasts. Let’s inspire, change together and make a positive impact in healthcare one story at a time.

Selin Kurnaz: Wonderful.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Christy Fernandez-Cull

Naji Gehchan: Welcome to SpreadLove in Organizations, the healthcare leadership podcast where we explore leadership with purpose.

Naji Gehchan: I’m Naji your host, joined today by Christy Fernandez-Culle, CEO of DaVinci Wearables and former leader of sensing teams at Waymo Google. Self-driving and lifts, self-driving division.

Christy played a key role at Apple contributing to autonomous systems and releasing the first LID module in the 2020 iPad. She has spanned both the development of defense technologies at MIT Lincoln Lab and at scale consumer product technologies at Apple. Christy advises VCs and startups in mobility, autonomous vehicles and digital health, and serves on several boards.

She holds a PhD from Duke University and an MBA from MIT and lectures at Columbia University and MIT Christie, it’s just so good to see you again and have you with me today.

Christy Fernandez-Cull: Yeah. Thanks for having me. I’m delighted.

Naji Gehchan: Uh, I wanna first hear more about your personal story from childhood to tech and now being, um, an incredible, uh, entrepreneur in the health tech world.

Christy Fernandez-Cull: Well, thank you so much. I mean, um, for me, my journey started as, um. A little girl. My parents, um, you know, this quote isn’t theirs, but it was something that we held true in our family. Um, outside of family always being first, um, and having a foundation on faith. Um, it was really, if not you, then who, if not now, then when?

So it was this notion of even if you see, um, doors closed, you know, build a doorknob or find another door. And so a lot of. Um, our family values is, is really what anchors me on a day-to-day. And, um, this notion of being a dreamer and trying to understand and, you know, really kneel into, um, information and data and knowledge, truth be told, knowledge being at the root of a whole lot of power with, of course not power over.

And, um, a lot of my creativity, you know, when I was a little child actually, um, I didn’t come from a family of engineers. In fact, um, they were a family and Stelara family of entrepreneurs and, um, uh, property managers, uh, leaning into real estate. But, you know, as, um, every child on a Saturday, what, what do they wanna do?

They sort of wanna wake up. Mom and dad, uh, run downstairs and start the day at the top of the morning, which for me was about 6:00 AM. Um, my parents worked in New York City and, um, lived, um, in, uh, New Jersey. And so you can imagine the traffic now, um, you know, it’s about two hours each way. The traffic then was not all that different, and so while I wanted to.

Get up. Mom and dad wanted to sleep, rightfully so, because they were two [00:03:00] very hardworking parents, and so at a very young age. Uh, long story short is um, you know, I was a little bit shorter, we’re a lot shorter, uh, more petite and I couldn’t reach, um. The door handle. Um, it was a little high, uh, nor could I reach, um, the location of where the bowls were.

And so that, to be honest, started my journey in, um, well, when I was in, I think it was like fifth grade, I decided to build a serial dispenser. I didn’t know how, uh, but, and my parents didn’t know how, but what they did know was there was a hobby shop. Over at the next town. And of course I imagine lasers and, um, you know, a variety of different mechanics and levers and pulleys.

Um, to, to be able to pour bowls, uh, or cereal into bowls and milk, into those cereal bowls for every little girl, right? That wanted to wake up on Saturday mornings. Um, but, but didn’t wanna wake their parents up because then they would, they would be told to get back to bed. Anyway, that was sort of, um. My, you know, small example of [00:04:00] how you can dream of something, want it to become a reality and not just solve it or resolve it for yourself from your childhood dream, but you know, for every other, you know, child or little girl out there.

Yeah.

Naji Gehchan: I love that. So did you do it? Actually,

Christy Fernandez-Cull: I did actually. I built, and, you know, my father helped me. Um, you know, I’m convinced, um, in another life he would’ve been an engineer. Um, he, you know, my parents have always been super patient. And, um, if they didn’t have the answers, they would try to find someone who could help me.

Um, and that persists to this, to this very day. So yes, I did build it, uh, for my, uh, fifth grade, uh, science fair. Um, and a lot of my teachers were in disbelief. They’re like, no, you didn’t build this right. Why would you build something like this? But yeah, that was my journey into, um, trying to understand physics and engineering.

Yeah.

Naji Gehchan: Uh, this is, this is awesome. And obviously you said like it’s engineering, uh, it’s very early and entrepreneurship practically as you, as you build [00:05:00] this, I don’t know if you, you sold it at school, but it’s, it’s a great, it’s a great way to start entrepreneurship journey too. And then you went, uh, to, uh, apple, worked on iPad, autonomous vehicles, and now wearable.

What is kind of like the common thread beyond engineering or the technical aspect of it? Is there any common thread in your journey?

Christy Fernandez-Cull: I would say, you know, I in some ways was reprimanded, not by my parents, but by school of always having my head, quite literally in the clouds. I would look at the window, outside the window during school and I would look up at the clouds because I was intrigued by how they cast a shadow on my, you know, white paper that I was supposed to be taking notes on.

And I’ve always been very curious and asked way too many questions. And while in middle school that was viewed as a. You know, you’re gonna get in trouble. And this is another example. My parents came in, right? And rather than, you know, saying, okay, Christie, you shouldn’t be looking at the clouds, they actually [00:06:00] questioned the teacher, right?

So I come from a home of that support and foundation of my voice matters, and that independence matters. And so the common thread here is this notion of perpetual curiosity really lends itself hand in glove into. Whatever folks might think is impossible to try to make it possible, and that certainly resonates with, you know, apple.

Right them counter eye acting IBM at the time of think, uh, versus think different, right? And so, um, a lot of the common themes and, and what I’ve been, had the privilege and been blessed to be part of is how can we think about the problem space differently? To leverage technology in order to create consumer facing solutions that can surprise, uh, surprise and delight.

So to me, that’s the common thread. So what was, what was a negative middle school all of a sudden became this, you know, ever flowing, uh, sense [00:07:00] of positive energy in creativity. Uh, which again, I, I hold with me, um, to this very day. Yeah.

Naji Gehchan: And, and this is, this is actually something, uh, unfortunately a lot of times we, uh, start framing kids, uh, and making them stop questioning, ask questions.

Yes. Like we’re, we’re both parents. Sometimes it’s so hard to ask like the answer, the 100 question during the day, but you’re bringing such an important example and reminder, right? Like this curiosity and asking questions and dreaming and looking up the sky is yes, can, can grow into who you are today.

Yes. So tell us, uh, and make us dream about what, about your work at DaVinci Wearables. I know we connected during, uh, school and I’ve seen it, uh, really boring, but it’s been a while we’ve been chat. Where you’re at with this journey and what you’re building.

Christy Fernandez-Cull: Yes, absolutely. So, you know, at 15,000 foot view, uh, we wanna be the body API, [00:08:00] uh, for, for better health.

And, and what that really entails is, you know, imagine if, you know, when we, when we wake up in the morning, right? Um, we really don’t think twice about. Putting on clothing, A, legally we have to wear clothes when we leave the building. But b you know, it, it’s, it’s almost like our source of comfort, right? Um, so when we think about how to align ourselves with body intelligence, right, because we lack the insight to this very day, there isn’t a user experience that allows us to know when we lack hydration, right?

We can all like. Go to the restroom and see the color of our urine, engage that. Right? But there isn’t this real time, um, feedback to say what is, you know, what are my hormones telling me as I age? Which is pretty critical in particular for females because we’re constantly in a state of change, post puberty, right?

And understanding your hormones, understanding your hydration, understanding your nutrition, um, you know. Us as little girls post puberty. There’s a huge focus [00:09:00] on how not to have children too early. There really isn’t this source of education and physical education of here’s how your body is changing.

It’s a beautiful thing. Here’s how you work out with your body from a mental, physical, and social standpoint. And so at Da Vinci, when we talk about being the body API, it’s. Aggregating data from what consumers are wearing today to bring them from the present into the future, where it’s not a question of if it’s a question of when.

Our closing will quite literally tell us a lot about our biomarkers so that it’s a persistent, proactive awareness instead of what it feels like today, which is something’s wrong with me. I don’t love going to the OB, GYN. I don’t think anyone does, and you’re trying to really figure out the root of how you feel.

And because you don’t have this file and data set that you can bring right to the medical professional, they’re also trying to [00:10:00] figure it out with you based on correlations and look of tables from their training, right? So imagine if you had. Garments, right? So as we aggregate data from smart bands, smart watches, et cetera, we’re also infusing a gateway where every day apparel, athleisure apparel is actually lined with, um, intelligence, right?

And that’s a gateway into the Da Vinci platform. So that’s, that was a mouthful, but that’s where we are. And that’s the vision that, you know, that’s the future that we, that we see.

Naji Gehchan: That’s a powerful, uh, vision, especially as you, uh, as you said, you’re really, uh, working for women’s health, women’s tech, which is for years and still is unfortunately, very badly studied because of all the biases and mainly men’s health, uh, being in all those, those trials.

So, uh, as your first, where, which stage are you? Do you have, are you starting to prototype? Are you starting to, any people using it? [00:11:00]

Christy Fernandez-Cull: Yeah, so we’re chatting with, you know, a lot of the market segments that we’re focused on to date. And then I’ll, I’ll highlight the beachhead is, um, uh, the first is, um, universities and colleges, um, when those universities and colleges are also tethered to, um, health ecosystems and organizations as an example.

So one example would be Indiana University and Indiana University Health. Um, I’m choosing Indiana ’cause we happen to be headquartered, headquartered at Indiana and operations in Cambridge. Um, and then. So, so that ecosystem works hand in glove with a potential pilot with Elance Health as an example, right?

So, so it’s, it’s colleges and universities, it’s health ecosystems. Um, and, and, and then it’s, you know, we mentioned garments being sort of the gateway into the Da Vinci platform. So that would be athleisure. Um, partnerships. Um, so that’s where we are today. We have our, um, we’re B2B SaaS, a subscription as a service platform.

Uh, and so right now we’re, we’re [00:12:00] preparing for some pilots, um, with a couple hundred individuals. That are really aligned with that sort of flywheel that I just mentioned, right? A college, a university, um, um, a health, uh, organization within the ecosystem. Um, and, uh, so teachers bright for us we’re excited.

Uh, we do have our champions, um, that have get early access to our beta mobile application, uh, which is where we aggregate data, like I said, from smart bands and smart watches. Now, the activity tracker and the liners. Um, so that we’re lining, um, it’s sort of like an hourglass shape. Um, any sort of apparel.

Um, you know, that’s, we’re, we’re fundraising at the moment, so, so, um, you know, that’s, uh, we definitely have the patent moat. Uh, but in terms of the manufacturing, we have some prototypes. Um, this is

Naji Gehchan: great. This is great. Congrats for all those, uh, advancements. Uh, as, as you’re, as you’re thinking through this, because we talked obviously again about, uh, [00:13:00] important.

I, I love how you framed it like Buddy, API, uh, for, for better health, uh, for women. There, there is, uh, I imagine a lot around also the education about how to use this data because it’s, again, it’s like we’re not used to have such metrics. And what to do with it, what to do with them. Like have you, are you also providing, because immediately you get into like health, education, et cetera, which is another big topic obviously in this field.

Yes. Are you providing this too?

Christy Fernandez-Cull: Yeah. Great. Great question. So when we think about the three things that the mobile application. Is, is doing not just endeavoring to do, it’s to understand right, to learn by asking questions and then to act. So at the top of our, our mobile application, um, we, we know where the female is in her menstrual cycle, whether it be 28, 29 days or otherwise.

Um, and we’re not only tracking, um, and this is human in the loop, right? [00:14:00] What have you been drinking? So we use computer vision, machine learning algorithms to automatically detect the cal a intake, uh, how much you’re hydrated. And then we do a corrected. Body mass index scan. Um, and then, um, we also have our Da Vinci Companion.

So our Da Vinci Companion knows your history because your wearables right, dictate not only your heart rate, uh, history, but your your physical activity history. And, um, we’re able to basically nudge and say, here’s some activities that you might wanna entertain because of where you are in your cycle Now, um, in terms of the education aspect.

We do have sort of a, you know, Reddit, not that you’re, you know, tagging, but sort of a Reddit for women’s health. Um, so we’ve created our own correlation engine, data mining, tons of resources in the internet, but having a human in the loop. So a medical committee looking in to see. You know, how valid is this research with regards to which topic associated with women’s health outside of the menstrual health topic?

And so you as the [00:15:00] individual can ask questions in private, ask questions anonymously in our groups. Riffing off of what to expect when you’re expecting, it’s what to expect going through puberty, what to expect in your twenties, in your thirties and forties. And you know, while they might not. No, that is the, the medical committee won’t know it’s Christie Cole asking this question.

They’ll know it’s a female in this age range. Who’s asking this question? Is it prognostic diagnostic? That’s not our intention at this point in time because we’re data starved. Um, but at least, you know, we have folks weighing in and looking at the questions being asked, so we call it our Da Vinci Companion.

It’s our own correlation engine, trained on questions, trained on data and research articles in a variety of fields for women’s health. So that’s, that’s added, that’s embedded is this educational aspect. And then you get rewarded for asking questions, for doing workouts, um, for reading articles. Um, so we, we, we marry the qualitative with the quantitative in a l lighthearted like emoji style.

Did you like your run? Did you like the article, et cetera.

Naji Gehchan: That, [00:16:00] that’s fascinating. So, and you, you said something de companion, like

Christy Fernandez-Cull: Yes.

Naji Gehchan: Practically. That’s the vision, like getting and helping out as a companion women throughout their journey from puberty to uh, to adulthood.

Christy Fernandez-Cull: Yeah. We wanna democratize that right now.

To get a lot of these insights, you have to go to these technology first spas or proactively go to these sensor. Centers where you’re tethered to a variety of devices. And so in, in, in our vision and world, right? If you’re lining yourself with, with, uh, da Vinci and getting that, that body intelligence, I can write now on the phone with you, right?

Say, and, and we do have voice to text and text to voice embedded in the journal entry and in, in the article query it would say, Hey, hey, DaVinci, you know, I’m on day six. Um. What is the heart rate zone? Because I’m about to go, you know, on a run shortly after, after the call. Um, and it would do the voice to text, natural language processing.

It would analyze my data. It would analyze the [00:17:00] different heart, heart rate zones. Versus when I cycle, versus when I run. And it would say, Hey Christie, you should really hone in on, you know, heart rate zone two for this amount of time. And then peak at heart rate, zone three, just as an example, sounds a little more complicated, but you could also ask it, you know, Hey, what’s the day of my cycle and how much more hydrated should I be?

Or, or how, what should I eat? And that’s sort of the the use case goal, right?

Naji Gehchan: This is, this is great. Uh, I wanna ask you more a question about your journey as a, as an entrepreneur now, and is there any one advice you would give, um, a female founder in the health tech? Uh, in the health tech world?

Christy Fernandez-Cull: Yeah. I mean, I’ve, I’ve had a lot of folks, you know, highlight, Hey, there’s so many nos, um, that, that you’re gonna receive.

And, and outside of just thinking about how many nos. I think if you know, if you’re being empathetic and focused on the customer versus the product of what you wanna [00:18:00] create. ’cause there are many products that don’t see the light of day, but ensuring that you’re iterating with your customer. And that, you know, your heart is in the right place is, is really all that matters.

And understanding how to fail quickly, as counterintuitive as that sounds. Um, and you know, when you need to feel inspired, this is way too many tidbits. But when you need to feel inspired, I mean go directly to your customer. A lot of the times where, you know, let’s face it, everyone has second thoughts. I, um, am no different like anyone else, which is, um.

There are these moments of inspiration where, you know, I’ll have conversations with our champions or uh, word of mouth, new folks that wanna be champions and they really hone in on, wow, I wish I had this like yesterday, or wish I had this in college. Um, and I’m excited to be part of this. Um, a lot of folks have just volunteered their time and I just feel like that’s a huge blessing and inspiration.

Uh, and a lot of, a lot of the times they don’t realize like they’re [00:19:00] inspiring me in that very moment, but try to find those, those, you know, nuggets of inspiration to keep you going. Yeah. And remember why you started, uh, what you were doing. Um. That’s what I would say that was, that was probably like five things in one.

And I know you asked for one.

Naji Gehchan: No, but this is, no, this is great. And actually you’re touching something super important, obviously in healthcare, as you know, like I’ve been in, in this field for years. Uh, I love how you framed that. It’s when you need to be inspired, go to your customer. Yeah. And, and it’s so true.

It reminds you of your purpose and it reminds you why you’re doing what you’re doing. And this is part of what you’re doing in the health tech world. Uh, a any, uh, learning or, uh, thoughts moving from you work for large corporations. You brought, uh, really breakthrough innovations, uh, in these and kind of futuristic views to now being an entrepreneur, setting up yourself by yourself, and now building a full, uh, a full team and company with this vision.

Any. Any major learning? [00:20:00]

Christy Fernandez-Cull: Yeah, I would say, you know, it is hard. Um, and, and all the things that I’ve worked on, um, I would say starting a company, um, and sales in particular right, uh, is extremely hard. And so I think what’s important is, um, not just to think about your customer and the product that you’re trying to bring to, to, you know, however small or big, really change the world.

And in this case, women’s health. Um, it’s, it’s. A long time in coming to kind of flip the switch and script on how it gets funded and, and, and addressed, um, let alone just including women in clinical trials, um, is to understand your own individual differentiation, right? What is your unique value proposition and what makes you stand out as an individual compared to others who do what you do, right?

So it’s okay if at some point along your journey you’re like, you know what, this just is. For me, like I said, I think [00:21:00] introspectively, right? We should also assign ourselves objectives and key results and keep ourselves honest to our mission and vision. And I think equally important, if not more, is thinking about the selfless act of your putting this energy in for that greater good.

Um, and so part of that is being empathetic with others, but also being empathetic. To yourself, right? Acknowledging your own strengths and and weaknesses. And it’s okay to have weaknesses. Um, I have far too many to, to elaborate on this, on this call, but I think it’s really important, um, um, to really balance that with what you’re trying to achieve and, and acknowledge.

Don’t be too hard on yourself. I think it’s really easy to be hard on oneself, whether it’s body image or body mindset. Et cetera with the list goes on. Um, so that’s, you know, that’s another thing I would say. And whether it’s a big company, um, you know, fortune five, fortune 100, or a company that you’re [00:22:00] launching right in the hopes of an exit or a, um, um, or an IPO, um, knowing your value is critically important.

Um, because even if you don’t know, someone else is gonna see and know your value. Um, and, and maybe not be, you know. Equitable or equal in, in, in how they value your, your, um, insider service, et cetera. So, um, again, that was, that was probably five things or three things, um, than, than what you asked for. But that, that’s what I say.

Just having been in on both sides now.

Naji Gehchan: Well, thanks for sharing. Uh, Christie, I’m, I’m gonna give you now a word and I’d love your first reaction to it. Yeah. The first one is leadership.

Christy Fernandez-Cull: Yeah. Um, when I think about leadership, um, I really think about, um, moral compass. So some folks call it servant leadership.

Um, others call it moral leadership. Um, and it takes me back again to, to, to my childhood and the foundation [00:23:00] that, um, really I grew from and learned about. So, um. Kind of riffing off of the last question in this question. It’s, you know, whether I’m in a big corporate, um, or small to mid, mid to enterprise company, um, you know, one thing that I’ve held with me is my moral compass, right?

And not only holding myself accountable, but holding also the leaders around me accountable and how we, um, you know, build others up. Right? Um. And empower others to grow alongside with us. So, um, yeah, that’s what I think about when I think about leadership. It’s that empathy, it’s that love, it’s that kindness, it’s that compassion.

And I’ve been on the receiving end of both folks that just amazingly were empathetic at, really at the top of, of the C-suite grid to, you know, the opposite. Those that may not, may not follow a moral, uh, or servant leadership style.

Naji Gehchan: What about women’s health? [00:24:00]

Christy Fernandez-Cull: Oh goodness. You know, when I think about that, I just, um, my heart just opens.

Why to I, I want change, right? I want more, uh, proactivity, whether it be funding. I mean, we’ve seen the executive order and the push not only at ARPA H but the executive order, right? Where a hundred million was allocated, tens of billion was, was requested. Right? And you can kind of see those numbers and, and think to yourself, well.

That sounds quite small. Um, but, but the point of the matter is changes upon us, you know, um, the importance, equal importance is the follow through, right? Uh, not just that one inflection, but the follow through of multiple inflections. Um, where, you know, we’re not, um. Still hearing the theme of, hey, women are not little men.

Right. Which, that’s by Stacey Sims. That’s not coined by myself. But, um, in saying that, she’s saying a whole lot, which is, you know, there, there is a difference physiologically and we really need [00:25:00] to pay attention. Um, so yeah, that’s what I think of is, is tons more change needs to be, it needs to happen. And I’m feel blessed to even play a little small role in, in, in helping that change or facilitating.

Naji Gehchan: Oh, you’re playing more than a small one.

Christy Fernandez-Cull: What

Naji Gehchan: about, uh, da Vinci?

Christy Fernandez-Cull: Oh, you know, well, so many words. I mean, he’s, a lot of folks don’t realize that he’s a father of wearables. Uh, granted he didn’t live in a digital era, but from an analog standpoint, he was the first to put together a step counter, uh, with pulley and so forth.

So, um, he’s an engineer, he’s an artist. Um, and contrary to his, um. Folks in his time, he, you know, elevated women instead of sexualizing them. Um, I’m neither saying that was right or wrong, it’s just a fact of what he did. And then when I think about, you know, what we’re building in our platform of, you know, empowering really just to be better, right?

Be [00:26:00] better for women’s health. Um, I don’t know. It makes me smile, gives me, you know, butterflies in my stomach for, for multiple reasons. Yeah.

Naji Gehchan: The last one is spread love in organizations.

Christy fernandez-Cull: Oh, I mean, I, I come from a family of so much love and compassion and it’s sort of focused on, you know, how you leave others with your words, with your actions, um, whether it’s by faith or whether it’s just by, um, what you stand for.

And so I think there’s a whole lot of. Love through mentorship, love through allyship, love, through just, you know, wanting folks to be better if they wanna be better, and giving them that, that, you know, that gateway right. Um, to, to, to be better. Um, so I think it’s a much needed. I love this, the, your, you know, your, your podcast and, and I love.

The message that it’s conveying. I think we need more of it, [00:27:00] especially in organizations because, um, we talked about moral leadership and servant leadership. The challenge to making that a reality is the ego, right? Of many individuals. So the more love that we can kind of springboard off of, you know, that naturally goes hand in glove to minimizing that ego.

So, um. Yeah, that’s what I think of. We need, we need more love in organizations.

Naji Gehchan: I, I certainly do agree. I need a final word that wisdom, Christie for, uh, healthcare leaders.

Christy Fernandez-Cull: Oh. You know, I mean, I think find, you know, pay attention to the customer, find what you’re most passionate about with regards to the customer need and out of passion.

And to your previous question, love. Right. That really transcends, um. Or is a mechanism for transcending any blockers that you might have, whether it be in your organization or whether it be from a regulatory, uh, [00:28:00] standpoint, right? And we saw a lot of that, especially through COVID, right? A lot of organizations basically took their hats off of profitability.

Don’t get me wrong, they did make money, but the impetus and goal was how do we save lives, right? So now, if we think about today, how do we get communities? To embody that same sort of principle, not saving lives, but rather, which it could, it could ripple effect into that, but like helping communities blossom, um, and health is a great way to make that happen because lots of health solutions are not democratized, um, to the majority that, that, that quite frankly need, need.

Thank you. Another word I would say is thank you so much for having me, Naji. It’s been a delight and a pleasure.

Naji Gehchan: Know Kristi, thank you for, uh, being with me today. It’s, uh, it’s really awesome to catch up and have this, uh, conversation. So thanks, thanks again for being here and for your great words. I, I will, what, what you said, help community blossom.

This is powerful and I think it’s [00:29:00] our responsibility at healthcare leaders to make that happen. So thank you again for being with me.

Christy Fernandez-Cull: Thank you.

Naji Gehchan: Thanks for listening to the show! For more episodes, make sure to subscribe to Spreadloveio.com or wherever you listen to your podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Michael Pietrack

Naji Gehchan: Welcome to Spread Love in Organizations, the healthcare leadership podcast, where we explore leadership with purpose. I’m Naji, your host, joined today by Michael Pietrack. Michael has been recruiting in the pharmaceutical industry for nearly 20 years. He and his team has successfully placed more than a thousand pharmaceutical professionals during that time, leaving a positive impact on the industry.

Michael started his recruiting career with the Alpine Group, where he led the medical affairs search practice. In 2015, he co founded TMAC Direct, an executive search firm exclusively devoted to medical affairs. Under Michael’s leadership, the company was named one of the top U. S. executive search firms by Forbes.

In 2023, Michael joined Kay Bassman to lead the expansion of the already established and high performing pharmaceutical and biotech search practice. Aside from recruiting, Michael is also a speaker, recruiting trainer, and an accomplished author, and was recognized as one of PhRMA’s 100 most inspiring people by PhRMA Voice.

Michael is also a fellow podcast host on the PhRMAverse podcast, where he engages in insightful conversations with industry leaders. Michael, it is so good to have you with me today. Thank you so much. Thanks for the nice introduction. First, I would love to hear more about your personal story. What brought you to be a recognized talent recruiter and specifically the pharma and biotech industry?

Michael Pietrack: Well, it was really an accident. I started off as a baseball coach. I was a baseball player in college. Didn’t really know what I wanted to do with my life, so I got into coaching, and I had a knack for recruiting, and at that point, you’re recruiting players and talking to their parents, trying to get them to come to your school and be on your team, and then at the end of that run, because it was not a lot of money to be made in that world, I hooked up with a pharmaceutical industry recruiting agency called the Alpine Group, as you mentioned, and they put me in a place called Medical Affairs, And, uh, I just tried to make the best of it using all the skills I had learned as a recruiting coordinator in the baseball world.

So that’s how it happened. It was an accident. I wasn’t seeking it. And then you never left. Never left. Never left. And now I can’t. And now I can’t even imagine

Naji Gehchan: doing anything else. So what is, what is for you, what’s attractive in the medical industry? And I know we’ve talked like the first time we chatted about the impact that you can have obviously on, on people’s lives and as a recruiter, you place those leaders who will have that impact.

So I’m, I’m intrigued. Why can’t you see yourself anywhere else now?

Michael Pietrack: Well, when I first started, you know, it was really, I like talking to people that were intelligent. I felt like that was, um, that was just something that, that really meant a lot to me on a daily basis. But now it’s really about patience.

You know, now that I’m getting older, now that I’ve, you know, have lost a parent, now that I’ve seen my friends go through different kinds of therapies and diseases and things. I realized that we’re all going to end up being patients at some point in time. And so I really just like being involved in this industry.

And as a person that can’t really go and affect a patient’s life, you know, but putting the best possible person in the best position to help is sort of how I help patients. So I get a lot of gratification around that.

Naji Gehchan: And as you said, we’re all here for that purpose. So certainly by, by doing what you’re doing, you’re helping the industry reach our purpose even faster and better.

Uh, hiring is probably one of the hardest thing and it’s the core of what you’ve done. I love the similarities you said with being a coach, uh, in the baseball field. Um, can you share with us, like, what are the top three recommendations for a hiring manager to think of? Regardless of the role, but more as

Michael Pietrack: Oh, good question. I think about this a lot. I think the very first thing that a hiring manager needs to know is really know what they want. Sometimes I feel like a hiring manager is shopping and they’re just kind of browsing. They don’t really know exactly what they want. So have a clear picture of what you want, what good looks like and be able to act on that.

The second thing is not to hire clones of yourself. Okay. I think one of the biggest mistakes rookie, um, I’d say leaders make is they try to find another one of them instead of trying to find a person that fits strategically within the team, maybe complements somebody else as far as being different. And then I would say, you know, trust your gut.

A lot of hiring is just gut instinct. And what I tell hiring managers is if it’s not an immediate yes. It’s a no. So in to move people in and out, like sometimes a hiring manager will want to put somebody on hold or on the back burner. But look, those people aren’t gonna get hired. Just let him go, give him dignity and let him move on.

So those would be the big three things. Know what you want to do. Uh, you know, don’t hire clones of yourself. And if it’s not a if it’s not a yes, it’s a no.

Naji Gehchan: I love those advice. So now if I look at it from a talent being hired, how do you, um, what’s your relationship with, uh, people being hired? Any different advice?

Or is it kind of the mirror of what you just said?

Michael Pietrack: No, it is different. I can tell you as a recruiter, a lot of people that are in my seat only do what we call marketing. So they’re only trying to get the jobs. And then they. outsource with a team of their own to go and get the candidate. But, uh, what I do is I do all of it.

Like, I love the candidate journey and, and being a, a character in that chapter of their life. I just love that. So for me, I would say the big three for candidates is to. No, where you’re trying to take your career to use a baseball quote, I’m probably gonna misquote it. But Yogi Berra said, Look, if you don’t know where you’re going, any road will take you there.

And so the same thing, you know, you want to make sure that the move that you make is on strategy and you have a clear picture of the strategy. Otherwise, everything’s gonna sound kind of good. The next thing I would do is, is to let the person, I guess, tell the person that the people that they’re going to work with is almost the most important thing.

So the job has to check the people box. So really diving in, getting to know the individual that you’re going to either report to and also the strategy of the overall leadership team is paramount. And then three, don’t be scared to take risks. All the leaders that I interview on the Pharmaverse podcast, they always say they took some big risk that catapulted their career.

So I would say those are the, those are the big three things. Know where you’re going, make sure that people box is checked, and also don’t be scared to make risks, take

Naji Gehchan: risks. So you just mentioned your podcast and these are great advice for, for our listeners on both sides. Tell us a little bit more about your podcast.

Michael Pietrack: Well, again, another accident. Um, well, I, I was thinking about starting a podcast, but you know, in my world, there’s a lot of podcasts like in medical affairs. A lot of my competitors do a really nice job with their podcasts and just like a pharmaceutical company doesn’t want to be late to the market. I didn’t want to either.

But I, as I was moving to Kay Bassman into a larger leadership role, I started interviewing established leaders that I had in my network that I really respect. And I started picking their brains about leadership. Well, one of the guys I was interviewing. Said, oh man, I wish that was recorded. And then the light bulb went off for me and, uh, and I, so I started a leadership podcast, it’s called the Pharma Averse Podcast.

And the reason I call it the pharma averse is I wanna pull leaders from all different areas of the universe of pharma to get sort of the best practices about leadership from a, a, a lot of different people. Sort of a composite sketch of best leadership advice. And so that’s how the pharma averse was, was, um.

Was originated and it’s really Interesting to be on this side of a podcast now,

Naji Gehchan: well, and you have, uh, so you’ve had several interviews now, um, approximately 20, I think, uh, and great, uh, leaders and you, you talked about different topics within, uh, pharma, healthcare, biotech, is there like a one big learning from all those different interviews or one big threat that you would take?

Michael Pietrack: I would say that, you know, your podcast, the focusing on love, um, is really something that I see woven through, I would say 80 percent of the people that I interview is genuinely caring, like not, not fake caring. But genuine caring and people can know, know the difference when a leader genuinely cares about their people, they’re going to be a very strong leader.

So all the people that I’ve been interviewing that has been the most consistent thing mentioned is caring or in your your case love.

Naji Gehchan: I love that. It reassures me. You know, mine is biased. Obviously, I interview healthcare leaders who believe in this. It’s good to hear that within our industry, it’s 80%. As you said, people you interviewed.

Um, I’m going to move now to a section where I’ll give you a word. I’d love your first reaction to it.

Michael Pietrack: Okay, I’m ready.

Naji Gehchan: So the first one is leadership.

Michael Pietrack: The first word that comes to my mind is leading from the front. Is that a word? Yeah, that’s fine. Tell us more. Well, so, uh, another thing that I see not only in my own experience, but also through interviewing other leaders is, Leadership is not from the back, cracking the whip, getting the, you know, the, uh, the sled dogs to go in a certain way.

That’s not really what leadership is. It’s really like someone leading from the front, being like the expedition lead saying, we’re going to go up that mountain. I’m going to show you the way, and I’m going to lead from the front. And then as you’re leading from the front, you kind of. Slowly move the way back, making sure everybody in your expedition is is doing okay.

No one’s falling behind. Um, and so that’s why I say leading from the front. What about legacy legacy? The first thing? Well, I wrote a book called Legacy, so that’s the first thing that came to my mind is the book. But really, legacy is more about the qualities that you exude that people then begin to emulate.

And that’s what this legacy book is about, is about more about the legacy. You leave your Children, and it’s more about the actions that you do. So the actions that you take. And that’s true in leadership. It’s true in parenting. You know, it’s, it’s like you don’t want to be the parent that’s smoking a cigarette saying, don’t smoke.

You know, um, you want to lead, you want to lead and, and, and show them what good looks like. And then that’s the legacy that you leave, uh, the, the generation behind you or, or your team. The third one is personal brands. Personal brand. I would say personal branding is, is very similar to legacy. It’s about what you represent.

It’s the, um, it’s like if you think of, um, any brand, you’re going to have an immediate reaction to that brand. And the same thing with when you hear someone’s name, what that, what they feel, what they think, what they remember, all of that is what your personal brand is about. Now, some of that you can influence You know, through branding, you know, through social media or whatever.

Uh, but most of that is again, how you act, what you do, what you stand for, what you do in times of crisis, what you do when you’re, when you have to make a big decision, all those, uh, create your personal brand.

Naji Gehchan: So, and these two legacy and personal brands, obviously you wrote a book on legacy and I know you also wrote articles about personal branding.

I want to expand a little bit more on, on this topic. I’ve, you know, we talk a lot about it. Do we need to care about our personal brand? And like my first reaction to people is whether you like it or not, you would have a brand, right? There’s no, you can’t like decide not to have a personal brand. It exists.

It’s a matter of. How you shape it, do you want to touch it, et cetera. So as you worked on it, is there anything, how, how do you push people to think about their personal brand as a leader and is there any advice on how to do it in a certain way for you to achieve what you want to achieve in life, I would say.

Michael Pietrack: Yeah. So let me take the first part first. Should you have one? And like you mentioned, you’re going to have one whether you want to or not. Um, but it has to be strategic. A lot of the people that I talk to about personal branding, they really don’t want to put themselves out there. They really don’t want to like, they don’t, they’re not big fans of social media or whatever the case may be.

There’s something that they don’t want to be involved in and they think they have to. Make it all about them. But like even you with this podcast. I mean for you. It’s about sharing love within organizations It’s not about you. It’s about love same thing with my podcast. It’s not it’s not the Michael P track show Let me go on a rant every other week.

It’s let me showcase a leader and let’s learn from them And so all of that is establishing our personal brands So, uh, actually we have a podcast coming up about personal branding with someone. I think that’s really doing a great job of it. And all he does is highlight how good. Employees are every post he puts out.

There is. Let me tell you how good my colleague is. Well, so, so if someone is not really like into personal branding, even if you’re showcasing other people, your personal, your branding yourself as someone who’s selfless, someone who puts other people first, you know, someone that’s a great leader and someone that you I’d want to work for.

And so all that creates a personal brand. So how do you do it? Well, the first thing that you have to do is you have to think about what is your medium? Like, are you going to be a podcast host? Are you going to be very active on LinkedIn? Is Twitter your thing? Or is there some other forum that you want to?

That has an audience that you want to brand to like, for instance, you know, any other brand may have a commercial and they may choose to do that at the Super Bowl because that’s when the biggest audience is there. Well, maybe your biggest audience is linked in. I know mine is. So for me, I do a lot of my personal branding on linked in.

So once you establish where your forum is, then it’s all about frequency and content. And a lot of people that I talked to about this are like, Oh, I don’t want to have to come up with content and, and, uh, everything is content, whether it’s, you’re having a review lunch with Jennifer, or you’re having a team meeting in Boston and you guys go see some, uh, iconic element in that city, whatever the case may be, those, that content, everything is content when you put it out there on LinkedIn or whatever the form is, you have to be consistent with it.

So I’ll stop there because that’s a lot of information, but that’s what I would say is, is how to do

Naji Gehchan: it, but this is great information. And as you said, consistency about the content, I think is a, is a great piece of advice, uh, along with all the other pieces that you brought. Thank you. The fourth one is spread love and organizations.

Yeah.

Michael Pietrack: Well, I got to tell you, the first thing that I thought about was. First Corinthians 13 four, uh, which is in the Bible says, I have it pulled up here. Love is patient. Love is kind. Love is not jealous. It does not brag. It does not get puffed up. And it goes on. And then in verse eight, it says love never fails.

So when I heard this podcast about spreading love and organizations, the first thing I went to is love is. And when I think about my own personal leadership style, I fail. Often, but this is what I’m trying to do. I’m trying to be patient. I’m trying to be kind. I’m trying not to brag about my own accomplishments, but highlight other people.

I’m trying not to get puffed up when when agitated or when my ego is bruised. Um, I don’t, you know, in the list goes on. And I know that if I do that, A drug may fail, a business initiative may fail, but love is not going to fail. And so for me, when you say love, I think of, I think of that scripture. Yeah.

Naji Gehchan: Well, thank you, Michael, uh, for sharing also vulnerably, uh, a part of, uh, you as a leader. So I really appreciate that. Any final word of wisdom for healthcare leaders? I

Michael Pietrack: would say what I’ve learned and speaking more about love is the best leaders. It’s not about them. When I’m on the phone with someone and they’re talking about their career, there really are two types of people.

There’s the people that are really worried about the people around them. Helping them develop his leaders. And then there’s people that are all about their own career and their own career progression. And sometimes when they’re talking to a recruiter, they are more eye focused. And that’s that’s understandable.

But I would say the best leaders are not hung up on titles. They’re not hung up on anything other than the scope of the work and the people they’re gonna do work with. And so if I could impart one bit of advice, not only to candidates, but also to leaders, is think about the work. Not the title of the job, not what it pays, not what the equity is.

Yeah, those things are important, but they should be secondary to how, how vital the work is. How much, uh, intrinsic value will you derive from doing the work? Who will you be doing the work with? Is this a team that you want to go and try to win the Superbowl with, even if you’re the backup running back?

So that would be my advice.

Naji Gehchan: These are incredible advice. Uh, for everyone listening, I truly thank you so much, Michael, for being with me. It’s been a great conversation. I’ll make sure also we, um, for my listeners, you will have, uh, your podcast also featured to listen to some of the incredible, uh, leaders that you interviewed.

Uh, and we can all expand and learn as, uh, as leaders, podcasters on the different podcasts that we have. So thanks again for being with me today. It’s been a pleasure. My pleasure too. And we have to have you on the podcast. We will. We will. Thanks for listening to the show. For more episodes, make sure to subscribe on spreadloveio.com or wherever you listen to podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jason Bhardwaj

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

Naji Gehchan: Welcome to Spread Love in Organizations, the healthcare leadership podcast, where we explore leadership with purpose. I’m Naji, your host, joined today by Jason Bhardwaj, an experienced life science executive with a broad background leading in startups and 20 years working in healthcare. Currently, Jason is the CEO of Nova and Cora, developing a recombinant protein-based treatment for DEB, Dystrophic Epidermolysis Bullosa.

Prior to this, Jason served for six years as CEO of another dermatology focused biotech. Jason has led or advised across a wide range of technologies, as well as indications in healthcare. Prior to life sciences startups, Jason studied biomedical engineering at Duke, received a master’s degree in business from Harvard and developed a decade of foundational experience in consulting, working with some of the largest healthcare innovators on a full functional suite of critical challenges.

Jason and his family are my neighbors here in Uten, Massachusetts, where he is involved in the community as a soccer coach, marathon runner, and most recently via a bid for the school committee. Jason, it’s so good to see you again and have you with me today.

Jason Bhardwaj: Thank you so much for having me. I’m excited.

Naji Gehchan: I’d love for us to hear more about your personal story. What’s behind the lines of your journey from biomedical engineering to consulting and now being a CEO of a biotech. Thanks.

Jason Bhardwaj: Yeah. Where to begin? I mean, I, I think, um, Healthcare and science have been a theme for me for a very, very long time, I think both by natural affinity.

But, you know, my, uh, both my parents studied engineering. Um, my mom was a mechanical engineer. She studied at Rice is where she met my dad, who was a PhD in material science there. And, um, so I, you know, I think that there was an infusion of that. You know, scientific thinking into our house, like we had the white board above the dining room and my dad would give us lectures when he came home, like that type of thing.

So that’s, that’s definitely the environment. And so, um, you know, I think there was a, a number of, I loved chemistry, uh, that was probably my favorite subject in high school. Um, and then when I got to, um, thinking about undergraduate institutions, et cetera, You know, Duke was really on my radar for biomedical engineering, and something had started to clip for me at that stage around biology, life sciences, and medicine, you know, and all those things at that naive stage for me were kind of on the table, and it felt like a good place to go and kind of figure it out.

Um, and so that, that was an important juncture for me, and I did think about pursuing medicine, and not really sure I had a great framework at that stage in my life for making the decision, but decided, you No, I wanted to point more towards an intersection of business and science. And so I studied biomedical engineering and economics, you know, uh, some institutions, uh, don’t have a quote unquote vocational business program.

Um, so that was my way of sort of, uh, doing, doing. That intersection academically as they were and, um, and then strategy consulting was meant to be like sort of a few year gig to figure out where to land in the health care ecosystem and I loved it and it ended up being more like a decade. But I always did have that sort of I want to build something type of an itch.

Um, and I, I did feel like the learning was there and I just love the people. Where I was working at Bain and, um, and so, you know, that’s, that’s what kept me there for ultimately bookends, a full decade. And finally, it was one of these, like, if I don’t push myself out of the nest now, like, when is it going to ever happen?

And, and so started, um, doing smaller, uh, healthcare, uh, ultimately life focus, life science focused startups. Um, and now it’s been a decade of doing that. And I’ve, I’ve just loved it. Um, and I, and I wouldn’t go back, but. The training and the exposure was really fantastic.

Naji Gehchan: Well, thanks for sharing, Jason.

What’s your biggest learning? As you said, now you’ve been on a decade building team, building biotech, being the CEO. What is your biggest learning through the past years of doing that?

Jason Bhardwaj: Yeah, I mean, there’s so many learnings. I mean, maybe to this, you know, discussion we’re just having of finding your path and what is it that you want to do?

You know, I think, um, There’s something to life science startups or, you know, or, or, you know, um, building a project from, from early stages. That, uh, for me personally, and I think everyone has their own personal index for, you know, gratification, satisfaction, et cetera. But the wins feel really big when you start at these stages and you bring something from, you remember when it was sketch on a napkin ish.

And, and so when you get the milestones like, um, IND moving forward into clinic. Or, you know, a successful readout from a clinical study or anything in between, you know, they, they feel really big. Um, and so that personally for me has been a real learning of, uh, find your place in the ecosystem that has that right balance of effort and gratification.

And look. There are losses too and you feel those too and you have to be able to make those, that kind of, um, arc work for you personally. And then I get why some people prefer a different, you know, portfolio approach or something like that. But for me, uh, that was a big learning is find your place in the ecosystem where you can add value.

And it really is a personal fit for your, for, you know, how you derive satisfaction.

Naji Gehchan: And it certainly is, as you said, humbling and gratifying at the same time, as you know, like this is something I also do. And. As you were speaking, like, each one of those myostones is so important and so big, and at the end of the day, you’re bringing hope and hopefully a new medicine to patients as each one of those myostones is hit, and as you take this molecule, From a piece of paper and to the bench preclinical and all those faces as we both know from, from that, um, experience, as you said, like building a project, building a company, uh, I’d love to hear more about your people experience while building those companies.

How do you think about building a team in a biotech to develop those breakthrough medications?

Jason Bhardwaj: Yeah. Um, the projects that I’ve worked on have been at the stage and scale as independent startups that we’ve had a very virtual model. Um, and so I think it really in that model, it really amplifies the importance of what you’re just describing of.

people decisions. Um, and so both of these, um, companies, you know, the one, the team I’m building now, and we’ve, we’ve just started hiring the core team. Um, and then the last company, you know, um, single digit size core teams. And as anyone who’s in the space knows, then you, you have a sort of portfolio of advisors, contractors, and other folks getting involved, CROs, et cetera, um, to augment that.

And so, you know, on both fronts, the, the sort of core team and The folks that you build around that, um, in that type of a setting that the people decisions are so, so important. Um, because, you know, if you have a sort of a weak leg of the stool, so to speak, or, you know, you really feel that, especially as a leader, um, you end up spending in order when there are weak legs of the stool, you end up spending way too much time supporting the leg instead of You know, kind of overall strategy and moving things forward.

And so that, that I think is the key lesson, especially when, when you’re architected that way, that the core is really important. And then, you know, similarly, though, I think, um, really making sure that you have the right partners. And for that, again, it’s a little bit like placing the ecosystem dependent.

There are partners who are really high capability that, um, are not geared to work with smaller stage startup entrepreneur. And so really, um, depending on the type of partnership, et cetera, like, um, having a, a, um, a sense of. What your criteria are and making those decisions, um, appropriately are really important as well.

You know, if you commit to a CRO for your key study and you just find that they aren’t nimble enough for the particular areas of your disease state or recruiting or organizing the sites, uh, it can be really, really painful to sort of switch gears.

Naji Gehchan: So I want to ask one more question about the core team, as you said, like, it’s hard to build a core team, uh, hard to hire the right people.

So how do you think about this as you’re hiring? Is it something, is there like one philosophy that you have throughout the past decade on hiring the winning team, uh, for, to help you build this, the biotech that you’re building?

Jason Bhardwaj: Yeah, I I’m gonna have to think about that. I mean, I the ones philosophy. It’s been so situational.

Um, you know, I’ll just give the example of how just having hired our first team member for a new team, you know, um, it for us right now. Manufacturing is the key. And so, you know, I think the framework and we were maybe it’s it’s a positive time to be hiring in the market, but we had some really great candidates.

And so, you know, really trying for that particular linchpin role for us, balancing the sort of, you know, the program management have because there’s so many resources. This role is going to need to direct versus, um, the thought leadership component, which is really do they have. Um, the requisite detailed expertise in the functional areas that really, really matter, you know, for us, it was downstream in particular, uh, development, uh, uh, for, for CMC of a recombinant protein, you know, that what I, what I do sort of ascribe to is that, you know, aphorism of, If you hire a B player, they hire C players, you know, so we really, really, um, I put an inordinate amount of time on the hiring process.

If there’s a rule there, it’s like, anytime I feel like I’m spending way too much time on, you know, the process or or number of candidates or, you know, orchestrating, you know, what my questions are, the interview versus my academic collaborator versus our CMC advisor. We put a ton of time and effort into that.

I’m glad we did. You know what I mean? Like the returns felt. So I don’t know that there was really, um, like a philosophy as much as a, like, making those investments to really have as high quality of processes you can and, and, and being very clear on what the particularities of that particular role are to, to, to make sure it, um, it, the person is set up to, to be the linchpin we need them to be, I think was really key.

Naji Gehchan: Awesome. Uh, another area you’re passionate about, uh, and as you were talking about your, uh, your dad,

I’m going to ask again the question. I’m not sure if you heard it, but there was. Okay, another area you’re passionate about, Jason, and as you were talking about your dad giving lectures, it reminded me probably of something you are working on currently. You’re passionate about community and education, too, and this is something you said from your very early beginning you’ve been very passionate about.

Can you tell us a little bit more about your work and involvement there, too? Because I feel everything is kind of interlinked at the end of the day.

Jason Bhardwaj: Yeah, yeah, that’s well, let me first address the analogy and then, uh, the specifics. So, um, yeah, I really do think that, um, a whatever it is a sort of learning mindset is so key to especially in our role and frame of work.

I mean, this is not, um, producing widgets. There is so much. Art and high minded science into what we’re doing and uncertainty. And so there is a lot of, you know, we’re students in life sciences. Absolutely. Um, yes, I, I do have, as you alluded to in the introduction, a new, um, side project, which is, um, school committee, um, bid here in Newton and Newton, Massachusetts and, um, you know, I think, yeah, absolutely.

There’s a lot of motivations for that. The biggest, of course, is having two elementary school kids, um, and then, which, um, many of my parents share that, and so, so that’s the skin in the game, and but I think, um, yes, there, there’s a lot of family history, not only what I mentioned with, um, you know, the lectures at dinner, but my grandmother was a, um, elementary school teacher and then principal.

Um, my mother went into, uh, teaching later in her career, um, English as a second language with my brothers in, uh, pre kindergarten education, and, you know, I, I didn’t pursue those paths, but I do, I do have a little bit of the bug. And so this maybe felt like a way to scratch an itch, I guess. Um, and not just that being involved in education, but sort of giving back in some mission oriented way.

Um, it sort of kind of coalesced for me. Um, and yeah, I was in between roles, uh, and had already been involved both in the community as a coach and other ways. a room parent and involved in the schools, but really started volunteering and signing up for whatever I could. And a buddy of mine was like, you, I think I was, you know, philosophizing around the soapbox about an issue.

And it was like, you should run for school committee. And my initial reaction was that’s crazy, but it sort of started a process. Um, that’s led to a few weeks ago, formally announcing and have. wonderful support from, you know, uh, other parents in the community who are helping me. So I’ve, I’ve learned so much.

Think about, uh, you know, ways to learn. I’ve learned so much about, um, schooling and the history of Ed, of Newton, which is a very, very rich history of education. The twists and turns that led us to where we are today. Um, and I think it’s an exciting time to get involved. So, yeah, that’s it’s it’s a long wind up for, um, an election in November of next year.

But, yeah, I’ll be running for my board. We’re 3, which, um. Every ward in Newton has a rep, there are eight, and, um, the entire town votes. So it’s, uh, that’s a totally new educational experience for me as well, the political one.

Naji Gehchan: But this is, this is great, and having an impact early on, I know we talked a lot, a lot about curriculum, how this is done, and being involved in the community and, and the education piece.

I know you’re big on steam, obviously. Uh, I, you know, like this is great to see this involvement from you and what you’re trying to achieve for, uh, for our community. Obviously I’m biased. My kids are also in the, uh, the Newton public school. So, so this is, uh, something also very close to my heart. Uh, and it’s great to see people like you helping out, uh, with the educational system.

Uh, I would love now to move. To, um, a section where I’m going to give you a word and I would love your first reaction to it.

Jason Bhardwaj: Right. So the

Naji Gehchan: first, the first one is leadership.

Jason Bhardwaj: Yeah. Leadership. I think, uh, my reaction is it is so multifaceted and it means so many different things. So we all can be leaders, but just finding a way to have an impact, to collaborate, um, to, to, to have an idea and move it forward.

I mean, that’s leadership.

What about biotech? Biotech. I think biotech, um, it just jumps off the page as exciting science and a way to help people. Um, we have so many unsolved problems in the world, medically, and it’s really just moving forward so fast now. I just find so much constant excitement from hearing what’s happening in the ecosystem.

Naji Gehchan: The third one is about education. STEAM.

Jason Bhardwaj: Yes. You know, I Steam gets talked about the most with gender imbalances, etc. But to me, I think that that connects to me with just excitement. Um, you know, science. And math and engineering. I mean, obviously, these were what drove a lot of my academic interest, etc. But I, I think, um, they shouldn’t be esoteric.

They should be approachable and fun and dynamic. And that’s how the school system should continue to approach them. And yes, find ways to broaden it to make sure it’s accessible to everyone of of all segments. I think, especially here in Boston, it’s easy to say that. I mean, we’re such an. Mecca for, um, steam based careers.

And so why not make sure we’re, we’re providing the, the, um, the, the best, um, seeding ground for, for the future innovators. What about spread love and organizations? Yes. Well, spread love. I I’ve now become more acquainted and I think. Uh, the, the name is beautiful and, um, you know, I think, um, spreading insights and connecting with people who are passionate about what they do is, is what an amazing way, um, to, to spread the love.

So, so I, I’m very honored to be, to be, uh, part, a part of the, now the, the volume of, of cool insights and learnings.

Naji Gehchan: Any final word of wisdom, Jason, for leaders around the world?

Jason Bhardwaj: Yeah, I, I think, um,

what to say, I, I, um, I think there’s so many different ways to go out and be a leader and make a difference back to my comments on the versatility of leadership. And so I think finding that way you want to make an impact, perhaps that’s attuned to, like we were saying, you know, your emotional profile. And and where you are most excited about making a difference.

You know, I think that’s where, in my opinion, you know, folks of abilities in all different spheres will have their greatest impact because you really like if you’ve got energy for something, um, that’s where it’s going to jump off the page. And I certainly feel that way with biotech and in my current line of work.

But maybe just bridging briefly back over to the school stuff. I mean, my wife noticed it with me, you know, for me, it was as I, the buddy was like, should you run for the school committee? And I was sitting there in my bed at 1130 at night. Watching old school committee meetings at 1. 5x, you know, like on, on, on Newton TV, it’s like, man, I really have energy for this.

It’s not work. It’s like, it’s, it’s fun. It’s play in his, you know, with a serious tone to that. And, um, and so I think finding that, that energy as you, you know, draw the arc of your career, I think is, is really great. Um, fun and important and will be ultimately how people find their greatest impact.

Naji Gehchan: Yes, and how you framed it is so powerful.

Find the way you want to make a difference. And there’s no small difference, right? And this is what you’re, what we’re talking about here. The difference in your community from education to healthcare. And obviously ultimately what you’re doing in the biotech world, bringing innovations to patients. So thanks again for being with me today, sharing.

your experiences and also what your, uh, all the impact that you’re trying to bring across Newton and beyond. Uh, it’s been a real pleasure to have you with me today, Jason. Thank you. Fantastic. Thank you so much, Naji. Really appreciate it. Thanks for listening to the show. For more episodes, make sure to subscribe to spreadloveio.

com or wherever you listen to podcasts. Let’s inspire change together and make a positive impact in healthcare, one story at a time.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Afarin Bellisario

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Afaline Belisario, a leader who bridges East and West, technology and the human condition, and past and present. Born and raised in Tehran, in a family with its feet in the past and its head in the future, she led a successful career in high tech and international business in the U.

S. After earning her PhD from MIT. But writing had always been her passion. Having written professionally in pre revolutionary Iran, she has published in major papers, including the Boston Globe and an essay, Movies with My Aunt, as part of the anthology, Love and Pomegranates. Today, she mentors startups, teaches, and writes about the clash between tradition and modernity and how the past can shed light on our technology fueled future.

A music lover, she is also a Cambridge Chamber Ensemble Board member and writes for their newsletter as well as on Medium. Afarine continues to discover new destinations globally. It’s a great pleasure to host you and have you with me today.

Afarin Bellisario: Thank you very much. It’s a great pleasure and honor to be on your podcast and speak with yourself and your audience.

Naji Gehchan: First, I’d love to hear more about your personal story. We’ve met through MIT Sandbox, where you mentor. I know you’re passionate about startups, but I really want to start with your personal story, from your childhood in Iran to high tech business to now being an author, teacher, mentor. What’s in between the lines of this great, inspiring journey of yours?

Afarin Bellisario: Well, first and foremost is that, uh, MIT Sandbox. I am, um, uh, I’m curious. I just want to know. I, I, I am, I learn, I yearn to learn and I yearn to, uh, interact with people and I’m not afraid of change. And that’s a good thing for, um, um, and at heart, at least. Entrepreneur. I mean, I work for big corporation, but I always have been.

And how they enter entrepreneurial or entrepreneurial if you like, uh, kind of, uh, position within those, those companies. Um, my story, of course, begins in Iran. I grew up in a family that, uh, and the mom was just telling me that, oh, there are parts of, uh, Iranians who, uh, will always, you know, the people, my, my age, a lot of them who are born in North Tehran, for example, they know nothing about the South Tehran, but.

I was fortunate where my grandparents, for example, were traditional people living in Bazaar. My grandfather was a merchant and my, um, but my father was a university professor. He was a doctor. My aunts, um, you know, everybody was educated. So we all moved to North Tehran, if you will. We, we were in the traditional part of Tehran and then we moved north towards more westernized, more modern Tehran.

And of course, you know, uh, more, um, secular is the same, same thing with lots of American movies and American, um, books and things like that. So I was fortunate to have my feet, one foot in one side, one foot in another, because I can understand the problems of this. This, um, this difference will, will, will create, uh, I know, for example, ladies who worked in North Tehran, in North Tehran, you have to be, um, you know, look like somebody who stepped out of a Bloomingdale’s or Harold’s or whatever.

And in South Tehran, people were, women were expected to wear, Uh, headscarf. And so therefore it is very, very different, um, different way of life, different way of everything. And, you know, uh, there were ladies who wanted to, um, to, to, to get ahead in life and they went to school and stuff and, um, maybe get a job in North Tehran in some of these, uh, beautiful glass, uh, office buildings.

But, um, And I know that for a fact. So they would leave their house because women in Iran lived with their parents. They leave their house, um, you know, with their scarf and a very long skirt and no makeup and something in their route to their office. They would be transformed. It’s sort of like a, almost like a Superman, but that would transform.

And it wasn’t that they wanted to be deceptive, but, uh, but that’s also explains what happened later on in Iran, because it’s, um, you know, so, so I started there and, um, I, my mind is like a sip. I mean, I, my memory, I mean, I, all the people were talking about, I was, uh, I would listen to everybody. I would just, you know, record all the stories in my mind and I would make stories.

I would change the stories that my grandma said and modernize it and things of that sort. But when it, when it, when I grew up, when I went to high school, it was clear that You know, uh, making a living with the writing is not something that, uh, one can do without, uh, sacrificing their, um, a lot of their principles.

And I wasn’t about to do that, and I was lucky enough to have a, um, to be very good in math. And, uh, you know, so I said, okay, I’m gonna, and this is not, I’m not the only one. A lot of people. Uh, a lot of, um, intellectuals in Iran have done that. They have a day job where they do whatever that there is that they do.

And at nighttime, they go and, and write books. So I was, I planned to do that. So at some point in my life, and now, you know, things change. I am, you know, the Iran was, uh, very tumultuous, uh, I, uh, Um, you know, uh, coming to United States to study, and I went to New York University, and then I, uh, transferred to MIT, and, you know, uh, sort of, uh, then the revolution happened, and that’s another story.

One of, one of these days I will write about that, because I was here, uh, when hostages were taken. And of course it was sort of, I

finished my PhD job and I said, okay, it’s here. Whatever. Then, uh, um, you know, uh, um, like many young people, um, I wanted a family. I wanted a husband, I want children. Uh, so it’s a, it’s sort of, I said, okay, well food here, maybe someday, but in my, in my heart of hearts, I knew that, uh, my life. And I was very lucky again that I started here.

I didn’t go back. I can, um, spend some time there and, and then he started my life like my father did. And that’s in America, as you know, better than I do. When, when you go to work here, you work full time and then you have a young family and there’s no evening hours to write anything. And of course, uh, English is not my native language, so, um, I had to learn a lot of vocabularies, you know, sentences, things like that.

And of course I read. I read, but I read everything. I read good stuff, bad stuff, whatever, whatever comes along. Um, so it’s a long story, but Eventually, I got to a point where my kids were were older and gone, and I had a chance to not work full time. And at that point in time, I said, Okay, I’m going to do consulting, I’m going to do mentoring, because I really and truly believe in, in sandbox and you have gone through that as well.

And you know how How useful that is to a lot of engineers and and students. So, you know, I said, this is my life. I mean, I’m not gonna, I’m not gonna spend more time in corporate America, which is wonderful when you are doing it. But, you know, and then I started writing and I, of course, you know, like everybody else, the first things first version wasn’t very good.

But I used my mentorship and my entrepreneurial spirit. I said, I’m gonna have people read it and people read the first chat first version. And everyone says a wonderful story. You got it right. You got it right. And then of course, you know, version two and three and four and five and As entrepreneurs, we all know that the passion and the inspiration is one percent, and then the hard work and sweat is 99.

Um, so here we are.

Naji Gehchan: I, I love that. And your book, uh, your book’s name is Silence Whispers.

Afarin Bellisario: Yes.

Naji Gehchan: And I’d love to, um, I’d love for you to tell us more about, uh, about the book. Uh, I have obvious questions about, is it fictional? Is it your story, a story of other women? So I’d love to hear your version of in between the lines of this book.

Uh, before we dig more into, uh, some leadership questions also, uh, I have for you, uh, with your, Leadership.

Afarin Bellisario: Absolutely. So the book, well, as I said, I’m a very curious person when I first started. Uh, having a little time to myself. Um, I looked at, uh, you know, the question of what happened in Iran has always been in my mind and also we are technologists.

I was in the first generation of the smartphones. I was one of the people who are evangelizing it from, from, uh, from standpoint of, I don’t know, technology, uh, you know, uh, as you have time to pause and, uh, my good friend, um, uh, you know, there are Many, many professors at, at Sloan, uh, Professor Ancona, for example, who writes about, uh, taking a pause, you know, take a pause, think about it.

And, and, uh, so I had a chance to take a pause and say, okay, what happened in Iran? And what happened in Iran, if you look at the modernization, you know, middle of the 18th century, 19th century, this was a, Truly backward country between two different empires, you know, one from the North Russians and one from the East, you know, British Empire, which was, of course, in India, and then the other side of it, the rest of Iran was Ottoman Empire, which was crumbling and, you know, it’s a segment of Europe.

Um, and of course, Germans were very much involved in it, and the colonial power were very much involved with Ottomans. So, Iran was sort of being squeezed from all sides, from other sides. So, Iran had no choice but modernize to try to defend itself, try to stay a sovereign nation. So technology came to Iran, science and modernity.

And the way it came to Iran was by a lot of students went outside and they studied and, you know, foreigners came to Iran and started businesses and some Iranians started businesses, you know, factories, things like that. But with this modernity came modern ideas and secure. secular laws, uh, right of women, you know, women can’t be, uh, confined to the home and the chador.

And Iranian women, uh, historically have been brazen enough. And so, uh, they became even more brazen. Uh, and, uh, so we, we had the, the, I think that the tipping point point was the Early 20th century when you had a very weak central government and that, you know, they started a constitutional monarchy. But then, you know, of course, World War One happened, Iran was being violated from left and right.

Eventually, Reza Shah came to power, Pahlavi dynasty started. But that 20th century, years, give or tell. And I, you know, I did a lot of studies. Again, research is what I, what I know how to do. I, that’s what Emma taught me. It’s, you gotta do, you gotta look for things. You can have answers for it. You have to hypothesize things.

And so after all of that, I, for a while I was thinking about, and these are very, um, This is an obscure, um, you know, corner of Iranian history from the standpoint of Americans, because, you know, Americans are very interested in 1953 and the coup d’etat and the evolution. They’re not going back far enough, whereas the root of all of these Breakup within, you know, Iranians are of two minds.

One mind wants to be more modern than Americans. One mind wants to be more restricted than Taliban. So, can’t live in the same country. Is it the same country? Is it, um, are we all And the other thing is that I, um, I Started seeing the, the same roots, uh, the same problems, um, in America, because we’re also getting further and further apart from each other.

So as I said, you know, our first idea was to write some, you know, a book, whatever. And then, believe it or not, one morning I woke up with the idea of Gohan, my, my main character, this young woman who is going through this transformative, um, life to transformative country. Um, and that transformations give her some, some chance as well as she can take advantage of that.

So, um, that’s, that was the first. Uh, first, uh, inclination, of course, as I said, uh, uh, then I learned I had mentors and I had teachers, uh, um, I was lucky to work with some of the good ones and I thought how to do, um, um, I learned how to do character development and the plot development. These all came later in the beginning.

I just wanted to tell the story of that time in Iran, uh, through the eyes of this young woman. that I imagined. So, so ask me any question you want.

Naji Gehchan: I, I, I love it. So I’m really, I want to learn more about this woman and how much you relate actually to her in your story. And also you talked about the unfortunate both sides that we’re seeing, the extremes.

That’s it. That we’re seeing all across the world these days. Yes. Yes. So I’d love for you to tell me her story, how you relate to her and how you’re living in a world of more and more extremism on all sides.

Afarin Bellisario: Yes. So number one, let’s just start with Gohar. When I first started to write the letter again and to write this story, I had no idea how to develop a character.

You know, this is a person who does this. That wasn’t good enough. And one of the things that I work with this lady, um, Ellie, uh, Ruben, that’s, um, you know, the two of us, she was both my editor and my mentor, you know, in terms of editing, she never changed anything. She just said, this doesn’t work. Go and change it, but change it in your own voice.

It was a process. Um, you know, sometimes I got angry and she got angry and we almost, uh, you know, but we work together and she’s a wonderful person. And, uh, today we still work together on the sequels, but, uh, the, the. The thing that she told me is that when I, when you develop a character, you gotta sometimes look into yourself.

You know, how would you do? How would you feel? How would you think? And so Gohar, um, you know, shares a lot of characters with me, but she’s not me. She’s a different person. She’s doing things that Gohar will do, not things that I would do. When I, one of the couple of things that we share. Is number one is that, uh, we both very curious.

So she’s curious. She’s always thinking, you know, sure. What, what is about telling me that? So this why is, is there. So it’s for me too. And the other thing is that we share the, I don’t sing. I, my voice is terrible,

but, uh, but I do, but I love music. I,

That also I share with her. So a lot of characters like that, and I share with her, but she’s not the only character in the book, and she’s certainly not Not the only female character in the book. Um, and for that, um, I basically went back and thought of a book that I knew in Iran and, uh, uh, brought out the stories and the way, you know, they, they manners and then they, they, their lives and things like that.

And when I say the book is, Women, it is true. Uh, it’s a fictional story. The, you know, obviously the, the characters don’t exist, didn’t existed, but people like, uh, and we

did exist. So in that case, it is true. Um, now, the other thing that is true, my great grandfather was Russian and he married my great grandmother who is, that is true too, there were lots of Russians who, like the Iranians, who came to Iran and lived there for a long, long time. Uh, my own, my, my, my, uh, father, My paternal side of the family, my grandfather was from, uh, originally from this town called Orduban, which is no longer in Iran.

It’s actually, um, in, uh, in Azerbaijan and Georgia. It is part of Azerbaijan, but, um, it is in part of Nakhchivan, which is also an interesting story. I want to go there someday, but not yet. Uh, so, uh, my grandfather, for example, was very, um, very active in trying, and there was a very short lived, uh, republic in the 1919, uh, right after World War I, um, in, in Azerbaijan.

And my grandfather was very much into um, you know, this is before my time, but she would tell me the stories and, and, uh, you know, uh, how he helped out, um, you know, he sent money and, and things like that. So, uh, some of those stories, again, I heard from them. Um, I augmented that with, uh, with lots of research, uh, clearly.

So, um, So here we are. So it is true that the Russians did marry Persians.

Naji Gehchan: Fascinating. And, uh, yeah, it’s, it’s such a region full of history, way more complex than what media or news want to tell us about all this part of the world. Um, so well, thank you for shedding a different light on, on this and a different experience. Before I will go to another section, but before that you, there’s something that’s really, uh, I’m intrigued as a philosophy that you have, which is the past can shed light on our technology future.

Yes. And you mentor a lot of startups, really building the future of tech through MIT and other institutions. I would love to hear more about the specific philosophy of yours.

Afarin Bellisario: Yeah, I mean, um, actually I just wrote a little piece for my, my newsletter. It’s a, it’s, We think that, you know, all of these things, I mean, this is the thing, technology is fast, human being and laws and things like that are slow.

Um, if you look at, for example, a hundred years ago when radio was becoming, um, I’m, I’m a student of history. I love history. When I teach entrepreneurship, um, I always have one or two case studies from some old companies there because there’s a lot of lessons. in their successes and also in their failures.

I mean, I talked to them about Polaroid, how great it was, and then it wasn’t, uh, about Lang Laboratories, and these are recent pasts, 50 years ago, 40 years ago, but they were all there. So, so there’s a lot of lessons. Underneath all of these technologies, a human being Who has to use it for good or bad. And every time that you have a radically new technology that is, um, rapidly commercialized.

So once everybody, I mean, yes, a lot of people knew about radio waves in 19, 1800s, but it wasn’t until 1920s that radio became a common place and people went out and bought it. And, you know, there were all kinds of. Stories about what what business model would this thing work at and how, uh, vicious it could be.

I just found an article in a magazine written in 1929, uh, titled radio curse or blessing. So, so, so change radio with the Internet, with AI, with whatever you want. At the end of the day, in the beginning, all new technologies that are radical are both fascinating to people and also scary. But at the end of the day, we just have to come to a, um, come to live with them, to use them, the way we need to use them.

We, we can’t have them rule over us. I mean, and human agency is what makes us happy. I’m happy because this book and read it or not. Um, if somebody constantly tells me, read this book, read, I won’t, uh, because I’m actually a defiant person. That’s another trait I, I share with my, uh, with my hearing. Um, anything on the face value.

So we need to first of all, from one hand, chill out. Don’t be scared from another hand, not to get. Blown up by the by the technology. We gotta take it. We gotta make it human. We gotta pick a pick and choose what we want. Um, it really, really angers me when I go and watch some, um, you know, television. I’m going to go with streaming services.

I’m Amazon Prime, whatever. And instead of telling me what are these genres that I can choose from, you know, they show me all these movies that I may or may not like. Yes, of course, they, they, they help me with, uh, with my choices, but it’s also, it’s sort of a little bit of, you know, it’s, I’m put off by it, it’s like, you know, what are they saying?

Why is this so important? Why is why is this book on the top of everything else? Is that because Amazon is making more money? Is it because is it really good? Um, so we are losing, you know, this, this choices, uh, that are coming together. I’m an engineer, you always optimize based on something. And unfortunately, the, the, um, the most of our social media and most of our, um, you know, most of what we see is, is, is optimized.

On eyeballs and you know, commercial and things like that. So I don’t expect them. I don’t expect Amazon or Google or Microsoft to be ethical beings. Okay, so they’re corporations. They have to make money. But I think as humans, we have to. Um, start taking control of your own, of our own, um, destiny, so to speak.

Um, so it’s, that’s, that’s the philosophy behind looking always at the past because that teaches us a lot.

Naji Gehchan: I want to give you now a word and I would love your first reaction to it. Sure. So the first one is leadership.

Afarin Bellisario: Okay. Leadership is to, you know, to take, um, a team of people, um, to a certain place. And there are many, many different kinds of, um, uh, styles of leadership, if you will.

I mean, uh, a military leader might be, uh, also an operative and convince people and take them somewhere. At some point, you know, you have to say, I’m not gonna, in the middle of a war, everybody’s shooting at us. We are not, we don’t have time to, to, uh, to, you know, discuss everything. But, uh, you know, to, to, to the collaborative as much as possible.

So, a leader is the person who sees the, the, it has a vision, has a, sees the future. A leader, the good leader will share that vision, the places to go with others and take the whole team there. So it’s not that the leader is, you know, uh, across the river, whereas everybody else is still in the, uh, in, in the other side.

So, uh, so it’s a leadership is to me, that’s, that’s what it means.

Naji Gehchan: What about innovation? Well,

Afarin Bellisario: innovation is coming up with something new. But to me, it’s always something new that does something better. Better, faster, cheaper. It’s just that, you know, we learn, we teach that to our teams. Um, why is this thing better?

I mean, it’s fun. For better, you’ve been in MIT. So at MIT, we deal with a lot of technology, and a lot of times, you know, it’s the technology looking for solutions. I always tell people, Fall in love with the problem, not with your solution and because, okay, it’s always good to be to, uh, to be curious and to work on something that’s we don’t know what it’s good for yet.

That’s science. That’s wonderful. And but, but, Innovation has to do with usability. You gotta make something that’s useful to people, um, and they can make, make their lives better. I mean, it could be something to, um, I don’t know, cure a disease, maybe make food better, whatever. So, uh, to me, somebody who comes up with a new fancy dish and it’s a very tasty dish, that’s innovation.

Naji Gehchan: What about startups?

Afarin Bellisario: Startups. Oh, yeah. We are a nation of startups. Um, startups, you know, to me, are people who have a passion, um, and, uh, decide that, uh, um, the, the tried and true ways, the operations or whatever doesn’t work for them for one reason or the other, and they start up. Something new. Um, again, it has hand in hand, hopefully with innovation.

You open a, um, a new bakery in a, um, in the, I mean, flour bakery in, in Boston, you know, flour way close to Sloan, couple of them. So, uh, You know, it’s opening a bakery is not a big deal. It’s not innovation, except that she came up with with a new way of approaching the problems that was innovated. And she started a startup.

to make that innovation possible, commercialize, make it accessible to people. So that’s a, that’s to me, that’s a, that’s a definition of startup. And

Naji Gehchan: the last one is spread love and organizations.

Afarin Bellisario: Spread love, I don’t know, spread passion, spread, cause everything in the world, love, uh, moves the world. And it’s not only love, love between two, two entity, two person, one person and an animal.

You know, love is love. You know, when, when we are thinking about somebody else besides ourselves or some other entities besides ourselves, um, that’s love. You know, and that’s, uh. That’s, uh, and, and that is the, that is what makes the, uh, the, that’s, that’s a huge, uh, motivation. Um, and if we have a, um, organization where people feel empathy towards each other, it’s a good organization.

Naji Gehchan: Any final word of wisdom offering for leaders around the world?

Afarin Bellisario: What is it? Any advice for them?

Naji Gehchan: Any final word of wisdom for leaders around the world?

Afarin Bellisario: Stop thinking about, you know, making, you know, uh, I mean, if you look at people, all these leaders, they’re trying to create chasms between people so that they stay in power.

Um, people have more in common with each other. And then then differences. But if unfortunately, today’s leaders are, um, I mean, and they’re not leaders in my mind. They are. They are ours. The powers of being strong people. But, but those people and my, my advice to them is that, you know, wise up, you know, bring people together because otherwise we’re going to have.

You know, just going back to past and future. Technology is a tool and the more we make it may make it stronger. It also has the effect of potentially more danger. I mean, an atomic bomb is millions of times more, more dangerous than a knife. And, you know, now we have generative AI and all this other technologies.

We have tools of destruction and they got to be careful. They got to be very careful about, um, you know, uh, put you over the fire and, and making the differences worse.

Naji Gehchan: That’s a great way.

Afarin Bellisario: Differences. Yes.

Naji Gehchan: Yes, thank you so much for joining me today. Let’s bring people together. That’s a great way to finish our chat today.

Thanks again and congrats for your, for your book.

Afarin Bellisario: Thank you very much and thank you for having me. And yes, I love nothing better than trying to be a bridge between people. I think that’s, that’s what we need today.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Angela Justice

Naji GEHCHAN
Naji, welcome to spread love and organizations. The healthcare leadership podcast, where we explore leadership with purpose.

I’m Naji, your host, joined today by Angela justice, an award winning Chief People Officer, executive coach and trusted advisor to top executives, a neuroscientist by training. Angela began her career as a management consultant at McKinsey, before holding senior leadership positions in medical affairs, patient advocacy and human resources. Most recently, she was the chief people officer and head of medical affairs at TCR therapeutics. Angela has diverse background and hands on experience in the C suites and boardrooms of healthcare, biotech and nonprofit sectors provide her with a unique and informed perspective. Her deep understanding of human and organizational behavior enabled her to drive sustainable change, helping leaders establish strategic alignment, address blind spots and leverage strength for exceptional results. As the founder and managing director of justice group advisors, Angela is dedicated to helping leaders earn and embrace their seat at the table. Angela, it’s

so good to see you again and have you with me today.

Angela Justice 1:13
Thank you so much, Naji. I really appreciate it. I’m so thrilled to join you here today.

Naji GEHCHAN 1:19
So I want to first hear more about your personal story and really what brought you to biotech, from neuroscience and now entrepreneurship, always, though, focused on healthcare leadership. So I’m really eager to learn more about you. Yeah,

Angela Justice 1:34
oh, thank you. You know, it’s, it’s really interesting. I think if I would have been asked, you know, when I was a kid. So I grew up in a small town in rural Minnesota, and if you would have asked me what I would be doing today, right? I don’t think one. I would never have even known the career of executive coach existed, that that would have never even entered my my consciousness. But knowing, you know that I’ve been able to weave together this career through, you know, academic research to management consulting, healthcare biotech, and now being able to advise and coach leaders and executives and teams in biotech and life sciences companies to help them achieve extraordinary results. And have, you know, a big impact in the world, it would just, I think, blow my young Minnesotan mind.

Naji GEHCHAN 2:31
So tell us a little bit more. How did that happen, like how, why neuroscience and how you ended up being so passionate about human behaviors, organizational behaviors, and you’ve touched through your career all those aspects, from actually building capabilities global leadership development to being Chief People Officer. I’m intrigued What drove you in that, and how do you see your current mission, being an exec coach, helping

leaders be better leaders in life. Science.

Angela Justice 2:59
Yeah, so, you know, I’ve always been just fascinated by human behavior. I’ve always been the person, you know, asking, Why did they do that? You know, how? How can we get them to do something different? What? What’s it going to take to make this change? All my life, right from the time I was very young, and in particular, one of the areas that always caught my curiosity was this concept of potential. You know, I was, I was a dancer when I was a kid, and throughout most of my young adult life, I was a dancer. And, you know, I even taught dance. So I was like an apprentice to my dance instructor for many years. And what I loved about that I love dancing, right? I love pushing myself to to be great. But what I loved even more was identifying those other dancers that had potential, and thinking about how you could help shape and nurture that, so that they could become the best they could become, so that the collective group of dancers, the company, the team, could really become great. And so this, this concept of potential, has always been something that’s been really like dear to my heart, and I’ve always thought a great deal about what it takes to both identify potential, but then also to shape and nurture and grow it. And that, I think, is really what led me to pursuing my my degree in psychology, and really understanding, or trying to understand the underpinnings of human behavior, and then ultimately taking that a step further and really trying to explore the neurobiological underpinnings, or neuro chemical underpinnings of behavior. Really wanted to understand this very deeply, but all throughout it’s been really driven by just this innate, intense curiosity for what makes people do, what they do, and how we can bring out the very best in people and help them achieve their very biggest goals.

Naji GEHCHAN 4:59
I love. So my first follow up question, and I’ll get back to potential, because I love how you framed it. But how do they do what they do? How do we as humans do what we do? And how can you as a leader

get the best of each one’s potential?

Angela Justice 5:13
Yeah, you know, I think I’m still trying to figure that out. To be frank, I think when you it’s one of those things, the more you know, the less you know right, or the more that you learn that you need to learn. But I think inherently, just having that curiosity about behavior really is seeking to understand why people do and continuously asking and exploring and kind of probing. You may not ever fully understand it, but at least it brings out, I think, a sort of empathy which also creates the platform where you can start making inroads, start having impacts, start understanding and then ultimately asking different and even better questions to move forward. So I don’t know that. I know why people do what they do. I do know that there are certain things that you can do consistently, or think about or ask consistently, that help shape behavior. And those are just some real basic behavioral science principles and techniques that I think are fairly universal, aligning incentives and thinking about reinforcing certain behaviors, both positively and negatively, and negatively meaning taking the bad stuff away, not not punishing. But I think there are certain concepts that that help us understand and help us influence. But boy, humans are still a mystery,

Naji GEHCHAN 6:34
and that’s what’s beautiful in being a humans and leading humans. And as you’ve been Chief People Officer, you’ve also led organization as an operational leader. Have you found the magic recipe to be able to foster this potential and make sure that you have a high winning team? And how have you, how do you think about this as an operational leader, but also when you were a chief people officer, how would you bring what are the key major aspects that you would look in within a leader, where you would know they would succeed with the team you have?

Angela Justice 7:10
You know, I think oftentimes what it comes down to is having a goal that’s bigger than oneself, and I think that happens both at the individual level, but also at the collective and team level or company level, right? If you’re focusing on something that is greater than you, something that really matters to you, right? And this is one of the reasons I love healthcare and life sciences so much, because we’re all in it, because deep down, we want to make the world a better place. We want to make things better and easier and safer and happier for humankind, and when you can really focus in on what it is that you’re doing and why, it propels action in different ways. Right? It motivates people to take the steps they need to take to get it done, because they’re not doing it just for themselves. They’re doing it for a bigger purpose, and that bigger purpose can be incredibly motivating, because it takes people away from, you know, themselves in this kind of egocentric perspective or perspective that they may have. So I think first off, as a leader, aligning understanding right the motivation, but then aligning to a higher purpose is something bigger than than just oneself. It sounds perhaps a little trite or cliche or obvious, but it’s critical, and it really works. So I think that’s really the first step.

Naji GEHCHAN 8:37
It is.

It is certainly critical, and certainly, as you said, in life science and healthcare, it might feel obvious, we certainly wake up every morning to bring innovation to patients and help help people, help us at some point live better. But as you said, it’s not that simple to wake up and remember that every day. So making sure that as a leader and as a team, we always bring this purpose beyond

any anything else, right,

like dynamics,

egos, what I think, what you think, I’m sure you’ve seen those throughout different experiences and big organizations, smaller biotechs, it always exists, but it’s really going back to, why are we doing what we’re doing? And at the end of the day, this is the main, big purpose that we’re here for. Yeah, exactly.

Angela Justice 9:30
And you know, so often you do, you know that, you know that’s your goal, you understand that that’s the company’s bigger purpose. And yet, to your point, you get stuck in these kind of squabbles, or, you know, turf wars happen, or conflict happens between teams, and to be able to take a step back, and I think it’s an active practice of taking a step back, but to do that and say, look, here’s the problem, right? Here’s the challenges that we’re facing. We’re trying to solve them because together. We actually want the same thing, and then looking at it as we’re in this together, right? We’re going to solve this challenge as collaborators, as, like, you know, allies, not as as people who are trying to compete or at different sides of the problem. We’re actually on the same side of

Naji GEHCHAN 10:16
the problem. Yeah, yeah, looking at competition outside, actually, versus inside and really in healthcare competition is just the diseases right that you’re trying to cure and fight for the patients. You said, you know, as you were saying, like daily practice, stepping back. Where do you place humility? Because I’m feeling the more you grow, the more you learn, the more you have to be humble and accepting that you don’t have the best ideas, and it’s actually the team who will bring the best solutions towards your purpose, have you? Is this something you consider, you think of as a leader, or as you coach leaders?

Angela Justice 10:54
Yeah, absolutely. I think that humility is is is critical, and it isn’t always a quality that is honored, right? I think, especially in in healthcare and in highly technical fields. Let’s say, when you’re building this tremendous expertise, you know, you think of the the surgeon or the physician who’s building this tremendous expertise, and literally have lives in their hands, right? Humility is is not necessarily the first thing that comes to mind is the competency that’s going to help them excel. And yet, when you’re leading in organizations, humility is absolutely critical, because to get the best solutions, to get the best answers, to move the organization closer to its bigger goals and bigger purpose. It requires the collective effort of everyone, and that means people need to be able to take a bit of a step back and be open to hearing and learning and collaborating with others. So inherently, that requires a bit of humility. It requires confidence too. But I think those two things can actually go hand in hand.

Naji GEHCHAN 12:04
So when you think about all the experience you had in the different roles and now being an entrepreneur and executive coach, have you set intentionally the direction of your career and where you are today? And I love that it started with the love of dancing and finding potential. So what were you intentional on all those steps?

Angela Justice 12:25
Well, given that when I was a kid, I thought I was going to be a trapeze artist, right? That was like my career goal, no, I can say with confidence, set the direction. It’s definitely taken some pivots and some turns, but I think that kind of guiding principle throughout has always been, you know, this, this desire to really learn more about people and have an impact on the world in a way that was somewhat meaningful, and healthcare, life sciences, that’s always been a guiding Passion. You know, I always approach to those, okay, directionally, where do I want to go? And kind of thinking, you know, if I can think, like, three moves ahead, then the next move doesn’t have to be the defining move. It just has to get me closer to the ultimate kind of goal. And so I’ve always tried to take that approach right. I want to be directionally correct. I want to have an idea of where things are heading. But I also want to have a little bit of optionality built in, so that I can take advantage of things as they come along, and be very open minded, really, in opportunities as they present.

Naji GEHCHAN 13:38
So I want to double click on this, as you’re obviously an exec coach with leaders, you’ve been a Chief People Officer also, and I mentor a lot of early career professionals too, and who are at different stages, but even advanced leaders, sometimes They’re more into focusing on today and the immediate job or the next promotion, versus taking direction exactly what you said, like directionally in the right way, and what I want to really kind of achieve in my life, versus, you know, my next career promotion, or the next 10% which I’m not saying is not important, but I’d love your thoughts about, how do you navigate this? And I’ve seen it in different countries, being very different. I can tell you, in France and some countries in Europe, it’s different than what I’ve seen also in the US of this, you know, like high stake of a title and, you know, a promotion, versus, like you know your purpose of the job and the impact you have. So I’d love to get your thoughts off. You obviously been a people leader for several years. Yeah,

Angela Justice 14:52
I think, I think you’re right. It, it is. It’s a tough it’s a tough topic in some ways, right? Because. There’s a lot of personal identity wrapped up in one’s career. And I think in the US, we see that in particular, like a lot of one’s sense of self worth comes from their title, their job, their role and and I think you know, what I like to encourage people to do again is to take a little bit of a step back and think about what it is that they really care about, what they really want to accomplish, what they want their legacy to be for their lives, and that isn’t just the next job. That isn’t the next type, right, that’s going to be taking a much broader, more expansive view. And when people understand or have a bit of clarity on what it is that really matters to them and where they want to head again, directionally, it liberates them a little bit to think more expansively about their careers. And look, I’m all for advancement. I think, you know, it’s, it’s wonderful to be ambitious and want to move up in organizations, but I think the concept of moving up in organizations is a bit missing the mark. I think what really people need to focus on is moving up in their lives and really moving closer to their ultimate goals. And when you think, you know, a little bit further down the line than just the next job, it also it opens again, it opens that aperture so you can be a lot more opportunistic about things that you take advantage of, right? So if you’re thinking, I want this next promotion, you might be laser focused on getting that and that job, and then if you don’t get it, you’re going to feel kind of bad. But if you’re more thinking about I want this ultimately, and these are the skills, experiences and connections, I need to get there. Then all of a sudden you see lots of different opportunities open up, and lots of different steps Open up. They might be in terms of advancement. They might be a job that moves you, you know, quote, unquote, up the ladder. But it might be about broadening your skill set. It might be broadening your experiences. And again, those just open you up for newer and different experiences. It kind of takes the pressure off, but it also just really makes you a much more rounded, valuable professional.

Naji GEHCHAN 17:14
I love what you said. Move up in your life. I will. I wrote it down. I’ll always remember this as a great advice for all our listeners, and one of the powerful questions you asked I always used that is, what do you want your legacy to be in life? Think, when you start thinking through this lens, you open up, as you said, to different different types of perspective and really the impact that you want to have on others and on the word as you live it. When we also discussed, you talked about potential today, we also discussed about amplifying your edge. So I think it’s related to potential. Can you share a little bit more your philosophy about this? Yeah, yeah.

Angela Justice 17:59
So you know, this is a concept that I I really honed, I guess, or really explored, when I was at McKinsey. So I was a management consultant at McKinsey and Company, and I was what they called a non traditional hire. So that meant I had a PhD, not an MBA. And, you know, look, I knew very little about business. I had run a dance studio. I had done a few little entrepreneurial things, so I had a business inclination, but I didn’t have traditional business skills or knowledge. And I remember, you know, the first month year, even at McKinsey, working so hard just to fit in, just to become more like my MBA colleagues, and it was exhausting, but it also wasn’t working. I mean, I wasn’t like, being revered as, like, this amazing hire, like, Thank goodness they brought me in. I knew that there was a gap that I had to bridge, and I wasn’t going to bridge it by trying to be like everyone else. So what I did instead was I thought a lot about what I brought uniquely to the table that gave me an edge, and what I came up with was, look, you know, they didn’t hire me to be an MBA. They have those that hired me because I was a scientist. They hired me because I was a behavioral scientist, and I could come up with different ideas and hypotheses and ways of helping our clients, helping the companies that we were supporting achieve their goals, by applying my knowledge of behavioral science. So rather than, you know, trying to fit in, I started to hone my edge, which was I was a behavioral science that approached questions differently. I took a very experimental approach to the work we are doing. And when I started approaching the work that way and really talking about it like, I started talking about myself that way and really showing up by bringing those behavioral concepts to the table, everything changed. Now, all of a sudden, I wasn’t, you know. The PhD who didn’t have an MBA, I was the behavioral scientist who was bringing you know, novel insights and approaches to our clients that would really help them make the strategies that we were developing stick. So I always think about coming up with what is your edge? What is it that makes you unique, different, valuable, gives you that competitive advantage that will help you, help your clients, your company, your team, whomever it is, achieve again, those bigger goals.

Naji GEHCHAN 20:31
Well, this is a great advice. As we think about diversity, I imagine also within our teams, diversity of thoughts, of capabilities, so as an organization and as leader, embracing that and being open for those who we brought for their difference and not trying to make them fit the mold, right? Is a great learning

Angela Justice 20:52
Absolutely. I mean, it really at the heart of it that really is a lot of what diversity and inclusion is about. It’s recognizing those unique perspectives, experiences, talents, skills, ideas that people bring to the table that are different. But so often, I see this with leaders all of the time, and I made the mistake myself, right? You want to fit in, and that was not what McKinsey wanted from me. They wanted me to stand out. They wanted me to bring those different experiences, and that’s so true in organizations as well. It’s really easy to want to fit in, but you’re there because you have something to offer. You need to learn how to articulate it, how to tell that story, and how to make it apply. But bringing those unique gifts to the table is exactly what makes organizations.

Naji GEHCHAN 21:44
So I will pivot now to a section where I’ll give you a word, and I’d love your reaction to it. The first one is leadership. Well,

Angela Justice 21:53
the first thing that comes two things come to mind, actually, one is legacy. And partly because we were just talking about the importance of leaving a legacy and envisioning your legacy, I think using that to shape your leadership journey. The other thing that comes to mind is followership, because I think it’s really two sides of the coin, but I personally like to focus a lot more on the notion of followership than just leadership, because I think when you think about others, when you think about the people that you are leading, you need to think about why they should be following you, what it is that you’re doing to help them, support them, elevate them, pull them together, and again, back to potential, how you can recognize the potential of your team to really maximize that for themselves, but for each other and collectively as well. So legacy and followership.

Naji GEHCHAN 22:48
So the second one you just mentioned is potential.

Angela Justice 22:52
Yeah, well, so what do I think of when I think of potential? You know, I just think of maximizing all ways, shape and form, and really try to understand potential, you know, it’s interesting, right? Because you’ll have people who have, maybe similar backgrounds, experiences opportunity, and yet some people just seem to have limitless success, and others seem to hit a ceiling. And, you know. So I think if we think about what it is that’s necessary to unlock that potential, for people, you know, again, to me, it comes back to having a bigger goal, something that’s bigger than oneself. I think especially for a leader trying to understand and unlock that potential is is really important. What about coaching, coaching, you know coaching. When I hear coaching or think of coaching, I think of it as just an incredibly valuable tool, a gift in some ways. I’ve, you know, had the great pleasure honor of both being coached and coaching. I will tell you earlier in my career, I wasn’t as convinced about the value of coaching, and then I got a great coach, and I saw Wow. What you know? What can really happen when you have somebody who is asking thought provoking questions, who is challenging you, pushing you, supporting you, guiding you again, the unlock for potential there can be can be absolutely phenomenal. I’ve experienced it myself by having a great coach, and I continue to get coached. It’s an investment that I make in myself. I think it’s absolutely worth it, and I have the great honor and privilege of coaching some really exceptional leaders and seeing the value it creates.

Naji GEHCHAN 24:41
The last one is spread love and organizations.

Angela Justice 24:44
I love this. You know, when I think of that, what immediately comes to mind is that quote. I believe it’s Maya Angelou who says, you know, and I’ll butcher the actual quote probably, but it’s something to the effect of people will forget what you said. They’ll forget what you. Did, but they won’t forget how you made them feel. And I think if leader, if as leaders, we can bear that in mind, and we can think about how we want to show up with empathy, with compassion, with love, right for the teams, the companies, the people that we’re working with, that creates a legacy. I mean that really, that changes everything. It creates a movement. It creates a legacy, and it unlocks the potential of individuals, teams and organizations,

Naji GEHCHAN 25:34
any final word of wisdom for leaders around the world.

Angela Justice 25:40
Mm, well, you know, I’m not sure if I have any particular words of wisdom, I will make an offer. Because I think a lot of you know, a lot of this really requires a lot of deep thinking and introspection, like, really, to maximize one’s own potential and that of your teams, you gotta really think about it. You gotta reflect and and really, you know, try to figure out what it is that you bring that is your unique edge, and how you can help others find theirs. And so I actually created for your listeners a worksheet that will help them identify their edge. So it’s a it’s just a simple worksheet with a number of prompts. They can just spend some time thinking about what it is that makes them uniquely gifted, qualified, differentiated, and how they can start communicating that edge and bringing it to their companies, their teams, their workplaces, and then they can use it to also help others do the Same. So hopefully the unlock right of potential here can can be, can be pretty magnified.

Oh, that is awesome. Naji, thank you so much for doing for doing it. I will certainly have it on the episode page with also, if you allow your contact so people can use it and ask the questions if they have, it’s really awesome that they will be able to practice what we talked about and discovering and unlocking our edge. I’ll certainly do it, and I’ll loop back with you on it.

Yeah, I’ll love to hear what you come up with. It’s a really fun exercise. It’s one that, you know, I think it’s worth revisiting from time to time, because obviously things evolve, but my clients that have done it have really found that it can have some pretty tremendous impact.

Naji GEHCHAN 27:29
Awesome. Well, great. Thanks

so much again for joining me and being with me today on this chat. And I look forward to doing the exercise and continuing our discussions offline, too. Thanks again for being with me.

Angela Justice 27:41
Thank you, Naji. Thank you so much, and thank you to all of your listeners.

Naji GEHCHAN 27:47
Thanks for listening to the show. For more episodes, make sure to subscribe to spreadlavio.com or wherever you listen to your podcasts, lest inspires change together and make a positive impact in healthcare one story at a time you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Rebecca Yeung

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I’m Naji, your host, joined today by Rebecca Young, Corporate Vice President at FedEx Corporation and leads Operations Science and Advanced Technology.

In her role, Rebecca is responsible for driving critical aspects of FedEx innovation and transformation strategy, including scaling up robotics and automation, uh, technology, autonomous vehicles, decision science, and electromobility. She sits on the FedEx Strategic Management Committee, a C suite leadership group that sets the strategic direction for the enterprise.

As an expert in both advanced technology and logistics operations, she frequently speaks at high profile industry forums including Fortune, Word50, Reuters Momentum, CES, the AI Summit Silicon Valley, uh, and several more. In March 2024, Rebecca was recognized by Reuters event as one of the top 20 trade blazing women in enterprise AI.

who are demonstrating real influence, impact, and leadership in large scale enterprise AI deployment. Rebecca joined two public boards in 2023, Royal Caribbean Group and Columbus McKinnon, bringing to both her technology and innovation expertise and strategic perspective. She has also previously served as Board of Director for the Mid South 2022, and most recently, she is the author of What’s Rule?

Think differently about success and cultivate a happy life. A book that inspires readers to challenge the status quo, dive deep, think differently, and charter their unique path to success. Rebecca, it’s great to see you again and have you with me today.

Yeah, good morning, Yunaochi. So good to be on your podcast.

Naji Gehchan: I’m eager first, before going to your book that I really enjoyed, I want to first hear your personal story from childhood in rural China to corporate boardrooms. What’s in between the lines of your inspiring journey?

Oh, I, I would just say it’s a very long arc. And, um, I grew up, like, if I rewind five decades ago, and I grew up in rural China without running water or electricity.

And, uh, really to see right now, um, I am sitting as a, uh, Fortune 50 senior executive and a board director. Um, my life journey begins with, uh, a lot of difficulties in early life that, um, no money and not even, and not even enough food to go around in the village, but plenty of that. And then I went to Shanghai, uh, reunited with my parents at the age of seven, but that’s the difficult journey start with me having, um, just diagnosed dyslexia.

And, uh, had a huge challenges in school, even being viewed as the most stupid kid, um, like by the principal, which was like a really harsh for a child to actually experience. And so I had a tremendous struggle trying to fit in and, uh, um, and that lasted for many years until my mother, probably at the age of 12 me.

Told me the biggest life lesson. Um, she basically just said, I know you’re miserable, but you’re actually really smart and if you didn’t like what you experienced, you should have fight with all your mind. And, um, if not, your choice is accept the reality and be miserable. Which choice do you really choose?

That was a reckoning moment. Just made me realize my young self realized. But in life, you always have to fight and for a different outcome. So that ignited me. I eventually went to an elite Chinese university, which is Fudan University. And then that actually in a very different period, I was an accidental English major.

Um, but that was the early 90s when China was under through a tremendous amount of pressure. Opening up to the Western world. So guess what? English is the best golden key to, um, career opportunities than to exposure. So, um, I, I did many interesting engagement did management consulting for British companies to.

Enter into the Chinese market, and that somehow also and as well as an American delegation as their English interpreter, um, and that really ignited of my American dream. So, 96, I pack up my two suitcase had a hundred dollars in my pocket and a scholarship. To an MBA program, and so that’s how I actually just had the courage at that time to had a one way ticket, which took all my family’s kind of savings and my dad literally back me at the airport.

Please don’t go because we did not know anybody there. And by the way, that’s a one way ticket. You do understand if you fail. I know we wouldn’t have money or means to get you back, but I was young in my mid 20s. I was like, I wanted to pursue the American dream. I finished two years. I had my MBA, um, had a lot of, um, landing a summer internship with, uh, FedEx for as a marketing intern and did not know that it turned into a 25 year amazing career journey.

And pretty much, um, took me from marketing to operations to customer experience to advanced technology and eventually lead it to the scene. 1 of the senior most position at FedEx. And so that’s a little bit. Um, I’ll call my journey and, uh, um, it’s it’s just incredible.

Naji Gehchan: Wow. It certainly is. And, uh, you’re, it’s, it’s really an amazing journey of resilience, grit.

As you said, uh, you, you said really strong words, uh, in your, you know, beginning struggle to fit in and how, I love it. I remember we had a conversation with, uh, our friend Gail also, and I, I wrote down actually what you said that you said again today, like at your lowest point of your life, you have a choice.

Accept it and stay miserable or fight and change it. And I think this is part of the thread you keep in the book. So if we go, uh, to, uh, to, to your book, What Rules, uh, tell us more about it. Tell us an overview and why you wrote it, uh, to, to start with. And then we can go and dig into the rules themselves.

What

motivates you to write books? Yeah, that’s a really a great question. First of all, I mean, I never really imagined I would write a book and what motivates me was one of a conversation I had with another executive in when he told me he wrote a book to multiply the kind of reach and effect. And that inspired me to say, there are many people I feel fortunate in my life and my way of paying it forward.

Is to share wisdom, share lessons, learn to inspire others to be their best, and so that was the motivation to write a book, and you may ask why the name what rules Gail actually had a huge part of it. She has been my amazing executive coach. So one day we were just having dinner and she asked a genuine question to me, which is Rebecca, you know, everybody.

I mean. How what you accomplish is very huge. And even for some Native Americans, that’s harder to achieve to your level. And especially as women in the U. S., we always needed to follow specific rules and specific ways of working in corporate. So how did you, as a person coming from China, figure out the rules and just advance?

And I was very stunned by her question. So I, the next two words came out of my mouth was, what rules am I supposed to follow any rules? And, uh, it took a gal by surprise. And I think she couldn’t, she burst into a laughter and couldn’t stop for a few minutes. And then she recognized, she said, Oh, my God, you break the glass ceiling because.

You didn’t not really like like view the those rules as constraint. You don’t even understand it. So by not understanding you, you played your own game. And that’s how you break through. And that really inspired me to use what rules as a book, book name, because I think in life, a lot of times there are tons of unseen, um, Like, um, good meaning rules that, uh, guide how we do and, and what, who we should become.

But in the end, we kind of live our life by someone else rules by the conventional rules. And, uh, I always believe like life is too short to live based on other people’s expectations and. Um, it should always, like, be much more fun and fulfilling to embrace yourself, live a genuine, authentic life, and, uh, and not following any of those rules.

I mean, for example, I just thought to give you one example, I would say if you ask most people, what is your goal? Like what? What is your goal in corporate? And most people say make lots of money from the corporate letters, right? Our success tends to be defined by conventional rules as, uh, the wells and this social standards, but very seldom did people ask.

Is that your real goal? I mean, what is your real goal in in life? And, um, even for the industries you pursue, right? Or the business you do. Are you really genuinely happy? So those are the kind of more profound, the common questions I explore in the book and not to preach any ideas, but as a genuine kind of sharing and exploration to say, let’s dig deeper.

Let’s dive in. Let’s figure out like our passion and what we want to do in life.

Naji Gehchan: So let’s, let’s dive deeper and talk about what rules I love the title and and the story and I remember you said break the breaking the glass ceiling. I remember you used the term also in the book and in our discussion track the bamboo ceiling.

As it relates, I think, to what you left. But let’s go there. Let’s talk about The six rules you have in the book, can you share them first with us, and then we can probably dig in one in particular that you think we should prioritize above any other.

Yeah, so I identified the six rules we commonly follow.

And there are the goals rule, the strengths rule, the opportunity rule, the limit rule, the either or rule, and the happiness rule. So starting with the goals, typically, in, by any normal convention, especially Asian culture, the success of a life goal is to make lots of money and achieve high social status.

And what. We if we dig deeper, sometimes we could achieve those goals, but miss the mark. Does that really make us happy? What is our passion? So the ghost rule is really trying to dig deeper into our inner self, our passion, because when we start our passion, our life naturally project to a more happy and fulfilling path.

And the second part rule is the stress rule. And, uh, particularly as a female, and we tend to have a tendency of the negative buyers. Like, every time we have a survey about ourselves, like, my, my mind will immediately go into, like, ignore all the, all the good things said about me, what are the, the kind of weaknesses, and immediately dive in.

And that’s pretty good. That helps me address some of the weaknesses. Gradually in life. I realized that if I spend all my time addressing only the weaknesses, I missed the opportunity of like exemplify my like amplify my students so I can break through and for example, my current role is very unique role at the intersection of technology and application.

That is where I find. Um, the students actually project me to a totally different space. You have a ton of technology like executives. You have a ton of operations executives, but the combination of the two brings more power because. The intersection of technology and business application is where the value is generated.

So, that teaches me the lesson about don’t spend all the time trying to address your weaknesses. You want to making sure weakness doesn’t become an object of your success, but you needed to actually spend more energy to amplify the strength. So to break out and to get unstuck. Um, the third rule, which is opportunity rules, and in a nutshell, we always say opportunity is luck, but is it really?

So I would say two things. Um, one is, do you recognize when the opportunity actually show up? Second is, do you have the courage to take the opportunity? Because that comes with risk, right? So dig deeper. And oftentimes that builds, if you’re clear about your passion and your strengths, then you are more likely to recognize the right opportunity and be willing to take them.

And the fourth rule, interestingly, is limits rule or the failure rule. By taking the opportunity, you may fail at some point. And then doubt the decisions we make and we, I, what I, I want to share from my experience is limit or failure is temporary. If you don’t try hard enough and fail at something and always in the zone, then that’s very hard to break through.

That’s more like a comfort zone. Right? So we needed to actually be more intentional about pushing the boundaries, pushing the limit. And not to be governed by. Okay. That’s a safe zone. So that’s a force on high level is a force or the last. Then the 5th 1 is either oral, which is something we always struggle is, um, do we will have a work life balance and as a mother as a woman, and I struggled with that at the beginning.

I had a very unique past that. I literally at FedEx, I will say it’s two, um, I would divide it in half. So the first 10 years I spent as a mother raising two young children, and I did not intentionally go for a promotion because I was trying to really weigh what my priority in life, which is Um, being the best mother I can to my kids and spend time with them and that, that is because I couldn’t reverse my kids age.

I can always pick up my career, but I couldn’t at the same time. It doesn’t mean that I just like bamboo growing shoots. It doesn’t mean that I’m just like stand still. I, I spend the 10 years trying to study. Every aspect about FedEx business from marketing to product development to technology to back end infrastructure operations, customer experience, et cetera.

So, I was using the time to build my strengths while spending a lot of time with my boss. So, the next 10 years, it just, it jump started my career. I had a very fast trajectory all the way to the senior leadership. So, that taught me that in life, everyone makes different decisions. But it’s about integration, integrating what’s important to you along with career.

So that is a, it’s not an easy or it’s more like, can we find a path that reflect your different stages of your life, different reflecting your priority. And the last rule is happiness rule, which is my favorite. And so I grew up poor and my, my parents, the only criteria for me is, am I happy in that? That has such a profound, like, impact on how I view life is not being viewed as the status or the money.

It’s more genuinely, did I live a happy life? And, uh, that also challenge our goal. Sometimes, oftentimes, The conventional wisdom is you right now you celebrate later, but do we miss the opportunity to view life as a journey celebrating everything along the journey so you don’t like to delay your happiness until you reach that elusive everlasting goal.

Like, because if we, we kind of have the mindset about delay now, but like the growing out in the celebratory later, it feels like you always will chase the next goal because there’s always someone more successful, more powerful, have more money. Right? So I want to challenge that to say, if we’re authentic to ourselves.

Can we really smell all the roses along the way and be happy while growing, while challenging the new norm? So that’s in a nutshell about the six rules I wrote in my book.

Naji Gehchan: Thank you so much, Rebecca, for sharing them. It’s a lot of wisdom and powerful, um, Uh, powerful, uh, pieces you gave us, uh, I really want to dig into all of them, but I’m gonna do the hard exercise.

You said happiness is your favorite, and that was my next question. Maybe not saying the favorite, but the one that you would prioritize above most. Is there one of them that you would prioritize above most as you think about your life?

Um, I definitely thought like I will prioritize the happiness like the in terms of the most it’s it’s more profound than just say the meaning of being just talk about daily happiness, et cetera.

It’s more reflection about what brings joy in life, because when we are joyful, we are more productive. They always say fund the job. Like, which align with your passion, then the job doesn’t become a job. If you’re so happy, you’re so involved into it. So happiness to me is the summary about all the rules.

It centers around that you live a purpose driven life, that you find the right integration for you regarding what you are doing to your passion, to the family life. It centers around you have enough confidence. And in the clarity that you are not swinged by a lot of other factors, like, for example, even I take teenager for these days, a lot of social media impact.

A lot of times you look at all these fabulous digital life of people, they have the perfect life, perfect body, perfect everything, perfect vacation, right? And that that amount of pressure is real. And so in order to be happy, you have to really have a solid foundation about the self to say, this is the life that’s an authentic real life for me that I, I am happy about it.

And as we grow older in professionals, there’s also a level of define enough. So I love the book psychology of money. And I remember there was one. Um, kind of chapter talk about a big yard party and with all the hugely successful rich people in this, but there’s a writer there and people ask, how do you feel he’s that I’m I’m perfectly content here because I have something they don’t have.

And people are like, oh, he’s sending enough. I can define my enough in life from a material perspective. So, so that’s why, like, I put everything together in order to be happy. It takes a lot to recognize yourself, your passion, recognize that the things you are doing aligns with your goals, recognizing you have the confidence to embrace life as it is, that you have the resilience, you have the grit, you You actually also happening by walking towards your goals and celebrating everything along the way.

So that to me is a very profound kind of way of summarizing a happy, fulfilling life to say, do you feel like you’re joyful? Do you feel you’re happy? That’s a hard question. So, Najee, if I ask you, how do Are you happy?

Naji Gehchan: I was going to ask you this question, but you’re bringing really an amazing point. And I, um, you know, and that was my question too.

And I can answer also your question. I’m not going to avoid it. Uh, but, but what, is there any tips or what did you do or recommend for leaders as a work to detach ourselves From what, like the, really the title of your book, like what truths, as you said, because I feel like several times. You know, we are in this craziness of doing good, doing fast, being ambitious, uh, trying to get to the next thing, making it good and even better.

And when you get, you want to do more, you know? And I think for some of us, it’s really built into how we function and within a purpose. So, for example, I, I can share with you, we know one another, like my, my purpose is to make, uh, life better for patients who needs it, developing drug, bring it to market.

It’s really my purpose, but you mix it to ambition and then it becomes, as you said, sometimes, uh, you, I talk a lot with, uh, with leaders where exactly, as you said, you are in this constant pursuit of something that might be better at some point and not taking the step back and say, well, Let’s enjoy each step of the journey.

And in the several interviews that I’ve had with, uh, uh, with leaders who have got to this place with really amazing careers, every single person told me the same thing we did not enjoy as much as we should. the journey and celebrating the small steps that we’ve done that actually are way more enjoyable than whatever job we achieved at the end.

So any tips or how do you do it to force yourself to change those rules, as you said, and find your happy place and your personal garden, as you call it in the, in your book?

Yeah, that’s a great question. So I heard that a lot. Also when people hugely successful people looking back, Would it be? I wish I actually spend more time enjoying the journey versus the never ending to go chasing.

So I think the kind of mental model we can think about it is a hamster on the wheel so you can always like a move, right? And but if it’s continuous, you never really, that’s a never ending goal. And we don’t want to be that. And first of all, I will say ambition is actually great. If we’re not ambitious people, we will not be aware.

We are right now. So having a goal in life have an inspiration. Ambition is, is amazing. But don’t feel that as the end goal is the only place you can celebrate. You want to break it down to say, okay, if I am, I view as my life as as a journey towards the destination. And can I just. Be more intentional about small wings along the way that gets me there.

So for each step, when you’re intentional. You want to be, um, and then you’re happy. So I’ll give you 1 example. Um, there was, uh, 1 summer, I attended a famous consulting companies, some, like, 1 of the summit. And it was hugely successful people. So the 1st exercise is pick 2 cards. And they have poster cards.

One depict what you feel right now. One depict what you feel hopefully in 18 months and never like almost universally. Most people pick now is like a lot of struggle. You can see the images. Lots of mad messy doing and so it was almost universal and interesting. I was at the stage. I was pretty content.

That moment, so I picked in my first picture. As a beach with hammock next to the palm tree. And then my next one is hot air balloon. They were stunned. They were like, that’s your first image. I said, yeah, I work so hard. I recently got a promotion the last 18 months. I got a promotion. I joined the two public boards.

So I feel like I should have a moment of celebration before I chase my next goal. It doesn’t mean I was standing still. But it doesn’t mean that I wouldn’t immediately discard that was like, Oh, what’s my next goal? So it boils down to be in being intentional about celebrating those moments that are being team with people you care.

Also, you love because I the joy of my life aside from a successful career is my beautiful family. I have a loving husband, two wonderful children. Cool when is a senior in college when it’s going to college? I’m so proud of them. We celebrate all the moment. They are proud of me. So, those brings additional joy to that journey.

I,

Naji Gehchan: I love it. Uh, and you’re, you know, as you’re sharing this great example about, uh, the picture, I, I feel like you, you were the only one actually who said this. And sometimes you have this pressure about, well, no, I, I have to be. like, you know, this other image of, you know, struggle to end up at a certain time in a happy place where actually you’re, it’s a great reflection on saying, well, let’s celebrate the small milestones instead of only, uh, the, the end point, which for many people like us, I think, It never like the end point keeps on evolving to be more and more.

So sometimes you end up like, I

mean, that’s why I said what the rules, the rules is you always like the bigger, the job title, the bigger, the paycheck, the more wealth anybody gets, it’s the happiest place, but the reality, if you challenge that, it was like. Is that a really?

Naji Gehchan: Yeah. Yeah. So can I ask you, how do you, what’s your definition of success that you as a leader and a person today, how do you define it?

I, I view the success is I’m a better today than yesterday. So it’s the continuous improvement is the ultimate definition of success. Is life is a journey. It’s about continuously learning, continuously experimenting, continuously be better. So, if I look back today versus last year, I can see I, I have new skills.

I, I actually mentored more people help other people. I touch more people to be more successful. I advanced a technology for that that actually will be hugely important for the business. I view that as success. So for me, the success, interestingly, is not a job title or the social status. It’s meaningful progress along the way, as well as continuously improvement of myself.

I guess that’s a non conventional. Definition of success. It’s a great one. Meaningful

Naji Gehchan: progress. It’s a great one. Rebecca, another question that I, you know, I was thinking as I read this and as you were talking today, as a leader within your organization, how do you apply those rules for your teams? So how are you translating all this wisdom and developing your people, hiring them, managing them, growing them, managing their performance?

I’d love to hear your translation of this.

So that is very important question is what the rules translate is create the most positive, nurturing environment. For team team members to achieve their best, which means encourage them to identify their strength. I mean, in my group, we do strength finders. So once you actually go through the exercise, you recognize everybody’s strengths is different.

So finding their strengths, um, elevate them in terms of giving them the right assignment. And, uh, and give them, like, um, I think really stretching assignment that were take them outside of their failure, like, outside of their limits and, uh, experiencing new potential, give them a joy and encourage them to embrace failures as opportunities.

So one of the whole cornerstone of culture, I help instigate academics is. Quality driven management whenever the key principle is view failures as opportunities. So, um, if you view that as a kind of guiding principle, then you give people the ability to fail small, fail fast in order to succeed and pushing their boundaries and limits.

And so I, so all of these roles actually play very well at work. Is help team members identify their strengths, give them aspirational goals and also as leaders be okay with sometimes the failures, not a huge failures, but have the ability to tolerate the necessary failures in order to have a breakthrough is a huge like foundation for a successful team, reaching their full potential.

Naji Gehchan: I would love now, uh, give you a word and getting a first reaction to it.

That’s fine.

Naji Gehchan: The first one is leadership.

Leadership is, uh, not, uh, it’s about bringing the best from, um, everybody.

Naji Gehchan: What about work life balance?

I wouldn’t use the word of balance. I think, like I said, the rule is the integration. When you look at the balance, it means almost like zero sum game. When you integrate work life, you have a much more positive kind of attitude towards challenges and, uh, just tackling the challenges and it makes the best out of the situation.

Naji Gehchan: The third one is touchstone.

So the touchstone gives like a me and I hope the readers orientation around the most important things in life and in my book there’s a whole section kind of dedicated to that is exploring deeply, dive deeper, exploring yourself, exploring your passions, strengths, and the core.

kind of opportunities that excites you and that leads to better orientation about what we want to accomplish in life and also do the trade off of what you can afford to lose and what you cannot. So making the decision that most relevant to each individual.

Naji Gehchan: The last one is spread love and organizations.

I think that’s all about creating the most positive, nurturing environment as I said. that helps people achieving their full potential.

Naji Gehchan: Any final word of wisdom, Rebecca, for leaders around the world?

Um, I would just encourage, um, like listeners, if, indulge me to read the book and identify, um, to, to actually break free from some of the conventional constraints and build a clarity about the passion, about the strength.

And also, uh, have, like, charter your unique path to success. That’s my final word.

Naji Gehchan: Well, thank you so much, Rebecca. I certainly recommend it too. And I love how you’re framing it, breaking from the conventional rules that we’ve set in our minds and really in this pursuit of, uh, of the breed rules we should set for ourselves.

Thank you so much again. It’s been a real pleasure to, uh, to see you again and have this conversation and congrats on your book.

Um, thank you. And, uh, my pleasure to be on your podcast.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Karim Benhadji

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

Naji Gehchan: I’m Naji, your host, joined today by Karim Benadji, Chief Medical Officer at Inspirno.

Karim has nearly 20 years of experience in biopharmaceutical oncology drug development and most recently served as chief medical officer at GV20 Therapeutics. He previously served as senior vice president head of clinical development and operations for At IO oncology, where he oversaw the development of early and late phase portfolio assets, including the FDA approval of lead Gobi in collateral carcinoma and the phase three sunlight that led to the FDA approval of long serve in combination with the vaccine.

Bifacizumab in patients with metastatic colorectal cancer. Prior to joining Tayo Oncology, Karim spent 13 years with Eli Lilly in oncology development roles of increasing responsibility, including overseeing several immuno oncology programs. Karim received his MD from the University of Oran and completed his oncology fellowship in the Universities of Oran and Paris.

He also received a Master of Science in Pharmacology and Therapeutics in Oncology from the University of Paris. Karim, it’s so great to see you again and have you with me today.

Thank you for the invitation, Nadji. Pleased to be here today.

Naji Gehchan: I would love first to hear more about your personal story. What brought you to medicine first and now being an executive in the biotech industry?

Karim Benhadji: Yeah, so it’s really an interesting question. So I was born and raised in Algeria. I grew up there and when I was really in school, uh, also including in high school, I was really, I had a passion for math, for science, biology, but also computer science. At the end of high school, I was really wondering what to do and I had really strong attraction to technology, uh, computer science, and you had to make a, to make a choice at the time.

And I opened myself to, to suggestion that medicine might. The, uh, good option for me because I like science, uh, because in the field you have research and so on. Um, but I didn’t really know much about it, uh, at the time. But I took really the risk to say, okay, let’s try medicine and see what could happen.

And I really loved it there. So I did my, um, I got my medical degree and then the question after that was, Okay, What specialty to pick up, right? Oncology at the time was really a confidential specialty, uh, not many options for patients at the time. And I had the opportunity to discuss with oncologist, oncologist that got, uh, uh, her specialty, uh, just around that time.

And I said, okay, this might be a really interesting. So let’s go there and see. And really, really quickly when I started my residency in oncology, I really loved it. I mean, I mean, you have really sick patient, you’re taking care of them, but you have the aspect that the field is really evolving very quickly.

You have the research aspect that you are really trying to look for innovation, new solutions for patients. So I really loved that. And I said, okay, this is really, I really, I really like it. And, uh, I would continue in this field. So I continued that and then, uh, moved after that to France to continue my training in oncology.

And because of a research aspect in oncology, I went to the lab and then spent one year in lab doing research. So that was a really, uh, passion for me, really research and looking for new, for innovation for patients. And after that, I was really facing dilemma what to do going back to, uh, clinical practice, uh, doing a PhD after the master, or I got randomly a cold call from a recruiter who was looking for physicians to go to industry.

And then I was introduced an opportunity for Lily to be a clinical research physician. And then I went Entered the industry at the time, I was really curious about industry because as physicians we’re not really export the industry. Your exposure is at most through, at the time through sale reps. Um, we don’t know really what was like black box.

I wonder with the idea. Okay. I, we spend there couple of years and see how it goes. And, and again, I love that Lily really gave me the opportunity to really learn about drug development in the industry. Uh. Got, uh, exposure, uh, to a local experience in France, regional experience in Europe, and then global experience later.

Uh, experience in medical affairs, late stage development, early stage development. So really great career, uh, at Lely that, uh, I really learned everything about drug development there. After nearly 13 years, after a little bit over 13 years as at Lely, the question, okay, what to do next? Um, as a drug developer, you’re to get a new drug, uh, approved for patients.

And I was introduced to an opportunity at Thai Oncology at the time to lead a team, build a team, but also, uh, to get a drug to the finish line like COBE, uh, that was later approved. And, uh, In try parts of Columbia, Katina, GFR to rearrangements. Uh, so that was the key driver where to go to Taiho ecology to get a drug approved.

And I was really glad that I had an opportunity with, uh, that could be approval, but also line extension for long serve in combination with the message in map and Colorado Council. I was able to build. Great team and also got exposed to a different set set up in the pharmaceutical industry, not a big pharma smaller size.

Uh, so you have less expertise in house. Uh, you have also a different style of decision making. Uh, so that was a really great experience and that drove me really to go. We should really further to go smaller organizations. So I, you know, Took the leap and then, uh, to take a job as a CMO in a small biotech and then changed recently to be the Chief Medical Officer at, uh, Inspir now.

So that, that’s really my journey. I really love and I have passion for drug development and bringing innovation for patients.

Naji Gehchan: Well, thanks for sharing this. And, uh, you’ve, you’ve finished it with the framing of your purpose, which is developing and bringing those, uh, medicines for patient. And it’s, we both know it’s hard.

Biology, it’s hard and having the opportunity to take an asset from early to late phase and getting it in patients hands at the end, making it the medicine is super hard. And you’ve done it, um, Early, late, small, big pharma from France, Europe, U. S., like in very different settings. Uh, what is your key learning through all those experiences, uh, building teams, as you said, and developing drug and oncology to get them to market?

Is there any key learning you would, you would give us?

Karim Benhadji: I mean, yeah, diversity. I mean, you, um, I mean, we come, we are all different, right? Even within the same family, people are really different. And, uh, you get exposed to different culture, different way of working, uh, um, different opinions, styles, and then even within companies and then even in the same country, you see a really different style.

So I think that fascinating aspect where you see different cultures, uh, you, Europe, uh, uh, U. S. Or Asia.

I

Karim Benhadji: always really loved it because it’s really you’re trying really to make your case and to bring people together from different cultures, different backgrounds together for a common purpose. That’s what I really love that aspect that we have that opportunity in Pharma to do it because we work almost globally to bring solutions for patients.

Naji Gehchan: I love it. Like you went immediately, you didn’t go into science and the technical aspect of drug development or clinical operations. You went into people and bringing diverse cultures together on a common purpose. So can you share a little bit more? Because my next question would have been leadership skills that you learned.

So I’d love for you to share a little bit more. What have you developed as leadership skill or the skill you look, uh, as a CMO to build in your team? Um, through through your journey.

Karim Benhadji: Yeah. So so we you don’t get any training about leadership, really. And when you’re really early in your career, you say, okay, oh, the CEO is really the leader.

When you talk when you hear about leadership is you’re really looking really behind. See, who is the general manager? Uh, those are the leaders of the company. But really, with time, you realize that. And then you learn that everyone can be really, really a leader. You don’t need to be a manager to be a leader.

Uh, you can be an individual, uh, contributor and then be a really leader. It’s really to bring people together, uh, and then, uh, working together for common purposes, we discussed, um, for leadership for me is really about being authentic. So we are really empowering others, bringing. People together, but you, you need to be a really authentic.

I mean, you can fake it. People will, will realize that even if they don’t tell you that if you’re, if you are high up. So I think authenticity, being humble, uh, being sometimes vulnerable and then, um, really trying to bring people together and telling them why we are doing this, because at the end of the day, it’s really for patients.

I mean, we all have. Being exposed to patients maybe, uh, directly in as an MD, but also, uh, hit by cancer in family and so on. So it’s really personal and then patients with cancer, I mean, if it’s advanced, they can’t wait really. And every day that we lose in bureaucracy or, uh, making a decision, it has an impact ultimately for patients.

So bringing that also perspective, uh, to everyone is really important.

Naji Gehchan: If you go back in time. to, uh, when you graduated from med school oncology, you went into research in the labs and then you joined pharma and biotech. What would be the advice you’d give your younger self

or something you wish you knew or acted on as you started your career? Yeah,

Karim Benhadji: I think I change over time and I think, uh, probably taking more risks. Because, I mean, culturally, I was probably not open to more risks, uh, as I am today. Uh, so, um, so I took some risks early on in my career, but, uh, I think really being more open for, uh, taking more risks.

Not meaning that you jump over right and left, but, uh, and then also being open to different perspectives, uh, early on. That would be my advice to my young self. Well,

Naji Gehchan: now if we look forward with the different, uh, drug you developed within the oncology overall, obviously it’s one of, um, the places where we’re seeing a lot of innovation, a lot of investment, and we just chatted briefly about, uh, the landscape these days.

What are you most excited about in the next decades for patients living with cancer?

Karim Benhadji: It’s really innovation. I think when I look back 20 years ago when I was just fresh, uh, young oncologist and today, I mean, the number of options, the changes that occurred for patients. I mean, patients are really, uh, took advantage of that, but we still have a lot of things to do.

Uh, I think you see innovation with precision medicine. That’s something. you have not dreamed of, uh, 20 years ago. So I expect that to continue and with, uh, precision medicine, giving access to patients because we have innovative tools right now, but not everyone really have access to those. And then it depends.

Where you are, uh, depends, uh, uh, if you are lucky to have the big center next to you and then access to those therapeutic, uh, options. We have seen a tremendous, um, opportunities with cell based therapies. Uh, so I expect that innovation will continue, uh, in, in those fields. I mean, the artificial intelligence will bring also, uh, new opportunities.

I think it’s I’m always, I call myself, um, a realistic optimist. So I’m really optimistic. I realize that 90 percent of what we do, we go to trash bin. However, in the process we learn a lot and then we make progress to patient. And sometimes it feels just small, but when you add up all the different, uh, Options that would be really, uh, great options for patients.

We see right now, uh, ready from a suppose a D. C. S. So, you know, ecology has, uh, just love these days. Uh, who knows? You will might get surprised in the future. So expect that innovation will come from areas that we are familiar with, but also it can come from. Uh, something that we are completely blind to right now.

Naji Gehchan: Yeah, and you know, as you were sharing your, um, when you were, you know, in Algeria, thinking about your future, you talked a lot about computer science and you love tech, and I was thinking, like, oh, this is the moment, you know, like this is, this is where the full circle is happening with tech coming in. So you shared a little bit about, Obviously, like everyone talks about AI, but really about like computational capabilities and what we can do with this from a drug development to discovery to, uh, any, any thought about this and how, um, the intersection about computing and biology might take us in the next years.

Karim Benhadji: Yeah, I think a lot of companies, a lot of labs are working right now about integration of AI and cancer discovery, basically identifying targets, but AI in order to work, you need really a lot of information, machine learning, and then build your model. And then, uh, so I think. Still have a way to go, but I think it can be there particularly if you use it for chemistry or identifying targets.

But at the end of the day, you still have to do the experiment to see if that works. Uh, so I expect also AI will help a little bit to make our life easier when you do clinical development and clinical trials. Uh, and also earlier on when you do, uh, uh, early discovery. That’s a way to go.

Naji Gehchan: Oh yeah. I fully agree.

And this is, this is the. where humility kicks in. Biology certainly humbles us once you do the experiment and get it into humans. Um, but yeah, exciting future ahead. I’m going to give you now a word and I would love your reaction to it. So the first one is leadership.

Karim Benhadji: So, yeah, I already mentioned it. I mean, the first word is really authentic.

Um, so you got to be a really authentic, uh, as a leader. And then you need really to have a mission that’s clear for you and then, uh, communicating to people. And it’s really as a leader up to you, really. to go to people and explain. Don’t expect people just will read your mind and understand the mission.

So it’s, it’s really, uh, you are here to serve the people, uh, and then get them going in the same direction and with the same speed, uh, toward the mission.

Naji Gehchan: The next one is drug development. For me, it’s the passion.

Karim Benhadji: That’s my first reaction. Um, drug development is really a long, can be painful process. Um, and I said already that in oncology specifically, a high rate of attrition.

But you need really to keep optimism because in the process, you might have a few patients, even if the drug is not working. And you need to Find joy in in simple things. I mean, initiating a trial way. That’s a big celebration. I’m getting a database log. That’s a good celebration. At the end of the day, you design experiments.

You need to execute them and get the results because we owe that to patients. If you start a trial, you have really a question that you want to address, and then you’ve got to execute it. So a lot of things. I mean, people really talk about child development about. We design, uh, trials, we design, you know, designs and so on.

But at the end of the day, once you do that, you need to execute that. If you don’t execute it, you won’t get the answer to the question that, uh, uh, you are asking yourself.

Naji Gehchan: Uh, I love that you’re bringing this because it’s, it’s so true, right? Like we always are excited, which is normal, right? With intellectual Part of drug development, designing trials, thinking about it, the probability of success, but obviously the discipline and how we execute.

And this is the long part, as you said, of making sure that you get, you get things done well executed for the patients where we’re serving is crucial. Uh, and you also reminded us, I think it’s always important to remember that few of those experiments actually end up with a drug being, becoming a medicine for patients.

And that’s truly the humbling piece of what you do every day, what we do every day. We, we celebrate The successful drugs, but also we should not forget to celebrate those who are advanced science, but probably couldn’t bring the, uh, the last phase three child for it to become a medicine. And so it’s, it’s a great reminder that you’re bringing, I don’t know if you have any examples or how you led your teams through this, because I think like those are the big parts of the biotech word that we live through.

We, we work years and sometimes it go and it’s great. And sometimes it Does not so I don’t know if you have any, uh, yeah, I think you’ve got

Karim Benhadji: to be optimistic. And then even when everything is really failing or you’ve got to bring that optimism to the teams and then have the team see the positive things and not focus on the negative things because things will go wrong all the time, but you need to have people say, okay, We, we, we, we got some negative things, but, uh, we are really marching toward our mission and then help the team see the positive things.

Um, at the end of the day, I mean, it’s really a process. Uh, I think people want positive outcome. That’s not always the case. It’s it’s really more the exception rather than the rule. Uh, and then helping people really understand that even if it’s a failure for the outcome of trial, we have patients at the end.

I mean, patient, they come with hope. Sometimes we had a few of them and then. Even if there is that small piece, I can see that. And then, uh, that’s really brings, uh, energy to the team. Say, okay, this is why we are doing it. Uh, and then we have those people in the process. If it’s positive, everyone is happy.

Naji Gehchan: Oh, totally. And as you said, like we, we really don’t control the outcome, actually. Like we can. design optimized, but really we control the execution and bringing a high, um, high quality data with, uh, integrity that we’re all committed to in this industry to answer the scientific questions we’re asking and making sure that we’re focusing on what we can control.

And then the other uncontrollable are really part of. The experiment itself. So what

Karim Benhadji: I say is really towards is really speed and quality. I mean, you’re in the quality, but it has to occur really quickly.

Naji Gehchan: Yeah. So the third one is, uh, somehow related, uh, biotech, uh,

Karim Benhadji: biotech. So it’s really an interesting world.

And, um, because

You have

Karim Benhadji: the concentration of really in a small environment of really everything. I mean, you have the science, you have the business, you have drug development in between, and then you have to juggle with everything. So it can be really overwhelming for people, uh, but can be also exciting because you will Uh, do very different things.

Really in the same day, you can interact with investors, the board, and, uh, you are still doing drug development. You talk about science, and you can still, at the same time, you have to fix the copier because no one will fix it for you. You have to do things yourself. So I think the, the biotech wise is really, uh, fascinating.

Uh, you get really, uh. Positive experience there, if you like it, and not everyone would really like it. Uh, you got to do things that you have done so many years back in your career. Um, you might not do it as well. Uh, you won’t have also the expertise that you’ll find in big pharma or midsize organizations.

And, uh, you need to admit that you can’t know it all. And if you need to find expertise outside when you need to, so it’s, it’s really a great, um, experience and it can be stressful because right now the environment for biotechs, uh, is, uh, is very stressful in order of, uh, raising funds. And then, uh, that’s, that’s, uh, complicated for the field right now.

The last one is spread love and organizations.

Karim Benhadji: Yeah, so that’s a really interesting one. So when I saw , your, the title of your podcast, I mean, first time. Okay. Oh n It’s really interesting because it’s really bored, uh, ’cause people don’t talk about really loving organizations. Right. Uh, but when you think about it, I really like, um, the bold approach that you’re taking it because at the end of the day.

I you need really to take care of patients, take care of all your people surrounding you to help the patients and you need really some love in the process. Otherwise it’s not going to work. Uh, so you can call it differently, but, uh, I think that’s really important. And then, uh, we want really to work together for a common mission and you can’t achieve that without love.

Naji Gehchan: Well, thank you for that, Karim. Any final word of wisdom for leaders around the world?

Karim Benhadji: Be positive, believe in your mission, um, and, uh, take care of the people, uh, that, uh, surround you and help you, and then you will find success in the process.

Naji Gehchan: Well, thank you so much again for being with me today and this great chat.

Karim Benhadji: Thank you for the invitation.

Naji Gehchan: Thank you all for listening to Spread Love and Organizations podcast.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Suman Lal

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I’m Naji, your host, joined today by Suman Lal, managing director of technology innovation studio, TINTS, a physical space in Kendall square that brings together business leaders, scientists, serial entrepreneurs, investors, Industry experts, corporate innovation teams, and policy experts to explore and apply tools and models in innovations.

Suman is also a senior advisor at the Cambridge Innovation Center, CIC, that operates innovation campuses and labs across cities in the U. S., Europe, and Asia, and in his previous role worked closely with the leadership team to advise diverse stakeholders, uh, stakeholders in cities and regions around the world on building innovation infrastructure and ecosystems.

He is also senior advisor to the Venture Café Global Institute that operates the Venture Café gatherings in 15 cities, often described as the heartbeat of several innovation districts. And I can attest to that. Suman has deep experience in the area of technology commercialization by making independent inventions, licensing intellectual properties.

From major research institutions to four new companies and operating venture studios, where he took interim CEO roles at the portfolio company. Prior to this, Suman did technical sales and distribution for 15 early stage companies over a five year period, gaining valuable insight into how early stage companies transitioned into profitable and scalable businesses.

He has an MD in clinical medicine and an MSc in human genetics and did his PhD in precision medicine and clinical pharmacology. Suman also received his MBA from MIT as a Sloan Fellow focusing on innovation and global leadership. It is so great to have you with me today and, uh, see you again. Thank you, Najee.

Suman Lal: Thanks for having me. And, uh, yeah. Looking forward to this conversation.

Naji Gehchan: First, I want to hear more about your personal story. We know one another, but I want to dig in your personal story this time. How did it all start medicine, genetics, pharmacology, and now a serial entrepreneur and startup builder.

Tell us more about you. Yeah, I know.

Suman Lal: Happy to, happy to give some background. So I’m, uh, you know, originally from India and, uh, back, uh, back home in Kerala, where I come from generally, you know, you don’t have too many career choices if you are good in your studies and, and then, you know, you go to medical school or, or become an engineer.

So I, uh, uh, just happened to, you know, uh, get through the, the entrance exams, uh, to, to med school. And, uh, yeah, in the second year of med school, what actually happened was I, I happened to pick up a book by Ayn Rand and, you know, read, read Atlas Shrugged and then Found and Head and at that time that kind of influenced me a lot.

And I sort of decided that, Hey, this is. I’m not going to be a doctor. I want to, I want to explore other things. So that made the rest of the four or five years easy in terms of going through med school, because I knew that I was not going to, you know, uh, continue in that place in that journey. And, uh, uh, I realized that medicine can be in some ways, put a lot of constraints around you in terms of areas where you can practice.

uh, geographically also, right? And so I, I decided to step into the world of research and that, that really took me to Singapore. And I thought actually I would stay for one year in Singapore, but, uh, you know, the place was very comfortable and, uh, Singapore was investing a lot into building a huge, uh, life sciences and healthcare innovation cluster in the city, and I thought I should just be a part of it.

And, uh, I ended up, uh, staying in Singapore for 12 years. Uh, so part of that was, uh, doing research, uh, doing my masters and my PhD. Uh, but then I also realized that, uh, I’m not. A lot of this has been like experimenting and actually trying to see if I really like it and if not, move on. Right. So that, that was the case with medicine.

That was the case with the research, but remember each experiment was. costing me five to six years, right? So, so that was my second experiment. And I realized I’m not going to be an academic research with a tenure track and stuff. So I thought I should go into industry. So I decided that the best way to do, uh, to learn about the industry and the world of business is to do sales.

And, uh, you know, I became a salesperson, um, I became a distributor, uh, for almost 15, uh, companies in the early stage, you know, life sciences, uh, field. I can tell you, uh, this was the most humbling experience, you know, your MD, PhD. Just gets thrown out of the window. Nobody cares. Right. You’re basically trying to sell and, uh, Oh, it actually helps you really prepare for your future dating life because you know, you get rejection every day, like, so, so, but, but amazing experience.

I think I actually gave a talk. At one of the institutes in Singapore to the postdoc association that basically the gist of the talk was all of you guys should just quit what you’re doing and do other things. No, no, you’re not going to get a Nobel prize. Okay. You’re not going to discover this molecule to cure cancer.

Um, there are a lot of other things to do in this world. So try, try other things. And one of them could be sales. Um, so, so I did that for five years and it was just incredible. Uh, very humbling, but very, very valuable experience. But, uh, after five years and, you know, becoming a Singapore citizen, I thought I should, uh, try something new, which is where we crossed paths in the world of MIT, because I only applied to one place by the way, right.

And I know, uh, when I was looking at what is a, what is a great, uh, Institution with a background for people like ourselves to go to. Uh, that is, it was not a question, right, in terms of, look, I should just come to MIT. And well, it’s been 10 years since I made that decision that I can share more, but that was really what, uh, the, the, the pre MIT US days were like, I mean, that, that was the first half of the journey.

Second half is like, yeah, we can, we can get into the details of that has been fun. Well, I want to get into the details of this and really maybe as you go through the details of the second half, as you said, or this past decade, I really want to think through it because you’ve been like challenging yourself.

And as you said, like each bet you made, like you’re an MD, you’ve done PhD. So it’s long bets. And then re challenge all your knowledge and all, uh, yourself to do something with curiosity, with more. And you obviously now building an ecosystem that would bring all those different experts that you’ve been at some point to bring, to bring breakthrough innovation.

So I’d love as you talk to us in this past decade, uh, in, um, in Boston after MIT, uh, how do you think through it? With your past experiences and expertise that you’ve built. Yeah, I think, you know, it’s, you know, talking about moving from one thing to the other, there’s, it’s a lot of, there’s a lot of good curiosity, but I actually think it is also for me about, I also, I used to think what brings me the biggest joy.

And to me, it has always been the joy of understanding something. And that’s kind of why I’ve stayed in school a lot, you know, learning, there’s continuous learning, right? So, I’ve always designed my life and career around, is there an opportunity to learn? So whether it is in medicine, whether it is in research, whether now you’re doing sales between by the, by the way, between all of those three, now we are talking maybe 15 years, right?

And, uh, coming to MIT of course was incredible learning experience, but then in the world of innovation, as you apply that in, in the real world. It’s, it’s nonstop learning again, right? And but this time, as was the case, uh, at MIT in the Sloan program, you’re learning a lot from not an academic environment, but also from, uh, your peers and your colleagues and customers and other innovators.

And you know, in the world of innovation, now this is, you’re talking about scientists and, uh, inventors and investors, entrepreneurs, and, uh, you know, industry executives. It is, everybody is trying to, and everybody I realize is like me and, you know, have their, had their own journey to get here and want to do something impactful and apply all their knowledge in solving, you know, the variety of problems that we have in this world.

And there is that, there is that connection that you have with all of these folks, but also a shared purpose and, and it has been just amazing to be able to work with. Interesting people doing interesting things. And that is what most of the last 10 years has been. And because of the broad background that I’ve had, uh, I could basically apply it in any area of healthcare and life sciences, when you talk about medicine and, you know, healthcare.

But, uh, interestingly, my first startup turned out to be in cosmetics. And, you know, I I ended up in hair care, who knew, right? But talk about pivoting. Uh, and you know, the market tells you where you should go and, uh, yeah, that’s, that’s, uh, that’s what got me started and that took me to New York. Um, so I spent five years in New York City.

Uh, where I was actually all about haircare.

Yeah. That’s fascinating. I didn’t know about that. Yeah. You know, guess what? The first job after MIT Sloan with my MBA as a Sloan fellow was to actually take over and operate a hair salon where I was the, I was a hairstylist. So this is what I did in New York for two years after graduation from MIT. And, uh, I can guarantee you, my parents were not happy.

I mean, they have not been happy since I left medical school, but, uh, since then it has been downhill because, uh, you know, dad calls me one day and like. You, you told me you’re going to America and, you know, going to MIT and doing an MBA. I heard now you are a, a stylist, like, what are you doing with your life?

So this was hard to explain. And uh, I did tell him that, look, this is about, um, product development and this is about, uh, entrepreneurship and, uh, yeah, that didn’t, that didn’t fly very well, but. Yeah, but it was an amazing journey because we were originally developing a product for medical devices and we realized that we could actually use the same principles of the technology to break the disulfide bonds in the hair.

And, well, we know the world of, uh, you know, uh, medical devices and drugs really well. There’s a lot of regulations. Guess what? In the world of cosmetics, there is no, nobody, nobody is regulating it. And, and because of that, there’s a lot of very toxic stuff out there, which is being used every day. And I found an opportunity to actually develop something that is safe, a safe way to straighten hair.

But then there was no regulatory hurdles. I could just open up a salon and try it. And I did. And, uh, yeah, that was the first few years of, uh, New York City and doing cosmetics and beauty and hair care in New York City. I can guarantee you it’s really fun.

So, so take us from, uh, doing cosmetics. And haircare in New York City to now building tents. Yeah. So, and tell us a little bit more about this amazing new venture that you’re creating. Sure. The short version of that is, uh, I, uh, I brought on a, an amazing CEO to, uh, to take over the project in haircare who came from the world of beauty and cosmetics.

And then I was exploring what else to do. And this is really serendipity, right? I was having a coffee with one of my friends. And, uh, really talking about what’s next. And he said, maybe I should meet his dad. And, uh, uh, I ended up meeting his dad who turned out to be a professor at Columbia who had developed an amazing technology, uh, using intravenous omega 3 fatty acids.

You know, the fish oil that we all take, uh, are supposed to take, uh, uh, which if you inject it, you could actually reduce, uh, tissue organ injuries. By 90%. Now we are talking about, you know, heart attacks and strokes, uh, which can be prevented by this injection of the safe, uh, fish oil. So I, I, I looked at the results and I was like, this is amazing data.

Um, I could actually commercialize this. And I actually formed a company from, uh, based on the technology from Columbia university, uh, to actually develop a therapeutics for treating stroke. And, uh, well, I joke that I didn’t really move from, you know, very far. I went from hair to brain, uh, but it really went very, you know, a completely different space from beauty and cosmetics to now, uh, early stage biotech.

So I found myself as the CEO of a startup in biotech, but that took me into this amazing world of, of drug discovery and development, which I think is the most fascinating The most complex, I once commented on LinkedIn that, uh, you know, it’s easier to send something to Mars than actually develop a drug.

I mean, it’s just, you know, it’s, it’s biology, right? I mean, you cannot predict what’s happening and yeah, I’ve sort of stayed in that world since that brought me back to Boston, which is the Mecca for, uh, for biotech, for doing that thing. So, you know, people like you and the rest of our colleagues. Uh, doing amazing things in Boston.

So I came here and, uh, you know, the first place I took a desk was at CIC, the Cambridge innovation center. And again, you know, uh, chance. I clicked the newsletter, which, uh, an internal newsletter from CIC, which, uh, led me to joining CIC in their consulting team. Uh, which, uh, was really about talking to, uh, cities and states and regions around the world to build places like Kendall Square.

So that was really about building innovation ecosystem. So I found myself on two ends of this innovation spectrum. On one end, I was trying to see if this molecule binds to this target. What is the affinity? Is this a development candidate? What kind of experiments you need to do to get, take it to an IND?

Um, Thank you. And at the same time, I was also talking to governments in Singapore and Saudi Arabia and, you know, Mexico and Latvia about, uh, how do you build an ecosystem and innovation ecosystem like this? And, uh, so that, that was an amazing experience, uh, which, which led me to really understand the power of communities and the utility of space.

Thanks. As a very anchoring mechanism to bring people together and, you know, post COVID, it became really relevant. And I should also mention that what we learned at MIT in the world of system dynamics is incredibly, which is an incredibly powerful field. I wish it was applied in a much more, you know, uh, in a variety of settings.

Um, and I, I looked at, if you look at Kendall square, it’s an ecosystem. And I realized that, Hey, I could actually build an ecosystem, a mini ecosystem in, if you look at it through the system dynamics framework, where space is the anchoring setup, like CIC, the Cambridge innovation center, where we just now the world’s largest innovation campus, by the way, um, where.

On top of that space, and that is, that is what I’m building right now. This is the technology innovation studio. If you take space as the base layer, okay, you’re talking office space, co working space, labs, all of that. And you build a layer on top of that, which is a, which is about a curated network. And you bring people around specific topics.

interest groups. So for example, I formed a quantum interest group to look at applications of quantum in different areas, starting with discovery, uh, one in consumer products, uh, you know, health, productivity, and wellness, biotech, et cetera. That becomes a very active layer where people come together. When you bring interesting people together in from different areas, Interesting things are bound to happen.

So that’s the second layer. The third layer is where I have opportunities to actually do consulting for all the people that want to engage with the Boston ecosystem and through the studio. And that’s mostly for large corporates. And the layer on top is an innovation lab where anybody can come with an idea and experiment and develop their MVP and do their customer discovery, market validation.

And if you think there is something interesting there, we form a company and then what, right? So that, that’s why I am building a layer on top of that. And this is in participation with the MIT. alumni angels of Boston, uh, and New York actually to form an angel group, right? So think about it as an ecosystem tense.

The Technology Innovation Studio is a mini ecosystem where it’s a combination of a dedicated physical space, a curated network, high quality events and programs. Consulting, product development and innovation and investments. So that’s, that’s really what I’m building. And I have no illusion that this is going to be quick.

This is a 10 year, 20 year game. It is really designed for keeping myself busy, satisfy that curiosity and joy, uh, aspects. But, but really ways to create value in the innovation world and also have structures and vehicles to capture that value. I know this is a, sorry, this is a long answer, but that’s really, you know, it’s, it’s really a, uh, a mini ecosystem that I’m building.

This is, this is ambitious, great, powerful. And my follow up to this is if you look into the next decade. You know, we talked about the past and now we’re talking about the future with what you’re building. What are you most excited about to deliver through Tins? You know, in the intersection of tech, medicine, innovation.

Yeah, so I think really what I’m hoping to be when I say I as in Tins becomes a When I say, you know, it’s a studio, but it’s actually also a playground. It is an, it’s a mechanism to accelerate innovation. And I sort of become, my keyword would be Playground, studio, facilitate and accelerate innovation, right?

If I can actually, and be an enabler, and if I can be all of that to work with different stakeholders, whether you’re a scientist, whether you’re an investor, whether you’re an entrepreneur, a small or a big company, I could actually work with each of these stakeholders In the innovation ecosystem, and you’re talking also about governments and agencies and all sorts of groups to help accelerate innovation.

And that could be by infrastructure, that could be by making a medicine, that could be by developing a new business model, uh, or education. I hope that TINSS becomes a new model for innovation, an innovation engine, which can be then replicated. In innovation cities around the world, and I want to develop that model, which I can then replicate because fundamentally these stakeholders and the nature of innovation in all of these ecosystems are the same.

And I want to develop that prototype here, experiment with it, get to a certain point where I can take it to other parts of the world, and hopefully I’m able to do that through my partnership with CIC, which is now the world’s largest innovation campus and is already present. In 11 going on 13 cities, so it is a road map to expanding globally through CIC, because it is also about physical space, as I mentioned, it is an anchoring element of this.

So CIC, if I may say, is the biggest sort of cluster. In all the cities that CIC operates. Okay. It started in Japan three years ago. It’s this biggest hub in Japan. Okay. Biggest hub in Kendall square, biggest one in Rotterdam in Warsaw. If I can actually work with the biggest cluster to actually now also deploy in these ecosystems, I believe it can be, it can be really powerful.

So that’s my dream.

And I know you do everything to get there. So I’m looking forward for this journey. Uh, that started really great. Like, you know, we will have backlinks in our podcast to your website. You’re doing amazing, uh, activities already through then. So really congrats on picking this up that fast. I’m going to give you a word now, uh, Suman, and I would love your reaction to it.

Yeah. So the first one is leadership. I have come to realize that, and I think about this every day. That to make true impact, I’ve looked at again from a, and I’m actually really making the Venn Sim diagram with my colleague on the system dynamics model of accelerating innovation. And if you draw that diagram with all the variables in there, you would really come to the point of realizing that it’s fundamentally about Issues like trust and leadership that makes the maximum impact and that has a, that has an enormous impact, which applies, which, which amplified impact, I should say across everything.

And part of the reason why I am developing an innovation immersion program for high school and college students intense is to bring them into our world and show them examples of leadership. Because that’s what makes all the difference. You have to, you have to lead. There are amazing talented people who are really great at what they do, but also need direction and that leadership to then bring that together into designing something or making a product or building a business and, you know, solving a problem.

So I find it as, and I, I try to be. learning and be surrounding myself with the leaders that I can learn from every day. And I find that, uh, yeah, there’s a long way to go. I mean, I know you it’s, it’s humbling. Uh, but, uh, yeah, long answer, but I should say that it’s, it’s really the most important word. I mean, I’m glad you, you, you mentioned that.

So the second word I’m sure you’d love to is entrepreneurship. Yeah. Well, I have some, uh, Bill Olet says that, you know, everybody can be an entrepreneur and, uh, you know, His book says it’s, uh, it’s, uh, it’s about disciplined entrepreneurship. Doesn’t apply to me because I’m, I’m really not disciplined about, you know, most things.

But, uh, I, I’ve been wanting to actually maybe take a class or talk about the case against entrepreneurship. I actually believe that it’s not for everybody. It actually, uh, requires it. It’s, it’s not just about getting out of your comfort zone. I think it requires a, uh, a lot of things to come together. Uh, to be successful in that journey.

And a lot of people are not really designed for it. And I, I, myself, I have been an entrepreneur for a very long time and I question myself every day, like, is this, is this the right thing to do? I was. Uh, yesterday evening, I was, uh, uh, listening to a founder who has built a 4 billion company who basically started his talk by saying that the biggest challenge for him was, was really trying to decide whether this is the right thing to do and to jump into the world of entrepreneurship.

And it was not easy. And we talk a lot about. people who are successful in the world of entrepreneurship because you know, that’s what we read in the news, but, uh, it is a tough space. It’s, it’s, it’s really about a lot about failure, but getting back up and trying again. So I think it boils down to grit.

And, and, and really not, not giving up and fundamentally how long you can keep doing that. I mean, we all, uh, look to the courts by Terry Roosevelt about, uh, you know, the man or the woman in the, in the arena who, you know, who, who is still standing and then actually, you know, fight in the battle. So I think, um, you’ve got to, you’ve got to really enjoy the journey.

And I think, I think one part that people also always may not consider is. health, family, friendships, uh, you know, whether your spouse, uh, is, is, is on board with these things or your partner, um, there are a variety of considerations and these are not taught in schools and, uh, you know, when you, when you just try to do this in the real world, well, uh, that’s, that’s when you get punched in the face and it’s, uh, You, you ought to, you know, at some point you’ll start enjoying it and drinking your own blood.

I think that’s, that’s, that’s the real world of entrepreneurship. So I, I would say beware of what you wish for. The third one is Kendall Square. Yeah. Yeah. I think I feel very blessed. I’m right now, uh, sitting at the Venture Cafe in Kendall Square at CIC. And if you look at it from, I sort of, you know, tend to take it for granted sometimes, but if you look at it from the rest of the world perspective, America leads the world in, in, in the area of entrepreneurship and innovation.

And if you go to zoom in, you know, Boston is one of the hubs, uh, for, for innovation and technology and entrepreneurship. And when you come to Boston, it’s Cambridge and in Cambridge, it’s Kendall Square, right? And it is the most innovative, without a doubt, I think it’s the most innovative square mile on the planet.

And to be immersed in that ecosystem and work in the center of the center of the universe of innovation. Uh, it took me 25 years to get here, but I think it’s a blessing, uh, to be surrounded by, you know, like minded people, uh, who are working to change the world. And, uh, it’s, it’s actually, it’s magical. And, uh, I think it is reproducible if you actually do it the right way, but it always takes time.

Uh, but meanwhile, one of my desires and goals is to Leverage what is in Kendall Square and develop mechanisms to transfer and share and collaborate and partner with other similar aspiring cities around the world. Because at the end of the day, we are all trying to solve global problems and it has to be achieved through collaboration and Kendall Square cannot do it alone.

And there is great talent. Technology, great people everywhere. And I would love to see that those highways being built between Kendall square and, and Riyadh and Singapore and, you know, and Madrid and Tokyo. So, uh, and, and other places. So, yeah. Um, that’s, uh, that’s how I’m, that’s my view of the world right now.

The last one is spread love and organizations. Wow. That’s, uh, you know, I. I am really, uh, looking forward to working closely with you on, on learning about, you know, all that experiences and, uh, that you have, uh, gained over time. I think it is also related to the topic of leadership that you started off with, because fundamentally if you don’t demonstrate and, and, and, and apply compassionate and authentic leadership in organizations.

then it’s very hard to achieve its full potential. And I hope by some of this work that you do and by others, we get to share that knowledge and experience of authenticity. of compassion, uh, of hard work and empathy. And those in combination is, is designed to make not just individuals, but also organizations really achieve their true potential.

And, uh, yeah, we, we continue to do our part and be in that journey. So, uh, we are all students, uh, in that respect. Of course, and, um, it’s one of the shared purposes we both have. Any final word of wisdom, Suman, to health, to healthcare leaders around the world? Well, I, I think, uh, healthcare, uh, is, remains out of reach to A big part of the world, even in 2024, and a lot of us in operating in different aspects of healthcare have a tremendous responsibility to, to bring care to where it is needed.

And sometimes it does not require amazing technology. It is really doing what is right, doing the right thing, um, and, uh, keeping the patient in mind. And sometimes actually even stepping into the world of actually prevention, uh, which is probably better than cure. And, and at those times, you know, we, we have to, of course we all have, we all have the responsibility to, to build a business and have the organization successful.

But in the world of healthcare, it really requires looking at problems through a different lens than in other industries where. You have the human being and the patient in front of you. And, uh, and that might require unconventional thinking and business models. And I hope, uh, industry leaders set an example for that and, and the rest of the world, uh, will, will follow.

Well, thank you so much again for being with me today. It was a great conversation. Thank you. Thank you so much, Najee. And, uh, yeah, I look forward to. Uh, continuing to, you know, hear, uh, more of your, uh, your, uh, podcasts and, uh, other speakers and also learn from all the work that you’re doing. So thank you.

Thank you for having me. Thank you. Same, same here. And I’m sure we will cross paths, uh, through tense, uh, in the near future. Thank you all. Thank you all for listening to Spread Love and Organizations podcast. Subscribe and connect with us on spreadloveio. com or wherever you listen to podcasts. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement our world so desperately needs.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Diana Haydar

Naji Gehchan: Welcome to Spread Love and Organizations, the healthcare leadership podcast where we explore leadership with purpose. I’m Najee, your host, joined today by Diana Haidar, Director of Direct Sales at NASCO Insurance Group. Diana has been a key part of the NASCO Insurance Group for 20 years, starting in third party administration and then moving into the direct broker business.

She now covers Middle East direct portfolio, including medical, general, and life insurance. Diana started her career as a certified psychotherapist. Then worked at a mountain hospital with children with special needs. She holds also a master’s degree in hospital and health management from OSCP and ESAR.

With 20 years of hands on experience in the medical field as a professional, as well as an insurance industry, Diana has been involved in various aspects of the business, from operations and sales to planning and growth. For over two decades, Diana has been empowering teams, encouraging fresh perspectives, and finding new ways for NASSCO Middle East to grow in the world of direct saves.

She’s a leader dedicated to making a lasting impact on the insurance industry. Diana, it’s so amazing to see you again after so many years and have you with me today. Yeah. Thank you, Naji. Really, it’s really amazing to see you too. We’re not gonna say for how many years, because let us keep our ages.

Diana Haydar: It will age us, yeah. Yeah. But a lot of years so far. And I still remember Naji from school days. From literally all the ups and downs and growing up, the teenager’s time, all these times that you spend together. I’m really happy and proud of what you are also Najee now, to be honest.

This is something that makes me proud a lot. Yeah same here, Diana. And really, my first question to you was, let’s catch up, let’s catch up on your journey from our school days, as you said, very early on in Lebanon to, then you did physiotherapy, and now you’re one of the known leaders in the insurance industry in the Middle East.

So can you share a little bit more your personal story with us? Yeah, sure. Naji, I grew up in a family, in a very modest family in Lebanon, Where my dad was in the army, in the Lebanese army. My mom was a housewife and we are four sisters. We are four sisters with very close ages. So we are really too close as you can imagine a house with four girls, how it looks like.

So growing up was extremely amazing. We have beautiful childhood memories. We have teenage memories, which are really amazing. We are so close to each other. Thank God. This is something this is a blessing that we still enjoy it till now, despite that we everyone is in different country. I have two sisters in the US, one sister in Lebanon, and I’m here in Dubai.

But despite all the distances, we are too close. And this is really what marks my childhood the most Najee. So we were at the same school. You and me at the same class, maybe for 14, 15 years, next to each other. So the school memories are the best memories that I have. We really enjoyed our time a lot.

And I think That our future started from school time because we were lucky to have a school where we had freedom of speech. If you remember very well, Naji, we used to do this political debate sociology, economy talking about the war, growing up during wartime. So we had a lot to talk about and which made made us a little bit older than our age comparing to to other schools where they didn’t have the chance to have these conversations with their teachers and with their superiors.

So it started from there. The leadership started from there being delegated the class representing the class. Many times you and me together. Also, actually, many times we were elected by our colleagues at school. So basically, my childhood was a very good childhood at home at school. The only terrible memories I have are the war times which we had to suffer from moving from a country, from a region to another, running away from where they are bombing now.

Are they bombing Beirut or or outside Beirut? So it was really it was really something that I can never forget. And having to struggle with, as I told you, Naji, my dad was a soldier in the Lebanese army. And at a particular time they were they were like attacked by other militia.

By other countries. There was like the civil war and then the war against our country neighbors and the Lebanese army were really attacked so many times. He had to hide at home. My mom had to clean his clothes and put them to, to dry inside house because nobody from the neighbor should know that my dad is here.

So that they don’t attack our house. So we have, I have this black side of my childhood. However, it taught me a lot, Najee. It taught me resilience. It taught me finding solutions. to any problem that we might encounter in life. It taught me all the family bonding that we have.

And the neighbors also, we were all on one heart. We were all hiding together in the same shelters. And so this war, wartime, it really marked my childhood also. We learned from it. We learned from it, especially that we don’t want it to happen again. So this is the childhood. I’ll move a little bit to my university university past.

So I started, as you said, as a physiotherapist in the Lebanese university, which is the national university in Lebanon. And I was lucky to to work at many at many areas, especially with the kids, with the children having special needs, with special needs, so that you meet these this segment of the population who are in need of, who are dependent who struggle, especially in Lebanon, at a country where it’s not really equipped.

For with people with determination, people with needs. So you have to, you feel with the parents, you feel with the children with the entire medical system, how much it’s, it doesn’t support these these diseases. They have to beg to do some surgeries for their kids because insurance companies do not cover congenital cases.

They have to go and get get help from the ministry of health. And the Ministry of Health in Lebanon is really is really politicized, if we can say it. So depending on from which religion you are, you might get help or not. So this is like the struggle that we used to have. And then I started to feel that I enjoyed the therapy.

To be honest with you, Naji, I worked as an establishment and as a freelancer for around from 2003 till 2011. But meanwhile I spotted in my character that I can be a leader. I can be more than a physiotherapist with my patient and one single and one single cell or cabinet. So I discovered some skills, which I didn’t know that I have.

And this is during my, my my career life. And this is where I was also hired as a consultant for physiotherapy and NASCO group. So NASCO at that time, we had the split with with an existing TPA, a third party administrator. Let me just explain what is a third party administrator. So we manage the the the insurance company’s entire cycle.

The insurance company, they sell the policy, the medical policy, and they pay the claims. The entire approvals customer service the contract with the healthcare providers, the claims processing, all these, the reconciliation, financial reconciliation are done by a TPA. So this was my area of expertise.

I started as a simple consultant for physiotherapy guidelines, So how many sessions to cover this? How many sessions to cover? What are the guidelines? And then I liked this job. I I got involved in in NASCO group for this role. And I did my MBA meanwhile, in the ESA, in Ecole Supérieure des Affaires, in hospital and health management, as you mentioned in the introduction.

And I started from there. And I started growing and and like getting promoted inside inside NASCO, and I’ve been with them for the past 20 years. So everyone now will guess the age, but it’s fine. And yeah, and now I’m I moved to Dubai three years and a half ago. I moved to Dubai when after the Beirut blast, There were so many signs.

There was the collapse the economical crisis, all the crisis, all this stuff. So there was there were so many signs talking in my head that Jana, you should leave. I have three kids, Najeeb. And I wanted so bad for them to be a little bit less afraid. Then I was when I was a kid, so the memory of the Beirut blast they heard it.

We were not in Beirut. We live far from Beirut. However, we heard it. My husband was in Beirut. We lost contact with him for about two hours, so it was horrible. This period was horrible to us. So and then there was, the revolution and before that in 2019, and which also we had to struggle a lot to reach work to all this stuff, but it was really horrible.

So I got this opportunity in the UAE and Dubai and I came here. I started. Literally from scratch. Picking a new house, all this picking new school for the kids meeting new friends starting from scratch, even though I’m still, I was still in Nasco. I was transferred from Beirut to Dubai.

However, you have to build. To to prove yourself in this new environment, and I can tell you, Naji, the environment in Dubai is the, is there’s a huge difference between the environment, especially the work environment in Dubai than in Lebanon. And I started, and thank God, now three years and a half have passed, and I feel that I’m, I’ve been here since forever, and I like it.

where I am. I’m extremely happy with all the changes that I’ve done in life. It only evolved me to the, it only took me to a better place for me and my family and my kids. So this is a small brief, not sure if it’s too small. Thanks, Diana for sharing. Obviously, a lot of what you said touches, goes to home.

I want to, before I ask you about Dubai, because I’m interested in what are the differences, as you said, really like leading cross countries, because I’m sure you are leading also a team across the region. So I’d love to go there. And for you being a woman in leadership, I’m really interested to dig in there.

But just before that, if we go back, you talked about school, you reminded me about the debates, the healthy debates we had, the revolutions we did sometimes. So what did you take from, from school, from your years in Lebanon with the childhood and war, really from a leadership standpoint, did you reflect about who you are today as a leader?

And what brought you to who you are today from what we lived before? Of course, Naji. I believe I am what I am now because of this period that we that we had in that we had in Lebanon and the school time and the war time. So you’re referring to school and war time, no? Okay. So it taught us a lot, Naji.

If you remember very well, we used to be at the classroom when they start when the bombs start falling. So they took us all in the bus, go back home or they call their parents, our parents to pick us home. So imagine you are a kid, nine, 10 years old, and then your life is at risk, your parents coming to pick you up.

Their life is at risk. Your siblings and other classes where you don’t know if they are afraid or not. All these it’s, it, it made us stronger. It made us stronger. It made us more agile in our corporate world now because change can happen like this. Everything is okay. You don’t know what’s going on.

Then suddenly you have something, a major thing happening around you, which you’re not involved in, but it is happening. So you have to act fast. You have to think fast. And most importantly, Naji, is the tomorrow. We used to go to home and we did, we do our homework because tomorrow we might be going back to school.

It’s not that the word stops. So I’m not sure if you also, my parents used to be extremely strict at that point, is that if today there are bombs, Tomorrow there are no bombs. You’re going back to school and you’re going to focus on whatever the teacher is telling you. So this split between the fear and focusing on your future is what we apply on every single day in our corporate life.

Because everything is moving. Look at the pandemic. Look now what’s going on in the Middle East. And I work in the Middle East. And then suddenly you have to shift this is going on. However, I need to go on also with my career with my objectives with my vision with leading my team with what’s going on.

What should be going on in my career. So this really made us what we are. So to double click on this, Gianna obviously you’re in an industry that is by itself transforming we’ve been hearing it for a decade at least now, and for sure tomorrow will be even more change and you’re in a region, as you just said, In custom turmoil and challenges.

So how are you applying those leadership skills that you just shared with us? And I love how you framed it. I’ve never thought about it that way, but I certainly lived exactly the same as you did, like dealing with the unexpected, but then immediately refocusing on tomorrow as if tomorrow will just be normal again, regardless, right?

And you have to go through it and doing your homework, right? I think this discipline of you have to do whatever you need to do, regardless of if tomorrow would exist. So how are you transmitting this Largely to your team now, and several of them did not live this right. I’ll you, I’ll give you a small example.

Before I came here I moved here to Dubai in 2021. So in 2019 there was the revolution in Lebanon, the civil revolution. And it was, it was a big thing back then. So half of the population was like participating to these riots. And I live, as I told you, I don’t live in Beirut. I live a little bit far from Beirut.

So they used to close the roads. With with how do we call it? Tires, like flaming tires. So I have three how do we call it? Obstacles of flaming tires on my way to work. It’s, if it’s, there’s at J’ita, there’s at Dawra, and there’s at Jisr al Watin. So I have to pass only because I live in J’ita and Zouk Mosbih, mainly.

And I have a team and we work in medical insurance. where people will not stop falling sick. People will not stop needing for for their medication, whether chronic or acute medication. People has have planned surgeries. You have all these stuff. And I used to handle the portfolio, a very big portfolio for best assistance.

So I had a thousands of members, which I need to take care of about. their, about their experience, their claims, their complaints, all this was part of my job. And I had a team of four, four people, and we all live outside Beirut. So every day, because they close the road at 5 a. m. Imagine they start closing and putting fire to these tires at 5 a.

m. And personally, not only because whether you are supporting the revolution or the riots or not, in my perspective of life, nothing should stop you from doing your job. I cannot make excuses that they are closing the road, the roads, they’re blocking the roads. I have to be there and so is my team.

So I used to wake up at 4 a. m. and it was the entire time of the revolution at 4 a. m. get dressed kiss my kids goodbye and my husband and go to work before they close the roads. And so is my team. And I had to do this you So that they also have the courage to do it also on their own and to come to the office because in our job, we cannot work remotely, especially with the internet condition in Lebanon, and there was not also the pandemic was not there when the revolution starts started.

So no one was really ready for a work from home environment. So I made sure. I didn’t skip one single day. We were there for our clients. We were there for everyone who needed us. Of course, we limited a little bit our moves because when they block the roads, you cannot go anywhere. We made sure to leave the office at also the exact time where they open a little bit the roads for people to go back home and then we reached we and we reach our home safe and we look at the tomorrow.

What time we’re gonna move. Would it be worse? Would it be good? So this is a small example. Where nothing stopped us where I have to to be the strongest. I have to look the strongest. I have to behave like I’m the bravest. Although I cannot tell you, Naji, that I wasn’t scared. There was a time where I moved a little bit late from home, and they blocked the road in front of me at Zouk Mosbih.

And khalas, there was fire everywhere. So I had to go from the mountains and Abu Mizan area, if going from Layat, Bikfaya, and going down like one, one, one hour and a half just to to skip all this in the mountains and then go to work. And I was extremely scared. Because I don’t know the roads.

I’m alone. I’m a woman. The security and safety at that time work like you can forget about them in Lebanon. So and but I made it I made sure to make it every single day for my team. And then I knew that if anything happens to me. The team will do the same with or without me. They will never skip a day.

They will never stop serving the people that they are supposed to do to serve. And this was for me and I believe for them, a huge lesson and resilience. and staying positive and on knowing your responsibilities, Najeeb. Yeah. And you’re touching something super powerful that, we talk a lot about, it’s this huge, true care for one another.

You said something powerful, like they would be here for me. They would be here for, Each other and they would never skip a day for again, because you’re the purpose also that you’re driving is you said something super powerful. Nothing can stop you from doing your job and I would add like because you see your job and it’s true, super important for patients who need it and they need you.

So you were here for them and your team was working in the health care industry. It’s a huge responsibility and an insurance particularly. At that time and the country like Lebanon is not something that that it’s easy. The insurance, the health, the access to health care is not something for granted in Lebanon.

They pay a lot for their insurance or their private insurance because the, like the national insurance, the ministry of health, no need to tell you how they work. So they pay a lot. For their medical care, they have the right to get the right access to this. So since you opened this, I had this question in mind because usually insurance in Middle East plus globally, I can tell you here in the US, it’s the same and Europe is the same.

They don’t have this. Very positive, let’s say, image on truly helping people getting access but rather, and I’m in an industry, as I’m in biotech, biopharma, where it’s also like the image outside can be different from, leaders like you doing what you do on a daily basis to get people access to medications and healthcare.

So can you speak a little bit about this and what you’ve done? Because obviously as you shared your story, everything was driven to make sure that patients get their treatment and you lived with with really, not full justice or fairness towards who can get treated. You talked about the kids you help who were not covered by the government.

So what is your perspective now that you’re a leader in this industry, in the insurance industry and how you make sure that access is equitable for patients? Actually, this is a very sad, ugly truth that we live in. So if the access to healthcare are splitted between Lebanon and the UAE okay.

In Lebanon, the access to healthcare, it’s it’s sitan looks. It’s something that not everyone can afford. It’s luxury. Yeah. It’s luxury. It’s non-regulated. It’s you can insurance companies can just put limits and exclusions on any disease. You have a cardiac disease story.

They can just put some limits unless you fulfill some some obligations having all this stuff. This is in the private insurance in the public sector. You have, unfortunately, Nagy, these are the statistics like three years ago. You have only 28 percent of the Lebanese population, they have private insurance.

All the other, all the remaining people, they fall under the public sector, which is broke, which is, it doesn’t even exist. The infrastructure is not even there. So the government, the governmental hospitals are somewhere where you run from, you run away from them, you don’t trust them because the employees at governmental hospitals are not there.

Our governmental employees. I don’t want to go through these politics. But unfortunately, the corruption in Lebanon because of the corruption, we lost all trust in anything that is related to the public sector to the government, including the public scheme, the healthcare scheme, including the governmental hospitals, including all these, all the entire healthcare system.

So you have this 80 sorry, 78% of the population without any insurance. Okay. Having to back at the Ministry of Health. To get their health care to have to get their procedures done. And this is was also part of a project which I worked on in 2016. I’m gonna tell you about it later on. It was a beautiful project that it’s one of the success stories that we made.

It was when the Ministry of Health did some privatization on the health care management, and they outsourced with TPS with third party administrators, but it was only for a period of four years. And we did a lot. Unfortunately, then they don’t have the budget. They don’t want to do it again. So they went back to the to the old to the old public man.

So you have all the the people that are not insured with the private insurance are all left. Alone, left alone, you have somebody who has who has a heart disease. If they have a heart attack, they go to a hospital. They would not admit them unless they put a huge amount of money as a deposit.

They will refuse to treat them. So imagine the, this, the struggle, the amount of struggle that people have in Lebanon for this. Moving from Lebanon to UAE, UAE is much more how do we call it? Regularized, excuse my English, Najee, sometimes. It’s regulated, yeah. It’s regularized.

You have the medical insurance is mandatory by law. In the UAE, it is mandatory. No one is entitled to stay in UAE unless they have medical insurance. They will not even issue your visa, your residency visa, unless you have a medical insurance. So this is a major change that I saw here. And plus, in UAE, they don’t have the right to exclude diseases.

to put limitations to to, to all this, like the struggle that we have in Lebanon. However, due to the difference and the and the purchase power and the UAE insurance is extremely expensive. And I was going to ask you like people, so you have to have it, but you should be able to afford it.

Exactly. So you have to be extremely at a certain wealth to be able to afford good insurance. Yeah. However, there are some basic products done by the government, which are okay. At least you don’t die at the doors of hospitals, even though they take care of you, depending on your policy, which is a little bit normal, but at least here in the UAE, you know that you can be taken care of.

In case you are in and this was an extreme relaxed mindset that I had when I moved here and I was extremely happy that I live now in such country. Yeah. So it’s interesting because obviously healthcare systems are pretty broken all over the globe. Like I’ve been in Europe as now in the U S so there is what you’re saying is true.

There are, there is this limit of. At least people in urgent need are covered for their health care. But still, unfortunately, we see it in every single country. And in the U. S., I’m sure you’ve seen all those debates about people not being able to afford health care. Because of as you said it’s either so social economics, it can also be because of diversity, certain minority groups.

So it’s certainly something that we we need leaders like you to keep on working and making sure that healthcare is is a human right as it is, but unfortunately it’s not applied that way. Yeah, exactly. If you, if we go back to my very first question I wanted to talk about, which is leadership in different countries and being a woman in leadership in the Middle East.

Can you share with us a little bit your learnings along the way? Yeah. Actually, I’m lucky that I work at NASCO, to be honest, where they really value women at all positions. I cannot tell you it was an easy journey. Because being a woman in the Middle East and the Arab countries, you are always labeled as fragile, you are labeled as dependent, you are labeled as being emotional at not being able to to, to think objectively, et cetera, you are labeled.

Whereas, now actually, I can tell you, not because I’m a woman, the hardest decisions, That are made and decisions. I want to split between decision making and execution. I can only see in my surrounding. I’m sure there are lots of leaders, men who are extremely amazing. But from what I see around me, the decision making and the execution, when it’s a woman leading these two areas, it is certainly a successful result.

Because we want to prove that we can, when men don’t feel that they need to prove it. It’s already for granted. He’s a man, he can do it. Whereas and they fall in this trap, because they take their work for granted sometimes. They don’t. They are not. I don’t want to say decision makers, but you know the confrontation between men and men, the frictions that happen in the corporate world whenever it’s a woman versus man, it’s softer.

It reaches to a middle ground. So I see this a lot. And again, I’m proud that I’m at NASCO because this is this. This place gave me a lot of empowerment being a woman. However, it’s not an easy journey at all. Every single day in every single meeting, Naji. Of course, I’m not comfortable in my skin as my men colleagues.

Especially when I am the only woman in the room, especially when also I’m with a client. And when I’m with another executive, I need to make this huge first impression to be able to crack the preset mind. If I miss this first impression, I will, I might be labeled with the nonsense that I told you previously.

So it’s not an easy job. It is doable. Again, it is how much the woman is focused to prove it and she can do it and she can prove it. But she has to stay focused really Najee. We women, we cannot take our jobs for granted. Unfortunately, like you guys, we need to fight harder. But again, fighting harder is also getting where we want and giving results more than anyone else.

And I certainly agree when you say about decision and execution and that you do it, we see it all over the world. Women leading get to better outcomes. And there is something I’ve also learned by moving to different countries. It’s what you’re saying can also apply to. To to minority groups, if you’re the only different person in a situation, it immediately becomes you want to prove that you can, right?

I love how you framed it because it’s You try harder. You try harder. You try harder. Yeah. Yeah. Which, which sometimes is, it feels unfortunate and unfair, right? Totally. Like why would we get all those assumptions as you said, why do women have to prove, over prove themselves to to get what, where they want, but you’re bringing the other side of it, which is actually, you will prove that you can and you’re doing it.

I want to move now to a section where I’m going to give you a word and I would love your first reaction to it. So the first word is leadership, heart and mind. Oh, tell me more. Two words. So this is something that I read recently. I had some leadership course with a great professor and he, he used to describe Leadership is winning the heart and mind of your team.

So anyone can be a manager, Najee. Anyone can calculate your KPIs. Anyone can make the job done, make the task done. Anyone can monitor your presence at the office. But not anyone can mobilize you to be a better person to look at the same vision to have a strategic mind. Mindset unless it’s a real leader.

So if you don’t win their heart and mind. With your empathy, with your humility, with your leading by example, with all this stuff, in my opinion you are, you will never be a leader. You are, you were never, and you will never be a leader. It’s not about having things done. Everyone can have things done.

It’s about it’s about looking at your team, talking to your team as if you’re talking to yourself, feeling for them as if you’re feeling for yourself.

What about insurance? Security.

So can you share a little bit more, especially how you, because security is very interesting and I’d love to get your thoughts about the future of insurances in the next decade. So imagine Najee, you are now you are now sitting in your room and your child is playing with the ball at the garden and then he falls.

Or she falls and they break their leg. Okay? You don’t you don’t know what to do, okay? You have the medical part, which, where should I go? Which doctor, which facility plus will I be able to afford if a surgery is needed? What if they need this? What if they need this? Having an insurance, I’m not, I’m only talking about medical, but I also manage all the other lines, but this is maybe the most like personalized example.

So imagine all of these, whenever you have a medical insurance, you don’t think of all of these, Najee, you just put your kid in the car, go to the hospital, which you have access luckily with your insurance card. You don’t have to worry about all the logistics. Somebody else is paying the bill. Somebody else is checking the eligibility.

Somebody else is doing the medical due diligence etc. You only, you are only taking care of your kids. Emotions and the trauma that they had, and you don’t have to worry about anything at all. This it was a lot. It was a lot because look at the countries where they don’t have this luxury. Somebody falls sick, they might think 100 times before they take them to a doctor because they cannot afford, they might take them to low level doctors or hospitals or whatever, because they cannot afford an average.

Medical facility. It’s not within their insurance cover, or they don’t have access to it for some reason. So they have ipso facto, they have a low level of health care. And this will this might mark all their entire life know how many people die because of lack of health care access.

Whether not being accepted at the emergency hospital, whether being treated by Medjugorj medical facilities or doctors, because this is the only way they can afford medical medical health care. Being late at their treatment, for example, in Lebanon now, Naji, I’m sure that cancer drugs are not imported anymore to Lebanon.

There is a shortage in cancer drugs. You know how many people in Lebanon are dying because they are not having their chemotherapy? I have one relative, two relatives actually, who are suffering. One of them died because there was no treatment. She was out of chemotherapy for more than six months. There’s no, because she’s not insured under a private insurance.

She has she has to go to the public insurance where they tell her, sorry, the government is broke. We’re not getting, we’re not getting any aid from anywhere. So imagine, so whenever you are insured, all this stuff you don’t have to worry about. And this is vital. This is not a luxury. This is vital.

So But would Jana, would the affordability of insurance become something where it is vital and accessible? Do you think we will be in a future where people can afford it? Honestly, they cannot all afford the same level of health care. We are not in like socialist regimes here in the Middle East or in the Arab world.

And which, in my opinion, it’s not something really bad. Because to have a good medical insurance, you have to be successful in your life. Which also, it might be tough a little bit, Najeeb, but people who invest on them, on themselves. at school, at university, at work, work hard, it will pay off. They will be able to afford whatever they want.

I’m not saying that everyone had the chance for this, but whenever you had the chance and you work on yourself, you can afford. Unfortunately for the people who didn’t even have the chance, the people like living in a war zone or in a very poor area, They will not have the chance to get proper education and then get high positions in, in, in in their work life and then get good insurance.

But the minimum, the bare minimum can be accessible for people as long as governments are regulated and not corrupted. Na. Yeah, and you’re bringing like that. That’s a whole different story. We can talk about trying to bringing the two visions of the word, right? And what a place like more in the U.

S. is actually very similar to this where you work, you succeed, you get what you want. It’s a capitalistic view of things. So those who can’t afford it would be considered the lazy ones versus those who work hard. And then there’s another view of work, which is more some parts of Europe where actually it’s not lazy, it’s just bad luck and the society has to take care of you as a human.

It is a big debate. But it’s. It’s one, I think we can go into in another podcast, but the third word I want to give you is Antoinette, yeah Antoinette everything that is beautiful in life. at school. Najee, you cannot know how much I owe this establishment.

You don’t know how much they, I have done great friends such as yourself and all the other friends that I have. The personality that we had, you remember Najee, one time we did a revolution because there was one student who didn’t pay his tuition. Oh, I don’t remember. You remember very well. So all these movements that we did at school, all the culture that we have.

I still remember, if you remember The teacher, the talks that we had about World War Two, about all the political regimes with Mr. Malham Nassar, teaching us what is Marx, although he was an Arabic teacher. We used to debate about communism, about Marxism, about socialism, about all this stuff.

I, I am so grateful to this period of time and which I I envy the students there now. I hope it has the same culture now. I don’t know, honestly, I’m too far from it now. I hope it still has the same culture. Yeah. So for everyone, Antonia is obviously our school where we went to the first 15 years of our lives.

Yeah. Yeah. And certainly, you’re bringing something that is so true that I feel I try at least to replicate along the way is having those healthy debates, right? You can have different views and we were a mix of different cultures, religions, backgrounds, but you can still open up and debate them respectfully while understanding others view.

If you remember Najee, we were few, like few schools had this diversity of religion and cultures. So we were really lucky because we had these debates. As I see some other, like my friends who used to be in a more closed school communities. They didn’t know there’s the other person, the other side of the religions of the cultures.

They didn’t know until they were, they, they were at work and their work life. We were lucky that we had this experience when we were too young. Yeah. Yeah, certainly. And again, like that’s a full topic, but it certainly helped you take out what unfortunately these days a lot of leaders are trying to do is putting fear in our heads about the other.

And if you really don’t know the other, the fear bubble up. But when you sit with them, play with them, you realize that as human beings, we’re all similar. You think they are all your enemies until you, you see their point of views. Yeah. Yeah. The last one is spread love and organizations is sorry, spread love and organizations.

A must, the word that I would think of is it’s a must. The corporate world is such an evil world Naji, unfortunately you have, I am sure that you know that very well. It’s the selflessness. that it’s not there anymore. It’s the selfishness. So everyone wants to reach their goals by crashing the others, by labeling the others, by ruining the reputations of others, by whatever.

So this teamwork, this spirit, the love, the culture, I’m not sure it’s there. enough anymore, unfortunately. But you are here, we are here, and there’s more than 150 leaders I interviewed who certainly are spreading it and trying hard to do it. Any final word of wisdom, Diana, for leaders around the world?

It’s not for the leaders. Actually, I’ll start with the people who haven’t discovered yet that they are leaders. So I would say this if my team is listening to me now or my old team in Lebanon is listening to me now. You all guys can be leaders. It’s just believe in yourself and be yourself because this is the most important bit.

Most important advantage that you have. It’s only be yourself and you can make it. This is for my team now and for the leaders across the world. This is a song like a cliche, which is nothing lasts forever. You will not be sitting in the same chair. You will not be sitting in the same position.

People will remember you for the good impressions that you made. And this is this comes with leadership. It’s not an easy statement, Naji, because we all struggle with stuff, with mental issues. The conflicts, the trauma that we have from our childhood. But, and we, unconsciously, we spread them on our team.

We might be tough, we might be non empathic, we might be, all this stuff. Guys Again, nothing lasts forever. Just keep this good impression while you’re here on Earth so that people will remember you. Now, my first boss, actually, this is a side story, he is my mentor. He used to be my mentor.

It’s been a long time I haven’t spoken to him. So Also, he marked a lot my leadership style because he used to be a great leader. So what I try to do also now is to have the same print on the team that I need. I wish that they will remember me the way I remember my first boss. I’m sure they will.

And what an amazing way to finish this conversation. Jenna, thank you so much for being with me today and sharing all those stories. Thank you so much, Nadia. Thank you so much. Thanks for listening to Spread Love in Organizations podcast. Subscribe at spreadloveio. com or wherever you listen to podcasts.

Together, let’s inspire change and make a positive impact in healthcare, one story at a time. Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Alison Fragale

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Alison Fragale, a research psychologist, award-winning professor, international keynote speaker, and author, on a mission to help others — especially women — work and live better by understanding and applying the science of people. Alison excels in translating her deep academic expertise is in status, power, negotiation, and influence into actionable advice. Alison is currently Professor at Kenan-Flagler Business School at the University of North Carolina and her research appeared in several news outlets such as Wall Street Journal, The Washington Post, The Boston Globe, to name a few… Alison, I am so excited to have you with me today and look forward to our chat!

Alison Fragale: So excited. Thanks for having me.

Naji Gehchan: I’m really eager to go into discussing your impactful academic work and also new book Likeable Badass, but first I would love to hear more about your personal story, what brought you to researching people!

Alison Fragale: 100%. I always say this was not my childhood dream. I don’t know if I had a childhood dream, but it was not this. So here’s my story. I am growing. I’m growing up. My dad was very raised, very poor and managed to pay for his way to go to college. He was a first generation college student and he was very successful in starting a small business where I grew up, but he had really raised me up.

You need to do practical things, Allison, practical things. And so when I was. Uh, starting out, I was thinking about a career in business because my dad said that’s a practical thing to do. And so I went to school and I was a math and economics major in college because that was the closest thing I could come to, to studying and pursuing a career in business.

And I had always had an interest in human behavior and psychology. There was a class offered in my high school. Every class that I could fit into my schedule in college I took, but at the time I had these words that I had to be. focus on a practical career and I did not have any guidance at the time as to how an interest in human behavior could be turned into my father’s wish for a practical career that could pay bills.

So I didn’t do anything. I graduate and I take a job at McKinsey as a management consultant. I wasn’t exactly sure what I wanted to do in business and everyone said this was a good job and if you could get it this would be amazing because you would see so many aspects of business and you would, if you didn’t want to be a consultant, you would at least learn a lot about where you wanted your business.

career to be. And I was not at McKinsey very long before I realized this was not for me. And I looked at the lives of my clients and I couldn’t find anything that I found inspiring that I wanted to do. And I describe it as my quarter life crisis. I thought, uh oh, I’ve picked this career. I was all set up to go to pursue my MBA and I wasn’t liking any of it.

And I hadn’t at that point. Um, ever really explore, like, what did I really like? What did I want to do? I just was following along, trying to get to the next level of success with what people told me to do. And so I always say, when I talk to younger students, or I talk to people now, and I say, the best job in the world is a job that you love.

And the second best job is a job that you hate. Because when you’re unhappy, is when you start to really explore what do you want out of life, out of work, and you get a lot better answers. So one night I walked, I lived in Chicago, I walked out of my apartment across the street to Barnes and Noble and I went to the psychology section because I knew I liked human behavior and I bought a book called Careers in Psychology and I took it back and as I’m flipping through it, I read Organizational Psychology, which I did not know existed in what I had been exposed to.

I kept thinking I could be a therapist or I could teach psychology, you know, in high school, organizational psychology. And there, all of a sudden I had this Eureka moment. I have this somewhat interest in business, although I’m not really sure I want any of these jobs that I’m seeing, a real deep interest in human behavior.

I was also, that interest in human behavior was very much sparked by being at McKinsey, which is an odd job from an interpersonal perspective, where you’re constantly a newcomer and an outsider in a world where your clients really don’t like you. I mean, they make movies about the consultants, right? No one wants to work with the consultants.

And so I had to think a lot about how do you negotiate with people? How do you influence them? How do you motivate them? So I was having all this real on the job. organizational psychology experience. And as soon as I saw organizational psychology, I thought, that sounds like a great blend of the things I know and the things I don’t know.

And I applied to go get my PhD in organizational psychology and apply. I was, you know, this is 1997. So yes, you can search things on the internet, but not quite as efficiently as you can now. So I had to figure it all out and apply. And I, and I went and got my PhD and then ended up. Uh, as a, as a professor, as an organizational psychologist, and it, I think I picked really well the second time.

I am very much inspired and love what I buy and what, love what I do, and I wouldn’t have found it, I don’t think, if I hadn’t picked, I don’t want to say poorly, if I hadn’t been in a situation that really didn’t fit me and, and prompted me to think about what, what do I really love and gone and got that book.

I wish I had saved it. I feel like it’d be like a great artifact, but it’s long gone in my move. So that’s how I ended up here. Well, thank you so much. It’s, uh, it’s really inspiring and I love how you’re sharing it. I had early in my career and what I discussed now with, uh, as you said with, you know, when I mentor, uh, people, there is sometimes this question, like, I don’t know what I love.

Like, I don’t know what I want to do. And I had this advice very early on. Well, someone who told me, you know what, write what you actually hate doing. And it helped me so much because I, like, it gives you some sort of framing of knowing what you don’t really want to do, and then it opens different perspective on what you like.

Naji Gehchan: So I really relate to what you said. I love that you framed it that way. Yeah. That was great advice. I’ve never heard that said that way. That’s totally true. Yeah. So now, as we’re thinking about organizational psychology, like, how would you frame it overall? And then I will go more into the four topics of your research that you’re passionate about.

But help me understand, like, we all know organizations have some psychology, have some dynamics, sometimes good, sometimes bad. How do you think about that? Yeah, so psychology, broadly defined, of any different kind, is going to be the study of human beings. What do we know about people? How are they similar?

Alison Fragale: How are they predictable? The organizational psychology, specifically, is going to be, what do we know about human beings that’s going to be advantageous to us? to work better, to work more efficiently, to work more effectively. So I always joke when I teach my MBA students, when an MBA students, they’re very focused on the quant classes, uh, my accounting, my finance, the things with right answers.

I need to get good grades in these things. And I would always joke with them, you right now in organizational psychology, organizational behavior, You’re not worried about this because you’re not, you’re not working right now, but I promise you, a decade from now, 20 years from now, everything about work that keeps you up at night is going to be a people problem.

No one lays awake at night worrying about their Excel spreadsheet. Everyone lays awake worrying about people who are not giving them the respect they’re due, who are not giving them the answers, who are, Creating obstacles in their way, you know, not taking the meeting, not respecting the boundaries, whatever it is, they’re all people problems.

And so that’s what organizational psychology is really about is to think about if you understand all the people that you have to interact with and want to interact with, if you understand on average how they’re likely to think, feel, and act, because they’re human beings and human beings are kind of predictable.

So if you understand that science. That gives you a tremendous advantage to think about, okay, well, you know, similarity attraction. We like people who are like us. That’s a well known psychological truth. Well, if I know that I can start to bring that into that knowledge into the way that I show up. Okay.

We have things in, you know, in common, neither of us really like to fly, but we fly all the time. That’s a point of connection. All of a sudden. Yeah. Um, we feel like we have some kinship. So that’s how we can start to use psychology and the, and the truths and similarities of people to how we can authentically show up in ways that are going to get us the results that we want.

And that’s what I try to help people do is I try to help people think about their audience. Like, what is this person doing and what do you want them to be doing? And then how are you going to be able to think about all the variables in your control to get the outcome you want from that? other person.

So that’s why I find psychology so fascinating because it has rules, but then there’s always individual circumstances to think about how do you use that science to work that, get that particular person to move in the way you want them to move. I, I, I obviously love it. And, um, I so believe in it. And as you are talking about, you know, like the technical aspect, the math aspect with your MBA student, we obviously see it like an organization, as you know, like I’m in a biotech word, you have like the high experts who are very scientific driven, et cetera.

So as you think through this, because it’s so, it’s so true, what you said, it all come down to people at the end, the organization of psychology and how things are dealt with. And this is what keeps me up. at night, as you said, way more than the scientific narrative, if you want, or the unmet medical need, which is way clearer.

But how would you help leaders see the importance of this, especially if they come from a background of purely technical, like MD, like me, PhD, who usually tend to see this as, you Secondary. Yeah, I think people tend to see it as secondary only until they’ve struggled. So that’s when I would have, when I would have my full time students, they were young enough that they hadn’t really struggled too much.

They hadn’t been managing people. They were in school full time. When you have somebody who’s engaged in working, so you take a physician, for example, if they’re a clinician, right? And let’s say they’re patient facing and say, try to get your patients to do. what you want them to do, what you know is in their best interest, right?

Is the spreadsheet or the data or the study or the paper the thing that’s going to move them? Maybe it should be the thing that moves them, but maybe it’s not, right? Maybe it’s the fact, right, that they’re, that they’re a big, you know, Chicago Bears fan and their doctor can talk Chicago Bears. Okay, now I’ll listen to your recommendations.

So thinking about, um, When people are in the, in the engaged in work and trying to collaborate with people every single day people will have some great successes and every single day people will have great struggles. And so what I help people do is I say, okay, tell me something where it’s hard for you to move people.

No one, everyone can think of an example. And then what I try to do is help give them strategies for how could you use human behavior in addition to. All the other tools that you have, right? So we are not going to, um, I mean, so being an expert is a psychological tool because people trust experts. People listen to experts.

So having expertise, having data, having science doesn’t run against psychology. It’s part of psychology. Why would this person listen to me? Because I come from, uh, I have data I come from, I’m educated, I come from a basis of knowledge, but there are all the other factors as well. And I help people point out what they are.

So I’ll use similarity as an example and then say, okay, well let’s think about how we could use this, or let’s think about how you could, where you could, um, where you’ve seen this type of thing work. And that normally is what I really like about it, is it, everyone is always a psychologist all day long.

So as long as they’re engaged in work, you can pretty quickly point out a problem, or They can agree it’s a problem. And then you can think about, okay, what tools do we have that we can add in to what you’re already doing that would get you more likely to get you the results you wanted. So I listen to you.

It’s a great segue to where it’s, uh, you mentioned it like status, expertise, power, influence, and this is. A big part of your research. So as you, um, as we talk about these four words, status, power, negotiation, influence, those you, uh, have really deeply researched. Can you share a little bit more with us your research on those topics, what comes out and how to think about them?

Yeah. So status and power. Um, status, I’ll talk about what they are first, I’ll spend, I’ll talk about those two first because that’s, uh, I speak about all of these things, but I do a lot of research in the area of status and power. So status is respect. It’s how much we are respected and valued by other people.

That is, if you look at status in the dictionary, that is one definition you’ll see. There are other definitions of how we use the term status, but when psychologists talk about status, we’re talking about that specific definition, which is how much does one person respect and regard another person. So it’s not your standing or your title, but it’s, it’s respect and value.

Power is. Do you control resources that other people care about? So I’m a parent of a teenager. If I have the keys to the car, the keys to the car are a resource that the teenager cares about. That gives me some power. If in an organization I have the formal authority to control the budget, to say yes or no, to hire and fire, those are all valued resources.

They give me power. Those are related but distinct. A lot of times the people who are the, are very highly respected, um, have the resources and they’re the people who get put in the positions to be able to control everything. So you can see them go hand in hand, but they are very distinct. And one of the things I help people understand is how to manage them separately because there’s a misconception that people have that is If I’m powerful enough, everyone will respect me and sometimes that can happen.

We can, we see someone who’s in power, we think we must have done something good to get there and we respect them, but a lot of times that is not what occurs. What’s more likely to occur is the opposite, which is if people respect me, they’re more willing to give me power. So when you think about situations where you have had the discretion to give someone power.

Sometimes we give someone power by electing to work under them. And we allow them to, we say, I’m going to give you power over me by being your subordinate. I’m going to give you power. I’m going to, I’m going to advocate that you should be promoted. I’m going to advocate that you should be paid more. We can give people power.

I’m going to vote for you in an, in a election, or if you’re applying for something. These are ways in which we can say, I’m participating in you getting more power in this world. Well, we’re only going to do that. If we have a choice for people that we respect, you would never put more control in the hands of somebody that you didn’t think would use it well.

And so we. One of the mistakes that people make is not recognizing how foundational earning respect is to being able to get all these other tangible things that we want. And for some people, and this is, I do a lot of work, I don’t exclusively speak to women or do work for women, but women, working for women is an audience that I care very deeply about, because what we know is that some, um, Characteristics are awarded less status than others.

So generally speaking, woman is awarded less status than man. And so what that means is that some people don’t automatically get as much status as others, and that makes it harder than for some people to get power. So a lot of the challenges we see with women being able to be represented at top levels of an organization, um, being able to be paid at.

you know, for their worth at the same levels as men, et cetera, can have their roots in status issues, which is if we don’t respect two people equally, we won’t reward them equally. And when we understand that, that’s painful, but it’s also gives us a path forward of thinking about, okay, well, as psychologists, we actually, back to this idea of thinking about your audience, we know a lot about how people decide whether or not they respect another person.

It’s not an arbitrary decision. We pay attention to certain things. Particularly how competent and capable they are, and how caring they are, how other oriented they are. And when we see somebody that we think, um, really knows what they’re doing, and really cares about people other than themselves, that’s the winning recipe to be respected.

If you think about, like, your Rolodex of who do I respect? Chances are, every, every single year, you’re like, yep. I think they’re very capable and very caring. Yep. Yep. Check. Check. Um, so that’s status and power. That’s the distinction. And that’s a lot of the work that I do is looking at really how to manage status and how to manage status as a tool for one, living a happy, fulfilling life.

Status and power are both fundamental human needs. I mean, we all human beings seek them and they are critical to our life satisfaction and our physical and mental health. And so I always tell people that. Lacking respect and lacking control are psychologically and physically just as damaging as living a life without friends.

But the, but the message that I really try to convey to people is Um, focusing on status as getting your audience to respect and value you is one of the most important things we can do when we’re interacting with other people, because once we do that, the other things that we really value, like being in control, and then negotiation and influence.

Negotiation is a tool for being influential. If you don’t respect people, it really doesn’t matter how many good negotiation tools and strategies I teach people. They’re not going to be successful sitting in front of their audience. So it ends up being the foundation for anything we want in our relationships.

And you can be respected and still be a poor negotiator, but it’s hard to be a great negotiator if you’re not very well respected. So this is, this is great. And let’s start first with the status and power, you know, like let’s talk. a little bit more. So on the status part, you talked about being respected and valued by others.

And it touches a lot as leaders, behaviors, how you show up, you talked about caring and delivering. But you also talked about, for example, women having this Already like a status that might be perceived as lower and I would say like minority group members not being born in a specific place, the genetic lottery.

We all live, uh, and we named them, right? Like several other pieces of, uh, of diversity that we can talk about. So this piece actually, this is where I would love to hear your thoughts about it because that piece is somehow we can’t control it. It’s who we are, and it’s more I’m feeling like the biases that can come with status that makes your status maybe lower or higher, depending on the society you’re in.

And then there is a piece where your behaviors are making your status to be respected by others, et cetera, because you care and you deliver. So help me understand these two and what part you should influence, not influence as a leader. Right. So 100 percent agree with all. First is many variables influence status.

It’s not just gender. Uh, so there are in status, we think of ascribed characteristics that influence status. So those are things we generally do not control. They have no basis for, for capability or anything, but, and they’re often things that are set. at birth, but they are outside of our control and unrelated to our actual skills and abilities.

So you would have gender, you could have race, you could have other kinds of physical characteristics, height, weight, ethnicity, religion, you name it, you can have a status, can be affected by it. Um, then you have achieved characteristics. So if I have Um, a Ph. D., which I have a Ph. D., so you might say, oh, okay, well, you have a Ph.

D., so I might assume that, although other things being equal, you’re more competent and capable than somebody in your field who doesn’t. Okay, that could be something where I have control over it to some degree, and people will draw conclusions about it as well. And then we have Um, all of the, the behaviors in which, uh, we can exhibit that we show up moment to moment that can affect how we perceive how capable and caring somebody is.

So, and those are things we can exert a high degree of control over. So, some people are potentially. I would call them at risk. So you come from a medical world, right? And I, as you, I’m not that kind of doctor, but some people can be born with greater propensity for some health, bad health outcome than other people, right?

That’s like an ascribed characteristic. It’s not your fault. You didn’t cause it. But guess what? If you live the same life as your neighbor, Your life statistically may not be as good because you have a risk for a health outcome that your neighbor just doesn’t have. And so therefore, what are the most controllable things you have left to make sure that you do get the life, the longevity, and the quality of life that you deserve?

You may have to change your diet, right? You may have to change your sleep pattern or your exercise or whatever it is, and your neighbor doesn’t? It’s unfair, but let’s talk about what variables you can control. And so in status, we understand the unfair piece, the piece that you inherited. And then there’s the pieces you can control.

And a lot of that is about how do we show up and recognizing that we have this at risk status, at risk situation allows us to be more proactive. And I always, you know, a lot of times what happens with, with people in status is people don’t worry about theirs until they find out they have a status problem.

You show up in an organization, you start doing your work, you’re like, I’m smart, I’m caring, I’m capable, like what’s, what’s to worry about? I’m not really thinking about my gender or my race or anything, like I just doing my work. Until someone undervalues you and then you realize they are not honoring your status and now you’re mad and you don’t like it and you want to fix it.

But now the, the per, the, the person has already decided that you’re not a person worthy of respect. Can you change their mind? 100%. You have changed your mind about people, I’m sure, in the past. I have too. But you know what? It takes a lot longer because once you’ve decided you don’t value that person, they have to consistently kind of prove you wrong enough times until you finally are going to change your mind.

It’s a lot easier to shape it at the beginning. So I always say like if you think you have a risk for having let’s say heart disease, no doctor would probably say just you know what wait and see if the heart disease shows up and if it shows up come back and then we’ll fix it. That’s often when people call me about status.

So what I like to think about is how can you be proactive and know that everybody is at risk at times. Based on some characteristic of being undervalued. The proactive things to do would be to control how you show up in interactions. And the simple advice I give people is in every interaction, ask yourself, like, what can I do in this moment to show up as.

Capable, I’ll often use the term assertive for that. It’s not just about being assertive, but to say I’m a person who has the skills and, and persistence to get stuff done. If you show up that way, that’s really beneficial for your status. And if you show up and say what’s the thing that I could do that shows that I’m very caring and oriented toward other people, that’s really beneficial as well.

A simple example would be offering advice where advice is welcome. advice allows you to show up as an expert. Hey, I know something. And if I’m doing it in service to you, then I can show up as caring. Um, talking about, uh, My, um, capabilities, right? And my, and my, um, qualifications. This is something I always used to feel really uncomfortable with when I stood in front of students.

I stood in front of audiences as I say, I don’t want to really give my resume. I just want to kind of show up and just talk to you. But people don’t know who I am. If I’m not saying to them, hey, um, Here’s my qualifications. Here’s the different things I’ve done. Then they would have no way of knowing and they’re drawing whatever conclusions they’re drawing based on my gender and everything else they can see about me.

Um, but I also want to talk about, you know, Hey, um, I’m, I’m caring as well. So I, even from an introduction on stage, I could talk about both my skills and accomplishments, but also things that create similarity with my audience and talk about my, the personal side of me so that they can see me as a person they’re connected to.

I may think of as. As friendly and other oriented, I tell jokes sometimes. That’s kind of my natural style, but jokes are actually really, um, affiliative behaviors. So you can start to think about how do I show up in interactions where I can bring both the capability and the caring and it’s subtle behaviors and things like that, that we do get a lot of control of.

And for people who are at risk of lacking status, I always say, The quicker you do that in a relationship before anyone has a moment to think about you, you want them to start thinking about you in this most positive way. And you can often do that in 30 seconds, five minutes in an, you know, in an interaction to, to get that relationship often in a way that advantages you.

These are such amazing advices. So I’m going to keep on getting your advice on another topic, negotiation. Okay. Can you share with us like the one advice. As, as you go into a negotiation, is there one advice or one behavior we should be doing to try and get to where we want to go in a negotiation? So I’m, I’m going to give you a couple, okay, move first, move first, okay, the, the, the first mover, the person who puts the offer or the proposal out there first is going to do better.

So a lot of times we want to sit around and see what the other person has to say generally does not help us out. So when you go into negotiate, go with an idea of what you want. And put it out there, okay? Even if it anchors the others? That’s exactly what you want it to do. You want it to anchor them in a way that’s advantageous for you.

The alternative is they go first, you get anchored in a way that’s advantageous to them. So, now, Again, when we, if we, if I was going to do a whole course on this, we can find exceptions to everything, but in general, the research shows, and this is one of the things that contradicts people’s assumptions a lot, they think the person that speaks first loses.

I should hear what they have to say. And you can, but what’s likely to happen, particularly if you’re not extremely well prepared as to what a good outcome is, is that you’ll start to be anchored to what they’re saying because you’ll think that’s what they want. If I move too far away from it, they won’t say yes.

I also want that person to like me and you’ll start to slowly creep, you won’t creep all the way to where they’re going, but you will start to creep in your own head to be a little bit more concessionary and that’s okay. It just doesn’t end you with an outcome that’s as good for your purpose. your side.

So when we go first, um, we can get all those same effects working in their brain instead of our brain. Now, if you’re nervous about going first, and I’d say even if you’re not, a corollary to go first is go first, with multiple solutions. So three is a magic number. Hoodings, like, here’s three different ways I think we could solve this problem.

I could see it doing A, we could do B, we could do C. And A, B, and C, what they have in common is they’re all solutions that you would find acceptable. But they differ in, um, there are various ways that you solve the problem. Of that strategy, It still allows you to go first, but it also is very good at building the relationship because we like people who give us choices, and when people give us choices, we see them as more reasonable, more interested in solving the problem, and particularly, you know, for, we know of a lot of science, women is one, is one category of people who, when we are too assertive about what we want, we get backlash in negotiations.

So a three strategy, a three solution, proposal is a really good way to do it because it’s saying, I’m still going first, but I’m, but by the fact that I’m giving you choice, I am managing how you think about how aggressive I’m being in a way that is building trust in me. That’s good for, good for me, but good for both.

So I’m going to venture now in a, maybe a tricky space, but since you’re passionate about psychology people, you said we are predictable as humans and like all the science of people and the current word, you know, where we’re going today, like, We’re seeing it all over the place. Wars, unfortunately, in all the parts of the world, extremism, etc.

Can you make sense out of all the ongoing craziness from your psychology of people, and how do you think about this? Yeah, I can make sense of it, um, I can understand it, and I think a little bit like, I’ll use the medical analogy again, um, that you joke, like you joke, like when depending, when you have a medical ailment, the salute, recommended solution depends on the specialty of the provider you go for, right?

You go to the surgeon and the surgeon’s like, yes, this is a surgical fix, and you go to, you’re the internist, and they’re like, okay, here’s the medical fix, um, so as I’m going to tell you, it’s status and power, they’re fundamental human needs. Okay, those are when those things are taken away from people, people will do anything to get them back when people feel like they are not respected.

They don’t behave well. When people feel like they don’t have any control, they don’t behave well, and they are desperate to get those things back. So if you think about things anywhere from world conflicts to, to like political debates at the holiday table, whatever it is, those are fights for status and power.

Um, now you layer in, um, a world in which now there is no such thing as a private conversation. Why I think why it feels like things are getting worse is that When we have an audience watching us, or a perceived audience watching us, all of the, like, lacking status, lacking power, now feel worse because everyone knows about it.

Now we feel ashamed. We feel like we can’t change our mind. It’s what people were saying, like, why are these negotiations now so intractable? Because negotiations involve people starting with position A and position B, and then figuring out how to find position C that works for everybody. But if you’ve gone on record to 10 people, a million people, a billion people, and said, I am going to go get position A, then you end up with position C.

You worry that the world is going to think that you lost, when in fact that’s not at all what happened. And so when we’ve created Uh, a world in which there’s no such thing as a private conversation. We’ve made it very hard for people to change their minds. We’ve made it very hard for people to pursue interest based bargaining, which is, okay, if you want A and I want B, C actually gets you everything that A gets you, it gets you everything that B gets you.

It’s a good solution. It’s just a different one than we both came in with. That’s actually what smart negotiators do. But if the world doesn’t understand that, then I’m now very concerned about how I’m going to be perceived. What am I concerned about? My status. Are people going to respect me less based on this?

So I am like the surgeon who thinks everything can be operated on, okay? Status and power can explain all of it. Adding in the fact that all of it is now done in front of essentially a worldwide audience is, is making these things feel fundamentally different than I think they felt to us at a point like earlier in our history or when we were kind of growing up.

That’s an incredible perspective. I’m going to give you now a word. And I would love for a reaction, like what first comes to mind. The first one is leadership. Difficult.

I think being a leader is really hard. I think it’s one of the reasons why it’s, you know, a, um, a topic that people can endlessly want to read about, learn about, be better, um, because it requires us to set vision. Um, I think that’s probably the easier part. And then mobilize people to follow that vision.

And that’s the psychological part. And that’s trying to reach a lot of different people, um, who want a lot of different things and get them all to act in concert on a, on a, on a vision. It is really, really hard. Um, and so I think, uh, it’s one of the things that gets me like excited about doing the kinds of work that I do is to know that to lead is challenging, predictable psychological reasons.

So I have a question on this. How do you reconsider leadership with status, uh, and power? Is it, are they totally related? Is there different types of status and power depending on your leadership position? Like, how do you think about this? Yeah. So, again, the, the academic in me thinks of a leader as somebody doing these two things, setting vision and getting people to follow them.

Not everybody then, and then there’s power is do I control resources? So again, if I go back to, if I have the car keys and my teenage son wants the car, I have power, but I’m not a leader, right? There’s no vision. There’s no followership. Right. Um, and you could say, and, and, and then status being respected.

Alison Fragale: Now, a lot of people who are well respected, people want to follow them. But then they also have to have the second component, which is, am I setting the vision and a direction for people to go? So that’s where you could find a Venn diagram, if you will. There’s certainly an overlap in the center where a successful leader is going to set vision and get people to follow them.

They’ll control the resources and they’ll be highly regarded and respected, and that’ll be part of mobilizing people to follow. So you have the space in the center, but you can always find people who are just one or two out of three, depending on what’s What’s going on? I would, I would say, could you have a leader that had you, you can, it’s hard to have an effective leader that has no status.

Cause I think you’d have a hard time mobilizing people to follow if nobody respects you and the vision. Um, but certainly you can have people in power who don’t have status. And then I would say, it’s not really clear. They’re actually leading anything. So you can get, I think you can get all of them. I think I, I can, I can draw the Venn diagram and put a person in each of those, each of those spaces.

The second one is influence. Um, yeah. So, I mean, I think about what comes to mind. Um, I think it’s what we’re what we’re doing all day long is getting other people to do what we want. And all of these things are tools. So status, power and negotiation are just different tools for influence. If you think about it, right, negotiation, if I’m going to move first, or I’m going to present three solutions, those are just specific techniques to get somebody to do what you want them to do, right?

I control the resources, so you’re a little bit afraid of me, and you need to do what I say, so that I get the resources, and I get rewarded. That’s a tool for influence. It’s why people want Uh, care about power. And same with status. If you really respect and value me, you’re going to more likely do what I say.

One because you trust it’s right, and two because you care what I think and what I think about you. And so all three of those come together and um, influence kind of sits at the top of the pyramid of our, our, our human goal when we’re interacting with other people. The third one is Likeable Badass. The title of the greatest forthcoming book on September 3rd, um, Likeable Badass.

Alison Fragale: So that’s my book, uh, uh, how women get the success they deserve. Um, it, uh, is really my catchy term for that stuff we just talked about with status, which is how do you get status? You get people to think. That you care about people other than yourself. That’s the, that’s my, I use likable for that. And then this idea of you’re capable, you get things done, I put something in your hands, you’re going to succeed.

That’s, badass is my term for that. I always joke that if I called it, you know, capable and caring, no one would buy the book. But, It, uh, it, it is, it has a specific meaning and I, I break it down in the book. I say that’s the way to remember it, but it’s really rooted in psychology of person perception is these are the two dimensions that people are paying attention to when they decide are you a person that they respect.

And the good part about this is that although it feels unfair. That some people have to be more strategic about getting the respect they deserve than others. This is what everyone wants to be. When I say likable badass, no one ever says, nah, not interested. Everyone’s like, yes, that’s exactly what I’m going for.

That’s how I want to show up. Absolutely. I, that’s how I want people to think about me. So there is an authenticity that can exist with this strategy, which is getting. Getting status is being, is showing up the way you really want to show up anyway and being perceived the way you want to be perceived. So that’s how I got the title.

Alison Fragale: And what I do in the book is break down the science of where does status come from, from these two dimensions, and then most importantly, how can people start to use the variables in their control to influence how people see them on these two dimensions? The last one is spread love and organizations.

amazing mission and goal. So I, when you, when we got introduced and you were telling me about spread law, I like, I was like a hundred percent, um, signed me up of thinking about how to be, and again, just like likable badass, right? I, have you ever found someone where you said spread love and someone said, no, not interested?

It is a universal, um, goal of things, things that we’re striving for, of thinking about, um, how to have, like, psychologists often talk about task significance, which is a much less, like, fun way to talk about it, of, does the, do the things I do matter, right? Do I, um, make a positive impact on other people’s lives?

And we see in psychology that the, when people have task significance and they think the things they do matter, it is one of the. biggest intrinsic motivators that human beings have. And when people feel like their significance is threatened, it does not matter what other perks, how much money you pay people, whether you have a foosball like table in the lobby, how many free drinks and snacks there are.

When people feel like the things they’re doing don’t have significance and don’t matter, it’s a, it’s a huge deterrent. It’s normally, it’s normally when people exit. So I think spread love is the, like one of the biggest. human motivators we have that gets us to show up every day and be excited about our work.

Any final word of wisdom, uh, Alison, for leaders around the world?

Alison Fragale: Final word of wisdom. Okay. Um, Be yourself in the most strategic way possible. This is one of the things that I always, um, say is that strategic and authentic are not opposites. You can and should be both. So, you know, just as an example, when I said we like people who are like us, like you can be strategic and say, hey, Hey.

We have a lot of things in common. I’m going to talk about those things that we have in common, but there are things we legitimately have in common that we can tell we both light up when we start to talk about. That’s the very authentic piece of it. So that would be my advice is, um, you know, don’t reject it.

being strategic because we have to be strategic with thinking about other human beings. But that does not mean, strategic does not mean the opposite of authentic. Look for ways to bring those together and one of the things I love to do when I talk to individual people is to say, tell me who you are and what do you naturally like to do?

And then let’s think about how we tweak that on the margin to get you better results without you abandoning the way you like to show up. And I always promise people there’s always a way. There’s always a way to layer that in. So strategic and authentic. You can be both. Well, thank you so much. I can really stay with you for hours discussing it.

Probably we need to do another follow up discussion after the book is out, likeable, badass. I’ll be waiting for it, reading it. I think it’s in September, right? September. Awesome. thank you again for being with me today and for this incredible chat.

Alison Fragale: Likewise. Again, I round to any time you want. I love it. Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Carl Dahlberg

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Carl Dahlberg, a physician innovator whose passion is solving important problems for real people.  Holding degrees from The University of Michigan Medical School and MIT Sloan School of Management Carl has a multifaceted background spanning technology, medicine, art and business.  He’s co-founder of the MIT Sloan Physicians Group and a mentor with the MIT Sandbox and UM6P Explorer innovation programs.  Carl blends medical proficiency with entrepreneurial spirit and relentless creativity to drive positive change in healthcare and beyond.

Carl, it is great to have you with me today!

Carl Dahlberg: Great to be here, thank you.

Naji Gehchan: I would love first to hear more about your personal story and what’s in between the lines of your journey.

Carl Dahlberg: Oh, I, uh, I always feel funny talking about my journey because it’s, I feel like sort of a, uh, pinball machine. I, I’ve had a whole, I’ve got kind of a weird background. Um, I started out as a computer nerd, uh, back in junior high school, before it was fashionable to be a nerd. And, uh, from there I went to college and I got a degree in computer science from the University of Michigan.

And I guess what I liked about working with computers was making things happen. Uh, you can give it instructions and tell it to do something and something exciting would happen. That always appealed to me. Um, from there, I worked out in Silicon Valley for a little while doing IT, uh, for a computer reseller.

And that was interesting. I love living in the Bay area. Uh, from there I went to Chicago and I worked in the financial, uh, derivatives trading industry, also doing IT for a while. And, uh, these were interesting years. Chicago was a fun place to live. And, and, uh, the trading industry is very, uh, how do I put this?

There’s a lot of human energy and making a trillion dollars change ends every day. And, uh, it was something that I just couldn’t get excited about. You know, the movement of money didn’t really matter to me. And I decided that I wanted to go to medical school. I ended up going back to my college, University of Michigan, where I kind of found that the people that most appealed to my personality were the emergency physicians.

I liked being the one to make a diagnosis and, uh, in emergency medicine, you never knew what you had to do next. You had some sort of problem and it might have been something that you had done many times, or it might be something completely new, but you had to interact positively in the situation. So I did my residency and then, uh, I moved out to Massachusetts and been practicing clinical emergency medicine for almost 20 years now.

And a few years ago, I started realizing that all that creativity and, and desire to innovate and solve problems that I liked about working with computers. Uh, just wasn’t, you know, uh, wasn’t being applied. I really looked at the way healthcare was being performed, and you watch the same problem being solved a few thousand times in a row, and you begin to, you know, shake your fist at it and think, can’t we just do something about this at a higher level?

And so, so it doesn’t happen again. Um, and that led me to get involved in a medical innovation event. Uh, there’s a whole bunch of, there’s a very good medical entrepreneurship and innovation community around Boston. Uh, And I kept meeting people that went to the Sloan School at MIT and found them very engaging.

And so I, I went there to get an MBA and training and entrepreneurship and global innovation. Uh, yeah, it’s kind of, it’s kind of a weird career among sort of ping ponging around different industries.

Naji Gehchan: Well, thanks a lot for sharing a card. It’s, uh, it’s a great journey. It’s not weird. It’s a great journey.

But I’m going to follow up on a question because you’ve been, as you said, your career span between tech, business, and medicine and kind of combining those. Is there, you feel any common thread in between all of these different experiences that you’ve had?

Carl Dahlberg: Yeah. I mean, I, I get excited about solving problems and, uh, I get most excited about solving important problems for real people.

I think this is a thing that drew me into emergency medicine is that, uh, you are, uh, whatever problem is in front of you is kind of by definition, the worst thing that has happened to that person, uh, in a while. And, uh, it’s an emergency, like they need something done with that. And I like the creativity of taking a situation and trying to make it better.

Um, and I think that that is why I didn’t stick with the financial industry because I like solving problems for people. Um,

Naji Gehchan: that’s the thread. I love that. Solving problem for people. And I, I’m an ER doc too, as you know, uh, it’s certainly, you feel that you’re solving a problem that is saving a life. And obviously in the healthcare industry broadly, this is what we, what we Uh, we, uh, we work for and this is what we do.

Uh, can I ask you what is the most exciting problem that you feel we will be solving in the next decade? Oh, boy.

Carl Dahlberg: Um, you know, I think there’s a total overhaul that needs to take place in the U. S. healthcare system. Um, This is not a specific problem that needs to be solved, but, uh, I think we have this sort of triple point where we’re spending an incredible amount of money, you know, far more than any other industrialized nation and getting very mediocre.

healthcare outcomes in terms of population health. You can, uh, you can measure that any number of ways. And we come out, you know, kind of the middle of the road when compared to other countries. And at the same point, uh, we’re same time, we’re burning out our healthcare, uh, workers, you know, physicians and nurses are, are leaving, uh, and honestly patients are firing us allopathic healthcare, uh, in frustration, you know, the systems that we’re creating, Aren’t solving the problems people have and I think the industry is the big problem is that the industry needs to be redesigned.

So it solves people problem better. And I think a lot of savings will come out of that. Uh, and that’s the problem I’m excited about solving right now.

Naji Gehchan: So can we dig into this? And I know you’ve been mentoring a lot of entrepreneurs, startups, obviously working in the healthcare space and trying to solve it.

Is there a single advice when you, uh, when you meet with those entrepreneurs? Who are solving those big issues that will help the society. Is there any advice that you would give them as they start this journey?

Carl Dahlberg: So every, every situation is different, but the things I mentor people on are, uh, sort of listening to the customers that, you know, talking to the people that are actually going to be using your solution to figure out, uh, what exactly the problem is as they see it.

And, uh, how they measure that and then designing a solution from there. Um, I think that’s a pretty consistent focus. I work with a lot of student teams at MIT and, and they’re very brilliant people, much smarter than I am. Um, but being brilliant often blinds you to, uh, sort of the listening that you have to do sometimes.

I think this will resonate with you as an emergency physician. You know, it doesn’t matter what you think is wrong with the patient. Um, what matters is what is wrong with the patient and you have to discover that and you can only do that by learning. Uh, so I think that’s the first lesson is to take your assumptions, uh, list them out so you know what you think and then put all that aside as you go listen and explore.

Naji Gehchan: I love this. Um, as you, um, as you’ve been doing this with several entrepreneurs, seeing startups and also through your, uh, amazing background of solving all over the time from IT to now saving lives, what is your biggest leadership lesson really between again, leading ER, And helping entrepreneurs and startups solve some of the most complex issues in the world.

Carl Dahlberg: So it’s funny that you ask that, you know, I, I, I didn’t used to think I was a leader in any way, you know, Hey, what do you do as an emergency physician? You’re not in charge of, might not be in charge of the department or the hospital or, but, uh, in emergency medicine, just working as a clinician, you lead people through, you know, some of the.

Most transformative experiences of their lives. You, you lead the team, uh, to align the incentives and. Uh get the nurses and the techs and and the radiologists and everybody else working on this problem any consultants you have Anyway, um, I think Aligning the incentives is the best model of leadership.

I have right now um I think that the old model of physician leadership is that the Physician has all the authority and all the knowledge and tells whatever everybody else to do and I think that’s very antiquated Um, I think modern leaders Are not The owners of intelligence and the owners of the plan that they, they embody the mission and that their main skills are to communicate the mission to the various participants or the various stakeholders or team members.

That, uh, you know, you bring the why and

Naji Gehchan: help the other people bring out the how. That’s powerful. Embodying the mission and aligning the incentives. I’m going to go to a section where I will give you a word and I would love your first reaction to it. The first, uh, the first one is innovation.

Carl Dahlberg: Innovation, creativity, and resilience.

What about entrepreneurship? So entrepreneurship is taking an idea or the idea of an innovation and actually turning it into something in the real world. To my mind that means solving an important problem for people. for people.

Naji Gehchan: So, so I, I love, I love how you always come back to not only the real problem, but for real people.

Can, can you expand a little bit more about this thread you have and this philosophy you have about, about it being for real people?

Carl Dahlberg: Uh, you know, when I, when I get involved in business, it’s an academic exercise for me. Um, I get most engaged when I am helping someone. I think that capitalism itself exists to serve the needs of people.

Uh, and, and this, I come to this perspective as a physician, uh, I have no problem with making a profit. Um, but I think that the organization should serve the needs of its customers, the needs of its employees, uh, and the needs of its stakeholders all together. And, uh, That makes healthcare a little different than other industries, right?

If you’re selling widgets, then you can sit back and say, I’m maximizing value to shareholders. I did my job, but I don’t think that’s enough in healthcare. And I think that we have too many people that view it that way. And, and it’s, it’s taking us healthcare off our mission.

Naji Gehchan: The third word is health equity.

Carl Dahlberg: So, Hmm. Hmm. Health equity is second nature to me. I, I think, I guess health, health equity to me means learning to see your own biases, your implicit biases that you don’t recognize you have. It’s kind of like learning to see your own eyeballs. Oh, which is tough and usually takes the assistance of somebody outside of you to do.

As an emergency physician, I provide health care without, you know, any knowledge of who can pay and who can’t. That doesn’t matter to me. It’s a fortunate perspective in the system. But I have to recognize that, you know, the places that I practice in the U. S., we have resources that other parts of the world don’t have.

Interestingly, one of those resources is not intelligence. You know, we are not the smartest people in the U. S. And, uh, I think that the creativity and the, the, the spirit of innovation that comes from working with limited resources, uh, is actually a great teacher and that we can all learn from that. Um, I’m not a fan of physicians that walk around saying, I know the best and I’m going to tell you how it is.

Uh, I’m much more of a, uh, a fan of a physician that says, here’s what I want to accomplish, and this is why, and how can we accomplish this together? Is that a reaction to that one?

Naji Gehchan: It’s a great, it’s a great reaction, and I relate to several things you said. The last one is spread love in organizations.

Carl Dahlberg: Oh, spreading love in organizations.

So, I’m a big fan of spreading joy in organizations. Love is a little nebulous to me, but joy, I understand instinctively. Um, you know, when you say go spreading love, you know, maybe you love your boss. That sounds weird. Do you love your employee? I think that empowering people to find joy in their practice.

Is is more on the mark. And when I say joy, you know, I’m in touch with my own joy when I’m solving problems for people like that is a joyful activity for me. It’s not always fun, by the way, there’s a often it’s confusion between joy and fun. Um, the two go hand in hand, but frequently you can be working on a really hard problem.

That’s really meaningful to you and not having much fun at it because you have to hit your head against a proverbial wall a few dozen times. Um. That makes sense to me that resilience and focus on the mission, uh, spreading love and organizations I think should be a natural by product of people finding joy in what they’re doing.

Naji Gehchan: I love this. Any final word of wisdom for healthcare leaders around the world?

Carl Dahlberg: Um, boy, I feel like, I feel like I have a lot of wisdom to offer. I just have, What I’ve experienced, I would say healthcare leaders, uh, should communicate and, and gather and bind together. I think there should be clinical input into leadership at all levels.

And because if you’re a healthcare leader, you know, your clinicians own the mission. They are the people that are enacting your mission. And if they’re not having input into the systems you’re creating, um, You’re potentially making a horrible mistake and you’ll never know unless you’re listening to them.Naji Gehchan: Well, thank you so much, Carl, for being with me today and this great chat.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Emilia McLaughlin

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Emilia McLaughlin, founder and CEO of kyron.bio, a startup based in Paris dedicated to pioneering tomorrow’s therapeutics. Originally from London, Emilia moved to Paris in 2017 to pursue a PhD in parasite molecular biology at the Institut Pasteur. Upon completing her PhD, she founded kyron.bio with the aim of enhancing the efficacy of protein therapeutics through innovative glycan modifications. Since its inception, Emilia has successfully recruited a world-class scientific team, established a state-of-the-art laboratory, secured core technology IP, and garnered over €1.2M in competitive grants from the French government and the EU. Additionally, she has raised €1.1M in equity funding. Currently, the company is testing its first therapeutic in human serum and has developed a robust pipeline of innovative products. In 2024, Emilia was recognized as a Woman in Leadership by the European Innovation Commission. She is passionate about empowering women to take on leadership roles and supports academics who aspire to transition into entrepreneurship.

Emilia, it is great to have you with me today!

Emilia McLaughlin: Thank you, Naji. Great to be here.

Naji Gehchan: I would love for us to hear more about your personal story.

What brought you to biology and now founding and leading a biotech?

Emilia McLaughlin: Yeah. Okay. Um, so I think I’ve always been very, very interested in people and, um, illnesses, medicine. I, I really strongly considered, um, being a doctor for a long time. Um, I don’t really enjoy being in hospitals and that was one of the things that put me off, but I, I really wanted to find a way to help kind of, um, deliver.

therapies to humans, whether that was me doing it personally or helping the kind of, um, the generation, generation of those medicines. And I, I thought a long time I went, I studied biochemistry and, um, I thought afterwards again about doing a grad scheme for, for medicine. Um, finally decided that it was not for me and that I wanted to pursue a more academic route.

Um, I fell into parasitology, um, while I was at UCL during my undergraduate and I ended up with a brilliant, um, professor, Professor Osborne, where I, I worked under him on the malaria parasite. And I absolutely loved that project because you never question why you go to work when you work on malaria, you know, half a million people die every year and it’s an incredibly, um, We need a lot of brains on this to work on this.

And I found it fascinating both from the biological side and also, um, from the human side as well. So that kind of led me into this world of parasitology. Um, I then wanted to continue in that field, um, and that led me to my PhD in, um, in parasite molecular biology at Institute Pasteur in Paris, where I looked at African sleeping sickness.

Um, I love my PhD, but I knew that I didn’t want to stay in the lab. I think at that point, I began to recognize there was a bit of a distance between the academic research and what was going on for people in the field. Um, and it felt that what I was doing, you know, spending hours on a microscope, looking, looking at tiny green dots, um, trying to count how many GFP there were or something.

I couldn’t see the translation and I’ve always been a people person and I love working with, with people. And I think that’s where. I didn’t know what I wanted to do when I finished my PhD. I’d never thought really about starting my own company. Um, and then entrepreneurship kind of crossed my path because, uh, actually due to a tech incubator that kind of had been contact in contact with me since the second year of my PhD.

And they were like, we think you should join. We think you’d be great. You know, they make it kind of no risk from the minute I joined them. The incubator is called entrepreneur first for people that know it. And they kind of put tech and business profiles together before they have an idea and before they have a team.

The minute I joined that incubator, I was like, this is the world I want to be in. This is absolutely fascinating. The pace, the impact, the, um, the possibilities, the excitement, being so people focused as well, you know, now my job all day, uh, day in, day out is talking to people, and I absolutely love that and what I, the work that we do is also for, for patient populations and for individuals.

And I think that’s always been really, really important for me. And whilst I loved the academic path. slightly lost that connection, especially where I was working on a rare parasitic disease that is basically in remission now. Um, the WHO doesn’t recognize it as a, as a public health concern anymore. So it’s like, well, yeah.

Well,

Naji Gehchan: thank you so much for sharing this. And I, what you’re framing at this really, I love how you said biology and humans. Uh, so, You know, as you were talking about what you do today as a, as a founder of, uh, of the biotech you’re leading, you said it’s mainly with people and human and discussing with them.

And obviously this is not, I would say what people would, the first thing would come to mind, uh, for startups and biotech, you know, like it’s more about the science, the discovery, what, what are you doing? So I love how you. framed it. I’m sure. And I know there’s a lot of science behind it, but I want to dig a little bit deeper on, on this aspect.

And how do you see the people aspect actually of the biotech as a leader?

Emilia McLaughlin: I think it’s absolutely central. I think it comes in a few axes. The first is in the people that you hire. Um, Um, and having a very, very strong team with you, um, and in being a leader to the people in the team that, that, that you’ve recruited, um, number one, so your job as the leader is to support them to, to be the best they can be.

Um, secondly, it comes in the external communications of the company and making sure that what you’re doing, um, is. There is a problem that you’re solving and someone needs what you’re working on because I think that it’s very easy as an academic biotech, you know, when people got academic backgrounds, just to solve scientific problems because they’re interesting and they’re challenging.

But that’s not what we’re trying to do. We’re trying to make an impact for people. So it’s really important that we’re constantly out there talking to patients, talking to physicians, talking to patient groups, talking to people in the pharma industry. Talking to people that have many more years than, than experience than anyone in our team does.

Um, because combined, that’s where we’re going to really be able to find where the pain points are and be able to make sure that any product that we develop is needed by the industry. And we’re not going to just develop something that someone else has gone and done anyway. You know, um, that’s the only way that you’re going to is by.

being people focused. And that’s what I believe.

Naji Gehchan: And really like focusing on this unmet need, as you said, and the people you hire. So if I, if I move to how, how did you build your team? How do you hire people? Uh, and how do you bring talent into your organization? I’d love to know your philosophy.

Emilia McLaughlin: Yeah. Um, I think hiring is one of the most important things for a startup success.

It’s, it’s incredibly challenging and it’s incredibly, um, It’s, it’s incredibly time consuming. The best advice I’ve ever been given was by another founder. And, um, am I allowed to swear on this podcast?

Naji Gehchan: Be yourself.

Emilia McLaughlin: Yeah. Well, basically he said, if it’s not a fuck, yes, it’s a no, um, that’s like, I’m constantly reminding my team when we’re going through the recruitment process and we’ve been recruiting for six months, nine months, whatever.

It’s taking forever to find the perfect profile. But I think hiring is somewhere you have to be a perfectionist in a startup. You’re going to get it wrong. Yeah. People change, people have different needs, people’s things, you know, their life changes as well. But I think that you need to really follow your gut in terms of who you think can cope and who can cope in an academic lab is very different to who can cope in a startup.

You really need to Cut out all sorts of perfectionism out of people because perfectionism kills speed in a startup. And so I’ve learned a lot in my personal journey about the traits that I’m looking for in someone. I want everyone in the team to be an entrepreneur. I want everyone in the team to be a hustler.

These are not necessarily easy things to find, especially when you’re trying to recruit directly out of PhD, but they, they definitely exist, but you’ve just got to hunt for them. And it takes time when you find the right people. It’s amazing. And it’s worth waiting.

Naji Gehchan: I love the, what you shared and I usually frame it and if there is a doubt, there is no doubt, like whenever you feel a doubt in it.

The more polite way to put it. Yeah, probably. So, you know, like probably the S side. Uh, well, you, you talked about some of the trade, entrepreneur, hustler, Obviously, like the background of science, et cetera. Um, so during the interview, like I’d love, since you’re passionate about this, like, how do you assess this?

Have you made wrong hires? What is the wrong hire? Is it the wrong casting? I’d love to understand how you think about these only have successes. Please let me know how you did this.

Emilia McLaughlin: Of course, I haven’t only had success. There’s another founder. Another piece of advice I had was it’s about a 60 percent success rate.

And I see, I find that as well. Um, and that if you’re hitting that, it’s pretty good. Um, I think I’m getting, we’re really learning as a team. Um, it’s not just me, it’s other members of the team as well. We’re learning to really assess. Um, what does someone truly and deeply want from their life? Um, and are they prepared to work out of their comfort zone and go the extra mile?

And I think there’s a lot of ways that you can assess that. You can assess it practically by putting them out of their comfort zone in a case study and saying, okay, come back to me with, with answers to these things in 48 hours and see how they cope with it. You can assess it by putting them on the spot with kind of more personal questions as well.

I like to like really ask people about, um, about more personal angles of how they cope with stress and things like that in interviews. So I think there’s, there’s a couple of ways that you can do that, but above anything, I think you have to listen to your gut as well, because while someone might on paper look perfect, if your gut feeling is that they’re really not just going to be able to handle it, then You know, you have to trust that and go with it.

And, and I need to also trust other people in my team when they’re recruiting that, that if their gut’s telling them, no, it’s not going to work, then that that’s, then that’s a no, you know, if it’s not, if it’s not 10s across the board, it’s, it’s a no.

Naji Gehchan: So you, you are also passionate about, uh, helping transitions from academic, specifically women into, uh, into entrepreneurship and, um, building startups.

Uh, what, what is your biggest advice for, uh, From your learning experience, you would give people who want to do this jump?

Emilia McLaughlin: I would just say be brave and take the leap. I think particularly with academics, we often feel that we need to get everything right. And we need to have everything, we have to have all the answers figured out. But you really don’t, nobody does, and you’ve just got to throw yourself in and do the absolute best that you can do in, in, in, in any moment.

Nobody knows the future. Nobody knows what’s going to happen. You know, we’ve got to just try our best, but it’s the opportunity cost of not trying, um, I think is, is where you, where you’re missing out. If you don’t put yourself out there, I think. I’m particularly passionate about supporting other women in this transition, because I think women have a tendency to be more risk averse.

And, you know, a lot of people, when I started my company, particularly female colleagues would say to me, you’re so brave. Wow. You’re so brave. Why are you doing that? And I’d look at them. I said, why, why am I so brave? What have I done? Like, you know, I haven’t jumped off a, you know, I’m not jumping off a. Um, a bungee jump or something.

I’m, I’m just trying, you know, it’s not, it’s not, I’m not, uh, it’s about your perception of risk for them. They, they were seeing all the risks, but none of the upside. And it’s like changing that mindset of like, yeah, but the possibilities are also incredible. So I don’t see it as, uh, as brave. I just see it as like, it’s, it’s an opportunity that you’ve got to grasp.

And I see

Naji Gehchan: that you would do it again and again. And I love this energy that is transmissible. Let me ask you something specifically about Women Founder. You know in the US, and I’d love to hear your thoughts about it globally and in France as you’re in France now. It’s, it’s unfortunately still hard, underrepresented and underfunded, even though I think like more and more data is showing that, uh, companies founded by women and led by women performs better.

So how is it in France? How do you see things in Europe? Are we getting better there? And how are you advocating for that?

Emilia McLaughlin: Yeah, I think it’s incredibly similar. It’s across the board. You know, it’s 1 percent of companies are founded by 100 percent female founded companies. And only a small proportion more are male and female co founded.

But, you know, it’s a very small proportion of companies that are just led by women. I think, um, that that there is challenges with the ecosystem, but I also think that there’s a lot to do with that risk taking mindset of female individuals and how we can support them to feel comfortable. You know, I’m part of a women in leadership program.

And when we get together as a group of women, you just notice how How much we were often afraid to make mistakes, I guess we want to have all the answers figured out and how to basically encourage women to just be more bullish on things, just to go for it. Even if they don’t have all of the answers and they’re not perfect, how can we just say, just give it a try?

You know, it’s worth, it’s, it’s worth the risk, take the leap. And I think we’re not taught as a society to take, to, to, to push ourselves in that way so much. Um, And that of course applies to many men as well. It’s not only women, but I think that that, that partly contributes. And then there’s other challenges around, you know, job instability of running a startup.

You know, there’s, there’s not much support for that. I do think as a, as a female founder, I get additional support actually. Um, I would say like, I’m very well supported by the European innovation commission. They’ve been incredibly supportive to me. I’ve got a I’ve got a, um, Women Tech EU grant from them that specifically, um, supports female deep tech founders in the EU.

Um, and through that, I’m mentored by some amazing women as well. Um, and that really helps me. So I think there’s things that I’ve been able to access and benefit because I’m a female founder. Um. That said, you know, the pharma industry, a lot of the leaders are, are led by, by most of the leaders in the pharma industry are men.

So I’m, I’m operating in a very heavily male dominated, um, industry when we look at the leadership side and that is challenging, but I’d say in the startup world, it’s beginning to become a more supportive ecosystem, but I think we need change at the level of empowering women to, to feel that they can take the risk and maybe some way of.

mitigating that it feels like such an extreme career risk, I think, for some women to take the leap to be a founder. So how can we support them in that?

Naji Gehchan: Certainly. And, uh, yeah, I’m, I’m obviously also passionate about this and what we can do, uh, not only from a startup, uh, I see those moves happening in a lot in Europe and the US to, uh, support for, uh, founders startups, but the, the it’s better, but as you said, there is a long road and certainly also for corporate where, uh, this is one of the biggest.

focus that we should be having as leaders, uh, empowering women. Um, how, how do you know when, if we move into the science part and just for people to know also about what you do, uh, within your company from a biotech standpoint, how would you define what you do in a simple, in a simple way? What are you working on?

Emilia McLaughlin: So we work on sugars. So sugars are carbohydrate molecules or glycans that added to the surface of, um, of protein drugs that are really important, um, for the efficacy and the longevity. So how well a drug performs and what we have at Chiron bio is a unique set of tools to control those sugars. So, um, physically how long they are, how many of them they are and how they behave in the human body.

And we’re applying this, uh, specifically to autoimmune diseases, whether it’s a, whether it’s a huge unmet need, um, less than 50 percent of patients are in remission from disease. And we’re using these innovative approaches to sugar engineering to design versions of drugs that have much, um, higher efficacy in, in, in patients.

Um, and so that, You know, we can target some of these major issues in the industry of, of patients being in chronic pain for, for life at some times. So developing much more, um, efficacious treatments for the patients.

Naji Gehchan: This is great and certainly impactful. What is currently your biggest challenge? Is it scientific?

Is it funding? What is your biggest challenge as an organization?

Emilia McLaughlin: That’s a great question. Um, I mean, there are so many challenges when you’re on the laptop. Um, they range from very, very small things to very, very big things. Um, I think the biggest challenge for us globally is getting the commercial development right, like making sure that we’re developing our, yeah, it’s our, it’s making sure that we’re really, um, yeah, it’s, it’s the commercial development side.

I can, I can dive into more of that if you want, but, um, it’s, it’s the making sure that we are developing a drug that rheumatologists will say, yes, this is going in my patient.

Naji Gehchan: Well, this is, this is, I love that you’re framing it that way. And can you remind us which stage you are, if it’s, Public, obviously, like, I don’t want you to go to things.

You don’t want to share, but

Emilia McLaughlin: yeah, you

Naji Gehchan: are. And why so early in your stage, you’re starting to think about that. That’s, that’s a great point. Uh, actually I talked with some biotechs. They, you know, they are focused on their pre clin and the innovation they have, and they don’t think about like, let’s make sure that it gets into patient’s hands at the end of the day, because this is what we should all be doing.

Great. So I love that you framed it that way. So can you help us understand where are you in the journey?

Emilia McLaughlin: Yeah, we’re preclinical, but I think we, you know, we, we have a set of tools that we can apply in a lot of different ways. And so my job as a CEO is to find the absolute best path where we can apply this.

And I think probably contrary to other biotechs where they’re spinning out one specific molecule and they’re fixed on their path, you know, they can’t do that. they can’t shift at all. We have a lot of potential with what we’re doing for the sugar engineering. There are so many ways we can apply this in the, you know, in, in the, in the pipeline for us, but for our first kind of commercial success, we need to get it right.

And that’s why it’s very, very important that. We are choosing the best application. That’s going to have the biggest impact in the clinic. Um, so, and for me, it’s really the clinicians, because those are the people that make the decision. Of course, in the U S there’s also the healthcare providers that we have to think about the pricing.

We have to think about this a lot, because if we can’t be competitive on pricing, no, one’s going to want our, our eventual drugs. So I think it, it’s very important for me that we’re building something that is for patients. And the person that will decide whether it goes to a patient will be the clinician.

So that’s where we’re very focused on, on that side of things, uh, in understanding, um, how can we make things better for the patients?

Naji Gehchan: So I mean, yeah, I would, uh, move now to a section where I’m going to give you a word and I would love your first reaction to it.

Emilia McLaughlin: Okay.

Naji Gehchan: The first one is leadership.

Emilia McLaughlin: I would say freedom.

Naji Gehchan: Oh, I want to, uh, it’s the first time I hear this reaction after 130 plus interviews, I’d love to learn more about it.

Emilia McLaughlin: You want me to expand?

Naji Gehchan: Yes.

Emilia McLaughlin: Yeah. Um, I think like being a leader is, there’s a lot of freedom in that. Like you, first of all, you’re, you’re, you’re, you’re your own boss, but also you have your freedom to run your team and, and, and do things be dynamic, be agile in the way that, that.

That you want to do it. I think there’s a lot of freedom in being a leader. Um, and you, you get to, I mean, I’m, I’m really talking about being a CEO here, but where you get to, to choose your team, you, you get to, you know, design how the team runs and things like that. And there’s an awful lot of freedom there.

Like the, the kind of

Naji Gehchan: what about entrepreneurship,

Emilia McLaughlin: uh, excitement,

Naji Gehchan: biotech,

Emilia McLaughlin: um, patients.

Naji Gehchan: The last one is spread love and organizations.

Emilia McLaughlin: Um, leadership would come in.

Naji Gehchan: Can you expand on that?

Emilia McLaughlin: Well, I mean, it’s what I’m thinking, what comes to mind when I think about your podcast and kind of building up like leadership and, and, and hearing from different leaders.

Um, but I think leadership is also about spreading love in organizations and, and within teams as well, and making sure we’re working together in a collaborative

Naji Gehchan: way. Any final word of wisdom for healthcare leaders around the world?

Emilia McLaughlin: Um, I think it’s just keeping the patients, um, at the forefront of what we’re doing.

I think it’s really, really important. Um, we have some amazing innovations out there. How can we get these to patients as fast as, as fast as possible?

Naji Gehchan: Well, thank you so much, Emilia, for being with me today. And a huge congrats to what you’ve achieved already with, um, with your company. And wishing you all the best in the next steps.

Thank you again.

Emilia McLaughlin: Great to chat today.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jonathan Levy

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. I am joined today by Jonathan Levy CEO of Pepkon. Jonathan is a Pharmacist from University of Paris with a masters in management from ESSEC Business school. He has worked in various environment of the healthcare sector in France from pharmacy to hospital, and also in big pharma and startups. His last role before joining Pepkon was within Truffle Capital a French VC; where he participated in several investments in biotech and also company creations, m&a and licensing deals. Two years ago Jonathan joined PepKon, a startup developing first in class therapeutic peptides in oncology, first as a COO, and now leading the company as its CEO.

Jonathan Levy: Thank you, Naji. I’m very happy to be here with you.

Naji Gehchan: Well, first, congratulations again on winning the first prize of the Boston Biotech Summit in 2024. Before we go there and what you do at Pepcon, I’m really interested and eager to hear more about your personal story, what brought you to pharma, healthcare, and now becoming a CEO in a biotech.

Jonathan Levy: Thank you. Okay. So, yes, so when I was young, I was, I was very interested in science, uh, medicine, and I think it’s, so helping others.

Uh, I really was looking up to my, uh, family members, like my grandfather and my aunt who had that DNA of being a doctor, you know, and helping others. And uh, and in the same time, I was very interested in the business aspect, leading companies and wanting to have a positive impact with my hands on, uh, you know, always daring to be in very challenging situations.

Uh, because that’s, I feel that’s where you learn the most. And so I have the example of my, uh, I mean, several entrepreneurs around me, like my father was CEO of a big company. So for me, being an entrepreneur in the biotech field is really a perfect mix of my aspiration in medical and business field.

Naji Gehchan: Thanks for sharing that. Can you tell us, uh, that now that you’re doing it, I love how you’re framing it between science and leading organization and the biotech feels like the best of both were to. Can you share with us what have you learned so far as a leader and as a, as an individual who has built this company from early on?

Jonathan Levy: First, I’d like to say that I didn’t create the company, I, I joined it a few months after it was created. And, uh, I think the first thing I’ve learned is, uh, I mean, I don’t know if that’s something you learned, but it’s humility because I’ve joined a project that was, uh, Uh, I’ve had a very, like a breakthrough science with a few amazing people.

And I, I had to like recruit some, uh, other, uh, great skilled people, you know? So the first thing for me was big, humble, uh, listening, learning. And then after a period, I. And I started to really, uh, take the leadership, uh, be the strategic vision, uh, take people with me, you know, and, uh, of course take the decisions.

So that’s why I, uh, I became a CEO of the company and, um, and I think it was an amazing experience for me to, to, to become a leader as a very young age because I learned, uh, a lot and very fast.

Naji Gehchan: So as you’re going through the journey, you know, I always said like science humbles us. I love that you started with this. Like there’s the humidity that you’re building, I imagine by building the team, as you said, but also with the science you’re, um, you’re starting, you have great science so far preclinically.

Can you tell us a little bit more about what you do and what you’re trying to solve at Pepcon? Sure.

Jonathan Levy: So at Pepcon, uh, we develop therapeutic peptides, which come from Uh, the academic research of, uh, the lab of Professor Philippe Caroyan, so it’s French academic research. And we developed first in class therapeutic peptide.

What’s very unique is we’re exploring a new, uh, cell based pathway, which targets CD47 in a very selective way, which means that it’s killing cancer cells while sparing healthy cells. It’s very different from what’s currently in development. And we, and the lead product we have demonstrated efficacy on several indications, including solid tumors.

Uh, several kind of leukemia also, even refractory patients. Uh, so we’re now conducting preclinical studies on animals and our goal is to start a first in human clinical trial, uh, end of next year. For that, we need a first to raise a Series A. And as of now, we’ve, uh, been lucky enough to raise 5 million euros, including several grants from a BPI in France, which is a look.

Naji Gehchan: Well, it’s also a testament of your work, you know, and I wouldn’t just frame it as like, even if you’re doing it. Um, so as you look through, you’re saying, but actually going through series A, building a phase, uh, phase one with multiple indication in oncology. Uh, as a CEO today of the organization, what is your biggest challenge and what is your biggest opportunity you see for the next, uh, month?

Jonathan Levy: So I think every biotech has the same challenge. It’s a race against time with limited resources and really like daily ups and downs. So I think one of the main challenges is raising money. And it’s also raising money and differentiate yourself on the scientific aspect. in a very competitive and international environment.

And I think it’s in, in, uh, oncology, it’s very, uh, I mean, oncology is really a very competitive field. You really have to demonstrate the differentiation and you need to convince not only the doctors, but also the investors, the pharma company, and, uh, uh, you have to fit with the strategy, you know, the pharma companies and also take.

In consideration, uh, the, the real data you have. So it’s really a mixed of, uh, of, uh, uh, the data, the pharma, uh, need the business investors. And, uh, of course, and what’s most, most important is, uh, the patient because it’s, it was started with patients at the end. The, the common goal is, uh, bringing patients, uh, safer and more effective treatment.

And that’s really the, uh, the, the goal of, uh, of PEPCON, and, uh, I would say another challenge. I think it’s a common, uh, common one for CEO, it’s recruiting the best team, the best skilled people. Of course, uh, you bring to the team people who are way smarter than you with skills that you don’t have yourself.

And the job of the CEO is to bring out the best of each of us, of each of the team member, uh, motivate them, inspire them to, to, to be with you in this, uh, in this journey. And then, uh, take the best decisions for the, for the company. So, uh, yeah, in the end, I’m very, I mean, I’d say it’s because you asked for the challenge, but there’s the opportunity to, I say the opportunity is that I’m just lucky to be part of the, this project, which is fascinating.

I’m learning every day with people who are, uh, way smarter and experienced than me, and, uh, I think the opportunity that they motivated every day. By this goal, which is, um, really a noble cause, which is, which I feel is bigger than, uh, than this. And

Naji Gehchan: this is, this is crucial as you’re saying, it’s the core of what we do in this industry, uh, trying to bring new hope, new medicines for several people who are in need, uh, for, for better treatments.

Uh, you, you did a great segue to my next question about team. So as you’ve been building your team, growing your team. within the startup. How do you think about it as you scale up your company and move from a stage to another? Um,

Jonathan Levy: so first, as I told you, the main thing is, uh, is to bring to the team, people who are very skilled, but it’s also bring people who have the same motivation and values. So, so we share the common goal, you know, of, of treating patients. And, uh, uh, we also look at personality and soft skill because we really need the team to be, uh, working together well in order to, to advance the project.

So yeah.

Naji Gehchan: Perfect combination of skills. And as you’re saying, uh, focusing on having the shared purpose, you said, and the shared values with your organization. Is it when you think about it, I know for the Boston summit, you came to Boston, where you won the prize. Is there like. Top line differences that you felt between the ecosystem that you have in France and in Europe compared to the one you saw in Boston?

Jonathan Levy: Uh, yeah, of course, Boston is really like when you go there, you arrive there, you feel that there is a huge ecosystem in a very small place with all the investor or the pharma startups and all the best hospitals. So I think the combination of All these very, uh, smart people in the healthcare sector is really, uh, a great opportunity to move the projects, maybe, uh, faster and, uh, and, uh, but I would say that in France, so we have a great ecosystem, which is, uh, growing up, um, more and more.

And we also have. Uh, great, uh, financing opportunities in terms of non divertive opportunities. So, um, uh, I’d say that, uh, the Boston ecosystem will be a great next step for us. And that today we, we are, uh, well established in the French ecosystem and that we have many great opportunities here in France.

Naji Gehchan: No, for sure. But I’m biased. I’m French too. But it’s, I think the science has no limits, has no frontiers, and you guys have great science and great teams working on this science to bring it to people. So wishing you all the best in this journey. I’m going to move now to a section where I will give you a word and I would love your reaction to it.

So the first one is leadership.

Jonathan Levy: As I said before, first is being humble, listening to people in the team, and then, uh, providing really a strategic direction that motivate them to, uh, give the best, follow you and, um, and, uh, you really also have to take the decision for the team in the end. It’s even if people give you a lot of advices, a lot of information, it’s you who have to handle the decision.

and give the example and the vision. Yeah. Second one is innovation.

Uh, I say innovation in, in healthcare is, uh, not some thing. It’s like not only something new. It’s, uh, it’s not only an invention it’s, Something that is new, but that also will have, uh, will be useful for patients that will make their life better. And that’s what we, of course, all work for. Um, I’d say that, uh, we’re lucky to have very smart people in the lab.

Very smart scientists with amazing, uh, inventions and, uh, to make them innovation, you need to take them out of the lab and bring them to, to patient. And, uh, that’s, uh, that’s the job. That’s the job of a company.

The third one is VC VC. You like venture capital. Yeah. Um, venture capital is, uh, necessary because you can’t Advance a project in biotech with without money. Uh, not easy to convince because they are very smart and they have smart analyst. Uh, but I guess they have the same goal on us to bring, uh, uh, value, to create value, but also to bring, uh, an innovations to patients.

Naji Gehchan: The last one is spread glove in organizations.

Jonathan Levy: Um, I’d say so spread love for me is to grow, uh, to help people around you grow as well. So to share your experience to help people help them be happy and they, um, achieve their personal goals and ambitions. Um But with the aim, like the common aim to, to reach a shared goal, which is, as I said before, bigger than every individual.

And that we can, we can only achieve by working together as a team, with the team, but also with partners, voters, investors, and of course patients. Uh, we, I mean, yeah,

Naji Gehchan: that’s it. Any final word of wisdom gen for healthcare leaders around the world?

Jonathan Levy: I don’t know if I , I have wisdom to share, but I taste that. I, I’d say that in, uh, in, in oncology, uh, but also in other, uh, disease. We all have friend or are relative who are sick, who have cancer. So our common goal is, uh, to help them, uh, to bring, uh, something new for, to, to increase the life of patients. I think it’s, uh, for us, it’s more than a job.

It’s, uh, it’s a patient, it’s, it’s a mission. And, uh, I guess together we, we’re going to, to, I mean, we aim to, to enhance, to advance science, but also advance, uh, uh, health care. And, uh, regarding that. Very often, you know, we have some, uh, um, started competition and I never look at my, uh, I mean, colleagues as competitors.

Really. I think there is, uh, uh, there is a need for everyone to, to bring its science and there, and there is not only one company that we reach. reach the goal, it will, uh, will need everyone.

Naji Gehchan: This is a great way to wrap up this great conversation. I love how you said it: It’s more than a job.

It’s a mission. And it’s so true. We, all of us, Share this mission to hopefully be able to bring more life To patients and more years to their life too. So thank you so much Jonathan for being with me today.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Anthony Yanni

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I’m Naji, your host, joined today by Anthony Yanni Senior Vice President and Global Head of Patient Centricity at Astellas Pharma. Anthony practiced Patient Centricity as a doctor and drug developer before the term even existed – by listening to patients and applying what he learned to offer better care. Now a veteran of senior leadership roles in hospitals and industry, Anthony is among the world’s leading advocates of Patient Centricity as a proven model for healthcare delivery and medicines development. In articles, interviews, talks, and now a book, he reveals Patient Centricity as an overdue disruption that will improve and speed up the treatments many people are waiting for.

Anthony Yanni: Oh, thank you, Naji. It’s great to be here.

Naji Gehchan: I’d love first to hear more about your personal story before going to patient centricity and really why you became a physician and what brought you to the industry and now being an executive and thought leader.

Anthony Yanni: Yeah, so, you know, my journey began a long, long time ago, um, when I decided I wanted to go into healthcare and become a physician. And, um, when I went to medical school, my focus was really on how do I spend as much time with patients? I was very, much energized by the interaction physicians had with patients in the exam room with their family members.

And so, when I graduated medical school, I did a residency in internal medicine, and I spent over 12 years working directly with patients in the exam room at the bedside intensive care unit, all the aspects of patient care that most of us are familiar with from, uh, internal medicine specialists. It was just an amazing experience.

I loved every minute of spending time in the exam room and talking to patients and their families. From that role, I also had an interest in business, and I, uh, subsequently became chief of internal medicine and then chief medical officer of a hospital system, which really gave me a perspective on the delivery of care.

In a broader sense, uh, how do systems deliver care? How do you manage systems? How do you deal with regulations and governments and payers? Um, and so I was really fortunate to see health care from the exam room, from the administration of hospital systems and the delivery of care. And then from there I went on into pharma, first working in regular clinical development role, writing protocols and developing medicines, and then finally into what is now patient centricity, uh, which, um, again, I’ve been in this space for, uh, well over 12 or 13 years.

As well, we could talk more about that.

Naji Gehchan: Well, thanks for sharing, uh, uh, Anthony, uh, you transitioned from being a clinician to the industry. And so you, you said the very early days of medicine, you were looking how to spend most of the time with, uh, with patients. So I I’d love if you go back in time, what would be your biggest advice you would give to yourself?

As you did this transition.

Anthony Yanni: Yeah, it’s it’s actually I talk about this in the book as well. And this idea of always be open to opportunities. I think I’ve tried to follow that path in my career. You know, you always want to have a plan. You always want to understand where it is. You want to end up, but always be open to change into opportunities that might Okay.

Not be something that was on your mind prior, but gives you an opportunity to do something that’s exciting and, and, um, and, uh, and gives you energy. And so that’s sort of how I approached the transition from clinical practice into hospital administration from hospital administration into industry. Each time I saw an opportunity to have an impact on patients, and that’s what really my, was my baseline focus.

Naji Gehchan: I love it. Opportunity to have an impact on patients. So let’s talk about patients and patient centricity. So it’s your focus, your passion, your obviously publishing, uh, around it for several, uh, years. And now a book, uh, can tell us, well, the name of the book is a Bandana and a Blue Hat. So let’s start a Blue Bird Band.

And a Bluebird. Yeah, A Bandana and a Bluebird. Um, so let’s start first by defining what you mean by patient

Anthony Yanni: centricity. So patient centricity has been a term that’s been sort of used over the last maybe five or seven years, and I think it’s been used in different ways. So I define patient centricity in two ways.

One is an operational definition. It’s the, uh, active integration of patient insights into all decisions leading to patient solutions. So the patient takes part in all of the activities when we’re developing new medicines, new solutions for them. And their inputs help us to make different decisions than we would have if we had not engaged and learned from them.

The second definition is a cultural one. It’s the conscious awareness of the patient in every role, every day, and in every activity inside of a company. Both of those definitions are critical if we are truly going to have a patient centric process that changes the way we develop solutions and changes the way we work together with patients and patient groups.

Naji Gehchan: So can we go on each of one and how as leaders we can influence each of one? So the first one, as you’re saying is, uh, if I did to make it in a simple way, correct me if I’m wrong, I’m thinking One is external. So how to make sure that the insights and the voices are of patients are influencing all the different steps you said from drug development to commercialization.

And then the other one is the internal work to make sure that we are making decisions based on what’s best for patients. So if we, can you give us some examples, use cases and how as leaders we can ensure both are going forward hand in

Anthony Yanni: hand? So I would define it just slightly differently. I think you’re right that it has to be an internal and external component, but I define it in two categories of work.

One is operational work, meaning how do you, how do you make actionable the patient insight? So for instance, many companies might go out and ask patients their opinions about certain diseases and certain treatments. But if you don’t connect that to action. We haven’t changed the way the next generation of solutions are being developed.

We’ve done part of the work, but not finished the work. Patient centricity is more than asking patients for their advice or their input. Patient centricity is asking for it and then utilizing it. So that we change the way we make decisions. So that’s the first piece. Operationally, how are we utilizing patient insights to change the way we develop medicines?

The second piece is the foundational piece. It’s the culture of the organization. The culture piece is what makes the act, the operational piece sustainable. So if you have, we have five teams that were four teams that work on the operational component inside of Estella’s and one team that focuses on the culture.

But if we didn’t have a cultural piece of the entire organization wasn’t saying every day that when I go to work, it’s for the patient. My job is to deliver solutions. you know, with patients for patients, the operational piece wouldn’t be sustainable. So what we do is we create a culture where everyone understands the focus of their work, the purpose of the day.

And that also helps with organizational recruitment and retention satisfaction at work. So there’s a whole benefit to the cultural piece. But if you can keep the cultural piece positive, the operational piece that you’ve created will be sustainable. Both of those are critical to having a patient centricity function that’s, that is impactful to patients.

Naji Gehchan: This, this is really great and I deeply believe in this, like, driven by purpose, obviously, for, for us to deliver for the patients we serve. Uh, are there any tips, example, as we go through it? Because both of us know when we’re leading large cross functional teams, and I’m assuming, but correct me if I’m wrong, the culture you’re talking about is really a cross functional culture.

the organization cross functionally, not only one, not only development, not only marketing, MetaFair, like I, are you thinking about it cross functionally? And if it’s the case, do you have any good examples where several times teams are so taken in the daily tasks and things we need to deliver that Patients become remote somehow, unfortunately.

So how can you remind people? How do you do it in a tactical way for your people across the organization to keep this always in mind? Yeah, so

Anthony Yanni: it’s, it’s absolutely true. It’s absolutely critical that it involves every geography, every role, every day. That’s the way a culture is built and sustained. So we do engage everyone from researchers to development people, commercial folks.

As well as finance and HR team members, everyone should understand that their role is critical to the work that we’re doing. The way, the way we did this is, you know, the how is creating cultural programs that are, that transition from passive to active. So many companies have Great. Um, you know, uh, pictures on their walls to talk about the culture they wish they had.

That narrative piece doesn’t last very long. It just becomes wall art after a while. If you don’t connect it to active ways, the team members can participate. and remind themselves and continue to learn that they are part of a culture that’s unique and we’re privileged to be part of. So, we have active programs inside of the company that everyone, everywhere can participate in, including a patient centricity university, which is a curriculum based learning opportunity for certification centricity, where you can participate in each level, grow, and ultimately in the final Um, in the final certification level, you can come back and teach the organization what you’ve done.

That was unique in delivering a patient centric approach to solve a problem. And then you become part of the teaching faculty of this university. So going from a passive to active culture is the key in any industry to having a sustainable, positive culture and impact.

Naji Gehchan: Certainly living it as you’re saying, living it with actions.

Passive to active, uh, when you’re, do you have any good, strong example? I’m sure you do on where this culture actually enabled what you said operationally can be done for patients. If there’s one you’re really proud about that you literally changed how we think about patients and one of our processes in the

Anthony Yanni: pharma industry.

Yeah, that’s a great question. And I I’m so proud of so many things. I can tell you that we have teams, the four teams that are active in the operational. part of patient centricity. We have a team that specializes working with research teams. We have a team that specializes in understanding the patient in the real world setting.

So they’re working with development and medical teams and commercial teams. We have a team that specializes in behavior, um, understanding the patient, um, in their interaction with the healthcare system, the healthcare providers, their caregiver. And we have a team that works with developing relationships with patients.

When we started, Each of these teams was meant to parallel the entire discovery to delivery system that exists in pharma. So, for instance, that team that works with the researchers, we have transitioned from starting to work with them to them requiring part, requiring their teams to, to engage our teams before they make decisions on the molecules.

They actually ask about. and regularly want to understand the exam room approach for the treatment of the disease they’re thinking about in the research lab. The commercial teams, when they’re talking about patients are talking about products. We don’t as a rule, patient centricity is brand agnostic. We don’t work with any brands.

We’re not salespeople. We bring the patient into the system so that all the teams can work more efficiently. But you know, I’ve been in rooms with commercial teams where they talk about Not how many sales they’re going to have in a region, but how many patients can be treated. How many patients are, you know, are, are waiting for this particular, um, solution.

I mean, that’s remarkable when you start to hear folks inside of an organization talk about patients first. Um, regardless of the role that they’re playing in. Many of these roles are highly technical, as you know, but to bring it back to the patient, it’s remarkable. And just as an aside, just as a quantitative measure, we, um, do pulse surveys periodically.

And the last pulse survey has been a while back now, um, just to level set the pulse survey nationally, internationally, globally, and in the U. S. The positivity rate of employees is In various industries, across industries is about 18 or 19%, meaning are you do you feel positive about the role you’re in? 18, 19%.

That was a Gallup poll in September of 2023. We did a pulse survey and 80 percent of the team members believe they were contributing to a patient solution. 80%. That’s a remarkable result. Of not just what we’re doing, but the belief, the true belief that they know they’re contributing in the work that they do.

And it’s important

Naji Gehchan: that it is remarkable. And I certainly relate to that and believe in this. Right. And as you’re saying, we, uh, we are all in this industry for for a noble purpose and being reminded day by day why we wake up and each one of us has this part. to at the end get it to patients. So I love how you’re framing it and where you’re going.

And ultimately, yeah, all that we do is. to make life better for, for those patients who need our treatment. So it’s, it’s really great work that you’re doing with, uh, with your teams. Thanks for sharing this. Any tech, uh, advances when you think about patient centricity that you’re, if you look at the future, the next decade, there’s a lot of discussions about not only, technology in life sciences, but also computational science, et cetera.

Is there any tech that you’re really excited about and you think that will transform and improve patient centricity?

Anthony Yanni: I think There are two specific areas that probably need to be addressed regularly. First is, I think the technology of virtual reality, augmented reality, bring opportunities for us to show internally or to share internally the patient experience more specifically.

We’ve done that with VR, uh, and patients who have impaired sight. I think that changes the game as far as how we understand the work that we’re doing. The people that are waiting for solutions and the importance of us doing it in the most efficient way possible. Um, and it changes the, the, the, the internal teams understanding of, of really, even if you believe wholly what we’re doing, it changes the depth of the understanding just to have that small little experience.

that patients might have. As small as it is, it helps for us to understand it. The second thing that always has to be addressed these days is, is um, artificial intelligence, AI. I think there’s this excitement about the opportunity and I do think it, it does present an exciting future for understanding the patient experience, but I am very cautious when it comes to that.

I think we have to be very careful. As it is deployed to understand what are the impacts of larger data sets. Large, large amounts of data does not necessarily mean better information. And sometimes larger data sets can actually confuse the issue and confirm things that you want, wish were true, and maybe not necessarily give us the truth of a larger population.

I think we need to accept the fact that this is something that’s going to happen. We need to understand. before we try to use these larger data sets in this artificial intelligence as to what is specifically the question we’re asking. How are we mining this information? How are we going to review this information to apply it appropriately?

And how do we most, most importantly protect patient privacy? at all costs because that’s the, that’s what they deserve with this most precious pieces of information. Um, the, the other thing with, um, AI is that it will never take the place of live interactions with patients. You need to be in the room or these days maybe on Zoom to talk to people to understand what it is.

that is important to them. As the conversation progresses, it can’t just be a static question that’s answered on a form in or in a data in a data lake that is that is captured. I want to see that patient. I want to understand their life. I want to understand their context. And I talk a lot about this In the book about context being incredibly important behavior being incredibly important.

We need to understand that each patient is different and while large amounts of data are going to be necessary because we can’t talk to a million patients talking to patients does add unique and valuable information beyond simply tables of information.

Naji Gehchan: So I want to move us now to a section where I’ll give you a word. It’s And I would love your first reaction to it. The first one is leadership.

Anthony Yanni: Leadership is a balance. Can I give more than a single word answer or can I, okay, good. I didn’t know if I was supposed to just give one word here. I think leadership is a re, a required balance between, uh, innovation and risk for us to progress in the future in a positive way for patients.

What about purpose? The reason for the day each of us in every industry need to have a purpose as leaders. We need to ensure we support that purpose too often in industries, not just health care, not just pharma. We expect the purpose, but don’t support it. And in fact, we’re letting down the actual team members who come on board expecting that their purpose.

will be able to be executed and fulfilled. So as leaders to the first part of the question, we need to support the purpose with a culture that is true to what we claim it to be.

Naji Gehchan: And I want to give a shout out to, uh, Jill Donahue, uh, who also shared this and have, uh, she has a book that launched.

previously on the power of purpose. Um, so I completely agree.

Anthony Yanni: Jill’s a terrific example of somebody who understands probably more than anyone, the power of purpose, uh, which is her book and the fact that purpose drives, um, efficiency, it drives satisfaction and it drives outcomes.

Naji Gehchan: The third one is a bandana and a blue bird.

Bandana and a

Anthony Yanni: bluebird is our symbols for patients, the patients that have taught me my lessons in developing the patient centricity function. They represent, they represent the very solemn and critical contribution patients make every day to our learning, to our evolution. And for me, It’s the commitment from, from me to honor their memories and their, their, um, willingness to share these private, private stories and, um, experiences with their health care providers and those in their network to hopefully change the way we deliver care for the better.

Naji Gehchan: Well, thank you for sharing this and your book will be. Uh, available very soon and we will, uh, we will share it on the podcast for, for several of us to learn more about the stories of those symbols and how we can improve patient centricity. The last word is spread love and organizations.

Anthony Yanni: That that’s that’s an easy one for me. I mean, everything we do should be with love as the common thread, right? We we are all going to be patients. We are all going to need the health care system We are all working every day for those people who are waiting for solutions and whether you’re in health care or any other industry Is there a better way to work than with love, than with that commitment to believe in what you’re doing, the greater good, and with the hope that at the end of every single day, we can go home and know that we did our very best.

And that the people who are waiting can rest assured they’re on our minds, they’re in our hearts, and that we’re doing what we can.

Naji Gehchan: Any final word of wisdom, Anthony, for healthcare leaders around the world?

Anthony Yanni: Yeah, I think, uh, my, my final word is one is a challenge. As I, as I point out in the book that this is the time. We can make a difference. We have a purpose. We are at a point now where we can disrupt the way things are and how we develop medicines and start to develop them with patients, for patients, with their benefit and their needs in mind.

We can change the way we deliver healthcare and transition away from treating patients and start to care again for individuals. And together, linking these systems, we can truly change the way. Medicine is developed and healthcare is delivered. Now is the time. We can do it. Let’s, let’s do it together.

Naji Gehchan: Now it’s the time.

Let’s do it together. I love this. Thank you so much, Anthony, for joining me today. It’s been a real pleasure to talk to you again and hear more about what all the work you’ve been doing. Thank you again.

Anthony Yanni: Thank you, Nigel.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Subscribe and connect with us on spreadloveio.

com or wherever you listen to podcasts. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement our world so desperately needs.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Collin Stultz

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I’m Naji, your host, for this special episode in collaboration with MIT Sloan Healthcare and Bioinnovations Conference, an event that brings the healthcare ecosystem together.

I have the pleasure to be joined by Colin Stultz, who will be Professor in Medical Engineering and Science, Professor of Electrical Engineering and Computer Science, Co Director of the Harvard MIT Program in Health Sciences and Technology, Member of the Research Laboratory of Electronics, and Associate Member of the Computer Science and Artificial Intelligence Laboratory.

Cullen is also a practicing cardiologist at the Massachusetts General Hospital MGH. Cullen’s scientific contributions have spanned multiple fields, including computational chemistry, biophysics and machine learning, for cardiovascular risk stratification. He is a member of the American Society for Biochemistry and Molecular Biology and the Federation of American Societies for Experimental Biology, and he’s a past recipient of the National Science Foundation Career Award and the Burrough Wellcome Fund Career Award in the biomedical sciences.

Currently, research in his group is focused on the development of machine learning tools that can guide clinical decision making. Colin, it’s an honor to have you with me today.

Collin Stultz: Thank you for having me, Naji, and thank you for asking me to participate.

Naji Gehchan: Before we dig in AI as a catalyst for care delivery, which was the topic of your panel at the conference, I’m eager to hear more about your personal story and what’s in between the line of such an inspiring journey.

Collin Stultz: Yeah. Thanks. I wish I had a, um, a simple way to explain getting from getting to where I am today. It was quite a circuitous route. Um, so I’ve been immigrant. I was Born in Jamaica, West Indies. We immigrated to this country when I was four years old. Parents came from poverty and came here to, uh, achieve the American dream.

And one of the things I like to, you know, tell people is, like, my parents, um, religion and education were terribly important to them. So, as a youth, the two things that I remember the most was going to church and studying. I was a big nerd for, for, for most of my life. And it was a good thing because it kept me away from all of the bad things in the neighborhood that I was Surrounded by.

Long story short, came to, um, Harvard, loved mathematics, did, uh, math and philosophy for an undergraduate major. And, uh, my parents wanted me to go to, uh, medical school and I really didn’t, wasn’t keen on it at the time. I wanted to do something in, in pure mathematics, but, uh, pure math really didn’t help people, um, the way that a physician could.

So I went to medical school, wasn’t really fond of that, left for a year, did research, came back, finished up medical school, completed a PhD. And then went on to do an internship and residency and several years ago. Here I am now. So the one thing I can say is what led me to this point is a bunch of different interests throughout throughout time.

And what I have followed more so than anything was, was what I liked. And it primarily dictated what my next, what my next steps were. And the only reason I belabor this point is, uh, because I, I am a little bit of an outlier, given the background, you know, I don’t come from an academic pedigree, parents do not come from money, but, uh, here I am at Harvard and MIT trying to do things I think that can benefit people long after I pass away.

And, um, holding positions that I think my father never would have dreamed. And, um, I think for anybody who’s listening from a similar background, such things are possible, um, with a lot of hard work, some tenacity and a little bit of hubris.

Naji Gehchan: Well, Colin, thank you so much for sharing this. It’s so inspiring.

Is there one thing that you would give your younger self advice as you were going through, uh, through this journey that I’m sure, as you said, it’s built on hard work, belief. Is there one advice that you would give yourself? When you were younger.

Collin Stultz: Yeah, failure makes you better. And, and, and I think that, um, failure is, is very hard to, uh, to, um, understand and process in the moment.

But after the fact, I think, you know, you realize, um, what you could do better when you fail. And that’s really important. So I think we view failure as being a bad thing. It never, it never really is. But it’s hard to get anywhere unless you do fail. What’s important is learning from when you fail. And if I could have Sat myself down and told myself that a long time ago.

I think the road might have been a little bit easier.

Naji Gehchan: So now if we go through, uh, one of the topics you’re fond of and the topic you discussed and led this panel on AI as a catalyst for care delivery. Um, this is obviously AI is a very hot topic. We hear about it a lot these days. Can you share first your high level thoughts?

about artificial intelligence, specifically in healthcare. How do you think about that?

Collin Stultz: Yeah, it’s, it’s, it’s a, it’s a great question. And I think a lot of this is, is conflated with what we see on TV, on science fiction shows, what we read in the, in the newspaper. We think about AI as being a series of, of techniques where you just press a button and then machines and algorithms do things that humans used to do.

Uh, well, that humans can do and I think in the health care for some things, that’s that’s that’s probably okay. But the health care, it’s not, I, I think decisions with regarding, uh, with respect to one’s health are typically done in an informed manner, taking into account the patient’s wishes and their value systems.

Things that are very hard for an algorithm to parse. So the way that I think that AI will, will function in the future in, in healthcare is that it’s going to provide important information that the healthcare provider can factor into their decision making information that leverages lots of data. So.

There’s, if you look at even the average person’s medical record, there’s tons of information there. Tons. Um, and so you can imagine the scale of information for those who have been ill and had many interactions with the health care system. Health care providers don’t look at all of those data because we can’t.

It’s too voluminous. But algorithms can computers not limited by large amounts of data, and it can process every piece of data without ignoring even the most the most minutia or the things like that might seem the most irrelevant and in that way, find new relationships and new new, uh, find out new things about patients that we would never have found out otherwise, because a piece of the data that we don’t look at.

And so I think that’s really the power of being able to uncover. hidden truths about patients, hidden facts about patients that are otherwise hard to decipher, and that the healthcare provider, that really is important for the healthcare provider, um, in, in helping them to discern what’s the right actions to take for a particular patient.

Naji Gehchan: So I think you’re, uh, you alluded to that. And if we want to go into a more use case, uh, specific, how do you see this playing in care delivery? specifically, and are you seeing some applications? I know your research is on this. If you can share some of those.

Collin Stultz: Yeah. Yeah. So I think one of the, so I’m going to focus on, I think I think it’s the most promising for the future.

And, um, it is a lot of care nowadays happens when the, a patient goes in to see their provider in the hospital or God forbid, they get admitted to the hospital with an acute, with an acute illness. And most of the of the therapies that are prescribed are when you’re sitting in front of a health care provider and they’re using the data right in front of them.

How do you look at that point in time? What’s your weight? What’s your blood pressure? What’s your heart rate? And what information they have up until that time in terms of what lab tests have you had with additional studies? But, but. But there’s so much of life that happens outside of one’s precise interaction with the health care system in a hospital setting.

And can you expand the information that the health care provider has to things that are at home? So, Information like, you know, how, how active are you at home? Can you climb up by the stairs or not? And can you record someone’s activity? How many steps they take throughout a day? Are they symptomatic at home?

What’s their heart rate at home? What’s their blood pressure at home? What’s their electrocardiogram? And I think we’ll be able to infer a lot of this information in an unobtrusive way in the future with our smart devices. So, um, case in point, there is a large, uh, Mayo has done a large study. in terms of detecting atrial fibrillation, which is a very common, um, arrhythmia that many patients have.

In particular, it’s very prevalent in patients with, with, uh, with heart failure and, um, from just from an Apple watch. So, you know, several hundred thousand patients have tried to detect when they have this bad arrhythmia from some, some such easily, you know, you don’t have to go into a hospital to get a 12 lead electrocardiogram.

You don’t have to be examined by anybody. It’s just by something rare on your risk. And so can we use similar types of data to infer more things? Can we infer things about the cardiovascular health? What’s the cardiac output? How much blood is your heart pumping per minute? And that’s something that typically you can only get by an invasive procedure by sticking catheters into the heart itself to make these measurements.

What are the pressures inside the heart? And can you use this information to predict are you going to be admitted to the hospital? What your potassium is, what your lab values are. I think we can get the same sort of information that you would get if you were admitted in the hospital and we could come close using simple sensors in the outpatient setting.

And so we like to refer to this as, um, um, like an inpatient information at home or inpatient, uh, uh, uh, monitoring at home. You get the same level of monitoring you would if you were admitted, but it’s in a home environment. And I think that’s a sweet spot for a lot of these things.

Naji Gehchan: This is great. And I saw recently Apple actually did get, uh, through the study, I think some approval, right?

Collin Stultz: Yeah.

Naji Gehchan: Yeah.

Collin Stultz: That’s right. Yeah.

Naji Gehchan: So, so you’re bringing this idea of expanding, I love how you framed it, expanding the information that you can get for in hospital patients outside of home and really leveraging just to have a more holistic view of the patient. When you are treating them and making a decision.

Yeah,

Collin Stultz: that’s right. So you could imagine if like the patient could be admitted to the hospital every day or come into the hospital every day and get information and titrate medications and make decisions based on that all from the in home environment. Because at home, you could get the same information you would as if they were standing in front of you in a hospital or in the clinic.

Naji Gehchan: So as you look into the next decade, right, and more of those connected devices, more data will be analyzed and ultimately having all our data records in one single place that we can probably use. What is the most exciting advancement in medicine that you think we should all be watching for the next 10 years?

Collin Stultz: It’s a great question and I, you know, I am biased. I’m biased. Right. Because I, I am necessarily biased to the things that we’re doing in, in, in my group. That’s the thing that I know most intimate, intimately. There are many things that are important. Uh, and just to be, just to be fair, um, we, uh, in a hospital, you could, you do a cardiac ultrasound and it looks at, it’s a very detailed study, just like an ultrasound looks at a baby moving the mother’s and the mother’s abdomen and pelvis.

You, um, can get an ultrasound to see how the heart is moving. and get a lot of detailed information about the heart function, the valves, and various structures in the heart. And there are data from a number of investigators. To suggest that you can get similar information from the type of, uh, from these, um, ECG monitors.

They are akin to what you get from the Apple Watch. Not precisely the Apple Watch or the Fit Beta, one of these wearable monitor devices. But you can, but from those simple signals, you can get similar types of information that you would get from an ultrasound study. And in our group, what we are working on is sort of the equivalent of digital twins.

For cardiovascular patients. So for a given patient, what can you infer from the electrocardiogram or the simple simple, uh, uh, signals? What are the pressures inside the chest? What’s the cardiac output? All of these things that are normally obtained from an invasive study in a hospital. Can you get them at home with just a patch monitor?

And can you use this to put on, um, to do experiments with patients? So what do I mean by that? So if I have two drugs. that I think, um, would be good for you to take. I could give you one drug, see how you do, take you off the drug, wash out, give you another one, and see how you do. Now that’s clearly not beneficial, right?

Because one of the drugs may have very bad side effects. Maybe toxic, but if I had a digital copy of you in the computer, then I could give that drug to one digital copy, the other drug to another digital copy and follow their trajectories in time to determine who’s going to have an adverse event and who’s not.

And so I can do these, what we call in silico experiments to come up in a reasoned way, the optimal therapy for a patient. And we’ve been putting a lot of effort into that. And I think if for some class of patients. So those certain types of hard failure, I’m very optimistic that we can do quite well in that endeavor.

So that, that’s the thing that I’m the most excited about, um, in the pipeline.

Naji Gehchan: This is phenomenal. Like having our digital twin, as you call them, to run those experiments instead of actually doing it on us. Um, how far are we from doing that? I know some companies, you know, They have research on, um, you have your research on how far away would I be able to test a drug as you said.

Collin Stultz: Yeah, I think, I think a lot of, um, work has been going on to try to make general digital twins. So that’s twins for any patient, irrespective of what their diagnosis is. irrespective of what their medical history is. And that’s a very, very hard problem. Many different diseases are in the textbooks. Um, and and if you’re going to try to do this, generally, you need a tremendous amount of data, a tremendous amount of high quality data to be able to do this well.

And it’s our premise. That if we can narrow this down to specific groups of interest, so we can do this for patients with a particular type of heart failure, can we do this for patients with particular type of diabetes, that we can make, that it lowers the data burden and allows you a better chance of building robust models.

That can predict patient trajectories, how a patient will do in the future over time and response to different perturbations, different medications, different interventions. So, so right. It is true. There’s a lot of work in the space. I think the work that’s going on in space necessarily because how the problems are posed.

are very data hungry, require tremendous amounts of data. Our approach is really a focused one and on specific diseases.

Naji Gehchan: So I love that because it’s a specific use case where you can gather the data you need and deal with it. So I have to follow up questions to this. The first one, um, I was born physician, I’m in drug development.

It is so hard. Up to now to predict once you get a drug, how are you going to react to it? So, um, I would love to get your thoughts about those in silico, the precision about it, how should you think about, and probably even getting it into clinical development, actually, instead of, uh, participation, but even as a predictor of response, as you said, and side effects that you can get, how do you think about, about it again, as science.

several times humbles us once it gets into human.

Collin Stultz: No, it’s good. It’s a good, it’s a good question. And the work is ongoing. So the precise, um, answer is still, is still stay tuned. But I will say that I think that one, all of the information that we have would be there, uh, in a patient’s genetic profile.

Their transcriptomic profile and the various tissues of interest, their medical history, what they eat every day, right, where do they live, their, unfortunately, where their, what their zip code is, all of, all of these things come in and affect clinical outcomes, and much of this information is encoded in, in the medical record, not all of it, but a lot of it, and their proxies for things like the genetic profile.

In the, in the medical records. So my sense is that there’s a, that there’s a lot of this at both the structured and the unstructured data that we’re just not leveraging as much as we can. It’s a hypothesis, admittedly, that all of this information is there. But if you can leverage it, um, leverage it, it is my view that you have a good chance of being able for, for important clinical problems.

You won’t do it for everything. I’ll do it for everything. But, but, uh, to give you a specific example, patients with heart failure, a certain type of heart failure called, uh, heart failure with reduced ejection fraction. There are four different drugs that we like to get all patients on. Not every patient can tolerate all four drugs.

So for the specific question of patients in this class, Can you experiment with these different four drugs and see who will tolerate it and who will not ahead of time? And I think the data are, are, are there and of sufficient quality to answer directed questions like that. So, so I think we can make progress, but like, you know, like most things, it’s for the right question.

And what’s the sweet spot?

Naji Gehchan: I love this. I want to go on the data piece. Obviously, everything is based on data, as you said, and the quality of data that there is in. And I can’t but think about the biases in the data. So I would love to hear your thoughts about this, specifically on the biases, the lack of data we have on certain ethnicities, on women.

You know what I’m talking about. So I’d love to get your thoughts about this.

Collin Stultz: Yeah, life is very unfair. Life is very unfair. And medical care is, unfortunately, suffers from some of the same, uh, unfairness. Um, as I, as I like to say, all individuals are biased. And I’ve said this many times before. Some people choose to recognize that they’re biased and mitigate it.

And some people ignore it. And, and I think, so I think we have to begin from the premise that there is bias in the data. Data are assembled and we decide what to, what to acquire by individuals who are inherently biased. And that’s again, as I’ve said on other occasions, that’s not a nefarious statement. I think it’s just a statement of fact.

So, um, realizing there’s bias, how do you mitigate it? I think the way that people ordinarily think about this is that they identify groups that have not benefited, um, like that others have. So women in cardiovascular care and in many other way, um, areas, people from underserved, uh, backgrounds. And you try to say for these algorithms, how do they perform in these groups that are traditionally underrepresented or where these methods don’t perform well.

And I think that’s a, that’s a necessary thing that we need to do. But the thing that is always in my mind. What groups are we missing? Because if you come to this with a preconceived notion about specific groups, are you missing, um, groups that you would not have, have, have thought of, right? So in the 19, uh, in the early 1900s, 18, I don’t know if anyone would have thought of black women as being a group.

That they should focus on. I don’t, I don’t think that would, it’s an extreme example, right? And I think things about mitigating bias would have excluded that group. And I just wonder, it’s always in the back of my mind about what are we missing that we are not paying attention to because we’re blind to.

So, for me, a part of this is not only coming into With it, with, uh, with some, with some prior notion of what groups are, are, we tend to have, we tend to be biased against, but trying to discover from the data, what groups we are not performing with, what groups, what subgroups are, are we intrinsically biased and learning about our bias from it.

So, I think we can try to mitigate the biases that we know might be there, but also try to discover new biases that originally might, might be blinded to it. And I think both parts of that. It tries to guide our work as well.

Naji Gehchan: This is so powerful. Uh, what, what you said, I always think about what groups are we missing?

This is. This is so powerful and so true. I’m gonna give you now, Colin, a word and I would love your first reaction to it. The first one is leadership.

Collin Stultz: So, my first reaction to a leader, well, I’m gonna, a leader is, the first word that comes to mind is follow. Because I think a leader necessarily is a follower.

Um, um, leadership in part is about listening to others And in a sense, following, or maybe following is the wrong term, but being sensitive and paying attention to the things that are important to them. So I said following, but maybe what I’m trying to convey is, is listening. And I think that’s an important part of leadership.

Um, you know, I don’t want to get on a political rant here, um, because, you know, it’ll get me in trouble. But I will say, in general, politicians, Right. Widely construed. Um, there are leaders, but they’re, you know, but listing is not part of their, of, of their, their portfolio. And I say that broadly and, and, um, for me, there are ports in many of them, many of them, not all, many of them are poor examples of, of leadership.

Naji Gehchan: The second one is health equity.

Collin Stultz: Hmm. So when I, when I hear health equity, the first one that comes to me, it’s a right. Health equity is a right. I believe it is a right of every individual to have good care that is the same as anybody else’s. And that’s, that’s a terse statement that’s categorical and that’s an easy one.

That’s an easy one.

Naji Gehchan: I certainly do believe in that too. The third one is Chad GPT.

Collin Stultz: Oh, let’s see. I don’t know what I want to say. It’s overrated. Overrated. So I, I think, uh, chat GPT for me, the, the really important thing, it’s an example of what some of this technology can do. What can we do with large foundational models?

Uh, you know, large transformer models, the types of things that they can do. Um, It’s, it’s overrated in the sense that we often believe what it says to a fault and in the medical space, there are numerous examples where it is incorrect. Producing, um, data that are, um, incorrect and harmful. So I, and I wish that others would sort of focus this as being an example of the types of things that the technology can do rather than focusing on chat GPT in and of itself.

Naji Gehchan: So before giving you the final word, I see a picture behind you. So I’m going to give you his name. Einstein.

Collin Stultz: Oh

Naji Gehchan: yeah. And I’d love your reaction to, to this.

Collin Stultz: So I love this. I love this quote. Um, I’m going to read it. It says great spirits have always encountered violent opposition from mediocre minds. And I am certainly not in the, in the, in the sphere of, of, of Einstein by any way, shape, or form, but the sentiment is something that I, that I, um, I think is a motivation, as motivates, um, in that, um, and I’ve had, um, many, uh, a number of famous scholars.

Um, tell me about the difficulties that they’ve had in their career when they had a new idea and an inability to get funded and an inability to have people to listen to them. And it took decades later. And they were, you know, my old advisors, the Nobel laureate in chemistry, amongst other things. Other very famous engineers here on the MIT campus.

I think are examples of that. So that for me is a motivational statement from a mind that was much greater than mine.

Naji Gehchan: The last word is spread love and organizations.

Collin Stultz: What was the first one? Organizations and?

Naji Gehchan: Spread love and organizations. Oh,

Collin Stultz: I see. Spread love and organizations. Um, that’s very broad.

That’s very broad. I, I think, um, there are, I think about doing good things in the world. That’s what I think. And, and I think that things that aspire us to learn from one another, communicate, um, and, and, and engage in dialogue, um, about new things. Um, technology and otherwise is, is only a good thing for us overall

Naji Gehchan: engage in dialogue.

So important. Any final word of wisdom, Colin, for healthcare leaders around the world?

Collin Stultz: No, no, I think, you know, I think the healthcare people like, like you and, and, and, and like I, we dedicate our professional lives to the health of, of those who are sicker than us. And, and, um, and I think it’s a, you know, it’s, it’s, It’s a noble profession, and I think as long as we, as healthcare professionals, keep that at the forefront of our mind, we can never go too astray in doing good.

Naji Gehchan: Well, thank you so much, Colin, again, for being with me today and this great chat.

Collin Stultz: Thank you so much. Hopefully I’ll see you soon in person.

Naji Gehchan: Hope to see you soon. Thank you all for listening to Spread Love and Organization’s podcast. More episodes summarizing MIT’s Sloan Healthcare and Bioinnovation Conference are available on spreadloveio.com and wherever you get your podcasts. Follow us to get most recent episodes and spread the word around you to inspire others and amplify this movement our world so desperately needs.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Patricia Boulogne

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Patricia Boulogne a Certified Functional Medicine Practitioner, Coach, Chiropractor, Speaker, and Author. Pat has helped thousands over the last 35 years stop adapting their lifestyle to pain, and chronic problems by focusing on the whole person. The result is that her clients and patients, find out the WHY and the CAUSE of the problem, and identify the starting point: what, why, where and how to begin their health journey to live longer, better and healthier. Pat is the founder and principal of AskDrPat ~ HealthTeamNetwork, a company dedicated to skyrocketing your health, lifestyle, and mindset with strategies and programs that make sense, and help you age gracefully, think, move and feel better, and live longer and happier!

Pat, It’s a pleasure to see you again and have you with me today!

Patricia Boulogne: I’m really happy to be here. You know, I love to share knowledge and I like to help. I like to see people thrive.

Naji Gehchan: It’s great. It’s really a

Patricia Boulogne: great opportunity.

Naji Gehchan: People thrive, live longer, happier. I think all, everyone is eager to hear more about how to do that. But first I want to start with your personal story.

What’s in between the lines of your journey and becoming the doctor and business person you are now?

Patricia Boulogne: Well, you know, one of the things that happened is that when I was going to chiropractic school and I just finished chiropractic school, but I knew my father was not well before that he dropped out of a heart attack.

And that was really quite upsetting, you know, at the time because, you know, I always thought about like, what is it that I could have done, um, or what, you know, with all the resources and tools that I had access to, he didn’t take care of himself. He didn’t, um, you know, he’s. Occasionally, he smoked a pipe, um, and had a glass of scotch and, but he really didn’t take care of himself.

He didn’t eat well. And um, it came as a surprise to everybody, you know, because it was, as I said before, it was sudden, but it always made me sad because I kept on thinking like, oh, I could, maybe I could have done something. And that, from that experience, I decided that I was going to help other executives and entrepreneurs and business owners, you know, live their lives to the fullest and be as healthy as possible, um, moving forward, because it’s a lot, sometimes it’s a lot simpler than what we make it out to be, and it isn’t as complicated or feeling overwhelmed, because a lot of times people, when they hear the word medicine, they kind of shut off.

And they don’t want to know, they’re thinking like, Oh, I’m going to leave it to the doctor, you know, and I like to speak very simple language. I like to keep it simple. Um, go back to like, you know, know that the cart isn’t before the horse, the horse is before the cart when someone leaves with working with me, you know, and going back to basics because you have to know your foundational lines in those numbers.

They really count.

Naji Gehchan: So thanks for sharing this. And you’ve been helping, as you said, leaders be better, healthier, more fulfilled leaders, uh, for themselves and their teams by focusing on the whole person. Can you share more about that and what do you mean by whole person?

Patricia Boulogne: Well, you know, a lot of us, you know, we, we get so busy, you know, that we start sacrificing our relationships, our careers, and our life to move forward.

And we don’t have all the tools, but if you. know what to do. You can go into the game with more sustenance. Um, and what I mean by it, people used to ask me all the time, because I had a very busy practice on Cape Cod, and people used to ask me all the time, like, how do you do it? I see you here, you’re like going.

And I ate well, I had good thoughts, you know, and I exercised, I moved, I did some, I mean, You know, what I told people to do, I did myself, and what I realized by doing those simple things of, you know, you’re, you know, you’re mastering your mindset. Mastering your mindset is huge, no matter what industry that you’re in, but especially for your health, when you have that mastered and that you become a priority instead of putting everything else ahead of you, then you can even be, you know, you can have more consistency with being productive.

You know, you sleep better, think better, move better. You’re like physically, mentally, emotionally, spiritually, socially, and especially financially. You can make better decisions.

Naji Gehchan: So, I love this idea of mastering your mindset. Can we double click on that and tell us how to do it and what happens next?

Patricia Boulogne: Well, I always, you know, I think, you know, going from having something that’s a habit into a ritual is a key component and essential.

And so that, um, you know, the habit into the ritual, you have to be silent. What is that? So, I have a, um, You know, something that I give out when I’m, you know, doing webinars and things like that where I talk about like what are those five things that you have to do. And I would say when you first get up in the morning, bathe your body in water, not outside but inside also.

Every organ in your body will love you for it. Also take 20 minutes in the morning. Maybe you have to wake up a half hour earlier to do that, but have that, you know, like so that you have that downtime and you’re doing it as a meditation or a prayer. Whatever it is that you need to center yourself, pick nine things that you can focus on that day.

Three for your business, three for yourself, you know, and three for your spirit or your family. Um, and then, you know, write those down and do and make a, A nine before nine ritual. Um, and, you know, the last thing is, is like, you know, be kind to yourself, you know, take breaks. I just posted something today about, you know, taking a one minute break for breathing, you know, breath work is really essential.

And I’m thinking, wow, in just one minute, you can, you know, energize your body, you know, you can have a quick fix. And you can also fix that last two by the way. Um, and then you can also be more calm. And so if you’re more calm, then stress isn’t going to take over you. You command stress. You’re in the commanding seat of that.

So that mindset portion of that is, you know, having that positive mindset with a positive mental attitude and all these other wellness initiatives gives you the success that you need and gives you the stamina and also the energy to make it through even your longest day.

Naji Gehchan: I love those practical advices you’re giving us.

Uh, can you share now a little bit more about your book? I love the titles. I’ll let you talk about your book, the title, and what’s in it.

Patricia Boulogne: Yes, the book is called Why Are You Sick, Fat, and Tired? And The book is about discovering your health’s weakest and strongest links. The purpose of the book is to show and shed light on where to start your health journey.

It’s a workbook. It’s a guidebook. It’s an advocating tool. You can take this to any learned physician. The results from the questionnaire, then there’s, it’s the questions, there’s 11 chapters of questions, 12 11, meaning men, 11 for women, and in those questions, it’s like a deep dive survey, like a system survey for the body, so that, I have, I’ve had people say to me, as a matter of fact, you know, like, my doctor’s never asked me that, you know, but it really helps you identify where your weakest link is at.

Cause then you know where to focus your time, your energy and your money. And then you can reset your mindset, you know, and also your health at the same time and be able to move forward and keep moving forward and a consistent fashion.

Naji Gehchan: So is there any, you know, any magic formula, uh, I would say if you want to try to improve your.

Lifestyle and be healthier because this is the promise you bring to, uh, people you see. So I’d love to hear from you if you have any, uh, any magic formula for, for, for me and all the listeners here.

Patricia Boulogne: Well, my first advice and magic formula is to make sure you’re well hydrated and you need 50 percent of your body weight in ounces, you know, for that.

The other thing is, is that everyone’s so individualized and everything’s personalized. Okay. And on some level, what I do is very concierge, um, is that I look at each individual, you know, blueprint of persons, like, you know, where do you want to go? What do you got going on? Where do you want to go? And what are you willing to do?

You know, and if you’re willing to do something, there’s always something you can do. I have a, lot of, you know, tricks up my sleeve, so to speak. Um, and how to like, Oh, do this instead. Or, you know, I told somebody I was talking to last night in my last call just said, I’m having such a hard time sleeping.

And I said, take a little extra calcium before you go to sleep. Don’t take it in the morning, take it at night, you know, and take it a couple hours before you go to sleep, you know, and then Make sure you’re, you know, distance from blue light from the TV if you’re watching TV or your, you know, computer or telephone, you know, and then, you know, stop that and just have that peace of mind with that a good two hours beforehand, a minimum of 30 minutes.

You know, and then have water next to your bed so that you can keep the temperature in the room, you know, and those, those are like, little things that people don’t think about very much. Um, you know, or they live someplace where, you know, this morning I had garbage trucks going down the street at 530 in the morning and I thought it’s time to get up.

It’s time to get up and do my routine. Um, and you know, and like get thicker skin, like stop getting so upset about stuff that really in the big game plan of life doesn’t matter, you know, and so that I’m thinking, is this going to matter to me 5 years from now, you know, a year from now, then don’t worry about it.

And maybe for better sleep. Because there are so many people, sleep issues are an epidemic in this country. And so, as far as the sleep goes, if you can’t sleep, just ask yourself, what is it that’s really going on here? And if you can do something about it, get up and fix it. Do it. Get it over with. And then give yourself permission to go to sleep.

And if not, dictate or write it down because in less than eight hours, it’s still going to be there. It’s not going to go away and there’s nothing you really can do about it. So when you adopt that mindset that anything is possible and that this aspect of this can be, it can be put off till the next day, you already put it off anyway.

So, let’s just, you know, just like accept it, move on, keep moving forward, you know, and keep good thoughts. So, start the day with a, you know, good positive thought and if it’s, you start and you have, uh, it get, you know, waylaid or derailed, you know, you just gently, energetically push that thought away, cancel it and then you keep on moving on forward because you, it’s just like you’re.

The energy that you need, it will cost you 10 times more energy when you’re upset or stressed out than if you just stay calm and stay centered.

Naji Gehchan: Don’t sweat the small stuff. I don’t know if you’ve read this book, but I love it.

Patricia Boulogne: I do. You know, I actually met that guy in Boston once. time. Um, when I used to live downtown Boston, um, we’re talking, this guy goes, Oh, I’m going to go see him right now.

And this guy knew a friend of mine in the building that was in, knew him. And I said, I want to meet him. And so he goes, we can come with us, you know, come and have a drink. And then, you know, he goes, we got something else we got to do, but we’re going to meet for a drink first before we go to dinner. Like, all right.

I meant, I never say no. That’s one of my big things. Never say no to a great invite. Yeah. Ever.

Naji Gehchan: That’s great. Uh, so it’s really, uh, you’re giving really great tips for us to take care of ourselves. And I love how you frame that it’s, uh, because we hear a lot about making it a habit, but you’re pushing us to start thinking about making a habit.

a ritual. So can you give us a little bit more what you mean by that?

Patricia Boulogne: Well, let’s just take, you know, the, there’s a, a thing, a rule called the 2190 day rule. And the average person takes anywhere from 18 days to 265 or 54 days, about eight and a half months in order to make a habit into a ritual. So it’s like, it’s a non event.

So you’re just get up and you go do it. And so, If you look at the 20 90 day rule, or the 21 90 day rule, if you do it for 21 days, you know, then you can do it, whatever that is that you are successful with for 21 days, then you just do it for an additional 90 days. And so if you do it the additional 90 days, you’re at 111 days, which is more than halfway through.

Um, and so it’s just, you know, it’s just being consistent. Everything is, you know, it’s like consistent. I use the word consistent a lot, because when you’re consistent, you get better results. And also, if you have an accountability buddy, You know, somebody that’s just like, you know, like, well, I have a hard time walking more than a block.

Well, walk a block until you can walk farther, walk as fast as you can, as far as you can for as long as you can, just get out and move. You know, my second patient in clinic was a 92 year old woman, and she was a little scared. She was a good old Southern Belle girl from Atlanta, Georgia, because that’s where I went to college.

And I asked her when she came in, I’m thinking what’s a 92 year old woman coming into a chiropractor for and wanting to get advice about how to do it better. And I’m thinking she has so much that she can teach me. And so I asked her what she did for exercise. And she said she lived in a neighborhood that was turning so she would take her Dixie cup out and go water all her plants in the backyard.

And I said, well, how many plants do you have? I thought she was going to say, like, 20 or something like that. And she said, Oh, you have 150 and I’m going like, you know, but and what she did is she just made it into, you know, exercise and put the mindset that that was exercise for her, which helped her stay in better shape, you know, and keep on moving because her line was, Dr.

Payette with his beautiful Southern accent, if you don’t move, you’re going to die. And that is just so true.

Naji Gehchan: So thinking about now more leaders, do you see anything different for us managing teams and organizations and how to ensure a better health and lifestyle for our teams and also for us? Like any different advice you would give?

Patricia Boulogne: Well, you know, you’ve got to look at what, you know, when I look at somebody, what I do is I look at, what do you got to do in a day? You know, and it’s just like, what’s the most important thing you have to get done so you’re not doing emails the first thing in the morning, or else you’ll get sidetracked, you know, and all of a sudden it’ll be 2 o’clock and you haven’t done anything.

And so it’s, it’s taking a look at that, like the, the eating, you know, proper diet and nutrition is, you know, is so important, um, proper exercise and getting up and moving so you’re not sitting down so long, you know, there’s studies showing that sitting is not a really good idea. And then, you know, getting enough sleep or even taking a nap or doing the breath work that I talked about today in my post on LinkedIn.

It’s just a simple, simple, simple thing that you can do. And there’s a lot of simple things that you can do that you just don’t sometimes think about. And then for like leaders, you know, to have that harmony and that balance and being able to think better, you’ve got to really have a clean diet. And you have to really be a little bit ritualized, like how much sleep am I getting?

You know, and not sweating the small stuff as you well pointed it out and at summation of that. Um, you have, you know, you first have to identify where you’re at though and that’s a big problem. A lot of people think that like, Oh, I’m okay, I’m healthy. You know, we’ve all heard the story about the person leaving the doctor’s office and a couple of days later dropping dead of a heart attack and they were given a clean bill of health.

You know, it’s a lot of times people can be very thin, but have a lot of fat around their organs. It’s called VAT fat And, or visceral fat and, you know, and then looking at like, you know, like, what is it that’s like leaders need, like, you know, like, what is it that, you know, what’s an easy thing for you to do on a regular basis so that it’s, you know, that you can have, you can think better, you can feel better and move better.

You have those tools with you, you know, so you’re always driving a Ferrari as opposed to driving a jalopy and for a body. Putting that, um, you know, and because you can, you know, delegate, leaders are really good delegators. And, you know, if you know that you like, I need this, this, this, and this, you can delegate it out so that it gets done for you.

And then that way you’re not consuming extra time doing something that is somebody else can do for you in that aspect.

Naji Gehchan: So I’d love to give you now a word and get your reaction to it. The first one, the first one is leadership.

Patricia Boulogne: Well, leadership, you know, I think that, you know, when I, when I talk to leaders and talk about leadership, I, you know, think about my first words that come to my mind are parents.

Because parents are children’s first leaders. They mimic you, and by the age of five, they get you down to a science, and wrapped usually around your finger, their finger. And so, you know, I look at, like, leadership. I look at, you know, when somebody can be who they say they are, and take the appropriate action to implement, to go, going forward.

And when somebody does that, and keeps their word, especially for me, How I feel is that I can honor that, and I respect that, and I can follow that.

Naji Gehchan: The second one is mental health.

Patricia Boulogne: Well, do you know that May is Mental Health Month? And mental health, we, I think a lot of times we have a problem with it, because in the United States, for instance, we don’t, Um, we’re never taught how to eat and the gut brain, um, connection is huge and a lot of mental health like the anxiety, the depression, you know, the, the antsiness, a lot of the times that comes from the foods that we’re eating and the miscommunication from the food to the brain and we’re eating poor foods, we’re eating fast foods, we’re letting that, you know, um, create, change how we.

respond in relationships and we don’t sometimes don’t realize people who are hypoglycemic sometimes are really irritable and or somebody’s really sick. They’re really irritable and you don’t really know that, you know, so that’s what, um, you know, the mental health part of that is like, that’s and the 1st thing I.

talk about in mental health is you gotta hydrate, you gotta eat well, you know, you have to exercise, you gotta create movement. I had a patient who was very depressed and when I was on Cape Cod and um, her husband says the only time she moves is when she comes to my office. And um, I said, well, what motivates her?

She goes, she likes you. And I said, well, tell her to come in Monday through Friday, you know, because, you know, I’m going, if that’s what it takes for her, you know, maybe a little bit at a time that can be reversed, you know, and, and I go in, in how that one thing, sometimes that we have stuff that happens to us when we’re growing up, that we hear something the wrong way and we keep on sabotaging ourselves and keeps on hitting the wall and keep on hitting the ceiling and not being in a free flow fashion.

So we all know what. Being in our vibe is like. You know, when you’re on your game, you’re moving forward, you know, and it’s everything is that all the pieces of the puzzle are fine in the places that you want to have them in. And when they don’t, it can be overwhelming. And even where work would be normal, in those instances, work feels like you’re being overworked.

And it’s just, it’s just like a different perception, like how do you change that? And it changes with mindset, one thing at a time.

Naji Gehchan: The third one is, Einstein’s time.

Patricia Boulogne: I love Einstein’s time. You know, I was driving on 495 in Boston and I got pulled over by the police. Well, actually I pulled over. They pulled in behind me because I thought I was having a problem.

And I was listening to this book that talked about Einstein’s time. And I wanted to take notes, so, and I knew I had enough time that I could listen to that chapter again and take down keywords and, um, and possess it. And what Einstein’s time is, like, when you’re in your vibe, um, is that, you know, things just flow for you.

And, you know, you don’t have, like, you don’t worry. You don’t have that level of stress you’re able to, like, you know, uh, Be in one with your situation. The day that I was listening to that, I was covering a doctor’s office up in Lawrence, Massachusetts, and, um, the one I walked in, I was telling this girl the next, the day before that, and I said, you know, what happened to that?

You know, so and so and so and so, cause I worked in this office before. And, uh, she said, well, how many people do you want to see? And I said, fill me up. And so I walked into the office and it was the standing room only when I got there at 9 o’clock in the morning. I went, Oh my God, I’m never going to get out of here.

And I decided to take that thought, get rid of it immediately, cancel it, you know, not look at my watch. Because if I looked at my watch, I was going to go back into Newtonian time and just do it. And I finished, I was like 15 minutes after the hour, but I, you saw a significant amount of people in a four hour time segment, like around 55 or 60 people.

It’s, you know, and it just like, it just flowed. I didn’t, you know, think, I didn’t think about it, you know, and it was enough. Where families, it was more of a family practice. So you had the mother, father, you know, and the brothers and sisters all jammed in this one room that thinking, wow, and just do it, get over yourself, you know, and do your best job that you possibly could do.

And if you run late, you run late, you know, it’s not the end of the world. But that’s Einstein’s time when you’re in your vibe.

Naji Gehchan: The last one is spread love and organizations.

Patricia Boulogne: You know, if you, you know, there’s a, I recently heard this song called, um, I am woman and, um, and it talks about, you know, when you put out what you want, you know, to the universe, the universe provides for you.

And when you’re in your vibe or in Einstein’s time, that happens all the time, all the time. So if you put out love. And you share the love that you’re, that you have within you, because we all have, we’re all geniuses, you just have to learn how to express it, and that whatever you put out, you, you, it comes back to you.

And you know, that’s, you know, when I, when you say that, that’s exactly how I feel about no matter who I meet. Uh, and someone, uh, coined me, um, the other day and we decided that I should, uh, market myself as a, um, as a grace magnet. And uh, they said, cause you just have that knack, you know, you have, you know, something happens and you get, you get it taken care of and, um, and I’m really resourceful, too, and I’m not scared to talk to anybody.

Naji Gehchan: Any final word of wisdom, uh, Pat, for healthcare leaders around the world?

Patricia Boulogne: Say that, the beginning part of that again, please.

Naji Gehchan: Any final word of wisdom? for healthcare leaders around the world?

Patricia Boulogne: Well, I think, you know, one of the things that when I was in chiropractic school and our schooling was very similar to, you know, Western, like traditional medicine doctors, except for we didn’t do the prescription part of it.

And, you know, I would look at people who are standing, you know, you know, treating people and I think you need to lead by example. And you need to, you know, so I think that healthcare practitioners should do exactly what they would tell anybody else to do, you know, and they need to be their own example and going forward because then you get people who are, you know, who can say yes to you, who respect you and who could trust you, you know, and if you’re going to have be a trusted authority, you better be your word.

And you better like, I want to see you in action. You know, when I see you in action, I’m going to, it’s like if it doesn’t, it doesn’t resonate to me, you’re the last doc, you know, you’re the last doctor or the last professional I’m going to see in that industry, I’ll go find somebody else. But I think it’s really important to be able to trust somebody and to be able to, you know, be able to ask questions and, you know, not talk, you know, when you go in to see them, not talk about their dog, whatever is going on with them, unless you have like, you live next door to them or, you know, and the such.

So I think that that’s important.

Naji Gehchan: I love it. It’s walking the dog as, as we say, you know, I’m being a physician, I definitely relate to what you said. And also you talked about leadership with your children. Uh, it’s, if you try not to walk the talk with your children, it’s even, you get immediately the feedback, right?

And it’s, well, you didn’t do this, and you’re telling me to do it. Why? So I think it’s, you know, amazing to these two, I love it.

Patricia Boulogne: Yeah. It’s just like, my girlfriend’s son was very incredibly intelligent, and, um, so he would ask me every once in a while when he was even, he was three years old, he could read.

Um, so he would ask me to read books to him and so I’d read and I didn’t feel like doing it. So I’d skip pages and he goes, Auntie Pat, you forgot the part about, remember, you know, go back a couple pages. You know, you forgot that. Did you make a mistake and turn too many pages at once? I said, sure did, Sam.

Never do that again. You know, he caught me every time. You know, but I think we, I think we need to spend time, you know, with, you know, children and they’re, you know, and developing their, you know, consciousness. I mean, this same kid when I was in, when I lived downtown Boston was sitting there and he was looking at his mother’s a doctor.

His father is, is a, a significant massage therapist in Boston and he was sitting there and he said, Oh my God, your spines. I had one of those spines that hung on a hook, you know, my off in my immediate office at home and he goes, Oh my God, that guy must be in so much pain. I said, why is that, Sam? He goes, look how crooked his sacrum is.

He was five years old. So, but he, he knew body parts. He, he was way ahead of the game.

Naji Gehchan: Well, thank you so much for being with me today and for this great chat.

Patricia Boulogne: I appreciate it. I really enjoyed, I really enjoyed being here. It was a lot of fun and it was informative.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jessica Leygues

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with ESCP Business School and its specialized Masters in Pharma and Biotech Management. I am joined today by Jessica Leygues, General Secretary of Women’s Cancer Institute. Jessica is an engineer by training from AgroParisTech, and started her career at Alcimed consulting firm where she spent eight years developing new healthcare markets (biotech/medtech) for entrepreneurs, start-ups, SMEs and large corporations as well as for the public and semi-public innovation sector, including the French Ministry of Research, research institutes, competitiveness clusters and knowledge transfer centres. Strongly committed to optimization initiatives for healthcare systems, Jessica then joined Celgene, where she was responsible for a partnership hub aimed at developing the healthcare value model. In April 2020, the midst of COVID pandemic, Jessica became the CEO of Medicen Paris Region, Europe’s leading health cluster, where she redefined the strategic positioning of the group in order to launch concrete reindustrialization initiatives to accelerate growth in the French healthcare industry and boost national sovereignty in order to recover from the COVID-19 pandemic

Jessica, It’s great to have you with me today!

Jessica Leygues: Hi, thank you very much. I’m really honored to be with you today. Thanks.

Naji Gehchan: Can you first tell us more about your personal story, from engineering to redefining healthcare at a country level, what is behind your inspiring journey?

Jessica Leygues: Hmm. Um, when I chose my, my orientation when I was younger, what I wanted to do most, of course, like a lot of people now is have a true impact on the world.

So when I chose the life sciences path with this agro biotech engineering school, I truly believed what we would focus on would be sustainability and so on. But At that time, it was still really focused on productivity and the values were not the ones I was looking for. So at the end of this higher education, uh, background, I really didn’t know what to do to be the most, uh, useful as possible.

So I started. As a consultant, uh, in the biotech, uh, sector, and it was really interesting because I had the opportunity to work with, uh, entrepreneurs, uh, with, uh, institution leaders, uh, with, uh, healthcare authorities, with, uh, um, industrial companies. So it gave me a sense of where You could have impact and where to start when you want to, to truly, um, spread values, uh, from within organizations.

And it was really inspiring to see, uh, that in France, that, that there was a lot of, uh, experimentations. And, and, and, and people organizations that want to change the system. Uh, so I had the opportunity to test what it is in the public sector, in the private sector and healthcare, obviously with a really, really, uh, um, a comprehensive, uh, sector to, uh, to, to, to, uh, to change things, uh, as a patient perspective, as, um, uh, a whole system perspective, uh, in, uh, in terms of, uh, macroeconomy.

So yeah, I never got back to anything else.

Naji Gehchan: So it’s through this incredible diverse experience, right? You talked about consulting, you’ve done biotech, you’ve done pharma, you’ve done government, nonprofit now, uh, is there like a key leadership thread that you’ve been taking with you across all those different experiences?

Jessica Leygues: Yeah, I would say there are many, uh, key learnings that I got along the way and, and maybe to start what is really important for me, uh, is. Where you can have the most impact is not necessarily when there’s 300 people in the room. And this is what I learned, uh, going from a big, uh, group to, uh, 30 people team when I was leading, uh, the medicine Paris region by your cluster.

Uh, it’s. Yeah, what stroke me is that when you have one on one discussions or really really small teams, um, a way of working and thinking this is at least for me and this is maybe a way of of uh of thinking and working this is Easier maybe sometimes to have a power to change lives and to influence people uh to have the opportunity to really Work on, uh, profound and deep, uh, change in people’s life, way of thinking and way of working.

So I would say today, uh, and today, uh, it’s even stronger for me because we are beginning from the start a whole new project. This Women’s Cancer Institute is from scratch. It doesn’t exist yet. Uh, so I’m building a whole new team now, and this is a great opportunity. Opportunity to me to have the opportunity to really work on, uh, personal life and, and, um, uh, professional life balance, for instance, and, and, and truly get to know people to get the best of them.

And, uh, and to help them, uh, get bigger and bigger, uh, in a, in a federative project that this is really something important for me. I, I, I meet a lot of people that think. Managing more and more people is a, is an achievement is an objective, but that’s not my objective anymore. I would say smaller teams are sometimes a bigger way to, to move forward to have an impact.

Naji Gehchan: So I want to, I want to go there. I want to go on two things. First, if you can tell us, uh, what, what’s your, what you’re trying to achieve in the women’s cancer Institute, as you said, you’re just starting. So I would love to, uh, for our agents to learn more about it. And from there, tell us how you’re thinking about building your team.

What are you looking for while hiring people? How do you build your team for you to be able to achieve the purpose of, of this Institute?

Jessica Leygues: I would say it’s all about values, but maybe I shouldn’t say that too loud because in France, you know, it’s all about the curriculum vitae and your background and your, and your.

Um, you know, degrees and so on, but actually when I look at CVs, I don’t, I barely look at the, the, the, uh, higher education background. I look at what people do in their personal lives, their engagement and so on. And this gave me. A sense of what they are what they truly are. Um, So again, i’m not saying it’s what everyone should do or it’s it’s enough But that’s where I start and for me, it’s really important.

And now we are starting this new team and really I they just Uh arrived a few days ago So I will tell you in a while if it’s working But this is really all about values and and shared share an objective a common objective You And another thing really important, I think, is, uh, it’s quite obvious, uh, you, you’ll tell me, but fight for what you believe in, and, and I know sometimes it can be really, really harsh because, uh, there are so many struggles, so many big challenges we are facing now, and we are all feeling guilty because sometimes we are not able to, to go to 100 percent of what we would like to put in place, uh, if we, if we, Think about environment, for instance.

Uh, we are not all able to change 100 percent of our lifestyles. Uh, but I truly think small steps are important and, uh, a step by step approach is really, really, uh, impactful. Um, and this is a small water drops that feel oceans. So this is also some, something I’m trying to work on with the teams. I, I’m looking to, to work with is really it’s you.

Um, to, to get happy with small victories and to work on concrete, small projects. Another thing I learned is that when you have, um, a strategic work plan and you know where to go and you’re really frustrated because people can’t always follow you, uh, it’s my, one of my key learnings is that you really need to stop and to help people Get on board and to listen to them and to help them, um, Getting into it and and feeling that this is a common project and again to do so you have to work on really Concrete things really small projects We all have Really high expectations and ambitions that we want to go there at once uh And and this is and i’m saying this but this is still something where i’m working on because sometimes it’s still frustrating things Don’t go fast enough never but on a human perspective, this is so Intense and so rich to stop and to talk to people and to learn from them and to include everyone’s vision into your yours into your vision and uh Bye Actually, you can’t do anything if you don’t, if you don’t do that.

Even though you succeed, if you’re by yourself, nothing works. So step, small steps, inclusive way of thinking, participating way of, of decision. I think this is, uh, what I learned, uh, along, along this short wait.

Naji Gehchan: Well, these are incredible gems you’re bringing. You know, you talked about small steps, you talked about inclusiveness in the decision making, um, and really this idea that you said, like, fight for what you believe in.

So along those lines, I’d love to know if you also go through your COVID experience, right? Like you had to manage through tough times, you have to manage on reindustrializing a country, sovereignty, et cetera. But if we go on the leadership aspect of all this, sometimes I feel like we, people can be hang on the idea they have in mind and fighting.

This is why I wanted to take what you said, like fight for what you believe in. Am I assuming correctly that you’re thinking about a general belief, a general purpose that you want to achieve, fight for it? and really get those small steps done for you to get there. And how do you think about this while managing team with setbacks?

I imagine during COVID times you had a lot of setbacks from different parties and then sometimes beliefs will go down or we’re never going to achieve it. How do you deal with this on a daily basis with a supreme, like a very moving environment that was COVID for you?

Jessica Leygues: This is a really good question. And even more accurate that I got, um, to the, um, uh, medicine management in April 2020.

So at the beginning of the COVID crisis. So had, I had never seen the team I was about to, to manage. And as you said, in a really moving and challenging environment where needs and expectations were just crazy from day one. But even though external issues and challenges and business model, uh, um, questions and positioning in the ecosystem and relationships with, uh, institutions and our members and so on, we are crazy.

I. Spent a lot of time internally with the teams because this this This organization is non profit as you said uh, it’s an it’s it’s something you you join because you want to Help and you want to be useful and and the team I joined at that time was Lost because the business model, it’s still, even though it’s not nonprofit, you have to pay people and it’s a 30 people team.

So you have to find ways of sustaining a certain amount of revenue. Uh, everything was changing so fast. We were wondering if we could hold on a nonprofit, uh, model, or if you were becoming a startup. You know, and it was really deep as a, as a questioning for, for, for the team, for the, uh, the values and the, the, um, the objects, uh, itself of the organization.

And to me, it was really important to spend. more than half of my time with the team to understand how we could build something that that would be really, uh, differentiating and impactful on the outside. And this was at the time quite, um, new because all, all people that succeeded, that, uh, preceded me, uh, didn’t Choose this way of working.

They didn’t spend much time inside. So it was a it was new and we built Values we built what we wanted to do with this organization and I think this is one What what really explains what we were able to achieve over the the next years and during uh, the covid crisis during which we had to again to understand, uh, a few thousand of of uh, You Players Expectations and so on and find the best compromises and solutions to help the whole ecosystem to grow so again What helped me is listening to these guys.

They were very different people, of course coming from different areas and Younger and and and older and so on but I learned from them and the the idea I I built on what we should achieve was theirs actually was it was really a Co a co construction And and I think this is So that’s something, um, that drives me over overall, because if I sum up the objective of the project I’m leading now, the Women’s Cancer Institute, actually, we’re talking about basic research, translational and clinical research, uh, care, But it’s all about a holistic approach, how to better understand what really matters for patients.

Um, what is their lives, their situation, their psychosocial environment, um, and how we can help them as much as we can. But, On their definition, and I know in the health care system, it’s really difficult because, of course, everyone wants to do their best and think they know what’s best for people, but it’s not always what we think.

So it’s all about including patient feedback, um, to build really personalized answers to every individual. And this is why this project is so important to me. And this is why we called it the Women’s Cancer Institute. It’s not the Breast and Gynecological Cancer Institute. It’s all about people, in this case, women.

But this is really, again, a matter of connecting to people, listening to their needs and co building what we can achieve with them. not thinking we think what we know and what we think is better than theirs.

Naji Gehchan: I, I love it. And I’ve, I’m sure you will have a tremendous impact that is needed for patients and women specifically, uh, within this Institute.

It’s, um, it’s so important. And I totally relate to what you said, like several times. We think we know what other one versus actually listening. And hearing what people want and act on it. So I love that it’s the core and heart of what you will be doing. Jessica, I want to go now and give you a word, and I would love a reaction to it.

The first one is leadership.

Jessica Leygues: It’s funny because these days I’ve been thinking about how leadership is close to Being a parent and how to think about health care as I just mentioned and I think and I heard Um a u. s. Psychologist a few days ago. I’m sure you know her It’s becky kennedy and she said for her a parent and a leader Was someone able to connect to to himself herself and connect to other and it was a definition of Sturdiness and I really connect it to this definition.

I think this is really something that that defines me as well um, because again, I think our strength is is is this Synergy this this ability to learn from others to better understand how they work what they can bring to the world to A family, an organization, a society, uh, and it’s just the same thing with patients.

So I would say leadership I could of course I could mention exemplarity and blah blah blah But what I really want to focus on today is really this this Ability to connect to others But also to connect to yourself. And this brings us back to what I mentioned before, fight for what you believe in. You really have to, um, to be aligned with what you say, how you act, what you represent.

And I think a good leader is someone who managed to do that. And it’s not easy, of course. And not everyone has the chance to find, um, the right place to do that. It may be a lifetime, uh, journey.

Naji Gehchan: Yes. And you talked about this alignment, right? Like the heart, brain, and practically the hands, right? Like that will make it, that will make it work.

The second word is innovation.

Jessica Leygues: I could spend days on this word because, uh, definition is different from one context to another. I think I will repeat myself, but for me, how, how. Translate, uh, discoveries into progress. It, it’s what we look, uh, we, we are looking for when we talk about innovation, and it’s all about, again, including the users into the whole process of innovation.

There are people with really bright minds and good ideas and the best intentions in the world that. Develop solutions without including, uh, the potential users. And we see that a lot in healthcare and specifically in digital healthcare solutions. And it has been a really strong fight for me when I was leading, uh, the medicine bio cluster.

Because, yeah, it doesn’t work. When you don’t, when you don’t work with people for these same people. So I would say it’s all about co construction and the ability again to connect and to understand what are the true unmet needs. Sounds obvious, but we see every day that even in 2024, it’s really not easy.

Naji Gehchan: I fully agree. And it’s like less construction these days than building together. But you’re here. This is why we’re here, right? This is why we have leaders like you and, and several of us trying to make it work. The third one is women’s health.

Jessica Leygues: Again, a lot, a lot of things to say. Um, Maybe I would start with a few, not figures, but at least, um, pieces of information. What we notice is that the, um, the number of, of death by cancers decreases more slowly for women than for men.

What we notice as well is that, um, in when, uh, when a cancer arrives in a couple, it happens a lot that the couple doesn’t survive. And it’s six times higher when the woman has a cancer. Of course, I’m talking about, uh, it or couples. Um, so these are a few examples of what we wanted to look further into, uh, women’s cancers.

More specifically, if I go back to women’s health more broadly, there are cultural challenges from the design of, uh, clinical trials to the way we look at symptoms of a, of a disease, um, uh, the way we look at the pathology. The how you how you use treatments everything is based mainly on men tests, uh, we know much better how a man reacts to a stroke or or any Uh a high number of uh Not funny, uh, events.

So this is a lack of chance for women because they die more because we are not able to help them as fast as we do for men. Uh, so this is again, something we have to tackle. And I don’t know that the exact figures of the world, but in France, it’s really, really high. There are cultural reasons. There are, uh, factual reasons.

I mean, even from the preclinical tests, uh, on mouse models, Uh, it’s male models we use most of the time. So we would have to change a lot of things. Um, and, and we have a lot of examples also of things that are moving quite slowly, but still they are moving. If we talk about. Endometriosis, I don’t know how to say that in English.

Um, for years and years, we thought that that women were just complaining about usual stuff. And it’s quite recent that we realized maybe it wasn’t only that. Uh, so, so this is a really a way of looking at things. And again, now this topic is on the table. I can see everyone is looking into it and I’m sure things will, will be able to evolve.

more efficiently than other topics. When you think about the fact that a few decades ago we thought babies didn’t hurt.

Naji Gehchan: It’s

Jessica Leygues: just crazy when you think about that now. Okay. But at that time it wasn’t. So we have to change the way we, we think of the way we look at it. It’s really a cultural matter. And this is why this Women’s Cancer Institute is quite a, comprehensive project because it involves as well prevention, health literacy, the way we tackle fake news.

So it’s really a broad approach, not only about how to better understand, um, uh, the cancer development and the, uh, the spatial temporal evolution of tumors, for instance. It’s not only that, it’s really much, much, much broader because we have to change the way We think and the way we act, even though we don’t realize it at all.

Naji Gehchan: Yes. And I love how you’re framing it, right? It’s really a social change that you will be acting and that we all need to act on versus just gathering data or fixing, you know, a disease. It’s, it’s beyond that. It’s really the way we look and think about things. And, and it’s interesting not to open the very hot topic of AI these days, but obviously, as you said, like, Everything is based out of data for white male.

Of a certain age, right? I’ll stop there. I don’t know if you want to. Yes.

Great. The last. No, please go ahead.

Jessica Leygues: No, no, it’s just about to mention that, um, again, AI. There are a lot of hurdles to be able to. Make the most of it and in france particularly and we were talking about social issues and cultural issues That could be another Dedicated podcast though. I won’t be long on this matter.

But again understanding what what what people uh fear about it Would be really helpful to unlock a lot of things in France at least Because when you see that people are able to share their data on any Channel, uh social media and so on but as soon as you talk about health Nothing is possible. I think we We haven’t Tackled the issue the right the right way yet

Naji Gehchan: The fourth word is spread love and organizations.

Jessica Leygues: I think we quite covered the topic actually from different parts, but it’s all about being yourself and connect to others. And I’m not sure love is the word I would use to, to talk about all of this, but actually we talked about kindness, care, deep interest, true listening, relationship, trust, respect. So what, what is it if it’s not love?

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Jessica Leygues: What comes to me first is the, is the Pareto distribution. Another thing I had to struggle with and to get over my frustration about was the fact that you cannot bring everyone with you. Uh, and actually it’s not a problem if you think about the 20 percent of early adopters and people that will be able to follow and to try and to experiment, uh, and then build on success stories.

That’s actually a quite good way to go. And for healthcare, I would say it’s also the way to do because there are so many difficulties in the global healthcare systems in terms of time, in terms of sense, crisis for different healthcare professionals types. And I would say work, experiment on what’s, what’s, what you truly believe in on a, on a, on a team team.

Scale on a hospital scale and then being able to show how it works and how you can spread it I think this is always a um Yeah, something to try and and go by even though it’s still frustrating on a day to day basis for me So I’m saying that to myself actually

Naji Gehchan: Several times what we reach we are applying it and trying hard to apply it for ourselves It’s it’s Well, thank you so much again, Jessica, for being with me today and this incredible chat.

Jessica Leygues: Thank you for listening to me and I hope it was useful and I’ll be happy to hear the hundreds of people you, you interviewed and, uh, and, and please continue doing what you do because this is so important.

Naji Gehchan: Well, thank you so much. It’s a, it will be beneficial for several of us listening to it. More episodes in partnership with the ESCP Business School are available on spreadloveio.com or wherever you listen to podcasts.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Mark Namchuk

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. I have the pleasure to be joined today by Mark Namchuk. Mark joined Harvard Medical School in January 2020 as the Executive Director of Therapeutics Translation. In this role, he works with HMS scientists to identify and harness basic insights into clinical therapies, creating an infrastructure that advances the School’s scientific discoveries along a translational trajectory while training the next generation of therapeutics investigators. Mark joined HMS after a 24-year research and development career in the biotech industry, working in a number of areas that included drug discovery, translational science and pharmaceutical development. In 2015, he joined Alkermes as Senior Vice President of Research and Nonclinical and Pharmaceutical Development. Mark had previously held a number of senior research positions at Vertex Pharmaceuticals over 17 years, including Senior Vice President of North American Research and interim Global Head of Research.

Mark, it is great to an honor to have you with me today!

Naji Gehchan: Before we dig in your masterclass during the summit about Optimal Roadmap from a New Idea To a Helpful Medicine, I would love first to learn more about your story and how you became this influential leader and pioneer in biotech?

Mark Namchuk: Sure. Uh, I always, from a scientific standpoint, what I first fell in love with Was how chemistry and biology interacted and and more specifically how biology seems to use energy in the most creative ways to do biological processes or get things thing one to stick the thing to.

And after finishing my PhD in enzymology and doing a postdoc in immunology, uh, I got my first industry job, uh, and about two years into it, this was when I was at Cubist, uh, I was made a project lead for my first antibacterial discovery project and really fell in love with the process of drug discovery, um, really from a scientific perspective, in order to do it well, you need to understand Chemistry, biochemistry, biology, pharmacology, properties of molecules, medicine, all of the pieces and how they fit together.

And every job I took since then has always had a little bit of that piece still in it. Uh, so as I, uh, left Cubist and went to Vertex, uh, started out at the bench and then was there quite a while, uh, and ended up in a more senior position and really had the opportunity to see Vertex go from a company that had its first drug, uh, all the way through to where it ended up today.

And that journey, uh, all the way along really kept to those same principles of. A love of what applied science and drug discovery can do, how can we do that better, how the pieces fit together. Uh, and then similarly, when I went to Alkermes, uh, different therapeutic areas, first time I’d worked in CNS drug discovery, uh, really passionate about trying to improve, uh, healthcare in the area of serious mental illness and addiction, and still very passionate about that area.

But a different, um, stage in my career. I came in as a senior person, wasn’t sort of building my career all the way through. So an opportunity to take a lot of the lessons I’d learned earlier in my career and, uh, decide how I wanted to build the research culture there and a chance to, rather than grow along with a company, but maybe put a stamp on something in the way I’d like to build it.

Naji Gehchan: So I want to go there because in the first chat we had together, we talked a lot about leadership, the culture we build and how this impacts science and ultimately the patients we serve. So you you’ve done it, uh, growing in a company, starting a company, you’re seeing company kind of being built and then going to the next stage.

What is your main leadership learning as you’ve done it and how you think about leadership, building a biotech science company?

Mark Namchuk: Yeah, I think I would touch on something you said in your intro. I, I’m a big fan of this term servant leadership. I think the first thing I’ve always felt is very important is to remember that drug discovery in particularly in the earlier phases through phase two is a deeply creative enterprise.

And everything you should be doing should be fostering your ability to support that creativity. So what are important components of that? A, uh, the people who you have on the team. Do you bring in people that A, have, uh, it, especially in Boston, we have this wellspring of extraordinary scientific talent, but there are these other pieces that are very important too.

How well do they think across disciplines? How much do The people on the team love working with that individual. Um, B, I think we all are familiar, particularly those of us that have worked in industry, there’s timelines and there’s milestones and all these pieces that can be important. You can’t let them, you can’t let the process completely hijack the creative enterprise.

And as a leader, sometimes your job is to fight that a little bit. And then, uh, I would say, lastly, uh, one of the things I always tried to do, and, uh, hopefully did well at times, but held my leadership teams to, is a couple of basic principles. The first is, Your job as a leader in of an enterprise like this is to be the coolest person in the room.

When bad news comes, your job is to also be the person that takes all the stresses that the company might put around that bad news on yourself so that your team feels free to still work creatively and do the jobs that they were hired to do. And B, how approachable are you, uh, from a scientific perspective?

I think too often you have, uh, you have scientific leaders that, uh, feel like their job is to be the smartest person in the room. And I always felt that, uh, That my job was to, to, uh, with conscious intent, not be the smartest person in the room, surround yourself with people who are brilliant and know that your job is to conduct the symphony, not necessarily, you know, ultimately, as leaders, sometimes you make the final decision, but you’re really trying to give everyone in the room a chance to play their instrument well, contribute to the beautiful music and feel like their part is being valued and seen.

Naji Gehchan: I love this example and image, right, about being the conductor and making sure that everything at the end, the creation of all those individuals and people, we’re doing it as, uh, as a larger team. Uh, and as you build this one key component in drug discovery development, I’d argue in any company, uh, is how you build this so that people can stay creative.

And deliver, because as you said, you touched on the timelines, certainly we need to deliver on timelines. You’ve lived also companies. You said from the very first idea to them becoming commercial, how do you combine all this? I know that you talked about servant leadership, the notion of trust to be able to make it happen.

Any, any big learning you would say to us as leaders and operation operational leaders. to keep this happening?

Mark Namchuk: Yeah, uh, maybe two things. Uh, maybe starting at the team level first, uh, one of the, I was really influenced by the book Quiet. Which is a book on introversion and, uh, many scientists are quite introverted.

And I think we’ve all been on teams where you’ve got the classic, uh, type A personality that dominates the room, et cetera. I’m a relatively type A person. So I find myself having to censor myself at times, but what are you doing in that team environment when you’re running the team to ensure that that brilliant quiet voice is heard, right?

At the right time, and there’s simple things you can do that, for example, is, uh, for folks that are, uh, That need a bit more time to think deeply about a problem, get in contact with them two days before the meeting, cue up what the topic is going to be and not necessarily have this as a debate exercise where in 30 seconds, you have to articulate your point of view, building a culture around all those ideas being heard and valued structuring meetings.

So there’s places where you genuinely intervene and those quiet voices are heard. I’ve found to be the most productive way. To make sure that all the ideas that are on the table to foster creativity. Uh, I would say the second piece, maybe a level up from that is to understand that when you are the leader of a project and a goal has been set.

When you’re going to take the responsibility for that goal, but sort of let the team off the hook. They’re 1 of the things that I really believe in is, uh. That ultimately for a scientific enterprise, you have control over the quality of the experiment. If you’re doing really creative science, you have no control over the outcome.

So as, as you get into a more senior role in a company, your salary, your bonus. And your responsibility is to the corporation. You now have, if you run a larger group, many ways that you can be successful. I can have project one work. I can have project two work. I can have project three work. That’s not the same as if you’re only running one project or if you’re running a component of that project and giving the people in the team the opportunity to continue to do good work and understand that if, even if the project doesn’t turn out the way you hope, but they did a work that they’re going to get an A is one of the most important ways that you can ensure that people continue to take risks in the work that they do, as opposed to try the easiest things.

And then I would say lastly, and this is something I talked to the students at Harvard Medical School a lot is, um, I think of biotech in particular as an argument between science, medicine, and business. And it is at times an argument. I, I think any of us that have been in senior management have been in times where everyone is working in accord and in times where it’s a relatively vigorous debate.

Um, I think if you get into a senior role like that, Part of the art is knowing whose turn it is to win. So if you’re the head of research, do you know enough about clinical development to know that for this project, it is now the time for the clinical development group to win in the argument. And that means you maybe don’t do some things you’d like to do or for the company as a whole, it’s time for the financial argument to win.

And so I think from a leadership perspective, training yourself to be bilingual enough that you can have a good conversation with the head of clinical development or the CFO to come to a good conclusion is really important, but also knowing when it’s your turn to push. That it’s researchers turn, for example, more of my career to win for lack of a better way of putting it, finding that balance is very important.

And I think that getting those right is how you can balance the necessities of the company at times, but not necessarily have the corporate goals washed down to your entire team where they feel like suddenly they’re responsible for the stock price. I think that can be a very dangerous way to make people take on a pressure, which honestly, as a leader, that should be your.

Not necessarily theirs. They should be creatively going on to do great science on the next experiment.

Naji Gehchan: Those are incredible insights. Thanks for this, uh, Mark. There’s a lot, a lot to learn from, uh, from what you said. And if I take them now from the leadership aspect that you brought, uh, into what you will be sharing and what you shared, uh, during the summit, really the roadmap and the optimal, uh, roadmap from new idea to a helpful medicine.

So there is. A lot. And as you said, so this is why I love starting with the leadership aspect of things because we hear about all those innovation, but drug development, discovery, development, and bringing it to market is hard. We’re constantly humbled by all those discoveries that never gets there and few of them getting there.

So, I’m eager to hear a little bit about your thoughts on what is the optimal roadmap and how can we bring those ideas from ideas to patients, actually.

Mark Namchuk: Yeah. And I think, uh, uh, I’ll start by saying, uh, I, I have a phrase that I use a lot to build on what you just said is, is, uh, biology will treat you, teach you great humility.

And so understand the world that we’re in, no matter how well planned we’ll have. Uh, I think that in my current role at the medical school, uh, a mission I, I, I want to take on. And I think is a value is to understand the impediments. Between an initial insight at the bench. To getting into phase two, where we can really ask that question in a human being, is this a medicine that has benefit and is well tolerated enough to be used?

I think you can divide many of those impediments into a few buckets. One thing that we’ve tried to do, Uh, within the therapeutics initiative is to bring expertise that would more typically be seen in the pharmaceutical industry in drug discovery science and have that scientific expertise available at the highest level to our P.

I. S. within the H. M. S. community right from the beginning of their idea. So if you are thinking about translational work, Can we partner with you as translational scientists? You’re a brilliant P. I working at the cutting edge of biology in this particular area. You’re interested to see what might happen in terms of drug discovery with that idea.

Let’s make that easy to do. Let’s bring in scientists that you’re going to respect because that are scientific imprimatur. Let’s have a science first conversation. As opposed to this is what you’ll need to do to get an investment opportunity. Let’s really focus on the science first and see if those initial steps can be done more efficiently.

I think the adjacent component to that that I’m very interested in doing is rethinking academic industry collaboration to make the transition from that initial idea into more hardcore drug discovery more efficient. One way to do that Is to work on collaborative structures where scientists from a company, for example, and the academic scientists are working hand in hand very early in the process.

And when benefiting from both sets of expertise to try and get to the best world that one can to, um, be able to, um, move that idea more efficiently. So, and then at the philosophical and business level, I think that we need to put more emphasis on the, how well a partnership facilitates high quality work, moving from the initial idea to phase two as a primary goal.

Maybe even when that might make the financial terms a little different. As opposed to the financial terms as being the primary goal, which sometimes can happen in these negotiations, particularly depending on what the stages of an asset and I think there is a lot of work that can be done to really harness the benefit of scientific minds on both the corporate side.

And on the academic side where everyone is doing what they’re really good at. So I’ll give you, let me give you like one concrete example that really bugged me during the COVID pandemic, but I think is, is a great example where there are things that, uh, we’ve done in industry for decades that are not as well inculcated into academia yet.

So, uh, if you’ve ever worked in infectious disease and you’ve worked on an antiviral or an antibiotic. You know that in order to have a clinically effective agent, you need to essentially shut down all replication of the pathogen. So for antivirals, and this has been shown for SARS CoV 2, for hep C, for HIV, if you take the, uh, adjusted for free fraction, IC90 plus potency of that molecule, it’s a reasonable predictor of clinical outcome.

And yet, for numerous, I’ll go as far as saying thousands of publications that came out from the academic world during COVID, they would use the IC 50 as the main driver of both efficacy and therapeutic index. And because of that mismatch, a lot of the work we did in drug repurposing was never going to work.

There’s an example where if what we knew on the act on the industry side in terms of drug discovery was more broadly disseminated in the academic community, I think we could have done more productive academic research during COVID. And those, that’s just a simple example of the secrets we don’t share with each other very well, but that the science in the middle could be so productive.

Uh, and so I think that’s really what I’m, part of what I’m going to talk about at the conference, but also I think a bit more of a call to action to rethink the process. I think there’s a lot of benefit to everyone involved, but to build it around scholarship and scientific advancement.

Naji Gehchan: Great. Uh, you’re talking and focusing really on the collaboration that we can do between academic partnership with, uh, with industry. You’re mentioning also about a different way of thinking on investments, right? Like where to take the risk. You’re pushing towards, if I understand well, and this is what I would love to dig a little bit deeper, um, early on starting to think about the phase two trials and how you’re getting to clinic and probably take a higher risk.

If I understood well, in the beginning to be able to keep being creative and building the drug that will get to clinic faster? Am I, am I getting it the right way?

Mark Namchuk: I’ll

Naji Gehchan: clarify

Mark Namchuk: it a little bit. I think that, that what I’m really advocating is, uh, if you’ve got a biology idea, even at the very beginning of an academic, in an academic setting, there are certain Experiments one can do that are more translational, that if you have a capability within the university and people that live that world, ask those questions earlier.

So in a way it’s getting to some of those hard questions very early in the process. Academia will never do a translational work on the scale that industry does. It’s just cost prohibitive and skills prohibitive, but are those first framed in a way that if the answer is yes. All parties, including a partner, subsequently, would see value in that answer.

And I think it comes back to being informed by what questions will eventually be asked as you go to the clinic. So I, I, I know your background, Nadja, you and I are fellow travelers in some of this. I always like to think about a project in the early phases in my industry days from designing the proof of concept trial.

To economize on the experiments you were doing to decide when the drug was ready to go. It’s set your pharmacology strategy. It’s set your non clinical development strategy. It’s set whether you had to invest heavily in a biomarker and find a responder population versus you didn’t need to and I think that same sort of thinking going to be applied in maybe in a less comprehensive way in academia.

So, uh, I, I, I think it’s less about, uh, the economic de risking. It’s more about the value of trying to find scientific synergy earlier in answering those questions in a different order than we have traditionally.

Naji Gehchan: Marc, as you were, as we were talking also about those, um, efficiencies as you frame them in those partnerships. I couldn’t, but you know, like these days everyone talks about AI and some use cases, right? And you gave this example about COVID, IC50 versus IC90. How do you think about AI in these things? You know, and I was, as you were describing the COVID example, I’m like, yeah, well actually if data is proprietary and we’re not putting it out, probably we wouldn’t have even know, like AI wouldn’t have picked it, but I’d love to.

Got to get your thoughts about use case of AI in drug discovery and improving efficiencies in the system.

Mark Namchuk: Yeah, um, I think a lot of the best use cases for AI are probably taking place in companies right now because they’re a gonna have a much deeper bench of data. That they can go back to an AI, like any computational approach is going to be best informed by best information.

So I, I, I can say that, um, a lot of work is being done in small molecule generative AI. That’s quite impressive where you can do more from an initial crystal graphic structure. Do a good job of a comprehensive early chemistry campaign. And I think that work is just getting more and more productive. But I would go back to, uh, it’s best informed by having a real bonafide hit on a real bonafide structure.

A question I’m asked a lot of times is, uh, now that we have alpha fold. Do we need all of these other iterative methods to do structure biology and things and the feedback I hear from my corporate colleagues are doing this every day is alpha folds. Okay, but it is a relatively low resolution. Apo structure so a little at this in its current incarnation.

Not that informative from a design standpoint. Now, will it get better with time? Sure. But I think we still have to go back to having a better partnership between the advances in AI in the experiments we run. And I think that partnership, but in the academic setting, one of the things that I, um, I would like to see more of is, uh, Really advanced computational people working hand in glove with people that have deep expertise on the drug discovery side.

So the experiments are designed and then fed into the most advanced models. Let me give you another concrete example is there was a lot of work used done during covert around, uh, repurposing to identify Targets that could be useful targets for covert infection based on large screens of of either the existing pharmacopeia or pharmacologically active molecules.

And, uh, often the mechanistic conclusions that would say, oh, this particular receptor is important for covert replication. We’re flawed because the screens were run at very high concentrations of molecules that are highly molecularly promiscuous. So that there’s nothing wrong with the AI and the computational people are brilliant.

And, and so, but what was fed in, uh, one specific example I, that I was, uh, uh, was some work I was involved in was, uh, seeing that, that, uh, receptors that were more traditionally involved in. Uh, psychiatric medicine like serotonin receptor, et cetera, we’re coming up in rescreening with molecules that hit those receptors, but at very high concentrations of the molecule, if you look at the pharmacologic profile of those molecules at that concentration, there are 100 targets that could be interacting at that concentration.

So it’s a simple example, but I think it’s where we have to think about. Goes back to the symphony example, how do we work together in experimental design to marry the advances that we have in machine learning pertinent data to the question being asked. So, I, I would like to see that done better. I think that’s held back having this, like, aha moment and true drug discovery for AI.

The advances are extraordinary. Our ability to create data is extraordinary. Um, but I, I would like to see it better married, I guess, would be my point of view at this point.

Naji Gehchan: So, Mark, I’m gonna now, uh, give you a word. In this section, and I would love your first reaction to it, whatever it comes to mind. All right.

First one is leadership.

Mark Namchuk: Uh, my reaction to it is I don’t know that there is such a thing as leadership as a proper noun. I think for it to be real, it has to be a blend of, of you and your authenticity and how that melds to the work that you’re trying to lead.

Second one is innovation. I don’t use the word anymore.

Naji Gehchan: Tell us more.

Mark Namchuk: Yeah, I, I, I, uh, it gets used so often in so many different contexts. I don’t know what to do with it. And so, uh, I, I will admit this is more of a personal thing. I have a bit of an adverse reaction to the word now, because so many things get categorized as innovative, and the beauty is in the eye of the beholder.

So, uh, I, I think I would, I guess if I was giving a one word answer, I would say overused. In the sense that, uh, I don’t know what it means.

Naji Gehchan: I love this reaction. If I take the word war that is also already used, innovation, breakthroughs, like all those words, the buzzwords that we have and really apply it to medicine and what we talked about, drug discovery and development and really outcome is bringing them to patients at the end and changing their lives.

Is there one that you’re most excited about for the next decade? Is there one technology? I want to say one innovation, but I’m afraid not to say the word innovation.

Mark Namchuk: Yeah, I would say no. I think as a, maybe a broader principle is, uh, if I look back to when I started 30 years ago, we largely had small molecules and the dawn of protein therapies as our only two, uh, methods.

for manipulating disease biology to get a good clinical outcome. That, those days are done. And so now there is a plethora of tools. They’re at varying levels of maturity. And I think for the first time we can now look at a disease and say, let’s pick the tool based on the nature of the disease, as opposed to say, we have to make a small molecule to treat this disease.

And I think the potential for that Is enormous. Uh, I think all new technologies have their impediments. So, for mRNA or RNA based therapeutics generally, uh, nucleotide based therapies generally, delivery is a big issue. But I think over time, that will get better and better and better. I don’t know where the speed of light for that will be, but I don’t bet against the progress.

And it just opens up an entirely different way of looking at a medicine. Like it, I’m not so sure we have to be concerned about drugability anymore. Because we have this whole argumentarium of ways that we can go after something at the expression level, where the only thing it has to stick to is the messenger RNA.

And that, that I’m very excited about that. That opens up enormous areas that we could get into that just were not available two decades ago.

Naji Gehchan: The third word is health equity.

Mark Namchuk: Yeah, I think that, uh, a responsibility all of us have to live into as best that we can, uh, probably as a discovery scientist, one of the places where I often feel like I can do the least good in the sense that, uh, the biology leads you to different areas that, uh, something looks like a good target.

What you’re going to take to the market is dictated by developability and commercial viability. So I think that an area where, uh, in my current work, I think a lot about it, and it comes back to the health equity principle, is there are areas of enormous Unmet need where, um, they’re just not great areas, uh, economically, but perhaps we can have more of an impact at the academic level.

A specific example of an area that is in enormous need of I’ll use the word innovation. Uh, but, uh, advancement, uh, is addiction therapy. Very difficult business. Generally speaking, uh, the, uh, the neurobiology is very complex. Yet, uh, if you take a look of places where addiction is most prevalent, it’s hard to not come to the conclusion that economic disparity in some ways is overlaying with our ability to get good care for these sorts of things.

And so I think there are, uh, disease areas that. Um, we should really put concerted efforts behind. I think they can disproportionately affect our most vulnerable and we can have, for example, have a cancer moonshot. And I think that’s a very worthy thing to do. But we have a pretty good system for bringing cancer therapies to patients.

It works quite well. I think the shame of it is our system for advancing medicines. Often fails worst in places where the economics, uh, and the people who would be best served just don’t have access to that medicine. I mean, uh, infectious disease is another great example where, uh, a lot of, uh, a viral infectious diseases are, are going to be most prevalent and most devastating in less prosperous countries.

And so how do we square that up again with my background being more as a discovery scientist? How do we get better discovery science aimed in those areas in a credible way that it actually eventually becomes a medicine? This is definitely something I’m thinking about in my academic career.

Naji Gehchan: Um, certainly in my work, as, as you know, I’m also constantly thinking about this and also my, where I come from, my upbringing is certainly something that I’m very attached to.

The last word is spread love and organizations.

Mark Namchuk: What was, I’m sorry, what was the first word? Spread

Naji Gehchan: love and organizations. And organizations.

Mark Namchuk: Uh, so, uh, boy, could we use a little more spreading of love these days. So I would just say bullion, let’s do more of it. I think that there, there’s a, um, there’s a, uh, a debate going on in our society now that I think would be well served To maybe embrace that philosophy that you brought up.

So I spent 24 years in the pharmaceutical industry, and I can think of no industry that is more roundly criticized yet. Uh, if 1 takes the economics out of it and takes a step back. I think a lot of the work that’s done in the medicines that are produced are unto themselves pretty virtuous and can help a lot of people.

So I think from an org, when we think about organizations, and we think about our critiques of organizations, and that can be government, that can be different companies, that can be different corporate entities. I think the organizations themselves need to think a little bit more about their sustainability.

Through the lens of how they benefit society and not just the pure money of it. And there’s, I, I’m actually kind of a, uh, a fan of the whole principle of conscious capitalism, where capitalism is very efficient, but it can have a heart. And when it does, it’s often a better business. I don’t think you have to separate those things.

And, um, I, I think that. One thing I’ve always believed and have been saying a lot lately, unfortunately, uh, just given how loud our arguments are these days is try and find the 10 percent of truth in any criticism. And then maybe take the moment to go back to the critic and thank them for that truth. And that’s just not our reaction these days.

And so I think that, um, we could all present company included do a lot better at trying to see the, the virtue in what someone’s bringing up as an idea or an advancement rather than only the critique. Maybe that’s a better way to find some mutual express on our way to trying to be a little bit more loving.

Naji Gehchan: Try to find the 10 percent of truth. I love it. And the criticism. Well, any final word of wisdom mark for healthcare leaders around the world?

Mark Namchuk: Sure. Uh, well, first of all, thank you for having me. This is fun. And I appreciate the opportunity. I think the, um, one thing I would say is, uh, what ultimately we do when we do it well, is a valuable and virtuous thing.

And I think when we’re focused on that. Uh, you know, if you go back to the old George Merck quote about being patient focused 1st, uh, I think we ultimately are both better, uh, more productive people. We give more back to society, but we create followership of principled people that are in things for the right reasons.

So, I think part of being a servant leader is making sure that your mission is appealing to the kinds of people that you want to have in your organization. So, I think, uh, all healthcare leaders. Have an obligation to explain to the folks that work for them the, uh, ethos of what they do and why what they do, uh, is, has, uh, value in its principles.

And I think that often is, uh, is going to get you a lot more buy in than the dollars and cents arguments, which we have to manage, but I think are often not as compelling.

Naji Gehchan: What a great way to finish our conversation. I could spend hours chatting with you. It was a real pleasure. Thank you again for joining me and being with me today, Mark.

Mark Namchuk: Thank you again for the invitation. It was a pleasure.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform. More episode summarizing Boston Biotech Summit can be found on our website or your preferred podcast app.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Matthias Lambert

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. Matthias Lambert a Senior Scientist in the division of Genetics and Genomics at Boston Children’s Hospital, and Instructor in the department of Pediatrics at Harvard Medical School. Matthias identifies as a patient-scientist, navigating life with a rare congenital myopathy. His research focuses on studying the mechanisms that contribute to the pathogenesis of rare muscle diseases including his own genetic condition. He is actively engaged in pioneering efforts to advance cutting-edge therapies for these conditions. His work is supported by prestigious grants from the National Institutes of Health, the Muscular Dystrophy Association (MDA), and the AFM-Telethon. In 2024, Matthias plans to establish his own independent research group.

Matthias, it is great to have you with me today!

Matthias Lambert: Thank you. It’s a great pleasure to be here as well.

Naji Gehchan: Before we dig in drug discovery and development, your passion and your focus during the summit, I would love first to learn more about your story and how you became this incredible leader and pioneer in research.

Matthias Lambert: So I was born in France. So I’m from France. Um, I went to science school. pretty quickly. So, um, after graduating from high school, um, I went to university in Lille. So it’s in the north of France. Um, I did a bachelor, master and a PhD, uh, on science, uh, and said physiology. And I was studying the muscle, uh, skeletal muscle.

And then I went for a postdoc. I went to Boston in, uh, 2017. Uh, I joined the lab of, uh, Luke Anker. Who discover the gene for, uh, the dystrophy in the, in the eighties. Uh, and so I’m working on different neuromuscular disease such as muscular dystrophy or, uh, al Myopathy. But more about my story, I would say I was a, a patient before being a scientist because I was born with a, a Lin Myopathy, which is a very rare, uh, neuromuscular disease.

Um, and so for 25 25 years of my life, we didn’t, we didn’t know the genetic cause of this is because I was the only one in my family, um, with this disease, very rare symptoms. And so when I was, uh, doing my PhD in France, I also had my physician in the same lab. Uh, so basically my physician became my colleague at the same time.

And at some point, you know, I was, you know, when I was studying the skeletal muscle, I, I, I went through, different papers that describe my symptoms for rare conditions. So I told my physician, you know, we should look at this gene. And basically what we did is, uh, took a blood sample and three months later the results came back.

And basically say that the gene that we were looking at was, uh, the good one. Uh, so it’s, this gene is called TPM3. And, uh, right now, I have established my, also my own research direction in the lab here in Boston. After my PhD, also working right now. on this DPM3 gene. And this is basically the, the basis of my future lab.

So yeah, this is my, my story.

Naji Gehchan: Wow. Thanks for sharing, uh, Matthias. And it’s, uh, it’s great advancement from discovering the gene to now opening a lab. Hopefully you can, uh, target that. So we’re going to talk about this. Uh, and I’d love first to get your high level perspective on drug discovery from a patient scientist.

As you would describe yourself, um, how is it different? And how do you think about drug discovery?

Matthias Lambert: I mean, this is different because we are not only scientists. Uh, basically the discovery that we’re gonna, we’re gonna make, they’re gonna be for patients, but also for us. Um, and so that’s the perspective is, and the, I mean, the perspective is very different because you wake up every morning and you say, maybe the discovery, the discovery that I’m going to make today, it is going to change my life.

Uh, in, uh, like, uh, health, uh, health wise. So, this is very, very important. That’s, I would say, the first, the first thing. Uh, and then, the, the, the drug discovery, uh, area, I think, right now, maybe, a little bit overlooked because we have a lot of gene therapy right now in the market, you know, we have CRISPR and I think it’s also a good time to, to, to recenter also our focus on genetic discovery because we have maybe more than 10, 000 FDA approved drugs that, for example, were not tested in my disease.

And so basically we have maybe drugs on the shelves that have maybe an effect on rare disease. So as those compounds, we know the toxicity of those compounds. We know that they are safe. Uh, they are already being done some development of those drugs. And so it would be very easy to, uh, repurpose, uh, those drugs to, to another condition.

Naji Gehchan: So as you were talking about it, you, you spoke about CRISPR, you spoke about probably screening the drugs that already exist. We know the talks about them and are they effective? Can I ask what are you most excited about from a technology standpoint that you think will literally change and accelerate drug discovery, uh, of, of this specific CPM3 gene, uh, and myopathy, but also in great diseases?

Matthias Lambert: I think I’m very, so I think there is two sides. I’m very excited by the gene therapy, uh, area because I think CRISPR, it’s an amazing tool to basically change the mutation, correct the mutation, the mutation you want, you can correct it. And we know how to do it in a dish. But right now it’s very difficult to get this correction to the cell in the body to basically deliver this compound, this technology to the muscle.

And so this is one thing that is very difficult right now. And we still more, I would say more development, uh, for the, I would say for the skeletal muscle area, for the neuromuscular disease area. Um, so that’s one thing. And the other thing is about CRISPR is right now. When you correct one mutation, it’s like I would say, like, uh, a personalized treatment because for a same gene you can have different patients with different mutations.

So basically you will need different design in your CRISPR to, to, to make it work. Um, so that’s, that’s one thing. So the second side I would say about drug, uh, so I’m talking about small molecule, it’s you can maybe find a small molecule like a common pathway across different patients. So it will be less personalized treatment, but like I would say a more common treatment across a population of patients.

And I think I’m very excited by combining both. So, having, uh, small molecules that could help the, for example, the delivery of the CRISPR in the muscle, that could be one thing. Or, decrease the toxicity, also, of CRISPR, that could be also another thing. So, I think The next step for me, as I see, is to combine a small molecule with a gene therapy.

There will be, you know, when you think about, for example, HIV, you have, it’s usually a tree therapy. You have three compounds that do different things. And so gene therapy is going to be the same, you’re going to have a cocktail of different drugs, different technology that will help each other to reach the same goal, which is to correct the mutation and to, to, to restore the pathology.

Naji Gehchan: So as you think about this, what are for you the biggest challenges you’re facing for you to be able to get there?

Matthias Lambert: Uh, money, funding, first, uh, people, second, uh, for, for example, for me, I would say on this disease, there is maybe five or six lives in the world working on my, on my gene for this disease. So there are only a few people working on it.

So the development is very, is, uh, slow, very slow. Uh, and also on a patient perspective. It’s even more slower, I would say, because you also, you have two different timeframe, you know, like one year for a patient is very long, you know, when in one year you can have your, like the series, you know, you can have, uh, the, your data that, that can, you know, be worse, you know, after one year, but for a scientist, one year, it’s nothing, you know, because one year you can get funding and you can get some preliminary data.

So it’s, It’s also a different thing. So first, yeah, coming back to, to your question. Uh, yeah, the, the, the, the people, the funding. So, I mean, both are, you know, together, you know, uh, if you don’t have money, if you don’t have money, you cannot, cannot hire people working on this. So yeah, that’s, that’s the main issue right now.

Naji Gehchan: And then, um, in money, I imagine you’re talking about funding, like having the funds for you to be able to do the research, build, build the company, have the people who can help you out with this. And I, uh, I really loved your framing between time perspective. So I want to talk more about this because as you said, for science, probably a year is nothing, but from a patient’s perspective, a year is a lot and a lot can happen this year.

So as you’re both, On this, uh, on this, uh, specific disease, I’d love to hear how you balance this and how you would push us actually as healthcare leaders to think about rare diseases, because it’s certainly one of those aspects that is hard to crack. Uh, and I would love to get your thoughts, what we should do.

Matthias Lambert: I think. Like, patients should be involved in the research, uh, that would be one thing, you know, like, uh, can be, you know, sometimes I go to conferences where, and you have both patients and scientists together, you know, and I think it’s a great thing to, to hear from the patient, you know, what, what do you need, what is the most, Like what do you need right now, you know, and sometimes you can be surprised, you know what they say, you know, sometimes for a patient just for him to just to eat, to eat alone, you know, on his own, uh, before being able to work, you know, uh, in my disease, for example, you know, uh, I can work, but the, the main issue is the, the breathing, you know, my diaphragm is very, very, very weak.

And during the night, you know, I have a, I’m, um, uh, sleeping with a by uh, a bipep. And so it’s a it’s a life threatening threatening disease, you know? And so I would like to have a for example, the technology uh, therapy that will target the diaphragm, you know, let’s say. So that’s one thing, you know? So when you can refocus your science to a particular goal, you know, that could, that can also meet the goal of a patient, you know, that’s very important, I would say.

And then you have to work with Industry, uh, and of course, like agencies like the FDA to, to accelerate the path, uh, to have, you know, right now we’re talking about end of one treatments, uh, things like, like that. But again, NF1 treatment will treat one patient. And so, you also have to have this balance also in what you want to do, you know.

You have to think about, you know, a path that can, that can work for every patient. And this is, I think, very difficult right now.

Naji Gehchan: Well, thanks for sharing this, Matthias. As you think through the next steps, with, so now you know which gene, you have some ideas about targets, what you want to do, how are you thinking about clinical research and drug development in this space, and the next steps after this huge discovery that you’ve, you’ve done in the

Matthias Lambert: So, so after I, um, I knew, I knew the gene, so I went to Boston working on condition with sclerodystrophy, and at the same time, uh, I talked to my boss and said, okay, I would like also to work on my gene and, you know, on my disease.

And at that time, there were no, no model, uh, no animal model, no cell, uh, Cell models about, about this disease. So what I did is to make a mouse model. And the cool thing about it is this model basically recapitulates, uh, the, the symptoms and the phenotype that we see in patients. So that’s, that’s one thing.

Um, and so with this model, so you can do one thing is to better understand the disease, because right now, you know, as I say, it’s a very rare disease. So we don’t have a lot of. patients in the world, which means we don’t have a lot of samples to study. So it’s very difficult to study right now this disease.

And so when you have a model, you can spend more time to study the disease. You have more samples, you have more materials, you know, to work on it. That’s one thing. And then the second thing is to treat. Uh, so you, my idea is to, and this is what I’m doing right now, is to develop different strategies to, to, to rescue the phenotype in this model.

And once I will get, I would say, a solid, uh, data and good preliminary data, that’s my goal will be to, to meet with industry and say, can we do something, you know, can we develop something that can go to the patient?

Naji Gehchan: Uh, yeah. Great. Um, it’s really massive work and great job that you are doing. I’m glad you’re advancing the science.

And again, as Uh, you’re passionate about it and you’re doing moves and it’s important to follow the steps. And I know, uh, the timelines are longer than you would ever hope and we all would ever hope. But, um, I’m really glad to see, uh, where you’re going with it and wish you all the best for it. Uh, I would, I’m gonna pivot now, even though hard to pivot.

Uh, but I would love to give you one word and get your reaction to it. The first word is leadership.

Matthias Lambert: Uh, leadership, I would say maybe leadership in science. Um, leadership in, um, I would say something pretty new or so, like, uh, inclusion in science, I would say. Talking about inclusion and again, we are talking about the patients being included in the research, but also being having like people with disability, you know, included in science.

And I think it’s very important to have right now this People, you know, working in, in this field because for the past 10 years, this is, so it’s, um, there is, um, a paper from, uh, that that’s been published and seeing that basically scientists with a disability are the only minority that has decreased.

over time in science, and you have a very few, just very few, uh, scientists with disability, uh, funded by NIH in the U. S., and I think, again, it’s very important because, you know, you need to have a leadership from institutions, from agencies, uh, in this because when you have, uh, the patients. I went to science.

This patient had to face so many barriers, so many challenges. And so, I like to say that patients, it’s a very good, it’s a very good problem solving. Uh, because we have to solve so many problems. Problems in our life because, uh, because of our health condition, this is, I mean, just for me, you know, when I go somewhere with a wheelchair, you know, sometimes I have to take a different path because you can have a step.

And so, you have to solve a problem, you know, and the, you know, you have to solve, like I was saying, life, you know, like, uh, um, in, in, in the moment. And so I think you need, we need to have more people like that in science and we need a leadership. We need people from the top that say, okay, let’s do this. Uh, we need to create a path, we need to include more, you know, we need a task force about this.

Uh, I think it’s very, very important. Uh,

Naji Gehchan: that’s such a strong reminder, uh, Matthias, for all of us. The second one is innovation.

Matthias Lambert: Uh, innovation, uh, I would say now innovation is going pretty fast. I mean, every year you hear about a new technology, you know, a new, a new innovation. Uh,

I would say that in the field right now, the innovation, to be honest, like the last 10 years has been CRISPR. Again, that has been the big innovation that I would say can, at some point, cure, I mean, that’s a big word, but cure any, any disease. Um, but what we are missing right now in term of innovation is how to deliver this in the right tissue.

And I think tomorrow, uh, if you have a company that fine, you know, like the right, uh, the, the right animal, molecule technology to deliver this, that’s gonna be a game changer. That’s gonna be a game changer because right now we know for any mutation, we know how to correct a mutation in the dish. Uh, we know how to correct.

the mutation in the mouse because the mouse is pretty small. Um, you have also less, uh, uh, I mean, response in the mouse, but when you go to the patient, to the human, it’s totally different. And, uh, there were a lot of cases right now, like in the past five years using, you know, genetherapy and the CRISPR that has, you know, adverse events.

And death, uh, in patients. And I think right now innovation tomorrow is definitely the delivery. If you have this technology, the game, the game is done. Well, there is

Naji Gehchan: a lot of work ongoing. The third one is rare diseases.

Matthias Lambert: Uh, I would say what, what is a rare disease? You know, that’s a big, you know, big question because I am in the field, but every day I learn something new, but rare disease, um, and depending on the, on the country, you don’t have the same definition of a rare disease, depending on how many patients you have, you will say, Oh, if you, you have this threshold and the threshold of number of patients is different in the U S compared to Europe, for example.

And so now we’re also talking about ultra rare diseases. Like mine, you know, when you have a few patients, and when I say a few patients in the world, it’s maybe 100, maybe maximum a thousand. And so, when you talk about rare disease to a company, and you say, oh, there is 500 patients like me. In the world, you know, they’re going to look at you and say, okay, but I’m going to get my money back, you know, uh, which is, which is true.

Uh, but so we need to have an ecosystem for rare disease that right now doesn’t exist. Uh, a path that can work for both, you know, we need to unite, you know, academia and industry on this question and, you know, involve, you know, investors. Uh, the FDA, of course. But right now, that’s, I would say one thing that is missing for rare disease is the ecosystem.

Uh, how to, how to make a, a, a compound technology treatment that can be, that a family can afford. Because when you think about some of the gene therapy, it’s like millions of dollars. And so, uh, it’s, uh, It’s a lot of money, of course, but also in the other, on the other side, you know, you need for the, for the, for the company to invest the money, you know, they’re going to invest the money and they need at some point the money back, you know, to find a path for this.

So we need a new, we need to think out of the box for the rare disease. And again, I think having patients. in the, in the discussion is very important.

Naji Gehchan: The final one is spread love and organizations.

Matthias Lambert: I would say, um, that’s a difficult one, you know, uh, I would say, you know, like Humidity is one thing, uh, because again, I’m having the view of a patient, you know, every day you, you, you know where, why you are here, you know why you are in the lab. And so you ever saw this? empathy. Uh, and sometimes you have, you have too many empathy, you know, when you have a rare disease, you know, uh, that can, you know, destroy you.

Uh, and so, but I think empathy, it’s very good to, to spread a good vibe and love in an institution. Um, and I was Thinking, yeah, um, again, empathy is, you know, every time, you know, I see, you know, when I have a difficulty, you know, in institution, you know, especially talking about my, my disability, you know, disability, I say, you know, you should maybe for 30 minutes, you know, take my wheelchair and you’re going to see what I see.

Um, and then maybe it will open, you know, your eyes. On the world that you don’t know, and it’s okay to, to, you know, you don’t know about the world of disability, you know, but it also opened my eyes in the world that, that I don’t know. And so it can be in terms of culture, it can be in terms of, you know, uh, belief.

Um, it’s basically how I accept. different, you know, views, but trying to learn about those views will help you. And so, you know, again, talking about inclusion, you know, it’s good to have, you know, when you talk about disability, it’s not, it’s good to talk not only to people with a disability, but also to other people that don’t, don’t have a disability, you know, trying to open this world.

So, yeah. Open the word. I will say it’s, uh, and I think open your, your world to others. It’s a good way to, for them to understand you and to spread, uh, love. Yeah.

Naji Gehchan: Well, mats, open up your word. That’s such a beautiful charge. And ask, uh, for, for us, uh, any final word of wisdom. for healthcare leaders around the world.

Matthias Lambert: Um, I would say listen, listen to the patients. Um, definitely include patients because, as I say, we are good problem solvers. We know where to go because we don’t have time to make a detour. Because when you have a rare disease, usually a rare disease is no joke, it’s life threatening, and you, you have to go to the point, directly.

And so, sometimes, I mean for me, it worked, you know. That’s a quick example, uh, for 25 years, you know, my physicians, My medical team in France didn’t know about the gene. It took me a few months to read some papers and figure out, you know, the gene that caused my disease, you know, and that’s one example, you know, I believe, you know, that, you know, when you listen to the patient, when you include patients, when you include, include patient scientists, you know, you know, our metrics Or not, you know, publishing in nature, uh, or metrics, or, um.

to save lives. And so that’s totally different, you know, uh, our metrics also to, um, I don’t know if I’m going to be able to make it today, you know, because I’m going to be too tired to go to the lab. Or, you know, uh, you know, our programs are different when our viewer is, is, I mean, our view is different.

And so again, if you include this view, um, and it’s on, you know, how to make, you know, the right decision for this, you know, Type, you know, this question, you should, yeah, it’s, um, usually the patient know more about their own disease than any physician in the world. So that’s, that’s one thing, especially when you have a rare disease.

So, yeah, again, I’m repeating myself, but listen, listen, listen to the patients.

Naji Gehchan: Oh, my chest, uh, can’t thank you enough for this inspiring and incredible chat. Uh, our metric is to save lives. This is how you framed it, and this is the main focus and, uh, KPI we should look at. Uh, thank you again for all you’re doing.

Um, it’s, you’re advancing certainly science and you’re improving, uh, lives, if it’s not immediate, in the near future, I hope, for several people around the world. So thank you so much again for joining me today and being with me on this show.

Matthias Lambert: And thank you so much for, for this opportunity. And I hope that, you know, if there are, you know, any, any patients, you know, listening to this, um, don’t, don’t be afraid, you know, if you want to, if you have an idea, go for it, go for it.

Naji Gehchan: You’re such an inspiration and a ray of hope for so many. So thanks again for joining me.

Matthias Lambert: Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform. More episode summarizing Boston Biotech Summit can be found on our website or your preferred podcast app.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Anthony Dowidowicz

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Anthony Dowidowicz a physician executive who has served as a senior physician  leader of health systems  and health plans.  Anthony is an emergency physician by background and is a graduate of the MIT Sloan school of management where he founded and coordinates the MIT Physician Leadership Group.   As an engineer and lifelong technology enthusiast, Anthony’s professional interests include physician leadership, health system design, and emerging computing technologies.

Anthony, so good to have you with me today!

Anthony Dowidowicz: Oh, thank you, Naji. I’m excited to be here.

Naji Gehchan: Our very first chat delved immediately into AI, Quantum computing and its impact on medicine but before we go there, I’d love to know more about your personal story and journey. What brought you to medicine and now becoming the leader you are?

Anthony Dowidowicz: Sure. Well, it’s probably worth noting that when I was much younger, I became fascinated with quantum mechanics and physics. Um, I also went on to be an engineer before medical school, and I sort of put that aside because it seemed so impractical and so futuristic that it really had no application. Um, I then went to medical school.

I trained as an ER doctor. I went into health system leadership and then went to, um, work for health plans. And sure enough, I was, you know, really, uh, excited to learn that quantum computers are now being, uh, developed that’ll be very powerful in healthcare.

Naji Gehchan: So you’re, you’re an ER and engineer. Uh, you know, before we go into, uh, our topic today, uh, you obviously experienced different, uh, different roles.

from being in emergency, leading teams in emergency rooms, uh, also being in healthcare plans, as you said. So can you tell us more about this and really your learning as a leader? If what is the key learning you had as a leader?

Anthony Dowidowicz: Sure. Well, after my residency, I was in New York City where I practiced emergency medicine as an attending.

But, you know, shortly after that, uh, a few years later, I, I really wanted to You know, advanced my career. So I went into leadership and that culminated with serving as the chief medical officer of a regional health system. That was an enormous experience and led me to go to MIT to expand my skills and to be more effective at being a physician leader.

And, you know, at MIT, I was really inspired to look at technology and how it could be applied to health care. And that’s sort of at the same time when I learned about quantum computing.

Naji Gehchan: And is there something, because you said physician leader, and I have several of those discussions with physicians who lead teams, any specific thing you felt that’s something I was missing as a physician and I learned at MIT to become a better leader or something you were doing well that you amplified?

I’m intrigued what’s the thing you brought from MIT after your, your learnings there into leadership? I’m intrigued.

Anthony Dowidowicz: Sure. Well, physician leadership is crucially important to the ongoing effectiveness and sustainability of health care. And the reason I say that is because it really is up to physicians who have an enormous amount of public trust to advocate for the right ways that technology can be brought into the health care system.

Um, and I think this is a perfect example of ensuring that we implement this in the right way for the right reason. Um, I also think this has an enormous. Um, and I think it’s really important that we use this, uh, potential to really focus on issues which may not be traditionally profitable, like focusing on the social determinants of health care, designing therapies targeted to individuals, including the poor, expanding access by bringing down costs.

The list is endless. I know that other industries like finance and cryptography are also, you know, grasping at quantum computing. Um, and that’s terrific. But I think in health care, we really are poised to make a difference in people’s lives.

Naji Gehchan: I certainly echo what you said, and the role we have as leaders in healthcare to make sure that the technology, as you said, is used for the good is so important.

So let’s talk about the technology you’re passionate about, quantum computing, and specifically in healthcare. Can you first help us understand what does this mean?

Anthony Dowidowicz: Sure, well, a very high level explanation of it, and trust me, the mathematics gets very deep. But, uh, quantum computing uses the unique and sometimes bizarre characteristics of quantum mechanics.

I feel this is very difficult to grasp and opens up some interesting philosophic question. But that’s outside of the scope of our talk today. Um, classical computers are based on transistors. They’re basically got little switches that have two states, on or off. These are called bits. We traditionally call them like zeros and ones you may be familiar with.

Now computers process those signals and manipulate them to give you a definite answer using billions and billions of bits. Um, now we’re hitting the physical limit of how many of those we can put into a computer. Um, enter quantum computing. Uh, where you, you take advantage of two unique qualities of quantum physics, one, you, um, there, one, you can cause a bit to be indeterminate.

So rather than a zero or one, it could be any, any value you’d like. And also, you can entangle two bits, meaning that they correlate, uh, so those two simple features, and there are others, uh, but those two features add enormously to the, to the power of quantum computers.

Naji Gehchan: So now that we understand how this is physically done, what are the implications that you see in health care?

How, what, what types of problem do you think this technology can be applied to in health care?

Anthony Dowidowicz: Sure. Well, let me just start by saying that quantum computing is not and maybe never will replace classical computers. They work just fine for most of the things that touch our lives. However, quantum computers are very useful in solving enormously complex problems, usually involving optimization or things called branching.

Now in healthcare, there are no short of problem. There are no shortage of problems that can benefit from a powerful solution like that. Um, I’ll start with one fact that kind of blew me away in preparing for this. Um, I didn’t realize that one third of the world’s data is related to healthcare. That’s an enormous amount of time and energy spent to collect information, but it’s also so much information that we can’t possibly process it and gain insights from the treasure trove, um, using our, our classic computers.

Um, there, there are many other ways that, uh, quantum can really, you know, enter, uh, enter healthcare, um, and, uh, you know, although the full technology isn’t quite ready for prime time, Um, you know, quantum technologies have been used, um, mostly in something called spectroscopy, which leads to the technology of MRI.

Also during the pandemic, although it was, uh, it was an experiment, uh, it was found that quantum computers could more accurately predict the variance of COVID that were emerging and that could have led to more accurate, quicker and successful vaccine development.

Naji Gehchan: That’s, that’s a great example, uh, with, with practical.

actionable. I tried like developing the vaccines, predicting what’s next. Uh, do you have any other specific examples of relevant are in practical work where this technology has been used in healthcare?

Anthony Dowidowicz: Right? Well, there are a number of areas where it is poised to be applied. Um, I should start by saying that.

This technology is not quite ready for prime time, but it very soon will be in a matter of years. Uh, McKinsey reports that by the year 2030, there should be about 5, 000 quantum computers, you know, actively doing research in the United States. Um, now, how are they going to be used in healthcare? There are a number of ways.

Um, the first is an extension of medical imaging. Um, you know, as I said, it’s already been used in imaging, but with full blown quantum computing, we won’t just be able to see the body, we’ll be able to see the actual level of tissue, and perhaps even down to the molecule. Uh, three research won the Nobel Prize in, uh, 2023 for working on this.

They’re called quantum dots. This same technology has, uh, has potential to be used as a cure for Alzheimer’s by identifying and clearing the debris that accumulates in the brain, causing the disease. Other areas, uh, of useful include, uh, you know, supply chain optimization. During the pandemic, we learned just how fragile and unresilient our healthcare system was, you know, optimizing and understanding the logistics of the supply chain.

We’ll make sure that it’s sustainable and effective and getting what people need. Clinical decision support, uh, is also another big area. Uh, for those who don’t, may not know what that means, clinical decision support are, uh, when a computer sort of, you know, provides a physician with information to suggest possible therapies.

Now, I don’t really foresee that quantum computers are ever going to replace humans in medicine, uh, but it’s extremely promising to offer support for physicians, particularly those who treat complex illnesses like, you know, cancer or autoimmune disease. There’s also been some studies showing how effectively it can be at understanding cardiovascular risk.

One, uh, one of the areas where I think I’m competing can really elevate people’s lives is in work on social determinants. Um, as many of you may know, um, it’s thought that social determinants and social determinants, uh, account for up to 80 percent of chronic illness. So, similar to clinical decision support, we can use the information to understand how to provide resources optimally so that they really go to the people who need them the most.

Again, this is another form of a massive optimization problem. One of the most exciting areas that you’ll hear people talk about and which, you know, I’m excited about is drug development. Um, you know, now traditionally, you know, drug development has been based on compounds that are originally come from nature and manipulated in the create new drugs, basically through a long trial and error period.

Um, after they, before they advanced to a new drug. You know, a long period of clinical trials. Um, so the complexity of assembling hundreds of atoms into an effective cure is practically impossible using the speed of the computers we now have. But with quantum computing, you can draw out what tasks you would like the drug to accomplish and have the computer formulate a sequence of proteins or atoms that will design a drug to do just that thing.

Um, it will, you know, it will accelerate drug development and lightning speed. A related topic is genomic analysis. Now, let’s face it, you know, our genes play a role in every human ailment, uh, but the vast bits of genetic information we have, one genome, uh, contains about 3 billion genetic bits, uh, to tell you basically who you are.

Now, just mapping that data for one individual alone is an enormous task that we’re just slowly doing, but the real power comes in comparing multiple genomes against each other. to see where correlations lie to improve illness. That will become a very, very powerful way to treat illness. Um, this leads to perhaps my favorite area, which is called precision medicine.

Um, this is a very exciting area. It’s also called individualized medicine because it uses an individual specific genomic information To create drugs that are specific to that very person. Um, if you can imagine how important this will be in, in treating cancers and, uh, genetic problems that, you know, are unique to an individual.

Um, you know, when they become, when we gain the capability to do this effectively, I foresee, uh, healthcare to be delivering therapies based directly to you, for you. Um, also, you know, the issue of health equity, that is people getting the, the, the best health possible. I would see precision medicine as being the ultimate form of health equity.

Naji Gehchan: Well, this is really exciting. And thank you so much for giving this overview on the different aspects where, uh, this technology and quantum computing will be able to, uh, help us.

Um, I’d love to hear from you what you’re most excited about in the future, as you said, in 2020, 30, but before that, AI is like the topic these days, everyone’s talking about it and some like, well, anyway, I’m not gonna say what I’m thinking about it immediately. I’d love to hear from you, you know, as you’re talking about those quantum computers coming in.

The impact that they will have on us that probably we’re not grasping as much as we should and AI being like the hot topic and everyone talking about a generative AI, all the things that I will be doing. So how do you think about these two aspects and the future of AI? of medicine.

Anthony Dowidowicz: Sure. Well, I’ll start with explaining AI, which often isn’t as I as we’d like it to be.

I don’t really view it as intelligence. I see it more as the classic dynamic optimization problem, um, which as I said, quantum computers are excellent at doing. So I agree with you that everyone wants to say AI. And similarly, they want to talk about the word quantum, but very few people really understand how to get under the hood and connect the technology with the need.

Now, in the case of AI, the way I would look at it is that quantum computing is the really exciting breakthrough, which may make AI more AI, but quantum computing is really the breakthrough. Um, artificial intelligence is an ultimate consequence of, you know, the exploding IT revolution.

Naji Gehchan: Great. And when you think of these two and how they will evolve and making the bet as you’re making that actually the computer itself and quantum computing will maximize and amplify what AI brings.

What are you most excited about the future? Of those that in health care.

Anthony Dowidowicz: Sure. Well, take it together. Um, I, I think that all of this will Korea has the potential to create a better health care system that possesses far more health equity, which is far more resilient and which can bring down the cost of care and by and remove financial barriers to getting care, which is shamefully one of the biggest problems in the U.

S. Right now, as I see it, Anthony,

Naji Gehchan: I want to now give you a word. And I would love your reaction to it. First thing that comes to mind. My first word is leadership.

Anthony Dowidowicz: Sure. Well, when I think of leadership, I think of, I don’t necessarily, I don’t always think of people reporting to me. I think there are great ways to be leaders, uh, a leader without really, without having, can we do that one again?

Naji Gehchan: So the first word is leadership.

Anthony Dowidowicz: When I think of leadership, I think of the ability to influence. I don’t think so much of power. In the case of physician leadership, I think those skills are particularly important as large corporations become increasingly prevalent in their influence on healthcare. I think it’s very important for physician leaders to push back against that and ensure that technologic advance is applied the right way.

Naji Gehchan: Health equity.

Anthony Dowidowicz: Well, health equity is, uh, is a simple concept to understand, but it’s a little bit challenging to explain. People are tempted to use the word health equality, but that’s a bit, uh, slightly misleading because it would imply that we all have equal health. Health equity is a bit different though.

It’s the notion that an individual can achieve the best health possible for them. For example, if someone’s paralyzed but from the waist down, they may not have health equality, but hopefully we have a system that accommodates them and let them live their best life.

Naji Gehchan: So I think I want to double click on this.

Um, I totally agree that sometimes we misunderstand equality versus equity in health. And you said the, one of the breakthrough that, uh, quantum computing will be bringing is improving this through personalized medicine, uh, precision medicine. But I can’t but think about the costs related to those and how would it be supported when we know unfortunately it’s an issue in the U.

S.? And across the globe, if we want to think health equity globally, so I’m intrigued as you’re thinking about those technologies. How are you thinking about actually getting to patients hands and helping them take out those financial barrier that they might have?

Anthony Dowidowicz: Sure. Well, I view health equity as closely related to social determinants.

And I think of the social determinants as very related to drug development. And by that, I mean, searching for patterns of illness. based on what non medical resources an individual may have. Things, for example, like education, health literacy, even things like air conditioning for those with chronic illness, nutritional support, transportation.

All of these things are really outside the realm of medicine, but as I said, they account for 80 percent of illness in some way.

Naji Gehchan: The third word is innovation.

Anthony Dowidowicz: Innovation may also be one of the most overused words. Um, I, I don’t like to use the word innovation so much as ingenuity. I think innovation is something that all of us make every our everyday lives to solve problems. Ingenuity, on the other hand, is a bit more personal and requires, you know, you know, sharp insight and real thinking to come up with solutions to answer the challenges.

Naji Gehchan: I love it. The last one is spread love and organizations.

Anthony Dowidowicz: Uh, yeah, at first I thought that the title of your podcast was a little bit, uh, you know, unexpected. However, you know, in thinking about and preparing for this, I’ve really come to understand how the healthcare system by its nature exists to facilitate spreading love and creating a better world.

Naji Gehchan: It certainly does. Any final word of wisdom, Anthony, for healthcare leaders around the world? I’m sorry, say again? Any final word of wisdom for healthcare leaders around the world? Can I find a word? No, um, let me just make sure this.

Anthony Dowidowicz: Sorry.

Naji Gehchan: No, no worries. I’m just, any final word of wisdom for healthcare leaders?

Anthony Dowidowicz: Sure. I would really urge them to look at the big picture and recognize how important leadership is in healthcare. There are times when you face very difficult decisions between doing what’s expedient and profitable versus doing what is right on the long term. What I urge healthcare leaders, particularly physicians who care for patients, to do is to understand that You know, health care doesn’t follow quarterly reports or balance sheets.

It has its own nature and its own very complex basis. So I would really urge leaders to advocate for their patients and not try to make profit, uh, immediately or, or view health care in that way.

You know, the corporate, I’m sorry. No, go ahead. I was going to say that the corporate practice of medicine is, you know, properly, largely illegal. However, the influence of large corporations does have a considerable effect on the way patients are treated. And that’s not always for the better.

Naji Gehchan: Most certainly.

And keeping in mind the greater good and making sure that we’re striving towards Uh, the purpose, as you said, of healthcare organizations all across, which is making sure we’re making life better for patients, uh, across all the world. It’s super important.

Anthony Dowidowicz: Another piece of advice I would give healthcare leaders would be to start thinking about the problems that they wish they could have solved in healthcare, because I would bet in the majority quantum computing probably has a way to provide the answer.

Naji Gehchan: Thank you so much, Anthony, for this great discussion and enlightening thoughts around a great technology that will be coming in very soon, as you said, and we will be seeing it in practice. So thank you for joining me and helping us understand better this.

Anthony Dowidowicz: Well, thanks for having me, Naji. And thank you also for having these podcasts.

I think it’s a great topic done in a great way. And it’s really nice to be and refreshing to see someone be focusing on virtuous leadership. So thanks.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Samy Sidhom

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Samy Sidhom. Samy is a physician leader and innovator, currently serving as the Associate Chair of Specialties and Chief of Pulmonary Medicine at Atrius Health, part of Optum, which is one of the largest primary care and specialty practices in Massachusetts. Samy also holds academic appointments as a Lecturer in Medicine at Harvard Medical School and Assistant Clinical Professor of Medicine at Tufts University School of Medicine. With a deep focus on innovative management of chronic conditions, population health, value-based care, telehealth, and healthcare ventures, Samy has been at the forefront of advancing medical practice and healthcare delivery.  He mentors aspiring entrepreneurs through participation in the MIT Sandbox Innovation Fund and has mentored at the MIT Hacking Medicine events. Prior to his tenure at Atrius, he played a pivotal role in developing pulmonary outpatient practices and services, and served as Chief of Pulmonary Medicine at Holy Family Hospitals in Massachusetts where he also cofounded the Center for Advanced Thoracic and Pulmonary Care. He has also contributed to public health policy and is a former member of the Board of Respiratory Care for the Commonwealth of Massachusetts.

Samy, so good to have you with me today!

Samy Sidhom: Thank you so much, Naji, and thank you for inviting me on this wonderful podcast.

Naji Gehchan: Our very first chat delved immediately into AI and Medecine but before we go there, I’d love to know more about your personal story and journey. What brought you to medicine and now becoming the leader you are?

Samy Sidhom: Thank you. Um, that’s a long, long story, um, but I will try to be as brief as possible. Um, this is, um, it sounds more cliche, but it’s been a lifelong dream to be a physician. And, um, I was born and raised in Egypt. Uh, I grew up in Egypt until I was 14.

And very early on, I would say maybe as early as eight years old, um, I gravitated to, uh, medicine, uh, probably because of my own personal hardship with a medical condition. Um, And I was a patient for a very long period of time during my childhood, uh, and I saw the difference a good clinician, physician can make in the life of a person and a family.

And it inspired me to care for others and to have some type of or degree of empathy that I share with people who I think we are all invariably become patients at one point or another. Uh, and it connects me to our humanity, uh, on a deeper level. And I felt that medicine really is my calling and, and something that did fit my aspiration and my personality.

Um, I kept my eye on that goal since, ever since then, and, um, everything I did was towards leading, uh, to a career in that, in that field.

Naji Gehchan: Well, thanks, Sammy, for sharing this. So really, as you said, we all can be patients. We all care for patients. Your story is so powerful from being a patient, becoming a healthcare provider and caring for patients on a daily basis. I would love to hear, as you’ve been also passionate about leadership, leading teams, treating them daily, uh, practically in, um, uh, today, uh, and being at the forefront of the pandemic.

I think you’re in one of those specialties that dealt a lot with, uh, with COVID 19 where over the pandemic somehow, but still, I’m sure you’re dealing with peaks of COVID these days. What has been your biggest leadership learning through those times and through those years of experience as you grew as a leader?

Samy Sidhom: I think the, this is a great question. And, and I think it’s not just limited to the pandemic. It’s really is a journey of a, of a clinician and physician is it’s a journey of. Adaptation and pivoting, um, and rolling with the punches and anticipating challenges and rising up to challenges that you could not anticipate and having that kind of skill set and mindset of eventually things will work out.

Eventually things will be overcome event. Eventually things will be managed. So long as that there is a kind of a growth mindset that we’re able to pull together from resources from learning experiences. and from knowledge and from science to be able to adapt to a new challenge and a new environment.

Um, for me, getting to where I wanted to, to be has been a challenge. I think anyone who has gone through medical training and, um, climbing up in terms of leadership and healthcare field, this is just nothing but a journey of challenges and, uh, obstacles. Um, whether it’s through, um, admissions and whether it’s through, uh, completing training, whether it’s through, um, internships and, and, and, and residency and fellowships and research and, uh, grants and publications and applications that get through and things that get turned down and things that, um, work out and changes that happen all the time.

Um, I think this really, um, allowed us and allowed me. To be able to deal with the challenges of COVID 19, despite the immense pressure and the immense, um, problems that we faced during those years, especially early on, um, being able to pivot, for example, into, um, our practices and change, uh, make changes necessary in the workforce.

Um, to go from, um, almost no virtual, uh, uh, medicine, uh, medical practice to a full telemedicine, uh, platform to dealing with the challenges of patients with long haul COVID. And 1 of the things that may have mentioned to you in our conversations before, you know, we had, um, established a multidisciplinary long call COVID clinic atrius.

Health where I work now, and that was dealt with a lot of the very complex and complicated long haul covid patients. And we ran that practice for quite some time until. Demand had weighed. Um, but this kind of, um, um, journey and setbacks and overcoming challenges is not going to just stop at COVID. It will be for the next, uh, pandemic.

And unfortunately, as history tells us, there will be more. Um, but I think us as medical professionals, we are very well equipped with that mindset to be able to adapt and pivot. And this is something that I really feel that Um, is very unique and valuable, um, for leaders who with, uh, medical training and healthcare training, um, we, we can, um, really go through some significant challenges and obstacles, but we are very resilient.

Naji Gehchan: And Sammy, I loved how you framed it on leadership, rising up to challenges you didn’t even anticipate. And I think you’re talking to that. So if I want to go more specifically about you, your journey, you came from Egypt, as you said. You had several challenges, you said, as you were getting into med school, growing in med school, and now leading a large organization and being an associate chair.

What is the biggest challenge you felt as a person going through this and any advice you would, you would give a potential med student or someone who’s looking to become a physician like you?

Samy Sidhom: Thank you. And I, um, I, I like that question. Um, I think it can be answered in many ways, and maybe I would have answered it differently in earlier years than in my latter years now in my career.

Uh, my answer now would be finding a balance. Um, finding a balance where you can

not just be a leader in the office or in the practice or for your coworkers, but also to be a leader among your peers and being. A leader in your home environment, and I’m not talking in terms of leader being a tyrant or being a dictator, uh, but just being that best person that the people around you want to look up to, look for, for guidance, depend on, rely on, collaborate with, share with.

Um, and be vulnerable with, um, and that spans not just the work environment, just having that balance at home with family, with children, with a spouse, um, with friends. With community. Um, not just not just the office, and I think finding that balance as an aspiring physician or an aspiring, uh, health care professional is very is very difficult.

Because you get pulled in different prior in different directions, you have to reprioritize things frequently. You have to always land on what your core values are, and what you feel is important for you that cannot be negotiated. For example, for me. My family is a non negotiable, they will always be priority and I always have to look at them and look at, at their needs and their, and, and their companionship and their support.

Because just as much as they rely on me, I rely on them. And they will always be there. There will always be different jobs. There will always be different careers. There will always be different schools and training and experiences. But the family is what holds, um, my core together. And that’s what I challenge any student, any trainee, any person going through the process.

is to try to identify the score value and to make sure that that stays sacred and protected and to be able to Develop those leadership skills in different aspects, not just professionally.

Naji Gehchan: That’s such a great advice, Sammy. Finding this harmony, this balance, as you’re saying, is really key for us as humans, right?

And several times, you know, with many leaders I discussed, it’s something we realized later on in our life and career. So as early as you just take it and embrace it and believe that those who are saying it like you is, is really true. I think it’s. is, would be super beneficial as we grow and, and develop our careers and our lives.

If we look forward now, um, thinking really about innovation in healthcare, it’s something you’re passionate about to touch us through your work. You, as we said, you work a lot with MIT sandbox startups, entrepreneurship. What are you most excited about when you look forward and things that you think will really improve population health?

Samy Sidhom: This is a very exciting time in medicine and in health care, and I’m, I’m really excited about this future. Um, and I’m very lucky and fortunate to be able to see it from the lens of one of the most innovative places and academic places on on the planet at MIT, and also through the lens of One of the most population health and value based care, um, centered and patient centric organizations, uh, atrius health, um, as physicians, we’re always looking for new tools.

We are always looking for new tools. This has always been the, um, driver for, um, therapies and, um, uh, algorithms and quality, uh, measures. Um, we’re trying to find new tools, uh, and innovate with new things. Uh, and it sounds redundant, innovate with new things, but we’re always looking for something new to use to improve patient care.

And now we have this very amazing, uh, tools of machine learning, deep learning and, and generative AI that promises to potentially continuously improve on processes that it had learned and continues to learn. And to be able to scale tasks. And to be able to scale

interventions, uh, not necessarily interventions that AI is going to be suddenly, uh, doing surgeries, uh, or, um, managing, uh, patients, uh, autonomously, but more so aiding clinicians, uh, to be able to deliver the care that they want to deliver with more efficiency, less burnout. And hopefully better therapeutic accuracy.

Naji Gehchan: So if we double click on artificial intelligence and all the hype around it, is there a use case I’m always kind of, you know, because we used to buy a buzz word, but I’m sure you like me when we discuss, it’s all about the use cases. Like how are you actually using AI to improve something very specific?

So you talked about processes, but is there a use case? That you’re really excited about or you implemented within your groups or you’re looking and a startup that is trying to do it to help improve patient care.

Samy Sidhom: Yes, sir. I have, um, one of the things that we are actually looking at right now and open to pilot soon.

Uh, and this is through, um, work from Optum as documentation, um, for physicians and in the electronic medical record. And I’ve been previously. Exposed to, um, an earlier version of that through our collaboration, uh, with IBM Watson, um, where, um, there was some effort to be able to summarize clinical, um, uh, cases, um, and, and, uh, generate some evidence based, uh, recommendations for managing management of patients with certain chronic conditions, uh, through, um, learning the patient’s chart and record.

But, um, currently we’re looking into documentation to improve physician, um, workflow and reduce documentation burden and burnout, which is a significant problem for physicians. Um, this is just a very simple and very benign case scenario, um, in terms of generative AI and language models. I think, uh, a lot similar to many practitioners nowadays, we are leveraging, um, generative AI to be able to compose, uh, messages and, uh, emails and communications, um, without, uh, of course disclosing any private information, uh, for patients.

Composing emails, composing messages, composing, um, certain algorithms. Um, those are, have been very useful. And I think that’s not just for medicine. This is just more of a business, uh, office, um, uh, case use in terms of entrepreneur, entrepreneurship and, and startups, um, there are certainly, you know, we’ve seen an implosion, uh, of many different startups, uh, using AI techniques and.

Uh, and methods, um, whether it’s from, uh, learning, um, certain patterns about patients, uh, conditions and suggesting, uh, treatments, for example, uh, learning about patients, um, vital signs and use of certain medications and pattern of using inhalers to predict, um, exacerbations of chronic lung conditions like asthma and COPD, um, have certainly come across a number of startups in that, in that space.

Um, and in addition to that, there’s also, um, the models for physical rehab, for example, and, um, patients, uh, analyzing patient’s movements and analyzing their, uh, posture, uh, to predict falls, uh, or to improve their, uh, uh, physical conditioning and gait, um, and so on and so forth. There is a numerous, uh, numerous, uh, Case uses, and I think it will be, it will take us much more than this podcast to go through.

Um, fortunately, actually, I’ll be hosting a panel of, um, uh, healthcare leaders shortly at MIT is through the Sloan Healthcare and Bioinnovation Conference, and we’ll be discussing exactly those. Um, cases and, uh, similar scenarios and the outlook and the vision for different leaders in the industry, uh, from care delivery leaders to, uh, tech companies, um, and such as Amazon Health, uh, Sciences, um, and, uh, that will be coming up soon in a couple of weeks.

Naji Gehchan: That’s great. And we’re partners of, uh, as you know, of the healthcare conference, uh, Spread Love and organizations. So we’ll certainly talk more about it, uh, with you and the panelists. Uh, as you talk about MIT, I feel it’s a big part of your story, your life. It certainly is for me too. Uh, you are graduating soon.

So congrats in advance. I would love to hear from you your key takeaways as a physician going through the program from a leadership lens.

Samy Sidhom: Thank you. Um, yes, we’ve, we’ve sat through the same classes, uh, and you’re ahead of me in the game. So I would be, uh, rehashing what you’ve learned. Uh, but MIT has kind of taken on a life of its own for me now.

Uh, the last two years have been transformational. I look at things very differently nowadays, uh, and I owe that to, um, the recalibration that we’ve gone through. Over the past, um, many months or the past couple of years, um, uh, I see things in a, in a different lens and I apply, um, uh, the, uh, operation processes, uh, lenses, uh, culturally, politically as well.

Um, so everything is, is, uh, is looked at with a different, uh, discernment and, uh, different, uh, I different vision and, uh, I look things a lot more deeper than just superficially. Um, Just a normal, uh, trip to the grocery store is, is different now, uh, looking at the pricing and the shelving and, uh, the

Naji Gehchan: workflow.

Don’t tell me you, you do also like all the flow once you get on the, uh, on the payments and Exactly, exactly. And, uh, looking to see

Samy Sidhom: Trying to But from a physician perspective, it did open up my eyes to the fact that, um, you know, we, as physicians, it’s not just about patient care, like, in terms of prescribing, um, medication X for condition Y, um, it’s more about, um, There is a bigger picture and, and this picture, I’m glad to learn it because I’m so keen and interested in population health management and value based care, meaning, you know, giving the, the most value, um, and highest quality care, not at a, at an exuberant, exuberant cost, uh, to the patients and to the healthcare system, but reasonable.

Um, and that’s through efficiency through knowing what, uh, what to prioritize, what to, uh, implement and how to manage populations, not just one person. Um, and I think we were very narrow, you know, as a lot of my, uh, my physician colleagues in the, uh, in the program, we enter very narrow minded as physicians.

Um, but we graduate this program as innovators, as people who can see a bigger picture, people who can involve. Uh, so many different facets of management into health care, and in that way, I feel like this is just going to be such a tremendous tool for improvement of health care. Uh, in this country, um, the business, the, this, the goal of be obtaining an MBA after an MD should not just because of making more money or getting higher positions and, and, and glamour or, um, improving the bottom line, but it’s more so to really improve the care for patients.

Because they care for the patients. It’s not just clinical knowledge, and we have to really understand that that’s the case. And this is something I encourage many of my physician colleagues to consider and that it’s not just the microcosm of science. Uh, it’s healthcare lives within a bigger ecosystem.

Naji Gehchan: Certainly, this system dynamic approach for us to be able to improve healthcare globally and increase our impact as, as leaders in the health industry. I would love now for you to give me your first thought when I give you a word. And the first one is leadership. Um,

Samy Sidhom: servant leadership.

Um, leadership is, is being a servant leader, uh, is for me is that that word service comes before leadership. And because leaders are elected or chosen or rise to the top to serve a purpose and to serve a population and to serve others. Um, otherwise, there’s, in my opinion, there’s no, um, need for leadership.

Naji Gehchan: What about value based care?

Samy Sidhom: Inclusivity. Um, and you have to be inclusive to provide high value. And I’m not talking about just socioeconomic. I’m talking about orphan conditions. Um, is just just as important as common conditions. Um, being able to afford quality care. Um, everybody should be able to be afforded quality, high quality care.

Um, the care that you receive should not be based on your color of your skin, where you come from, what zip code you’re at, what your title at work is, uh, who pays your rent. It should be based on you as a human. Um, and that’s the common denominator.

Naji Gehchan: The third word is entrepreneurship.

Samy Sidhom: Um, I was just reading the other day that entrepreneurship is an act of rebellion. And, um, yes, and, um, you’re basically are, um, driven, uh, out of necessity or out of the, um, uh, dissatisfaction with the status quo to innovate and to create a new product. and to be able to get that product off the ground and make it successful and afford it to people who need it.

Um,

Naji Gehchan: and the last one is spread love and organizations,

Samy Sidhom: with transparency and honesty. Um, and I think this is, um,

one criticism I, I had once Uh, from a colleague is that I lead with my heart and, um, I took it as a compliment. Actually, initially it bugged me, but eventually it became more of a calling and, uh, more of a, uh, rallying cry. Um, yes, I will lead with my heart and I would lead, uh, with empathy and with transparency and with honesty, uh, because that’s what the world needs.

We don’t need behind closed door. Um, deals. We don’t need, um, bait and switch and leadership. We don’t need, um, deception and lip service. Um, and if we follow that concept of servant leadership, we really have to serve the people that we are with and the people that we serve. We cannot serve without honesty.

We cannot serve without transparency. Yes, of course. Organizational secrets and trade secrets. Intellectual property, uh, are important. Uh, and it’s not what I’m talking about. I’m talking more about, um, having a mission that’s clear and apparent and transparent, um, having intentions that are transparent, having goals that are clear and, um, and delivering it, uh, with all honesty.

And I think that’s when you have buy in. That’s when you have people believing in your mission and their mission and, uh, will enable you to become a leader, an effective leader.

Naji Gehchan: This is so powerful, Sami. What you said is really, is powerful. You said, I will lead with my heart, transparently and honestly. I might borrow this from you.

I love it.

Samy Sidhom: Thank you.

Naji Gehchan: Any final word of wisdom for health care leaders around the world?

Samy Sidhom: Um, We need more leaders, and, um, I know this has been somewhat controversial in, in healthcare as many people are looking into administrative positions, uh, and less clinical positions. And, but at the same time, it’s really important that each physician and health care person, um, is a leader, even on their own small scale and leadership.

As I met, as I mentioned earlier, my view on it is a servant leadership and, uh, I don’t have, I don’t need to have, you know, 50 or 100 or 1000 people directly reporting to me to become a leader. Um, I can be a leader within my own patient panel. Um, and my own small office. Um, but we need better leaders who are able to cross cultural and ideological and political barriers because when we are guarded in our own little, um, uh, ecosystems, um, then we don’t have growth.

We don’t have collaboration. We don’t have, uh, this cross federalization and, and my calling would be to be able to Have many of us that are able to overcome to become more of the dominant population of leaders are the leaders who are able to collaborate and be able to cross barriers, um, because unfortunately, many leaders rise up to the top, um, but don’t don’t have, um, that view and don’t have that, um, um.

Spreading love with leadership view. Um, it’s more of a very hierarchical and, um, uh, and more of a power of view, uh, of, of leadership. And, um, I challenge everyone really to be transparent, to be honest, to be inclusive, to have empathy, to have compassion. And to be a servant leader.

Naji Gehchan: Those are great words of wisdom for all of us.

You said something that is really powerful, especially during these days. I think it has always been, but in days where we’re seeing more and more polarization, more and more, unfortunately, hate more than love. Having leaders, as you said, who can overcome cultural, political thoughts, personal beliefs and barriers for us to be able to collaborate and make the world a better place is so crucial.

Thank you so much, Sammy. Um, I know you’re doing it on a daily basis, impacting several patients and impacting your organization and beyond. So thank you for all that you’re doing and for being with me today.

Samy Sidhom: Thank you so much, Nadia. I greatly enjoyed our conversation and, uh, I’ve been really looking forward to be here and, um, um, your questions are insightful and wonderful and they did not disappoint.

And thank you. I look forward to hearing more episodes with you and other wonderful guests.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Britt Wahlin

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in collaboration with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I have the pleasure to be joined by Britt Wahlin is the Vice President for Development and Public Affairs at Ibis Reproductive Health, a global nonprofit research organization working to advance sexual and reproductive autonomy, choices, and health. She leads fund development, communications, and policy and advocacy initiatives and serves on the senior management team. She is proud to be part of the leadership of Free the Pill, a coalition-driven campaign operated by Ibis that aims to move birth control pills over the counter in the United States and ensure they are affordable, covered by insurance, and available to people of all ages without a prescription. Before Ibis, Britt created public engagement campaigns for social justice-themed films and worked in women’s and girls’ philanthropy. She obtained her Bachelor of Arts in Modern Thought and Literature and Master of Arts in Humanities from Stanford University. She lives in Charlottesville, Virginia, with her husband and two daughters.

Britt, it is great to have you with me today!

Britt Wahlin: Thank you so much for having me. It’s a pleasure to be here.

Naji Gehchan: Before we go and dig in transitions to over the counter products, which was the topic of your panel at the Sloan Healthcare Conference, I’m really eager to learn more about you, about your personal story, what brought you to healthcare, and now being a leading voice on such crucial social topics of reproductive health.

Britt Wahlin: Sure. Yeah, I’m happy to share my story. Uh, so yeah, looking back, um, when I was growing up in California, I was always focused on, like, what’s doing, what was, doing what was right. I care deeply about social justice. Uh, I led service organizations. I volunteered in high school. Um, but it actually wasn’t until I was in college that I, uh, understood you could actually have a career working in the nonprofit sector.

I just didn’t know there were so many options out there. Um, and it was also in college that I followed my feminist calling, um, both in my studies, um, in the internships I did. Um, I, one day, my first year in college, walked into the Women’s Center, like, what can I do? How can I get involved? Um, I ended up working with, um, an organization focused on electing women to public office, uh, which was great.

really gratifying and I learned so much. Uh, I also in college took a class called Philanthropy and Social Justice, um, and I learned how to write a grant proposal. Uh, and so then as I was looking about what to do after college, uh, I was really interested in resource mobilization, uh, and distribution. I was really, um, interested in how philanthropic dollars could be used to reduce the wealth gap, um, and also to reallocate resources to communities.

Um, so the first job I had was with what’s now called the Women’s Foundation of California. Um, I worked with organizations and leaders around the state who were doing incredible work. Um, they were. organizing, providing health education to farm workers in the Central Valley, uh, groups that were supporting young women who were part of the street economy in San Francisco and transforming them into leaders.

I, uh, and these groups, they were so appreciative of our 10, grants, and they did so much with those funds. Um, but I had a strong desire to Amplify those stories, um, to let more people know about these amazing leaders and the work and the impact they were having. Um, so I really wanted to kind of shift into, uh, communications work.

I moved to Boston. I continued working with, um, private foundations that were committed to investing in women’s and girls issues and organizations. Um, but I also did more of this communications work, um, I worked with an organization called Active Voice, which I think you mentioned in my bio, um, harnessed the power of character driven, social issue film, um, to inspire community engagement and action.

I also had the privilege to spend a year overseas, um, mostly in Burma, um, officially known as Myanmar. Um, after my return, I, Looked specifically into opportunities that were global in scope and, um, specifically kind of global health, um, I, I also wanted to return to what felt like my true calling of advancing gender equity, um, uplifting women’s and women and girls health and rights.

And that led me to Ibis Reproductive Health, where I am now. And I was hired as the first development and communication staff person. And that’s where I’ve been for the last 17 years. I’m now currently in the role of Vice President for Development and Public Affairs.

Naji Gehchan: Oh, thank you so much, Britt, for sharing your journey.

And what you’ve been doing is really impressive and inspiring. Um, I, you know, we’re going to talk about, uh, obviously, OTC and your thoughts about this. But the follow up question to what you said, you talked about gender equity, and you’ve been, um, an advocate, an activist, and working, uh, intensely on this.

I would love your view about it. How do you, where do you see us today? Do you see improvements? Are we there yet? Are we not there yet? Consistently think and talk about those things for several reasons. And I’d love, I’d love your view as an expert on this.

Britt Wahlin: Sure, that’s an excellent question. It’s, gosh, a big question. Uh, yes. Are we, um, there are a few, maybe two ways, um, I can start to point to some progress. Um, first, um, I think we, We now have, um, much more sophisticated and inclusive frameworks for talking about these issues. When I was, you know, back in college, I was talking about, like, women’s issues and, and actually girls issues, because girls were really forgotten for so long.

And, um, that was such a neglected area of, like, say, youth programming. There was not a gender lens applied to it. Um, but I, you know, I think we were missing the, the racial justice angle. Um, also, um, when I was in college, I think we were only just then starting to talk about kind of reproductive justice, something broader than, you know, what pro choice, for example, like for so long, the, um, women’s movement was.

As many say, like very much defined by kind of white women’s issues and, um, focus specifically on abortion rights. Someone made that argument. I mean, that I think it was always more than that, but that that was certainly true in many cases in some of the larger organizations. And so, um, The reproductive justice framework, which, um, was created by black women, um, and actually, it’s going to be the 30th anniversary of those women coming together to create this framework, um, came up with a much more, um, a broader and a more inclusive framework, um, recognizing that, um, whereas, um, so much of feminism and second wave feminism, um, uh, up to, um, Um, into the, the 1970s had focused so much on, um, the right to abortion that for women of color, it was a lot about the right to reproduce and reproductive justice, um, that the main kind of tenets of that are that we have the right to have children, the right not to have children, and the right to have parents in communities that are safe and free of violence.

So I think we are seeing that framework and pieces of that framework very much more in the space of gender equity and reproductive health rights. and justice today. Um, and so that is an advancement. I think we, we have a much more sophisticated and inclusive framework, um, and much more of a focus on, um, ensuring that, uh, women of color, people of color, indigenous people, um, Latine folks, um, Asian, American, Native Hawaiian, Pacific Islander folks are at the table, um, and in leadership positions.

And I think our kind of organizational movement space looks much different than it did, say, 20, 30 years ago. Um, but of course, we’re facing so many setbacks in reproductive, uh, health and, and rights in this country. So it’s also, um, A really frightening time for any person who is capable of being pregnant in the United States.

We have many advances that I will talk about that are helping deliver care and bring increased access in innovative ways, but also, um, policies and politicians that seem really determined to take away, um, people’s bodily autonomy.

Naji Gehchan: Yeah, well, thanks for bringing this up. And I think it’s a good transition to, uh, to your work, uh, with free the pill and the OTC word, and this is part of the topic you discussed. So if we start. on a broad position about transitions to OTC. What was, how do you think about this? Uh, which type of drugs should get there?

And what really did you discuss during this panel about those transitions?

Britt Wahlin: Sure. Uh, well, you know, ultimately creating, uh, More over the counter options for, uh, health products, for drugs, medications, devices, can bring care more directly to people, bring health, you know, put health care directly in people’s hands.

Um, so I think that was one of the really big takeaways of the panel. Um. My, my focus and, and as you mentioned, um, at the beginning, um, IBIS reproductive health, uh, leads the, the free the pill, um, campaign. It’s a coalition driven campaign. We have over 200 members representing, um, researchers, advocates, uh, health professions, associations, young people, activists.

We’re a very broad based, uh, coalition. Um, This coalition started 20 years, actually, almost to the date, um, 20 years ago, um, because a group of researchers and advocates, um, were interested in exploring how, um, removing the birth control, removing the requirement, prescription requirement for birth control pills, um, could expand access to safe and effective contraception.

Um, birth control pills have been around for now over 60 years. They’re well studied. They’re, they’re safe. Even 20 years ago, the, this group felt that they met the criteria for over the counter status. Um, and it was IBIS Reproductive Health’s founder, Charlotte Ellertson, who convened that very first meeting, um, 20 years ago.

And, um, it took 20 years of evidence generation, coalition building, kind of building support. And then, of course, a pharmaceutical company, um, HRA Pharma, which then became Parago, to bring a product through the FDA regulatory process. Um, and the FDA approved the first over the counter birth control pill back in July of this past year.

So

Naji Gehchan: this is a great achievement for your organization and for women in this country. Do you feel the work is done?

Britt Wahlin: The work with, uh, The work of gender equity or reproductive,

Naji Gehchan: yeah, specifically on advancing, yeah, yeah, yeah, yeah, productive justice through, uh, through lifting this barrier on birth control.

Britt Wahlin: Yeah, so for just to stay with the topic first of, of over the counter birth control pills, um, That that was a huge achievement getting FDA approval of the first with the kind of birth control pill and, um, and, and we really believe our coalition sees this as a movement when that this was a broad coalition and people clamoring organizations clamoring for this and, um, Making the case for why this is so important because people face too many barriers to accessing contraception.

And here’s a really innovative way to help increase access. So, um, so we did it. We hit, we hit that, um, big milestone, um, But and now, you know, you can go look in your local pharmacies and some grocery stores. I hope to see that the product is called Opal is on the shelf. Just the last couple of weeks, it’s been hitting the shelf stores around the country.

But now we need to make sure people can access the product. It needs to be covered by insurance. Um, that’s now only happening sporadically in a few states, um, that require coverage of over the counter contraception without a prescription. Um, we need there to be federal change, federal, um, that the administration could make that change right now and, and offer guidance through that this falls under the Affordable Care Act to require insurance companies to cover coverage over the counter contraception without a prescription.

Um, and we also need other innovative ways to get the product to people. You know, it’s, it’s 20 for a single pack. It’s, that’s, that’s unaffordable for many people, um, young people, um, people working to make ends meet. So we, um, the company is offering a community, uh, consumer assistance program. Um, and we need to support innovative ways for people to get the product, um, at affordable, at an affordable cost through their for to introduce to you, Title 10, um, family planning clinics, um, at a sliding scale, uh, through vending machines, um, through just free product donated to community, um, centers where people can access it.

So, so yes, the work won’t be done until we, we ensure that people can. Um, access the product, anyone who needs it can, um, and that, you know, that’s one piece. I’m happy to talk about other work that needs to be done. Um, IBIS works on, um, so many different topics, um, contraception access, but also, um, abortion access, and there’s, there’s a way to go in, in all of these.

On all of these issues, but, um, I think, uh, we are making progress and bringing innovation, um, in terms of how we deliver these services to people, um, whether it’s over the counter or methods like, um, models like telehealth, which is also helping, helping more people access services.

Naji Gehchan: Well, this is, this is again, uh, great impactful work that you’re doing and step by step as you’re saying to move the needle and help, uh, several, uh, women, uh, what’s your biggest learning as a leader, uh, you personally having led such important social issues, which unfortunately several times are becoming divisive.

political issues rather than human, you know, topics and social topics as we should discuss them or sometimes medical topics actually, um, that we should discuss. What’s your biggest learning in this and is there any advice you would give for young leaders passionate about social impact these days?

Britt Wahlin: Yeah, that that’s a great, that’s a great question.

I, I think one of the parts of my work that has been the most satisfying is, is how value centered it is, and how. We at IBIS, um, and in our coalition work and work with partners, um, can always, um, kind of lean into values, um, around equity and inclusion, um, trust. We engage in what we call principled partnerships, which are based on kind of shared power, mutual trust, transparency.

And. You know, in the example of, um, the Free the Pill coalition, um, that coalition led with its values. Um, one example is we, um, wanted to avoid the FDA imposing an age restriction on the product. That happened with emergency contraception plan be many years ago when it went over the counter it took six years for it to be fully over the counter and and not requiring people to show an ID to get it behind the counter.

So, uh, we did not compromise on that. Um, and we Uh, engaged in an adult youth adult partnership. We worked with an amazing organization continue to do so advocates for youth. Um, we, they created a platform for young people to speak up about the issue. And they test young people testified very powerfully before the FDA about why having an over the counter birth control pill was so important and about the barriers that they and their friends have faced.

Um, and at the end of the day, like. We, we won by leading with our values. So, you know, I think it’s, it’s a tough moment to work in reproductive health rights and justice. And I, you know, my colleagues, um, I work with at IBIS, organizations we partner with in this, um, in the United States. Um, it, it can be, it can be tough.

We have, we have We had the Dobbs decision a couple of years ago come from the Supreme Court. We’re now awaiting more um, abortion related decisions from the Supreme Court and it can be hard to be working so hard trying to like do what’s right. bring, um, help to people to access the services they have every right to and then face these setbacks.

But there are these wins like free the pill that, you know, those are our bright spots and, um, and, and those will come. I think you, you can’t give up and can’t compromise on your values. Um, that the losses are going to come. Regardless of whether you compromise, I think, you know, there are sometimes forces that are going to, um, no matter what you do, get in the way.

So, um, working in collaboration and principle partnership and kind of leading with your values. I think it’s always what’s going to help you win at the end of the day.

Naji Gehchan: I love it. Principal partnership and leading with your values for, for, uh, for you to win, for us to win. Uh, I’m gonna now move on giving you a word and I would love your first reaction to it.

The first one is leadership.

Britt Wahlin: Collaboration. You know, that, that’s, if you’d asked me like 20 years ago, I don’t think I would have said that. It’s like my first response. Um, I. When I think about leadership these days, it’s so much about collaboration. It’s about kind of stepping back and listening and listening to your team, listening to your partners, not needing to be the one who’s out there.

Um, but the 1, who’s seeing the strengths and everyone you work with and finding the ways to to make. Each person, um, shine using their strengths. And knowing, I mean, the work is. It’s, you know, our, our vision, it’s, it’s too ambition, ambitious to be ever, um, focused on as, as one individual, um, we’ll only get there by working together.

Naji Gehchan: The second one is health equity.

Britt Wahlin: Health equity to me means that we are designing systems that meet everyone’s needs. Thank you. And especially the needs of those who’ve been most impacted by systemic inequities, by structural racism, um, by barriers to, to getting the care that people really do deserve. And so that means, you know, creating really inclusive systems that, that meet people where they are.

Naji Gehchan: What about social justice?

Britt Wahlin: You know, I feel like, again, this is one of those, like, way back when I thought so much about social justice, and now I think much more about human rights, um, and kind of justice writ large, um, think our frameworks have changed, like I spoke about earlier, we, we talk now about reproductive justice, and gender justice, and climate justice, And is social justice, it feels like really an inadequate kind of term now, um, for, for all of the justices potentially that are part of that.

And, um, to me, the broadest framework we have is, is human rights, um, and achieving justice is ensuring that everybody is able to realize the human rights that they have.

Naji Gehchan: The last one is spread love in organizations.

Britt Wahlin: Well, first, I think you need to love what you do. Um, if you don’t, that’s going to show up somehow. When you’re a leader in an organization and, um, and when you love what you do, you, you bring that love to, to the people you work with. And this has been a learning for me to really show up authentically and to build trust and really build relationships with your team, your colleagues, the other groups you partner with, um, that requires some, some vulnerability.

Yeah, that is, that continues to be my learning edge. Um, I think I kind of started out as a, my, I started out my career feeling like my professional and personal boundaries were like very distinct. Um, and of course we, we all need to have our boundaries. That’s important, but, um, you also really just need to show up, um, as, as who you are and to the people you work with.

And, and again, that requires. Letting your, letting that guard down a bit. Um, also important to that is being able to, yeah, show your, you know, you’re human. You’re not perfect. We all make mistakes and letting your team know that. So to me, that kind of vulnerability is a way of bringing love, spreading love within your organization.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Britt Wahlin: Healthcare leaders. Yes. Well, you know, you don’t. There’s there’s so many ways that health care leaders, whether they’re working for profit kind of entity for pharmaceutical company health care system. It doesn’t have to just be a nonprofit organization like mine to be really making a difference and and bringing a helping to bring about health equity.

Um, so I guess I would encourage health leaders to think about, um. Innovation. For expanding access, um, that could be in a specific product or a service delivery method, but it also could be looking at your own kind of practices as an organization and what you’re doing for your employees. So you offer robust.

Reproductive health coverage for all of your employees, for example, cover over the counter of contraception without a prescription. You can look at your own policies and practices. And then the second thing I would impart is, is what was, I think, part of what has been successful about, um, or one of the key things that’s been successful about the free the pill movement and having an over the counter birth control pill is.

Um, we, there’s been a different kind of switch. We, there was a pharmaceutical company, Paraga, who ultimately took this through the FDA process, but, um, this was not just driven by pharma, this was driven by communities, by advocates, by people wanting, um, this option because it would expand access to contraception.

And I. I would, I want, I, my advice would be healthcare leaders to the healthcare leaders is to listen to communities, hear what communities need, what to patients need, what, where do they see room to improve and expand access. That’s, that’s what’s going to make your innovation, your intervention successful in the end and have it really be impactful and expand access for people who need it most.

Naji Gehchan: Uh, and as you said, uh, going back to this principled partnership, and if we’re all leading with, uh, our values and trying to solve for patients, for our communities, I’m sure the world will be a better place. And thank you so much for joining me, for making the world a better place for, uh, several women. So thank you so much, Britt, again, for being with me today.

Britt Wahlin: Thank you, Naji. It’s been such a pleasure. Thank you for having me.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Michael McKeown

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in collaboration with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I have the pleasure to be joined by Michael McKeown acting CSO/head of research for a stealth start-up at the Pagliuca Harvard Life Labs. Michael started out in California getting his BS in Chemistry at UCSD and working in the Nobel Prize winning Tsien lab on fluorescent proteins. He then moved to Boston, earning a PhD in Chemical Biology from Harvard while working on novel cancer therapeutics at the DFCI. During this time, Michael contributed to several start-ups spun out the the lab, ultimately joining Syros Pharmaceuticals. As part of this work, he developed novel patient biomarker and pharmacodynamic markers to enable selection of the right patients and kinetic monitoring of response. With 10 years of industry drug discovery and development experience in the Boston area, Michael has contributed and led multiple successful programs. Most recently, he led pharmacology at Kronos Bio supporting combinations, biomarkers, and PD assays for the clinical programs as well as leading biology for their most advanced pre-clinical program generating an asset currently in IND enabling studies.

Michael, so good to have you with me today!

Michael McKeown: Thanks for having me on.

Naji Gehchan: Before we dig in “innovation and decentralization in clinical trials” the topic of your panel at SHBC, I am eager to hear more about your personal story. What brought you to the biotech industry and now heading research in biotechs?

Michael McKeown: Sure. Thanks. Um, Yeah, you know, I’ve always had a very strong interest in science, and, you know, I was very fortunate, uh, when I was at UCSD to be able to work with the Chen lab, um, you know, and getting to experience flexible proteins and imaging, um, and from there, you know, I moved to Boston, and, you know, Um, I got to hear a lecture in one of my classes from a professor, James Bradner, who was just starting out at the time, um, but he was so inspirational and so passionate about cancer therapeutics and helping patients, and especially as a physician scientist, that, um, I signed up and joined his lab, um, when he was at Zanf Harbor.

Um, of course, he went on from there to, to head up NIBR, and he’s now at Amgen. But it was just such a cool experience to be able to do, to be able to do research in a context where, you know, we were passing by patients, seeing them, you know, seeing the real effects of this every day when we were getting lunch and, and in the building.

Naji Gehchan: So going from there and from labs, as you said, to a startup word, several startups spinning out of labs, and now up to pre IND assets. So I’m, I’m intrigued by your leadership learning. What did you learn along the way moving from academia to entrepreneurship and building biotechs?

Michael McKeown: That’s a good question.

I mean, And I think part of the learning happens through, you know, classes and stuff. And there’s always, you know, like a little bit of the HR training and development at companies, but so much of it comes from, you know, mentorship. You know, I think the, the CSO at CIROS, um, when I was there, Eric Olson was really inspirational.

Um, you know, taught a lot about, you know, how to, how to manage organization that, you know, You know, people are important that, you know, one of the key things is, is, um, reducing unforced errors, right? Science is hard. So we’ve got to just reduce our incidents of mistakes that we could have prevented. Um, the other part is learning.

So, you know, in reading and actually my wife and I both, you know, we’re both in biotech. And so we purchased book series from like Harvard Business Review and, um, took classes at HBS and stuff. Um, I think that was really helpful, but yeah, yeah. I feel very fortunate that. There were some very good mentors and examples and leaders in some of the earlier organizations I was at to learn from.

Naji Gehchan: So if I double click on this, now that you’re acting CSO, is there one leadership behavior or one, one of the leaders who inspired you most that you would replicate what they have done as you are leading teams? And I loved how you framed it on the science part, right? Like science is hard. We need to reduce incidents of mistakes.

And as, so as you lead those teams with the ups and downs, this, this is where I’m asking these questions.

Michael McKeown: Yeah, so I think one of the one of the interesting features of science leadership in particular is that you’re trained to be a technical expert in your career, right? You go to grad school, you get a PhD, maybe do a postdoc and even work up in early levels of science and industry.

You are a technical expert and ever, ever deeper into your technical niche. And then suddenly. At some point, you start getting reports and you start to be more of a manager and a strategist and budgets and timelines and stuff, and you haven’t really had much training to prepare you for that. Um, so I think, you know, part of this is, you know, really embracing that, trying to learn, trying to learn from people around you, and especially some of the more senior people.

Um, you know, especially if you get some of the consultants that are actually like, you know, industry veterans that are semi retired. Um, the other one, I think a lot of scientists and, you know, I, I’ve struggled this with this. And so either colleagues or managers is that your skills will become obsolete someday.

And so, you know, your technical skills, like the way that I learned to do a Western blot is no longer how any of the labs do a Western blot, right? That’s okay. It’s much faster now. That’s wonderful. But, like, I have to be okay listening to the people who are now the technical exp, and, you know, understanding that my most important contributions aren’t micromanaging them.

It’s listening to them.

You know, the strategy and the value that we can create as a company and how it can help patients and helping to match that with what the scientists are telling me to make that fit into, you know, what we can actually accomplish with our budget and runway and timeline.

Naji Gehchan: I love this. And you’re framing it through practically unlearning sometime, uh, what we’ve learned before and also be humble enough, right?

On, on those aspects where you’re not an expert in managing teams. So that. I’m, I also have in my team scientists and physicians, so I, I relate to what you’re saying. And it’s an important piece of being humble and say, okay, I’m going to learn how to lead people and manage people. So I love how you frame both.

If we now go to your panel discussion, uh, I’d love first to hear your view, your personal view about innovation and decentralization in clinical trials from a broad perspective.

Michael McKeown: Yeah, so there were kind of two main things I was really trying to push, um, you know, in bringing to the panel and I want to make sure we covered for the discussion.

And one of them was getting the right drugs to the right patients. You know, there’s been a lot of talk about precision medicine, biomarkers. This has been driven by the ever, you know, cheaper ability to do NGS, for instance, you know, next generation sequencing, which used to be quite expensive and prohibitive, and now is actually quite commonplace for a lot of patients, at least at research hospitals.

Um, you know, so actually leveraging a lot of biomarkers to match the right patients with the right drugs, and then also getting more innovative, more Um, you know, as opposed to, you know, moving away from kind of the history of just, well, let’s get to MTD. Let’s do an all all comers advanced trial with the end stage patients.

They’ve seen a ton of prior therapies. Um, I just don’t think that that has a very high probability of success. And even more, I think it actually weeds out drugs. That would have value if they weren’t put through that process. So that’s kind of it at a high level.

Naji Gehchan: Great. So now let’s dig a little bit deeper.

If we take, because it’s a broad topic, and this is why I wanted to start at a high level, right? Like innovation and decentralization. So let’s now take the decentralization piece in clinical trials. A lot has been said, a lot is going on. COVID kind of reshaped or accelerated, I should say, some of those pieces.

How do you think of it today? And really behind this question, I’d love for you, if you can share, what are we trying to solve? With the city.

Michael McKeown: Yeah. So on the decentralized side, um, I’m actually a big fan of the investigator sponsored trials where, you know, this gets back to kind of hypothesis testing. So, you know, if you could open up your clinical trial, and there were some umbrella trials a few years ago, but they’re actually a bit less common now.

And I was hoping that trend would catch on more. But, you know, what I’d like to see is if you could open your trial and maybe the company or the original sponsor has an initial hypothesis they’re testing, but you just can’t possibly know everything. And so we’ve got to be able to, you know, capture the value of all these other scientists and physician scientists around the country and around the world that are coming up with innovative applications and ideas.

And so if they come to you with an IST. It would be nice if we could kind of bolt that onto the umbrella, figure out kind of the fastest way we can test this hypothesis, figure out if there’s a there there. And if you do get some traction, then, you know, expand out your path to try and cover that and get, you know, approval.

And this could work for, you know, maybe you find a new, Um, accelerated path to your first approval that you hadn’t even thought of. Or maybe this is an opportunity to expand. Um, and I think this is actually especially impactful in some of the smaller disease areas. Because maybe, you know, your, your original science had, couldn’t really model it.

There, there’s not as good modeling available. It’s not something that was originally on your radar, but, you know, if a really motivated physician scientist or patient community comes to you with this hypothesis, we’ve got to find a way to kind of, you know, decentralize, loosen up the structure to allow this sort of hypothesis testing.

Naji Gehchan: And as you’re thinking about those hypotheses from an investigator dance, uh, and from a company, then, so, uh, you’re trying actually this umbrella idea and then taking innovation from it from outside, say, say new indications or other pieces, put it in this one in like umbrella, uh, trial you’re thinking of, how do you think about, um, and did you discuss in the panel, the patient’s implication?

Of decentralized trial on their participation in those trials and how it’s done globally.

Michael McKeown: Yeah, that was discussed a bit. And, you know, particularly around, you know, matching people up. And so I think there, there is kind of some need for innovation there that. You know, if you, if you go to one of the main, you know, research hubs to a major research hospital, getting on a clinical trial is going to be a lot easier.

But if you’re not, you know, in 1 of those areas. it can be a lot harder to find. Now, I think one of the models that is really encouraging to me is with some of these patient groups. Um, so there’s, there’s some foundations and, you know, patient, patient disease centric organizations that have kind of taken this from a grassroots approach, and they will help connect patients with the trials, with the cutting edge research.

Give them a community of other people to talk to. Um, and that could be phenomenal. I’ve seen cases where, you know, they were concerned. Oh, that’s a rare disease. We’ll have really hard time enrolling it. And because there was a foundation and a patient group behind it, that actually became the fastest enrolling cohort on the trial.

Um, which, you know, nobody really expected, but that just shows the power of, you know, what we can do in the digital age and the power of, you know, the patient experience.

Naji Gehchan: Sure. And, and we’ve seen there’s tremendous work of patient advocacy group, uh, as you said, to help patients through their diseases and clinical trial, uh, can several times be actually the best treatment option for patients.

And so the working with advocacy group is certainly. impactful and we should all be grateful for what they do. Um, and you touch on something that was kind of my follow up question, uh, on some area, you said some areas might not have those trials and especially in your idea of, for example, IITs or IIS, it depends which academic group most probably will have the trial, et cetera.

So I’m thinking from a diversity and equity approach of those initiatives. Has this been discussed and how decentralized clinical trials or innovation in clinical trials can help improve diversity in clinical trials?

Michael McKeown: That’s a really interesting point. I mean, I think just being able to capture, um, more diverse geography helps that a lot.

You know, um, some of the research hospitals and hubs happen to be in cities that that may not capture the full diversity. Um, and so, you know, just being able to make sure you’re capturing, um. You know, potential patients from, you know, maybe, you know, rural areas. More in the South and Midwest. Um, you know, I live in Boston, and so we’ve got, you know, MGH and Dana Farber and Brigham and, you know, just the South or Mario Sloan Kettering, you know, multiple research hospitals in New York, but, um, you’ve got to have mechanisms to be able to boost awareness, um, and access.

And then, you know, the other thing I think has really helped there, Um, is um, you know, foundations have helped with patients getting to those sites. So maybe the only way to get that new treatment is to get to one of those research hubs. And if that’s the case, there’s got to be a way to help cover the costs.

Because I think that, that is one of the prohibitive things is, is just, can you afford to, you know, leave your hometown, get on a plane, fly, and put yourself up? In that area for, you know, an extended period of time, if you’re going through, you know, multiple infusions of a therapy. Um, so, yeah, you know, there’s got to be some mechanism to cover that.

And I don’t think that’s generally going to be coming from, like, insurance reimbursements as is currently structured.

Naji Gehchan: Yeah, those are those are great points from from a participant plans, right? Especially for underserved communities, how we work with advocacy group or other mechanism to, uh, to ensure the time, uh, the transportation, as you said.

So these are great examples. Uh, you’re giving. Uh, and then also community sites, I think, is one of the important pieces, uh, for, for diverse enrollment. Um, as you discuss those, I would love to hear your point of view. What excites you most from an innovation standpoint in clinical trial that you think will literally change the way we are, uh, from designing to executing our clinical trials in the future?

Michael McKeown: Yeah, I mean, I kind of touched on it earlier with the biomarkers, but, you know, it still feels like a very nascent application. The promise of NGS, of sequencing, of knowing exactly what the mutations are, what the What the condition is of the patient. Um, that’s still being rolled out, you know, and so I think some of the front front runners here and like, um, so in blood cancers, they’re actually restructure stratifying the disease based on your mutational profiling and linking that to what treatments you should get.

Um, so, you know, that’s starting to happen for, for standard care treatments, but even on new clinical trials, um, you know, there’s still so many trials out there that just go into the, the phase one advanced all comers, you know, solid tumor, for instance, and oncology or, or try to go for a very broad SWAT.

And I understand that, that, you know, capturing the broad SWAT, you know, has a potential potential implications for a larger market share down the road. And you know, also people say, well, it’s just a phase one that’s just supposed to be for. Um, and to set the dose. But, you know, a lot of investors and a lot of people are watching those trials now and do expect to show some sign of activity.

Um, you know, reason to believe that might be a bit unrealistic or optimistic in some cases, but, you know, nevertheless, that’s kind of what’s happening. So I just worry that, you know, by using these kind of older approaches that we’re actually missing stuff, it could be quite impactful if you were using them in the right patients.

And so. Yeah, I am a strong, strong advocate of leveraging all that science, you know, preclinically that we’re doing. And, you know, using biomarker approaches at the earliest stages of clinical work, at least as a correlate. So you can understand, well, did the people that were positive have a little bit higher activity than the ones that weren’t?

Um, this is actually what, what Ciros, the first company I was at did, you know, we showed that there was an enrichment of response in the biomarker positive patients. And then. When we go to the phase two and now phase three trial, we’re only looking at selected patients. And you have a really, really high response rate because you’ve pre enriched patients.

Um, and what that does is then that actually gets you a smaller trial because you don’t need as many patients because you’ve You know, essentially aren’t enrolling as many likely negative patients in terms of response. Um, and so, you know, if you need less patients, you can enroll faster and complete your trials faster, which is a huge component of the cost.

So, you know, a lot of the cost, you know, a huge portion of the cost in, um, new drug development happens during the clinical trials. And so anything you can do to shorten that and reduce the number of patients and not treat patients who are not likely to benefit. Is a good thing and, you know, furthermore, I look at even even older drugs, you know, you look at something like for septum, which is using her to breast cancer.

You know, that was going for the highest level of expression initially, and that got through and got an approval. And then subsequently, and partly because of real world evidence, and you know, what was happening in the clinics, they’ve since opened that up. And so they’ve figured out that there is benefit for, for an expanded, you know, swath of biomarker patients.

And I, I think that’s a really good way to go. You know, get your, get a fast tactical trial done, you know, um, relatively more efficient. In a selected population, and then open up exploration later, um, and potentially, you know, do more of these ISTs, get the community engaged and find out, well, where else can I use this?

Naji Gehchan: Can I ask a follow up question on biomarkers and your thought about, uh, what’s the hurdle to overcome to get where you’re saying we should go? Uh, and then your thoughts about. We’re hearing a lot about digital biomarkers. I’d love to hear also your thoughts about this.

Michael McKeown: So there’s a couple hurdles, right?

Um, you know, so, so technically, um, are patients able to get these assays done? Are they able to get sequencing done? That hurdles rapidly falling away. Um, you know, another one is, you know, if the samples exist, can you access them? So if you if a. company or another physician would like to run an assay on some of the, maybe some of the bank samples, maybe FFP blocks or, or frozen TBMCs or something from those patients.

Can you actually access the, those samples from the patient? Or will you have to go get that patient to get a new assay done? Because if you can access the archive stuff and that’s still relevant, then that’s going to be another acceleration. Um, the other is kind of on the corporate side with, with kind of with understanding, you know, Market, you know, there is pushback on, well, I don’t want to restrict what my potential, um, you know, uh, label will be down the road.

Uh, I still think that’s, I still think there’s, there’s kind of a double edged sword there that, you know, maybe you’re going for the widest possible label, but if that significantly reduces your probability of success, then I don’t think that’s actually. An advantage there. Um, and then maybe the last is, you know, if you have to run a diagnostic to prescribe a drug down the road, that could create an extra hurdle.

You’re going to have to get. Reimbursement, you’re going to have to make the, uh, diagnostic more available, but, you know, I actually think that also will go away because you look at how many patients, you know, particularly in cancer are getting sequencing or just the general population getting 23 million and stuff like that done is I think a lot of patients are already going to have sequencing done.

And so you’ll have a pretty good idea. Um, whether they’re going to be positive for your assay when you, when you run it, if you’d even need to, because, you know, if they’ve already had good quality sequencing done, maybe you don’t even need to, and I’m focusing, you know, on, on gene sequencing here, but, um, this would be true for some of the more complex, you know, flow cytometry and, and pathology, um, which are all having advances, um, lately.

So, you know, um, Yeah, so access accessing the samples, accessing the data, um, and then convincing people that this is a good way to go, even though it faces some restrictions. Um. You know, this is also, you know, doubly so for some of these rare diseases, because it’s, it’s how are we going to find these patients?

How are we going to find enough of them? Even if we have a good idea that they would be biomarker positive, but, um, that gets back to the trial design issue and the access to trials. And so I think, I think all this stuff’s getting solved. I think it will get better, um, especially with all the digital technologies and even social media that’s helping connect people.

Naji Gehchan: Any thoughts about digital biomarkers? Any thought on the digital biomarkers?

Michael McKeown: Um, you know, I think, I think it’s got promise, but I do worry about how good, you know, medical records you’ve got to get your medical records have to get up to car. So, you know, AI and all these, You know, computational techniques suffer from quality of data and, you know, I, like a lot of Americans have gone through multiple insurers as they change jobs have gone to multiple clinicians.

And so having all of your your own data in a coherent and systematized set that’s actually interpretable. It’s a big hurdle. Um, I was actually working on a project a while back where we were able to import a ton of medical records and anonymized ones to do some data analysis on. And the computational biologist came up to me, he’s like, yeah, I’m looking at this field and there’s 14 different string entries here.

And I look at them and it’s like, HIHI, HIGHIGH, you know, plus sign up, you know, it all meant the same thing, but. That’s actually a huge problem. And we had to create, you know, a database of synonyms just to to work on like one field of patient sample data. So I think that, you know, as we get better at this, as we get to more digital and systematized medical records, that’ll be a big help.

Naji Gehchan: So Michael, I want to now give you a word, and I would love your first reaction to it. Okay. So the first one is leadership.

Michael McKeown: Yeah, I mean, I think that that’s That’s important. Um, and, you know, it touches on, you know, what we started with here, which is You know, leadership really needs to be learned. Um, you know, they talk about natural born leaders, but I think there’s a lot of learning to be had both for mentorship and classes and books and reading.

Um, and to be a good leader. It means that you have to really take that seriously and take a commitment on yourself to you know, constantly be learning and becoming better as a leader.

Naji Gehchan: Drug development.

Michael McKeown: Man, it’s, it’s expensive, but um, you know, I think that these techniques that we were talking about, decentralization, biomarkers, I think there’s ways to accelerate this. And, you know, and make it a lot more efficient, which will make it more, more cost effective, cheaper and, and raise the probability of success, you know, overall, the, the probability that any single, you know, pipeline or, or discovery program actually gets to an approved drug is pretty low.

It could be that lowest 5 percent in some, some fields, but, um, I think we’ll be getting a lot better at that because of all things we were just talking about today.

Naji Gehchan: What about innovation?

Michael McKeown: It’s it’s an amazing time, you know, and I think, you know, especially being in a hub place like like Boston where I’m surrounded by all the amazing research coming out of Harvard and M.

I. T. Um, you know, I’m working out of. Harvard Innovation Lab, there’s ShareSpace, and you’re getting to hear all the amazing ideas that people are coming up with, um, either from bootstrap effort out of academia or working with venture funds, um, this is truly an amazing time for innovation, and kind of, I think, an unprecedented leap for, for life sciences, and especially as we’re coming, being in 2024, coming out of kind of the investment lull, um, you know, things are really roaring back.

Naji Gehchan: The last one is spread love in organizations.

Michael McKeown: Yeah, um, you gotta lead with heart and you’ve got to care and. You know, you care about your people, care about your mission, you know, I’ve mostly worked in, in oncology and small molecule oncology space and, you know, reminding people that you’re not just, you know, running an experiment today, you’re, you’re potentially taking a step forwards towards, you know, giving somebody another, another Christmas with their family or, or, you know, giving them more time with the loved ones.

And we work in, you know, I work in the life sciences, this has impacts on human health. And, um, But at the same time, don’t just grind your people and use that to make them work harder. Love the people in your organization and love your mission.

Naji Gehchan: I love how you framed it, uh, from caring for your people. To caring for the patients we serve, because this is exactly why you wake up every morning in this industry. Any final word of wisdom for healthcare leaders around the world?

Michael McKeown: Um, you know, listen, be humble, and you never stop learning.

Just because you’re, you’re at the top, you still have opportunities for growth and learning, and that is a constant, lifelong process.

Naji Gehchan: Well, what a great way to end this conversation. Michael, it was such a pleasure to have you with me today. Thank you.

Michael McKeown: Thanks so much for having me on. This was a lot of fun.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

More episodes summarizing the MIT Sloan Healthcare and BioInnovations Conference are available on spreadloveio.com and wherever you get your podcast. Follow us to get our most recent episodes and spread the word around you to inspire others and amplify this movement our World so desperately needs.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: JR Clark

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in collaboration with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I have the pleasure to be joined by J.R. Clark, Senior Vice President of Health Plan Product and Strategy at Paytient Technologies, where he partners with thoughtful employers, insurers, and health systems to help people better access and afford healthcare. J.R. is a former Director and Actuary of Anthem, where he was known for his public exchange marketplace strategies and creation of alternative products in the Individual and Small Employer segments. He began his career as a nuclear engineer with Florida Power and Light in Juno Beach, Florida, where he developed optimization strategies for spent nuclear fuel. J.R. obtained a Bachelor of Science (BS) degree in Mechanical Engineering and completed graduate coursework in Nuclear Engineering from the University of Missouri-Columbia.

JR, so good to have you with me today!

JR Clark: That is great to be here. I appreciate you bringing me on.

Naji Gehchan: Before we dig in “removing financial barrier to care” the topic of your panel at SHBC, I am eager to hear more about your personal story. What brought you from nuclear engineering to healthcare and now solving this crucial issue of access and healthcare affordability?

JR Clark: great. I’ll give you a little background and it isn’t a typical transition, but I think what is typical for a lot of the guests on this, uh, is that, you know, People don’t always end up where they expected to be, which is what’s fun in life. So I guess a quick background, maybe I’ll go a little bit back or, you know, to young ages to kind of give a little bit of foundational story here.

Um, so when I was growing up, I was born and raised in St. Louis. I currently live in St. Louis and, you know, my, my parents owned a small business. And it was always interesting to see growing up as a child that, you know, my parents put a lot of their time and effort and energy into their company. And, and even within that, you know, my, my dad was always the person who rolled up his sleeves.

He was often like the, the dirtiest person at work, you know, coming in with the dirtiest clothes, doing the most dirty jobs. And, and he was always, and he was okay with that. Um, My mom was always the first person at work every day. She, you know, she’d get up at 2. 45 in the morning and head to work. And she was there all day.

She often worked, uh, very late. And I think kind of the lessons that they really demonstrated for my brother and I is that it takes a lot to get things done sometimes. And you have to really be willing to put in that extra work to do it. And sometimes you have to do that even when you don’t. You don’t like doing it because you look at the outcome of what it’s doing and, and, you know, invest as a consequence of that.

But I think also on top of that, my parents really spent a lot of time and, and really like focused on sending the message that you should never expect more of others than what you’re willing to do yourself. And that’s not just a talking point. It really is a, like a practice, not just a, Oh, I did that once.

And so now I expect others to do it all the time. It really is. Um, if I expect others to do it all the time. As employees, and I really need to be doing it all the time as well. And so really, those were key lessons informative for both my brother and me. And I guess maybe the 3rd thing that they were really demonstrated.

Well, is that somehow with all that, they really managed to stay involved in their church and with their friends, especially being intimate in their friends lives. And. Honestly, that there’s an art to that, like, of how you balance that. And admittedly, it’s something even today. I don’t think I do well. Um, so it really was a lesson that really, whatever your level of busyness is in life, like, there really is value in investing in others.

So they really kind of demonstrated that pretty well. Um, so anyway. My brother and I started working at their company at a very young age and like when I say young age, I mean, like, early elementary school, we did jobs like, you know, cleaning the office and the bathrooms and doing things like, you know, sitting with the adding machine and totaling up bills for people.

And I think that’s really where it kind of, like, I probably, I, my, my math side of things comes from is that starting with, you know, sitting in front of an adding machine and putting things together. So kind of fast forwarding from that, you know, my. I also happened to meet my wife at a young age. My wife and I met when we were in high school.

And, you know, she is a, she’s a very charismatic and caring person. And probably by now your listeners can tell I’m not a very charismatic person. And that’s why I’m an actuary right now. Um, but really like it was, it was really neat to see, like, She was the first person who I really spent a lot of time noticing how her actions of caring for others really, like it really caused a response from people because people really like to feel valued.

So when you value somebody, there’s a different response that you get from them because they are valued by you. And it’s not a manipulative valuing. It’s got to be a genuine value. And my wife really is good at that. Um, you know, and so I guess moving forward into college, you know, I, I am very fortunate in life that I had an older brother that actually wanted to be around me.

And he, you know, he’s incredibly intelligent. He’s very, very diligent and invests a lot in whatever he puts his mind to. And he headed towards being an engineer. I didn’t know what I wanted to do, so I just kind of followed in my brother’s footsteps and became an engineer as well. And, and really, like, In college, and I guess I’ll even say college and into my first job as being a nuclear engineer, there were a couple of things that were really impactful.

Um, that really is the first time in my life. And you think when you go through school, you’re kind of trained like to get from a point to a to point B in the most efficient manner. Like you sit in a math class and it’s like, these are your rules, use the rules and you get to a final result. And the reality of it is that in life.

You know, sometimes the right answer is to straight line from point A to B, but there are other times in life that while it may seem less efficient, there’s actually a lot of value in meandering between point A and point B. That’s actually where a lot of the like learnings and the discovery happens. And so, you know, that really was a valuable lesson learned it very much.

So both in college and in graduate school, and then definitely in my first job in nuclear engineering. So kinda here comes the, how does it. How does somebody go from being an engineer to being an actuary, uh, and the crossover into healthcare and everything on that front? Really what happened was, you know, we were working in Florida, in Juneau Beach, Florida, Florida Power and Light, and my wife and I, you know, we knew that we wanted to have a family.

We knew that we wanted to be near our family, and so we, we decided that we were going to move back to St. Louis. St. Louis, Missouri is not a hotbed of nuclear engineering jobs. And so, uh, you know, so basically I had to think through what, what would the future look like? I happened to be in a conversation with this woman who was like, Oh, my uncle was an actuary and she.

You know, he, she was saying he takes these tests and when he takes tests, he gets pay increases and promotions. And I was like, that sounds interesting. So I looked into it. The thought of it was great. I took my first test and then immediately jumped into consulting. And, and so I went to work for a company that’s now Willis Towers Watson.

At that point, it was called Watson Wyatt before all the mergers. And so really like. There was where I got my start in understanding what it was like to be in a fast paced kind of lifestyle of almost think of it as mile wide, foot deep, uh, type of information and I loved it because what, what we did in consulting really was around the idea of take little pieces of information.

And then figure out what to use of that to, to assimilate it into a package that is a value to somebody else. And, and what that did was it created a lot of like, I call them high five moments. They’re like the moments, the moments in a company where your team thinks that there’s no way possible to pull off a task.

And yet you continue to work together. You continue to kind of struggle together. You continue to, like, press and you get to this final state where you actually do it and you actually deliver something. And like, there’s just a satisfaction of the team. It’s that high five moment where you know that Collectively, you worked through something that you thought you couldn’t do.

And you got to a point of completion on it. And that’s been really like, that’s been really core. You know, you think about things that are like core memories or core experiences. Those high five moments are very core experiences. And I think they’re very motivated, motivating and inspirational for people who work, you know, in companies.

So all that being said, I loved consulting. I love the teamwork. I love the atmosphere of it, but I also realized, you know, at that point, Uh, I, no better way to say it than this. I didn’t think that I could be both a good consultant and a good dad simultaneously. And my son was on his way and, um, some people pull it off very well, but for my skill set, it, it was not something that I felt like I could balance well.

And so I needed to take a kind of a turn in my career and move to something that was a bit more stable. And so I moved into insurance, um, really kind of a big difference between think of consulting versus insurance is that in consulting. Like I said, it’s mile wide, foot deep. In insurance, it’s a whole bunch of tranches of foot wide, mile deep.

The NAU Insurance has the aggregated, like, efforts of a bunch of foot wide, mile deep people. And I was fortunate to get to be in a spot in my career in insurance where I got to take all of that deep knowledge of everybody who was doing that mile deep work, I got to aggregate it and make business decisions off of it.

And so it really was It was a cool spot to be in. It was a, I mean, just so it really was a wonderful place to be great people to work with. And there were a bunch of lessons that came out of that. You know, in terms of that environment, kind of lesson number 1 is that, you know, when you’re setting up a corporate structure, oftentimes it’s like, how do we trim redundancy?

You know, how do we how do we make things as lean as possible? But really, in the same way that there’s a value in meandering between point A and point B. There’s also value in redundancy, and I think that value that gets overlooked is the fact that when you have two people that have a portion of their task or a portion of their mindset that overlaps, what ends up happening there is that when two people can kind of bubble up together on, on some portion, it’s almost like a I don’t know, it’s almost like a nuclear fission situation where the, the end outcome is much bigger than the combination.

You know, the whole is greater than the sum of its parts or whatever you want to call it. And so I think we underestimate the value of redundancy in the typical corporate structure. Second lesson really from the insurance side of things is that good managers are not one size fit all. Like, you can take, take two people that report to the same people or under the same organization structure, and one person may hate a manager and the other person may love a manager.

And so it’s always interesting to evaluate, like, what is it that causes those differences? And I, I, I think, and this is a personal opinion, I don’t know if everybody would agree with it, but I think there’s value in having that where a manager isn’t trying to be one size fits all for everybody. So I think of two managers in particular, one of my favorite managers I ever had his name, Steve.

And he operated his business and his teams just like he was a basketball coach, 100 percent like a basketball coach. And he required a lot, he expected a lot, but in return, he would go to the mat for anybody that was on his team. Like once you earned the spot, like you knew you had somebody backing you up.

Now some people hated that, some people loved it. I personally loved it. And, but I can see why other people maybe wouldn’t, I think is fantastic manager. And then I, another manager is one of my most favorite managers. Her name is Jen. And she, she knew better than anybody I’ve ever worked with how to prioritize things such that for herself and her team, she made sure to let the things that weren’t a big deal, slip off the plate and focus energy and effort towards the things that were a big deal.

And I think what that did was kind of circling back to this whole idea of value. It made people realize that they were valued and they had the ability to contribute to the value of something, which was impassioning, you know, their, their ability to do well at their jobs. So, you know, and I think with all that, when you think about that, you know, it’s valuing what is important, not just to yourself, but to your team, even on a personal level, like valuing what’s important to them really does bring a positive outcome at the end of the day.

Like I flat out through my career, I’ve seen tons of examples of people who are working 60 hours a week and giving up on the things they valued outside of work, where, when we focused on saying what’s important to you on your time outside of work, like, Oh, you have Thursday night where you get together with your friends and you have pizza and you go somewhat go watch some show together like that’s important to you.

Well, don’t skip that because of work. And what ends up happening is having that extra value outside of work and feeling valued. Ends up producing more output and better experience and better mood, better, like feeling more loved and appreciated. It has positive consequences in the, the lesser hours that a person’s working because they walked away to go do that thing that they value outside.

So I love that. That was a great lesson in the, in a large organization in particular. Uh, kind of, I know I’m probably having on long, so I’ll say the last couple of things really quickly on this is that. You know, the last lesson I learned in insurance, it actually happened after I broke my leg. Uh, and my leg and my hip and ended up in the hospital.

I was ice skating with my daughter and unfortunately just took the wrong fall at the wrong place. And that was the first time I ever experienced firsthand what people feel when they’re in a moment of, of kind of a healthcare crisis. Um, and you know, I’m a very data driven person. I spent a lot of time in Excel or in data or working through making decisions off of data.

But And what oftentimes I don’t do well is to stop and think back, like, Oh my gosh, what is it that our. Our folks that we are serving, what are they experiencing and how does that impact like the overall ecosystem with what they’re experiencing? And so, you know, we, that was actually kind of illuminating in the sense of, you know, I’ll say, like, 1 day, we were sitting there going through some, some cost of care reports in a meeting and I realized that we didn’t ever spend any time focusing on members out of pocket costs.

We spent all of our times focusing on all of our time focusing on. Like the plan paid costs associated with healthcare. And I was, it was like a light bulb moment, like, man, we need to be focusing more on out of pocket because that’s the first thing that people experience. And because of that, like there’s a downstream impact that can happen.

And so ultimately the reason I left insurance is really because. I really want to focus on what we can do to help people get care at the right place, right time with the means to do it so that they’re prospectively thinking about care instead of retrospectively thinking about it. Because I think that the downstream consequence of that is healthier people who are able to make better decisions around what their health care should be.

And ultimately that has planned savings, which saves employers costs. It saves, you know, health insurers costs. Ultimately makes a better outcome. And then even the, the underlying thing of it is that health systems get paid for the services that they’re rendering. Like, there just is a net benefit that happens all downstream as a consequence of it.

So anyway, uh, I think that’s kind of the, the quick backdrop. So that’s why I’m at patient right now. It’s really honestly to help people. Access and afford care on that front line by basically giving them them the means to pay for that front line care.

Naji Gehchan: Well, what an inspiring journey and incredible story of of impact and what you’re doing today within your organization to help patients before we go.

To this specifically, because I really want us to, um, to talk about how you’re doing it within your company and the topic of the panel. You talked about high five moments. I love this concept. Any major, is there one leadership learning that helped you, that you used or help you get into those high five moments with your teams?

JR Clark: Yeah. So maybe I’ll, uh, yes, I’ll say leadership. Leadership way of doing it is honestly, it’s. Putting people in a spot where they are able to do what they do best. And maybe I’m going to sidestep it for a second and then bear with me. I’ll come back to answering it directly. I think in, in a leadership structure, we oftentimes fail to recognize that everybody isn’t going to be good at everything.

And, and what happens when you do that is that you’ve ended up putting people in spots where they’re more prone to either do something lackluster or even utterly fail at it. And I don’t think that’s a fair thing to do for folks. I don’t think that’s the right thing for them to position, put people in for your employees.

And so I think the step number one in it is doing projects and building, like building out solutions that fit with the skillset of the folks that you have. Sitting there on your team and not expecting more of the things that are outside of those skill sets. And then kind of part two of that is building teams where people have overlapping skill sets, but also independent skill sets.

So it allows them to kind of bring something to the table that nobody else is able to bring to the table in that team. And so I think that’s kind of the foundation of creating those high five moments and then frankly, like kind of the direct answer is I think life just tends to bring itself.

Situations that you can make high five moments out of as, as managers, as leaders, um, by really taking on things that. Maybe others hadn’t really focused on or finding like early on. Here is something of value that we’re really not yet putting our energy toward and let’s try and do something with it. So hopefully that answer what you’re.

Naji Gehchan: Yes, yes. And I love how you frame this. You know, I always talk about, I don’t think anyone in life wakes up not wanting to do a good job, but several times we have wrong casting. For the job. So it’s not about the person and their capabilities. It’s just like ground casting. And as leaders, we should be accountable for this, right?

And make sure that we’re getting the right people to be at their best in the right places. So if we now go into the panel’s discussion, this is obviously a very important issue we’re facing in healthcare, financial toxicity, financial barriers. Can you share first your thoughts about how to improve this?

How to even remove these barriers?

JR Clark: Yeah, so maybe I’ll, I’ll take it kind of from two sides for the answer. The first is maybe I’ll, I’ll talk a little bit about the MIT Sloan Healthcare and Bio Innovations Conference and kind of what the focus was of the specific panel. So the panel itself was comprised of, you know, a handful of folks from industry being direct insurance, but kind of alternative insurance products.

Uh, so there was a person named Allison from Shurist that was on there. Uh, there was a woman named Nikita who, uh, she was from Fortuna Health, which their, their mission is really to make the, uh, make the ability to, like, enroll in Medicaid a lot simpler for folks so that they get access to care, because in a lot of cases, people just don’t get access to care because They don’t know how to get through the process of enrolling something that would get in, in something that would get them access to care.

And then there’s a woman named Laura, who was there from Amazon, uh, Amazon pharmacy. And her focus was on how do you get, how do you get medications or drugs to people in an easier way for a cheaper price? And so that was kind of the backdrop of it all. And it’s kind of some unique perspectives in there, but also some overlapping perspectives.

And I think maybe I’ll start by saying, you know, the number one focus in all of it. Was how do you make sure that people know that they can get care in the 1st place? And so that’s that is step number 1 and all of this. So, whether it’s, you know, Amazon giving cheaper prices for drugs or whether it’s, you know, surest, uh, finding alternative health plan mechanisms so that people can get care, uh, with a lower out of pocket than what they otherwise would have been or whether it’s, you know, Fortuna actually just getting people enrolled in Medicaid in the 1st place or as patient, you know, my company.

Making sure that when people are exploring getting care and they’re going to have an out of pocket component that they make the right choice because they have the ability to pay. And so I think all that kind of combines just to say, like, there’s an underlying structure here where it’s almost like trying to take mentality and say, like, I don’t, I don’t want care to just happen to me.

Instead, I want to be able to think through and act on my own behalf and be an advocate for myself. In actually getting care taken care of when I need care. So I know from the patient side of things, we see all the time. Like I’ll, I’ll take another sidestep here and sorry, again, more blabbing. But you know, we, when the company was formed, we had the hypothesis that people weren’t getting care because.

Like, oh, shoot, I have a 3, 000 bill at the hospital that I’m going to have to pay, and so I’m not going to get care, or I already had care, and I have to pay 3, 000, and I don’t know how I’m going to pay for it. The reality of it is, you know, 5, 6 years into it, what we actually see is that, like, people need help getting routine care.

They need help for specialist visits, the 70 copay for a specialist visit, or the 50 pay for an urgent care, or even, no joke, like, How do you spread out the cost of a 10 copayment at the pharmacy? Like, that’s a legitimate need of the population right now. And there’s a lot that happens on that side of things solely because people don’t have that prospective ability to know that they can get care.

And so I think that’s kind of the underlying theme of the, the panel discussion at the conference, but it’s also the underlying theme of what all the companies represented there are trying to achieve.

Naji Gehchan: So as you discuss this, and obviously your, your company is focused on improving this, should we be hopeful that we will see less financial toxicity in the next decade?

JR Clark: Yeah, that’s a great question. And the answer to me is yes. No. And, and the reason I’d say we should be hopeful is because there’s a lot of focus being put on this. And maybe the way to say it best is, you know, you hear the cliché phrase of, like, creating win win wins, right? People say that all the time.

But the reality of it is that, like, number one, the foundational structure of our healthcare system is good. The intentions of the people operating it are good, like, I’ll give a quick example that my mom, you know, she had lung cancer and had to have part of her lung removed. And we were, we were sitting in this, there’s like a special waiting room for people who are having more serious surgeries.

And unfortunately, one of the other families that was sitting in the waiting room, they got the notification, like, while we were sitting there, that their family member didn’t make it through surgery. And I walked out of that waiting room. And when I walked out of the waiting room, there was no joke. 80 80 staff members of that hospital lining the hallway to kind of, for lack of better words, I’ll say, call it provided like a processional for that family as they left and these hospital administrators were in tears.

These doctors, nurses were in tears and you can’t look at a situation like that and say, health care is broken when that many people are showing up to work every day with that much care. And so that gives me hope that number one, our health system at its core is right. Uh, you, you won’t ever hear me say, you know, healthcare is broken, but what there is with inside of our healthcare system, there are little nuances or little inefficiencies and.

Like, when we talk about creating win win wins, what we, what we want to be doing in the healthcare system is inserting different solutions in each of those inefficiencies, so that we push out whatever is creating that inefficiency. I think from patients side of things, we see that paying, like, the kind of barrier to care that is paying for it, that creates downstream impacts.

We have 67 percent of our members that say that they would have, Deferred or foregone the care that they got, had they not had access to pay for to pay for their care with their patient cards. That creates a downstream inefficiency for the system. So just by plugging this little hole there of helping people pay for care.

People take their medications that reduces cardiovascular events in the health, you know, in, in the hospitals, people go see their specialists. They like, they do what they need to be a little bit more proactive in the health side of things. And so I think from your kind of direct answer to your question, am I hopeful?

Absolutely. Because I do think that we’re seeing like a little turn in the tide. Of just plugging more of those little inefficiencies in the system to help solve them.

Naji Gehchan: Oh, thanks for sharing this and hope your mom, uh, is doing okay. Yeah, all great. Yeah. Thank you. Great to hear. Um, so as you’re, I love how you framed it into kind of plugging some small solutions that will have a larger impact at the end of the day, like really tearing it down to some small inefficiencies and making it better.

So a question on this, do you, do you believe that the technology by itself will help us improve financial, uh, you know, toxicities over here to care, or do you think there is still a big social question about how do we think about healthcare, you know, and I’m biased, I’m coming from, you know, like coming from France, where we think healthcare is a human right and like there’s a lot of discussions about how we do healthcare and I’m not saying that we don’t have issues we have actually probably even more issues than here but certainly finance from a patient experience is very different.

Patients do not think about it. The society thinks about it from another perspective. So I’m intrigued. How do you see this? Is, is it technology that will solve it? Do you think there is still a social component to it? And how, how will all this be resolved in the next decades?

JR Clark: Yeah, so I don’t know how it will be resolved, but here’s here’s my hopeful guess and all of it.

Um, I think that we have the good fortune as a society in the United States that we’re starting to see all of the parties that kind of have a hand in In like, call it the, call it the, um, I don’t want to say reconstruction, but the, like, improvement of the system, all the price, whether it’s health systems or health insurers or employers who have benefits that they provide for employees, uh, financing mechanisms.

Like, everybody is starting to kind of come together with a little bit more realization of, oh, yeah, if a happens, it produces B result. B result if, you know, is either going to have. You know, a bad C outcome or a good D outcome and, like, starting to understand that there’s some binary decisions here that all kind of have a downstream impact that are either going to make things better or worse.

And fortunately, like, you know, I know in the red, like, when you were opening, like, we talk about patient working with thoughtful thoughtful partners. We’re partnered with nearly every major health insurer now, because health insurers are recognizing, like, oh, man, paying for frontline cost of cost of care.

Is an issue for a lot of people, and that has downstream impact. And so they’re working towards a solution by partnering with us. Hospital systems are realizing that they’re kind of their distribution of kind of on collectible debt, or whatever you want to call it process. It’s not working right now, and so they’re partnering with solutions like us to help kind of fix that employers are starting to see, like, man, I’ve been raising my deductibles for my employees as a cost offset.

But now it’s really starting to have an impact. So what can we do to help fix that? And, and so just kind of the fact that all of the stakeholders that should be thinking about it are thinking about it and should be acting on it. Are acting on it. I really do feel like that component is really a valuable thing.

Now, I guess maybe towards the social, like, the pure social question, like, if you start thinking about even from the government standpoint, even if you look at, like, um, Medicare Part D, you know, under the inflation reduction act, we just have the, the, you know, the passing and implementation of what’s going to be a payment plan.

For every single senior who is on a part D drug drug plan to be able to spread their costs, their out of pocket costs over time, it gets that same type of kind of kind of mechanism. So I feel like there is a social component, and it is kind of nice that that several folks are partnering in the solution.

Naji Gehchan: Well, that’s that’s great. And I really want to go back to something you shared, having either like you and other leaders in the healthcare system. We all strive and wake up every morning to make life better for patients. And I think this is something that is super important and starts with leadership, right?

All of us around the table trying to make the right decisions on behalf of patients, because all of us are patients at one point. So thanks, thanks for bringing those ideas here. I want to move now into a section where I’ll give you a word. And I want your first reaction to it. Okay. So the first one is leadership.

JR Clark: Okay, so first reaction. Um, maybe I’ve, I’ll repeat a little bit of what I said, but maybe with a little different nuance to it. Is that leadership, I, I’ll say it this way. Leadership doesn’t have to be thought of as hierarchy. Um, leadership, leadership is best when a leader is involved. They’re caring, they’re empathetic.

Okay. But they’re also very maniacally focused on what the end result is, uh, what, like, what the conclusion should be. And, and I guess when I think of leadership, I think of, like, again, like I pointed out the two leaders earlier with Steve and Jen. And they are people that balance that very, very well, um, setting expectations, valuing their teams, and understanding that, like, you all either win together or you lose together.

And and I really appreciate that side of things when I think of leadership. So that’s maybe a short and sweet answer. But yeah, we can go from there. What about health equity? And so when I think health equity, I think of it in terms that, you know, when somebody wakes up in the morning, whoever it is. They shouldn’t have to fear the idea, or they shouldn’t, let me say it, they shouldn’t have to have to make a different decision than somebody else based upon, uh, whether or not they can pay for care.

And so what I mean by that is, if, let’s simple example, if my throat hurts in the morning, like, if I, I have a high fever. Uh, the difference like I shouldn’t have to act differently in terms of my ability to seek care because of of my financial means in that moment. And so if I need to get a, I need to get a strep test and a antibiotic, I should be able to get that whether I am a person who has the means immediately or does not have the means immediately.

And, and so I think about that as kind of the concept of removing barriers to care. That really is the core function of removing barriers to care.

Naji Gehchan: I love this pragmatic example. It’s, it’s really a powerful way to think about it. The third one is work life balance.

JR Clark: Yeah, so that’s it. Uh, that’s multiple words there.

Uh, so work life balance. Admittedly, I’m a massive fan of work life balance. Um, I gave the example before I I’ve had multiple teammates where at the onset they were working, call it 60 ish hours a week, but by producing more, I I’ll give one example. I had a teammate, somebody on my team who. Um, she was working like 60 hours a week, and we set a goal to prioritize things outside of her life, get her work down to 40 hours a week.

And she inherently was somebody who, it’s already a two X producer. So when she works 60 hours a week, we were getting 120 hours of productivity out of her. Unbelievable person. And we worked to get her down to 40 hours a week by prioritizing things outside of work. And she did, she was able to get down to call 40, 45 hours a week, but no joke.

There was zero difference in the amount of productivity that happened within work, zero difference. In fact, like in some places, she actually like had more inspiration to step up and take on new responsibilities and new ownership that she otherwise wouldn’t have when she was buried in her. For 60 hours a week.

So I, I, at my core am a massive fan of work life balance. I know it’s idealized in some cases, but I think it’s something that we should as leaders really promote and really focus on because I think we undervalue the ability for folks to feel valued outside of work. And what that does. Uh, and how it produces a net positive result inside of work.

So, and back to kind of the stuff we talked about earlier, uh, it’s, there’s just such a, there’s such a value in valuing people and, and just like we all want to feel valued too. We feel better when we feel valued. So,

Naji Gehchan: yeah, it’s, it’s probably a perfect segue to my last word, which is spread love and organizations.

Uh, there you go.

JR Clark: Yes, that’s exactly right. I mean, your, your concept is, is absolutely amazing and it’s absolutely spot on. And, and I think of it all the way from like even deep examples of like, so I’m a father of two children and my son and my daughter were raised in the same environment. They are, but they’re vastly different people, vastly different people.

And. And like the way that they see a situation, they respond to it differently because of kind of being different, different people. And that’s true inside of an organization as well. And that two different teammates could respond to the exact same situation in a different way. And as leaders, when we think about spreading love in our organizations, it is a matter of being able to say, like.

I understand that two people are not going to respond in the same way, and I have to understand, like, I have to, I have to know that that’s okay, and I have to know that that different response is what produces better outcomes than if we always had everybody responding in the same manner. Back again to the meandering thing at the very beginning, there’s There is value in discovery.

There’s value in that meandering in life, and there’s value in the, in the different responses and perspectives of people.

Naji Gehchan: Certainly. Any final word of wisdom for healthcare leaders around the world?

JR Clark: Man, uh, uh, maybe I don’t want to call this a word of wisdom, but Every single day, I am continuously reminded that there are so many people out there that are way more competent than I am, that are way smarter than I am, that are way more, like, infinitely better at things than I will ever be.

And giving people the freedom and flexibility to use that, Produces such great outcome and stifling that produces such, I guess, such the ant antithesis of it. Like there’s nothing that’s more of a poison in an organization than not allowing people to to thrive with with their own talents.

Naji Gehchan: Wow, J. R. This is such an amazing way to finish up our discussion. Thank you so much for joining me today and for this great shot.

JR Clark: Thank you. I really appreciate having the conversation with you. Thank you for the opportunity.

Naji Gehchan: Thank you all for listening to Spread Love, an organization podcast. More episodes summarizing the MIT Sloan Healthcare and Bioinnovation Conference are available on spreadloveio.com or wherever you get your podcast. Follow us to get our most recent episodes and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Joubin Hatamzadeh

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.


I am Naji, your host, joined today by Joubin Hatamzadeh Chief Operating Officer at Greentown Labs, a community on a mission to solve the climate crisis through entrepreneurship and collaboration. Prior to joining Greetown Labs, Joubin served as the Head of Operations and Administrative Services at French Tech Hub, where he led a team that helped international technology companies expand and succeed in the US market. He has also worked at MDL Corporation and NeuroRx Research.

Joubin, it is so great to have you with me today!

Joubin Hatamzadeh: Naji. Pleasure is mine.

Naji Gehchan: I would love first to hear more about your personal story and what’s in between the lines of your inspiring journey.

Joubin Hatamzadeh: Fantastic. So, uh, my personal story is I don’t want to go too back that I wanted to be, you know, cowboy or Superman when I was a kid, but, uh, I always, you know, I had the desire to.

To go to medicine and engineering was something really, uh, something that aspired at some point. So I ended up studying biomedical engineering. Um, I was born and raised in Iran. So, uh, I, uh, I, you know, got the opportunity to get a bachelor’s degree in biomedical engineering back in Iran. And working the medical devices company right after the school, but always wanted to explore the world.

And, uh, learn new things and kind of stretch my boundaries. So, I pursued my graduate degree in Canada. In the same discipline and, uh, joined, uh, a lab, which is affiliated to the school that I got my master’s degree and then there was a spinoff. That that’s been up was a startup company that I really enjoyed being part of the team.

1st, few employees to get a lot of things done from setting up the office to be the project manager to be the. Person who’s also 1 of the people who was analyzing the images for multiple sclerosis. Uh, servicing to, uh, uh, but they can form a company. Uh, to, to serve the humanity on, uh, basically on, um, clinical trials, and then I pursued my, I pursued my heart, which was my, my girlfriend at the time, who’s my wife now, uh, was at business school in Philadelphia, wanted to be with her and, uh, found an opportunity that was also enticing to me.

And that was joining manufacturing company, so you may not find correlation between what I studied at a manufacturing company in a lighting environment and then the lighting industry, but it’s all about the transferable skills. And using basically something like the concept search certain disciplines and engineering that you can apply.

So, I joined this, this company, um, being the head of quality control. And, uh, that that that was really, really. Uh, Energizing to me and motivating, because I could solve problems. Uh, things that I could not even imagine that. That that I could know from smaller things to. From small things to kind of a bigger thing, but it’s saving, you know, companies.

Uh, costs improvements, uh, improving the teams and so on and then, um, so all of these have been kind of entrepreneurial. Environment that I work at and at some point, we decided to move to Boston. After my wife finished the program, I joined the consulting company. And I also found a boutique consulting business, which was a subsidiary of a French government supported entity.

And that was basically my journey with a company initially called in France and then optic 21 and finally changed to a French tech hub and, uh, joined as a business developer for life sciences. And, uh, grew into operations, led basically the, uh, designed and led the operations, uh. And administrative services that we’re serving over 100 French clients and focused in, uh, technology.

And then, uh, you know, spending 11 years in that company, the company. Was sold that that business division was sold to an accounting firm and that was basically a moment for me to realize that what I want to. To next with my life, because I was not an accountant and I was looking for a kind of a different.

Type of work and, uh, and, uh, I joined green. Basically, the opportunity that I found at that time as the operations hit the. Hit the check mark. So what inspires me? Um, one of them is. Has been the opportunity to learn and do things that I did not have any background necessarily in area that has been created seemed creative for me and I had the ability to problem solve.

Be with smart people and also be working with people who are good people and, you know, by the time that I joined, what was at the end of the day important to me at that point. I had to 2 little children were. Now, uh, older, but, uh, what is the story that I want to tell my children. That’s what I do and what kind of impact the work I do as.

And, you know, now working in the environment, the impact is very obvious to everybody, and it’s not deniable that this is something to saving the future for our children and the generations after that, and being better people, not destroying the earth further.

Naji Gehchan: Wow. Thank you so much, uh, VIN for this inspiring, uh, journey and several things. So I have different questions for you, uh, sure. Going from here. So, um, you were born, raised in Iran. You left, you lived in several countries, uh, and I felt throughout your focused on impact. So how, it’s interesting you started in healthcare.

The majority of, um, our listeners here are healthcare, uh, leaders, uh, so, uh, focused on this purpose of making life better. And obviously now what you’re doing is exactly this from, uh, in a large scale of making, making the world better, uh, from, uh, from the climate crisis we’re living. I would love to hear your, your personal journey, what you took from those different experiences and different parts of the world from, uh, Where you were born to where you are today.

Uh, what, what is kind of the key life lesson you take with you to lead today, your teams, uh, in your company today and, and other experiences you had?

Joubin Hatamzadeh: Uh, thank you. I would say two things. Number one, um, going back to, you know, to the fact that my father is an architect and I was just, uh, following him to, you know, going, going to, to his office.

After school for a change, or sometimes to the construction site, just observing, seeing, enjoying to see that how things are being made following this conversation that I had no clue what it was about, but with the, with the builders, with the masons, with the welders, et cetera. So, I, I knew that, you know, there is a lot of interest in learning things and doing right.

And at some point in my life, it was during the summertime. I was 11. We had a neighbor in the. In a countryside when we had a place. And, uh, our neighbor happened to be an architect and he was making sitar instrument. That was basically my introduction to, uh, an Iranian musical instrument. And it was a summertime, I stayed with them and I became his apprentice, just watching him doing wood, uh, uh, making instrument.

And I was helping, you know, here and there. And, and later on, I realized that, you know, I learned some carpentry. I learned this and that. Um, Uh, somebody at some point told me that listen, it doesn’t matter what you have learned. At some point, those skills become useful and I always believe in that. So, you know, transferable skills.

I think it’s one of the most important things. Uh, in life that we have to invest and the curiosity is very important and, uh, focus is important, but curiosity is important that, okay, what you’re exposed to, uh, what we can learn because we never know where life takes us. And we try to predict life, but sometimes it works.

Sometimes it doesn’t work. And all of those become handy at some points. So that’s I really believe in now, but the, the other points that, you know, 1 is the transferable skills and the other points, um, I blank on my 2nd question. Would you be kind to to repeat your question? 1 more time?

Naji Gehchan: Sure. So looking at key life lessons you take from your experiences being born in a country, traveling and living in other experiences.

Now I got

Joubin Hatamzadeh: it. Now I got it. The other point is how to deal with uncertainty, which can be nerve wracking. And it happens in work and happens in life. And the lesson was, uh, I was born a few years before the Iranian Revolution, so you can calculate my age very easily. And, uh, as I was in the period that I know what was going around me, uh, there was a war between Iran and Iraq.

And at some point, uh, I remember that Both countries were bombarding each other, so there was an airstrike both ways, and you’re just going to shelter, and there was no shelter. The shelter was the basement of the building we were. So we could live after an explosion, or we’d never know that it was going to impact us or not.

So that was a big point of uncertainty, right? And there was no escape. I had to live there. We had to live there. My parents, my father had to go to work. And I had to go to school. So that was one big point of uncertainty. And then those kinds of airstrikes stopped and then they relaunched by sending missiles, which you couldn’t even expect.

There was no siren sometimes. So you would hear an explosion and then it was a change moving from a company country to another country. So I did it. You know, twice in my life, once from Iran to Canada and the other one from Canada to the US. So everywhere you go, there is an adaptation. There is a cultural adaptation.

There is something that you take in, you have to really, uh, contemplate, you have to adapt, digest. So the key lesson in life is, uh, being flexible and learning to, to deal with uncertainty. And I think that at certain points. I’ve been successful to do that, and sometimes I’ve not been successful to do that.

And I could see that, you know, during the pandemic. It became very handy to me that. I was overseeing team. That the work was tied to the physical space. And physical space became a concern because people were working from home. But at Greentown Labs, which is a climate tech incubator, and we have lab space, desk space, desk got very low occupancy during the pandemic.

Everybody was working from home, but lab was a space that People need it and they could not do those kind of work at homes. So we needed to keep the space safe and I had to basically find kind of a meaningful work to retain my team and keep them also motivated and inspired during a very uncertain and dark.

Naji Gehchan: Oh, thank you so much. Uh, I unfortunately relate to part. Of your story with living war as a child, as you know, um, and really, I love how you frame the key lessons from learning from uncertainty and keep on pushing and moving forward and making an impact as you’ve done. Um, when you talked about, uh, the, what you’ve done with your teams to keep them, uh, Safe, motivated, and literally building tech, that changed the word.

I’m intrigued. How did you do that? Was there like a special recipe? Now looking back, you say, okay, this is what I’ve done that helped them do it well. And that you will replicate next time. And comparatively, is there something you would do differently?

Joubin Hatamzadeh: Certainly, so number 1 thing, I think that, you know, pandemic has taught us a lot of things and 1 of the key takeaways from pandemic.

Was the entity, so I realized that entities very, very important at this point. And being mindful of people, because they are going to a really, really major thing and it sounded and felt apocalyptic for

all of us or the majority of us. In the entire world, so connection with the team was very important for me. From day 1, when I joined, because I was initially heading the operations team and the operations team consisted of people from different. Uh, you know, disciplines working in different functions.

Somebody was running the facility. The other 1 lab, the other 1 front desk reception. Another person doing administrative, even though they were in the same group or team, but their work was completely different. Their lingo may not. Be the same, so, uh, so early on, I, I realized that connectivity. To. Between the team is very important.

So I started having kind of a daily standing meetings. And it was literally standing, so we’re standing around the circle and people were sharing, you know, what they want to do on daily basis and came up with kind of a cadence and the cadence was, you know, on Mondays, we share. What is the goal for the week and every day we touch base that, you know, what are what’s on my mind or what kind of help I need or what are the challenges and on the end, at the end of the day, at the end of the week.

Thanks so much. Was basically sharing the accomplishments that can celebrate all together. So that helped us because that keep us going. Kept us connected every single day that we reduced it, but being very much in touch with every person in my team and try to understand, try to be flexible. There was a, you know, enormous level of anxiety because, you know, when I’m overseeing the physical space, it’s under my purview.

I can’t excuse myself that. Oh, sorry. I’m a family. I can’t come to this. I had to come to this. And you would see people who are to wear mask deniers to people who were religious about masks. And you had to keep a balance. You had to really. Uh, work it out that, you know, people have to be compliant, but actually they are also your customers.

And you had to basically support the team to do to do the same thing. And some people are not comfortable. Bye bye. So, you know, my presence was very important to prove that I’m with the team. Um, um, you know, there’s no excuse. I would put myself on the same location as the team to be together. Uh, we’re problem solving.

With each other, and I realize that it doesn’t matter. You’re the leader or you are a manager. At some point, you are 1 of the team members. And every input is important because people can bring a lot of value that that was really, really proven pretty well. And the other thing that was very important was, you know, in a growing company, you have a lots of ambitions, but you never have time focus or bandwidth to, to have a lot of things that you hope you could have done.

You know, but what we did, I realized that, oh, there’s something called policies and guidelines. That we have been lacking, and that was my idea since I joined. We never had the. Chance to, uh, you know, uh. Obviously, it’s at that point with our with our clients. So, what we did was, you know. I asked the team to to work together and build that it was a little bit difficult.

In the beginning, people had to get into that pattern, but when they warmed up, they enjoyed it. They enjoyed it and that became a huge accomplishment because at the end of the day, it’s sold pretty well and that became kind of a. Like a guideline for, uh, managing the space, answering questions to our members for the users of the space or customers and people saw something rewarding.

And it was also show them the capability that. Okay, you know, you don’t work in the space, but your work can be still meaningful and you can share this accomplishment something that. You may not even think that you were doing this job, but you, you can do it. Uh, and it created kind of bonding between the team.

Naji Gehchan: Thank you for that. Now I would love to talk a little bit about sustainability, climate crisis, uh, those topic you’re heavily working in and bringing new tech through entrepreneurship. Can you first tell us a little bit more how you would approach this topic? How

Joubin Hatamzadeh: I approach this topic? Definitely, you know, I would say that, it’s.

Uh, I would say the way I would see a climate change and climate entrepreneurs and, uh, what I see now that may be in the view of many people, right? You know, sustainability is a big topic, right? And maybe my focus goes into the entrepreneurship based on what you’re thinking about is there are a lot of motivated people, a lot of, uh, creative people, uh, That they, they, they want to make an impact and their work is really.

Addressing climate change and environmental. Issues that’s within the purview or under the umbrella of sustainability. Right. And, you know, 10 years back when green town lab was created, I just use green town labs as kind of a reference point. For what I what I try to to make if you go to to to that space and you’ll see that people are, you know, somebody is building a balloon to take a generator.

Up in the air, because at certain altitude, there’s always wind to capture the wind to generate power on the spot for places that there’s no, uh, you know, access to power and you’re not burning something carbon based to pollute the environment, sounded something really cool, right? The question was, how do you make money?

Where do you sell it? And there were hopes and wishes. So they were like the surviving artists. that you passed by said that this guy is so talented, amazing, but how does he live? How does he make a living, right? So investment and, uh, the focus on environments or did this kind of work was like that, looking at them as surviving artists.

Uh, but, but now after the Paris agreements and also the awareness, the global awareness about, you know, Uh, seriously, we are in a critical situation with the climate and we see the evidence of the climate change every day. And some people are more, I mean, they, they look long term that you have seen waterfalls.

You have seen. Uh, you know, uh, woods, you have seen places that you enjoyed and you wish that your Children, your grandchildren, their Children, et cetera, would enjoy the same thing. And you don’t want to see that the quality of nature declines. Which has impact on a lot of things from food. From vegetation from ecosystems.

And also the life you’re going, we’re going to experience. So, you see that, you know, the investment, the government focus has, has come through this way. And now, you know, investors are looking at climate tech companies more seriously. The way they’ve been looking in biotech or life sciences. So I say correlation because you pointed out that I worked in life sciences.

That has a good will in it and now in environment and there is some similarities that at least solving some fundamental problem. Related to human, right? Because we are selfish enough that. Whenever we talk about the environment, the interest of human being is there is not just the interest of, you know, sky or soil or water by itself.

It has a use for human being. So we are trying to address that. At that point as well, but in general, we work with a lot of, uh. Inspiring and creative people, which is a definition of a lot of entrepreneurs that you see in different sectors. that they really believe in what they do and they really believe in making the world more sustainable and you know it puts you if you work with these people over time even though If you, you are not a believer or you, you, you have kind of a rigid mindset, it puts you in kind of a growth mindset to, to really learn, explore and view things differently and be more mindful.

Naji Gehchan: And I’m sure they giving you hope. So that, that’s my question to you. Is there hope you said, you said at the very beginning, you’re trying, like you used a word that really stayed here in my head about climate, uh, kind of slowing the degradation or trying to stop the degradation. So my question to you is, is there hope?

We will make real strides toward a better, more sustainable world.

Joubin Hatamzadeh: Yes. Yes. And we know you, the people has asked, okay, you’re talking about bunch of entrepreneurs, bunch of startup companies that they’ve Do cool things, right? Some of them don’t escape or some of them are being acquired. Some of these businesses are being, you know, getting over.

That’s true. And what is the impact of the 9 employee company in Massachusetts over East Asia, West Asia, you know, South America, Antarctica, et cetera. Maybe nothing. But when you look at number one, That population of these entrepreneurial entrepreneurs are growing. The whole focus, and then also. Because of them, because of the area of innovation, something that brings money, something that brings inspiration, something that.

It is just, you know, all these forces are also shaping some of the larger companies. To definitely look into these companies, acquire them. Adapt and change their perspective that is really enormous, right? You know, sometimes, uh, people may say that, you know, the category of, uh, corporations, for example, oil and gas.

That has been under criticism, right? Uh, you know, you can’t just say that, you know, those companies are, uh, doing, doing only bad things because if you, you can put, put all, you know, every type of company in one bucket, you see that, uh, they’re, they’re, they’re doing some, some, some great things. And some of them are really helping to change and, you know, think away just from the fossil fuel, invest in a renewable energy.

So we say that it’s a step at a time. And those steps matter. And the great thing is, uh, sometimes I think we are impatient and we we want to achieve the answer right away. But if you look back 10 years ago, 15 years ago, we have seen that we have come a long way, right? Awareness has been made. Now the investment is being made, you know, acquisition, adaptation, all those things are being made.

There are a lot are being figured out. And, you know, think about other technologies 20 years ago, 30 years ago, there were skepticism skepticism around them. There were big questions about them. Some suddenly boom collapsed. But overall, it changed to where we are now. And I see the same thing about sustainability industry.

In the long run, I don’t think there is a point of return. It’s a point of no return, technically. It just forward,

Naji Gehchan: which is, which is great for, for all of us and for the future generations as I said, I’m going to give you now a word, and I would love a reaction to it, whatever first come to mind. The first one is leadership.

Joubin Hatamzadeh: That’s a good one because that’s the one that I try to have a definition for myself.

Definitely leadership is something to be able to inspire, motivate, and help moving forward.

Naji Gehchan: The second one is greenwashing.

Joubin Hatamzadeh: It’s a bad thing. You’re faking something. And it’s a bad intention. It has bad outcome.

Naji Gehchan: So if I flip this around, And double click on it. What is your biggest ask for leaders today from a social impact aspect? Whatever industry we’re in, what is your biggest ask for us to make real important good strides towards a more sustainable world?

Joubin Hatamzadeh: Be genuine, be intentional, because you know, to make this sustainability move forward, Uh, you know, to to get where we all desire. It gets, uh, it’s to it, it requires a lot of commitment, a lot of work, uh, not not giving up. So, and really, really, you need to put a lot of efforts in that and be very, very genuine about what you do.

Because people it works out when you’re genuine people see that and believe you and follow you and they, you know, you, you have more buying and the other bond that that I said, you know, in addition to that, be intentional. It is very important. I can give leadership. And then other things, I think it works pretty well.

Naji Gehchan: The third one is sitar.

Joubin Hatamzadeh: So sitar is the indian instrument and sitar s e t a r uh is the one that I play and uh,

it’s like love and kind of

You know something that you would it’s it’s a medium of conversation to to express your heart

Naji Gehchan: What a great segue to my last word spread love and organizations

Joubin Hatamzadeh: spread love in organization. It’s fantastic. Yes

Naji Gehchan: Any reaction to it?

Joubin Hatamzadeh: Yeah, it’s very important. It is very important. Uh, spread loving to any organization. I think is, is something that I, that I really relates because at the end of the day, uh, uh, during a pandemic being in a very, uh, you are, you have been to bring down lab. You have seen the space. People enjoy visiting the space.

People enjoy working here. It’s cool. It’s nice. It’s vibrant. But when the pandemic happened. I felt very depressed every day I came because the energy was not the same. It was felt like Sunday evening that the occupancy was 1 or 2 people. Rather than over 400 or 500. On a daily basis, right? So, I realized at that point that.

You know, in an incubator you don’t have intellectual property, you have a lot of assets. Now what’s the meaning of these assets when nobody’s using it? You know, even for a month or two months, you have to pay a lot, you know, for hvac, electricity, and all those things. For who and for what and what. What’s important at that point is you would be able to.

Uh, keep something that is meaningful and that is personal and the team. So the team was the biggest asset in my opinion. Even though the company doesn’t have, you know, intellectual property, that is the biggest intellectual property. How can you keep people in place? You know, people are incentivized, but incentive money becomes a number and people adapt their lifestyle to, to that number and.

But it’s not a long term motivator. Work is the type of work they do is motivator, but the human connection is another motivator, and love describes it pretty well. Love, affection, empathy. They work all hand in hand and create kind of a stronger human connection.

Naji Gehchan: Any final word of wisdom, Joobin, for leaders around the world?

Joubin Hatamzadeh: Your job is asking really, uh, uh, difficult

I think being empathetic is very important.

Having empathy is important, and be intentional about that.

Naji Gehchan: Uh, Joobin, you broke, so I’m gonna re ask the question, and if you can give me the answer again. It just broke, I didn’t hear it, actually. Okay, can you hear me?

Joubin Hatamzadeh: Sorry, but that Internet connection I would say that, uh, uh, have empathy have empathy is very, very important. You know, business is important mission is important. Responsibility is important, but, uh, as long as you work with human beings. As for a leader,

uh, I think any manager level for any person working with. Any other individual. That’s the important factor.

Naji Gehchan: Well, thank you so much for this great conversation, this inspiring chat. Thank you for joining me from the lab itself. Uh, and this is, uh, labs are always moving people, as you said. So this is why from time to time, I know, uh, you were moving also around some of the discussions and the lively things happening in the lab.

So thank you so much for your time. I know you’re. Doing great things and super busy to make sure that our children and our grandchildren will have a better word and a better earth. So thanks for being with me again today.

Joubin Hatamzadeh: It was a real pleasure and thank you so much.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Clarissa Gorin

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with ESCP Business School and its specialized Masters in Pharma and Biotech Management. I am joined today by Clarissa Gorin a pharmacist and ESCP alum. Following her initial professional experience focusing on the blockchain industry and the fight against counterfeit medicines in developing countries, Clarissa joined Ad Scientiam in 2020 as Head of Medical Affairs. Ad Scientiam, a MedTech company originating from the Paris Brain Institute, specializes in developing digital biomarkers that enable the monitoring and prediction of the progression of certain neurodegenerative pathologies and rare diseases. These innovative markers are derived from proprietary algorithms for measuring precise analysis movements, vocal activity, or image processing derived from smartphone sensors and AI technologies.

Clarissa, It’s great to have you with me today!

Clarissa Gorin: Yeah. Well, thank you for the invitation and for the great introduction and, uh, the opportunity to, to share my professional experience and, uh, insights in the medtech, uh, sector, which, um, I hope will be useful to, to others.

Naji Gehchan: I’m sure it will. So before we go into this passion you have since, uh, early on about innovative tech and now AI that became a big subject. Can you first tell us more about your personal story, uh, why becoming a pharmacist, now being a leader in this edge of tech innovation and healthcare?

Clarissa Gorin: Yeah. Well, sure.

Thanks for the question. So I think, well, I come from a family of, uh, doctors, so like the health, uh, sector was always a subject when I started to, to look for different, um, well, specialization and, and, um, well, um, uh, formation. Uh, so it all started quite classically, uh, with this, uh, pharmacy, uh, sector, uh, from which I chose, uh, the industry sector.

Um, I wanted first, uh, to build a career in the pharmaceutical marketing, uh, but much more related to the drug, uh, industries. And, um, with my first Pharmacy diploma in hand, I joined this, uh, ESCP, a master of science, um, specialized in pharmaceutical and biotech, um, management. Um, for me, it was very interesting because the, the pharmacy sector is very, offers a wide range of, um, professional, um, path, uh, such as hospital, uh, city based pharmacy and industry.

Um, so for me, who wasn’t very sure about, uh, what type of, um, well, Pathway I wanted to embrace. It was interesting to have such a different options. Um, but very quickly, uh, doing the, the ESCP master of science, I was, um, quickly offered the first, uh, opportunity, uh, professional opportunity, um, which. Can we say diverted me from this classic path of marketing and in pharma?

As I joined the entrepreneurial adventure, uh, doing the master with some former classmates from the faculty of pharmacy who were launching this, uh, by a blockchain, uh, technology project that you were talking about, um, with the ambitious aim to fight, uh, fake drugs in sub Saharan Africa. Um, so yeah, well, I believe that, uh, it was very interesting.

It was much more related to, you know, uh, public health, uh, consideration and despite my knowledge in the, well, drug system, drug, uh, distribution process, I was, you know, Immediately confronted with a new challenges, um, both in terms of, you know, understanding a new technology, the blockchain, uh, which was very famous in that hand and also a major, um, cultural differences, um, in a, in a market that was very different from France.

Um, we, we were able to travel a lot, uh, to Hebrew coast. Um, so yeah, it was a very. Interesting first experience and a great opportunity for me, uh, going from a more classic path of, uh, industry and pharma to, uh, open my eyes to new, uh, horizon. And in particular, uh, to grow my, my passion for the application of new technologies to the healthcare field.

Naji Gehchan: I want to go a little bit there because it’s a, it’s a great, uh, experience on how you’re framing, uh, try to, uh, you went from the, what you say, the classical path. into more tech. You also discovered other challenges that we do not face in countries because you’re, we’re talking now you’re in Paris and France.

So, um, where, where you had, uh, your, your studies, um, and also entrepreneurial. So there’s, different levels of cultural differences that you had from work to also the patients who were serving. So I’d love to go there and understand now after the facts, when you look back, what is the key learning, uh, or the key leadership lessons that you had through the experiences you’ve been having.

Clarissa Gorin: Sure. So yeah, for me, it was very, um, instructive, uh, first experience because as you said, uh, we were coming from our well, well developed, uh, countries idea, um, project proposition. And, uh, once arriving in, uh, Africa, um, Hebrew coast, it was really a challenge to understand the cultural differences also, uh, regarding the adoption of new technologies.

Uh, you know, we were. Coming there was a great idea to fight this fake medicine problems, which is very important in such countries. But we had also this very fine tuning technology called blockchain, where we wanted to capitalize, to capitalize in. And it was sometimes very difficult for us to, well, to educate also the local population of the potential of, uh, such a fake medicines and also, uh, the usage of such a new technologies.

Um, even, you know, like, uh, using a smartphones, uh, on a daily basis, but not something that was so usual at the time, uh, in Africa in comparison to, um, well, um, Europe and, uh, specifically, uh, Africa. Um, so for me, uh, it was. Very, uh, important, uh, to understand and to have adaptability process, uh, in mind, uh, to make sure that we adapt the technology to the real needs of the fields.

And it was, I mean, for me, it’s one of the most important, um, capacity of, uh, leaders is to have a great adaptability mind process to support, uh, agile. Team culture and also personal cultures of work, um, to be able, you know, to quickly, um, react if there is some, uh, dynamics, for example, here, a new challenge in new countries, uh, with different cultures, uh, to be able to adapt, um, such technology in the, in this case.

But also, um, it enables great leaders to encourage. And exploit new opportunities and to take on new challenges. So I think it was maybe for me, the greatest lesson learned on this first experience, that we need to adapt our thoughts and beliefs to the actual needs of the market. And especially for new technologies that come from another situation and other markets to be able to adapt it to local specificities.

Naji Gehchan: So do you look now at new technologies in a different way about how they would actually impact patients across the globe?

Clarissa Gorin: Yes, sure. Um, so I believe that my different, uh, now look on a new technology and in particular in this, uh, medical sector, uh, is that sometimes, uh, we do not need to have the most sophisticated, uh, technology to be able to tackle some, uh, specific needs, you know, sometimes when we discuss with, uh, doctors, nurses, um, in, uh, hospital centers, uh, Um, they describe us their needs and their daily problems.

And sometimes we just look back and say, you know, we don’t need a very fancy technologies to be able to answer to that need. So it’s really a challenge for us working in the tech where we want to make sure that our technologies are adopt, adopted, um, by every populations. But sometimes, I mean, a. For us, it’s, uh, it’s important also to know, uh, where we do not need actually, um, new technology to answer this needs.

Um, it’s very different, I believe, from, um, other industry, um, where sometimes it’s the more important is actually the, the technical concept of the technology, but I’m pretty sure and from now on to have been able to discuss with lots of different stakeholders in the medical sectors, it’s much more related to if there is a specific challenges and what is the fit for people’s technologies that could answer to this needs to be able to achieve a full adoption by the different users.

Naji Gehchan: Thanks. So that’s, that’s a great points you’re bringing. And really it reminds me like there’s. We’re a lot of work actually in the healthcare sector, as you know, about low tech that can actually improve and impact patients. So there’s always this idea of certainly high tech has done tremendous work, and we’re going to talk about this and where you’re excited.

But not forgetting that some. Some places low tech can really bring a huge impact for people. Uh, and we, we should continue to consider it.

Clarissa Gorin: Yeah, totally. Uh, low tech, but also, uh, making sure that, um, all, uh, accessibility aspects are taking, um, in consideration when developing and conceiving, uh, this technology products.

Uh, we’ve been working, uh, in AdSensia means very different, uh, age courses of patients, uh, meaning children. uh, elderly patients. And, um, every time we ask ourselves what is the best technology to be able to achieve accessibility, uh, so, you know, like, uh, capacity of, uh, using the tool. Uh, but also, uh, there is some accessibility aspects related to, uh, disabling aspects of such a chronic disease, uh, hearing loss, for example, and other aspects.

And, um, it’s true that sometimes, um, new technologies are the answers, but sometimes they are not. And so, I mean, being humble about, uh, what those type of high tech, uh, products can, uh, can perform and achieve in the health tech sector, um, is very important, um, for me, uh, so on.

Naji Gehchan: Yeah. And how you’re framing it, uh, would correct me if I’m wrong.

I’m feeling like we should always think about. What do we want to achieve and the technology, whether it’s like super high tech or it’s not, is actually just a mean.

Clarissa Gorin: Sure. And it’s just a mean, and also it could be different, uh, with different means, you know, like being able to really identify which is the specific medical challenges or.

Unmet needs that you want to tackle, um, is very important. And for one specific medical challenges, you could think about different, um, tech solutions to, to answer to it. Um, and for us, sometimes, uh, um, we, when we start a new project, um, we can identify that sometimes our projects are not the best solution to answer as a specific medical challenge.

And it’s. It’s totally, uh, okay to, to, to stop, uh, the project and to answer that we do not have, um, the best project to answer this and to be able to, yeah, once again, being humble about, um, what your, your project can do and what is not the best, uh, to do is very important.

Naji Gehchan: And it starts, as you just said, with the unmet medical need.

It really starts with patients. What are we trying to solve to make their life better?

Clarissa Gorin: Totally patients, um, but also doctors, uh, sometimes, um, we can see that, you know, in particular in France, uh, we, uh, where we have a public health sector, um, that sometimes, um, isn’t. Is in difficulty. Uh, sometimes we can see some very specific national, um, um, errors or like challenges, uh, to be tackled by new technologies.

Uh, I believe that there is a lot to do in hospital centers, expert centers, uh, to make sure that, um, the whole, uh, care pathway is more efficient. And also, you’re totally right. Much more related to, um, well. Direct benefits for patients and for their daily life, but both are very important to understand, um, either if it’s a specific, um, medical for doctor use or a patient use, because it will be very different in your, um, development process and, um, well, concept phase, um, to be sure to have the best fit for people’s, um, project.

Naji Gehchan: Awesome. So we just said, and you said that you don’t have like, there’s not only one solution, there is several and it depends, but I’m going to still ask you this question, since you’ve been in this field and you’re looking into the future, which one of these solutions do you think Or a couple of these emerging techs are you most excited about for the next decade that you really think they are going to change our health?

Clarissa Gorin: Yeah, well, of course, I will talk about, uh, well, digital biomarkers because, you know, I’m working on it and I believe there is a lot of to do. Um, but also I would say that, um, Well, AI and VR can also have a lot to do. For example, uh, I’ve seen a lot of projects, um, coming from virtual, uh, reality systems, uh, that could have a strong impact in the field of, for example, digital therapeutics, uh, where we can see that such tools can be used, um, to be Really like intervention based driven by software programs to, uh, help prevent, uh, manage or treat some medical disorders and disease.

Uh, for example, like VR can be used to, uh, treat, um, chronic pain or, for example, to, uh, Hades, um, in, uh, rehabilitation programs by, uh, incorporating sensors and, um, software technology to provide a real time feedback and guidance to, to patients, uh, directly at home. So it’s really something, uh, that can be very useful in, for example, neuromuscular disease, uh, other orthopedic, uh, diseases.

Regarding artificial intelligence in particular, um, we’ve been, uh, understanding and hearing a lot regarding how, uh, AI will, uh, replace, uh, human doctors in the near future. Um, I really don’t think it would be the case. Uh, I much more think that it will become critical tools, um, to help augment medical practice and, um, much more important to reduce the burden for healthcare providers.

So for example, we can think about diagnostic tools that helps doctors to improve real time decision making for clinicians. For example, by analyzing a lot and a lot of data at the same time, so the healthcare provider, uh, Could not be able to do it from, for example, a patient’s medical records or scientific articles or medical guidelines, um, for example, to give, uh, some treatment recommendation or to identify some drug interactions, uh, much more easily, uh, and with a tons of data analyzed at the same times.

Regarding, uh, digital biomarkers, um, for me, I believe that, uh, such tools as you introduced, uh, that are really new measures of, uh, physiological or comportmental, um, aspects of, uh, patients and that are, um, generated directly by patients by the means of, uh, digital devices. Uh, they have the power to really, um, well, understand some mechanisms that are not well understood so far, for example, to monitor or predict, uh, some diseases and specifically neurological diseases.

Uh, where we know that, uh, usual biomarkers such as, uh, imaging biology are not fully, uh, sufficient to understand the clinical evolution and response to treatment of individual patients. So, it’s a really a major, uh, research challenges for clinicians and, um, well, for the scientific community at a whole.

And, um, for me, it was very, uh, important. Um, to try to see how those digital biomarkers could be useful in such a pathology. Uh, so yeah, well, I think it’s a three examples. I know that there is tons of more, um, but I see here some very, uh, specific and practical, um, aspects and, uh, objectives because we know there is also lots and tons of technologies that are still in research and development, but.

That have not, um, well, indication and usage are ready for the next years.

Naji Gehchan: Thank you so much, uh, Clarissa for for this. Can can you give us a couple of one or two use cases, for example, for digital biomarkers, which is one of the specialties here. And I’m interested to learning more on specific use cases that have had an impact on research or on patients.

Clarissa Gorin: Yeah, sure. Uh, well, maybe some first, uh, example that we, that we have, um, I could say that, uh, in multiple sclerosis, that is a neurological disease, autoimmune disease, um, where we know that patients are evolving, uh, during the years and progressively, um, going into a late progressive phase, uh, where they tend to act Cumulate some disabling aspects of their disease, um, and which is the first cause of, um, disability in young patients after traumatic cases.

So really, uh, major. public health impact, um, for such disease and where, uh, as so far, it’s very difficult, uh, for clinicians, so mainly a neurologist, uh, to understand, uh, why some patients are progressing more rapidly than others. And we know that it’s a very specific challenge, uh, to know and to detect Earlier, uh, when a patient will be progressively, um, going into this progressive phase of the disease, uh, where it’s very important to, for example, adapt the treatment, uh, to slow down the disease and, uh, and, and stop the, the progression of the disease, uh, um, inherently.

And so here, uh, we know that So typical biomarkers are not, um, sufficient to detect and predict the true moments, uh, where such patients will be, uh, while transforming into their disease phase. And that’s where, uh, one hypothesis is that, um, digital biomarkers by enabling, uh, much more frequently measures of the functional impact of the disease of the patients, for example, regarding the walking capacities.

Cognitive impact, uh, vision related disabilities are upper limb and dexterity impacts, uh, would be able to gather enough data, enough specific and sensible, uh, markers, uh, to be able to detect it, um, earlier. So that’s one hypothesis, uh, that we have as so far, um, it’s something that is already used by neurologists, um, just to, uh, well monitor.

For, um, their patients and for example, see if there is a deterioration, uh, when we, they put in place some novel treatments to assess, uh, the individual treatment response of patients and for example, switch treatment earlier if we see that there is a negative impact. So maybe that’s one example, uh, much more related to patient care, um, but also research because of course it’s very important for industry players, um, to making sure that they have some specific markers of response to treatment to be able to treat earlier the good patients at the right, at the right time.

Um, so yeah, that could be, uh, maybe some, uh, first, uh, example. And maybe the second example that I could have, um, a recent example that we saw, uh, much more related to psychiatry, uh, where we know also that it’s very, uh, difficult to understand the different, the different biomechanical pathway of, uh, in a psychiatry and much more in acute phases of psychiatry, uh, dimension.

And, um, another example that, uh, that we developed, uh, and is, uh, currently in the clinical validation phase is to being able to identify novel digital biomarkers of, uh, treatment response in a antidepressant, um, populations. The challenge that we wanted to tackle is that, uh, so far when a patient, um, a major depressive patient, um, is, um, uh, being prescribed some antidepressant, uh, medications, uh, we need to wait a long time to be a, being able to really see if, uh, this treatment is, um, efficient on the patient or not.

So the hypothesis is that we developed some vocal biomarkers of the voice of the patient, uh, which we know, uh, are correlated to their depressive state or not. And with the combination of lots of other biomarkers, um, it could, uh, be, we could be able to detect very early if the patient is, uh, uh, answering to, to his treatment, uh, or not.

Those

Naji Gehchan: are great examples. I want to ask you how you’re thinking about, uh, sensors. Voice recognition. How does this get incorporated in patients lives? Because we’re like surrounded by sensors. Right. And what I have like one watch here, another one here, do I have to input the data? And I’m not, I’m not going to go into, unless you want to like all the GDPR data, privacy field of science.

Right. Uh, but really more from a user. If I’m thinking about a user, me as a patient. And the amount of sensors I would have and how I interact with them, how I make sure they’re giving you the information. How are you guys thinking about this? Is it like a new technology, like physical sensors or technologies you’re bringing?

Are you trying to incorporate with whatever the big tech companies have? How do you think about that?

Clarissa Gorin: Well, I believe it’s very depending, uh, on the, well, usage and indication, uh, that you want to achieve, um, for us. Um, it’s very important that, uh, the technological tool is incorporating in the real life of the user.

So, uh, we want to. Capitalize of some tools that the patient already have in his own hand. So that’s why we mainly work on the smartphone of the patient, making possible to transform the smartphone into a really a medical recording system that the patient doesn’t have to, you know, to, to equip and to buy another external sensor that is sometimes difficult to put in, uh, in his own daily life.

Well, if it’s, for example, for a clinical study or for a research based, uh, program, where we know that is, uh, you know, during a certain amount of time, uh, but it’s, uh, only during a few weeks or a few months, we can totally imagine to have like, uh, a very specific, uh, external sensor, very, um, sensitive, very, uh, very, uh, hard tech, uh, product.

But if, uh, we believe into a real life usage as, uh, we are working with in, in Adsenciam, we try to work, uh, with the most, um, you know, known, uh, products of patients at no cost. For patients. It’s very important for us also to achieve equity. Um, and, uh, well, large usage, adoption in the, in the general population.

Uh, so that’s why we, we capitalize on the different sensors that are already embedded in the smartphone. Um, it’s totally possible to work also with, uh, some external sensors that the patient would. Already have, uh, it’s always just a question of interoperability, uh, that, uh, well, Lots of, uh, technical providers can, uh, can put in place.

Um, but if you’re all Just talking about a clinical study, clinical research usage, it’s very difficult different because you, you know, you don’t have all this user experience requirements to put in place as there is no long term adoption and usage questions to to answer to. tool. So, I mean, it really depends on the type of projects, but for real life usage, we totally recommend, and that’s what patients are telling us, uh, to use the, the most easy tools that they already, almost all of them have in their pockets, which is, which is the smartphone or smartwatch or any other, um, known product for, for patients and easy to use.

Naji Gehchan: So Clarissa, I want to give you now a word and I would love your reaction to it. The first one is leadership.

Clarissa Gorin: Um, well, I would say to answer that, I would say, um, leadership is about organizing and training, uh, the collective, uh, to, uh, maybe extract its, uh, best. quintessence, if we can say. Um, it’s always to being, making all the different people, uh, working together to achieve, uh, same and common, uh, objective.

But also, uh, the second word that I would, uh, that I would keep is authenticity. Um, it’s what I try to apply, uh, to, to the best every day, uh, is to, um, well, Staying true to yourself, being transparent about your strengths and areas for development, um, especially in the med tech sector, uh, where there is a lot of uncertainty, um, related to projects or businesses, uh, scenario.

Um, so for me, it’s really not enough to have a great competence expertise, uh, to being a great leader. It’s much more related to. Um, people trusting you and trusting your integrity. Um, and also feel a direct and personal connection with you. This is why I place a great emphasis on the importance of, um, you know, sharing passion, personal, personal information, um, with the team.

Um, because, uh, I believe, yeah, like authenticity and confidence, um, is very important because otherwise, um, people will be reluctant to, to take risk and to, uh, to, to work alongside, uh, with you. So, yeah, I would say like, uh, this, uh, It’s three aspects, if I would say, um, organizing and training the collective together, but also, uh, bringing more intensity, uh, authenticity, sorry, and, um, and also, uh, sharing some, uh, uh, always, uh, personal information and, uh, and gaining trust of the people that are around, uh, around you.

Naji Gehchan: The second word is diversity. ,

Clarissa Gorin: um, diversity, I’m sorry if it’s not a, a single word . It’s, that’s fine. That’s fine. Sometimes it’s a, it’s a bit, uh, longer. Um, but diversity, uh, specifically in the, in the MedTech, uh, sector, I would say that, uh. Very important, and also for leader working in this sector, is to making sure that the different projects that we develop are alongside this different diversity that patients can have.

So yeah, diversity and inclusion, I would say in terms of both words. Um, we know that for a long time, uh, this high tech products, uh, were mainly developed, um, for well profitable populations and, uh, well, not, uh, used by all of the different. diverse population, uh, that were targeted. Um, and I know, uh, that, uh, the medtech sector can really help improve, uh, such a diversity and inclusion in the healthcare system.

For example, um, capitalize of such a techno capitalize on such technologies to Improve the diversity in clinical trials could be very important. Um, for example, you know, like adding some new device that could make able some, um, uh, participants to to join the clinical studies that are living abroad that are living in, uh, or the types of population that were not Principally targeted in, uh, in clinical research, uh, can be, uh, important.

Naji Gehchan: I love this and I love this great example. I’m working heavily on diversity in clinical trials with, with my team. So yeah, we can, we can have another session specifically on that. Yeah,

Clarissa Gorin: totally. Well, I really believe that, uh, well new, new texts and, uh, for example, as such a, well, smartphone based or like connected device, um, to be included as a, You know, like digital endpoints in clinical studies could have a great impact in diversity and inclusion of different populations that we usually don’t see in clinical trials of, of a drug, of new drugs, clinical trials.

Naji Gehchan: The third one is blockchain.

Clarissa Gorin: Blockchain. So, well, I would say, uh, a lot of, uh, a lot of noise, uh, a lot of, um, uh, how to say, um, Lots of, uh, I don’t remember how to say, uh, uh, a lot of hope. Yeah. Sorry. A lot of hope that was, uh, that was done in, uh, in the health healthcare sector, uh, regarding, uh, the blockchain.

Um, I remember that, uh, when we started, uh, on this first project, uh, on the fake medicine, uh, um, project, uh, we were hoping that, uh, such tool could could, you know, like help, uh, tracking the different, uh, path of the supply chain of, uh, drug systems. We believed, um, because it was also from the financial, um, industry that it could help, uh, well, tackle some, uh, specific breach of information related to drug distribution, um, process.

Um, but so far, uh, not a lot of, uh, well, scenarios and applicable, um, solutions. Um, so yeah, I would say a lot of hope, uh, at that time. Um, but still some, uh, um, some scenarios of specific projects, uh, to, to be, to be developed.

Naji Gehchan: The last word is spread love and organizations.

Clarissa Gorin: Well, spread love in organization, um, I mean, for me, much, much, uh, related to, uh, what we discussed so far to, um, well, promote, uh, well, authenticity and also, uh, promote, um, uh, trust around people, um, by.

giving them the opportunity also to discuss, to talk, to have their own point of view in our process. That’s really something that we try to put in place, um, at, uh, at Atsensium. Um, you know, it’s, it’s very, um, It’s very, uh, scaling dynamic in this health tech, uh, startup environment. Um, when we know that there is, uh, some more junior profiles that are coming, some tech profiles that are not, uh, always, um, Very well known about the healthcare sector.

And for me, a spread love in an organization would say like giving the opportunity to each to give their own point of view, uh, as part of their process, as part of our process, methodology, uh, just making sure, um, that even if it’s, you know, there is not this lots of, uh, yeah, she, uh, in between the different people in the organization, but making sure that, uh, All the, the different voice of people I heard and, uh, also, uh, putting trust into this, uh, different people.

Naji Gehchan: Any final word of wisdom, uh, Carissa, for healthcare leaders around the world?

Clarissa Gorin: Um, when I would say that, uh, for me, and I, I’m not a great example of it, uh, leadership is not, uh, innate gift or like, uh, superman, uh, abilities, uh, that people are born with. Um, I believe it’s really, you know, a journey of self discovery.

Self development, um, much more related to willingness to embrace, uh, learning, learning new things. Um, it involves usually like stepping beyond, uh, comfort zones. Um, maybe immersing in, uh, unfamiliar territory as I did at the very beginning of my professional path, uh, you know, like coming from the classical, uh, pharma industry sector, uh, believing, uh, I would be, uh, uh, joining a marketing or commercial path to a new technology, blockchain, digital biomarker, artificial intelligence, uh, which for me was really new I didn’t have, and it.

It could only be your life. I’m telling you that I always had this, uh, you know, this, uh, mindset for tech and, uh, and nerd profile, which is not the case at all. Uh, so yeah, immersing in, uh, unfamiliar territory and, uh, maybe navigating, um, challenges to, well, Ultimately inspire and try to guide others. Um, I would say that are, well, yeah, the most important aspects of, um, such leaders.

And in particular in the, the med tech sector, uh, where we know, uh, once again, that there is a lot of uncertainty, uh, it’s really a constantly involving, evolving and dynamic, um, environment. Um, so very important to, uh, well, Step aside and try a new thing to, to try to, um, to collect new also, uh, inputs and insights from others to, to, to try to guide them at the end.

Naji Gehchan: What a great way to, uh, finish our chat. I love how you framed it. Leadership is a journey of self-development. That’s a great charge for all of us as leaders. Thank you so much, uh, for joining me today and, uh, for this great conversation.

Clarissa Gorin: Well, thanks to you, uh, thanks for the opportunity also to, um, once again to to share my, uh.

Well, young experience, but, uh, I hope, uh, interesting for others. Um, there is a lot of opportunity in the med tech sector, a lot to do. Uh, there is still new things that we, we, we identify and that we, we believe could be done in the next future. So thanks again for the opportunity and for the really nice chat with you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform.

Thank you all for listening to Spreadlove in Organizations podcast! More episodes in partnership with ESCP Business School are available on spreadloveio.com or on your preferred podcast app. Follow “spreadlove in organizations” wherever you listen to podcasts and spread the word around you to inspire others and amplify this movement our World so desperately needs.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Moktar Diallo

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Moktar Diallo founder and CEO of Mangabey. Dedicated to transforming global pharma data interactions, Moktar brings over two decades of expertise in creating cutting-edge business intelligence systems, leading change management and transformative data architecture for multinational commercial operations. At Mangabey, Moktar leads a team of data and analytics experts, driving commercial data operations focusing on lean, open, and unified data ecosystems. Moktar’s impact extends beyond technology and operations; he is passionate about helping top-level business leaders navigate enterprise-wide change. Prior to Mangabey, Moktar’s successfully led Business Intelligence teams at Sanofi and Bristol Myers Squibb.

Moktar, It is such a pleasure to have you with me today!

Can you first share with us your personal story? What brought you to the pharma industry and being passionate about data in healthcare?

Moktar Diallo: Um, so first of all, thanks for inviting me to your podcast. And I’m very delighted to, you know, to discuss with you today and, uh, and share some of my experience.

Um, You know, starting with pharma, um, I’ve started in pharma 20 years ago, as you, as you mentioned, and it was pretty random. Um, originally I, um, before that I was working in data, uh, at some, um, after school, I had some interim jobs, um, You know, um, trying to, uh, basically earn my life. I, uh, I was kind of a dropout school.

Uh, I had the talent in, um, in computing that I’ve developed very early in my, uh, my life, very young. Um, I was good at school, but, um, when I left my home and, uh, and started to go to high school, um, I started to get prepared for, um, Uh, you know, engineering school, but, um, the level was too high for me in a way, uh, the pressure was really high.

I was far away from my family and, uh, and I had a kind of, um, kind of a dual, um, way of, of being. I could be very serious, really hardworking and very determined to, uh, to succeed in, uh, in getting good marks and, uh, and so on. But I was a kind of a rebel as well, um, and, uh, trying to, uh, to figure out what would be my, uh, my future, uh, in a different way.

And, um, so I left school and I started to, to earn my life working, uh, in different places and, uh, at some point in time, uh, I came back to, to data and IT, uh, working in different companies. Um, You know, I started to work at, uh, Shep, DHL and, uh, and different places, uh, that, uh, that would be, uh, you know, calling me for interim jobs.

And after a while, I, uh, finally started to work in, uh, in a pharma company called, uh, uh, Boots Healthcare. And, and Boots is a British based company, but they had an affiliate in France and we were selling, uh, uh, OTC products. And that’s where I started to, uh, to get accounted with, uh, with data, with analytics and, and so on.

Um, and after that, uh, the opportunity to work at BMS, as you mentioned, and go there, uh, in Paris, um, working with different affiliates, um, living to the UK for two years, um, and then back to France working for Sanofi. Uh, that’s where I’ve really, uh, uh, Um, you know, build my vision around what I was doing and the first thing that really struck me was The amount of waste of money that could happen in those companies to do something that was, uh, potentially, uh, you know, optimizable to an extent that was unseen.

Um, and, uh, I was seeing millions spent in project and so on where, you know, there would be opportunities to optimize and do a better job. And, um, And for me, we’re talking about, uh, the life of patients. We are talking about medicines. We are talking about health care. And the data was at the core of it. And, um, the, if you want, uh, the lack of, uh, of professionalism, the, the lack of, uh, of focus on making this data, uh, right and, uh, and optimize the cost managing it, um, coming from where I’m coming, you know, I’m, I’m coming from, uh, uh, very modest, uh, neighborhood.

Um, that was for me almost, uh, indecent to see this. And, um, and as I had a kind of a talent managing, uh, data, doing, uh, some IT work and, um, and building tools and algorithms and, uh, and, uh, and computing work. I dedicated my, uh, my time to, to improve that, generate savings and, and trying to do a better job than, than what I was seeing at the time.

And, um, and finally, after that, I’ve, I’ve made that my own business with Mongabay and, uh, the story.

Naji Gehchan: Well, thanks for sharing this. I’m intrigued. You said. Coming from mother’s neighborhood and you shared your upbringing and now leading data, a data company in healthcare, which that specifically it’s indecent to see how the waste of money and even practically the waste of data management and those large organizations.

Can you share a little bit more? Why what you saw and why you said it’s indecent and linking it to your background as you share it

Moktar Diallo: Yeah, I mean, it’s a strong word, but um, I wouldn’t say that now, uh, but back in time when I was 27 and uh, And I was trying to, to make my, my space. I was working really hard to, to build systems and, uh, and they were projects, um, similar projects around, uh, and people, they were almost building those projects to, um, to do the things, the way they were done, uh, and the things, the, if you want the way they, they had to be done, uh, in a, in a corporate environment.

So you set up a budget, you, you ask people, uh, to run a project and, uh, and distance to become very large. And, and basically doing data was a project, whereas people were working on data every day. And, uh, some of those people, they were building a real, uh, knowledge on how to do this in a way that was way.

cheaper and way more organized and those people, they were really undermined in the organizations. Um, so it was, uh, somehow it was me, uh, but, uh, the more I started to know about the organization, the more I was working with countries and different places. I was connecting with similar people. They were always the people in the middle of the organization, Um, you know, doing kind of 80 work data work, but that was crunching.

That was the way we were calling those people. The data crunchers 20 years ago. I mean, 15 years ago. And, um, and for me, that was, uh, it was difficult to see, uh, big companies coming and, uh, and running those projects for one year, two years. And at the end of those projects, people telling, okay, we, we tried, we learned a lot.

Yeah. We didn’t do anything with, uh, with those millions invested, uh, but at least we learned why those guys, uh, managing the everyday data and trying to do their best to automate and to serve their, their colleagues. They were very undermined. So this, you know, gap between we need data, that’s the shiny thing.

And, and the way people really working on it, we are treated on a daily basis. That gap was, uh, to me, um, a real, um, I mean, that was a real, uh, uh, issue.

Naji Gehchan: I love this. And it’s really what you shared since the very beginning, right? You’re a rebel and a smart, determined student. I feel within, within the work and what you, what you saw. there was this gap. So how did you deal with this gap? I imagine this is one of your leadership learning, working from corporations to now building a company where data is at the heart.

And certainly what you said is definitely true. Many times we talk about data, but at the end of the day, it’s, it’s, I love how you framed it. It’s a project. Um, well, our companies these days are more and more putting data at the heart of what we do and value it and really valuing it. But certainly for a while, it was more a project that someone would put and someone would stop.

So how did you deal with this to now building a company and what are your leadership learning along your journey?

Moktar Diallo: I mean, um, I had to be hands on. I had to go to the, uh, to the ground of, uh, of the needs. Um, to the ground of, um, of the data itself, I really had to go really to the level, uh, the most granular level.

Um, so I had to build very strong knowledge as to what is the data that exists? Um, what is the need that is out there? And what can I bring that is, uh, superior in terms of experience? Should it be faster access to the data, uh, best, uh, or better visualization? Um, fancy and, uh, an unseen, uh, indicator. Uh, I think that building that knowledge and that know how was really the base.

But the second is, uh, is to value the work you do the really, um, at that, at the time I started data was not, uh, the shiny thing that, uh, people are talking about today. Um, at that time, no CEO of a company would talk about data, no VP, no one would talk about data as such. And it’s very recently that this started, but at that time, no one was believing in this.

Uh, and, um, So I had to believe in that. I had to believe in the value of data as a piece of communication, as data, as a, as really, uh, uh, uh, basically the, um, the glue, uh, that connects people to each other in a modern organization. Um, really had to believe this and to see this very clearly to, to believe enough and suffer the way you suffer because you’re not valorized in the, on the work you do with data.

At that time, uh, that’s second and third, um, to work with early adopters. So I had the chance to, um, to work with people who were believing in this. So, um, uh, some, uh, some of my managers, uh, uh, uh, Delphine Aguilera Caron. Uh, Ron Cooper, uh, Daniel Kinney, uh, those people from different horizons, uh, some of them, uh, uh, French, but, uh, working in the UK, some of them US people because US guys are, are way more advanced.

In the way they see data than people in Europe as well. There is a cultural difference. Um, at that time, the U. S. was already quite advanced as well. Uh, versus Europe talking about data and leveraging data for for superior results. And I think those are the three elements really building the knowledge.

Don’t know how believing in, uh, in the in the vision, setting the vision and really be, uh, be loyal to that. Yeah. Vision and, uh, and, and third, uh, working with people who believe in you, uh, because you cannot, um, I wouldn’t be where I am today without the support of, of those key people I’ve mentioned and others, uh, a lot of others who share the vision and who love the know how.

Naji Gehchan: That’s a great framing, uh, Moctar. When you look back, really starting your company now, would you do anything differently?

Moktar Diallo: Plenty. Um, yeah, I mean, uh,

I think it’s important when you, when you start a company to really strongly believe in the value you bring on the table. Um, because when you strongly believe, uh, in that value, If you want to, um, you don’t, you don’t sell it in a way that would be detrimental to yourself in the future. Um, because you know, when you start a company, you’re not necessarily sure of the value of what you’re doing and you get a customer and, uh, and when you start to have a customer, everything the customer is telling you is, uh, is, is incredible.

And you don’t necessarily protect yourself of the consequences of some of the lines in some contracts and, uh, some, um, if you want, um, behaviors that you undermine and so on, um, and the return to reality can be very, very difficult to manage. So I think it’s important to really strongly believe in the value to be proud of it.

Uh, and protect yourself as much as possible. It’s not easy. It’s easier to say that after you started and, and, and seen the issues, but at least it’s important to be conscious of the weaknesses that are there, uh, in the relationship with, with clients, uh, as opposed to discover them, uh, down the road and, uh, and be a little bit naive.

Naji Gehchan: So let’s talk now about data. Your company focuses on lean, open, unified data ecosystems. Can you help us understand what do you mean by this? And what is your personal vision and beliefs around data?

Moktar Diallo: So, you know, the data we’re working with is, uh, the data is like a fluid. It’s like, uh, it’s like water. Uh, it’s like a liquid and something that needs to be consumed. It, it, it comes from different sources and, and gets together, uh, at some point in time for basically feeding, uh, you know, business insights and, uh, and actions.

Um, and to correctly pilot an organization, which is supposed to be one body. You need to assemble all this knowledge. That’s the basic thing. You need to assemble all this knowledge at some point in time. And an organization has this magical effect of, of moving different parts together. Um, but, uh, but you know, the brain is centralized somehow in an organization.

So the brain at some point in time needs to receive all the information. You can have the arm, the legs, the everything moving around. It’s important as much as possible to be able to concentrate that information. So I, I’m a strong believer in, uh, in data unification, um, as opposed to, uh, uh, data silos. And one thing that, uh, that happens when you have silos is that, um, instead of, Of having, uh, data being a tool of performance, which it is when it is, uh, transparently shared and, and, uh, and, uh, you know, assembled, it becomes a, an instrument of self power when it’s remained, uh, in silo and so on.

So people tend to keep the data for themselves. Because they, they believe that, uh, this piece of intelligence is what makes their work more efficient. And I think it’s not a modern idea. Uh, we are, we are, uh, more and more, uh, changing that. And technology as well is, is pushing for a different, uh, path. We see, uh, generative AI.

Generative AI doesn’t work with, uh, um, with big data. It works with diverse data. The more diversity you have, the, the, the better the intelligence can be. And that’s, and that’s, uh, diversity comes from assembling data from different pieces of the organization, as opposed to keep them in silos and, and, uh, where they basically, uh, uh, stay a little bit poor, uh, we can say the same for human being and all those things you need to, you know, mix, um, uh, informations for, uh, getting the, uh, through, uh, richness.

Naji Gehchan: I certainly agree with this. It’s fascinating how much data is actually siloed, you know, within our organization. And when we think about healthcare, the non connectivity of the different data, you know, I’m thinking back when I was chief marketing officer and we’re starting to do some pool databases and the complexity of making data connect.

And more recently, in France, I’m sure you’re aware, all the work the government is doing to connect data and have some medical shared platform and databases and the complexity of doing this, even though We would argue the assurance maladie, so the healthcare system in France has all the data for us, but still nothing is talking to nothing for us to be able to predict and do better healthcare.

Any thoughts about those? And probably Pivoting from this to what’s exciting about the future if we get to a unified, uh, data system.

Moktar Diallo: Yeah, it’s, um, it’s incredible how, um, artisanal, um, how, um, uh, how much crafting is behind data. I mean, people don’t imagine how much it is of manual work, of, uh, uh, human interaction to make, uh, to make sense of even raw data and build those assets.

I think that’s, uh, that’s something that people don’t necessarily realize that it is a tedious work to, to do. To create a database, to, to work on it and so on. Uh, we tend to see the really, the the last piece, which is the, the insights and the, the, the moment the data is, is refined. Um, and that’s what is, uh, is incredibly important, is the fact that it is a real effort.

A real conscious effort to make this happen. It won’t happen. Um, automatically, um, we, we work at Mongabay. We work on a lot of strategies to make that happen, to facilitate that transformation so that, um, it’s, it’s effortless if you want, but, but the reality of the work of data management is a really tedious work.

Um, especially when the data doesn’t have. Uh, the same format, uh, especially when the data hasn’t been built in a way that it would connect automatically with the, all the other pieces, all this work of unification or stitching together different sources of information is something that needs to be done.

Even that work needs to be done in a certain way. There are sciences to transform organizations and drive them towards the unification of their information systems. It’s not only an IT work that says, okay, we’re going to take a database, uh, you know, like, and structure it and make it happen. Um, if it was only this, the organization would be completely aligned for decades.

Naji Gehchan: Yeah, no, for sure. And I, and as you said, like, this is the, the heavy work that needs to get done. All executives, we get excited with like, Oh, we clicked on something and we saw it right. Like data visualization is obviously what excites us. And you know, you get. Whatever you need as an info, but really realizing the value that companies like yours or internal teams that work on those data to make sure that this data is relevant.

Well done. You have categorization. Well, all the things that you guys do is many times, as you said, in the very beginning of this episode. Many times not valued or not even seen. And it’s all the people actually working to make sure that those are relevant, clean, correct, in the right categories, well transcripted, etc.

is a key part for you to be able to visualize fast and most importantly to get the right vision to make the decisions.

Moktar Diallo: At the moment, just to rebound on that, at the moment, we, we start to see the masses as this is a subject that starts to be interesting for organization, we start to see the masses around what’s the cost of data.

Um, how can we maintain. Especially in the post pandemic where, you know, costs needs to be reduced and data is exploited because of digitalization and so on. We have an explosion of the amount of data to be managed by the organizations. And at the same time, there is a need to reduce the cost of this data.

Data represent 5 percent of the revenue of companies. So that’s a huge amount of, uh, of, uh, of, uh, Of basically financial transactions around data acquisition around data management around data consumption, and that needs to be kept at the level that that allows, you know, to basically maintain and contain the explosion of this data, and that becomes a problem for organizations to make sure that they can still.

Uh, you know grabs the the the value of data because if data goes in silos We discussed that before you cannot really grasp the benefit of it But the cost of putting that together is so high that you need to work on Optimizing that cost so this is becoming a very strategic issue for Not only for pharma, I would say pharma perhaps a little bit more than other industries, um, but this is a real general problem for, uh, for any organizations.

Naji Gehchan: So I’m going to give you now a word. And I would love your reaction to it. The first one is leadership.

Moktar Diallo: Loneliness. Oh, say more. For me, leadership is a lot of loneliness, um, thinking, thinking, thinking, um, and, um, and that’s, yeah, that’s the first reaction that I felt, um, about leadership. Um, you listen a lot, uh, you think a lot, um, you, you suffer a lot.

But meanwhile, it’s extremely rewarding.

What about change?

For me, change is bringing joy. I think there is nothing more important than change. Change is what makes people go further. You know, the routine of things is what is slowing down. So sometimes we need to slow down and enjoy the routine. Uh, but change is really for me an accelerator,

health equity, um, you know, have my roots in, uh, in Africa. Um, so, uh, I think that, uh, there is a duty, uh, human duty to bring health everywhere on earth. Um, and I believe this is, uh, one of the missions, uh, we would love, uh, uh, pharma, perhaps being a little bit more, uh, Um, vocal about, uh, and that’s, uh, that’s something that is still, uh, you know, a coming issue.

Um,

Naji Gehchan: do you think data and all that we’re saying generative AI, all the access to, to, to those preventive and also predictive? Models to better health care will help from this or do you see it as actually the data that we have is not representative of all the communities and the word and thus is biased by itself.

How do you think about those?

Moktar Diallo: We talked before about the fact that data should be raw data or intelligent data because at the end You know, it’s recycles. So, you know, what we, what we get from GPT is new data that can be used to feed another system. So data at the end, as we said, uh, if it’s in silo, uh, it will be an instrument, if it’s transparently shared, it will be a tool of performance.

And, um, and as the same for, uh, for, uh, you know, the, the most, uh, advanced way to, uh, to produce data. Um, if it is shared, um, it will become a good thing to spread more equity, more, let’s say, um, really to bring more power to empower people who have not necessarily the capacity to, uh, to get access to data.

So I think it. It goes in the right direction anyway, uh, there are dangers to it. But, uh, at the end of the day, we talk about sharing knowledge and, uh, knowledge is, uh, the most powerful, uh, um, let’s say asset of, uh, of any human being.

Naji Gehchan: The last one is spread love and organizations.

Moktar Diallo: I mean, transparency is extremely important. That’s the way I see it, uh, to have the courage of, uh, of being transparent and honest. Um, I believe is the base for, uh, for, uh, healthy and sane relationship. Not always easy, not always easy. You don’t do this. You don’t do everything day one. You know, uh, even love needs to be built, uh, as well, uh, because, uh, we, no one is, uh, they won’t, they will never be perfect love.

They will be always people learning to, to live with each other. So, um,

but I think transparency is a, is a good way to, uh, to accelerate this

Naji Gehchan: and your final word of wisdom, uh, Mokhtar for healthcare leaders around the world.

Moktar Diallo: I mean, for me, uh, I strongly believe about, uh, the fact that, uh, the models organization will be clear about their data, the more they will be doing, uh, best decisions, good decisions, um, healthy decisions, uh, as opposed to, uh, To, you know, fill the gaps with, uh, with, uh, guess second guess and, and biased, uh, point of view.

Uh, so, you know, understanding the data, sharing the information, the analysis, and, uh, and, uh, having an unbiased view on everything, um, is the, the, the best way to, uh, I believe, uh, be a good leader.

Naji Gehchan: Well, Moktar, thank you so much for being with me today and for this great chat.

Moktar Diallo: Thanks, Naji. Thank you so much for the discussion.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Kate Isaacs

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, having the pleasure to be joined today by Kate Isaacs scholar, teacher, and strategy advisor who designs organizations and stakeholder partnerships for people and places to thrive. Kate draws on design thinking, system dynamics, and developmental psychology to help leaders create conditions for collective intelligence, agile performance, and transformative change. Kate is a Senior Lecturer at the MIT Sloan where I had the pleasure to take her course on nimble organizations. Her work on Nimble Leadership was actually selected for publication in HBR at 100: The Most Influential and Innovative Articles from Harvard Business Review’s First Century! Conrgats! Kate also consults with organizations in all sectors on strategy and culture change, and she specializes in designing peer-based learning experiences and facilitating multi-stakeholder collaborations. Kate is a frequent author on topics of leadership, innovation, systems change, multi-stakeholder collaboration, and corporate sustainability for publications including the Harvard Business Review, the Sloan Management Review!

Kate, It is so great to see you again and have you with me today!

Kate Isaacs: Great to be here. Thanks for inviting me on.

Naji Gehchan: Your class is still living in my head with the different great frameworks to make us better as teams, some I applied already! But before we dig into your research work on organizations, can you tell us more about your personal story and how you became this incredible thought leader, thinker, and change maker?

Kate Isaacs: Well, thank you for the kind words. I am happy to share a little bit about my journey. I am really driven by a passion for Connecting people to who they are and their deeper purpose and, and to each other and to living and expressing that deeper purpose, I grew up, um, all over the country, our family moved around a lot and I was always struck by the fact that.

The world is such a beautiful place and human beings are capable of such extraordinary creativity and beauty and we are also capable of such destruction and evil and I saw those two things happening for whatever reason I was just always very aware of our capacities for beauty and good and evil and ugliness and destruction.

And it was really hard for me to hold those two things simultaneously. Um, it was created a lot of tension for me as a child where I’d be out, um, exploring the world. I love nature and suddenly I couldn’t walk on my front lawn because it had been sprayed with chemicals. And they said, keep off the lawn.

And, um, there was all sorts of. trash in the woods where I like to walk and things like that just got me thinking at an early age about, um, who are people and how is it that we’re capable of such different expressions. And furthermore, then as I grew up and got older and, um, I was studying biology, um, because as I said, I was interested in nature and the natural world.

I thought I would be a forest ecologist or a marine biologist. Or something like that. Um, and, and as I went along in my career in education, I, I was more and more interested in, in human beings and how do we function and how do I help, um, help enable people to connect with the part of us that is capable of Capable of such extraordinary things and such creativity.

So I became a social psychologist and work with, with leaders and organizations, and just as if, um, just like you, if you work with an individual or work with myself, starting with myself and. Change my paradigm or my ability to express my purpose and clear some of the cobwebs out internally so I can, um, do more of what I feel I’m here to do on the planet in my lifetime.

Um, that’s like a ripple effect that goes out from each individual and enables them to design and lead better teams and design and lead better organizations and design and lead better societies. So that’s really what motivates me. It,

Naji Gehchan: I can’t, but ask you how, like this question you asked in the beginning, I really got off every single morning, unfortunately, with the craziness and horror happening in the world, acts of hate.

And then you have tremendous act of love and beauty. I constantly ask myself this, like how, so did you figure it out with your work or how can we at least impact our small environments to make it? Better and be only from one side of the equation. I’m interested to learn since this was really what drove you to where you are today.

Kate Isaacs: Well, I, I think I’ve learned a lot of tools along the way, uh, for how to connect people or help people connect with that inside them. And all of us that is capable of, of incredible. Creative things. And I would say, first of all, that we all have that. We all have that inside ourselves. And moment by moment, we’re always making choices to align with that part of ourselves.

I would call it the bigger self or the bigger self. You know, depending on on your belief systems. Um, some people are very spiritual about it. Some people aren’t. But, um, I think in all of us, we all know that we’re capable of those acts of compassion, generosity, beauty, creativity, where we’re operating at our best.

And every single human being has that as our birthright. And so, um, one of There are many ways to get there, but one of the things that I think works the fastest is to simply practice a spirit of appreciation and gratitude for what’s right about myself, about others, about what’s right in the world. Um, and there’ve, there’ve been a lot of studies on, you know, monks who practice compassion and, and their brain, what happens to their brains when we, when we practice the, um, active compassion and gratitude.

And it, it literally changes our neural networks and our wiring, um, in our brains and, and in our bodies. And so we, I love there’s, um, a kind of fad out there, um, that some. Talking about the idea of glimpses. So everyone’s talked about triggers and things that trigger us, and that’s common in our parlance now.

And now there’s a, there’s a new thing about glimmers or glimpses, um, and those are the things that, um, in our lives on a day to day basis that are really working well, where something comes together and it’s happening and we experience a sense of joy, pleasure, ecstasy, um, calm, peace, relaxation, and Focusing on those things and what enables us to experience those things, whether it’s how we design our lives or our mental attitudes or the care that we take with our relationships, um, you know, in our lives.

What are the things that feed into those glimmers and glimpses and how can we expand those experiences so that we’re, we’re living more and coming more and more from that place. And those, those. Experiences.

Naji Gehchan: Those are great, actionable tips. We can we can do. And you talked in the beginning about the deeper purpose.

I remember also in your class, you talk about the purpose with big P for for us personally and organization. Um, what is it if you can, like, tell us a little bit how to get to this purpose? And then as leaders and organizations, how can we make this really live every single day? Despite what’s happening, not only in the work, but also in the work itself and operationally every day.

Kate Isaacs: Well, the first thing I would say is, is take a little time, whatever time you have, it could be just 10 minutes. Once a month, we’re all busy and have a lot on our plates, but carve out a little bit of time to think about what is it that gets you up in the morning? Why do I get out of bed and go to work?

Good, really good question is what’s the contribution that I want to make? Um, some of those questions. Need our attention. And when we’re too busy just running around and doing the things that we do, and we don’t allow any time. Most of us don’t allow much time for that kind of reflection. Um, but you people are, you can be surprised how little it takes just 10 minutes to journal and get off your screen for a moment and get out a piece of paper and just journal about it, about some of those questions.

Um, and, and then. See if you can get it down into a single statement and put a period at the end and, and see if that fits. And I know I’ve done this and over time that purpose statement has changed and morphed and transitioned as I’ve gone along. And it’s, it’s really a guiding North Star for, for me and all of us.

really unique. It’s like a fingerprint. Um, we all have a unique purpose and signature that’s a product of our own unique configuration of our passions, our capacities and talents, how we grew up. It’s totally different for each of us.

Naji Gehchan: And the power of when you connect your personal purpose to what you do every single day, and the work you do, and then the organization is just massive.

And you literally manage to make things move forward for the, for the work, for the society. If I go now into more nimble organizations, something you’ve worked on, you’re an expert on, um, and Cultivating nimble organizations. Can you first tell us a little bit more? What does nimble mean?

Kate Isaacs: The idea of nimble is about being responsive to the world and being able to, as one organization that we studied in depth, WL Gore says, to organize around opportunities so that if you’re nimble, you are You, you’re doing your sense making into the world.

That’s another thing we talk a lot about at MIT, uh, concept that’s been really popularized by my colleague, Debra Ancona. So you’ve got your feelers out. You’re looking out to the world and sensing what’s going on, what’s changing, and you’re making sense of that in a way that is aligned with your organization’s purpose.

Also, it’s values. Values are qualities of character that guide how you do things. Purpose is why you’re why, as Simon Sinek says, values are equally important, um, because they, they tell you how to make the decisions, especially under pressure. So if you’re nimble, you’re making, you’re out there, you’re making sense of what’s going on in the world.

You’re bringing that information in your. Using your purpose, your values, your strategic priorities to then decide how are we going to respond to changing markets, technologies, trends, political trends, things are moving very fast. And it’s, um, often looks like a foggy road out there when you’re a leader looking to figure out how to move forward.

Um, but if you’re doing that sensemaking and some of the other things we talk about around combination of. Visioning also and executing and innovating and also relating. That’s another really key leadership capacity. You and I are relating right now. We’re having a conversation. You really need to have all of those capabilities in your organization, but the sense making and relating are often.

Underappreciated as leadership capabilities. Usually when we think about leadership, we think about the heroic leader, the person who’s visioning and inventing, um, the sense making and relating are so important, especially these days when we’re in a stakeholder world, and so many people are looking to organizations around our can we trust them?

Are they being transparent? Are they leading from values? Um, And so being able to, to do that external and internal dance as I’m talking about, um, and use your purpose values to, um, orient how you’re going to respond to your sense making that you’re doing is, is really key and we see that in nimble organizations.

They return again and again to those purpose values. Um, as guiding North stars for how they do respond.

Naji Gehchan: So I love this and it’s and you’re going correct me if I’m wrong, I think you’re going beyond just this idea of agility and innovation and you’re touching more aspects of the purpose, the social responsibility of the organization.

So do you feel this is nimble organization is really for all type of organization? Or is there pieces where, like, you know, sometimes we think of agile as you have, like, hierarchical structures and then people kind of co working, brainstorming, bringing innovation. Is it that or is it like even broader when you think about Nimble and more as a concept to improve the society as a whole versus just profits?

Kate Isaacs: Well, we, we studied organizations that are high innovation organizations. So I’ll caveat what I’m saying around just to say that, um, so Nimble is about being adaptive and responsive and, and being able to change. At the same time, um, you do need to be able to execute with consistency and regularity and predictability.

So, um, that is also really important and organizations need to be able to do both. Um, there’s this idea of ambidexterity. So, uh, I would say though, that there are the, some of the principles of Nimble are applicable in both kinds of contexts, whether you’re in an industry that’s. Well, all industries are changing, but, but if you’re part of the business is, you know, highly regulated, um, you know, and you’re doing the same kind of task over and over and over, you need to do exactly the same thing.

Um, the principles are still applicable and that fundamentally nimble is about. Uh, pushing decision making authority down as far as you can in the organization and giving people autonomy to make as many decisions as they can in line with how the organization is expecting to carry out its strategy strategic priorities.

So in order to do that. In order to free people up and give people more autonomy to do the business of the organization, there have to be some guardrails in place. Now, command and control bureaucracies give people big binders of rules or the, you know, or people are expected to just do what the leadership says.

That takes away people’s autonomy. But if you, but you still need to have some guiding guard rails in whatever context you’re in. So what do you replace the big thick binder with or the command and control from the CEO down? Well, you replace that with, um, in some parts, purpose and values and, and expected behavior.

you also replace it with, um, that, that’s, that’s part of what replaces the thick binders. If you tell people, this is what we stand for as an organization, we expect you to behave in line with these values and purpose in, in our strategic priorities. And if everybody understands that, you have a better chance at having people.

Who are autonomous, make decisions in line with what the organization wants. The other thing is that, um, nimble or organizations, if you assume that people are autonomous, you assume that they can make their own decisions. And so you can’t just tell them, um, what to do. You have to, in a sense, get them on board and engage them, enroll them in your vision.

If you’re the CEO or the senior leader. So there’s an element of. Persuasion and assuming that you have to get people’s buy in one way or the other. So a lot of leaders and nimble organizations spend a lot of time explaining why we’re making this decision. You know, senior leaders still have to make decisions for the on behalf of the organization.

We’re going into this market or we’re shutting down this plant. So those are decisions that have to be made. It’s not a democracy here. Um, and they tend to explain why. Because people want to know. And, um, there’s just a lot more transparency, listening. Um, and I think those principles are applicable, um, no matter what kind of business that you’re in.

Sure.

Naji Gehchan: And, you know, the majority of my audience is in healthcare. So I, what you were saying, highly regulated. certainly part of what we do, but also the things would apply for, for sure. Uh, so when you’re thinking about those, you talked about cultures, how senior leaders, uh, we talk about it. I’m interested to learn more from you.

How do you think about culture at the corporate level, for example, as an organization and also the. cultures within the teams and organization. I’m sure you’ve seen differences. Is there a way to say like, this is an overarching culture, or do you still see subcultures that can be actually not really what the organization is putting out as values and cultures for itself?

Kate Isaacs: I think you’re, you’re absolutely put your finger on it in terms of there are many subcultures and organizations all over the place. Culture is not a homogenous thing at all. At the same time, they’re off. There is a dominant culture in the organization that, um. You can, you can usually pick up, um, you can usually pick up and you can actually diagnose it.

You can measure culture in different ways and, um, depending on who is leading a particular unit or function or team, that individual, it’s the ripple effect of. Of, of an individual’s fingerprint or footprint, if you will, on a, on a team or a unit, whoever they are as an individual will influence the, the dynamic of the whole collective and, and how they lead meetings, how inclusive they are, um, whether they’re more directive or, um, solicit more input before making a decision, um, those, everybody’s very different.

And so the. different cultures will form around different folks who are leading different areas of the organization. And there is still usually a dominant, pretty dominant culture, those subcultures sit in inside of. I’m curious what’s behind the question.

Naji Gehchan: Well, there is, because I think we discussed this also in the class, things, you know, written on the wall and then in the water.

And, you know, I feel like there is more and more organization now looking into. Ensuring whatever culture or purpose, uh, are really kind of within what we’re looking at as a society these days, right, like incorporating social impact, incorporating really why we wake up every morning. Uh, and I’m wondering, like, is this sufficient and what is the roles actually of different leaders within this company and each one of us as a leader on the subcultures we actually create, even sometimes without realizing.

So this is, this is why I was asking it.

Kate Isaacs: I love this territory and it gets to something I’ve been thinking a lot about lately, which is an organization can articulate its purpose, its values, and, and, and have a culture that may or may not be representing that. Hopefully it does. And you still have all of the individuals who have their own individual purpose and values and.

So it’s what we’re not trying to do is to get everyone to say that the organization’s purpose and values are my own as an individual. Um, what, what this is really about is if you think about the organization as like a, uh, an attractor magnetic. Putting out a, a tractor beam or, uh, maybe that’s not such a good analogy because we don’t want to think of ourselves as aliens being teleported up.

But, but like, uh, putting out a magnetic field or, you know, a, a lamp in the darkness, if you will, and the organization broadcasts. These are the values, the purpose we stand for. Um, Leaders back that up with their actions. Um, the incentives are aligned, et cetera. And then what happens is, is people are drawn to that because they feel a resonance.

Um, they feel a resonance with that we’re going to what that organization stands for and what they individually stand for. So it’s, it’s a resonance thing, um, that happens. And that’s why companies with. That stand for something beyond just profits and really are making a positive contribution in the world have an edge on hiring top talent because of that resonance phenomenon and people want to work for a place that is allows them to align their personal sense of meaning and purpose with with something that’s bigger than themselves.

Naji Gehchan: I love this resonance. Phenomenon. I love it. Thanks for sharing this. I’m gonna now move into a section where I will give you a word and I would love your reaction to it. The first one is leadership.

Kate Isaacs: You want me to just react to the idea of leadership? Yep.

What I’m thinking about is an exercise I did with my students in a class I teach called discovering and developing your leadership signature. And I gave them a sheet of many, many different definitions of leadership. Some was about influencing people. Some was about developing people. Some was, some of the definitions were about producing outcomes.

I don’t think there’s any single definition of leadership that, I would say this is it. I think like many things we have to, I define what that is for ourselves. I, for myself, leadership is about inspiring and others. To live from their own purpose and values and, and doing something collectively to change the future in alignment with what we believe is possible.

That’s for me, what inspires me about leadership and it’s about change and it’s about other people and it’s about doing something bigger than myself for others and with others.

What about

Naji Gehchan: polarities?

Kate Isaacs: Oh, one of my favorite topics, uh, and I

Naji Gehchan: love the during class, the student of, uh, ,

Kate Isaacs: I’m a, a, a student of the DA Jing, which I think is the authoritative manual of polarities. It is a book of opposites, and I think if anyone who. Anyone who really wants to understand polarities could take a deep dive into the Dao De Jing, um, several thousand years old commentary on, on polarities.

They’re, uh, found everywhere in the world, in our bodies, in nature, in organizations. And they’re absolutely the, the creative tension of life and, and what makes life interesting. One of the most fundamental polarities is our breath. We breathe in and we breathe out many, many, many times a day. And we have to do both of those things in order to have a healthy functioning body and mind.

So. You need both of these ends of poles, um, and it helps to know that they exist and that you can get stuck in one side or the other and, and it helps to know some tricks to get unstuck. And, and start to see, uh, what my, uh, friend and mentor and colleague and Indigenous, um, elder in Canada, John Rice, calls two eyed seeing, so that you can begin to see the other side of the polarity and the validity of it, and, and get disembedded from an over identified With one side or the other, and then you’re in a real position to lead, um, because you can see, recognize and respect the truth of both ends of the pole and the people who represent the voices on either end of the pole.

If you’re talking about an organization, then you’re in a different position to help make, uh. the miracle happen in the middle, if you will.

Naji Gehchan: I love it. And I really enjoyed when you talk and thought that’s about polarities. Can I double click with maybe a tangent to this when you’re saying so the leader’s role or the power and the magic happens when you see those two polarities for you to be able to take a decision.

There is more and more ideas about should you take sides when it’s. Polarities really kind of splitting the word as we’re saying like there’s a lot of polarities today’s in the word that are social issues. How do you think about this for leaders is our role to see those polarities and ensure people can speak up.

They exist and we understand them. Are you one who would advocate we need to take a stand, take a side? How do you think about all this in our current world?

Kate Isaacs: Well, given what I just said, you probably could predict that I won’t say that you need to take a side. Because as soon as you quote, take a side, you’re missing all kinds of information and intelligence that the other side can provide. And So one of the things I have studied, I think I mentioned this in class, is the abortion debate, and I studied a dialogue where six women, um, spent five years in secret conversation because the, at the time, the um, Topic was so highly charged as it is again today that they couldn’t meet publicly.

So for five years they met And, and talked about this and I think it’s a, it’s a hopeful story because they didn’t ever see eye to eye on the issue itself. They still were very firm in their beliefs that their point of view was the correct one. But what they realized is that they could still have a respectful relationship and a civil dialogue, even though they had very different beliefs.

And they also realized that it was very interesting to talk with people on the other side, and to really understand where they were coming from, even if they didn’t agree with them. Because they it taught them so much as they said about their own beliefs and why they believed what they believed and, you know, fast, fast forward that was That was back in, uh, I have to recall the exact date, close to 20 years ago that that dialogue was happening.

But fast forward today, there’s an organization called Braver Angels, which is, um, hosting a lot of quote, red, blue dialogues so that they can create a space for people to just simply hear what the other I Folks on the other side of the political divide believe and why and they hosted some workshops around abortion in Kentucky, of all places very politically mixed environment.

I mean, of all places meaning it wasn’t like a. It was a very politically mixed environment is what I mean, and they were able to reframe the debate away from. having people argue about whether their point of view was right or wrong into what’s the problem that we’re trying to solve here. And what everybody could agree on was that no woman wants to have an abortion.

No woman willingly wants to have that happen in her life. And so what they could all agree on was that they all wanted to help prevent unwanted pregnancies. They wanted to help women prevent that. From happening. And so what could they do to help women prevent unwanted pregnancies? Well, they agreed on two moves.

One is around, um, sex education in Kentucky schools. And the other was around long lasting contraception. And this was a group of conservatives and liberals, reds and blues who came together and agreed on that. So it’s just an example of how the Reframing the problem that you’re trying to solve allows you to, you know, maybe not totally let go of your beliefs around a particular issue, but still lets you move forward in a productive way because you’ve identified something in the middle, that common ground that you can work on together.

Naji Gehchan: I love it, Kate, and I’m just such a big believer in this. We did actually end up doing healthy conversations and healthy debates with my classmates during MIT, during these tough moments. And this was the whole idea, where we can bring our differences and actually have healthy conversations for us to move forward as a society and as leaders.

I love your example. The third word is storytelling. Mmm.

Kate Isaacs: I come from a long line of Irish storytellers, so storytelling is, is in my blood and I, I love to tell stories and have, actually teach storytelling, as you know, um, and, and how can we tell great stories? I think that, uh, storytelling is Thanks. is a bit of a lost art, and it’s coming back because people are realizing how powerful it is to change minds, to change hearts, and to make connections with the people that we’re Our peers and folks we’re trying to lead or influence whether it’s up or down in an organization.

We are hardwired for stories and there’s some really interesting research about what happens to our brains when we hear stories and, um, there are different brain chemicals that get released, our mirror neurons turn on, um, we are along for the ride when we are listening to a story. We are Right there generating our own internal imagery of what’s happening and one of the great leadership skills is to be able to put pictures in people’s minds and bring people into your experience so that they can go on that ride with you and then come out the other side and, um, And, and, and be open to what you might suggest about what’s next.

So I have a great example. I don’t know if we have time, but, um, a great example of where I saw some executives doing this, if you want me to share, there’s, um, um, group of hospital executives in Chicago led, uh, Initially by Rush University Medical Center. So this will relate to, you know, the industry that you’re talking about.

Well, Rush University Medical Center, uh, led by a team that had done a lot of research on the, um, racial health gap. And, uh, the former chief medical officer, David Ansell, wrote a book, um, actually called The Death Gap in Chicago where he, he and others who were on the team at Rush University Medical Center told the following story to try to get other hospital executives in the region to work with them on closing the death gap.

You get on the Chicago subway in downtown Chicago, um, you can expect to live into your 80s. That’s the average life expectancy downtown. You get on the blue line in Chicago and you go down into the subway, you get on the subway and take it seven stops and get out on the West side of Chicago. And if you get out and you live there instead of downtown, you can immediately lose 16 years off your life expectancy.

just because of the environment, um, and all of the risks associated with, with living in that West side neighborhood where Rush University Medical Center is located. And there’s a whole lot of reasons for that, um, uh, historic racism and under invested in neighborhoods and, and things like that. And so Rush.

began to ask itself, well, this is the neighborhood that we’re in. What is our responsibility to help close the death gap here? And, uh, they, they began to tell this story and it’s a horrifying story. Um, 16 years of life expectancy just by living in this neighborhood instead of in downtown wealthier Chicago.

And that, that story, which put pictures in people’s minds, um, lit a fire under the other health system executives in the region. And so they, um, got together and decided to do something about it. And one thing that came out of that was to launch a new nonprofit called Westside United, which is committed to, um, systems change and, um, all sorts of systemic interventions into the community to deal with, to basically help people, people live.

With, um, greater health and, um, safety and a sense of well being. So, this is one of my favorite examples of where a really clear story, um, coalesced people around a collective agreement that this has to change. We’re going to put some money into it, and they’ve attracted many millions of dollars to do this work in the West Side neighborhood of Chicago.

It’s incredible.

Naji Gehchan: Well, thank you for sharing this, uh, this powerful story. The final word is spread love and organizations.

Kate Isaacs: Say it again. Spread love

Naji Gehchan: and organizations.

Kate Isaacs: Spread love and organizations. Spread love and organizations. Well, I am actually really happy that we can use the word, the L word in business now.

Um, because it, it used to be a no no. It was a four letter word that nobody was willing to say. But, you know, in the end. What’s the point if it’s not about love and loving what we do, loving each other, loving our customers or our patients? If you’re in health care, why do we do anything in the end? Why do we do anything in the end if not for love?

I wouldn’t say anything more than that. It’s all about love. It’s all

Naji Gehchan: about love. And I will say I love it. I don’t know if you can say it in corporate, the L word, but for sure I’m saying it. And I, I really love that you also push for it. So any final word of wisdom for leaders? around the world.

Kate Isaacs: Say it again.

The sound cut out for a sec.

Naji Gehchan: Sorry. Any final word of wisdom for leaders around the world?

Kate Isaacs: I think for me, the next decade is going to be going deeper into the territory of how do we use our, our intuition, our awareness of what our bodies are telling us, our emotional intelligence.

All of the kinds of things that aren’t about data and, um, but are intangible. And I would dare say, perhaps a more feminine way of leading. I. We’ll be going into that territory. And I, I would just invite people to start to pay attention to, you know, what is your gut telling you? Yes, we need data and we need to have good logic and reasoning.

I mean, I’m at MIT, I’m trained up in that. And, and you have to pair that with an intuitive gut sense, um, paying attention to where do I feel alive? Where’s the energy? In whatever I’m trying to do. What about passion? You know, those dimensions of human experience are so important. Where do I feel joy and pleasure?

It goes back to that thing we were talking about, about glimpses and glimmers. And, and I would like to really elevate that as part of what leadership is about. Go to where you feel most alive and do that and pay attention to where you and others are most alive and expand that space because that is where, that is where change will happen.

And that’s where the future lies.

Naji Gehchan: Where do I feel alive? Thank you so much, Kate, for being with me today and this incredible discussion. Thank you.

Kate Isaacs: Thanks, Naji. Thanks for having me. Such a pleasure.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Adam Castano

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, for a special episode in partnership with Jill Donahue for her new book “A Dose of Inspiration: 100 purpose stories from Pharma Leaders”. I am joined today by Adam Castano, VP of Global Clinical Development at BridgeBio after having led Global Clinical Development teams Merck. Adam is a board-certified cardiologist and industry professional dedicated to the singular unifying purpose of bringing innovative therapies and breakthroughs that improve patients’ lives. Previously he led development programs in cardiac amyloidosis at BridgeBio and Pfizer Inc. He also served as Assistant Professor and Co-Director of the Center for Cardiac Amyloidosis at Columbia University College of Physicians & Surgeons.

Adam, it is such a pleasure to have you with me today!

Adam Castano: Thank you so much, Naji. Pleasure to be here with you.

Naji Gehchan: Can you first share with us your personal story from your passion to cardiology to now joining the biotech world. What is your purpose?

Adam Castano: I guess we can start, um, with my, my story starts with my parents. I would say, um, my, my mother, uh, is a, uh, Freudian psychoanalyst.

So as you can imagine, you know, Uh, someone who thinks very deeply about the mind. Uh, my father is a cardiologist. Um, so again, someone centered in the heart, uh, like myself. And, um, um, so growing up in that context. With two parents who sort of, you know, one talked a lot about, uh, thought and deliberate, um, process and, um, sort of, uh, intellectual topics, um, and the other, um, being more, uh, uh, heart driven, if you will, um, was someone centered in sort of the Uh, you know, uh, the, the, the marks of sort of, uh, I don’t want to say emotion, so to speak, but, um, more, more raw intuition.

Um, uh, and, uh, so I grew up with, with sort of that, um, overarching philosophy. Um, and this was all in an international setting. So I, I went to an American school, um, uh, the American school foundation in Mexico city, um, for early parts of childhood. Um, and also, um, spent, um, a majority of childhood here in New York City, where, um, my mother’s family is from.

And so in that context, um, had sort of an international influence on, um, you know, how I viewed the world, um, and that, you know, drove me, I think, uh, growing up, um. Uh, I had a early affinity for science. I remember my, uh, parents, uh, gifting me a microscope when I was young. Um, and, uh, spent a lot of time with that, perhaps too much time.

Um, but enjoyed it. And that flourished into a love of, uh, science, um, that continued on throughout, um, you know, my, um, high school and then eventually, uh, undergraduate training, um, at Princeton, um, where I studied molecular biology and Spanish literature, um, and, uh, again, one for the heart, one for the mind.

Um, And, uh, and then went on to study medicine, um, uh, and it wasn’t until sort of medical school that I. Discovered that cardiology, um, was, was, uh, you know, a field of internal medicine that was best suited for my particular, uh, background and interests and, and sort of future aspirations. And so that, that brought me to, um, you know, my clinical training.

Um, uh, I, I did that at the University of Michigan in Ann Arbor, go blue. Um, and then, uh, after that, um, had, uh, the opportunity to come back to New York where I essentially stayed and have, um, done, uh, the rest of my medical training. So, uh, residency, um, at Columbia University, uh, in internal medicine, and I stayed on for fellowship in cardiology, um, during that period of time, I, I.

Um, took some research years and also, um, got a master’s in patient oriented research and, um, clinical trial design at the Mailman School of Public Health. Um, and then stayed on as well for an extra advanced, uh, cardiac imaging, uh, fellowship. Um, so, um. You know, that’s why I have a lot of gray hair spent, um, perhaps too much time in training, but enjoyed every 2nd of it.

And, um, it was during that training that I came across my 1st academic mentor, uh, Matt Mauer, who. Really inspired me, um, um, from an intellectual and a clinical sense. Um, um, we encountered a patient with cardiac amyloidosis that really fascinated me. Um, this was at the time a rare. Um, um. Uh, disease that. Uh, was, uh, undiagnosed, uh, underdiagnosed, uh, not a lot of, uh, physicians, uh, knew about it or how to treat it.

There were no therapies, um, and I thought to myself, you know, I was a young intern at the time. Wow, this is really a fascinating, um, disease process with, you know, not a lot of therapy and it’s an awful disease. These, uh, these patients often, um, develop end stage heart failure and live, uh, quite a Um, poor quality of life, um, if untreated, um, especially if they’re under, you know, unrecognized as this disease often goes, um.

And so I decided to sort of buckle down and start studying that disease with my mentor at the time at Columbia and we, you know, we’re lucky to have come across some early findings and how to diagnose the disease early. We made some clinical observations of, um, potential populations at risk, uh, that were not thought to be at risk.

Um, uh, patients with aortic stenosis, for example. And even made some therapeutic advances, um, with, uh, the development of the 1st, uh, stabilizers, uh, to treat, uh, the, the disease, um, and that, um, eventually brought me to my faculty position, uh, at Columbia, so I co directed the cardiac amyloid center with him for a couple of years and enjoyed every second of it, really I think my favorite part was the patients and the day to day patient work, um, but sort of nagging at me in the background, um, and this is where the international context of sort of my childhood comes in, is that I felt that I, I wanted to have a more global impact, um, with the day to day work that I was doing.

Um, and, and that’s when an opportunity came, uh, about for me to join, um, a team at Pfizer that had just, um, come to the Uh, end of phase 3 for, um, uh, to famine is the 1st, um, TTR stabilizer for a TTR cardiac amyloidosis. Um, that, um, my mentor and I had helped actually work on on the, on the academic side and now there was this opportunity to come and.

Um, you know, bring bring this breakthrough therapy to patients across the world, um, on the biopharmaceutical side. And so I decided to make that important leap, um, uh, into the biopharmaceutical industry, um, that brought me to Pfizer. Um, I. Uh, really cherish that experience. I sat at the apex of sort of, you know, the intersection between, um, development and commercial interests and, uh, regulatory interests and, um, uh, business development and, um, legal, et cetera.

Um, really learned a ton, um, early on in that process, um, and had an opportunity to see what a, you know, a major global launch was all about. Um, and then, um, um, I had, uh, after that, a new opportunity to lead, uh, an important program, um. Uh, in prevention at, um, bridge bio, um. Which is, um, uh, biotech based, uh, in Silicon Valley, uh, that is developing, uh, a novel, um, second generation, or I should say next generation TTR stabilizer called Acarimidis.

Um, and the, um, work that I do there is focused on, um, supporting that, um, important, uh, potential therapy, uh, after the completion of its, uh, phase 3 clinical trial, um, just earlier this year, um, and, um, furthermore to advance the science of, in the field to help, uh, essentially understand the question of whether we can use these novel therapies Um, to prevent disease or at least slow the onset of disease.

Um, and that’s a hypothesis that’s not been tested clinically. Um, but certainly makes sense. Um, when you think about the mechanism of disease and, um, really could do a lot of good to, um, to patients who, um, who, uh, might otherwise not have been diagnosed or, or die, get diagnosed too late and then end up, um, you know, in this continuous sort of, uh, spiral of, Late diagnosis, um, and and, you know, unfortunate outcomes that that result from that.

So that’s that’s sort of in a nutshell. Um, I should say, I, I had a, a year as well before this current, um, last, um, process where I spent a year at Merck, uh, in clinical development. Uh, helping to bring a novel, um, oral PCSK9 therapy, um, to, uh, phase three. Um, and I helped design the clinical, uh, trial for that, uh, particular compound, which I, I hope will, will, um, you know, uh, ultimately I think has a lot of promise, but we’ll see how the, the clinical trial, uh, reads out in the next few years.

Um, and I also, um, learned a lot working on a phase two clinical trial, um, or a separate compound called, so tattercept, um, that is being studied for the treatment, um, of pulmonary hypertension. Um, so that, that in a nutshell brings me to, uh, present day. I hope that wasn’t too long winded. No, that’s

Naji Gehchan: great, Adam.

And I’ll obviously go into some of the pieces you already shared and I relate to several parts of what you do. Um, as you know, I’m also leading development in the breast cancer field. Um, so I’d love first, you said you took a big leap and moved to pharma and I, uh, I know like this is usually how physicians we would feel when we, uh, when we move from clinic being in front of patients to, uh, to the biotech.

Pharma industry word. First, the first question on this is really more personal from a leadership from a personal leadership standpoint.

Adam Castano: Yeah.

Naji Gehchan: What is your biggest learning? And is there a common thread you felt from moving from academics? you still rely on strongly or ones that you felt you need to let go?

I don’t know. Like it’s more, what is your biggest learning as

Adam Castano: a leader? Sure. Um, yeah, it’s a great question. Um, I, I would say the biggest learning I’ve had, and I can’t emphasize this enough. Is that, um, you know, leaders talk a lot about different skills to, you know, organize and, and, um, sort of motivate or galvanize, um, people around them and, you know, within their spheres of influence to accomplish a particular task.

Um, and that’s all really important, but I think 1, 1 thing I’ve learned in particular, um, and this started early on, I think. Probably in, in early medical training was the idea of humility, um, and, and it’s something that I think gets brushed over perhaps, um, too often. It’s something that I think should go into, um, much more formal, uh, types of leadership training, both in business and medicine, um, in law and other sort of, you know, across the board.

Um, this idea that, you know, humility. And what what we bring to the table is is important, but there is a whole world out there that that other people also bring to the table. Um, that we can learn from. Um, and it really is what what we do in in life is a team sport and and that. Is something perhaps that, um, you know, when you think of medical school and medical teams and, you know, sort of how health care tends to be structured, there’s sort of.

Um, you know, the, the doctor at the flagship, you know, who sort of commands, you know, the ship, um, and everyone around them sort of is in a supportive role, but, um, one thing I’ve really come to learn and appreciate, especially in the biopharmaceutical sphere is that, yeah, we need doctors to help develop, you know, important breakthroughs, um, but, uh, we’re just a Piece of the puzzle, right?

And we’re not any more or less important than, um, other members, uh, of, uh, large biopharmaceutical, you know, um, uh, structures, right? Uh, we need, um, the expertise of legal colleagues and regulatory experts and, um, you know, um, People who are more on the basic science side of things to help us understand whether molecules can even do what we expect them to do in a mechanistic sense, right?

Can they bind the target? Um, we need safety experts to help us prove that our therapies are actually safe to put into humans, right? We need. Um, globally, business leaders and commercial folks who, uh, can help us understand the landscape of how, um, a particular, uh, breakthrough can get translated, um, into a product that can help, um, you know, the most number of people, um, where it’s needed, um, you know, most so, so, um, I think, I think, I hope that answers the question, you know, so it’s a sense of humility within a team structure, and that’s, that’s something I’ve really come to appreciate, um, over the years.

Yeah, it certainly does, and

Naji Gehchan: that’s, that’s such a great, uh, learning, and you, you certainly appreciate, as you said, it takes a huge amount of people and expertise. To bring a drug from an idea to pre clin and through all our clinical stage and at the end really getting it in the pharmacy and for the patients, it’s you really beautifully expressed all the different functions and several others that will get together along the way to get it as a reality for patients.

So what would you say to physicians and I’m sure you do as I do talk to several physicians who are thinking about this who are usually. Kind of worried of losing this immediate impact on patients. And I was an ER doc, right? Like you, you, the impact you see it, you, you have, you have, yeah. So what do you, how do you talk with, uh, with physicians who are thinking about this and thinking of broadening their impact, but differently?

Adam Castano: Yeah, it’s a, it’s, it’s, um, a very natural question that I think a lot of folks ask when they’re sort of at the crux of uh, an important decision and it is an important, you know, this is perhaps one of the most important decisions, uh, physicians ultimately, um, make if they decide to transition, um, into a biopharmaceutical role.

So, um, I would say You know, when I, when I, I’ll share a bit of my personal sort of journey and then, you know, perhaps that can help help us sort of glean some, some understanding. Um, but, um. I didn’t want to lose the, uh, day to day patient care aspect of it at 1st and I had something I wasn’t ready to give up.

Um, and I was fortunate when I 1st joined. Uh, Pfizer and, uh, Bridge Bio and even at Merck that there was flexibility built in for me to be able to continue to see, uh, patients in a clinical setting, um, as long as, you know, the, there were parameters put around that in terms of sort of, um, you know, time spent and, um.

You know, allocations of, uh, windows of time within my sort of global work schedule. Um, and, uh, um, in addition, and this is an important piece to ensure that there’s no sort of overlying conflicts of interest between the clinical work and the biopharmaceutical work. And as long as those boxes are checked, um, I think it’s something that, um, I think most pharmaceutical companies would actually encourage.

And that’s been my. My, um, my experience is that I was encouraged to say, Hey, if this is part of your journey, and you feel that this is important to you, um, uh, you should, you should definitely pursue this. And, um, and so I appreciated that flexibility. And so I continue to see patients from a broad preventative cardiology standpoint.

Um, um, for a few years into, um, my biopharmaceutical, um. Work and, um, and really enjoyed it. Uh, eventually I found that, um, my, um, my biopharma development work, um, was essentially satisfying, um, a very important piece of what I needed to feel like I was making, uh, a difference and bringing again, the ultimate sort of lighthouse at the end of, you know, a dark tunnel, um, for me is, you know, am I, am I, Achieving my purpose, am I having impact on improving the lives of people around me?

And the work that I did in bio pharma, I eventually came to, uh, realize and be quite satisfied with achieve that purpose. So I found the need to do clinical day to day work less and less. And so I’ve gradually, you know, sort of wound that down. Um, and that’s, you know, that’s probably common for many physicians, I think, who enter the pharma space.

Some actually give it up entirely. Um, right off the bat. And that’s part of, um, another part of the journey. Um, I think it’s different for each individual. Um, and there are some who continue it all throughout their, their pharma, uh, careers where, you know, they still see, uh, or teach, uh, in medical schools or have important roles, um, uh, in, uh, an academic setting.

Um, so I, I think, you know, we frequently think about these as a dichotomy, but I, I actually think it’s a false dichotomy. It’s something that can, can coexist. Um, there, there, uh, is crosstalk between academia, clinical and biopharma industry work. It’s necessary for effective drug development. Um, and, um, I would hope that it continues to be fluid and that those walls, you know, do not get thicker or taller.

If

Naji Gehchan: you will, I said, I certainly agree with you, um, Adam on this and, um, it’s, it’s important to keep those instructions. And as you said, the impact is just different, right? And what you will be able to do it instead of being. On the frontline, it’s obviously helping more patients by, you know, two steps, maybe further away, but you’re still helping and bringing impact, uh, on, on people.

Uh, so how are you ensuring, because we talked a lot and we’re obviously always passionate about the impacts you have on patients at the end of the day. That’s why we do what we do. How do we bring this to life? With your teams on a daily basis, constantly having to juggle the operational things like a lot of, uh, really tactical pieces.

And how do you make sure that your team is always centered around the patient at the end of

Adam Castano: the day? Yeah. Yeah. So I love that question. And this is something I actually share often with my teams. Um, first I, I tell everyone that I work with, if you’re in the meeting and you’re. You find yourself discussing something or being asked to do something or, um, you know, uh, you’re, you’re, you become pulled into something that doesn’t quite jive with, you know, your personal mantra of, hey, uh, am I achieving my purpose?

Am I, um, is this ultimately going to, uh, create. You know, a meaningful advancement for the grander purpose of bringing breakthroughs, um, forward to patients, then don’t don’t do it and tell everyone that Adam said, it’s okay not to do it. Um, and and and so. You know, again, it means, you know, hey, maybe this meeting got off track.

Let’s refocus on sort of what what is the most meaningful thing we can accomplish here. Right? And so that’s sort of the North star. I think that should guide. Uh, I hope guides all of, um, the folks I work with and. And it certainly does, um, the, the 2nd piece, I would say is, um, this is something I share a lot and comes back to sort of the earlier childhood sort of heart brain connection that when we do something, I think there’s an important.

Um, uh, interactivity there where it has to make intellectual sense, it has to be logical and, but it also has to be driven from a place of heart, a place of passion. If it’s missing any of those elements, then it’s, it’s going to fall flat. And so any initiative that we embark upon any project, any work, any PowerPoint presentation, um, you know, memo meeting, whatever it is that you might have it, um, it has to accomplish those 3 core things.

Does it help patients at the end of the day? Does it meet intellectual rigor and is there heart and passion behind it? So those, those are sort of my 3. Big things that I try to impart. Um, they’re, they’re. You know, overarching big concepts, I think, uh, maybe get talked about, um, in different ways. Um, but for me, I’ve found that they, they seem to resonate and, um, and bring about, um, productivity.

I love

Naji Gehchan: that, uh, help patient. It doesn’t make sense scientifically, intellectually and heart, and it goes back to your very first story with your parents, right? You said heart and mind, and you’re taking this and putting it through your career and life. That’s great. I’m going to give you now a word, and I would love your reaction to it.

And the first one

Adam Castano: is leadership.

It’s a big word. It’s loaded in many ways, but, um, I think the 1st subset of words that come to mind are those that center or cluster, if you will, around the concept of, um, character. Um, and that’s also a loaded word, but, um. You know, I think all of us seek to, um, lead meaningful lives that are centered in, um, you know, doing the right thing, um, some moral center, right?

Uh, or, um, a compass, if you will. And that can mean different things for different people. Um. But leadership, I think, is not any different from that. I think character is, is inherently a very important piece of leadership. Um, people tend to want to follow leaders who they feel display, you know, ethical and moral character.

Um, people who are driven by, you know, values that are, um, clearly communicated and I think resonate with with others. Um, and so that’s, that’s, uh, I think probably the 1st piece of this that that comes to mind. The 2nd, 1 is

Naji Gehchan: health

Adam Castano: equity, health equity. Um, that is, um, again, another, you know, commonly discussed concept.

Um, but is increasingly more and more important now, perhaps now, you know, more now than ever before. Um, it. It means not just, you know, um, getting people, um, equitable care, but also, um, in clinical trials, you know, from where I sit, um, ensuring that the drugs we test. Are tested in as broad a population as possible in order to answer the scientific question at hand and to be able to say broadly this drug was shown to work in X, Y, or Z population.

So, therefore, based on again, go back to the scientific method and here, you know, it makes logical sense to do this. And also there’s part and passion behind it. Um, we can tell you it works in, you know, this subgroup of the population, this set of ethnicities, this, uh, country, this geography, et cetera. And so, um.

Talked about a lot needs to be talked about even more. Uh, and more more than talk action upon an actual, um, you know, um, workflows and clinical trial goals, um, that we set forth for ourselves. Um,

Naji Gehchan: I love that. You’re bringing that. I don’t have, um, obviously I, you know, we spontaneously think about access.

and equity in access and also equitable health care. And I’ve been working a lot, uh, on, uh, equity in clinical trials. It’s such an important, uh, it’s such an important topic. And We will never do enough, but making sure that we have a diverse population within our clinical trials, both to bring access.

Sometimes clinical trials are the best option patients would have in the current schema of treatment. And exactly, as you said, also to make sure that whatever we’re developing has its effect as we are envisioning, not only at a broader population, but really at the different, for different. People, right?

And, uh, ethical, uh, art is super important. So thanks for sharing that.

Adam Castano: Yeah. Yeah. And thanks for bringing the access piece up to that’s that’s obviously a critical piece of the equation as well. The 3rd word is Lego Lego. Um, my 5 year old loves Legos. Um, that’s the 1st idea comes to mind, but I will say. Um, I love Legos too, actually.

Um, I know

Naji Gehchan: we both share this passion of Lego. This is why I saw this.

Adam Castano: So Lego, I find Lego actually to be a little bit like yoga. There’s a Zen to it. Um, you know, there’s a process. Um, and in order to achieve this higher state of sort of Lego mastery, if you will, you know, become a Lego Yoda master, you have to buy into the philosophy of There’s, there’s an order and a process, right?

And so you can’t just build the unstructure by throwing all the pieces, you know, into a bowl and, you know, trying to replicate the picture that you see on the box. You have to open the manual. You have to understand the steps. You have to sort the pieces. You have to put them, you know, in different categories before you even begin.

And then once you start, it makes the process a lot easier. You take things in little pieces, and that’s kind of what we do in biopharma. Um, right. You, you don’t just magically think of a molecule and, you know, go to the pharmacy and say, Hey, let’s, let’s make this pill. Um, there is. A intricate, an intricate process, um, that is much akin to Lego building, I would say.

So I actually love that, that, um, that, that concept.

Naji Gehchan: That’s, that’s a great analogy. And yeah, I never thought of it purely from a process. And it certainly is, right? Like there is this creativity, the process, the creation that you do. So I, I love what you’re sharing. The last one is spread love in organizations.

Adam Castano: Yeah, yeah, I think that speaks to, um, you know, we hear this concept, a lot of authenticity, um, um, being, you know, again, and this gets back to the sort of moral centeredness of things and character. And if, if we share bits and pieces of our personal stories, um, our authentic selves with those who we interact and work with on a daily level.

Uh, I think others will feel that sense of community, um, and, um, it helps build ties, right? Important ties that are necessary, um, to make teams effective and functional. Um, and, uh. And ultimately, I would venture to say, perhaps loving, um, you know, that’s a, it’s a, it’s a big leap there, but those are the most effective teams, I think, where you kind of feel the love, uh, everywhere, um, there’s joy and camaraderie, um, and, uh, a true, um, sort of looking forwardness, if you will, positivity to doing the day to day work is needed.

Any final word of

Naji Gehchan: wisdom for healthcare

Adam Castano: leaders around the world? I’m sorry. What was this? Do

Naji Gehchan: you have any final word of wisdom for healthcare leaders

Adam Castano: around the world? Yeah. I don’t know if they’re words of wisdom. They may just be words, but, um, one thing I think, I hope, um, we see a lot more of, uh, in healthcare leaders and this spans the gamut, not just in biopharma, I would say all healthcare leaders within all healthcare industries is, again, purpose, keep the patients first.

It is, does this. New initiative patients and how will it do that? And how will it make lives better? Is this is there an intellectual thorough rigorous process that has been put behind? This new initiative that we’ve done our homework, you know, so to speak, um, and 3rd, um, love and passion, right? Again, it’s it’s tying the 3.

It’s a marriage. I think I’m happy triumvirate of 3 things that, um. That I hope if, if are at the forefront of everyone’s, uh, mind and their day to day work, I think can ultimately help, help us get to a better state, um, uh, for everyone.

Naji Gehchan: What a great summary, Adam. I’m really thankful to you for being with me today and it was great to connect again.Adam Castano: Thank you. Thank you, Naji. Really, really enjoyed it!

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Vinit Nijhawan

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.
I am Naji, your host for this episode joined today by Vinit Nijhawan a strategic visionary who has conceived and built several technology organizations that have been acquired by companies such as Boeing, Motorola and Qualcomm. Vinit is an admired leader and mentor who has built or inherited and then effectively managed several high-performance teams. He has worked in many industries: computing, aerospace, logistics, medical devices, biopharma, synthetic biology, and others. In 2008, Vinit intentionally pivoted his career from technology entrepreneur and CEO, to helping other entrepreneurs with a special focus on academia. He began teaching Entrepreneurship at Boston University and subsequently led the Office of Technology Development from 2010-2016. In this role, Vinit participated in several BU committees and organizations and has represented BU on several boards and business plan/grant review panels. Subsequently, Vinit took the OTD experience and launched a national academic IP monetization program with 40 institutions engaged, including UC Berkeley and UCLA. He launched Waterloo Alumni Angels at his alma mater. Most recently, Vinit is the Managing Director of MassVentures.

Vinit, It is such an honor to have you with me today!

Vinit Nijhawan: It’s my pleasure.

Naji Gehchan: First, can you please share with us your personal story, and what’s in between the lines of your inspiring journey?

Vinit Nijhawan: Well, you know, truthfully, uh, when people look at my LinkedIn, it, it looks very confusing because there’s a lot of stuff there, but really my story has been a very simple one.

So, um, I started my first company as an engineering student at the University of Waterloo in Canada. And, uh, Subsequently, uh, was part of five startups. Um, three years CEO and they were all in, um, obviously tech startups, but specifically in aerospace and telecom. That’s what I did for 25 years. And then 15 years ago, I decided to move from being a parent, as I call it, you know, running companies to becoming a grandparent, helping other entrepreneurs run their companies, you know, with successfully.

And that really took two directions. Um, one was teaching at Boston university. And the other was investing and the teaching kind of led to running the tech transfer office at Boston University for five years, where we launched eight venture backed companies, primarily in life sciences and healthcare.

So as you

Naji Gehchan: founded several startups, you scaled them, exited them. And I love now how you talk about being a parent and a grandparent, helping other launch their companies. Uh, what is for you, or is there even a magic formula that you think makes startups a successful venture?

Vinit Nijhawan: Man, that, if I had the answer to that question, I’d be a billionaire right now.

You know, that magic formula. But look, ultimately, there are three things that conspire, right? It’s a good team, a good technology, and the right timing for a market. right timings for markets is very, very hard to figure out. Uh, good technology is important, but you know, there’s so much good technology in the world.

So it really comes down to the team, in my opinion. So, uh, I put a lot of emphasis on the team, even when I make investment decisions. And so can you,

Naji Gehchan: yeah, sorry, I was going to ask you, can you tell us a little bit more about, uh, about what you look at? For a team, a founding team, what are the capabilities you look at?

What are the specificities beyond capabilities?

Vinit Nijhawan: Maybe. Yeah, so, uh, you know, number one, um, it’s helpful if it’s more than one person, right? So I don’t know what the ideal size of a startup team is, but I, I think a team of three I find to be, you know, quite an effective, you know, startup team size. The other thing, you know, you’re looking for are the right kind of qualities and.

Um, in particular, the one thing that I look for are, um, people that are coachable, because, you know, there’s always a lot to learn, you know, when, when, when you’re a startup, and especially if you’re a first time entrepreneur. The second is, um, the best entrepreneurs in, in my mind, um, are those ones who are like this perfect combination of determ Determined, yet flexible.

So what does that mean? You know, I think the way, I’ll use an analogy which might sound funny. But, uh, excuse me one second. But it’s, you know, it’s what the Buddha taught us, right? What the Buddha taught us is that there are many paths to the truth, but there’s only one truth. It’s the same in startups.

Right? There are many paths to a startup. Any startup, you will find you need to be determined about the end result. So you’ve decided what your vision is or what you’re trying, what pain your point you’re trying to solve. That’s your fixed point. That’s your truth, but there’ll be lots of little pivots.

You know, in different paths, you have to take to get to it. So that’s the flexibility. So you have to be sort of completely focused on that end point, but you want to be flexible enough because you’re listening to the market all the time and trying to do those little pivots, right? And if you’re smart, you do a lot of small pivots.

If you haven’t done it well, you have to do some big pivots, and that really kills companies.

Naji Gehchan: So, talking about companies, you shared that you also look into, um, into healthcare now, companies. Can, is it, is there anything different in those that you look for, or do you think what you shared, and I love this mix of determined, flexible, team of three, coachable, is it kind of like the same makeup regardless of the industry you’re in, in other words?

Vinit Nijhawan: I think it’s the same makeup. Um, you know, I think what’s different about healthcare is unlike other big markets, you know, like pick anything, you know, consumer goods or, you know, cars or, uh, you know, real estate. Those markets by and large function the same way all over the world. Healthcare, however, doesn’t.

Healthcare functions very differently, you know, in different countries. And so, you know, you have to be very knowledgeable and cognizant of the fact that it operates very differently in different countries. Um, so you need a team, I think, that has some knowledge of the country they’re in and how, how it functions.

And, and, of course, that, that leads to the fact that, you know, if you can’t be a global player, because each Nation has its own health care system, and you’ve got to be in a big enough market opportunity, right? So the U. S. Is about half the market for pretty much anything in healthcare, whether it’s new drugs or new medical devices.

Um, so the US market is a very important one, but it functions very differently than, you know, say the Canadian market or, or you know, parts of the European market. Sure.

Naji Gehchan: I, I, I totally agree that differences in. Healthcare, uh, in each one of the countries is, is always an interesting challenge when you’re looking at global companies.

I’ve been into different markets, different geographies. It’s, it’s different, even though at the end, the purpose is the same, right? We’re trying to make life better for patients, but I agree how you get there and the regulations are always very different.

Vinit Nijhawan: Not just the regulations, but how you get paid.

Yeah, that is like a big piece of it.

Naji Gehchan: Yeah. So you also, as you shared, uh, you also that team successfully and had very high performing team and, um, in tech and telecom, uh, before moving into, uh, investing and, and being, uh, being a professor, uh, at BU, uh, how did you personally. Let teams and how did you define high performing team and how did you let those what is your biggest learning?

Um, I’d love to hear more about that.

Vinit Nijhawan: Yeah, and and look let’s be clear. It was an evolution, right? It wasn’t like I woke up one day and became a great leader It took a lot of You know, learning and coaching along the way, I just started early. And, um, look, I mean, first and foremost, you know, a leader has to be very clear about that vision, about that truth that I talked about earlier, right?

So be very clear in your mind of what that is, because now you’ve got to articulate it to not just the people you’re trying to hire, but also your customers and, you know, investors and others. So if you’re very clear about what that endpoint is now, you can sort of work backwards and say, okay, what does my team have to, you know, look like, what are my investors have to look like, right?

Who are my early adopter customers? So you, you want to figure all that out before you start hiring people for your team, because, you know, you want to have a, a really good picture and some people call it a business plan of where you’re trying to get to. And, um, and, you know, once you have sort of a clear business plan, now you can think about what kind of people you want around you to help you.

So,

Naji Gehchan: so talking about people, if I want to be more specific, there is, you know, through the 80 plus interviews I already had in this, uh, in this podcast, uh, there is different views about complementarity of a team. Uh, some ideas about you need a team that build obviously trust, but how you can build also conflict sometimes that are positive and ends up with innovation.

I’d love to hear like, as you’re building team, what is the construct you usually look for?

Vinit Nijhawan: Yeah. You know, so the one thing I’ve also learned is that, um, different cultures Bring, you know, sort of different views of how you construct your team. So, you know, the U. S. is a very professional culture, right?

Which means, if I hire a VP of sales, or I hire a CFO, or I hire a VP of engineering, I can almost certainly find somebody who’s done that role before. And I don’t, I don’t have to hire somebody that I know personally, or I’ve worked with before. It can be somebody completely out of the blue that I’ve hired.

And immediately once I hire them, they’re inside the trust envelope, right? Because it’s, it’s, it’s, it’s kind of a very professional market. That’s not always the case everywhere, right? And, um, so, you know, I’ll give an example. I find a lot of European companies, French companies particularly, when they’re expanding to the U.

S. They will send one of their trusted people from Europe to come and establish themselves here, right? But do not know the market here at all and I try to explain to them that listen if you hire somebody here a business development person or vice president of sales Once you’ve hired them, they’re, they’re, there’s no conflict, they’re not going to go anywhere else.

They’re only going to be dedicated to you because that’s the kind of professional, you know, workforce there is here. And people find that hard to understand because I think in many other cultures, you know, you, you want, you first have trust and then you think about, you know, the roles. Um, I, I, I think it should be the other way around.

I think the trust, trust develops. First you think about the absolute right people for each role that you’re hiring for. The best. And then, then a good leader builds the trust, you know.

Naji Gehchan: Yeah, yeah, I love those. You’re touching several points on cultural differences, leadership within cultural differences, and then how you build trust, obviously, which is, you know, do you start with trust?

How do you deal with trust is trust something that you just say, okay, we trust one another and it works or not. So it’s, it’s really a powerful

Vinit Nijhawan: voice you’re bringing. Yeah. And look, I mean, the reality is for any leader, trust is constantly earned. So it’s not static. I mean, you’re, you know, you’re constantly, people are always looking at you to see, okay, you’ve defined this truth.

Is it really, or are you like shifting, you know, so there’s, there are a lot, you’d be surprised. I mean, people are very astute. Yeah. They can figure out whether a leader really believes in the direction or doesn’t. Oh, for sure.

Naji Gehchan: For sure. And as you said, it’s, you know, it’s always so hard to get to this trust, but it’s, it, you can’t destroy it in fractions of seconds.

So there’s always this. Yeah. As a leader, do you really stand for what you’re saying and do you really believe in what you’re saying? I love this framing. What I’ll go to now, Vinit, I want to give you a word and I’d love a reaction to it. And so the first word is leadership.

Vinit Nijhawan: Uh, well, you know, I think it’s, it’s, it’s an overused word. Um, but you know, the, so let me use a little example. So when I first kind of moved into a big office, space, I, I wanted to be, have my office be in the same place as everybody else. And all the employees basically pushed back on that and wanted to put me into a corner office.

And, you know, what you realize is that, that hierarchy is something that, you know, I just fundamentally exists in, in, in human nature. Um, so, you know, so that’s why the word leadership, I think, has become important because Ultimately, you know, people are looking for a person, both people below that person, by below I mean kind of the ones who are executing, as well as the people above, you know, who are investing.

So, That’s what leadership means to me as an individual. So did you, did you

Naji Gehchan: end up accepting it? Uh, I’d love to double click on this, you know, with the example you gave of

Vinit Nijhawan: being in the Yeah, I ended up accepting the corner office, yeah. Okay, so you

Naji Gehchan: don’t, you just, so how, how is your view now on hierarchy?

Did it change? Do you think it’s something that is here? You’re saying it’s fundamental for human

Vinit Nijhawan: nature. Yeah, I don’t think it’s changed. You know, people, people talk about kind of Millennials and Gen Z and you know, how They want to have a lot more say which Look at what’s happened Twitter, right or some of these tech companies.

Of course people want to have a say and they might be More willing to be verbal, but I don’t think that’s changed, you know Look, I’ve always find that there’s three types of people in organization, right? There’s Um, you know, they’re the type who understand the direction of the company and are bought into it, right, vocally.

Then there are the people who vocally dissent, right, for very legitimate reasons. They don’t buy into it, but are very vocal about it. Those are really good people to know because you want, you want to be open minded and listen to them. You don’t want to fire them like Muff does, right? Every time somebody says something bad about Twitter, he fires them.

From his team. The third type, which I think is the most dangerous, is the silent opposition. And that exists in every organization. So there are people who don’t believe in the vision or the direction of the company, but aren’t vocal about it. But, but they, they aren’t vocal about it to the leadership or broadly, but they’re the ones who are gossiping and, you know, saying things.

Next to the water cooler. Those are the people you have to find and root out.

So the

Naji Gehchan: second word I’d love a reaction to is entrepreneurship.

Vinit Nijhawan: So another overused word, um, it’s, it’s, it’s interesting if you, if you look at what the, all the universities are doing is, um, they don’t use entrepreneurship as much anymore. Now what they use is a term called the entrepreneurial mindset.

Because most of the people, you know, doing MBAs, for example, aren’t going to go to startups. They’re going to go to bigger companies, but these bigger companies want that entrepreneurial mindset as well. And so, so what is an entrepreneurial mindset? I mean, basically, it’s someone who is always questioning the status quo, right?

That, that is what a good entrepreneur is. You’re always questioning the status quo. In other words, You’re constantly thinking about better ways to do things, right? And that’s what an entrepreneurial mindset is, that even within a company, you’re always thinking, well, how can this be improved? I mean, if you’re a surgeon, you know, you’re all the good, the really good entrepreneurial mindset surgeons are always thinking, okay, What if I had this instrument instead of this instrument?

I could do my job faster and better. Right? Now, the hard part becomes going from an N of 1, where, you know, you, you know that your life would be better if you had this change or this product or whatever. Now you’ve got to find out whether there’s a hundred other people like you that feel the same. And that’s what a lot of entrepreneurs have a hard time with, especially the technical entrepreneurs.

I, I used to be like that too. You know, you just said, Hey, this is a better technology. I know it’s a better technology, so everybody else must know it’s a better technology, but that’s not how it works, right? You have to go out there and, and do your customer discovery. So, um, I don’t know. I may have used too many words for my response to entrepreneurship, but no,

Naji Gehchan: it’s great.

It’s great. Uh, the third one is Ana Preta. Sorry, am am I pronouncing it correctly? Ana Preta, you broke up again. I saw you pr Vanna Preta. I saw you practice. This on LinkedIn, but I might be mispronouncing

Vinit Nijhawan: it. Okay. Hold on. Now. I’m let me just is it on my LinkedIn? Yeah, let me just take a quick look.

I think I don’t know what you’re talking about. Make sure I get that, right?

Maybe if a vein

Naji Gehchan: of Presto

Vinit Nijhawan: Or is it?

Let me tell you wait a second wise. Yeah, just put in the chat. So Yeah. Oh, here it is.

Oh, Vana Presta. Yes, I’ve put it. Um, I mean, I, I think it’s a Sanskrit word if I remember correctly. Uh, that’s, uh, a lot like, um, um, well, you, you talk about servant leader, right? So, uh, so Vana Presta is, is, So in Hinduism, there are four stages in your life, right? And, um, so, uh, vanaprastha is the third stage.

So your first stage, brahmacharya, is as a student. Your second stage, grihastha, is as a family person, right? Where you’re like, like you’re, you know, like you’re creating a family with children. And I have. Vanaprastha is when you’re giving back. It’s your giving back stage of your life. And then you’re the last stage, which is very controversial, is your sannyasa stage where you give it all up and become an ascetic, right?

To get nirvana, you put on a, you know, you put on the saffron robe and you beg for your food and you, you own nothing. Okay, that’s the

Naji Gehchan: hardest. That’s the controversial piece. Yeah, so, so, and I saw on LinkedIn, you talk about empathy and practicing panaprastha. Hey, I’d love to hear more about how you think of this.

Vinit Nijhawan: Yeah. So, I mean, so fundamentally in the first two stages, you know, you’ve built up a lot of knowledge, maybe some wealth. And, and your third stage of on a process stage is when you take that knowledge and wealth and you spread it to other people. Right. And, um, and there’s, of course, many ways to do that.

Um, the way I’ve practice it is teaching and investing because I think they’re both. Very relevant, because in both, you’re, you’re, you’re, you’re passing your knowledge on, but you’re also passing wealth on, right? And, uh, you know, because, frankly, I want my students to become wealthy, right? I mean, that’s Um, you know, part of the goal of passing them knowledge.

Um, so empathy, uh, let me back up. So, so I, I’ve created this top 10 qualities of a successful entrepreneur, you know, Letterman style. Um, and, uh, my number one quality is generosity. Right. Empathy is in there too, but I think generosity in some ways is the ultimate empathy and what I mean by generosity is like all the best entrepreneurs are very generous, they’re generous with their time, they’re generous to their family, they’re generous with their stock options.

They’re generous to their customers. They’ll never let their customers down. Um, and so I think generosity is, is a very critical quality of, you know, of a good leader. Yeah, I love how

Naji Gehchan: you said it. Generosity is the ultimate empathy. I’ll take this one.

Vinit Nijhawan: Yeah.

Naji Gehchan: The last word is spread love and

Vinit Nijhawan: organizations. Uh, you know, so I, you know, it’s interesting.

I, I’m, I’m a very sort of, um, physical person, right? So, um, you know, I’m always hogging my employees and, you know, just having that sense of, of connectivity. And, you know, the world has changed a lot and people, you know, even my wife says, you know, you really shouldn’t be doing so much of that because, you know, you’re going to get yourself into trouble, you know, um, with the Me Too movement and all that.

And I said, look, people always know when it’s genuine. Do you know what I’m saying? Yeah. So, there is a sense of genuineness that people are very attuned to. And, uh, so first and foremost, I think, you know, love comes from being genuine where you’re genuinely interested in these other people in their success.

You’re generally interested in, uh, their career growth. Like, I literally sit down with all my people and the first question I always ask is, okay, where do you see yourself five years from now? Where do you see yourself 10 years from now? And you know, and then look, how can we work together to, to get you on that path, right?

Five years from now, you may not be working in this company. You could be somewhere else. So let’s figure out what the best way is of getting you there. Right. So, so I think that kind of genuineness. In helping people with their careers. That’s the ultimate love in organizations.

Naji Gehchan: Yeah. Thanks for that. And yeah, many times we, we refer to it genuine care on this podcast.

Many talked about this and I still believe in it. So thanks for, for your words about it. Any final word of wisdom for leaders around the world.

Vinit Nijhawan: Yeah, I think that, um, especially in healthcare, there is a huge opportunity for change. And, um, you know, healthcare has been around for centuries, right? If not millennia.

If you look at the old texts Uh, Chinese texts or Indian texts. People were practicing fairly advanced healthcare 5, 000 years ago.

We’ve lost a lot of that knowledge, right? And you know, like for example, a simple thing like diagnosis. That, that family doctor, you know, who had the pattern recognition, who could diagnose just by looking at you, looking inside your throat, feeling your pulse, feeling your temperature or whatever, that’s gone now, and now we’re, we’re dependent on instruments and blood draws and, you know, all those things.

And in some ways, you know, diagnosis is so poor in today’s healthcare system all over the world, and that Creates an enormous amount of cost the healthcare system because if you start with misdiagnosis, then you’re just going to spend money on the wrong things. And so, um, so I think there’s a huge opportunity for new leaders in healthcare to evolve our healthcare system to truly being one, you know, that’s not fixing problems, but, uh, you know, but being ahead, you know, it’s really it is.

Yeah. sort of wellness, right? Not surgery. So, I mean, we need surgery too, but, you know, there’s enormous lack of wellness in human society that needs to be rectified. And we need the leaders, you know, who recognize that. And we’re starting to see that in the younger generation. Yeah. Yeah.

Naji Gehchan: And it touches all preventive medicine, well being. general health. And, uh, I totally convey with you on this. Thank you so much again for being with me today. It’s been such a pleasure.

Vinit Nijhawan: Of course, Naji.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Richard Dale

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, honored to be joined today by Richard Dale a seasoned, values-driven executive known for his strategic acumen and operational excellence. He has consistently delivered proven results by translating vision into market realities in startup, large company, and non-profit contexts. Richard currently specializes in Executive and Leadership Coaching, Health Sector Advisory, Impact Consulting, and Team/Culture Facilitation. Until recently, Richard held executive roles within Optum (part of UnitedHealth Group) for over ten years, where he played a pivotal leadership role in founding and operating OptumLabs, and subsequently as a Senior Vice President for Health System Alliances in Optum, leading efforts for multi-billion-dollar cross-enterprise partnerships and innovation collaborations. Beyond his professional work, Richard serves as on different non-profit boards touching healthcare, environment, and global peace initiatives.

Richard, It is so great to see you again and have you with me today!

Richard Dale: Thank you very much, Naji. It’s great to be here.

Naji Gehchan: I remember our first chat where we were passionately debating AI in healthcare and what this next decade will bring us when we combine computational science to lifescience! Let’s take though some steps back, how did you get into healthcare and leading teams transforming its ecosystem?

Richard Dale: Well, I realized recently that I am on career number five. So, uh, I’m originally from the UK, but my wife and I moved to the States many years ago. Now, um, my first career, I was, uh, a techie. I was a software engineer and a database engineer.

Uh, and number two, I was an entrepreneur. Um, number three, I worked in venture capital for over a dozen years. And then I joined optimum United Health Group, and I was a health care executive there for over 10 years. And now I’m an executive coach and strategic advisor. So

I think looking back, you can always draw a line. Maybe it wasn’t so clear looking forward. But, um, a good friend, Paul Bleicher, um, invited me to co found PhaseForward, um, back in the mid nineties, and that was the, um, the startup that he and I co founded, and that was, um, that developed internet based, uh, electronic data capture for clinical trials.

Uh, and we sold mostly to the pharmaceutical industry and the CROs. Um, and really, that was the first time I was involved in something related to healthcare. Uh, and I was working with Paul, who’s an MD PhD, um, who taught me a lot about healthcare broadly and the pharmaceutical industry and clinical trials in particular.

And from that, when I moved into venture capital, um, I was, you know, seen as the healthcare expert, even though I had a pretty narrow view of what that was back then. But because of that, I got to see more healthcare tech, um, as that came through our pipeline. And the firm I was at invested horizontally across all industries in, in, um, technology, but we had a few.

Health tech investments. And I was involved in many of those in certain ways. Um, and we were very involved back in those venture capital days looking at big data. And so I was interested in the intersection of big data and health care. Um, and my good friend, Paul, who I had co founded face forward with, um, and I was very interested in the intersection of big data and health care.

Um, he had gone on to, uh, to Humedica as Chief Medical Officer and that company was acquired by Optum and then he was tapped to lead Optum Labs and he brought me in, um, to be Chief Operating Officer at Optum Labs. And I did that for a few years. And after Paul retired, I then took over running Optum Labs.

And Optum Labs was an innovation collaboration. Research and innovation collaboration with 30 or more leading healthcare institutions around the country, starting with Mayo Clinic. Interestingly, AARP was one of our core partners, and then academic medical centers, disease foundations, government agencies, uh, and other players in the health ecosystem working together to generate new insights from healthcare data to improve the system.

And so that’s kind of the path that I took over the years.

Naji Gehchan: Well, thanks for sharing this. And it’s, it’s fascinating. You’ve built team, uh, in a startup. You obviously led in a big corporate groups. You partnered with external groups and now you’re coaching execs on how to lead better and build team. And I know it’s one of your passions, building high performing teams to deliver for patients.

Can you share with us? How you personally did that and what are the key advices or key learnings that you take with you from

Richard Dale: a leadership standpoint? I think, um, you know, I describe myself as, uh, coming to really understand leadership, um, late in my career, really only 10 years. Before that, I would say I was an unconscious leader.

I think I was, I was an okay leader. Some people would say good things about my leadership, um, stretching back over the years, but I really got to grips with it, um, actually during my time at United, um, and through the opportunities they provided me, um, to really see leadership from multiple perspectives.

Um, and I’m going to tell a very short story, and this is, um, many of your, uh, subscribers and listeners may, uh, be familiar with this. David Foster Wallace told a story at the beginning of a commencement speech back in 2005, and it’s called the This is Water story. And the story goes that there are two young fish swimming along one morning, and they pass an older fish swimming in the other direction.

And the older fish says to the younger fish. Hey kids, how’s the water? And they pass each other and they each keep on swimming. And then one of the younger fish says to the other one after a few minutes, What’s water? And, you know, the story illustrates very beautifully how, um, there are, there’s an environment we’re all swimming in, which we don’t really notice, or even know what it is.

Um, because it, it’s all around us and it’s always there. And, In leadership or in an organizational environment, you know, one could say that the water we’re all swimming in is culture, but organizational culture is not so invisible anymore. Maybe 10, 15, 20 years ago it was, but nowadays most people are aware.

As they join an organization or they’re part of an organization, they will talk about culture. So culture is visible. My philosophy is that leadership is what shapes culture and leadership is that invisible, um, medium, which generates the currents, which often, very often, nobody really sees. And as you become a more conscious leader, as you know, if I can use that phrase, you begin to understand that, uh, as a leader, you’re responsible for shaping that environment.

And so you have to see what is invisible, um, so that you can shape it. And so, um, that now, you know, underlies my approach to leadership. I think, you know, with that goes, um, understanding your own values and being true to those. Um, and, uh, understanding some of the levers of leadership, which, you know, become a little bit more mechanical.

Um, but once you start to see leadership, then you understand how those leaders work. Does that answer the question?

Naji Gehchan: Yes. Yes. And I want to double click on, uh, on this and really on the culture piece. I, I certainly relate to what you said and I love how you framed that leadership is the invisible medium creates culture.

Uh, so you’ve, you’ve done and you created culture throughout different organizations. Um, and really organizations that were driving. innovation in healthcare, which is sometimes some people would say it’s easy to innovate and some others say it’s so regulated, it’s so hard. And I think it’s both right.

Both are right. I’m interested on how you have done this and what type of leadership or what was the most important ingredient that you had in the culture to be able to have high performing teams that are innovating

Richard Dale: in healthcare space?

I think that, um, and that’s a great question. I think there’s a mixture of two or three things and, and, uh, nothing I’ll offer here is, you know, brand new to anybody. I don’t think it’s, um. You know, it starts off, you know, it’s great to have a high performing team and great people who are committed to the mission.

Um, and so there’s an element of hiring, um, which goes into that, um, alongside that goes psychological safety on a team and an example I give that people talk about psychological safety, um, and we kind of know what it is, but it’s not necessarily clear how we create that. What does it mean to you. allow for failure to celebrate failure, um, to allow people to have opinions and express opinions, which might be different from what the leaders or what people think the leaders might might believe.

Um, so one example. Which I put in place at OptumLabs and I had used previously, um, is a root cause analysis, discipline and process. So, um, if something went wrong, which it did, you know, all the time, um, we would do a root cause analysis. Now, if something went right, we would also do what we called an after action review, um, which whether or not things went well, we would, you know, inspect what we did to learn how to do it better the next time.

And if it was a great success, then let’s, um, distill out what did we do well so that we can repeat it. But in particular, if something went wrong, um, we did a root cause analysis, and we were very clear that, um, we were not looking to blame an individual. That if something goes wrong in any organization, it’s a system failure.

And if we’re relying on an individual to be at the top of their game and remember everything in their head, Um, that’s a system failure, you know, everybody’s favorite, um, analogy is with the airline industry, which is everything has a checklist. So, at its simplest, you know, why are we asking somebody to remember what three things to do when they could have a checklist?

Um, why are we asking people to remember who to tell what when we could have a checklist? A racy chart, you know, who are we supposed to consult with? Who are we supposed to inform? Um, why are we making decisions, you know, based on opinion and anecdote when we could be looking at data, or we could be all looking at the same strategic criteria and scoring rubrics.

And so these root cause analyses would look at what went well and what went wrong and what was lacking in the system. And we would say over and over again, we’re not looking to blame anybody. And even if it looks like when we do this analysis that one person happened to be. You know, standing there when something bad happened or their action or inaction was a key part of the chain of events.

We can’t expect to rely to have a system succeed by relying on an individual to remember or be on the top of their game. What are we doing to support those people? And then we would separately say that doesn’t take away the responsibility and accountability for managers. To have expectations for their team and to do performance evaluations, um, at least on an annual basis, and to share feedback and to help to grow their people.

But managing an individual and their performance is separate from root cause analysis and, um, uh, at United Health Group has at many large organizations. We had a big matrixed organization, so we were working with, um, partners from other parts of the organization, and in particular we worked with, um, people in IT and data management, um, but also in compliance and in finance, and in those kind of organizations, people can be very quick to blame somebody from the other organization.

Oh, it’s their fault. Um, and so when we started doing root cause analyses, not only did I have to reassure people within OptumLabs that I was not looking to blame any one of them, I had to reassure our partners from other parts of the organization that we were not looking to shift the blame to them. Um, and over time, you know, I just made everybody do these root cause analyses over and over again, even on very small issues, as much to get into the habit of doing it and to Demonstrate that nobody was getting blamed and nobody was getting negative consequences for analyzing correctly what we could do better next time.

So that’s a long answer about psychological safety. Um, and then I’ll pick on one other facet. There are probably many more. Um, you know, how do we stay open and curious to innovative ideas?

And that’s learned as well. Um, so the little parable version of this is, you know, somebody comes into the office and comes into my office and says, Richard, we should paint the walls lime green. That’s an innovative idea. Right? We’re going to paint the walls lime green. And I, the first thing in my head is, why do we need to paint the walls at all?

And why lime green? And it’s the wrong color. And we don’t want the paint smell. And why is this innovative at all? Um, and when people come to us with innovative ideas. It’s very easy to fall into that kind of critical, judgmental expert, you’re using your expertise to immediately see that, um, the things which could be wrong with an idea.

So one trick I offer people is before you give voice to that, ask the person with the idea, what did you observe that led you to that idea? Did you see a problem or an opportunity? Really, what did you observe? And in this example, the person says, well, the walls are all crumbling, so we need to fix them and paint them.

And it’s like, okay, I may or may not like the idea of painting the walls, and I may or may not like the idea of painting them lime green, but I understand there’s a problem if the walls are crumbling, and that is something that we can work on together. And so trying to get under the thinking and honor the fact that a person is trying to come up with a solution and not just point out a problem, right?

Everybody’s told, don’t show up in my office with just a problem, bring me ideas. So ask, what’s the opportunity? What’s the challenge? What’s the problem? Now you have a conversation where innovative ideas, um, can be discussed. And even if you have to give a little bit of coaching to somebody, which is, well, you know, the corporate color is Blue, you know, well done for noticing that the walls are crumbling.

Let’s think about how we can fix that. One last thing I will say about health care, innovation in health care. There are many very large opportunities to innovate in health care. And the reality in health care is very often the best we can hope for is incremental innovation. And I think that we need to honor that and be realistic about that.

And we need to have a big vision and we need to keep our eyes on the prize. And we need to be okay with incremental improvement and incremental innovation, because changing healthcare involves. You know, organizational change. It potentially and very often involves changes in delivery of clinical care.

And so clinicians, physicians, nurses, other providers, um, who are under all sorts of pressure and now being asked to rethink how they’re delivering care. Rethink workflows. Um, and there are being asked to do that from all different angles. The financial flows in health care are very complicated, and there’s a lot of resistance to those changing outcomes.

And so we have to keep our eyes on the big vision and go one step at a time and celebrate those steps as moving in the right direction and creating a culture where it’s all about the big vision where we can never expect to get there in, in the small amounts of time and within any given planning cycle sets you up for disillusionment, but recognizing that this is a stepwise process for the most part.

Um, you know, hopefully creates the space for people to feel good about the steps they’re taking and the trajectory that they’re on.

I love the framing about,

Naji Gehchan: you talked about people, psychological safety, being open and curious. And as you shared at the end, it’s incremental, uh, innovation. And as you were talking about, um, you know, how to, uh, build a psychological study gave this great example. Um, and, and, you know, it made me think because you use the words discipline and kind of like the underlying culture of caring for one another, like being disciplined on doing them.

consistently when things go wrong and when things go well, and then ensuring that there’s a culture where people are trusting and not finger pointing. This, this is, this is exactly the philosophy we built. I thought a lot about this, um,

Richard Dale: even in, in

Naji Gehchan: businesses where, or in situations where you’re dealing with life and death, usually the more you’re disciplined on making sure that you’re learning.

For to improve and giving feedback that is more a constructive feedback for the team to learn rather than, as you said, finding who’s guilty. Like, it’s not about this, but consistently in the organization, we, we fall several times into. this other part of finger pointing. So, and I’m sure it relates to the culture you built in the beginning for you to have been able to deliver on what you’ve done at the end.

Richard Dale: So

Naji Gehchan: if we go to AI, which is one of your other

Richard Dale: passions,

Naji Gehchan: uh, what are the things you are most excited about for AI

Richard Dale: in healthcare?

It’s interesting because, you know, things are moving so fast that Um, as we know in the general conversation about a I, the opportunities seem endless and the risks seem, you know, in your face. Um, things that could go wrong or or might go wrong or do go wrong. And so, um, I’m excited about the long term opportunity for all of the information that we theoretically have.

About an individual person and their health and wellness or disease or health trajectory and all of the information we have about health care pathways and medications and other interventions and devices, um, and all of the literature which is published, um, about how to engage people in their own health and wellness.

There is so much of that information out there that without help at the point of care, it becomes very difficult to bring the very best for that patient in that moment. And I don’t think Any clinician, however, expert in that very particular thing at that very particular moment would say, Oh, I always remember everything which might be relevant.

I can always see everything about this person in front of me. So the ability to provide for the people at the point of care, the right information, the right Um, almost hints, you know, have you thought about, you know, maybe it’s differential diagnosis, but all of these different elements, um, and by the way, which, which are not only oriented around the specifics of the person we’re caring for, but also about the care team and what their strengths are and what their blind spots might be, um, to me, I think the end goal of all of this, it’s.

is coming back to what we’ve talked about for several years, if not many years now, you know, the right care for the right person in the right dose at the right time. Um, now, before we get there, and I do believe that that is not immediate in any sense, um, not least because the data is not really available properly yet.

Um, although, you know, the CMS final rule, which came out yesterday, continues to move that ball forward very slowly and incrementally. Um, before we get there, there are many other places that, um, AI can be helpful. So one example is, um,

you know, when you leave a healthcare encounter as a patient, do you really know what you have been asked to do, uh, as a patient? You know, if you’ve left the emergency room or an inpatient admission, you have pages and pages of discharge notes. Um, even if you’ve just left a primary care annual physical, you know, the doctor has said to you or the nurse practitioner, um, you know, please make sure you do X, Y, Z.

In follow up. Um, you know, it’s very possible that artificial intelligence knowing you as a person can make sure you understand, you know what you have been asked to do this. And this one is the really urgent one. And this is the one you should focus on after that. Um, and unfortunately, I have heard of stories of people who checked out of a primary care setting or an urgent care setting and did not understand that they had been advised to go to the emergency room.

They

did not understand they had been advised to go to the emergency room and they did not go to the emergency room. And later on, they ended up in an ambulance going to the emergency room, um, with potentially worse outcomes because of that gap. So that’s an extreme example, but helping in the communication.

Of what’s going on for an individual, potentially for a care team. I think that potentially comes sooner because it’s a more compact example. And then there are all of these diagnostic opportunities to just get better at diagnostics. And there are all of these, I mean, in, you know, in drug development, there are all of these programs now looking at drug development and it helps.

We’ve got, um, protein folding seemingly, you know, finally we’ve cracked that nut. And so, um, looking at all the different ways that we can look for candidates for a drug pipeline, um, look at potential toxicity profiles, look for efficacy profiles, um, look for new targets, look for new candidates to address those targets, um, you know, those are exciting opportunities as well.

So, it’s everywhere. And it’s nowhere yet. That’s,

Naji Gehchan: that’s a great summary. And as you said, so as you said, it touches drug from discovery to development. It touches care. It

Richard Dale: touches prevention,

Naji Gehchan: treatment. So eager as you are to see how this will impact us as a humanity. Anything that keeps you up though at night when

Richard Dale: you think about AI and its impact on humanity?

Yeah, it’s the same thing which keeps other people up at night. I think that, um, even before AI, um, you know, the first layer is to say the spread of. Disinformation and misinformation that can be accelerated and magnified by A. I. Um, and for people who have malicious intent to just create content at a much higher volume than before, and they might not believe they have malicious intent, but this goes to the next level.

If you peel back the onion one layer, why is there more distrust off the health care system, the medical system, caregivers? Science, why are there, um, you know, arguments about the, um, you know, the meaning of, um, results which come from well run, well orchestrated, randomized, controlled clinical trials from other scientific work, which is.

You know, at the gold standard, um, and underneath that erosion of trust is, um, both an explosion off knowledge and a more and more specialized. A generation of knowledge and a whole gap. Um, you know, I have a friend who works in the space between civics and science and helping think about how does society understand and absorb, um, scientific progress in a way that, um, is appropriately skeptical and knows how to ask the right questions.

And yet, is able to listen to reasoned thinking and, um, and understand why a sci scientific consensus emerges. And then recognizing that the science will continue to change and, uh, we will have a, uh, an initial set of knowledge, which we generate from, from the data and from experiments. Uh, and we can all agree that’s good science and it’s a good conclusion.

And five years later, we might find we’re wrong and we, we missed the boat. And I believe that there’s continues to be an open question about the, the mechanisms underlying Alzheimer’s disease. Are these proteins in the brain cause or effect? Um, and that’s a great example of good science. And even though many people, um, who are, you know, great thinkers can disagree on that, I can hold open the possibility that further work will, um, uncover hopefully a better and more compelling story behind it.

So all of that underlies the fact that to somebody who’s not educated scientifically, it’s difficult to know what to trust in the scientific and the medical field. And so we have this growing distrust, the inability to really manage that. And it doesn’t help that there are newspaper stories or internet stories published every day, which do not tell the difference between correlation and causation.

So that adds to the mistrust. And so now we’re back at the top layer, which is it’s so easy for misinformation to spread. For people, even a goodwill to be misinformed and spread information, which is harmful. And AI can support that or even accelerate that.

Naji Gehchan: I want us to pivot now and I’ll ask you a word and I want your reaction to it. The first one is

Richard Dale: leadership.

Uh, so the word which came to mind was authentic. And I think it goes with integrity. Um,

And I, some people confuse authentic leadership with transparency, and I think there are times you cannot be transparent as a leader. As a leader, you might be party to confidential information about your organization, which you cannot share, but you can still be an authentic leader, and you can still have integrity in every organization.

Conversation you have with somebody on your team or, or anybody. So authentic integrity, those are the three action. What about health equity?

Health equity,

you know, Sachin Jain posted on what was then Twitter and now X. And I think maybe he wrote a blog post about this a year or two ago. He said, why do we keep on talking about social determinants of health when really we’re talking about structural poverty and racism and inequality? And these are societal problems.

And so health equity, I think, um, is one facet of, um, the need for more equity in our society as a whole. And it’s driven by all of these things and that, um, I agree with his. All to not be blind to the human underlying causes and impacts of what drives inequity or equity by slicing and dicing it so small that now we’re talking about access to transport or pharmacy deserts, and it becomes very technical when what’s going on underneath it is the responsibility of society as a whole to fix and society Through its choice of leaders and policies needs to address this very broadly, and the health care system can only go so far in doing that.

Third one is Bill Gates.

Um,

I don’t know, maybe it’s become clear that I’m not somebody who likes to personalize things. Um, I will say that, um, I will answer your question in a minute. I will say that many years ago, I had the privilege of having lunch with Bill Gates. I was at a startup based here in Cambridge, Massachusetts called Vermeer technologies, which made front page, which was the world’s first WYSIWYG webpage editor.

And that company was acquired by Microsoft. When Bill Gates was still CEO and the entire company, all 30 of us flew up to Seattle, um, and we had a, you know, a round table lunch with Bill when he spoke about, um, why they were acquiring us and his vision for the, uh, for the acquisition. Um, and interestingly enough, you know, what you see is what you get with Bill Gates as well.

You know, in person, he seems to be the same person as, as, uh, we see on television and in documentaries. I think Bill Gates commitment to philanthropy and commitment to science driven philanthropy is laudable. I think he’s a very complicated human being, and I do not want to judge him. Um, we’re all complicated people with strengths and flaws.

Um, and if we all could try as hard as he has to make the most of the privileges that we might have, um, the world would be a better place.

Naji Gehchan: The final word is spread love and

Richard Dale: organizations.

You know, we don’t often talk about love in organizational settings, in most organizational settings. Um, but a few people and I congratulate you on being one of them talk about love in organizational settings. Um, and as we know, you know, love can mean many things. And, um, and it can be easy to kind of go off track with that.

But insofar as love means.

Going and showing care for the people that you work with and who work for you and who therefore you are serving kind of servant leadership model there. Um, and acting in a way that you would hope, for example, you know, the colleagues or the boss. Of your spouse or your child would be, um, behaving towards your spouse or your child.

Um,

um, not being quick to harsh judgment. Um, looking for ways to lift people up. Um, having authenticity and integrity in your dealings with them. Uh, these are the hallmarks of, um, of love. Of caring for somebody. And the mission, um, in a way that it is analogous to other places that we talk about love and in some faith communities and certainly in our families or with close friends, we think about love and, um, I think it is appropriate, uh, to use that language, um, and to be aware of its pitfalls.

Because, you know, unlike in ancient Greek, there’s one word for many kinds of love in English. Um,

but I think that kind of, um, you know, perhaps that’s one of the things which is invisible in the water that we need to make a little bit more visible and be aware of in our leadership.

Naji Gehchan: Any final word of wisdom, Richard, for healthcare leaders around the

Richard Dale: world? Um,

I think that, um, as

you become more conscious of The water, the leadership, and as you become more conscious as a leader of your role in shaping those currents, Um, I think it’s okay to be, to share that with the people you’re working with. To say to them, you know, I’m thinking about my leadership in a new way. I’m thinking of trying something different.

Um, I’m seeking your feedback. Um, that requires some vulnerability, you know, you can say to yourself, you know what, I’m going to try and do this a little bit better. I’m going to try and do that a little bit better. And you keep it to yourself. And maybe you have a coach or you have a friend who you tell it to.

Um, but you’re not necessarily telling the people you’re working with. I think that Um, it might be a good idea to think about sharing that with people and helping them support you on your journey. Um, and inviting feedback from them. Um, and by the way, if they start to see changes, you know, people find change difficult.

They can freak out with change. And so even if you are changing in positive ways. You know, you might somebody might come into your office one day, but you’re being so nice to me. Are you going to fire me tomorrow? Um, and so you can lower the temperature around change by telling people the changes that you’re planning to make.

So, I do think that vulnerability and that authenticity and that being kind of explicit with yourself and with your team about what you’re doing can be very powerful. And, you know, can I finish with one last story? Sure. Um, somebody who worked for me, uh, at that stage for a few years. And I’m going to use his name, um, Scott Regenstein, great guy, still a good friend.

He was, uh, a direct report of mine, and he one day said to me, Richard, can I take you out for lunch? I’ve got some feedback for you. So here’s a direct report telling me that he’s got feedback for me and can he buy me lunch? Um, so I guess that already starts that I, I guess I did something right. And Scott is a special person, but that was the setup.

And, uh, we went out for lunch and he said, Richard, I want to give you some feedback about how you delegate. Um, and delegation had been on my list forever of areas where I just, you know, every year in my performance review, it’s like, you could do a better job of delegating, delegate better. And I was like, I delegate great.

I don’t know, what, what more do they want from me? Scott told me that day in four words. Delegate outcomes, not tasks. So many people who are good at delegating know that. Uh, for me, that was a mind blowing moment. It completely changed how I thought about delegation. And I thought about it for not very long, and I’m like, Okay, I see that.

And I would look at the emails that I had sent people delegating things, and I had delegated a 25 point List of tasks where really the outcome was make the customer happy. Maybe you’ve got a better idea than me about how to make this customer happy, but I’m delegating that to you. Anyway, changes like that are not easy.

I worked out what I needed and I worked out. I needed. Um, support. And so I sent to all of my direct reports a little thing, which said, Look, I’m trying to get better at delegating. I know that this is where I fall down. Please help me. Give me feedback. Um, this was before COVID. I even had a little piece of paper on my, taped to my desk, on the other side of my desk, facing where the person would be sitting with the same little thing.

Help Richard delegate. Give him feedback if he’s not being clear about outcomes. Tell him to stop giving you tasks. And so there’s two or three different leadership lessons there. One, what a gift it is to have somebody like Scott, um, be willing to give their boss feedback. Number two, what great feedback and what great advice, and I recommend it to anybody.

Delegate outcomes, not tasks. And thirdly, maybe you can find ways to think about how you ask people around you to help as you look to improve your leadership.

Naji Gehchan: Well, that’s a great story and really a great way, uh, to, um, unfortunately end our chat. Uh, we could talk for hours and, um, it was really great to have you Richard with me and, and discuss those important topics for us in healthcare for being with me. Thanks.

Richard Dale: Well, thank you very much. I loved the conversation and I’m glad to be part of the Spread Love mission here. I wish you continued success with it. Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Nejma Chami

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, for a special episode in partnership with Jill Donahue for her new book “A Dose of Inspiration: 100 purpose stories from Pharma Leaders”. I am joined today by Nejma Chami Global Head of Medical Affairs at Grünenthal. Nejma spent years working in a medical practice before joining the pharmaceutical industry. She has since served in several leadership roles in medical affairs at Abbott, Novonordisk and now at Grunenthal. Nejma is a purpose driven leader with a mission to lighten the load of people who are suffering to make lives better.

Nejma, It is such a pleasure to have you with me today!

Nejma Chami: Thank you. Happy to be with you. And thank you for inviting me. Oh,

Naji Gehchan: sure. Can you first share with us your personal story? Why medicine? Why pharma? What’s in between the lines of your inspiring journey?

Nejma Chami: So, oh, you sent me back, uh, far, far away. So, um, yeah, why medicine? Um, before considering medicine, to be honest, I considered, uh, having, um, Pursuing law school because my father is a lawyer and I was always impressed by his way of impacting the people’s lives.

And he was always eager to find solutions and to see the impact he can have. On the daily life of the people he was interacting with, not only the people, but also their family. And, uh, so it, it was a drive for me, but then when I, uh, once I, I was considering what, what kind of career I want to have and what kind of, uh, of studies I want to, to, to follow.

Uh, I’ve seen that medicine. Cautious the, the line. So, so the, the tick, the box that I was looking for. So in, in medicine we are able to, to to, to completely change, uh, the, uh, the life of people and, uh, make them less suffer. And not only the, the, the patient we are treating, but also the, the, their family members.

So this is why I, I, I’ve chosen to, to, to have this. To follow the, uh, the, uh, the medicine school. And when I left Algeria to come in France. Um, I did a specialization in, uh, in oncohematology and I discovered that not only in my medical practice in the hospital, I can impact patient life, but also in working in pharma.

And this is where I became interested in the, in working pharma, I discovered what we can do and how. But by developing new treatments, we can, we can, we can have this great impact. So this is why I joined pharma. And I started from the field as an MSL and then I did all my career in medical affairs. So it was very, um, uh, a very, how can I say, rich.

Experience not only about about because of the the products I was working on, and the developing but also because of the people I was able to meet and to work with either. Within the company or especially outside of the company with interacting with the key opinion leaders, um, listening to their expectation and trying to understand where are the gaps and where we can have this added value and this great impact.

Well, thank you, Sharama,

Naji Gehchan: for, um, thank you for sharing a part of who you are, Najma, with us. Uh, you, you talked about your dad. I know your upbringing had a lot of influence on the way you think about your purpose. And how you are a service, uh, driven leader. Uh, how do you think about this in your daily job today, being in the pharma world?

You really chose to become a doctor to make lives better, as you said. So now looking back at your upbringing and what you do today, how do you make sure that you’re achieving your purpose in the pharma industry? And do you feel you’re fully achieving it?

Nejma Chami: I think that’s the way to make sure that I’m doing it.

Thanks. is by not losing the nose stuff. There’s one promise I did to my father when I moved to pharma because he was very disappointed with that when I moved to pharma and he considered that yeah you you you did medical school in order to not treat the patient and to move to pharma so you are in a way you you are not Respecting respect.

The, the, the view you, you did and the engagement you had when you entered the medical school. And the, the, the, the promise I, I, I, I gave him is that I will never, ever lose this north star. Being that the, the, the end user is a patient. What we are doing and everything we do is driven by the patient. I, I know that it, it can seem and, uh, cheesy.

But, but not at all, because if we don’t lose this drive, we know why we are thriving. We know why we are doing things. We know why we are working every day within the teams, within, with the experts in order to develop the new treatments and offer new solutions for the patients. And we, it gives us this.

ability to, to take always a step back, not being always driven by our projects, not always driven by our objectives, our KPI, because it’s a word we always have in pharma and having, I have worked also in commercial. So I, I, I know, uh, the, the, the, the pressure of the KPIs, but when we remind ourselves and when we mind our teams, what are we talking about?

And what kind of solution we are providing. It give us this, yeah. This north star, it give us this direction. We, we don’t lose. And that’s the, everything we do, we do it for the patient. And every change we can have or impact we can have on each patient life worth the effort we are doing. So, and this is what I try to, to, to, to share with my team members.

This is what we try to do on daily basis. And when the, the, the, the teams are overwhelmed. We always try to take this step back and remind ourselves why we are doing what we are doing.

Naji Gehchan: I so relate to that, uh, on different levels. I was really smiling when you were talking about your, your dad. I think several of us have, have experienced this, especially coming from certain cultures, I should say.

Uh, I’ve experienced, uh, this from our parents, our friends, and also. our colleagues, you know, as other physicians, um, and, and then how you talked about remembering every single time why we do what we do. And it’s really for those patients we serve. Do you have any tips on a daily basis? How you remind your teams?

Is there a way for you to pull back from, as you said, key performance indicators, projects being overwhelmed with operations we’re doing? To always keep this North Star you talked about any tips for other leaders listening to us.

Nejma Chami: I don’t know if it’s a tip. What I try to do is to be always a listener. Uh, so I’m, I’m, my door is open.

My laptop is open to, to, to my team members. And I, I always make a priority to provide, to give them the time to express. Any concern, any stress, any questions, and when they are overwhelmed about the, the, the, the timelines for the, the, the project becoming time consuming, we, I always tell them, yeah, we don’t speak about the project.

Let’s put the project aside. And let’s tell me, why are you here. Why are you doing what you are doing. Let’s remind ourselves that we are treating patients. We are not selling any product we are selling and providing treatments that will change patient life. So just have this thing to step back, think about it, and let’s talk in 10 minutes.

And I give them this time and we discuss again and my they know that my my door is always open because I know it’s easy to say and myself sometimes I’m just in the daily work and some and I need on a regular basis remind myself. Najma, you are you are losing your north star. So just take a breath and rethink why you are here.

This is what I share with my team

Naji Gehchan: members. And that’s really powerful, uh, and, and certainly constantly reminding yourself, ourselves that what we do is so important for the patients, uh, at the end of the day. As you said, this is, this is why we’re here. This is what every day, every single thing we do at the end of the day is going to hopefully benefit and positively impact patients we serve.

You’ve led teams in several organizations. You’ve done medical, commercial. So I’d love first to know when you move to commercial, the reactions probably of your surroundings to, you know, like there’s always for physicians, I feel people will say, I moved to the dark side to the pharma. And then when you say move to commercial, it’s like the very dark side.

And I’m sure both of us disagree with this. So I’d love first your thoughts about this. And then any guiding leadership principle that you always took with you throughout those experiences you had.

Nejma Chami: Yeah. When I think that the first reaction from the sales team, what, what is she doing here? So she’s coming from, uh, from medical.

So she won’t understand what we are talking about and she can’t understand our daily life. So, and, uh, it was, um, a very humbling experience. Because in this kind of experience, You need to come as, um, as a learner. You need to open your mind a maximum. Forget a little bit your expertise because in medical affairs, we rely a lot on our expertise.

And this is what everyone is expecting from us. But when you are in commercial, I think that the first thing is to listen and understand and make sure that the commercial team feels that you speak the same language. As them and you understand what they are doing and what you can provide them is also this direction when I was leading the sales team, and they were we were discussing the objectives.

I was always telling them, don’t think about the number of box of boxes of treatment, you will say, think about the number of patients. that will benefit from the treatment you are providing. So the more you, you, you, you, you, you give, the more patients will benefit from the treatment. It’s a shift of way of evaluating or considering the sales on the field.

And it’s being also able to understand What they are doing. They need to feel that when they speak to you as their leader, they know and they are sure that you understand what they are doing and what their daily life is about. So it’s always, it’s an exchange and it’s a trust relationship. You need to build trust.

I think that my first three months in my position in commercial was about. Listening, understanding and building the trust.

Naji Gehchan: You said, and it’s so true, right? When you think about it, patient by patient, right? And this is always how I felt about commercial or our commercial organizations. And while I was leading teams, it’s, it’s practically the last mile. Like without the work we do, patients would not get the medicine in their hands.

Right. And as you said, like it’s every impact is one patient’s being helped on the medicine they need to do. with the right balance on benefits and risks of this medication. So I loved how you framed it. So you said listening, understanding, and building trust. Is building trust for you listening and understanding or was there anything else that you did to build trust in your teams?

Nejma Chami: It was also about being hands on with the team, always supporting the team, challenging, but supporting them. They know that even if I challenge, I’m there, I’m there to support them, to make them grow, to grow together. So when every organization I joined or every team I joined, especially as a leader, my first objective was to make the people grow.

And I consider that I succeed. Was the people don’t need me anymore because they, they, they can manage without me being behind each of them because I showed them how to do things and they did it by themselves and they learned how to do it so they can rely on themselves. It’s this empowering people.

That’s key in our functions and for me, it’s the it’s the key driver. I’m happy when the team don’t need me anymore.

Naji Gehchan: But this is this is a real big testament of your leadership. You know, I I thought when I when I reflect on those things, I really relate to what you’re saying, which is I’m sure through transformations and leading leaders.

It’s sometimes one of the most terrifying things for a manager when they’re like, Oh, but what would be my job if my team knows to do everything? And for me, it’s always this transformative piece where you get to a point where actually. They really don’t need you. And this is where you obviously grow and you’re able to impact at the broader level.

So I love how you framed that, uh, on

Nejma Chami: their daily basis because they, they, they know the basics. They know how to do it. They know we agree on an objective. We agree where we want to go. We are very clear about the direction and the destination where we want to go. And then I’m eager to, to, to listen and to hear how they will go to the same destination because I can follow a path.

You can follow a path and both of us will arrive at the same destination at the same time. So I need to respect that everyone don’t have to apply my way of doing things. Or to follow the path I will follow to get to the destination. But I need to make sure that the destination is clear for everyone.

And that this is what we want to achieve together. This is where we want to go. And this is our main objectives. And what we want to reach. How we will reach it? I’m happy to listen from you. And perhaps I will learn from you and I will change my mind. And this is what I find very fulfilling in a leadership position.

It’s this seeing the people providing their own solution and not just waiting for me or saying because it’s easier when you are very directive. Yes, we do it this way. And I want it this way. And I want this timelines. It’s easier. It can save you time. It’s more time consuming. To let people try and fail and try again,

Naji Gehchan: you’re bringing several concepts here that I really value and love.

And it’s a great segue to my next session. And I’m feeling the humidity and what you’re saying. You’re really a humble leader to willing to learn and be open to others. So that’s a great segue for my next session where I’m going to give you a word and I would love your reaction to it. And the first word is leadership.

It’s

Nejma Chami: serving the people we are working with. It’s not managing them. It’s working with them and serving their best interests. Because what makes you a leader is the team you are working with.

What

Naji Gehchan: about patience?

Nejma Chami: It’s the main driver for everything I did until now.

Purpose.

Purpose is being honest. In everything I do and see the impact of every action. I can have

Naji Gehchan: the last one is spread love and organizations,

Nejma Chami: trusting people and be humble. Any

Naji Gehchan: final word of wisdom for healthcare leaders around the world?

Nejma Chami: Well, tough question. A word of wisdom. I think it’s, um, I would say, believe, believe in your dreams. Believe in what makes you, you believe in the change you can have and the impact you can have on people’s life, either your team members or each patient you, you can serve and Yeah, I think that I’m a strong believer.

And I do hope that I will continue to be this one.

Naji Gehchan: Wow, what an amazing charge and words of wisdom for all of us in the healthcare world. Thank you so much, Reshma, for your time and for being with me today. Thank you, Najee.

Nejma Chami: I was very happy to exchange with you. Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Angela Giannantonio

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, for a special episode in partnership with Jill Donahue for her new book “A Dose of Inspiration: 100 purpose stories from Pharma Leaders”. I am joined today by Angela Giannantonio, Senior Vice President, Human Resources, and member of the executive team at Travere Therapeutics. She has more than 15 years of experience in human resources management, with a strong track record of delivering a best-in-class employee experience and keeping patients at the center, while also driving successful growth and innovation across complex and global organizations. Known for her relentless focus on employee experience and engagement, Angela most recently was the head of human resources for Alexion Rare Disease where she led the company through its integration with AstraZeneca. She previously served as head of human resources for global commercial operations and corporate functions, leading the organization through hyper-growth and a complex pandemic while ensuring high employee engagement and performance worldwide.

Angela, It is such a pleasure to have you with me today!

Angela Giannantonio: Thank you, and it is a pleasure to be here.

Naji Gehchan: Can you first share with us your personal story? What brought you to HR, specifically in the pharma world, and now leading at an executive level in biotech? What’s your purpose story?

Angela Giannantonio: Absolutely. I reflected on this, and it is a bit ironic, because I didn’t intend to be in HR.

I didn’t necessarily intend to be in the pharmaceutical industry. But as I took the time to reflect on this in partnership with Jill, I really started to think back on my childhood and my mother and the compassion that she had with me growing up. Um, she was a young mother, a single mother, really focusing on her daughter and not herself and making sure that I was set up to have a strong life and childhood.

And during that time, I didn’t necessarily realize all that she was putting on her shoulders. Um, and during my childhood, she also took on, uh, being a caretaker for my cousin Kenny who had been diagnosed with Huntington’s disease. And now that I’m older and reflect back, I realize that it was something that was instilled in me that I wanted to help others.

And whatever I wanted to do, I wanted to be like my mom. And so as I went through my career, I gravitated towards people while I was in business and operations and sales, I always wanted to do something better for the people. And as my journey took me, I moved into HR because I realized that if I help the people internally, I can help more people externally.

And as that came to a realization for me, I also wanted to find a purpose driven organization. And so as I moved somewhere where it was really helping people in the company that I was in, I saw that it was the best opportunity for me to make a difference. Thank you

Naji Gehchan: for sharing that. Uh, you, you talked about HR and helping people internally, so I’m really interested and I’m going to immediately go there before we talk about the purpose.

Is it only a matter of HR helping people internally or employee experience? As you talk about it, I’d love to get your thoughts on this as you help, I imagine, several other leaders in the

Angela Giannantonio: organization. Absolutely. And so first, what I always say to my team is that we have to start with ourself. Because if we don’t take care of ourselves, then we can’t take care of others.

And I think a lot of times, when you’re in an organization under a GNA function such as HR, you really only focus outward. And so we start with taking care of ourselves, and that enables us to help the rest of the organization. And so for me, it’s helping leaders lead. And it’s also helping managers grow.

It’s helping each individual be their, their best selves. And so what we can do, um, around that is really critical. And I think for me, the change point for HR is that it used to be considered something that was in the back office and reactive and really operational. And that has changed. It has changed dramatically over the past few years.

I think as mental health has become an awareness, I think during COVID, HR became pivotal in helping employees navigate all of that was going on. And so with that, it just is this opportunity to really set up the organization and the external partners that we have to be their best selves.

Naji Gehchan: Yeah, certainly.

And I, you know, I relate to that. I’ve never been in HR, but I feel that the accountability of every leader is also making sure that we can create those positive experiences and people for people to be at their best. And your role is definitely crucial within an organization. create this. So as you have been passionate about employee experience and keeping patient at the center, you talked also about being in a purpose driven organization.

I would love to learn more from you on how do you do this. on a daily basis with your people, ensuring that those are really at the center of what they do every day.

Angela Giannantonio: I would say that, you know, I’m a very authentic leader. And so what you see is what you get. And so when I’m, I think it’s really important to, to create that trusting environment.

And so when we think about purpose at the core of what we do, Where I am today and where I’ve been previously is for our patients. And so we have our meetings where we come together and we’ll either share a story of a patient to ground us or we’ll share our wives and why we have chosen to be at the company that we are at.

And as you learn about everyone has a history and a path that they’ve gone on. And it creates sort of this trust and ability to think forward on what we need to do and where we need to focus on and let the small things really go. And so we can have a really crazy week. We can be in the middle of doing 150 things.

And if you stop for 5 minutes. And reflect in either one show appreciation or talk about someone who, while we think it’s really hard to have a 12 hour day for some people, it’s really hard to put on their shoes and to be able to go outside. And when you stop and really think about what matters, it changes your whole focus.

You can take a step back. You can breathe. You get done what you need to get done, but you also appreciate

Naji Gehchan: what you have. Going, going back to why we do what we do and wake up every morning. And as you said, I’m fascinated by how people in pharma and in healthcare industry are always here for a reason, right?

We all have this purpose. Sometimes we didn’t work the story behind it, but we’re all here for a reason. And this is why we wake up every morning. It is. Yeah. And you’ve led companies through growth, acquisition. So I imagine growth is something positive. It also comes with challenges when it’s like extreme growth, how you keep the culture and you’ve been accountable, uh, somehow with, uh, with the leaders you have and across the company on making sure that those happen in the best way for people.

This is your passion and what you do. So what is your biggest leadership learning? Throughout those experiences of expansion or and or

Angela Giannantonio: acquisition transparency. It is needed. You need to celebrate and own the mistakes and be okay with it and communicate those. Um, and and if you because what that does is goes back to that word.

I’m going to continuously use. It creates trust. And when you have trust in an organization, the ups and downs don’t matter because you’re all in it together. One of our core values is stronger together. And so that is something that is just a part of who we are. And I’ve seen that at every organization that I’ve been at, you know, where we, when we’re able to, and when I say be transparent, that’s all leaders.

That’s not just myself. It’s really critical. For the C. E. O. For the C. F. O. For people, managers to be equipped and be okay and feel comfortable to be transparent and own what we’re going through and that maybe it’s hard or that maybe we made a wrong decision and we’re going to pivot and pivot quickly and come together.

The other piece, I would say, on top of that is creating a speak up culture environment. Where employees feel safe to share what they’re feeling and how they’re feeling. You can do that anonymously, but you can also create an environment within your team so that they feel as though they have the right to speak up.

Because when you’re going through tremendous growth and change, they are the people that can help drive to success. They see the ins and outs. They see the holes. They also have great suggestions that we may not have. Um, and they can be a tremendous asset to helping build and maintain that culture.

Naji Gehchan: I definitely agree with that, especially on the speak up, uh, and obviously the trust.

It’s all about what, you know, we talk about in this, uh, in this podcast. I want to double click on speak up though, as you’re going through again, speed growth or speed acquisition, we’re always feel, and we’re all as leaders, always impatient and we want things to be done fast. How, how did you always ensure that we, there is a culture Where a speak up is not only said that it’s important, but it’s actually done and done in a proper way while balancing the speed to I several discussions I have said, Oh, well, it’s going to slow us down if we want to hear everyone, etc.

But at the same time, as you said, like, it’s the only way actually to accelerate. So I’m interested if you can give us some tips on how you ensure this speak up culture is always really done as you go through those changes.

Angela Giannantonio: Well, first, I’m going to say that we, I, have made many mistakes along the way in this, and so I don’t think that there’s a perfect science, but some, some things that I would say worked well are, one is, you know, always having the ability to have an external resource as a survey, um, and so having the right platform in place, you can very quickly gather sentiments from your employee base and see it in, and so to your point of not slowing things down, um, You can see it in a word cloud.

You can see a heat map of how people are feeling within 24 hours of putting a survey out and you can make it quick. But I think in other ways that have worked is helping them be involved in the change and the growth. And so you do that. And by doing that, you get a good sense of how the employees are feeling.

And really asking them to share in what we want to do in the purpose of driving us forward. And so you can do that. You know, we’ve had to pivot, but previously it was coming together in small groups and brainstorming and sharing here are our cultural values. What are we going to do to keep that and bring that forward?

What are we all going to commit to? And really making them a part of the process. So you’re not slowing it down. You’re embedding them in it because quite frankly, if you embed them in creating it, then you’re not going to have to come back and fix it. And so in the end, you’re not slowing things down.

You’re actually speeding it up.

Naji Gehchan: I’m going to give you a word now, and I would love to get your reaction. So the first one is leadership. Authenticity.

What about employee engagement? Critical to success. Can you tell us a little bit more? I know it’s a big passion of yours. Yes.

Angela Giannantonio: So if you’re employees, you have to find the secret sauce for your organization. And for us, it’s purpose. And as I said before, as you learn about each employee, every single one of us has a story that we go back to.

And when you really, truly understand your employee base and build that trust, The engagement comes and employees are willing to do and give 110 percent all of the time. And what’s even better is that with that, they feel fully satisfied. And so if you have a fully satisfied employee, because they are engaged.

Your company is going to do well, but in the end, you’re also all feeling really good about yourself and to do a full circle of that. I have to call out the importance of mental health. And when I think of employee engagement, I don’t just think about how an employee is engaged at work. I think about how they’re engaged all the time.

And so we need to make sure that we’re putting the right tools and support in place for our employees from a mental health perspective to ensure that they can be engaged both at work, but also at home.

Naji Gehchan: So how are you thinking about, uh, about this specifically, right? Like there’s several times and I obviously think about it all the time as a leader and, and people, uh, people manager.

There was always this misconception or the reality, maybe some years ago, of you put your things outside the door and you come physically probably to an office, which we don’t have anymore. But really kind of this disconnect of what’s happening at work and then your life. Where I feel these days, it’s so blurred and we live.

the craziness of our current world with unfortunate events constantly happening and more hate than than love and compassion. And it’s just so hard to put them outside of work. So how do you think about this these days, ensuring that obviously we talk about it, we ensure there’s an environment where people feel safe to bring them their true selves and don’t feel You know, they cannot do that.

So I’m intrigued on how you think about this because you mentioned mental health beyond only at work. So how are you thinking about it as an HR leader?

Angela Giannantonio: So I would say, you know, it first starts with me and my leadership style. And so I’m a working mom. And you know, when you ask me who I am, I’m a mom first.

Um, and you know, head of H. R. comes after. And I struggle with that. And so I’m using that as my, you know, one example here is that I show my team, but I also show Trevere and others. When I’m struggling and when I need to go be a mom and when I need to be present at work because I want to give permission for others to do that so that they can find the right balance in their lives.

Um, and so I think it’s really important as leaders to show that to show that we all have. This balancing act that we’re playing, whether we’re a caretaker, a mom, we have a pet that is new to the family, whatever it may be. So that’s the first piece, right? And so showing my vulnerability in that there are days where they’re tough, it’s tougher for me.

And that’s okay. Or there’s days where I’m on an executive call, and I’m cheering for my daughter at a soccer game, and they’re all comfortable and supportive of that. And that is something that is so critical, I think. And that’s not just me, that’s our leadership team in creating that environment. But then secondly, when there are events that happen, which seem to happen on a consistent basis, it’s when those happen, and I’m either with my own employee.

In a group setting, whether it be with the executive team or leaders, before we get into what we’re getting into, I stop. How’s everyone doing? What’s one word to describe how you’re feeling today? One word. We go around, we share our one word, we talk for a bit, and then we move on. It just allows for that moment again, because to your point, we are all working so hard and you just get into the day to day to day if you stop and take that moment that is so critical, it really helps people to feel as though, okay, I’ve been able to share at least how I’m feeling today.

It could be I’m exhausted. I’m overwhelmed. I’m really sad about today’s events. Um, it allows for that, that ability to be able to do. So this is such a

Naji Gehchan: great tip. I’ll, I’ll use it. I checked on emotions. I do it. Um, I learned how to do it. I should say from my daughters. Actually, since you shared about being a mother and It’s so powerful, but I love the idea of putting one word behind it.

I’ll try it. The third one I’m going to give you is D E I B.

Angela Giannantonio: It’s a must. And so, you know, as we think through, I think there’s, there’s so many different ways to think about it. I think it all starts with inclusivity and having that sense of belonging, but you need the diversity of thought, of background, in order to have it all come together. Um, and it goes back to that ability to have that speak up culture and to share what you’re feeling and what it may be right or what it may be wrong.

And again, goes back to vulnerability and being able to say, I’m not sure I quite understand that. Could you explain it to me? It’s an education. It’s an evolution. Um, but it’s an absolute must because without that a company can grow stale.

The last word

Naji Gehchan: is spread love and organizations.

Angela Giannantonio: This one just brings a smile to my face because, oh well let me think of the one word first, um, powerful.

Naji Gehchan: I want to know why it brings a smile.

Angela Giannantonio: Well, I think that, you know, love can be seen as something as, I think, a weakness at work, um, and it’s not. And I think that’s why, for me, it’s, if you have the compassion, you have the trust, the integrity, It automatically creates and builds high standards throughout your organization.

And if you spread that, it is such a powerful thing. And I’ve been at organizations that may not spread love, and I have been at organizations that do, and the differences are tremendous. You wake up every day and no matter what is happening, you feel safe and welcome at your work. You spend a lot of time at work.

You want to feel welcomed. You want to feel as though you can succeed. And if you have an environment where it’s safe and people are spreading love, it is truly a different experience and no one’s ever going to want to leave.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Angela Giannantonio: I would just say continue to be your authentic self with your teams. I think it can go a tremendous way and it builds an opportunity for others to be able to lead in that same way. And the other piece that I just want to say is there are quiet people on your team, pull them out.

Don’t necessarily put them where they’re uncomfortable, but seek their opinions and their thoughts. Because a lot of times. They don’t share them, and they have some really great insights that may be overlooked or missed.

Naji Gehchan: Well, thank you so much, Angela, for being with me today and this inspiring chat.

Angela Giannantonio: Yes, thank you. I’m honored to be here.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Rob Perez

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, honored to be joined today by Rob Perez. Rob is an Operating Partner at General Atlantic, providing strategic support and advice to the firm’s investment team and portfolio companies in the Life Sciences sector. Before joining General Atlantic in 2019, he was Managing Director of Vineyard Sound Advisors, LLC, an advisory practice focused on growth companies in the biopharma industry. Prior to that, Rob had several roles in the biotech/pharma industry starting as a medical representative to becoming President and CEO of Cubist Pharmaceuticals before its sale to Merck in 2015. Rob is also the Founder and Chairman of Life Science Cares, an organization that provides human and financial capital from the life sciences industry to the best non-profits working to alleviate the impact of poverty in the US.

Rob, It is such a pleasure to have you with me today!

Rob Perez: Thank you Naji, a pleasure to be here!

Naji Gehchan: I remember the first time we talked, you shared that if there is one thing you’d want as your legacy, it is a legacy of impact in life science. And what an impressive legacy you’ve built… How did it all start?

Rob Perez: Well, Life Science Cares actually started, um, with, I guess I can go back a little bit and say the reason that I got involved in, um, kind of giving back and community service is I’ve felt since kind of my early days in my career that I’ve been very fortunate to have found this industry.

Um. It was really dumb luck more than anything else. Uh, I didn’t know about the industry growing up. I didn’t have any desires to do it when I was in college. I wasn’t even that big of a fan of science to be candid. Um, but somehow I lucked into a job as a sales representative in, um, in biopharma coming out of school.

And that’s how I kind of started in the business. And so, um, the, the fact that that dumb luck, um, afforded me this amazing life, this amazing career, when so many that I grew up with, so many of the people I went to school with had even more or just as much certainly talent and smarts and, and desire, um, as I had, but they didn’t have the same luck.

So because of that, I’ve always felt like part of the return for this blessing is to, um, give other people this chance, try to help other people access this amazing, uh, this amazing industry and frankly, just help people generally. So it’s been a big part of my life, and it was a big part of who we were at Cubist, a big part of the culture that we built at Cubist.

And so when Cubist was acquired, uh, we, you know, I really wanted to do something else related to community service. And so I, um, talked to a lot of people in Boston about philanthropy and, and ideas, uh, on how I could be involved. And the, frankly, the idea for Life Science Cares. hit me in the middle of the night one night like a lightning bolt.

Um, and, uh, I’ve been kind of following that, that epiphany ever since. And so that’s really what started life science cares. And since that very night when I wrote out the deck or what would become life science cares, uh, and I sent a message out to an A number of dozens of leaders asking what they thought with a lot of fear, frankly, that they would come back and say, Hey, this is crazy.

And B who are you to be asking about this? You’re not like the leader of the industry. Um, they all came back and said, this is great. How can we help? We’re in. And that’s the way it’s been since the very beginning.

Naji Gehchan: I love it. And for sure, we’re going to dig more into what you do, uh, through a life science case.

But before that, you talked about the culture you built in Cubist, uh, and you’ve had several roles in biotech. You led Cubist Pharmaceuticals as its CEO and through acquisition with Merck. So I’m intrigued about the culture and what is really your biggest leadership learning through the journey as an operator in, in the biopharma industry.

Rob Perez: Well, culture was a big part of what made us different. We weren’t the biggest company. We were competing against large pharma in markets that were, that were typically, um, dominated by larger pharma previously. And so, uh, you know, we believed that we needed to have a different business model in order to, uh, be effective at our size.

And part of that was having the right people. And in order to attract the right people, you really need the right culture. So, um, I would say I could, could, could describe cubists, um, uh, culture in, in three words, one was patience. And that was the first. Um, the second was, uh, employees. We were big on our people and the third, which may be a little bit different, was community.

Um, and we, we really believe that if we got those three things right, um, we were going to attract the best people we were going to do right by our shareholders and ultimately, um, Deliver tremendous, um, and outsized outcomes for them and ultimately, um, do right by the world. And so we spent a lot of time thinking about our broader community, allowed our people to, um, both get involved with the things that the company was involved with from a community standpoint, but also individually, we encouraged them to, to do what they felt was important to make the world a better place.

And. I always had this view that, that extraordinary people, which is who we were targeting, are not just extraordinary when they’re in, in between your walls, they’re extraordinary all the time. And so to ask them to only focus on being extraordinary for you is a little selfish. And so what we did was we tried to get extraordinary people to be extraordinary.

And that meant with Cubist and in other ways, and because of that, we attracted extraordinary people.

Naji Gehchan: I love this vision. And I’m so I’m intrigued, you know, in moments of growth, obviously, with investors, and shareholders, as you said, how did you convince them that focusing on this is as important as anything else, if not more focusing on people and community service?

Rob Perez: Yeah, we didn’t need to convince them. Um, the, the, the fact that, that they were the people who they are, um, or who they were, uh, uh, was, uh, something that they were looking for. I mean, the reason, one of the reasons that they chose Cubist was because of our commitment and our focus. Both in terms of patients, most importantly, um, but also on the broader world.

So, um, we, I believe culture is something that if, if your, if your culture is like everyone else, if it’s kind of milquetoast. You don’t really have a culture. Um, and so your culture should, uh, attract those who your company and business model need and frankly repel those who aren’t going to fit well in your culture and in your environment.

And so, um, this, this focus on togetherness and on, you know, doing something bigger for the world. Which we were trying to do in the anti infective space when, frankly, most companies had left. We were going to attract people who had that kind of mindset. And the folks who were really kind of more self, uh, more independent, if you will, you know, they wanted to just do it for themselves and, and were all about kind of the financial driver of their independence.

Those people weren’t going to fit that well within Cubist. And so they, they tended to roll off. Um, and what, what it left was an organization that was very much aligned on how we were going to win. And so when you have a strategy and a culture that align, that’s when the magic happens. And I think that’s what we had at Cubist.

I certainly

Naji Gehchan: relate and agree with any tips that you give leaders and healthcare on how to build this culture because we hear about it. We talk about it. And as you said, it’s not only saying that it’s actually living it and ensuring your people live it and transfer it across the organization. So any, any tip you found as you were building it, uh, super important.

Rob Perez: Yeah, I speak on this a lot with companies and, um, and it’s not easy. And so the first point is what I said before is, um, you have to ask yourself how much your culture is unique. Because what I find a lot is, um, management teams and leaders trying to develop a culture. They often involve, you know, consultants and, and, um, you know, these broad groups and you end up with this, uh, very middle of the road.

Um, set of principles, whatever, that if you closed your eyes, it could be any company USA, right? Or at least any company, healthcare and life sciences. So that’s the first thing is to make sure you avoid the, um, the, the cultural norms that, um, could be anybody’s because then it’s nobody’s. Um, the second is trying to create a culture that isn’t really you.

So the, you know, the cultures that, um, have. Uh, this aspiration. But if the employees look at it, they say, that’s not us. That’s not who we really are. Um, that is really can be actually damaging, um, because it’s not authentic. And so the, the wiring of the leaders, um, I think really does matter. And you have to kind of look in the mirror and decide who you really are.

And then the third thing, um, is I think cultures have to match how you’re going to compete. Um, we are, and, and you realize that you’re, like strategy, you’re making choices with your culture. No culture is perfect. So, at Cubist, we wanted to Um, we were competing against larger companies, and we did not have the scale that they did.

So our belief was, we were going to be smarter, we were going to learn faster than, um, our competitors. So that was our competitive differentiation. We were going to learn faster, adapt quicker, and move To what the customer needs better than our competitors. Well, if you have that kind of environment, you’re not gonna be able to have a culture that is very kind of dictatorial, very top down, et cetera, because you’re never gonna learn sitting in a home office.

So we had to have a culture that enabled people to challenge to, to bring new ideas. To, you know, we had a culture where anybody could, um, could come up with an idea and could share it with the president and CEO. Um, you know, the, the Mike Bonney and I would have lunch with employees. In the, uh, cafeteria, you know, uh, between the two of us, like two or three times a week and just employees from all levels.

And we get everything from people questioning our, our strategy to our shareholders, to what are you going to do to fix the phone in the Washington conference room, right? There was, but when you’re. When you have a culture where anybody can comment about anything, um, that’s, that’s the kind of place that you have to, you have to realize.

And, but you give up some things too there, Naji. I mean, you, we weren’t as fast as Some companies would be we were not competing on speed. Um, and when you have this kind of culture where everybody has a comment and the ability to comment, it’s not as easy to say we’re going right. And everybody just says, Yes, sir, we’re going right.

That’s not the way it worked. The cubist. If I said we’re going right, people would say, Why? Right. You know who chose right? Who gave you the right to say it was going to be right, right? So it was very, very collaborative. Inclusive environment and that worked with the way we we competed. If you’re a different company and you need to compete differently, then you have to think about how that culture fits into your competitive dynamic.

Well, that’s

Naji Gehchan: certainly a culture as you’re describing where people were thriving and obviously it led to great results. Anything you would have changed in it through? You know, growing the company to acquisition anything when you reflect, you would have done differently.

Rob Perez: Well, look, I think, um, different, you know, I was a cubist for 11 years.

And so the company went from a small company to well over a thousand employees. And that change involves. Uh, you know, kind of evolving the company as well. And so the culture had to change. Um, you know, well, I shouldn’t say the culture had to change. The processes had to change and we tried to do it consistent with the culture, but you also had to realize there that there were times when you just had to adopt new thinking.

I used to write a blog at, at, um, uh, Cuba’s to try to the employees to try to help them to understand this. Some of these changes that we need to make as we got bigger and A lot of that blog was about trying to, to, to understand that even though our cultural values remain, our processes do need to change from being a 1200 person company, from a a 200 person company, there’s things that we have to do differently.

We can’t have everybody in a meeting room. For example, um, you know, at some point when you’re in a meeting room and you’re broadcasting that meeting to a different meeting room, you’re probably off the rails in terms of inclusiveness. So, at some point, we had to say, look, not everybody needs to be at every meeting.

Um, and so, uh, some of those cultural norms. Start, you know, kind of busting at the seams as you get bigger, and you need to, you need to try to figure out ways to, in a way that’s consistent with who you are, um, develop the processes that are, that are needed for a bigger organization. Well, thanks for that.

Those

Naji Gehchan: are great learnings. Uh, let us know more about Life Science Cares and how really your organization is empowering the life science community to make change and impact on one of the most intractable social issues. poverty. That’s a very big commitment you’ve done and you’re having impacts. Can you tell us a little bit

Rob Perez: more about what you do?

Thank you. And thank you for the question. Yeah. So life science cares essentially is the industry’s way. And when I say industry, I define that broadly in life science. It’s not just biopharma companies, but the industry’s way of trying to harness the amazing talent, resources, and compassion. Of the life sciences industry and bring those resources to bear on issues related to poverty.

So what we do is we aggregate resources, both human and financial with an emphasis on human, frankly, um, and then find the best nonprofits. Doing work, um, in poverty in, in one of three areas. The first is, um, areas associated with access to, to needs of basic human survival. So hunger, homelessness, um, opioid addiction, health equity, et cetera.

The second area is access to education. And we define education pretty broadly from early at all the way to college entry and college success. And then the third is access to economic opportunity or nonprofits that Um, work on breaking the cycle of poverty, and those are organizations doing work in job training, job creation, um, uh, economic development, et cetera.

So, um, we, we search for the best nonprofits who can really use our help and partner with us, and we provide financial and human resources to help them do what they do bigger and better. So we started that in Boston in 2016, um, and are now operating in five. Um, uh, life sciences hubs. So it’s Boston, Philadelphia, New York, San Diego and San Francisco Bay Area at present.

Um, and there’s a, there’s a fledgling operations just getting underway in Basel, uh, in, in Switzerland as well, which is. Oh, wow. Yeah. There’s a few folks there who’ve taken it up. So, um, and really the goal is to, um, to, to make a difference, to make an impact. Um, it, it really is a very simple idea and it’s a very grassroots effort in, in those.

In those communities, the leaders of the industry have come together to bring themselves and their companies, um, to, to, to make a difference. As a matter of fact, the, the organization is essentially funded, all the administrative or back end costs are funded by the leaders of the industry. In each, in each area, there’s a board of directors and a board of advisors.

Uh, in Boston, I think there’s 200 plus board of advisors. And those those individuals give money out of their pocket every year to cover the administrative costs of the organization so that when we take in donations from companies or philanthropists, we can give give pass that through directly to our nonprofit partners.

So it really is a grassroots effort. That, um, has, you know, just blown up. And so I’ve just been amazed by the, um, the impact of the organization in a pretty short amount of time. Oh, it’s certainly

Naji Gehchan: impressive, uh, all the impact on, uh, people, as you said, and the communities that you’ve been able to, uh, touch and help through these.

Three different areas you’ve been focusing on, uh, and any specific program you would like to highlight. I know there was some communications during JP Morgan that happened last week. Anything you want to highlight specifically on the program as I know you’ve been expanding?

Rob Perez: Thank you. Yeah. So, um, a couple of things.

Well, one is JP Morgan was kind of a, a pinch me moment for me. Uh, I was really blown away to have, and we had a panel at the conference. Looking at industry reputation, which was amazing. Um, JP Morgan helped us to have a reception at the Westin, which is like unheard of, um, and, uh, um, you know, just, uh, amazing support.

Additionally, we had a, um, the Gilead foundation agreed to match. Funding that came in in and around the conference up to 250, 000. And we’re, we’re really close. We may have hit it. I haven’t heard today, but there’s still time if people want to donate, they should go to our website and help us to get over the top.

But we’re going to be really close, if not at that 250, 000. Raise. So Gilead will put in another 250 to get to 500, 000 raised to impact poverty just around the JPM conference. So that was just really cool. And again, to see this idea taken up like that was was crazy. And then the other thing that we’re super proud of, as I mentioned, one of the areas of our focus is in economic access to economic opportunity.

And the one thing we didn’t see. Um, nationally, at least, was an internship program. There’s great data about the power of that first internship, particularly for students who don’t have access to those, to those kinds of connections and resources. So we created, um, our own, uh, internship program called Project OnRamp.

We started this in Boston a few years ago. And the goal is for students who’ve been impacted by poverty, um, and though all these students are what’s called Pell Grant eligible, so they, um, they are, um, in college now, rising sophomores and juniors, but all who’ve been impacted by poverty, many of whom are, um, students of color and first generation students.

We allow them to get their first paid internship in a life sciences company, and that includes. You know, clinical and lab, um, lab internships as well as business, uh, internships within companies and well as well as companies associated with or that serve the industry. This has been tremendously successful for students, many of whom have gotten their 1st job now that we’ve been doing it a few years, um, in a life sciences company.

But what I’m really impressed with. What’s been really remarkable. I love to hear the stories from the, from the young people. That’s always great. And always, you know, pulls on your heartstrings, but so many individuals in the industry have talked to me about, um, how impactful this program has been for them because they didn’t realize that there was talent at the types of schools that many of these kids.

Um, uh, go to or attend. So we’re talking about state schools, frankly, schools that I school like the one I went to that, you know, weren’t places that biopharma companies usually recruit at. Um, but but these students are showing that there’s talent everywhere. And that’s the point of this. We really believe that we can make a difference in the workforce of the industry.

So we now have a, um, uh, a philanthropic donor who’s remaining anonymous, who looked at the program and what we were doing and said, this is amazing. I’d like to see if we can do it bigger. And so he has given us a challenge. To figure out how to get to greater than 1, 000 student internships a summer, um, in over the next, it’ll be now for we’re in year one of that plan, um, uh, over five years.

And so last year we did about 300 internships last summer, and we’re growing to to get to over 1000 kids every summer. So that’s another fund that we’re raising to get the remaining. Um, it’s like a 6 million commitment. Um, we’ve got about 5 million in, um, and so if people are interested in donating to Project OnRamp, we can use their help to get us over the top there as well, but I truly believe that that program is going to be impactful for, um, for the industry because it will expand the talent base, um, where we’re targeting, and that I think can ultimately lead to new insights, new innovation and ultimately serving patients better.

Uh, certainly.

Naji Gehchan: And this is, this is really congratulations. It’s impressive, inspiring, and definitely it will help us, uh, grow, think differently, be more inclusive and ultimately serve better the patients, uh, that we, uh, we have constantly on our minds. Thank you. Going out of JP Morgan, also a lot was happening during this week, and you’re an expert in the biotech field.

What are you most excited or looking forward to for our biotech industry when you think for the decade ahead of us?

Rob Perez: Well, I think, first of all, the pace of change. You know, I’m an old guy. I’ve been in the industry 30 plus years, and innovation has been a part of the industry, obviously, for all 30 and certainly predating me, but the pace of innovation, in my opinion, has sped up.

Um, you know, we’re talking about cures in diseases now that we couldn’t have imagined when I started. Um, the, um, the amount of I know I’m in the capital markets business in my day job. Um, and I know there’s times when, uh, this past year when folks were hurting a little bit from a capital markets perspective, but the amount of capital that’s that’s available currently for that for these innovations is also something that we’ve not seen previously.

So I’m really bullish on the industry. Um, I think the, the, um, you know, we’re just scratching the surface on the types of technology that can really make a difference in human health. So, um, overall, I’m, I’m definitely bullish and I, I wish I was younger and I wish I had another 30 years, um, because I think what we’re going to see over the next Over the next several decades, it’s going to be just mind blowing.

Naji Gehchan: You’re still young, Rob, and your impact is beyond only capital. As you’ve been doing, you’re touching communities, bringing young talents throughout our organizations. It’s just impressive what you’ve been doing.

Rob Perez: Thank you. Well, the other, one other thing I’ll mention, um, and back to J. P. Morgan. The other thing that we did at J.

P. Morgan is I’m a co founder of an organization called Block. biopharma leaders of color. Um, and another just amazing, uh, night, we had a reception at JP Morgan and to see a room full of, and I mean full, of leaders who were at the JPM conference who are black and brown people who, um, frankly had never been to a meeting like that, where they were, uh, you know, not one of the only.

Um, people, uh, in a room, um, to be in a place that was full of high level C suite leaders, um, and as well as young people from the industry together. And that’s another thing that I think is really exciting about what’s to come is we’re tapping into talent everywhere. You know, we had a fireside chat with Yvonne Greenstreet, who’s a good friend, uh, who runs, uh, El Nihilum, and, um, Yvonne was amazing in that, but it was great for, uh, people both, uh, at the top of their career and folks who were just getting started to hear her story and to see The kind of leadership that, you know, the, this is a woman of color leading one of the industry’s most significant companies, and that’s happening over and over again.

So that’s another area of great pride. Um, and, uh, area we’re looking to grow to be able to help enable. And, um, and amplify, uh, people of color in the industry. For sure. And

Naji Gehchan: it’s, uh, it’s, it’s a good start, but so much still needs to be done. And you’re definitely making a huge impact to make these things move forward.

I’m going to give you now a word, and I would love your reaction to it. Okay. The first one is leadership.

Rob Perez: Um, my first reaction is misunderstood. Um, I think, you know, number one, I think leadership, great leadership is, um, is still more rare than it should be. Um, and that’s because A, it’s misunderstood. B, um, people don’t work at it the way that they work at their technical skills.

And because of that, I think we sometimes, um, don’t achieve potential because, uh, leadership is lacking. I know in the capital market space, and a lot of my venture capital friends will tell me that they’re, that the, the, the capacity constraint on their, um, starting companies and growing companies It’s not ideas or technology, it’s leadership.

Um, it’s finding the right people, not, not people who aren’t smart. There’s a ton of smart people in the industry, but finding leaders. So, um, my first thought there is, is, uh, I think leadership’s a bit misunderstood and mis uh, and underappreciated. Um, and I think if people spent more time both studying and thinking about leadership as they think about their technical skills, uh, we’d have even better companies.

The second one

Naji Gehchan: is DEIB. We talked about a lot diversity inclusion before, but I’d love your perspective on

Rob Perez: that. Oh man, if we only had more time, Nagi. But look, I’m, uh, I’m concerned about, uh, about DEI because I think, um, it is being kind of misappropriated as a culture war, um, topic. And that’s unfortunate because I don’t think it’s, um, you know, I, I think there are people who, uh, you know, want to kind of weigh in on that part.

I don’t, I don’t go there because I, well, I have my own points of view on, on the fact that it’s the right thing to do. I don’t think that’s the reason why companies should adapt, um, DEI policies. I think the reason to adapt it, um, DEI policies is because it’s good business. Um, there is tremendous data that suggests that companies that embrace, um, D.

E. I. Policies do better, um, for their shareholders. And it’s not rocket science. It’s because you’re tapping into talent from everywhere. You have a bigger pool from which to, um, to, uh, to gather talent and your customers, your shareholders and your employees. all happen to be, uh, people who come from all walks of life.

So why you wouldn’t want to tap into talent from all those walks of life, um, also just kind of, um, uh, remains a little confusing to me. So I think DEI is good business. Um, I think it’s become A, you know, political, um, and, and it actually being turned into a negative statement, which is really unfortunate.

And I guess part of a sign of the times, but without going into that part, which again, I have lots of opinions about, but probably not the right time and place. I would just say that I would ask people to think about. The benefits to the business. Um, uh, last week, I think Mark Cuban and Elon Musk were going at it on X about DEI Mark Cuban said something like, look, I hope you, you, uh, uh, you get rid of all of your DEI policies and, and basically piss off all of the.

Uh, candidates who don’t come from your one, um, kind of way of, of attracting talent. I’ll take all those people. I’ll take all those people, I’ll take all that talent and I’ll beat you every time. Um, and that’s, that’s, he’s not arguing that it’s a, um, that it’s the right thing to do. He’s arguing that it’s the best way for his business.

And I think that’s the way I think about it is, um, we really need to, to appreciate that ideas can come from anywhere. And the more we do that, the better off we’re going to be. Oh, for sure.

Naji Gehchan: And it’s proven again and again. And personally, how I build team, I’ve seen it building team that are diverse from, uh, different perspective, thoughts, ethnicities, et cetera, would definitely bring richness to, uh, to the work and, and impact broader.

And there’s something else you said that really resonated with me. When I think about being different or being yourself at work, you talked about, um, the energy tax. Of being different in the workplace. Can you can you share a little bit more

Rob Perez: about it? Sure. Um, I wrote a blog about this, um, you know, several months ago, or maybe even years ago.

Um, and, uh, it was about this, this, this energy tax. And a lot of people, I think it resonated with them because they, they, they feel it. And the point of the piece was not necessarily written towards the different. But written towards the people who were in the majority, um, to be able to say, Hey, understand that this exists.

We’re not asking you to change anything. We’re not asking you that there shouldn’t be government programs on it. That’s not the point, but just understand that it exists. And let me just go a little bit deeper. So people understand what I’m talking about. Um, first of all, different is in the eye of the different, right?

And so in, in, uh, you know, you have protected groups. I’m not talking about that. I’m talking about situations where you feel like almost everyone else. comes from a very similar point of view. They all kind of get this spoken and unspoken rules. And you have to interpret them. Um, you have to kind of be in that environment and you have to go through some mental process to try to understand how to best fit in, in that environment.

That’s what being different feels like. And it’s, again, it’s the, it’s, it’s women in boardrooms, it’s people of color in management suites. It’s, um, it’s, you know, people who, um, are LGBTQ who are, um, you know, working in a, in a team where they’re the only. Uh, person with that sexual orientation. Um, so those folks, when they, uh, have an idea, or have a point of view, they don’t just get to spew it, out of, from their brain, out of their mouth.

They’re, that, that thought has to go through a process of, okay, if I say it this way, How might that be perceived? May or will I be offending anyone? What will they think of me? Will it impact my advancement? Um, all of that, uh, wiring is exhausting and it is a, it is a, um, an extra filter that, um, others don’t have to do.

And you could argue that even in the most Um, welcoming environments where people would say, why would you do that? I have no, no inherent bias. I, you know, you’re the greatest. Even in those environments, they’re going through that process because that is how they achieve. That’s how they’ve gotten to where they’ve gotten.

So the point that the point of the piece was really to say, be aware. that this exists, both for the people who are going through it and who may have this, this fatigue, um, that builds up over time and, and weren’t really sure what it was, but also to the people who are in the majority to say, it’s not, not a bad idea to check in with people at times to say, how are you doing?

I get it. And how can I be helpful? To make sure that this isn’t a problem for you. So that was the point of the piece. Rob,

Naji Gehchan: for sharing it here. The third word is health equity.

Rob Perez: Oh, wow. That is a, that is a really huge, um, issue, uh, particularly right now, I think. Um, and for Life Science Cares, it’s something that we’re scratching our heads on how we can engage, um, uh, best.

Let me, let me break it down a little bit and talk a little bit about at least how, how I’m thinking about it as a, as a chair of Life Science Cares. Um, and this is only one small part of health equity. But, um, I think people in the industry will, will appreciate this. Those of us in the industry, even people like me, who I’m a marketing major from Cal state LA, I am my family’s go to person on medical issues because of the access that I have to, uh, to care, to the medical industry, and I’ll bet that most people who are listening now.

Either those who are absolutely qualified to be them, but even those like me who are unqualified tend to be that person within their broader circle because of the access that we have to information to, um, experts, et cetera. Now, think about. Uh, the person who is in an inner city or in a, in a rural area with no connections at all.

Um, you know, uh, I’ve, I have, I’ve had, you know, like most people my age, health things that pop up, um, and I, you know, can access the best physicians. Um, and be able to cut months off of the time that it would take me to get it. Um, that’s just because of the, the blessings of my career and, and, and the access that I have.

But then I think about people who are, who don’t have that access and who, you know, have diseases that progress because they just don’t, either they don’t trust. the medical system or they just don’t have the access. And that’s one of the things that we love to try to work on it. Life Science cares is how can we tap into this amazing resource?

That is the life sciences community and help people to get more access, help people to, um, to, you know, just essentially get more information, get more access to care. And again, I’m not blaming our healthcare system. I know that this is a challenge and I’m on the board of Dana Farber, which does a fantastic job in the community.

And I know how much we talk about it at Dana Farber, trying to make sure that we have access to, or that people in the community have access to. The Institute, and they do a great job. Once people get in, the problem is getting in can have a lot of barriers. So when I think about health equity, first and foremost, I think about the barriers to access.

And what we need to do to be able to break down those barriers for everyone. And this is a great

Naji Gehchan: reminder for all of us as healthcare leaders to think about access, health equity, and how we can improve it. I’m eager to talk more about this, and I know we can’t in this forum, but I’d love to talk a little bit more about this with you.

Thank you. The fourth word is spread love in organizations.

Rob Perez: Well, first of all, I love what you guys are doing. And, um, ever since I kind of heard about you, I just thought, wow, this, what a great idea. Um, first and foremost, we need more focus on kindness, compassion, and love in the world. Um, you know, if I might editorialize a bit there.

So the fact that you’re, you’re talking to some of the industry’s most accomplished people about this topic, um, is really extraordinary. So thank you for doing what you do. Um, the other is it’s not surprising to me that the people that you’re talking to who are at the top of their game, um, are also people who have leaned into, um, spreading purpose within their environment.

They are purpose driven people. Um, who care about the world and it gets back to kind of what I was saying before about I think extraordinary people, um, are not just extraordinary in their day job. They’re extraordinary all the way around. And so, um, being able to have this forum and frankly, all forums to use it to, um, to make the world a kinder, um, better place.

Ultimately is going to mean better business as well. You know, the, the, at JPM, the, uh, the panel that was, uh, where Lifescience Cares was featured was really focused on industry reputation and, um, you know, how do you reboot this industry’s business? Unfortunately, terrible reputation. And, um, I know I don’t have all the answers there, but there’s two things that I do think I, I know.

One is the answer is not, you know, more ads about, uh, how great the industry is. Um, that’s just not going to work. Um, but what I think the answer is, the second point is to just show people the compassion, the commitment to human health. That, um, our industry is focused on through our actions, through our actions, um, that I think is where the answer lies.

And, um, you know, there’s I have a this friend who wrote a book called Good is the New Cool is actually written a couple of books after Aziz. Um, it’s called Good is the New Cool and after, uh, focuses on, um, companies and marketing that leans into doing good and how attractive that is to employees to shareholders and most importantly to customers.

Um, that this is, I think, what the industry needs to embrace the good that we do, um, because I think the more we share that with people, the more they’re going to realize, wow, this industry is, um, it’s full of extraordinary people and really about helping people, not about all the negative things that we get tagged with.

Naji Gehchan: Can’t agree more than what you said. It’s a, you know, for me, it’s every time taking it back to this human level we are. And as you’ve seen hundreds of people working in this industry, I’ve seen, I had the pleasure to interview now more than 130 leaders and what’s fascinating is this purpose we all have, right?

We all wake up in the morning with this service that we want to bring good. We want to help. People live better, and I think those stories will shine way more than any advertisement campaign. And it’s not, I’m a marketer too, so it’s not around not, not having impact, but it’s really about us making this industry at the end.

It’s the industry is the people and the passion of scientists, physicians, and all the employees working hard to make life better for the patients we serve. So I definitely agree with you. Thank you. Any final word of wisdom Rob for healthcare leaders around the world.

Rob Perez: Um, I don’t know. I guess my word of wisdom is really thank you and gratitude.

Um, I, uh, feel extremely fortunate to have, uh, been a part of this Industry and to have met so many amazing people, many of whom you featured on your podcast. Um, and there are folks who are out doing things that I couldn’t even imagine. So first and foremost to healthcare leaders, my point is, is to say thank you.

Um, keep it up. Um, there’s, there’s so much more to do. And, and I guess my call out because, you know, they’re focused on their day jobs of, of, you know, working on really hard problems. Is let’s come together and see what the benefit of collective impact can do on issues associated with our community. I think life science cares is the way that, um, that, that, you know, we put together and we think it’s only think it’s the best, but it’s not the only way to do it, um, regardless of how I hope everyone will consider, um, their part in helping the world to be a better place.

And the good news is you don’t have to do all the research yourself. You don’t have to find the right organizations. We’ve kind of done that for you. So whether you’re a small company, um, uh, that needs, that doesn’t have the resources and needs to kind of outsource its corporate social responsibility, we can help you with that.

Um, or a larger company that has a lot of resource, but needs to kind of connect with others within the industry so that we can make a collective and larger impact. Um, regardless of where you fit on that spectrum, I think we have a way to, uh, really harness the passion. The enthusiasm and compassion of the industry at life science care.

So I would really encourage people to get in touch with us. Our website is life science cares dot org, um, and, you know, or ping me on linked in and let me know that you’d like to get involved and I’ll get in touch with the right person. But we together we can have a huge impact on people. We’re doing it right now, and I think it can be bigger and better over time.

Well,

Naji Gehchan: thank you so much, Rob. I will, uh, I will definitely share all the contacts about the life science cares on on our on your episode and on our pages. But really, it’s it’s impressive what you’ve been doing. And I love the charge you’re keeping us with and asking us to really think about the collective impact that we can do together as a healthcare industry to, um, to improve and make health more equitable and also make sure that Poverty disappears.

I think that’s the ultimate goal that you’re trying to push with organizations. So thank you for for that.

Rob Perez: Amen. Thanks for having me, Naji. I appreciate it.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Julie Kim

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, for a special episode in partnership with Jill Donahue for her new book “A Dose of Inspiration: 100 purpose stories from Pharma Leaders”. I am joined today by Julie Kim President of the U.S. Business Unit, U.S. Country Head and member of Takeda’s Executive Team. Julie joined Takeda in 2019 through the acquisition of Shire, where she held several diverse roles with increasing responsibility. Julie has 30 years of experience in health care, with leadership positions at global, regional, country and functional levels. Julie is known for strong, collaborative and inclusive leadership that enables Takeda to meet the needs of the people the company serves while driving innovations that will improve patients’ lives. Her global outlook, a result of having worked in many countries in Europe, Asia and Latin America, as well as having lived in the U.K., Switzerland and the U.S., have helped her create teams that are diverse in multiple dimensions to enable inclusive decision-making that keeps the patient at the center. Julie serves on several boards and was named one of Boston’s 50 Most Influential Asian American Pacific Islanders in 2023, The 2022 PharmaVoice 100 list and Fierce Pharma’s list of 2020’s Fiercest Women in Life Sciences.

Julie, It is such a pleasure to have you with me today!

Julie Kim: Well, thank you for inviting me. It’s a pleasure to be here.

Naji Gehchan: Can you first share with us your personal story? What’s in between the lines of your inspiring career and journey?

Julie Kim: Sure, I guess if I’m going to share that story, I do have to go all the way back to my childhood for a brief moment. And I say that because I was born in Korea, and I was born to, you know, parents who had a very progressive way of thinking. So although the culture of the country at the time was very much Um, a hierarchical patriarchal society, my mother had chosen to go to medical school and practice medicine after she graduated, which was not.

And when she had me as a girl, that had certain implications. So for women in general, the idea of having a career and having a self directed life was not the norm. It wasn’t accepted. And so my parents decided to move. To the U. S. At that point, so we relocated to the U. S. When I was very little, um, and I grew up in Ohio.

And at the time, Ohio is not a very diverse place to grow up. I was the only person that looked like me, um, at school, and you can imagine all of the challenges that that brings to a child growing up. So I shared that little bit of the very beginning of my life. Because it had a significant impact on how I showed up as an individual in the in the workplace later on in life that aside, I would say that the early part of my career was really focused on the what making sure that.

I could deliver the best results, the best answers, the best solutions. I started in consulting and so it was about making the client happy by having the best solutions. And I didn’t really give a lot of thought to how I did things. Um, and unfortunately my, my mother passed away during this time frame.

And. You know, when she did, um, and I’ve, I’ve shared this story in, in other, uh, situations and other, um, podcasts and whatnot, but her, her funeral was, uh, uh, a turning point for me because there were so many people, uh, at that funeral. And I remember in having the conversation. With my dad at the time, like, I was very bothered by all the people who had come to, to something that I felt was a very personal family, um, event.

Why were all these strangers here? And, and he explained to me that they all wanted to come and pay their respects to her because she had somehow touched. Their lives, uh, and it was important to them to come and pay their respects, you know, and I, I had that, you know, moment of, wow, if I were to be hit by a bus right now, maybe I would fill the first couple of queues, not, not the whole church, because I knew I wasn’t, uh, the way that I was operating, as I said, I wasn’t really focused on the, how I wasn’t focused on the people around me per se.

I was just focused on delivering the results. So that began a very long journey of, okay, how do I still deliver top quality results, but do it in a manner that. Brings people along with me. And so that’s not necessarily on my CV, but I would say that was a big part of the early part of my career in terms of My story.

And then I would say the other piece that I would share that again is a little bit reflected on the on the CV is that I didn’t necessarily take a straight path. I had a mentor early on who said to me that when you are given the options, you won’t always have an option. But when you’re given the option, try to take it.

The option that will challenge you more. That’s the harder one. It’ll stretch you. You will feel uncomfortable. You, you might feel like you’re going to fail, but you will learn so much more by doing so. Um, and don’t necessarily be so caught up in, in, you know, going for the next promotion, make sure that you are stretching yourself and you are learning.

And that’s what I’ve tried to do throughout my career. So when you look at my CV, sometimes you might look at. Uh, the role, um, one role to the next and go, huh, I wonder why she did that. I wonder why she did that. I, why, why didn’t she just go from this level to a higher level, to a, the next higher level within a particular function?

And, and that is a, a big part of why I didn’t, and having this broad experience across different geographies, different functions, uh, different roles. I think it’s part of what contributes. to me being able to operate at the level that I operate today. So those are just a couple of things that I would share that are not necessarily, as you said, obvious from the CV, but I think play a significant role in getting me to where I am today.

Thank

Naji Gehchan: you, Julie, for sharing those powerful stories and experiences. I want to go back to the first experience you talked about the how. So can you tell us how you are combining now this impact on people and delivering exceptional results?

Julie Kim: Yeah, so I would say that the first piece is really spending time up front with the team in terms of what the expectations are.

Are that’s the starting place, because if everyone is not on the same page, here’s where we’re trying to get to here are the expectations here, the parameters, the time frame, et cetera, then it’s very difficult for people to be self motivated and to to drive forward to achieve objectives. So that needs to be clear for the team, right?

We talk about purpose. You talk about objectives. You talk about expectations. You make sure everything is clear up front. Then you have to let them know that I’m here to help. I’m here to support. I can work with you if something is new and it’s not clear. But otherwise, I’m going to let you find your path.

I’ve got my experiences. And, and I might have an idea of how I would like things to get there, but I’m not going to make everyone conform to my way and my experience. Because I think you shut off so many opportunities for innovation and creativity and improvements, to be honest, when, when you do that and selfishly a bit of learning.

So that’s, that’s the second piece. Being able to step back and giving your team the space to create on their own to learn and to find their way. But as I said, at the same time, making sure that they feel supported. So if they do get stuck, if there is a roadblock, you are there, I am there. To help remove the roadblock or to help show them.

Okay. Well, here, let me help you. If you’re stuck and you, you, you don’t have a clear path forward. So you can’t leave them completely alone to, to, to struggle a little bit of struggle is okay. But you also have to be there to support so that you can help them be successful. So I would say those are a couple of the things that I do to allow them.

The work to happen in a way that, um, uh, leverages individual strengths, individual creativity, but also provides enough support so that they can, uh, progress in their own learning.

Naji Gehchan: I loved how you’re framing it. And really in the beginning, you said something about being focused on the what, and in the what it was always providing the best.

The best solution. Uh, and then the how, uh, later on. So a lot of times, and even for people more in the expertise path, I would say in our industry, right? The, the, what is really important, like the excellence and what we’re delivering is really important. Uh, and I see sometimes executives having a hard time just letting go, as you said, and accepting that, you know, it.

Might not be exactly how you would do it, but it’s okay, actually. It’s not that it’s wrong. It’s just different because you let someone else was also brilliant to it instead. So how did you manage to get to the stage where. Really, you let go and you trusted your team, what was it only because you didn’t have time to do it anymore, or did you really do this work?

And so the fruit of this diverse, you know, outcomes that might happen. How did you get there?

Julie Kim: It’s hard for me to say that there was one pivotal moment. That got me there. I can give you a few different examples of things that helped me, um, move to, to this approach. I would say one thing is, uh, you know, I’ve had the, the fortunate, um, opportunity of having really good managers in my past and.

They did this for me, right? So one way is you, you learn from working with really strong managers. Okay. I really like how they did that. Let me try. So that that’s one piece of it. The second, um, I was attending a leadership meeting.

Over a dozen years ago, um, and they brought in a speaker and his name is, uh, Benjamin Zander and he and his wife had written this book called the art of possibilities. And one of the things in there talks about. Giving people in a right. So you give people trust to begin with in the story in the book.

The story is he gives his class, um, an A at the beginning of the semester, and he tells them to write an essay in terms of what they’re going to do to earn that a through the rest of the semester. And then he tells all of them, okay, so now you have an A, so show me that you did, you know, do the work that you said in your essay and the A is yours to lose, basically, instead of you have to, to earn it.

And so that was a really. Um, I would say a powerful aha moment for me before that. I was definitely a person that said, okay, you nausea, you have to earn my trust. I need to see you do X, Y, and Z before I will trust you to do something. So I was like, okay, well, let me, you know, again, try the reverse. And I’ve had some managers show me trust.

And I know how it makes me feel, right? I, I wanted to do 150 percent uh, more for that individual because they gave me that trust versus someone who says, Okay, Julie, I’m just going to give you this piece to do. And then once you show me that you can do that piece, well, I’ll give you a slightly bigger responsibility.

So that was the second piece. And then the other component around that is. Um, and I said a little bit the desire to keep learning and the humility to know that even though you think you’re a smart person, there’s always going to be someone who’s smarter and there’s always going to be someone who has a good idea and those good ideas can come from anywhere.

So I would say it’s a combination of all of those things that that have brought me to the place of. Being able to let go being able to, um, you know, learn from the team and allow them to experiment and create and give them the support say, you know, look. You might make a mistake here or there. That’s okay.

That’s how we learn. Right? So all of that put together, I think, is the way that you create the environment that people feel safe to do what they need to do, uh, and experiment, learn and grow.

Naji Gehchan: Certainly. Um, you talked about also the beginning, uh, purpose. objective expectations and the importance of setting them.

Uh, so I’d love to know how you, specifically on the purpose, since we’re in an industry where we’re waking up every day to make life better for patients. Even in this industry, several times with my teams, with people I, I talk to, it’s sometimes hard to remember that With all the hundreds and tons of things we’re doing every day operationally, right?

Like, it’s easy to forget why we’re doing what we’re doing. So I’m interested in how do you make this purpose live on a daily basis for your broad organization?

Julie Kim: Yeah, I, you know, I agree with you in terms of our industry. It’s It’s relatively easier than some other industries to have that purpose that, that, that drive to you because we’re all focused on the patient and making a positive impact, um, for them.

So I think that is not any different, um, in my organization, uh, I would venture to, to guess in any other pharma, um, organization, but it is being able to bring it to the forefront. On a regular basis. So, you know, within our organization, we have something we call P. T. R. B. Patient trust reputation business.

And this is our decision making framework. Is it the right thing to do for patients? Does it build trust with society? Does it support a positive reputation for the company? And then, you know, Does it help build a sustainable business? And it’s always in that order. And so you’ll hear this vernacular in our discussion when we’re debating something.

Okay, but is this really? PTRB, are we forgetting the P or are we forgetting the T or et cetera, et cetera? So part of it is in the language that we use and we’re able to always bring it back to the patient. And the second thing is bringing some of those stories to life, especially when you get into a heated argument and you know, maybe you’re trying to trade off OpEx and and it’s really, you know, you’re deep in the numbers.

You have to have sometimes the the wherewithal To pause and say, okay, but look in the end, right? Remember who we’re doing this for. And is this actually going to help us achieve that goal for this patient group? Yes or no, right? So it’s in little ways. Um, and then it’s also in, in, in bigger ways, like, you know, bringing patients into speak at a town hall, um, you know, playing a patient video before a cross functional meeting kicks off.

A variety of different ways to make sure that we bring that purpose to the front.

Naji Gehchan: You know, one of my favorite questions and it’s reminded me while you were talking about it was, would a patient really care? I, I used to ask it a lot for my marketers and say, you know what, you’re debating opex, as you said, or even sometimes like colors or what can we have on a, you know, on a leaflet or whatever, like what a patient really care at the end of the day.

And this is how you always would bring it back to patients. I want to pivot now to, um, what something you’re passionate about. And I think you, uh, shared, uh, early on your story and, um, and being, um, in, in Ohio. You talk a lot about inclusive leadership and you’re passionate about inclusive leadership. So I’m interested to learn more.

How do you define this and how do you link it to business impact too? Yeah.

Julie Kim: I, I think a simple way that I think about inclusiveness is about Giving people a voice. So, again, having grown up in the environment that I did, I was often the outsider. I was often not given a voice. I was often made to feel less.

I was often made to feel that even if I was given a voice, it wasn’t heard or it was less. Of a voice. So again, that context, I think, helps to, um, create the appreciation for wanting to give everyone, uh, a voice that should be in the room. So this is not about, you know, um, having 100 person meetings so that everyone can can have their say, right?

But that’s that’s dysfunctional. But when you are looking at whether it’s a meeting or particular topic, Making sure that the stakeholders all of the relevant stakeholders do have a voice so that it’s not just the loudest person in the room gets to say what they want to say, and everyone then aligns to that or that the leader.

It’s making the space so that the different voices can be heard so that we can then have a robust debate and dialogue about the different views that are represented in those voices, and then coming to a decision. And there’s plenty of research on That will show you when you have those multiple voices to inform a decision, the decisions tend to be better.

And you then that’s where the performance piece comes in. That’s where those, you know, high standards come in and being able to drive that. That excellence. And so that over time has happened. So being able to demonstrate that you can deliver high results, excellent results comes from, for me, having these diverse voices being heard, being accounted for, and then making decisions based on.

I

Naji Gehchan: more than relate to this. So thank you for sharing it. I’m going to give you now one word and I’d love your reaction to it. And the first one is leadership.

Julie Kim: My reaction to leadership. I think leadership is something that is sorely needed in the world today. Let’s just say in a, in a broader context, uh, leadership, I think is something that is earned.

It is something that, um, everyone can do in terms of leading them self, but leadership at an enterprise level is something that is earned. It is not something that is ordained. You might be made CEO, or you might be made a leader of a particular team. But if you really want to be, um, to wear the leadership, uh, mantle, you need to earn that from the organization.

What about growth mindset? Growth mindset to me is a little bit about what we’ve talked about earlier. It’s about allowing, um, individuals to experiment, to try different things, to make mistakes, to learn from that and to keep growing. It’s to reframe and look at what is possible instead of saying why all the things can’t happen.

Belonging.

Belonging to me is, uh, you know, if we go back to what we were talking about a little bit before, that you have a voice and that you are heard and that you are welcomed because of it.

Naji Gehchan: The last word is spread love and organizations.

Julie Kim: Me, this is about caring and I think caring is something that I remember earlier in my career. I was told that you shouldn’t care. That is a sign of weakness. It’s not about caring. It’s about just delivering the results. And I would say that today, that is the worst advice that can be given.

And absolutely, you should care. Care about yourself. Care about your team, care about your stakeholders, your, your organization, and that caring to me is about is how you spread the love.

Naji Gehchan: I love this, Judy. And obviously, if you care, you’re going to hold yourself and your people to an even higher standard and deliver even more.

So I. Totally relate to that. And that’s the idea of all this, this podcast, bringing incredible leaders like you who are doing it and who care for their people and the patients we serve to deliver exceptional results. Any final word of wisdom for healthcare leaders around the world?

Julie Kim: Healthcare is a very difficult, complex area. It is not something that, uh, We can be successful as a single organization or a single set of stakeholders within the whole healthcare ecosystem. I think everyone would agree that the healthcare ecosystem is stressed at the moment and we all need to work together in order to make it a more sustainable environment.

And so I would just ask that we continue to reach across. And work with each other, um, from, let’s say, a multi stakeholder approach to try to make sure that we can build thriving, sustainable healthcare ecosystems globally.

Naji Gehchan: Well, thank you so much, Julie, for being with me today and this incredible chat.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Kevin Williams

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, for a special episode in partnership with Jill Donahue for her new book “A Dose of Inspiration: 100 purpose stories from Pharma Leaders”. I am joined today by Kevin Williams, Chief Medical Affairs Officer, Global Medical Excellence & Innovation, at Pfizer. Kevin joined Pfizer in January 2004 as a Director, Regional Medical & Research Specialists working in the HIV disease area. After moving into a Team Leader position in July 2005, he has served in various leadership roles during his career in the company. Kevin is also Co-Chair, Board of Directors for SAGE, the country’s leading national non-profit organization focused on advocacy and services for LGBT+ elders. Kevin received his medical degree from the UCLA School of Medicine, a Masters in Public Health and a Juris Doctorate from Harvard Law School. Kevin, It is such a pleasure to have you with me today!

Kevin Williams: Thank you. Thank you for having me.

Naji Gehchan: Can you first share with us your personal story? From being on the forefront of HIV/ AIDS patient care to now leading a large organization in pharma… What is your purpose story?

Kevin Williams: I grew up in Baton Rouge, Louisiana.

My father was a physician. In fact, he was the third African American physician in Baton Rouge. And I grew up. seeing him in practice, watching him, uh, take care of patients. I often went on hospital rounds with him or, uh, on house calls back in the days when physicians still made house calls and, uh, I got to see up close and personal, the practice of medicine and his work inspired me.

Um, when I became a teenager during the summers, I actually. I worked at his office for two weeks when his receptionist would go on vacation and, uh, I got to help him, uh, take care of patients. I managed the front desk, checked patients in, took them back to the exam rooms. And, uh, I was inspired by, by what he did and knew that I wanted to go into, uh, into medicine.

And so after college, I. Apply for medical school ended up moving out to Los Angeles and going to medical school at at UCLA. And I will say that part of that decision, um, was influenced by personal factors within within my life. And I think it’s an important. Point to note that I am a member of the LGBTQ plus community because that that did impact the decisions that I made in terms of where I went to medical school.

And, you know, at the time I went to college, uh, in New Orleans at Tulane University, 60 miles away from Baton Rouge, thinking that, uh, I would be able to come out, um, and Live my my life is in my as my authentic self and I found that I still remained in the closet because I was so close to Home, so I’m when I just made a decision to go to medical school I decided I need to get far away so that I can be my authentic self as well as study medicine and and so I ended up in Los Angeles and after a medical school did a residency in internal medicine and wasn’t sure at that point what my next step was.

I had a pull between going into private practice and seeing patients, but also being interested in academic medicine. So, I decided to do a fellowship in health services research. and got a master’s in public health at that time back at UCLA in Public Health and was doing research looking at access to care for HIV positive individuals and the impact of access on outcomes.

It was, you know, fascinating research. It was really important and needed at the time, but I found that during the two years of my fellowship that my clinical skills were deteriorating and, you know, I actually did end up taking an academic position, um, at UCLA. But after six months, I ended up leaving because I really felt that I needed to take care of my community.

And that’s how I got involved in, in HIV and AIDS care. Um, when I left, uh, academic medicine, it was really the height of the AIDS epidemic. So I, I finished my fellowship in, uh, 91 and began practice in the beginning of 1992. At the time we went into practice, there were very few. medications available for, uh, people living with HIV and AIDS.

At the time, it was really AZT, DDI, and DDC were the only medicines available. Um, but I knew that I had to be down in the trenches, taking care of my community. Um, and that was really what drove me into leaving academic medicine and going into private practice. And I ended up staying in private practice for eight years.

Doing HIV medicine and it was an amazing time. It was incredibly rewarding. Um, I felt that I was able to take care of members of my community to be there in a way for them that I thought was important, knowing that many of them were not going to survive this illness, but being able to be compassionate, caring, empathetic.

force in their lives. Uh, as these 2030 40 year old people were dealing with death and dying at a time when they should be really experiencing the best parts of their lives, having aspirations and doing new things and they’re dealing with issues of death and dying. So it was a very very rewarding time to, um, work with those individuals to have very intense relationships with patients.

And, you know, that things changed and In HIV, we got combination therapy, different classes of medications, and patients were doing better. And my practice was beginning to evolve. It was becoming less HIV, more general internal medicine, and I thought maybe There was an opportunity now for me to do something different because I thought I had skills and capabilities that were not being fully utilized in the practice of medicine, leadership skills, strategic thinking, uh, that I wanted to put into effect.

And initially I had the idea of getting involved in health care policy and I decided that I would go to law school with the idea being that. Having a background in medical practice and HIV, uh, mass and public health, uh, and a law degree would paint an interesting package for somebody who wanted to get involved in health care policy.

Um, so I ended up moving from Los Angeles to Boston, uh, went to Harvard for law school. And after I graduated. Decided that that actually was not the career path that I wanted to take and was really at a crossroads because now I had to figure out what that next move was. And I actually wasn’t sure what it was.

I ended up moving down to New York and started looking for opportunities. And. Um, honestly, was not looking to join the pharmaceutical industry when this opportunity, uh, arose at Pfizer. Um, uh, you know, for for those of us who went to medical school or pharmacy school, uh, it will sound familiar when I say that they drill into your head that the pharmaceutical industry is the dark side, the evil empire.

And So honestly, I had that perception of industry when this opportunity presented itself to me at Pfizer, and I was not really looking to join industry, but this opportunity was, uh, too good for me to pass up. It was an opportunity to get back into working in HIV and AIDS, which is an area that I was passionate about as a field based medical individual, MSL.

And so I decided to take a chance. And I joined Pfizer, uh, in January of 2004 and never looked back. I mean, 20 years later, still at the company, um, had an amazing career during my, my time. I’m at Pfizer, you shared some of. uh, the opportunities that I’ve had and my ability to move into different roles, different leadership roles to have different experiences in different therapeutic areas and develop both personally and professionally.

So it has really just been an amazing journey.

Naji Gehchan: Well, thank you so much, Kevin, for sharing this powerful and inspiring journey of yours. I certainly relate to Several parts of it. I want to start with with one specifically, uh, you said you were you worked in the trenches, right? You help people the moment they needed it most.

Um, and obviously, I’ve had this as I shared briefly with you before, uh, in moment and tension and war. And then now you’re doing it in a different way and impacting people in different ways. So I’m sure you two talk with a lot of scientists, physicians who are thinking about this transition. What is your number one advice of how they should think about their impact moving from really immediate care for patient to the pharma industry?

Kevin Williams: The impact that you have is, is different in, uh, it’s at a different level, um, in private practice. The impact that I had was very immediate and it was very individual. Um, as I saw patients. You know, evolve, improve or perhaps not improve. But there was that kind of one on one immediate interaction relationship and immediate feedback.

Uh, I think in the pharmaceutical industry, it’s a little bit different. Uh, the impact is not as immediate, but it can happen on such a larger scale because you’re bringing medicines Uh, to patients that, you know, have these medical needs and you that are making a difference in their lives, and you’re doing it on a much larger scale than than you’re able to do when you’re in private practice.

So it’s a different type of impact, but it’s, uh, equally as powerful. And I think, you know, they, uh. Um, I’ve often been asked which is which is better. And I would say that they’re different there. You know, it’s not that one is better than the other. The impacts are so different. And the experience of what you’re able to deliver is so different when you’re one on one versus when you are working in a large company.

Um, and You know, there are other aspects of working in a large company that I think, um, uh, are also, uh, critical, at least for me, they were, uh, because it’s not just the impact that I have on patients. But one of the things that, you know, that I, that I talked about in terms of skills and capabilities that I felt that I had that were not being fully utilized in medical practice was that I love.

to teach, and I love to mentor people. And I didn’t really have that opportunity as much in medical practice, uh, as I did when I moved into the pharmaceutical industry, the opportunity to lead large teams and groups and organizations to help colleagues develop and advance in their career paths. To help watch them grow in their careers is very rewarding.

And so in addition to the impact that I could have on patients, there’s also the impact that I could have on my colleagues, uh, and which. You know, just add so much more to the experience.

Naji Gehchan: So talking about this specifically, the leadership impact and your leadership impacts you’re having on your teams, you’re a purpose driven leader, I believe.

I’m intrigued how you drive this purpose and making sure that your team on a daily basis, as we all can be so taken into our operational work and forgetting this larger picture of why we do what we do. I’m interested to know how you drive this with your teams at a large scale

Kevin Williams: now. We always keep the patient front and center of everything that we do.

We often talk about The patient, uh, talk about patient care, talk about the importance of the work that we do to bring medicines, uh, to address unmet medical needs. Uh, so ensuring that you’re always keeping the patient front and center and all that you do, uh, always talking about the importance of that is really critical, I think, to maintaining your purpose and to keeping it as your North Star.

You said something in

Naji Gehchan: the beginning. I would love to go back to you talked about authentic self. And those days, unfortunately, we’re seeing more acts of hate. If I don’t think we should call them non love, but really acts of hate towards different communities and a lot of tensions instead of care and love as we both believe in leadership.

Um, and it’s. We had this discussion yesterday, even with my partner and we’re saying, yeah, well, do people keep these things at check at the door before they come to work? How should we deal with it as leaders? So I’m interested to understand from your lens, how, how are you doing this? How are you ensuring your people come and can be at their best and can really be who they are?

Kevin Williams: I think the best way to do that is to role model the behavior. Um, if you bring your authentic self, um, uh, show your vulnerability, be exposed, uh, it encourages others to do so. If you create an environment where people feel comfortable being themselves, then they will excel and do their best work. Uh, and so the way that I do that is by Being my authentic self.

I’m, I’m very open about, uh, being a, a gay man. Uh, I, I think it’s important, uh, uh, to model that behavior and that openness so that others, uh, who May feel less secure or less comfortable being open about whatever it is that, you know, that, that, that they’re not letting others see, you will feel that they’re in a safe space where they can be more open because I think the more you’re able to do that, the more you’re going to enjoy what you’re doing, the, the, and the more you enjoy what you’re doing, the better you’ll be at it.

Naji Gehchan: I’m going to move now and give you a word. And I’d love a reaction from you. So the first, the first word is leadership.

Kevin Williams: Leadership is about, well, I’ll tell you an interesting, this is my, this is how I think about leadership. Um, I was watching the, uh, NFL, the National Football League. Playoffs. This is probably 10 years ago. And before the game started, you know, they’re doing an interview and they’re interviewing, uh, Shannon Sharp, his former tight end for the Denver Broncos.

And they asked him. What do you look for in a coach? And I thought his response was so spot on that I used it all the time when I talked to people about leadership, because what he said is, you know what I need from a coach is someone to put me in a position to succeed. And then let me do my job. And so when I think about leadership, you know, my job as a leader is to make sure that my people have the tools, the resources, the feedback, the coaching, the support that they need to be successful, and then trust that they know what they’re doing and empower them to do their jobs.

What about patient centricity?

Patient centricity is the north star of all that we do. It is the hallmark of being in a medical role in the pharmaceutical industry. Uh, it is the hallmark of being in any role in the pharmaceutical industry. Uh, It is critical to all that we do that the patient is the reason that we do what we do, and patient centricity means not just thinking about the patient, but including the voice of the patient.

One of the things that you mentioned is that I’m co chair of the board of SAGE, which is a non profit. Uh, LGBTQ plus elder organization focused on advocacy and services for LGBTQ plus elders. And one of the things that we say, uh, is nothing about us without us. And, you know, it’s a, it’s a phrase that, that many will use, uh, but I think it’s so important that when we think about patient centricity, that we include the voice of the patient in all that we do and understand that it.

You know, it is not our responsibility to speak for the patient. It’s our responsibility to listen to the patient and make sure that The medicines that we’re developing are meeting their needs, not the needs that we think they have.

Naji Gehchan: That’s so powerful. Nothing about us without us. And I love how you said our responsibility is to listen to patients and bring their voice to what we’re doing daily. The third one is health equity.

Kevin Williams: Health equity. Is understanding that

you can develop the best medicine in the world to treat a specific condition, but if you are not taking into account the other factors that influence whether or not that medicine makes it to a patient, then, uh, you know, you’ve, you’ve failed at your responsibility. People come to the table with different levels of understanding.

Access education background, socioeconomic conditions, all of those things influence their ability to access the health care system to access medicines to understand the, uh, the dynamics, the importance of, uh, taking medicines, uh, all of these things contribute to the health of. The individual patient and unless you are able to understand all of the different influences and address them, you know, you may very well be feeling that patient in front of you because, you know, either they don’t understand, uh, what you’re asking them to do, um, they don’t have access.

They don’t know the questions to ask. Um, and I’ll give you An example of, um, a situation I had with a, uh, with a, with a patient. Um, and it was a It was a 70 year old black male that came in to see me and he had, um, he was, he was HIV positive and I treated him, uh, with medication at the time, Virocept, a protease inhibitor.

And the way that you take Virocept is it’s three pills, um, and it’s taken three times a day. So a total of nine pills a day. I told him, uh, And when I prescribed the medications, three pills, three times a day, I found when he came back in three months later, he had been taking one pill three times a day.

And so I asked him about that. He goes, well, you said three pills, three times a day, which he interpreted as one pill, three different times and three different times. Uh, and it occurred to me that. You know, just because I understand something doesn’t mean that the patient understands and it’s important to check for that understanding health literacy, big part of health equity, right?

So that’s and that’s just one example. And, you know, the consequence of that misunderstanding could be fatal because he could develop resistance. To the virus can develop resistance to that produce inhibitor because, uh, he was having an adequate blood levels of that medicine. So, uh, it’s important, uh, to be sure that you are clear.

Uh, you understand all the components of what’s going on in the patient’s life to ensure that you’re able to deliver the best care possible. What a great

Naji Gehchan: example. I’m sure if I want to just double click on that. How are you translating this today as an executive in the pharma world? Like how I also constantly thinking about this, obviously.

Uh, and I’d love your thoughts, how you translate health equity and our responsibility at healthcare leaders. Uh, in the pharma industry to ensure that we’re making real moves to improve that.

Kevin Williams: I mean, I think it’s important that, um, that that be part of what we do as pharmaceutical leaders, that it’s not just about bringing medicines to market that address medical needs, but that we’re also funding initiatives and efforts that address some of the The issues around health equity, whether that be around access or whether it be around health literacy, work that you do with plain language summaries to make sure that patients have access to information and in a way, uh, that they can understand it and digest it.

So we can’t just be about bringing the medicine to market. We have to think about all those other influences on. getting access to that medicine and where we feel we can make an impact and make a difference. We also need to, to be involved and, you know, to resource those areas.

The last

Naji Gehchan: word is spread love and

Kevin Williams: organizations.

I think it is, um, one of the things that, uh, I have always tried to do in, uh, in standing up a team or a group is to create an environment where people feel nurtured and cared for. Um, and, you know, that means creating an open, transparent. Environment where people can come to you. I mean, again, I talked about being their authentic selves and so modeling that behavior I think is important.

I think it’s also, uh, listening more than you speak. Um, it is asking people, you know, how they feel, ensuring that they feel cared for and listened to, um, and creating an environment where they feel they can do their best work.

Naji Gehchan: Any final word of wisdom for healthcare leaders around

Kevin Williams: the world?

I think you have to, um, well, I actually, there are a couple of things I would say. One, uh, uh, I think you have to be willing to step outside your comfort zone. Because only when you step outside your comfort zone, do you grow and learn. If you just keep doing what you already know how to do, you’ll never grow.

Uh, so it’s important to step outside your comfort zone, no matter how scary it is. I feel with every opportunity that I’ve taken on that was new and challenging. Uh, it was, it was terrifying, but I was a better leader. Because I took on that opportunity and maybe the corollary to that is I would say, so it’s important to believe in yourself and to believe in your ability and do your best.

I will tell you one final story that I love that my father told me. When, um, I was growing up, uh, and it’s a, it’s, it’s, it’s, it’s kind of about believing in yourself. Uh, when, when my father was in medical school, he went to Howard, uh, uh, medical school, he said he had a classmate and the classmate, uh, said to him one time, he said, uh, Al, his name was Alvin, he said, Al, Um, you know, medical school is so hard and I don’t know how I’m going to make it.

Um, and when I start to feel that way, I go down the hall where they have all the pictures of the previous graduating classes. And I look at all of those photos and I say to myself, you know, I’m going to be fine. I know I’m going to make it through medical school because there’s got to be somebody up there who’s dumber than me.

So you got to believe in yourself.

Naji Gehchan: I love it. Well, thank you so much, Kevin, for being with me today and this great chat.

Kevin Williams: Thank you so much. I appreciate

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jill Donahue A Dose of Inspiration

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by I’m Naji your host and I’m thrilled to be with Jill Donahue a global thought leader in pharma. Jill has won multiple awards for her work, author of 2 soon 3 books, delivering talks at global conferences, publishing in industry journals and serving pharma teams. Jill also co-founded The Aurora Project; a global volunteer group of thought leaders trying to illuminate commercial pharma’s path to patient centricity. This is my second episode with Jill, for a special “dose of inspiration”.

Jill, it is always good to see you and such a pleasure to have you again with me on the show!

Naji Gehchan: Before going right into your new book, Dose of Inspiration, can you tell us a little bit more about your story?

Jill Donahue: Sure. Well, and I’m sorry, because you know my story, but let me, let me share with others, I guess, and, and that really goes to why I’m, I’m writing this book, I suppose. So, my story goes back to, um, a long career in the industry and, um, very, very interested in the behavioral science aspect of how we better engage people.

And I think that really the big fuel for that was, uh, you know, watching my father die as a result of prescribing her and, uh, being in pharma. Reflecting on, you know, what if, what if dad’s doctors at MSL, KM, rep, whomever, had have been better able to access and engage my dad’s doctor, uh, to know the right product at the right time for the right patient, you know, things could have been so different.

So, I left Big Pharma two years after dad died and, um. I started studying this full time and was learning stuff that I was really excited about and wanted to share. So I wrote a couple of books about it and started speaking from global stages and, and, and, and, and talking with leaders around the world.

And that’s where I met you actually a few years ago in Barcelona, right? That was, um, how we met around that. So, um, That led to teaching, teaching what I was learning and one of the big things I was learning was when we are purpose driven, we do better, you know, that mindset shift changes everything. So we created this, this journey and that brings me to the book, this latest book, but we created this journey called The Power of Purpose, where we, um, take people through an exercise to help them connect with their why, you know.

Where’s the meaning for you in work? Why do you work here in pharma? And I’d run these programs with people and, um, groups would share their stories. Right. And it was so powerful. And then that I found myself going into the kitchen after these group shares and, and, you know, often through tears, sharing with my family, Oh my gosh, you won’t believe this story.

It was so amazing. I’m so inspired by these people. And then it occurred to me, this is silly. right? Like, why would I just share it with my family? What if I could share these stories, these amazing stories of how people in pharma find their purpose and meaning in their work? What if I could share them more broadly?

And so that’s when the idea came up for Well, let’s put them in a book so and so that’s what we’re calling it a dose of inspiration a hundred purpose stories of farmer leaders. And, um, so you got more than you asked for there. You asked me what my, you know, my background and I gave you that and then more.

Sorry about that.

Naji Gehchan: No, but I love it. And this is that was my first question. Now that you heard more than 100 purpose stories. Why are you putting them in a book? But you answered this. So let me go to what are you hoping this book will bring? to those who would read it. Well, what difference Are you hoping this book will make?

Jill Donahue: Yeah. Well, our experience is when people connect with their purpose, and interestingly, you know, studies show there’s just a McKinsey report that said about 15 percent of us, 1. 5 percent of us, are connected to our purpose at work. And that’s just such a shame, because there’s also huge evidence that shows the people who are connected to their purpose, those are your best People, they’re the ones who go home happiest, the ones that have the highest results, they perform better, they’re healthier, they live longer.

There’s incredible evidence, right? So when people connect to their purpose. They do better, they go home happier, they ultimately create better patient outcomes, right? So if we can, and I know, you know, I love the groups that I work with, I love having this impact on people, but there’s so many pharma people in the world that I’m never going to touch.

So if this book You know, back to your question, what do we hope this book will do? Our hope is that it will be literally a dose of inspiration to get people to think about, Hmm, why am I here? Well, maybe I should think about connecting to my purpose too, because I know from my experience with these programs and from the incredible literature, the evidence out there, that when people do connect with their purpose in pharma, we change more lives.

Not only the lives of the people in the Indi in the organization, but the HCPs that they touch, the, you know, the stakeholders out there and ultimately the patients. So that’s my hope that it’ll inspire people to think about it.

Naji Gehchan: So as you know me pretty well, I’m definitely connected to my purpose and this is why I wake up every morning coming to pharma trying to help patients live better.

One of the first feedback when you start working on your purpose, it’s not, it’s not easy. Some people feel it’s too broad. Is it even true that if I connect to it, uh, something will happen? So how, what would you tell your audience, right? Like it’s, we’re doing kind of the similar work, inspiring others to podcast on the stories.

But I’m intrigued, someone who wants to connect to their purpose, what would be your biggest advice to them on how to do it?

Jill Donahue: Yeah, it’s so interesting, Najee, because The way I see it is we’re on this hamster wheel, right? We’re going, going, going, round and round and round. And we don’t often take the time to step off and look back to where we’ve been, right?

So that we can better see where we’re going. Another way of looking at it is taking a helicopter view of your life. You’re so busy in life. You’re in this forest and you can’t see. The forest through the trees or what is it? The trees to the forest, forest to the trees. Anyway, you can’t see where that path in front of you, but when you step out of it and allow yourself to dig in.

And the funny thing is when, whenever we talk about purpose, I know if I could see the bubble over people’s heads, I know they’re immediately thinking of family, right? And I don’t want to deny that, of course, for all of us, when you, you know, why do you live? Well, for my family, right? Yes. My kids, my mother, my, whoever it is, right?

Whatever family is to you and you can go further. So I want people, I want to say to them, you know, when you think about purpose, you can think about it in three ways. There’s one, your personal purpose. So for many of us, that’s family. Then there’s your organizational purpose that you work for. And we’re so blessed.

In pharma right in health care that any organization that we work for ultimately is doing good in the world, right? Saving improving lives. That’s a beautiful. Organizational purpose, and then there’s a third purpose, which is your role purpose. So Daniel Pink, who I just love and admire, and I’ve had the privilege of interviewing him a couple times, he describes it as the organizational purpose is your big P, capital P, right?

And he said, in pharma, you’ve got that in healthcare, you guys got that right, save and improve lives. But that little P, that’s your role purpose, how you feel connected to that organizational purpose that he says is missing. And when you can connect those. That’s when the sparks fly. So my advice to people is look beyond.

Yes, of course, your main purpose in life is to serve your family. And if you really want to live your best life, find meaning in your role as well. Connect your role purpose to your organizational purpose. And I think everyone out there can do this, no matter what your role in the world is, especially in pharma.

Like our organizational purpose is so noble. And when you connect the dots between what you do and how that ultimately impacts helping people, purpose always comes from helping people, basically. So, think about it. How does your role help people, help people, help people, help patients, potentially?

Naji Gehchan: Yeah, I, I certainly fully agree, you know, and as you’re saying in pharma, we have this noble purpose with a huge responsibility, right?

Of, of making life better for patients. And every single person working is making it happen. It’s sometimes tough, you know, when you’re, as you said, into your daily. work into the weeds of what you’re doing operationally to just think about it, but each one of us is making it closer to patients somehow, either faster or more broad, but every single person in the healthcare system is working towards this.

Jill Donahue: Yeah. Otherwise you wouldn’t have a job, right? You’re there for a reason. And it’s interesting because so many people will say, Oh yeah, but not me. They’ll have their arms crossed and say, you know, I don’t touch the patient. I was like, well, very few of us touched the patient, right? And your role is still important.

And I tell the story about, um, Johnny Johnson. Have I told you this story, the Johnny Johnson story? He’s a, um, He’s a, uh, a bus driver, like a shuttle bus driver. And I met him on the shuttle bus from our rental car at the airport to the terminal. And in the, in that moment, you know, that five minute bus ride, he managed to get all of us smiling and feeling good with his energy and his announcement over the loudspeaker about how proud he was to serve such an amazing group of people, because we were the ones who not just planned a trip, but we made it happen.

And anyway, I approached him after and said, Johnny, I just. I love your attitude, like where, where does that come from for you? And he said, well, I had a choice, you know, I had my master’s home and I came here and I drive the shuttle bus to, to make a living and I had a choice to make, was I going to be just driving a circle or, or trying to help people make a difference?

So I decided my job was to make people smile. And I said, wow, so you go home with this gorgeous smile on your face. We all have smiles. Plus I said, I bet you make more money than the other guys. And he said, yeah, I make, uh. About a hundred bucks a day, and I said, well, that’s fabulous. So what do the other guys make?

And he said, 40. And then he added, you know, one day on my birthday, I made 500. And I said, oh my gosh, amazing. And then he said something and I was like, okay, that’s the mic drop moment. That is exactly what I teach in the program. He said, he put his hand on his heart and he said, it’s got to come from here.

It’s got to be authentic. I said, ah, that’s it right there, right? You need to go inside yourself and discover what it is about helping people that makes your heart sing, right? And, and I also advise the people I teach, you know, if you really don’t care about people and patients, I’m not sure healthcare is the place you should be, because that’s really what it’s all about, helping people.

So, yeah, dig deep, go in there to peel back the layers of the onion. I also say back to, you know, what’s my advice for people? Peel back the layers and find out, you know, where does that desire to help people come from? And we’ve discovered some things through the, through our experience with helping hundreds and hundreds of pharma professionals, um, about where the origin of that might be.

And we talk about that in the book. Um, you know, for a lot of people, it, it comes from values that they were taught. You know, I find your story fascinating, right, from, from your upbringing. And if people haven’t heard that episode, they should really listen to your story, right? I don’t know if you want to give a little Thanks, Jill, for the mention.

Where do you think your value, yeah, where do, where do you think your connection to that meaning came from? Like, if you were to summarize that, where do you think?

Naji Gehchan: Yeah, certainly. As you said, and probably some of the listeners heard it before, it certainly came very early on, right? Seeing, um, being a kid who was born during the war, seeing how we can help people in need.

Uh, I certainly very early on wanted to make sure that I can help people, uh, what they are most of their need. And this is why I ended up in, you know, becoming a physician and working in humanitarian work. Uh, and as you said, you said something, uh, very true. Several times you hear people saying, yeah, we’re not touching the patient.

So I can tell you I’ve, I’ve I’ve been fortunate enough to be able to help people in ER or in, uh, during wartime and bombing zones, et cetera. I certainly touch patients. So you see the immediate impact that you can have, but being now in the pharma biotech industry, it’s just, it’s just different. I’m not touching them physically and helping them one at a time, but I’m so proud after now serving for more than 15 years in this industry.

Being able to say, I managed to launch drugs that help millions of lives that touch globally, right? So I think this is where sometimes we get into, okay, I’m not touching immediately, but actually the impact is, is massive and broader. Sometimes that’s what you can do at a hospital base or at a scene, uh, scene place.

Jill Donahue: Exactly. And the more people can get in touch with that, the better they do. And that takes effort. You know, the other thing I say to people back to that advice is it’s a choice. Being purpose driven is a choice. It doesn’t just happen. It’s something that you need to think on. And that’s another thing that we do in this program is how do you create that culture, right?

What are the things you need to start, stop, and continue to do? Number one is connect with your story. Like, why is helping people important to you? Like you, you can take it right back to that first moment as a child that you watched that Red Cross volunteer helping people. And you’re like, I want to be that person.

Right. And that drove you and still drives you. And what is it for other people? And you know, other people like, wow, I didn’t, I wasn’t born in a war zone, but you know, what is it for me? But you know, I was just talking to a person this morning and she talks about her, her mother was such a loving teacher and taught her the value of helping people.

And, uh, you know, or my grandmother invited everyone in around the dining room table. I saw the value of helping people there. Like, where does it come from for you? And then once you make that connection, then what are you going to do about it? You know, how does that change? What, how you, you know, think what you say and what you do, it changes everything.

Naji Gehchan: Yeah. And how you will take it and make sure that your team every single day. is remembering the purpose and what we are serving and who we are serving daily. You know, the other challenge I’d love to get your thoughts on is, uh, purpose, values, culture. You talked about pieces where several times you hear some, some leaders, execs think, okay, the, all this is great, but at the end of the day, I need to deliver results.

So how do you think about this and how you combine both?

Jill Donahue: Yeah, I love that question. It’s so interesting because in our industry, we are so evidence based right with the life sciences. It’s all about evidence. Well, I encourage leaders to please look at the evidence in the behavioral sciences because it is abundant and rich.

The studies consistent that when we focus on our purpose. Good things follow for everyone. It is unequivocally the best thing that’s good for health care. It’s good for the employee. It’s good for the HCPs. It’s good for the company, which is the question you asked, and it’s good for patients. So the evidence on it being, um, contributing better outcomes is, you can’t deny it.

It is strong evidence. Interestingly, in the book, because I get this question so much like, Oh, yeah, that’s all good. Nice feel good thing. But I need to deliver numbers to global. I’m like, Oh, man, if only you knew, this is the way to do it, right? This is your biggest mistake that you’re not looking at the behavioral sciences about how, how to inspire people to do their best work, how to empower people to do their best work.

You know, there’s so many studies that say purpose is far less expensive and far more impactful than any incentive. I don’t know if you’ve ever heard of the incentive program you’ve ever put in place, so just look at the literature and so in the book, I provide at the front of the book, a lot of that evidence, because I know.

You know, once people get it, the purpose is important, then they have to convince people that this isn’t just a feel good thing. This is actually, makes really good business sense. So I provide a lot of those references and studies to help people have that very discussion that you’re just introducing there.

But just, you know, bottom line, you’re evidence based people. Look at the evidence. It’s there. It’s abundant, rich. It will, it will change your mind on it. So we’re eager

Naji Gehchan: to, uh, to read the book, read all those stories and, and see those advices. Do you have one big learning after interviewing those 100 pharma execs?

Uh, what connects them to the purpose? Any common thread you felt in this book that you want to highlight?

Jill Donahue: Yeah, and, and this book is just a hundred of the many, many, many hundreds of, uh, pharma people around the world that I’ve, uh, worked with on, on purpose. And I do have a few key learnings and I share those in the book as well.

And I think, you know, the number one thing is, oh my gosh, Najee, people in our industry are so awesome. I just. Love working in this industry. I’m inspired every day by the people who work in our industry and how focused they are on making a difference and helping people and bringing their brilliant minds, whatever their expertise is to this big picture of healthcare to try to make it better.

And, um, and that inspires me, right? Just the, the. Quality of the people that we work with. That’s that’s one of my big takeaways. And as far as the takeaway on on where their purpose comes from, which you talked about earlier, um, there’s some different categories that I think for some people, it’s a first hand health care experience for themselves or a loved one.

But then there’s lots of people that that isn’t the case. And then they’re like, Oh, geez, I don’t have anyone who I’m like, No, that’s good. That’s okay. Right. Um, so for other people, it could be, um, we’ve seen for some people, it’s a real commitment to equity because of some equality that they had in their life and they want to help with that in healthcare.

Uh, for others, it’s, you know, these personal values and belief beliefs about helping others in healthcare and the importance of, of, um, service. And for some people, it’s like wanting to pay it forward, giving back, um, inspiration from parents and role models is another one. Um. Intellectual scientific curiosity is the beginning for some people, right?

So there’s many different triggers and everyone’s story may have a combination of those things too. It’s not necessarily just one thing. And also stories evolve over time, interestingly. Yeah, in the book I think I have, um, my six big takeaways from all the interviewing I’ve done, um, so those will be summarized too, uh, in there.

Naji Gehchan: Love it, Jill. And as you said, every everyone has a story, right? And everyone has a great story that inspire others. So I really love what you what you’ve done in the book. It’s why you talk about 100 as you know, we’ve been 100 and 20, uh, interviews also and podcasts and episodes with great leaders. And it’s certainly inspiring every, every person has an incredible story.

And I feel fortunate to be in this industry and hearing those stories every single time. I want to give you now a word and I love your reaction to it. The first one is leadership.

Jill Donahue: Love. Um, Yeah, you know, you and I both know that people are uncomfortable with that word in business, but um, whether it’s love or purpose, so perhaps I could have used the word purpose when I think of leadership, because I think it’s driven by, and purpose and love to me are connected as well, but it’s driven by that authentic caring for people, leadership, you have to care for people, and that’s what makes people follow you, with title or without, but that’s leadership.

You know, when people, um, admire you and trust you and believe you care for them, and perhaps the patients you’re serving together, that’s when you have leadership. That’s when people engage with you. That, to me, is the most important thing. For people to trust you, admire you, and believe you care for them, and the patients you’re serving together, that’s leadership.

In our industry, especially. What about story story? Um, so important. Interesting because, you know, people wear their business suit, right? We put on this suit and we present ourselves or we present the science. And we think that that’s going to engage people. It does not. And we work with so many scientists who are so driven that way, right?

And they think that the story, there’s no room for that with the business suit. And I encourage people to, to open that up. That the story is powerful beyond measure. That your story, the patient’s story, you know, I, I teach um, Scientists, MSLs and physicians, how to be more engaging presenters and I joke and say, you know, the first 30 seconds of your presentation will make or break the engagement with your audience and it better not be your disclosure slide, which, of course, they’re like, Oh, shoot.

Uh, so, you know, start with your story. Why are you here? Open up with. Before I get started, I think it’s important for me to share with you why I’m here and what my intentions are and give your four sentence version of your story. It will change the way people respond to you. Story is important. Long answer to your one word.

That’s a

Naji Gehchan: great, it’s great. The first one is a dose of inspiration.

Jill Donahue: The next word you want is a dose of inspiration. A reaction to it. My reaction, a dose of inspiration. I think that’s You know, I think of ripple effect, right? Um, if that dose of inspiration starts something, I love to think of the ripple effect that, that goes on from there.

So if I can just do that little drop, I think of it too, like, um, dose of inspiration, vitamin P, you know, we all take our vitamins every day, and I say, what’s your vitamin P for purpose every day? So maybe this dose of inspiration will be a little bit, you know, that vitamin that you take every day, you read one story to inspire you on a gray, tough day.

So, yeah, ripple effect, I guess. I’m hoping for. And do

Naji Gehchan: you know the last one I always ask, so I, I wanna ask it again. Spread love in organizations.

Jill Donahue: Oh, brilliant. Love it. As you know, you and I are on such a parallel path, Najee, and I am so, um, proud is the wrong word. It’s, I’m so impressed and grateful for the work that you’re doing, spreading love in organizations.

Um, and I, I just think it’s brilliant and so grateful that. You’re doing this work and so gratitude appreciation and, uh, yeah, keep going spread love and organizations.

Naji Gehchan: Oh, thank you so much. It means a lot and you’re definitely a big part of my journey and story as I’ve told you several times. Any final word of wisdom for healthcare leaders around the world?

Jill Donahue: I don’t know if I have wisdom. Um. I just encourage you, encourage people to, uh, don’t give up, you know, it takes effort to be focused on our purpose, but it’s well worth it. It is well worth it, but choose that every day and do what you need to do to choose that. Maybe this book, um, will be your first, uh, you know, drop in that ripple to see good things happen.

By the way, it’s free, right? We, I don’t think we’ve mentioned that. We want this book to spread, so we’ve made it a free ebook, so, um, yeah. Uh, maybe that’s my, my, uh, wisdom, as you say, but, uh, start somewhere with the, you know, keep that vitamin P going or start vitamin P, download the free ebook as a little place to start.

Naji Gehchan: I love it. Vitamin P. I will, I will add this and for sure, we will put the links to download the free book for, uh, for all our listeners, uh, and we’re eager to, uh, to see, read, hear those hundred stories. Thank you so much, Jill, for being with me again today. It’s just a great pleasure to talk

Jill Donahue: to you every single time.

And thank you. Think about the hundred people. You’ll see them soon in the book, but I have a huge thanks to them for being so vulnerable to be willing to expose their, their story, their journey to inspire others. They’re amazing folks. So big thanks to them. And thank you to you for hosting to you and Zena.

Thank you so much.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jeff French

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Jeff French a resilient, collaborative, and influential global leader who leverages deep expertise on digital and information technology, customer experience management, and brings broad business accountability experience in international sales, marketing, manufacturing, and finance in both the pharmaceutical and aerospace industries. Jeff has held multiple regional and global leadership roles, digitally transforming organizations, re-engineering and standardizing business processes, establishing and embedding next-generation systems and capabilities, all in pursuit of building better customer experiences and driving real value generation. Jeff is currently Senior Director at DT Consulting, a specialist strategy consulting organization supporting the pharmaceutical industry leadership in modernizing their organizations across commercial, medical, and R&D functions. Most recently, Jeff was the Chief Digital Officer at ViiV Healthcare and focused on building next-generation channels and services that leverage bold innovation and digital technology to deliver exceptional and unifying customer experiences, as well as valiant digital health innovations in the HIV therapy area. Prior to ViiV, Jeff worked at Biogen, Lilly, and also Rolls-Royce Aerospace.
Jeff, It is so great to see you again and have you with me today!

Jeff French: Thanks, Naji. Great to be here and appreciate the opportunity.

Naji Gehchan: Can you first share with us your personal story? What led you to healthcare, leading large transformations and digital teams and becoming a senior executive in health industry today?

Jeff French: Yeah, sure. Um, it’s been a, it’s been an exciting adventure. Um, one that was, a lot of people say is a bit unusual, uh, because what, where I started was in finance. Um, and coming right out of university straight into the aerospace and the finance capacity, um, and really focus some, my energy a lot around, uh, making sure I understood how the business worked.

Um, that’s the beauty of finance. You get to learn a lot of different things, uh, from, you know, manufacturing to, uh, you know, the, the HR people, administration, sales, marketing, everything. Um, and what kind of drove me, uh, from aerospace was, um, The opportunity that technology presented. Um, I was helping the, uh, the company I worked for implement, uh, SAP, right, which is back then was the big thing.

And everybody really, uh, focus some energy and some investment in it. And obviously at that stage, I was young. Um, I was traveling around the world for, for Rolls Royce, helping to implement new sales and marketing, uh, warranty programs. And then I got, I got a call after doing the IT work saying, Hey, why don’t you come help us out in a small, um, Uh, effort at Eli Lilly and company.

And so I did. I jumped ship and went over there. Um, still in a finance capacity, but focusing on I. T. And specifically S. A. P. Implementation for for finance. Um, and that’s what really got me into health care and what got me hooked. Um, and I started really understanding the way that the pharmaceutical industry works.

Um, the misunderstanding that sometimes is associated with that. Um, and how the real focus is on helping people live longer, better, healthier lives. And, but really understanding that, that from a lens of, of it and finance. Um, so I understood how the drugs were developed, how they were produced, how they were sold.

And that really carried me forward, uh, for kind of the middle part of my career in many different avenues. And I was fortunate that, um, one of those was to join a program that allowed me to go around the world, um, and work in many different countries in support of that goal of producing better business processes in the kind of finance IT arena.

And that just opened my eyes completely about the realities of global health, uh, the realities of what it meant to, uh, to, to help influence therapies in different countries on, on improving health outcomes globally. And, and it made it so that’s where I realized at that point I wanted to stay. Um. Um, and also at the same time, it also made me realize at that point, I spent about maybe half my life in the United States and I was sitting here going, okay, well, what’s next?

And the opportunity outside the U. S. also came, uh, to fruition where I was able to, you know, work in many different countries, but really cemented myself in the UK. Um, and that was great. Um, and, and from that point, it’s, it’s been a learning journey and it was in the UK where I started owning and controlling and managing.

Um, everything related to I. T. For Eli Lilly. Um, both on the infrastructure, the technology, the business side, but more importantly, also is where I got my first taste of the commercial side of the business and really implementing. Programs that made a difference in utilizing CRM, the websites, the emails, all that stuff really started coming into and that’s when I started owning and controlling that it was the place I wanted to stay.

I knew that I hit the sweet spot of the focus area that I wanted to be in. And it was it was new. It was, you know, we were all feeling it in our in our personal lives, and I wanted to figure out how to make that live and breathe in health care. And that’s what carried me forward. So from 2010 onwards, I focused pretty much solely on commercial, um, technology, digital engagement, digital transformation, data and analytics, um, and all in the support of building better customer experiences, better outcomes for patients, et cetera.

And so I did that with Lilly. Um, really, they helped me You know, kind of through that experience, build it up, learn it well, also taught me how to work with my leadership, you know, in that capacity to really make a difference. And then I left Lily to go work for Biogen, do the exact same thing, but globally with Biogen and, uh, really, really appreciate that, that opportunity, uh, but expanded a little bit, not only from, um.

An I. T. Perspective, really focusing squarely on digital and what that could do and do it differently. Um, and also get a little bit takes innovation at that stage. So I started playing around in the innovation world and the innovation agenda and how to think about the next generation of care standards and how to, um, create new ways around that.

And then that led me to be, uh, where I absolutely loved my time at B for four and a half years doing exactly that. But more importantly, pulling it through, um, making sure that everything that we, we helped create at VEVE actually pulled through into the lives of the people that, uh, were depending on HIV treatment.

And, um, it’s the first place I can honestly say at scale, we achieved a lot. Um, both in terms of getting the digital transformation out there, getting it embedded within the organization at a global level, and making sure that, uh, You know, campaigns and, you know, engagement activities were all leveraging these, these new standards of innovation around digital transformation, customer experience, management, um, and making sure, you know, we’re starting to see the real fruits of that, that, um, implementation and activities.

Thanks, Jeff,

Naji Gehchan: for sharing your story. Before we go into your passion of digital and tech, I’d want to start really from the leadership front. You’ve been leading through large transformation across multiple geographies, different countries. I’m interested to learn more about One of the key learnings you had dealing and managing those large transformations,

Jeff French: the first, probably the biggest one.

Um, and I learned it very early on. Um, and again, goes with kudos back to the leadership at Lily for helping me to realize this. Um. First and foremost, when you’re dealing with large transformations on a technical level, focusing on what creates a common understanding across the leadership is absolutely imperative.

And the common understanding in a healthcare organization is all about what you can do to create better outcomes. Biggest learning I ever had is always take it back to the people that matter for the organization. And in our case, in health care, the people that matter are the people that are taking the, um, and taking the product, taking the products and the patients, right?

At the end of the day. Um, and that’s the biggest learning is if you can always take it through. To that conversation about what the difference is going to be, what it will make in terms of value for the patient. Um, it’s something that gets everybody on that equal playing field. Um, and that’s something I still to this day hold very dear.

You always think about the outcome of what you do and that carried me forward. I think from Lily and the conversations executive leadership teams driving to common agendas. Right. That’s the other big thing. This is a common agenda around the patient, um, making sure those common agendas, common objectives across the leadership are shared.

Um, and in the case of IT and technology. It was hard, right? Because back then it was more of a service function, right? So it’s, how does that, but nowadays it’s part of the, the, what do we call the, the, the fluid nature of, of the healthcare business. And everybody has a bit of technology and everybody has a bit of finance.

It’s no longer a separate function that has to service. It’s actually something that’s embedded in pretty much everything they do. So that’s allowed me to carry this. You know, leadership focus forward on on the end result on the actual patient outcomes. Um, and it made me smarter in terms of how to talk about it, how to think through business cases, how to create, um, you know, discussions around return on investment and return on objective, which is also something that’s near and dear to my heart.

So these are things that, um, really, I hold dear. That was the first thing I learned, and it’s the thing I still to this day carry forward.

Naji Gehchan: I can totally agree and relate, obviously, all we do is having patient at the heart and the center of why we’re doing what we’re doing on a daily basis and in health care, and you touched on this.

So, uh, I’d love to get your thoughts. I think you kind of answered that, but it’s definitely cycles, right? Where you have always this debate between digital I. T. Business R. N. D. Sometimes we go and consolidate everything. Sometimes we separate them and it becomes more infrastructure and, you know, and customer experience who owns it.

So I’m sure you’ve gone through all those different journeys across thinking and in different companies. I’d love your perspective. And now if we look forward, as you said, like those pieces of technology are embedded in everything we do. But how do you think about it organizationally and how for you a successful.

Organization should look like to answer and integrate actually those breakthrough innovations we are having both from obviously the medical side and healthcare, but also incorporating all those breakthroughs in tech.

Jeff French: Yeah. So that’s a great question. Um, and so it’s an interesting one. Cause if, to your point, the cycles have continuously evolved towards the element of everybody having to have some responsibility towards it.

Um, but if you think about what’s next and where as a leader, how, You know, effective companies really grasp and take hold of what these new technologies bring to bear and take advantage of them. They’re starting to showcase those companies that think in the leadership group that think about that as a core competency.

Those are the ones that are getting ahead. Those are the ones that are doing the things that everybody else wants to do, but their history, their culture, the things that, um, Uh, you know, got him to where they are today are actually slowing them down because their mindset to to take hold and take advantage of these technologies is one of incremental innovation versus those that are really trying to change the game.

And you can see that in healthcare right now, and especially with a lot of the new startup. Um, you know, healthcare companies who are really taking full advantage of the fact they just don’t have all that debt. They don’t have all that history. They don’t have all that baggage, right, around their technology and digital.

It’s harder for them to just pick it up and shift, whereas new companies are doing it instantaneously from day one. And it’s a bit of a cliche, right? You know, startup companies, you know, like you saw in the dot com era, could come in and just, you know, boom and create new business models really, really quickly.

Well, the funny bit is Those who are taking the risk to do that now to really jump into that space, and it’s a bigger risk than it used to be, I think, um, are the ones that are actually achieving more right? Um, as you would expect, but it’s the mindset of the leaders that’s been in a, uh, in a conference room.

And talk about where do we want to take those risks? What are the risks worth taking? And, and because technology has caught up so fast and it’s about ready to leap frog even faster with generative AI. And if people are willing to. Think through it, understand how, uh, large language models work, understand a little bit about the risks that they’re taking, then they’re the ones that are actually going to get ahead faster.

I’ve seen some recent, um, a lot of writing about AI, and I’ll use AI as an example of latest and greatest technology. It’s not the only one, but it’s, I’ll use it as an example. Um, but how pharma companies, as an example, are starting to think through it. A lot of pharma companies, big ones, are stepping their, you know, dipping their toe in.

To try and figure out what this thing is going to do for them. A lot of them are focusing on internal. They’re trying to build the understanding of what it can do, the types of risks that it’s going to create, the type of, they’re taking what I call the incremental approach, you know, to get to that next generation of technology utilization.

However, other organizations, new ones, are going, I don’t have to worry about that. Here’s how I think this needs to work. Here’s the processes that I need to build trust. Into my large language models and my generative AI such that they know the outcome on the other side is going to be valuable and some people make it a bit of a leap of faith on that trust factor.

Others are actually, you know, trying to qualify it along the way very early and those that are doing so are achieving much greater results. So the leader in this in this day and age, it is about taking bigger risks, but it’s calculated risk. And I think in the technology and digital landscape, it’s more important that they do that faster than any other time in history, because it’s so hard to incrementally innovate in the new technology landscape at this moment.

You have to take a risk to try something completely different, and people just have difficulty in doing that. Many, uh, Walk of life, but now in business, the team bigger,

especially

Naji Gehchan: in health care. So can we go a little bit more deep in this? And really, I’d love to get your view, actually, of those breakthroughs.

And how do you see it pan out somehow in health care? So you talked, obviously, about AI. We’re trying in different spaces to touch AI in the pharma industry, obviously. Uh, you can hear about, you know, some years ago about digitalization. We’re not even there. I think, you know, from, from a healthcare, if you look from all our value chain, we’re not digital or even thinking about customer experience digitally or omni channel, et cetera.

You have health tech, tech bio, like there’s a lot of buzzwords these days. So you who are an expert in this domain and consult with executives daily about. All the stack. What is what is the future vision? How do you see us? What is the possibility? I’d love to get like a futuristic view from you, Jeff, looking forward for for biotech

Jeff French: and formal.

Sure, so I can tell you my perspective on how I think things are going to pan out over time. And obviously, this has yet to be proven, but it is my opinion, but it’s. It’s one that, um, I think there’s some natural stuff that’s just going to evolve. Let’s first maybe start on the research side of health care, because I think that’s where the biggest implication, uh, will, will be.

Um, you know, what generative AI, what these new technologies do is process large amounts of data quickly and help propose new models on how to evaluate the effectiveness of, of, of what the data is telling them. So, by default, that lives in R& D. That is the bread and butter of R& D. That’s, that’s where we, you know, the, the power of computing will generate new avenues of opportunity for the healthcare sector faster than they’ve ever seen before.

The key factor there is trust, and trust in the data, trust in the, the ability to evaluate that data. But it’s going to happen. It’s going to happen fast. Um, and those who get there and focus their energy there, Will be the ones to first create the newest opportunities in product. And I think that to me is massive.

Um, and if every pharma company, which so far I’ve seen most, focusing their energy a little bit in that space to start doing that learning, building that trust, um, they’re, they’re gonna, they’re gonna achieve big things. But probably the piece that people aren’t thinking about. Um, is and we have a lot of people talking about internal operation efficiencies and how any I can create better opportunities there, et cetera.

But it goes back to what we said or what you what you said a few minutes ago. Historically, the industry has been the laggards when it comes to customer experience. Um, the funny bit is there’s there’s lots of data that we have around, um, you know, our products, what’s used, how it’s used. Um, there’s Especially in certain markets in the world where you can actually validate that with, with real time information, um, AI can now take a look at that and start to predict, you know, trends that can start to predict behavioral shifts around a product that can start to predict, you know, what worked and what didn’t work on or what could work or couldn’t work on, um, campaign development.

What’s important information? Um, historically, you know, Uh, pharma has always been scared of getting to what we define as, uh, in the, in the commercial world as an end of one, really understanding the individual customer and understanding what makes them tick, what their needs are, because it’s in our world, it’s hard to manage, it’s hard to support, it’s hard to provide new information at an end of one.

Well, with the power of AI and the power of generative AI, that can be done. So, specific, tailored campaign message around a specific therapy need for a given physician, uh, which has a patient portfolio of X, you can start to leverage that understanding and that power much more effectively to generate real time, responsive, uh, information to requests that those physicians may have on the product.

Um, so that’s being led by the physician and we’re there 100 percent to support it. And historically that would take weeks, if not months, to answer. Right? Now it can be done in seconds. And so the construct of commercial and medical working to support the portfolio of patients that a physician has is becoming clearer and nearer to, to, to healthcare’s focus.

And it needs to, um, cause I think only collectively between the likes of, uh, the pharmaceutical companies, the healthcare insurance companies, the physicians, the hospital network, the clinicians. Does the, does the uniqueness of a given patient actually become solvable, right? In terms of appropriate care, the constructs of, um, of, um, personalized medicine, right?

And tailored therapies. It becomes a reality, but all that has to start coming together. And historically, it was always kind of shied away from. Everybody thought it’s possible, but the complexity to make it happen was too difficult. But now, because you have this, these engines that can do that in almost real time, I believe strongly that that is what’s going to lead us down to tailored therapies.

Um, And it’s all because it’s based on information that they’re able and the technologies that bringing together. It does mean contracts have to be different. Liabilities have to change. Uh, the realities of who’s doing what and ways of working has to shift in support of patients. Um, and that’s no mean feat, but the technology will enable it.

Um, and it’ll make it so it’s no longer a question of can I, it’s more of a question of should you. Right. Um, and that’s what I think it’s really an interesting dynamic that, uh, uh, the healthcare industry has to grapple with. But the technology will be there. It’s no longer a question of if.

Naji Gehchan: Well, this is a great and hopeful vision.

Actually, where you’re touching, as you said, from the development early phases to drug discovery to the amount of information we can manage there, but also touching commercially and making sure that each customer and patient get the reliable information that they need. So it’s, it’s really touching all those different.

Functions. I love that you talked about contracting, you know, contracting procedures, like through those transformations, several times you look at those shiny things, but it’s a lot of work actually on the pieces that sometimes are not shiny, which is make sure your SOPs are aligned, reshape them, rewrite them, you know, all the databases, how you, you talked a lot about trust.

So do you really trust the data you have, how you ensure it is reliable and also. putting some light on some of the biases that your data have, especially when you look on clinical trials and how medicine is

done

Jeff French: these days. And to underscore that even further to put it in kind of a technology leadership terminology, right?

If you think about the role of technology leadership, historically, it’s always been about, you know, the fundamentals of architecture and how everything plugs and plays moving forward. It’s going to be around that data quality. It’s going to be around data management. It’s around security. It’s going to be around the things that surround the technology and ensure that it’s working, not necessarily the technologies themselves.

Right? So it’s, it’s making, I was literally in a conversation this week where we were having a chat around, you know, does the future state of healthcare and pharma specifically need to invest at a completely different level on its data? And the simple answer is absolutely. And it should have done it yesterday because the, you know, it’s the old adage of technology.

Uh, you know, garbage in garbage out. If you feed your system with bad data, you get bad data out. And so it’s so important now to build that trust that you spend the time, you spend the energy to make sure your quality of processes, how you’re ingesting data, how you’re integrating with other sources, making sure that those sources have good quality, uh, data management.

Practices in place to ensure that what you’re bringing out to the customer out to the patient is of high degrees of quality as well. Absolutely crucial. And this is the new world of technology. This is the new world of digital practitioning. It’s making sure the data works because the technology that’s the things that are making it all happen.

That’s actually getting easier because it’s all becoming off the shelf. Right. And I see that just evolution continuing. Um, back in the day when I mentioned earlier when we were doing SAP, everything had to be configured. All the data had to be managed by people, right? Nowadays, it’s all in the cloud. It’s all being done for you.

You have little buttons you can push, and it changes the way entire processes work, right? And in the future, those buttons won’t need to be pushed because it’ll be automated in some way, shape or form based upon predictive artificial intelligence. These are the things that will just make sense.

Automatically happen. It’s about how well the data is, how well those triggers to automate are actually curated and care and validated by the data itself. So just new roles and people in leadership positions have to understand this is coming. So skill sets and capabilities and training around this to to build this.

This new ecosystem

Naji Gehchan: is going to be crucial. So Jeff, one of the questions I frequently get from leaders and leading those transformations, right, whether commercial or R& D, probably more in commercial, because I think in R& D, we’re used to invest and wait longer to get a return on our investments, right? I feel in commercial, there’s always this question like, yeah, okay, you did this digital transformation.

Where is there a return, right? And you talked about, uh, in the beginning that you’re a fan of, uh, return on objectives. So how do you think about this? Because what you’re sharing is really deep investments in things that probably we won’t see in three months as a result, but more down the line in the customer experiences and lifetime value of, uh, of customer experiences.

So how do you help execs? Think about our I and their time frame specifically in this high tech transformation. We’re living.

Jeff French: Yeah, it’s um, it’s an interesting one because, um, obviously everybody wants to return faster, right? They want that validation. They want the ability to to confirm that their investment is worth everybody doing within the organization and scaling it quickly to be able to maximize.

And I think this is where a new rule. A new thought process goes a little bit to what I mentioned early on about um, kind of wiping the slate clean and starting from scratch. There, there needs to be an expectation in leadership. When you start to go down these paths, there’s different ways that you can do it.

Um, you can actually now basically start anew. You can, you know, carve off a country, carve off a business line, carve off different functions, start anew, look for that business value quickly, stand up those new processes, get that ROI or ROI, return on objective done and defined quicker. Um, it is doable.

It’s more expensive, typically, to, to, to do that kind of an approach, um, in the short term. But it’s it actually validates your your opportunity faster versus the other way is people incrementally innovate. They incrementally try new things, but they’re always then comparing that with what they already do.

Right. And that’s where people have tendency to get stuck in this new world because sometimes. Um, the values clear, right? Case in point. You can now use generative AI to create content, right? So there’s a mechanism by which you can leverage data to say, Hey, I need a new piece of content that’s going to go out on this email and I need an email created for this prompt and I need it to say X, Y or Z.

That can be done in seconds. Whereas historically, that would take you weeks, right, for something like that to be produced. Um, because you got to validate the market research, you got to validate the data behind it, the customer segments, you got to do all that stuff. But with generative AI, it takes seconds.

Right now, the question is, do you incrementally roll that into play within your business or do you start and for a whole new business and try, try a new and I would argue what back to the risk discussions. Most leaders have tendency to say, well, I don’t want to upset anybody in my organization and basically all that work that they historically have done or what they’re used to.

It’ll be easier if we increment within this culture of our organization. But those that are on the edge who try things differently, they start anew, they build from scratch, they try something completely different, validate it, and get it, say, yep, they pilot, I know I hate that word, but the reality is they try it, they focus it, they look for the result, did I get it, yes, okay, scale, right, and it’s, it’s about Constantly measuring, right?

It’s about making sure that whether you’re incrementally doing it or whether you’re doing it anew, you’re constantly measuring and looking for that value driver constantly. Just know when you incrementally do it, it’ll take you longer to get there, right? But know that up front and leaders have to agree with their other leadership that that’s the path we’re going to take.

Because that’s the, maybe the, perhaps the way that company wants to take it versus others who might be more aggressive, go, we’re going to do it this way. But once we do it, I need your agreement. We’re going to scale fast. Right. So it is an element of constantly measuring. I think there’s a new world of measurement.

I’m going to sidetrack for two seconds here, Nanji, because I think it’s important. You’ve got the practical side of speed and efficiency, right, which is easy to measure, right? How fast do things get done? Very easy to measure, right? What’s difficult to measure is quality of delivery. Right. You know what we call effectiveness.

Did it work? Did it change behavior? Did it provide the level of education that was needed to inform that, uh, let’s say physician on the possibility of, of, of a treat of a new treatment? I, um, paradigm for a different patient type. Did it actually change behavior? That’s the stuff that’s a little more more difficult to manage, but technology and the use of behavioral science with technology is starting to showcase the power of knowing whether or not that’s working.

Faster, and I think you’ll find that with some of the latest trends in this space, whether it’s some sort of, um, kind of CX measure that a lot of organizations are now going to, um. That is one. It kind of near term mechanism that’s being created for people comfortable and to build trust around customer experience measurement.

Um, and they should everybody needs to get on that. Um, because you got to get comfortable with it. If you look at what’s happening in our personal lives with our phones with, um, our online shopping experiences that’s happening. All the time in the background, people are constantly evaluating how long it took you to hover over something before you bought it, right?

Or how long, how many different car websites did you go to before you pick the one that you landed on and stayed there the longest, right? Because you were interested in something, or you went to the configurator to validate something. All that trend, that journey. It’s being measured and being behaviorally and this is the kind of stuff that we have to start getting comfortable with in health care to say, Hey, look, when a, when an individual clearly is not happy with their treatment, they’re going on this path, right?

What is that telling us about that individual or that group of individuals for that matter about what’s maybe going on in their lives? Um, and being able to infer that to help define better options and to optimize their treatment. It’s an example. So I firmly believe it’s, um, it’s a combination of those two kind of how do you want to approach return on investment?

Is it a quick way? Is it a slow way? And then on top of that, the mechanism we use. To determine value is shifting considerably. You have the old tried and true finance, the old tried and true efficiency. And then it’s about this new world of customer experience. And is that generating a shift in behavior?

And that’s the piece that I think is the new edge where everybody should be going to. For sure. And

Naji Gehchan: it gives a lot of hope for, as you said, patients taking in charge and, you know, and talking about this. As consumers of non health and health, it’s sometimes mind puzzling how much you can influence things that are not related to health, where with this transformation, it’s giving more the power back to patients who are making, who should be part of the decision of how they are taken charge.

Jeff French: Absolutely. And I think there’s some, there’s the, if I, if I even cast forward beyond kind of where we are at the moment within this space, I firmly believe that technology companies, uh, the apples of the world, the Samsung’s of the world, they’re going to have to start helping. People with managing their preferences, managing their, um, the stuff that helps them on their day to day basis, whether it be with their health or with their family or with their routines and administrative work that they have to do, um, it’s all going to be automated moving forward.

Um, and so the question is, how do you instruct your technologies that you interact with to help manage that for you? Right. So it’s not to your point. So it’s not giving you false positives or it’s not giving you information that you don’t want to see. Um, I had a great opportunity recently where I was with a, uh, an individual or a group of individuals and we were talking about the future of, uh, of technologies like Alexa combining with, um.

Generative AI, right? So we think of, you know, audio, uh, search and what that might mean for for the future. It’s something as simple as, you know, you’re sitting at a dinner table with the family and you’re talking about your next vacation. You want to go on and then all of a sudden, you know, the one of the one of the, let’s say the parent decides, hey, um, Alexa or whoever.

Um, we just had this conversation. Give me some options. Tell me what, tell me what my options are for that kind of a holiday. The whole time it was listening, the whole time it was, it was understanding that family’s conversation about where they wanted to go, what type of holiday they appreciated. And then on top of that, it’s got all that history, right?

Of understanding what they’ve done historically, what they’ve purchased, where they’ve gone, et cetera. And all of a sudden you can propose three, four or five options about what might be doable within a price range or within a subset of prompts that the, that the family gives it. And my whole point there is, yeah.

You have to tell Alexa that you want that, right? And that you want the, you can’t just assume that it’s going to happen. And this gets into some of the data privacy issues around the world at the moment in security. People have to take control of their health and people have to take control of what they want these technologies to do.

Technology companies have to allow that to happen.

Naji Gehchan: So Jeff, now I want to give you a word and I’d love, uh, what first comes to your mind. The first one is

Jeff French: leadership.

Community is the first word that comes to my mind when I think of leadership. Um, and that’s because to move anything in this, in this business and in healthcare, it’s a community of leaders that make things happen, not just one person. And they all have to cut back to the common agenda, common objectives.

Um, and I, you know, and my previous bosses will even probably hear this echo, um, in their ears right now, if they’re listening, because that is the thing that I strive to focus on the most is creating that sense of community across my peer group. As well as those that, you know, provide the, the, uh, the capability that we’re trying to develop and transform with.

Um, because it takes a group to move a mountain, right? And we have a lot of mountains to move.

Naji Gehchan: What about innovation?

Jeff French: Innovation is, um,

opportunity is the 1st word that popped into my head, but at the same time, it’s, it’s also about focusing on innovation and opportunities that make sense. There’s a lot of playing going on and a lot of people trying things because they can, um, I always felt like opportunistic innovation is not one that’s going to create value for anybody.

Innovation for purpose and intent to change things, we need to focus more around. Um. Because a lot of what we do is people are trying to find the next big, you know, shiny object that’s actually not adding any value to people’s lives. And I think in our sector, true innovation will occur with purpose, will, will occur with a purpose.

And I was, you know, my, my time at V taught me that it’s, um, true, true purpose led innovation achieves amazing things. Um, those that it’s opportunistic, just basically you invest in it, goes into a cupboard, sits in a desk drawer, doesn’t really ever come out again. Um, but the stuff that really tries to make a difference in people’s lives and that that’s, that’s different and that’s normally a, a community of leaders.

That make that happen. How does equity? Ooh, good one. Um, inequity is what I first think about it. It’s the first thing that comes to my mind. I do think we have a lot of work to do in this space. Um, lots of innovations have occurred a lot of that and lots of great innovation, even in global health markets.

Where, where the help is needed, uh, great, great things have happened there, but I would argue not great, not good enough. Um, the, the, the inequity continues. Um, and I, and I think that’s in this day and age, when you have therapies and medicines and products and services and processes, where it’s all about trying to stop it, you know, from for diseases to get out of control.

I mean, cobit proved we can stop things. Um, and yes, there are bits of it that are still continuing that have evolved, et cetera, but we all don’t have the confidence that it can be done. I think there’s. Work to be done to make sure that, and I think it would prove that there’s any quality inequity. Sorry in, in getting that medicine and those treatments out to the places where it’s needed the most.

Um, so I guess, yeah, don’t mean to put a downer on that, but I think there’s more work to be done. There’s more thought leadership around how to do it. That needs to be put in play. Um, and how technology can, can fix some of it. I think there’s a lot of opportunity there too. Um, yeah, probably not the right that, the answer that, that, you know, not the high, the, uh, positive answer you wanted to hear, but it’s definitely how I feel about it.

Naji Gehchan: The last one is spread love in organizations.

Jeff French: Yeah. I think there’s, it goes back to my community principle, I think with a clear common purpose. People can move mountains, like I said earlier, and if people put their personal ambitions aside. And start thinking about the group ambitions and the community ambitions,

the construct of spreading love within an organization will rise. And I’ve seen it and in organizations where the passion, the commitment, the focus on the outcome is what’s really driving them and the focus to resolve personal strife, uh, through, uh, particular issues and disease areas. When people focus on that, it, it, it works and everybody’s.

You know, feeling like they’ve accomplished something in their in their life, and I’ve been fortunate to be part of one of one of those. And now I want to continue that. So spreading, spreading the opportunity and the two on how to go about championing, you know, these, the next generation of technology to solve these kinds of problems and help people think about this community spirit and be as one to drive and solve problems.

Yeah, it’s a great, it’s a great feeling.

Naji Gehchan: Any final word of wisdom, Jeff, for healthcare leaders around the world?

Jeff French: Yeah, I’d ask a lot of them to think differently about technology and digital. Don’t think about it as an incremental thing that’s going to help your existing core business. Think about it how it can change your business holistically.

Um, think about how, what plans you’re putting in place to, to do exactly that. Um, you’ll save money. You know, initially, maybe you may have to invest to do that, but over time, you know, process costs should reduce. I mean, that’s what these technologies are bringing to bear for. Um, and so there’s an element of, you know, ensuring that these opportunities are on the agenda, you know, that it’s a common agenda that the leadership are always focusing in this space.

And it’s not, how do I create, you know, what everybody else is doing. It’s how I’m doing it different than everybody else. Um, cause I think there’s, there’s huge opportunity there for people to think differently in the healthcare space versus just be one of the same. Well, thank you so much,

Naji Gehchan: Jeff, for being with me today.

Jeff French: Thanks, Naji. It was an absolute pleasure. Really, really appreciate this. And, um, yeah, let’s, let’s keep spreading the love cause this is, this is a fantastic podcast. I really enjoy it. And, um, and I think we’re going to make a big difference.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Saloni Behl

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Saloni Behl an accomplished leader with over 16 years of experience in building high-impact strategies to grow companies and make them more efficient and effective in bringing transformative medications to patients. Over the last 10 years, Saloni has been in Otsuka Pharmaceuticals and has played a critical role in helping the company grow its portfolio within Neuroscience and Nephrology. She has undertaken leadership roles in New Product Planning, Business Development Strategy, and most recently R&D. Saloni believes in leading teams by observing, understanding and empowering. Her childhood experiences have taught her to see things other might miss, to bounce back from challenges, and truly value the people she works with. She is passionate about making a real difference in brain health.

Saloni, it is such a pleasure to have you with me today!

Saloni Behl: Well, thank you for having me here. And I’m also very excited and I feel privileged to be here.

Naji Gehchan: Can you first share with us your personal story? From biomedical engineering to leading R&D in pharma, what’s in between the lines of your inspiring journey?

Saloni Behl: So actually it starts way before biomedical engineering. Um, I. Uh, my childhood was spent in in Mumbai, India, and I had a little bit of a rough upbringing where I was abused.

I was exposed to a household where there was a lot of trauma. My father was, was an addict and he was pretty much addicted to, uh, anything, whether it’s tobacco or alcohol or, um, you know, gambling or, um, abusing my mother. Um, and growing up in that sort of a household, uh, I very early on became very acutely observant of what was happening in the world around me.

Um, and I went through a lot of my childhood as almost an observer of life, very passive, average student, um, doing the bare minimum needed to get by. Um, I was very, thankful and very lucky that my mother, um, garnered the courage to eventually get out of the marriage and, um, you know, start to rebuild life.

And within a couple of years, she met a wonderful human being who, um, she got married to and, um, we moved to the U S. Um, with with our with our family. Um, but as my as my life progressed and childhood progressed, um, uh, I continue to stay while while life was rebuilding. I would say around me. I continue to be more of this acute observer of life.

Um, and just when things were, you know, starting to rebuild. I, um, I remember I was in a classroom in my in a physics class. In high school and, um, my, my left eye protruded about two inches out of its socket. And, um, basically three years, many misdiagnoses and many, uh, hospital visits later. Um, I sat in Mayo Clinic and was told that I was at risk of losing my eyesight because I had, um, basically a tennis ball sized tumor pressing against my optic nerve.

And, um, for me, that was probably a turning point in life and a big turning point, um, as they say, sometimes a crucible, um, where essentially I realized that, um, you know, it was time to not be an observer of life, but actually be an active participant and start to shape life, um, you know, in a way that you can actually drive change.

And for me, that change was, was healthcare at that time. So, um, for me, a lot of my childhood has shaped honestly my, my leadership journey. Because even today, um, you know, I lead by obs. I, I lead by observing and then by understanding and being more resilient. Being resilient through challenges. And a lot of that has come from, from my childhood.

But as you know. But, you know, post that, I think my life is what you mentioned, where, you know, I decided to study biomedical engineering, um, and since then I’ve been on the health care bandwagon trying to drive change wherever, wherever, um, wherever possible and, and never looking back, essentially. Oh,

Naji Gehchan: Saroni, thank you so much for sharing this part of your, your story.

How you framed it from acute observer of life to an active participant and driving change and you’re certainly are driving change and bringing, I know you brought recently drugs also to patients and this is, this is why we do what we do and you’re certainly doing it every day with your teams. So I want to start with, you said, observing, understanding, empowering.

This is kind of your leadership. and how you lead teams. And it certainly comes from your past experiences. Can you share a little bit more about this, about your leadership signature, about how you drive your teams towards the purpose of making life better for patients?

Saloni Behl: Yeah. I mean, I think, um, you know, as I mentioned, it’s a good question.

I mean, as I mentioned, a big part of my leadership is observing, understanding, and empowering people the way I, the way I, um, the way I Utilize that in my day to day is, um, I’m very acutely observant of if there, for example, there are inequities in the workplace. If people are being mistreated in the workplace, if their voices that are not being heard in the workplace, if people are not, if the workplace is not being adequately represented with certain voices and diverse voices, um, so I use that sort of to my advantage, um, because I In meetings, I will, you know, try to make people speak up who, for example, are not getting a chance to speak up.

We’ll try to be as inclusive as possible when we’re discussing strategy, for example, for a product or for the company. Um, that’s how I sort of apply. My observational skills that, um, you know, I think have shaped my leadership and then in terms of, you know, trying to empower people. It’s linked to that because, um, if you’re somebody who sees a lot, then it’s it’s your job to act.

And, and, um, and do something about it. So, um, I do wherever wherever possible. I make sure that, um, that that individuals, whether they’re on my team or individuals I mentor, which there are quite a few within my company, um, are empowered to speak up empowered to act and and not just observe.

Naji Gehchan: You know, several times I was asked when we say spread love, if love is an acronym for something. And it’s, uh, it’s interesting two of the words you have. So at some point I was, you know, reflecting on it, it’s listen, observe value and empower. So we, we certainly do align on, on how leadership should be. And you’ve done, you’ve been a leader in different functions, uh, within, uh, within your company.

Uh, from commercial product planning to now leading RNC cross functionally, uh, on, on one of the assets. Uh, what are your biggest learning? As you have moved function and led different capabilities, different, uh, different people. Also, uh, is there, was there a common thread and all those roles from leadership perspective that you had?

Saloni Behl: Yeah, absolutely. I mean, the, I think the common thread for me is. Being able to elevate voices across the organization and elevate opinions, elevate insights across the organization, which I think whether you’re a leader in commercial or a leader in R and D or your leader in business development strategy, um, to develop effective strategies, no matter where you sit in the company, you need to bring the right people to the table, the right voices to the table, make sure you have, you know, discussions and elevate risks, elevate, um, You know, elevate roadmaps that you need to put together.

So I think that’s been a skill that I’ve had, which is mobilizing teams in an effective, effective and efficient manner towards driving milestones and decisions. And so wherever I sit, um, you know, it’s It really doesn’t matter and that’s what sort of helped me move around, I would say, and drive change.

Naji Gehchan: So your passion is in neuroscience, and these days it became, I should say it has always been, but it feels like these days it’s really an exciting field. Like we’re seeing so many advances from gene therapy to Alzheimer’s, everything’s happening in those fields. So it’s certainly an exciting, um, time to, uh, be passionate about neuroscience and most importantly for the patients, right.

And in this, uh, suffering from neuroscience diseases, I’d love to get your view and what is most exciting for you, uh, in the future of this therapeutic area.

Saloni Behl: Yeah. I mean, that’s a great, that’s a great question. And there’s so much exciting. There’s so much exciting work happening. So it’s, it’s hard to pinpoint one thing, but I would say, um, within neuropsychiatry, let’s say as a category, the, the two areas I’m most excited about is, um, one digital therapies that are, um, actively being developed, um, in the space to treat a lot of, um, mental illnesses.

And then second, um, I’m seeing a lot of, uh, very, very robust evidence come out in from psychedelic based therapies, actually, um, in the neuropsychiatric space where you’re looking at, um, you’re seeing some really interesting phase two and phase three data emerge that shows that these medications could potentially treat the brain in a very different way than traditional therapies.

So I’m, I’m excited about that. I would say I’m very excited about the digital therapy space as mentioned. Um, also because of, um, the number of patients this could potentially access. Coming from a country that’s developing and a lot of people don’t have access to therapists or physicians there in places that are far away from doctors offices.

Um, I think if one, but I think if you’re able to get digital tools to those places and, you know, somebody can get. Get treated by an app that could be transformative and imagine the number of patients who could get care that don’t currently get it. So I think that’s the aspect of digital therapies that gets me very, very excited.

And, you know, there’s, there’s, there’s, there’s challenges to navigate across all of this, but it just, I feel hopeful.

Naji Gehchan: That’s why we’re here, right? Like, making sure that we overcome those challenges. And I know you’re doing it. On this, you, you talked about access. and inequity in access. You talked about where you come from.

Um, I also, uh, come from a country that has challenges where, where I was born through access. So how do you think about health inequities or health equity globally as a healthcare leader these days?

Saloni Behl: That’s a that’s a good that’s a good. That’s a great question. Um, globally. Yeah, I mean, I think there’s more inequity than equity, to be honest, and a lot of a lot of the globe.

So, um, I, I think it’s, yeah, I mean,

think about this a little bit.

Yeah, I mean, I mean, I think it’s health and equity is Related to related inequities and so many different arenas, right? Like, uh, income, inequ, inequity, um, you know, uh, d uh, just like the access to, like hygiene for example. Like there’s inequities in so many different arenas across different countries, and I feel like the countries that are really struggling in, um, education, in hygiene in.

Um, uh, you know, income inequalities. I think they’re having to struggle with a lot more health. Health and equity just goes hand in hand with that. So, um, my Yeah, I thought that is just that it’s so it’s so linked to what’s happening, you know, and it’s a big question.

Naji Gehchan: I, I definitely agree with you. You know, I think of it and we both when you are currently a student at MIT, but it’s certainly the system dynamic, right?

As you said, like, it’s so interlinked those there is. systemic inequities built in, in our societies, right? From, as you said, uh, information, education, like it starts very early on to unfortunately health equity. Um, so, so it’s certainly interlinked and we, we have, uh, we, we have this responsibility as healthcare leaders to look at it, think about it and, and make a change.

Saloni Behl: And think about it to your point holistically at a systemic level because it’s so linked. Yeah. Yeah.

Naji Gehchan: Yeah. So I’m going to move now to a section where I’m going to give you a word and I would love your reaction to it. The first one is leadership.

Saloni Behl: Responsibility. Um,

Can you share more about it? Yeah, absolutely. I mean, I think, um, as you as you grow into leadership roles or as you have a leadership position, I think your responsibility increases to be, you know, responsible to give back. You’re responsible to, um, to do more. You’re responsible to empower people around you to also grow as leaders.

So I think with leadership, with good leadership comes responsibility. Responsibility to contribute to give back, um, in whatever organization you’re in, whatever role you’re in. Um, and and even outside, um, the organization to the community and, um, and to society

diversity, um, inclusivity. And the reason I put those together is I don’t think diversity by itself is enough when you have, for example, a diverse workforce. What’s the point if you can’t build an inclusive environment where the diversity can actually speak up? So diversity without inclusivity is, to me, um, not enough.

Uh, yeah. What about brain health? the most complicated, uh, problem that we’re, we’re sitting on today. So brains, um, you know, unlike a lot of other parts of the body, the brains, I believe truly believe are the most complicated machines on this planet. So, um, brain health. by default is, you know, trying to solve problems, um, to fix parts of the most complicated machine on this planet.

Uh, so complex.

Naji Gehchan: The last one is spread love and organizations

Saloni Behl: necessary. This, this, uh, organizations can’t operate without love, without empathy, without, um, understanding, um, So I think that’s just the core of the DNA, the blood of organization that keeps organizations going, um, even in this, this, this, the world of AI and generative AI, um, love is what keeps us.

I love that.

Naji Gehchan: Any final word of wisdom, certainly for health care leaders across the world?

Saloni Behl: I would say that what, like, I think, you know, just that I think people should just health care leaders across the world should just remember that, um, health care will and always be some of the most pressing need, um, globally. And, um, it’s really important, um, as health care leaders of tomorrow and today, that That leaders work together with each other to to try to solve some of the needs.

Um, it’s time to not work in silos. It’s time to work as a community to towards figuring out some of the most solutions towards some of the most pressing problems that the world faces in health care.

Naji Gehchan: Well, thank you so much, you’re such an inspiration for many. And I really thank you for your time, your generosity and your vulnerability being with me today on this podcast.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Shawn Nason

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Shawn Nason, CEO of OFFOR Health, a company that reimagines outdated healthcare models to accelerate access to care for those who are under-served and under-resourced. With over 15 years of experience in creating and transforming experience ecosystems, Shawn is passionate about reimagining how people interact with health and wellness services and products. As a former Disney Imagineer, Chief Innovation Officer, and founder of the Disruptor League, Shawn has a proven track record of leading and executing innovative projects that generate significant revenue, customer loyalty, and social impact. Shawn is also an author, speaker, podcast host, and neurodiversity advocate.
Shawn, It is such a pleasure to have you with me today!

Shawn Nason: It’s great to be here and thank you for having me Naji. Um, it’s an honor to be on your podcast. Thank you.

Naji Gehchan: Can you first share with us your personal story? From Disney to healthcare, what’s in between the lines of your inspiring journey of social impact?

Shawn Nason: It even starts before Disney, Nadja. I, um, I was a professional musician who, um, was a pastor. And in 2005, after leaving pastoring full time, my wife and I, um, lived in Orlando, Florida. My wife worked for one of the big hospital systems there.

And I didn’t know what I was going to do. And so, all of a sudden, We had this moment of what’s next. And my wife looked at me and said, Hey, why don’t you go to work for Disney? And I said, great. And we’ve always been a Disney family. I said, great, let me go apply. I said, there’s only one condition. I don’t want to do entertainment.

Like I was done doing entertainment stuff. And so I went and applied and got hired. Long story short, stayed at the company almost seven years, had many different roles, um, but my last role, um, and my longest role there was with Walt Disney Imagineering, um, and that’s where I really, um, Learned and probably changed my life forever around what experience could be like for guests, for customers, for cast members, or associates, employees.

Um, and, and that, when that journey was time to end, came to, time to end, uh, I was recruited into healthcare. I had been exposed to a book of If Disney Ran Your Hospital, and some of that program, and helped bring that to life, and so I was recruited into healthcare by Humana, and that started my journey into healthcare, so three years at Humana.

Then I went to be a chief innovation officer at a university to stand up a health care consulting group at Xavier University, um, and then I started my own company called Mofi, M O F I dot C O, and it’s an experienced design group, and uh, Mofi still exists today. Um, we do ton in the experiential space, we do ton in strategy and innovation, um, for organizations.

We’re a boutique consulting firm. Um, and then earlier this year I had the opportunity to step in and be interim CEO for Offer Health. Um, I was there for eight months and left there, um, here in the middle of September. Um, and now looking for what’s next for me and what the universe has for me. Well, thanks for sharing,

Naji Gehchan: Sean, your, your journey.

I’m intrigued about how you’ve been using your learning, as you said, which was a transformational experience in Disney, Imagineer, to now solving such a crucial issue in healthcare, access to care. Can you share with us a little bit your learnings and how you’re applying them into

Shawn Nason: the healthcare world?

Yeah, I will tell you, um, it’s, uh, it’s so simple, but yet so bizarre for people and, and I will, I’ll wrap it up in this saying, and the saying is, if you get the human experience right, you will get the numbers you need, and so what that means, and, and how even that translates into bringing access to care and rule, um, Areas, um, or just in general, um, because we know it’s not just about rural areas.

It’s about access to care in general, across our, our country is treat people humane and they will do what you need them to do. And so my experience as a leader has been build amazing teams, treat them as humans, and then you can go conquer the big problems. And so. Even at All4Health, that’s what we were doing there when it came to providing access to care for pediatric children on Medicaid.

My journey at Humana was around bringing access to care to to those in the state of Mississippi, as well as in the state or in the city of San Antonio. So I have a passion for that. I have a passion for the underserved under resourced communities. And the way you’re successful in that is just start treating people humane.

Um, it’s not an easy answer anymore. And I think we’ve tried to boil the ocean in healthcare. Let’s just take it one bit at a time.

John, I love this. And

Naji Gehchan: we always hear how much healthcare is broken as a system in the U. S. We can also talk about healthcare inequities here in the U. S., but also globally. And I love that you’re making good. really focused on treating patients or even people, right? In a humane way. Can you give us concrete examples?

Because I know you impacted local communities and you gave two of those communities in the past work. How specifically would you do this? Is it through the patient plans? How do you do it with health care providers with systems? I’m intrigued if you have a couple of stories you can share with us on specific impacts we can do

Shawn Nason: as leaders in health care.

Yeah, I’ll share. Um, the most common one and, um, the, the most recent one for me because I think it really is an impact, um, uh, we at Mophie have the honor of partnering with the former CEO and president of Walmart Health and Wellness, Sean Slavinski is his name. And. We were brought in to help design the experience and launch what today is known as Walmart Health.

And that’s their clinics that are attached to many of their stores in particularly, um, in Georgia and Florida. I think this year alone, they’re, they’re opening their 23rd in Florida. And we were, we were honored. to be able to be there for the first opening and be a part of what that journey looked like for the organization.

So that was a disruptive model when it was brought to market because we did it on a cash base only. So we didn’t look to the payers We didn’t look to the big insurers to come in and partner with us when we were there. And it actually kind of freaked people out at first because they’re like, there’s no way that, that people are going to pay this type of money.

Well, the thing of it is, is we actually made the access to care affordable, um, so people could, could get it. And so prime example, when we launched, you could get a behavioral health, um, session. A counselor for a dollar a minute. So you could have an hour session for $60 or you could go see your dentist ’cause there were dental in those clinics and you could get an X-ray and a cleaning for $25 a visit.

And surprisingly enough, I remember the first time a mother came with her four children to get this done and had a little bit more work done. But for the five of them in the dental clinic spent 200, which if she had to pay through insurance and co pays, it would probably even been more than 200. Um, and so that’s a prime example of find a niche, find an area, again, don’t try to boil the ocean.

I’ll go back to the story at, you know, Offer Health and what they were accomplishing there. They found a niche in pediatric dentistry for Medicaid and went after that and are making an impact there. There are many organizations Doing that today. I’ve become familiar very recently with an organization here in Ohio who does nothing but serve the LGBTQI plus community.

Um, and they’ve made an impact with 21 or 22, um, particular clinics here in the state. They’re providing access to underserved, under resourced communities. Um, in a very impactful way, and that’s going to ultimately change the landscape of health care. Those are

Naji Gehchan: great examples, and I love it because several times we talk a lot about doing big things, but actually, as we said, if we take a small piece of the problem and really act and work on it and solve it.

Well, the impact is going to be broader at some point. Can you, when I’m hearing you, I’m hearing this passion towards underserved other resource communities really focus on access. And with access, you talked about price and the cost of access. When you think of it from a broader lens, right? We can talk about preventive medicine.

We can talk about educational, um, medicine. What are the key challenges? Because I know you’re passionate about this experience. We live as humans throughout our health and wellness. Are there other verticals, if I want to call them, or other parts of a patient journey that you think is really disrupted and you want to

fix

Shawn Nason: it?

Well, um, I, I had the honor on the podcast that I host, the Combustion Chronicles, I had Dr. Adrienne Boise, former Chief Experience Officer from Cleveland Clinic, and now the Chief Medical Officer at Qualtrics, and I remember doing the episode, having a conversation just like you and I are, and she started talking about, let’s not talk about the human experience anymore, but let’s talk about the humane experience, and for Oh, Several days I thought on that, and I thought, well, really, what’s the difference?

And then it kind of hit me. You can have a human experience that’s not humane. Um, listen, I went through April 15th, 2022, I was diagnosed with stage 3 colon cancer. I went through some experiences over that whole year, 12 rounds of chemo, that I would not necessarily call humane experiences. Because… My insurance company tried to drop me.

Um, you know, bedside manners by all were not the best. And sometimes I felt like a number during my journey. So where I think things need to be disrupted in healthcare today is two things. We need to get out of a system that is built for paying claims. Um, and that’s what our system is today. How do we get claims paid?

How do we get the insurance through that? The second one is. Let’s be humane again. Let’s make people feel, not just human, but respected, no matter their race, their gender, their sexual preference, whatever disease they’re going through. I mean, a prominent thing that bugs the shit out of me, I’m just gonna say it, is we still use the terminology chronic conditions.

You know, that’s not humane, in my opinion. People that, you know, you know, people and patients that are identified with being told, Oh, you have multiple chronic conditions. That doesn’t always feel good, you know? Um, one of the things that kind of bugged me on my cancer journey that I, uh, I’m having to, is they use this terminology called NED.

And I heard someone say to me once, Oh, I’m NED. And I’m like. Who’s Ned? And it’s the terminology, no evidence of disease. So they don’t tell you you’re in remission anymore because they don’t tell you you’re in remission for five years. And I know you know some of this where you work and what you do, but I I’m Ned.

So I have no evidence of disease that doesn’t always feel humane, but it’s a human experience. That’s where I want to get disruptive.

Naji Gehchan: Thanks. Thank you so much, Sean, for sharing this. This is really profound what you’re saying. And definitely on several pieces of those journeys we live as humans, we’re unfortunately, we lose humanity and being humane and thinking of it more holistically than just what we’re treating. Um, so I want to go into your leadership beliefs and I think you’re touching some of them where since the beginning, like how you build, uh, teams within the companies you work for to help others build this humane experience in healthcare and medicine.

Um, your heart centered. As I’ve seen executive, this is how you, uh, you identify, um, and really into this mission to human, uh, humanize the word. Can you share more about your personal vision and how you apply it daily and how you apply that daily with your teams and your organizations?

Shawn Nason: Yeah, so, um, this is real easy for me.

Um, I told you I used to be a pastor and so I tell people I have my basic three point sermon when it comes to leadership. Um, and it’s all based, let me preface it, it’s all based in four core principles or values that are what I would consider my heart sets. Um, and we wrote a book about this called Kiss Your Dragons in 2020.

Um, and mine are Honesty, Integrity, Transparency, and Loyalty. So knowing that, that that’s the core of who I am as a leader, I tell leaders, there’s three things you need to do to be amazing leaders. One is be transparent. Don’t hide stuff from your teams, from your organizations or anything. Be transparent, let them know and let them see the human side of you, right?

The second one is This concept of build radical relationships. So build relationships with your organization, your teams, that are diversified, have different thoughts, have healthy tension and healthy conversations in them. Because it’s going to make everyone better at the end. And the third one, Which is so simple, but blows me away is I don’t see how you cannot be a leader and not love people, but yet we continually promote people into roles that don’t want to deal with people.

And so how can you be a leader?

Pretty simple to me.

Naji Gehchan: Simple, but yet extremely complex, it seems. And as you said, we promote and it’s, it’s interesting. I would not going to go into like naming some of those that are considered or like that have a lot of airtime on media who are considered successful leaders these days, and actually really modeling quite the opposite of, of love to, to humanity, even.

Yeah. So it’s certainly. Unfortunate when I, when I see these pieces, um, when you shared your 4 values, the 4th one was loyalty. I’m intrigued by this one, you know, especially. In business life, there’s a lot of discussion, like, are we loyal as a company? Loyal? Are we loyal as people to who should we be loyal?

Can you be loyal to a big corporation? Like there’s a lot about loyalty. So I was very intrigued when you said loyal as a value. And how do you deal with this? You know, joining a company, leaving a company with colleagues.

Shawn Nason: What is your thinking process around this? Yeah, so it’s one. It’s one that Many people that are very close to me, um, and in my very close circle would say it’s to a fault for me.

Um, many times, companies are not loyal to you. Um, that, it’s not going to happen in a company. Now, I hope for those that have worked for me and worked for me at Mophie, know that I’m very loyal to them and have done everything I could, um, to provide the best for them. When I think of loyalty, I think of relationships and it goes back to that building radical relationships.

Um, just recently with my experience, um, I have a team of executives that are very loyal to me that have said, Sean, wherever you go next, we want to go with you because I respected them. I treated them like human people. Humane, not looking down on them, giving them the space, and listen, I’m going to say this, and I probably should have said this earlier with the loyalty piece, and with my three point sermon as well, your job as leaders is not to be in the day to day, your job as leaders is to remove barriers and obstacles so your team and your organization can do what they need to do.

So when I sit in the CEO role, my job is to remove barriers and obstacles for the people that are closest to our customers, to our patients, to whoever it might be. Because the reality of this is C suites and executive leaders are nothing but overhead costs. And so get out of your ego, get out of your own way, and be there for the people that are serving your customers, your patients, whoever it might be.

I

Naji Gehchan: want now to move to another section where I will give you a word. And I want your reaction to it. So the first word is leadership.

Shawn Nason: You have to live it.

Health equity. I’m boggled that we don’t have it right now in our country. Kiss your dragons. Chase your fears and hit them, um, straight on.

Naji Gehchan: I want a little bit more about this. You have a book named like this, so I want my, you know, my audience to know more

Shawn Nason: about it too. Yeah, so. The whole concept of Kiss Your Dragons, if you’ve ever seen, if you have kids, or if you don’t, because some of us watched cartoons before we had children, there’s a movie series out there called How to Train Your Dragons.

Um, and the concept of the, the, the young boy and the dragon who he was taught, um, to fear dragons from the very beginning and the dragons were bad. So a fear of them. But when he got to know Toothless, he, he changed his whole society and that’s what was hard. Hiccup. Which is the young boy’s name. He faced his fear head on.

So much so that he almost lost his relationship with his father. But through that, something they feared, dragons, ended up changing their society. Let’s talk about it happening today. People are fearing AI, right? But it’s ultimately going to change. I tell people in healthcare, don’t fear it. Let’s figure out how to use this concept of high tech and high touch.

How do we use that technology to take the administrative burdens, the BS off people’s plates so people can go back to care for people. Don’t fear it. So, that’s leaning in and kissing your dragon.

Naji Gehchan: I love it and it resonates so much with me. The last one is spread love and

Shawn Nason: organizations. Yeah. Um, again, I don’t understand how you can be a leader and not love people. I love to be around my teams. I love a CEO. I love to walk the floors or be on the calls or be in the field with the teams. Um, so, so I can just love on them. So that’s what, it’s very hard for me. Um, it’s just very hard for me to understand how you can’t spread love in an organization.

Naji Gehchan: Any final word of wisdom, Shawn, for healthcare leaders around the world.

Shawn Nason: Don’t be scared to help change the system. So lean in and kiss your dragons.

Naji Gehchan: Well, thank you so much again for being with me today!

Shawn Nason: Awesome. Thanks. It’s great to be here.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Rehan Ahmed

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Rehan Ahmed, an ophthalmologist passionate about improving eye care. Rehan has extensive experience in the patient eye care journey, from direct medical and surgical patient care, to retail optometric settings, medical OD/MD practice environments, drug development, and novel diagnostic and treatment modalities. His expertise is bridging strategic gaps between patient care, providers, payors, and regulatory agencies. Rehan is a practicing ophthalmologist, Medical Director in Global Clinical Development and Operations at Santen Pharmaceutical, founder of Texas Eye and Vision Associates, and Chief Medical Officer at Blink, a startup in remote ocular healthcare; he also advises multiple med-tech startups. Rehan received his MD degree from Vanderbilt University School of Medicine. He completed his internship at the University of Texas, residency in ophthalmology at Baylor College of Medicine, and MBA from MIT Sloan School of Management.

Rehan, It is a pleasure to see you again and have you with me today!

Rehan Ahmed: Naji, I’m happy to be here.

Naji Gehchan: Can you first share with us more about your personal story and what led you to this multi-facet successful career in clinical practice, medtech and entrepreneurship?

Rehan Ahmed: Yeah, I know. Well, first of all, thanks for having me. Um, it’s really a pleasure to be here and looking at the list of other speakers you’ve had, I definitely have, um, this, um, sense of imposter syndrome and like, I really don’t belong with your luminaries that you’ve had beforehand.

I’m, I’m, I’m glad I somehow snuck in. So, um, Yeah, you know, my, my story really begins in the basement of my home, uh, growing up in a small town in central Illinois. My dad came there. He’s a physician from Pakistan. He settled in essentially a small town. We’re surrounded by farmland and cows. In the middle of, uh, essentially nowhere, uh, but I remember growing up and being surrounded by books, like floor to ceiling books.

My dad was an avid reader, and I would follow through, and on sort of the hot, humid summer days, I would go downstairs, and I would just read voraciously. And, um, and that sort of led me to a lot of just being really interested in a lot of different things, um. And I got obsessed with computers. This is sort of the mid 90s, late 90s, really obsessed with computers, computer programming, so much so that, um, you know, I taught myself C and I got into artificial neural networks.

And I was, I was at the university as a high school student, um, working on an AI project. Again, it’s like the early 90s. I wish I’d stayed with AI. I would not be sitting here probably if I stayed with, with AI, I was on an AI project doing vision software, and that got me really interested in, in eye, vision in general, and eyes, and, um, and then, um, I got interested in the idea of philosophy, philosophy of mind, like how do, how does perception work, and what are thoughts, and what are, what is consciousness?

So then I went to university, I majored in philosophy, uh, particularly in philosophy of mind, thinking, you know, maybe I’ll do degrees in philosophy. Uh, and of course, um, I didn’t do that because I got interested in the biological basis of, of thoughts and consciousness. Okay, well, let me go to medical school.

So then I went to medical school, think I’d be a neurosurgeon or neurology or something. And then, um, I fell in love with the eye. Anatomy the first semester of medical school. Uh, and you’re a physician as well, so you remember the an anatomy and anatomy where I went to med school was, was, was a wonderful course.

Um, and there was a lot of reverence around the person who donated their body and the eye. And I was just, I was just so intrigued by this beautiful organ. And when I did rotations in ophthalmology, looking at. The eye in a magnified way is a different experience entirely. If you have, if you go to the eye doctor, you just sit there and you see a light shining in your eye.

But what the eye doctor is seeing is really a miracle. Uh, when I first looked at the, the iris, which is a colored portion of the eye, you could start to see the hills and valleys and the undulations of the iris structure, and it looks like you’re looking at mountains on the surface of the moon. Um, and then the, and then the pupil sort of constricting on light, it was just, it was just beautiful.

I thought, I thought this, this organ was such a powerful organ. In fact, um, you know, people would rather, I don’t know if this survey is true or not, but people say they would rather die than go blind. I mean, if you believe that. So the sense, the sense is such an important sense. And I just got, I fell in love with it.

Uh, and so I did my ophthalmology residency. Uh, and I, I loved, um, I loved that. Ophthalmology for me is a very practical field. Uh, because you can change someone’s life in a relatively short procedure. Um, like cataract surgery. I remember one of my first cataract surgeries was a patient, she had bilateral cataracts from diabetic cataracts.

And she hadn’t seen anything for three years. She was in her early fifties. And the first time she saw was after I did cataracts, which was the morning of. And I remember her taking off her patch, and she gave me a big hug right afterwards. And it was just a wonderful, you know, like a wonderful experience of being, having that human connection and ophthalmology.

And it was just, uh, it was a fantastic experience. Um, so that, that’s how I got into ophthalmology as just, um, it’s kind of a, uh, different things from philosophy of mind and color perception and neurology, but ultimately into ophthalmology. And that’s been, it’s been a wild ride. Well,

Naji Gehchan: thanks. Thanks for sharing.

And I love how you you’re framing it as it was just simple, but it’s definitely with your curiosity and how you saw things a little bit different that brought you to ophthalmology to take us a little bit further within the journey. So now. interested in entrepreneurship, you’ve built different startups, you mentor startups.

So how did you move into more of this also managerial and leadership and entrepreneurship side?

Rehan Ahmed: Um, so this is where it delves into a little bit the personal. I’m happy to chat about that because, um, after I finished My residency and fellowship, I got one of these ill fated phone calls that we always sort of, you always sort of hear about that changes your life in a direction.

And, um, it was a phone call from my wife at that time, who said they found, we were trying to have children, who were doing routine CAT scans, and they found a meth on her kidney. And, um, it turned out after everything that it turned out to be an aggressive form of kidney cancer. And, you know, we were 31 at the time.

She was, you know, my best friend. I met her when I was 17 years old. We got married at 20, um, married for 11 years. Uh, that moment, I mean, there was a very dark time, uh, and a difficult time after about 20 months, um, he went through chemotherapy and surgeries and more chemotherapy, and it was very difficult for her and, uh, and her caretakers.

And, uh, she passed away, unfortunately, 20 months afterwards. Uh, but to answer your question, that, That after that, that was like a lot of lessons there, right? I mean, tons of lessons. We could fill up multiple hours and probably hours of therapy or something, which I haven’t done, but it sounds, you know, you could do a lot of talking there, but it really made me view life in a, in a way that I wanted to do something more transformational.

You know, at least I wanted to try. Um, and I was happy having that sacred relationship with a patient, but I thought, you know, like, you know, we have, why don’t I try just to do something, uh, where, um, the beautiful thing about medicine is that you have this one on one relationship, but there’s another way that you can think about it is having, um, Scaling that relationship to thousands and potentially millions of patients.

So that’s what got me into medical devices and drug development and thinking more systems thinking and bigger picture, which sort of changed my trajectory to something else. I know it’s kind of a long answer to such a straightforward question, but that’s it.

Naji Gehchan: Oh, well, thank you. Yeah. And thank you, Ryan, for answering and sharing this part of your story.

Um, so you’re saying, and I love how you framed it, the amplification of your impact, right? From one patient to being able to help. Thousands with what you do. So I’m intrigued as you’ve done this, and I hear it from several physicians where we’re really used to have this adrenaline, this immediate impact on one patients that you heal that you save.

How do you see this when your impact is indirect now that you’re leading an organization or leading other teams for them to be able to impact lives?

Rehan Ahmed: Yeah, so I, so I sort of, um, I’m hedging my feelings a little bit because I still do patient care. And that’s, uh, that’s really important to me. I, I, I, I am still clinically active.

And so I think having that connection to patients is crucial. As you sort of start expanding your reach into doing something a little bit more wider impact, um, it’s definitely different, uh, and you can, I think the best people are the ones to have to still have some connection to real patient care who are still with physicians or nurses or healthcare providers in the trenches, uh, because that’s where the change actually occurs, not for some ivory tower.

Far away. You know, we may come, some of ’em may come up with some brilliant idea, but it’s the, the people on the ground who are touching and talking and listening to patients who are actually affect the change that the, the, the others are sort of wanting. So, um, so I think, you know, maybe I push back a little bit from the premise.

I think you need that patient care in order to, to really, um, drive change. And that’s why, you know, partly why I did the MBA. I think physicians have to have a, a louder voice at the table. Um, and really be involved because we’re best positioned, we are, we are well positioned to, to, to, to have those conversations with multiple stakeholders because we’re really at the center oftentimes between the patient and the sort of healthcare system in general.

Naji Gehchan: So that’s cool on this one, because one of your expertise and what you, where, where you say you bring a lot of value is really bridging those gaps, right? And putting all those different healthcare stakeholders. You know, in one place and helping them, um, you know, move better care. So can you share a little bit more your view about this?

So I understand that you want to, uh, remain focused and anchored on patient’s care at the end of the day, but how do you do it and how do you see, you know, bridging those gaps actually

Rehan Ahmed: happening? Yeah. So that’s a great question. Um, I think it starts. By asking yourself what problem, and you know this from, from our, from our classes, you know, that we’ve seen, what problem are you solving for?

That has to be the, the guidepost question for all your subsequent decision tree analysis. What, what, and that has to keep, you have to keep reminding yourself, what problem are you solving for? Because as I advise a lot of MedTech startups, they have brilliant ideas, and brilliant technology, and fantastic stuff, but Um, if there’s not really a pain point, um, there’s no, if there’s no problem, then no one’s really going to pick up on the beautiful solution that they came up with.

And I’m sure you see this all the time as well. So for me, it’s thinking about very specifically on that and reminding myself and the teams I advise on that fundamental question.

Naji Gehchan: Is there one fundamental problem you’re trying to solve these days? So I’ve

Rehan Ahmed: been thinking very deeply about, you know, I think about eye care in general, but, uh, and there are a lot of technologies about separating the exam, uh, from, well, tele, tele eye exams, like tele, tele ophthalmology or tele optometry.

It’s, it’s amazing that during the pandemic. One of the worst specialties, if not the worst specialty in all medicine was ophthalmology and optometry and, and being able to provide exams. Why? Because we need. Uh, that technology at the patient level, like in front of the patient, we can’t, we don’t have yet the ability to do an eye exam over a computer.

And this stuff is coming, but it’s not great. And, uh, there’s still a lot of work to be done. So I think thinking about that problem, that’s the fundamental problem of doing a real tele optometric or tele ophthalmic exam is actually the problem. I’ve been, I’ve been working and spending a lot of time thinking about it the past couple of years.

I love

Naji Gehchan: that. And as you said, you know, now that you’re bringing back COVID, I think it’s definitely one of those organs, as you explained, that we really value, but definitely it was one of the last priorities we thought of. When we were during COVID time, like who did his ophthalmology exam during COVID, which is, which is crazy, as you’re

Rehan Ahmed: saying, right, exactly.

And the other thing that’s really amazing about the eyes is kind of a tangent, but I think about the eyes, a sentinel of disease, and we, you know, a lot of med techs are looking at. You know, various surrogate markers of disease, like what can they look at to predict other features that are, you know, one wouldn’t think of and, um, but looking at the eye or the retina in particular, because that’s one area of neural tissue, brain tissue that we could actually see, you know, without slicing open someone’s head and looking in their brain, we actually look at real nervous tissue through a retina exam.

What other things can we learn about? Is there a connection between Alzheimer’s and Parkinson’s and someone’s retina? Can we diagnose? Alzheimer’s a decade before it actually clinically manifests by looking at their retina. What about other neurological diseases? What about cancer? Uh, and so a lot of groups are looking at this, uh, and so it’s something I’m super excited about, thinking about the eye as a, as a way to evaluate for other cardiovascular neurological diseases.

Naji Gehchan: Also, I want to go to more your leadership skills and how you’ve built those through the different experiences you’ve had. You shared one crucifix, obviously, and how you grew from that moment, but also you’ve led in different places. Different type of organizations, um, and also managing patient care constantly up to now, when you think about this, I’d love to hear more about your leadership signature, as we would call it as Sloanies, I’m intrigued about this, how do you define yourself today as a leader, and what has, what is the biggest learning through the journey, and as you mentor all also those different startups and founders.

Rehan Ahmed: Uh, so I like to, in thinking about my, my sort of leadership signature, um, I anchored in my own curiosity of, as, as a, as a little boy in the basement of, uh, of, of my home reading books on from philosophy to biology, to learning about other people. I think that’s sort of a fundamental thing to really care about someone, to really know someone and love someone is that you actually have to be curious about them.

You have to actually ask questions. about them. So I manage a team of doctors and whenever any issue, any issue comes up when I just talk to my, I was. I would really actually try not to fake any curiosity about them. I really genuinely want to know about them, about them, their family, their lives, what their interests are.

Um, I think that is a foundational and really being a good leader. Curiosity about your world, curiosity about your fellow man. Um, curiosity about the problem you’re trying to solve, about the system. I think that is a bedrock for a lot of the kindness and love and happiness and joy that you’re trying to bring to the world.

So for me, that is the foundational way of, I look at my own leadership signature. It’s about an, uh, just sort of like a beauty of the world, you know, of this time together. You know, I’m informed a lot, you can probably tell by, by grief and, and suffering and that, but it really comes down to like, you know, we have, uh, this life is a beautiful life.

We have a beautiful. Like, the time that we have is beautiful, and to be having great gratitude toward that, um, to me, stems a lot just from curiosity, and just like, this mystery of this beautiful world. And these beautiful people that you work with and learning about them. So if you, if you take, when I take that mindset, I find that everything else sort of falls into place really well.

So for me, um, my foundational leadership principle on the ways to organize my life, interacting with people is from one of curiosity. Well, thank you for sharing

Naji Gehchan: that. And it’s got off a great segue for my next section where I’ll give you a word and get your reaction. So I probably know your first. Words reaction.

The first word is leadership.

Rehan Ahmed: Yeah, exactly. I mean, it stems again from curiosity. I think that that is the bedrock. I sort of answered that question in advance, but it’s really a genuine curiosity. It’s not something you can’t really fake it. You really have to want to learn about other people and their time and the world.

And when they feel that it’s magic.

So the second one is intrapreneurship, um, problem solving. Problem solving. Um, in medicine, we see this a lot. Um, there’s, there’s a tech that’s really great, but it’s not solving a problem. And, and, um, or it’s not looking at all the other stakeholders that are involved, you know, ensure, especially in the U. S.

Um, we have, you know, accountable care organizations, we have insurance, regular fee for service, we have insurance, and so, um, it’s, it’s a complicated landscape, and so thinking about, um, the problem and who’s, who’s willing to pay for the solution, um, those are, those are the things to, to, to keep in mind. The third one is MIT.

Um, for me personally, it’s. A second chance in a way, because I, um, the only reason I only applied to one school for business school and for the executive MBA was MIT, I actually got in as an undergrad and I was about to go, but for a variety of reasons, family, et cetera, I didn’t, I didn’t go. I went to a school, um, locally in Chicago.

So I actually, I didn’t go. And so for me. It’s a second chance to, in a way, make things right, because I always wanted to go, and I was so excited when, when I got in, and when I went on campus, I thought, well, you know, you don’t get a second chance at life, you can’t redo things, but sometimes, you know, you can do things a little bit delayed.

You know, and that’s okay. And

Naji Gehchan: the last one is spread love in organizations.

Rehan Ahmed: Really understanding people, getting to know them and being curious about, about their lives and what makes them tick. That will, that will move organizations and your relationships in ways that you can’t imagine.

So

Naji Gehchan: usually I would ask for a final word of wisdom, but with all our discussions and really deep discussions we’ve had, um, you’ve been still doing a lot. You said you’re still a clinician, you’re a mentor, but you have your company. You also manage physicians. What are the questions I frequently have for those of us who do like so many different things is how do you do that?

So I’m going to ask you this question. Tell me, how do you

Rehan Ahmed: do that? Um, it’s not just me, basically. Uh, it’s a team and it starts with my, my, my wife of, um, Uh, since 2016, uh, she’s been wonderful. We have two kids together. And so, uh, it’s been, uh, she is the rock for me. Uh, and so that, it takes a team, uh, and it starts, it starts with that relationship because if that’s, you know, if that whole relationship’s not good and everything else falls by the wayside.

So, uh, for me, it’s the, it’s the, it’s the people you surround yourself with. Namely for me, it’s my spouse.

Naji Gehchan: Oh, great. That’s, that’s a great, um, that’s a great summary, I would say of how you do it. I I can, I can certainly relate to it heavily. ,

Rehan Ahmed: I’m sure. Yeah. Yeah. Sorry. No, yeah, I’m, I’m sure you can relate because there’s no way that people can do, there’s always an army of, of people below, um, who are actually doing all the work.

Naji Gehchan: Any final word of wisdom, Rayan, for healthcare leaders around the world?

Rehan Ahmed: You know, the problem is grand. You know, and I’m just working on one little, uh, organ, on one little, you know, system, and particularly the U. S. Like, so… The problem is grand in front of us. And so I think this is the most, um, healthcare is the most pressing problem. I think facing, um, um, our, our world and sort of moving forward.

There’s many, many other problems, but for me, I think it’s the biggest problem because if we don’t have our health, then what do we really have? Um, and it involves multiple areas, including climate and, and, and the stump and environment, et cetera. But. Um, yeah, I think for us it’s time to, to get to work, to get our voices heard, to get at the, to, to be at, um, to be at the table and speaking for our patients and our communities.

Naji Gehchan: Well, thank you so much for being with me today!

Rehan Ahmed: Oh, it’s a pleasure. This has been wonderful. Thank you so much for the opportunity and the time.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Fabrice Barlesi

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Fabrice Barlesi CEO of Gustave Roussy, a Leading Cancer Centre in Europe, ranked third world’s best oncology hospital and first outside the United States. Fabrice is a lung cancer specialist and a major contributor to research in the field of novel oncological therapies. He was appointed CMO then CEO of Gustave Roussy since 2020. Fabrice is a Professor of Medicine at the University of Aix-Marseille and joined Paris Saclay University in 2022. He has been head of the Multidisciplinary Oncology and Innovative Therapies Department of the Nord Hospital in Marseille and the Marseille Centre for Early Trials in Oncology (CLIP2) which were established by him. Fabrice is also co-founder of the Marseille Immunopôle French Immunology network. Fabrice is the author and co-author of some 400 articles in international journals and specialist publications. In 2018, the European Society of Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) awarded him the prestigious Heine H. Hansen prize. He appears in the 2019 world list of most influential researchers.

Fabrice, it is a pleasure to see you again and have you with me today!

Fabrice Barlesi: Thank you, Naji. It’s a great pleasure to bewith you and to make this podcast with you.

Naji Gehchan: I would love first to learn more about your personal story. Why did you choose medicine, oncology, and now leading one of the most renowned cancer institutions in the world? What is the story behind this incredible journey?

Fabrice Barlesi: I think it’s, uh, quite a simple story. In fact, um, I, I have been, uh, interested to medicine by a neighbor of my parents who was, uh, a gp.

And in fact, uh, when I grew up, I was discussing with him, he was, uh, showing me or explaining me what he was doing, the patients he was seeing, what he was doing with the patients. And, uh, and then I, I, I became passionate by, by medicine and by. Doing six for others, I will say. Then, uh, I started, um, the School of Medicine and, uh, and I have to confess that during, uh, my training, uh, uh, at least I will say during the theoretical training because in France we have six years of, uh, theoretical training and we have students at the hospital, but we are not in responsibility of patients during that time.

And, uh, I was really not And even it’s the contrary. I was quite sure that I was not made for oncology and In fact why because I believe that when you look at oncology on the theoretical point of view, you know you are learning a lot of Classification a lot of different treatments But you are not seeing the other face of oncology beyond medicine and beyond science That is the patient that is the humanity of the patient that is saving life And, uh, it’s, it was during my first, uh, uh, resident, uh, uh, stay, I would say it was in a, in a small hospital in the, in the, the suburb of, uh, of Marseille.

And, uh, I was, I remember, I will always remember, it was, uh, an old patient. She was, uh, diagnosed with an ovarian cancer. And she was here at the beginning of, uh, of this, uh, this training and, uh, I was discussing with these patients, uh, while I was seeing also a lot of lung cancer patients. But I remember this patient because she was, you know, she was so, uh, courageous regarding, uh, regarding her disease, et cetera.

And in fact, she was waiting for her grandchildren and she was waiting for the visit and that came for Christmas. And I saw her for the last time on the 24th of December. The grandchildren came on the 24th in the evening, and on the 25th she died. And I, uh, it’s for me the example of what we should do for those patients.

We should try to make them having the life they want to have, to support them during the disease. I would say now find new treatment in order to cure those patients. But I always remember because this example is showing what is oncology for me. Oncology for me, it’s the perfect mix between science and human.

Naji Gehchan: Wow. Thank you so much, Fabrice, for sharing this. I think all of us who’ve done rotations or went to oncology, this, this human side that you described is so powerful. And we really see. How courageous as you said those patients are and what it means actually to add even a day when when a day means so much emotionally for patients.

You moved from being a clinician and I feel your passion as a clinician and researcher to leading now an institute as the chief executive officer. Can you share with us your learning And challenges probably through this transition and how you

Fabrice Barlesi: go with it. In fact, um, you know, um, when I was, uh, based in Marseille, uh, I had the chance to lead, uh, I would say a large, uh, uh, departments of, I would say.

General oncology, but also the early phase drug development center. And it was really exciting, but I would say Gustave Roussi was, uh, was always for me like a model, you know, and when I was in Marseille, I was saying, I want to make the Gustave Roussi of Marseille. Uh, at Gustave Roussi, I had a lot of friends with Jean Charles Soria, with Benjamin Bess.

And then we had a lot of exchanges and with Jean Charles, we were resident at the, at the same time. And, uh, I would say we always add collaborations through the large clinical trials like the SAFIR trial, but also some of the projects like the biomarker France project that we, uh, we ran together. And, uh, and in fact, I came.

In Gustave Roussy beside the admiration I had for this institution to join Jean Charles and Jean Charles asked me to come early in 2020 when he came back from the U. S. to take the head of Gustave Roussy and at that time I came as a CEO and also leading the clinical research organization and I would say for me what I discovered in Gustave Roussy is something that was even more amazing and Fascinating, uh, than than expected because of not of the size of the institution that you made, uh, realized from from outside, but because of, I will say the extreme dedication of all the people here, you know, both the, uh, the, the nurses, the, uh, the, the researchers, the, uh, the MDs, everybody is, uh, Doing things with a lot of patience that they want really and really the the mindset here is to say Everything we are making is to cure more patients today and to cure more patients tomorrow through the research we are, we are carrying out.

And, uh, clearly it’s, uh, it’s something that is, that you may see every day, uh, and, uh, every day of the year. And, uh, uh, it’s, it’s what I see here. Uh, it’s also a place that was a leader for many innovations in oncology, uh, but a place also where we can still try to, uh, to improve our activities, our organizations, because we know that this organization and the needs of the patients and the expectation of the, the society are still Moving, uh, for one and we need to to adapt ourselves to this new world Both regarding the expectation of the patients, but also the expectations of our professionals and we know how much it changed after the covet crisis and I really believe that in gustavo c giving Our hospital, giving the research centers, giving also the other pillars that make Gustavus Union unique.

Our education, we have a large part of education, more than 300 programs that are dedicated to all the professionals. But also our international activities, and we are taking care of more than 1, 500, 1, 500 patients, uh, international patients every year. And we are going to, uh, to open some, uh, facilities outside, uh, France, but also, uh, our spin off, Gustave Roussi Transfer.

That is. Clearly trying to make what has been made very nicely in, uh, in the U. S. And especially in Boston, that is transforming the product of our research into new drug, new devices or new pathways. And the idea is that it’s all we really want to have associated impacts with our research and change the life and the future of the patients.

That is awesome.

Naji Gehchan: And really, you’re taking what’s been there and you’re expanding this and exploring even beyond. I love this idea about also drug development, as you said, and how you can expand those, uh, globally. Um, I want to go back to this moment where you came to Gustave Gosset as you shared in the early 2020 and obviously you came and COVID crisis hit.

Um, you shared the dedication and the devotion of your people. So I’m interested to learn what was your biggest leadership learning during those times of tough moments for your patients and also health care providers going through this crisis.

Fabrice Barlesi: Uh, the big lessons I will say is the, uh, is probably the, um, adaptability of the people when they are facing a huge crisis. Uh, I would say that, uh, we are lucky that, uh, No one of, uh, of us in our generation had to face, uh, a war, uh, at least I would say in, uh, in, uh, in Europe. And, uh, but I would say the COVID crisis was like, uh, a small and of course, quote, uh, uh, smart, uh, war against the virus.

But, uh, it was really, um, uh, the adaptability, the capacity of the people to work 24 hours in order to take care of patients, uh, finding new solutions. And the leadership, uh, during this crisis, I would say was quite, I would say, easier, I would say, because all the peoples We are dedicated to one goal. We want to take care of those patients, whatever they are coming from, and even what is really special in Gustav Rossi for the first time we had in our intensive care unit patients without any cancer.

It was the first time in the story of Gustav Rossi in more than 100 years. And it was really a special moment, but it was quite easy. And what was really important at that time, it’s important every time, but at that time was really to Capture the information that we are coming from all around the world regarding the epidemiology, the knowledge about the virus, the knowledge about the treatments, the knowledge about how we can protect ourselves and protect our people, but also the patients, how we can continue to treat our cancer patients.

Even in this special situation, then we adapted the, uh, the institution and, uh, and finally, uh, the, uh, the, all the, uh, the importance of the vaccinations and how we can go back, uh, to a, to normal life. Uh, I would say not very rapidly, but we wanted to, uh, to, uh, to be able to provide our patients and our, uh, employees with quite a normal life, even if the Covid was still there and through the different waves of the, of the Covid.

Naji Gehchan: So thinking, thinking now forward, uh, we’re at another, uh, what like. We’re at another incredible moment in time, right? And oncology, I’m sure you would agree where innovation, um, will be at this tipping point to cure even more patients with some cancers. We thought we would never be able to tackle or to treat, um, thinking about.

Gene therapy, AI, immuno oncology, a lot of those that are ongoing that will help us really cure patients. So I’m, I’m intrigued. How do you think about the future of oncology for the patients you serve and also for your care teams? Who is treating them daily.

Fabrice Barlesi: Yeah, you’re absolutely right. And, uh, I cannot imagine another work that is more fascinating than oncology as of today.

Uh, it’s really amazing how we change in the last 20 years, I would say, and even more rapidly in the past decade. Um, what, uh, how we foresee the future of oncology is first I would say oncology will not only be dedicated to cancer patients, but also to subjects at high risk of cancer. Then we should also try to prevent the occurrence of cancer by a more dedicated, more precise prevention, but also we should progress to have more.

compliance with screening, then diagnose patients very early. And because it’s one of the way to cure more cancer patients. The second is to be more precise. Also, in the early stages of the disease, I would say in the past. We were sometimes simply saying, okay, the patient has been operated on, then he’s or she’s cured, and then it’s done.

We know that now we have some aggressive disease, even in the early stage, then we should use what we learned in the precision medicine field. And to, uh, uh, apply it for, um, for early stages. And it’s what we do, uh, for, for, uh, patients regarding the, the advanced stage it’s also, I believe that, and we believe in Gustavo C that probably we should be more smart in using local treatment, surgery, radiotherapy, international radiology, even in the advanced stage, uh, or I would say Oligo metastatic disease to say to to use a word that is easily understandable.

And we believe that we may be able to cure, uh, more patients, uh, with the use of this, in using this new, this type of technology, even in metastatic stages. Beside that, regarding, uh, medical treatment, medical strategies. We believe that there are two different big ways. The first one is, uh, to better understand, uh, all the, the, the molecular profile of, of the tumors finding on oncogenic addictions, but also how co molecular alteration are jeopardizing the, uh, the activity of targeted drugs and we can try to combine it in order to overcome the potential resistances, uh, uh, driven by these co molecular alterations.

Thank you. It’s all the work that we should do in this field of precision medicine. The second one is, of course, immunotherapy at a large sense, then saying that the use of checkpoint inhibitors, the one that we have in our hand, but also to develop new drugs, how we should combine it with the new, uh, uh, I would say, uh, strategies that are coming and we are developing in Gustavus Uh, department that is called the immune cell and answer, then we don’t want to, to, to discuss about just, uh, target the cell therapy, I would say, but saying that we could manipulate the immune system and the immune environment with the many type of drugs that are on development or.

For some of them already available, and we believe that it will generate the new strategy for for the patients. And finally, regarding this, uh, this, uh, medical oncological treatment, we believe that we cannot anymore be, uh, have built our strategy on Um, that’s empirical decision. We believe that patients are waiting for more objective decisions.

It’s why we are developing, uh, both biological and digital avatars for our patients in order to be able at the lab, uh, to test, uh, different therapeutic strategies being more and more precise, uh, uh, over the time, uh, with this kind of strategies, just in order at the end to be able. In the time frame, uh, that that will be a turnaround time that would be, um, uh, compatible with the queue of patients, uh, being able to clearly define what will be the strategy with the highest probability of activity in a given patients at a given stage of the disease.

And we believe that this. Ultra precision of the treatment is a part of our future. And finally, the final part of our development and what we foresee is the fact that we will cure more patients. And when we see the data that we have for the moment, we know that we are curing more and more patients, I would say, over the time.

But we want to give these patients back to a normal life. And we have to understand what are the patients with long lasting adverse events with sequelae from the treatment and probably in some of them we, we can go to de escalation of the, uh, of the therapeutic strategy. Then we are, I would say, enlarging the activities and the research in order to, uh, fulfill of this, uh, uh, I would say field of research.

Uh, in order to be, uh, to be more precise for our patients, more potent and cure more

Naji Gehchan: patients. Thank you Fabrice for this great overview and certainly gives hope for, for many of us as caregivers or potential patients. Um, I want now to move to a section where I will give you a word and I would love your reaction to it.

So the first word is leadership.

Fabrice Barlesi: It’s, uh, take the blame and give the credit.

Well, I love that. Can

Naji Gehchan: you, can you share a little bit more? Because I remember also a discussion where you shared your thoughts about what’s your job as a leader and CEO of an organization, and you talked about people and talent. So I’d love to dig a little bit more here.

Fabrice Barlesi: Uh, I believe that the, the, for me, the, um, One of the most important things regarding, uh, the leader in an organization like Gustave Roussy is to be able to attract talents and, uh, attracting talents means that You have the good facilities, you have the good projects, you have, in fact, it’s the, just the final, uh, demonstration of the, the rightness of the decision that you took before, in fact, and, uh, I believe that you, you, you may be able to attract talent only if you have, all the other things.

Then for me, uh, it’s really important to, to discuss with young people to, uh, to know what are their expectations regarding the research, what are their ideas, all the, but also how they want to live. What are the expectations regarding both their professional life, but also the personal life and try to make the good mix in order to have to have the best institution and not, uh, I would say, uh, just trying to, uh, to set up an organization, an highly efficient organization like that, things that were not in the past, regarding the, uh, the efficiency of the companies or things like that.

The second word is

Naji Gehchan: precision medicine.

Fabrice Barlesi: Precision medicine is, um, is first the, the DNA of Gustave Roussy, uh, with the, uh, and I say the validation of an idea that came more than 20 years ago, that was the idea to use the techniques that were used for research in the labs and transfer this technique to patients. And demonstrate the value of the use of these new techniques.

In, uh, in clinical trials. And then, uh, I would say everywhere. And, uh, it’s what we did, uh, when, uh, uh, what the leaders of Gustave Roussy did at that time, supported by, uh, by Professor Tures, who was the, uh, the CEO of Gustave Roussy at that time. It was clearly to transfer the genotyping of the tumors that was done only at the lab for patients.

In a turnaround time that was, uh, uh, that may be used for the, for the management of patients. Then we set up a new generation of clinical trials, the SAFIA trial for breast, for lung cancer, etc. Demonstrating the use, the efficiency. Of this strategy and then participating to the development in the, uh, in France of the, uh, the network of, uh, of, uh, uh, genotype genotyping platforms in order to provide all of the patients with this kind of strategy.

Then it’s the DNA of precision medicine is the, is clearly the Roussel. And we are trying both to improve what we did in the past, but also To find what are the new technology from coming from the research that we should transfer to the patient and it’s what we are trying to do with a single cell and spatial mix in order to build these biological but also digital avatars of our patients.

Naji Gehchan: And this work for our listeners has really transformed care for patients. So, thanks for all the work that you guys have

Fabrice Barlesi: done. Yeah, clearly, when, when we look, you know, I remember as a lung cancer specialist, when I, when I started, in fact, it was, you know, in the, in the middle of the nineties. In fact, I would say the, the life expectation for stage four lung cancer was like six months.

Now, I have patients that I’m following for more than 12 years, then clearly it changed a lot. And even we have patients that were treated just at the beginning of the era of immunotherapy through clinical trials that are still alive after 10 years with a stage 4 disease, then clearly it changed a lot.

We still have a lot of things to understand both regarding the biology of the tumors and the, uh, how we, we, we made, uh, modulate the immune system, but, but clearly it changed the life of the patients clearly.

Naji Gehchan: Yeah. And as we said, we still, we still have a lot to do, but it’s great to see the road that’s been on and hopefully we will, this is why we wake up every morning to, to make sure that we can cure more patients and help them out.

The third word is health equity.

Fabrice Barlesi: It’s, uh, it’s a huge issue, you know, you know, because, um, when you are leading a big centers like Gustavus here, but I would say it’s also true probably when, when you are leading a research group or even a small hospital, you are always trying to improve what is happening in your immediate environment.

But if you are trying to look a little bit, uh, uh, uh, in the future, you realize that it’s absolutely impossible to imagine that the progresses you, you are making. Are just dedicated to the small number of patients that will come to your institution, then it’s really important. And it’s clearly something we are discussing every day in Gustavus.

It’s how the progresses we are making will be disseminated across the country, but also internationally. And the first step for that is education. It’s why we set up Gustave Roussier education with both national and international programs. Because without the knowledge about the innovations, you may not disseminate innovation.

The second is the clinical research. And we set up some very simple, pragmatic trials that maybe run everywhere in the world, but that are set up in order to answer a very simple question. You know, like the lung art trial that we did in, uh, in the past. Should we do radiotherapy in stage into lung cancer or not?

Something very simple, but we have a lot of example like that. And also some, a part of this trial will be dedicated to de escalation. Can we de escalate? I would say, uh, the dosage of immunotherapy or the length of immunotherapy as an example, something that is simple that may be done everywhere. And, uh, and also it’s also the reason why we set up our alumnis.

The alumnis are not only, I would say, like a club where people are happy to meet one time a year during the ESMO meeting, but it’s also. A way to run clinical research everywhere in a large number of countries and, uh, making the possibility for some patients everywhere to accede to molecular genotyping, some strategies regarding research.

And the last one, the last, I would say, uh, uh, pillar for, uh, health equity is also when you are developing. Uh, therapeutic strategy or diagnosis strategy. It’s also to say, okay, I want something that is quite simple and that may be done everywhere at a price that would be affordable for all the patients.

And it’s what we try to do, you know, even when we are developing, uh, very, um, sophisticated tools after that, we move to say, okay, how can we simplify? And, uh, being sure that we may reach the same results because, uh, there is no future for techniques that will be dedicated only, uh, to, to, uh, highly privileged peoples, uh, uh, or some specific centers in some specific countries, we should make progress is available for, for everyone in the world.

Naji Gehchan: I can’t agree more. The last one is spread love and organizations.

Fabrice Barlesi: Um, I would say, it’s, uh, what is important for me is, um, uh, is to, to build organization that, uh, that, um, that, that are, that, that are always, um, dedicated to the, to the largest, uh, I would say institutional interest, I would say. Uh, what is important is that everybody should be aligned with the, uh, with an organization that is serving patients and the patient’s research, education, and the strategy of the, uh, of the institutions, and no one, even the CEO is more important than the institution, and it’s what we try to do, we try to, uh, educate our fellows like that, we, uh, and we have always huge leaders, I would say, in Gustave Roussy, as you cannot find people that are more interested with the institution than people that are working here.

And I can cite, I would say, not all of them, but, you know, Caroline Robert, Karine Kizazi, Benjamin Bez, Fabrice André, uh, it’s a big stars in the field of oncology and I’m sitting only people working in the field of, uh, Technical research because they are very well known everywhere, but we have also basic researchers like Florent Gineau, Olivier Bernard, etc.

And, uh, all of them are really everyday thinking to the institution, what we can do for the institution, how can we attract talent, what are the projects we can fight for, etc, etc. And clearly for me, the organization is, uh, is serving the strategy of the institution. And, uh, and should be both flexible regarding the expectation and the need of the researcher we should be, uh, you know, you should give researchers some freedom in order to think and to develop the, the, the hypothesis they have, but also with always the alignment with the strategy and our strategy regarding, uh, especially research is to say, we want to have a societal impact.

And we, we want to, to, uh, to, uh, conduct a research with associative impact. We want to change the outcome of the patients in a, in a, in a close future.

Naji Gehchan: Any final word of wisdom Fabrice for healthcare leaders around the world?

Fabrice Barlesi: Uh, the first one is, um, I would say we know that we are in a big competition and, uh, clearly, uh, all the countries, the institutions are trying to, uh, to do their best in order to find a new generation of treatment and to develop a new generation of drugs or pathway or devices.

But at the end, and it’s, uh, the strengths of all of these academic centers, I would say, We know that we are clearly strong together, uh, by also sharing our knowledge through, I would say, the international societies, the different meetings that we have, and clearly aligning both this competition and this collaboration.

They are not the opposite. They are just the two faces of the same coin.

Naji Gehchan: Well, thank you so much, Fabrice. It’s an incredible chat. Thank you also for what you do as a CEO and for all Gustave Roussy’s team. The social impact is more than clear and obvious through all the years and hopefully even more exciting innovations for the years to come, coming from you.

Thank you so much for joining me today.

Fabrice Barlesi: Thank you, Naji. It was a great pleasure.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Alicia Tozier

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Alicia Tozier Senior Vice President of Global Market Access and Marketing for Outlook Therapeutics, a company specializing in Ophthalmic products. Alicia has served as a Global Healthcare Senior Executive, leading teams across the full product life cycle and 18+ launches spanning 8+ therapeutic areas in 70+ global markets, via multiple innovative modalities including: medical devices, digital therapeutics, and pharmaceuticals. She is a purpose-driven leader, guided by integrity, values, and a deep focus on the patient informed by her own experience as a caregiver. She holds a bachelor’s degree from UC Santa Barbara, an MBA from Colorado State University, and is an alumnus of the Stanford Graduate School of Business Executive Program.

Alicia, It is a pleasure to see you again and have you with me today!

Alicia Tozier: The pleasure is mine, Naji. Thank you for having me.

Naji Gehchan: Can you first share with us your personal story? What led you to healthcare and becoming a senior executive in biotech today?

Alicia Tozier: Great question. I would say health care is definitely where my passion lies.

Um, and I tend to be very purposeful, right, in terms of my desire to be in health care. Um, I think one of the ways that you and I were actually first connected was in terms of my desire for being a purposeful leader and I actually am able to participate in a non profit book that’s being put together by a good friend, Jill Donahue.

Um, I have an excerpt I could actually read for you, Najee, if that makes sense. Yes, perfect. We both

Naji Gehchan: got connected through Jill, so we’re

Alicia Tozier: both fine. We did. Indeed, indeed, indeed. Um, so, uh, what I wrote was, uh, titled For Those of Us Struck by Lightning. A confession about what motivates me. It’s 2 a. m. I’m at my child’s bedside.

He’s asleep now. The seizure ended 3 minutes ago. But the fever that caused it rages on. His hand is resting on mine, bigger now, than it was when I first held it, when they placed him on my chest at the hospital. But he’s still my baby, my angel. And it kills me to see him this way. In 4 hours I have a conference call, in 6, a presentation.

This has been my life more times than I care to remember for the last eight years, ever since my son was diagnosed with a rare genetic disorder that thankfully he will grow out of. I don’t want you to feel sorry for me. It’s a small price to pay to have the privilege of having such a wonderful human being in my life.

I tell this story because I want folks to understand for me. That working in the rapidly advancing field of health care is not just a passion, it’s personal. I have another confession to make. I hate when someone, especially a doctor, quotes statistics at me. I’ve had two different neurologists tell me that the chances of Ethan’s symptoms being Gefts Plus with no prior family history was less likely than being struck by lightning.

Well, for those of us who have been struck by lightning, the fact that it’s a rare occurrence is little comfort. Accordingly, every time I hear of a novel therapy or new indication for a previously existing product, especially one that treats a rare disease, I think of Ethan. I think of a parent sitting in a dark room at the bedside of a sick child and remember how lonely a place 2 a.

m. can be. We all got in this field for different reasons. We’re all motivated by different things. But I wanted us all to take a moment to remind ourselves that we work in an industry that generates health care solutions for real people, and I, for one, couldn’t think of a better use of my time. So, that’s really what I wrote, uh, Najee, and I think it’s my heart on a page.

You know, it’s truly important what we do. Oh, thank you

Naji Gehchan: so much for sharing this part of your, uh, of your story. So can you take us a little bit back in time when you really started in the health care and how you shaped your purpose as you were going through and what you’re doing today as a

Alicia Tozier: leader? Yeah, yeah, absolutely.

Um, you know, as I started back in health care, I’d love to claim it was part of a grand plan. Um, but it wasn’t, you know, I, I saw health care as an opportunity to give back. Um, and if I rewind back even before there in my life story, a lot of what has shaped me. Has to do with my upbringing. Um, so I’m third generation.

My grandmother on my mother’s side, uh, didn’t actually speak English and my grandfather was literally a hero, um, in the war and, uh, you know, came back to the States and had two jobs, worked hard, was a small business owner, um, raised a family and was an incredible role model for me growing up. And so I knew.

That leadership was going to be a part of what I wanted to do, and I knew that career and achievement could be tied in a noble way to giving back to others. And so for me, as I thought about my career early on in the early days, I knew that leadership was going to be a part of what I wanted to do. I knew that work ethic, another thing I learned from my grandfather’s modeling, was something that I wanted to pull through in everything that I did.

Um, I started out in health care on the pharma side of the business, and, uh, I would say I earned my first role, um, when I had no business even being in pharma. I had no experience, but I was passionate about diabetes, um, at the time, interviewing for Sanofi Aventis. And, um, you know, it ran in our family, so that was a passion of mine.

And somehow or another, I convinced the interview team to hire me. Um, and that was the way I started in pharma. And since then, translated across the device world, digital therapeutics. But when my son was born, and again, this was about eight years ago, I think it really reinforced my desire to be in healthcare, and really solidified what I wanted to accomplish.

Naji Gehchan: So you, we see the, we hear it, I see it, but we hear the passion you have in your voice and healthcare throughout giving back, helping others. Very early on. And then what you shared with Ethan, your son and how passionate you are to bring innovative therapies even even more for one single person who might be suffering and rare diseases, which is really noble.

And I think it’s great. that we are seeing advances in gene therapy today and other domains that will hopefully help, uh, those patients, uh, can you share with me a little bit more how you would define your purpose? How do you define it personally? I always get this because all of us in healthcare are here for a reason.

We all have this strong purpose that we have. And we really want to do good and help patients live better. But frequently I get this question, how do you get to define your purpose as a person? And then how would you translate it to your teams on a daily basis? So I’d love to hear how you get to this point of defining yours.

And then how do you do it with your teams to drive them constantly to bring innovations

Alicia Tozier: to patients? Yeah. Yeah. Um, so great question. Um, I guess I would say the beginning of my purpose, if I were to think of what drives me is certainly my role as a caregiver and the experience that I’ve had, you know, um, navigating, you know, as a caregiver, a rare condition with my son, as well as other health conditions, right, that exist in the family.

Um, what I’ve pulled from that from a leadership perspective are a couple of things. You mentioned passion. So I think passion for the patient is front and center and everything that I do. Um, when I think of how I translate that into teams and team dynamics and achieving goals, truly it’s about reminding ourself on a day to day basis that what we’re doing at the end of the day impacts a patient.

Impacts a caregiver impacts a family member, and I’ve been given, you know, that gift of having a medicine truly impact and change our lives personally. So ways, you know, just pragmatically that I pull that into what I do is just, you know, um, ensuring that we bring patients in. To our meetings, ensuring that we know as much as possible what the experience is like for patients.

Um, if it’s vision, you know, showing pictures of vision loss and the fact that the center of your vision is blurred. Oftentimes, our meetings will begin with pictures like that. It can be small, tiny ways just to remind us that there’s many noble professions and we have quite a big responsibility in health care.

that we have patients lives at stake. Um, the other part I’d say I learned in the gift I gained as a caregiver is just compassion. So it’s important to put the patient first, but I can’t be at the sacrifice of the team, right? So having compassion for team members is something that I try to bring through.

Um, and that can be in, in simple ways, right? I think that You know, we need to set audacious goals. We need to have accountability, both ourselves as well as our team members. But there’s ways to do that with compassion by checking in and saying, Hey, what’s getting in your way? What supports do you need?

How can I help? And I think continuously doing that as a leader can model that for others to do the same.

And you’ve

Naji Gehchan: left the team in both big pharma. As you said, you started there. You moved to biotech. You’ve done my devices. I’m intrigued. Is there a specific leadership trait or capability that you really relied on as you’re doing those? Because you led also globally. Large teams, smaller teams, but always with the same passion at the end of the day to bring innovation to patients.

Was there something that you feel like a trait as a leader that you really all the time relied on during those different experiences?

Alicia Tozier: Yeah, yeah, I would say a trait that has served me well, um, is truly this concept that the best idea wins. And, you know, whether it’s leading large teams at a global level, U.

S. level, um, device or pharma. Um, I would go back to my roots. And one of the things I learned as I observed my grandfather as a leader is that everybody’s voice counts. And the best ideas can come from anyone. Um, so as I faced business challenges, what I try to do is just to ensure that I’m capturing the voice of many.

Um, when I scale teams, I purposely try to recruit talent that bring unique skill sets to the table and different experience sets, whether it’s coming from a large company, coming from a different part of health care, um, but truly trying to arm a team With diversity of skill sets and experiences. Um, and my kids, you know, like many of us love Disney.

So if you’ve seen Ratatouille, you know, it’s like, you know, you know, anyone can cook, right? So in my mind, any idea, a great idea can come from everywhere. Everyone’s not a great cook, perhaps, but that great idea can come from any pocket

of the organization as well. I love

Naji Gehchan: this. So we’re going here into what we would call as, you know, like the IP, right? Like all this diversity, how you include, how you’re equitable. And then we discussed both of us, not in this podcast, but quite a bit about belonging. So I’d love to get your view. Once you’re saying best idea wins, everybody’s voice.

really counts and is important in the game. How do you do it practically as you’re building teams? How do you, can you give us some stories or maybe tips for, for us as leaders and to how to ensure that it’s not only hiring diverse. People, but really making sure that the culture is built around, including them, hearing their voices and then building the sense of belonging.

Alicia Tozier: Yeah. Yeah. I, I think sense of belonging is absolutely critical. And I think, um, anchoring down in terms of this best idea winning and truly hearing from different pockets of the organization. Um, There’s an example that comes to my mind, and this was, you know, many moons ago, uh, but I was, you know, walking into a launch scenario.

It was a couple years before launch, and it was like a perfect storm. Um, we had a supply constraint, over 50 markets we were launching in, and we had to start to prioritize which markets we were going to go to. So, I see you smiling. You know, these, these instances do happen. And, uh, as I walked into the situation, the initial concern was it’s a supply constraint.

So I immediately started saying, how do we solve the supply issue? Can we get high capacity lines? What could we do to solve this problem? Um, and it turned out that wasn’t actually the real problem. That wasn’t the real challenge. And so that was a good learning. And I actually had to pivot myself, but the way I discovered this was by asking questions from folks beyond just, you know, your typical leaders, general managers, et cetera.

I started to talk to our different cross functional partners, and it wasn’t until I had a conversation with an I. T. Gentleman was building the platform, um, and really having a conversation and seeking his input and perspective that I realized that the actual issue was translation hurdles. And the fact that we had prioritized markets based upon which, um, languages we would have available.

So you had markets like Estonia launching before Germany. So obviously, you know, this created a dilemma. We went back, we restructured our launch sequencing, we aligned it to our strategy, business objectives, what patients needed in those markets, and we actually chose to exit certain markets. And differentiate different product offerings based upon that.

So it was a big sort of reboot. But where I go back to is just that conversation I had with somebody who wasn’t the typical person sitting on the leadership committee. And I think the learning I took away from that, and I try to bring through within teams is that everybody’s voice counts the great idea, the great aha can come from anyone.

It doesn’t matter if it’s the IT person, the HR person, the janitor, or the CEO, right?

Naji Gehchan: I love this example, and yeah, we’re faced with these examples, and I, what you said is so critical, right? When you have a big problem, try to go see and assess, right? And really listen to people who operationally are trying to fix it.

It’s such a great example you’re giving. Thank you for that. I’m gonna now give you a word, and I would love your reaction to it. So the first word is leadership

Alicia Tozier: leadership. Well, my first reaction I’d say is it’s tough and it’s a lifelong journey. Um, and the reason that I say that is because I think all of us leaders that strive to be the best versions of ourself that we can possibly be requires constant desire to adapt to change to grow. And I would say for myself in particular, that’s certainly been the case.

I’ve had plenty of bumps and bruises along the ways learnings that I’ve pulled forward. I don’t think I’ll ever get to a point where I’ll have life licked. And I’m like, all right, I got it. You know, I think there’s always this desire. To learn a bit more. And I had the good, um, I was grateful to go through a recent leadership program, even as of this last year.

So it’s like you get your MBA, but you can get to a point where you’re like, you know what, there’s new things to learn. And I was surrounded by 70 other leaders who were very accomplished in their career, clearly very smart. And yet they chose to be there. They didn’t have to be there. They wanted to be there.

And that was such a perfect gift for me that I’m really grateful for to just remember that leadership is about constantly wanting to learn and grow.

Naji Gehchan: I love it. We’re constantly work in progress, obviously, as leaders. Yeah. But you need to that you’re demonstrating once again to say, like, I still have a lot to learn.

Right. I think this is part of the traits you’re breaking in this discussion. Uh, so if I want to double down on this one, is there anything that you wished you knew as leader, like 10 years ago or 15 years ago when you started to lead teams and manage teams?

Alicia Tozier: Yeah. Um, You know, what I would pull is a Mr.

Rogers quote, uh, my kids will also watch a show called Daniel Tiger. And one of the phrases is it’s okay to make mistakes, try to fix them and learn from them too. And I think early on when we’re all go getters and we’re trying to build our career and show the world what we can do, it can feel like you can’t make mistakes.

But failing forward is actually one of the best qualities I think a leader can have. We all stumble and I think it’s all about acknowledging the mistakes, learning and growing from it.

The next word

Naji Gehchan: is

Alicia Tozier: purpose.

I would say beating heart. It’s for me, the beating heart of what I do. And we shared in the beginning of the conversation, some more specificity as to why. Um, my son has taught me so much and, you know, I was interested in health care, certainly before, you know, we had Ethan, but it has only become more solidified.

And my purpose is truly, for me personally, my beating heart. It’s why I really like doing what I’m doing. And I just expand upon that story a bit further and share that even today, we’re experiencing challenges in our journey. It’s still an ongoing journey. We’re trying to get access to medicine. And so as a leader, I oversee marketing, market access.

And what I do every day is think about how we can get access to therapies for patients. And yet on a daily basis, even as of this week, I’m trying to get approval for this unique medication for my son. So purpose to me is the beating heart because it’s so intertwined with what I do, I can’t even separate it.

Naji Gehchan: Yeah, you, you bring up access and it’s certainly, yeah, it’s one of those problems we’re facing and, and globally and in the U. S. it’s just mind puzzling and in a country like the U. S. having issues with access or worrying of getting a job. Approved for patients who need it, but it shows that we have still a lot of work to do as health care leaders.

Alicia Tozier: Yeah, and we’ve made great progress. I would just acknowledge that. I think we are on the path to providing more options. There’s rare diseases that are being studied and evaluated with models that can allow for access. So I would say, yeah, is there opportunities? Absolutely. Um, are we on a great path? Yes.

And that’s part of what I want to contribute towards.

Naji Gehchan: We’re, we’re lucky to have people and leaders like you striving every day to make that happen. So thanks for sharing this. Uh, cia, the third word is lightning. Hmm.

Alicia Tozier: Well, , I literally had lightning, um, as part of the title of my excerpt, and I would say what I think of when I hear that word is the first seizure that Ethan ever had. And it’s, it’s part of the, the humility back to the comment around learning. And a trait that I have found to be really meaningful as a leader is, you know, the first seizure that occurred.

We were literally struck by lightning. We never thought something like that would happen. We didn’t do everything right. We did the best that we could, but then we rapidly learned after that. And I think all of us face different situations in our lives where we’re caught flat footed. Sometimes we’re knocked to the ground.

And it’s all about how we get up and it’s all about how we learn and how we take that forward.

Naji Gehchan: Well, this is so powerful and inspiring, uh, what you’re sharing, uh, can I ask a question around? Also, you shared you’re a caregiver, you’re a mom, you’re an executive, you’ve been super successful as a leader in healthcare and And beyond, I would say, with the influence you have on the systems, you’re, you’re a student too.

Now, again, you’re really such a great role model for many who sometimes don’t feel they can do all this. So I’d love to go there. And if you can share any advice, how, how do you do it? How, how you would encourage others to try to do things? I’d love your take on this.

Alicia Tozier: Mm. Well, that’s a great question. And Nagy, if you ever get the recipe, I would want to I would want to hear it and see it.

I would claim that I don’t have the perfect recipe. So to answer your question directly, how do I accomplish that imperfectly? Imperfectly, and I think it comes back to grace. We talked a lot about compassion for teams, but oftentimes I think one of the biggest tasks we can all face is having self compassion and giving ourselves grace that we’re doing the best that we can.

It sounds very simple, but it’s not always easy in application. So I would just acknowledge that first and foremost, um, the other piece that I would just share is that I have an amazing spouse. Um, I met my husband in high school, so I was, uh, high school sweethearts. We’ve lived our lives together. Um, he is a full time dad.

And so in terms of managing everything at home, you know, things have ebbed and flowed, but I am incredibly grateful to have him, you know, Fully focused on our Children, our family being an incredible partner. So I think that that’s given me, um, basically the ability to do what I do. I think he’s Superman.

Um, the other part I would just share is, um, you know, uh, mindfulness. You know, it’s funny, and all the things that you just listed off, I do carve out time just to be mindful, and that’s sometimes the biggest challenge. I mean, when we wake up in the morning, each of us are wired different ways. It takes different things to help us show up in the best version of ourselves.

But, you know, I have my own routine that, um, I go through in the morning, um, and it helps me be mindful and stay healthy. Thank you for

Naji Gehchan: sharing this. The last word is spread love and organizations.

Alicia Tozier: Um, number one, I agree that that’s important. Um, you know, I think it’s incredible that you’re doing this podcast, Naji, and I’ll just say that right now. Um, the more we can be learning from each other, the better. When I think of the phrase spread love, what I think about, um, is bringing passion. And compassion.

Um, and that’s the gift that I’ve been given as a caregiver to bring forth to everything I do, whether it’s at home or at work, but when I hear spread love, I think of how can you bring passion to what you do, whether it’s a love for your community within work, whether it’s the passion for what you’re going to accomplish through all of your efforts, and then compassion is just giving people grace.

I mean, we all have things going on in our lives. And I think the more that we can try to learn from one another, the more we can check in and ask, how are things going? What support do you need and how can I help? I think the better.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Alicia Tozier: You know, um, I’m struck by what you’re doing with this podcast, Naji, and I’m so glad that you are. Um, I’m inspired by the sharing of stories. I think my story is one, um, that could be helpful, but I know there are many. Um, and so I would just put a call out there to share your story however you can, um, because I think we all can learn from one another.

We talked about this earlier, um, and anyone can cook. Great ideas can come from everywhere, um, and I think you can learn something from everybody. So I think the more that we’re able to share, um, our journeys with one another, the better. And I think just staying open and curious to learn and grow.

Naji Gehchan: Well, thank you so much, uh, Alicia, for your words.

I certainly learned a lot from you. What an incredible, uh, chat. Thanks for your generosity, vulnerability, and exceptional leadership that you demonstrated today. Uh, so it’s, it’s been a real pleasure and honor to have you. Thanks. Thanks again for being with me.

Alicia Tozier: The pleasure is all mine, Naji. Thank you for having me.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Thierry Hulot

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

This episode is very special. In partnership with ESCP Business School, I’ll be giving the mic to students, our leaders of tomorrow, to discuss with incredible healthcare executives about their journeys and leadership beliefs.

ESCP Students: Hello, I am Charlotte Périsset, special master’s student at ESCP Business School in Paris, and I’m thrilled to be joined by an outstanding innovative leader. General manager of Merck, France, and president of LEM, the French organization of pharmaceutical industry. Thierry Hulot has a degree in pharmacy and an MBA from Auschwitz Business School.

He started working at Merck in 1995 in research, in research and development in Lyon, in France. After a different strategic position, Thierry Hulot has taken on the role of general manager of the biopharma division of Merck in France. This lover of art is also involved in the defense of the interests of pharmaceutical companies in France as he was elected as the president of LEM in July 2022.

Thierry, it is such an honor to have you, to have you with us today. My pleasure is mine, Charlotte. Thank you very much. So to begin, um, we know that you have such an amazing career path and you are now involved in two main positions. So how do you deal with this position and your personal life and passion

Thierry Hulot: for art?

Well, actually, that’s a good question. And, you know, and well, there was elected as head of the trade association as well. My life is going to go completely south. So let’s take time to breathe and organized. And actually once upon the time when I did my MBA, I read only one management book and the name of the book was more time and less stress.

And it’s a very funny story because he says, let’s imagine that your boss. Drive into your office and say, Thierry, I have an outstanding project for you. You have, it’s a, it’s a unique career opportunity. It will take 25 percent of your time and you have to do it on top. And you are stupid enough, you will say yes.

And the worst is not only you will say yes, but you will deliver. So what is a learning, my friend, is actually in your current setting, you have already those 25 percent of time available. You ignore them. So organize yourself better. And you will find this air to breathe. So, it’s funny, every time, to say, oh, pause, what are the critical things I need to do, to achieve, to deliver today?

And I spend every morning time to, to really consciously think, what will make this day a success? And there’s no rewind. Time passes. So let’s make sure that this day will be successful and success include enjoying the enjoy, enjoying the show, enjoying the time, having fun in the drawing.

ESCP Students: Thank you very much for sharing your story. So, Perx, can you tell more about your greatest strengths as a leader and what are the biggest challenges you had to face in your career path?

Thierry Hulot: Well, I’m absolutely convinced that, uh, leadership has different facets based on people, individual personalities, and whatever is your facet, it’s okay.

As long as you’re authentic and authenticity is a super high value for myself. This is what I’m looking in others. And this is somewhere, I would say this is my north start.

The second part of your question is, what is the biggest challenge I ever, ever had? I would say it’s not one challenge. As I discover along the journey that in many, many situation, I was brutally confronted to completely unexpected situation. Situation that nothing in life. nor a university class, nor an MBA, nor a pharmacy degree can prepare you for.

But all your previous experience give you clues and insight on how to start addressing the problem. So my philosophy in life, my leadership is, guys, let’s be prepared for completely unexpected things. And the day they happen, Stay strong and solid on your on your value. Stay authentic. Stick current and on board your team.

ESCP Students: Thank you. It’s really inspiring. And, uh, to continue about the leadership, uh, what should today’s leaders focus on for the future, in your opinion?

Thierry Hulot: Well, I don’t know. It’s, it’s something really to focus on. What I would say is My leadership vision, you know, there’s many, many books on leadership and the one that works for me and hopefully for the team I want to inspire every day is quite simple and it has three basic rules. Every time I have a decision to take, the first question is, is the decision I’m going to take good for my company because I strongly believe in my company value.

I strongly believe in my. Company vision and mission. And so the question I’m not, is this good for theory or is this good for my department or is this good for the French affidavits I’m running? No, this is good for my company. Right? No, it’s Mac means it’s this link back to authenticity. Let’s assume that I will not be aligned with my company mission, my company vision.

I will quit because this is me first is have this high degree of coherence. Ask yourself. The decision I would to take is trying for my company. If so, let’s deliver it. And you know, when you’re a leader with a huge team, it’s not a send an email to the team and say, good luck, my, my friends, as at time, you have to be hands on with the team to help them solve the issue to get your hands dirty.

Time to time you have to make a deep dive into the details to understand the technicality of it, and really support the team by demonstrating. That you are and with and with them to solve the complicated issue and my third rule for leadership is at the end of the day in 1999 percent of the case. So one who will really deliver on the business.

It’s your team. So take care of your people. Take care of their development. Make them feel rewarded, acknowledge, give them opportunities. And with this, you can navigate.

ESCP Students: Thank you very much. Those are really great advice. Thank you for sharing your vision. Um, I have a question regarding, um, my experience and the experience of, uh, junior people.

Uh, what advice would you give to a junior who wants to have a strategic role in the pharmaceutical industry?

Thierry Hulot: Get started. Get started. And, you know, you don’t know which opportunity will pop up. And the, get, get started. And at one time, a dossier will come to your office, uh, an event will happen that will require people to be smart, to be engaged and jump on it.

Don’t, don’t shy, don’t hide, embrace the problem and, and speak up, speak it and then deliver, deliver on your commitment. Say, okay, I’m willing. To take the risk to truly help on this dossier, let’s get it

ESCP Students: done.

Thank you very much for this advice, Thierry. Um, just to, to, to be back on your leadership style, uh, can you define more, uh, about your, your leadership style? And can you tell us more about your point of view about this topic?

Thierry Hulot: Well, I already cover the basics, my, my free rules. We know when I have to decide what is good for my company, let’s be hands on.

Let’s really. Take care of the team and do this in full transparency and authenticity, you know, at time, uh, you’ll see also have to speak up and what we call here openly disagree. Now, let’s make sure you give space for your colleagues for your team to challenge you to disagree with you if they have a different opinion.

And at the same time, let’s have a very clear rules. We discuss, then we decide after getting everyone’s opinion, and once we have decided, we all act as one. We don’t second guess the decision, we don’t recook the decision, we have discussed with each other’s point of view, now it’s time for action. And this, let’s say, segregation of action.

Time for discussion, time for action. And when we act, we are all as one.

ESCP Students: Thank you very much for this inspiring vision. Uh, now I would like to jump to another section. I will give you one word and when to get your reaction about this word. Are you ready? Yeah. Okay. So the first one is leadership.

Thierry Hulot: Of course.

Leadership is fun.

ESCP Students: Thank you. Patient.

Thierry Hulot: Patient is on North Star. Sustainability. It’s a must, and I feel ashamed that my generation has ignored sustainability for far too long.

ESCP Students: Okay, thank you. And the last one, spread love in organizations.

Thierry Hulot: Well, uh, spread love in organization, uh, for me is another, and I would say more original, more creative way to tell every colleagues, you matter, and I’m going to take care of you.

ESCP Students: Thank you very much. So, uh, any final word of wisdom for health care leaders around the world you want to share?

Thierry Hulot: Guys, around our small planet, there’s millions of people suffering from highly, uh, disability disease. So there’s a need for innovation. There’s a need for new treatment. And you leaders in health care, young leader in health care, in the years to come, will be the one making the difference. to help all the patients. So embrace it. Don’t shy. And let’s start working, guys.

ESCP Students: Thank you so much, Thierry, again for your time and such an inspiring discussion. Thank you so

Thierry Hulot: much. Thank you. My pleasure.

Naji Gehchan: Thank you, Thierry. And thank you all for listening to Spread Love in Organizations podcast. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow.

Naji Gehchan: Thank you all for listening to Spread Love and Organizations podcast. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow. Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Anette Steenberg

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

This episode is very special. In partnership with ESCP Business School, I’ll be giving the mic to students, our leaders of tomorrow, to discuss with incredible healthcare executives about their journeys and leadership beliefs.

ESCP Students: Hello, we are Guillaume and Johanna, students in a specialized master’s program in biopharma at ESDP Business School, and we are thrilled today to be speaking with Anette Steenberg, the CEO of the Medical Valley Alliance located in Denmark. Anette is a leader in health innovation in Europe. She graduated in International Trade and Negotiations and worked for the Ministry of Foreign Affairs of Denmark. After several years in that institution, she joined the Danish pharmaceutical company, Leo Pharma, where she had leadership roles. Anette is now the CEO of the Medical Value Alliance and board member of multiple organizations, such as the Red Cross and Healthcare Denmark.

Aneette, thank you for taking the time to be here with us today. We are so honored to have you. We would love to first hear your personal experience and story and why did you decide to take part in Medical Valley in Denmark.

Anette Steenberg: Thank you so much Johanna and Guillaume and thank you for inviting me for this podcast.

I’m really excited about talking to you and I hope I can bring you a couple of insights or ideas for you and your exciting The future that lies ahead of you as leaders and the talent. We great needs in life science and other sectors as well. Well, my personal story a bit like what you already very briefly mentioned is that I have worked in the Ministry of Foreign Affairs for many years, actually two decades before that.

And even after that, I’ve traveled extensively. So I would consider myself. Some of the two common themes and threats in my career and my life has been international and it’s been internationalization of especially companies, but also basic collaboration across border and international. So that’s some of the key areas that I’ve always been working with.

I have spent 15 years abroad as well. I’ve been very fortunate to study in France, uh, though, do not switch into French. I do understand most of it, but my, my memory of speaking it takes a little time, maybe a week in France, then I’ll get back to that. Um, but, uh, I truly believe that the traveling and visiting, working and living and studying in other countries has been very valuable to me.

And I’ve learned a lot from that, including from my wonderful time in France. And, uh, yeah, you asked me why I I’m here where I’m at right now. Well, it’s just, you could say another step, uh, on my path of internationalization and collaboration across borders. I have now worked for about 10 15 years within life science.

It is an extreme international business as well. So in that sense, it’s, it’s not a big surprise I ended up in that area. It’s an area that’s growing. International is becoming always more important. At the same time, We also have a lot of exciting new innovation that is good for all of us, uh, as patients, uh, and as human beings wanting to be healthy, strong and live a long, good life.

Thank you

ESCP Students: so much for your answer. And now I’d like to know, as a multiple board member and because of your career working as a CEO, which qualities do you think are necessary to be a great

Anette Steenberg: leader today? I think, of course, you need to be a strategic thinker. You need to have the long view, some clear targets on where and direction of where you’re heading.

At the same time, I also think as a leader, you, you don’t have to be the expert, but it’s very important you great at setting the right team. I think the team you have, whether it’s a small team or it’s a huge company, it’s extremely important that you’re good at setting a strong team. And what is a strong team?

Well, a strong team, of course, is experts within the areas that you are working within, but it’s also a diverse team. It’s, uh, it’s very important. It’s not the same type of people that comes out from the same mold, whether we talk diversity in gender, it could be nationality, it could be also background in terms of different education, I don’t believe the best team.

Is the team where you all graduate from the same, even if it’s a conical. But if you’re all from the same school you’re all from the same, maybe line of business, basically the same age, maybe even the same gender. I don’t believe that will make a strong team I do believe diverse team is very important.

And you as a, as a CEO, as a managing director need to be able also to dare to bring on people who are much smarter than you. Um, that’s actually the best team you can get, uh, what you need to do. Of course you need to be, you could say you are the conductor of this team. Um, and you need to be able to, to make sure a team, uh, compliments, uh, each other.

I also very much believe in being a genuine leader. Uh, this is something I have always looked for in, in the people I have, um, I have had as managers. It’s, it’s a quality I really, uh, respect and appreciate. And I try to be that. Being a genuine leader is also a leader that sometimes makes very difficult and very unpopular decisions, and you have to be willing to take that.

I do believe people rather have a genuine and honest answer and direction than being unpleasantly surprised at maybe an unfortunate situation. Well, that said, I would also say, uh, I believe that, um, you need to be willing to take risks and you also need to accept and be willing that sometimes you make mistakes.

Even yourself or your team, of course you need to, uh, learn from the mistakes. And of course, you shouldn’t be making too many mistakes, but if you don’t make mistakes, you don’t take risk, and I don’t believe you, you develop, you’re not innovative enough. And I, I truly believe in most line of businesses today.

You need to be able to be innovative all the time to keep up and be competitive. And I actually have a little quality I learned some years back. Well, I think it’s a quality. Most people laugh at it when I say it, but with my team members over the past at least decade, I have always made sure once every quarter, um, we make the mistake of the quarter.

Competition and we also have an annual competition of the mistake or mishap, misunderstanding of the year and we celebrate it. So it’s a, it’s a little funny why you should celebrate mistakes and failure, but actually from when you look back where you’ve learned the most is typically where you made a mistake.

And if you deep dive into that, that’s actually when you learn. You don’t always necessarily learn a lot from successes. Successes are great and that’s what we should have the most of. But if you want to keep on developing, it’s important that you, uh, you also celebrate your mistakes and learn from it.

That means you are also, um, you’re willing to talk about it and you’re not afraid. And it’s, it’s not a, it’s not a shame to make mistakes. That just basically means that you are active.

ESCP Students: Thank you so much for that insightful answer. Uh, you’ve had so far a very successful and busy career. Uh, which project do you think challenged you the most as a leader? And how did you manage

Anette Steenberg: to achieve your goals? Um, I don’t know if I can find a specific project. I think one of my biggest challenges and one of my biggest learnings is to understand that people don’t necessarily respond the same to the same kind of management or leadership style.

As mentioned, I have worked many years abroad and I’m a dame, but working, for instance, in the U. S. They have a different, um, uh, leadership style and employees also want a different leadership style from the manager. And I believe that this management leadership style I came with was the right one just to find out that that was not necessarily successful to Americans.

That was a very big eye opener for me. Um, and I’ve learned a lot from it. It’s something I can still, uh, get surprised that I keep on making some of these mistakes. I believe, uh, it could be cultural differences. It could also just be even within the same culture that people respond differently to.

Different, uh, to leadership styles. It’s all going back to get who said it’s a cultural differences about, you know, power distance, uh, individualism versus collectivism, uh, avoiding uncertainty, um, time perception. So it’s, uh, even now I’m working in a Swedish organization. And for you in France. Or elsewhere, you might think Scandinavians are all alike, and in many ways we are, but in many ways we are

not. And there’s a different style of collaboration, and you need to understand what the perception is. I think that’s where I as a manager has learned a lot, and I’ve made a lot of mistakes. I really made a lot of mistakes. I think one curious one was in the U. S. in the Danish leadership side, we have a very flat hierarchy, which is a little different from what I remember from France.

You have a bigger power distance in France. So I maybe the French is closer to the U. S. I’m not sure. But in Denmark, it’s very flat and people get very, very upset if managers. Micro managing, uh, other, uh, people. Basically, they just want to be left alone. They don’t want their leader to interfere in their work.

Um, and that works in Denmark. But, uh, what I learned in the U. S., they actually enjoyed me interfering, um, or checking up on them, as I felt it was. And, um, and they thought that… Because I didn’t do it, it meant that, um, I wasn’t interested in what they were doing. And for me, it was just the opposite idea. I thought if I meddled too much, I would be annoying them and taking their initiative and independence away from them.

And they perceived it as me not being interested in them. So that’s just an example of my perception was totally wrong. And, um, Yeah, I learned a lot from that. And I truly believe that that is something I keep on learning from even today, but it’s something I’m very aware of. Another challenge is, of course, when you reach my age and experience, you’ve had a lot of challenges and failures and downtime.

And that, I believe, is also areas where I’ve learned a lot from, and it has been made me stronger. You have this saying that what you don’t die for, you, you, you, you get stronger. And, and I definitely believe that’s true. It’s not fun when it’s happening, but in the long run, I believe that, um, you cannot go through life that’s both professionally or personally without having bumps in the way.

Sometimes those bumps are harder than others. But if you, uh, if you really dive into it, that’s also where you grow the most. It’s from learning from that and getting up afterwards. So I would say persistence is one of the, um, resilience. Something I, I believe strongly in. It’s not easy. But I think it’s necessary if you want to, uh, to move up the ladder.

Yeah, it’s not a popularity context.

ESCP Students: Yes, that’s very true. Thank you so much. Uh, the last question I had for you today was, uh, what should leaders, today’s leaders should focus on for the

Anette Steenberg: future? I was going to say you. And what I mean by that is talent. I really believe talent is key. Uh, it’s about what attract talents.

It’s also about what rate retains talents. Uh, you, the young generation in, in general, now I’m generalizing, but I still believe it’s pretty much true of also what I know from France is that you are much more purpose driven than your parents. Your parents and even the older generation were maybe more focused on how much money they can bring.

I know there’s still a lot of young people being focused on that, but I think being purpose driven, wanting to have a work life balance. is, uh, is important. And if we as employees, uh, do not, uh, are not aware of that, we have, we, we will have an issue. So I really believe it’s one of the focuses we should have.

That also includes the, the open mindedness, the inclusiveness, the diversity, as I mentioned before. Uh, so I believe that, uh, talent is definitely my number one and number two, and then I strongly believe in collaboration. Uh, I, I believe in, in growing the pie. I believe that if one and one, that makes more than two.

So, and that doesn’t matter whether it’s collaboration internally at a workplace or it’s nationally between maybe even national competitors or it’s internationally. Between competitors, I do believe collaborating makes you stronger also individually. So, but that’s not a, that’s not a change I think it’s always been like that, and I think it will continue being like that, but otherwise.

Challenge you guys. Thank

ESCP Students: you very much, Annette. Now I’d like to jump to another section of the podcast. I will give you one word and want to get your reaction. So the first word here is

Anette Steenberg: leadership.

Yeah, well, um, I would like a role model, just one word. You are just, you can say

ESCP Students: a couple of words as you want.

Anette Steenberg: I, I believe it’s important leadership that you show role models, and it doesn’t have to be yourself. I believe, though, a leader should be able to be a leader so lead the team and also make the difficult choices and do the hard work themselves, though I think it’s, it’s, it’s also very much this, I mentioned earlier, being a conductor.

Setting the right team, not necessarily being the expert, but being the expert in setting the right team and letting the team basically do the work for you. But, um, yeah, being a conductor.

ESCP Students: Thank you very much. The second word is innovation.

Anette Steenberg: For me, innovation equals the future. It equals what we have to live from and off.

In the future, um, especially in our part of the world, we cannot compete on salaries. We can compete on our brains and our in ability to innovate. So, um, so I believe it’s a collaboration. It’s, uh, the necessity for countries like France and, and also Denmark and Sweden to, uh, to, to develop and evolve. Thank you

ESCP Students: very much.

The third word is

Anette Steenberg: Denmark. Mm hmm. Well, when you say that, the first thing I think of is our flag, uh, but, but otherwise it’s, um, it’s a… I’ll see if I can remember this, uh, there’s a poem. It’s a famous Danish poet called Piet Hein. And, um, he has a, I’ll see if I can remember, it says, uh, it’s one of my favorite.

Denmark seen from foreign land seems like but a grain of sand. Denmark, as we Danes conceive it, is so big you won’t believe it. But let us finally compromise about Denmark’s proper size.

Since we are something about, uh, smaller than we at all. But basically what it says is that we are a tiny country. But we believe we are much more important than we are at the same time. We have a certain level of humbleness. So we work hard and we really are striving to become better. And we do that through collaboration.

So, um, yeah, I think it’s, uh, it’s, uh, it’s ambivalent in the way that, uh, we are a tiny country that’s trying to make an effect on the world. We’re very international. It goes back to the Vikings. Denmark is a wonderful little country, but we would be nothing without the world around us. We are so dependent on the world around us.

We, uh, we are wealthy and competitive because we’re good. at collaborating. These days, we do it in a more friendly way than what the Vikings did, and I hope we can continue doing that. Thank

ESCP Students: you very much for that. Uh, and finally, the last word is spread love in your organization.

Anette Steenberg: Oh, I think it’s so exciting.

I’m, I’m, uh, I don’t know enough about you, but, uh, when I learned about you, I thought it was such a great initiative, what you’re doing. So, uh, and I love the, the, The word, the title. So I wish you all the best and I would love to follow you, uh, going onwards. And I, and I look forward to, to meeting a lot of schools, also a lot of students from your school soon, uh, later this month.

ESCP Students: Yes, very soon. Thank you very much. Do you have any final words or advice for aspiring leaders in the pharmaceutical industry or just for anyone looking to excel in their roles as a leader in their own organization?

Anette Steenberg: Um, maybe a little bit of the repetition, as I mentioned, you need to be able to set the right team.

You need to be less, um, less focused on yourself. You have to be humble, but you also have to be bold. And that might be an opposite, but it can go hand in hand. You need to be humble in the way that you cannot do it on your own. You need other people. You need to set the right team. But you also need to be bold in showing the way and also allowing for mistakes.

Even your own. Don’t hide it. Share it and, uh, and if you do it, then other people would do it, too. And you can grow together.

ESCP Students: Thank you very much, Annette, for your time today and for such an inspiring discussion.

Anette Steenberg: You’re most welcome. I hope you’ll have a great day and I look forward to seeing some of you soon in Denmark.

Naji Gehchan: Thank you all for listening. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow.

Naji Gehchan: Thank you all for listening to Spread Love and Organizations podcast. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow. Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jean-François Brochard

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

This episode is very special. In partnership with ESCP Business School, I’ll be giving the mic to students, our leaders of tomorrow, to discuss with incredible healthcare executives about their journeys and leadership beliefs.

ESCP Students: Hi everyone, we are Rita and Mohamed, two students at ESCP Business School in Paris, and we are delighted to be here today and welcome Jean François Brochard, General Manager of Roche France and Director and Chairman of the LEEM, which is a French organization and pharmaceutical companies. With over 25 years of experience in the pharmaceutical industry, Jean François held various leadership positions in both developed and emerging markets in Europe, North America, and Asia.

Before joining Roche France in 2018, he was the president of GSK France. He’s also the director and chairman of the Gross Regulation and Conventional Policy Commission at the LEEM. And in this podcast, we will discuss his career, leadership, and the future of the pharmaceutical industry in France and worldwide.

So, Jean François, thank you for being with us today. You’re welcome, Mohamed. This is, this is really a pleasure to share some of that. Hopefully the insights and experience that can benefit others. So, okay. Let’s start with a few questions if you want. So the first one, can you please tell us first a little about the major steps in your Kariv path and what marked you the most before you arrived at your current position?

Jean-François Brochard: Well, thanks. Thanks for the question about the career path. I think there’s always a lot of fantasy about career paths. So you asked me a very direct question, Mohamed, about, you know, what were the key steps? I think, you know, I must say, I, you know, I’ve been, I’ve been very, very lucky. Uh, I think my first job was actually in Mexico and I was I was thrown out of my, uh, native country.

Uh, I had to learn a language. I had to learn a different culture. And I, I think this, this has been the, one of the biggest opportunity in, in opening my eyes and, uh, expanding my horizons, you know, reaching in this, you know, At the time it was like 21 million people living in Mexico and, and, you know, and you had to make new friends and you had to learn the language.

And that was just, you know, I was what, 24 at that time and it was just fantastic. So I think there’s a bit of luck. And then I think I grew a passion for, uh, international career. And I had the chance to work in many different continents now and countries in the US, uh, in the Far East, in the Philippines, and then later in Europe, uh, in, in Belgium and Italy for a long time.

So I think one of the key thing is really, uh, the, the chance that I had was really to, uh, to have access to, uh, those opportunities. I created some, but most of, most of those opportunities were offered to me. And, uh, I think. You know, you don’t, I, one thing that I did is I did not overthink, uh, those opportunities.

I, I just jumped on them. Maybe it was, I was, uh, also, uh, I didn’t have a family, uh, uh, at a younger age, and that’s probably easier to move from, uh, I don’t know, the U S the Philippines and, and back and forth. But, uh, so I really think that, you know, you, you need to go and then, you know, learn and grow. Uh, so that, that’s one, one thing.

I think the international dimension would be my first answer. The second thing is, um, I was also very lucky to, to have a few, uh, very inspiring leaders, very inspiring mentors that were, you know, both I think integrating Uh, what I would call in French, uh, exigence, which means demanding, but in a positive way, and then also a lot of support.

So they were integrating both those things, you know, being very supportive and being very demanding. And, you know, they were also, uh, giving, you know, me a lot of trust, at least I think of two of them. Which were amazing in, in both as in all models, you know, the way, you know, I would, I would pick up a lot of their good habits and the things that I really liked about them, the way they were, they were visionary about the business, the way they were supportive with the teams.

And I think, you know, having great mentors is a good thing up to a certain level, actually, where I think that, uh, if in your career, you don’t feel. You have a strong mentors around you. It’s worth asking the question, Should I should I should I look for something different? And actually, I had to ask myself this this question a couple of times in my career, and one of the learnings I eventually did move to another job.

But I think I could have, I could have moved, I could have moved earlier. There’s, I don’t think there’s any experience which is worth, I would say, bearing, you know, a bad, a bad boss. So, you know, you, we, we need good mentors and sometimes, you know, they’re not your bosses, other people, but you need to have.

inspiring surrounding people, uh, if you want to go. So, you know, those are the two things. And then, you know, keep an open mind on things, you know, when, when you’re thrown out in, in the Philippines at what 20, you know, plus something, and you don’t know anything about, you know, being a general manager, but you, you ask to, to, to be one, don’t try to pretend just, you know, at least, uh, show that you’re, you’re eager to learn that, uh, you know, you work hard and you’re, you’re willing to also.

Uh, show some candor in your relationships. And eventually, you know, you, you, you, you, you manage through the, the content of the holes and, and you find your ways, you know, uh, with, with your uniqueness, this is what, you know, happened to me in the Philippines. Uh, and that was, that was always, you know, great, great, uh, experiences.

So I think those two things are, are, are the most important international and, and there’s probably much more things to it. Uh, especially, you know, the, the, the, the, I think what I kept about all those years outside of my native country is really the relationships that I, I, I built and that’s one and marvelous people.

Uh, and when they were not marvelous, I try either to adapt or change. And, uh, I think the other thing is also the. The chance to get to know another, another culture. Uh, and I think it, it make, makes you realize, you know how lucky you are, uh, at least in my native country, where you have, uh, free schools, free health, and you know, you come when you realize that people either in the Philippines or Mexico don’t have any of this and, and must fight very hard to get decent health or decent education.

Uh, you realize how lucky we are in some of our Western countries, and, you know, this gives probably more value to those great things. And I think it makes also me more prone to actually make sure that, you know, we preserve those extraordinary things we have in a country like France, like free education and free health.

ESCP Students: Okay, thank you very much for this interesting and complete answer. So, let’s move on to our second question. So, have you always wanted to be a leader? And do you think this is something that is innate or that can be built from scratch? Once again, thanks Mohamed for that very insightful question about, you know, either, you know, born or made leadership.

Jean-François Brochard: I think it’s a bit of both, actually, you know, I think we need to oppose both of those visions. You asked me the question directly, so I’m going to answer you directly. I don’t know if I always wanted to be a leader, but at some point I realized that at least trying to be one, trying to be effective and, and bring, bring people along.

So this is what, you know, leadership is about. Uh, not against, but with them is something that actually, you know, got me a lot of satisfaction and, and, you know, uh, and I felt good about, you know, bringing people along and, you know, having them on board on, on projects. So I was, I think, so you have to, you have to vibrate if you want, uh, to the signals of good leadership of, uh, at least effective leadership, if you don’t vibrate.

If you’re more interested in tasks or I don’t know, working on Excel sheets or doing whatever. Uh, I think it’s okay. You know, it’s not like, uh, leadership is more important than, you know, being an expert. Uh, and sometimes you don’t have to oppose those two things, but I, I think, yes, you have, you have to feel, you know, leadership is kind of right for you.

And both in difficult times, because obviously sometimes, you know, it hurts when, when you feel you’re not effective as a leader, you, you, you missed, I don’t know, you missed a take out with a, with one of your colleague, you, you actually, you thought that, uh, uh, the, the intervention you just made with your team actually was kind of, uh, I don’t know, not very engaging and this happened.

So. Uh, you both need to be stimulated by the things, you know, you want to improve, but also satisfied, uh, when, when you see signals, when you capture signals that, you know, whatever, uh, you’re doing is actually engaging people and they either, you know, uh, get more excited about their role or, you know, they want to engage more.

So you, you have to kind of like it. I think that this will be the first thing, the second thing, you know, the second part of your question about is it innate or is it something you can, you can actually work on it, as I said, you know, let’s not oppose those two things. I think if you are wired kind of to be, to, to be a leader, to vibrate to, uh, the, the good signals of leadership, I think it facilitates things.

But then I think there’s a lot of, uh, Things you can work. Uh, giving you an example. Maybe there’s something I was not doing very consistently at the beginning of my career. I was not, you know, at least sending strong signals that I was wanting feedback, including I would say challenging feedback. So I thought I had it all and you know, I didn’t need anyone to tell me, you know, what to improve.

And I think obviously this was a mistake because you need, you need, you need the looks of others and you can’t just see things through your own lens. And I think with the time I just opened to the idea that maybe people have a lot to tell me and a lot to teach me actually. So this is, this is one thing you need to be open to, uh, open to this.

And then also I think, You may do this in a very structured way. And most of the companies that provide you most of the tools, you know, the feedback, the 360s and, you know, some, some very structured models that helps you, you know, maybe grab some realities. And also all the. And if you don’t have the theory behind, uh, then you need to put this into practice.

But, you know, so I, I think you, once again, you need to look at those tools and those opportunities with a very open mind. There’s, there’s nothing to lose actually. And, and, you know, maybe sometimes it will hurt a little bit because some of the feedback say, well, you’re not very inspiring in this instance, or, you know, what you said did not really, I don’t know, help me in my job, or I think you can give me more support, but there’s nothing you can lose.

You, you, you, you just. The only thing you can, you can do is, you know, getting better at being a leader, uh, receiving this feedback. And I think, you know, I think probably I would say what differentiates, you know, um, improving leaders and, you know, playing leaders is precisely this ability to, to listen to feedback and be open to feedback, but, but not only to.

to hear, but actually to act and leverage this feedback as something you can, you can, you can actually, uh, actually change. So, you know, I received a lot of feedback in my, uh, in my career and when I started and I started, you know, I think I, I, I, due to this feedback, I evolved also from I would say self centered leader is maybe not, you know, the exact, uh, way I would put it, but that’s what comes to my mind, at least, you know, kind of self centered to something, which to something which looks more like, and I would say, uh, uh, team conscious and maybe collective centered, uh, leadership, uh, along those years.

And the, the, the, the way I grew this, I would say collective leadership is really through, through, through listening to feedback. And then, you know, reasoning and exchanging with colleagues and also looking at, you know, leaders that were doing this very well, uh, mentors back to the mentor question. So, you know, to your question, Mohammed, I think this is really about, uh, about both, you know, uh, and I, I think there’s always.

Always an improvement margin, you know, whatever the level you start from, uh, there’s always, but you need to enjoy it. You know, you need, you need to, you need to love coming to a room with 200 people and say, you know, I’m going to, I’m going to try to inspire them. I’m going to try to share some, some, something with them, which actually will help.

them to actually thrive. If you don’t like this, well, it’s going to be much harder, but, but there are, I think, many types of leadership too. And there may be less, you know, I don’t know, inspiring leadership, uh, more intellectual ones. I don’t know, but, uh, you know, I think you need to like it and you need to be open to, to, to progress.

Those are the two concepts that I would keep.

ESCP Students: Well, thank you again for sharing your different ideas on this topic. Thank you again. And, uh, now I will let the mic to Rita for the next step. Okay, so moving forward to question number three, how to maintain the commitment and motivation of your team in a sector where obtaining result and progress is a very long and uncertain process, specifically in moment of transformation or reinvention of the company.

Jean-François Brochard: Uh, thank you, Rita. For if I had the answer, I think it would be a noble price for leadership. I don’t think this exists, but we may want to invent this. Uh, the truth is, uh, I don’t know if there’s a recipe for this, uh, maintaining engagement. I think there’s a few, uh, there’s a few, I would say elements that would definitely help this, at least in my experience.

The first one is, I think you need you need to keep true to to the somehow the vision if you want the the inspiring elements and honestly, they can’t be 25 of them or you know, they need to be a few, a few, a few when you do a transformation. I think you need you need to be able to articulate the why of your transformation or the why you need to embark on a kind of a difficult journey.

in a very, you know, concise and simple way, you know, what are the two, three, four elements that you really want to change. And, um, you know, to give you a practical example, uh, when we, we had a very deep, uh, transformation, uh, within Roche. A few months ago, a few years ago, and it was really about rewiring the company, uh, from, from, you know, top to bottom, if you want.

And there was actually four principles that we wanted to, to materialize in the future that were not materialized now. So we wanted to have a more. Engaging partnership like relationships with our customers. We wanted to have a more fluid way of allocating resources in the company. We wanted to, uh, leverage digital, um, uh, more, uh, effectively.

And four, we wanted to start with the need in the market, the need from our customers. So you see four elements, not 25, just four of them. It’s, it’s maybe already too much. And we kept on, you know, like four, if you want both stars that would help us. Navigate through it. And I remember even in difficult times, like the teams were feeling a little bit, you know, this is too much and there’s a lot of change we need to go through.

And also, you know, uh, work force constant relationships where people are saying, that’s a lot of layoffs for, you know, this, you know, we were constantly, I was, Uh, able to constantly remind the why we are doing things. So this is one element is really, you know, kind of, you know, let’s, let’s remind us why we do things.

And if you can’t answer the question, why I think this will, this will demotivate your teams because they say what, you know, Uh, and the good thing about being clear about the why people can also position themselves from the beginning about, you know, do I want to embark in this or not? And I, I, we had a few people, not few, but you know, some actually said at the beginning, you know what, we’d rather work in a traditional way.

So we can actually leave the company. And I was absolutely all right. And I think at least, you know, engaging with why helps you, uh, not only. You know, uh, while you are transforming and when, you know, some, sometimes the weather is a bit rough, uh, but also at the beginning in, in having people, you know, asking the key questions, are you, are you up to this?

You know, that’s kind of the initial, initial contract. So that’s one thing. Uh, then the other elements, I think it’s about, uh, how would I, you know, I would call it proximity.

It’s being close to topics, it’s being close to problems, it’s being close to people, more importantly. You know, it’s about being there, especially when the times are rough. Because people will want to ask you a few questions, they will want to, you know, have a look at you, whether they feel you are still engaged.

Even because, you know, in those in those transformations are always rough times always and I think you and sometimes it’s okay to say, You know what? I don’t really have the answer, but I’m here. You know, I’m here to support and you know, we’ll find we’ll find a solution together on you always do eventually.

So I think it’s really about, you know, getting this this very close to, uh, to people and topics to understand And although also there’s one thing, you know, just to give you an example, we did one thing with the, um, uh, with, with the leadership team in the French affiliate of OSH, where we had this, uh, we, we called it, if you want the changing rooms, uh, so it’s like, you know, when you do collective sports, uh, whatever, this is usually have a moments in the, in, in the changing room where you can tell things, you know, very open hearts.

And, you know, so we didn’t have any, uh, obviously agenda for, for those moments. They, they lasted about half an hour from, from time to time. And we were, you know, sitting in a very comfortable sofas and we were throwing, you know, the things that would affect us. Uh, and amazing things actually emerged because at some point we realized that one of our colleagues.

We’re actually bearing most of the weight of the pain in the change. And, you know, it allowed, you know, the team to redistribute a little bit this, this pain and actually support our colleague just because, you know, we had, we had a safe space. There’s this changing room space. where you could actually actually, you know, talk with an open heart.

So those are the, you know, little tricks, uh, that, that helped, you know, maintain the, uh, the, the, the team very much engaged. But I think what eventually keeps the, um, the team, you know, engaged, you know, in, in times of transformation and overall is the feeling that they’re very useful. You know, as long as you can set up a context and an environment for people including you where they feel.

They are useful, you know, they will thrive. And obviously, you know, you need to, you need to have more than decent compensation, incentive systems, and all those things are useful. But I think the most impactful one is really, you know, Making sure that, you know, uh, you, you, you ask them, you know, things where they feel very, very useful, useful for others, useful for the mission and useful for themselves in terms, in terms of, uh, personal development.

When you go through a Uh, transformation. You learn, you learned a lot about your own leadership. You learned a lot about and this, you know, really feeds, you know, the self confidence and, and the, uh, the, the degree of engagement of, uh, of the team. So those are the themes. Maybe I’m not super structured here in my answer, but those are the key thing, you know, the, why the proximity and, you know, feeling useful.

Uh, there’s probably many other things. I’m sure they are super theorists. Of this, I wrote full books about it, but as a spontaneous answer, this is what I would say.

ESCP Students: Thank you for sharing this, and we’ll move forward for a question about what, uh, what are for you the biggest challenge of today, both in leadership and in the pharmaceutical industry, and how do we overcome them?

Jean-François Brochard: I’ll start with the easy one, which is the challenge, you know, in the industry and then I’ll go back to, I would say, challenges in my leadership, if you want. I, um, I think the biggest challenge, you know, working in the industry is really the challenge of, of true and sincere partnership with our, with our stakeholders.

And this is maybe more true in some markets. Uh, it’s likely to be the case in France. I’ve lived in other markets in Belgium. It’s, it’s a bit different, for example. Uh, there’s a, it’s easier to set up, you know, uh, sincere, uh, partnerships, but in Mark, in some markets, it’s more difficult. So I think there is, there’s this thing about, we have, we have an image of an industry that makes a lot of money to some extent.

You know, it’s true, but we are delivering also huge amounts of values to a patient journalists across, you know, uh, the world. So I think it’s about how can we find, you know, the means to, to establish how do, how, how can we leverage our leadership externally to actually, you know, help our stakeholders believe in, in, in, you know, co writing things.

Together for improving health in one particular country. And sometimes we’re very much considered as a, you know, supplier if you want. So the lowest the cost, the better for them. And it’s truly hard to make them, you know, understand that this is much more nuanced and systemic and holistic than they think.

And the pharma industry, you know, is also a promoter of a, of a healthy, you know, knowledge economy. Uh, you know, it’s about, you know, uh, also working with the, uh, uh, academic centers across the world and developing knowledge. And this is, this is huge as a value and they don’t necessarily recognize, you know, those things.

So it’s, it’s really about establishing this, uh, how do you do this from a leadership point of view? Once again, you start with the, why you try to, you know, uh, be sincere. And you also need to be clear about, yes, you know, we also have some economic, uh, expectations, you know, uh, investing in research is, is a huge investment and, you know, we can’t have, uh, the U S market, uh, paying for, you know, uh, the world innovations, if you want, which is kind of the case today, maybe two third of the, uh, of the economic proceeds of, uh, of a new drug is coming from the U S at least in the last 15 years.

So, you know, we, we, we, we, we, we need to have, you know, to help our stakeholders realize that Paying the lowest price, you know, is not sustainable, you know, if you want to continue to have this, uh, uh, innovations, you know, therapeutic innovations and diagnostics, innovations, they need to evolve. So this is, you know, as far as the external, the pharma industry is concerned, I think this is, this is the challenge.

And I think. One of the ways to resolve those challenges is to make sure also, and Mohamed made reference to some of the responsibilities I have in the National Pharma Association, is also trying to align our colleagues in different, many other companies. And to the same kind of, uh, approach, but, you know, being a partner to the system.

And, you know, most of them are, you know, and they, they think alike, but it’s, it’s about the lining this now. It’s not, not just one company that can, that can do it. It’s a whole industry. I can start moving and also adapting their commercial models, adapting their partnership models, if you want. Uh, so that this becomes big, it becomes possible, but, you know, as soon as long as Our R& D organizations will continue to produce amazing, you know, therapeutic innovations.

I think we will have, you know, the necessary conditions to actually, you know, make this partnership work in the future. Now, you also asked me about my personal challenges in leadership, and I started by saying that I welcome, I welcome, uh, feedback and challenge. So, you know, I hope I have a good answer to this, uh, to this one.

I think the, um, the, uh, the key challenge or the key things that I would, I would, I would like to continue to improve is really about this, uh, being a systemic leader by systemic leader. Uh, it’s not about the leader of the produce, uh, performance or leader produced engagements. It’s really about a leader that produces systemic value, value for the company you work for, value for the people you work with, value for the system, the health system you work in, and value for the, you know, political world that’s around you, you know, what I said earlier about the knowledge economy.

So this is, this, so It’s not only about being focused on your team and, you know, making sure that, you know, they thrive, uh, they are engaging, they are motivated, but it’s about also linking this with the external world and your corporation. Because you could feel that you are autonomous in an affiliate and to some degree you are, but you know, you have to integrate those dimensions, you know, the society.

Uh your affiliate if you want and you’re the corporate and I think it’s about finding ways to be effective and navigate through through all of this Sometimes it’s easy. It’s easy. It’s easy because everything is aligned you know the interest of your system is the one of your affiliate and one of your corporate and you kind of You know, it’s like in sailing when your, when your wind is coming from the side, that’s kind of easy sailing.

And sometimes, you know, corporate and the affiliate and, and, and, you know, the, the local decision makers, you know, are not aligned and, you know, you need to, you need to find ways to, uh, to establish, you know, You know the partnership also, you know, say, you know, say clearly the things that needs to be improved The things you’re willing to put on the table and the things that you do you are demanding, uh that they improve so Most of my time is actually more on this kind of situation where you have to to manage through a bit of conflicting Priorities here or there But

uh, this is You know one I would say one of the key challenges making sure that what you do, you know work systemically and not just you know in your team or you just You don’t just pride yourself because you know, you know, you you inspire with your people and uh, that’s okay Uh, so and you need to do I think you need to do uh, you need to integrate Um, i’m not sure.

I like the word balance, but it’s more integrating those things. It is making them, you know, coherent one and another so this is Uh, yeah, what I’m I think if I can get much better at this, you know, I would be very happy. It’s very clear.

ESCP Students: Thank you. So now I would like to go to another section. We’ll give you one word and want to get your reaction about leadership.

Jean-François Brochard: About leadership. I think this is really what, what, what, what, what makes, you know, Miracle possible. I think this ability to, uh, to bring larger group of people, you know, do something which is meaningful for another group of people, uh, by leading them, by giving them the vision, by providing them the tools, by providing them the environments and the context, you know, this is.

This is just great. You can achieve amazing things. We can, we can solve huge problems, you know, like health problems, like, you know, people are dealing with, you know, difficult lives and you can just by, uh, kind of, you know, uh, this ability to lead, you know, different groups of people actually make this happen.

Uh, but leadership is never. I think eventually it’s never, it’s always about one individual if you want, but, but it’s always so interdependent. So we are so connected with the others that, uh, you know, attributing, you know, the quality of leadership to one individual, I think is a mistake. And it’s really about, uh, You know, working, you know, as a network and, you know, we are very, so much interdependent.

One of the things I know you asked me one word and I’m making a long, a long, a long speech here, a long answer here. But, uh, I think there’s a traditional leadership journey, I think is less and less about. Myself and more and more about ourselves. I think this is this is a natural direction I think I see many other leaders and that are sharing the same kind of experience.

It’s less about yourself It’s more about you know, the system and we’re trying to improve for others.

ESCP Students: Yes about innovation innovation, um, I think it’s it’s it’s both a um, well innovation is both a blessing and a curse Uh, it could achieve amazing things. Uh, like look at what we’re doing in health.

Jean-François Brochard: Bringing therapeutic innovations that, you know, are fundamentally, you know, making people live longer, live in better conditions. You know, sometimes actually, you know, garish from, from some of the disease they suffer. Uh, look at, you know, the promises of, uh, gene therapy is massive. So, you know, it’s, it’s both amazingly, uh, potent, but at the same time, You know, it’s, it’s, if you don’t, uh, anticipate some of the consequences of it, you know, it’s, it’s, it’s becoming a bit of a curse and, you know, look, look at, you know, we can have a long debate about, you know, global warming.

And, uh, so, but you know, the, the, the scientific evidence is there and some of the reasons why we are in this situation and, you know, the, the, the destruction of, you know, complete natural ecosystems is because of innovation too. So I think is, you know, innovation without wisdom, I think brings chaos. And I really think that we need to think very thoroughly, especially companies like us that, you know, you know, put, uh, innovation, uh, to the forefront of our mission, making sure we understand the consequences and how can we actually continue to innovate?

Without paying such a high price on global systems and, you know, I’m thinking about, you know, global warming as one, I think the, the reduction in biodiversity is, is, is one other. And I think we have a responsibility. We can’t just say, you know, we, we, we, we try to bring innovation at any cost. So once again, you know, to maybe to, to, to make a more concise answer about the innovation, it’s really, you know, uh, you know.

Use wisdom so that it does not become a curse. But you know, you keep the blessing. So about the general management, what about general management? Yes. Um, I think we need general manager. Now I’m gonna be a bit promoting here, but you know, I think this is, you know, you, you, and whatever it is, whether you know, it’s, it’s, it’s a plant, whether it’s, you know, an affiliate, whether, whatever, whatever it is, you need the general manager.

You need, you need kind of a, I believe in incarnated leadership. So, you know, it’s about people. So I’m fine. Yes. When I’m walking into the, into, you know, the office in Paris, it’s okay. They see me as, Oh, you know, yes, he’s kind of, he’s our leader. And hopefully I’m up to that expectation. And some days I am sometimes some, some days I’m, I’m less that’s okay.

But, you know, I think it’s okay. You know, you have to kind of, uh. Uh, be at ease with the idea that people will look at you and say, you know, you know, you, you, you have a responsibility to kind of help us, you know, look at, you know, what’s right. You know, what’s what’s the right direction? What’s the right mission?

What’s the right vision? It’s okay. So you need you need this and it’s to be incarnated. It can’t be something that I don’t know. An email you send through whatever channel or, you know, on an app and suddenly, you know, you become, you know, a leader, I think it’s incarnated, you know, people need to see you, you need to be able to articulate this, you know, drinking a coffee with one person or you need to articulate this in front of a thousand people telling them the same story.

Jean-François Brochard: So general management, general management is absolutely useful to, to, to companies and it needs to be incarnated. Yes, and finally about the spread love in organizations. Spreading love into organization. I, uh, that’s a, that’s an interesting one. I, uh, so the thing that would be many meanings to the world, uh, love, but I think there’s something that has to do, you know, the, the, the Greeks had actually three names, uh, for this.

Which I think is interesting. We only have one in English, only have one in French and many languages. We only have one. I don’t know about, you know, many, I don’t know, Far East languages, but the point is that there’s different ways of, so, uh, I think here we are dealing about, I think the essence of love.

Is this ability to, uh, wish well for others without necessarily being recognized or, you know, being, you know, incentivized for it. This is what, you know, love is all about. And there’s, there’s, there’s something around, you know, it’s okay to, uh, I think if we can spread that kind. Of, uh, attitude. If you want that kind of leadership that you know, as long as we do well, even though sometimes we are not recognized, that’s okay.

You know, if companies if systems can actually spread this kind of love, this is fantastic. At the same time, Rita, I think, you know, we shouldn’t be also thinking that you can manage, uh, you know, the way you love your family, for example. Is one thing and companies can’t, or I think it would be a mistake to manage a company in the way you, I don’t know, you know, you deal with your family.

Uh, so it doesn’t mean you don’t need to be generous. You don’t need to be supportive. You don’t need to be challenging, but I think it’s different, different orders. Of love, if you want. So, uh, my answer would be, you know, spread the love that actually, you know, do, do, do good for people and don’t expect to too much, you know, say return or recognition on it.

So this, this, this is, you know, what I, what I would say about spreading love. Perfect. Thank you. Many final words of wisdom for aspiring leaders in the pharmaceutical industry.

Yeah, maybe it’s, it’s really around, um, you know, think system, think, think partnership. This is not about, you know, going on revenues only. This is really about making sure that, you know, what we do has a systemic impact and a positive one, you know, on society. Uh, so rethinking also the way we engage with, with our stakeholders in a way that, uh, you know, we, yes, we improve patients life, but we also improve systems and, you know, we are conscious about.

You know, some of the constraints that our health systems or our political system have, and we can’t be blind to this. So I think it’s, you know, if I had one advice or, you know, maybe an invitation more than an advice, it’s about, you know, really think systemically, open, open your, your, your guts, your hearts, your brains.

To, to something that is, you know, in partnership in nature, you know, find the sweet spot about, you know, not only, uh, win yourself, but, you know, make sure that the system also wins because otherwise, you know, it’s going to be unbalanced and, you know, it’s, it’s going to lead to either you having a bad reputation.

And this is what happened to the pharma industry, to be honest. And, you know, let’s, let’s make sure that, you know, we, we deal with another, Uh, era here, you know, but more, you know, trusted partner era rather than just, you know, being predators of resources in their systems.

Yes. Thank you so much, Jean Francois, again for your time and such inspiring discussion. Well, thank you, Rita, Mohamed, and Naji.

Naji Gehchan: Thank you all for listening to Spread Love and Organizations podcast. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow. Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Marc De Garidel

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

This episode is very special. In partnership with ESCP Business School, I’ll be giving the mic to students, our leaders of tomorrow, to discuss with incredible healthcare executives about their journeys and leadership beliefs.

ESCP Students: Hello, we are Sarah Boutros and Bouchra Taha, Specialized Master’s students at ESCP Business School in Paris, and we are thrilled to be joined by an outstanding, innovative leader, Marc de Garidel, CEO of Syncor Pharma, a biopharmaceutical company that develops therapies for patients with cardiovascular diseases, and recently acquired by AstraZeneca.

Marc is a graduate of a cusp. It sounded probably a leading French civil engineering school and holds a master’s degree from Thunderbird School of Global Management and an executive MBA from Harvard Business School. Mark began his career with Eli Lilly. Then in 2000, he was appointed. He was appointed general manager of Amgen’s French affiliate and progressively oversaw an increasing number of countries before heading the southern region of Amgen International.

The group’s most important vision in terms of sales in 2000 and then Mark left Amgen to become the CEO of Ipsen, where he helped transform the company by focusing on research and development and expanding Ipsen’s international presence. Under his leadership, since market value increased significantly prior to joining Syncor, Mark served as CEO of Corvidia Therapeutics, a private Boston based biotech company that was acquired by Novo Nordisk in August 2020.

In addition to that, Mark has had an extensive nonprofit responsibility as VP of Europe Pharma Association for three years, as well as chairing the French Pharma Association G5 for six years. Mark is also a recipient of the French Legion of Honor. Thank you so much for joining us today, Mark. To start, we would like to know more about you.

So can you share with us the story or the events in your past that influenced your decision to pursue your current

Marc De Garidel: career path? Well, thank you. I’m glad to be here with all of you today. Well, you know, it’s, uh, it’s hard to say what, uh, you know, when you start your career, you don’t really, uh, exactly know where you’re going to end.

And if you had told me 40 years ago that I would be a CEO of biotech companies, I would have said you’re dreaming. But I think fundamentally what, uh, you know, what drives, uh, an individual and, and, and me in particular around the, uh, pharma industry is the fact that, um, it has some characteristics, which I think are, are, uh, are wonderful.

One is, uh, you know, you develop drugs for patients and, uh, knowing, uh, what you do can make a difference in the, you know, the life of, uh, of patients, of your family members or, or people you know, is, uh, And absolutely, you know, incredible, uh, you know, luck, uh, you know, to, to, to do something, uh, you know, for, for, for these people.

So that’s one, I think two, what’s also fascinating about this industry. It’s in the middle of the, you know, of a big evolution in science where, uh, you know, innovation is coming from, from, you know, obviously a greater knowledge about how the human body functions. And it’s a fantastic adventure. To be part of projects where you are in touch with some of the, you know, the, uh, leading doctors of the world in their specialty and where again, you’re trying to, to, to develop a new therapies for, uh, you know, for, for the benefit of, of patients.

That’s, I think, you know, extremely unique, uh, intellectually. Uh, to be part of that, uh, of that adventure. And I think the third dimension to me, which has, uh, also been, uh, uh, very rewarding is this is an industry which is really global. So you have to, to work, uh, you know, in different countries. You have to, you know, uh, you know, diseases are not, uh, you know, they are, they are spread.

They are widespread. They happen in no way. In, in, in every country. So adding as a taste for, uh, no, uh, understanding, um, different geographies. And certainly now see more and more, uh, the development of the pharmaceutical industry has been in the U S with, uh, it’s innovation engine, uh, is something that I always have been attracted.

And that’s why I did my MBA in the U S and why I, you know, I enjoy, you know, being, uh, you know, in different places of the world.

ESCP Students: That’s actually very inspiring. So let’s tackle the second question. Do you believe that everyone is suited to be a CEO? Is it true that the skills and traits necessary to be successful? A successful executive can be learned, or are they something that a person is born with?

Marc De Garidel: Well, I think it’s both. You know, you have some characteristic, uh, you know, from, uh, from a C e O.

You need a lot of energy. You need, uh, you need to withstand the storm, uh, because, you know, it’s not easy to, uh, to, uh, to deal with, uh, you know, a lot of issues, uh, as you, as you progress. So you need to be very, uh, resilient. Um, so there are, I think, you know, you’re going to be very, uh, very, uh, you know, dynamic and, and, uh, because it’s just, you know, the workload of, of doing things is, is, is pretty high.

So I think these, these are things that some people do have, they have good health and unfortunately don’t have good health. Uh, you know, uh, I think you also need to have the, um, appetite, certainly if it’s in the biotech industry. Uh, to, uh, you know, to, to, to withstand the risk and to, uh, appreciate risk to leave it under a lot of uncertainty because you never know exactly what’s going to happen to, to you, to the company.

If, uh, you know, the drug fails, you know, everything can, uh, can, uh, become very difficult. So, um, So I think that, that’s the part where I would say, you know, the innate, uh, you know, part of you and how you are born, uh, plays a role. But this being said, uh, you know, it’s not, obviously, uh, it’s not enough. It’s probably a necessary condition, but it’s not enough.

And I, I think part of the, um, uh, you know, becoming a CEO is the learning as you go through. I think having a great mentor, you know, I’ve been lucky, uh, in my career. I had, uh, always great bosses and I would say that actually when, when you look for a job, that’s probably, I think to me, one of the most important thing is make sure you respect the person that is going to hire you.

And this person, you know, will help you, uh, you know, grow and, and, and, and get better. So I would say, you know, the, the environment under which you operate. Uh, I think you need to have something in the pharmaceutical industry, a constant appetite of learning because science, technology are evolving very fast and you need to be curious to, uh, you know, try to understand what’s going on.

And certainly for me, probably even more because I was not, you know, medically trained. So you have to learn, uh, you know, on the go to be credible, you know, in the field. Um, so I think, you know, it’s, it’s, it’s, uh, You know, working in a, in a big organization first, at least in my case, has been, um, certainly helpful because I have learned, you know, how to operate, I’ve seen mistakes being made, I’ve seen, you know, good things being made, um, but having a big boss, also, uh, someone who can help you grow is, uh, is essential.

And then, uh, you know, what’s actually kind of, uh, I think, uh, you know, sort of, uh. I am sort of not a very traditional person because, you know, I started in order to work in big companies and the more I progressed in my career, the smaller it has become. But, but, you know, the more I have actually enjoyed the, you know, uh, um, you know, doing this, um, and, and, and, and fundamentally, you know, you need to, to, to like.

Having an impact on things. I think you, you, you have to, to, um, you know, there are some people who like to, to, to follow. There are some people who, who, uh, who like to, to, to, you know, to try to, yeah. To, to not change the world is a big, is a big, uh, is a big, uh, big, uh, probably to too, uh, to ambitious, but at is, you know, trying to impact, you know, the few things you can do.

So, um, so that’s, these are I think important for, for A C E O.

ESCP Students: That’s really impressive. And your answer actually makes the perfect transition to our next question. So as a leader, you’ve been confronted with several challenges. Can you tell us about the time where you had to make a difficult decision? And how did you ensure that you made the right choice?

Marc De Garidel: Uh, it’s, uh, Yeah, I mean, certainly when you are in, uh, in, uh, you know, in a more executive positions, you know, there are times where, uh, you have to decide, uh, you know, which path to take. And you have also to try to convince others that, uh, you know, this is the right path to go. Um, so. You know, part of that process is, is to, uh, again, to try to, uh, to figure out, you know, I’m talking obviously about big decisions, decisions that can impact.

You know, tremendously, uh, you know, the company and the people, uh, you are, uh, you, you have, uh, with you. Um, so I, you know, I use the example often about the Ibsen decision to go to the U. S. You know, when, when I was, you know, if Center was, uh, you know, a midsize company, uh, doing, uh, doing well internationally, but in the US that, you know, unfortunately failed to, uh, to, to do well with a couple of acquisitions that didn’t go too well.

So when I was confronted, you know, in the mid 2010, so it was around 2013, 14, I believe, uh, with the idea that we could launch our own drug. You know, in the U. S., the big question was, you know, Mark, is this, uh, is this realistic? We have failed until now. Uh, this could be a disaster if we fail again. And, uh, you know, and what, uh, you know, what are the consequences of that?

And I have to say, I was confronted with a lot of skeptical people in the company, including in my management team. I would say probably more than half of my management team thought I was crazy. It was a completely, uh, uh, completely crazy. But what I did is. Because first, obviously, I knew the U. S. market because I had worked in the U.

S. for a number of years. But, you know, what I did is I went with some of my, uh, with my medical director to, uh, to the number of centers in the U. S. to figure out, you know, what, what are the, the, uh, the, um, opportunities for a drug, uh, like ours. And even though we are, again, a tiny little company and we’re Novartis, which was obviously the big oncology, the sort of a big player, you know, I tried to figure out that we have a chance to succeed.

And, uh, you know, To cut a long story short, I convinced the board, I convinced, you know, my management team, this was the right thing to do, but there were a lot of risks. And, uh, I knew that, uh, if I had not been successful, it would be, you know, bad, obviously for, for, for the employees would be, but for me, because I would be fired.

But, you know, at the end of the day, we did it and, uh, you know, we became the market leader, uh, you know, we beat no artists, uh, in the U S. And, uh, that transformed ultimately Ibsen from becoming truly a global company. So these are, you know, these are decisions that, uh, the big decision, as I say, you need to take time.

Uh, you know, you need to, uh, to mull over them. You need to speak to a lot of people. You don’t have always, you know, uh, you know, the truth in yourself. So you need to consult a lot, but at the end of the day, as a leader, you have to, you know, you have to go and, uh, you know, and you have to live with the consequences of what you do.

And sometimes it’s good. Sometimes you make some mistakes. I mean, you know, a number of mistakes in my career, uh, in general, I try not to make once, but, you know, it’s part of, uh, it’s part of the adventure. You know, you can’t, you can’t succeed in doing, uh, you know, again, having an impact, a real impact on certain things.

If you don’t take some risk at some point, and that’s, I think, you know, for all of you, you know, while young and talented, you know, you have to go, you have to try and, uh, and then what I find is obviously in the US market, uh, yes, people tend to be much more forgiving, except that, uh, you know, when, when, when you try things, if you fail.

You know, you, you learn from your failure. It’s, it’s not, nothing is bad. You know, you learn, obviously you don’t want to repeat them, but you learn. And that’s part of, uh, you know, the journey to becoming a leader. So that’s the path.

ESCP Students: So, Mark, you mentioned previously having a mentor that provided guidance and support in your path to success within the pharmaceutical industry.

Could you share a story about their impact on your journey?

Marc De Garidel: Well, you know, I can give you the first example. Well, I mean, the first example was actually with Lily. I was a young, uh, young guy. I was, you know, sort of the pharmaceutical controller of the French subsidiary. And, uh, the head of Europe of India came to, uh, to do a business review.

And my boss said, you know, Mark, you’re going to present the whole of the budget presentation. And, uh, and, um, I say, well, I was a bit obviously stressed, so I prepared myself know a lot for that. And then when I did a presentation to this, uh, head of Europe, uh, you know, I think I was able to answer all the questions and I knew I was going on.

And then the person, you know, was Terrell, who became actually ultimately the c e O of, uh, of, uh, of Lilly. So, You know, he helped me, uh, you know, go relatively fast then in, uh, at leading to, to, to my start, which was obviously a great foundation for ultimately my success later on attention and so on. So these are, you know, this is just one example of, uh, of someone who, uh, you know, have me navigate, uh, in my early career in terms of, uh, you know, building the right, uh, foundation for, uh, you know, ultimately success, because, you know, if you go too fast.

So danger, you know, obviously when you are young, you want to do, you know, a lot of things. Uh, but, you know, in the pharmaceutical industry, it’s still very complex. So you want to make sure you, you, you learn, you know, the fundamentals gradually. So that again, when you are in the position of a real responsibility, you don’t make too many mistakes.

ESCP Students: We still have one more question before we jump to the next section. So what misconceptions do you think people have about the role of a CEO or executive? And how does your current job differ from your initial

Marc De Garidel: expectations? Well, probably, you know, the things that, that, uh, uh, I think the biggest change when you get to a CEO job, Compared to where you were before, before you were, you know, running a division or you were running something, uh, you know, but you were reporting to, to, to the c e o.

And when, when you become the c e o, you know, you, you, you’re the c e o. So you’re as a, you know, Ronald Reagan said the, you know, the buck stop here. So that’s, you know, ultimately you, you’re responsible. But what I think I, I fully, you know, underestimated is the fact that even if you’re c e o, you’re not the boss because you have always the boss and the boss is actually your board of director.

And, and what you have to do is to work actually extensively with a, with a board to make sure that, you know, the things that you are doing, uh, you know, the success, the failures, the things you, you know, you, you, you, you are with your board, you, you, you exchange, you learn from them, but you are very aligned with them in terms of the direction of the company.

And that’s, you know, I think that’s some, some, you know, that’s, that was to me a big, big surprise. Because I, I thought I spent a lot of time with the board, much more than I would have anticipated just running the operation.

ESCP Students: So now I would like to jump to another section. I would give you one word and want to get your reaction. The first one is innovation.

Marc De Garidel: Well, that’s a wonderful part of what we do in the, uh, the human body is extremely complex. There are unfortunately still a lot of diseases that need to be treated and, uh, Innovation is a way to, uh, to, uh, you know, to find, to try to find solutions for, for, for the patient.

So. Um, you know, innovation is accelerating, uh, you know, at a tremendous pace and being part of, uh, the process is again, is wonderful, but you can, you need to have, uh, you need to be ready to accept the failures that are associated, uh, since, uh, especially in the industry, as you know, in among 10, 000 drugs that are discovered in early stage and you want to make it, make it to the market.

So it’s a very, it’s also a very difficult, uh, you know, selective process innovation.

ESCP Students: All right. The second word is leadership.

Marc De Garidel: I think, you know, leadership, there are different ways to, to, uh, to be a leader. And, uh, I think there are different distinctions. I think, especially when you grow in your career, uh, you know, you are, you’re, you’re taught to be, to be, to, to, to be, uh, especially in the early days. You know, to be very strong technically and to be a great technician, but I think as you grow, so you’re essentially a manager.

And I think the difference between a leader and a manager is that over time, you know, you, you’re not going to do so many things yourself. You, uh, you, uh, you, you have to, to, the work needs to be done through, through your team. And, uh, you know, I do so often the analogy of the conductor of an, of a, you know, an orchestra to me, a leader is more, you know, you don’t play the music, it’s your people who play the music, but what you do is you, you know, when the music is, is kind of going wrong and you know, how to, uh, to orchestrate, so, you know, the different, uh, you know, different, uh, players, musicians, so that it rings, uh, you know, it sounds, uh, it sounds great and it’s very difficult, uh, It’s a very difficult, uh, uh, job to do.

And, uh, you know, again, multiple mistakes, but I think that’s one. And two, I think, you know, the team is so important, you know, you, you have to. You know, you have to create a team that, uh, uh, is, is, is together, is aligned so that you know, you can conquer together and you fail together. But it’s not, you know, just one person who, who can, uh, who does, uh, thing.

And, uh, you know, finding the right people, creating that environment for, uh, for, for, you know, for innovation, for success and sometimes for failure is, is one of the key attributes of, uh, of a, of a leader.

ESCP Students: So let’s move to the third word, which is biotech.

Marc De Garidel: Well, biotech is, you know, it’s a broad, uh, it’s a broad, uh, term, you know, which essentially is the, uh, industry that has been created at least initially, you know, back in, uh, by, I would say Genentech in the early, uh, you know, in the early nineties.

But it’s become symbolic of, of, of trying to exploit, you know, again, the understanding of how the human body functions to try to target, you know, more specifically some diseases or some, some things. certain things that happen in, in, uh, in diseases and to try to figure out how to circumvent that, that, uh, that, uh, that process.

And obviously it has exploded in different technologies. Obviously you have from gene therapy, cell therapy, uh, large molecules, small molecules. There are plenty of different modalities that are now, uh, being, uh, uh, exploited to, to try to, to combat, uh, you know, uh, um, you know, multiple diseases. And

ESCP Students: finally, the last one is spread love and organizations.

Marc De Garidel: Well, I think, you know, it’s part of the things that, uh, is challenging. But, you know, I, uh, you know, there is one person I really, um, admire when I was actually in the U. S. Uh, he was the, uh, coach of, uh, of, uh, a football team. His name was Lou Holtz. And he’s, uh, you know, he was with Notre Dame and he made Notre Dame the football team, one of the most successful ever in college football in the U.

S. And when, uh, you know, he’s talking, when he was talking, you can watch on YouTube actually, you know, he said, There are really three things that count if you want to be successful. One is, is, uh, you to trust the people. Two, you need to do the commitment of your people. But three, you need to care about them.

And I think the, the, um, you know, I, I think the leaders need to care about, about their, uh, you know, their, their employees. Sometimes, you know, caring doesn’t necessarily mean always, uh, You know, obviously you want to motivate them. You want to, to, uh, you know, to, to, to, to, to, to carry the company with them, but at certain times, unfortunately, caring about them is letting them know they are not in the right spot.

Maybe they’re not, you know, productive in, in, in the, uh, in where they are and they could do much better in, in a different position or, or potentially in a different company. So I think caring is absolutely critical, and that’s, I think, one of the role of the c any, uh, you know, leader manager to, to, to truly, uh, help.

Uh, you know, the employee on the person, uh, you know, as part of the organization to grow and to give them feedback and to have them grow.

So

ESCP Students: before we wrap up, do you have any final words or advice for aspiring leaders and the pharmaceutical industry or for anyone looking to excel in their role as leader? And their own organizations.

Marc De Garidel: I think, you know, one of the key things is do what you like, right? Do, do, do things you, you, you, you, you enjoy.

Because at the end of the day. That’s going to be critical, uh, for, for, for your success. It’s, it’s, you know, and don’t be worried. Don’t, don’t get worried about what people say about you and like that, not try to be meaningful to, to, to, to, uh, To, uh, to your passion. Uh, you know, do it. Learn from it. You’re going to do mistakes.

Uh, that’s okay. But, you know, do do really what you what you like to do and and don’t care too much about what the others think about you because, you know, they you’ll shine by yourself and you’ll, you know, you’ll succeed. So whatever you do.

ESCP Students: Thank you so much, Mark again for your time for this inspiring discussion.

It was really a pleasure, a pleasure to us.

Marc De Garidel: You’re welcome. Thank you so much.

Naji Gehchan: Thank you all for listening to Spread Love and Organizations podcast. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow. Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Karine Duquesne

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Karine Duquesne, Vice-President, General Manager of LEO Pharma France. Karine previously held the position of General Manager at Actelion Pharmaceuticals France, and Johnson & Johnson’s rare disease subsidiary prior to its merger with Janssen in 2020. She holds a Doctor of Pharmacy degree and has more than twenty years of experience in the pharmaceutical industry within various positions, from Medical Affairs to Head of Marketing and Sales. Karine is French and has enriched her career with international experiences in the USA within Janssen’s Global and Strategic teams in Immunology and Neuroscience. Karine is passionate about people development, innovation, diversity and inclusion.

Karine, It is a pleasure to see you again and have you with me today!

Karine Duquesne: Thank you, Naji, and thank you for hosting me today for this podcast on leadership.

Naji Gehchan: I would love first to learn more about your personal story. So what’s in between the lines of you becoming a pharmacist and now leading pharmaceutical companies as a general manager?

Karine Duquesne: My career is more Link to opportunity to really something that I have decided for a long time, um, science and caring for people was something very important for me when I was young, but, um, deciding between medicine, being a doctor or being a pharmacist was more because of some leaders I met.

during my, uh, my, um, my studies. And when I started as pharmacist, as a student, I decided first to work in a retail pharmacy in France because of the relationship you can have with people, with patients. I was so dedicated to patients that I thought firstly that my Part to play was to be close to people.

And then I met a fantastic leader, a woman from a GSK. And, um, she, uh, she shared with me, uh, job, uh, passion for the industry environment and how you can impact being part of, uh, the industry, uh, uh, company. So. I asked for a change in my student part and I moved from a retail pharmacy to, uh, to the, uh, industry development.

And then I joined, uh, Johnson as, um, as a mentee, not a mentee, as a trainee. And I spent 24 years with Johnson growing through the company. I think I have done, I have held all the position you can have, uh, in medical affairs, in commercial, in training, in compliance, everywhere. And I, I grew up like that, more, once again, it’s not a straight line.

It was more opportunity, new project, new people, new leaders that who really inspired me. And then I’m here today.

Naji Gehchan: I love it. Thanks for sharing this. Uh, you, you’ve led through, uh, out your career, as you said, different teams, uh, different functions, metaphor, commercial, and now general manager. You’ve also led in different countries, different companies.

Uh, now Johnson was your longest company you stayed, but you’ve, you moved since. Do you see a common thread or kind of a leadership theme leading people across all those experiences you had?

Karine Duquesne: I think the, the common thing is more linked to myself first is that I am really authentic. When you see me at work, I exactly the same person in my personal life, and it’s one of my conviction supporting people to be themself at work.

It’s really important. Um, the other thing is about passion. I think it this type of job. Um, you need to be passionate by your job to be sure that you can deliver and you can, uh, Go the extra mile because in our job we need to deliver. We need to care to take care of people. We need to manage so many different topics a day.

Um, we need to to start the day be so passionate, but. By our job and the reason why and my personal purpose is to serve the patient across, uh, the French environment today, but across the world and be sure that I can be a small piece in a big part and contribute to that. So you shared this

Naji Gehchan: as you transition from being in retail pharmacy and working with patients directly to now this word and you go back to your purpose and passion that I think many of us, if not all of us in healthcare actually really have this helping patients live better.

Can you Tell us a little bit, because I have a lot of those discussions with still practitioners, how do you see your impact daily? How are you missing this patient interaction, for example, that you had in the pharmacy, or how do you see it today? Um, the

Karine Duquesne: way I am see today is more across the patient organization.

I had the chance that’s really important for me to keep a strong link and relationship with the, the, the people leading a patient association in France. It was really important in rare disease for sure, because especially during the COVID period, I remember. The time we spent with the head of the patient association we worked with at that time, just to be sure that we can, uh, be present even during the COVID period and to serve patients.

And we, we, um, we were so passionate to be sure that we can support them more than before, that we can push all the barriers with the support of the French healthcare system. And for example, for people, um, suffering from pH. going to the hospital during the COVID period to receive their injection, it was too dangerous for them.

And you can’t, um, bring the treatment to their home in France. During the COVID period, we had exceptional authorization for the health care authority to do that for them. So it was tough to imagine we can do that. But in two weeks, We make that possible. So that’s for me the best example about caring for patients and be close to them, even if you work in a pharma company.

So you can do that every day. Next week, um, we will organize, um, a race. And the race it’s about the patient suffering from, um, infirmary chronic disease. Uh, and we will all the employee of the company running for them. So there are different way to support and to be present, uh, for patient according their association.

And every day when I woke up, I wake up, I know that I will work for them. Whatever, that’s my way to think about that every day. It’s

Naji Gehchan: certainly why we wake up every morning. I’m interested now to take you a little bit back in time, but one of the questions that I frequently have since I also, like you, French, moved to the U.

S., I frequently get this question about your, your experience in the U. S. So I’d love to get your thoughts on this. What’s common and how did you lead in different cultures? What did you learn from those, uh, different experiences?

Karine Duquesne: Yes, the it was an amazing experience for me and for my family because I moved with my kids and my my spouse.

It was really amazing. The difference in terms of culture is huge. But when you talk about leadership for me, there’s no difference. Um, remaining who I am. So optimistic, so energized every day, so passionated by my work, um, how I can impact, how I can support my colleague, be a good partner. I guess I did that in the same way than what I was doing when I was leading an organization in France.

And very, very quickly, I was the French woman. People would like to have lunch. With just to share something new. And, um, when I was in France before moving to us, I had a lot of opportunity to mentoring people to mentor people. So I have mentee in Europe, um, in France, in my organization, outside of my organization.

And I’m, when I moved to us, I realized that it was known and. U. S. colleagues asked me to mentor them or mentor someone in their team. So for me, that means that, uh, being authentic, supporting people, look, be so, um, focused on people development. It’s something that you can drive or develop in the same way, whatever the country.

Naji Gehchan: I definitely share your view about how to lead and the way you lead people. It’s kind of human, right? Like the human way that you’re describing. I’m interested. You said, uh, you were the French woman when you were in the U S and I know. You’re passionate about diversity inclusion on those topics are sometimes tricky like we have different views you might have enjoyed being recognized a French woman or not, actually, so I’m really interested in your view about this specific example, but also more broadly, how do you think about diversity equity inclusion within within your teams?

Karine Duquesne: It took me a long time before being so focused on the Um, woman traits of leadership, because firstly, being a young leaguer, um, It was really important for me to be recognized as a leader before then being recognized as a female leader. But right now, knowing the, and having a young woman, um, I talked with about their career.

I realized how it’s still difficult to grow as a female and be authentic. And, uh, even right now with more mature female leader, they’re There is always this question. Can we be ourself as a leader? I am a mom of two teenagers. To be honest, my more difficult job is to be a mom. It’s more rewarding, but it’s so difficult every day.

So I think that being able to be vulnerable at work, it’s perhaps something that seems to be a female traits, but I’m sure that you are someone that can show your vulnerability, Najee. I know you a little bit. I know you can. So it’s not only female traits, but because the gender equity is not there, we need to be supportive and be sure that there are equal chance for young women to be, uh, Perhaps more supported and to have the same change that the young men to develop themselves and to be themselves and not trying to change their way of working to make people understand that they can be a good leader.

Can you share with

Naji Gehchan: us some examples where you helped young leaders, women, uh, leaders throughout your organizations and how do you do this to ensure that those opportunities, especially that now you have this influence and power, if I can say, you know, as a general manager, how do you ensure this is happening consistently across your organization?

Karine Duquesne: I do that through different ways. The first thing is that, uh, um, being a role model, Uh, not to be a focus on myself, but just to be sure that, uh, I can show young female leader that you can be yourself. You can be a mom. You can say, I can’t join this meeting because my son is sick or because it’s his birthday.

And it’s more important for me that this meeting, you know, these small things that in business, most often you keep for yourself and you manage as you can. And just showing that, uh, you can develop yourself, you can grow. In a company, in an organization, why be so clear that your children will remain your first focus and, um, same thing being authentic, sharing some, uh, personal difficulties, sometimes not my personal life, I can talk a lot, but just to share that.

It’s difficult for me too. Some days, I’m sick. Some days, I’m not in a good shape. And don’t try to hide this difficult moment because it’s human beings. So same word, being authentic. In another way, I use different mentoring program because I think sometimes it’s not only about someone being there. You need to structure the approach.

And help people just to say I would like to be supported or what does that mean to to have a mentor compared to a coach or compared to More senior leaders pushing on your back. So just giving some example and um and having um a structured approach meaning something that will last long time enough to be supportive because on only one discussion or one touch point is not enough to really deep dive and support someone in the right way.

Those are great

Naji Gehchan: practical examples. And I love what you shared about having your kids birthdays or any milestone in their life. I remember a great mentor once told me, uh, you will, you will always remember a missed birthday, but you will never remember why you missed it or the meeting you were in and what decision you made in the business side.

So I love those examples. Um, you, you. You’re talking a lot about authenticity, and I want to, like, ask you a question, and vulnerability, like, this is something, as you said, I also believe in. One of the pushbacks, or one of the things people would be afraid of is being perceived as weak, once you’re in leadership positions, if you’re sharing those vulnerable moments.

So, I’m intrigued throughout your career. Up to this, the now where you are and being able to say vulnerably, like I’m not feeling well, or you know, all the discussions we’re having on mental health, how do you think through this and making sure you’re not weak when people actually need you to be strong or being vulnerable when you feel is the right moment?

Is there a moment in time where you feel like you can share, not share? I’m intrigued about how you think about

Karine Duquesne: this. I think it took me time before really. Sharing that with authenticity. Um, for two reasons. The first one is that, um. I think I’m strong. People knowing me, most of the, the leaders I, I knew for years, they started to tell me, you are a man disguised in a woman.

That’s the worst things you can tell me because I’m a woman. So, but perhaps my self confidence and the way I, I say what I think. With a lot of transparency, I’m very direct. So people see me as a strong person and, um, as a man, you know, it took me a time to share vulnerability because it was difficult for me, for me to see my own for new vulnerability, but with experience, because life is about experience, you learn step by step by step that, uh, um, it’s more failures that make you learn than the success you had.

So with that in mind, um, I started to share and it’s about one person. I remember one of my extraordinary PA, my personal assistant, one day she told me, you’re sick, you’re not in a good shape, but you are still there. What do you think? What do you think about the example you give to the young people in your team?

That means that even if you will die, you will come at work. Are you proud of yourself? That was a wake up call for me. And from this day, I can remember this day, um, and I remember Nejima telling me that And with that in mind, I totally changed my thinking about that. And, uh, I started to, to listening to myself first.

And it, the starting point is to start with yourself before telling the other one about vulnerability. And, uh, and right now it’s easy for me to share that. Um, but most often, especially young female, they told me it’s easy for you to, to say you are vulnerable. Because people don’t see you like that. But for me, because I’m, uh, I’m, uh, young, I’m blonde hair.

I seems to be weak by myself. If I share something personal, people will say, Ah, she has too much emotions, too many emotions. Say no, you are who you are. But it’s, uh, it’s a kissing.

Naji Gehchan: No, for sure. Yeah. And, you know, thanks for sharing this and saying it’s just. Like, I don’t know if it’s absurd or not, but it’s the reality, right?

Like what you shared about you being a man disguised, right? Like we, we constantly hear this. It’s, uh, I’m sure we as men hear it less. I heard though, like it’s my woman side of things when I’m more into the humanistic part of, of leadership, which, which. Which is mind blowing, right? Like, it’s just how we separate these.

I’m in a constant fight also, even in retail stores about why my daughters can get their NASA shirts or, you know, astronauts shirts it’s in the voice section, it’s just like, this is how we construct all those biases, unfortunately. Socially. So thanks for doing what you’re doing and pushing people and the society to be better.

Karine Duquesne: Yeah. And my, my way to, um, I love your expression to spread love for me. My way to do that is to spread some of my tips and I do that with all the women I mentor and with all the general manager, female general manager, I am. I met, I told them if I support you, if I help you, if I am a. your mentor and you, you feel that it helps you.

I just have one, one question and one request to yourself is please do that to two other women after. Because if I support you, you need to do and to replicate the same at minimum to two other female. So that’s a way to spread. So I am, I check after they do.

Naji Gehchan: I want not to go into, uh, Kind of a game where I will give you a word and I would love the first reaction that comes to your mind. So the first word is leadership.

Karine Duquesne: Um,

servant leader, two words.

Naji Gehchan: Can you tell us a little bit more?

Karine Duquesne: Um, for me, it’s, it’s really, uh, related to what I mentioned before. Um, and it, it means for me a lot to be. Not only focused on people development, but to look how I can, uh, support the team just to be sure. Um, I will listen to all the voices and be sure that the time I will dedicated to them will be something really, uh, supporting COVID

period. I spent a lot of time to think about the way we will lead our organization after the COVID. And, uh, for me, servant leadership is one of the most impactful way of leading an organization right now. And, uh, be sure that, um, we can, uh, be part of a team, but be sure that everybody at of the, uh, organization as a world.

Uh, as a voice that, uh, will be listened and, um, as opportunity to understand that, um, they, they can make a difference and that really important in the organization. It was part of my introduction yesterday during my sales meeting that you are all. an important piece of our own team, of our own puzzle. And every day, the impact of the difference you will make, at the end, that will make a big difference for the patients.

And that’s for me, uh, the most important thing.

Naji Gehchan: And this has always fascinated me, right? Like in healthcare when comparing to healthcare provider, which is also an enormous noble purpose, right? And you help patients every day, but truly through leadership and our organizations, the impact that you can have and each one.

work is so important to change someone’s life. So reminding our people constantly about the importance of our purpose and why they do what they do is so important. I’m going to go through attention and not another word because I’m, I’m interested. Uh, since, uh, one of the big topics is hybrid work, you said you thought a lot about how, how to lead organizations after COVID.

It’s one of those big topics these days. How do you think of this as a, you’re leading a country and, uh, actually says it’s pretty virtual usually. So I’m, I’m intrigued. How, how do you think about hybrid work or future work, whatever you want to call it.

Karine Duquesne: For me, hybrid is, um, It’s still about relationship. I remember during the COVID, starting every morning with a coffee.

So we had time virtually to take our coffee together like before the coffee machine, but be sure that we can start together. And for me, it was an opportunity to check that, you know, the small signal, someone feeling alone, someone not doing well. And just be sure that this personal moment can make a difference.

Right now, it’s quite different because you have face to face meeting. You have virtual meeting, and you have this hybrid part where part of the team is, uh, is in virtual, the other one are in the same meeting room. And for me, whatever the mode, if you have built before a strong relationship and you take care of Each person in, um, in the meeting room, virtual or not?

You can, um, you can do the same. The difference is that you need to be more, um, explicit, uh, giving some rules. For example, be present when you are in a face-to-face meeting. You can be present and you can have your computer. just in front of you and looking at your emails coming and not being present to the meeting.

So in virtual mode, you can’t see that. So it’s something you need to check more or to share some rules that are part of the way to live together and not being in a meeting. So it’s about human relationship. And what is the most difficult things for me is, is COVID. Plus the new generation with remote time.

What will be the key clue to motivate people? How can you make and design a team or make people feeling they are part of a team or a company if most of the time they are working from home? The question is not about working or not working. It’s about feeling that you are part of the company. Because you are so far from your colleagues, you have not all these, uh, small moments that are more personal than professional.

And, uh, that’s a key question in, uh, for me. That’s a

Naji Gehchan: really important one. Belonging, right? Making sure that people feel they belong. And that’s one of the most important parts of diversity, equity, inclusion, actually, if you feel this. Feeling of belonging and part of a bigger purpose. The second word is innovation.

Drugs.

You have to share a little bit more.

Karine Duquesne: No, treatment for sure. Being part of a, of a pharma company. Innovation means new treatment. And for me, it’s, um. The hope we can cure most of the disease because most often I launched treatment that were for chronic disease where we were a treatment to make people having a better life with their disease, but the few opportunity I had in my career to cure a disease.

It was only one time in hepatitis C. So to be honest, it’s not enough. That’s perhaps. Innovation. It’s more about hop.

Naji Gehchan: What about general

Karine Duquesne: management? Diversity.

It means for me that every day you can touch so many different topics a day. And, uh, because I’m so curious, you have opportunity to deal with many different topic in your company. But being curious, that means you have a lot of external interaction. So it’s like, for sure, you lead your organization, you need to deliver your, your target.

But you have opportunity to open a lot of new doors. Giving opportunity to deal with new ideas and create something new, new ways of working, new ways of developing people. And it’s exactly what I love. And it’s not about the size of your company. It’s about the way you look at your job.

Naji Gehchan: The last one is spread love in organizations.

Karine Duquesne: Kindness.

And the reason why I use this word is because I love the word love. But when I talk about love with people, they told me it’s not for a company. It’s for your personal life and most often kindness when you translate in France, in French, it’s very mis, uh, misunderstood because for me, taking care of people, it means that you be, you will be supportive, but you will be.

Demanding in same time. So it’s not something a week. It’s something about looking at people with positive eyes, giving them a safety space when they can learn, they can grow, they can share their difficulties or this and be able to to be celebrated for success, but same time when you are authentic, you are direct and positive.

You can share with people constrictive feedback. Sometimes tough feedback, but you can help people to understand if they fit with their job, with their position. And it’s not about themselves. They are not bad people or good people. It’s about being sure that at this moment of your life, at this moment of the company with this culture, you are fitting with this position.

What is the core business you need to deal with and be sure that you are happy. With that. So it’s not you need to be courageous. So for me, kindness, love. Most often people misunderstood. What does that mean? And it’s, uh, it’s about challenge. It’s about caring. It’s a mix. Lack in personal life, huh? .

Naji Gehchan: Exactly.

And I love how you framed it because when you truly care, you’re supportive and extremely demanding actually. Yeah. Because you believe in people capabilities and you want them to be at their best. So I love how you framed it. Any final word of wisdom kain for healthcare leaders

Karine Duquesne: around the world? My final words will be, um, perhaps the one I started with, saying that, um, uh, being authentic, be yourself, whatever happens, it’s something that will drive you to your best, that’s my personal conviction, and, uh, it’s about alignment.

With yourself, your purpose, what you are dealing with every day, and I’m sure that the best way to be a happy to develop yourself and be able to support. and develop others around you. Well, thank you

Naji Gehchan: so much for such a great discussion and for being with me today.

Karine Duquesne: Thank you for the opportunity and, and, um, it was great to have opportunity to, to discuss leadership because most often we talk about figures and talking about leadership and people.

It’s really important for me. So thank you for this opportunity. Naji Gehchan: Oh, thank you for being here. And as you said, several times without leadership, you obviously cannot deliver exceptionally well. So it’s interlinked and thanks so much for all your vision about this. Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Gaurav Mehta

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Gaurav Mehta, CEO at Alveolus Bio, a biotech Harnessing the power of the microbiome for the prevention and treatment of lung disease. Gaurav has raised multi-million dollars in the form of dilutive and non-dilutive money. He also has progressed long term global strategic partnership deals that authenticate his team, their capabilities, and science with the intent of obtaining investments for his company. He has also created a revenue-generating-business to create value, sustain the company in market volatility and mitigate dilution. While in this capacity, he also advises multiple life science businesses. Gaurav has co-founded multiple companies. His 20 years of building and scaling depth include having led global operations, business transformations, top and bottom-line improvements, M&A execution, and a turn-around. This experience has been across large to small firms around the globe in BioTech, MedTech, digital health, and tech.

Gaurav, so good to see you again and have you with me today!

Gaurav Mehta: It’s so great to see you too, Naji, and thanks for, for having me.

Naji Gehchan: Can you first share with us your personal story from biomedical engineering, manufacturing to now CEO of Alveolus, what’s in between the lines of your incredible journey?

Gaurav Mehta: Wow. That’s a great question. Um, I, I’d be lying if I told you that I was actually, you know, it was all planned because it wasn’t, you know, it, it was more about trying to find my own self journey and the process and trying to figure out what I really wanted to end up doing. I always knew that I, I wanted to help people.

In fact, I started out thinking maybe I should be a doctor, uh, a medical doctor, and it turned out that, I worked under a doctor and I realized, you know, that’s not something that I’m super excited about. Um, so I decided to go down this path of biomedical engineering, and I’m like, okay, is this is exciting.

I love stretching. I love growing, and I just kept trying different things, stretching myself, growing in different, different capacities. But over the years I finally realized that, you know, it’s not, um, I, I can bring value to people and to me, I realized I could take all these skills, these experiences that I’ve accumulated over the years to make a broader impact.

Maybe I can bring, uh, meaningful therapeutics or medical devices or whatever way I can collectively bring a team together, bring the right culture, bring the right mission, help bring these solutions to life. Be part of that equation. That ultimately ended up being where I’m, uh, today. And, you know, it’s been a journey where it’s been a lot of understanding who I am, uh, as part of the process as well.

Naji Gehchan: Can I double click on understanding who I am as you frame it? Yeah. What, what is, what are your learnings? How did you get to learn who you are through this process?

Gaurav Mehta: Yeah, that’s a another, uh, tough question. I think in the beginning, you know, I was confused. I was doing all these different things. I was very much like stretching myself in terms of I love challenges, I love problem solving, but I’ve always had this question about, okay, what is it for?

What am I going after? What’s my compass? Right? And, uh, it’s a process of. Constantly throwing myself in the deep end of the pool and starting to realize, okay, this is what’s interesting. This is what’s exciting me, this is what I can provide value to. But I think entrepreneurship is, uh, especially in the past several years, is what really stretched me so far.

Where it was like almost a breaking point where, I started to understand, you know, it’s okay. It’s not a destination, it’s a journey. And the journey is, you know, we don’t know what that final outcome looks like, and that’s okay. And we may not ever reach that. We may have an idea of what that may be, and we may not reach that.

But every day we’re peeling the onion. We’re kind of sculpting. Who we are, and I’ve come to to terms with that, where I’m much more happier and I’ve realized there’s two things in life. There’s the contentment and then there’s the happiness piece. Contentment is being at peace with yourself and being comfortable in your skin.

And going after what we believe in day in, day out. But then also the happiness is not necessarily the same thing as contentment. I could be doing anything trying to solve a problem, but that necessarily may not bring me happiness. Happiness is some deep calling that I personally believe. We all are unique.

You know what? What we wanna do, our dreams, our values. If we pursue that, we are happy. And especially if you’re content and you’re following your dreams, you’re following your values. I think that’s what really cultivates the happiness aspect of things as well. And so that’s my, I’m much more comfortable in my skin, especially because of this entrepreneurial journey and learning to be more mindful.

And that, you know, I’ve pursued these things, uh, like Headspace, which is like a mindful, uh, guided mindfulness and whatnot, which has just really allowed me to understand myself, witness myself, witness others, and realize what contentment is and what happiness is.

Naji Gehchan: I love it. We’re immediately in deep discussions right about yourself as a person, as a leader, uh, as, as you went through this journey.

And we discussed, uh, last time, uh, both of us, uh, really kind of turbulent. Time we’re in as, uh, in the biotech industry, something we’re both passionate about. Uh, I, I’d love to understand how you’ve been using those capabilities to keep growing, but also to lead teams in those moments at the end of uncertainty.

Right. I love how you framed it. It’s about a journey. We’re kind of wired several times to think about the destination we want to go to, right? And we wanna achieve it and reach it. So how have you managed along your personal growth, uh, as you gracefully shared leading teams to understand that the important piece is this one step at a time for us to uncover the next innovation for healthcare?

Gaurav Mehta: Yeah, no. To me, I, I’ve realized, uh, another piece is that I’m only a piece of the puzzle and part of that piece of the puzzle is the team that we belong to. Um, and so the people that we surround ourselves with can make or break you. Right? And, and I don’t mean just by functional work, but I also mean the energy that is an intangible.

Whether it’s my boss, whether it’s my direct reports, I feed off that energy myself and as a leader, we also have to bring our own energy to the table, which is the whole contentment and happiness aspect. But it’s also so important to, to be around people who are also like inspired and driven and it becomes like a system dynamic, um, where we’re feeding off of each other, right?

And so sometimes, you know, there are people. Within the team who may be down and we come to the table and also bring our energy to the table. And it’s just a self-fulfilling reinforcing loop where if, if you’re negative, it’s going to feed off and create that negativeness. But if you’re positive and you are pushing yourself to think out of the box, or if your team members are pushing you to think out of the box as a team, as an engine.

We, um, we propelled forward and I have a great team around me and, um, whether, who’s our executive chairman, who’s, uh, who’s also our founder, he is, you know, he’s very driven, he’s very motivated, and he’s thinking out of the box. I love that energy that I get from him. At the same time, the people that work within our team, they’re also coming up with different ideas and you’re like, Maybe it is possible, and you know, and so we keep feeding off of this, and I think that ultimately makes you think of different, different ideas.

Whether it’s like, Hey, maybe we can generate revenue off of this thing and try to keep ourselves afloat. And you’re providing value to other companies. At the same time, you’re thinking of grants, you’re thinking of foundations, you’re thinking of different, different things, and you’re like, Hey, that’s promoting our science moving forward, and.

I think we can also provide value to disease X, Y, and Z. You know, and I think that ultimately is progressing us in that direction. And we may or may not get to that destination, but I think we’re chugging along in times. It’s tough at at times. It’s like, Hey, it’s all exciting, but I think every day you have to wake up and.

Remind yourself that it, it’s a journey and if we fail at the end, it’s okay too. And coming to grasp with that takes that whole anxiety, that whole edge off. But when you do, you thrive, in my opinion, at least that’s the case for me.

Naji Gehchan: Can you share a specific example, about, you know, those challenging times. If it’s funding, if it’s data readouts science, like I, I always feel we’re, uh, in our space, we’re humbled with this double uncertainty of biology and business all the time. Right. So, yeah. How, how would you deal with this, with your teams in those times, as you said, that are challenging?

Gaurav Mehta: Yes. No, absolutely.

I think, look, I will say if the science doesn’t work out, it doesn’t work out and we can’t do anything about that. It is what it is. And you have to be, integrity is one thing that if you’re not integral in our business, you don’t belong here. Right. And so I think that I can’t do anything about, we have to follow our gut and I personally.

Not only do I feel the science is amazing, but the gut tells me that this is very much de-risk. Now I have to convince that to others who may or may not believe, like for example, whether it’s microbiome, they would like, oh my God, all these other microbiome companies are failing. But I’m like, that’s the gut.

It’s much more variable. But the lung isn’t, you know, this is something that’s uh, found in the lung. And to me, I think. Not only the science, the data speaking very positively, so I wholeheartedly believe it Now to do that, we we’re like, okay, how do we convince people? Now we’re thinking of different animal models.

Even though the FDA doesn’t require us to do it, we’re looking at ferrets, we’re thinking out of the box to make sure that we can, um, de-risk this further, to get people to be more convinced. And, you know, even from an investment standpoint. We’re hitting every single angle. If institutional VCs in the current market are not willing to invest, that’s okay.

We’ll look at angel, angel groups. We’ll look at wealthy individuals, even though you have to be very careful who you, who you, uh, partner with. That’s another thing, but every day if we don’t try, we’re not gonna find that right partner. But at the same time, we’re looking at foundations. We’re like, okay, we’re thinking about Bill and Melinda Gates Foundation for tuberculosis.

You okay? That’s one angle that we feel very confident. Cystic fibrosis Foundation, we feel like we can do, you know, and we’re thinking about combinational therapies, all of these things to just to try to see which way makes sense. Can we create a partnership with various different companies? You know, it’s, it’s a tough market.

Um, and we’ve had several that went, but even those companies sometimes may struggle, right? So again, it’s every day you chip away. I’m confident that one day something very favorable is gonna come about, and that’s what keeps me going.

Naji Gehchan: Well, that’s that’s great. And I love this iteration that you’re talking about that’s really this entrepreneurial journey that you said you’ve been embarked in and you’ve been enjoying for the past decade. Uh, so when you think about, uh, transmitting, if we go out of your specific company, I know you mentor a lot, you’ve worked with a lot of startups, biotechs, med techs. What is the one advice you give founders CEOs when they building that company? Is there, after your, all your experience globally and yourself as an entrepreneur and as c e o, what is this one advice you give to leaders founding their companies?

Gaurav Mehta: Um, yeah, no, I think in that regard, there’s several things that come to mind. One that’s very common is who are you serving? Who’s your end customer? What’s your game here? Um, how are you targeting? So there’s that business. Find mindset to make sure that you’re crafting a business around it. But I’ve often found a lot of, uh, companies, a lot of leaders within those companies, they get too hung up with the storylines that people themselves have created.

Whether it’s like, oh, I’m, I gotta have this equity, I gotta do this, and I’m like, A 0% of zero, uh, a 0% of whatever equity is still zero. Right? And so you have to make progress. You have to compromise at times to, to make certain things move in the right direction. And that those storylines goes back to the contentment piece that I was talking about earlier, because we have these storylines in our head to that, you know, prevent us from thinking.

In a peaceful way, thinking about what’s really the end goal? What’s driving them? What are their values? What are their dreams? Now, don’t get me wrong, I’m not trying to say, oh, we should take whatever dilution that comes your way. No, the focus here is don’t get stuck in, in, in your journey thinking about like, okay, you know, this is an end all, be all.

You have to start thinking about. What are the roadblocks and how do I get around it? You know, what are, what are, and those roadblocks are a lot in our head. And um, and I think a lot of the founders, a lot of the entrepreneurs break because of not being able to handle their own mental struggles. And you know, when I first.

Embarked in this journey. People told me, oh, entrepreneurship is is hard. I’m like, I’ve been doing hard work all my life. I’m not afraid of hard work, but I must say it’s been a hard journey and it’s, it’s a very, very hard journey because you realize, It’s a lot of emotions that are involved and it’s emotionally tormenting.

And so I think once you reach the self-reflection, self-understanding aspect of things, you give a whole lot more to your team, to your, uh, to what you’re trying to accomplish. And you are much more content. And, and if you’re following, if, if what you’re doing is aligned to your. Your passion, passion, your, your, your vision, uh, your dreams, your values.

Then you’re happy as well as content. Right? And so I think, I think that’s, that’s what I see a lot.

Naji Gehchan: Thanks for sharing Gaurav. I’m gonna give you our word and I’d love your reaction to it. And the first word is leadership.

Gaurav Mehta: Leadership. What’s my reaction? I think leadership is, It, it goes back to understanding who we are and getting rid of the storylines that are in our head and realizing that it goes back to the whole destination piece. You know, we may strive, we wanna, people wanna make money, we all wanna, you know, all do all these kind of different things, but at the end of the day, we’re not gonna die with all of this.

Yes, it’s important to do all those things, and it’s important to make money for the investors, but I think you can only do. If you realize that you have to be humble, you have to be, uh, you have to be aware of yourself and your team members and your surrounding to. To provide the most productive output that you can and that favors the investors, that favors your team, that favors the product that you’re creating.

It favors yourself. Otherwise it’s misery involved. And that’s, that’s my re reaction.

Naji Gehchan: That’s a great reaction. I’m, uh, we’re we, several times we’re used to have leadership and thinking of others, obviously. I love that your first reaction is, Self-reflection. It’s, uh, it’s deep self-understanding for you to be able to lead others.

That’s, that’s a powerful, the second one is innovation.

Gaurav Mehta: Innovation. Um, I think innovation, you, you have to define the word innovation and the word, in my opinion, innovation is combined with two things. One, It’s the idea, but then two, it’s all the execution that goes behind making that idea something that’s accessible to a broader market.

It’s commercializing it, right? And to do that leadership. And it, it doesn’t mean that you have to be leading a team, it’s just how you bring yourself to the. It goes back to the same story that we’ve been talking about, um, is in order to to to bring that innovation, we have to bring our best self forward.

We have to realize who we are to be our best self forward, and, and that is what takes two. Inspire people to, to get a team of people together, to get investors motivated, to be able to sell that in a passionate way. Um, people will see that people feel that energy and that’s what really ultimately moves the needle in terms of the business, in terms of innovating.

Naji Gehchan: The third word is entrepreneur.

Gaurav Mehta: Entrepreneur, entrepreneur is, um, the first reaction is getting rid of the storylines in your head and to be able to, to able to bring the genius in you out. Uh, I personally am a big believer that we are all born with an innate genius within ourselves. We all have a different offering, a value offering that we give to this world.

And the thing is, we oftentimes, including myself in the past, we sometimes get caught up in the storylines and we stop these beautiful things that we have just because we think that we have to conform to somebody else’s mold that we have to follow something else. To be our best self forward. And I think that is actually self-limiting.

And to be an entrepreneur, you have to be able to create, bring that genius to the table. And the only way that you do that is believe in yourself. And believe in, in the idea that you’re bringing to. But also be realistic. If you find out that the way that you’re doing it is not gonna work, either pivot or stop.

And I’ve realized pivoting is huge in entrepreneurship. It’s like constantly pivoting and you’re constantly trying to find that sweet spot that has to happen. But um, yeah, that’s my reaction.

Naji Gehchan: Get rid of the storyline you have in your head. I, I love it. You said it several times and I think it’s really a, a deep sentence.

When you think of the storyline that we create, the ones that even our parents create, I’m sure you’re familiar with. Yep. Uh, Debra and Kona’s Paper on the Ghost and the exec committee. Right. Like, I think there’s so much in it and so many storylines we built in our heads that sometimes prevent us from. Achieving the greatness we all have. ’cause I’m, I’m a big believer like you, that you all have a genius in us.

Gaurav Mehta: Yeah, yeah. It’s, it’s, you know, we, we unfortunately can’t lead our best life forward. And I finally at, at this age in my life, I finally realized this, we can’t live our best life. Unless we let those storylines go, unless if we’re willing to put our anxieties, put our self-doubts, put our, you know, false sense of securities aside, we just can’t, we can’t accomplish the dream that we want without it, without doing those things right.

Naji Gehchan: I’m going off the question, but I, I’m intrigued if there was a moment or crucifix or something specific that helped you realize this and just transformed, or is it really this continuous journey of, you know, pivoting, learning, facing, uh, yourself?

Gaurav Mehta: Yeah. No, I, um, I think it’s, it’s a very iterative process, but I, I often, you know, even if you asked me two years ago, I’d be like, oh my God, why did it take me so long?

But I think it’s constantly throwing yourself out there and taking risks and sometimes just following the path of, you know, what’s ahead of you. Um, my parents think I’m crazy. My, my sibling, one of my siblings thinks I’m crazy for, for, um, you know, putting my career on hold and going back to, to, to grad school, to, to upskill myself and go after this journey wholeheartedly and again, that’s the storyline saying, well, you know, Go to school, work hard, you know, make decent money and then you’ll be fine.

That’s a storyline. That’s a storyline of itself. Like you said, you know, we’re. And so yeah, your family members are like thinking you’re crazy and sometimes you doubt yourself thinking, oh my God, I must be crazy, but you, you keep following it. And I think there was no special point. I think that iterative process and allowing my perfectionism to also let go that comes with the engineering mindset is, is at least for me, and, and then just allowing myself to witness my own behavior.

Eventually that came about and I think there’s some great mindful, uh, tactics out there too that really helped the process.

Naji Gehchan: I certainly relate and. I think your openness, humility, and willingness actually to really test yourself. You’re not talking a lot about this, but you, you can transform if you don’t start being vulnerable yourself and willing to transform as a leader for you to, to bring this great transformations and growth.

The last word is spread love in organizations.

Gaurav Mehta: Yeah, the spread love, I think it comes naturally. Um, and it comes naturally if you’re willing to be, like you said, vulnerable, uh, like to be humble and to understand that you yourself are not perfect and that you are also work in progress just like everyone else, but it, you know.

Inspiration is one, but when you are opening up your own vulnerabilities, um, and you’re able to connect with people, I think people are also able to emotionally connect with you and they feel like, okay, they understand you have to treat people in a way that if you were to put yourself in those same shoes, do they, um, do they get it?

Now, don’t get me wrong, like if you asked me 10 years ago, I was more functionally oriented. Right. But now it’s like, over the years I started to realize we all have a very limited time on this planet and we, we need to, you know, just explore how best we can live this. And the best way, again, it goes back to the contentment, happiness piece, but it, it’s more like, how do you how do you make yourself, um, real? And if you’re real with yourself and you’re real with others, that love genuinely comes about because they, your team members also feel like they can also connect with you and you don’t create these arbitrary, like ridiculous rules that people feel like, oh my god, you know, has a high sense of anxiety.

When you’re able to connect and when you’re able to talk about difficult items, which is also very important. You can’t be just very much, you know, you know, never have to work. No, you have to be pretty aggressive, but at the same time, you’re, you’re also being vulnerable. You’re also being able to connect with people and understand and help.

The love aspect naturally comes when you bring yourself to the table.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Gaurav Mehta: healthcare leaders around the world? Um, I would say, you know, everything that I’ve said here today, um, I think it doesn’t just apply to healthcare, it applies to. Any type of work that you’re trying to do. But I would also go far as saying, you know, one thing is, and this is going to, what I was saying just a moment ago, is you have to stretch ambitious goals.

You have to set ambitious goals. You have to go after it. Don’t, if you don’t aim high enough, you’re not going to be able to solve bigger problems. And I. We as humans also tend to have this self-limiting thoughts of saying, this is as best as it’s gonna get. And I think unless if you push the envelope, unless if you go after the big problems, you’re not gonna be able to solve the big problems that are out there.

And I think people limit themselves just because of that mindset. And so whether it’s healthcare, I’m a huge believer. I mean, I love the fact that now we have orphan drugs and all of that. Previously, all of these rare diseases people couldn’t tackle. But I think if you’re passionate, if you think that, you know, you wanna go after these things, don’t be afraid.

And I’m not a, I’m not a medical doctor, I’m not a PhD. Um, I don’t know every little thing that’s going around me, but I can put a team around me and I can connect with people and try to understand what they’re trying to accomplish. So you don’t have to have that. But set ambitious goals, I guess, is the last thing I would like to say.

Naji Gehchan: Well, thank you so much, Gaurav for being with me today and for this deep chat we had.

Gaurav Mehta: Thanks for having me. I enjoyed it.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Marja Pronk

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Marja Pronk, CEO & Founder GLOBAL YOUNG LEADERS, Global experts foundation and MH PRONK HEALTH CARE CONSULTANCY. Marja is driven by the patient, health-care perspective ‘to have access to the right treatment’. Her training as a medical doctor at the Erasmus University of Rotterdam and her years of experience at the pharmaceutical company, GlaxoSmithKline, inspired Marja to create the first specialized market access consultancy firm in the Netherlands. She since then helped contributed to more than 650 cases in 35 disease areas across Europe bringing innovation access to patients. She is also founder of Global Young leader where they equip young people with personalized life skills so that they can create life by their own design.

Marja, It’s a pleasure to see have you with me today!

Marja Pronk: Thank you, Naji. It’s a pleasure.

Naji Gehchan: Can you first share with us your personal story from becoming a physician, then going to the pharma industry, and now being a successful entrepreneur and life skills expert?

Marja Pronk: Yes. That’s quite a journey. Um, uh, I studied medicines in Rotterdam and, uh, finishing my, my, um, my study, I was thinking I’m not the type of treating patients directly, and I was looking for an alternative. And, uh, when I jumped into the pharmaceutical industry, they gave me that room. To develop marketing commercial skills. And I felt that that was more, uh, up to me. Uh, I, I felt that I was very commercial and, uh, I dedicated then my time to, um, organizing healthcare, uh, environments from first, uh, the pharmaceutical perspective later on, uh, in my con own consultancy from a broader perspective, from, uh, multiple stakeholder perspectives. My joy was to bring stakeholders together and to guide or lead them to a final result where everybody, uh, could work with that result. And by coincidence, uh, I came across a lot of young people because I’m a mother of, uh, three kids and, uh, a lot of young, uh, guys and girls, uh, were in our house and what I saw is that there is a kind of, uh, mental wellbeing. Issue among young people. And that inspired me being a medical doctor from a background, uh, for what’s going on. And, uh, while doing my my pharmaceutical reimbursement project, uh, at the same time I started to, to interest myself in the mental wellbeing. And that led me to, um, working with the life skills, what I’m uh, doing right now.

Naji Gehchan: This is incredible. Uh, Maria, so I, I’d love us to talk more about obviously mental health and your work with, uh, the young leaders. But before that, since you’re really an expert in market access and bringing innovations and drugs to patients, I’d love first to hear your thoughts and your views about healthcare access today in Europe and even globally.

Marja Pronk: I think that, uh, having seen so many cases, uh, not only in the Netherlands but also on the European level and, and a little bit from the us I’ve seen that healthcare is, is really a business, uh, that was. Confronting me the first five years of my, my work as a consultant. When I experienced that, even governments have to look at it as a financial, uh, aspect. And I always, uh, was looking for an integration of the human aspects with the financial aspects. I mean, uh, the trees do not grow into the sky, so there’s a limited healthcare budget. But we need to manage that in a balanced way, not only from a financial point of view, from a profit point of view, from pharmaceutical industries, but also from what works. And what I’ve seen in the healthcare today is that, uh, the real decisions are avoided. Uh, let’s say, uh, governments do not discuss societal, um, standards. It’s all about case after case, after case. And I think when we have a better, uh, communication, better discussion on what we really need as healthcare or as a healthcare package, I think, uh, everything becomes more clear to everybody, not only to the providers, but also to the consumers. And this has to do with, uh, what your organization is, is, uh, also talking about it’s the opposite between fear and love. From a fear point of view, maybe we want to have all the healthcare, uh, possible, but from a loving point of view, we, we need to stand still and see, okay, what do we want to provide? What is the person’s own responsibility? Find a mix there and to see what all the people together can do to create a better healthcare and not leave it up to, uh, some organization, some governments, but to take a common responsibility from a loving point of view and, and take out the fear there and, and to accept that life is real and, uh, to take decisions in that perspective.

Naji Gehchan: This is super powerful, uh, Maria, and obviously you talked about love already. You shared in the beginning really this co-working space that we need to get to in healthcare. You talked about bringing stakeholders together, um, and really kind of making those decisions as a society for a better health, and you’ve helped and worked ensuring access to innovation across geographies, as we said. Do you see any particular skill. These days, and especially for the future with more and more breakthrough innovations coming to patients, but as you said, at at a higher cost with other complexity, uh, in the systems, any particular skill for us healthcare leaders and pharma and biotech you think is crucial for us going forward through these milestones for the companies, but most importantly, for the patients we serve.

Marja Pronk: Yeah. Uh, I, I definitely see one, uh, common central skill, and that is communication together. So not, uh, act in these silos, eh, in these pillars, but to cooperate, to communicate. And that’s also about love and fear, not to fear the other party that what have, for example, pharmaceutical companies are only money driven. These. Uh, prejudice this, um, opinions. If you take that out and you create a, a, a floor where everybody can say what he wants, uh, then you have a real communication and you can find solutions, um, and, and take out the fight between those stakeholders. If you first create a a floor, then after you can do your own tactics. If you do not have a common floor, it, it’s, it stays like, um, yeah, uh, uh, tactics, uh, which are not sustainable in the long term. So communication and co-operation.

Naji Gehchan: So if we shift gears now to global young leaders and what you’ve been doing there. So you, you shared a little bit about how it started by watching, observing, uh, young talents and young leaders and the impact on mental health. Can you tell us a little bit more how it started and what you’re actually doing now?

Marja Pronk: Um, it’s. This leadership and, uh, this term, um, we call the global young leaders not to create new presidents for the future, but to make young people aware that they have to be the leader of their own life, um, and to lead your own life. We saw that some skills were missing. The today’s education is, and, and I, I’ve gone through this education as well, but what I see more and more is that young people are, uh, pressured to, to have a lot of, uh, knowledge, uh, to perform, have high grades, and slowly the, the, the life skills that you need to perform and to sustain yourself, um, have been skipped. So, What is the end product of education nowadays is, uh, a lot of, uh, young people with high grades, uh, with good university, uh, uh, references. But when they start working as a young professional, um, they find themselves, uh, running against the wall because they need skills to manage their daily life, their working life. Also, as a student already, you see a lot of students. With burnout, which is absolutely crazy. I mean, 50% of students are, uh, have a burnout. You see a lot of young professionals with burnout. And to me the answer is, uh, I’ve seen that growing. Uh, and, and when talking with a lot of young people that when they have the skills and simple skills and not, uh, complicated courses, uh, where you first have to get your degree. Before, uh, you have those skills. Now the skills are very simple and the simpleness to bring that back into the whole curriculum of young people and, and bring it also into organizations solves to me a lot of problems. And, and it has directly, uh, um, a relation to, to love. But I, yeah, we can talk about that.

Naji Gehchan: Oh, yes, I wanna talk about it. And, and you know, as you’re, as you’re talking, it’s obviously as, as a parent, you know, my two little daughters, obviously with my, with my partner. We think a lot about this and really those life skills, as you said, we’ve been educated in systems, uh, probably super strict academically. Uh, but then you get to life and you have those life skills, and I, I would argue that life is getting more and more complex, so probably we need to focus even more on, on those social and human skills. So I’m, I’m eager to hear. As you provide personalized life skills, as you call it in, in your, um, in your company, for people to be resilient, empowered, uh, to tackle important personal and professional challenges, uh, and really create life by their own design. I love how you frame this. So can you tell us a little bit more about your philosophy and maybe couple off tips, uh, on what are those key skills that we need to make sure our young leaders have?

Marja Pronk: Yes, of course. It’s a joy to, to give some examples. Um, if, if you look at those life skills, life skills to me are, um, the solution for, for the individual, but also for organizations, for companies, for groups, for, for everything. Because if you. Look at life skills and you, you have them on board. You can manage through all kinds of situation. Uh, life skills is about, um, learning that there is no wrong decision. For example, uh, learning to, to change your mindset. If you change your mindset, your reality changes and you see it already in daily practice. It’s nothing new. It’s just something that is not put on the table. For example, if you take an athlete, this athlete, if he wants to have that medal, he needs to have a positive mindset. I mean, that can be, uh, applied to somebody in a company. If as a company, uh, you want to be successful, you need to have the right mindset. That doesn’t mean same time that. You need to perform according to what the organization says to you or according to the, what society says to you or, or according to what, uh, your parents say to you. I think there’s the key. These life skills help help individuals to manage, to lead their own life within this whole environment. And, and to be, uh, transparent about it. For example, um, if your parents want that, you, you study law because that’s more successful than becoming a musician, for example. And you don’t want that. I think you need to be transparent because it doesn’t serve anybody, uh, to have an unhappy lawyer. Because he, he will not be kind to his clients and he will not perform at his highest level because the highest level is coming from within the human. So if you do not do what is, um, close to you, then to my opinion, you cannot perform to a max. That’s the same as in an organization. If a company wants to have all, uh, high performing MBAs, Uh, leading the, the company through success. That’s not possible. If you do not look at the, the people and, and you find a mix like in an orchestra, eh, you cannot conduct a, a company if you do not have a, a view for the human in that company and to find out what, uh, is his f what, what is triggering him, how the people within a company. Um, can perform best. And, and for that you need life skills. You need the love, the love in organization, not the fear. Because fear is not leading through transparency, eh, from a fear, from a performing point of view. Uh, also look at the, the person that needs to study law from a fear point of view, he’s going to study law. But that’s not leading to, to success because he will fake what works. But if he really finds his resonance, and if employees in a company really find their resonance and they get the room for that, and the company has to provide this open space, this non-judgmental space, and to to, to make the, the employees aware that with the life skills, Uh, how you can manage situations, how you can shift your mindset, how you can use your intuition, uh, how to take risk, how to not, uh, make a wrong decision. Then all of a sudden this person, uh, is, is starting yet to, to produce from within, uh, and to a maximum level. And then you, you, you come to success. So to me, To make this shift with life skills and to, to take out the fear. And to bring in the love. That’s why, yeah. The, the title of your, your organization resonates very well with me to bring in the love. Then you have the perfect environment to produce and I, I would love to, um, To give nuance here. Love is not a pink cloud. Uh, it’s not being kind to other people. To me, love is a reality can be hard. You have, as an organization or as a person sometimes, or in a family, you can take decisions that are maybe painful for other members or it can lead to saying goodbye that a person, uh, gets another job. But at least it’s, it’s transparent and with transparency, uh, it’s like, uh, snakes, uh, uh, uh, sorry, snails come out of their house. Only if there is an open environment. And, and then you can say, I don’t belong to this environment. If you find out that it’s not your thing and, uh, exactly as this lawyer, I wanna produce music and he becomes a successful musician. But you have to provide this environment. And then the company will also see, okay, uh, a few people leave the company or a few people, uh, simply, uh, restrict their job to this, uh, performance. And they can push other ones who want to be pushed. So you get like in the orchestra. A different composition and, and you have to look that because an orchestra cannot give high performances if the individuals are not heard. I mean, then they’re less successful, I’m sure about that. So that’s my passion to work with those life skills because they’re very simple and very simple to apply. But it’s, it’s, it creates a lot of clarity for, for the individual, for the company, for the organization. And it invites people to, to bring the best out of them, uh, in the open. And I think that’s, that’s success and that’s love. And then people are happy and not burned out.

Naji Gehchan: Oh, Maria, this is, this is so incredibly powerful and so close to my heart and my beliefs in, in leadership and driving high performing teams. You, you talk, you mentioned so, so many set, uh, really great concepts around diversity. I love the examples you’re putting this diversity in the orchestra and how, how we read this. There’s a lot of, there’s a lot of examples as you shared. Uh, on how a conductor and then all the team brings their best to be themselves. Uh, uh, it’s, it’s really. Powerful what you, um, what you just shared, and I’m with you. Love is transparency and sometimes it’s, um, it has to have a transparent, tough discussions, but with the other best, with the other person’s best interest in mind. So I. It, it all, this really resonates so much with me. Uh, my question is with those young leaders, as, as you are in contact with several of them, um, too, also, but more into hiring, recruiting, probably for me, I’m, I’m intrigued how you’re feeling those, uh, those young generations reacting to those skills that you’re building and also as you are nurturing those skills, how are companies. Reacting or endorsing or embracing those young generations asking for more loving environment in, in the corporate world?

Marja Pronk: Yeah. Young people are inspired because they feel that, uh, going through this whole education system wherever you are, whether you’re in Africa, India, us, Europe, They, they all experienced the same type of issues. That was very funny when we did our research with the Global Young Leaders Organization, um, is that whatever the context is, the culture, the environment where you in, if it’s an easy environment, the difficult environment, the the issues are the same. And that’s how we developed, uh, the, these life skills that are applicable to. All, um, all areas of the world because it addresses the, the key. And the key has to do with how can you, um, bring out the best in you to the table, uh, on a personal level. On a professional level, and you need skills for that. So if you combine that with your education, Then you can manage successful through all your experiences. Then you can manage successful through your first job and maybe make another decision after that experience and to go to another job where you perform even better because, and that’s one of the key elements. What we make clear is that you have to experience. You. What you see among young people is they try to find, they try to find the perfect, uh, position. They, they want to make perfect, uh, decisions. And that’s not possible that, that’s artificial. You, you cannot predict what’s the best, uh, decision because you only experience that, uh, when, when doing it. Um, and, and that’s where the key is. That’s. If they, um, allow themselves to jump into that experience, whatever, uh, comes out, it is no wrong decision because the experience brings you to new solutions because in, in the hard work, in the difficult work, in the challenges you have encountered, you all of a sudden see. Where solutions are or where your own skills, um, are where you are strong at, where you’re not strong at you, you, you learn more about yourself. And, and that is something that’s a, a, a, I would say, a backpack that you take with you in every situation, whether it’s a job, whether it’s in a family, uh, whether it’s on a journey. Because you have experience that in a challenge when it’s difficult, um, that you find solutions, you have, uh, found your own power. And it doesn’t mean that you only have this power when you are working in the same environment. No, it’s applicable to everything. So this experience to me is key. And if the young generation can be convinced that it’s not bad, Uh, to choose something and just experience. That’s the only way. That’s how you arrive at your point where you think, okay, this is it. Here is where I perform best, and that’s the only road. And you, you just have to jump, uh, in it. You can of course, do some research, but the final decision is a jump. And, uh, you only know, uh, how it is when you have experienced it. And that’s, I I often give an example. If you look at an athlete, he’s training, training, training. Uh, it takes a long time. Uh, he’s the best. He gets this, this golden medal if it, the, the decision that he was, uh, going to the Olympics and the moment that he has this golden medal are just moments. What is in between is something that you cannot capture. It’s not in a book, it’s, it’s not in the education system. It’s the experience and, and that’s something you have to go through yourself because this athlete has this package in between and he knows how to do it next time. And what the young generation sees today is okay. This person is successful. He has, uh, reached this golden medal, so I need to do this, uh, as well. And, and that’s the only goal to have this golden medal. But they forget that it’s, the experience is the holy grail because through this experience, you can manage yourself in every environment after, with this gold medal, if you have it, it doesn’t mean a guarantee for the next experience, uh, and, and for your success. Every time. Again, it’s the experience and the package you get with that. If you focus on that, people um, dare to jump. And I think that’s a concept we have forgotten. And that’s exactly the same concept for, uh, for the individual, for families, but also for companies. Because if the companies allow to, to work with their human capital, And, and let their human capital speak up and maybe do something new that the company didn’t do before, but to, to make a decision together to go for it. And if the company then discovers that this has led to success, then you create an environment where there is room for, for new things, for new experiences. To me, that’s, that’s leading to success. And you can be a wonderful company with a good, um, uh, profit, uh, profitability. But the real success lies in the creativity. And if you give room to creativity and you take out the fear that to fall because it can also go wrong, okay? Then the whole company learns from it. And maybe through this experience. They have another solution, found another solutions where they haven’t, uh, seen before. So it’s always leading to success. And, uh, in the end I say to everybody, if you give room to your human capital and you create an environment, whether it’s in a family, in a group, uh, for this, uh, for the individual. Uh, of course you need a strategy and you need objectives and, and you need clarity about the goals. But within that, if you give room to also these type of things and new experience, you will find new ways, new success, new innovation, because innovation comes from letting somebody work. And all of a sudden he finds something. But if there’s no time, if, if companies are so organized, so time manage, really organized, then you kill out, you kill the creativity. And without creativity, uh, to me there is not the top success. And for an individual, without the creativity for yourself, there’s not, uh, um, individual happiness. So that’s within the life skills. If you give room to this environment, um, this open environment, nonjudgmental environment, not, not judging, is also a life skill. If you give room for taking decisions where there is no wrong decision. If you work on the mindset, if you work on intuition, eh, that’s also creativity. And if you learn people how to deal with challenges, yes, it’s not easy. We learn from challenges. We learn new things about ourselves, about the company, so give room to it, let it in. And it’s like an all oil to me that you need in your personal life, but that companies need into their company life.

Naji Gehchan: Thank you for this. Uh, and I love how you framed it. It’s about the experience. It’s more the journey than the destination and getting this gold medal. Uh, I I want now to go to a different section where I’m gonna give you a word and I’d love your reaction to it. The first word is leadership.

Marja Pronk: Yes. Leadership to me is, uh, general is, is wonderful. Everybody is a leader. Uh, leadership is leading a company, leading a country, leading a universe, but it’s also leading a family, uh, leading a, a sports club, leading the army. Uh, In the end, leading yourself as an individual because if you don’t, do not take the lead about yourself. Um, it’s the same on a micro level. So macro, macro and micro is the same in everything. There’s leadership.

Naji Gehchan: The second word is health equity.

Marja Pronk: I didn’t hear health. Health equity. Health equity is a very interesting topic, um, that relates within me to transparency. If we create transparent healthcare packages, uh, accessible for all individuals, of course. Then I think it’s clear to everybody what’s afforded and what’s not afforded, and people can live with that. Uh, because it’s clear, you better have a clear answer than uh, uh yeah, an intransparent answer. So I think we need to create a clear healthcare package. Uh, and if somebody doesn’t like it, okay, it’s a pity. Um, but we need to have clarity because that is transparent to, to patients, to consumers in what can I get and what is not there for me? What about, and that’s, that’s equity to me. Sorry, that’s equity to me.

Naji Gehchan: What about life By own design?

Marja Pronk: It’s bringing the best out of yourself because if you reach that, um, that frequency, uh, to happen, you create life by your own design because you and what you’re doing, uh, are in, in the same vibration. And that leads to. Uh, happiness and to maximal performances. So to have the room for each individual to create life by your own design, even within a group, doesn’t mean that we’re all a bunch of individuals. It, it can be within a group, but there are situations also in organizations, even in the army and in groups where you need to have the room to create life by your own design and. This morning I came up with maybe a silly example, like, um, the, the token two film to me gave an example that even within a very strict, uh, discipline, nice environment, there must be room to create life by your own design, because that’s in, in some situation, there is no, uh, you, you need to have room for this creativity. The people that have that room or take that room can create the life for that situation in the army. And, and that was exactly, uh, presented in this top, uh, gun to film. It was very inspiring to me.

Naji Gehchan: The last one is spread love in organizations

Marja Pronk: really necessary, uh, urgent. Um, To get rid of this fear and not love. And I think company ha companies have, um, a fear for it’s, it’s all too, becoming all too soft. But love is not, uh, the same as being soft. Love is, to me, clear transparency and room, uh, give room and fear is not transparent. Is, is. Uh, killing, uh, creativity. So love, love is really necessary everywhere. And not as the pink cloud, because, but as something real, as as honest, uh, clarity.

Naji Gehchan: Any final word of wisdom, Maria, for healthcare leaders around the world?

Marja Pronk: For healthcare leaders, I would say that we need back to, uh, the connection to the connection of, of our society, um, and define, um, what our lives, uh, mean. And that we’re not kind of, um, uh, how you say, uh, living units that can be fixed anytime, any place, anywhere. Uh, and to recognize that within all the technology, there’s also this, um, this human aspect, this mental aspects, this, uh, this, this consciousness. We haven’t even, um, Uh, yet I think, uh, we are at the beginning because it’s something that goes together. Healthcare is not a topic, it’s an an holistic thing of, uh, uh, an individual. And there’s more possible with technol, uh, with if, if you regard the human as as a whole, then with technology alone.

Naji Gehchan: Well, thank you so much, Maria, for being with me today.

Marja Pronk: It was a pleasure, Naji, and, um, wonderful.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Dheera Ananthakrishnan

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Dheera Ananthakrishnan an academic orthopedic spine surgeon, currently practicing at Emory Healthcare in Atlanta. Dheera is also a philanthropist and entrepreneur, having worked with Medecin Sans Frontiere / Doctors Without Borders in Nigeria and the World Health Organization in Switzerland before moving back to the US., In, addition Dheera is co-founder of Orthopaedic Link, a non-profit that matches unused orthopedic implants with surgeons and hospitals in developing countries. She has also most recently cofounded the Women’s musculoskeletal initiative.

Dheera, It’s a real honor and pleasure to see you again and have you with me today!

Dheera Ananthakrishnan: Thanks, Naji. I’m happy to be here.

Naji Gehchan: Can you first share with us your personal story from breaking your leg at the age of 10, to your love of math and orthopedics, then your inspiring journey as a surgeon, philanthropist, and entrepreneur in healthcare?

Dheera Ananthakrishnan: Oh, sure. Yes, I’d be happy to. Um, I, uh, I grew up in, uh, a little in Poughkeepsie, New York, which is a little bit north of New York City. And, um, I was born and raised there in Poughkeepsie. My parents are immigrants from India. They met and married in, um, in New York. And, um, I was a real tomboy growing up and, um, Really got into a lot of, uh, like dissecting animals and running experiments. And, um, these kind of culminated in me breaking my leg when I was 10. And, um, I had a huge crush on my orthopedic surgeon and I pretty much decided the day that he flipped those x-rays up that I said I, I wanted to really be just like him. So, um, This became my driving force. I like fell in love with orthopedics and it’s like 40 years later and I’m still in. And, uh, yeah, it’s, uh, I actually ended up, um, I thought I would go to kind of just straight to medical school, major in biology. And then my father, who was an engineer in India, he went to Indian Institute of Technology and, um, Illinois, came to the US and to go to the o, other i i t, the Illinois Institute of Technology. He was like, set on me going to m i t and I was like, I don’t know. I don’t really wanna go. But he said, you know what, we’re gonna go. I said, all right, fine. We’ll go. And the minute I walked onto the campus, I, I was sold. I just, I felt this amazing energy. Um, yeah, and it’s, uh, and I’ve been lucky enough like you to have gone back, uh, also and it’s still got that same energy. So I, um, yeah, so I, I, I went to m I t, um, as an undergrad and I was planning on major in biology and, uh, I, I didn’t really fit in with the biology kids so much. Um, but, um, I really liked that my math classes and I got involved in a. Prosthetic project and, uh, Woody Flowers Lab. Now, Woody Flowers, unfortunately, I think he just passed away like last year, but he’s an icon at M I t and um, mechanical engineering professor. And so I decided to, to major in mechanical engineering and, um, plan on going to medical school. Um, So that’s, yeah, that brings me to getting to medical school. And then, um, that was tough actually. I, I recently, I recently gave a couple of talks and, uh, you know, getting, uh, I had a, at least one C on my transcript as an undergraduate. And, uh, I had some undergrads at m I t asked me, how did you get into medical school with a C on your transcript? It really wasn’t easy, but, um, It was m i t was really tough as an undergrad, but it really, um, taught me a lot about problem solving and, um, and, uh, yeah, about being humble and learning new things and that, uh, served me well. But, um, yeah, I had a lot of, a lot of struggles, uh, getting into orthopedics and then even going through residency. We had a particularly brutal residency in, um, in Chicago. Uh, it was, yeah, it was tough. Um, but it’s, it’s all been, uh, I would say 20 plus years of doing this as a surgeon. Um, have, uh, there have been ups and downs, um, but I would say overall trending positive.

Naji Gehchan: thanks for sharing part of your journey and you. As you mentioned, I, I wanna go back to orthopedics and your journey there. Uh, you said it wasn’t an easy journey, um, and really now you’re one of the most renowned orthopedic surgeon. You take complex spine cases and solve ’em, fix ’em, treat patients. Um, how, what, what is, what was your biggest learning along the way? As you were going through those pieces, you also, I know we talked about this, uh, the part that you’re a woman doing, orthopedic surgeon, you know, I’m, I’m an MD myself, and that was like always the case, like, oh, women don’t do this. Right. So I, I’d love to get your perspective as you obviously went through this and achieved what you wanted. What, what is your learning, uh, as you reflect back on your journey?

Dheera Ananthakrishnan: Uh, yeah, so it’s interesting that you say that because those, I, I actually got those messages really early. Like when I deci, I dec, I decided at age 10 I was gonna be an orthopedic surgeon. And then, you know, you go to dinners with your parents and people would say, oh, what do you think you’re gonna be, you’re gonna be a doctor like your mom. My, my mom is a pediatrician. And I said, actually, I’m going to be an orthopedic surgeon. And it’s amazing to me how. Um, just a chance encounter, people will take the opportunity to discourage, right? Like the first thing is like, oh, well, you know, that’s really difficult. Or, you know, girls don’t do those things. And the like, immediate, almost visceral response is a negative. Which to me is like, it’s terrible, right? I mean, why, why would you say that to somebody? Um, what happened to me was it actually was very motivating for me. Like, I’ll show you, you know, you think I can’t do it, I’ll show you. And um, fortunately or unfortunately, that’s actually become a lot of my life has been like that, right? Used to swimming against the tide used to it is like, oh, somebody thinks I can’t do that. I’m gonna show you I’m going to do this. And, and it becomes, Almost like a part of like, I, I don’t know. I can’t remember not being like that, like not feeling that kind of like drive to like prove almost to prove people wrong. So like, you tell me I can’t do it, I’m gonna do it. It might take me a really long time. I might get a c I might like cross over the finish line laugh that has happened to me in certain, certain, uh, athletic endeavors. But I’m gonna do it. Um, I’m not gonna, um, To me, it’s actually, it, it’s, it’s, it’s funny to me when you, you ask this question, like, if I’m reflecting, I’m actually really proud of the C that’s on my transcript because it’s easier to drop a class, right. And be like, oh, I’m gonna drop that. I don’t want this c on my transcript. And, and I think, um, finishing, you know, I mean, you and I are both in, you know, gone to elite institutions, we’re used to being at top of the game, but like, Being, you know, human and like kind of finishing ugly is not there. There’s a lot to be learned from that. I actually teach our students and residents and fellows that, you know, many times, um, you know, you, you have to like learn not only learning from your, your failures, but learning from your struggles and also learning from your successes as well. Right? Like just high fiving and being like, Hey, we did a great job. Maybe you did a great job in spite of X, Y, and Z. Right? You. And so doing a deep dive and really reflecting, um, has, I think is really important. But, um, I would say that that discouragement and being the only, I mean, when I was at m I t I was kind of used to being one of the few women, but like being used to being the only woman in the room and being, um, you know, the one who’s like, well, I’m, I’m gonna do that thing that you think I can’t do, I’m gonna. Do the hardest case. I’m going to, you know, stay the longest I’m going to just to prove that I can do it. And now it’s become a very difficult habit to break actually.

Naji Gehchan: And, and you’ve done it. And I love how you’re framing it and really reflecting both on failure successes and how you can get better and be even better, uh, while taking those challenges. Uh, if you think about your experiences within, uh, Uh, and w h o, how did those come into play and shape your, the leader you are now?

Dheera Ananthakrishnan: Uh, yeah. So I would say that, um, I decided to go take this sabbatical with, uh, net San Frontier and the, uh, W H O uh, B. Because I was having a kind of a crisis of conscience. So I was in my first job in Seattle and um, it was my first job as an attending surgeon. And it was, it was tough. Um, I, I had a lot of struggles. It was a, it was a bit lonely. Um, and I had, um, I. I think, you know, everybody needs like a different environment. This is kind of speaks to this, the, the like con context of each individual situation, like where you are and what you need and what you get out of things. Um, really vary from place to place. So it, when I was in Seattle, and I would say if I went there now, it would be very different than going there as a junior surgeon, um, being sort of. Green and kind of being thrown into a very intense environment and where there was a lot of scrutiny, I was the only female spine surgeon. There were quite a few other women orthopedic surgeons, but I was the only female spine surgeon. And um, I. I mean, I didn’t have very many complications, but every time I had a complication, I was really under, under a, like a magnifying glass. And then the next week somebody, one of the guys would have a very similar complication and it would just get passed over. And those types of things happen kind of again and again and again. And I was really starting to doubt that maybe, you know, I, I started thinking, well, maybe all of this like, Pushing to be an orthopedic surgeon. Maybe I’m really not supposed to be an orthopedic surgeon, right? Maybe I am really, um, not good at this, right? Everyone seems to be telling me I’m not good at this, I’m not good at this, I’m not good at this. And that was kind of my message when I was a, a resident, but it wasn’t the message when I was a fellow and I was. Hoping that I would be in a better position to, um, but, but it was tough. And so I decided that I, I had wanted to do some developing world work for some time. Um, and uh, I decided I was going to, uh, leave Seattle. I was actually quite, quite miserable. It was sad to be in such a beautiful place and be really miserable. Um, and then I went to work with Doctors Without Borders and the W H O and they took about a year off. Before coming to Emory and I, I really, that was like a remarkable, remarkable experience for me because I went from a place where I was like, I don’t know if I know anything. And I got dropped in Nigeria and I realized I knew a lot. I could teach a lot. I was, uh, one of the nurses actually about a, after about a. I think I was there, I’d been there for about two weeks. She came up to me and said, you know, Dr. Dira, you’re the local expert on femoral nailing. And I thought, oh my gosh, if that’s true, like that’s a problem. And then it turns out it was true and it wasn’t a problem. Like I really knew what I was doing. And, and, uh, I was teaching Nigerian surgeons how to do things and how we do things back home and how they could do things better and. It was a, it was really a remarkable experience for me. Um, and so that, um, coupled with just like the o the other, the other thing that kind of came about at that time was the genesis of, um, the idea for orthopedic link. Um, because I mean, I would be rounding in the ward at, with M Ss F and you know, Trying to measure people’s legs to see if we had the right size implants for them and say, you know, you gotta wait till next week, the shipment is coming in. And then once I, I got to Geneva and I was working a little bit with some, um, Device companies and they told me, you know, we have a lot of surplus things that we just throw out and maybe we can try to kind of work together and, uh, and see if we can try to solve like a problem on both sides. So it was, it was really a transformative experience for me to, to pick up and go to a place that was completely, it was a little bit lawless. I was in Port Har court, Nigeria, and, uh, I kind of found myself there.

Naji Gehchan: Thanks so much for sharing, uh, also with your, with vulnerability and humility, this experience. I, I think those are things we rarely talk about. Uh, how, you know, how you feel the impact of others as you, you are delivering, especially for people who ha are humble already and have imposter thoughts. Uh, so it’s, uh, yeah. Tha thank you for, for sharing openly your experience and, you know, th this part of your journey. Uh, do you wanna talk a little bit more about Orthopedic Link? I think you’re doing just exceptional work there and helping so many people. So, uh, I, I’d love to hear a little bit more about it and that our audience know about it too.

Dheera Ananthakrishnan: Yeah, so Orthopedic Link. Um, as I mentioned, it kind of started after, um, after I’d been in Nigeria. I got back to start my job at Emory. Um, I was working with, um, Jim Kercher, who’s a local orthopedic surgeon in town. He was a resident at the time and his wife. Who’s a supply chain expert and he had been asking me about my experience and I said, you know, it’s really kind of strange that even in an organization like Met Sound so Frontier that we didn’t have enough equipment and that, you know, I’d also been talking to these device companies and he said, you know, this sounds like an, and both Jim and his wife Heather, were also engineers. We’re all like three engineers kind of in, you know, in the medical arena. And we kind of put our heads together and. I started, um, we started, uh, talking to implant companies reps to see, you know, is there like, do you guys have really have surplus lying around? And it turns out they did. Things were, you know, older generation of implants were sitting on a desk collecting dust. And um, and then we had to find a site and I started going to some international conferences just to, to try to meet people. And I happened to sit down at lunch next to. Dr. Gilbert Lon, who’s a Filipino surgeon, and he said, you know, I, he was like the perfect, it was just serendipity because he said to me, he said, you know, um, I am, I’m. Filipino surgeon. I trained in Australia. I trained in Hong Kong, I trained in Canada. I came back home. I have all these skills and I don’t have the equipment to treat the most, um, needy patients that we have. Um, and it was an equipment issue because they, you know, they had, they had mostly the infrastructure and, and then, um, started trying to work with some other NGOs that were in the space. Um, and we were able to, Had orthopedic links started. That was in 2009 with some, uh, older, like first generation Medtronic sophomore dynamic equipment for spine surgery. And, uh, yeah, took that over to the Philippines. And, um, we actually also based on the W H O, um, assessment tool, created an assessment tool of our own to focus drill down on orthopedics. And, uh, yeah, that’s where it started. And we’ve, we’ve helped, um, hundreds, I think it’s close to 400 patients, um, across multiple countries. The, we have. Least two self-sustaining, um, sites. Um, we’ve worked with the Scoliosis Research Society in Bulgaria, um, and that place has become a regional site of, um, excellence and the local surgeons have learned so much just from. All kind of related to us initially getting this donation planted there, so that it was really, um, a, uh, massive, um, impactful thing to just bring the implants, leave them there, and allow people to learn with supervision, but not be tethered to purchasing equipment or having to have it shipped in and out. Um, it’s been really, uh, yeah, it’s been really remarkable. We had really grand visions for what it could become. Um, and one lesson I learned from working on this project is that, you know, even if you. Your vision of like a big alliance on one side. Uh, like we had this vision for a corporate alliance with all device companies on one side and N G O Alliance on the other side, and we would go be the go between. That didn’t really happen, but even because that didn’t even. Even though that didn’t happen, um, we’ve made a really good impact and I’ve, I’ve learned so much from other, about the industry, from another side, from other sides, from the side of the donors, from the side of the device companies, from the side of the, um, manufacturers, from, and, and also of course from all of the surgeons and the patients on the ground and all the providers.

Naji Gehchan: Wow. As you said, like it’s really remarkable impact that you’ve done across the globe. You do it every day with your patients. You’re doing it with patients in need across the globe, so it’s really remarkable, uh, work that you’ve been doing. As you think about all those experiences, uh, JIRA, uh, is there one lesson you would highlight specifically for future generation of women getting in med school? Men, you know, who are with ’em in, in med school or who are in leadership positions in residency, et cetera. Uh, and maybe something that you wish you knew very early on in your journey.

Dheera Ananthakrishnan: Um, So I, I think one of the things that happens in medicine, and I can really contrast this to engineering and now with my Sloan experience to the business teaching, is that, um, medicine is a very, um, it’s, it’s, it’s kind of isolating. It’s funny, you know, when you, you and I have talked about this, you know, spreading love in organizations. We don’t have much love in our medicine, in our medical organizations. I, it sounds terrible for me to say that because we’re humans taking care of humans and humanity and there really is not much love and there’s not, even just getting into medical school is so difficult and it’s, it’s like you’ve gotta step on other people to get in. Right. Which is counterintuitive to what you’re trying to do in medicine, I think. And so one of the things that I, I mean, I learned this at at, at m i t and I, I learned it, you know, and I feel like I’m, I’m learning it every day, but that, that other people can teach you a lot, right? Like people, you can always learn things from people. It doesn’t matter. They don’t have to be another doctor. It doesn’t have to be another, you know, another surgeon can only learn from another surgeon. There’s a lot of elitism and, um, I think I. It’s to our detriment because everyone who is working in a hospital, in a healthcare system is there to, to care for a patient. They’re there to provide care and to make, and, and hopefully, and I don’t know that our healthcare system necessarily does this, but hopefully to make people healthier, um, I feel like we have a disease care system rather than a healthcare system. And so there’s a lot, there could be a lot of conflict in terms of people’s motivations. But, um, but I think that, um, really trying to, um, collaborate, reach across disciplines, reach across titles, um, having, I, I think a lot of times, uh, medical students, um, don’t think that nurses can teach them anything. Don’t think that physical therapists can teach them anything. Um, And, uh, I think we have to break down those barriers. Um, we’ve seen with the Covid pandemic how important nurses are that you can’t, I can’t do my job. That’s one of the things I actually learned when I was in Nigeria, that, you know, come in and think that I’m the, I’m the bomb. And then it turns out that the washer woman who washes the sterile drapes, her son got sick and she couldn’t come in yesterday. No sterile drapes. It was surgery. So it becomes very evident how connected we’re all connected. And I think, yeah, I, I feel like we have to bring love into medicine and it’s, um, to your point, I think that it has to start with the younger generation. It’s not gonna be you and me, Naji. Well,

Naji Gehchan: yeah, we, we have to inspire, but I agree it’s younger generation will help out. And I, I’ve been, you know, I had the privilege to, uh, to mentor, teach younger generations. I’m, uh, I’m very hopeful when you see what they worry about and the things they are focused on from the questions. Uh, really the social impact they can bring. How to work together. Yes. Um, I’m hopeful we can, you know, bleed from a place of love and be physicians and treat patients in all industries too, you know? Yes. Whether in, um, in a hospital, in a clinic, in the pharma, biotech industry that I’m in as a physician, I, I really loved how you framed it. We’re all connected, uh, right? Yeah. And, and truly we all have the same shared purpose. Uh, if we are here, yes. We want to make life better for patients we are serving and caring for. So we, we all share this. I’d love now to get a reaction to a word I would give you. And the first word is leadership.

Dheera Ananthakrishnan: I have, I don’t have a good reaction to the word leadership. Um, I, I actually was a generous with somebody yesterday who said, um, you know, we have bosses in medicine and not leaders, which is, um, I, I think, um, it’s, and, and I, I don’t want to disparage anyone in particular, but I, I feel as though we, in medicine, Don’t model leadership well. Um, and um, I don’t think of myself as a leader really. Like, I feel like a leader. I. In my gut, I feel a leader is a person that has a title and is, you know, in charge of a big organization. Um, I, I know, I know intellectually that’s not true, but, um, but, and I feel that it’s very difficult to be a good leader. Um, I do, I do think if you put the word servant in front of leadership, I, I understand it more like I, I feel that the person, um, I. The kind of leader that I would like to be is the person who’s in the weeds, in the trenches with people maybe in the front trying to guide them, but is in, in there in the mud, leading people through difficult times.

Naji Gehchan: Well, that’s the leadership I believe in, and you are definitely, and certainly a leader, and there’s, you know, titles are very different than actually a leader. You can have a big title, but not being looked up for and not being respected, not being followed. So we had this debate. I know you’re certainly a leader and we look up, uh, to what you do. What about health equity?

Dheera Ananthakrishnan: Health equity. Um, health equity is, that is a tough one because I, I don’t, I don’t think we have it. I know we don’t have it here in the us. Um, and I don’t know how to get it because I think it’s, I mean, it goes back a little bit to what I was saying with, uh, Um, us as you know, providers, physicians, and then even in your industry, in the food industry, in the device industry, we actually make more money if people are sicker, which is a counter like, you know, we, I don’t, I. I make more money operating on somebody than if I send them to physical therapy, get them to lose X number of pounds, get them to do their exercises every day, and then they’re feeling better. And you know what? Maybe they don’t need surgery or maybe they need a less invasive surgery that then I don’t make as much money from. So there’s a, a, um, There’s a conflict of interest I think in the system. The way it’s set up now. You can see it in the number of procedures that we do, um, and, um, in the number of, um, medications people are on in the level of health people have in their a s a rating. Um, and um, I think it’s a lack of, there’s a lack of education and there’s a lack of, um, Maybe ownership is not the right word, but a lack of a little bit of a lack of personal responsibility I think. Um, and uh, there’s also learned helplessness. I have a lot of patients that come to me and you had mentioned I do a lot of complex deformity surgeries. So they’ll have come to me having seen maybe five surgeons before. Um, sometimes they’ve actually had a surgery that’s gone awry. Um, and they’re hopeless, they’re depressed, they’re in pain. Many times they’re on narcotics and they come and they wanna fix, they will say that like, I want you to fix me. And changing, trying to be able to change the situation between a, like, I’m, I’m a person bringing my car to the mechanic and you’re gonna fix me. Versus we’re partners in this and this is a relationship and you are gonna need to do X, Y, and Z. Not only to get ready for surgery, but also afterwards. And there’s some things you can control and there’s things, things you can’t control. And if we enter into this relationship, a partnership, a contract, so to speak, then I think people, and and actually interesting thing to me is that when. Um, I approach these problems this way. These are complicated problems the patients have. They are very appreciative. They actually feel like they have a little bit of control. Like, it’s like, oh, I have a prescription. They’re not bouncing from doctor to doctor, getting a prescrip, you know, getting a pain medicine or getting something, and they’re being told. I mean, I can tell you. I do all my exercises every day when I’m in clinic because I demonstrate all of them to my patients like, you need to do this, this, and this. You need to do it every day. I give them a prescription for, for health and wellness, and then I say, you know what? I. You can get yourself to this point and then we’ll be able to do surgery and your outcomes will be better. And I can tell you, people come to my clinic and they’ll say to my nurse, oh, I heard Dr. Nancy Christian’s a hard ass. And she’s like, yeah, but you, you’re gonna wanna, you’re gonna like it at the end of the day. ’cause sometimes people need that. But I, I do think that the, our lower socioeconomic statuses really, really struggle. And um, those are the patients that, um, I. Our, our loss, I think with regards to their health and it’s a shame.

Naji Gehchan: Yeah. And you’re bringing a, a very important point, right, about health holistically, like from prevention to how you take care about your overall health versus like just treating or fixing, as you said, a symptom. Yeah.

Dheera Ananthakrishnan: Yeah, well, there’s a lot of conflict. Sorry to interrupt you. Go ahead. Yeah, no, go ahead. Go ahead. Yeah, no, I was gonna say there’s a lot of conflict, and this won’t be very popular, but you know, I mean, I work at Emory Healthcare and it’s, it’s funded by Coca-Cola, right? Like that’s a, there’s an inherent conflict of, of interest, even in the food that we have in our cafeteria. Um, and, uh, you know, I mean, I like a Coca-Cola as much as the next person, but I don’t think it should be in a hospital. But, you know, that’s the, that’s we’re fight. It’s tough to fight against that, right? Because we need the money from Coca-Cola. But one could argue that I. Coca-Cola is causing, or other soda drinks causing, you can X this part out if you want to, but they’re causing problems, right? You’re causing problems that then we’re having to spend more money to fix. So one could say, well, why can’t we just stop causing some problems or try to cause fewer problems? So, but yeah, these are controversial topics. Don’t know they’re necessarily spreading love, but I think that it’s important to, um, these are the things that are dragging us down, I think as a. Looking at our healthcare spending and looking at where we fit in the global scheme of things. Other countries, I think, do a better job.

Naji Gehchan: Yeah. No, it, it is controversial and I think this is why as leaders we need to have those debates, right? And talk about ’em. And it’s, it’s not something that it’s with or without, right? It’s a matter of how you can think of those systems holistically and talk more about, because everything is interlinked, right? Like it’s either we wanna say things separate or we wanna really think from a something. We both love a system dynamic way. And start thinking about those impacts, right? Like you go from prevention to healthcare and even health, being part of a global ecological system, we can go into climate change, right? And all this are interlinked. Even though we wanna think of them separate. Yes. We just are not, right? Like we can go and debate like, should I go to work running or biking versus. Taking my car. Like that’s another piece, right? Because all these things are to health and ecology and

Dheera Ananthakrishnan: the other pieces. Yeah. And then I, I, I think to that point, like it becomes like we become kind of numb to it. Or you think, well, what’s the difference if I drive my car, like one day I drive my car, one Coca-Cola one. You know what I’m saying? Like it’s only like, when you see it in these small segments, it seems like it’s not that big of a deal, but the in aggregate. It’s, it’s huge and so, so impactful. So I think that that like, you know, how much personal responsibility that each individual person has, um, to, and, you know, to facilitate health and facilitate change is, it’s very difficult. And you know, I mean, you like your car, I’m sure. I’m sure you have a nice car.

Naji Gehchan: So the third word I have is, uh, impost, uh, imposter thoughts.

Dheera Ananthakrishnan: Imposter thoughts. Yeah, imposter thoughts. Um, those, I had those a lot. Um, I, I don’t, I don’t have them so much any anymore. I, I actually, to be honest, I’m starting to have them again as I’m like making a career transition. Um, but. I can tell you they, I think that those have motivated me a lot. So it’s like this, you know, yin yang, like good, evil, like the, um, goes back to maybe that, like I’ll show you, you know, I can do it and then it maybe inside I think, well, I think I can do it, but I also like a challenge. So, but the imposter thoughts, I mean, I can tell you when I, when I first got to Emory, um, I was, I’m sitting, I mean, I’m in a group with really world renowned surgeons and, um, really incredible people. And I kept waiting for the first probably three years to have somebody, um, tell me that I, they made a mistake and I wasn’t supposed to be there. I also, um, I remember reading Cheryl Sandberg’s book, lean In. Um, and she talked about sitting at the table and how like we as women, like never sit at the table. And I realized I did the exact same thing, like even as an attending surgeon. Like we had this conference and you know, all of the other attendings would be sitting at the table and I’d always sit at the back. Right. And somehow felt uncomfortable sitting at the table. Almost like, yeah, like, I’m like, well, I know I belong here, like on paper I belong here, but I still feel that I should. Not sit at the table. And, and some of it also is, it’s a little bit scary because if I’m sitting at the table next to all of these world renowned people, then they’re gonna expect me to have world renowned thoughts. Right. And I mean, I just feel like I have regular, everyday thoughts. So then there’s a lot of pressure. Like sometimes if you put yourself in the back, you know, the, I’m a, I’m always a sitting in the back of the class kind of person. So if you put yourself on the back of the class ab, you’re not gonna be expected to kill it every time you raise your hand and say something. So it may be, you know, there’s. Getting rid of the imposter thoughts also puts more pressure on you too, I think. Um, but um, yeah, I feel like as a, as a spine surgeon, I, I don’t have imposter thoughts anymore. For the most part, say 95% of the time. As a leader, I have a lot of imposter thoughts.

Naji Gehchan: We all do.

Dheera Ananthakrishnan: Yeah. Well, so that makes me good to, it makes me feel good to hear you say that because I. Every day. Okay. That’s helpful.

Naji Gehchan: That’s helpful to know. Yeah. And there is, there is actually, uh, I’ll send you the link, but I, I did a great episode with, um, uh, on imposter thoughts. Um, and, and I’ll share with you the link with some, um, with some good data and discussions. Uh, we had, um, sp specifically on this, um, on this topic, like there’s some good research actually from, uh, M I T. Uh, about this. So I’ll, I’ll share with you the link right after.

Dheera Ananthakrishnan: Yeah. I remember we talked a little bit about this at school, like, is it really real and does it motivate you? And is it really, um, is it imposter syndrome real? I. Yeah. Yeah.

Naji Gehchan: And it’s, it’s, well, professor Bafi, I don’t know if, yes. I had the, I can remember her. Yeah. I had the pleasure to be in one of her bosses and she did great research. I interviewed her. I’ll, I’ll send this to you.

Dheera Ananthakrishnan: Oh, okay. I’ll have to, you’ve interviewed a lot of people, so it’s been hard to catch up on all your episode.

Naji Gehchan: That’s totally fine. The last one is Spread love in organizations.

Dheera Ananthakrishnan: Ah, I knew we were gonna get to this. So, uh, yeah, this was for whatever reason, I, I would say this is like really tough for me, um, because, um, and it wasn’t until I, I think I shared with you that Khalil Giran poem about how what you love, you bring to your work. Um, and yeah, I think we don’t have much love in medicine in organizations, but it makes me sad. Sorry. Yeah, it makes me a little sad. Um, and I would like to think that I’ve spread love to my patients and to people that work with me. Um, but I think, you know, there’s a lot of burnout in medicine. I. And particularly after Covid, I think it’s been really, really difficult for, um, there to really be a lot of love in organizations in medicine. I’m curious to see what, what you think, um, on your side of the coin, but, um, I think it’s, it’s been tough. I think doctors have, um, Not had the brunt of it as much as nurses have, I think nurses have really, um, really not felt the love in healthcare for some time. I think that’s a lot of what’s driven this issue with, um, funding and the traveler traveling nurses. Um, Disrupting. Um, it’s very, it’s been very disruptive, um, for our industry to have nurses try to go off and like go across the street and make five times as much money working with someone else because they don’t wanna, like, organizations don’t wanna pay increased nurses nursing pay. And I do feel if maybe there was a little bit more like love and humanity in healthcare. Um, I think that, uh, it would, I, I feel like that type of motivation, the, I don’t wanna say mercenary, but maybe more financially driven, um, exodus from home institutions, that kind of thing would, would be better. Um, sorry, didn’t mean to get so upset, but it is, it is a bit of a source object.

Naji Gehchan: Yeah. And well, thank you to share this transparently and openly and honestly. And, you know, you, you asked me what I think, uh, you know, uh, we, we started this because I really believe we can, we can have a huge impact as leaders by leading from a place of love, at least making the world better for those around us in small circles, and then literally making the world a better place. And you’ve been doing it through your work with. Your patience with, uh, the nonprofits you have, but certainly there’s, there’s a lack of this in the world, but when you think even more holistically, I think we are seeing an increasing number of acts of hate, of wars, of hunger, of extremism. Uh, but I’m hopeful, you know, I’m still hopeful because there are leaders like you, we love to fix the unfixable and try to, you know, take the hard problem and make it better. And even if it’s a small piece with what you shared today, I’m sure you’re gonna be inspiring other leaders to really believe that they can do things differently and probably not. Take the examples of those. Others who lead from a place of hate and, you know, stepping on others to do better. So it’s, there’s still definitely a lot to do. But I’m hopeful when I talk to leaders like you, you’re, you know, you said I had many, I had the pleasure to have more than 120 episodes now, and it’s all really accomplished leader who have the same belief. I really think we will be able to do things differently and lead and deliver, you know, both for patients and also for the different stakeholders in the ecosystem. Um, but doing it from, again, a place of love to deliver even better results because we can deliver results, right? Both ways is just a matter of do you deliver it with people and people feeling good about it and wanted to do it again with you and together, or you do it. And everyone is burned out and you’re in a very terrible mental. Yeah, right. I think that’s kind of like the difference.

Dheera Ananthakrishnan: No, I, I completely agree with that. I, I think sometimes people don’t understand what it actually means. Like when you say, okay, we wanna spread love, but what does that mean? Like in what you do day to day? Right. You certainly, I don’t think anyone would say they’re spreading hate. Right. But it’s also more of like spreading indifference or spreading like, Disrespect or you know, like not engaging people, like people at all walks of life wanna have some agency into what their life is like and what their job is like. And they, if, if we’re, you’re asking us as leaders, if you’re assuming I’m a leader about bringing love to work, but you want everybody to bring. Love to work, right? Whether it’s your, the, the person who’s fixing your car or the person who is cleaning the hospital or the person who’s making the food. Right? And so how do you get those people to feel that they are seen and they are respected and that it makes a difference that they’re cooking your food Because they’re feeding me before I go back into the operating room. Right. And I, I think it can be as simple as, Saying hello to them and knowing people’s names and interacting with them and asking about their family. And then they know, they feel that they’re part of the organization and they’re helping you. Thanks so much because I’m hungry and I have to go back to finish my surgery. And, and rather than it being a transactional thing, right. And then, you know what, then it’s like, okay, well, It doesn’t matter if I serve food here or at a prison or at a, or at a McDonald’s or whatever. Like, it doesn’t matter, right? So I’m gonna go where they’re gonna pay me the most. And that’s what’s hap that’s what’s happened, right? Like, so that I, I think, I think spread love in an organization sounds like a really big idea, but it’s this, it’s a, what are you doing as an individual, right? Are you, you know, maybe. Maybe you’re driving your car versus walking, like maybe one day you just say hi to one other person who’s, you know, cleaning the room of your patient or like, those types of things. I, I, I think, I think that there’s a disconnect between what it means and people think it’s gonna cost something to spread love. That’s the other thing. It’s like, oh, we don’t have time, we don’t have the money to spread love. Right. Yeah. But that’s not true at all. Right? It doesn’t cost anything. Exactly. Naji Gehchan: I, and I love it because this is all about those. Small things and practical things that actually made a huge difference. You, you gave the best example I can ever think of. So thanks so much, Dira, and we can Thank you Naji. I, I’d love to hear your final word of wisdom for healthcare leaders around the world. Dheera Ananthakrishnan: Um, my final word of wisdom for healthcare workers around the world is I think try to listen to people that are not like you. I love that.

Naji Gehchan: Thanks so much. I could spend hours talking and chatting with you. It’s been a real pleasure and honor to have you with me today. Thanks for being with me.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs

EPISODE TRANSCRIPT: Jean Garrec

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. I am joined today by Jean Garrec founder and CEO of Biophta – Bioadhesive Ophthalmics is a biotech startup company willing to transform Ophthalmology by relieving patients from the burden caused by their eye diseases. Jean is the son of 2 ophthalmologists strongly rooted in Brittany, pharmacist by training, ESCP MSM Healthcare Management alumni, and Exec MBA at ESSEC. Before founding Biophta Jean held several leadership positions in pharma and medical devices for more than 20years mostly in SMEs and family owned companies and startups. He is also a sailor who participated and won several regatas, in France, USA, carraibeans… Jean is passionate about sight&eye, entrepreneurship and innovation, and wants to have an impact in ophthalmology & changing patient’s lives.  

Jean, I’m honored to have you with me today!

Jean Garrec: Thank you for hosting me today. I’m, I’m glad, uh, having this chat with you.

Naji Gehchan: I’m really happy to have you here, and first big congratulations on winning the first prize of the Boston Biotechnology Summit. And this is why you’re, you’re here, uh, because also of your amazing leadership and what you’ve been doing in healthcare. So before going into really biota and, and your biotech that you confounded, uh, I’m eager first to hear more about your personal story. What brought you to healthcare? What brought you to Pharma MedTech and now being a c e o and founder of, uh, of this new venture?

Jean Garrec: of course. Uh, so, uh, first of all, uh, I’ve always been attracted. Not to the medical and to the science, but to ophthalmology. Uh, being born and raised from, from two ophthalmologists. I’ve been soaked very early in my life into this world. Uh, I think the first time I went to the operating room for watching an eye surgery, I was like 15 or 16 years old and, and, uh, very early been attracted by this world of, uh, so I. Um, pharmacy, uh, school, and I completed, uh, my, my, uh, doctor of pharmacy, uh, degree. And, and then I always knew a second thing beyond ophthalmology. I wanted to be an entrepreneur. Uh, I wanted to do something with my hands. It doesn’t have to be big. It could be a a, a one man show, but I had to do it, yet I had sat deep inside me. So, uh, and the third thing, uh, I learned is that brought, uh, brought me to this, uh, journey, uh, is, um, my, when, when I signed my first, uh, uh, job, uh, contract, my first employment contract, uh, it was a, after the pharmacy school and the business school. And, and my boss said, okay, very good profile, John. You did very well. Um, uh, proof is that we offer you a job after your training period, but uh, you’re still missing one thing and one thing I’m sorry to tell you, it’ll take you a long time to acquire it, and it’s very important is the utmost important if you want to be a good leader. I was like wondering, what is he telling me? Is he going to sign my contract? And he told me, what you are missing is experience, and now that you start working in our company, you will have to. Many different positions and, and try many different things in the company to, to different jobs. And at this point I say, okay, well, uh, I’m working in ophthalmology. I want to do a my own business. And now what this guy is telling me is that I have to make different jobs before I’m ready to be an entrepreneur and to do it on my own.

Naji Gehchan: I love this. Thanks for sharing this. Uh, Jean, I, I don’t know how you reacted to this, but I was smiling as you were sharing about this piece on experience. We constantly hear it. It frustrated me in the beginning of my career. I’m. Well, I, but I know how to do things. I wanna learn things. But actually, as you said, like those experiences build up and help you become an even broader and better leader and obviously be able to build the company. So can we, can we now move into biota? Obviously all those experience shaped you and now you are combining what you love, which is entrepreneurship, having those experiences and ophthalmology. Biotech biotech. So tell us more about what you do today. What’s your purpose in this company? What’s the mission and what are you trying to solve for patients?

Jean Garrec: Well, uh, a biotech, uh, is a preclinical stage biotech company, a French company, uh, but having also a footprint that is being built in the US as well, since we are going to do the phase one trial. Uh, in Boston and our company, uh, transform ophthalmology with a new standard of care, uh, which is made to replace topical hydros, but also invasive intraocular injections that are performed to treat retinal disease. And our technology is based on the new family of biopolymers, and this polymer allow, uh, topical, noninvasive, and self applied. Continuous control dose for one week for treating rein. Uh, so that’s, that’s in a nutshell what we are doing. Um, today. There are many disease, uh, of the eye that have treatment and, uh, and, and treatment which, which are efficient and marketed. But, uh, still, still millions of people continue to lose sight because of disease, which could be treated. And the reason for that is that, uh, approximately half of the patient don’t take their treatment, whether it is eye drops or injections, uh, the compliance is in. Uh, it’s really a problem, uh, that people are getting blind, uh, despite their treatment. And this is what I, I want, uh, uh, to, to fight, uh, to take one very simple example because you all know about glaucoma, about high, uh, degeneration, uh, about all these disease which are affecting our world. Um, actually, uh, the idea and the, the wish to make this company did not start it there. Besides the fact that we are doing a glaucoma treatment at the moment, that’s the first use case. But where we started is that, uh, you may have heard there is a disease named Oma. Uh, it’s a number one cause, uh, by the World Health Organization. It’s a, it’s a disease that affects, uh, 90 million people and there are, uh, 2 million people in Africa, which are blind because of, and it’s a very simple bacteria. That you can treat with Teraline. So a very cheap drug, existings. So why is there so many people who are getting blind? Because this is because it, in the area in Africa where people, uh uh, Cannot have access to an eye drops three times a day during, during six weeks. People just don’t do it. Uh, and if we were having such a simple treatment that could be applied topically for one week period, I’m sure that we would not have had two people, 2 million people blind because of tma. So this is what drives me every day. Uh, I, it, I, I think that 21st century, uh, people should not get blind because of disease. Where there are cheap treatment available.

Naji Gehchan: That’s, that’s really great. And we definitely wish you all the best as you’re, uh, really transforming patient experiences and hopefully being able to treat more patients and those who cannot be reached with your, with your technology that you’re building. Um, what are your biggest challenges? Opportunities as, as you think about it, uh, as a biotech taxi, c e o today and having started this company?

Jean Garrec: I think that, uh, uh, no wonder that, uh, money and raising, raising, uh, funds is, uh, is clearly an issue today. We, for all the, the startup, uh, founders and, and managers, I mean, that’s, that’s no surprise. I mean, uh, uh, the current economic context for that startup makes it not easy at the moment. And, uh, I’m pretty sure that we, it’ll become even more difficult in the, in the coming month. But I mean, that’s, that’s part of the game. And I would say that’s, that’s life. Uh, what the, the biggest, uh, issue, uh, I face at the moment is, um, try to, to, to convince. Uh, and convince talented people to join the company, uh, because, um, uh, as a matter of fact, uh, if the economic context is difficult, uh, people tend not to be quitting their job to go, uh, in a company where, uh, it may be even more uncertain. And, and, and that’s, uh, that’s the biggest difficulty because, uh, a startup company like ours, Uh, the most important thing is not our technology is, is the people who drive the project. Um, and we are always looking for the most talented people. And to be honest, it’s a, it’s a big challenge at the moment to, to find the right people and to find quickly, uh, the best people on the market who could drive this project forward.

Naji Gehchan:This is a great segue to my next question actually, because I, I wanted to go into people, so I’m, and I’m hearing it’s one of your biggest challenge, and you said it beautifully. There’s the technology, but also the team that will be driving this project forward. So how, how are you thinking about your team as you scale up your company, you scale up your biotech, what do you look for? The first employees, if you can share a little bit where you are now, how many employees you have, and then how you think about scaling up your team, specifically as you’re going through this first, uh, first phase, uh, on your job. Yeah.

Jean Garrec: Uh, first of all, I’m, I’m, I’m tried to be very humble, uh, about, um, about driving the company and managing the company. Uh, I had the original idea to. Uh, but the thing is that I know almost nothing. I know quite well of terminology, but, uh, I had a chance to meet my co-founder, who is named John as well, who is an expert in drug development. He’s a pharmacist as well, but he spent 20 years developing new drugs. He holds a. PhD in pharmaceutical science. He has been, uh, making, um, an academic, uh, research on, on developing new drugs as well. He has been the head of, of r and d in, in some Novartis, uh, um, uh, business units. So developing new drugs he knows, and that’s, that’s where we started the company. Uh, one knowing ophthalmology and the other one, uh, knowing how to make it happen. Uh, I mean, um, my job is to know where are my limits and, and where, uh, uh, where do I need, uh, to get some, some expertise in? And, and trying to find people who know things better than I, simply as that. Um, and, and, uh, so the first thing is, of course, uh, to bringing, uh, a chemist. Uh, our technology is based on biopolymer chemistry, so that was not an easy one. Uh, because we are looking for one specific expertise. Then we are looking for, uh, pharmaceutical development experts, uh, then, uh, an expert in pharmacokinetics and drug design. Uh, so originally, uh, as you may have understood, the team is very technical. Uh, uh, to, to, to, for the first early start of the company, uh, based on, on r d. Then, uh, we started to hire people. This is what we are doing now, uh, uh, rather in the field of clinical development, pre-clinical trial toxicology because, uh, now we are preparing the dosage, uh, to submit for the phase one clinical trials that happen in 2025. So, uh, at the moment, uh, these are the, the profiles that we are looking for. Very open to people. Again, uh, I don’t need to hire people who on things that I know already. Uh, but that’s very easy since I don’t know much to identify the people who know more and that could bring something to the company.

Naji Gehchan: I’m sure you know a lot, uh, you’re, you’re a humble leader and I I appreciate that Jean. I, I would give you now one word and I’d love your reaction to it. So the first word is leadership. Uh, teammate.

Jean Garrec: What about innovation? Transforming lives of people, of patients.

Naji Gehchan: Can you share more because you’re in the heart. Uh, with biotech, you’re in the heart of innovation. I’d love to know how you think about it since you have practically a platform, but I heard you’re specifically going for, uh, glaucoma in the beginning. So I’d love to learn how you innovate, iterate, get things done as, as you build your company.

Jean Garrec: No, the, the, the first thing we did, we did, uh, when before, uh, at the moment we were starting the company is, uh, try to understand the life of people. So, uh, uh, very simply, we contacted the patient association and ask them to, to talk to the patient, to talk to the people having glaucoma for. Uh, uh, 20 years, 30 years, and we, we were talking to people because glaucoma can’t be cured. Um, um, it’s a lifelong disease. And, um, these people are really desperate and it may mean nothing because they are not going to die because of glaucoma. They don’t have a cancer. But these people, they were telling me, okay, you know what? It may be nothing, seem nothing to, to, to people, uh, that I need to put eyedrops every day. I cannot stand it anymore. I, I put these stupid eyedrops three times a day since 30 years, and with a threat that if I don’t do it correctly, I will get blanked. So if you can do something for us, if, if you can change our life, um, and your treatment that you are explaining us once a week, uh, clearly change it a lot for us, uh, that will change my life. So, When you hear that, when you understand, uh, the perspective of the patient, what do they leave every day? Then uh, you can imagine how you can change their lives. And it’s not only, uh, about having a treatment that is easier. It, we see it that as fighting blindness, uh, half of the people don’t take the treatment. So we’re going to fight that. We fight blindness.

Naji Gehchan: I love, I love the straight purpose, and you’re bringing great examples about going to patients and really solving a real problem and a real patient need. What about sailing?

Jean Garrec: Uh, sailing is something that, uh, when I do it, I don’t think anymore about biotech.

Naji Gehchan: No, I, I love that. Can, can you, so I was, you know, as I, as I saw all you do with sailing and you say you don’t think about biotech. So I’d love to see if there’s any learning from sailing actually that you apply in your management, uh, or your leadership. Um, and probably it is not thinking about that, but like, I’m getting this headspace.

Jean Garrec: And I agree. And, and, and that’s, that’s, uh, um, yeah. Thank, thank you for bringing that because, um, uh, I’m, I’m used to sail, not alone, but in a team. Uh, so we are, we are having a crew on the boat, uh, five or, or between five and eight people. It depends of the, of the type of boat and, and clearly, uh, of course, uh, there is one that holds the steering wheel. Uh, but, uh, if there is no crew, uh, to, to, to, to, um, uh, make the sail, uh, to, to, to, to drive the, the speed of the boat and to look, uh, around, uh, where we are going, uh, the man behind the steering wheel can’t make his boat moving forward. And, uh, you have, uh, the skipper who is one who decides of the direction. But you, he needs a team. And we all depend on each other to make the boat move and go as fast as possible to, to where we, we are heading to. Uh, so, and that’s very similar to any company, of course. Uh, there is one who needs to be the leader and to, to, to, to, to, to drive the strategy of the company. But he can’t do it alone. And you need very talented people to. Uh, and that’s very similar on what it is in the, on the crew of a, of a selling boat.

Naji Gehchan: What a great example. I love it. The last word is spread love in organizations. Uh,

Jean Garrec: I see, and that’s very similar to the, to the. Is, uh, first of all, we have to help each other. Uh, we are a team, so, uh, uh, we, we, we need to, to, to work together within our organization. Uh, and, um, uh, and if we want to, to, to make it happen, to work together, um, we have to identify one common goal. And, uh, common goal is, uh, Within Biota, we all want to fight blindness and, uh, we want to have a noble cause to fight for, uh, and because, I mean, you all know that working in a startup that’s not easy. Uh, you have some days, uh, with big downs and big ups, and it’s, it’s not easy to manage. But if you always have this gold, uh, this goal in mind, which is to fight blindness, uh, then you can only spread love. Because that’s a noble cause that will help people. And, uh, I just want to, to, to make the life of people suffering from my disease better. And that’s my way of, of spreading love.

Naji Gehchan: Any final word of wisdom, uh, Jean for healthcare leaders around the world?

Jean Garrec: I think that’s, uh, it’s all about, Uh, patients. And that’s, uh, where we started, at least with the company. Uh, o of course, uh, uh, in the end we always to have to, to work with VCs and, and, and, uh, different people who change the company. Uh, but, uh, again, don’t forget, uh, the origin of the company and the, the noble cause that you’re fighting with because this what.

Naji Gehchan: Well, thank you so much for being with me, Jean today, and really all the best with what you’re doing. I love the focus that you have on patients. As you said, it’s about patients. It’s definitely about. Um, also you mentioned funding. It’s about, you know, bringing all those challenges, biology, uncertainty of business, but at the end, the heart of what we do is to make life better for patients. So never forgetting this true north is so important. And thank you so much for such an inspirational chat, uh, and I wish you all the best with biophta and hopefully we will see your product soon.

Jean Garrec: Naji. Thank you very much for hosting me. I was glad having this discussion with you. Thank you,

Naji Gehchan: First congratulations on winning the first prize of the Boston Biotechnology Summit! I am eager though first to hear more about your personal story. What brought you to healthcare, pharma, med tech and now founding biophta?

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Vanessa Elharrar

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. I am joined today by Vanessa Elharrar, Vice President, Vaccines Business Strategy Lead, Clinical Research, at PPD, part of Thermo Fisher Scientific. Vanessa joined PPD in 2016 with more than eleven years of experience at the National Institutes of Health (NIH) where she served as a medical officer, deputy branch chief, and director of HIV therapeutics research at the Office of AIDS Research.  Vanessa holds a Bachelor of Science in Physiology from McGill University, a medical degree from Indiana University School of Medicine, and completed her residency in Preventive Medicine along with a Master’s in Public Health at Johns Hopkins University.  

Vanessa – I’m honored to have you with me today!

Vanessa Elharrar: Thank you Naji for the opportunity, and lovely to see you as well.

Naji Gehchan: Naji Gehchan: Before we go in your workshop’s topic of “Partnering with International Sponsors to Launch Trials in the US and Globally”, I am eager to hear more about your personal story. What brought you to healthcare, NIH and now being an executive in a large CRO?

Vanessa Elharrar: So goodness, where to start. I’ve always, always, always had an interest in science, I think since grade school truly. Um, and that continued through high school and then wrestling with myself on what to major in, in college physiology was what attracted me most. I was always very interested in it. Um, and I always also wanted to help people. Help people with health in particular and help a lot of people with health. And that’s something that I think followed me, not just through my undergrad but through medical school. When I decided, goodness, do I want to do clinical practice? Do I want to do research? If so, what kind of research? Um, and I ended up pursuing a residency in preventive medicine and public health specifically because, Of the millions and millions of people that that could be affected by the type of research, um, done through clinical trials. Um, I ended up at n i h, specifically in h i v prevention research for that same reason, truly because at that stage of the pandemic, it truly was out of control, um, in, in Africa and many other regions, especially as well in the us and I wanted to make a dent in that and, and. Hopefully do some significant work with the team, um, that could help people and a lot of people, not just one-on-one.

Naji Gehchan: Well, thanks for sharing, Vanessa, Vanessa, and it’s really around the impact you’re obviously now having also in your current role. So I’m, I’m interested to double click a little bit on this. So now, now being in clinical research, How, how do you see your impact today? You who really loves bringing this help for patients, as you said?

Vanessa Elharrar: No, that’s, that’s a very good question and I think that brings me to the part of my career where I’m now at P P D. I mean, there have been certainly some successes at N I H, um, in very large h I V prevention trial networks, H P T N trial network studies that have made. Big strides in H I V prevention, non-vaccine prevention. But my time at P P D I switched over from h I V to vaccines, and the first several years of my career at P P D was a medical monitor overseeing vaccine trials. Um, and about three years in, I decided to join the commercial organization, um, and learn a little bit about a different area of clinical research. And then of course, the pandemic hit. And there I go back to vaccines. Um, this time more in the clinical development role, which I used to occupy at n I h quite a lot and also in early customer engagement. So I think the impact, the major impact thus far in my career has been working in vaccine development, um, during the, the Covid pandemic and interacting with dozens, dozens and dozens of biotechs and biopharmas. Trying to develop interventions to combat covid. Um, truly the highlight and I think the part that has helped, um, and made the biggest public health impact really.

Naji Gehchan: So I’m gonna immediately go there and then Sure. We’ll back up to clinical trials. ’cause I know you’ve done remarkable work within the covid vaccine development. Uh, what, what are your biggest takeaways? Learning from this experience as you brought this vaccine to, to humanity?

Vanessa Elharrar: Um, I think, I think you’re referring probably to the Moderna vaccine, which is it’s public knowledge that P p D worked on that vaccine. We’ve been working with Moderna for, gosh, since they’ve gone into clinic, truly. So, um, that vaccine definitely had a big impact. I think the lesson learned is that we think vaccine clinical research, Can be done a certain way or takes a certain amount of time, and I think we broke a lot of barriers in terms of showing that, you know, we can do it faster, we can do it better. We can learn from this experience and take those learnings into everyday life, non pandemic life, and make vaccine trials move more quickly, make them more efficient, make better use of our resources. I think it also drove home the point that partnership with clients is key. Had we not had that absolutely rock solid partnership with Moderna for many years prior to the pandemic, those relationships and, and, and positive working relationships in place, um, I don’t know that we could have gone as fast and as far, quite frankly. So I think number one, challenging processes and timelines, and number two, the real true importance of partnership and how that can make a huge impact on, on success, frankly.

Naji Gehchan: So if you take a step back into clinical trials, so beyond covid, and obviously this. Uh, really the example as you shared about strong partnership and how we can move fast. So now when you look at clinical trials overall, uh, and vaccine where, where you said, but you also touch different therapeutic areas too, and you see it, uh, can you give us a little bit an overview of what are the main opportunities you’re seeing or the main challenges also in clinical trials

Vanessa Elharrar: overall? So, Challenges, what was the first one? Najee. I’m sorry I missed it. Opportunities. Opportunities. So I think we have, I’ll start with the opportunities, like to start with the positive. Um, so just recently, um, Varda came out with amendment to their b a a looking for next generation COVID vaccines. And that is an area frankly, that has been stalled. Due to lack of ability to procure comparator vaccine, so many biotechs that have had innovative technologies, different routes of delivery, intranasal, oral, et cetera, patches, um, have been steamed frankly in this clinical development and regulatory environment in their development because they could not procure comparator, um, funding was tight and now there’s been an. A new avenue of funding opened for next generation Covid vaccines. Um, the vaccines that are currently on the market are going to be commercialized soon, if not in process right now. So hopefully comparator procurement is going to be much easier and hopefully we can learn a lot about what works. For respiratory illnesses. In terms of vaccines, do intranasal vaccines truly work better? Um, what about patch vaccines? What about oral vaccines? I think there’s a whole area, um, of vaccine clinical research that’s gonna be opening up now that we’re in a different environment with Covid and the funding is there and hopefully comparator is now available. So huge opportunity. And I think that speaks to a challenge that we faced just recently in vaccine development. Um, and I guess with challenges come opportunity, right? So I think that as the landscape change changes, um, you will find new opportunities, but also new challenges. Um, and I think that’s the example of next generation Covid vaccine development. A good example of that.

Naji Gehchan: Are you seeing any challenges, uh, in clinical research for vaccine with also what’s happening in the environment? So beyond what we do in, you know, pharma and biotech and the science we have, obviously there’s a lot of myth around vaccines. There’s a lot of challenges from the public view around, around those. Have you seen this impacting, obviously clinical trials and then our ability to keep on innovating in the vaccine area?

Vanessa Elharrar: So I think that it has raised the profile of clinical research. The pandemic has raised the profile and education level on clinical research. To the population. People understand trials now. They understand the different phases. They understand why we’re doing it, the importance of participating, um, the altruism that goes into, um, participating in a trial. Um, and I think they understand the importance. I think the significance of the contribution they’re making is much more obvious given the global health threat that we all recently faced. Um, so I, I feel like participants are more inclined to really be interested and eventually participate in clinical research, um, because of the global education we’ve received from the pandemic. Uh,

Naji Gehchan: I wanna pivot to another, uh, theme that is obviously discussed as part of the summit. It’s discussed all over ai, you know, I, mm-hmm. Many of us now don’t like this word, these two letters anymore, uh, because we’re hearing it so much. But I’m, I’m interested in your view about AI in clinical research. Do you see any rule for it here? Are you looking into it, uh, as an organization and how to think, how do you think about it?

Vanessa Elharrar: So very good question. So we are looking into it as an organization. I am not quite public yet. There are certain areas in which it’s already used, I would say. Um, I, I personally, um, love the idea of using AI earlier than when you hit clinical trials. Meaning in basic discovery, for example. How best to present an epitope to the immune system. Can you model that? Can AI help you hone in on how best to do that? Um, or which types of neutralizing antibodies would be best for prevention? Which one would decrease viremia most quickly? For example, in chronic viral diseases such as H I V, um, it’s, I. I it for whatever reason, I see the benefit of AI a little bit earlier in, in, in the, in the process of, of, um, drug development. But I do also see that, um, it can be used in clinical research, it can be used in in lab type environments that are related to clinical research. Um, and we are actually in the process of, of honing in on that and seeing where we can apply it most, um, most effectively.

Naji Gehchan: I’m gonna give you now a word and I love your reaction to it. Whatever comes through your mind. Okay. So the first one is leadership.

Vanessa Elharrar: Oh goodness. First thing that comes to mind is altruism. Do you wanna share more? Yeah. I think that as a leader, it’s, it’s a huge responsibility and you need to think not just of yourself, but of your team and everybody that your team is impacting. So it requires a level of selflessness. And removal from, you have to lead from a place of, of very little. If no ego be, be altruistic, be selfless, and give of yourself. I love that.

Naji Gehchan: What about innovation?

Vanessa Elharrar: The heartbeat of clinical research. I think that innovation is what gets us new medicines new. New, new forms, new approaches to treating disease and preventing, um, infections. Um, it’s, it’s, it’s what got us all interested in science in the first place. I bet. ’cause it’s just so exciting. Health equity a must. It’s absolutely a must. Um, health equity is something that, In clinical trials, we manifest it as diversity and, and diversity and inclusion. In terms of the subjects we enroll in our studies, we absolutely must gather data, efficacy and safety in all communities such that our results are representative of the population and can be applicable to all communities within the population. Um, it, it’s critical and that’s, A critical way that we contribute to health equity in the clinical research environment. Yeah.

Naji Gehchan: Can you share a little bit more about diversity in clinical trials? Because this is definitely something we’re all striving for. Mm-hmm. And we should, so we’d, we’d love to hear if you have an example or a story around this.

Vanessa Elharrar: So I think the best example, um, was actually the Moderna phase three covid vaccine clinical trial that we ran. We enrolled 30,000 subjects in about three months, in exactly three months as a matter of fact. And, um, about, if I’m not mistaken, about eight to 9,000 of those subjects were minority subjects. Um, a good number were of Hispanic origin, African American. Um, so really we ended up with a a, a subject. Population within that trial that it was an, a true reflection of the United States of America. Um, and I think that helped give comfort to everyone that this vaccine is not only safe for certain communities, but for all communities and effective in all communities. Um, I think that’s the best example of, um, truly enrolling a study quickly. And doing so with the diversity in your study subject population that that inspires confidence in, in, in folks who are actually going to use the product.

Naji Gehchan: The last word is spread love and organizations

Vanessa Elharrar: I think be generous. Be generous with your time. Be generous with your mentorship. Be generous with your expertise and help. Um, I think that all of all, being open and always willing to give of yourself in an organization is a way of not just spreading love, but spreading knowledge and spreading goodwill. Because many times people learn from your example and also want to pass on the help and the time and the mentorship in return, paying it forward, so to speak. So I think that that’s something that’s actually worked well for me. And you never know. Also when, when that generosity is gonna come straight back to you. It usually does in one form or another.

Naji Gehchan: Any final word of wisdom, Vanessa, for healthcare leaders around the world?

Vanessa Elharrar: Well, I would say, Do what you do because you want to do good and help people in whatever capacity that may be. It does not have to be in clinical research. It can be in technology. It can be in mental health support. It could be in any area. Just make sure that what you’re doing is of help and is doing good. Um, I think that’s key because that’s what’s gonna drive you and get you through the hard times and get you through all the obstacles, is the knowledge that, okay, what I’m doing is making a difference. It’s helping people.

Naji Gehchan: Well, thank you so much for being with me today. It’s been a real pleasure to chat with you and to learn from you. Thanks for being here.

Vanessa Elharrar: Thank you. Thank you, Naji very much.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Yvette Cleland

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with Boston Biotechnology Summit, a bridge to collaboration and innovative synergies between healthcare stakeholders. I am joined today by Yvette Cleland CEO of Cpl Life Sciences, a global talent firm. In 2019 and 2021 Yvette was nominated by Staffing Industry Analysts (SIA) as one of the top 50 most powerful women in staffing globally. After eight years working in the pharmaceutical sector, she moved to professional staffing and combines knowledge of both life sciences & staffing in her work at CPL. In 2012 she joined Clinical Professionals to scale the business for acquisition, drive growth and expand the brand portfolio and global footprint expanding into the US in 2017. Under her leadership, the business was successfully acquired, launched the award-winning Graduate Academies and CEO/CMO Biotech summits, and was involved in the UK apprenticeship trailblazers. In 2019 she wrote a Parliamentary Review on life science skill shortages, speaks regularly for industry around the “wake-up call” and her passion is addressing the growing skills gaps in life sciences.   Yvette – I’m humbled to have you with me today!

Yvette Cleland: Well, I’m very humbled to be here as well, so thank you.

Naji Gehchan: Before we dig in, talent management in the era of artificial intelligence, which was the topic of, the workshop you’ve done at the summit, I’m eager to hear more about your personal story, what brought you to the pharma world and now being one of the top 50 most powerful women in global staffing and healthcare.

Yvette Cleland: Um, I, I sort of fell into the pharmaceutical industry if, if I’m really honest, I started my career with a company called Janssen, part of j and j, um, working on their female health products. And then I moved over into, um, more of their palliative care movement and, um, pain control, um, within the farm industry. So, um, I worked on launching the first transdermal fentanyl patch within industry, which, At the time, and it was many, many, many years ago, it, it was, you know, such an advance in technology to have a reservoir patch that could deliver, um, pain control. Um, but I’m, I’m quite a creative person and I love the industry, but I, I love working with people. I started finding the role quite lonely. I couldn’t use a lot of the creative skills I thought I. I sort of fell into recruitment by Pure accident, and there was an organization that was growing quite rapidly. They were looking for individuals that had worked within the pharma industry to crossover and help develop out their staffing. So, um, I made what was seen at the time as an incredibly unusual move to be part of a large, global, very successful pharmaceutical business and move over into a tiny, tiny staffing business. Um, and I have to say the first four months were pretty awful. I didn’t have any training or development. Um, I didn’t really know what I was doing. Um, I wasn’t sure it was going to be right for me, but I made my first placement and I used my creativity to do that. A lady, um, I was actually going out to sell Enbrel, which again was a new launch at the time. She wasn’t a profile, but I knew she was passionate about the role, passionate about the job, and I really had to sell that to the vice president that was staffing that business up and. He kept rejecting me and saying, no, no, no. So I said, look, I’ve got three people that are the perfect profile. You say you are looking for, and I’ve got this lady as well. Will you interview her with the other three? And if I’m wrong and she doesn’t get the job, I’ll never call you again. And she got the job. So it shows me that really understanding people, what drives and motivates ’em, their passion, um, how they’re going to perform with a client. Their motivation and wanting that role. And that’s what got that lady, that job, um, and the VP listening to me and sort of giving me that opportunity and chance. Um, and that then I’ve never looked back from that day. Um, so I understood human to human. As long as you can always speak to somebody and you can rationalize why you want to do something, you can really move something ahead. And also the level of personal satisfaction. I gained in that lady getting that job. Um, and consequently, pretty much every placement I did as a recruiter, um, just continued to inspire me, particularly in the advances in medicine and having to find maybe people that don’t have perfect skills, but have the perfect competency to go on a journey with a business as long as they’ll develop and train them.

Naji Gehchan: Thank you so much for sharing this. I love it. And I love where we’re gonna be going because you shared really, really interesting pieces, uh, in how you think about leadership, how you think about staffing. So let’s start with staffing actually. So in 2023, um, this is like, we’re in a current environment. Things are moving. We’re constantly hearing, uh, about the challenges of finding the right talents for the right organization, especially in healthcare. Uh, so how do you. Really in a global perspective, how do you think about staffing today?

Yvette Cleland: So, um, staffing by some degree has been replaced quite a lot by internal teams, now, internal talent teams. But I would always say this to a client when you engage with a staffing partner they speak to or should do, if they’re a good partner. Of different people. If you are a talent person, you can only ever speak about your business and what you do. We go out often globally and can reach into. Passive candidates or corners of the market or because our expertise, um, are seeing how other companies have developed to bring their talent in. We can lend so much to an organization. Um, but, but quite often, I guess, Staffing can be seen as an expensive solution, um, where actually it can be very cost effective if you have the right partner, not the wrong partner. Um, so I guess one of my greatest frustrations and something that I’ve seen in the last 15 or so years is when I joined Janssen, literally 50 or so graduates joined in that year. Um, and everybody was trained and developed, and everybody stayed with that business for a very, very long time. Some of the people I joined with are still with Janssen, 30 odd years down the road. Um, so they’ve stayed a long time. They were looked after, they were trained, and they were developed several years ago, 10, 12 years ago. The trend was to outsource everything. Training and development of people. And we’ve then seen this surge in the last 12 to 15 years of really some incredible new technology, some incredible new biotech businesses. Um, Global pharma are not training people the way they used to. They’ve outsourced a lot of that. These smaller growing biotech businesses don’t feel they are in the position to train and develop people. So as a leader in staffing, I’m now seeing a diminishing pool of candidates. Um, Less and less employers willing to train and develop and to make that commitment. Um, which has then made the industry itself quite cutthroat. Um, it’s meant that we’ve got a lot of stability in companies because, um, every time somebody moves, they’re commanding a greater salary to move. Um, or they’re asking for a promotion and maybe that promotion is too early for their career development. Um, So I think we find ourselves at the moment globally within life sciences and a little of a turbine, and we’re about to go through another radical change with the development of AI that’s coming through and has been coming through the industry for several years. I. And again, around the AI piece, I understand fully how technology companies really engage deeply to get the best talent into their businesses. I’m not sure at the moment that the, um, MedTech industry. Are doing the same thing or as much to attract those incredibly gifted people into their businesses. And even if and can if, and they can do that, maybe the training and development isn’t there. Um, whereas the tech companies are, are really better down and making sure they get people through and they develop them. So I think we have some quite big challenges ahead of us as an industry and I think they’re going to grow year on year.

Naji Gehchan: So can we double click on the talent management in the era of, uh, ai? So you talked about talent management, um, globally and staffing. So if we go into this, Era of AI piece, uh, where do you see the challenges? So I love you linked also development, uh, developing people into practically even retention and helping people to grow and have a long career in a company and keep on building their, their capabilities. So where, where do you see AI getting in the way? Where, where is it, where are the challenges coming from in ai? Is it other companies hiring those talents and engineers and we’re not. Like, how, how do you see it?

Yvette Cleland: It’s, I, I, I think it’s a twofold problem. I think number one, the pharmaceutical industry really, and, and biopharma needs to look at how it is actually going to attract that talent in the first place because there are so many amazing technology companies. So that’s number one. Um, looking at that, then we have AI within staffing itself, and it’s a little bit to me, I’m not anti technology. I’ve seen what it is doing at the moment within drug development and some businesses, um, that. But I think where we’ve got a problem with, we’re always trying to get, um, technology to do a lot of the job that we should be doing. And I think one of the most personal things you can ever do, um, as a hiring manager or a business is, um, give people your time and your feedback if you’re trying to bring somebody into your business. And we as an industry tend to do everything we can possibly do. To not do that. Um, we put more and more barriers between ourselves and our hiring managers. Um, we. Sift cvs through technology. We, um, want chat boxes to go and speak to candidates. We want pre-assessment tools. Um, so every step of the way we’re sort of removing a little bit the humanity from that process. Now there are some really clever things, um, like applicant tracking systems. That can have bolt on products, um, that help you be expedient in terms of how you are hiring. Um, but then I want people to really sit back and think about what a candidate journey feels, feels like for another human being and what touch points you should have with that human being. Because you are in the most competitive market in the world for global talent in life sciences. And actually the effect, having the best talent available on the patient population is massive. So to me, let’s not, we, we don’t take the patient out of humanity. So let’s not take the one-to-one people connection out of our recruiting process. In fact, why not be really different and put more of the human into that? So I often get feedback from candidates that have been through an interview process, um, within the, in, within industry. And often they’re taking far too long, they’re not agile. So somebody has given up on some occasions, um, eight or nine hours of their time. They’ve had first interview, second interview. They have, um, spent time with your HR department. They’ve then maybe had a panel interview or gone and meet with six or seven different stakeholders. So they get to the end of that process and sometimes they don’t get offered the job. Oh, sorry, I’ve dropped my, um, so sometimes they don’t get offered the job, um, and they get no feedback. They get no feedback on their performance. Now the problem with that is that person that you turn, turn down on that day, a year later may be the perfect person for your job. Or they may be the brother or sister of somebody that’s perfect for. I think pharmaceuticals can often be a bit like a village. People talk about bad experiences and if you’ve given a candidate a bad experience, they will tell a lot of other people about that bad experience.

Naji Gehchan: I thi this is so important. I love how you frame that. Bring more humanity in our recruiting process. And certainly I’ve experienced it myself, hiring people, like giving feedback after, and sometimes before if we are actually not willing to have this person, you know, if they get into this process where they are presented to you and you just don’t go for it. I, it is just respect for people to take, to take the time to tell them, you know, because again, not Yeah. I, I totally agree on what you’re saying about this. If you. People you’re hiring for leadership positions in healthcare, uh, as, as you do frequently, what are the one or two top capabilities you would look for in those leaders?

Yvette Cleland: I’m gonna throw a little bit of a curve ball at you now ’cause I think there are two skills that we need moving forward into the future. Now, a resume is great at telling you what a person’s skill base is. Personal view of mine is the two most CRI critical competencies that will be needed in businesses moving forward will be an emotional quotient or emotional intelligence and critical thinking. We’ve got two things that are coming at us like a STEAM train at the moment. Number one is data. You have to have critical thinking. To really understand what data you do use, what’s important data, why it’s important, challenging that data. When I say challenging that data, you’ll have different stakeholders are looking at different pieces of data with their own motivation as to why something will or, or won’t be important to. So that sharp, decisive, critical thinking on balance, getting the tone right and, and being able to sort of negotiate in that field is going to be really important. And the other thing as well is emotional intelligence. Um, understanding what drives and motivates the team, particularly if that team is now less connected. Because we now live in a world where everybody wants work-life balance and hybrid working. They want, um, I, I don’t think the gig economy will affect the biopharm industry as much as it is other industries, but it’s definitely a pathway ahead of us at the moment. And I think emotional intelligence, um, you know, sometimes I’ll go on to a, a Zoom or. Meeting with a team member or a Microsoft teams meeting and I can see someone isn’t quite, um, happy. You can notice shoulders down, someone are not as quite as communicative. So sometimes we need to intervene because sometimes it can be lonely at home. Um, and people want that work life balance. But sometimes you need to create. Um, an environment that allows hybrid working and in team working and how you engage your teams and people knowing they’re not actually gonna have as much sort of touch time with you as they may have done in years gone by. So to me, um, and I do it now in all of my hiring, I don’t look at the person that’s joining the business today. I look at that person and think, what will they look like in two to three years time? Are they going to be somebody that can be in my leadership team? They’ve got to, um, be able to deal with a lot of data here now as well, um, in staffing. And they’ve gotta be able to read reports and, and know what to read from that report and what to share with a client and how to map a market. And they also have to work differently in, in a team remotely as well, and also in person, in offices. Um, and we’ve, we’ve seen people struggle coming back into offices after. It’s sort of forgetting really how to engage. Um, or, so here’s a primary one. I’ve had quite a few people come back into our offices and we’re, we’re a sales business. Um, and they don’t like noise. I’m sitting there thinking, oh my, but we are a noisy office. We’re full of people. We are vibrant, we’re full of life. But you’ve been used to working at home with no noise. And now you don’t like coming into this vibrant environment. So I think all those things, and I think exactly would translate to, um, a, a biopharma business or a medical technology business. These same things will, will transpire. So I think we just need a built in awareness around that. We need, um, people that understand people. And if you’re not a people understander, but you may be very gifted in other ways, we need to understand that too and how to accommodate that.

Naji Gehchan: This is so crucial. I totally relate to it. Right? Like and sometimes they are put one against the other, unfortunately, like it’s a people person or critical thinker, but actually it’s the combination of both that will make things work. Right. Especially for the teams and organizations to deliver.

Yvette Cleland: Yeah, absolutely.

Naji Gehchan: So Yvette, I’m gonna give you now a word and I want a reaction to it. So the first word I have is leadership.

Yvette Cleland: Okay. Um, emotional intelligence, vision and integrity. They’re the main things for me in leadership.

Naji Gehchan: What about women in life Sciences, glass Ceiling.

Yvette Cleland: Can you say more? I, I worked on a really, really senior role last year. I was approached by, um, I’m not gonna say who because of who they are, but it was big. And they came to me and asked me personally to recruit a highly significant role, um, within that trade body. And I hadn’t recruited myself for about 10 years. Um, and I was questioned when I did my final shortlist as to why it was all male and the majority of women that I approached for the role were either just quite not senior enough or didn’t feel they could compete within that’s sphere. And that made me quite sad. Um, I, I have met some of the most inspiring women, um, in life sciences I’ve ever come across. And my daughter works in technology and she also, um, has come across just some incredible, just incredible women. But I, when I went back and wrote the report, I wrote in the, I wrote a fully d n I report for the. Organization. Um, and, and I gave in-person commentary about what, how these women had responded to me and said, I, I don’t think that would be for me. I, I don’t think I would fit into that world. I’m not sure. Then a year later I had to recruit the role one below that, and for that I had a really diverse. Um, shortlist because there were more women at that level, more women prepared to go into that. So I think it’s a little bit industry and a little bit women. Um, if I approached you for that role, it was ’cause I felt you absolutely and utterly had the skills and competencies to nail that job. You should have had more faith in that. And number two, I did go to that organization with some slight curve or female candidates. Um, and they would, they, they wouldn’t look at them. So it was like, well, there you go. Um, I’m saying, this person has the future skills. You might need to spend 10% more time training them, but you’ll have a more diverse, you know, Application level for what you’re looking for. So, um, so that’s why I say glass ceiling, although I think we’ve come a very, very long way, a very long way from the years when I was in pharma.

Naji Gehchan: Sure. And, and I, I, I wanna double click on, on this piece, uh, especially, you know, your recruiting obviously diverse, uh, population and, um, and placing them in, in the industry. Um, We, we’ve seen, right, in research, like men would say they are more comfortable. Uh, they say they can do the job. Like, so how, how do you deal with this? ’cause the example you gave was women actually saying, no, this job is not for us. It’s higher. So, but probably it’s the same for men. They just came across more confident. So I’m interested as you go through those processes, how you make sure you’re taking those unconscious biases. That even the person doing the interview has in mind, like the glass ceiling is at the beginning within our heads, right? Not pushing us to go further. So how do you make sure you get into really those talents for you to push them to get placed in those roles?

Yvette Cleland: Sometimes I use my story because I never, ever, ever, Expected to be chief executive of a staffing business. Um, but no one ever told me I couldn’t. So may maybe I thought a little bit more like a man, I dunno, I don’t know if I’m allowed to say that anymore, but I just never thought I couldn’t achieve something I didn’t expect to necessarily, but I never made the assumption I couldn’t. Um, and, and actually with one of the women, but I did speak to, um, I did go through that with her and she then did step up and say, do you know what? Then put me forward. I’m going to go for it. And I couldn’t then convince. To take her forward and allow her to compete alongside that panel, even if she hadn’t have gotten the role, it would’ve given her the confidence. Um, and there was an already really good shortlist there, so I think. Sometimes we have to realize we, we, we can sometimes achieve the impossible. I don’t know if it stems from, and maybe it will be different in the coming years because I think, um, when I think about my education, when I was younger and, um, and actually when I think about things like, um, when I first started in industry, men and women were paid differently for doing the same jobs. That happened to me. And when I went to HR and they said, well, he’s, he’s got a family to support. Well, I had a family to support. Uh, so that would never happen today. It, it just wouldn’t. And, and, and I shared this story recently on International Women’s Day, and there were gasps from the audience. Oh my God. You know, and somehow it

Naji Gehchan: happened. What, what, what wouldn’t happen is someone probably saying this to you, but unfortunately we still see discrepancies between pay. Even in large organizations between women and men, like we’re catching up, but we, we’ve all seen it.

Yvette Cleland: I think we, we have, um, and I don’t want anyone to think that women are wingy because we’re not. Um, but, um, You know, we, we get out there and do our bit and you know, um, fair pay is really important. Yeah. So the reason I bring that up, it’s not a wind, Ramone, the world has changed. The context of the world has changed. Um, put it this way, it may still happen in terms of there being some disparity, but nobody would would ever actually say to, or nowadays, I’m not paying you the same as your male equivalent because he’s bringing up a. Yeah, that, that wouldn’t happen anymore. Um, so we have moved on, but going back to the education system, I guess when I was a little girl, my head was programmed to be a certain thing or to go in a certain direction. Um, it’s not so much that I ripped the rule book up, but because no one ever told me I couldn’t do something, and actually one of my greatest advocates as, as a young woman going into leadership, I was actually a male that just always said to me, you can do what you want. Just get, just get out there and you know, you work so hard, you do this. So, um, The world has changed, but I think for, for certain women there is still that slight mindset. I know there’ve been quite a lot of, um, over the years research done around male and female graduates and how they approach things and their, their mindset around what they can do and what they can’t do. But those are quite, they’re relatively old pieces of research now. And I would imagine perhaps are young women graduates today. They have a slightly different mindset. They’ve been brought up in a different educational environment, a different world. Um, there, there’s just a, a different way of thinking now. So hopefully in the next 10 to 15 years we will see quite a shift. Um, But there’s always work to be done. So I always see myself really in a way, um, of, you know, wanting to go in and break those glass ceilings and, and why not? Uh, and why not share those experiences? If it only affects one woman that may not have thought she could do something, then my job’s done. I, I’m, I’m happy. So, yeah.

Naji Gehchan: Yes. What about Wake up call? I know you’ve, you talk about the skills gap in life sciences and that we should have this wake up goal, so I’m, I’m intrigued. Yeah. What are your thoughts?

Yvette Cleland: Like, um, I speak more to the industry than I do to the staffing industry, if that makes sense. So I’m more likely if I ever go and do a talk or if I’m, it will, and it will generally be on skill shortages. Um, and I’m gonna tell you, Something that I find so frustrating. Um, I, for the last seven or eight years have taught week in, week out, month in, month out about skill shortages. Um, and, and let me give you another example. This is quite UK centric, but we, um, I, I’m passionate, um, about diversity and inclusion and I include within that kids from maybe, um, A challenging background that maybe wouldn’t have gotten to go to university. And we in the UK have apprenticeship schemes and they’re degree based. We can take really talented youngsters gifted in science and put them through those programs. And if you are a c E O of a company and you ever want to really look at. What your property properly. Um, look at your ED and I program. If you just did that and nothing else, you would be bringing such a diverse, um, talented. Gifted, um, level of people into industry. Um, but employers don’t do it. So they talk a lot about skill shortages. I get a lot of inquiries about some of the things that we’ve done in, um, in, in engaging and training graduates. Um, and, and we’ve done that and paid for that and put the capital there to do that. Um, because we are passionate about it and we want give back, but I don’t see that coming from industry. Um, And if we don’t do it, and if we don’t seriously have that conversation. So every time I go and do a talk, I have an audience that’s nodding and agreeing and like, yes. Um, uh, and they walk out of that conference. So they walk out of that room and they never do anything about it. I get messages, you know, come and talk to me. I want to hear more about what you do. And I’ll try and call someone or message them. They never get back to me. I will always give my time. I’ve gone into schools, into universities. Um, we’ve developed award-winning programs to bring life sciences graduates and educate them into what the industry is actually about and then get them their first two industry role. Um, I’ve loaned my, um, IP to universities in the UK that are training, um, uh, apprenticeships. You know, we do a lot as an organization, but I do not see companies paying that back. They’re not, they’re outsourcing everything. They’re going to A C R O, they’re then expecting the c r O to train loads of people. But the truth is, the CROs can’t. They’re on thin margins to try and deliver work. They can’t. Blend into that. Lots and lots of training and development. Um, so again, we are fishing around in this same pool of candidates and we are not bringing into industry, um, enough new fresh talent. We’ve got. So many people that are going to retire in the next few years, and we just simply do not have the skilled workforce to, um, replace ’em. And then on top of that, we’ve got lots of new technologies coming down the road that we already don’t have the skills to do that. Um, and yet we’re not investing in that training and development. Pretty much every c e o that I’ve met from industry pays lip service to that. Um, and, and it really needs to get real. It really needs to get real. The four,

Naji Gehchan: uh, the fourth word is spread love in organizations.

Yvette Cleland: So, um, I think the greatest thing you can do in any business is be kind. Um, and that sounds a little bit oversimplified. Um, you can train, you can develop, and we do, we train and develop our people. We, um, we, we give them good work to do. We, you know, we pay good salaries, we pay good bonuses. Um, we offer, um, emotional support schemes for our staff because people sometimes sign themselves in difficult scenarios. But there’s one thing, everybody will wake up on a day and have a bad day, or they’ll have a tragedy in their life, or they’ll have something that happens where they need kindness. And for me, um, I won’t have anyone working with me that I don’t see that trait or that ability. I think it’s what sits at the heart of our business. Um, and we don’t always get that kindness payback, so we don’t do it. You know, it’s sometimes we’ve very kind to people and they let us down, but equally well, um, I’ve got a really strong, very long-term leadership group that, one of them has been with me 17, 18 years. The other’s eight, 10 years long, long time. And they’re good kind people. And my boss is a good, kind person. Um, and the business I am part of and the reason when it was acquired, we, we had quite a few people that wanted to buy our business. Um, and I went with C P L because. They’re good people. They’re kind people. They’re focused. When they say they’re a people business, they really mean it. So my c e o, Lorna, Is a really compassionate, kind, incredibly talented business leader. Oh. Um, and my, my direct boss as well, the person I deal with, um, globally for life science. Again, he is an incredible leader. Um, and I have that again in my leadership group, and I think that’s what retains a lot of our people. They know on a bad day we’re there for them and we do it with kindness and.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Yvette Cleland: Please, please start training people. Put a budget aside. Look at what you’re gonna need as a business in the next five to seven years. Programs in place. Go and partner with other businesses, even if they’re competitors with you. Get academies going get apprenticeships, schemes going, don’t talk. Pay at lip service, go and get some youngsters or maybe some older people that have got fantastic skills that you can transfer into your business or younger kids that maybe wouldn’t get the opportunity to go to university, but you could sponsor that for them. You wouldn’t just change that individual’s life could change their whole family’s life. Um, to do that, if you’re gonna do nothing else, just do that. Invest in. Proper training and development. Don’t always rely on outsourcing for everything

Naji Gehchan: It’s been a pleasure and honor to have you Yvette with me today. Thank you.

Yvette Cleland: Thank you so much for inviting me. I really appreciate it. Thank you. Take care.

Naji Gehchan: Thank you all for listening to Spread Love and Organization’s podcast. More episodes summarizing the Boston Biotechnology Summit are available on spread love io.com or on your preferred podcast app. Follow spread love and organizations wherever you listen to podcasts and spread the word around you to inspire others and amplify this movement. Our world so desperately needs.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Nate Beyor

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today by Nate Beyor, Managing Director & Partner at Boston Consulting Group. Nate leads Health Tech for BCG, based out of Southern California.  He is passionate about the interface between technology and biology, with a healthy appreciation for operational rigor. He has spent his career exploring different avenues at this intersection, from microfluidics, to biologics manufacturing, to stem cell therapy development, and now in digital health. At BCG, he has hands-on experience launching digital solutions remote monitoring, clintech, supply chain, and precision medicine.  Nate believes in the power of technology to change how we treat, how we heal, and how we live.

Nate – I’m honored to have you with me today!

Nate Beyor: Nice to be here. Nice to talk to you, and good to see you since we first connected at MIT.

Naji Gehchan: Yeah, good to see you again. Before we dig in, digital innovation, specifically data, uh, the topic of your panel, uh, at the the healthcare conference. I’m really eager to hear your personal story. What brought you to the focus on healthcare in a consulting world?

Nate Beyor: So, you know, you sort of led with the, the preamble there, which, uh, I’ve generally.

Always been intrigued and enthusiastic about places at the interface of different technologies. So for me, I, I came up more as like an engineering person. Uh, I studied applied physics in college and then very later on in my undergrad career, got into biology as well. But they were very distinct. There was like biology classes and then there were engineering classes and there were a few that were, where there was a nice overlap, but I would say it was still very early days there.

Um, And I got really into, uh, kind of exploring that interface and, and going into grad school, uh, in bioengineering. And I, I went to, uh, the joint program between uc, Berkeley, and U C S F. Uh, ended up at a lab at, at Berkeley, though. Started at one in U C S F. Uh, that was a nice way to explore that interface.

Uh, and, uh, how do you get into consulting from there? I, you know, I started doing some startup stuff along the way in grad school and realized that getting into, uh, top tier consulting, Was a way to get off the bench and I, frankly, I never thought of myself as particularly capable on the bench. Uh, but again, really worked well in interdisciplinary environments where I could bring that technical lens and more business environment.

Um, and yeah, ended up role in a role in consulting, you know, thinking it would be short term, but ended up liking it a lot and, uh, had been in and out on sort of consulting and startup side over my career. Well, thanks

Naji Gehchan: Nate for sharing this. Uh, if we go into, uh, digital innovation, uh, which was one of the topics you discussed in the panel, uh, how do you define that and what, uh, is included from your point of view in this large word of digital

Nate Beyor: innovation?

That is a large word. The the and, and so when I think about innovation, and I think my, my favorite joke about this are, you know, when you. Talk with companies that say we wanna be innovative. Show us someone where you’ve been innovative before. We wanna be innovative like them. And that’s sort of like, you know, by definition is not innovation anymore.

It’s, it’s repeating something that’s already been done. Um, so when I think about the word innovation, I think that it, it evolves doing new things in a, taking on risk. Uh, bringing together multiple disciplines is really critical here. Um, and that doesn’t necessarily mean that. I’m going to take a person that’s totally from the consumer world and drop into a healthcare setting and expect magic to happen.

Um, but it is about, uh, being multidisciplinary so that I can take someone that, you know, really understands what it means to have white glove hands-on services that consumers expect and apply that within a healthcare setting. But they might work alongside someone that understands the underlying incentive structures between, uh, clinicians and payers, uh, in order to.

To actually build something that’s transformational. Uh, the other piece that, that is key in innovation, and I I’d use the word intentionally in in the last statement, is build. You have to do not just talk about, uh, and so we work with our clients to build solutions. I’ve been. Part of many software solutions that we put in the market, and we tend to push our clients to get hands on as quickly as possible.

Uh, one of my favorite examples that’s been my dream project for years, I’m running it right now, is a, a slide free project. Literally zero PowerPoint slides. There’s only engineers on the team and they’re not allowed to make PowerPoint slides. They’re only allowed to, to create actual working solutions.

Uh, and you know that, that. I think for me is, is how we move the ball along a lot further. Uh, it get getting our hands dirty and, and building things.

Naji Gehchan: I love it. You talked about having a diverse group, uh, working together and then prototyping and building actually solutions rather than talking about it.

Uh, and this word digital that comes before innovation. Uh, how, how do you think of it? Right. In large organization, we can talk about digital from. Digital tech solutions that touches patients to just digitalizing whatever tools we were using commercially, for example, uh, into now whatever, you know, software we have.

How, how do you think of it when, in the broad length of healthcare and digital innovation?

Nate Beyor: Yeah, I mean, you sort of. You hit a good point of, uh, like the simple version is how do I go to screens versus paper, especially in healthcare where there’s just too much paper, but that doesn’t get you a lot of value, right?

Just going to a digital environment doesn’t necessarily change the way you work. Uh, for me, the litmus test is more along the lines of how did I remove steps to get something done? So if I have a 10 step clinical workflow, if it’s still 10 steps, but you know, the three paper steps are now three screen steps.

That doesn’t actually add any value. It just changes where I’m looking or you know, how I’m writing something down. I have to go from 10 steps to six steps to really get a fundamental change. And so, I think, and I think we’re getting there, and part of the enablement is, uh, due to better penetration of, uh, compute and storage, uh, and, you know, for the development of, of, you know, stronger analytics and algorithms.

We’re, we’re at this moment where we can see a lot of automation. On the horizon and, and happening already in some cases. So you can start to see places where the automation can take out steps in a process, whether they are in a direct clinical processes, processes in the background on the administrative side.

Uh, or I, I work often in pharma services. For instance, you might see more kind of B2B things on, uh, clinical development or supply chain or manufacturing, uh, where there’s a lot of opportunity for automation. So back to the critical piece, it is really, um, You know, digital is about changing the way you work through technology.

It’s not just adding in a technology component to something you already do. So

Naji Gehchan: you, you touched about algorithm and different solutions for us to improve the process. Actually, as you said, instead of just making it the screen, uh, be behind this, obviously there is data. So what is your take about data? Is it the new oil, as many would say?

And how do you think of data with, obviously in healthcare, we have a lot of this. Many times never talking to one another as, as the, you know, data rooms, et cetera. Uh, how do you think of this and what is the type of structure do you think we need to strive

Nate Beyor: for in healthcare? Uh, Well in, in health data, I think we’ve seen a lot of changes over the last few years.

Uh, even when I started at B C G coming on six years ago, the notion of integrating something within an E H R workflow was possible, but seemed so hard that. Nobody really wanted to deal with it. And a lot of solutions were actually stood up in kind of like a separate web environment that might force a clinician to go outside of their, of their E H R.

The, um, interoperability is much more real right now and know people understand the need to integrate within the workflow and within the systems that are in front of clinicians. The, um, That’s just in a, in a few years. And so, uh, I think what I’m excited about is from a data perspective, we are seeing, you know, a stronger infrastructure where these systems can talk to one another.

Um, even back then, five years ago it was harder to come by really scale data sets. But you have a lot of, you know, claims, data sets and, and, uh, associated solutions that are out there right now and easily accessible to drive analytics. I think we’ll continue to see more and more of that. Um, It’s not necessarily a consolidation at the infrastructure lever, uh, layer, but, but more access and more connectivity as that infrastructure layer that will go.

As I mentioned, we have claims we’ll get into clinical data. Uh, increasingly we’re having more remote solutions, whether that’s, you know, your Apple Watch kicking off data or, uh, eCOA systems as part of a clinical trial. Uh, those create other points of data creation and, and other types of data that we’ll have to, you know, connect to these systems.

Um, It will still be relatively fragmented there, you know, there’s still a lot of different players out there creating, creating solutions. There’s a need for, um, sort of a custom integration points, uh, through a p i or, or in other ways. Um, but I’m excited that we go from, you know, one dataset to the next.

Better connectivity, uh, ways to map identification or to de-identify. And then more power on the compute side is, is feeding this automation like we talked about before. So, you know, as,

Naji Gehchan: as you were talking through it, I, I get, but think about G D P R in Europe. I had to implement it as, as a chief marketing officer at that time, uh, in those countries.

Uh, what do you think about privacy? Privacy in the US is also kicking in, so I’d love your thoughts as all those interconnect and obviously we’re gonna be using those data to make better decisions for ourselves and probably for others. How do you think about privacy in all this

Nate Beyor: setting? You know, it’s a funny one cuz I, I remember building solutions and people’s people would have this reaction.

Like, oh, well they, I have to be HIPAA compliant when I build over in, uh, over in this way. And so that’s, that’s too burdensome. So I don’t wanna do that, do it. But I, I always felt like, you know, it’s a standard and a standard. It’s actually kind of nice cause it’s something specific you can build to. Uh, there are certainly, uh, sort of, uh, compliance, uh, associated, uh, aspects to it and regulatory ones that, that can be more burdensome and costly.

Uh, for instance, how you might have to set up Waldorf data environments or even distinct legal entities in some cases, depending on the type of organization you are. Uh, But in general, I like that there’s a standard, uh, and I think the standard is appropriate. So it, it’s a overall, it’s a good thing. Um, But you know, we don’t yet know the value of privacy at this point, which is, which is interesting.

I think there’s this general fear of people finding out about my health data, for instance. I don’t know what they’re gonna do with my health data when they find it. You know, my employer who pays my insurance already has all that data and can, you know, adjust premiums accordingly. So I, at the end of the day, I think we’re still operating very cautiously.

Um, But I do like the standards. Uh, I think they’re important. Uh, and, you know, we, we spend a lot of time worrying about this stuff, right? That engineering team I mentioned has been spending a lot of time thinking about, you know, how they operate compliantly, set up the right environments, uh, scrub the data when needed, uh, in order to meet those standards.

Naji Gehchan: So now that you talked about data standard and how to build, uh, to, to answer this compliant piece, you talked also about algorithm that will help us obviously make decisions either as healthcare, healthcare providers or as individuals to make better decisions for our health. I’d love your thoughts on.

Ai, which is obviously a hot topic these days, and chat G P T everyone’s talking about, and I remember during the conference there was this question about do you think AI will replace individuals and specific some healthcare professions?

Nate Beyor: What are your thoughts about this? I think inevitably AI is going to be the less risky option versus humans in some circumstances.

I think it’s. Naive to assume that humans are going to be making all the same decisions that they are currently making. And we are going to have to adapt to, uh, AI oriented solutions that are better at making those decisions. Now, are they generative? I don’t know that they might be a fixed algorithm in some cases.

Um, but certainly just very simply, we talked about data. There’s a lot of data getting produced. There’s more data than any one clinician can handle in the. 12 or 13 minutes that they see a patient. I’d rather have a computer looking at my data to make sense of it and at least triaging that and teeing up a range of insights that a clinician could then build upon versus completely relying on the human to to do that analysis in their head.

We’re already doing this to some extent, so the question is how far you draw the line. Um, that said, You do have to draw the line, right? If I think about it very simply in terms of like AI for radiology, um, you know, ultimately they, even in a triage environment, they’re going to have to highlight certain images or highlight certain areas of images that could be of interest for a clinician to make a diagnosis.

Depending on where they draw that line, which images to highlight or what areas we are making an assumption around sort of, uh, statistical tolerance, um, uh, around that AI system. Um, so there is some. Some critical design questions, uh, and that we have both from a systems level and from, uh, you know, a broader industry or society perspective in terms of, you know, how much tolerance we wanna allow for these AI system to have.

And, uh, even when they are, you know, feeding humans to make the final decisions. I love

Naji Gehchan: that. Certainly agree to it, and I think it’s, it gives also this power of a human connection at the end that only a human can do it, or a physician with a patient, but using the power of ai. To get us closer to a diagnosis somehow.

Nate Beyor: Although, did you see all this stuff last week about this, uh, this study that showed that the, the generative AI system, I, I don’t remember which one it was. If it was, I think it was GBT four, but it outscored the humans, uh, in terms of empathy. Um, Uh, in terms of the answers provided, I haven’t read the study in detail.

I’ve only seen the headlines and some lightweight analyses on it, so I can’t, I can’t claim to have a clear understanding of it. But, you know, there is, has been this notion that like, uh, one of my favorite posts was, was a friend say, say something on LinkedIn about, um, you know, they say the AI can’t hold your hand, but when was the last time your doctor held your hand?

You know? And, uh, and so, uh, Yes, humans are necessary and they add value, but realistically, where is that value and how do we double down on that and really sort of make that valuable and important and then automate what we can and use computational power, you know, where there is a lot of data availability, let’s use the computational power and take advantage of that and do the best most of it.

Yeah. Yeah.

Naji Gehchan: So when, when you look into the future, what are you most excited about in this technology? In HE healthcare?

Nate Beyor: Well, I’m excited about a lot of automation, um, making steps go away, not making me deal with chatbots instead of people along the way. That’s one. So like, you know, how can you automate, uh, scheduling and interaction points and, and, uh, delivery of information to patients and clinicians to, to make things more efficient?

Um, I am really excited about. You know, we talked about lightly on the, on the services side. I think there is a lot of headroom when it comes to clinical development. Uh, AI discovery is certainly one where there’s been a lot of investment to date. Um, now a lot of those companies are maturing such that you’re having compounds into the clinic.

And so we’re starting to see, you know, a lot of say AI generated molecules actually go through clinical development and we’ll see how that plays out. Similarly on the clinical development side, You have a lot of disparate systems in that IT chain, uh, that can be better connected. Um, and there’s a lot, uh, a lot of opportunity to drive towards more value, whether that’s through more focused trials around looking at an efficacy or safety signal or, you know, faster trials, uh, through more advanced protocols, uh, uh, being delivered, uh, in trial operations.

So I think at clin, clin dev side, ton of ’em for opportunity, uh, and that ultimately will lead to, um, you know, more and better therapies in the market.

Naji Gehchan: I wanna move now to a section where I’ll give you a word and I’d love your reaction to it. The first one is leadership.

Nate Beyor: Leadership. Uh, my reactions to it, so this is very open-ended, is it, uh, the, uh, You know, I’ll reflect on, uh, it’s, it’s funny, I think leadership, your first assumption is more of a top down leadership and, you know, guiding a group of people, I often found some of my best learnings were, you know, the, the people say managing upward, but it’s not necessarily about, you know, the political questions for it.

It’s, you know, how do you take ownership over. Something you’re guiding and create trust at cascading levels below and above you in an organization such that you can move it along as quickly as possible. Um, I think leadership really does is about an ownership mindset, having empathy, uh, upward and downward of the rungs in your organization and beyond, uh, in order to make sure that what you’re owning actually gets to success.

The second one is health equity. Uh, this is a very broad one. I’ve actually, this is the third time this has come up today in my conversations, um, that health equity is of high importance, uh, right now for all stakeholders. Um, I think one of the key things sticking out to me though is how closely it’s linked to data.

We can make a lot of calls around what needs to happen from, uh, for changes in health that could drive changes in health equity, whether that’s from an AR access perspective, whether it’s from a trials perspective. Um, But unless I have the visibility through data over where there are challenges and opportunities, uh, and I’m able to, to, you know, make changes by accessing the individuals that I, that, uh, are visible in that data, that doesn’t necessarily mean an identifiable way, but, uh, unless I can actually drive change, it’s not possible.

So I think there is a really close link between the technology systems, uh, and possible changes in health equity. So the

Naji Gehchan: third one was actually data.

Nate Beyor: Well, we talked about that a lot. I, I did. I want to double down on this point. We’re all excited about it. It’s really easy to forget how recent all this compute and storage is in the world, especially in healthcare.

I mean, all of. You know, US providers are not yet on the cloud yet. You know, I mean, it’s still, there’s still a lot of facts and so we talk about it like it’s all possible and it’s like right around the corner. There’s a lot of straight up work to do from an infrastructure perspective. Um, now, now to the cloud and compute, there’s a lot of opportunity.

To move things to, to cloud, um, and to leverage a lot of the computational power that’s coming online. And I’m excited about these gen AI tools because they are. They’re just creating such, uh, sort of enthusiasm in the market for people to get on there and start experimenting. And interestingly, some of the things that people are doing, they’re so excited about gen ai, but really it’s more traditionally advanced analytics.

It’s not necessarily, you know, true gen AI at this point, but whatever it is, uh, To, to get people motivated. I, I’m loving that there’s just a lot more traction right now to move things to cloud, get more experimental, and think about data as core to anything that we do, uh, in the sector of health tech. Can I, can

Naji Gehchan: I just double down on, uh, mixing both health equity?

You talked also about diversity in clinical trials, uh mm-hmm. And data. So there’s obviously data that we have, uh, available. Unfortunately, we know how diversity in clinical trials or the data that we have in healthcare, uh, that is many times. Inequitable unequal. We don’t have data for underrepresented group, et cetera.

Uh, and then obviously though these, this is the data that is feeding in systems for us to be able to make decisions. Uh, but also those data are helping us see where we have issues for us to be able to address them as we are building current clinical trials. So I, I want to have your views about.

Diversity, equity, uh, in, in healthcare using this data are things we don’t have. And we need to make sure that it’s a conscious, uh, bias that we’re looking at,

Nate Beyor: uh, and how to address that. I mean, there’s a lot of fragmentation, right? The, the, if you just think about, you know, one system to the next, and the way that they organize their data, Let alone how accessible it might be, you might introduce bias, um, purely in the friction it takes to actually connect to systems and for no other reason, right?

Um, and so,

You know, on the plus side, it’s a very hot area. Companies are investing in this. Whether or not they have any direct r o i, they recognize this as a necessity right now. Um, which is great. Um, it is a, uh, The connections to the underlying data infrastructure are huge. Um, and I think that, you know, with you, similarly on the data infrastructure side, people that wanna invest in that often struggle to prove their I r I.

So to have, you know, this kind of marriage between the need for broader data infrastructure, the imperative on health equity, I think there, there’s a way for, for these. Initiatives that seem distinct to actually push together. Um, and you’re also having a lot of conversation around sort of, especially on the clinical development side, on access, uh, to patients internationally too.

Um, which, which can support, you know, uh, goals for, for each of those threads too. So the

Naji Gehchan: last word is, is spread love and organizations.

Nate Beyor: I’ll come back. I mentioned the word empathy associated with leadership, but I think, you know, in healthcare that’s, uh, obviously a critical one. We, we think about, you know, how you are, um, empathetic to patients and for certainly patient centricity is huge. I’d like to be possibly a bit more cynical on that and think about, you know, empathy associated with, with all stakeholders.

Uh, and, you know, think about clinicians. Um, we often think about their workflow. Um, we think about the burdens, uh, placed in front of them. Uh, and we talked about the potential to automate a way the clinical work that they do. But right now data shows that half their day is spent entering information into their.

It systems anyways, so I’m sure they’d love to automate that away. You know, I’d love to consider sort of spread love and, and you know, broadly empathy, uh, around, uh, what they’re doing and, and to change the workflow. Because in my mind, unless we think about all stakeholders involved and, uh, you know, how their worlds need to change and that needs to go, like I said, well beyond just a patient-centric view as to consider all stakeholders, to incentivize them to make their lives better.

We’re not gonna see the clinic clinical clinical impact that we wanna see. I love

Naji Gehchan: that. And you find a word of wisdom named, uh, for healthcare leaders around the world.

Nate Beyor: As I said earlier, build first. Just get out there hands dirty. You’re gonna learn more by trying to do it than you will by, uh, you know, spending a year debating what to do.

So I’m, I’m just a big proponent of, you know, getting the technical team involved early and, and trying things. But always staying compliant. That’s a key aspect to all that. For

Naji Gehchan: sure. Thank you so much, Nate, for being with me today. I appreciate our discussion.

Nate Beyor: Yes, fantastic. Thanks for the opportunity.

Naji Gehchan: Thank you all for listening to Spreadlove in Organizations podcast! More episodes summarizing the MIT Sloan Healthcare and BioInnovations Conference are available on spreadloveio.com or on your preferred streaming app.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Allyson Jacobsen

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast joined today by Allyson Jacobsen a Global Marketing Executive who has led award-winning teams across the U.S., Europe, and Asia that were the recipients of 5 Gold Quill Awards. With over 20 years of expertise, her background in entrepreneurship and technology expands across industries, including Healthcare, BioPharmaceutical, Financial Services, and Public Sector. She is also a passionate mentor and presenter on topics around Women in Technology, AI, and Digital Marketing Transformation. Allyson is dedicated and driven to change the dynamics for the future by using visibility, diagnostic tools, and technology to help save lives across the World.

Allyson – it is great to have you with me today!

Allyson Jacobsen: Yeah, it’s great to be here. Thank you so much for inviting me.

Naji Gehchan: Can you please share with us, um, first your personal story from science to marketing and your passion for technology to save lives around the world?

Allyson Jacobsen: Yeah, I’d be happy to. You know, it’s interesting as I, um, I, you know, I was born and raised in Virginia, a little bit south of the colonial Williamsburg area, and as, as I went through school and I got into my career, It just naturally happened that I ended up in some of the.com startups back in 1999, 2000 timeframe.

So I think that’s when my love for technology for innovations, right, for bringing new, unique things to market, really got solidified.

So can you share

Naji Gehchan: a little bit more how you ended up working with, uh, healthcare Biopharmaceuticals and also this passion around marketing and leading marketing teams?

Allyson Jacobsen: Yeah. You know, it’s interesting. I really kind of fell into healthcare, um, and I shouldn’t have been surprised. I was raised by a mom who was a nurse for 40 years.

And I can remember as a child, um, going to the hospital with her and, and gosh, this would never be allowed today, but I can remember sitting in the nursery and holding and feeding and loving on the babies or the whole time I was in the hospital. So when I was, you know, probably in my late. Thirties, early forties.

A really good friend of mine that I had worked with before went over to GE Healthcare to start putting AI into the medical devices. And I had such an interest for technology and for AI in general and thought, you know, wow, this is a great way to bring my historical knowledge and love of just hospitals and patient care.

You know, my mom’s history with the technology and start to. Use that and to use my marketing expertise to solve problems that really will help healthcare for my children, my grandchildren, right. Generations to come. Um, and, and just like I said, got lucky. Maybe it’s serendipitous, um, that I came back into something that I’m so passionate about and I have not looked back since.

Oh,

Naji Gehchan: thank you for sharing. That’s, uh, that’s great. And you have led since successfully marketing teams, uh, across different sectors, different industries. Um, what made you be the successful, uh, global award-winning marketing executive?

Allyson Jacobsen: Um, you know, I think it is all about this crazy trajectory that my career has taken, if I’m really candid about it.

I, um, I spent the long haul, probably eight to 10 years getting my undergraduate degree. Um, I needed to work full-time as I studied. And then again, when I got out, I, you know, went to a.com startup. Then I ended up in the Department of Defense, kind of owning and operating my own marketing, public affairs agency to then, you know, going to big ibm.

And I’ve just done this back and forth between. Industry sectors, entrepreneurialship, you know, large scale fortune companies that have structure and process and procedure and move a little bit slower. And I, I think it’s been that trajectory that’s allowed me to. Have that entrepreneurial mindset to be able to talk to our customers in a way that resonates and is impactful while.

You know, working within some of the boundaries and constraints of not having deep, endless pocketbook, not having, um, you know, months to deploy something, to generate leads and to generate revenue. So really having to bootstrap, be fast, be thorough, you know, test, fail, uh, revitalize, right. I think that’s the, that’s the cycle that makes a great marketer.

And I, you know, I still strive for that every day because within marketing, this digital platform, it, it does change. It does transform. It’s a, it’s almost a life source in and of its own. So you have to constantly, um, stretch yourself, try new things, uh, be educating yourself on new technologies and platforms and, and trans.

You know, transforming that to really be successful. So I think it’s just been that mixture of mindset that has allowed me to continually grow and outperform. So,

Naji Gehchan: Well, you, we feel the passion about digital transformation and how you’re framing it and you’re talking about, uh, marketing. Uh, can you share with us how you define digital transformation?

You’ve worked a lot on it. And where do you see the healthcare industry in its digital transformation journey today?

Allyson Jacobsen: Yeah, I think digital transformation crosses every, organi, every department within an organization, right? You’ve got, um, in healthcare today more, more particularly, we have physicians burning out at a rate that has just never been seen before.

We have populations aging, um, needing more medical care every day. We even have less physicians entering the marketplace. So it’s, it’s this cusp where being able to do more digitally and letting the physicians. Actually spend time with their patients is the most critical. You know, I read a study a couple of years back and I think it was Harvard, um, but, but I hope I’m not wrong on that.

That said, physicians only spend an average of 25% of their time indirect patient care. And that to me is. So sad and it has to change. So with digital transformation, we are able to now do things with AI that can elevate critical records in the workflow so the physicians see them faster. Can. Make manual tasks that clinicians of all type do more accurate so that we don’t have to do repeats, um, can help with, you know, smart scheduling so that a physician can take into account, you know, the number of patients who may cancel an appointment and ensure that they don’t overbook or under book.

Um, there’s just so many new ways digitally we can try. To simplify and consolidate all of the things they do operationally and administratively so that they can actually spend those times with patients. And that’s, that’s where we’ve got to get, we need more human element and not less.

Naji Gehchan: Sure. And really, as you said, using this technology to optimize, obviously, the time of physicians on their highest value, uh, versus all the administrative pieces that they, they have to do today.

Um, and as you’ve led this also internally in the different organizations that you add, uh, any key leadership, learning from your side, leading all those transformations,

Allyson Jacobsen: There has been, you know, it’s, um, it’s a windy road. I th and, um, I, and there are lots of lessons, and I hate to say this, but I think sometimes we as leaders learn the best lessons in the times of trial.

And what I mean by that is, You know, I mentioned it earlier when I was in my late twenties. I ended up starting and running my own marketing, public affairs agency and was really successful at that. Grew the business, um, really quickly and really large. But the problem was, I, I was young and the financing the business growth to keep up with the demands of the contracts became more than, you know, my husband at the time and my budgetary capabilities.

And we ended up, you know, selling the business off, you know, in our GSA contracts and that type of thing, and, and, Having that real moment of humility and having to let people go and having to know how negatively you were impacting their life and those stressors that you were putting on them. And their vulnerabilities, um, I think is when I became a better leader.

I learned a lot more about empathy and about connecting with my employees and, and how to lead them through uncertain times, um, and, and help rebound in those hard times. And I think that, Dramatically changed me and helped me become a better leader. It was no more just about getting the task done, meeting the business objectives.

It was about purpose and mission and passion and, um, that empathetic connection with every employee that you lead.

Naji Gehchan: Thank you for sharing, uh, sharing your learning across this, uh, journey. Uh, I would now give you a word and I’d love your reaction to it. The first one is leadership.

Allyson Jacobsen: I think leadership is, you know, uh, less about.

The job description or leading people to complete a job. I think leadership is about teaching skills and practices and teaching folks how to. You know, love one another, support one another, you know, drive towards a common goal and mission. It’s about building a culture where a team feels safe to try things right, and to stretch and to grow and, and to fail.

More importantly, and, uh, leadership really is. It’s a complex mixture of emotional intelligence, you know, practical intelligence, common sense. It’s, it’s all of these things wrapped up in one package to help folks grow.

Naji Gehchan: What about women in tech?

Allyson Jacobsen: Women in tech? Is that what you said? I’m sorry. Yes. Um, women in tech.

Gosh, for me, it’s, it’s, um, empowering any woman who loves technology to excel and to grow. It is still unfortunately, you know, balanced as more of a male industry than a female industry. And technology can be. So many things. It can be marketing technology, accounting technology. It can be actual coding and development.

It, it can be so many different things, and I want women to embrace the field and to not be afraid of the field, to have a voice and to, to grow their career if it’s something that they’re passionate about.

Naji Gehchan: Chat g,

Allyson Jacobsen: pt. Oh goodness. Chat G gp. You know, it’s really fascinating. We are starting to use it in a lot of ways in marketing. I’ll tell you just a personal example. Last week I needed to really quickly write a press release and I gave, you know, chat G P t, a couple of cues, and it spit out a press release for me in a matter of seconds.

It wasn’t right. I mean, it wasn’t. It wasn’t there. It wasn’t finished, but oh my goodness. It gave me a framework to really quickly modify and finish a project in. 10 minutes versus what might have taken me an hour to do. Um, I, so I love it. I, I really do love it. I think that there are some awesome opportunities for it.

I think like all ai, we have to interact with the ai, we have to train the AI with the, teach the ai, and it does still take that human. Peace to make it work. So do I think it’s gonna take over the world and eliminate, you know, jobs? No, not so much. But I do think back to that physician example, it’s gonna let us do so much more, um, with the limited number of hours that we have.

So, love it. Love it.

Naji Gehchan: I, I’ve been hearing a lot of stories from marketers actually using it already in, in similar ways as you shared. It’s funny, it’s also, I, I have another story exactly with, uh, with press releases. The last word is spread love in organizations.

Allyson Jacobsen: Oh, spread love in organizations. Oh, it’s so important.

We, you know, we live in a time where people are moving so fast and the race to succeed and to beat our competitors and to pivot. Um, it can be stressful, it can be scary, and. Again, it plays on those employees vulnerabilities. And I, I just love to turn that upside down. I love to, you know, inspire the employees, let them drive to achieve the company’s mission and objectives.

Um, to be empathetic, to be honest and kind and, um, You know, more importantly, not ask anyone to do something I’m not willing to do myself. So I think, you know, love in organizations is often overlooked. It’s often not really seen as a cultural initiative. Um, but we have to be servant leaders and we have to love on our employees, and we have to be honest to our teams to really.

Maximize their growth and potential, which ultimately means the potential of the organization.

Naji Gehchan: Oh, thank you so much for sharing those, uh, those great words and summary for how to spread genuine care and lead our teams to be themselves, uh, for them to deliver the outcomes. We’re, we’re, we’re here for, uh, the patients in healthcare specifically.

That’s right. Any final, any final word of wisdom, Addison, for healthcare leaders around the world?

Allyson Jacobsen: I, I think for me it’s like you said, never forget your purpose and your passion and why you joined healthcare. Um, that we, we really are on a mission. To solve some of today’s most challenging needs for the patients, and everything has to center around the patients.

Um, so whatever we can do to drive efficiencies or empower clinicians to be able to be better caregivers. That’s why we’re here and that’s our mission. And folks just, you gotta always remember that it’s gotta always remain a passion.

Naji Gehchan: That’s a powerful charge. And thank you so much again, Addison, for being with me today.

Allyson Jacobsen: You’re welcome. I’m, I was so glad to have the conversation. Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Gaurav Deshpande

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Gaurav Deshpande, an Experienced healthcare professional with 12 years of clinical, academic, and global health experience. Gaurav is currently the Head of Medical Oversight and safety at one of the largest cleft NGOs in the world, Operation Smile. He is Clinical Assistant Professor of Surgery at PennState Hershey school of Medicine with several publications in the craniofacial and cleft field. Gaurav is passionate about global surgery and is constantly looking to bridge the gap between patients and healthcare corporations by helping develop and disseminate high quality products and therapeutics.

Gaurav – It’s a pleasure to see you again and have you with me today!

Gaurav Deshpande: Thank you so much, Naji. It’s a pleasure to be on your show. And, um, you know, I’m, I’m very excited, uh, about this, uh, um, this meeting. Thank you so much.

Naji Gehchan: Can you share with us first your story from dental to specifically cleft surgery, MIT Sloan, and now leading medical in one of the largest NGOs?

What’s in between the lines of this inspiring journey?

Gaurav Deshpande: Well, I mean, if I would write, uh, this story, it probably would inspire a Bollywood movie for sure. Um, because, uh, there are so many. Unbelievable events that happen in, in, in, in between all this, um, you know, phases of my life. Um, So I did my orals and Max facial surgery residency in 2010, and I was an assistant professor at one of the teaching hospital in Mumbai.

And there was this opportunity that came in where Operation Smile was doing, uh, a humanitarian, uh, mission, uh, surg, short term surgical program in the northeast part of India Guha, um, which not many people knew. You know, it’s, uh, It was considered a remote area. There was a lot of, um, insurgency problem at that point of time.

Lot of political instability, et cetera. So what’s, you know, not a very great place to go, but, uh, you know, when they came there and started a program with the, with the Ministry of Health, um, and I got to know about it. I, um, Signed on on that program as a, as an observer, because to be honest, I had never ever seen a patient with clef lip and p and you know, this kind of, um, facial differences in my life because all those usually went to the facial plastic surgery department, not as, So I was here, I showed up, I got selected as an observer, and the team leader asked me, how many CLEs have you done have?

How many cliff surgeries have you done? And I was like, you know, should I tell him a few? Or, you know, the devil was pointing me with his trident. But, uh, you know, I, I told him the truth, you know, was I’ve never seen a, a case patient with my life. He was just theoretical article from the books and, you know, you should have seen his expression.

Well, long story shot. Um, I started working with

Naji Gehchan: them. Yes. Sorry for, uh, for stopping you here, but can you share with us a little bit more about clef patients? I’m not sure everyone listening to us who they know

Gaurav Deshpande: about it. Sure. So, uh, so clef lip andal is, um, the most common facial congenital, uh, anomaly, uh, in very technical terms.

Now, let me make it simple. It’s basically, um, you know, when a human being is developing in a mother’s womb, um, There are chances, um, one in 700 times, uh, that that baby would not have a complete union of the facial tissues. So what that leads to is there is, um, you know, like a hole in the pallet or the lip as we see them.

Uh, you know, we probably have seen, uh, people with a scar on their lip. We’re not able to talk clearly, uh, when we speak with them, uh, either on Subway or one of our friends or somebody’s friends. Uh, and as I said, it’s um, you know, the incidents is one in 700, so it’s pretty common, and especially it’s more common in countries, uh uh, who lack.

Resources, you know, whether nutrition is a problem. Uh, healthcare is not very good. Diagnostics are not very good. So, so this is what left mentality is like. It’s, uh, it’s, it’s a condition that we are born with. Uh, so, uh, yeah. So I started working with this gentleman. His name is Alex Campbell. Uh, we became Friends for Life and he, he’s my mentor teacher.

Uh, and I was also inspired by this that I decided to shut down my practice in Mumbai and moved to Guari and work with them at the center. Uh, my wife joined later, after six months, uh, because she was running a clinic and, you know, it was not very easy for her to directly shut it down, but, She came in, she started a dental department there.

Uh, we worked for around four years there. I took care of 16,000 patients. Uh, was, was a, was a great experience for us, not just helping kids, but also to develop our personal careers and life. Um, and then we moved back to Mumbai, started a similar center at a teaching hospital in Mumbai. Stayed the same work for six years with the Ministry of Health, uh, uh, the government of, uh, um, family welfare and uh, and health, um, you know, helped more kids.

And I always wanted to do administration because, you know, when we were running our center, a lot of things we did at that administration. Flavor to it, but we never knew about, like, you know, formally management. You know what it is? I had no clue. Because doctors in medical profession, you know, the problem is they do not, and you, you’re aware of it.

They do not teach us anything about finance. They do not teach anything about economics, accounting, nothing. Right. And it’s so important because doctors in a way are business people. So, um, yeah. Uh, so covid hit, we had to shut down elective surgeries, which is, you know, we only were operating emergency surgeries.

So, um, that gave me an opportunity to appear for the G R e, uh, perform decently well then, uh, apply for, uh, for Sloan. And, you know, luckily got there and pursued, uh, my dream, uh, course.

Naji Gehchan: Well, thank you for, for sharing this. Uh, I, I, I, I wanna go, let’s start by the end. So, you said your dream course, you talked about administration, uh, and, uh, how, how to lead, you know, organization.

So you, you moved from academia, from clinical surgery, uh, where you were having immediate impact on, uh, majority kids. Um, to now leading a nonprofit organizations more on the admin side, uh, as you described it. Uh, what have you learned through this transition and do you have any advice you can share with those who are thinking about such

Gaurav Deshpande: transitions today?

Yeah, that’s a great question, Naji, and I think it’s very common these days for clinicians to, you know, um, Pursue their dream. Uh, and that may not be surgery. Uh, and you pointed it out correctly, right? When you are operating on a kid, you are impacting that kid and their family. Um, it’s a 45 minute operation.

It’s a, I’m talking about left surgery. It’s a very simple operation, but has such a big impact, right? Uh, I always thought that, you know, Whether it’s a good idea to, to leave this because you see that happiness in the mom’s eyes when you give that, you know, new smile to the child. Um, but then I realize is that okay, this is, surgery is great, it impacts one child at a time.

But what if I pursue this dream of administration and workforce, let’s say Operation Smile. At that time it was not, uh, fixed. But even healthcare companies, even bio, uh, biotech, you know, pharma, uh, any healthcare company would gimme an opportunity to impact larger audience in that amount of time. So I think it was that thought that, you know, the, the, the impact that I would create, Over a larger population in short amount of time.

Uh, that was very pleasing for me. Uh, and, and you know, that gave me inspiration to, to change this field. Uh, and I think the same advice goes to whoever is at this point thinking about it. You know, um, we all are passionate as physicians, um, but we all. Sometimes, uh, are stuck in that idea is that direct patient care is the only way we can impact as physicians.

Um, but I think there are so many other alternatives to that. And you’ve, you’ve been doing that Naji yourself, uh, and we have so many other examples where people have actually impacted a larger population with, you know, uh, in a shorter period of time when they pursue both. And for me actually, um, operation Smile is uh, kind of a dream job as well because I can operate on the medical programs, so I can go as a volunteer and, you know, continue that surgical skills and practice administration.

So, you know, I get to have, enjoy the, uh, uh, both parts of the world. That’s,

Naji Gehchan: that’s great. I’m talking about large impact. It’s just incredible what you’ve been able to do through this journey, and it feels like a full circle now, being in this organization and doing it at that big scale globally.

Gaurav Deshpande: Yes.

Naji Gehchan: I’d love to hear, uh, as you are going through it, and really you’re in the nonprofit with Operation Smiles.

How, how do you see NGO’s role. In the healthcare ecosystem several times, you know, and as you said, so I relate to your, to, to your journey. And also I’m in the biotech biopharma industry. We hear about several partners, but it’s true, nonprofit won’t. It is not one of the first that would come into place, even though it has such a big impact.

And usually unfortunately, with underrepresented or smaller populations or those places, Where healthcare is a need or is a lack. So I’d love to get your thoughts as you’re now a leader in those organizations. How do you see your role as NGOs in the

Gaurav Deshpande: ecosystem? So I feel, uh, naji that nonprofits are like the catalyst to the process.

Uh, they can never be, uh, the sole ingredients. I mean, they could be the sole ingredients of the, um, of the process, but, but to, to make things more efficient, to make things, uh, you know, work favorably. It’s always good to partner, uh, with. Other organizations and that could, that could be governmental organizations, which is very important for nonprofits, uh, given the work that they’re doing.

Uh, and when we work with governments or ministry of of health, um, you know, our work is kind of made simple by them because, you know, they know the lay of the land. Um, many times, you know, we are far into that particular place. So it helps a lot if you’re actually able to partner with the government. Um, you can also.

Uh, partner with corporates. I mean, that, that’s like, um, you know, might sound funny, but, uh, but with the CSR initiatives with companies that have similar vision, you know, like, um, uh, if, if there is, I don’t want to name any particular, uh, organization, but if there is any, any, um, big corporate partner. Who have similar vision, who want to do the same work in that particular area, then you know, we can work with them, uh, in making sure that we have, um, the right elements to the, uh, to the process.

So I think nonprofit is that catalyst. So it brings in the government together, the corporates together, it has its own team, uh, you know, has been doing this for, um, that particular, um, specific job for many, many years. That helps to build the contacts as well. So, um, you know, working together is always the, the best way going forward, uh, especially in the low and low middle income countries because, uh, again, you know, we can impact the lives of many more, um, people by doing so.

Um, talking about Operation smiled specifically. Uh, we’ve always historically been, um, a surgical mission, humanitarian and mission driven organization. Uh, so what we did was we used to form a team and then send them into the, into this countries to, you know, to take, and we had local foundation who would, you know, find these patients who needed the care.

We would go there, operate, give them comprehensive care, and then. You know, the team flies out with a few people staying in the country to take care of the after surgery, um, care. Right? But now we are moving forward towards strengthening the local healthcare system. So our focus now is on education and training.

So whenever we are taking care of children, we are making sure that we are actually harnessing the local. Healthcare, uh, resources like surgery, anesthesia, pediatrics, biomedical, and we give them the necessary training so that they can now start taking care of their own children. Uh, and this is again, done in partnership with either the Ministry of Health, um, large corporations, which for-profit, who help us, you know, in donations in kind cash, uh, which help us to, uh, You know, take care of the pa the patients, take care of the surgery, give them a complete care, not just surgery, which includes dentistry, speech therapy, psychosocial care, et cetera, which is also very important.

Um, so, you know, I dunno whether I was able to answer your question, but, um, uh, long story short, I think it’s the, uh, the non-profit role as a catalyst that is very important in bringing all this partner together and forming that good uh, uh, team. You, you

Naji Gehchan: answered this question and my second one, which was around bridging the gap, uh, it’s one of your passion between patients and corporations, and you, you definitely talked about how you are doing it with your current role.

So let me pivot it to another question that is more personal, um, and talking some m MIT Sloan language, I’d love to hear more about your leadership signature. How do you define it? And how your leadership journey has been going.

Gaurav Deshpande: I think, uh, to define the leadership, uh, in one word, I would, um, say it as, uh, being an empathetic leader is so important.

Um, you know, um, many times we are so engrossed into what we want to do. We’re very focused on achieving our goals. And that point of time, we forget that, you know, there are human beings around us who are also doing the same thing for us. I remember us, uh, I was working with a senior plastic surgeon in India.

He was an American plastic surgeon and spending six months with us at this center, he would operate all day. And in the afternoon when it was lunch, there was no lunchtime. But you know, whenever you finish your surgeries, you come and you have lunch. This gentleman would go and see the patients who are waiting.

And when I was to say, Sam, you know, you should come and have your food. You, you are must be tired. You’ve been working all day. He said, but these kids are also waiting for us all day, so, you know, let me take care of them so that they can have their food and I can have it, have it later. So that kind of empathy, you know, when you see from people, you get so inspired.

And I think, um, uh, Sam Fuller is the name of the gentleman who has taught me that. Uh, and I would never forget, uh, uh, spending six months with him. We are still great friends. Um, Is to care for others, to take them together, you know, join hands. Um, there would be instances where, you know, there would be deadlines, there would be crunch times.

Uh, but I think if you have developed this relationship with your team, um, I think it goes so far, uh, uh, to, to solve the purpose rather than, you know, being, uh, very objective about, about the, uh, the work that we do. So, um, so I think, uh, it’s, it’s a mixture of that, but to, to summarize it, I think being an empathetic leader, um, is so important, uh, in today’s world.

Um, and that’s, that’s all I can say. Uh, and

Naji Gehchan: Guo, you talked about something that might seem obvious, but unfortunately we don’t see it. It’s this empathy to word your patients when you are a healthcare provider. So it, I’m saying obvious because many times you think like, yeah, healthcare providers are built that way, which is, as we both know, not always the case.

And, and then you also talked about empathy towards the people you’re working with. To provide this, this care, or in your nonprofit world to be able to lead and bring even more impact. Uh, do. Do you have any thoughts or stories, especially in Operation Smile as you are leading across cultures across really different countries, how do you think about those really?

I don’t wanna say cross-functional, but really like putting people from different places with a huge diversity to be able to bring an impact in those underserved population. How does the magic work somehow for you to be able to impact, uh, kids’ lives?

Gaurav Deshpande: It’s, it’s such a great question, Naji, because it’s so relevant to us.

Uh, so Operations Mile headquarters, uh, are, is located in Virginia Beach, Virginia. Um, And we work in 36 different countries. Each of them have their own foundations. Each of them have their own leaders. So, um, you know, it’s not the way that we can actually direct them to, you know, do things like this. But rather than, you know, respecting the local culture, respecting the local leadership is so important in this case.

And I think the communication is extremely important. Right. Um, Not just the communication, but the way it is communicated is so important. Um, what we do at Operation Smile Headquarters is, you know, uh, our, like a backend support for them. So we encourage the local leadership to take care of their own problems.

And whenever they have any pro any issues that are, you know, um, um, difficult to address, then we are always there with our resources to back them up. So I think the most important point here is to, to respect, uh, the, the local foundations, the local people. Many times what happens is, um, you know, we have the right experience, we have the right knowledge, but we do not know how that right knowledge and right experience can, um, you know, be, uh, of relevance in that local particular region, um, that we are working in.

So I think. Mutual respect to our colleagues from, from the local foundations to the local organization, the local, local companies is very important to get their perspective in rather than having a unilateral decision. Um, we believe in having that dialogue with them and discussing, brainstorming the difficult problems.

Easy ones are, you know, disolve it, we say, awesome, great job. Uh, when there are difficult problems to solve, we all sit together, uh, you know, get their ideas. We do. Definitely give some recommendations from our side, uh, and obviously offer help with other resources that, you know, as a headquarter organization would have.

Um, so I think it’s that combination of respect and good communication, uh, not being, uh, very, uh, direct about, you know, telling them how to do things, but rather getting the ideas from them and then mutually agreeing to what works best in that region. Um, is what is working so well for us. So I’ll give

Naji Gehchan: you now a word and I’ll want your reaction to it.

Okay. The fir, the first one is leadership,

Gaurav Deshpande: um, hard.

The second one is health equity.

Um, we are getting there.

Naji Gehchan: Yeah. Do, do you think, so do you feel we’re, we’re striving, do you think we’re getting there? And what is your thoughts? You’re, yeah, but I’d, I’d love you to get your thoughts. You’re obviously working on equitable issues with Claf.

Gaurav Deshpande: Yeah. So, uh, you know, when, uh, during our time at M I t, um, I was, uh, in Healthcare Club and me and three other amazing, uh, individuals we worked with Biogen.

Um, on health equity, the same topic. And that was kind of an eye opener for me. Um, you know, when we were doing our research, the background research is how far we are, but the kind of, um, Excitement that Biogen showed with what our findings were and they implemented what we recommended, which was a big deal.

You know, these are four students from some business school coming and recommending them something. It’s a multi-billion dollar comp corporation, and they actually implementing that was. Such an amazing feeling for all of us. Um, and, you know, that showed us that confidence that, you know, people are really thinking about it.

And we have so many other examples. I’m, I’m probably ignorant about other corporations, but this is my personal example. Uh, same thing is with Operation Smile. Um, you know, as I said, uh, before, uh, the, the core now is. To make sure that we reach to the patients rather than the patient reaching to us. So what we are doing now, our strategy for the next decade is going to, uh, work in a similar fashion, like a cycle tire, right?

Hub and spooks. So what we are doing is now with the local foundations, we are trying to identify hubs which are this big, um, high activity. Academic centers, um, which can, you know, be the source of education, training, service, delivery, care delivery, clinical care delivery. And then we are also trying to find the spokes, which are, you know, well connected to these hubs, but are in the periphery towards the patient.

In doing so, what we are doing is, you know, we are trying to reduce the catastrophic expenses that the patients. Might experience and also make sure that they get the timely care, right. So, uh, instead of sometimes we have seen patients traveling for 16 hours, you know, sitting on a donkey, then riding a boat and sitting on a bus in a train, and then coming to the hospital for care.

And sometimes, you know, it just doesn’t work. The the kid is not, well, he cannot undergo the surgery. He has to go back. So that made us think like if we take that care and go to the patients, they have to just travel for less than two hours. That’s our aim. So whenever they need care, they can immediately go and get in there.

So, you know, that’s the way we are trying to, um, work on getting equitable healthcare to everyone. But again, you know, as I said, there’s, the journey is long, but I’m so glad that whatever my recent experiences are, uh, not just with my current organization but with with several other organizations, is that the journey has started.

We’ll get there. Yeah,

Naji Gehchan: I, I have the same hope. Uh, and I really think as healthcare, as a healthcare leader and all of us, uh, healthcare leaders, it’s just the right thing to do. We cannot be healthcare leaders and not think and act on health equity. And the example you gave is such a powerful example on, you know, thinking about the holistic experience, not only providing care, but actually for some patients, the journey for them literally.

To get to a center and get care or even what, what are the resources they have to be able to get and uh, and have care is, is so important. Thanks for sharing this. The third word is Sloan

Gaurav Deshpande: Fellows. Uh, the best possible, uh, the course. If you want to change to administration, um, I really enjoyed the, the experience, um, just because, you know, it’s in the, in such a, a unique kind of offering, right?

It’s not mba, it’s not executive, it’s a mixture of both and that makes it so special. So, you know, you spend time with young, very, uh, energetic. Folks from the, the regular two year mba. You also spend time with the senior leaders who are currently working. And then you have yourself a cohort, um, who are accomplished managers, uh, you know, with 12, 15, 20 years of experience themselves.

So I think it’s kind of the most unique experience that I, I you could imagine, um, Plus it’s m i t, it’s the kind of, um, you know, the, uh, the resources that just come with that name. Um, I always thought I was well traveled. I always thought that, you know, I’ve done fellowships at, uh, international universities, uh, I’ve done clinical rotations there, and I thought, oh yeah, well, I’ve seen the world.

When I came here, I realized I was living in a big pond, you know, uh, and. That was just an eye-opener for me. The kind of things I took away. The, the kind of people I met, the friends I I I made, uh, is just amazing. Um, and, uh, you know, there’s so much, um, positive energy that I took from there. So much positive learnings that I took from there, which are gonna be lifelong for me.

Yeah. So, uh, in one word it was amazing and, um, you know, a life-changing experience for sure. I, I was so

Naji Gehchan: afraid when you said the young mba, how you’re gonna describe, uh, the exec mba. So I don’t know how to take senior. It’s not all that please, but, uh, yeah. Okay. I, I take that the, the last word is spread love in organizations.

Gaurav Deshpande: Um, very needed. Um, and, um, let’s, you know, let’s do it together. Uh, that’s, uh, that’s a wonderful feeling, you know, when you, uh, give a compliment to your coworker, uh, when you just, you know, give them that encouragement when they are really down, um, when you, you know, in simple ways, very, very simple ways.

Show your appreciation. And the kind of, you know, impact that it makes on them is so huge. Um, you know, we’ve all, all heard and we have all, uh, in various fields have experienced toxic culture. We have also been lucky where we have found that one or two, or three or four, uh, coworkers who have been completely opposite, very positive, very optimistic, you know, full of love.

And we all agree that our. Uh, output. Our efficiency is the, is very high when we are actually working with these, uh, individuals who are positive. You know who, who mean love, who, um, you know, I keep using this word too often. Empathetic. Uh, it’s so important in my life and I’ve, uh, seen how it benefits. Um, so I mean, I am, whoever is listening, I can just request them.

You know, it’s a very simple, um, Uh, thing to do is just to, you know, be kind, be, um, uh, empathetic towards your, um, your colleagues. Make sure that, you know, you see their side of it. Sometimes, you know, we are, as I said, we are very focused on our outcomes and we do not see that, okay, this person is also human being.

May he also has a family, may have some issues, but when we start thinking holistically about all those things, I think, um, you know, just not. Um, better humans, but also better managers. So I, I sincerely hope that, you know, in the next decade or so we’ll be in a different place.

Any

Naji Gehchan: final word of wisdom, uh, gu for healthcare leaders

Gaurav Deshpande: around the world? Uh, well, I mean, I, um, I have been very, um, honored to, to have, um, see and experienced, uh, different styles of healthcare leaders. Um, and the only thing I would, um, you know, um, suggest, I mean, I, I’m not sure whether I even have, uh, that position to, to recommend, but, uh, what I could just suggest from my end, the small experience that I have is, um, You know, there is so much need in the world.

There are millions of people who, who lack access to, uh, safe care, safe clinical care, uh, safe medicines, you know, safe diagnostics, and, you know, we are losing precious lives because of that difference. In the distribution. Uh, so my humble request to all the healthcare readers in whichever field, you know, they are, is if we can work together and think about this inequity in the distribution and make sure that, you know, we work towards that, uh, we make sure that, you know, we have the resources that we can, we can distribute it around the world where it’s most needed.

Um, I think that would. Be very helpful, you know, to humanity and, um, uh, in general, uh, it’ll be very, very impactful. So that’s, that’s the humble request to everyone. That is such

Naji Gehchan: an important, uh, issue and topic that needs to be addressed. Thank you so much, uh, again, for being with me today and for this incredible chat.

Gaurav Deshpande: Thank you so much, Naji. Um, you know, uh, you and. An inspiration for me. I’ve learned a lot from you, uh, with our short chats during Sloan as well. So thank you for this lovely endeavor that you’re doing. I, I follow it very keenly. Um, you know, and so many fabulous, uh, leaders that you’ve, uh, you know, spoken to in the past.

And I’m, I feel lucky and honored, uh, that you thought of me. Thank you so much.

Naji Gehchan: Well, thank you so much. Your words mean a lot. We’re, we’re so many leaders more than a hundred now, who are definitely striving to make life better around the world by leading from a place of love, and you’re one of them. It’s been an honor to have you, Gaurav Thank you.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Jami Taylor

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together.

Jami Taylor is joining me today for this episode. Jami is Vice President of Corporate Affairs at Protagonist Therapeutics, and a Global Justice Fellow at Yale University, working to design new models to improve access to medicines in the world’s poorest and most challenging settings. Earlier in her career, Jami held global leadership roles at Johnson & Johnson across key divisions and was a founding member of Johnson & Johnson Global Public Health. Jami has served as a member of the National Academy of Medicine Forum on Microbial Threats; the Private Sector Delegation to the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the Chairman’s Circle at the Center for Global Development; the Global Health Advisory Council at Harvard Medical School; and on many other committees and forums addressing priority issues in medicine and society. In 2014, Jami was named a Cross-Sector Leadership Fellow at the Presidio Institute, a program created by the White House Office of Social Innovation and Civic Participation to advance the work of leaders addressing society’s most complex challenges.

Jami – it is such an honor to have you with me today!

Jami Taylor: Thank you so much for having me, Naji. It’s great to be here.

Naji Gehchan: Before we dive into accessibility in a global health setting, which was the topic, uh, of your panel at, um, S H B C, I’m eager to hear a little bit more about your personal story. What brought you to healthcare and this inspiring journey of impacts you have.

Jami Taylor: Sure. I’d love to recount it. It, um, it’s something that I reflect upon a lot really. It’s the tension between innovation and access that’s defined my career and in many ways my own personal life and even my childhood. I grew up in Washington, DC and both of my parents worked on key legislation affecting the business model of the pharmaceutical industry, namely the Orphan Drug Act, and later Hatch Waxman known for really creating that split.

Between the innovator industry and the generic drug industry, which really defined that tension between innovation and access, and in some ways defined responsibilities between those two sides of a coin, so to speak. And so the innovator industry was. Tasked really with the work of innovation, uh, and the work of r and d and investments therein, whereas the generic industry was seen as sort of taking the baton on access after a particular IP period had expired.

And I think there was a satisfaction with this model, despite all the tension that remained within it for a long period of time. But ultimately, when we think it globally, and think about how the models played out. It’s fair to say that there are imperfections in it and the waiting period between the, the innovation as it comes forward.

And the medical sphere and accessibility, especially when we think about the world’s po poorest and most remote communities. It um, it strikes me that there, it always struck me that there were solutions that needed to come to the fore more quickly. And thinking about that sense of urgency, my childhood was really incubated in the crucible of the H I V crisis in the us.

I had an uncle who contracted h i v via blood transfusion in the early 1980s, and that sense of urgency and real desperation for innovation and for access was very much, uh, formative as I observed that as a child, and it imprinted itself upon me that experience. You know, well after his death many years later and is really a guiding light for me when I think about and knew that desperation at the time as it was experienced by my family.

And then now that I’ve traveled the world and spent a great deal of time in frontier and emerging markets and communities and all kinds of situations socioeconomically and other, economically and otherwise, you know, seeing that desperation as it manifests its itself. In many different contexts across many different disease states really drives my passion for expanding both innovation and access and looking for ways to innovate for access in the context of the innovator industry in which I now sit.

Thank you so

Naji Gehchan: much, Jamie, for sharing part of your story. Uh, let’s first, uh, talk about ACC access, right? You shared about accessibility and healthcare specifically. Can you share with us, how do you define this?

Jami Taylor: So, I define access, uh, pretty broadly. I use the term healthcare everywhere. I think healthcare really should be something that is integrated into every aspects of our lives.

Healthcare treatments within arms reach the ability to access physicians or train healthcare providers within a moment of need whenever that moment might arise. Thinking about healthcare very expansively and very ubiquitously helps us, I think, to set the mindset around access that we need to then drive innovation for access.

So if we

Naji Gehchan: take this into a global health setting, as was the panel, uh, discussion during the conference, uh, what are your thoughts, uh, as of today about ACC access accessibility in global

Jami Taylor: health setting? I think we remain in an urgent state where access falls far beneath the levels at which it should.

When we think about healthcare everywhere as a goal, as an ultimate aim, we fall far short of that. And I think obviously the recent pandemic laid bare many of those inequities, but those inequities. Are constant and I think we find too much satisfaction in the status quo. I, for example, find it completely unacceptable even when we’re able to scale old and toxic drugs and this sort of self-congratulation that accompanies that often on the part of, of, of companies in the industry.

It, it’s, Always important to scale. I mean every possible medication, but where we allow these sort of waiting games that I referenced prior and where we tolerate the absence of innovation, where unmet need is so clear and urgent. I just truly believe that there’s more that we can do and that sense of dissatisfaction is very much a driving force in, in my day-to-day work.

Naji Gehchan: So I love that you talked about dissatisfaction more we can do, and you really come from this, uh, place of, uh, urgency to ask, right? With the desperation that you shared. So can I double click on this and hear from you? What do you think we can do and we should do to improve accessibility?

Jami Taylor: Oh, absolutely.

Well, I mean, I could probably spend all day, you know, you know, a relative soapbox on this one, but I’ll just offer some perspectives just based on my own experience. One, it starts with the belief that we can do something about it. I know that’s many times, especially sitting in the pharmaceutical industry, we feel really almost straight jacketed by.

The systems in which we operate. There are legal frameworks, regulatory frameworks. There are just business models that in some ways have so deeply entrenched the status quo that I described, that it drives that sense of. Complacency around access to medicines. Uh, we’ve heard many times, at least in past years, even top leaders in the pharmaceutical industry accept that sort of bifurcation of responsibility that I mentioned, which I believe is a false dichotomy.

Innovation versus access with. Really generic industries responsible for access. I think we’re all responsible for access and frankly, I think we’re all responsible for innovation. And so driving an innovation for access MI mindset, grounded in that sense that we can do better. There’s, there are gaps that we can fill.

The status quo is not necessarily where we need to remain. I think there’s, I think it begins there. I feel very strongly that even. Where we feel like those deeply entrenched business models are, you know, sometimes insurmountable. There’s a role for advocacy and that can happen not only outside of our organization and the context of the policy and legal frameworks and regulatory frameworks that I mentioned, but it can happen in inside even large organizations and even small cap companies like where I sit, we can ad advocate for investment.

That has innovation and access as twin concepts and as pillars and priorities for how we allocate r and d dollars. We can advocate with our benefactors and shareholders for those who invest in our companies, we can push for an innovation for access mindset. And I’ve seen that kind of advocacy where it’s built upon, I think genuine intent.

And then of course, certain capabilities that can un unlock and realize a goal. I’ve seen that kind of advocacy really move mountains. Uh, early in my career, I worked with a group, kind of a ragtag group within Johnson and Johnson at the time. There was an attempt within j and j to turn around the pharmaceutical sector of the company, which wasn’t its high performing sector in the early two thousands.

And there was a huge profit margin imperative. A massive transformational INF innovation imperative, but less so at the time, an access imperative. And this was an observation that a few of my colleagues and I recognized. And so what we did was we created on our own an access and affordability team. It had three people, actually four, but one defected very quickly when he realized maybe this was radioactive from an internal political perspective.

But we, we began to really advocate around this idea of access and affordability and building into the priorities and the strategic, strategic pillars at a really critical time for the, for the company in this particular segment of the company. You know, at the looking back, it really was a risk in many ways, but in some ways we were seizing upon an opportunity of the moment where there was this appetite to shift a whole collection of innovators.

And it was a time when. Jansen, which is com comprises the pharmaceutical companies of Johnson and Johnson, was really begin to getting to brand itself and really understand itself as a single entity underneath the Johnson and Johnson umbrella. We seized upon, uh, a lonely asset that had been a development very quietly in our labs in Belgium for, uh, that appear to be very clearly effective against multi-drug resistant tuberculosis.

Certainly that would not be, uh, a sort of, Big win blockbuster by any stretch, but we were able to really craft a narrative thinking about the ad advocacy angle as entrepreneurs where we were able to elevate this M D R T B asset as a driver of business model innovation a means of. Reaching communities and driving new access models that could help support our, our aims in terms of global expansion across the company’s portfolio of products and where we could push and test these new models.

In what, what, because there was no real profit to be had. That where we could test these models in ways that would confer reputational, gain, help to build rapport within new markets or markets where we had a lower footprint and where we could, where we could develop relationships and new public-private partnerships with governments in ways that constituted its own sort of innovative model.

That kind of advocacy proved to be very, very powerful, and I’m proud to say. That despite lots of obstacles along the way and a huge amount of internal and external skepticism, because we believed it was possible because we brought a mindset that said, access and affordability is a priority, and innovation for access is a meaningful direction.

Even for a major company with all of its pressures from shareholders and other stakeholders, we were able to, at this point save many, many thousands of lives around the world to prove out and new treatment regimen for multi-drug resistant tuberculosis and potentially TB more broadly. And we were able to, uh, elevate what has now become from a three person team, what has now become many hundreds of people engaged in the formal work of global public health within that organization.

Naji Gehchan: Wow. Thank you so much, uh, Jamie for sharing this, and I love it. It’s a concrete example with impact, uh, that, that you’re sharing here and along with a lot of entrepreneurship that you know, I believe in. And obviously you’ve done it in, in large organizations, uh, and you talked about. I love how you framed it.

It’s belief innovation and access advocacy, and there’s the piece of access and affordability. So if I wanna double click on affordability, you know, especially in the poorest and most challenging places on earth, do you think cost is the only challenge? Or is, is it one challenge and there’s other pieces?

I’d love to get your perspective about how you think, uh, through affordability for the poorest spaces on earth.

Jami Taylor: One, I believe in models like the Global Fund to fight aids, TB, and malaria, where there’s. The opportunity to collect funds together in sort of a massive way even, and use that as a driver of effectively subsidizing costs for access as a priority for communities that otherwise could not afford innovative medicines or even generic medicines for that matter.

So there’s, there are models out there that I think offer us real guiding lights. But if, but as, as I’ll probably say through, through the course of this whole discussion, there’s more that we can do, right? We can never be satisfied as long as healthcare isn’t everywhere. And so to that end, one of the, one of the observations that I’ve made, you know, climbing mountains and Rwanda and, and trudging through, you know, banana plantations and Ecuador and really moving in lots of places in between.

Touring hosp TV hospitals in Chenai India. One observation has been this sense of absorptive capacity, where you have limited infrastructure. How can you bring some of our most sophisticated technologies to the market to really, uh, achieve the health health outcomes that you’re seeking everywhere. And that’s where that real innovation for access mindset can come in.

And where we can make palpable gains in that direction, we can obviate the need for heavy infrastructure for that so-called absorptive capacity. And one example is it comes from the company where I am right now, protagonist Therapeutics. It’s a moonshot company really taking areas of medicine or disease areas that are typically treated through heavy infrastructure treatment modalities.

Doctor’s, office based infusions, for example, of monoclonal antibody bio, large molecule biologic drugs. There are, um, diseases that are treated as first line with phlebotomy, for example. Where patients have to go in and have complic, it’s sometimes complicated procedures carried out, or even simple procedures are out of reach in some of these markets.

And so where you can look at those barriers and ask, how can we traverse those barriers through the power of technological innovation, harnessing a lot of human ingenuity along the way, that kind of creativity coming down to new drug formulations, new drugs that can. That can essentially displace and replace heavy infrastructure.

That’s the aim of the work that I’m engaged in right now. Really excited about the gains that we can make in that direction. Helping to solve for last mile problems and helping to keep some of these communities where. I mean even, uh, an an in reach healthcare clinic is out of reach. Putting ourselves in a position where we can scale medical therapy that can be used conveniently at home and preferably in pill form or even, or in long-acting injectable form or some way that keeps patients from having to go into, into experts to receive expensive medicines.

I think that innovation for access. Perspective and companies built around. It will really define the age of access, which I hope is very much upon us. So,

Naji Gehchan: Jamie, the, these are great example and really thanks for sharing what you’re doing daily, obviously to improve this, uh, this important, uh, issue we face, uh, since decades.

I, I wanna bring also this, you know, there’s the access piece. There is also a lot on the trust. Of the system, the trust of those companies. Um, everything around, you know, misinformation, miscommunication, which is becoming like even countries that can afford treatments. Unfortunately, we’re seeing people dying because they don’t believe in those treatments.

So I’d love to get your perspective, how you would, especially that you’ve gone through places, uh, that are underserved, uh, you know, countries where you have. Poor challenge to access. How do you see this fit in and how can we solve also this piece? Is it only about getting those drugs, for example, to this market or to this population?

Or is there more to be done also from, from a trust, from a communication standpoint, from any other aspect you, you think would be needed for us to solve this problem?

Jami Taylor: Naji, this is such a great question and I really appreciate it. It almost brings me to a very vulnerable place, reflecting upon the case study that I shared around M D R T B and the work that we did to bring Baklan now under the brand name curo to markets all across the world.

We really believed, I think, in our naivete that the moment we received F D A approval and were able to unlock that access to this drug, And given that, of course, that this was the first innovation in tuberculosis in more than 40 years, that there would be this organic outpouring of praise and celebration and uptake that we would be embraced as a company, that the drug would be embraced quickly across every community where it was needed, that we would have partners pouring out their own resources to, to support and shore up, and scale up all of that effort.

We were very surprised and frankly, at a personal level, I was very. I mean shocked and, and hurt at the time when we actually received quite a bit of criticism with the rollout of the drug. Much, much of that criticism looking back, was well placed. I mean, we struggled with the pricing model and attempted to be as innovative as possible and the pricing model around what we called equity-based tiered pricing.

But we did a really poor job of explaining the rationale there, and it almost looked like we were placing artificial limits on access. We’re trying to force a pricing model. Uh, in, in markets that where we hadn’t primed it, so to speak, we hadn’t done the work of patient intimacy in achieving that, that sort of deep listening to your customer to know all of the hurdles that they face, we were so engaged with the biology of the drug and, you know, understanding how it operated, you know, in that sort of physiological sense.

And so proud of that, that there was a lot of community engagement. That needed to happen pre-approval that we just didn’t even perceive as a requirement. And so when criticism came in, and I should say there it, there was that sort of organic that that slice of organic celebration, but there was also a fair amount of criticism in print and otherwise we took it very, very hard.

But in ways, in some ways, I’m glad that we did because. We taking that criticism so seriously, really prompt us, prompted us to reflect and reset and understand community engagement, stakeholder engagement at a whole new level. And from there, I think we were able to set a foundation for what would later become, as I mentioned, Johnson and Johnson Global Public Health set a foundation of intensive partnerships.

Intensive government engagement, intensive community engagement. We began to dispatch our teams into some of the most far flung areas of the world. We were camping with hippos in Uganda. We were touring hospitals, as I mentioned, TB hospitals throughout Southeast Asia. We were really beginning to understand the settings in which we were working.

Well beyond what our preclinical work in Petri dishes could indicate for us. And it takes both. It takes that scientific excellence, but also that stakeholder engagement excellence. And that’s really the lesson from that case study and certainly a lesson that informs so much of the work that I do today.

Naji Gehchan: That’s great. And really talking about this combination about science and underground, what people need in population. We’ve heard it several times during, during the discussion, uh, in the conference. W w with all that you’ve seen, you’re learning, you’re an expert in this field now. Uh, are you hopeful for the next decade that we will get there as a society?

Jami Taylor: I’m hugely hopeful. In fact, I’m, you know, with this sort of driving understanding that there’s so much more that we can do. I think that perspective helps to unlock a huge amount of optimism. On the research side, we’re seeing accelerating drivers of new research. New research timelines effectively where r and d can be compressed so that we’re not waiting 20 years for a drug to come to market, but rather through the strength of new regulatory pathways and certainly even new discovery modalities and lots of new tech being applied across the board.

I think we’re seeing our ability to move from bench to bedside. With a whole new, I mean, to use a term that’s become its own catchphrase, warp speed, and I want to see that, as I’m sure you do, and many in the audience here want to see that applied to the access space and the innovation for access space.

I think we’re seeing lots of other factors outside of healthcare proper that are coming into view, transportation and logistics, innovations that from drone delivery, for example, and, and so forth. Those innovations are helping us to traverse that last mile, which for many years just felt like was, it was such a firm barrier to access that we would never jump over it.

But by engaging some of those other actors in that space, we’re seeing some whole new ways of getting healthcare. Everywhere. We’re also seeing, uh, remote monitoring and telemedicine taking hold all across the world. I mean, even for some of the momentary quarterly earnings calls that suggest a decline in the usage thereof, maybe here in the US or other high income markets in in low and middle income markets, it is taking off like wildfire in ways that are very encouraging and hopefully we can continue to stoke that momentum.

We’re also seeing non-traditional actors, like I mentioned, like tech companies, seeing some of these longstanding gaps and creatively considering ways that they could help to fill those gaps in equity. And I think there are some powerful roles that some of those actors can play in ways that, uh, will emerge the benefit of, of everyone across the world.

I’m thrilled with the level of innovation that we’re seeing right now in diagnostics. I remember years ago listening to the president of Tanzania saying that the crippling aspect with of healthcare, the weakest link within their healthcare system there in Tanzania was lack of reliable and accurate diagnostics and access to diagnostics.

And here we’re seeing tests that are now reliable, accurate, and diffused. Everywhere and the power of some of those, those, those, the MedTech innovations that I mentioned to carry diagnostics forward at new levels across all kinds of disease areas. So absolutely thrilled about that. I think we’re seeing.

If not with the warming of the capital markets to this direction, we are seeing a lot of innovators jump into innovation for access. With access as an explicit priority for an innovation agenda among small cap players, your garage biotechs, some of your publicly traded biotechs, and I think we’re seeing large pharma really begin to set the tone.

I think. The industry is an entirely different place from a values point of view and how those values are expressed. When we think about, say, 1999, big pharma versus the large pharma actors today, and we see increasing evidence of this access imperative. All the time. And that advocacy within those organizations and outside of them can continue in ways that I think will really, truly bring us a new golden age of biomedical innovation, innovation for access, and will help to realize this vision of healthcare everywhere.

And when I say everywhere, I mean everywhere. I will shift

Naji Gehchan: gears now and give you words, and I would love your reaction to it. Okay, great. So the first one is leadership

purpose-driven.

Jami Taylor: Can you share, so a word, a word back, or

Naji Gehchan: I, I have to get Oh, yeah, you can, you can share more if you’d like. And, and I’m, especially when you talked about the values we have in biotech and in pharma, I think obviously leadership plays a big role on setting the tone and how you wanna drive this. So I’d love a little bit

Jami Taylor: more on this.

Oh, absolutely. Okay, good. Well, I’m glad you’re giving me more room too, to sort of opine. So, in leadership, I think there’s, there. Is something so powerful about that sort of fixed firm value system and how it evidences itself in every aspect of a of a, of a company or a movement. And I’ve seen that certainly in the case of Johnson and Johnson, where we were able to appeal to the fundamental credo values that hang on every wall in which are etched in stone at the company’s headquarters.

Think when it comes to leadership, there’s always something courageous about the best kind of leadership. And I mentioned early in our conversation all of these barriers that are deeply entrenched and systemic, right? I mean, where you’ve got, I. Uh, high regulatory bars to that, that dictate large timelines and large co or long timelines and large costs.

Takes a lot of courage to have a vision that’s often many years out. And to see that vision through many, uh, innovators today face, uh, lot of, uh, let’s just say heavy input. From investors, uh, the investors upon which they depend in order to carry out some of this, you know, more moonshot oriented work and sometimes, uh, whether it’s it, it’s shareholders of publicly traded company or early stage BC investors, what you find is that they can place pressure on you to adhere.

To the system as it stands and not to try to go against the grain in ways that, uh, potentially imbue more risk in the enterprise. And so leadership requires that courage and then that tenacity to see things through and to see a bigger vision through. And I think where the, where a vision can be expressed in ways that are deeply connected to values, then you can have the success of advocacy that we’ve discussed.

What about

Naji Gehchan: health equity?

Jami Taylor: I’m so glad we’re talking about health equity because, uh, years ago there really was almost wasn’t a place or a forum or even a, a, a phrase to really capture, uh, Inequality as it’s, it’s very clearly evidenced, uh, across either the healthcare access sphere, whether it’s in communities here in the US or, you know, certainly as those inequalities are present on a global basis.

And so simply the fact that we’re able to talk about health equity as this clear phrase and one that is familiar to probably everyone listening, I think it represents a leap forward in the dialogue that really governs the industry and where it should go. We talked about large cap pharma and MedTech companies, really setting the tone and leadership, setting the tone.

When I think about health equity today, I’m extremely encouraged and really enthusiastic over the number of CEOs that we see emphasizing health equity as a priority, and we see it not only in sort of you, I always worry about sort of glitzy social media posts or what I call the red carpet. The red carpeting of, you know, some of the, um, you know, some of the priorities that we’d like to see, you know, much more substantially connected to business models.

But we see health equity now connected to business models, and that’s evidenced in earnings call transcripts and, and. And the way organizations are being designed right now and the way leadership is being constructed across some of your largest healthcare players. And so I’m very enthusiastic about healthcare equity.

I’m, I’m extremely glad that it’s become such a familiar catchphrase and I believe that it is really is one that has teeth and will for the long term, and will be a driving force, you know, as it is a driving priority right now for many leaders of companies, large and small. Global justice. Okay. I love this word because it’s much more expansive than healthcare.

I love this phrase, global justice. I mean, we talked about some of the fundamental sort of framing tools that can help to give us the lens. That can situate a value system around healthcare access, and that can help to orient innovations and allocation of resources toward innovation for access. Global justice is almost even deeper than everything that we’ve talked about here and certainly much more expansive as a frame.

It suggests that there is something wrong with lack of access. To medicines and it does so, or it prompts us to consider that conclusion in ways that force self-reflection as across especially high income countries that are in many and, and markets and players that are in many ways responsible or at least partly responsible for injustice as it applies to healthcare.

And it’s, you know, in a world of a lot of moral relat, and I’ll certainly, you know, concede that everyone can have different views thinking about healthcare through a lens of global justice. I think it just hits deeper and it prompts us to think harder and it really raises that sense of urgency for moral reasons that I think cascade.

Across many different actors at many different levels within the healthcare ecosystem, and I hope that that justice lens can come more firmly fixed into the collection of lenses that we use to explore access to healthcare challenges going forward. I

Naji Gehchan: certainly, uh, deeply agree with you on, on this piece, and coming from a country where w we felt injustice, where even being in the US in a country where depending on the community or on you feel there is no justice and healthcare is delivered.

So it’s, it’s really, I think, a great point on how you’re framing it. The last word is spread love in organizations.

Jami Taylor: So Naji, I love this because in some ways it’s the thread. Looking back through our whole conversation. Yeah, that really opens, I would almost say doors, but I think that’s too modest. It really opens the floodgates to progress in this area. We talked about stakeholder engagement and patient intimacy. And I mean, I’m almost emotional reflecting on some of the moments where I’ve had the opportunity to sit down with patients who have multi-drug resistant tuberculosis, patients suffering from severe head and neck cancers and places like, like Uganda.

Without access to any kind of sophisticated care and the pain that they have to sit with is so powerful. And in those moments, sometimes it feels like love becomes its own medicinal force, but also this driver to bring. Medicines and tools and resources and expertise to really conquer these issues. It prompts us this sort of spread love approach prompts us to relieve suffering.

And I think that’s what love entails so much. And I think that’s the essence of compassion, which is the essence of access to healthcare, access to medicines. And I’m glad you reminded me of that today.

Naji Gehchan: Oh, thank you. Thank you, Jamie, for sharing those, um, those moments that you’ve lived a and I think we all have this, um, this responsibility as leaders in healthcare to ensure a better just word in in healthcare.

Any final words of wisdom for healthcare leaders around the world?

Jami Taylor: I really believe that we are on the cusp of this healthcare everywhere era. I believe that we are entering a whole new era of biomedical innovation that’s ed up by. All these different factors that I mentioned. Diffusion of diagnostics, the leaps forward, innovation in transportation and logistics. The entry into the space of new tech players and MO technology modalities that can infuse with our work, whether it be on the r and d side or the access side and everywhere in between to really accelerate our progress.

I think it really just takes a pre. Prioritization of innovation for access, with access as an explicit priority of the work we do to drive new medicines. Technologies, medical care approaches forward. And as we think about speed and scale, as has been many times discussed in the context of climate, as we think of speed and scale in the context of healthcare access, and as we take that bigger lens of global justice and the even.

Bigger lens that you’ve mentioned here of really love, compassion, and relief of suffering. There’s no stopping us. I really believe the sky’s the limit as an innovative community and as a community of leaders in the healthcare space today.

Naji Gehchan: Thank you so much, Jamie, for being with me today.

Jami Taylor: Oh, I was thrilled. Thank you so much, Naji. I really appreciate the opportunity. Thank you.

Naji Gehchan: Thank you all for listening to Spreadlove in Organizations podcast! More episodes summarizing the MIT Sloan Healthcare and BioInnovations Conference are available on spreadloveio.com or on your preferred streaming app. Follow “spreadlove in organizations” wherever you listen to podcasts and spread the word around you to inspire others and amplify this movement our World so desperately needs.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Enrique Conterno

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host today, excited to be joined by Enrique Conterno CEO of Fibrogen. 

A native of Peru, Enrique is a mechanical engineering with an MBA from Duke. He joined Eli Lilly in 1992 and spent the next two decades working in the U.S. and internationally across sales, marketing, finance, business development, and general management roles. Enrique became the President of Lilly Diabetes in 2009. In addition to those responsibilities, he took on the role of President of Lilly USA in January 2017 before retiring at the end of 2019 after 27 years of service with the company. I had the privilege and chance to work in Enrique’s teams, learn from his leadership, and grow in the culture he has created.

Enrique – I am so honored to have you with me today!

I would love to learn more about your personal journey? What is in between the line of the incredibly successful leader you are.

Enrique Conterno: Well, thank you very much. I appreciate the opportunity to have these chats with you and matching. Great. Great to see you again.

Naji Gehchan: Great to see you too. I would love Enrique to learn more about your personal story, your personal journey, what is in between those lines of this incredibly successful, uh, career and that either you are today.

Enrique Conterno: Thank you. I’m not sure exactly where to start, but probably I have to start when. I decided to, um, embark on the journey outside of Peru and pursue my education in the United States. At that time, I was a swimmer I think. And, uh, therefore I had the opportunity as a swimmer to get us a scholarship or scholarships in the U S but beyond that, I think.

Uh, what, uh, that, that was the start of something that I believe shaped me throughout my career, which is, um, we have to take chances, personal chances, certain risks. Uh, it was not easy at that time for me to leave Peru, but I decided to do so. Um, and I think throughout my career, I’ve taken a number of, um, personal risks and for the most part, um, I’m delighted that I took those chances.

Not every single one. Worked in the way that I was expecting them, but we do have to take, be thoughtful, take appropriate chances and, and, uh, And then adapt to changing circumstances. But, um, I think in between the lines, I, um, uh, we’re all, I think our product of our experiences, and I think that’s something that has really shaped me is basically taking chances, uh, thinking certain risks and then, uh, uh, manage in the, in the best way possible to produce excellent outcome.

Naji Gehchan: When you’re talking to Enrique about taking chances and tourists, obviously you said you took it personally. I know as a leader also, you’re taught a lot of risks and you gave people opportunities and chances. Uh, how do you, how do you do this? How have you managed to always build successful teams, lead them towards even bigger successes for the organization stats.

Enrique Conterno: Yeah, there’s no question that talent is at the very heart of successful organizations and creating diverse teams, I think is critical to do that. And, um, and I think I always reflect on. As we, uh, build teams and give people chances. And the opportunity to grow one has to reflect the, somebody took the chance on us to take larger responsibilities.

And in some cases, maybe for us to step up in position, the maybe we thought we were not ready to take on and we have to reflect on that as we basically provide opportunities for, uh, others. Um, At the end. I think there’s no formula when it comes to hiring people or building teams. But I do think there are a number of elements that we want us to look for in a culture that one wants to create.

Um, and we can speak a little more about that, but there’s no question that, uh, people and talent are at the very heart of, uh, continued success in, uh, organizations.

Naji Gehchan: Yeah, I would love, I would love to hear about those elements. I’ve, I’ve, you know, I’ve lived that. I think the country, you build a caring culture.

I, you know, I personally call it loving culture, but truly from this shared purpose, the strong values, and then leading your teams to where it’s exceptional execution, uh, to, to deliver on, uh, uh, on this chair and common purpose. I’d love to hear more about the elements you use shared. You shared those, but I’d love to hear more about.

Enrique Conterno: Sure. So, um, and you are absolutely right. I think it’s, um, it’s all about, um, I think centering on our common purpose and, uh, key values and what do we basically expect from all leaders or, uh, employees? Um, all of our colleagues in an organization. Uh, all of that I think is. Part of, uh, starting to create the culture, to the extent that one lives, those values, you start to create those, that culture.

Just try to, uh, uh, not just retain, but attract talent to the, to the organization now it’s, uh, clearly I think, um, there are, um, a number of other elements. Claim to that. Um, I’m a, I’m a huge believer in looking at a track record of success when building teams, uh, not just experiences, but really looking at the track records of, uh, individuals.

And, um, this sometimes can be misunderstood. Um, yes, we look for. The outcomes and outcomes are critical, but it’s also how people dealt in many cases with failures, I think, or, uh, with maybe a, uh, a hand that was not quite perfect. And well, what, what were the actions that the individual then the individual took to improve the situation to, to, uh, make the situation better?

Um, as we, uh, I think about that. I think, uh, we need to, um, and we build this culture and you call it a loving culture, um, a caring culture. Although I think all of that is true. I like to think of it as an empowering culture and you’re right. I think the leader in many cases, trying to serve to ensure that people can basically give, uh, Uh, the most, um, um, given their capabilities, the opportunity that they have.

I think all of that I think is very much true. Um, at the end of the day, I think, um, uh, empowerment needs to also come with accountable. And, um, I’m a big believer on, uh, marrying those two, uh, which is, uh, people need to be empowered, but at the end, I think that empowering needs to lead to increased accountability.

And hopefully the organization then works, I think, in a much better way, um, uh, so that everybody can contribute as long as the priorities and the purpose is clear. I think it’s, um, everything tends to work, um, much more effectively and efficiently.

Naji Gehchan: And thanks Enrique. And I know you’re passionate about DNI and you mentioned that try trick twisting at the first team, uh, while building this culture.

Uh, any, any advice, you know, as you are. Bringing those leaders. Uh, many times we, uh, we are faced with some of the inclusion challenges, and I remember something you always talked about remaining yourself, be yourself and continue to be yourself as you’re, uh, leading and, and in the organization. What, what, what do you do to make sure that people, as they join, uh, don’t change to be in the mall, but try to be themselves and being able to deliver to the expectations?

Enrique Conterno: Yeah, a discussion that I will, that I, uh, come, you know, often have, is that the responsibility of both the leaders in the organization, but also. The, um, the, the, uh, employees coming into the organization to ensure that we can build an inclusive culture. Um, It is through, we need to create that type of environment, a leader, but there’s also responsibility on the person coming in, um, to, in some cases to take that person arrest.

To always, um, uh, be able to speak out and quite frankly, not to just, uh, sort of, uh, come in and be just like your organization that are coming into the reason we, um, organizations can benefit so much from new blood, from fresh thinking from new talent, new hire. It’s because of the unique perspective that they bring from the outside.

What a period would it be that the second day coming into an organization that we lose that because they’re trying to fit in. And there’s no question that there is a bit of a compromise trying to fit in. And, but, um, to the extent that those individuals can be true to themselves, who they are, I think we have a best chance of the organization thriving and ensuring that the individual collective.

Uh, growth, uh, uh, benefits the entire organization. So yes, there is a responsibility of the leaders and there’s also a responsibility of the new hires to ensure that this culture can be built.

Naji Gehchan: Pivoting now to, uh, I, I know you, you know, you share it and you did it on leading in crisis even before, you know, if we want to talk about the current pandemic. Uh, but even before that, I read one of the articles you wrote about leading through moments of crisis. Uh, so can you share more about your learning experiences and did anything changed, uh, leading in this global crisis that we’re all

Enrique Conterno: living.

Yeah, I, um, my, uh, sense, I think when you’re living in a crisis, um, uh, one of, one of the key, um, it’s, it’s always, uh, critically important to remain true to your values. And do the purpose and to understand where the north star is for you and for the organization. Um, otherwise one can, uh, get lost, um, whether it’s a crisis or a.

A moment where you’re going to Sage is thriving. I think we have to recognize that there are, um, a few, I, I call it a few critical decisions each year that really shape, uh, the business, uh, outcomes, the people outcomes, the cultural outcomes of the organization and being thoughtful about those decisions, I think is critical.

Um, it’s um, A crisis, um, tends to, um, uh, challenge all of us because maybe it was, uh, an outcome we did not expect, uh, or an uncertainty that got resolved in an unfavorable way or personnel exiting the organization for other opportunities, whatever the crisis might be. I think it’s always good to remember the crisis.

So. Both, uh, opportunities in itself, it becomes reframed in the right way. So it could be a matter of, um, somebody succeeding. It’s the opportunity to, um, promote somebody. You maybe bring new talent in the organization and, uh, how, you know, how welcome we do that. Um, it’s, it may be a matter of refocusing that priority.

So the organization, or for us to think about, um, um, um, what those new priorities are at the end of the day, though, I think one critical thing throughout crisis. Uh, we all need to be grounded. What I call that reality. Of the ground, the real yet, and the relatives of the situation. I think it’s critically important as a leader that we can objectively assess the situation.

And at the end, uh, provide the direction for the business on the enterprise. Our people, um, sometimes in a crisis is one, one vents to maybe color how things might be. It’s just critically important that we don’t have those roads with rose-colored glasses and we’re able to tackle, I think the challenges.

Naji Gehchan: That’s great. You talked about being true to the values, right? To your personal values. You started with this, uh, around the common and shared purpose. Um, looking at it from an opportunity standpoint, are there things to do to refocus and then ending on a objective objectively, always assessing the situation?

The communication I imagine you mean in this is super important, right? Like giving hope, but at the same time being realistic to what we’re going through. Uh, is key,

Enrique Conterno: right? It is, I think, without being realistic, I think it’s, um, the changes not very lasting because. You lose credibility over time. Um, and at the end of the day, people can kind of objective, really assess what the situation is as well.

Um, so it is, uh, I think it is critically important than, uh, that the organization or the other days align and needs to be aligned on those. In, uh, a grounded view of what the realities are, uh, because I think then I think the priorities are better. Understood. Uh, demonization can be best aligned. And at the end of the thing, then I think, uh, um, that, that grace, a certain.

Um, build trust and trust is critical. I think, to be able to execute with agility and speed.

Naji Gehchan: Yeah, definitely. Uh, Enrique talked about failure. Uh, we, we, we, we look at you, we see huge successes all over even, uh, you know, we we’ve seen you in your, in the different leadership role that you had taking things and making them happen, right.

Like, Challenging pieces, giving again through a vision and taking all the organizations to amazing, huge successes. How do you do this? Like, and did you ha did you have some moments of doubt you started in the beginning saying sometimes you have to take jobs, even doubting that you can, even to them, what, like, do you have a story that you can tell us, uh, around this and how you manage to, uh, to build all that you’ve been building throughout the.

Enrique Conterno: Yeah, I, I, there are there, there are probably many that I can share, but I think we can start. I think, uh, you were mentioning, we both worked together in, uh, diabetes. You were, I recall when you were working in, in France and I really wanted to show that you could come to the U S. In, uh, and I was delighted that you were able to come in and so that we were able to work together.

But, um, uh, 1, 1, 1 piece, I think. Maybe people don’t realize is that those, those first few years in diabetes, while everybody looks a little bit diabetes today, and it’s an incredibly growing successful business, the first few years were challenging. Um, um, it, they were challenging because, um, we were having a number of setbacks.

We had, uh, uh, uh, we’re losing market share with some of our key products. Um, we, our pipeline was not where we wanted it to be. And we had some setbacks in our pipeline. And at the end of the day, I think we needed to. Take stock of really where we were at at that time and make some, um, some pretty big decisions.

Right. Um, um, all of that did not change overnight. Um, it was a matter of basically building, you know, starting, you know, uh, at one point in time, we entered into Alliance with Boehringer Ingelheim, um, with. That today, of course, highly successful. Um, but at that time there was, you know, um, those, those, uh, uh, products were, uh, promises, if you wish.

Um, we were trying to build, uh, GLP one pipeline. And, um, you know, we’ve had some, uh, also a challenging, uh, collaboration at that time, uh, with, uh, with another party. So all in all, I think it w we were looking at a business, the what challenge, but had potential. And if there was, uh, There was something that I can, um, maybe look back it’s I’m, I’m glad that we felt, you know, um, the, we were committed to our strategy and we allowed for the strategy to play out over time.

It took a little bit of. Patients, um, net, net and, um, vision was needed at that point in time, because I think for Lilly, uh, overall I think, uh, the situation was a challenge, but it was not just for diabetes. Um, but we saw the potential, um, while, um, we, we, we didn’t have what I’m going to call it the perfect plan or the perfect roadmap.

Um, we saw what were the key levers to try to.

We followed those I’ll be honest too. We had overtime, we had some good breaks and some people say we took advantage of them. That’s true. Uh, but some of the journey and some of these strategic initiatives took several years to develop anything from that collaboration with Boehringer Ingelheim that is highly successful in everything from developing the pipeline and the new products.

Uh, from, um, being much more cost efficient or, uh, our cost structure. Those were the, your projects. And over time, I think, um, we, uh, we were able to build that thing. Together with a great team, I think, um, um, a great organization, but it, it took time and I keep in mind that I was in that job for what is it?

Over 10 years. Um, so I had a chance to see the cycles of it. Um, and yeah, I’m, I’m, uh, very proud of what we built, but, uh, yeah, it’s. Everything else. It wasn’t all always roses. There were, you know, what’s a little bit of a rollercoaster in particular in the.

Naji Gehchan: Yeah, but it’s the, the millions of patients around the word help through, uh, what you’ve built and, and the value that your breath is just, is just immense.

Um, you, one of the things, you know, we always talk in strategy. Uh, and I’d love your take on this that you said you had to be patient, try to build this strategy. You believed in it. We all believed, believed in it, and then you have to be patient. And we here on the opposite side. So now being, uh, see, oh, um, in a, in a different company and in biotech, we hear a lot about agility, changing the gap, making sure that we understand what’s going on and change if needed.

Any, any thoughts about this when to change strategy and when not to change and be persistent on it?

Enrique Conterno: I think it’s, um, clearly the circumstances, um, um, the, the fine, what the strategies should be. Uh, the strategies should be able to overcome setbacks, but I think sometimes that’s easier said than done. And I, uh, Depending on, you know, the, uh, resources, the size of the company.

And, and so for some of his strategies might be more valuable than others. And I think we need to reassess and adjust the strategy as circumstances change. Right. Um, uh, you mentioned, um, I draw a lot from, um, some of the challenges when we’re building the diabetes business, as I think about five region where we are right now, uh, the fact that we have, um, yeah, we had a pretty significant setback, uh, when it comes to a complete response letter in the U S at the same time we’d been approved.

China Europe, Japan, uh, to be able to commercialize rocks, reduce that. Um, so to me, I think it’s, um, um, clearly, uh, uh, as I’ve mentioned, I, uh, drawing on all of those experiences and thinking about how do we ground ourselves in and the realities of the situation. How do we adjust our priorities? Uh, how do we basically think about greatest, significant value for our shareholders, their patients?

How do we keep our purpose, uh, in front of us? And, um, and once again, honestly, assessing where, where we are and, and, um, and what is it that we have to focus on right now? So, Uh, as leaders, I think, um, we have to keep in mind that all of these experiences serve to ground us, right. They give us confidence for the path ahead and the ability that we can have to be able to, uh, basically for job, a very successful future.

Naji Gehchan: Thanks Enrique. I would love to get your first reaction to a couple of words out. I will, I will be saying, uh, and the word, the first one is leadership. What would it be? The first,

Enrique Conterno: first thoughts on, on leadership is change agents. Um,

Bias for action and, uh, working doors, um, working towards, uh, outcomes, uh, aligning or, uh, organizations.

What

Naji Gehchan: about mentorship?

Enrique Conterno: Uh, And, um, and mentors should have been a bit different from sponsorship. Uh, but men mentorship is basically, um, providing, uh, the advice and, uh, they use sites. At the personal and professional level for, for talent to be, um, uh, you know, as successful as they can be and different from and sponsorship because sponsorship, in addition to all of that, I believe it also includes advocacy and a real action from the leader in terms of.

Um, you know, uh, taking a, had done, um, basically allowing for that individual to, uh, take additional jobs or, uh, responsibilities as they basically grow.

Naji Gehchan: And I know you’ve, uh, you believe in reverse mentorship, I think too, right at where it got it. Any thoughts on this too?

Enrique Conterno: All of us to make sure that we are truly at the other, they connect it to what’s going on and receive informal feedback. I’ve I’ve had reverse mentioned mentorship one-on-one and also multiple in one meeting, just being able to hear people. And I, um, to do that, I think curiosity is incredibly important, uh, and openness, the ability to really.

Um, uh, here and try to understand as opposed to try to justify. You know, uh, why sort of things are what they are. So that’s, that’s a thing, the, uh, the power of it, but, uh, mentorship is a, um, you said is, um, dual way street. And anytime one is mentoring somebody in the way that I mentioned one can be mentored as well.

One is open to that.

Naji Gehchan: Yeah. I totally agree. Um, vacation.

And I’m asking this because you wrote about it. Yeah. It’s um,

Enrique Conterno: I’m a big believer on, um, uh, working hard and playing hard as well. Um, uh, Uh, I believe all of us need to take that diamond space, you know, to refresh and replenish ourselves. And to do that. Sometimes we do have to disconnect from our daily work.

So, uh, uh, allowing for the space and time to be able to do that, I think it’s, um, critical. Um, so I’m, I’m a big believer in, uh, Ensuring that, um, that, uh, balances is going to be there. Sometimes people ask me to quantify what that balance should be, but I think that balance is very personal. It’s like people say, well, define for me with a work-life balance is how many hours I think it’s different for.

Different people. And each one of us needs to understand our own personal boundaries. And what is it that allows us to basically be as effective, you know, at work. Um, and we have to be self aware to be able to assess and evaluate that, right. Maybe somebody is able to work many more hours than somebody else and we need.

Naji Gehchan: We’ll be able to

Enrique Conterno: respect those, those boundaries and what we at the other day should look for is, um, what are the outcomes? Um, um, and how are the, uh, how, um, how effective is each one of us, uh, being in the positions that we have. So no hard rules, but, uh, finding that personal balance is incredibly important and the organization cannot find this balance for you.

You have to find it for yourself. Yeah,

Naji Gehchan: totally agree. And I think you shared it at the beginning. You’re a swimmer. I’m not sure if you. Uh, continued to spend, but I know for a while, that was also because I’m thinking about how every day, not only taking vacations, but even everyday how to disconnect, try to refresh our minds as leaders super important for not only us, but our teams, our families, uh, as I know, for, for a while, swimming was part of this for you, but definitely it’s important.

I imagine to disconnect daily, to.

Enrique Conterno: Yeah. I, I, I, I, uh, whether it’s swimmer swimming on a different exercise, I think it’s good to be, uh, active and, uh, and I’m pretty big believer for awhile was swimming every day. Um, Maybe between, uh, you know, when I was in my mid forties to my maybe early fifties, I was swimming every day and even competing in masters competition.

Uh, um, and I, uh, I got a lot from it. Um, but I wasn’t doing it just to be active, you know? And, um, but it’s, it’s fun, you know, because you can see your progress and you are getting in shape. Uh, so yeah, I need, it’s fine to compete. So I, I it’s, uh, I got a lot of satisfaction from that. I’m not swimming today, but I’m doing, uh, I do go to the gym at least four times a week.

Um, and I do spend about an hour. Um, so it’s, it’s, it’s something that I believe in that I think is critical. I think it’s as part of, at least my personal balance.

Naji Gehchan: Yeah, that’s, that’s great. And it’s great to hear because many times we have those idea. No, you cannot, you know, work, be successful, be have your family, your network, and then do also train.

But another amazing example, uh, your, your setting here, Andrew, uh, the last word I’d love your reaction is spread love and organizations.

Enrique Conterno: Yeah. It’s um, That’s, that’s probably an easier one, uh, from the, uh, questions, I think aside, um, as you work, I think in the organizations you, uh, closely with people and when you align on, on, on purpose and objectives and when you’re committed to, uh, to a cause or, uh, an objective.

You, you tend to spend a lot of time with, uh, with each one of our colleagues. And of course, as part of that, you, um, you develop a certain closeness and you, I think all of us care for the people that are all of our colleagues that are working with us, um, And I think though the way that I think about spreading to this is your quote spreading love through the organization is, um, is caring, truly caring for four people and demonstrating that in a number of different ways.

There, there are a number of, uh, maybe axioms or. Uh, truth that one has to abide one, uh, uh, abide by one of them is to really be, uh, completely truthful to people and not just for people to hear what they want to hear, but truly what they should be hearing. And I know that sometimes people say, well, that’s hard.

Love it is really not. It is just truly caring about the person. Why would you want to say some person that is not really helping them, uh, maybe make that interaction easier, but at the end, I think longer term, I think we’re not, uh, the person is not going to grow. So when it comes to, um, uh, spreading love or care, I think it starts with, uh, the intent having the right intent and, uh, having a transparent, honest relationship, uh, with, uh, uh, with, with your colleagues.

I think that’s the basis, uh, for that.

Naji Gehchan: I love it and I will definitely keep it in mind. It’s not tough love. It’s true love, which is definitely true. Any final word of wisdom for the leaders around the.

Enrique Conterno: No, thank you very much for, uh, you taking this initiative, uh, with this, uh, set of, uh, podcasts. Uh, it’s exciting to see you again, and, um, I’m glad that you’re doing well.

And once again, thank you for the opportunity to share some of these thoughts with you. Naji Gehchan: Uh, thank you. Thank you for being here and sharing a part of your story and amazing advice. And for this inspiring, genuine discussion.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Elsbeth Johnson

Naji Gehchan: Hello, leaders of the world. Welcome to “Spread Love in Organizations”, a podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this exciting episode from our new series focused on us as leaders. I’m joined by Professor Elsbeth Johnson, Senior Lecturer at MIT Sloan School of Management and an expert on leadership, strategy and change. The main focus for her research is on what leaders need to do to help their organizations execute strategy, or deliver long-term, strategic change, without the need for the leader’s ongoing, personal involvement. Prior to joining MIT, Elsbeth was taught leadership at London Business School and London School of Economics.

Prior to academia, Dr Johnson worked as an investment banker, a sell-side equity analyst, and a corporate strategist. She also spent three years as a special adviser to the first Blair Government in the UK.

As a consultant and executive educator, Elsbeth has worked with a range of companies, helping them develop their strategy and the capabilities and culture that will deliver it. I had the opportunity to be her student this year in the MIT EMBA program and couldn’t but ask her if she can share her wisdom and advice with all of you!

Elsbeth – I am thrilled to have you with me today!

I’m eager to hear more about your personal story from investment banking to politics to now a professor of leadership! What’s in between the lines of your journey?

Elsbeth Johnson: Um, so I, I mean, investment banking was very much where I started and actually I loved the city. So the city has kind of what we, it’s the UK equivalent of wall street.

Um, lots of smart people, all of whom worked really hard. I really felt at home in that environment, but I’d always been very interested in politics. So as a teenager, um, as a student I’ve been interested and involved in. And so it was a bug that I had to kind of give into, um, until I felt like I didn’t want to be a professional politician myself.

And so I worked on, um, the labor campaign in 97, which resulted in, you know, the largest labor landslide and since 1945, not that, that was personally done to me. Um, but, um, and then I joined the labor goes or I left the city. Joined the government as a special advisor, uh, worked in three different departments of state.

Uh what’s on another two election campaigns. So it was very, very enjoyable. But what I, I guess I realized was there was quite a few things I missed from the private sector. Um, and there was quite a few things that I didn’t necessarily like about, um, doing politics. Professionally kind of for living. Um, but I guess if, if I looked at the red thread that linked.

Banking and particularly the kind of the kind of work that I did in banking. So corporate strategy, corporate finance, structure, finance, um, thinking about businesses and, and why they make money. I mean, that’s basically, you know, uh, sell-side actually almost essentially a well-paid financial journalist in many ways.

Um, and the sort of work I did in politics and the sort of work I’ve done since then. I mean, basically it’s thinking about. Two things it’s thinking about strategy. Um, you know what what’s, what’s not just the best way to do this, but what’s the right thing to do. And secondly, then once you’ve settled on what, what you’re going to do is what are the activities that leaders need to focus on in order to get that work done in the most effective way.

And so essentially, I mean, that’s that, I suppose to the extent that there is a red thread,

Naji Gehchan: Awesome. You touched it on, you know, this, um, this thread, uh, with your life or the decisions that you’ve made. And I know in, uh, in the very first course touch, we had video and the discussions we talked about, uh, you know, the green circle, blue circle, if you can touch it maybe before you say, but what I would love to hear from you is your, your personal green circle.

If I may, what is your personal purpose? I know you make us work a lot around this, so I’d love to hear that.

Elsbeth Johnson: So that’s a really good question. And, um, and it’s not the first time I’ve been asked this question and every time I’m asked it, I think, wow. I’m not sure my answer is very good. I’m not sure. My answer is probably as good as yours now is when, when not given, I asked you this question in class.

So I think, I think about the purpose of why, why I continue to do what I do with, particularly with clients, because I could just either teach all the time or retire or. I think what I really like doing is finding, and I think about, you know, the businesses with whom I work these days and the leaders with whom I work.

I guess what I really liked doing is finding and helping people find the work that they most love. Um, because an awful lot of people, um, you know, I, I don’t think spend enough time really focusing on the work that they really love to do. Um, you know, that a lot of people are very good at lots of things, right?

So they’ve, they, they’re in a spoiled position of, of having lots of options open to them. But if they were to focus on the work they really love doing, I think, I think that’s particularly interesting. I have to say, I think the most effective leaders out there are the ones who really want to lead rather than simply be senior in an organization leading and being senior are two very different things.

Um, the reason you, you do those things are very different, right? Um, so if all of our leaders are just the people who are obsessed with gaining and retaining positional power, then I suspect we’ll end up with leaders who are. It’s as good as the ones we, we could end up with. If we, if we really focused on getting people who really wanted to lead.

And so one of the things I really enjoy about my, my work outside of teaching outside of MIT is I get to spend time with people, both who are already like. But also people who are maybe one or two below C-suite who are thinking about, do I want to be on at the C level? Do I want to be a leader and really kind of helping, you know, finding the ones who really want to lead as opposed to simply be senior and then helping them get that is, is just incredibly real.

Naji Gehchan: I love where the discussion is going. Uh, you, uh, you know, I, I always say life is too short. , life’s too short. And I know sometimes it’s hard. It’s easier to say that into, but it’s just incredible when your personal, why isn’t total coherence with what you’re doing. I just think good morning. This is where I think magic starts.

Elsbeth Johnson: Yeah, absolutely. I mean, I’m not sure that I’m, I’m always as disciplined. Like I really need to read my own slides a bit more than I do. Right. I’m not sure. I’m always as disciplined as. Could be about the Y I mean, you know, I really have no excuse to not focus on, um, you know, the stuff that I really enjoy and the stuff that I think has most value, um, because I’m in a privileged position of not, you know, not needing to work.

And so I have no excuse not to be doing the absolute, um, You know, most value adding work or most enjoyable work. And yet, you know, there’s still days when I just think, oh, why did I agree to this? You know, we’re all, you know, we’re all we all, we all, sometimes aren’t quite as focused as we ought to be. Um, but it’s the 80 20 rule.

As long as you’re doing it. Most of the.

Naji Gehchan: Exactly. As long as work is not more than, you know, 20% not liking a trap. We all have our jobs, things we do with sort of the people at that 20%. I do the same rule when you were talking about leaders, right? Is senior execs, C-suite leaders, younger managers, leaders that you have.

Is there a, what is for you the most important trait? For the leaders of the 21st century. If there’s one thing I know we discussed of different topics in class, taught us a lot about this, but for you, what is the most important one to have?

Elsbeth Johnson: So for me, and you’re right, there’s lots of traits that we know from empirical research or really.

But for me, and this probably says something about my own value set and upbringing. I am always looking for a combination of two things. One is high capability, and I guess what I mean by that is really high capability. Uh, really clever, very applied high capability with low. Now I have one or two clients who in my mind personify exactly that combination of high capability and low ego, and they are just a treat to work.

But I think if we can get more leaders who are in that combination, I just think regardless of the culture of the organization, that’s always a great combination because what that enables that, that what that combination enables is obviously high capability, right? People are smart. They’re able to get stuff done.

They’ve got a lot of processing power, but low ego means that they, they put the work, they put the business. They put their clients, they put each other, they put the people, the next generation of leaders before themselves or before their own. Need for validation or, um, or promotion. And, and I do think that’s important.

I think, you know, history is replete with examples of when, if an individual or a collection of individuals put the greater good, the quality of the cause ahead of their own need to, um, to benefit then. Chances are higher, that good things will happen. Um, I mean, as someone once said and forgive me, I can’t remember who this was, but it’s amazing what a mate, it’s amazing what good things you can do if you no longer care about who gets the credit.

And that’s kind of what I mean by, by low ego that they put the work and they put other people ahead of their own need for validation or.

Naji Gehchan: And do you think if I followed a double pick on this, do you think those are skills that can be developed? That can be COVID right.

Elsbeth Johnson: So, I mean, what, what psychology would tell us is that, um, you know, I mean that capable of both capability and low ego are a combination of, um, How we’re brought up and a little bit of nature, um, particularly capabilities.

Some of this, some of these intellectual or, um, cognitive skills are, are to some extent inherited. Uh, but our environment, particularly our young, early age environment is very, very important. I think, I think the low ego stuff is largely around how. What we, um, what we come to value and also, um, what our organizations value.

So, you know, I, I grew up on an island, um, where most people knew each other, a lot of people were related to each other. It didn’t matter if you were really, really clever. This island did not suffer tall poppies. So, so, um, you know, like you, you had to get on with everybody because you know, when, if the blizzard came and you needed somebody, hell you better have not been a joke to them at any point in the previous three years because people are on an island have long memories.

Right. So I think to your point about, is it, how, how do you, how do you get this combination of high capability, low ego? I think some of them. It’s nature, some of it’s nurture, but I also think it’s what we’re brought up to value. And so, you know, I’m, I’m pretty allergic to high egos because I grew up on an, in a, in a world, literally an island where hikers, just one tolerated, you know?

Um, so, so I think our own sensitivities to these things are, are largely a product of our value set. However that that’s been.

Naji Gehchan: You, you, you, you talked also, you know, we talked here about the traits of leaders. Um, you talked about you in your book. I, I have to, uh, relate to it and honestly the, the strategic leading strategic change and the framework that you, uh, that you give and, uh, and step up and step up that book is really amazing.

And you’ve touched on something that is called meaningful autonomy. So I’d love to hear about it. But before that, Why I’m talking about the book, because you summarize it in one sentence at the end of the class, and you talked about it, uh, just in the introduction here, you said something I would always remember is that the most essential Java either is to create more leaders.

So that, that is so powerful. And I think it clinks into the skill ego and how you care about your people, how you bring you sat in the beginning of the next generation. So a little bit more about the

Elsbeth Johnson: office. Well, let me, let me explain a little bit more on that. Talk about, um, meaningful autonomy. But, but I, I do think, I mean, this was, um, Mary Follett who’ve, um, originally came up with this idea that, or the statement that, you know, that the primary job of leaders is to create the next generation of leaders.

Now you obviously at one point or in one way, as a leader, you use your positional power to create the next generation of leaders just by promoting. Choosing a pipeline of successes and deciding who’s going to get the top job. I think the problem though, is that that either creates a vicious or a virtuous circle.

If the existing set of leaders are all, um, highly ego, um, you know, value certain things. What we know about human psychology it’s called the affinity bias is that people will choose. Um, they will essentially self-replicate, they will choose successes who look and smell like them. And so the real risk or danger is that if you’ve got an existing set of perhaps quite high ego leaders, is chances are that, that for, for a set, for a set of reasons, including that people self-replicate, but also that the candidates for leadership will look up above them and the low ego ones will go.

Oh, well, there’s no point in me trying to be a leader around here because when I look up above me, the only people who are in positions of power are high, he goes, so either I need to change and stop being low ego, or I need to go somewhere else and try and be a leader where my low ego tendencies are, are not going to be punished.

So the cell replication that we very often see in organizations around leadership and who gets promoted typically means. It’s quite hard to break the vicious circle of high ego leaders. But assuming that you can then, then yeah, your, your job as a leader is, is, is to create this next generation who can understand what good leadership looks like.

Who’ve been taught and coached about how to do it well. Um, because, because then it becomes, you know, you just cascade that down. So.

Naji Gehchan: Before you jump, make it to the autonomy piece, because it’s a very important one. You talked about affinity bias, self replication. Um, and I want to extend that even more.

It’s something I constantly have in my mind, try this. At some point, I remember very early in my career, someone told me, usually we recruit our clones, which I hate, you know what I think about it. Yeah. Especially when we think about diversity equity inclusion, right? So. Yeah. So this circle that we need to break on high ego, it’s the same that we need to break on.

Man. Women do diversity ethnicities. How do you consciously and intentionally look into those unconscious biases and every recruitment I make with the teams and the things specific you’ve seen and been successful on breaking this vicious circle last week.

Elsbeth Johnson: Well, I think two things. Um, I think first of all, getting as many people involved in the recruitment and promotion process as possible, um, if you like that, that’s not to reduce any individual affinity bias that any individual leader brings.

That brings to the table, but all it does is create a portfolio of hopefully different affinity biases, assuming that, you know, not all of your leaders are white, straight able-bodied men. In other words, assuming that there is some, both cognitive and social diversity amongst your leadership population.

If there isn’t, then you need to be looking outside for some help on that. Um, from, you know, recruitment consultants or, or head hunters to really force you to look at candidates who you, whom left to your own devices, you wouldn’t think of as plausible candidates. So that’s the first thing is to broaden the portfolio of afinity biases as to say, as individuals, we all have these biases because we’re human the best, almost the best we can hope.

Is that we, you know, if you and I are both recruiting somebody, you’ve got a different set of pharmacy biases for me, and therefore, you know, yours, yours will challenge mine and vice versa. So that’s the first thing. The second thing to say is that the process of recruitment. Um, has to be very carefully structured and managed.

So, um, you know, it frightens me, but it’s true that there are still some organizations in the world who don’t even use structured interviews, that they, they just kind of bring someone in for a chat or they meet over coffee or they recruit out of their network. And what we know about all of those sources of, uh, of candidates is because our networks will, will sell.

Um, there’ll be, and when we just chat with someone, we are essentially trying to work out, we’re trying to discern social fit. In other words, oh, look, we went to the same school or we, you know, we both play golf at the same club or we both, you know, do the same running track. Um, so it, it. So human beings are incredibly, um, almost invisibly skilled at sniffing out social fit.

And so if you just quote, unquote, have a chat with someone, um, actually you will be doing a terrible job, recruiting them or interviewing them. You’ll be doing a great job working. That whether you could be friends with them. Um, but so, so at the very least what what people need to do is have structured interviews.

In other words, you know, if I’ve got six candidates, I basically asked them the same question, hopefully in a sufficiently conversational way. So I don’t sound like a robot, but, but I am asking them the same set of questions. I can form my, um, my assessment of them across, but even more than that, we should be going beyond interview because most care human beings are actually very good at impression managing.

And so, you know, if, if you asked me to give you an example of where I’ve been really collaborative in the past, guess what. Semiotic human being. And I’ll probably come up with a couple of really plausible sounding examples of me being super collaborative and you’ll be thinking, oh, wow, she’s amazingly collaborative.

Actually I might not be, I might just be impression managing. So a much better way to test that is not in an interview scenario or setting at all, but actually in an experiential setting where you put me in a, in a group of other people, perhaps under some stressful conditions and you watch and see whether I can collaborate rather than ask and, and listen to me, tell you and quite possibly.

You know, fabricate some of my, um, collaborative tendencies. So I think there’s lots of ways we can get smarter about how we recruit now, the problem with all of the things that I’ve just talked about is they take longer and they are more expensive ways of recruiting. And so for those of us who, perhaps for organizations that don’t have that much time on or enough budget, it’s it’s, um, it can feel like.

Um, it can feel easy and free to compromise on our recruitment process. Whereas actually compromising on our recruitment process is one of the most expensive mistakes that organization can make.

Naji Gehchan: Definitely thank you for that. Going back. I want to go to this, these two words, uh, about meaningful autonomy and bed to talk about because.

Many people, some people would be afraid of the word autonomy. Some others would be excited about it, but I love how you framed it, which is meaningful. But me, what I have thoughts about this and for us as leaders, uh, how to get to that. Really good position where our people can, can be meaning fully

Elsbeth Johnson: autonomous.

Yeah. So the reason that I call it meaningful autonomy is because in my research, so my research is in inductive research, which means I go and watch and ask people, um, you know, very open-ended questions. Um, a lot of it done, um, by watching and observing. So ethnographic research. What is it that makes your autonomy meaningful or sorry?

What, what, what is it that, that, um, sorry, what, what is it that means that you don’t have to go and ask your leader for input or support or. And, um, a number of my informants, um, said, oh, well, in other words, what you’re really asking me is what makes my autonomy meaningful. And that’s the critical point that, that this, this, these words actually came not out of my mouth or my head, but out of the mounds of my informants.

And so that became a really interesting research question. Um, and it turns out there’s two things that really help someone come to work and access. The autonomy, the decision rights that they have technically been given. Um, but, but, but that where they feel that they can actually exercise these rights without having to escalate and go back to their leader and say, help me, or referee between these two options or tell me what I should do.

So the two things are when the autonomy, when the exercise of the autonomy is. Uh, in other words, they’ve got enough resources. Um, they’ve got enough time, uh, the scope isn’t stupid, um, or too great. Um, so in other words, lots of structural elements, all of the structural elements are in place to enable the, the, them to exercise their autonomy.

But then beyond the structural element, there’s almost a psychological element, which is that it is not. Possible, but also pleasant. Um, but they’re comfortable in exercising their autonomy. They don’t feel like they are having to go out on a limb or take on unnecessary risk. Um, and the elements that really help them.

Um, oh, when the leader has really put really signaled in every possible way that they can, what they want and, um, and back that up. So not only been clear about what they want, but also align the organization and been consistent in that, um, Uh, a period of time. That means that people don’t have to second guess, you know, well, you know, you say that you want this, but that’s not what I see you role model, and it’s not what you measure.

And, and by the way, that’s not how you know, it’s not all my OKR is contained. So, so all of a sudden, if you’re sending me in congruent, I’m having to second, guess what you really want me to do. And the critical thing there is that good employees who want to come to work and do their best. They do not want in congruent inconsistent leaders because that does not help them.

The Corolla is also. That your, that you’re less good employees who kind of wants to come to work and have a slightly easier time or not do amazing work. They upset you love it when leaders are inconsistent or in congruent, because it gets, gives them a get out of jail card. They can come to you at their performance appraisal and say so sure, I know you said you wanted me to do this.

You haven’t brought it in my job description, but I don’t see you role model and it’s not. You’re going to reward me and it’s not even what we measure. So you can’t possibly hold me accountable for the thing that you asked me to do. So that’s really what we mean by, um, by meaningful autonomy. And I guess the most interesting thing about, um, or, or almost counterintuitive thing about this idea is that autonomy needs to be constrained albeit in certain ways, in order to become meaningful.

Now this can feel a little bit paradoxical. First time I say that, right? What do you mean constrained autonomy. It’s almost an oxymoron. Actually. It isn’t unconstrained. Autonomy is. Actually frightening for your best employees because they, they actually really do need to know. And have you signaled consistently what you want?

Unconstrained autonomy is Nirvana for your back for your worst employees, because they just they’re rubbing their hands with glee. At that point, they, they get to do exactly what they want. They get to spend shareholder money doing whatever they fancy their hobbies. So unconstrained autonomy is fabulous for them, but this idea of constrained autonomy, it’s the constraints, the clarity and level of prescription that leaders give in the constraint that sets up that frees up, that they’re the people who report to them to really shine.

In delivering what the leaders have asked for. And so the, the, the quality of the autonomy experienced by managers is directly proportionate to the quality of, of prescription and the clarity of that prescription, uh, given to managers by leaders.

Naji Gehchan: That’s amazing. I’m not gonna detail. You know, things in

focus consistency. We’ve got to talk about these also a little bit more, but really the framework is super helpful. I’m going to jump into the section that is a little bit different. So I’m going to give you one word and I’d love to have your first reaction to it. And yeah, you can, will discuss a little bit about it.

So the first one is authentic leader.

Elsbeth Johnson: Um, and do you want a one word response or just, just my response

Naji Gehchan: and response. I’m going to be one. We’re going to be a fellow first thing in mind.

Elsbeth Johnson: So I guess my one word response would be misunderstood. Um, I know for a lot of people, I think certainly a lot of the leaders that I work with, they, they hear the words authentic leader.

And they, they, they misunderstand it in one of two ways. They either think, okay, in order to be authentic, I just show up as myself. You know, I just kind of vomit myself into the room, like a human hand grenade and, you know, whatever I’m kind of, you know, however I show up, that’s just my authentic self. So like, what else can I do in otherwise it’s relatively uncontrolled.

And that’s a huge mistake, obviously, because. As long as we have an obligation to manage ourselves for the benefit of, you know, our people, our organization. So, so that’s the first way in which I think a lot of leaders misunderstand authentic leadership and the requirements that it puts on them. I think the second way that leader is very often misunderstand, authentic leadership.

That they something in my experience, they don’t always realize that that who you are changes over time. Um, now I think that, that sounds really obvious when I say it, but you know, we very, again, part of the human condition, another, another cognitive misconception is that we very often. Underestimate the extent of the changes that will undergo as human beings over the longterm.

We typically overestimate how much we can get done in the short-term, but we underestimate how much we can do and how, how, how much we can change over the long-term I’m talking decades rather than months or years. And so I think as a result of that, we very often think, well, you know, in 20 years time, I’ll basically just be the same person, whereas actually, Johnson’s all that’s not true.

Um, but more than that, if you think you’re, you’re not really gonna change that much or that you don’t think you could change that much, you might be missing some opportunities that you could be looking for in your career. And I think that’s a real shame. So I think that will be my reaction. It’s it’s very often a misunderstood.

Naji Gehchan: Yeah. And then you talked to, I remember you talked also about the different sounds try. It’s like in different places situation. So it’s really every day how we change over time. Right. The second word would be focused.

Elsbeth Johnson: Well, I mean, focus for me is the thing, it’s the secret. I’m going to say secret sauce, because that makes it sound like it’s kind of some secret recipe. Focus is for me, the thing that explains whether some strategies get implemented and some leaders make it versus other strategies that actually probably intellectually were equally good strategies, but they didn’t get implemented.

Um, focus is the thing that, that means that we, it requires choice. It requires deliberate choice to do certain things. We’ll spend time on certain things or invest in certain things and not others. And I think, I suspect we are much worse at this as human beings than we have ever been, because I think a lot of people they’re so used to.

No doing without in their lives, at least, you know, in the first world, right. You go on Amazon and you can have whatever you want. Um, you know, things are. Uh, available. Um, I mean, they’re not currently available in my country because we’ve managed to cut our own supply chain. Cause we’ve just, you know, left a 40 year trading arrangement unilaterally.

But, but assuming you, you don’t live in an irrational country that, you know, commit economic suicide, um, you know, things are available and, and I don’t think people have. Choose the often, but actually that’s a complete misconception because the most important things in life, like time for example, is completely finite.

So back to your point earlier, you know, life’s too short. I mean, that’s a classic example of the AFR. Uh, a series of choices. We only have so many hours in the day and so many days in our lives, so we have to choose how to spend them well. And, and, and focus is, is really the thing that focuses, what results from your, the choices that you make.

So the fact that Mo that an awful lot of people and organizations like focus, I think is basically because people just don’t want to.

Naji Gehchan: I love this frame, a bit of red choices, you know, and many times we see here discussing with leaders and organizations, right? The list of priorities that keep on moving and changing.

So I’m more, I’m more just talking about like, what are the choices, what are the two, three things that you want to do and be great at, right. And it’s, yeah, it’s tough to choose. And so what we need to do for able

Elsbeth Johnson: to be. But I would add to that, that I think the other problem is that, you know, an awful lot of organizations will run a strategic planning process, almost like an event, you know, um, once a year or once every two years, an ounce of that may actually come some pretty clear choices.

But the problem is that over time the clarity gets corrupted, um, because they add in, you know, so-called additional priorities. Um, and so one of the things that I, uh, I wouldn’t say force. Cause I mean, you know, I can’t quite force my clients to do things, but one of the things I very strongly advise my clients to do is that for every additional priority that they say they want, they have to take something off the list.

So the total amount of what. It doesn’t increase. And therefore the total amount of bandwidth that is being sucked up doesn’t isn’t eroded and therefore employees continue to have the slack that they need to stand back and think and reflect and learn about the work rather than just do the work. It’s what I call in the book, the tea party test, um, this idea that, you know, the total amount of.

Well in the tea parties, case legislation, doesn’t sort of passively accumulate over time. It’s exactly the same with work and organizations. You, if by all means, choose on alternative or another priority, but you can’t do that at the expense of the overall, um, you know, amount of work that’s on. So, so if something’s going to be added to the list, something else that was already on the list needs to be taken off it.

And it’s actually, by the way, amazing. When you say to people, okay. If you want that additional thing, that means you can’t have one of the things that you said was really important. It’s amazing how that focuses minds. Um, and an awful lot of people go, oh, okay. Well, in that case, I don’t really make that.

Naji Gehchan: And did the dude, did you find, uh, a good cutoff cycle to force leadership to go through the exercise and take, if you add something you, you take on something else or because you know, one of the things I’m always amazed by how organically things boil up and after like three months of clarity, if you don’t keep on having the same.

Discipline. Right. And coming back and making sure that it’s really focused on two, three things, organically things grow, right? Like it’s, it’s, it’s always the case,

Elsbeth Johnson: such a good point. And it, it that’s that organic growth is essentially the thing that you’re trying to, uh, I mean, a bit like a Gardner is always trying to kind of keep the wildness at bay.

Right. Um, so one of the things that we always encourage is, uh, Sure leaders to kind of take a cold, hard look at themselves in terms of, you know, are they, are they helping create and protect slack for their managers? But we also, um, encourage managers to give leaders feedback on exactly that point. When we have a set of diagnostics that we run in these organizations to say to test things like how much bandwidth has been taken up, um, to what extent is your leader giving you additional priorities that, that, um, that suck up the time that you previously had as slack.

And, um, and if we get a signal that, that that’s becoming a problem, then that’s the kind of red flashing warning light that says to leaders that they probably need to go back and, and prune the activity.

Naji Gehchan: The last word above the reaction is spread love and organizations. What’s your reaction to this?

Elsbeth Johnson: I mean, I suppose, I mean, obviously this, it, this is the total of your organization and, and, and it perfectly encapsulates the ambition of the organization. Um, part of me just feels really sad that we even have to say this and spell it out because I mean, I mean, I love the word love.

I mean, I love how, how kind of, um, Because I’m sure in some jurisdictions that that must feel a little bit edgy to people, but, but I just feel like what would be the alternative, what spread hate, um, you know, spread antagonism. Um, so I just feel almost kind of, I almost feel sad that we even have to have to for this to be the invocation, um, because you know, the, the most effective leaders, um, are the ones who.

I mean, they might not describe it as spreading love, but they’re certainly spreading, um, you know, respect, um, you know, they’re spreading the talent, they’re sharing their skills, that teaching people that, as we said earlier, that bringing on that next generation of leaders. So. For me, um, I feel kind of sad that we even have to ask for this to be done in this explicit way.

Um, but I just think that’s a pretty damning indictment of about what, you know, what that says about the leaders who get promoted and a lot of the organizations that we see

Naji Gehchan: any final words of wisdom for all of you. There’s this thing there, the word.

Elsbeth Johnson: I think I would say two things. I think the first is, excuse me, and this might not be a word of wisdom. And just the kind of word of warning is that very often in organizations, we confuse confidence with competence. Um, in other words, the people who walk into our office and you know, are incredibly eloquent and, you know, sell us on an idea.

Um, Yeah, it’s perfectly possible that they are incredibly passionate and competent and their idea is the best thing that they’ve ever worked on. It’s also possible that they’re just incredibly. That they came through, you know, a private school, Ivy league education, and they’ve acquired the trappings of confidence and it has got absolutely nothing to do with confidence because the really dangerous thing for organizations is these things are not necessarily.

They’re not perfectly negatively correlated either, but, but, but when we conflate them and think that when we see confidence, it must mean that there is competence. That’s a very dangerous assumption. So I think that’s the first word of warning. The second thing I would say to all of those leaders who are out there thinking, Hmm, I’m not really sure that I want.

Like it feels a bit icky. Um, uh, and there might be some people that are particularly, um, particularly women, I think have, uh, have, uh, a bit less of a natural inclination to seek positions of power. Um, I think I would, I would just remind people that unlike every other type of power, social power, Uh, you know, the power of, um, networks or, or, or, um, or authority, um, positional power is a zero sum game.

And what I mean by that is if you have, if, if, if you and I are both going for the, for the top job and you get it, it means that I haven’t got it. So let’s make sure that the organizations that we’re putting. Give the positional power to the people who are most worthy of holding it and exercising it and using it for good, because if all of the good people who would use positional power, well, if they all take themselves out of the game and say, oh, no, no, no, no, no, I don’t want positional power.

No, no, no. I don’t want power of. Then the only people, the only candidates for positional power positions will be the people who just want to be senior rather than those who really want to lead and lead for the best. So I think that would be the final thing. I’d say, make sure that, that if, if you want to lead for the best reasons, make sure that you’re working out how to get your hands on positional power, because it is a zero-sum.

Naji Gehchan: Thank you so much, Elizabeth, for such amazing discussion, the great tips that you gave us to be better leaders and go use all that we can do for us to change the world for the greater purpose.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Dries Hens

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

This episode is very special! In partnership with ESCP Business School, I’ll be giving the mic to students, our leaders of tomorrow, to discuss with incredible healthcare executives about their journeys and leadership beliefs.

Hello, I am a specialized master’s student at ESCP Business School in Paris and I am honored to host Dries Hens in collaboration with Spread Love in Organizations, who is in a mission to transform healthcare, continuously improving patient outcomes with previously unavailable insights.

Dries Hens is a medical doctor and a successful entrepreneur. Dries knew he did not want to go toward clinical practice, but still wanted to remain in the field. He wanted to do more in healthcare, by making the most of all the unexploited data. In parallel to his studies, he began to set up his company: LynxCare Clinical informatic. Dries is currently Co-Founder, Chief Business & Medical officer. Actually, Lynxcare transforms medical data into insights for hospitals, physicians and patients.

“Hospital system is on an edge: today we have a lot of relevant data, almost everything is picked up but the next challenge is: what are we going to do with it?”

Dries Hens: Thank you. By the way.

ESCP Student: Thank you. Uh, you have a once month that you wanted to do more and have cared and being an ethical doctor, and you wanted to do something that would have an impact. Can you tell us why you have this vision and how that assimilated to the thing beyond medicine?

I would love to hear about that.

Dries Hens: Yeah. So, uh, it’s uh, of course a long story, but, um, in terms of impact, of course, I have to say that that medical doctors really working in hospitals have the real impact of treating patients, but, um, After med school. So I studied, uh, like energy medicine. I did it in Belgium.

Uh, after seven years of med school, you have two choices or you going to specialize, for example, in orthopedic surgery, or you become a general practitioner, um, But for me at that time, uh, I prefer to dirt option because I was really intrigued by the health care ecosystem as a whole. And that’s why after med school, I started to, um, yeah, doing biopharmaceutical management and yeah, fire this program, I learned really how the whole healthcare ecosystem works from life science companies to hospitals to insure Speyers.

Dries: Uh, and this is where I saw a lot of opportunity really leveraging. Yeah, my education into a more broader, uh, complete story, uh, of really changing healthcare. Um, and at that moment I was still studying in Paris. So my co-founder contacted me and he said, let’s do something in medical data. And yeah, I was directly convinced of the added value that better healthcare means better data.

And there’s still a lot to do, like you said, in need introduction. And that’s why we started the company straight out of philosophy. Which is right now, a scale-up with 35 people. Um, and it’s a really nice, nice potential and they story

ESCP Student: and to do other regrets with.

Uh, yes, she was the path of, uh, non medicine. Uh, uh,

Dries: exactly. So, yeah, it’s a question that I got, uh, yeah, a few times during my, uh, the course of the company. So everyone, the beginning, a family friends of course found it really weird that I was, uh, not specializing or not further advancing really to become a healthcare professional work in hospitals, directly with patients.

But, um, The moment that , and that’s also how I am personally, the moment that I was convinced of the ID and that we had the bigger goal to serve with our company and that I could have maybe an even bigger impact by starting this company and trying to successfully, uh, I’m trying to successfully yeah.

Build up this company, um, that we could really have a, a further division or mission is being that we want to improve health care by making sure that more and relevant data is becoming, uh, actionable, uh, towered healthcare professionals to. The first use case that we did with our company, we directed, demonstrated that our company really can, uh, in case, uh, healthcare outcomes without me being really directly involved in the patient, uh, uh, process.

And that’s why from that moment on, I didn’t look back and I didn’t have any regrets that I’m not active in the hospital.

ESCP Student: That’s nice. And what made you the leader you are today and how are you preparing the floor to the young leaders of tomorrow?

Dries: I think, um, um, of course it’s so still young. I’m now 32 years old, but, um, the big, yeah. Stepdad, you have to learn because we co founded the company with one co-founder. So we were too in the beginning, but our company grew quite exponentially.

Uh, the following years going to five to 10 people then going at 2 35 people. So, uh, your position as well as, uh, an entrepreneur, but also co-found the changes along the way. Um, and I think my. Biggest path of learning, uh, internally as well was, was more self knowledge. So you have to know really, if you want to become a leader or you have to know what you’re good at and how you really want to support the company.

And you have people that are really good in daily management. On a daily basis managing people within the organization. Uh, but this was not really my strong point and by being transparent as well to investors or to my other co-founder of course, um, we were, um, yeah, the heck the, on a path where I could be more motivational and inspirational to young people in the company, uh, by letting them, uh, in, in, in the field of healthcare data and trying really to push.

Uh, to blossom, uh, in our organization, which in my opinion is crucial. If you want to make sure that, um, your company succeed, you have to make sure that your organization and the people really working in your organization, uh, can blossom professionally. Uh, and this is still, I think the biggest impact that you can have as a, as a leader.

ESCP Student: Thank you. Address. And based on what you just said, can you link who you are today with an event that shapes you in the.

Dries: Um, can you, sorry, I didn’t understand the question.

ESCP Student: Um, can you link who you are today with an event that shaped.

Dries: Um, of course with, with, with a single event, that’s of course difficult.

Um, you have to know if you start a company, uh, or, or scale up company to really a coaster. So there were multiple events that, that shaped, uh, what am today and, and how I am, um, pursuing my professional and personal life. Of course. So it’s always a balance, um, thing, the biggest event. That changed me professionally is really something personally being, uh, yeah, the, the birth of my first daughter.

So my first child, uh, which really gives me, or gave me the necessary, uh, how do you say the necessary, uh, Hawk eye view on the cost to a helicopter view on the company. Uh, and which, in my opinion, makes me a better leader professionally, because I could zoom out into problems that are not really relevant.

Yeah.

ESCP Student: That’s amazing trees. Uh, you also mentioned that you started, uh, your, uh, your career from scratch with a few people and you made them. So let’s talk about your first hiring experience. Can you tell us about it and, uh, uh, what was the impact on the evolution of links care?

Dries: Yeah, so, um, the first real hire that we did is still someone that works in our company.

I remember 12, the, uh, because we, we were on a budget, so my co-founder Josh is CEO of the company. So he is the executive leader of the business in all transparency. But, uh, the first guy that we hired T actually did his internship straight during university as well with us, the moment he finished, uh, school.

It was really, um, yeah, we knew that we had to get that guy incentivized. And as of today’s still the lead data engineer in our company, really making sure that the platform is, um, how we are seeing it as a school founders. So that really, of course, was a big impact into a company. And he is still one of the most important people as well in our organization.

ESCP Student: And deal with the true leaders like you, they will, they will always stay. Uh, now, uh, how about the fundraising? How challenging did you find that to, uh, to establish links care?

Dries: Yeah, so, um, we had S and you have to know, uh, five, five years ago when we started the company. Healthcare data was something that people knew of, but a lot of people thought that the importance of what we are doing was not really there.

Um, but, uh, Josh and I, yeah, we kept going and we kept really convinced, uh, for our vision and our mission that healthcare really needs better data. And then of course, uh, COVID 19 QA came, uh, two years ago where. In one moment everyone saw from whether you worked in healthcare or not. Everyone saw the importance of having good data in order to, for example, control a pandemic.

Um, and that moment for us was, uh, was a real game changer. Um, also business-wise because, uh, yeah, our business model for our company, uh, pivoted a little bit, uh, in that case, and that was a accelerator. So to come back to your question, being fundraising, that. The first three years, it’s really difficult for us as a company.

It was not that easy, um, to really find the right investors because, um, the problem or the problem was not that’s. How do you say visible, uh, through the whole industry? Uh, two years ago, when COVID-19 hit, everyone jumped on what we were doing, uh, and we are still doing so fundraising right now for us comparison with Tibet four years ago is a lot easier.

Um, And I have to say. If you, for example, start a company and everybody says you have to start your company with, with family and friends, capital, et cetera. I’m not a big fan of this because I’m not a fan of mixing personal with, with professional life. Um, At first, you really need to have champions in your company being business angels, who already did this before and who can guide you to a first bigger round with, with, uh, venture capital.

Uh, and that’s just crucial, the moment you hit the right metrics, raising funds in the time where there’s a lot of money, a lot of, uh, cash, uh, on the banks to invest that that’s not the most difficult one. It’s the zero to one that is really. The most, uh, the most difficult funding process in my opinion.

ESCP Student: And did that being a true leader, doesn’t also it doesn’t on here. And make people blossom, but really to, to face the challenges and keep going. Uh, now that you have, uh, in non traditional non-corporate path where a medical doctor, you founded and launched your startup right after graduating from the STP, can you give us some tips for that?

For the young graduates on how it should either an entrepreneur has no age limit?

Dries: No, exactly. It doesn’t have fast, no age limit. In terms of being an entrepreneur or being, or starting a company in the dependent on, on whether you just graduated or you’re already spending 10, 15 years in corporate life is, um, by really being convinced of something.

Um, and being convinced of an ID is simple, but you have to have also on a personal level, the drive to really, um, go all in. And this is where for a lot of people, this is a step difficult to make. In my opinion, I see a lot of great people that have great ideas, but will never, um, yeah, never jump out of their golden corporate cage in order to develop that idea.

But, um, but this is yeah. Something where I as well, want to play a part in and try to convince those people, of course, with the, with the right when, when the market and the company and the business model is, is clear, uh, try to push them to, to becoming an entrepreneur because it’s, uh, not the life that everyone thinks of.

So it’s not the most, uh, Easy life, to be honest, because I think a being or having a startup is often, um, romanticized to our, how do you say it in English? Uh, it’s really at all at Cosa, but you, you have to be ready the moment. Of course you can validate your initial ID or you can validate, uh, the mission of why you started this company.

And you could put it on paper that you realized it, uh, this ID, this is I think in my opinion, the most, uh, compelling story to, uh, to start a company. But you have to be sure whether or not it’s not age-related, but you have to be sure that you see opportunities this first, uh, and you see, or describe risks as challenges to overcome.

Another lot of people, uh, do it in that order.

ESCP Student: Thank you. Now, we would like to jump to another section. Uh, we will give you one word and we want to get your reaction. So we will start with purpose.

Dries: For me. Purpose is a yeah, it’s a way of living. Of course, you could see pers purpose as a professionally or personally. For me, it’s, uh, the purposes of course, to become happy, to stay healthy. And in that view, my purpose as well as if I start a company or with links care, what we really are doing is, uh, really try to optimize healthcare, uh, in a way of using better and more data.

So for me, the main purpose being. Healthy being active and being happy for the three points that are crucial in everything I do. So a, there will always be of course, a link, uh, professionally and personally, but this is what I, what comes up to me when I hear purpose. Yeah.

ESCP Student: So it’s probably, uh,

Dries: Leadership for me is, um, the best leaders are invisible at the moment that the company goes well, because if you have a lot of young, talented, or not only young, but talented people in your company, uh, and the company goes well, then they deserve all the credit to, in my opinion, true leader is when some things are not going well in a company that steps up and gives all the tools and support necessary.

Uh, to make sure that the internal issues or problems are being solved and that’s for me, truly leadership.

ESCP Student: What about technology?

Dries: Technology is a mean to, uh, to achieve a certain goal. For example, links care. We are really technology, product driven business. But the real capital or the real value is still in the people working in our organization.

So I think technology is always a mean to go from place a, to B, but it shouldn’t be the end goal.

ESCP Student: How about.

Dries: Yeah, a great, a great project, you know, a great program, you know, that, um, really, uh, yeah, always happy when I land in Paris or London to give the year the courses, I think. Um, yeah, if I speak personally, I think that everyone that studies medicine or studies from these should have during his education, the opportunity to.

To be, uh, included in a certain track. Like we have at the MSM, uh, thirsty bay for me, it was a game changer because yeah, in six months time, you really know. Quite well, how healthcare ecosystem is working, but also by seeing so many professionals talking about what they do at their company, you can really, um, make up for yourself what really interests you as a person and where you think you can blossom.

Because again, I think leadership starts with knowing what you’re good at and pursuing in something that you’re good at, of course, a true leader as well notice weak points. And then it’s. Are you going to solve them yourselves or are you going to be surrounded by team members that can make up for, for your, uh, for your floss?

Yeah,

ESCP Student: I totally agree with you. And now we will end up with the word spread love and organizations.

Dries: Yes. It’s spread love. Um, if I’m looking at a. The trajectory that we did with our company, because that’s the thing that I know best with links scared in the beginning. Yeah. It’s, it’s really chaotic. And especially if you don’t have too many people, uh, in your organization and you have to do a lot of work then, um, yeah, I can, I can look back.

Of course. As well see that we made Atlas, uh, uh, as, as the beginning founders of this company, by maybe pushing sometimes people in the company too much, because we have a lot to do a lot on our plates and we didn’t make enough time maybe to, uh, Yeah, to really support people the right way. And this was really, uh, as well for me, a learning exercise, um, by yeah, creating the time and really creating as well, an environment where people, um, can get to the necessary support and feed.

But, um, in all honesty, this is of course, something that you can do from a certain scale in the company. Don’t I think it’s not that easy to do it directly from the beginning. Um, but if I would start again with my company, um, I think. The much more, um, susceptible as well from a management perspective to how our coworkers or the people in our organization really, uh, feeling.

Um, and by, for example, two years ago, there was an experienced CEO joining our company. And the first thing that. Was he implemented a survey system where each, I think each month or every two months, uh, all the people can, uh, can fill in a survey and we can see how happy they are with the workload, how happy they are in the organization, what they want to do, et cetera, et cetera.

But that gave us so many insights related to. The better as well from a management perspective in the company. Um, and that would be something that I directly as well, which would switch, implement, uh, know,

ESCP Student: I can agree, uh, any words of wisdom, trees for leaders and entrepreneurs and healthcare around the world.

Dries: Um, of course as a true leader, I just want to not only incentivize people, but for me, um, we are taking big steps in healthcare. In general. There are a lot of big companies transforming the way, how they are looking at healthcare.

Uh, I think it’s a positive evidence. We’re really value-based health care comes into play hopefully in the next two to three years. Um, it’s, we’re still not there, but, uh, I’m convinced that everyone that listens to this, as well as, uh, everyone that works in the industry works for insurances, but also works for, um, yeah.

In, in, in hospitals, the real healthcare providers, um, and everyone really, uh, It’s aligned in a value based healthcare model. Um, and that’s for me, something crucial for the coming years.

ESCP Student: Definitely. I can totally agree on a attest to it. Thank you for sharing your experience with us today. It was such an inspiration.

We can really spend hours with you and never get enough. Thank you so much for your time.

Dries Hens: Thank you. It was my pleasure.

Naji Gehchan: Thanks, Dries, thank you all for listening to spread love in organizations podcasts. We have such an important responsibility as leaders of today to plant the seeds for the leaders of tomorrow.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Doug Bruce

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, joined today by Dr Robert Bruce Associate Chief of Clinical Affairs at Boston University School of Medicine, and Director of Primary Care at Boston Medical Center (BMC). Prior to those roles, Robert transformed healthcare in the New Haven community focusing in the largest health center in new haven on quality and value based care which resulted in significant savings for CT Medicaid and the community. Doug was also Chief of Medicine at Cornell Scott-Hill Health Center and Associate Clinical Professor of Medicine at Yale University. He is a global expert in substance use disorders in people with HIV and hepatitis C. He has published widely on the topic of substance use disorders and HIV. He has provided technical assistance to CDC, NIH, and the United Nations.

Doug – I am so honored and humbled to have you with me today!

I would love to hear your personal story, from childhood to becoming an expert in HIV land hepatitis C living with and helping some of the most touched countries by those pandemics. What defined your journey and the incredible leader and physician you are today?

Doug Bruce: That’s a great question.

So, um, I grew up in the Cambridge kind of Boston area as a little kid, and I grew up and had lots of pulmonary problems actually. So I had like lots of asthma and what’s in and outta emergency room all the time. And so. I had some really good pediatricians and some not so nice pediatricians. And so at an early age, I thought, you know what?

I wanna be a doctor. I wanna be, I wanna be one of the nice ones but I wanna be able to help people. I want to be able to bring, um, joint and comfort. I, I realized that. What stood out in my mind as a child was not, oh, this doctor has more knowledge than that doctor. Right? It was more just, oh, this doctor seems to care about me.

Now, this one seems like I’m a widget. Um, I wouldn’t have said widget when I was a kid it was kind of the feeling. So I, uh, for a long time, felt like. I really wanted to be in healthcare. Um, my faith is really important to me and I realized when I was working in the public hospital system. So I, I went to the university of Texas Southwestern med school in Dallas.

And I worked at Parkland Memorial hospital, which is a big county hospital system. And I was taking care of marginalized populations of groups of people. Kind of, you might think of were forgotten by the system and began at that time, it was the aids epidemic was working with people with HIV, people, with substance use disorders and, uh, saw all kinds of things that, um, I felt like there were great inequities and great trials and tribulations that people were facing.

And that one of the jobs of being a physician was to be an educator, but also an. And so after I finished my training in Dallas, I went to Yale university and did a graduate degree in philosophical theology, um, because I wanted to read widely and think, and be very reflective about the care of those groups of people.

And then started working with the LH program and providing street level care for substance users and people with. And from that began developing programs and then working internationally with marginalized populations to try and systematically make things better for people who may not be able to advocate for the.

Naji: You, you have served, uh, Doug in countries hit hard in moments where few innovations were even existent for those diseases to treat those patients. Can you share with us your experience stories, learning that you take with you today leading in healthcare systems in the

Doug Bruce: United States? Yeah. So, um, I guess two, two things stand out.

One. I spent a fair amount of time going back and forth to Ukraine and what’s happening. There is a tragedy when I was in Ukraine. Uh, one of the trials that we faced was how siloed healthcare is, and we know that healthcare can be siloed in many countries. And so my time in Ukraine taught me that creative ways to try and overcome.

Seemingly impossible silos. So, uh, just concretely, for example, in Ukraine, if you take care of drug addiction, you’re an oncologist and you’re not allowed to prescribe medications or offer any treatments outside of your narrow scope. So like unlike in America, right? I’m not a psychiatrist, but I legally could prescribe psychiatric medications and Ukraine.

If you’re an oncologist, you’re not describe. Treatment for tuberculosis, even if your patient has tuberculosis, you have to get a special doctor, APH physiatrist who will do that. And then that person is divided between those who do it on the inpatient system and those who do it on the outpatient system.

So I kind of learned in that environment, just the critical need to begin asking questions to talk, not just to government officials or healthcare officials, but stakeholders. And, and I had known that in the, in the. Aids epidemic stays in the nineties and the importance of stakeholders, um, and importance of voice and people giving people agency and voice.

I think what I learned differently was also, um, sometimes the way to get to the truth is you have to just talk to so many different people. And that’s what blew my mind when I was in Ukraine. I didn’t understand the limitations and I. Because people were not forthcoming. I represented a government or I represented a university and people felt that they had to answer me a certain way, but when I would go talk to drug users or people with HIV and community, people were very forthcoming.

They’re like, ah, no, this doesn’t work. Or this is the real problem. Um, and like a classic example was when I was in hair song Ukraine, and we were just talking about like TB adherence rates and it was just, it was really difficult to understand. Like what the problem was because on one hand, like there are no problems, but eventually we got to the realization of, oh wait, you can just walk up to the pharmacy at the TB hospital and by part of a TB regimen.

So what, what we found out was like, if you were a substance user, you would go and get admitted to the hospital. You’d had no treatment for your heroin problem. So you got sick, which meant that you left, but you had started some treat. Your new treatment was important. So after you left, you could go to the pharmacy, but TV treatment was for medicines.

So you can’t afford four medicines, you buy one medicine. And so that helps you feel better until you get drug resistance. And so it was kind of this systematic problem, but it was very difficult to get at it through one lens. And so I think that was one thing that was really important to me. And I carried that with me when I went to Tanza.

And the need for stakeholders. So, um, an example of this was, um, so in Tanzania there’s a big heroin epidemic. That’s kind of really fed into the HIV epidemic. And we had a situation where those most at risk for HIV were female sex workers who also injection drug users. We had very, very high rates like in the survey samples that they had done, like over half of the women had HIV.

So we’re trying to get them into treatment on meds. You. But when you looked at the clinics, the clinics were mostly men that were providing services. And so what did we do? We had to go out and actually meet with the women and talk to them and find out like what’s going on. And they brought up just very logical reason, right?

Like what the clinic doesn’t have the hours that are convenient for me. Right. Cause the con the clinic had morning hours. The women were sleeping cuz they’d been up all. Uh, with their trade over, over the evening and using, using substances. So we had to think about, well, how do we lower the threshold so that women can get in?

How do we create a safer environment? What do we do with the men that are loitering around? How do we create an environment that’s, um, safer women. And, and that was based on the feedback from, from the women.

Naji: Uh, those are, those are powerful examples that, that you’ve, uh, led. Uh, so how, how do you ensure like this curiosity, but also this need actually to go on the field, understand what’s going on and bringing it back and change the system because you practically had to change systems to make this work for patients.

Doug Bruce: Yeah. So, um, I mean, I. You have to tailor it. Right. But to, to your point, just, just because someone recognizes the need doesn’t mean that they’re willing to help. I mean, an example of this is, um, we were showing that the tuberculosis rates among the patients in that first drug treatment program in Tanzania were very, very high.

It was not surprising. It was one of those things. You know that there’s a high probability that, that this is gonna be the case. Substance users are using drugs together. They’re in closed environments, inside poor ventilation, HIV increases your risk of tuberculosis. So the probability is that there’s gonna be TB among the substance users.

The there was no active program to search for TB. So one of the early programs we did intense and after we set up the drug treatment program was to check for HIV, offer HIV therapy, but then it was to start trying to be active in, uh, searching for tuberculosis. And so a, a student of mine went out there and, uh, started doing active case finding and the teams in Tanzania supported this.

So they were all really interested in. And part of the team’s interest, as you can imagine, was they didn’t want to get TB. And so, um, it was kind of playing off the enlightened self interest of this is a real material patient concern, but if there are high rates of this, this is a real material concern for all of the healthcare workers in that environment.

Cause. I mean, we didn’t have, they weren’t in 90 fives floating around for everybody to wear for TV prevention. Right? The main TV prevention is great ventilation, open windows, staying outside, um, where UV light kills it. So that program found that there were high rates of TVB like, not as high as south African mines, but like 20 times higher than the national average of tens.

So very high rates and eventually. You know, it’s not surprising, right? So you change your infection, protocol, infection, prevention protocols, you have better ventilation yet. Don’t put people in isolated environment. And, uh, eventually actually the TB program from the university hospital system in Tanzania started spending time taking care of patients.

And so it changed the system. But in this case, it was playing off on that enlightened self interest, which also paired with the patient. But then we tried to get, you know, external funding from a separate government agency that for all intensive purposes, you would’ve thought would want to fund this. Cuz their enlightened self interest would be like, oh, like you can get credit for this, but they didn’t wanna get involved because a different agency was funding.

The, the larger work that we were doing. And so they were worried about, they never said this, but it became apparent that they were more concerned about. Uh, who got credit for the activity, then the activity itself, which is very disappointing. So I wasn’t able to, to change them. They’re they’re much bigger than me.

Naji: well, yeah. And it touches to all those lenses. We, you know, we both learned in, in class mm-hmm um, the, obviously this is a huge impact that you had in, uh, again, in countries with. Tremendous need and in moment of crisis, uh, obviously in those countries, uh, I would love to get another leadership learning from you as you led teams there.

So you had students, you had physicians who were working with you, uh, and it’s kind of potentially also relatable to so many folks. And you went through the COVID pandemic yourself as a, as a healthcare provider. How do you lead teams in such moment? High pressure, attention, uh, emotional, uh, struggle and really life threatening diseases that you’re dealing

Doug Bruce: with.

That’s a great question. So I think probably the most important thing that I did in Tanzania, um, was to come in, in humility and say to the teams, cause like I’m a guy from the United States coming in. And I’m, I’m hoisted upon the people and people there, and they’re, they’re smart physicians there in Tanzania.

And so it can be very, uh, off putting, if you are, you know, a academic in the local university there in Tanzania, and some guy shows up from the west and says, I know more than you do. Right. So what I had to come in initially in the, even in the beginning meetings to say, I’m only here because I’ve done this before.

I have a body of knowledge. And so my job is to, to impart that knowledge and to work with you, but you have to figure out how this is going to be in contextualize in Tanzania. I’m not Tanza, I don’t know the local politics. I don’t know how to do this here, but we’re gonna work together to be successful.

And so I told them from the outset. I, there will be a day when I don’t come to Tanzania anymore because you won’t need me because you will be the experts. And so I think that resonated very strongly with them because they had been through, as you can imagine, a series of kind of us government funded activities, where people come in, kind of tell people what to do and set it up.

And, and it’s not as value driven from the, the people there. And. What I saw in my role as was just, I’m kind of your consultant, I’m your, your information person. And I’m really here to support the team, but you’re gonna actually contextualize it. And so a lot of that then became more about empowerment, more about working with the leaders to say, um, so like kind of an example, They were very worried about overdosing patients, which is a, a legitimate concern.

This was a methadone program in Dar Sal lump Tanzania. So they are keeping the doses really low. And so what that, what that happens is if you don’t give somebody adequate replacement therapy, they continue to use heroin, engage in risk, but they were afraid to go up on the dose because they thought, well, if I give the person more methadone and the person continues to use heroin, they can.

Which kind of is a logical fear, but the reality is as you go up on the methadone dose, they go down on the heroin dose. So, so I said to them, look, you all the very smart people. Why don’t you, um, just set up a small mini trial, just take some proportion of the patients, go up on their doses and see what happens.

You don’t have to make it a clinic-wide policy, but just use it as an opportunity to learn. So they did. Right. And this is this, I’m not like announcing this. I mean, this is just like private conversations with people and they did that. They went up on doses. Patients stopped using heroin and they were like, this is amazing.

And then the next thing I know, they have generalized that throughout the system and then they’re really dosing patient. But again, it was, it wasn’t about me coming in saying, this is what you have to do. It was. Let’s have a conversation and let’s talk about our options and why don’t you consider this kind of a pilot project.

And so I think humility is the most important thing that I learned in interacting, especially in international projects, because so often people are coming in again and just kind of telling people what to do, and then that’s so devaluing. Right. But as I talked to them and said, You’re the experts. How would, how do you, how do we do this intensity?

Like, what are we facing? How do we address this? It was, I think it was very empowering. They eventually set up training programs there where they were training additional physicians and, and who are now leading other programs, which was exciting. Um, but that’s something that I then took back to Boston and, and to other places of just, um, never underestimate the information and the power of the person that you’re meeting.

Regardless of education, regardless of position, they have something to teach you. And, and that, by valuing that person and partnering with that person, you can make a lot of change, more change than you thought you could. And it’s a great

Naji: pivot to my next question. You talked about humidity empowerment.

These are really strong, strong words. As a leader. In the last years, you’ve been focusing on innovation, operations, optimization, practice transformation, like all those large change management projects in academic, uh, medical practices in the us. So what is the main challenge you’re facing today and how do you lead through those large organizational

Doug Bruce: changes?

Yeah, inertia is a huge problem. I’m just amazed at how physicians, nurses, medical, assistant administrators really almost feel like the system can’t change, or if the system can change, they view it as, you know, one or 2% on the margins. Um, they view it through the current lens that they’re that’s, they’re passionate about volume value.

Um, Finishing my charting, right. Not spending the evening doing that. And so I’ve found it challenging to kind of help people understand that, wait, should you reconsider the entire paradigm here? You’re like, you’re living in this soup in this swimming pool, whatever you’re in. Maybe you should get out of it.

Like maybe we would need to completely rethink things. Um, and so some of that has then. You know, as I always do in a new environment, you spend a whole lot of time just talking to people, surveying the faculty, getting feedback, and trying to create an open door policy. And then also trying to help people understand.

Look, I’m not gonna take it personally, if you come and tell me that the system is dumb and it’s broken, like I’m, I’m, that’s fine. I want information and I want information so that we can make it better. But I would say like, inertia is a big thing and, and the pandemic. In many ways, because the pandemic was this push into the lives of people where people felt disempowered, they felt hopeless.

Like there’s this external factor and I can’t fight against it. And I think certainly where I’m working now, people have transferred that into their work environment. Some that, um, you know, my clinic got flipped from, in person to telehealth. I didn’t have control over that or. Alerts keep coming up in the electronic health record.

And I can’t control that. Or, and so there’s this sense that I’m powerless and because I’m powerless, I’m not really engaged with change management because I’m kind of hopeless about change. And so a fair amount of what I’ve been trying to do is find some small wins to show people that change is possible, but change is possible when we work together, change is not really possible.

Doug Bruce by himself trying to make change. Right. That’s completely ineffective it’s as we work together and come together that we can make change. Um, but fighting against inertia has been painful.

Naji: And this is a very interesting insight because as you said, pandemic has challenged all of us, right? And many would think that it challenged us in a way to change that now will be sustainable change, right?

Like from work from home and the hospitals, all telemedicine the speed of developing drugs, et cetera. But I’m hearing from you, the state of mind of healthcare providers today is not that like I heard. Hopelessness. We’re not powerful enough to make those changes. Where, why do you think that as we know, there is a huge mental toll on, on healthcare providers.

And many times I’ve shared it before we applauded them in the beginning of the pandemic, but actually didn’t change much of the, the struggle they go through, uh, after a couple of months. Right. So what do you think is happening and how can we do it as healthcare leaders across the different, uh, healthcare industries?

Doug Bruce: Yeah. Well, I, I think the, one of the things that I’ve been trying to do is actually apply some of those lessons that I learned in Tanzania and into academic health centers, because, um, academic, medicine’s a very hierarchical system where people don’t feel like they have voice or agency, um, and, and promotion systems and things can be somewhat opaque.

And so trying to give people an opportunity. And so some of that is. And this is seemingly silly, but I think people have found great value in it is personally replying to the emails that people send me. Right? Like I’ve, I’ve, I’ve heard what you said, you know, or taking time to you have a question. Well, let’s set up a call, let’s have a conversation about this, you know, do you wanna mean person?

Do you wanna meet on zoom again? It’s it’s really trying to be responsive. And then to be honest, I mean, the thing that I’ve been trying to tell people is like, look, I’m I’m, I’m not gonna lie to you about this. I’m gonna just tell you where it is and it could be. Your issue is completely legitimate.

Unfortunately, like right now we don’t have resources to address it, or we don’t, we can’t address it. We don’t have the technology or it could be like, I’ve got this fire over here and we have to address this fire before we can do this. And the faculty, I think at least in the feedback they’ve given me is that they’ve been very appreciative of the transparency and the honesty, um, because that builds trust.

And so then when there’s some trust and then you. We can do this. Like, Hey, like we can, like, there’s a pathway forward. We can make this change and make it happen. Well, people start to say, well, Doug’s been honest before. Maybe he’s being honest about this. Maybe he’s not just saying this, like people have said in the past to try and motivate us.

So we see some more patience. Um, so I think building trust through transparency and honesty is really important. If we’re gonna start trying to help healthcare providers. Get out of some of that inertia and hopelessness and feeling that they don’t have voice and they don’t have power. And so we have to create opportunities for voice and agency and we have to listen to that.

And then we have to be responsive to that.

I love that.

Naji: Uh, I, I would give you one word and I would love to get your

Doug Bruce: reaction to it. So the first

Naji: word is leadership.

Doug Bruce: I guess when I think of leaders, I think about people who get on the front line and work with and like, or in the, in the middle of the battle. Right. I don’t think of leadership as detached from what’s happening. Um, the, the most success I’ve had in leadership has been. On the front line, learning from people, teaching people and changing the system there.

Innovation,

I think increasingly when I think of innovation, I think I would say I used to think of that as change, like modify the current system. And I, I think of that now as creativity I think more and more of innovation. What’s a better system. Like just what’s a completely better system. And so I would say I’m learning in that space again, having a breadth of people speak into that is really important because of the, the realization that I could say the current system is bad.

Let’s make a new system, but it shouldn’t. My new system, it should be our new system. And so well, who are the, our, and so often, like the physicians in the practice will say, what’s, what’d the doc say? You know? Well, what, what about the nurse practitioners and the PAs? What about the nurses? What about the medical assistants?

What about the front desk staff? What about the stakeholders? What about the patients who are the actual people who are coming right? And so the more that we branch that out and the more that we give agency and voice, I think the more we can be truly innovative and have something totally different, um, which is what I’m now thinking more about as the word innovation, just making it completely different and better intellectual

Naji: property.

And it comes from a debate we had

Doug Bruce: Yeah, I think so. I, I really do believe that you need to protect intellectual property. So I’ve changed in my view of this, right? Like I, I was in the, probably more supportive of act up and like, Get meds to the world. I still believe that we need to find ways that we can get medication across the globe, to everyone who leaves it.

Um, the, the very reason that we did a methadone clinic in Tanzania versus anything else was because, um, it’s the cheapest thing to do. It’s also the most effective, which is kind of rare that the cheapest is the most effective, but it was incredibly effective, but because it was cheap, we could treat more people.

And, you know, in public health interventions, it’s really about treating large numbers of people. If you’re going to make a difference, right? If, if we only vaccinated 10% of America against COVID, we really wouldn’t be having the kind of successes that we’re having now. So public health interventions, especially with infectious diseases require large scale intervention.

I think that if we don’t protect intellectual property, people will not be innovative. They will not create completely new drugs. They will not create completely new solutions. I mean, I’m amazed when I started taking care of people with HIV, they were fists of pills that were incredibly toxic and horrible life limiting side effects to now, now, today, like, I mean, this is crazy to me.

It’s easier to treat HIV than high blood pressure and. Like I, if you had asked me in the nineties, in the middle of the aids epidemic, you know, someday HIV will be easier to treat than diabetes. I would’ve said you’re nuts. Like that’s just not gonna happen, but it happened because people, because let’s be honest, right.

There was a profit motive in, in doing that the same with hepatitis C. Like I never thought that we would be curing people as easily as we can now with hepatitis C treatment and. I want to preserve the intellectual property that helps foster innovation for companies to make a profit, because that’s why they’re innovating in the first place.

I just wanna find a way where we can, that those medications don’t just stay in rich countries. And then the patients that I care for in, in other nations of the world, who are people too, and who have I. Dignity as people and rights to good healthcare that they can’t access it just because they were born in a foreign country.

Right. That just doesn’t seem right to me. Um, but I do fear that if we just do away with IP in these things, or we fight against them, then people will say, well, why, you know, we’ll invest our money in real estate or something. And I don’t want, I want people to continue to invest in developing great medications, especially when there are some serious diseases still in the.

That we need people to be innovative about. I mean, malaria, for example. Yeah. What about

Naji: spread love in organizations?

Doug Bruce: Well, I think that, I mean, that kind of goes to everything that we’ve been talking about. Right. Um, I, you know, one of the things I, I tell healthcare providers who can be so serious sometimes , I’m like, you know, if all we do when patients come is tell patient.

How they failed in everything. They failed to lose weight. They failed to take the medicines. They failed to like, go get it. Just whatever, like who wants to come see anybody? That’s that negative? Who wants to come see the healthcare provider? Who’s like, yeah, you, you failed come back. Um, and my own life.

Right? So my, my doctor told me one that, um, cuz I was like, I don’t wanna exercise. Why don’t you just give me a statin for my Cho. And like the guy looked at me and was like, you’re a smart guy. Figure it out. Like just go exercise. And I didn’t go see him for a year because I was like, I wasn’t exercising.

And then I like exercised two weeks before I see him. So I could answer the question and be like, yeah, I’m exercising. And he didn’t even ask me. I was so upset. I was like, really, but that’s not necessarily a productive healthcare relationship. And so when I think of spreading love, I think of spreading love, both among staff.

So one of the things that I do often is I try to remind every member of the staff, their vital importance. So I’ll tell the front desk staff, like you’re the first point of contact when people walk into the clinic, like your role is incredibly important because that’s gonna set the tone for the rest of the visit.

If I’m mad after the front desk, I’m gonna be mad when I talk to their medical assistant, I’ll be mad when I talk to the nurse. I’m mad when I talk to the doctor. So, and then empowering medical assistants, like you are getting a proper blood pressure as like real material, healthcare consequences, like your role’s really important.

And so I think part of spreading love is helping people know that they are valued and that they’re not just parts of a machine and that we, I can flip a switch and easily replace you. It’s like, no, no. Like you are bringing you to work today. And you are valuable and you are important and what you bring is important.

And so I think as people feel that value as they feel that like coming to work’s really important, I like, I need to go to work today. Well, why? Cause I’m really important that then spreads to patients, right? If I’m really happy and experiencing joy in my job, because people hear value and care about me, I spread that to patient and that’s infectious.

I mean, I like infectious disease. Right. But like it’s really infectious. And so I think we just need more and more to do that. And it just starts with saying you have dignity as a person, and I need to treat you with dignity. And as I do that, I’m spreading well,

Naji: I love that Doug. And, you know, I, I thought a lot and you kind of touched on the four letters that I sometimes use with love.

It’s listen, observe value, and empower you. You literally talked about all of that. Thank you so much for those amazing examples. Any final word of wisdom for healthcare leaders

Doug Bruce: around the word?

Uh, I would say be creative, be a listener and be humble. The, you know, I I’ve had, um, high school educated substance users, um, teach me things. I’ve had people with multiple doctorate teach me things.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Dimitris Bertsimas

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode joined today by Dimitris Bertsimas Professor of Management, Operations Research, and Associate Dean for the Master of Business Analytics at MIT.

A faculty member since 1988, Dimitris’ research include optimization, stochastic systems, machine learning, and their application in different sectors including healthcare. Dimitris is also a serial entrepreneur, he cofounded several companies like Dynamic Ideas sold to American Express, Benefits Science, a company that designs health care plans for companies, and MyA health, a personalized health care advice company. 

Dimitris has coauthored more than 200 scientific papers and several books. He has received numerous research awards, including the William Pierskalla best paper award in health care.

His work in healthcare through analytics contributed to improve many patients’ lives, and still more to come!

Dimitris – I am humbled to have you with me today!

Dimitris Bertsimas: It’s a pleasure to be with you.

Naji Gehchan: First, I would love to hear your personal story from electrical engineering, to math, computer science and analytics, and now being a serial entrepreneur and MIT professor what’s behind this impressive journey of yours.

Dimitris Bertsimas: Well, um, I was born in Greece and came to finish the computer science department there graduated in 95 and then came to the U S at MIT in that year of 1995.

And I have been at MIT ever since I finished my PhD in eight in enjoying the faculty that. Uh, so th there is, um, but back in my childhood, I mean, uh, there is, uh, my, both, my parents installed in me the idea to, to Excel in whatever one does. Um, so with these preconditions, um, we see something I try to do, I try to do as good a job as I can.

Um, then, uh, when I find myself in. In the, um, in the Boston area and at MIT, which is, uh, an environment that, um, sort of excellence is a given, uh, I thought, uh, and inspired by the, by the environment. I, I thought that it might be. Um, a reasonable idea to apply what I, I study and I do research on in the real world because in the end of the day, I, I believe then, and now that, um, the best theories are those that solve the problems that originated with theories and other results.

I have been involved in the beginning of the nineties in. In this early in the financial sector of Boston, Boston has a very strong one of the strongest in the world asset management area. But then later in healthcare, healthcare in Boston is very strong. Some of the best hospitals in the world are here.

So the combination, therefore of my predisposition to effect, to have impact, to matter, to affect the world, the environment at MIT that, um, uh, motivates people. Uh, for all ages to do as good a job as they can, and the opportunities that are available to somebody like myself, um, and, uh, who has both the mighty connection, deep connection, and it has an entrepreneurial spirit, um, to achieve these objectives.

Naji Gehchan: Thank you for sharing that you have a passion for healthcare, and you mentioned it’s here, um, as your work contributed 3d to change people’s lives on many of the research and the work that you’ve done. Why healthcare? Why is this passion specifically for this sector?

Dimitris of yours.: Um, at some point, um, I definitely have a predisposition to have impact, but, um, and in the beginning of the 2000, there was an opportunity with a close friend of mine to start a company called who also in healthcare. Uh, and I started, we started the company. Oh, my, he was doing well at decisive point was also that my parents also got sick.

My, I lost my father to cancer in 2009. She got sick in 2007 in the same year, 2009. I also lost my mother. So this is a period of roughly middle age. When you, you think about your. And, um, and you observe that, um, what is important. Um, and I thought, um, affecting the lives of people in a positive way is more important than, uh, perhaps making money and making rich people richer that I was doing when I was.

In an earlier life when I was working in finance and services. So I, I’m not that I have any negative opinion about these matters, but I definitely believe that, um, researching the and helping people to improve the lives, um, is a value is a worthwhile effort. And I have also observed that with the evolution.

All for analytics, namely the data in electronic form in healthcare, the opportunities are significantly higher than they were in the past. So, um, that’s some of my, um, aspirations.

Naji Gehchan: Yeah, and we definitely share this similar purpose of making life better. And in healthcare you would frequently, I think you met with people who share this purpose, uh, deeply, uh, you, you start talking about, uh, data, uh, AI and what this can bring to healthcare.

So there’s obviously a huge hype on, on this, on big data AI and how this will disrupt the healthcare industry. You know, those trendy words these days, you’re obviously an expert there. I would love to hear your thoughts about

Dimitris Bertsimas: it. Um, so let’s take an analogy. Um, in, um, I was involved, um, in financial services in the late eighties, early nineties using quantitative approaches, analytics, beta, and so forth.

And, uh, it can have a significant impact in the field, um, in healthcare. The availability of data and electronic form of, uh, both fractured and unstructured, electronic medical records, uh, computer vision scans, uh, language is starting to become increasingly available. I would say in the last decade. Uh, so if you think about human doctors and how they, they, uh, reach decisions, uh, diagnosis and, uh, and prescriptions regarding their patients, they definitely involve data of this type electronic records test.

They do scans, they read reports that they read. Uh, recently genomic information. So it makes reasonable sense to me anyway, to utilize the same type of data that human doctors do to, uh, to make these predictions with a difference that computers, unlike. Typically don’t get tired. They are, they have less bias.

Maybe they might be biased on the developers, but, uh, of the algorithms, but, um, but nothing else. So it makes sense, you know, rationally to consider. The use of methods that have been unusually successful in other areas. I mentioned finance services, but you know, energy production, if you think about energy production in the world regarding why we have electricity today, and it works quite well, and I leave the keys behind it and we use of data and so forth.

So it’s makes sense that, um, given the availability, um, to, um, to attempt to do that, Um, and of course, many people realize. And when people try that, there is a complexity that unlike other areas, we are dealing with humans, both human doctors and human patients. So therefore other elements besides data, mother, understanding what drives them, understanding the culture, how they react to compliance that’s um, that makes it as what are some more active.

Um, in addition to being potentially. Can we double

Naji Gehchan: click on this because I love how you frame it, human doctors. Uh, I dunno if it’s compared to computer

Dimitris Bertsimas: doctors that something, that’s my that’s what I expect in the future might be at least in assisting doctors. Um, so, okay.

Naji Gehchan: Can we talk about this? Because many times we see innovation, some would see innovation as, you know, disruption, or like the end of.

Certain type of jobs. So you shared the complexity of it. Like, what is your vision about it? Shouldn’t be afraid as healthcare professionals, uh, from the technology or embrace it. What is your

Dimitris: view on this? We have seen disruption innovation in many industries over the centuries then. So it’s definitely the case that the type of jobs change, but humans are not replaced.

Take for example. Doctors, the medical education in the world has not changed primarily since 1920s. When John Hopkins introduced the care and structure of training doctors, the appendix, the append, this type where data doesn’t play a significant role. Um, this is, uh, I think in my view, this is about time to change because it makes good sense, given that the technology has now advanced, it might be not yet at the level that we can trust it a hundred percent, but it’s definitely has improved dramatically to train doctors in this way.

Therefore, it’s not that we’re not going to have human doctors. Of course they were going to have, but they are going to be in my office. Uh, the doctors of the future will be drained, trained differently. They are trained today in addition to anatomy, in addition to, um, do what they learn at the moment. And the experiential aspect is very important.

I think understanding. Uh, data and their exploitation using machine learning AI, I think it will be part of the story and programs in digital medicine. I, I already observed them reluctantly being in some universities, but I believe it was. Main stream in the years to come. And if you train young people in this way, this will take a generation.

Don’t take me wrong. It’s not going to be simple, but I have little doubts that in 10, 15 years, uh, the experienced patients will have in visiting doctors. In assessing, um, what will happen to them from a healthcare perspective would be quite different from what is today. But I do not believe that this would replace humans.

It will just be an adaptation of what the doctors do as opposed to replacing them.

Naji Gehchan: Well, you shared a in the class, I had the opportunity and pleasure to be in, uh, in, in your classes. Uh, great examples on how data and AI really transformed, uh, some of the care for patients, uh, and things you worked on. I would love if you can share one or two of these examples to give tangible.

Dimitris Bertsimas: So, um, I have a long collaboration with Hartford hospital. Um, hospital in connected cars and have for healthcare in that we have implemented, um, and, and, uh, machine learning, AI approach that, um, predicts for every patient. The length of. The probability of mortality, the probability of, um, going to ICU, leaving the ICU.

So in other words, for every patient in the hospital, based on the data they have, based on who is updated regularly, because there’s new information, the hospital, we basically can, um, make predictions about. The future and why this is relevant. Suppose you observe a patient. As we have that. The, the mortality probability we used to be, let’s say 2%, 1%, two days ago is now 3% today, 5% tomorrow.

So even though these are still small numbers, In the scale of things, the fact that our increasing might reveal and condition that human doctors, it’s hard to, it’s hard to observe. And in fact, in this particular case, this particular person developed, uh, an infection that was slowly developing. And the fact that we’re able to observe this, the album picked up the increasing probability gave you opportunity to doctors to actually attend to this.

Uh, even though the algorithm in other words was not designed for this purpose, the fact that you can use it in this way helped the outcomes. That’s one example. Here’s another example. I have been involved for a decade now in a company called benefit science that you mentioned its objective is to design healthcare policies for large organizations in the United States, but also around the world.

Healthcare is primarily the responsibility of the employer. So the employer typically provides the funding provides healthcare and they typically self in soar in that, but they also have to decide what type of plan. So rather than basing, only on demographics benefit science looks at actual data to design.

What is the best quality of policy of a policy? What combination of health savings account, um, PPO plans, HMO plans. To maximize quality subject to a budget. And we have found that, um, the companies, um, save money, but the quality also increases. Another example is another company that you mentioned, Maya health, my analytics health, that takes the perspective of not the company, but the patient.

So, so let’s say you are, um, you have a health savings account. So what is the best way from a to. Um, to monitor and optimize your health. For instance, if you want to do an MRI, what do you do the MRI? If you, because the price is very, very significantly, the quality of care at various places for various specialties also, uh, significantly changes.

Data provides you an objective view of reality. Data can allow you to, um, to basically take the bias out and make more objective and overall better. So this is an example from hospitals to two companies to patients. And it’s really endless. I could go on give you many other examples. Yeah. Thank you.

Naji Gehchan: Thank you for those.

You said data gives you an objective way to look at things I want to, I want to get into more leadership, uh, discussion. With data. And my first question on this would be when you shared the example, for example, uh, on, uh, on the healthcare, uh, hospital or the institution you worked with, uh, we always see reluctance from healthcare providers from experts.

Uh, whenever there is data saying something. And we don’t really believe or buy into, right? Like the model is wrong. No, it’s different. You know, we even see it in our industry is when we talk with different countries, like data shows something, but you always have, oh no, we are an exception. It’s different here.

How do you deal with this? Have you seen this and how do you deal with

Dimitris Bertsimas: it multiple times? There is skepticism that comes from culture, but also sometimes correctly. I mean, you deal with significant decisions about patients, life and death, this situation sometimes. So it’s appropriate to be skeptical. So in this particular experience with Hartford is I was fortunate to have met, um, two people.

Uh, there were four men, executive MBA students. I met them in the classroom. Uh, who have leadership positions in the organization? Um, Barry Stein and RJ Kumar, both of them are in the leadership of the Carrefour healthcare hospital system. And, um, I had the opportunity therefore, to be introduced to them and at least start in a relation of trust with these two gentlemen and over time, because I started working with people.

And then so forth. Um, there, the level of trust increased dramatically, a particular important moment is that I gave a class to about, it was just before COVID. It was 2000, January, 2020, just before March. Uh, and I gave a lecture, a set of lectures, um, to about a hundred professionals about the art of the.

We are the other possible in healthcare and this educated many people at the senior level physicians, nurses, administrative personnel, um, about what can be achieved using data and analytics and this open the door. Even for example, we, we developed a model for COVID, uh, for trying to help, uh, hospitals.

Size their ICU needs given that you don’t know how the, how the disease will develop. So the fact that they were already seen the benefits and the realities of analytics. Mainly leaders in the hospital to at least approach it with more trust. Of course you have to verify, but, but the door was open and therefore the method had an impact in the hospital.

It allowed them. Two sides. The ICU is not only my main hospital, but the eight hospitals of the, of the system, uh, and the rest was relevant. And the trust is not only at the leadership level. Healthcare is local, no matter what the CEO of the hospital says in the end, the decision maker is the nurse and the doctor who, who are, who are in, um, Near the side of the patient.

And if they go and that’s what you’re going to say, it doesn’t matter who supports. So my experience therefore, is that, um, the, the literacy aspect allows. The missile contact, but then we, we, the way we developed all these methods is that even today on a weekly basis with various groups, with the patient, the doctors that attend to the patients, the doctors that attend, um, surgeries, uh, surgeons, nurses, and so forth, we have weekly.

So as a result, when somebody asks, I don’t explain, they explain and it’s much more effective if your colleague who is, of course you have a decades relations whom you trust say something, it has a different gravitas. And, um, I have found that, uh, Understand, you know, understanding the culture of the environment and gaining trust, not gaining trust by, by basically demonstrating to people that we, first of all, you, you trust their opinion.

For example, if the algorithms benefited from their comments and if this, if this happens, it’s not anymore, the album I developed is the algorithm that we have. And that’s how it is presented. So I would say this is a combination of leadership from the top, but also literacy from the base. Uh, and in some cases, one is much more effective than.

Naji Gehchan: Yeah, that’s that’s great. Um, you, uh, well, we had Barry in one of our episode, various time for the listeners who want to know more about his story, you shared Demetrius about, uh, all this power of data and really how they impacted lives and the most recent example with COVID, as you said, Um, there’s all this informed.

Decision-making also that as leaders we can do now, even better with all the data that we can, we can process. How do you see leadership? In fact evolving? Based on those data analytics algorithm that we can use. Do you see it changing or will it change? And what is the role of leadership overall and this a

Dimitris Bertsimas: massive word of that to set an example from yes.

So yesterday, one of the largest, um, Italian companies contacted me with the idea to they, they decided to increase, uh, the digital, uh, aspect in their company. So the use of data throughout. Right. I mean, they have no groups, but they have this desire to do it. So they are asking me very detailed questions about my experience on that.

So here’s a company that is not really not. It is not, I mean, yet they are thinking about, and this is of course the story of many other companies. It’s not that this is an exception. Um, I expect it has already been happening. It’s not even if this is not even a prediction, I’m probably stating a fact. Um, it is already today, but I think it’s going to increase in the future that I’m a chief digital officer.

It’s if analytics officer, there are multiple names and so forth, we’ll, we’ll be at all that many companies already have, and we will be fulfilling in the future. That would be the accurate reporting to the. Which means if, you know, typically a CEO of a large company has 10, 10 direct reports, um, you know, 10, 15, no more than that.

And I believe that one of them would be that that officer, it already is happening in many companies. I know. So it is my. And this is also by the way, through the hospital systems that I collaborate people that have responsibility on, on data and analytics report to the hierarchy of a company, the highest echelon of the company.

So it is my view that this is already happening and it’s going to increase as a result. Another instance of that. Is this access that the master of business analytics program that I started 2016 has had over the years. So currently the program has of, uh, maybe this year 1600 applications for 80 positions.

That’s a 5% selectivity. There aren’t too many places at MIT that have that level of applica application. And I would expect that in years to come, um, the demand for MBA. We’ll be lower than the demand for people with that. This experience has already happened in many places, not at MIT yet. So currently we applications for MBAs, roughly double, maybe 3000, 3,500 versus, um, 1600.

But, but I think this gives will meet as they have met before, because there is a high. I observe and I don’t observe it now. I’ve been observing it for decades. That’s why we started the analytics program. Uh, I have been observing it and in healthcare, I would say definitely I see the need. I see, uh, places, some of the major hospitals having one or more analytics group.

So it’s definitely, this revolution has started.

Naji Gehchan: I know, not to jump into a section where I will give you one word and I want your reaction, a word or a reaction to what happened to the word that would mention. Uh, so the first word is leadership.

Dimitris: Commitment is the word that comes to mind, um, and understanding.

Naji Gehchan: Can you tell us a little bit more, I’d love to hear a definition

Dimitris: from you. Yeah. Um, I believe that, um, the way I see it is that I better like the work on analytics, which is the science of using data to build models. That make that lead to decisions that impact the world positively data models, decisions, value, uh, AI is nearly a synonym in that it also uses, um, data sources, not traditionally utilized.

For example, computer vision. Um, languages, language, you know, answer actual data, but, um, the process, which I believe is our future, our collective future, using data to make decisions that impact the world.

Naji Gehchan: What about personalized medicine?

Dimitris: Personalized medicine is, is, um, also, uh, a very bright, an aspiring future.

If you can, only medicine is by and large, not personalized. This is what, one of the major reason in my mind that we haven’t been in cancer yet. Um, so if you look at how, um, one of these major killers in the world cancer is, uh, I lost my father to that is being treated it’s more or less a size 50. I had this, you, you, you diagnose somebody with cancer.

You give them some protocols that has been, uh, have been developed for, uh, for everybody, not the personal, uh, human, a significant human. We observed very different outcomes. In my personal case around the time that my father was diagnosed with, with cancer, gastric cancer, there was a lady friend of my father who was diagnosed with exactly the same disease and, um, sees a, to.

Um, and see what’s the same way, but it worked for her. It didn’t work for my father. So it is if there’s overwhelming evidence that, um, personalization mothers, I mean, we already see, I mean, we observe that some women, for example, have mutations that lead to development of breast cancer very early in their life.

Uh, at least in this case, we have taken action, but it’s hard for me to believe that cancer is not one disease. It’s multiple diseases who have an composite in one, in one name, and then they meet personally. The attention. This is not only about cancer. I mean, you know, think about, um, think about impact of COVID.

There are many people have COVID very few die, but, but, uh, clearly there’s personalization aspects. I mean, humans are different. They have different genomes. They have different. Even cultural components. They have many different things, diabetes. I, who do I start? I mean, you know, I, I think medicine, when I talk about this is all medicine and personalized medicine.

Uh, these are medicine can lead to personal life.

Naji Gehchan: And we’ve been, we’ve been hearing a lot about personalization in medicine, but yet it’s, we’re seeing a little bit more personalized care. Uh, but what do you feel is in the way, is it truly time technology and time that will get us there? Or do you feel like there’s something else?

Dimitris: I mean, um, the key aspect is education. Thinking about how we educate our doctors. We have not changed the education of our doctors since the 1920s. It’s a century ago. If you look what people learn, um, then, and how they learn it, you know, Does not play a significant only vis education. So when you educate young people, very talented, the doctors are fantastically talented people.

I do not believe they are appropriately educated at the moment. So as a result, you have to educate them in the art of the possible of personalized media. We have some successes. If you, if you educate a large collection of intelligent people, um, so that their mind goes into that, they start doing research, they start doing developing new methods.

Personalized medicine will be a reality, but you have to start. And I would say the key is, in my opinion is education and it’s starting, but you know, it takes as everything in life. It’s not. It takes some time

Naji Gehchan: and it’s, but it’s definitely a future we should aspire for. The last word is spread love and organization.

Dimitris: And organizations you would like you ask, you want to ask do as my reaction, you know, I, you know, in my view, uh, love is this most significant aspect of human happiness. Um, so specifically I say to my, uh, to my students that the two most important aspects of life is to find somebody to. And to find something that you love to do.

So love is in there in the definition of happiness. So spread love is in a way, um, aspires the way I understand it to increase the overall happiness of receivers. As well as givers of love and my, uh, I mean, in a way, one of the reasons I, um, I mean, there’s no security. I love working with my doctoral students.

I have a sizeable group of very young, very, very talented young people. Um, and the big aspect of our relation, at least on my end is luck. So, um, And as I mentioned, um, it increases my happiness increases. There’s

Naji Gehchan: any final words of wisdom? Uh, Demetrius for healthcare either is around the word.

Dimitris Bertsimas: The only, uh, the most significant in my opinion is, um, to, to make change. You have to have. Um, sometimes you enter an unknown, you know, utilizing data. You never know what you’re going to find. You might actually find that one or one of your departments using data.

It’s not doing a good job, but on the other hand, if you don’t know it, it still does it not a good job, but you don’t know it. But if you allow open your mind, And, uh, allow data to enter over time. Fantastic things will happen to patients, which is our ultimate objective as, as health professionals, but also to ourselves, to the hospital, to ourselves.

I think our life would, um, would be, I would say in a higher plane.

Naji Gehchan: Thank you so much. Uh, the interest for being with me today and this amazing.

Dimitris Bertsimas: Thank you. Nice to be with you.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Assaad Sayah

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today Assaad Sayah, President and CEO of Cambridge Health Alliance. Assaad was named CHA’s President and CEO in January 2020 after serving as the interim CEO since June 2019 and chief medical officer since 2013. Before that, Assaad served as the chief of emergency medicine and senior vice president of primary care. In the Emergency Department, he led tremendous advancements at all three CHA hospitals, resulting in enhanced efficiency, quality, volume and patient satisfaction. He spearheaded primary care growth by more than 50 percent, expanding CHA’s access in underserved communities and integrating primary care and behavioral health services and systems to address social determinants of health. Assaad also plays a key role in CHA’s commitment to the communities it serves, including his tenure as the co-chair of the Cambridge City Manager’s Opioid Working Group established in 2018 to develop recommendations for strengthening the city’s response to the opioid epidemic. Additionally, Assaad is Assistant Professor at Harvard Medical School. His research and publications focus on operational efficiency, improving the clinical environment and patient experience of care.

Assaad – I’m humbled to have you with me today!

Assaad Sayah: It’s a pleasure, Naji. Thank you. It’s, uh, truly an honor being here.

Naji Gehchan: Before we dig in, value-based care, the topic of your panel at UH, S H B C, I’m eager to hear your personal story. What brought you to Medicine, er, and now running Cambridge Health Alliance and having such a tremendous impact on the communities you serve.

Assaad Sayah: Well, I appreciate it. Um, um, and, and, uh, it’s a long story, but I will keep it abbreviated. Uh, as far as medicine, um, this is, uh, calling, uh, I, as far as I can remember, I always wanted to be a doctor even before I knew what doctor’s all about. Um, I am the, uh, first, uh, college grad in my family. Nevermind, uh, a medical, uh, uh, professional.

Uh, and, uh, I have the, uh, truly the, the, the privilege of, uh, of representing, uh, my community and, and my ethnic background. I am Lebanese in origin, um, in the, in the greater Boston area. Um, medicine, uh, to me is, is truly more of a calling than, uh, than a profession. And, uh, what, what got me into emergency medicine?

Is two reasons. One, um, I am an adrenaline junkie by, by nature. So, uh, uh, anything, uh, that, that, uh, that’s up and running and, and exciting, I’m into it. And, uh, the second and more important thing, um, it is truly doing the right thing. Cause historically and even, uh, currently the emergency department is the only place where anybody can get care, regardless of their ability to pay 24 7.

And, uh, you know, this is a place where you get care and then we ask you for your insurance card versus anywhere else. Uh, as far that I know, you, you have to present your insurance card before you get your care, uh, for whatever it’s worth. That’s what brought me into, into emergency medicine. Uh, what got me into, um, Uh, into administration is curiosity and, um, uh, my, uh, difficulty in accepting things, not working very well around me.

So I always ask the question, how can we improve things? How can we do things better? And when you ask those questions, people say, well, go at it. If you can do it better, go ahead and give it a try. The more you try, the more you do, the more people ask. And one thing led to the other. And here I am, the c e o.

Wow. Thanks so

Naji Gehchan: much for sharing. Uh, let’s start now with value-based care. Uh, how would you define

Assaad Sayah: this? So, uh, value-based care, um, is, uh, is the combination or the formula that combines. Quality and cost. So if you, if you wanna say value equals quality over cost, the higher the quality, the better the value, the lower cost, the better the value.

The worst situation is an environment where you have low quality and high cost, no value at all. So you wanna improve to the best that you can, to the best you can, the level of quality while managing the cost. And, uh, the difference between, uh, Current value-based care and other attempts at managing healthcare cost is, is the equation that involves quality before.

Because if you go back to the nineties, uh, during managed care, it was only managing cost and there was no alignment of incentives. And with value-based care, one would think that the incentives are aligned between the patient who want the best quality. The organization that wants to provide excellent quality and get the best reimbursement and the payer that wanna manage cost.

And hopefully that combination is the magic sauce that will lead to the best work and the best healthcare environment.

Naji Gehchan: So you’re touching, uh, you touched upon those, um, the key players. So can, can you frame specifically who are the key players and what really needs to change today for us to be able to achieve?

High value based care.

Assaad Sayah: The, obviously the, the, the, the, the three major players in healthcare. I mean, there’s a lot of players you will add the government and policy makers and communities, et cetera. But the, the, the three big buckets are one, uh, the consumer, that’s the patient. And that’s the most important piece of all of healthcare.

We are all here for the patient to do the right thing. And the patient, what the patient wants is great quality and the best experience possible that is timely. Um, and that there’s a level of commitment and trust. Cuz trust is absolutely critical in healthcare. What the provider wants is, uh, the appropriate resources to provide.

The needs and meet the need and exceed the needs of the patient in an efficient way. And that requires funding and the right policies and the right pro, et cetera. And the right training. And what the payer wants is a partnership with the provider where when they give the provider the resources, cuz the payer doesn’t, uh, practice medicine.

The payer is basically the vehicle between the patient that’s paying premium. And the provider that’s providing the care, and they wanna make sure that as the care is provided, provided, it is provided at a good, qu good cost at the good price. The new paradigm is adding quality to the equation, is putting certain metrics, uh, that are reportable, that are measurable, that at least directionally define the level of quality that is provided.

Naji Gehchan: So do you think we’re well equipped? As a society to get there and, and really I would love your thoughts on health equity within the scope. Yeah.

Assaad Sayah: Um, we still trying as far as value-based care and in my opinion so far it is the, the best formula that has the highest probability of success. Um, Believe it or not, healthcare, uh, in general in the United States is all still, um, fee for service, which means you do something, you get paid for it.

Just like, you know, when you, when you call a plumber or electrician to your home, they come, they do the work, you pay them, they’re done, but you don’t know, you can’t evaluate the quality of their work. It could be great for the first day, the first week, the first year, but it could falter after that. And that’s basically fee for service.

There’s an hourly rate. You get paid for it. The incentive in here historically is the more you do, the more you get paid, but that’s not good. At the end of the day. You wanna make sure that you get the best quality, the best value for that job that you are giving to your plumber. Let’s, let’s say that. In the value, in the, in the, in the value-based care, basically, you get paid a certain amount to provide a certain amount of care at a high quality.

So the best way to cut down the cost is provide less. Care or enough care, but with the highest quality possible. And that’s how you manage the level of the cost of healthcare. That’s really going above and beyond. It’s always almost 30% of the G d P today, and some reports say that it’s higher than that.

So it’s gonna break our society if we really don’t manage our cost. Now, when you add the, the equity to the form, the equity piece to the formula, And as a healthcare organization, we are the only public hospital in the state, and our mission is to serve a, a safety net, uh, population historically and continuously.

And that population historically has been underserved and, uh, under-resourced at all levels, including with healthcare, uh, because one. The, the demand is greater. Uh, this is a patient population that has a lot of complication, whether it is mental health or social determinants of health, food, transportation, housing, you name it.

A lot of this patient population is, um, first generation immigrants. Many, uh, they don’t speak English. They have issue, issue with housing density. Many families are, are living in very small sh very tight knit, tight quarters. So there’s a lot of challenges in here. They’re all working, uh, difficult, many low paying jobs to really make ends meet.

Which complicate things. They complicate the ability to get healthcare. They complicate their ability to get, uh, to be transported there, to make certain appointments, to take time off of work. Uh, when they get there, their ability to communicate, understand, and follow directions, ability to get medications and follow medications.

That patient population is very complicated anyways. Not only the immigrant patient population, but also. Uh, the, the patient population that, that is, um, uh, less resourced from multiple ways, whether it’s financial, societal, uh, education wise, or even their ability to have access wide. Um, that’s what equity, uh, uh, plays a big role because historically, uh, we have not invested as a society.

In improving the condition, the, the living condition of, of that subpopulation so we can provide them, so we can keep them healthy and not only care for them when they’re sick.

Naji Gehchan: So can we double click on the, on this, because I know you’re doing a huge work, uh, and impacting those underserved population and you, you shared about social determinants of health.

So can I, can I get your view about this and how you have been leading your organization specifically to improve healthcare delivery for those underserved communities?

Assaad Sayah: Uh, one is you have to identify that community. So we are in the community. Uh, we do have, uh, um, 12 clinics out there all embedded in, in our communities.

Um, All our clinics, uh, have, um, primary care and behavioral health, and to a certain extent even dental involvement. So we can provide comprehensive care to the patient when they get care, get their, not start sort of shuttle them all over the place. Um, we have, uh, invested in, um, in our, um, Uh, multicultural department and, and that’s a department that is for the community, by the community that provides not only, uh, interpreter services, uh, but also support in multiple ways, uh, uh, speaking over a hundred languages, uh, out there, available in person and, um, uh, um, sort of virtually, uh, in our, um, Our ambassadors are not only there to interpret when the patient shows up, they’re also there to support the patient in their community.

So, um, you know, if they need their medication, they’re connecting them with the pharmacy, finding ways to get the medication at a discount, uh, or for free, uh, linking them to certain, uh, resources, um, and grants so they can get appropriate support, not only in healthcare. But in housing, housing, food, social services, et cetera, uh, going with them to follow up appointments, uh, you know, advocating for them, uh, when it comes to immigration, law, et cetera.

So they’re involved at all levels, not only to support that community, their community, cuz they come from that community, uh, uh, in only in the interface with healthcare, but in general to make their, uh, their environment more conducive to being healthy. I

Naji Gehchan: love that being, being there with them. It’s, it’s powerful.

I will now give you a word and I would love your reaction to it. The first one

Assaad Sayah: is leadership. Uh, leadership is, um, setting a strategy and creating a team, uh, that is committed to this strategy and to the work that needs to happen.

Naji Gehchan: Tell us more about it. I’d love to hear your story and how you do it with your teams, cuz you’re, you have a large team committed and I’m sure you’re, you’ve gone through a lot, uh, with, with pandemic and even today with everything’s happening around you. So I’d love, uh, to know how you keep your people engaged towards this purpose.

Well,

Assaad Sayah: I mean, uh, the, the, the most important, um, Role of of A A C E O and I call it be being a cheerleader. Uh, you have to be positive. You have to smile, you have to be a resource, you have to be available, uh uh, and you have to make sure that. Uh, you’re surrounded by people that are smarter than you, uh, and that I believe in, in the mission and the work that you’re doing.

Uh, because one person cannot change the world, they cannot, you cannot do the work yourself. You have to provide the environment and the resources for the people to do the work and the space. Uh, for them to do the work. Uh, it includes trust, which is the most important element in a team. Uh, and it includes clarity, transparency, and accountability.

Uh, and it’s a two-way street. Um, you know, I, I work with my team as a family. Uh, God knows we spend more time with each other than their own, their own, our own families. And, uh, we rely on each other, uh, good, bad or or indifferent, uh, every day to really do the work and make sure that we are, um, uh, maximizing and optimization, optimizing the resources we have, the opportunities we have to better serve the community and support each other.

I love it. What about care delivery? Um, care delivery, you know, I, I, I don’t like that word, to be honest with you, that, that, that terminology, uh, because it’s so narrow, believe it or not. Uh, but, but in general, uh, care delivery is, uh, um, meeting and exceeding the expectation of, uh, of the patient in the communities.

And, um, going above and beyond, uh, the healthcare system can do so much and has the ability and resources to do so much, unfortunately, that is not matched with the needs and it’s not matched with the expectations and the knowledge of, of the patients in the community. So we can do, we can do a lot more than than, than we do and, uh, and we should be able to do a lot more than we do.

So, um, care delivery is, Traditionally is the organization that provides care to the patient when they’re sick, when they need it. In my mind, uh, the best way to improve care is to, uh, provide, uh, what’s needed, what’s necessary for the patients to remain healthy in their communities and not need. Prevent them e every time a patient comes to the hospital or most of the time they come to the hospital, it is a failure of the care delivery system in my mind.

So the ultimate success is be out of business, believe it or not, and, and decrease the gotcha the needs, the traditional needs of the patient to really consume the amount of care that they consume.

Naji Gehchan: So true. You’re touching on prevention, how we do it, health

Assaad Sayah: education, absolutely. All of the above. All of the above 80% of people’s health or over 80%.

Happens outside the traditional healthcare system. It is what happens at home. It is the habits that happen at home, whether it’s, uh, smoking, obesity, you name it, drugs, alcohol, psychological issues, uh, food, transportation, you name it. Uh, that’s what influences people’s health. You know, there’s a, there’s a piece that’s related to the genes, what you’re born with, and there’s a piece that’s related to everything else we do to keep you healthy.

But the big chunk of it, uh, is what you do every day. And that’s what we need to invest, where we need to invest in early prevention, in screening, in early childhood, uh, screening and prevention in education of the families and the kids. So they have, uh, healthy habits so they remain healthy. So the third

Naji Gehchan: one is health equity.

Assaad Sayah: Um, health equity is, and this is not equality and this is not, it is basically, um, be thoughtful and purposeful in defining and bridging the gap. Uh, in the gaps in our society between the, um, safety net and the rest of the population, the population, that that has a gap. And so it’s not giving everybody an equal amount, it’s defining the gap and providing extra resources to bridge that gap at all levels, whether it is in healthcare or you name it.

There is equity in the, the digital divide. There’s equity in finances, there’s equity in education, there’s equity in healthcare, there’s equity in culture. I mean, you name it, there’s a historical gap, uh, that happened over decades and hundreds of years that, uh, The only way to, to, to, uh, mitigate that is to provide the appropriate resources to bring, to narrow that gap.

So the amount of growth and the amount of resources has to be exponentially greater here, so we can make up that gap with time. Otherwise, if it’s equal, there’s always be gonna be, there’s always gonna be a gap. The last

Naji Gehchan: word is spread love in organizations.

Assaad Sayah: Um, As I, we talked about trust. We talked about working as a family.

We talked about, uh, approaching things, uh, the way you wanna approach things, the way you should be approached things. And, and I have, uh, certain, um, rules that, that I live by. Uh, one of the rules that you hear about is, um, uh, you know, treat people as you wanna be treated. And, and that’s not my rule. My rule is you gotta treat people the way they wanna be treated.

Uh, because there’s a big difference. You can assume. How you wanna be treated. And, and that may not be satisfactory to others. And I think that’s a very important piece in love because you cannot, when in love, you cannot project your own definition. You have to project the other person’s definition of what love is about because that’s what matters is to the other person, is what they define it, not how you define it.

And that is true across all our society. Uh, and, and, If we approach things the right way, the way we conduct and live our life, not only professionally but with family and neighbors and society, I think that’s what matters is treat people the way they want to be treated.

Naji Gehchan: Any final word of wisdom has had for healthcare leaders around the world.

Assaad Sayah: Um, do the right thing. That’s another, that’s another piece. Um, and, you know, you’re always cha uh, seeing challenges and, uh, always facing issues that sometimes are insurmountable. But at the end of the day, we are all judged based on the work that we do. And, uh, at the end of the day, uh, the best way to be judged is for doing the right thing and sometimes.

Um, it may not be the most beneficial thing or the most lu most lucrative thing, uh, but doing the right thing always at the end of the day will lead you to the right place.

Naji Gehchan: Well, thank you so much. I, I can talk with you for hours, but, but I know you have to go and it’s been a really, an incredible pleasure to have you with me today.

Thank you so much for joining me.

Assaad Sayah: Pleasure Naji, and good luck to you. Thank you very much.

Thank you all for listening to Spreadlove in Organizations podcast! More episodes summarizing the MIT Sloan Healthcare and BioInnovations Conference are available on spreadloveio.com or on your preferred streaming app. Follow “spreadlove in organizations” wherever you listen to podcasts and spread the word around you to inspire others and amplify this movement our World so desperately need.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Andrew Plump

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this special episode in partnership with MIT Sloan Healthcare and BioInnovations Conference, an event that brings the Healthcare Ecosystem Together. I am joined today Andrew Plump President of Research & Development and Board Member at Takeda. His career spans nearly 30 years in the pharmaceutical industry and academia. Andrew has been recognized for his contributions to the healthcare industry, education and the arts. He serves on several non-profit boards including the Board of Trustees for the Boston Symphony Orchestra, the Sarnoff Cardiovascular Research Foundation, the Biomedical Science Careers Program and as Chairman of the Board of Directors for the PhRMA Foundation. Prior to Takeda, Andrew served as head of Research & Translational Medicine, deputy to the president of R&D at Sanofi, based in Paris, France. Prior to Sanofi, he served as worldwide cardiovascular research head at Merck. Andrew received his M.D. from the University of California, San Francisco (UCSF), his Ph.D. in cardiovascular genetics and his B.S. from the Massachusetts Institute of Technology (MIT). He completed a residency in internal medicine and a fellowship in medical genetics at UCSF.

Andrew – I’m humbled to have you with me today!

Andy Plump: Hello Naji. And, and thank you. Uh, thank you so much for the privilege of joining you on this terrific podcast.

Naji Gehchan: Thank you. Before we dig in, challenges in scaling biotech innovation, the topic of your panel at, uh, S H P C, uh, I am eager to hear more about your personal story, really what brought you to medicine than pharma and now leading R n Z at Takeda.

Andy Plump: Well, it, it just so happens the timing for that question is impeccable because this past Sunday I gave a talk, something I’ve never done before. It was actually a mentorship talk to a group of. Emerging diverse, uh, scientists and clinicians and organization called the Biomedical Sciences Career Program or B S E P, I think you mentioned.

I sit on the board of this, this organization, and it’s an organization that’s existed for 30 years. Has about 10,000 members, incredible individuals. Many come from underprivileged or marginalized beginnings, so motivated to, to grow and to make the world a better place in, in life sciences. So I had a chance to give a talk and I was able to unpack some of my beginnings.

And so, so I thought through this and. This is audio so nobody can see the picture. But I had a slide that had a picture of me in my 1970s plaid bath, you know, bath ba bathrobe, um, with my mom at the age of four. And then a picture of me in, uh, uh, tuxedo actually as I was getting married in 1992 with my dad.

And, you know, and I think back, it’s, it’s a large measure to my parents and to my, my upbringing when I start to think about my journey. And there’s one piece of my childhood that was enabled so wonderfully by my mom and my dad that has really carried me through these many years, and that’s curiosity.

I’ve always been so interested and curious in what’s happening around me. And the two stories I told at the conference, which I’ll share with your, your audience, Naji are my mom at the time that I was four years old, maybe three, three and a half, with, in that bathrobe I was the third born. We ultimately had five of us in the family, but the twins were, you know, unexpected.

And so I was meant to be the youngest child of, and I had an older brother and sister who were five or six years older than me in school, and I would just, Follow my mom around everywhere and ask her question after question after question, and finally she looked at me one day and she said, Andrew, It’s time for you to go to school.

And the other question that you know resonated was I told, took my dad aside very earnestly one day and I said, dad, you know, if you could bring the person who had all the answers in the world and give me that person for a full weekend, I still wouldn’t be able to ask as many questions as I have. So curiosity has been what has propelled me.

Naji Gehchan: But thank you for, for sharing, uh, Enzi and I, I love how you’re bringing it, uh, with the fact of being curious. And, you know, I, I was thinking as you were saying this, how many times we actually as parents make this mistake of stopping our kids from asking so many questions. And I, I’m, I’m sure you, you throw.

By asking questions and learning. So now if we go into really the challenges in scaling biotech innovation and what you shared, uh, during the conference itself, I would love first your view on the most exciting current innovations in biotech. How do you define those? How do you look at those personally.

Andy Plump: Well, I, I, we’re in a golden era of healthcare, and if we get it right by the end of this century, we, we can have a, um, a therapy, maybe even a cure for every disease that’s, that’s known to Man. There’s no question we have all of the tools and foundationally there are, they’re the three pillars that allow us to be so bold and aspirational.

Our human genetics, we learn so much. But by dissecting the human genome in terms of target identification, in terms of somatic mu mutations that affect cancers, that’s one. The second is tried and true mechanistic biology that typically occurs in academic laboratories. So thinking through what it takes to generate a hypothesis and test that hypothesis in unraveling biology.

Our ability to do that at scale. And it’s not systems biology. Typically it’s an individual student or a postdoc, really thinking through the details of a, of a problem. That’s the, that’s the academic medical system that exists today. And then thirdly, this explosion of modalities that has come about over in principle in, in particular, over the last decade.

When I started in this industry, we had 90 plus percent of the molecules in pipelines were synthetic small molecules, natural products, or vaccines. Now if you look at the aggregate pipeline across our industry, those three form the minority. We have recombinant proteins, we have genetic therapies of multiple flavors, and we have cell therapies.

And so our ability to put these three together allows us to have the courage and boldness to think that we can tackle any disease. And in fact, the last 10 to 15 years has, has told us that, that with this toolbox we can, we have the potential to do anything that. That we can now, there are forces that work against us.

You know, one, one are intrinsic forces to our industry and it’s greed and avaris and, and behaviors that damage our reputation because we’re a highly regulated. Industry, what, you know, what we do really matters. Not just, it’s not just a business. There, there it, there’s a right to healthcare. And when we are, when we’re egregious in our pricing, when we, um, fail to abide by the compliance and quality codes that countries ask us to abide by, we’re damaging ourselves.

That’s our own intrinsic potential roadblock. But extrinsically, there are many roadblocks and we’re seeing this with. Regulatory agencies, which, which move up and down in terms of their conservatism. And we’re moving today towards a much more conservative regulatory landscape, particularly in the us. Um, there’s reimbursement policies, you know, especially in, in Europe, it’s, it’s very hard to demonstrate in diseases where you have existing therapy, um, that you have a better therapy that, that deserves reimbursement.

Because, because it’s impossible to show oftentimes in head-to-head studies. Um, that you are better and, and that’s what’s being asked of us. And so, so there’s, there’s, there’s this, um, the, the, this tunnel vision, I think that’s happening. We saw this with Ira, was having conversations recently, the inflation reduction act.

There are elements of IRA that make a lot of sense. We need to reduce costs in the US for patients, but there are a lot of elements in the I I R A that will squash innovation. So huge potential, but also, uh, huge, huge headwinds. So let’s

Naji Gehchan: double click, and I love how you framed it and so agree with you on the interest intrinsic, uh, roadblock that that we bring and those external ones.

And when we think about those innovation biotech, we’re frequently think about those nascent biotechs, those startups who are trying. To nail down one of like the most challenging targets, the most challenging technology science. Whe when you think of those, wh wh where do you see the biggest challenge for starting a biotech?

Like if, I want to think from those startups, what are the main challenges for them in 2023 after probably a boom in the last decade? How do you see those these days?

Andy Plump: Well, it, it’s, it’s a terrible time right now for, for the biotech, uh, ecosystem. And the, the, the challenge is getting funded right now.

There’s, there’s, there’s still a tremendous amount of venture capital available, but there’s a, there’s a, uh, fear a bit in, in the market, and so there’s been much less investment in new ideas. Now than there have been in the past. I, you know, we’ve seen cycles like this before, so I’m, I’m convinced that we’ll cycle out of this and that we’ll end up in a better place.

I don’t know if that’s gonna take a year, three years, or five years, but we’re in a particularly depressed market. So funding for biotech is, is taking a, a really big hit. But I think there’s a more fundamental concern, which gets back to my comments earlier around some of the extrinsic headwinds that we’re facing.

It’s just, You know, when you’re, when you’re dealing with more conservative regulatory agencies, more challenging reimbursement, um, environments, when you have the country, the country in the us which is responsible for 50% of reimbursement on our industry starting to really limit, um, access and, and price, um, that’s a problem for biotech because it all.

You know, it all cascades downward. And the starting point for most innovation is biotech. You know, two-thirds of what any pharma company will ultimately bring to a patient in the marketplace starts in laboratories outside of our own. It starts in biotechnology laboratories and academic laboratories.

And so if we’re not funding that and supporting that early innovation, it’s going to greatly damage, uh, access for patients.

Naji Gehchan: So I’d love to double click on the access piece because as you said, breakthrough innovations, uh, and really in a global environment that is becoming more and more challenging to bring those innovations, not only from an r and d standpoint, but once they are in the market to patients across the globe.

How, how do you think about this in a global aspect, again, of those breakthrough innovations for. All patients who need that.

Andy Plump: Yeah. And maybe I’m not using the word correctly. Cause when I’m, I’m talking about for biotechs, it’s not about access, it’s about actually being able to make a medicine, having it approved and having it reimbursed at some level.

And that doesn’t, that’s not, you’re right. That’s not the same as access. And in fact, when I think of access, I think about it in the context that you’re articulating, which is access to the seven plus billion people across the globe. But even within the United States, you know where you have 300 plus million individuals and you have marginalized and underprivileged groups who have poor access to many of these medicines, and we saw that in during the Covid Pandemic.

When you looked at the groups that were most affected by this lethal virus, it ended up that many of the more marginalized, socioeconomically depressed groups were much more affected. So we have an issue here in the United States that we have to get on top of. Of course the issue on the global scale is, is much larger.

You know, many companies have, global pharmaceutical companies will have marketing presences in 30 or 50 or 75 countries across the world. And so more than 50% of countries are not actually represented by commercial organizations. And that’s a real problem. It means we’re not developing, studying our medicines in those other countries, and we’re not bringing our medicines to those countries in in a systematic way.

Um, I think, I think we’re, we’re up and down in, in access, you know, one area where we’re, we’re, we’re driving immense accesses in China. You know, where you have, you know, one point, what is it, 1.4 billion people, which means 1.4 billion potential patients. And you know, What, what the Chinese, the C D E, the C F D A, the regulatory equivalents in China have done over the last eight or nine years.

China has made it a mandate that we, China wants innovative medicines available for its population. And so they’ve overnight, it feels like they’ve changed the regulatory policies to enable development in China, and they, they’re stimulating innovation. So an example, the c d E, the one of the, the F D A equivalent essentially had listed a couple of years ago what they consider the top 50 most innovative medicines.

And they said, we know we, we want you to be developing your medicines in Chinese patients, so we understand how those medicines perform in pat in patients in China, but for those 50, let’s just register them and then you commit to a phase four study to study them after they’re registered because they’re just too important not to be available to patients.

So that’s a great example of a business model for companies. Company stepping in and, and a government really opening up the for, for those individuals. But we have a long way to go. I agree. We have a long, long way to go to, to achieve access at the scale that each of us would, would truly want. Now thanks

Naji Gehchan: for this example.

It really shows this collaboration of stakeholders at the end. And if we really can work as partners, uh, the, you know, co every time I think of this, I think of Covid and how we developed and brought innovation with speed, like vaccines, treatments, et cetera. Cuz we were all together. Uh, As key stakeholders of the healthcare for the patients we serve, keeping the patient at the heart.

You talked about funding. I would love to hear your view about not only funding for biotech, which is a ch obviously one of the biggest challenges, but what is the role of leadership in building up and scaling biotechs?

Andy Plump: Leadership in, in what context? Within the companies themselves? Yes. Yeah, in the ecosystem.

Oh, well, I mean, everything is about leadership. You know, I, and, and I can take, I I’m asking for you to qualify the question because I can take it in so many different directions. You know, I think it starts with policy and how we, as we’re talking about and how, how, how, let’s just focus on the United States, how we create policy, regulatory policy, reimbursement.

Policy pricing policy, that’s leadership, and there’s a trickle down effect if we’re too shortsighted about some of the decisions we’re making. I mentioned the inflation reduction Act, where there are many provisions that are absurd and will destroy innovation. I’ll give you one example, by the way, which is that there are provisions in ira, which allowed.

The cms, which is the kind of federal agency that manages pricing for Medicare and Medicaid products. There are provisions that allow CMS to step in and to negotiate price with a sponsor. That’s okay and and there as long as that’s managed correctly. But that timeline for when C M S can step in and negotiate is different if you’re a recombinant protein or a small molecule.

If you’re a recombinant protein, they can step in at 13 years, and if you’re a small molecule, they can step in at nine years. Why? It makes absolutely no sense. In fact, it should be the opposite because it’s much harder to make a generic version of a recombinant protein than of a small molecule. But the reality is both can be transformative in terms of their potential for patients.

That’s an absence of leadership. That’s, there’s, there’s something behind that. I’ve actually spoken with many former, former officials in the, in the government, several ex FDA chiefs, to try to understand where that’s coming from. And the only answer I can get is there’s, it’s politicized in some way, in ways that I can’t even begin to, to understand that’s poor leadership.

So leadership is important at, at all levels. There’s, there’s also, there’s also something about our business, which I find quite interesting, which is that, Our business is somewhat stochastic, right? You can be, um, you can have poorly run organizations and toxic organizations that can do quite well for a short period of time, and maybe in your career you’ve been in bad situations that you were just not happy as an employee for where a company has done well.

It’s actually very hard in most sectors to sustain yourself for any period of time when you have a toxic culture. In our industry. You’ve had many companies that have been able to do that. Now, of course it’s, it has a runway. If you have a toxic culture, bad leadership, you will. You will Peter out. But in our industry, because our life cycles are 10 to 15 years, if you have a Keytruda and you’re America, not suggesting that Merck is a toxic culture, but that can propel you for, you know, 10 to 15 years and give you an immense amount of funding for that period of time.

And so you do have organizations where you have bad leadership, where you, you see stochastic breakthroughs. Oftentimes they’re not because of brilliance or because of luck, and that happens in our business, and you can sustain those environments, but I’m not advocating for that. But really, if you wanna be successful in the comp, in the environments that we work within, where the, the competition for talent is so intense, especially in your area, Naji in oncology where everybody is in oncology and there’s such a talent, a dearth.

If you’re not leading, if you’re not creating cultures that are positive cultures, you’re gonna, you’re gonna lose there. There’s a great line that now I think every biotech c e o uses, which is, excuse my language, but the no asshole culture right now. But, and actually that was something that 10 years ago, I don’t think anybody was really that concerned about.

Cause everybody was so caught up in that stochastic luck process. But now everybody tries to create a culture that’s strong and, and leadership is the foundation of all of that.

Naji Gehchan: This is a great segue to the next section where I would give you one word and I would love your reaction to it.

Andy Plump: So the first word is leadership necessary.

So I, did you want a one word reaction or did you want a Uh, you can give more. Well, I mean, I’m just shaking my head because it’s very interesting. I’ll take an aside here. Cause you’re, you’re, you’re, you know, you’re, you’re kind of, um, rattling you, you’re sha you’re shaking me, and then you’re, you’re hitting a chord.

So, so one, one of the things that struck me in r and d in our industry is that oftentimes the leadership within r and d organizations, Is more variable than what you see in in other parts of, of our organizations. You know, for example, to be a commercial leader, you obviously need to be smart, you need to be accomplished, but you know, you, you’re often selected more on your leadership.

Whereas in r and d organizations, especially in in highly technical areas, you know, where the pool size of individuals gets to be quite small. Where accomplishments and intellect and technical expertise tend to be valued more greatly, let’s say, than leadership. You’re often seeing organizations promote individuals based on their technical merit merits in intellect accomplishments rather than their leadership.

And so many r and d organizations are mismanaged with, with poor leaders. And, and actually it kind of makes some sense because you’re. You’re, you’re we’re dealing with people who have trained as physicians, who’ve trained as scientists and as engineers and have never really thought about leadership. So I think it’s abs it’s an absolute necessity.

And one of the things I’ve done, you know, I we’ll see if this will work out at Takeda cuz, cuz our we’re judged over a long period of time, is I’ve first and foremost emphasized character and leadership. Technical excellence expertise is a necessity, but you can’t be on my team unless you have strong leadership chops, uh, and strong character.

The next word is health equity a problem. I mean, you know, it’s, it’s a challenge and actually, um, we come out of covid. And there’s the, you know, the, some of the silver linings that come out of the pandemic are a recognition of the inequities that exist in society and what, what make, what’s quizzical about my saying that is, why should that be something that we’re, we figure out in 2022 and 2023, this has existed for decades and centuries.

Um, you know, hopefully these realizations will stick and something that I’ve really. Um, become more and more aware of and more cognizant of my, my privileges as a white male and my responsibilities in terms of being an ally and stepping up. Um, we have a long way to go and, you know, fundamentally it starts within r and d, certainly within our institutions, ensuring that we’re creating cultures that are diverse, equitable, and inclusive.

And all three of them, not just diversifying our, our population, but ensuring that we’re listening and being truly inclusive. That’s really requires learning, education and growth. Um, but then as we start to think about the patients that we’re aiming to serve, you know, if we’re not studying the effects of our experimental therapies in diverse patient populations, we’re doing.

An injustice to, uh, to those patients and, and not contributing to health equity. And so it starts early on in the process. And when you look at, um, when you look at industry across the industry and you look at clinical trials, they’re still nowhere near where they need to be. I think we’re on the right track.

You have guidances coming out of, you know, f FDA for example, and other organizations. So I think we’re all moving in the right direction, but it’s something we all have to own. And I still don’t see that ownership as. Uniform is, is what it needs to be. Even within my organization where we have, you know, there’s a huge foundation and focus on health equity and clinical trial diversity, I sometimes listen in meetings and, you know, it’s not oftentimes the first thing that are, it’s brought up when we’re talking about our program.

I think if we’re really equitable, we’re really thinking about health, equity and access. It’ll be the first or second thing that comes up in almost every conversation, and I just don’t, don’t see that we’re not quite there yet. I love

Naji Gehchan: it. I can’t agree more with you on diversity. Not only it starts internally, as you said, this is parts we can influence immediately, but definitely clinical trial diversity is a big, is a big topic we need to be

Andy Plump: focused on as leaders.

No, on this point I was, I mentioned this talk I gave on Sunday, which is a very, Powerful talk for me. It took a lot of time, a lot of preparation, and I thought a lot about it. It was not an easy talk to give, but my second slide after my title was two people sitting on a couch and in between the two people was a big elephant.

And I said, here the elephant in the room is here I am a 50 something white male. Talking to a group of 500 diverse, aspiring, um, healthcare and life scientists. You know, but, but the elephant, so what can I tell you? How can my experience help help you? And so my, my, my theme was that there are, there’s a perspective that I have that that can be helpful to anybody.

And there’s also a recognition that I have that we all, we all have our identities and our identities will shape. Our, our lives and our career, and for some of us, we’re able to be more opportunistic because of the color of our skin and our gender perhaps. And for others, we just need to be more purposeful.

But it’s not, it’s not incumbent. On just the diverse, marginalized individual. It’s incumbent on all of us to step up and to ensure that we’re helping create more, more equity in the world. And that’s where I think my, you know, my responsibility is as someone who’s actually experienced so much and through a life of white privilege.

The third

Naji Gehchan: one is, uh, symphony Orchestra.

Andy Plump: It’s, I mean, the Boston Symphony Orchestra. So even more specific. Yes. Are you, are you musical naji? Are you musical yourself?

Naji Gehchan: Yeah. Yeah. Guitar and piano.

Andy Plump: Well, so, okay, here’s the story. I went to school, uh, pointing this way cuz Mass is right behind me. And m i t is right after the road. I went to school at m mi t as an undergraduate, and I’m not particularly musical, but when I came to Boston, it was a town.

I mean, it’s, it’s changed so much. It was a town with m i t and Harvard and then Townies, you know, and it had a very unique kind of small town culture, but there was one institution. That was that, put it on a world scale and that was the Boston Symphony Orchestra. And so I, I loved the institution. Um, six or seven years ago, uh, I, we, we actually at Decat became sponsors of BSL because we were trying to, we were trying to imprint ourselves in, in Boston and nobody knew who we weren’t, right.

And it was trying to hire and build an r d organization here. And I would talk to people and they would say, Taketa the airbag company, like, no, no, Takeda. So we needed to, to, to, to market ourselves a little bit. And so we had two opportunities. The Red Sox, the Boston Red Sox, or the Boston Symphony Orchestra.

I’m a New Yorker. I could never, I could never promote. And I’m a big fan of the Boston Symphony Orchestra. And so we became involved and then I got involved in some fundraising and some development efforts, and I realized how how distanced the life science community in Boston was from this iconic institution.

So you had to me, now today in Boston, there are two defining elements. There’s BSO and there’s the life science community. And so it felt like a match made in heaven and I was able to help to catalyze, um, that that match and. A couple years ago, they asked if I would be willing to step up and serve on the board of trustees, trustees, which of course, I, I, I’m more than willing, and it’s been an amazing experience.

And

Naji Gehchan: the last one is spread love at organizations.

Andy Plump: Well, I’m looking at you and I’m, I’m, you know, I didn’t, I have to be very honest. It’s one of my Achilles heels. I didn’t know about your podcast or your, your group until I was a, until I, I met your colleague. What was her name? Z. Z Zena. Zk. Zano, yeah. Z.

After my, after the panel at m i t, she came up to me and, uh, we talked for a few minutes and she asked if I would do this, and she told me a little bit about it. And, um, you know, I was more than, more than pleased to step in and, and I love what you’re, what you’re doing and reaching in and helping the, our community grow.

And asking the kinds of questions and that many people don’t ask. I never get asked about the Boston sy new orchestra. I get asked about leadership, but it’s not the most common thing I get asked about. And so the way you’re approaching this and the way you’re opening up our community to, to unique perspectives, perhaps from standard people like, like me, I think it’s really terrific.

So thank you for doing this and congratulations.

Naji Gehchan: Oh, thank you, Angie. That means, that means a lot. Any final words of wisdom for healthcare leaders around the world?

Andy Plump: Well, I’m an internal optimist, you know, and I, I, I have to be in our business, as you know, Naji, cuz a lot of what we do doesn’t work. And so you need to really be optimistic, um, and.

You know, as I said earlier, I think we’re in the golden era of, of healthcare and I, I, i, I, I don’t know if our, if these decades will be remembered for life science or for computer science, cuz both are making huge headways. Um, but okay, but I’ll, I’ll tell you a bit of an, an analogy. So in, in, in history, there are dark periods of time that are often characterized by war, by pandemic and by social injustice and unrest, and we’re just coming out of one with covid.

If you look back in history, there are many very similar examples that are characterized by that same triad of, of darkness, always. These dark periods are bookended by greatness, and typically that greatness is scientific or technological. You go back to the 19 early 19 hundreds with Albert Einstein, for example, world War I, and then some of the work that came after World War I was Sir Arthur Edington.

Um, you go back to the 1960s with the difficult period. Bookmark by greatness in our in space exploration. And if you come to today, we’ve established a left bar benchmark in my mind of this dark period, and it was the work that came out of Jennifer Doudna and Emmanuel Chappen with crispr. What we can do in terms of genetic manipulation is just amazing, and the potential for disease is just incredible.

I don’t know what the right bookmark of this dark period will be, but the people who are listening to your podcast will be defining it, and I have to imagine it’s gonna relate back somehow to our ability to manipulate our genome and create good.

Naji Gehchan: Well, thank you so much, Andy. It’s such a great way to finish up with an opening on hope for after all the darkness, as you said with the triad we’ve been going through.

Thank you so much again for being with me today. It’s been a privilege. Thank you.

Andy Plump: Thank you very much. Naji.

Thank you all for listening to Spreadlove in Organizations podcast! More episodes summarizing the MIT Sloan Healthcare and BioInnovations Conference are available on spreadloveio.com or on your preferred streaming app. Follow “spreadlove in organizations” wherever you listen to podcasts and spread the word around you to inspire others and amplify this movement our World so desperately needs.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Michael Ullmann

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Mike Ullmann. Mike retired from Johnson & Johnson earlier this year after over 33 years with the Company.  For the last 11 years, he served as a member of the J&J Executive Committee and the Executive Vice President, General Counsel leading a global organization of over 2,000 employees in 60 countries encompassing Legal, Government Relations & Policy, ESG Strategy, Intellectual Property, Corporate Governance, Data Privacy, Compliance and Security.  As General Counsel of the world’s largest Life Sciences company, he successfully guided JNJ through high-profile and high-risk situations, while helping to grow the business to annual sales of $94 billion, increase shareholder value and maintain its reputation as one of the most admired companies in the world. 

Mike – It’s a pleasure to see you again and have you with me today!

Michael Ullmann: Oh, thank you, Naji. It’s a pleasure to be here, and thank you very much for inviting me.

Naji Gehchan: Can we first start with your personal story, the in between, the lines of your journey to the exec committee of j and j and the inspiring leader you are today?

Michael Ullmann: Well, look, you know, I, I like to say Naji, that, that first and foremost, um, I’m a husband, a father, a son, uh, a grandfather, uh, a friend. Because I do think it really starts, um, with who you are as a person. And I think that, um, leadership really devolves I think from that, that individual level. And I think one of the things that we’ll talk about today is that balance between the individual and who you are as a leader and leading a large organization.

Uh, because to me, Um, in particular leading an organization of several thousand people, um, you always have to make sure that, that people see you as a person, as an individual, and that you’re not just a figurehead or you’re someone up on top of an organizational chart. And so I would always, um, in any of my conversations in, in any time I talk with people, Uh, would let people know what was going on in my life, and not, not to the extent of just talking about myself excessively, but just acknowledging, Hey, this is, uh, this weekend, uh, we had a, a birthday party for my grandson, and then I, I played golf.

And so, you know it just a little bit about who you are as a person. And so that’s what I like to talk about. Um, when I start off. And then look, I think that, uh, my story as a leader, uh, probably like many leadership stories is not a straight line, or certainly not like a straight upward line. Uh, you know, there are some twists and turns along the way and, you know, I, and I think, uh, happy to, you know, talk about that, uh, just to kind of trace my journey.

Yes, I’m,

Naji Gehchan: I’m

Michael Ullmann: eager to hear more about that. Yeah, well, look, you know, I think, um, to some extent I think my, my leadership journey was somewhat unexpected. And, you know, I, um, in fact, uh, when I was in my twenties and early thirties, um, I don’t think, uh, in fact I know for a fact that people that knew me, uh, did not expect for me to end up where I did.

Um, I, I wouldn’t say that I was a slow starter, uh, but I certainly was not like a shooting star and a wonder kid that everyone thought from, uh, day one in the workplace that I was going to be super successful. Um, and I think what I’ve learned was that, um, you know, for every person, there’s a, there’s a right environment, there’s a right role.

There’s a right company or organization. And so I didn’t really change as a person, but I changed jobs, I changed roles, and then eventually, um, I think I found the right environment and the right role where I could flourish and achieve my potential. And, and so, you know, part of why I like to focus on this is that.

Um, I’d like to tell people, look, if you don’t feel like you are achieving your potential in your environment, yeah, it may not be you, and it may not be the environment or the company, right. It may be that this is not the right match. And don’t, don’t be afraid to, to make a change. Don’t be afraid to do something different until you find the right, the right company, the right match.

Um, because you’ll hear people say, oh, well, like, that’s a really good company, or That’s a bad company. And I think it really depends upon, you know, what’s the right fit. Now for me, the right fit was eventually when I got to Johnson Johnson and being able to fill a multitude of roles. But then secondly, I think the second part of my, uh, leadership journey.

Was that I was not particularly ambitious. And you know, that’s probably not what you hear from many of the leaders, you know, that, that, that you talk to. But I was very happy with my life. Um, you know, my wife and I had been married a few years. Uh, we had three kids. Um, I lived close to where I worked. I was, you know, focused on trying to be a good father.

And, uh, and I loved my job, so I was certainly working, but my feeling was, Hey, I wanna do a good job. I’m in healthcare. And we can, we can certainly talk more about being in healthcare later on. Um, but it was, look, let me, uh, let me find that right balance, uh, you know, work life, home life. Um, but I think because I was not overly ambitious, What I focused on at work was helping other people succeed.

It was, you know, how do I help, uh, the people I’m working for succeed? How do I help my, my colleagues succeed? Uh, you know, at the time I wasn’t managing people, so it wasn’t helping people, uh, you know, that I was managing. But I was really, look, let me, uh, do what I can to make the company successful, to make my colleagues successful.

Um, ultimately that was recognized and appreciated and that began my journey as a leader, I think, in part because I was perceived as someone that was, um, you know, looking for the success of the organization, not for my own success. And then I think ultimately that kind of transitioned into the type of servant leadership.

That, you know, I have always been a proponent of and as I’ve moved up in the organization, tried to follow.

Naji Gehchan: I love that. And thanks for sharing first and really, you touched on incredible co uh, concepts. I would like to go and dig a little bit deeper. I loved what you said about the fit and this is why I was smiling, cuz even, you know, we’ve seen people who were, who are unhappy or performance is not there, and that’s one of my beliefs.

It’s probably the casting. And as leaders, we have responsibility for our people to, to share with them this, because every time we talk about servant leadership, people mismatch performance. Like how do you deal with performance? Actually, if you really care about your people and they’re not performing, you’re gonna tell the person.

Help them out find a better fit if it’s really a job fit as you shared. I, I, I love this part too. Um, I, I’m sure it’s hard to kind of summarize 33 years of, uh, of your experience at, uh, at j and j with one leadership learning, but I would love to kind of go there if there is one. What, what is the biggest.

Leadership learning during these years, that is also what you would like to transmit for, uh, for leaders moving forward?

Michael Ullmann: Yeah, look, um, there are obviously many, uh, learnings I could share, but it, but if I had to pick one, I think it would be, um, a sense of humility, right? Meaning that, um, I, I never felt that I had to have all the answers.

In particular because I, I was fortunate enough to lead a, uh, very large, you know, organization in many different areas, but I always felt that my job was not to be a, a superstar. My job was to, you know, be kind of, uh, the person that would motivate, empower other people. And I think if you surround yourself with good, smart, hardworking people, And you, you trust them and you give them the, the latitude that they need.

That that’s really the, to some extent, the secret sauce of leadership, at least in a large organization. And you know, to some extent, well, what I’m about to say is not very humble. And so when I talk about humility that may, it may not quite sound that, uh, I have humility, but I do think that. That, um, that level of humility that I had, which is, look, if the, if it’s the people around me who are shining, like I don’t need to shine as the leader, uh, because they, if my organization does well and we are accomplishing even more than what’s expected of us, then that will reflect well on me as a leader.

And I, I think that, um, That sometimes is counterintuitive to people who feel that if I’m a leader, I, I need to make sure that the most senior management, you know, sees me as the critical part, the critical hub in the wheel, that I’m the one that’s really making everything work. And I was always very comfortable just kind of, again, I have, I’m not a wallflower.

But I was very comfortable making sure that the people around me had that opportunity to make decisions to, to show what they knew. And then frankly, if you do that, you attract better talent. So it becomes somewhat self-serving because you know, good people want to work somewhere where they’re gonna get recognition and they’re gonna be respected.

And they’re going to get that type of exposure that they want.

Naji Gehchan: So Mike, I’m obviously a big believer of what you’re saying and and truly thank you for highlighting those important pieces. You know, I can, but think about some of the leadership today and some of like those who are in big lights. With quite the opposite actually of what you’re describing.

Like those who want to be in the light and reading dark organizations. And I, you know, I don’t want to go into politics also, but it’s those type of leaders obviously that you’re reading a lot about. Uh, and, and sometimes we’re discussing about kids before I’m, sometimes I reflect on this and why are those leaders having most of the lives?

While we both know the, the negative effect of this type of egocentricity, I, I’d love to get your reaction, how you think about these pieces and if, if you’ve ever been challenged about the way you lead people. You talked a lot about humility, shining through others, putting the others in the front, helping others be successful.

Have you ever been challenged on, on your style of leadership being too nice too kind? Several people I talked to, they would tell me. You know, I’m considered too kind. I’m too nice. What, what, what would be your reaction to this?

Michael Ullmann: Well, you know, naji, um, kindness is one of my favorite words. And, and I think it is underused in our society.

And, and interestingly enough, um, you know, I, I would use the word kindness to describe my leadership style. Now, I think that kindness though sometimes is, um, Is misinterpreted, right? Kindness doesn’t mean that, you know, every employee gets an A plus, right? Kindness doesn’t mean that, um, everyone is wonderful and does great at their job.

To me, what kindness means is treating people with respect and trusting people. Um, but you know, there are times where. Um, you do as a leader have to make tough decisions. Uh, and even there, you can do that with kindness. Uh, you can do this in a respectful manner. Um, so did I ever get challenged in my leadership style?

Yes, I did. Um, you know, and usually it would be that, uh, there was someone that maybe wasn’t performing. It didn’t happen a lot, but. Someone wasn’t performing well and I’d get push, uh, pressure, like move that person out or take action. And my feeling would be, look, let’s, um, let’s give this person a chance.

Let’s, let’s make sure there’s appropriate feedback that someone has the opportunity to kind of correct. Um, and sometimes that works, sometimes it didn’t. But it does get back to, I think something you said earlier, Naji, which is. What’s the right environment in the right role for people? And you know, it doesn’t mean if someone is not succeeding, it doesn’t mean that they’re a, they’re not smart.

It doesn’t mean that they’re a bad performer. What it may mean is that they’re not in the right role in the right organization. And I think, you know, I would say almost all the times I had to deal with that, um, the person realized that, and, and the person kind of welcomed that feedback. Because no one, no one likes to be unsuccessful in a role, right?

No one doesn’t wanna perform well, uh, but sometimes there’s inertia. And so I think if you treat people with kindness and you, you make that effort to help them succeed, even if at the end of the day they don’t, I think people kind of realize that, you know, things worked out for the best, and I think that’s important.

But I would say on the whole, you know, over 95% of the time, I think that people accepted my leadership style or my, the senior most leadership did, in part because my organization was successful. And I think that there was that realization that, look, you know, I, I, in fact, my, our c e O would say this sometimes, you know, Mike, you have your way of doing it.

It’s not the way other people do what their, their duties is manage, but you have good results. And so that’s okay. And look, frankly, I think it, it says a lot about a C E O and, and people at that level. Uh, and I try to do the same with my own organization, which is recognizing people have different leadership styles and, you know, as opposed to I’m the leader.

And you’re all going to manage in my way. I think another key part of leadership is recognizing and respecting different people, manage in different ways and lead in different ways. And as long as they’re creating the right culture, you know, as long as they’re treating people with respect and uh, and, and making ethical decisions and, and achieving results.

I think as a, as a senior leader, um, you, you do have to allow people to manage in style that’s right for them.

So

Naji Gehchan: Mike, uh, as you are, were working in j and j. You obviously took the company also during the last 11 years to a multi-billion, uh, successful company and serving so many, uh, patients and, and consumers in healthcare across the globe. Uh, you also went, uh, through developing a Covid vaccine and literally j and j single dose, uh, COVID vaccine.

Help humanity get out of, um, of the pandemic. So, uh, uh, can you share with us this particular journey you’re learning, leading those teams? In unprecedented times, delivering with speed, integrity, high quality. Also diversity. You worked a lot on how to make sure that you, you are representing the, the populations, um, when obviously all humanity.

What was watching you and you did it, you delivered. I’d love to, to hear the story behind the scenes and your

Michael Ullmann: learning. Sure. Um, well, look, I, I think there is a lot of pride there. Um, you know, the fact is while in the US the, the change hit Covid vaccine is really not being used. Uh, it still is in many of the developing parts of the world still being used, um, frequently in Africa, in other areas.

Uh, because it is one dose requires regular refrigeration. Uh, so there is a lot of pride in the fact that we continue to have an impact now to go back to really three years ago exactly to 2020, um, look, it was obviously a very difficult time for everyone personally as well as professionally. I, I think that to some extent the, um, one benefit that we had at Johnson and Johnson was we had a purpose.

And whether you were working on the vaccine, but really everyone in the organization, even if you were, you know, working on the Tylenol brand, you were working on other healthcare products because the need for oncology products and immunology products and surgery, it didn’t go away because we were in a pandemic, right?

The, uh, the healthcare needs of the world were still there. Um, and so I think that when people went home in March of 2020 to work, It really helped, um, our people because they actually felt that, um, rather than being bystanders to this pandemic, that we were working to make a difference. And, and I think that as a leader, that was very important.

And the message that certainly that, you know, I really took from there was when people feel they have a purpose in what they’re doing. They will work, um, very hard. They will work very passionately and they will really care about what they’re doing. So I think that then the next balance that I would say I, I found as a leader during the pandemic was, um, the importance of optimism, right?

That I would do meetings almost every day and I would do webcasts and zoom meetings. And I think people want their leaders to be hopeful to be optimistic. We’re going to get through this, you know, this is the worst, you know, health crisis of our lifetime. But, you know, with people like us working on this, you know, there is a, a way out.

Um, now you have to be realistic. It’s not like next week the pandemic will be over, but I think that element of optimism is very important in leadership. With that, however, I would say also came a, um, the importance of being openness, right? I would, uh, in, in all of my meetings and webcast, you know, I would talk about my own vulnerability, right?

Here’s, you know, I’m worried about, my mom is 90 years old, you know, uh, we worry about her. Um, you know, Thanksgiving, uh, first time I haven’t been with my children, you know, since they were born and, and things of that nature where, That balance. And I think, you know, Naji, that’s something as a leader that, um, you kind of have to work on developing.

But what is that right balance between being optimistic and being hopeful, but also sharing some of the, the challenges that you’re facing? And I, I think based on the feedback that I got, that that. That was effective. It was genuine. You know, there’s a lot of talk nowadays about authentic leadership. Um, I don’t know if I really was thinking that way, but I think that’s the way it came across.

And then I guess a fourth thing I would say about, um, leading during the pandemic was, um, the importance of being able to trust and delegate to people because it wasn’t like, you know, Pre pandemic where you might gather everybody in a room and, and make a decision that people, especially the people in my organization working on the vaccine, um, they had to make real time decisions.

And if you were working in Asia, like we didn’t wanna wait 12 hours every day for someone, you know, here in the US to make a decision. And so it was very much about, you know, Come to me. I mean, the, the, the message that I had was, you know, if you need more resources, if you need more money, you know, if you need more time or people let me know.

But other than that, you know, or if I can be of any help, you know, because you want my advice. But other than that, like you decide, you know, you’re qualified, you decide, you go ahead and make those decisions. And I think that following the pandemic, um, I, I, I won’t say that. Uh, I think we have made improvements in that.

I think we have continued that. Maybe not as much as we did during the pandemic, but I do think I see a bit more willingness to delegate and let people lower in the organization, make, make decisions. I love those

Naji Gehchan: and, and I hope we, as you said, we keep some of the, if we can say positives of the pandemic, but really in the leadership style, in the managerial Yeah.

Way of how things were handled and the, the pace, right. Uh, that we developed innovation for patients. Um, You, you mentioned it, and this is why I always like to take this pandemic, cuz as you said, I think it really brings this idea of we’re all here for one purpose and overworking. And I remember you shared an anecdote about relaxing afternoon where Yeah.

Where you were sent back to work. Like even from family standpoint. Uh, if you wanna share this for sure. Um, But the, I I’m, I’m interested also to hear, you know, without the pandemic, so after it and before it, how did you make sure that your people constantly think of this purpose and have patience in mind when taking the decisions?

This is where sometimes I feel it’s hard, right? Like each of us running through operations, leading organizations, Our, our team sometimes can be in the small details that we forget this big picture of patients. So I’d love to hear from you how you managed to keep this after the rush of adrenaline in a pandemic or even before

Michael Ullmann: that.

Yeah. You know, Naji, I would, I would say that that to me, um, was always, I think one of the biggest challenges of my role. And in particular because, you know, I, I’m not a scientist. I’m not doing, uh, research and the people in my organization, you know, were not developing vaccine. You know, they were not actually working in the labs, developing the vaccines, creating new cancer drugs.

Uh, there are people in functional roles working at a death and so, You know, how do you inspire people and how do you make sure that people understand that they have a purpose? And so I think what helped is even before the pandemic, way before the pandemic, um, that was something that I always worked at.

And frequently it would be when we would do, um, webcast, uh, getting patients, people who had benefited from our products, getting doctors, people who use our products, but. Making sure that the people who were sitting in the company headquarters of the desk had line of sight to what, you know, what is actually happening in the real world, and what do people look like?

What do patients look like? What did doctors look like? Hear them talking about our products. That was always very important. And then frankly, it really was, I think. What I always tried to do when I talked to different groups, and let’s suppose I was talking to a, a group of, you know, paralegals, which is just making them understand is that, you know, any pharmaceutical company, you know, it, it’s like being on a sports team, right?

Not every position is a glory position, but you need people in every role. And so, uh, a pharmaceutical company, Needs, uh, a, uh, an intellectual property group and they need, uh, patent lawyers and they need patent paralegals. And, you know, while it may not look like your job is a glory job or that you’re actually impacting patients, the, the people that are developing the next line of cancer drugs, they could not do that without you at your desk doing your job.

And so, That was always part of my talk track. Uh, and I think very important because again, when people realize that their role is critical, they will, they will go through walls. They will work as hard as they can. And that to me is a leader, is really what you’re trying to do. You’re trying to inspire people to be their best.

So

Naji Gehchan: Mike, now I’ll give you a word and I want the first thing that comes to your mind.

Michael Ullmann: Okay, so the first word is leadership. Uh, responsibility. Uh, do you want me to expand or just give you one word? No, you can expand. Yeah. I mean, responsibility, leadership is, um, whenever I would talk to, you know, people earlier in their career, like, what are your aspirations?

It’s like, well, I want to be a leader. I wanna manage people. And it’s like, well, why? You know, and it’s, uh, you know, I think that to me, um, the, the larger your organization is, the bigger leadership role, the greater responsibility that you have is, and so to me, the one word that leadership is, is it’s about responsibility to other people.

What about E S G? E s G is a critical, okay. One word, uh, future. Um, and I would say that, um, you know, we had spent quite a bit of time over the last four or five years on E S G, but the reality is social responsibility has been, um, part of the ethos of Johnson Johnson going back over a hundred years. Yeah.

We have, uh, like pictures. Of j and j products being delivered, uh, in the San Francisco earthquake of, I think it was 1908, uh, but part of the culture and the, the history of the company is being at disasters, being in times of crisis and, and being in healthcare, being able to play a role. So yeah, where we are today in E S G is somewhat of a, it’s a progression.

But I think that to me it is you’re constantly working on and improving not only your company, but the world around us for the future and for future generations.

Health equity. Health equity is, I think, uh, boy, one of the critical, critical unmet needs. Right now in our society and, and health equity, certainly just in this country where, you know, we have embarrassingly high infant and maternal mortality rates. I mean, among the, uh, the highest rates in the Western world, uh, where we have, you know, people that don’t get appropriate, healthcare is frankly inexcusable.

And I think even on a global level. Where, you know, the, the unmet healthcare needs around the world and the variations and life expectancies in a world like Earth is, uh, is very hard to justify. And so, look, I know from my perspective, um, you know, you, you can talk about large issues like this and it’s almost like boiling the oath, right?

Which is. Health equity, how, how are we going to self health equity? Um, what I tried to do in my organization was to, uh, you know, come up with projects, right? Like four or five projects. They’re not gonna solve health equity in the world or in the United States, but, you know, can we help? One project we did was in public housing and asthma, and that, the, that the fact, a large number of children, Living in public housing have asthma because of poor environmental conditions.

So we had a group of people in our organization work on public housing in Washington DC. So again, it’s, um, I think as a leader, when you talk about big issues like this, um, it, it’s helpful to say, okay, what can we do on a bit of a micro level? And again, you’d love to be able to solve the issues of health equity around our country, around the world, but let’s, let’s try to at least have an impact

Naji Gehchan: that’s, that’s super powerful and really thinking about local impact that can happen and make it, and make it happen.

The last one is spread love in organizations.

Michael Ullmann: Well, I think that, uh, look, the way that you spread love and organization, it starts with kindness as we’ve talked about, right? It, it talks about as a leader, um, what’s the culture you’re creating? And that to me, um, as a leader, probably the most important role that you have. And in particular, you know, in a large organization.

Is, you know, you can’t impact. I mean, to some extent, as a member of our executive committee, I was leading an organization of 140,000 people, you know, 2000 directly, but, uh, company of 140,000. So you can’t touch, you can’t touch that many people individually. You can’t touch 2000 people individually. What you can do as a leader is create a culture, create a culture.

Where you can, um, really demand kindness. I was going, I wouldn’t say just encourage, but ensure there’s kindness. Uh, ensure there’s ethical leadership, that people are making value-driven decisions, treating people in an ethical way, uh, looking out for patients and consumers in a, uh, values-based manner.

And so I think that by creating that culture, That’s how you spread love in an organization.

Naji Gehchan: Any final words of, uh, wisdom Mike for healthcare leaders around

Michael Ullmann: the world? Yeah, look, I think that it being in healthcare is really a privilege because we do have the opportunity and the responsibility, um, to impact healthcare, um, and impact the lives of people and.

You know, I think that it is so gratifying on those occasions when, you know, I, I meet people, I talk to people and they will say, oh, uh, Johnson or Johnson Johnson, like, uh, yeah, my mom was on your cancer drug. Or, you know, my dad takes this product and, and it’s made a difference in his life. And I think you realize that that ability to actually.

Help people live happier, uh, longer and healthier lives. Uh, I can’t think of a better field to be in, a better industry to be in. Um, it’s why I gravitated to healthcare. It’s why I stayed there for almost 35 years. And in fact, now in a nonprofit way, I continue to remain involved, uh, working with the, uh, the global healthcare ngo Americas.

Um, where I’m on their board of directors, but so I continue to be in healthcare. I always will be in healthcare because again, it is, uh, a privilege and, uh, it just, it really makes you feel that, that you can’t spread love around the world and really help make a difference in people’s lives.

Naji Gehchan: Thank you so much, uh, Mike, it’s definitely why we wake up every morning in this industry, uh, trying to make life better for patients.

Yeah. Thank you so much for being with me today. It’s such an honor and, uh, great chat. Thank you.

Michael Ullmann: Well, thank you Naji, and, uh, I really, I love what you’re doing. I love the whole concept around spread love because I think it really is such a critical message. And Naji, you’re doing a great job. So thank you for what you do.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Dorota McKay

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Dorota McKay a creative problem solver with a passion for finance and personal development. Dorota is currently a Vice President Controller and Chief Accounting Officer for Vapotherm, Inc., a publicly traded medtech company that develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Dorota holds active CPA, CMA and CFE designations. Prior to joining Vapotherm she was a Controller for Decibel Therapeutics and a Finance Director at Oxford Immunotec. She is also corporate trainer and coach certified in Canfield Methodology and a Certified Culture Transformation Tools Practitioner with the Barrett Values Centre.

Dorota – It’s a pleasure to see you again and have you with me today!

Dorota McKay: Thanks, Naji. It’s great to be here.

Naji Gehchan: Let’s start first with, uh, your personal story. What brought you to accounting specifically in healthcare, and what’s the story behind the great leader you became today?

Dorota McKay: Yeah, so, so it wasn’t a straight path for me. Um, and I think an important part of my identity is, uh, being an immigrant.

I was born in communist Poland under martial law, and I, uh, lived in communist Poland until. At the age of seven, that’s when communist fell. And um, I still remember that moment actually. It was, um, extremely important for us. And I, I remember the, the shortages of those years. Um, and I remember our neighbors actually hiding in our apartment for, from the militia.

So, um, was definitely a, a very different reality from, uh, where I live today. Um, and my parents were both teachers, uh, when I was growing up in Poland. My dad w is a linguistics professor and my mom was a high school teacher. And so when I grew up, I decided to follow in their footsteps and also become a teacher myself.

And I studied English studies and I got, um, masters in American literature and American Studies. My masters was on virtual and real in, uh, American science fiction. So very different from what I do now. And, um, after graduating from, um, a university in, in Poland, I decided to, uh, pursue doctoral studies. So I became an academic teacher and, um, I was also an exchange student in the summer.

That’s how I ended up meeting my husband, um, in Maine of all places. And, um, after a couple years, we, we decided to get married and I, uh, moved to join him in the, in the United States. And, um, I continued to work on my doctoral thesis, uh, remotely. But in, in 2009 during the great recession, my husband lost his, uh, job and he worked for a nonprofit on the, on the coast of Maine that provided us with, um, our only source of income and our source of housing.

So when he lost the job, Uh, we basically ended up with nothing. Um, and, um, that was a pretty difficult time in my life. So I was, uh, new to the country. I didn’t have a, a community, I didn’t have a lot of friends. I didn’t have a job. I was working on a, on a doctoral thesis, uh, remotely. And, um, I remember having, having, um, a very difficult time just adjusting.

One day I ended up walking down the beach and, uh, just crying. I f I was feeling very miserable and, uh, and very, very down. And I, um, as I was walking down the beach, I tripped and I fell, um, head first or face first into the sand. And as I was, um, as I was, um, you know, on the ground, I saw this little piece of, um, uh, seaglass.

On the ground, and it was just beautiful and, and, and, um, very blue and, and this like, colorful thing in this very, very depressing reality. And it allowed me to just take a pause and think to myself that in every hard situation there was something positive. And I got up and I decided to really change things.

Um, so the, the transformation just took place in that very moment. And so I decided I was going to quit my doctoral studies do something different to better adjust to, to the reality and help my family become, uh, financially independent and, and successful. So what I end ended up doing is I, I quit the doctoral program and I went and got a job as a waitress at a local Olive Garden restaurant and I enrolled in a, a community college.

Um, and from there I did really well. Ended up going to, uh, state, uh, university. Uh, getting a degree in, in business ad administration, becoming a cpa. Uh, I got a job with a local, um, public accounting firm. And then from there I moved to, uh, the big four, uh, firm in Boston. And things just started happening for me.

And so while I was at, at, at, uh, Ernston Young, I worked with a, um, a large pharma company, and that’s kind of where I, uh, really, uh, started. Appreciating the, the pharma, biotech and medical industries and, and felt that I wanted to pursue a career, um, in those industries. Um, so after, after spending about four, uh, four and a half years in, in public accounting, I wanted to really, um, go and work for a business just to go really deep and, um, and help grow a business as opposed to just being a generalist.

And so, um, my first, my first job in medical device was, um, was actually, um, with Oxford Immuno Tech. And I stayed there for several years and, and grew my career there. Um, and it was a company that made, uh, tuberculosis tests, um, and really, um, very patient-centric, um, that, that, um, Allowed me to grow my career from, you know, a manager position to, uh, to a director.

Um, and what I would say is coming to the us, you know, starting in a, a completely different country and then basically start starting from nothing in the US and getting to where I am today, which is, uh, you know, a vice president of a publicly traded company. Um, For me, it’s proof that the American dream still exists and, and you can still be successful, um, if you really devote yourself to it and, and work hard.

And if you’re also fortunate enough to have the mentors and, and help that I had. And I think for me as a leader, it’s important to give back to others what I’ve received on this, uh, journey.

Naji Gehchan: Wow. Thank you so much, uh, Dota for sharing, uh, with us, uh, this, this journey. Uh, it’s powerful and inspiring, uh, for sure.

Uh, and you shared specific moments, uh, a as we call them, sometimes crucifix or other peak experiences. Uh, I’d love you to, to kind of share with us a little bit more, uh, on how you take these into leadership. You shared about, uh, the early moments in your life. When, uh, in, in Poland and then coming to the US and then the crisis in the US and several others, uh, I, I’d love to know how you took those, and you obviously reacted to them in a way that brought you, uh, where you are today and being this incredible leader.

Uh, can you share a little bit more this, those, those moments and what are the key leadership learnings that you’re taking with them, from them, with you?

Dorota McKay: Yeah, I think definitely, uh, starting, starting my career in the service industry in the US was, uh, was a really great experience. I think it learned me, it, it, I think it, I learned the respect for, for hard work and also the, the humility.

So I think the advice I would give to others is just be humble. Be open to opportunities. When things come your way, just say yes. And I think. My success has mostly been because I said yes to new assignments, new opportunities, um, and I, I definitely worked very hard, uh, throughout the years to, um, to advance within the various companies that I worked for.

But, um, I think just saying yes to new opportunities and often being uncomfortable was what got me to where I am today. So you’ve led

Naji Gehchan: teams and organizations in a very specific domain of the company. Uh, you’ve done auditing, uh, finance, financial controller, and accounting. These are usually functions, uh, that are challenging, uh, internally.

Uh, I, I don’t know. You might disagree with me, but I, I actually would love, uh, we’d love to hear from you how you approach those roles. Internally because they are crucial roles, but again, sometimes might be perceived as challenging or controlling, et cetera. I’d, I’d love to

Dorota McKay: get your thoughts about it.

Yeah, it’s definitely a challenging working in an administrative and support function in healthcare because you, you don’t really deal directly with patients all the time and you don’t necessarily deal with customers all the time, but you have internal customers and I think there’s also a sense of mission, um, especially for a company that might not yet be profitable.

Where you know that the, the financial results, the financial reporting that we deliver to our shareholders is basically what helps the company survives is we get additional funding to help us continue going for, for a couple more years until we show profitability. So I think, uh, my team has definitely had a sense of mission and, uh, working at Vapotherm specifically.

A company that makes devices that, um, you know, help address respiratory distress. It’s been an extremely interesting experience, um, and challenging during the pandemic because we, we literally had to do everything we could to make as many devices as we could and deliver them to customers because it was a life or death situation.

So I think in that way, it made it easier for my team to have that sense of mission and just work through, you know, long hours. Um, Constant deadlines. It’s something that we definitely deal with. And, um, I struggle sometimes with, uh, staffing as well because as you know, uh, usually in support functions there’s, there are budget concerns.

So I think it’s very important as a leader for you to fight for your team to make sure that you have adequate resourcing and that people are, you know, not working 70 hour weeks, uh, or 80 hour weeks. Um, cuz it’s just really, as much as we’re mission driven, it can have a negative impact on, on people’s wellbeing and, and health.

Um, and so I always, um, I always make it a. Make it a point to, um, to tell my team to, you know, recharge after periods, which are usually very busy for us, which is quarter ends, year ends, audits, things like that.

Naji Gehchan: Can I double click on, uh, the mission? As you shared, it’s important. Sometimes you feel you’re a little bit more, uh, like far from the patients and the impact you have, even though it’s a great example of what you’ve done and the impact.

You obviously help actual patients, uh, through the pandemic. How do you make sure that this stays alive daily with your teams these

Dorota McKay: days? Yeah, it’s, it’s, um, definitely been very different for us. After the, the pandemic ended, um, we we’re focusing now on a different subset of patients. Uh, so we’re focusing more on C O P D patients and our more traditional, um, kind of patient groups.

Um, for example, um, you know, patients who, um, Come down with the flu or RSV or, or similar respiratory conditions. Um, but I think what has been, what has united us together is after the pandemic ended, our company has been through several restructurings. So, you know, during the pandemic we worked extremely hard to make sure that the patients were served and, um, Our sales were really booming.

Then when the pandemic ended, the market has really been saturated with, uh, um, respiratory support equipment. And so we’ve seen a, a really pretty steep decline in our sales in, uh, 2022. And the company went through, um, you know, downsizing, uh, twice last year. And for my team, uh, it’s been especially challenging because we get to see all those changes, uh, firsthand.

And, um, I think just working together as a team and focusing on the, on the wellbeing of the company and helping the company as a company survive that, that difficult time has been what kept us together. Uh, cuz we. You know, have a lot of influence on, we’re watching budgets, we’re making sure that, uh, um, the financial resources are being used, uh, responsibly.

And, um, and we’re also responsible for, um, we’re helping with fundraising and we’re helping with reporting that, you know, uh, helps us, uh, continue as, as a business and as we’re retooling our business and making a lot of changes in it, we’re also expanding globally. We’re hoping that we can come out on the other side stronger.

So there’s, there’s still a lot of, there’s still a lot of patients who need our help and something that really drove it home for me is I visited one of our clinics, um, at one point that was serving C O P D patients. And I heard firsthand the patient who was doing the rounds around the clinic and how difficult it was for him to breathe.

No, I think. After hearing that, I feel like our mission is as much alive as it was during the pandemic. Not being able to breathe is one of the, the worst feelings in the world. And um, you know, as long as those patients are out there, we’re gonna be there to serve them. Oh,

Naji Gehchan: I, I love it. And really the centricity around patients right there is the urgency that the pandemic brought.

But at the end of the day, what we do, what you do, what what I do every day is really trying to improve life on patient at a time, at a time, make their life better. Uh, tell us, you touched it a little bit, your, your. Growing your team, you’re dealing with uncertainties, uh, with several different transformations.

Also business transformations growing, uh, you know, uh, funding, et cetera. Uh, and you have a passion for cultural transformation. Can you share with us a little bit more your learning as a practitioner, uh, and how to make sure that those transformations are

Dorota McKay: successful? Yeah. So, uh, so, uh, for me, uh, the culture transformation is really about understanding your teams and your own values and translating them into the ways that they, they map onto your organization’s values.

And so the first step you need to do is, you know, identify the values that you have, and there are various tools available for that. Uh, that I’ve worked through with, with my team. And then you also map the, the company’s values, which usually have the mission, the values that’s, that’s stated, and then compare it to what the company’s actually doing to see if it’s living those values.

And then if there, hopefully there’s an overlap bef between the two. And if people understand that overlap, it’s easier for them to bring themselves to work because. You know, their own values are aligned. So for example, if somebody’s value is, uh, family and wellbeing, you want to make sure that the organization is also providing them with time to, you know, devote to their family and wellbeing.

And if there’s no overlap, then you’re probably, your people are in the wrong organization, or the organization needs a lot of work. And usually what we do, um, as part, as part of the cultural transformation, it’s just showing whether there’s overlap and if there’s no overlap, what can we do to bridge that?

Naji Gehchan: I want now your first reaction that comes to mind when I tell you a word. So the first word is leadership.

Dorota McKay: Okay.

I think, uh, service is what I would say. Women

Naji Gehchan: in tech.

Oh.

Um, can be more than a word.

Dorota McKay: Can be more than a word. Yeah. It, it brings, it brings to mind. A little bit of oppression, but then also examples of some really amazing, uh, tech leaders. So I think maybe, uh, future, maybe hope. And

Naji Gehchan: if I go down this one, is there a specific advice you would tell yourself when you started your career in MedTech that you would now take and give it to other, uh, brilliant

Dorota McKay: women?

Yes. I would say, um, I would say, um, don’t be afraid to take risks and, um, always ask. Ask for opportunities because as women especially, I think we tend to, uh, just expect that people will notice us. And, and you know, if we’re doing a really good job, somebody will come to us and say, here, how would you like to be promoted?

Or, how would you like to try this new opportunity? And I think we’re sometimes afraid to ask for things. And if you go to your leader, mentor and say, Hey, I’d like more exposure to new opportunities. How about this role? Do you think I could be good in this role? Uh, they will often say yes. And the worst that can really happen is they say, no.

And you’re exactly in the same place where you started. So I think always ask, ask, ask, because you might actually get what you want.

What about Six Sigma? So, uh, six Sigma. I’ve worked in, uh, in a, in a couple manufacturing, uh, type, uh, companies. So every medical device company has, has a manufacturing function and I was fortunate to work for companies that, um, were very keen on process improvement, uh, lean and Six Sigma. And, uh, the companies that I worked for actually put.

All of their employees through the process, uh, through training when they started with the company. And, um, really Im implemented this, um, need to, to improve processes and understand processes, uh, from day one. And that was really helpful for me as a leader in the finance function. You know, you might think that this is very different.

It’s not a manufacturing process, but it’s a process. You know, there are inputs, there are, there are steps in the process. There are bottlenecks and there are outputs. And so I’ve fled, uh, several kaizen, um, process improvement events with my finance teams at various organizations. And we always find that that.

Brings the teams together. And it also makes their jobs more fulfilling because they can see exactly how their, um, job and what they do interacts with other parts of the process. And, um, we often discover that. People sometimes don’t talk to each other and they just don’t know that something that they’re doing really hurts somebody else.

And so when you bring the team together, you actually take that time to put them in the room for a couple days and, and walk through the process. And then maybe have, you know, couple fun events, um, like, like a dinner or, or some sort of a, a team bonding game that really, really, um, helps improve the day-to-day.

And, uh, we see a lot of, uh, benefit from that. Love it. You’re

Naji Gehchan: combining cross-functional work with fun, with a purpose. I, I love this. The last word is spread love and organizations

Dorota McKay: spread. I, I really love this, um, the, the premise of this entire podcast, and I, I think we should all be doing that. Um, so I think. The way, the way I like to spread love in organizations is by helping other people learn and grow. I think, um, it really makes me happy when I can coach somebody and, and provide them with opportunities for advancement.

Sometimes it’s hard because that also means that they might leave your team or they might even leave your organization. But I think as a leader, you, you have to be, um, Happy with that. You have to really be happy, uh, with the fact that somebody might develop so much that they will no longer, you know, be satisfied with, uh, with either your department or, or your organization.

Um, and I think, um, I think also as a leader, you know, it is a bit of a cliche where, where, uh, people say leaders take all the blame and give away all the credit. I think it’s very, very, Needed, um, because you need to provide psychological safety to your team. So people need to be, um, confident enough to be able to make mistakes and they need to know that if they falter or or if they make a mistake, um, there will be somebody there standing up for them.

And so, I would say that whenever something an issue happens in, in our team, we try to focus on the solution and not point out, you know, who did it. We might, we might, um, investigate why something happened, but it’s not a people problem. It’s usually a process problem. And so that makes it a lot easier for us to, uh, to proceed and it’s, it helps people come to you as a leader and bring up problems instead of try trying to hide them.

Well, thanks

Naji Gehchan: for sharing this. And it’s, uh, you’re bringing powerful concepts around psychological safety, about recognition, teamwork, and obviously, uh, another point for your incredible leadership, uh, grounded in resilience as you started, uh, this podcast sharing about, uh, your story. Any final words of wisdom that you would like to share with, uh, healthcare leaders around the world?

Dorota McKay: Yes. So my words of wisdom for healthcare leaders probably especially important for finance leaders, but I think for, for everyone is if you are ever in doubt, always choose integrity and follow your moral compass. I think your, your reputation is more important than any kind of short-term gain. You take it with you everywhere.

Naji Gehchan: Thank you so much Tta for, uh, for your, those final words and for being with me today, uh, and all this incredible chat. Thank you.

Dorota McKay: Thank you so much. My pleasure.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Melanie Ivarsson

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host today, having the pleasure to be joined by Melanie Ivarsson Chief Development Officer at Moderna. In this role Melanie leads the Clinical Development Operations department and delivers with her team all clinical programs within the Moderna portfolio. Prior to joining Moderna, she was Head of Global Clinical Operations at Takeda and spent 9 years at Pfizer in Clinical Development. Melanie also held roles within the early clinical development group at Eli Lilly. After receiving her PhD from the University of Bristol, she completed postdoctoral research at Lund University and New York University. Melanie also holds an Executive MBA from MIT Sloan School of Management.

Melanie – It is such an honor to have you with me today!

Melanie Ivarsson: Thank you so much. It’s great to chat to you. The honors is mine.

Naji Gehchan: I would love to hear first your personal story what brought you to pharma in the first place to joining a month before the pandemic was declared one of the companies that helped humanity be out of the pandemic with vaccines – what is in between the lines of your inspiring journey?

Melanie Ivarsson: Absolutely. So, um, as you nicely summarized at the beginning there, um, I started off in academia as a neuroscientist and did a couple of postdocs. Um, and I’ve really enjoyed. So how that helped my brain be trained to think, to deeply analyze problems.

That was an amazing training for me. I’m a systems neurophysiologist by training, so I’m thinking big connections, big picture. And that actually is really the arc of my entire career. It’s the building, the big picture, how things connect together is what really fascinates me. Um, so during my academic career, I realized sitting in the lab at two o’clock in the morning that I actually didn’t have any interesting questions to ask about that were narrowed, that I wanted to ask the big questions.

Um, and that made me start to think that maybe, um, research grants and very focused academic work. In that discipline wasn’t the right place for me to be. And so I started my career at Lilly, um, in their clinical pharmacology department and spent, you know, 20 years moving through very large pharma company where you get to talk about very big problems.

Big organizations that are connected together in lots of sort of different ways. And you get to ask those big questions. Um, and I went all the way through Lilly, then Pfizer for nearly a decade, um, Shire, which then got acquired by Takeda. And in the last couple of years of my time in the sort of Takeda um, era, I was also doing my executive m MBA at M I T in parallel.

And that really gave me a different way of looking at some of these big picture problems, how to build organizations, organizational processes, strategy, how to put teams together. And it was at that time that I thought to myself, I could go. You know, do approach this differently, these learnings. Let’s don’t go and do something different.

And Moderna reached out to me looking for a, a new chief development officer. It was a newly created position at the time. Clinical development had 30 people in it. And they hadn’t even done a large scale clinical trial, and they wanted somebody who could come and build their organization slowly over a couple of years, a nice slow build.

And I thought, well, I’m never gonna get an opportunity like this. Go and build it the way I want to. Slowly. Over time, thoughtfully, carefully build out an organization that can deliver its first sort of phase three study in 18 months from now. Wow. As history shows, that isn’t quite what happened. I turned up on the 3rd of February as we all were about to get sent home as the pandemic was being declared and the weak Moderna decided that they were gonna go and develop a Covid 19 vaccine.

And so my nice gentle build, um, Uh, literally had to take place in days and weeks rather than the years that I thought. Um, and, and you know, the rest is history. We went off and developed our Covid 19 vaccine, um, in partnership, um, with, with the government and, and many others, uh, that enabled that. And, and it was an incredible experience, not what I was expect.

Um, but just an incredible experience and I learned so much about leadership and building teams. Um, and now where we are today, um, we, we are at again, a yet another inflection point. So, uh, an amazing leadership journey.

Naji Gehchan: Well, thank you so much for your, for sharing it and, and I, I’m gonna go and dig into this a little bit more from a leadership standpoint and, and your learning.

So you obviously led team as you said, like you thought you had 18 months to build and scale up and growth. But actually you did it in a couple of months in a crisis mode where not only in internal cr like the word was o obviously anxiously waiting for you to bring us hope, and you did. So what is the key leadership learning you took with you from this experience?

Melanie Ivarsson: So it is all about the people and how they make decisions together in a, in that moment of, In that moment, um, I think what I learned is that I absolutely did not need to be the smartest person in the room, but I needed to enable everyone else to talk to each other and make the right decisions and move things forward and put things in place, have the right conversation, and that’s a time when a leader has to actually lead from behind or, or take a step back and look at the full extent of the.

Of the problem ahead of them. So I’d never developed a vaccine before. That was not my expertise. It wasn’t a case of me turning up in Moderna and going, this is the way to do this. There were many better people who had all the right expertise. Um, we asked ’em to come on the journey with us and through our own team.

We have an incredible, very small, nimble. That this was their reason for being, this was the public health crisis that they hoped they would never have to live through. But for all people who develop vaccines, this is what they’re actually trained to do. That one day, a rapid vaccine response is going to be needed by the world.

Um, and this incredible team of people came together to do this, and my job was to not get in their way, get out of their way, enable them as much as. Get them what they needed. Um, open doors for them, wipe away their tears, be there for them late at night, early in the morning, um, and help get them up this incredible hill that we had to climb up together.

Um, and that took many different forms from going into really quite controversial and difficult conversations in the early days, trying to work out who was gonna do what and how. Thinking through, can we do this to, um, sending, you know, when everybody had to work through the weekend, um, sending everybody, you know, a, a nice food package so that they could just put things in the oven and not have to worry.

You know, it takes many, many forms to keep a team going through all those different times. Um, and my job was to just enable and not be in the way.

Naji Gehchan: I love it. Like I said it several times, enabling others and not getting in the way to do it. And, and as you said, there was this, I love how you framed it, right?

Like there was this big purpose that is so important and everyone was waiting for it. Uh, would you have a story or an example because you shared some of those, and I think in those moments of crisis, um, you, you always have ups and downs. Like there is this big purpose, but there is also some time.

Negative news that you get and you have to help the team go through it and keep on going. Like you have stories and examples on how you lead teams, specifically in those highs and valleys that they go through emotionally also in development. Any example on how you’ve done this for them to keep having the faith to get to the

Melanie Ivarsson: result?

Yeah, and I, well, I think it’s. One of the greatest challenges for all of us during the pandemic was leading when you couldn’t be in the room together. So there is a, particularly in a, in a small biotech, there’s a lot to be said for just getting in a room. The leadership at Moderna historically had been very in person, and so they walked the corridors.

I turned up at the beginning of February and we all got sent home within six weeks. So most of us had never met each. I had to hire a team almost entirely remotely. We all did. Um, and that team, um, needed to find a way to get to know each other virtually. You build a lot of trust through that sort of personal connection.

Being in a room with somebody shaking their hand, um, taking a few moments to sort of, Have the kind of conversation that helps you build stronger, uh, professional connections that is incredibly difficult over a Zoom call. And, um, that’s also very difficult when time is of the essence. Not only did we have to do that within ourselves, but we also were under operation whoop speed.

We were working with government partners, we were working with a network of investigators, um, that we’d never worked with. Everybody had heard the call to action. Everybody was there incredibly well intended, wanting to do the right thing. And you have this bringing together of private public partnership.

The government, the n I h uh, academic trialists, this little tiny biotech that had never done this before, that had. Technology that was full of hope. And then we also had to partner with other companies that were in the race as well. We all had to get out of each other’s way. We, the collaboration there was extraordinary.

So, you know, everybody was so well intended, but there were days when you just had to remember that because, You know, everybody was used to doing things a certain way, and so you bring all those people together, you can’t get them in a room. Um, you’ve just got to kind of cut through it. We threw time at it.

Time was our most important resource, and so we made enormous amounts of time for each other. Our friends and families really suffered during this period, but it was the most extraordinary experience of all our careers. So if you needed to be on the phone at eight o’clock on a Saturday morning or a Sunday morning, To have the right conversation with someone.

You did that. And so making enormous amounts of time for each other and also carving out times in the day where you’d say between six and eight, go be with your families. Have dinner. Take some time away. Let’s all get back in here at eight o’clock tonight. We don’t. We have to rest as well. And so finding that balance of being there for everybody, asking them to do this exceptional.

And then trying to preserve some sense of sort of wellness and rest, um, and making sure that people were actually able to sort of physically and mentally cope, um, was really, really essential. And as a leader, you’re going through it yourself, and you can only see people from the shoulders up, right? You can’t see.

How, how they’re really sitting. You, you’ve got to become this incredible good reader of those little small signals. Um, and I, after a while, I started to, uh, feel that I could read people, um, through their emotions, through the Hollywood, you know, the Hollywood squares on the, the screen in front of me, and became very good at detecting that face of that individual that.

They’re not where they need to be right now, and a quick follow up call. Everything okay? How are you feeling? What’s going on? Um, so emotional intelligence had to become a finely honed skill in a completely different medium. Um, and so I would say for leaders, um, nothing prepares to you for that kind of experience.

Um, but we all became very good at, at doing it. I.

Naji Gehchan: Well, thanks for sharing this. And uh, Mel, during, as you were, as you were talking, obviously what you’ve done, what other, uh, pharma companies stood up for the execution and did was something we all hoped for, right? Like you talked about this multi-stakeholder partnership and speed to get to a solution, uh, in on percent time.

And obviously this is what we all hope for. Doing all the time. Right. But obviously you cannot operate as we operated during Covid and like relentless hours, et cetera. But at the same time, there’s other people who still are waiting for better treatments. Mm-hmm. In all different diseases. So I’m wondering what are the key learning that you’re taking with you that we can implement at healthcare leaders?

In a more normalcy word, but we’re obviously speed and impatient for patients Yeah. Is still so important.

Melanie Ivarsson: It’s, it’s such a good question and, and one that we are, we’re all grappling with as an industry now. So what made. Covid such an exceptional time for our industry is that the entire ecosystem became focused on one thing.

So companies themselves didn’t compete with each other. We knew that we had to make enough doses between us or successful vaccines for the world, so we became. United in that mission, regulators, um, ethics committees, clinical trial sites, suppliers, CROs, vendors, labs, everybody. Um, were prepared to prioritize the vaccine and therapeutics work above all else.

And I think that is the reality is how much of that machine it. To deliver on really what ended up being just a few successful vaccines, um, and a few successful therapeutics at the end of the day. Um, so when you then try to, um, you know, bring that out into something like cancer or Alzheimer’s, what it would take to deliver the same focus, that becomes incredibly challenging.

Do what I hope it also does though. Recognizes, helps companies recognize what parts of their process they don’t actually need. Um, it’s very easy to believe that you need to go through number of steps to get somewhere, and it takes six weeks when at a time like that you can do it in a day if you can get the right people.

At the table, the virtual table in our case, to do it. And so I think, um, Moderna had never created any of these processes, so we were creating them as we went along for this development plan program. And now that we’re scaling up to doing so much more work, um, we are trying to recognize what got us there and what we can.

Where do we need to create more process, and where do we just always want to be this nimble? So strategic decision making is an example of somewhere where you really want to be very crisp and nimble. You don’t want to have teams having to wait weeks and months to go to governance and have to go and do all those pre-meetings and navigate all of the, you know, the different opinions before they go into the room.

You’ve got to decide what to your culture going to be of decision making. How are decisions going to be made? Are you then prepared to operationalize and execute on those decisions with great speed? And, and how quickly can you do that? Um, and sort of hold onto the core of that incredibly nimble pandemic, strategic and execution capability.

That we developed. And I think, um, I remember talking to one of my peers who was working for a much larger company, one of the big giants that was, um, in the vaccine development space with us. And I was. Talking about the need to get something approved and having to sort of hunt down two people to do it.

And she said, well, I have to get it through about 600. Right? And that’s the difference. I know she was being, you know, a little sarcastic probably in her comment, but I think she was trying to say the point that. Um, you know, everybody has, wants to have an an opinion and then that’s when you start to realize how important it is, how you structure your organization and the processes you put put into it.

Um, and when you start to feel that things are really slowing down because you need to go and gain yet another opinion on something, then you probably need to kind of sit back and go, okay, if we got this right, because we didn’t need all of that last time on, what’s changed?

Naji Gehchan: I love it. It’s reminding me about organization, lab, and, you know mm-hmm.

All the design work we need to go through. It’s, it’s, yep, totally. Uh, if I, if I double click last question here on, now that your adrenaline cutoff is going down, how are you making sure that your team and how can we make sure as leaders, uh, that our team constantly think of the purpose and why we do what we do after the adrenaline rush?

Melanie Ivarsson: Yeah. Again, another fabulous question. Um, you know, one of the things that we grapple with here all the time is how do you pull that culture through an organization and how? Um, how do you do that when you scaled so quickly? So I’ve, in the last three years have done a 20 x build. So I started with 30 people.

My organization’s now about 600 and it will grow again, maybe nearly double, um, again within the next year. That’s an extraordinary build because actually, I used, I’ve gone from knowing everybody’s name and knowing them reasonably well to not, and, and that’s difficult for any leader. And so you need to disseminate out, um, the culture and what’s important and be visible and contactable.

Um, we had a lot of people in the pandemic wherever they were. And so we’re not, it’s, we can’t even just bring everybody back into the office. I think the whole industry has grappled with virtual ways of working. So we’ve created, hopefully an environment that is much better for people’s own wellness, lifestyle, work life balance, because they can work where they’re at and they can fit in other important things in their lives much more easily.

Um, but at the same time, Cultural core of an organization. And that purpose of, of what’s important is becomes very dispersed in that. So we created, at Moderna, we created something called the Moderna mindset, and they, these are 12 mindsets that cover many of our, the ways we, we think about things. Um, it’s.

We pursue options in parallel, we pivot fearlessly in the face of new data. We’ve, we obsess over learning. These are just examples of some of them and there are way of speaking to each other in our own language, um, to make sure that we’re asking each other the right questions. We’re challenging each other the right way.

They’re, they’re sort of path, our cultural core and that really helps us. Move programs, move our work forward together because we, we have a very strong culture that everyone’s bought into. Um, and it allows us, I think, to have the right conversations. We’re always learning. Um, and as we evolve and grow, we’ll probably think differently about this and evolve and, and grow.

But for now, Those mindsets, that understanding of how you shop together every day and bring people together has been an incredibly strong, um, and effective, uh, mechanism for us, I think. So I would

Naji Gehchan: love to give you now a word and I looking for a reaction to it. So the first one is

Melanie Ivarsson: leader.

And you want me to tell you what I think when I hear that word? Yeah. Yeah. I think leadership is, is for everyone, right? Leadership, everybody in an organization, um, has the opportunity to demonstrate leadership. But I’m gonna react with a word that may surprise you, and that is, I strongly believe that leadership can be kind and there is nothing wrong with leadership taking the full picture into account.

Um, and so I’m gonna react with the word kind.

Naji Gehchan: I love it. It’s, it’s all my podcast co with the mission of spreading love and leadership. So I totally by kind the second word is impact.

Melanie Ivarsson: You want me to react with one word or a sentence?

Naji Gehchan: We can do a sentence.

Melanie Ivarsson: So I think, um, an Im, again, impact is, um, can mean very, very different things to different people.

Um, we. Had the opportunity to have enormous impact on the world. Not everybody gets an opportunity to be part of something like that, and it will define them. I, I see that in my team and my colleagues and the people around me that, that, that, that experienced be defines them to a certain extent now and something they’re rightly incredibly proud of.

Um, but impact can be something. Different. And for me now, it’s about enabling others to be the best that they can be. So the impact I would love, um, to leave is my impact on others to amplify what we’ve done and what we believe in. Um, and to, to go on to amazing things. Um, and that’s part of the legacy. So if by working with.

Um, my impact on them is something around the way we’ve done things together and made decisions and the, the joy they’ve taken from that and they carry that forward. Um, I would be very happy.

Naji Gehchan: What about health equity?

Melanie Ivarsson: Oh, that’s an incredibly important topic and one that we all became so aware of during the pandemic.

Not only. Disproportionate impact of covid itself on people from different backgrounds, but then access. Um, and so health equity, um, is something that we built into the way we have done things. So, you know, people are possibly aware that we actually made the, uh, very difficult decision halfway through our clinical trial to actually slow down enrollment.

The white population because we actually had a largely white, um, Number of clinical trialists, and so we actually stopped enrolling white people into our clinical trial in order to give access to people from different communities the information to make an informed decision about whether to enroll in the trial.

We thought that was incredibly important thing to do and it allowed us. To go out and build relationships with the different communities. Um, and we built, um, a diversity and inclusion board with a number of health equity experts, and that was probably one of the most single, most important and informative things for me personally that we did.

This was something that, like the rest of the industry I knew was important, but had done very little about person. And now it has become incredibly important to us. And so we now move forward with all our development programs With this in mind, um, And that is very, very important that you not only health equity starts with the way you study a new vaccine or treatment.

Um, we, 20 years ago, we talked about the fact that we didn’t have women in clinical trials, right? That everything was just studied in healthy, young, mostly white men. We’ve, and that then meant that all prescribing information and access actually was only fit for purpose for one small part of the popul.

Um, in order to make sure that there is access for all and equity for all, we’ve actually got to start by asking the right questions for all of mankind, and that starts with the basic clinical research and this topic I’m very passionate about getting right.

Naji Gehchan: The last word is Fred Love and organizations.

Did you say gridlock? Spread love. Can organizations,

Melanie Ivarsson: oh, spread love in organizations. Yeah. I, I, I couldn’t agree with you more. I think, um, people give their hearts and souls to their place of work. Um, they, people in healthcare are just the most incredibly dedicated, passionate, and committed, uh, people in the industry.

Unbelievably altruistic in the way they will put, um, The, the, the project they’re working on, um, above all elses for them. So I think we should thank them by making sure that we know that we want them to look after themselves. Um, wellness is incredibly important. Um, and we strive always to make sure that people take care of themselves first.

And it’s something I always say to people. I do a new high coffee connect once a month for all the new starters into the organization, and I go, Put yourself first, work out what it is that you love and who you love, and put them at the top of your list every day. Um, because nobody should be sacrificing what they love.

Um, for this place, one of the little anecdotes I would, um, share with you is we offered some clinical trialists, um, a a a token of, of appreciation. And they could, um, either exchange it for, um, something for themselves or they could exchange it for a charitable donation. It was extraordinary, the incredibly high number of people who’d not only gone into a clinical trial and dedicate, dedicated their time and effort to the advancement of science, but then when, um, offered.

The opportunity to sort of take a token of appreciation, chose to then even give that to charity. Um, I thought that was, uh, remarkably, uh, interesting about true altruism, um, and how it sort of works in in healthcare.

Naji Gehchan: Any final word of wisdom, Mel, for healthcare leaders around the world?

Melanie Ivarsson: I think, um, We are so blessed to have the opportunity to work in the sector of the industry that we do. Um, hang on to your, um, your true self through all of this. Um, I’m not ashamed to talk about the fact that as a leader, I believe kindness is incredibly important.

That’s who I am. Don’t try and be somebody else. Don’t try and emulate a leader. That you see somewhere else and think, I need to be like them. Be yourself. Whatever is important to you, show up every day. Be principled. Bring yourself to work. Care about the people in your organization. Enable them the best you can get out of their way.

That’s something I spend a lot of time trying to do, um, and, and enjoy it. It’s a real privilege. It’s a real privilege. And one day. You’ll be sitting on a plane next to somebody who’s had their life changed because of something you worked on or developed. Um, in our case with the vaccine, it happens a lot.

Um, it’s incredibly rewarding. Um, but yeah, just look after yourself and look after each other. Wow.

Naji Gehchan: What, what an amazing way to sum up this discussion. Thank you so much, Mel, for being with me today and this incredible chat.

Melanie Ivarsson: Thank you. That was wonderful to meet you. Thank you so much.

Naji Gehchan: Thank you all for listening to SpreadLove in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Sema Sgaier

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, joined today by Sema Sgaier CEO and Co-Founder of Surgo Health, a healthcare technology company developing a revolutionary socio-behavioral analytics platform and generating novel, real-world data designed to inform and improve health equity and outcomes by enabling a greater understanding of the complex factors that influence how individuals engage in their healthcare. Sema is a serial entrepreneur with close to 20 years of experience in healthcare. She co-founded and led Surgo Foundation and Surgo Ventures, where she led the development of analytic products that solve health problems with greater precision. She was Initiative Lead at the Bill & Melinda Gates Foundation, where she brought innovations in data, consumer insights, and product introduction into large-scale health programs globally. She has over 60 publications and is a frequent contributor to The New York Times and prestigious media outlets. She is an adjunct assistant professor at the University of Washington. She completed her fellowship in Genomics at Harvard University, Ph.D. in Neuroscience from New York University, and M.A. in Neuroscience from Brown University. Sema is a member of the Board of Directors of the United States of Care. She was selected as a rising talent by the Women’s Forum for Economy and Society.

Sema – It is such an honor and pleasure to have you with me today!

Sema Sgaier: Such a pleasure to be here, Naji. Thank you for inviting me.

Naji Gehchan: Can you share first with us your personal story from genomics to development and now being the CEO and Co-founder of Sergo Health?

What’s in between the lines of your inspiring journey?

Sema Sgaier: Sure. Um, my personal story actually starts, uh, during my childhood. So I was born in Libya to a Libyan father and a Turkish mom. And I was born in a, in a, in a country where healthcare was actually really challenging to get, and I, I had a, a condition that required, um, advanced care.

And so my family, um, had to take me abroad. Uh, and I spent a good chunk of my childhood in hospitals and a good chunk of my adult life having to get. Um, but that really got me inspired in, in health and it got me really inspired and really, um, bringing health to a lot of, uh, people. I was also, um, you know, uh, very interested in science and so that led me to a career, or I started my career, I should say, in genomics and, and neuroscience.

But very quickly, um, missed the, um, the needs or, or really missed working with people and communities. I’d grown traveling all over the world and, and, and really missed that. So the journey started with moving to India. Uh, and starting on the ground, uh, developing surveys in communities, in villages to really understand their needs when it came to help, uh, you know, going door to door, asking families, asking mothers, asking husbands, asking children.

Uh, and that was really the beginning of understanding the power of data, uh, and the power of the human voice in being able to. Not just governments in terms of what the gaps are, but really inform all sorts of activities in communities, um, by companies, et cetera. Um, so, you know, long story short, I won’t, I won’t, uh, describe every step, but I ended up, uh, then eventually joining the Bill and Mill and the Gates Foundation.

Um, in India and lived there, um, for seven years working on, uh, an H I V prevention program. Again, working with communities. Um, and then from there, moved on to work on h I V prevention in Southern and Eastern Africa. The key part and the crux of, of really what I do, um, and I’ll, I can dive deeper into this.

The key part of my, what I learned and all of that work is that we really need to understand what people need on the ground and what. What is behind, um, their actions, their decisions when it comes to how they interact with healthcare, uh, and you know, how they consume healthcare. And, and for me, the really big question that we need to answer is the why question behind people’s behavior.

Um, because we often don’t approach healthcare, uh, you know, by un trying to understand the why. We start with what’s happening in the ecosystem. Um, and so. The three organizations that I co-founded and, and I’ll, you know, I’ll go of course into more details. Sergo Foundation, Sergo Ventures, Sergo Health.

Really the core mission of all three is bringing a big data approach to answer that question for every single individual so that we can inform, um, healthcare in a way that’s personalized to everyone.

Naji Gehchan: Thank you so much for, uh, for sharing part of your journey, and this is really a great segue. My question, actually, the first one was the mission of Sergo, uh, the different entities and, and really if you can tell us a little bit more your vision about data and how you’re gonna be able to answer those, uh, health issues.

Sema Sgaier: Yeah, absolutely. I mean, let’s start with just thinking about each of ourselves, right? You know, uh, and, and the people that we know. So we know that what people believe in, uh, what they, who they trust and, and, and how they trust, um, you know, the various barriers they face in the ecosystem, whether it’s the time, uh, whether it’s the transport, um, really.

Um, you know, how, how they interact with the healthcare system. And so, but when we look at the health ecosystem today, there’s a lot of data. There’s no lack of data. We’re actually swimming in billions of data. But a lot of it is really telling us, uh, as I mentioned, what is happening so we can map, for example, in the US the complete journey.

You know, which providers that they would, did people see, what were their diagnoses? What medications did they TA take? So that really tells. You know, that pathway, but if you were to ask me, okay, so, so why did this person living in this community not see a provider in the first place? I would be hard pressed to find that data, you know, readily available.

And so really the mission of of, of Sergo, you know, when we started Sergo Foundation, it was, it was really an operating foundation meant to incubate an idea and it was really meant to incubate this idea of how can we bring a big data approach. To really understanding people. So not beyond doing focus groups and having conversations, but how do we generate this data at scale and, and more importantly, and, you know, how do we analyze the idea?

So what are the innovations in the analytics space, and then how do we make it actionable for, for various stakeholders. Um, so Server Foundation, um, again, was really meant to. Demonstrate, incubate this idea. And we successfully did that in various programs actually in India. Um, and then let that led to the spinoff of Servo Ventures and from their um, servo health, which happy to go into the why behind those spinoffs.

Naji Gehchan: Yeah, I love it. Before we go into the why of the spinoffs, can we double click cuz you’re, you’re talking really about something that means a lot to me. Insights, right? Like you’re looking into, uh, patients insights, customer insights, to understand the why. Uh, can you share with us some specific example of how do you see, how do you gather those insights at scale?

And then mm-hmm. How do you run those analytics for us to be able, uh, to solve problems, as you say, with precision? I like this word. So how, how, how do you do this practic?

Sema Sgaier: Yeah, there, there are many ways to, to gather data, but I think fundamentally where you have to start is what is it that you wanna collect?

Uh, and I think, um, one of the things we learned very, very quickly is that, um, stepping back and, and really being clear what are the variables that need to be collected to answer the why question is really an important part of the equation. And so, We’ve built, um, over the years, um, a team of, a multidisciplinary team of actually, um, scientists and I would say behavioral scientists who come from various disciplines, right?

So when people approach human behavior, they approach it from a, from various disciplines, right? You have the behavioral economist who are really looking at just biases and heuristics. Uh, you have social scientists who really emphasize the, the social, uh, ecosystem in which people live. But in reality, all of these things really matter.

And so the approach we take in, um, in designing these data collection efforts in, in stepping back and saying, you know, beliefs matter, biases matter, heuristics matter, social norms matter. Um, and then in the context, the laws and policies matter. The systems matter, the access. Influencers, media, all of these matter.

And so we really need to be comprehensive in what we collect and, and so that we can get a complete picture. And so the first, the first step is really making sure that you have a good sense of what you wanna collect. The second step is then, of course, figuring out how, how you, how you collect it. And we have various methodologies.

But one of the things that we do, um, to get scale is a, is actually design a large scale survey. So we collect data in, you know, in the thousands, tens of thousands and, and sometimes hundreds of thousands depending on what platform we use, whether it’s, um, whether we, um, you know, use some of the social media platforms in, in way to get respondents or whether we use panels.

So that gives us the first scale. And then from there we apply our machine learning, um, analytics or predictive models, approaches to be able to then predict that for, you know, all the people that were not part of that initial data collection effort. So there are various steps in this journey. Thanks for sharing

Naji Gehchan: those.

Uh, you, you know, as I was looking, you’ve done incredible work, obviously on several different disease states. H I V you shared about, I saw your work where on Covid 19 and, and the CDCC is taking it. You know, I kept thinking data, precision science, really in an era where I’m like, many times I’m feeling misinformation.

Uh, like wrong theories, hate populism is somehow ruling, sometimes policy actions, but even like people’s actions towards their health that is actually harming them. So since you’re collecting those, Data, are you seeing this trend? Is this something real that you’re seeing? Is this something that is coming out?

I, I would really love your thoughts about precision in data and then actually what we’re seeing that is more fictional, I would say.

Sema Sgaier: Yeah. Um, yeah, unfortunately we are, and, and during the Covid pa pandemic, we, we did see, and in fact we were one of the, the, the first and few who tried to really measure some of this misinformation.

Particularly we measured conspiracy theories, uh, that people were believing in. And, and so we really looked into, What are those theories and actually went in and measured those and, and when I say measured, really tried to understand what percentage of people, for example, believe that, you know, government is using covid to control people, you know, are implanting chips.

Like there’s all sorts of conspiracy theories. And so we wanted to see not only how often, but really who specifically is believing these conspiracy theories. I think when it comes to misinformation and, and, and you talked about data, you know, people at the end of the day believe in. Uh, it’s not about the data, it’s the story and the power of the story.

And, and even as scientists ourselves, you know, what’s really on us is when we want to communicate our data, the, you know, quote unquote, Real true data, we really have to put effort in, in using stories to tell, to tell that so that people can really align to that emotionally. We’re emotional beings. We’ve learned to, you know, listen and hear stories, you know, from thousands of years ago, and that’s what resonates.

And so I think. Storytelling is, is really an important part of, of this equation. And Naji, I don’t know whether that’s the answer you’re looking for, but, but I think that’s really important as scientists and data scientists who sometimes can seem very boring and just crunching numbers.

Naji Gehchan: Yeah, no. Well, actually that was my question and I think you answered it.

The, the next one was really from, because you look from a customer, uh, lens, uh, on, on those data. So my question was, is data enough to convince? But I think you, you said it beautifully, it’s really about the story and how to shape those data in a language that is emotional enough for, for patients, for customers to change behavior.

Uh, I’d love if you have some specific example where actually. Because you talked about the actionability of what you do. So I’m, I’m intrigued and interested to, uh, to see how you turn those insights into actions to improve at the end patient’s health.

Sema Sgaier: Yeah. Yeah. I’ll g I’ll give you, uh, I have two, but I’ll, I’ll start with one and then, uh, happy to move on to the site.

And so the first one actually goes way back when I was working in India, uh, on h I V prevention. And there we were working, uh, with high-risk groups. And these were, um, sex workers, injecting drug users and, and men who had sex with men. And actually what was really interesting about this program was that community members were the, um, were people that were leading and delivering this program to their peers.

Uh, and so here you had, um, sex workers who had to go out to the community to be able to provide the services, and so it was very important for them. To know where these members were. And it was very important to them to know, for example, where the nearest clinic healthcare clinic was, where the nearest police station was, where the nearest safe house was, et cetera.

And so while the, um, you know, the, the scientists were collecting this data to put in the hands of this community. The question was how do we communicate this data in a way that they, you know, that, that they could use? And what they came up with was, was so interesting was, um, drawings, right? They, they took this data and rather than having these like sheets of like line items of here’s, you know, here’s where this person is and their address, they actually did these beautiful hand drawn, um, kind of, um, diagrams where they actually mapped locations and, you know, there were, there were like these children’s maps, but they showed where everything was.

And so this was. For me, it was an incredible example of taking hard data, right? Transforming it in, in, in, in a visual story and then putting it in hands of, um, actually people who deliver health so that their day-to-day healthcare delivery was, was, you know, effective. And, and, and it was, you know, we, we had a lot of evidence that this worked.

Naji Gehchan: I love this. Can you share the other, other

example?

Sema Sgaier: Yeah, absolutely. Yeah. The, the other example goes back to Covid. Uh, and again, you know, we all lived Covid and we also know that it was, it was, um, bombardment of information for all of us. Uh, and one of the, one of the approaches that we took during Covid is, uh, actually.

Data visualization and, and, and really, again, bringing art to telling that data story. So, uh, we, we had this amazing, we did these amazing stories with the New York Times. And so one of the stories that we did was a, was called Find Your Line in Your, find Your Place in the Vaccine Line. Uh, it was, I think one, it was the top red story of the New York Times that, that year or something like that.

But it, but it, you know, I don’t know if you remember in the early days, we were also concerned, when are we gonna get our vaccine shot? How long were we gonna wait? Now it’s a very different world. And so the, and we had that data. So we, we actually, um, were able to, um, show which group was gonna get their vaccine when across the United States.

And they did this beautiful visual where you could go in and put a few of your details, like your age, where you lived, and then they would draw this, uh, visual line and they would tell, You know, you’re gonna get your vaccine in 300 days or so. I’m, I’m making this up. But it was such an impactful way of actually communicating, um, you know, this notion of there’s, uh, an order at which these vaccines are going to be delivered.

You know, there’s certain priority populations that need to get it first. Um, and it, it was, it, it was, you know, so well read and people resonated with that. People understood it. They understood that whole vaccine delivery schedule, right, that we had in the early days through, through data and story.

Naji Gehchan: I love it.

What, what you’re talking about is just, it resonates so much, right? Like from, from really data, it’s all about data, right? But from data generation to understanding the why, not only the what and and what’s going on, but also on how you tell and how you share the story to make an impact at the end on, on people’s lives.

I love this. I wanna pivot though to, uh, to a question more on leadership. So you’ve had several experiences, uh, obviously in in non-profit, uh, with, uh, the Gates Foundation. You’re a serial entrepreneur. You’ve also founded a profit for-profit, uh, company recently. Uh, I’d love to, uh, to get what are your key learnings from a leadership standpoint, uh, that you are taking with you today from all those experiences and running, uh, your.

Uh, endeavor as a c e O.

Sema Sgaier: Mm-hmm. Um, Being a leader is, is, is an, uh, you’re always learning how to be a leader. I, I, I think it’s every day you’re, you’re, you’re going, you know, two steps forward, five steps backwards. I, it’s, it’s, it’s, uh, it’s a never ending, I would say, um, learning process. Um, and, and I, you know, I certainly have a long ways to go in, in, in that, in that place.

Um, so what are some of my learnings, you know, Several, but one I would say, um, is that leadership, um, in many ways actually, um, has to be adapted to the culture and context and environment that you’re in. Um, you know, I I, I worked in many different countries and many different types of organizations, but one of the.

I’ll give you an example. So when I first started my, my job in India, that was kind of my first job outside of academia. And I was, you know, leading, um, you know, these research groups on the ground. You know, really my first job managing teams, or I should say big teams. And I would, you know, show up into these trainings and, uh, you know, day one people show up.

Day two people showed up. And then day two before they started, like falling, you know, Two people were missing three people. And then one day I was just so down and I went home and, you know, I had a roommate, she was, uh, from India, and I said, what is going on? People are not showing up. And um, she said, you know, you have to adapt to the culture.

You know, you have to, you have to lead in a way that resonates to them. And so that led me really to introspect and, and to really adapt. And so, and, and that was really true across right From there, then I moved to, um, you know, the, the India Office of the Gates Foundation, which was a small team of 15 people that was led by, um, the ex country head of McKinsey, India that everyone else was, was ex McKinsey.

And that was a totally different environment. My point is that, uh, when you are leading teams, The culture can be so different depending on what country, which country you are, and what type of organization you are. And so in many ways, you need to adapt your leadership skills, um, you know, to that. Really, that was one of my, my key learnings.

Um, the second one I think is, is, is really being authentic, right? I, I think in the initial days I was thinking, well, how do I become like that person or that leader or, you know, people that I admired and, and. Quickly learned that that’s, that’s a bad idea. Um, you are who you are. You, you cannot change who you are, but you can adapt.

Um, but you really need to be au authentic as you know. And you need, you need to be, um, honest and, and, you know, and, um, you know, be who you are in, in that environment. Um, so those are, for me, the, the key learnings. I have many, but those, I would say stand top for me.

Naji Gehchan: Thanks, Sarah, for this. Uh, I would give you now one word and I’d love your reaction to.

So the first, the first one is leadership

challenging. The second one is women in science. Inspirational. Can you share a little bit more? I know you’re, you’re passionate about diversity and, and women in leadership and

Sema Sgaier: science. Um, I, I’m, I’m very inspired by, um, well, first of all, I’m a scientist and I think, uh, women in science, uh, are, are really phenomenal and, and we need way more of them.

Uh, and I find it really in. Inspiring, uh, to actually coach and develop and, and have women in science grow. And, and I’ve actually dedicated a lot of, of, of my, I should say, leadership, uh, you know, skills to that as well. So, so I, I, I find it inspiring seeing more women in, in science.

Naji Gehchan: Can, can you tell me the number one advice you give to, uh, women and uh, and young girls that are in science or want to go there?

Sema Sgaier: Uh, be bold. Uh, you know, go for

Naji Gehchan: it.

The third word is health equity.

Sema Sgaier: A must the, I give you a two word answer.

Naji Gehchan: Give me more. I, I wanna hear more about how you look at equity, because I know it’s, uh, one of the core values of, uh, of also sergo.

Sema Sgaier: Yeah, I think we look at equity as something on top, right? Like something else. Something in addition.

Equity to me is everything. It’s core, right? Equity. To me, equity is everyone. Equity means that, you know, every single person needs to be part of that. And, and that’s really equity, right? It’s, it’s not about like, There’s, there’s the core and then there’s another group. You know, it, it really, if you have equitable healthcare, essentially what that means is that you’re making sure that the barriers to, um, you know, living a healthy, happy life is for all.

Uh, you remove the barriers for all, and those barriers are exist for all. And they’re very different for all right? For you and I, it may be a time issue, but it really is a must and, and that’s something we should all strive for, uh,

Naji Gehchan: for. The last one is spread love in organizations.

Sema Sgaier: Oh, amazing. It actually reminds me, uh, if you don’t mind, Naji, since you brought, uh, you brought this, um, I, it reminds me of love languages, and this is something I’ve been thinking a lot about, you know, talking about leadership. One of the things about leadership, I think that’s really important is, um, how to motivate, you know, knowing how to motivate different people, uh, and understanding that different people are motivated by, by different reasons.

And it was really interesting. One of, one of my, um, one of my colleagues, one, you know, during his first week shared his love language with me just out of the blue and said, you know, my love language is words of affirmation and I. Okay. You know, I was like, that’s weird, you know, sharing your love language.

Uh, that was first week, but then, In retrospect, it, it is actually we need the, our professional love languages, right? We, we need to understand what is it that really motivates us, or what is it that really, um, gets us, you know, to, to be loving. Uh, and I, and I, and I think that’s really important, right?

Whether, whether it’s words of affirmation, whether. You know, it is the outcome or you know, whether it’s quality time or, you know, you can, you can translate it to work. But, sorry, the, when you said that spread love, I, it reminded me of the love languages and, and I think it’s a, it’s an important piece of the puzzle.

Naji Gehchan: It certainly is, and it’s a great reminder for all of us. Any final word of wisdom sum up for healthcare leaders around

Sema Sgaier: the. Um, I think this is, to me, it is the most important, uh, one of our most important topics of our time. And I, I would say that for everyone, be bold, uh, step up and, and really go after big ideas.

I think we are at a time where we have the opportunity to actually take a lot of big ideas forward and, and make this something for, you know, health for all. It’s, it’s really important. So, really go for it.

Naji Gehchan: This is such, such an amazing charger leaving us all with. Thank you so much, uh, SVA for being with me today.

Sema Sgaier: Thank you. It was an honor. I appreciate it.

Naji Gehchan: Thank you all for listening to Spread Love in Organizations podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Amy Kimball

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode, joined today by Amy Kimball an Executive & Leadership Coach and former biomedical research CEO. Prior to launching her coaching business in 2022, Amy had been coaching professionals on the side for 15 years, while she held leadership roles in academic biomedical research. During her tenure as CEO of a midsized biomedical research institute, she led a turnaround to rebuild a culture of excellence, high performance, and people-centered service. Prior to that, she held research administrative leadership roles at large, Boston-based academic medical centers. Amy holds an Executive MBA from MIT Sloan School of Management and has completed Georgetown University’s Leadership Coaching program. She coaches CEOs and other leadership positions that feel “lonely at the top;” mentors and advises start-ups; and serves in peer coaching roles within the helping professions community.

Amy – so great to have you with me today!

Naji Gehchan: Can you share with us first your personal story and what’s in between the lines of your journey and the inspiring healthcare leaders you are today?

Amy Kimball: Yeah, so it is a bit of a story. I think there’s sort of two parallel paths to follow in this. So, um, the first path would be my pathway into biomedical research, and that actually goes back to, um, a thread that’s tied from growing up, which is growing up with undiagnosed A D H D and really struggling in school, um, having a very inconsistent experience.

And I poured my energy into persistence, grit, hard physical work. Um, instead of really finding a way to navigate the academic system that worked for me and I was actually not planning, I didn’t think that I was college material, so I wasn’t planning on pursuing a higher ed path. Um, but I was fortunate. I had a guidance counselor who invested deeply in me and basically made it his personal mission to get me into college.

And he did. So I went to, um, undergrad, just loving science and medicine and math, and wanted to pursue a pre-med track. But found out early on in my first semester during cell biology that I just couldn’t process the learning, um, in a way that made any sense to me. And I flunked out of that intro class.

Um, had a conversation with my advisor and basically it was made very clear to me, this is a four year track. You have to keep up and because you’ve already flunked the first class, there’s no way you can pursue this major. So I switched over to an English major. I struggled to stay in school. Honestly, I had a very low GPA initially until halfway through.

Yeah, again, just through sheer persistence and grit, keeping myself going halfway through my college experience, I got this sort of earth shattering, um, awareness of what A D H D really was about and got my diagnosis and treatment. Um, so I graduated with an English major. Which I really felt opened every door for me.

It was not restrictive. It was something where I could take communication skills and good research practices and really defending a thesis towards anything. And when I came out of college with, by the way, a, a pretty high GPA in the end, because of this turnaround that happened with my, my diagnosis and treatment, I was just eager to get in the workplace and get doing.

So I chose, I moved back home to the Boston area and I chose to look for just any general admin job in a hospital setting so I could be close to healthcare because I was still very passionate about it. And I found myself in a biomedical research setting within a, a teaching hospital. Um, I noticed early on that the labs were engaging in sort of, um, a very science centric only approach, and then there was this administrative sort of divide happening, the rules, the compliance, the, the black and white thinking, and I was in administration.

And I was really unsatisfied with that divide. I just didn’t understand why it had to be that way. So I took a, a deep interest in the science to try to understand what that world was like. And in the process of, of talking with folks and going to scientific talks, I learned a lot about the science that I wasn’t able to learn in that college setting.

And I started to really understand what was going on and have a deep appreciation for the work. Um, and so what I did was I basically said, look, I’m interested in everything. Give me anything you wanna give me. I’ll take it on, I’ll figure it out and I’ll try to make your life. And of course people loved that.

They jumped all over it. Um, I was given a lot. I became sort of the resident problem solver and my goal was always, how can I make science easier and less friction and more successful? Um, so I, I kind of quickly rose through the ranks within that organization and, and other organizations in town. And basically built a career on the basis of this creative problem solving.

And after a few years I, I was able to see a shift in perspective where it was moving from no longer me, the sole doer of problem solving, but really into investing in teams of people who also were interested in this problem solving and helping to lead that and cheerlead on behalf of the organization in leadership roles.

To get things done better and to. Deliver that customer-centric service to making research thrive. Um, in 2017, I became the c e o of a mid-sized organization, biomedical research organization, and through that investment in our people and in our processes, but really through their eyes. What’s the work you are doing?

What’s working? What’s not working? What would you like to see? How can we better serve our customers? We, as a team, were able to drive a very significant turnaround of an organization that wasn’t working well and that had some divides with its own customers. To an organization that helped the science thrive and really was able to advance things forward in a productive way, and also a culture that people love to be a part of where they felt valued and individually invested in.

So that’s the, the thread of biomedical research, but ending on that piece where people felt valued and invested in, there’s also this thread of my executive coaching. Which goes back about 15 years and started because people would just start approaching me in systems initially within my system. And talk to me about potential leadership development.

Um, what they were observing was something really common in systems, which is managers and leaders were getting promoted on the basis of skills and e. And like many systems, they just hadn’t been invested in in terms of their own leadership development or management development. And they didn’t know how to let go of the doing and the skills and that deeply embedded work.

And so it was frustrating for members of teams to, to live with that and feel like they couldn’t progress. So they would come to me. And the beauty of it is, you know, I think a lot of people think they want to trash talk the situation, but it wasn’t about negative talk about managers. It was about. What do you want for yourself and how can we help you get there?

And that’s coaching. So that work continued to expand on the side. Um, people just kept, kind of kept coming my way. And that work expanded beyond my organization into other organizations and higher levels of leadership. Um, and when I had completed the turnaround as C e O, I started to think to myself, you know, I’ve achieved my career goals faster than I thought.

What’s the thing in my life that really brings me the most fulfillment that I wanna invest in now? And the answer was such an obvious, it’s this executive coaching work, it’s human and people development. And, um, I took this bold risk of quitting my executive job last year and going full-time dedicated into this private practice that I started.

And I’ve absolutely loved the work completely. Thanks so

Naji Gehchan: much, Amy, for, for sharing, uh, part of your story and it’s, uh, incredible how you’re framing both of them. Uh, I’d love to start, you know, before going into your current company that you founded on your current practice, uh, you’ve been, uh, really in several leadership roles in academic and nonprofit, biomedical research organizations as you shared, uh, I would love your thoughts about leading nonprofits and.

Learnings along the way when you compare it to executives you coach in the profit

Amy Kimball: sector. Yeah, so this topic has a lot of misunderstanding surrounding it, and I’m glad you asked about it. So one thing is that people often feel that there’s a very big difference between for-profit and nonprofit work, and that can be true, but not in all cases, especially in biomedical research.

I found. Most people on the surface wouldn’t have known we were in the nonprofit sector. The only differences were, instead of shareholder value, we were focused on stakeholder value and reinvesting our profits in our programs so that we would continue to advance them. And the other thing is just simply how we derived our funding, which was a lot of federal grants and industry contracts.

Um, but day-to-day, You know, the practices are the same. And if you, especially if you’re a mission-driven leader in any sector, it’s all about thinking about the mission and perpetuating the mission’s advancement. So when I work with, and I typically do work with in my coaching people who are very oriented, I feel no difference.

And I’ve never, no one’s ever really cited a difference from me either. And, and I would really like to, People understand that there doesn’t have to be a difference, right? It’s especially in healthcare, like we’re all servant leaders and we’re all dedicated to terrific outcomes for the people we’re caring for.

Yeah, I, I’d

Naji Gehchan: say we all should be, you know, servant leaders and I think we, we’re trying, we’re trying to get there and I’m sure with your coaching, it’s something you’re focused on. So let, let’s go to the specific example that you gave about, uh, what the time when you were the C E O. Uh, and did a huge turnaround.

Uh, you talked about helping sign Thrive and the culture you created Drew and, and you rebuild this culture of excellence, high performance, and people centered. I’d love to know how you did this, because it’s usually with turnarounds, uh, it’s tough moments, tough decisions to be made, and then creating this culture.

Of people feeling safe and thriving. You used the word servant leadership. So I, I’d like to hear from you how you did that and how you’ve put all this together for its work.

Amy Kimball: Yeah, and it wasn’t easy and there were a lot of moments that were very, very lonely at the top. Um, which by the way does inspire my coaching work because, um, it’s a way to allow leaders to not be alone.

What happened was, so I came into an organization that, um, on the surface what I knew about it was that we were relying on business walking in the door and being handed to us. And I, I just, that didn’t sit well with me. I felt like no matter the circumstances or how needed we might be, we should be earning our business and we should be doing that through relationships and through our ability to serve our clients in a useful way that adds value in their life.

When I started to uncover what, what had gone on, I found more and more that just this culture had been created that represented sort of a div again, the divide in practice administration versus science. And I, I had been there and I thought, we can break these barriers down, but we have to all be in as an administrative team.

We have to all value that and care about that and want that. And it couldn’t be all but one of us. It had to be every one of us united in that mission and in that way of viewing things. So initially I started by engaging in working with the team in just talking and listen. Asking questions, asking them about their experience.

Um, why do you work here? Why do you like working here? Why don’t you like working here? Um, what’s most fulfilling in your work? What’s least fulfilling? What’s most frustrating? And we uncovered a lot of common themes between us around some of the things that, you know, that that really worked well and didn’t.

And we started to find over time. That a lot of our frustrations were the same, which is really interesting because people don’t talk about their frustrations. And I think that these subtle divides start to emerge around like, it’s your fault. No, it’s my fault. No, you don’t understand me. I don’t understand you.

How could you prioritize that? I’m prioritizing this, and it feels like they’re in competition. But when we started to openly. What’s frustrating to you? What would you like to see improved? There was more common ground than anyone realized, and then, you know, I think people would’ve ever believed. So the first moment of magic in this turnaround was when everyone, we did an exercise where we just simply listed out the things that were Bo, that were worrying us and shared it with the.

And, and we did it on individual post-it notes. And when the same theme was brought up, we would layer it on top of the Post-It and people got to see visually, whoa, there’s a lot of layering going on on this one theme. Wow, we’re actually sharing the same worries. It’s not about you versus me, it’s about us.

And then from there we started to invest in, from a bottom up perspective, what would you like to. To solve you. And I said, as leader of the organization, I said, you are closest to the work. You know it, what would you like to do to improve this situation? And that was very empowering because it had been a, an organization of these are the rules and people were very afraid to cross those lines.

So that, that energized the team around like, oh, great, I get to do something here. I get to have a say and a stake in this. And they really designed amazing solutions that, that worked for them, those the people like in the trenches doing this. Um, that we, we had to have the discipline to do in a very incremental way so that it could be sustainable.

Um, so a big, I would say that the majority of the transformation was culture. And when the cultural stuff started to come into place, the structural stuff quickly followed.

Naji Gehchan: I love this. You talked about listening, you ask questions, obviously, uh, a lot, and you listen to the answers. And it’s really about you’re bringing this idea of cowork and practically co building and let people who are operationalizing things.

Think about it and cowork and cobalt, the culture you want to create. This is, this is really great. Um, anything you would have done differently leading such a major organization? Uh, organizational change when you think of it? Oh,

Amy Kimball: I’m sure there’s a lot of things. Um, there were, you know, I, I guess I started the story by saying it was lonely at the top, and I always felt very supported by my team and by my board.

Um, they were just wonderful, wonderful colleagues, um, who were truly lifting me up in the process of lifting ourselves collectively up. But there were probably moments where I turned a little bit too inward and a little too isolationist because I felt like the world was on my shoulders alone. Um, and where I, where I could and would invest in the team.

There were these moments where I just thought, no, I can’t drag them into this. This is mine to resolve. And I just would say that’s kind of a red flag for our, our own thinking. If we think that we own a whole problem and its whole solution alone, that’s probably a trigger to start thinking how might that not be true?

And what else could we. That’s a great watch

Naji Gehchan: out. Uh, as you coach today, executives in different industries, I assume, what’s your number one capability you urge them to nurture or to develop

Amy Kimball: introspection? So it’s, a lot of people come to coaching thinking that it’s about skills building and concrete skills when it always ends up being.

Self-development looking deeper what’s going on below the surface. And it hearkens back to the earlier point about people love to, they find relief, I think, in complaining about their surroundings. And you know, my manager’s not fair to me, they’re not investing in me. But that doesn’t get anything done.

It doesn’t change circumstances. So how can we flip that into, well, what’s going on with. What do you notice in yourself whenever you get into these common patterns that make you feel really awful afterwards, what can you notice? What are the trends and how are you handling it now, and how might that be perceived by others?

And we explore all of that, and then we talk about, all right, well, what do you want for. And I think it just opens this world of, wow, I have a choice in this. You know, there’s actually some levers I can pull and things I can do differently, even though my circumstances aren’t great. That can influence outcomes in a way that’s much more values aligned for the person and also can create a new dynamic.

Naji Gehchan: It’s, can we double click on this because obviously there’s a lot. Coaches, I’ve been, you know, as, as a leader manager, obviously it’s one of your biggest job to coach people as you’ve done for several years before getting into fully your business, now being executive coaching ca, can you share a little bit more and help people understand what it, what is it about?

Because there is so many, like the coaching industry, I feel is kind of exploding. We’re seeing so many people starting to be coaches. I’d love, Kara, what is your take about coaching and how do you approach it, uh, with executive.

Amy Kimball: So I approach it similarly to what we talked about with the team at the beginning of any engagement is about me listening and learning.

So I like to get to know someone, hear about their background, hear about their story, and some of the things that have shaped them. And I think that serves a dual role of me gaining understanding about them, but also them releasing some understanding about themselves and connecting some of those dots around.

Oh yeah, this is something that really shaped and influenced the way I show up in life all the time, including work. And from there we start to talk mostly about, so in a session, someone will bring whatever’s going on in their work right now that’s frustrating them. And through some introspective questions that I’ll ask them, we’ll start to talk about, well, you know, I can understand how frustrating this situation is.

Um, what can you notice about. And so it really goes very quickly into that introspective place, and I, I believe that that’s the role of executive coaching. There are other forms of coaching that can be very skills development oriented, and there’s a great place for that. Um, but executive coaching, people who have risen to these levels have the skills they have.

They’re incredibly smart, incredibly driven, incredibly skilled skills, is not the problem. If there is a problem, it’s about have you been able to look deeper and, and by the way, the higher up you get, the less direct feedback you get from people around you. So have you been able to look deeper and think about and process what could be going on that you can do something about rather than just the external environment?

Naji Gehchan: I would give you now a word and I’d love a reaction, uh, that comes to mind. So the first one is,

Amy Kimball: So I think leadership is about an ability to make decisions under uncertainty that are for the collective good and the collective whole. So moving beyond yourself and what benefits you to, what benefits the whole system.

What about mentorship? I think mentorship has a really important place in this too. I think mentorship is more around being a direct sponsor for someone and serving as a role model. Um, and that’s where some of the life experiences and the shared approaches and exchange of ideas really comes in more directly through mentorship.

And that’s about enabling yourself to learn from other people’s experiences. And help shape what decisions they wanna make.

Naji Gehchan: What about lonely at the top? And you said it a couple of times.

Amy Kimball: Yeah. Um, I think lonely at the top is in inevitability in some ways. Um, there is a lot of weight on the shoulders of leaders and. There isn’t a lot of direct feedback. Um, there are a lot of resources and there are a lot of support structures, but there isn’t a lot of direct feedback, and I think loneliness at the top involves not having a, a real sounding board.

And I think that’s another role for executive coaching is just having someone to air some of these challenges that you really can’t bring the whole system into in a safe, confidential space. The reality is while you’re working through the ambiguity, there are moments in time where you just can’t bring the team into every single level of that ambiguity.

Once it’s ready in some way, I believe in sharing some of the uncertainty and being very honest about the way things are, including when they’re not good. But I do think there’s some working out that needs to happen, and that’s part of that loneliness at the top.

Naji Gehchan: And does this, uh, touch all the part of like, being supported?

There’s, you know, I, I had the pleasure to talk with several, you know, coaches, thinkers, and even executives who share, uh, you know, like, I, I don’t wanna use the word mental health, right? But it’s, it’s somehow the loneliness that you feel leaders. We don’t take care of ourselves enough. Sometimes we are really thinking about others organization.

To, to a point where unfortunately sometimes it’s a little bit too late until we realize we need to take care of ourselves. Is this something in the lonely at the top that you think of or you discuss with, with executives and leaders?

Amy Kimball: Yeah, that’s such a good way to put it, naji. It’s, it’s so true. Yes. It, that has been a universal quality that I think every one of my clients has felt and expressed, and as you said, we aren’t taking care of ourselves, so in many cases, I think it takes us a long time to even realize and be willing to admit to ourselves that it’s true.

Because I think that in our drive we have so much ambition and so much passion that we just put ourself and self-care and self-compassion, not even on the back burner, but not on the burners at all. Um, and I’ve noticed this correlation between. Highly driven people who have really risen to the top and a desire to please and a somewhat of a perfectionistic tendency that we often break down and challenge and talk about.

Um, even just exploring how has the path that’s led you here changed who you are today and how is who you are today? No longer needing to be anchored to the way you were, because that’s another point that a lot of people sort of have a hard time realizing, like, I’ve crossed the threshold that I’ve driven my energy towards all this time.

Now, what do I want for myself?

Naji Gehchan: The last word is spread love in organizations.

Amy Kimball: I think it’s really great what you’re doing with this. I, I couldn’t agree more that love needs to be spread in organizations. Um, it’s what it’s all about. You know, we, especially when we’re thinking of concrete skills, we could apply our concrete skills in just about any setting.

What makes us wanna stay with an organization, hopefully is the culture and part of that culture is. And is finding joy and mission and passion in what we do. And I, I hope that we can do more, finding that love and that more leaders can really lead with more heart, so that we can all just feel human in the place that we’re giving most of our energy too.

Naji Gehchan: I couldn’t agree more. Amy, any final word of wisdom for leaders around the world?

Amy Kimball: Oh, I love that you said leaders around the world because it really is a global community. Um, global is a small community in so many ways, and we’re so interconnected. Um, I just hope that we can keep working to break down these perceptions of competition and divide and just think about what are our common goals and how can we lift ourselves?

Naji Gehchan: Thank you so much for being with me today. Thank you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Ashoka Madduri

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast joined today by Ashoka Madduri. Ashoka grew up in a small village in south India. After completing his undergrad and masters he obtained DAAD matching scholarship and moved to Germany. He completed his PhD in Organic Chemistry from University of Groningen, Netherlands, where he worked on anti-cancer complex natural products. He performed his post-doctoral research to understand pathways involved in multi-drug resistance in Mycobacterium tuberculosis at Harvard Medical School. Over the years he has worked in multiple biotech companies and developed expertise in business development & corporate strategy. He received his Executive MBA from MIT Sloan School of Management. Currently, he is a Blavatnik Entrepreneurial Fellow at Yale Ventures providing strategy & enabling multiple early-stage life science startups. He’s a Co-founder & CEO of TargetSite Therapeutics, a Yale spin-out, and Partner at Vestra Associates where he advises biotech companies on strategy and partnerships.

Ashoka – it is so good to have you with me today!

Ashoka Madduri: Thank you, Naji . Pleasure is all mine.

Naji Gehchan: Can you share with us, uh, first your story from growing up in a small village in India to Germany, Netherlands, US, and practically always being passionate about healthcare?

What’s, what’s in between the lines of this incredible story? Sure.

Ashoka Madduri: Uh, nai, it’s a long story. I think, uh, I will start, uh, my, uh, in a story from, uh, the s I grew up in South. We were, uh, we were a farmer’s family. My mother passed away when I was around six years old, and it was a really tough time for me and my dad.

My dad left us and, uh, remarried and left the villas. Uh, my, uh, my aunt, my dad’s, uh, sister took me in, uh, special woman who changed my life forever. Uh, so we used to, we used to form together to sustain. So we grew rice, cotton, vegetables, flowers to sell raised buffalos to salt their milk. Uh, so I couldn’t go to school full-time.

Uh, I had to work in a farm and take buffalos for grazing. Uh, so fetched, uh, drinking water from over two kilometers while, while I’m growing up, and sometimes the pot would break halfway. So, uh, so now your water is gone and your pot is gone. You can start all over. That is, that is really in a nutshell, my story when I’m growing up.

So, so basically, uh, uh, with that, uh, uh, growing up story in small villages, uh, I somehow finished, uh, uh, my childhood and my thought, uh, before I leave, I left my village right to bigger city to continue my college education. My aunt, the special woman in my life, taught me hope, optimism, and patie. That is, that is really, I took that to heart and I, wherever I go in my journey, I took it with me.

And that really helped me to, uh, you know, to be where I am and also spreading to the community I’m in, family and also industries. So, uh, I, I think, uh, uh, after I left my villages, uh, we, uh, I moved into, uh, town where I finished. My undergrad, my undergraduate, and also my master’s. So, Another religious during this time, another religious, my mom’s brother took me, uh, took me to stay with him, uh, for college.

Uh, it was totally different world in the city. I studied for Bachelor’s in science. Uh, the books were in English because, uh, in, during my villages, uh, my education was in, uh, local telegu medium. So I never exposed to studying textbooks in, uh, in English. So I had no idea what was written in them. So I purchased the same books in.

Local language and studied both books. Uh, side by side. The relative supported me temporarily. Even families can’t even make ends meet during this time. Even the small amount of Lao they showed. Done miracles in my life. So imagine if we can get even more in our families, industry and communities we are living in.

So that is something, uh, I always, uh, go back and remind myself, uh, how much, uh, smaller, uh, affection and, uh, care and love had impact in my life. So that is, that is my college’s life. Uh, uh, na you know, once I finished. Undergrad and masters in chemistry. I took, uh, my first flight to Germany, uh, by obtaining a dad matching fund scholarship.

Uh, so, uh, uh, follow following that, I finished my PhD in university, uh, CRO Netherlands, where I met, uh, uh, my wife, uh uh, my wife. Life, life law because this theme of your podcast is Lao, see Changed over my life Forever. Forever from there. And it’s a, it’s a, it’s a ki kind of big memory for me. Like during that time, I’m also discovering myself, uh, there is education part and also I’m also discovering myself, um, and found this, uh, law and, uh, spreading throughout, uh, in my college education and also meeting the communities, uh, under, under the impact it has, you know, in my, on myself and also the communities.

Uh, I’m, I’m, I’m living, I’m living at the time, so, uh, Nai, I’m sorry. I, I think, uh, I’m thinking, if you don’t mind, can you pause this? Sorry.

Uh, thank you nai, uh, that is, uh, really a, you know, uh, a heavy question because I, I see this in a couple of parts. Uh, so one is a hard work education, uh, discovering. Family, friendship, work on giving back. So I will, I will, I will, uh, touch base, uh, e each, each segment one by one. So I grew up in a small village.

We were a farmer’s family. My mother passed away when I was around six years old, and it was a really tough time for me. My dad left us and remarried, left the village. My aunt, my dad, sister took me in special. Women who changed my life forever. We used to farm together to sustain us. We grew rice, cotton, vegetables, flowers to sell, raised buffalos sold their milk, so I couldn’t go to school full-time.

I had to work in farm and take buffalos for grazing, fetch drinking water from over two kilometers, and sometimes the pot would break halfway. So now water is gone and the pot is gone. So we, uh, so we can start all over. That’s, that’s, uh, my life in a nutshell. Uh, during growing up in a small village, during this all the time, my aunt taught me hope, optimism on patience.

I took this close to my heart. Uh, I always take this, uh, wherever I go, and I always try to cultivate this, uh, hope optimism patients in communities, families and industry. Wherever I worked, I’m applying to, uh, work going. So this is, uh, my childhood. Uh, now the released by me goes to City. Somehow I finished school and, uh, another lady, my mom’s brother took me to stay with, with him for college.

It was totally different world in the city. I studied for Bachelor’s in Science. The books were in English. I had no idea what was written in them. I purchased them same books in my local language and studied both side by side. Uh, the relatives, uh, supported me temporarily. Even families can’t even make Smit during this time.

Even the small amount of Lao they showed. Done miracles in my life. Imagine if you can get even more in our families, industry and communities we are living in. This is, this is really something, uh, uh, that really reflected on my life. Uh, imagine the small amount of care and love and affection changed my whole life forever.

Imagine. We can spread this throughout the communities and families industry we are living in. And, uh, what, what are the things we can change under the impact we can have in the. So, uh, uh, after, uh, uh, finishing, uh, my undergrad, uh, in the city, I obtained a spirit of, uh, excellent scholarship and, uh, completed a master’s in chemistry.

Following that, I obtained a prestigious, uh, dad matching funds fellowship, and moved to Germany. Uh, that is, was my first flight to flying to Germany. I thoroughly enjoyed it. Uh, so following that, I finished my PhD, uh, from, uh, in west of Krogan Netherlands. Uh, I found my. My wife, I fell in Lao and that changed, uh, my life, uh, uh, forever.

Uh, as this, uh, podcast theme is Lao and that is one of the important component, um, of, uh, finding Lao not only in families, but also in communities and also the education, the place you are in. Uh, so, uh, following the, finishing my PhD, uh, I crossed the pond once again, moved to hardwood medical school to finish my postdoc.

Continued my professional journey, uh, in, uh, in, in, in the, in United States here. Work in small and medium sized biotech companies. Uh, built teams. Started as a, uh, head of r and d research and development built teams from scratch. Uh, uh, continued my, uh, professional journey into business development, corporate strategy and consulting.

While I’m doing this, I also finished, uh, my, uh, m mba, uh, from m I t. Uh, currently, I’m, uh, also working as a blaa entrepreneur fellow helping faculty. To, uh, you know, helping faculty on, on strategy help, uh, strategy to take their companies to next level. Uh, so I’m also, uh, uh, running a, a small company that’s a el startup is target side therapeutics.

It’s a small team, uh, but still in, even in a small team, the. Care, nurture, uh, em, uh, empowering people is very, very important because we are building from scratch that set the tone for our next generation of, uh, employees that are going to come into the company. So I’ll stop, uh, here. Nai, you know, uh, uh, I’m, I’m happy to continue if you have any other questions on this.

Well, thank you

Naji Gehchan: so much for sharing. It’s just such an inspiring story. Um, and thanks for sharing openly, uh, all, all you’ve done and, and your leadership and beliefs, uh, that I definitely believe like you and, uh, can you share with us? You’re learning specifically on being an immigrant, like there is more and more discussions about the immigrant mindset being an immigrant and you know, entrepreneurship, et cetera.

I’d love to, to see if your story of, you know, immigration moving those countries, uh, with the hardship that you shared, has this impacted at all your entrepreneurial journey and how you lead teams?

Ashoka Madduri: Excellent question, naia. I think, uh, totally, totally right. Uh, for me, I see entrepreneurship as, Is, uh, rewarding, but first of all is a really high, highly risk taking.

So I think, uh, coming, coming back to, uh, my personal story Rise, uh, and also, uh, it, it, it’s, uh, same story for any immigrant, right? Living their, uh, country taking risk to go to different country and new environment, new people, new language, uh, until, uh, uh, really. Kind of being com being comfortable learning that stuff, uh, and producing that is required.

Uh, you know, to sustain your life is not easy. Actually. I think that same thing you I’ll see in entrepreneurship too. It’s risk taking. It’s a lot of risk involved. Uh, so I think as immigrant, uh, I think it is, becomes a. Second nature to you to take that, uh, uh, risk and, uh, really build the companies.

Actually, I think, uh, that is the reason I see, I believe that, you know, um, uh, United States become United States just because that, uh, uh, you know, uh, risk takers like immigrants, people who come here and build this, uh, country, what it is now today. So

Naji Gehchan: you’ve been working in several biotechs and you co-founded one.

You’re running it as, as the chief exec, uh, officer. Um, and you’re also mentoring along the way, several other founders, biotech founders, life science founders. What, what is your key advice when you talk to founding teams starting life science companies?

Ashoka Madduri: I think, uh, the key advice is, uh, uh, I think of course we are in a very highly technical industry, right?

Science needs to be there for sure. I think, uh, more than science, right? I think, uh, building right team, right team is really important. Uh, I think, uh, Really, you know, last, first three or four people who are, you are really hiring, nurturing them, empowering them, and they’re the ones setting tone for your company’s growth, actually.

So I believe in really building team now, along with the, having a strong science foundation. So I think that’s where, uh, I, I, I put a lot of emphasis actually, you know, and this advice I’ll give to any entrepreneurs out there. Planning to build their company from scratch. Look for that, um, right. People actually who shares the value and to nurture the people, uh, that they work with.

Uh, that, that’s going to set the tone for the, uh, for the development of the company. So, so can you share,

Naji Gehchan: uh, with us a little bit more like those leadership skills? And how do you look at this, uh, in a founding team? Is it complimentary? Is it specific leadership skills you believe foundationally they should have?

I’d love to get your thoughts because specifically on this team, as you said, like this is the biggest piece. There’s science and team. Uh, how, how do you look through this and what are the skills and capabilities you

Ashoka Madduri: look for? I think, uh, uh, plus for sure, you know, Any, any, any team you’re building initial, right.

It’s always good to have complimentary skills. I think that is a, uh, uh, that is a given, uh, you know, uh, the, besides having complimentary skills, right. You know, I think, uh, people need to understand the vision, uh, vision of the company in, uh, in two ways. I see. One is really from technical point of view where we are.

Where we want to go in few years. And second thing is, uh, what kind of team we would like to build. So that’s where I really focus emphasis on actually whenever we are hiring, uh, new employees want to make sure that they share the same vision. For the technical side as well as for non-technical side, how to really build the teams and the company as a, uh, as a, as a, uh, as a, uh, you know, in, in small institute Right.

You know, ourself to nurture each other. So, so I think, uh, the important focus is really what values they share and, uh, uh, and, uh, whether they, they, they, they share the common vision with us to really build these teams, uh, uh, to take this.

Naji Gehchan: I love it. You mentioned a couple of times and you touched it on culture that this team is trying to build.

So there is the values, shared values, a shared purpose, uh, as, as you’re building this, especially when you’re a small team. Um, and then there is what you’re trying to build as a culture. And you said the first hires are key. Can I double click on this and ask you, what are you trying to build as a culture?

For example, if you take your, your venture now as a ceo,

Ashoka Madduri: I think, uh, culture is the key, right? Know, uh, na you know, the couple of reasons for this, right? Uh, you know, you attracting talent in this competent environment is not easy. Uh, you know, there’s plenty of options for, uh, People who are just coming out of school, uh, you know, they can choose to work in different companies, uh, in our at any time.

So keeping the talent in in-house or, that is very key actually. What it starts from is culture. It’s having the really culture actually, and the, uh, trust teacher there. And you empower each other and really having a, that, uh, caring affection love. I think that is very, very important at this stage actually.

I think, uh, money component is there. Some people really get motivated by money, but I think a lot of times I’ve seen is actually having that culture, care and empowerment and love, I think, uh, keeps the people together for longer time. I think that’s, that’s what, uh, for me, culture means. Actually. I think people who share these values and believe this is.

Way to go forward. That’s, I think, for me, the culture actually. I think, uh, this starts from first few people actually that you are in, in our company that is, I believe this is like, uh, uh, what’s your cycle? If you have three people and the share same values and you keep moving actually with the, with the team you build going forward.

So,

Naji Gehchan: So this, this is, this is very powerful and obviously I’m, I’m biased. I’d love to know how you do it in a, you know, in a small team to show this. Because culture, you can, you can say, I want this, but obviously it’s the perception of what’s going day by day that is making it lived or not. So I, I’m intrigued, especially in a space where, You’re fundraising.

It’s tough. Science is tough, and it humbles us every day in drug development and discovery. You’re talking with VCs constantly, and then you’re coming with like, I have science and I have a team, and I have love and passion. I would love to know how you’re.

Ashoka Madduri: So I think, uh, there’s no magic bullet. Uh, na you know, I think everyone knows, you know, fundraising is hard, uh, and also, uh, being a c for a startup company, right?

It, it is also highly risky job. It’s not fun too. You know, there is a lot of things can go wrong. We are, we’re trying to get the data that required to raise the funding. You may not even get it actually. So I think, uh, the one way I’m keeping, uh, all the things together, uh, I’m also learning from each other, right?

Not only me actually also looking to my early employees point of view, what they see. What the issues we’re facing actually. So learn from each other actually, and also at the same time, right. Understand being a good listener, actually. So I think a lot of, uh, uh, times I see in, uh, early CEOs, right? You know, they do have some kind of idea how to run the company, but I think they’ve, uh, failed to listen to the.

The early stage employees actually who are key instrument of the company. I think listening, I think this is very, very important actually. That really solves majority of the issues, uh, that early stage companies are facing. So that’s something I cultivated. Uh, na or listen to your employees and, uh, and uh, and see what they’re saying, uh, and act according to that.

That, that going to solve really a lot of issues. So I think that’s something, uh, you know, like cultivated in our company. And also second thing is, uh, having that bigger vision, actually, yes, you do have upside downs. Maybe things won’t work out the way you want. Uh, maybe even raising capital takes more than time required data you are looking for.

It may not get actually, but I think, uh, having that bigger vision, right, that belongingness like, okay, we are here for each. We can support each other, we can get through this. Actually having that kind of mindset, you can, you know, that can sustain you for a longer time. So certainly, and

Naji Gehchan: you mentioned a key, a key point, which is belonging.

Uh, and, and I think focusing on this can solve a lot of issues on retention, feeling part of something bigger as you already shared, be before. Uh, if, if I ask you a question more, Technical practically. Now, you’ve, you’ve been helping so many biotechs and you’ve been on the edge of new technology. I’d love to get your thoughts on how’s the biotech environment in 2023, since we’re the first couple of months of the year, and what’s your take on it moving forward for this year and

Ashoka Madduri: next one?

I think a, for sure, right. You know, public markets, as you can see, uh, uh, is, is brutal right? Environment. So I think. Just because there have been plenty of money already being raised in Covid time. That disruption happened during Covid, so so. So basically a covid taught us so many things, right? You know, especially biotech, a pharma industry, even though as much as they allow, it’s still a conservative industry compared to other, other, other, uh, industries.

We have a lot of regulatory environment here. We need to follow certain rules and regulations, you know, to really keep this industry moving. So I think, uh, uh, coming, but again, I’m really optimistic actually. So I think it’s kind of, uh, I believe in, uh, Uh, blessings, uh, uh, in disguise. Disguise, sorry. Uh, disguise in blessings is, uh, sorry.

Nazi. Uh, can, can I pause here? You, if you don’t mind. Can I take that question again?

Naji Gehchan: Yeah. Do you, do you want me to say it again?

No, no, no worries. Drink

Ashoka Madduri: water. Yeah, maybe I can start the question maybe again. Okay. Yeah, yeah. Sure.

I can, I, I know the question actually, so,

Naji Gehchan: okay. So gimme just two seconds for us to be able to edit it. Yeah. So we Pause two seconds and then you can start again. Okay.

Ashoka Madduri: Yeah.

Got it. So I think, uh, that’s a great question. Uh, NAZA, you know, Covid, uh, really disrupted biotech industry a lot. Uh, I think, uh, in 2023, uh, we, we is still seen a lot of headwinds in, uh, in, especially in public markets and also some in, uh, private markets. But I’m really optimistic in, uh, uh, uh, the lessons we learned from, uh, COVID, right?

How to be flexible. You know, how to be resilience. I think that, that these are the lessons actually very, very important for biotech industry. How, how we can be more flexible and resilient in this changing environments. So I think the hybrid culture is really going to stay for a longer time. Uh, there is something, uh, you know, industry.

Never thought is is going to happen. I think this two years kind of, uh, accelerated almost like 10 years of a life, uh, lifetime in biotech industry. So, uh, I think keeping this in mind, right, hybrid environment and also technological, uh, uh, uh, uh, uh, evolutions that happening, especially in gene cell therapy and also mRNA, uh, the industry is, uh, good to do, uh, more things, uh, that, that.

Kind of can’t imagine actually 10 years ago. So that I’m, I’m really optimistic for this industry and, uh, I’m, I’m, I’m, I’m going to play one of the small company c e o key role going forward actually to really bring a transformation therapies actually that much more safe and focus for patients. That’s

awesome.

Naji Gehchan: And we, we, we need so much of all the innovation we are all working on, uh, patients actually cannot and should not wait. So it’s, um, thanks for all you’re doing with, with your new adventure and also advising all the other biotechs too. I would give you now a word and I would love your reaction to it. I’m, I’m sure you were ready for this section.

Sure. So the first, the first one is leader.

Ashoka Madduri: So for me, leadership is, uh, all empowerment. You know, uh, expand on that, you know, especially after Covid, people gone through so many transformations, being hybrid, uh, I think empowering, empowering is, uh, is kind of undervalued actually. So I think I really touch base on, uh, you know, any leaders out. Empower people around you.

I think even the small change, the small, uh, you know, feedback, the positive feedback that you, that you give to the person, that changes the life, that per of the person tremendously. So I think for me, empowerment, leadership is always empowerment. What about health equity equally? Health for all. That, that is, that’s what comes to my.

But, uh, is it really truly happening, uh, in our, the country we are living in? It’s still far away. Hopefully as a leaders, we collectively find the answers to make that, uh, e equal to all happen soon. The third one is

Naji Gehchan: fireside shots.

Ashoka Madduri: It’s scary. So, uh, but I think, uh, It’s scary. Uh, but if, if you, if you take that, uh, you know, moment to think about it, what kind of impact it can have, the organically sharing your story and genuine to and truthful to who you are, I think, uh, that can change your, and also that can change a lot of people life actually.

And I have a, in a positive way, having greater impact. Uh, it, I totally support, uh, five set charts in. There is something, you know, you won’t really see that you see normally, uh, you know, in other stories. So, uh, highly, highly recommend that you know any, any entrepreneurs, leaders, how do themself and also ask other people to do this.

Actually, that’s the only way we can, we can build a strong community.

Naji Gehchan: Just as a background for our listeners, the fireside chats are actually moments where we share our stories and we, we, I, I had the opportunity to be in the same program as, as you Ashoka, this, it’s really those moments where you have the opportunity to share your story and tell it.

Um, and it’s definitely. Powerful moments as you did today, sharing your personal story with, uh, with all of us here. Uh, the last one is spread love in organizations.

Ashoka Madduri: So it’s a, it’s, it’s a continuous, right? It’s a journey. So I think, uh, as someone said, life is a journey, not as a, not a destination. I totally believe save.

Same is true for Lao. Love is a journey, not a Destin. The reason I say this is, you know, you can even in a family’s right? You know, he found Lao, he got married. That is not enough. Same thing I see in industry and communities. Once he found Lao, you need to not share, uh, Look at the, look at the issues that you are saw, uh, going to stop, solve and facing every day and find solutions.

Actually, I think, uh, I feel this law is a journey. It’s not a destination and we should keep, uh, uh, cultivating this culture throughout our career, not only industry, also in family, and also in communities we are living in. And we’re

Naji Gehchan: trying here to do our part, bringing incredible leaders like you who believe in this.

And hopefully we can keep growing this, uh, this journey together to, to lead from a place of love for us to be able to execute and deliver for the patients we serve. And all the stakeholders. Any final word of wisdom for healthcare leaders around the world?

Ashoka Madduri: Empower people. Uh, empowering people is, uh, one of the thing, uh, I take, take very close to, uh, my heart, uh, uh, na, you know, uh, and what you are doing, uh, through your podcast, uh, you know, spreading Lao, I, uh, I love the theme. And this is, this something, uh, hope many people, many leaders will spread the law and empower, empower their people and, uh, empower their people.

Uh, this is, uh, this is, uh, you know, this is the way we can build a stronger communities and we can have a greater impact, uh, on society as a whole. So. Well, thank you so

Naji Gehchan: much, uh, Ashoka for being with me today and for this incredible chat.

Ashoka Madduri: Thank you, Naji. what you’re doing is great, and, hopefully, you continue doing this and spread love across the world.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Georgia Perakis

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode from our new series focused on us as leaders. I’m thrilled to be joined by an exceptional MIT professor of Management, Operations Research, Statistics and Operations Management: Georgia Perakis.

Georgia teaches courses and performs research in analytics, optimization, machine learning with applications in pricing, revenue management, supply chains, transportation, energy, and healthcare among others. I had the privilege to be her student the past semester, and not only I learned about data, models, and decisions, but I learned about leadership from her as much!

In her research, Georgia investigates the theory and practice of analytics and its role in operations problems.. She has received numerous Awards and have several prestigious publications. Currently, and Georgia serves as the codirector of the Operations Research Center and on the council for the College of Computing, and faculty director of the Executive MBA (EMBA) program at MIT Sloan. I’ll never be able to share all her incredible work and impact so I’ll stop here and listen to her!

Georgia Perakis: Hello, Naji. Thank you very much for inviting me. Nice to see you.

Naji Gehchan: Georgia, before going into the world of data and leadership, I really would love to learn more about your personal story and journey to becoming the great MIT professor you are today.

Georgia Perakis: So, uh, I was actually born in the south of Greece in the island of Crete. I came from a, what I would call a very academic family that starts from my father who, uh, arrived before the second world war started. He was in Switzerland, uh, doing his master’s degree in civil engineering and studying airplanes, unfortunately, because of the war he had to come back and he had to serve the army for five.

So the dream of he used to pursue graduate studies did not work out. Uh, but as a result, uh, both my brother and I, uh, he basically instilled in us the passion to basically study and be academics. Um, and so both my brother and I are professors in the us in different universities, myself in, uh, what I would call applied math in business or analytics and my brother and sister.

So I, I would say in short, I’m trying to say that this is all because of how our father inspired.

Naji Gehchan: Oh, wow. That’s a, that, that’s awesome. Uh, and I’ve, I’ve seen you, you’re talking about how you get into MIT, academics, uh, and well, all the amazing work you’ve done so far and still doing there. Uh, and, and before going, you know, more into the data, I I’ve seen you leading your team, the PhD team that you have during the, you know, the sessions that we had, uh, and the course, uh, and it was really amazing to watch you like truly how you led the team, how you value them, how you brought them in front of the class.

Uh, Yeah, for me, I really felt it’s practically a real team. It’s one, it’s a one team that has, that is doing this. So can you share a little bit your leadership beliefs and your leadership journey and how you ended up in academia and building really strong teams with your.

Georgia Perakis: So how I ended up in academia, I already mentioned, and I came to the U S from graduate school.

I felt that I was just going to finish my master’s and PhD and go back. But of course, many double digit, won’t say how many I am still here. Am I teasing and incredible? Uh, it’s, I call it like a huge candy store with grape candy that it’s hard to choose from. But what I think is extremely unique are the students that we have at MIT, whether there are people like you, the MBA students, or whether there are PhD students, like the ones in the operations research center, which, where you’re doing.

So I consider myself very, very lucky to be able to interact and basically be among people like them and you guys. And so basically my goal is what I would call enabling these people to bring back back, to bring out the best of them. And that’s kind of my core belief actually in everything I do. Bring in enable the best in other people.

And so I know I have the luck to be among incredibly talented people. So bringing out their skills and enabling them is what I believe in doing in everything.

Naji Gehchan: Well, this is such a powerful, uh, such. Powerful word, you know, for a leader is right. Enabling others and making sure the environment and tries to return a lot about what is the environment that you’re creating for us to enable, uh, enable people to be at their best.

Uh, you know, um, I’ve seen all the work and the word I’ve seen all the work you have done with your team, and it’s also part of leadership and how you pivoted, I think with your team. The round. COVID try. I know many don’t want to talk about it, but it’s important where it’s still somehow in a, uh, can you share a little bit with us?

How, how you took your team into modeling all that was happening in COVID and ultimately the impact that you are having on, on policies, uh, now with the data and model, I think it’s a beautiful example on how you can. Take data and do something actionable about it. And it’s a, it’s a great. Leadership lesson, I’m sure you had, as, as things were, uh, on feeding during the pandemic.

Georgia Perakis: So I would say basically that, uh, when the pandemic started and we all had to go very quickly virtually, uh, the first thing that I wanted to do is to create community actually with my. And we have been working on many different types of algorithms. We sub groups of my students. So I thought in order for them to not feel isolated and so forth, it would be great to create community and see how we can do something.

Good. Everything we were doing that where, for example, for the retail space or somewhere for basically other healthcare applications, and that’s how this journey actually got started. Um, we, we tried to basically find data sources and. And actually there was an MBA student at the time, at the time, uh, that also was involved in the team because he talk to me and she told me, Hey, uh, I would like to be involved as well.

Um, so that’s how the discussions got started. The next step it happened. And since we were doing this, uh, and we then got contacted by MIT quest for intelligence, which is sort of the air over my. That sits, you know, it brings together many parts of MIT as it comes to AI. And they notice that we were starting to do this work.

And so they said, well, maybe you can help us because we are trying to understand how cases, how deaths and so forth will evolve. And that will also help us to reopen them. So now, you know, what was just about community building and about let’s make our work mean something, it became something that was sort of more tangible.

It was like, okay, let’s see how we can have on it. Understand how the evolution of cases, the evolution of deaths in different states and counties in the United States and in particular, Massachusetts. Because if we understand what’s happening in Massachusetts and my ticket now make decisions about different measures they could impose in order to make things work.

Because as you know, MIT believed that we in-person experience is something very important. Everybody knew that this is not going to be perfect, but it’s better than just being all virtual with no in-person component. And so we thought it would be great to basically help them do. It was a lot of hard work.

And again, I give all the credit to the students because they work tirelessly and very excited. They had ownership of this. This was their baby, and I was lucky to be part of that conversation. And then we decided, well, we actually maybe can help a little bit more at the national level. So, um, Contacted Fox from the CB CBC.

And then we started actually submitting our models. We are still doing this every week, uh, for predicting for the next week, two weeks, three weeks, four weeks ahead, how cases and deaths are going to evolve. So that’s kind of the summary of a long journey.

Naji Gehchan: Yeah, well, wow. And again, like it’s, uh, you, you always told us data is better than nothing.

And then the ultimate objective is making decisions, right? So it’s, it’s really impressive. And w before going to data machine learning, I want to ask a question on this, but before that, I really want to summarize, you said things that are super powerful. You, you started by, uh, creating a company. Doing something for good.

Right? And then you go into ownership, empowerment of your team, enabling them to be at their best. And honestly, what a humble leader you are, because again, you say it’s your team, but I’m sure without her leadership, you wouldn’t have, they wouldn’t have achieved what you guys have achieved. So, yeah. Thanks for giving all those dealerships tips for all of us.

Georgia Perakis: I think of my team, some amazing students. I honestly believe that at all. And I consider myself very lucky to be part of that environment. Uh, and so I believe success of people is by understanding the abilities of others and helping bringing them out. So, and then we all look good. They do. And actually, so do I find it a bit selfish?

Naji Gehchan: Yeah. I so agree with this. Um, well you mentioned words, right? Data models, machine learning, it’s such trendy words, right? So I would love to get your take on this. I had the opportunity to hear you about it for many hours that I enjoyed. I would love to hear your take on those and the most important advice you would give us for leaders who either are talking about it or dealing with it and our organizations.

What are your, what is your take about all

Georgia Perakis: those strategies? Right. So, first of all, understanding what data we each have in our organization, how we can use them in a good way, how we can use them to have a competitive edge. Or realizing the limitations of our data, maybe what we do not have and we could have, uh, and how, what we don’t have, we can actually collect and use it to do better things.

That’s sort of the first step, basically, uh, understand what is your data environment? Where can you get it and what can you not get? But you could potentially. The second, also an important thing is to understand what you could do with it, potentially what are some areas where analytics and in analytics, I put machine learning, AI optimization, how analytics could actually improve the way you are doing things in your organization and recognizing those opportunities.

And recognizing areas that my lead picks can have a first order effect as I call it. It’s not just a small parentheses. Uh, and so, you know, recognizing what are these areas also extremely important. And then flowed that I wanted to do with the class that I was teaching is to make sure. And I’m not sure if I should use this word, but, and maybe I have not used it, but that nobody can, uh, talk another person.

Nobody can be as you.

And that, you know, and so I’m proud whenever I hear, uh, people, uh, who took my class, that they go in meetings and they recognize, and they ask questions and, you know, people, don’t not trying to pull a fast one over them and that’s extremely satisfying.

Naji Gehchan: Yeah. Yeah, you definitely, you definitely helped us see this for your, you know, for those of us who deal with data constantly and those who don’t, but it’s important to kind of think of it that

Georgia Perakis: way.

And I would say that this past month I was contacted by two former students of mine that graduated one maybe three years ago. And the other two years ago, Sort of talking to me about problems that they had in their organizations and recognizing how some particular tools that I taught them was useful.

And so that happened to me twice in the last month. And, um, even asking me to, to remind them of what software had I recommended back then and so forth, and that’s extremely satisfying, then I feel okay. Yeah, I did something.

Naji Gehchan: Oh yeah, no, definitely. And there are many who don’t come back to what are actually doing it.

So that is for sure. What is the last question on this? Uh, since you’ve worked a lot in academia, but you obviously work it out with companies, right? You mentioned retail and healthcare and many others. Uh, what is the most challenging? When we touch those, you know, machine learning, AI, all those concepts and organization, what is for you?

The most challenging piece a leader should start with if we’re launching this type of projects or transformation.

Georgia Perakis: So I would say first understanding what are the problems that the organization have? What are the right questions and what are the limitations also that they have? What are they capable of?

And then they towel. So because, you know, everybody talks about big data and I say a far more important thing is what happens when I have little data. When I have missing data, actually I would say this is hard there. I’ll talk about big data. Let’s talk first about little data missing data. So I would say those three and in that order first.

Okay. What is that? I problem for me, is it. But maybe by using ethics, I could make a difference for somebody.

Naji Gehchan: Yeah. I will always take this. As you mentioned that many times, right? What is the problem you’re trying to fix? And this is usually the toughest question to ask because yeah, we can have data, but you know, what are we trying to fix and which type of data we need, and then try to deal with this.

So I, I would, uh, I would be moving into giving you one word and I would love to have your reaction to this word, uh, in a sentence or more, right? So the first one is leadership.

Georgia Perakis: So, um, my action is empowering others actions.

Oh, my God. The extremely important having diversity in an organization is what brings power to the organization.

Naji Gehchan: Okay. Can you share it a little bit more because I know you’re passionate about it, then you’ve done a lot of work within MIT on DNI. Can you share with us a little bit more, you know, from beta to auctions and thoughts on,

Georgia Perakis: right.

So a couple of things, the first is that by recognizing that if you bring a lot of different voices, You know, my analogy to data would be if you have different and diverse sources of data and even methods that you can buy, you will actually have a much more powerful outcome. In fact, what we did in our algorithms to predict was exactly the principle of diversity.

We basically developed a lot of different and diverse. Algorithms that capture different aspects. If you like, we brought different voices and by ensembling them together, we created a much more powerful. So it’s almost like taking the model of diversity and putting it in an algorithmic setting. And that’s one example, but I believe it in everything I do and I see it in my group and I see that MIT and I know now.

And in general, MIT takes this very seriously. We can do much better, but you know, recognizing this is the first step to success, I would say.

Naji Gehchan: Yeah, no, I love it. Well, recognizing the problem right

Georgia Perakis: then,

Naji Gehchan: uh, I have to ask this many of the listeners won’t know where it is.

Georgia Perakis: Data models and decisions, how you go from data to recommending good decisions that will bring value and value. Doesn’t have to be just revenue profit. It can be improving the world in some way.

Naji Gehchan: Awesome. This is one of the best courses in this ever programs.

Uh, the last one I’d love your reaction on is spread love and organizations.

Georgia Perakis: So do you need one word or Western, whatever

Naji Gehchan: you want,

Georgia Perakis: you don’t spend? I would say basically feeling compassionate and trying to understand. Other people in your organization so that you can embrace others and you can embrace the diversity or the lack thereof of an organization, and then bring diversity to the organization.

And by sort of having that empathy and compassion with others and spreading it is what would make the organization successful. So, as I said before, in a way it’s kind of understanding and enabling and embracing others.

Naji Gehchan: Awesome. Uh, Georgia, any final word of wisdom for all the leaders around the world.

Georgia Perakis: So I would say one thing, which is extremely important to me and I will put it in mathematical terms, what I call the law of large numbers and what I mean by that is persist and look at the long-term goal.

That’s what I learned in my career. And, you know, things didn’t just come on my plate as I went along in my career, but, you know, uh, I try to focus on the end. I’d rather have a look at the failures that I had right in front of me. And I call that the law of large numbers that if you persist and look at the future, long-term it will work out eventually

Naji Gehchan: the “Love of large number.” I love it. Thank you so much for your time today.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Paul Hartung

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.
I am Naji, your host for this podcast joined today by Paul Hartung, a longtime life sciences and technology executive with a proven track record in launching successful startup businesses and leading Fortune 500 organizations. Paul currently serves on several Board of Directors including Leuko and Verisense, he mentors at MIT VMS, MassBio MassCONNECT, and The Capital Network, and serves as a judge for MassChallenge. He served as President & CEO through successful Phase II of Cognoptix, which has developed an innovative eye scan for early detection of Alzheimer’s disease. Paul also founded Sonivance, and has held senior management roles at 3Com, Summit (LASIK), Trumpf, Laser Fare and GE.  Paul graduated with honors from MIT with an MS Degree in Mechanical Engineering. He is an active speaker, author and inventor on a number of patents.

Paul – it is an honor to have you with me today!

Paul Hartung: Well, thank you very much, Naji. I really appreciate the invitation.

Naji Gehchan: Can you first share with us, uh, Paul, your personal story from mechanical engineering to life sciences and impressive entrepreneurial track record?

What’s, what’s behind this inspiring journey you have? Yeah.

Paul Hartung: You know, I, I guess I like to categorize myself as an engineer who loves to make things right. So early on, uh, my research at m i t was at, uh, lab for Manufacturing and Product. . So I got involved in all kinds of manufacturing processes and advanced materials.

And actually some of my work is being taught today at M I T and my research. Um, so I started in the aerospace industry, which is a manufacturing industry. And then I looked around and I, I realized that, um, you know, manufacturing was really changing and I wanted to do something. So one of the things that caught my interest was lasers, and there’s lots of different things you can do with lasers and, and photonics.

I I started looking at, um, industrial lasers, high power lasers, and got a whole taste of, um, the whole process of, uh, mergers and acquisitions of companies. . I, and I had a crash course, uh, in that I, I went from GE to a, a small company. . Um, then another small company that was acquired by a bigger company and merged with another company all in a period of years.

And that’s what ended up being described on my resume as as Trump. But it started as a spin out of combustion engineering, which is an energy company. Um, , but then I, I got exposed to, uh, medical technology first using lasers as a manufacturing tool cuz you know, they’re used to make pacemakers and things like that.

Um, there’s things you can do with lasers that you can’t do with other manufacturing processes. So, um, I went to, I, I spoke at an M D D I conference, which is on medical devices, uh, using lasers and manufacturing tool and. Lo and behold, uh, after a little bit of a journey, you know, through these mergers and acquisitions, I ended up getting a call from a friend of mine who was working for a medical laser company and a startup that was called Summit Technologies.

And, uh, that was a company that developed lasik. So, um, I, you know, made this huge pivot in my. To, to do that. Um, and at the same time as, as developing skills sort of across business, rather than doing an m mba, again, I haven’t, you know, a couple of engineering degrees. Um, I decided to learn different aspects of the business.

So I actually applied to a manufacturing job and this, this startup was sort of expanding. They, uh, wanted to do manufacturing in, uh, in, uh, Ireland. and take advantage of some, some tax breaks and what have you. So, um, I came in to kind of run manufacturing locally and we didn’t have f d a approval yet, so had to go through the whole process of, of, um, getting f d a approval and learned that firsthand and.

You know, I, uh, then got distracted. Uh, I, I ended up doing that for several years and I got a call, um, you know, sort of the whole internet of things industry was starting to blossom. And I got a call from a company called Threecom Corporation, which I hadn’t even heard of at the time, but at, at that time, its bread and butter was connecting everybody to the internet.

I mean, there were basically devices that you plugged in to every laptop to connect to the internet, but the company grew, grew through acquisitions. So every month the company was acquiring another company. So now what our smartphones kind of evolved from something that was called the Palm Pilot. I dunno if anybody remembers that, but, um, these, these, uh, PDA.

We’re, uh, kind of a precursor to smartphones and, uh, Threecom bought the company that makes those. Um, I, I learned, oh, I’m a mechanical engineer by training. I learned all about, uh, kind of software intensive businesses and uh, uh, electrical hardware done at very low cost. And, um, I learned partnering as well, uh, the global supply chain because we had three internal factories.

um, like four subcontractors that we worked with on the outside. And I ended up with this global operations role, figuring out how to make new product, how to design new products anywhere and make them anywhere. So in concept, um, And then I got back into, um, startups. Uh, I, I joined a company called Win Foria that was acquired by Motorola and developed, uh, another mobile technology called Push to Talk.

Um, so after that little diversion into Into Tech, okay, I decided I was gonna do a medical device. And I, um, ended up being in the right place at the right time. I, um, started researching how to kind of raise funny first for startups and went to a little conference put on by a law firm. And, uh, I enjoyed one of the speakers, spoke to him in the hallway and he said, oh, you need to meet.

Scientists who are putting together this, that made this great discovery of amyloid in the eye that, uh, kind of parallels what goes on in the brain with Alzheimer’s disease and, um, you know, your photonics background, you know, working with the eye with lasik. Um, my business background, I ended up at my kind of first, uh, founding c e O job.

and, uh, that was initially named Neurotics, uh, changed its name to Cog Optics at one point due to a trademark thing with another company. But, um, we, it was quite a journey. Um, you know, I, coming from a very successful tech startup that had raised a lot of money from venture capital, , uh, I thought I could, you know, raise money quickly through vent venture capital instead.

Um, I found myself being introduced to Angel financing and cuz it was Alzheimer’s disease was too scary. It, the market at that time was, was very tough. So, by accident I syndicated the first, uh, angel deal in the Northeast because I couldn’t make enough money through, you know, Uh, angel Group. I put four together and, you know, did of financing.

So, you know, I ultimately raised 3 million in angel financing and, um, did the development that was needed to sort of get ready for, uh, venture financing. And, um, what happened? The economy crashed. This was back in 2008. and luckily I was, I was kind of searching internationally for, uh, venture venture funding.

I had a lead investor in, uh, Europe. Uh, and we closed a, a financing in September when the whole US economy had shut down that year already no one was getting financing. So, um, that, uh, helped hurdle me forward and. . Yeah. You know, that that was a wonderful journey for me, uh, that that company, um, you know, we were one of the four leading inventions by, you know, the Alzheimer’s Association.

I do an international conference in, in, uh, 2015. And, uh, really positioned for success. Uh, a real issue was no company had a treatment. And that ended up being a real kinda barrier to, uh, you know,

Naji Gehchan: Well, well, thank you so much for sharing. This is really inspiring and incredible journey, and you shared so many times the word learning, uh, and it seems every, everything job you took was based out of curiosity learning.

So I’d love to double click on this a as you were taking those job, and obviously it’s, it’s risky, right? Like you’re jumping, I imagine what you felt. Also kind of constantly move to jobs, uh, you know, new jobs that I don’t know about. Right. What, what was your backbone, is there like a backbone capability or something within your core or leadership signature that you always kind of relied on or something else that made you, you know, go learn fast

Paul Hartung: and?

Well, something that’s great about m i t is, uh, they teach you problem solving skills. So that’s one thing at the core, you know, uh, kind of being able to kind of step back, be humble, learn as much as you can about a situation before jumping to conclusions and, and, and jumping to the solution space. So, um, again, problem solving is a process.

And I also look at, um, product development, uh, as a process that, uh, translates across industries actually. Um, you know, a lot of people and, you know, a lot of people are very successful kind of choosing, uh, sort of an industry segment and, and role even sometimes, so you know that they’re very effective.

and going very deep. Well, I’ve found that, um, you know, I, I talked about, um, working for a company like ge. Well, guess what? They, they did some military business. It was, uh, it was, um, uh, military helicopter engines was one of the things that they made, you know, where, where we were, which is a regulated industry.

Right? Um, and there were some. Grants associated with the kind of work I was doing, you know, writing and, and supporting grants is kind of a general skill. Um, I, I found that, um, the process of, of, uh, team building. Um, one thing I’m, I’m passionate about is, is developing cross-functional teams and starting having an interest in manufacturing.

there’s this traditional wall between engineering and manufacturing where they used to say that, uh, you know, ideas would be kind of thrown over the wall and manufacturing people would have to figure out how to make it. Well. Over time, we’ve all learned that it’s most effective to, um, bring pe, bring all the stakeholders in early, you know, in, in the process, and, uh, create these cross-functional teams that are very effecti.

So, um, I’ve done that on the level of job functions and more recently done it on the level of complex things like drug delivery, where, you know, you need to have people who understand the pharma side and you also have people who understand the sort of mechanics of, of, of, of drug delivery or, or understand advanced materials.

and, um, you know, it, it, it’s interesting getting a diverse team together in, in the same room and trying to figure out how to move forward to a common cause. Love, and that’s, I love they developed over time. And I, I

Naji Gehchan: wanna go there because I love what you said about the wall, you know, between engineering and or tech and then manufacturing.

And I’m sure you’ve seen another wall once. This is, you know, produced like a wall for marketing and sales to figure out how to sell it, right?

Paul Hartung: Yeah, absolutely.

Naji Gehchan: So as you are building and working those with diverse teams, uh, as the leader of all those teams, what, what, what do you practically do? You said like, put people together in a room.

Uh, in today’s world, it’s. Possible physically. Sometimes our teams are remote, I’m sure. And,

Paul Hartung: and you were the same. So I can be done remotely.

Naji Gehchan: Yeah. So I’d love to learn more from you, like what are the tips, how have you done it to build really this cross-functional team that is going towards a purpose, as you said, a common purpose, uh, to deliver on the mission they had.

So how, how have you, how have you done this?

Paul Hartung: Well, I think, um, part of it is effective meeting management. Um, everybody. Gets quickly sick of too many meetings. But if you have, uh, a structure where there’s a periodic team meeting, say weekly, and um, you know, you have to have a manageable number of people.

And that partly has to do with, with, uh, how big the project is and the structure of the team. But if you have, you know, 10 people in the room, let’s. , you give everybody the opportunity to give a quick update from their perspective. And um, also they may have an ask. And, um, at first when you know people are, um, hearing something that’s very foreign to them, they think it, maybe it’s a waste of time or they don’t understand it or whatever, but it starts to sink in.

They start to get an appreci. of all of the pieces of the puzzle. You don’t have to become an expert in everything. But knowing a little bit about, and, and understanding what impacts your fellow team members, um, it’s those intersections, you know, that are, are, that are most important and someone from a completely different discipline may have a great idea or, or great solution for, for one of their team.

So that’s, that’s part of it. I think another part of it is just having really good project management. You know, I’m, I’m a believer in, uh, project plans and, and Gant charts and those sorts of things. And, you know, trying to work to a schedule and if there are delays, figuring out what, you know, what things can be done independently, what what can be done to mitigate, um, um, issues with the.

Um, but yeah, I mean, usually with a complex project, um, the, the solutions may come from anywhere. You know, they, there’s different facets to the project and to work around a delay in one area, um, someone may need to step up in another area.

Naji Gehchan: It’s reminding me of what we also at m i t learned, right? Like all this dynamic work design and, and how to do this.

Have you seen a difference between doing it in startups? So you’ve done like all. all scales of companies, right? Like upside up to, to large corporations. Yeah. Is there any difference, uh, doing it through those? And I, I’d love to hear the cultural perspective as you’re managing those teams and building those effective high

Paul Hartung: performing teams.

Sure, sure. Well, you know, I’ve, I’ve seen, um, speed come from. Almost like, you know, volume. You know, I have a, have, have a big team. Uh, one example was Win Foria. We, we were actually a, a startup, but a very well funded, you know, VC back startup. We had 120 software engineers in three countries. And, you know, having Boston effectively, Madrid and Bangalore, India, we could have software development 24 by.

and, you know, because people are in different time zones and the challenge was kind of knitting together all this work, but, um, you know, in, in contrast and, and that that’s more difficult than it may seem. Right. You know, knitting together work of software engineers, but they’re tools. , right? They’re, um, these, uh, configuration management systems that, uh, knit the software together.

And, um, you can, you know, you set up the proper processes and, um, you can be effective and have good leadership. You know, that’s communicating a across the teams. But, um, I would say that, uh, startups these days and, and. Tics, the example I gave you before the Alzheimer’s thing, that was a complex project cuz we were doing, um, we weren’t doing a treatment, we were doing, uh, a diagnostic, but it did involve a reagent with, which was formulated into an ophthalmic ointment.

So it’s like a, like a drug development project. Not for treatment, for diagnosis in parallel with a complex optical system. You know, the system had, um, six ax axis of motion and um, you know, did a, a, um, measurement in milliseconds and, you know, it was, uh, a fluorescent spectroscopy measurement. It was, you know, quite sophisticated.

We had, um, five people in the. I mean, you know, our, our team was tiny. And how did we do it? We did it through, uh, partnering and we chose really good partners and, and, and the top-notch team. But a lot of it was, um, in a way, you know, project management, it was realizing that we weren’t gonna be the manufacturer, so we had to have a manufacturer that had all the certifications.

Proven track record of doing this kind of complex product on the device side, and we had to separate, right then we had to find, um, someone to make the a p i. We ended up, um, uh, moving that manufacturing to India for cost. , we ended up, um, having a complex formulation. We had searched the world, you know, found a partner in the United States that was one of the only ones that could handle the formulation of our product.

We even, uh, created patents for some of the formulation steps because it was so complicated. And I won’t get into the details, but, you know, um, but we wouldn’t have been able to do it ourselves. We wouldn’t have been able to create our own bricks and mortar and, and, uh, do that. on the development side, it’s, it’s trickier, you know, um, there’s a range of possibilities you can hire, in some cases, one company to do your development for you to do your design work for you, right?

Um, I haven’t been so successful at that. You know, what I’ve done is, uh, tended to. , um, kind of break things into pieces and use a company that’s really good on software development. Use a company that’s really good on, um, you know, say mechanical design. Um, maybe another company that’s really good at, uh, electrical design.

And then, uh, kind of have them work together as, as a team, you know, and, and, and bring everybody.

So Paul, you are heavily

Naji Gehchan: involved in, um, helping ventures, helping startups, founders through the different Yeah. The different work you do. Uh, what, what is the number one device, uh, advice that you would give for founders of startups

Paul Hartung: and healthcare?

Um, number one, I would say,

one, make sure that you’re addressing an unmet need and that people at the end of the day will really care, you know, identify who, who will care, care enough to pay, care enough to utilize care enough. So that exploratory process. Um, and it, it, it, you know, took me some time to learn this. Um, But I’m seeing it more and more.

It’s been formalized in programs like icor, which you may have heard of that. Um, you know, to get an S B I R grant, you have a 40% better chance if you go through this ICOR program. And the principle is you have a great idea. Reach out to about a hundred stakeholders, potential stakeholders, and explore the idea and make sure you’re addressing so.

that’s really a pain point out there because, um, sometimes current treatments or, um, cur current methods aren’t optimal, but they’re kind of like good enough that, uh, having something that’s a little bit better doesn’t move. The bar doesn’t, you know, for one, it’s hard to raise money, but at the end of the day, you can go through all the work and.

you know, it, it’s, it’s, uh, it’s quite a journey. You know, you put blood, sweat, and tears into a, into a program and after several years find out, you know, you’re basically done, but there’s no real market for what you’re doing, or you can’t find a commercialization partner because there just isn’t a strategic fit.

So I’m a believer in working on those issues very. , you also have to make sure that, um, your science is really solid. So I think there are some spinouts that are premature that, um, really need to, um, make sure their, their, their science is very solid. That, um, uh, the way I look at it, data is your currency, right?

You, you, you can tell people that it’s gonna work, but really have to show them data that’s, um, that it’s gonna work because you have to have something that works, that, again, people will care about right’s. Those two pieces,

and too often that, that, that second one of, you know, well, people really care about it. It’s not an easy thing to get to. You care exactly. The, the entrepreneur, the founder, you know, feels passionately about it and maybe thinks everybody else is stupid because they don’t get it. They don’t. , but it’s really important to sort out.

Yeah. And, and you mentioned care

Naji Gehchan: about and willing to pay, like there’s this value, right? At the end of the day, value creation and capture that you need to figure out.

Paul Hartung: Right.

Naji Gehchan: Uh, Paul, I’ll give you now a word and I’d love your reaction to it.

Paul Hartung: So the first one is leadership.

Uh, leadership. Okay. It’s, it’s, um, to me it’s, it’s, it’s keeping a team motivated through the tough times. It’s always easy to, um, stand up and, um, give praise for alls all the successes. But the real challenge, particularly in, in, uh, in a startup. and even, you know, in companies, uh, that are working on, on, on programs that are difficult programs, it’s the hard times in figuring out the Plan Bs and, and, um, I’ve even been in situation where, um, my whole team went off salary for several months because we were kind of between financings and that takes more than just kind of the, the traditional.

Carrots that you hand out in, in, in business, it takes developing a, a passion as a team for what you’re

Naji Gehchan: doing. Can I double click on that and if you can tell us the story and how you develop this passion to make sure that people keep on coming.

Paul Hartung: Yeah. Well, um, I can expand on that particular story. Um, and that that was, um, it was a, a point in, in, uh, Cognos life actually.

I, I, I had mentioned that, um, we were trying to raise money, uh, when the economy collapsed. Well, just before the economy collapsed, I actually had a syndicate of investors ready to invest. And, you know, your board becomes part of. Expanded team of a company. Well, um, the particular group of investors sort of became, in my mind, toxic.

They weren’t working well together and one of the investors was sort of becoming very manipulative. And, um, we thought that we were ready to close a financing. And then at the last minute terms were. . So finally I had to make the tough decision based on the fact that, uh, I would need to live with these people.

You know, they’re not only, you know, giving us money, but you know, the, the next few years of the company, we’d be tied to these people. I, I realized that it wa it just wasn’t gonna work, and, uh, took a big, took a big gamble and tested loyalty of my earliest investors. They came back and did a, a small bridge to keep us going while I pivoted to find a different set of investors.

That’s when I went to international, you know, and, and, and found, uh, um, you know, an inter international lead investor. But, um, the team, uh, had a choice. You know, we, we either continue working. Effectively, we, you know, had to kind of mothball the company. Everyone wanted to keep going. Um, I had actually one, one person leave, but it was actually right before I closed the next financing.

And you know what? Everybody was made whole. Uh, you know, we ended up for that time that people took off. They, they all get. For that time in the end, once, once we, once we closed the financing. Um, so it was scary, but we just kind of put our heads down and, and, um, carried out our mission.

Naji Gehchan: Oh, and I’m sure it talks to the culture you created for people to keep on Yeah. Showing up and, and being here. Yeah. Yeah.

Paul Hartung: The second word is innovation. innovation. Yeah. One of those words that, uh, I love, but, you know, may, may be overused, uh, . Um, you know, I, I guess, um,

there are lots and lots of good ideas that merge every day. Right. Um, and unfortunately a lot of innovations never. Polite of day, you know, people may file a patent. I know that, uh, all of the major institutions have piles of patents that they, they can’t even license out. They, you know, they don’t know what to do with.

So, um, you know, it’s, it’s an issue of, of, um, finding ideas. that actually can make a difference, that can have an impact. Um, and that gets back to some of the things we were saying before, of, of really exploring the landscape, understanding, um, if it’s in a treatment space, understanding the kind of landscape of treatments that are available today.

Really understanding, you know, the, the unmet need, um, before putting a lot of. Effort into your particular in innovation? Um, again, building off something I said before, um, I think some of the more important innovations are, um, based on, um, kind of a combination of things. It’s like a convergence of technologies.

another, you know, overused one is ai, for instance, right? Um, a, you know, ai, ai, everything. But the, um, if you look at, um, you know, advances in materials, you look at, at advances in, uh, nanotech, you know, being able to get down to a, you know, much smaller scale, um, you look at. All of the discoveries around d n a and r n a and and uh, and gene editing and you know where that can possibly go.

Um, and you, you think about the problems of, you know, treating the right individual in the right location in their body that’s affected without creating toxic effects on the re on the rest of the body in an um, , you know, effectively say, monitoring their dosing. Uh, it takes a village, it takes, you know, kind of a combination of technologies.

So I’m a great believer in kind of innovation in these systems that, um, can solve the bigger problems.

What about board of directors? Board of director? , um, you know, board of directors. Uh, I’ve been on some, you know, very effective ones, um, to a certain extent. Uh, you know, that they’re for support and, um, and guidance and, and it kind of depends on the maturity of the, of the management team. Um, you know, sometimes it comes down to kind of advice.

There’s some formalities around, uh, you know, governance and responsibility, fiduciary responsibilities to, to, um, the shareholders and that sort of thing that are kind of the basics of, of, uh, business structure. Um, and, you know, being, being incorporated that, um, you know, you have to maintain. But I’m a believer in, in making sure that.

Management team, uh, feels supported that they have a structure in place for, um, being rewarded and incentivized, you know, and, um, things like stock options and, and things like, uh, uh, periodic review of, of, of, um, the overall, you know, cash compensation plan and making sure that there’s some sort of bonus structure in place.

and, um, giving them support as they’re looking at, um, partnering possibilities, you know, leveraging connections and giving them, you know, some, some guidance on how to even approach that process. Uh, yeah, I mean, I, I kind of wear both the ad advisor and, um, you know, there’s a bit of over. , you know, in the role of, of director and as an independent director, I, I really enjoy kind of helping bridge the gap.

Sometimes there’s tension between investors that may, um, have their own timelines, you know, um, get a little, I impatient about return on investment and the management team that’s doing the best they can to, you know, to deal with some difficult problems and. , I can help kind of moderate a bit there.

Naji Gehchan: And the last word is spread love in organizations.

Paul Hartung: Well, uh, I try to spread a lot of love with my, with the teams I work with. Um, I think it’s maybe part of, part of developing that, um, passion across the organization, if you will, for what we’re doing together, you know, so, , um, I kinda, I kinda lead by doing and, and I try to lead, lead with my behavior as well.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Paul Hartung: You’re doing important work, you know, keep it up. The, there, there are lots of, uh, big healthcare challenges out there and, um, we all need to be thinking of novel ways to approach them and, and get them to everybody.

Naji Gehchan: Thank you so much, Paul, for being with me today.

Paul Hartung: You’re very welcome. I appreciate it. Thanks

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Jason Dupuis

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast joined today by Jason M. Dupuis, a thought leader, speaker and organizational behavior enthusiast who believes in the power of Human Experience as a key driver of organizational performance and strategy. Over the last 20 years, Jason has served as the Chief Experience Officer for PM Pediatrics Care as well as the Administrative Director for Admitting and Emergency Services at Boston Children’s Hospital. Most recently, he joined Fidelum Health as a Consultant and Principal Healthcare Advisor to bring the Human Brand concepts of Warmth and Competence into the Human Experience in Healthcare. As a Core Value advocate and fanatic, Jason has devoted his career to successfully demonstrating that being “human first” and leading with personal and organizational core values can create efficient and profitable operations while simultaneously delivering an exceptional experience for patients, families, and care teams. In addition to his professional roles, Jason is an Adjunct Professor in the Hellenic College School of Leadership & Management as well as recently joining Boston College as an Adjunct Professor in their Masters in Healthcare Administration program.

Jason – it is such an honor to have you with me today.

Jason Dupuis: It is a tremendous honor to spend some time with you today and, talk about leadership. I’m looking forward.

Naji Gehchan: Can you please first share with us your story, how you ended up in healthcare, uh, and now teaching leadership management and being passionate about organizational behavior? I’d love to learn more about that.

Jason Dupuis: Yeah, no, of course. Um, you know, my path into healthcare was kind of an interesting one. So my, uh, it all started because my dad was in the army. And, uh, so growing up as a kid, I moved around quite a bit and, uh, when I was very young, um, my father actually, uh, became a nurse in the Army.

And so as we moved around living on, uh, military posts around the country, you know, they’re very small communities and on, in every one of those communities, they also have a hospital. And so, Uh, you know, I was able to spend a lot of time at the hospital seeing my dad and then my, my mother will also report that I spent a lot of time in their hurt, injured, and, uh, because of the crazy things that I did as a kid.

But, you know, so I spent a lot of time in the hospital and I always saw hospitals as just like a cool place where my dad worked. That was, I was comfortable there. I was excited to go there cuz I got to see my dad, um, you know, during his working hours, if you will. As I got older, I would ride my bike to the hospital when I lived in Fort Knox, Kentucky, and I would go see my dad or we would have lunch and uh, you know, so it was just kinda like hospitals were always this very comfortable place for me.

So when I got to college, I was trying to figure out what I wanted to do, knew I wanted to work in healthcare, but I didn’t wanna be a nurse. Uh, I didn’t wanna deal with any of the, kind of the blood and guts, if you will. Uh, and then, uh, I found a program at the University of Hampshire called health Management, and I was like, you know what, like, This is for me.

So my, my drive to get into healthcare was just trying to bring this idea that I’m very comfortable as a human. I’m very comfortable in the healthcare setting, whether it’s a hospital, a clinic. I grew up around it with my dad, and just saw an opportunity to bring that comfort to other kids or other patients that were going to the hospital that don’t have those feelings of, you know, they have fear and anxiety and the, and I just didn’t have those as a kid.

I, I saw it. Fun place where my dad worked, you know? And so, uh, I kind of followed in my dad’s footsteps, I guess. But, um, but that was how I actually, I really ended up in, uh, in healthcare was, was through kind of being around it as a kid and, uh, finding it to just be this amazing and fascinating place.

Naji Gehchan: Thanks for sharing Jason. And yeah. How, how, how did you end up being passionate about organizational behavior?

Jason Dupuis: Well, I don’t. Maybe watching it, right? We watch enough organizational behavior and, uh, and we become, or at least for me, I just became fascinated. Um, you know, that for me, that really developed during my time at Boston Children’s as I, as I was kind of climbing through the leadership, uh, organizational ladder and just seeing how organizations.

You know, made decisions and how all of the moving parts, like how dynamic, um, the moving parts of, of every organization are. And I just became fascinated by it. And, and what I started learning and realizing, which ties into the human stuff is like the organization. Is gonna do what an organization’s gonna do.

It’s gonna make its decision, set its strategy, create priorities, make goals. But at the end of the day, it’s the humans. The humans underneath it are the ones that you know, you have to understand, build relationships with and grow with. And so for me it was this organ, not just understanding organizational behavior, but understanding really how the humans respond and react to the organizational behavior.

And how can we. Lead through that instead of, um, allowing it to kind of control how we do something, uh, or how we execute, how can we kind of lead, you know, and understand the organization’s behavior enough to understand how to lead in it within it, the construct of the confine.

Naji Gehchan: So let, let’s double click on this.

I’m intrigued, uh, by what you describe as power of human experience. Uh, can you share with me a little bit more what do you mean by that and how does it translate into organizational

Jason Dupuis: performance? Yeah, of course. So, you know, this was a journey for me, and I know a lot are on this journey too, in, in healthcare, trying to understand human experience.

But, you know, I, I can share a little bit about when I, when I started really realizing this, um, and I, if I can, I’ll tell a very short, but a quick story. Um, you know, shortly after the height of the pandemic, I, I was with p m pediatric care at the time as the Chief Experience Officer and right after the height of the pandemic, you know, we started seeing an increase.

In, um, negative events, what we call threatening events happening within our, our sites, within our physical locations, with patient families coming in. And we had this one particular event where, um, we watched video and we saw, um, uh, it was a grandmother and our front desk person getting in. They were in some sort of an exchange we could not hear.

We could only see, and the front desk person, this particular front desk person was somebody that I knew. I had met multiple times. I knew them pretty well, and I saw them kind of just. Like they, they broke down in that situation too. Very heated exchange. The staff person actually had to be restrained, you know, pulled back away from the desk.

And it was in that moment that I realized, hey, listen, everyone is struggling right now. Right? That’s the human experience thing is like, this is not just. An angry parent or an angry grandparent with their kid and and frustrated or what, you know, that they have to go to the doctor. It’s like our staff are frustrated too.

And it was, watching that video was really where I started realizing like, Hey, we’ve gotta start shifting and start thinking about this in terms of not patient experience, not employee experience, but human experience. We need to focus on the fact that at the core, we’re all just humans. Um, and we have certain, uh, and similar behaviors and characteristics that drive our actions and reactions.

But we have to stop separating and say employee and patient. It’s like they’re really going through the same thing. And the pandemic for me was a huge example of that. Like us all going through that no one was immune or right. We, we all went through that together. It didn’t really matter. We all felt it.

We all saw it. Um, and so that was what kind of really got me going and saying like, Hey, We need to start thinking about this differently, but I wanted to go beyond thinking. We need to start looking at data differently. We need to start providing support differently, um, and be more human-centric, or as I like to say, human first, that every decision we’re making, or as we’re doing things, we make ourselves in the mind of a human before we start making strategic decisions or taking direction that we think is a human first.

How would this feel? How will it be perceived? How could we execute on it? Understanding humans under.

Naji Gehchan: Well, thanks, thanks for sharing this. It’s super powerful. And obviously you, you touched on something in healthcare. I was just reading a new, um, uh, article, uh, that, that went out. It seems, uh, it, you know, all the frontliners have been really struggling.

With also, you know, wrong behaviors and yes. And being aggressed. Uh, but, and, and I love how you’re sharing it. Everyone is struggling, right? Like there are both sides. And I think as leaders within organization is taking care of your people. And it’s a great segue to by second question, which is people, uh, you say, Human first.

I was going to say people first because I, I always say this. Uh, you, so I like how you framing it. It’s human first. Uh, so can you, you devoted your career practically to demonstrate that it should be human first. Um, and so can you tell us a little bit more about this? Uh, you shared the story about what brought you to this belief, so can you share a little bit more now how you’re taking this and making it a real practice?

I would say for

Jason Dupuis: organiz. Totally. I, you know, I think the primary thing, um, in as far as bringing it into practice was really reentering and refocusing within the sphere of core values. And, you know, so some of my reading, you know, that I, that I do, I call it for fun, uh, but, uh, some of the reading I do for fun isn’t necessary fun.

It’s actually very challenging and I, I enjoy it. But, um, there were two big books that I’ll mention that kind of helped this and got me onto this, uh, or reinforced rather my, my core values. As being like a true north and like that’s what’s driving everything. The first book was Sapiens, which, um, yeah, it was a book that most people, I think at this point has at least heard of.

Many are afraid to pick it up. Uh, myself was, I was included in that, uh, actually a, a former colleague, a guy by the name of Pat Dillingham, who used to work with me in, in patient experience at PM recommended it to me in an airport and he was like, dude, you gotta read this. It’s gonna be amazing. And it actually blew my mind.

And what it was, you know, what I learned in Sapiens in the first part of it was, Hey, we’re still programmed, like we were thousands of years ago. Yes, we’ve changed and technology has changed, but inside who we are at the core is still the same. And so that to me was very, you know, reassuring about core values of what we look for in other people, how we develop trust.

Uh, and then the second book, um, which is what actually and ultimately led me to Fidel Health and, and working with them was a, a book called The Human Brand, um, which was a book written. Why we love or don’t love organizations, uh, why we interact as consumers with organizations, or we don’t. And in that, uh, the, the author, uh, author Chris Malone and, uh, his, uh, colleague Susan Fisk, actually put forth warmth and competence that humans judge other humans on warmth and competence.

And when I got underneath that and started reading and studying that I saw underneath that, when we think about something like warmth, what does that mean? It means kindness. Do I trust you? And I said, core. Core value , right? These are core values, trust, kindness, respect. Um, and so it was really through kind of combining those together and saying like, at the simplest form, we are just humans.

So are we over complicating this by putting too much process, too much digital technology, too much right strategy? And are we forgetting. Kindness, empathy, compassion, respect, understanding, and it. And so I kind of see it as a back to the basics and that, and that was really how I got on this pathway was core values and reading books that were using science and um, studies to show that we’re still acting the same way we’ve acted for the last thousands of years in spite of her, despite the technology.

Yeah. Pretty wild when you think about it, right? Oh yeah, yeah,

Naji Gehchan: certainly. And this is what actually brought me to love as the name of this podcast. You know, it’s war. I, I call it love by its word. Yeah. So how, how do you ensure this, your daily work or working now with organizations really reflects what, what you like this deep belief of core values, uh, this deep belief of human first, when actually there is a constant stress, pressure on results on how we’re gonna get there.

Uh, and I’m, I’m asking you this question that I. Always receive, right? Like I, I’m a big believer of this, so I’d love to see how you frame it and how you make sure that it’s in daily practice in your organizations.

Jason Dupuis: Yeah, I think the number one thing and um, you know, I just had the fortune. I did a a a a lunch and Learn yesterday with an organization, and it was on, uh, a similar topic.

And what I was talking about with them is that, how it really starts is making sure that we individually share our own core values. Um, that we know what our core values are, and that we’re willing to discuss them and share them. And most importantly, Back them up by living them. And you know, my three core values are passion, dedication, and integrity.

And I always say passion. I love what I do. Dedication, be there, and integrity, do the right thing. And so I have tried to live my life. I have failed many times at all three of those, you know, of, you know, we all make mistakes. Um, but it really, I think, starts at that individual level. So when we say human first, it’s like, okay, so as a human I describe myself as someone who is passionate, dedicated, and operates with integrity.

Um, and I’ve spent a lot of time, or when you’re working with organizations, and I always say, I try not to work with organizations, we try to work with the team because those are the humans. It’s trying to understand what are their drivers, what are their values, what is it that they’re saying to me where I can extract what their value is.

Um, so for example, if I hear somebody saying, you know, Joe’s always. Making up something. It’s like, okay, that person, whoever that was saying that values punctuality and punctuality generally relates to respect. They wanna feel that their time is respected, right? This idea that we. , we’re very good actually as humans at making those connections.

And so I think it all starts with what are, what are our individual core values? Can we quickly create alignment around do we agree that respect is important? Do we agree? You know, I kind, I guess it’s ground rules, right? I mean, that’s what we’re saying is how do we set core value, ground rules? And then of course, it’s always my next layer to that is what are the organization’s core values and are we living them?

Right? And uh, so what are your core values? How do you. You know, is this, do people know them? Are they, are they aware? And again, I I, every time I have a conversation like this, I always say the same thing. I don’t think I’m saying anything novel. I think what I’m pointing out is like, we have removed ourselves though, from the action backing up the words.

And as a result we have a say, do gap. You know, we, we say our core values, we don’t do them. We say them though, cuz that feels good, but we need to do them more. And so as I work with organizations or I give talks or I even a podcast, it’s always, that’s my focus. Know what your core values. Be sure that others know what your core values are and spend time learning theirs.

And in that you will always find alignment, always.

Naji Gehchan: So going, going there. Uh, when you talk about values, so I’m, I’m interested, I, I know you’re teaching also leadership. Uh, is there one or two core values or. It’s very different from capabilities, but I’m intrigued if there are like one or two that you think the leadership of today leader in the 21st century specifically in healthcare, should

Jason Dupuis: have.

You know, I’m gonna be cliche in the first one, and I’m gonna say empathy and, um, and I’m using empathy on purpose, and I know it’s a bit of a buzzword now, right? Brene Brown brought us this idea of empathy and vulnerability and understanding. We all, and everybody knows it, everybody puts out content on empathy.

But, you know, when I really look at healthcare leadership, I see a tremendous lack of empathy, um, for in specifically post pandemic. The insanity that the care teams went through during the pandemic, and I think there’s a huge opportunity to be more empathetic to the struggle, more empathetic and understanding to the burnout, um, and really focusing on riding that ship, um, that has already sailed and is sinking.

And I think that, that, I see that. I read that. I hear that. And I feel that. And I think that that’s, so that’s one of the areas where I say I think empathy has to be in there. Um, and the other from a healthcare perspective has always been, and I still believe in this, is defying the status quo of, you know, that simple acceptance of what the system is.

And our willingness out of fear of change to allow the system to persist is a huge leadership problem. You know, and it’s. , um, you know, you keep doing the same thing over and over again, expecting a different result is considered insane, right? Like that, there’s a quote somewhere in that, right? That’s the definition of insanity.

Doing the same thing over and over again, expecting a different result. And so I do think that what, you know, the system from a value perspective is starved from, you know, people defying that status quo and not just simply accepting it for the way it’s. Been for the last hundred years, you know, and I think that’s, so that’s two areas in healthcare leadership where I think if, if leaders are paying attention to being empathetic to those in their charge and they are helping the people in their charge also push the envelope of innovation and defying the status quo, that that success will come behind that.

I’m gonna give

Naji Gehchan: you a word, uh, now and I’d love to your reaction to it. The first one is

Jason Dupuis: leadership passion. . I think, um, I think leadership for me is, you know, if you’re not passionate about it, you’re gonna fail. I think it’s not, you know, there’s the difference between managing and leading. Um, you know, the difference between a manager and a leader.

Uh, and I found that out early on, that like, if you’ve really enjoyed the people component of it, You have to be passionate about it. If you’re gonna be successful as a leader, if you’re not passionate about it, everyone sees through you very quickly. And so every time I hear leadership or anything like it, I think I’m passionate about it.

And you have to be passionate, . I mean, uh, because it’s not easy. It is not an easy task. And if you’re, as soon as your passion goes, it’s time to go. I, I really believe that.

Naji Gehchan: The second one is health.

Jason Dupuis: You know, I think for me what comes to mind is my human first statement. That if we, you know, if we really start paying attention to the fact that, you know, things aren’t fair, um, and we start paying attention to the fact that we are all humans, that it helps us.

Shift the paradigm a little bit. Not to separate out groups, but to say, Hey, can we rally around the one thing that we all have in common? And that is human. So let’s be a human first and then start building systems that consider all humans as humans and not build systems here and there and everywhere.

That never takes into considerations. Humans in general. And so, um, yeah, no, that was, that was actually equity, health equity or equity in general. And healthcare has always brought me into my, that human first brain of saying if we can do that really well and treat each other just like humans, we can make a lot of headway.

The third

Naji Gehchan: one is

Jason Dupuis: sis. Homeostasis. You gotta love it. Um, , you know, one of the big teachings of my dad as a, as a kid, uh, and then as a teenager, and then as an adult, and then as a grown man to give him credit was balance and right. The, the definition of homeostasis, essentially balance in a system. And, you know, so anytime that I kind of feel that there is an imbalance in a system, I feel like it is our responsibility.

To not just try to fix it, but to understand it and try to fix it. And I think oftentimes homeostasis in healthcare doesn’t get achieved because we just try to fix it and we don’t always understand the problem. And I think we’ve been action oriented that way by organizational decree, by history, by organizational structure.

And so I would say every time I hear homeostasis, the first thing that comes to my mind is balance. And if you wanna establish balance and you wanna improve, you have to understand the problem that gives you the balance. That true under. Love it.

Naji Gehchan: What about spread love in organizations?

Jason Dupuis: You know, I have been very fortunate in my career, you know, between Boston Children’s and p and pediatric cares that, you know, I’ve worked with extremely passionate people and I’ve worked with some not passionate people, right?

Um, and this idea of being able to spread love to each other inside of an organization is really talking about building community. Whereas, um, as you’ve all would say in Sapiens, you know, building your tribe, um, and when you have love in your tribe, there’s trust, there’s belonging, uh, and there’s progress.

Uh, when you don’t. , you have war and separation and you know, all the other kind of the negative components. And so I hear love. You know, I think organizational love or love throughout an organization is really getting everybody on the same page and believing in each other, which then allows you to believe in the organization.

I, I think very rarely do people just believe in an organization. They believe in the people within the organization, and you can put love into that.

Naji Gehchan: That’s, that’s so powerful and I can’t agree more with you, totally. With this. Any final word of wisdom, Jason, for, uh, healthcare leaders around the world?

Jason Dupuis: Yeah, you know, I would say that, uh, the one thing that I learned, I learned it during the pandemic, I learned it during my time in the emergency department at Boston Children’s, was that the number one thing a healthcare leader can do is. and, um, you know, that goes into my core value of dedication, which translates to me to be there.

Um, there’s never really a reason as a leader that you can’t show up. I think showing up is a choice that every leader makes, and that the best leaders, the most amazing leaders that I worked with were never, ever afraid to show up, never ever afraid to show up and listen, and never, ever afraid to show up and listen.

And, and, um, you know, so for anyone that’s in healthcare leadership or trying to grow a career in, in a career that brings you into healthcare leadership, I would, I would say those are the things I would take away is always showing. Um, it’s, it’s the easiest thing to do sometimes is to physically show up.

Uh, but it matters when you do and everyone notices. It does.

Naji Gehchan: Thank you so much, uh, Jason, for being with me today and for this incredible chat.

Jason Dupuis: Thank you. Unbelievable, unbelievable pleasure. Thank you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Minette Norman

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

Naji Gehchan: I am Naji, your host for this episode, joined today by Minette Norman. Minette brings decades of leadership experience in the software industry to her consulting business focused on developing transformational leaders who create inclusive working environments with a foundation of psychological safety. Minette has extensive experience leading globally distributed teams and believes that when groups leverage diversity in all its forms, breakthroughs happen. Her most recent position before starting her own consultancy was as Vice President of Engineering Practice at Autodesk, where she transformed how Autodesk developed software. Responsible for influencing more than 3,500 engineers around the globe, she focused on state-of-the-art engineering practices while nurturing a collaborative and inclusive culture. Minette is a keynote speaker on topics of inclusive leadership, psychological safety in the workplace, and embracing empathy. Named in 2017 as one of the “Most Influential Women in Bay Area Business” by the San Francisco Business Times and as “Business Role Model of the Year” in the 2018 Women in IT/Silicon Valley Awards, Minette is a recognized leader with a unique perspective. Minette has co-authored a book about psychological safety for leaders, The Psychological Safety Playbook: Lead More Powerfully by Being More Human, which will be published in February 2023. Her second book, The Boldly Inclusive Leader, will be published in August 2023.

Minette – great to have you with me today!

Minette Norman: Thanks for having me, Naji. It’s really nice to be here.

Naji Gehchan: Can you share with us first your personal story from drama and French, uh, at school to leading tech and software companies, and now being focused on transformational leadership? What’s in between the lines of this inspiring journey?

Minette Norman: Inspiring an improbable journey, I would say from drama French.

You’re right. You know, I got out of university with this double major in drama in French and wanted to be a professional actor, but realized what a hard life that is and I hated rejection and auditions and so I really fell back on my second major French and I got a job in my mid twenties. At the French trade, or?

Yeah, the French Trade Commission in New York City. And it was at a time when they were transitioning from. IBM electric typewriter on every desk, two PCs. And so suddenly I had this PC on my desk and I discovered I was quite good at understanding the technology and also helping others learn it. And that’s what actually led me into my 30 years in Silicon Valley.

I, I moved. Back to California where I had grown up and I got my first job in tech at Adobe in 1989 when they were developing Photoshop 1.0. And my first assignment was to write the Photoshop 1.0 tutorial. And that was the start of this, this 30 year career. And I loved it and I loved. The technology, but I really liked working with people.

Like even when I was trying to figure out the complexity of some software that I needed to describe, my favorite things were just sitting down with the engineers and picking their brains and trying to understand how can I take this really complicated technology and make it digestible and simple? So I did that for about 10 years as a writer, and then at one point my manager at a different company said, you know, I need you to manage the team of writers cuz I have too many direct reports.

So that was when I went from being an individual contributor to a manager. and I didn’t plan for that. I didn’t aspire to management or leadership. I kind of went in a little bit kicking and screaming that I didn’t think I wanted to do that. But you know, that connection that I loved to have with people was actually what I learned was the most important thing in being a manager.

In being a leader is that I really loved managing people. Cuz it’s all about human connection and it’s all about getting to know people who. Different talents and different backgrounds and different skills. So I, I ended up embracing management and leadership and I just progressed through very, you know, probably, I’m trying to think.

I probably had six to eight different jobs within the same company, starting as that first. First level manager of technical writers. Then I moved into a totally different area. I managed localization, which is getting all of the products translated and localized for international markets. And then finally, my last job, which you actually described was that I ended up as the VP of engineering practice.

And I kind of briefly just tell how that happened, which is that I had been leading a big team within a company and I had really done a big transformation. And then suddenly my boss, who was the VP of engineering said he was leaving the role. and I thought, huh, well that would be interesting. And I raised my hand and I said, you know, I would love to apply for this role, even if I’m not the most obvious person to lead engineering.

And the the senior vice president who was hiring for the role said, you know, I know your reputation. I know you’re good at what you do, but you know you’re not an engineer. , and you’re a woman and it’s such a boys club, so you’re gonna have to break into the boys club. And he gave me a 90 day trial for that role.

And so I was an acting VP for 90 days, which was really hard, and it’s probably another topic for a different podcast. But at the end of the 90 days, I got that job and I did that for five years. And in that time I realized that our transformation wasn’t about technology. , even though we had things we had to do technically, it was really about human interaction.

It was about collaboration. It was about listening to other people who might have great ideas instead of digging in and saying, I have the best idea, or My team has the best idea. And so I really worked on collaboration and trying to get people to listen to one another and inclusion and having empathy for various perspectives.

And I discovered, uh, the whole. Science of psychological safety and all the research on that and realized how critical that was and how lacking it was. And ultimately after five years in that job, loving it, but also realizing there’s only so much I can do in one company. I left and I started my own thing because I wanna really work with many more organizations to help them lead better, lead more inclusively, and really create an environment where everyone can thrive and do their best work.

Naji Gehchan: Thank you so much mi for sharing your, uh, your story and really those, there’s lot of powerful things you said, so let’s take them, dissect them and, and dig into it. So the first piece is really about this, um, this role you had as a vp, uh, leading this global team of experts, engineers around the globe. So you have diverse people and you said boys club.

So I’m, I’m interested to get your perspective on this too. And really, Delivering this transformation, as you said, through collaboration and inclusion, which is not probably spontaneously what you would think of VP of Engineering. Engineering in a tech company. Right. So I, I’d love to get your story behind this and how did you manage to do it and deliver exceptional results?

Minette Norman: Well, you know, it started with, I kind of got an edict from on high, which was that everyone had to get on a common set of tools. So we were moving from having like 20 different source code repositories to getting all onto GitHub. So that seems like a very technical challenge. How do we get all this code from all these disparate systems into one?

But what I was discovering in the process, cuz I had a great, I hired great people who worked with me and for me and who had very, very technical skills. And what I realized when they were trying to get teams to adopt new technology is that all of the teams were very siloed and they all thought that they had the best solution.

Very smart people, you know, a lot of them had come in through acquisitions and they had just retained their knowledge and cultures from, from the acquired companies. And so what I realized is that, I have people I’m working with who understand all the technical nuance and details. That’s not really where I need to focus.

Where I need to focus is how on earth can we get three more than 3000 engineers in all different countries all over the globe working. Together for com, like actually sharing code instead of rewriting code. How can we do that? And so I started, we put on a big technical summit and I would keynote there every year and I started researching, I mean not doing original research, sorry, reading other people’s research on collaboration and neuroscience, cuz I was really interested in how we work together and how we don’t.

And so I just basically got myself a great education and I started talking about these things. So I would lead meetings. I would give a talk at a conference internally, and instead of talking about how are we gonna get all the code into GitHub, I would talk about how hard it is to collaborate and how we can do better, or how we might have empathy for people that don’t see eye to eye with us.

And that’s how it began. And I will tell you, I felt like I was jumping off this very, very scary cliff the first time I gave one of those talks in front of a room of a thousand engineers. I remember the night before one. Saying to myself, oh my God, you’re gonna get up and talk about empathy to a room full of engineers.

How’s that gonna go? You know, there was a sleepless night, . But what I’ll tell you Naji that surprised me in a really positive way is remembering that we are all human. It doesn’t matter how brilliant or how technical you are, I had people who were some of the most. Technical people in the company come up to me after one of those talks and say, you know, Minette, thank you so much for bringing up these topics that we don’t talk about enough.

We need more of this. And it just reinforced that shared humanity that we too often ignore. And it’s what makes work hard. And it’s ma, it’s what makes people suffer at work because we cut off our humanity and we cut off our emotions, and we think we have to have this f facade of perfection at work and leave all the emotions at the door.

And that’s not how human beings operate.

Naji Gehchan: I so relate to what you’re saying. This is why I was, I was smiling all the time. It’s, you know, I, I had the same feeling, uh, saying that I wanna spread love in the organization, , and with all that comes with love. And, and you had it with empathy, I think. And the interesting piece is, every time I’m discussing with leaders, thinkers, um, like, like yourself, there is always.

Fear practically of talking about this to people and then suddenly the surprise of actually maybe people didn’t know about or it’s great that leaders are talking about it, but yet like we, every time our. A little bit afraid or anxious about bringing those topics to organizations and to people. So thank you so much for sharing this.

Uh, and you touched also on psychological safety as it’s a key component of your leadership and how, how you’ve done it. Um, you even have a playbook, uh, about psychological safety and how we should do it. So can you tell us a little bit more on how we can apply it in our organizations as leaders, and what are your key learnings of actually being a practitioner and doing it?

Minette Norman: Yeah. And you know, it’s, it’s so foundational and, and there’s tons of research out there that shows that organizations that have a high level of psychological safety have better performance and higher innovation and higher employee retention and engagement. And so, you know, honestly I was doing it by trial and error when I was leading teams is like, how can we try to get people comfortable speaking up?

And I’ll tell you what informed. My interest in it was actually being in meetings where I did not feel comfortable speaking up. And that was, I would say unfortunately that was more the norm than the exception. You know, I would be in these leadership meetings and there would be sort of the dominant two or three people that would speak up all the time.

And that’s like, that’s just common group dynamics. And then there would be the others that are just holding back. And I was often one of those others who felt like, Ooh, I have to weigh every word carefully, and especially, you know, Being a woman in tech, you’re definitely in the minority. I was often the only woman in the room, and I felt this burden of, if I say something, it better be the most well thought out, most intelligent thing, and not like just an idea off the top of my head or just, you know, something that’s a half formed thought.

but then I realized like when you think back to the best teams you’ve ever been a part of, and I had remembered being in a team early in my career actually, um, where, you know, we never knew the word psychological safety, but we had this group of people, there were probably eight to 10 of us, and we collaborated in a way that was like every single person fully participated.

every single person’s voice was heard equally. No one dominated. We had fun. We put out a great release and we respected everyone’s point of view. And I’m like, this is possible. I know this is possible. How did we do it? And so I, I worked on, you know, I certainly read Amy Edmondson’s work. I read the big Google study project, Aristotle.

I read everything I could find on it, and then I just started practicing. And by the time. It came to writing this book. I met this, I met this woman in Germany, in in a virtual class, Caroline Hek. And we both were realizing that there is lots of research about psychological safety and so many people buy into the idea that it’s important, but there’s little practical information on how to implement it.

And she reached out to me with a crazy idea saying, why don’t we try to write something? And that was the origin of the Psychological Safety Playbook, which just came out a little over two weeks ago. . But you know, I’ll give you an example of something in there that’s just very tangible that you can do, and especially for leaders.

I tried this when I was leading teams. It’s like people looked up to you. You have this sort of, you know, hierarchical power, whether you want it or not, or whether you believe in it or not, but you do. And people are watching your behavior. And if you say like you’re putting forth the strategy for the quarter, people are not gonna question you on it.

Generally. They might do it behind your back. But, so I wanted feedback and I would say, What am I missing? What have I not thought of? And that’s like one of the first things in our book is that powerful question of what am I missing? Because what you’re signaling, especially if you’re in a leadership position of any kind, is that you are not perfect.

You are not omniscient. You can’t possibly know everything, and you’re welcoming other perspectives. And you know, I know your podcast is particularly geared at the medical community. This is super, super important in a medical setting. And in fact, Amy Edmondson’s original research, you probably know, took place in the medical field and she found.

For example, if people are willing to challenge a doctor, someone who’s not a doctor, challenge a doctor, like, I think you made a mistake in dispensing this medication that can save someone’s life. But if that, for example, if it’s a nurse who doesn’t feel comfortable, challenging and saying, I think you might have made a mistake.

I think you might have missed something. Then, you know, a patient’s life could be at risk there. And that’s what she found in her research. So this is so critical that no matter how elevated your position, that you realize you can’t see everything. You can’t know everything, and you need to deliberately invite other people to call you out on that.

And you have to be open when they do challenge you to not getting defensive and saying, Thank you. I really hadn’t thought of that. And oh gosh, I really might have missed something here. And being open to those perspectives. So that’s one of the 25 tips that we have have in our book as a practical thing you can put into, into practice immediately.

Naji Gehchan: This is, this is great. And, uh, yeah, I had, I had the opportunity to interview actually on the podcast, Amy Edmondson, where, where she shared about her research. Um, and definitely in the healthcare system we see it, we see it everywhere, right? So I think you’re bringing great pieces on, speaking up on being vulnerable also as a leader and humble enough to say, Yeah, sometimes, I don’t know, sometimes I make mistakes.

Sometimes I want, like, I want the feedback, I want it back to me. Uh, so it’s really, uh, tho those are really great practical tips. You’re, um, you’re sharing with us, uh, you know, another piece on psychological safety, I, I never shared, uh, I’d love your reaction to this. Um, I, I was in a team where some people actually, you know, when you get into a managerial position, Again, like people would expect to know, uh, and because of a lack of psychological safety environment, people might keep on doing things, not knowing what are they doing, but just because they are afraid to say, I don’t know, because the expectation of the organization, they managers, they should know.

So this is for me how I started to be even more and more interested in psychological safety. But when I discovered at some point that part of my managers. Really never took a certain training on a specific capability, but actually they were afraid of saying that they never did it because everyone expected them to know.

Also, I think like there’s a lot of things around psychological safety that are super powerful and can be actually risky, as you said, in, in, in medicine where you might end up taking the wrong decisions for the patients you’re serving. If, if we talk about the challenges you faced as you were doing this as a practitioner, and I’m sure it’s in the 25 tips and advices you’re bringing, but what is the biggest challenge you faced as you were building this culture?

As you were building this, um, those really fundamentals pieces of leadership that you believe in, in your organizations with your managers too, who also manage people, uh, and how did you manage this, and how did you get around of those pieces? .

Minette Norman: You know, I think that the, the hardest piece was overcoming people’s resistance and defensiveness when we’re trying to drive change, when we’re trying to get them to work together.

Because there’s, I mean, I think there’s this fear. I, I do think a lot of resistance is fear-based, that if I work. with someone else and their idea actually comes out as the winning idea or you know, we adopt their technology or their methodology, then I will be diminished somehow and my skills will not be seen as, you know, top-notch skills because someone else’s solution one out.

So I think there’s a lot of ego involved in it, and I definitely saw that and, you know, people butting heads and not listening to each other. Just digging in and like, I’m only gonna advocate for my perspective. I’m not actually gonna listen to understand. Your perspective, and that’s why, you know, we have a whole chapter in our playbook on listening, because what I found is people were preparing how they were gonna respond and defend their position rather than truly listening to another person’s.

Idea or another person’s solution. And so that was why I focused so much on collaboration and all the skills around collaboration cuz I found that people would dig in and I think it’s based in fear and it’s based in ego. And even my own staff members, like I had sort of a disparate group of, of disciplines that reported to me and it wasn’t obvious how they could all work together.

So I was saying like if we’re trying to drive the company to work together, then we eight people need to work really closely together. But there was a little bit of like, that’s not my area. This is my expertise and I don’t wanna cross over. So I think it’s just this, you know, It comes back to biology and our brains in some ways, in that we feel defensive.

We go, we feel like if someone’s on our turf, if someone’s attacking our idea, we go into that fight, flight, freeze mode. That’s our amygdala taking over. Right? I think it comes into play. all the time in the workplace because we are feeling attacked in some way. And so what I had to learn, and I had to learn this myself, naji, I was actually one of those people that would, you know, snap at people if they attacked me or if they said, you know, that’s a bad idea.

I had to learn to actually calm my brain. And, you know, take that pause. If someone says, you know, Manette, that’s a, that idea’s never gonna work. Pause, take a breath. And then instead of, Defending or attacking back, just going. Okay. Can you explain to me why? I really wanna understand, you know, and that was a, that is something I’ve had to practice and I’ve had to try to get my staff members to practice.

Um, we, you know, one of the most useful things we ever did as a staff was we, we had someone in our organization who was an improvisation actor, and we did improv training. And it was that idea that let’s not shoot down one of, you know, one another’s ideas. In improv, you have to go Yes. And, and just continue the improv.

And so we put that into practice in our staff meetings. And it was, it was a funny thing, like we did this improv day. It was really fun. And then after that we followed up in our staff meetings. When we got back into those bad patterns of shooting down each other’s ideas or getting defensive, we would just use the phrase yes and, and it would remind.

To keep our minds open and to keep our hearts open. And so, you know, it’s a, it’s honestly an ongoing practice, but I think it’s, it’s super valuable.

Naji Gehchan: I love it. It was one of my best courses, improv leadership and, you know, taking the offer and building on it. So I, I have a follow up question on this cuz we talked about ego, about your idea being taken and obviously as you said, it’s something human, right?

Like it’s ingrained in us and sometimes you can get defensive, but I wanna touch on incentives also and as leaders, how you can build those system because somehow the incentive you bring. . If you’re gonna recognize at the end of the day the idea that won, probably you’re unconsciously creating this. Like you wanna have an idea that wins for you to be recognized.

So how did you think about all this? Like how, how did you incentivize people who idea didn’t won or. Do you even talk about ideas winning or, you know, or more like a we team winning, I’m, I’m intrigued about also the incentives team

Minette Norman: around those pieces. Yeah, we, I actually had to focus, this is such an important question, Naji, because I had to focus on that.

It’s like, what do we reward? How do we reward the behavior that we want to see? And it’s not an individual idea. It’s not an individual. So we actually started to put into place incentives for collaboration. So, and it was, it’s hard to measure this, but we started, so one of the things we would do, like, for example, for our annual summit, we rewarded teams that presented a paper together, you know, where a team from one group would present with a team.

From another on a shared solution. Everyone wins. Everyone is rewarded. You know, I would get up and, and you know, publicize these kinds of wins across collaboration. We started to do something a little geeky, but it was actually quite interesting is that we started to get metrics on. Who was, who was actually using code from another team in GitHub.

So we were measuring poll requests and like, oh, are they coming from other organizations? And then let’s, let’s elevate that and, and celebrate that. So we were finding all sorts of creative ways to recognize and reward. Collaboration and cross pollination of ideas rather than, you know, the brilliant genius who came up with something alone.

And that was not what we wanted. We wanted really, and so that was, we had a different reward center and, and certainly really elevating collaboration and, you know, cross pollination and not celebrating individuals as much.

Naji Gehchan: So what, what would you say for people who think if you don’t have enough competition, In between teams, you’re gonna lose on innovation.

So was collaboration bringing more innovation than putting people and making sure that egos fight and one wins, in other words?

Minette Norman: Oh, that’s so, that’s such an interesting one and I’m probably don’t even have a great, a great answer to that, but you know, I think, I mean, competition is also can be really healthy, right?

We all, I mean, I don. I’m competitive. I, I love games and I love to win games and like, I think that can be fueling good energy, not bad energy, but I think it can’t be based on like one winner and everyone else is a loser. It has to be that our overall goal is really to make this organization successful, make our customers successful, and that it has to be based in.

Bigger aspiration, you know, that we are, we’re changing the world. You know, whether, you know, your, your group’s in through medicine, but ours were through software that was really having very, very positive impacts on the world, and it has to have a greater meaning. So yes, we can compete to come up with the best solution.

It’s not. Because we’re gonna get a big bonus ourselves. It’s because the world is gonna be better. Our customer’s gonna have a new solution that I think can be healthy competition, but it’s not like the zero sum gain of everyone is, you know, someone’s gonna lose here. It’s that we are all working together towards a common goal and a common purpose.

And then competition can be healthy if it’s, you know, I think there has to be an element of fun in competition as opposed to cutthroat. I win, you lose, you know, type of, I

Naji Gehchan: love it. What’s your number one advice today for the leaders and transformational leaders? You are. You are helping out with your new

Minette Norman: organization.

I think the number one thing I would say is that you have to start with your own behavior. Your own self-awareness of how you interact with others before you can drive any kind of a transformation. So start with how are you listening? How are you reacting when people challenge you? How are you inviting, dissent?

And you can do this through little, little changes in in your next one-on-one meeting. In your next meeting, listen differently. Invite the quiet person to speak and. Take that pause if you’re gonna have a defensive reaction and don’t, don’t respond defensively. Just ask a curious question. And I think that if you start every day with this intention of I am gonna have better interactions at work and I am going to invite everyone to fully participate, you can make a huge difference.

And I think it’s a daily practice, honestly.

Naji Gehchan: So Vinetta, I’m gonna give you a word now. and I want to get your reaction to it. What comes first to mind? Oh boy.

Minette Norman: Okay,

Naji Gehchan: so the first one is leadership challenging. The second one is inclusive culture

Minette Norman: required. . Can you say more about it? Yes. Well, inclusive culture, if you, if you want to really benefit from every single individual in your organization, then you need to create a culture in which everyone can fully participate in which all of their ideas can come forth and which.

Each one of them can share their wild ideas and their brilliant ideas and their half baked ideas, and they will not be embarrassed or excluded. So the inclusive culture is what go, is going to create your breakthrough ideas. If everyone can fully be heard and seen and respected, but if people come to work feeling like, sorry, this is, we wouldn’t be well beyond one word , but if people come to work feeling like, I don’t dare speak up.

I’m gonna mask who I really am. You’re not gonna benefit from all the, the magic they have inside themselves.

Naji Gehchan: What about transformational leadership?

Minette Norman: This is still a one word answer.

Naji Gehchan: You can do more . Okay? It’s a two word. So you can do more

Minette Norman: Transformational leadership, I think. coming back to, it starts with you.

It starts with you. You have to be the leader that people want to work with, and you cannot drive transformation without everybody else around you. It’s not a one person job, so you have to be inviting, maybe I would say, you know, inviting is a really important word. You have to invite all the ideas and get everyone marching in the same direction, moving in the same direct.

Naji Gehchan: And the last one is spread love in organizations.

Minette Norman: Yeah. You know, it’s so funny when you, when I saw the name of this podcast, so you have that reaction. One has the reaction of love in organizations, and I would say to me, that’s about care. It’s about caring about every human being as a fellow human being.

So it’s caring. That’s love.

Naji Gehchan: any final word of wisdom? Milad Four leaders around the world.

Minette Norman: I would say that you have so much more power to change the workplace than you know, even if you’re not in the C-suite, if you’re a first line manager or any level of leadership, people are looking at you. They’re watching your behavior. They’re watching what you reward. They’re watching. What you ignore, and they’re watching what you punish.

And so you are in the spotlight whether you like it or not. And so pay attention and become, we say become bravely self-aware of your own behavior and how you’re showing up and show up in the way that is going to be inspiring to others because that’s, that’s what you have. You have that platform. Use it for.

Naji Gehchan: Thank you so much. That’s powerful words and a charge for us as leaders, uh, as we go forward leading our organizations and improving and changing the word. Thank you so much, Minette, for being with me today and this incredible chat.

Minette Norman: Thank you for inviting me, Naji. It’s been a pleasure.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Phil Budden

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode joined today by Phil Budden Senior Lecturer at MIT Sloan focusing on ‘innovation-driven entrepreneurship’ (IDE) and innovation ecosystems. Phil’s approach combines academic, historical and real-world perspectives on how different stakeholders can all contribute to building successful innovation ecosystems. Prior to MIT, Phil had undertaken projects on innovation and entrepreneurship for the British Prime Minister’s office and served as the British Consul General to New England where he had been responsible for transatlantic business issues, including trade and investment, corporate/government affairs, as well as science and innovation. Phil has held several diplomatic posts with the British government:  British Cabinet Office; British Embassy, Washington DC; 1st Secretary and Adviser to the PM. Phil holds a BA and MA in History from Lincoln College, the University of Oxford; an MA in History and Government from Cornell University; and a PhD in History and International Political Economy from the University of Oxford.

Dr. Phil – it is such a pleasure to have you with me today.

Phil Budden: Naji, it is a pleasure to be with you. Thank you for having me on your podcast, and I’m looking forward to chatting.

Naji Gehchan: It’s a really special episode today, having a great diplomat who, uh, I had this pleasure to have as a professor at MIT during innovation entrepreneurship classes.

Uh, can you tell us, uh, Phil, more about your personal story from learning history to diplomacy and now teaching at m i t mm-hmm. . What’s, what’s in between this great, uh, journey you.

Phil Budden: Well, uh, nudge, it’s a great question and you were a great student. It’s one of the things I really enjoy about being at m i T.

So, uh, uh, yes, you went through my cv. I was training to be a historian. Uh, turned out I had a good memory. Um, for historical dates, I was an introvert. I loved reading, and so I wanted to be a historian and I was training to be a historian until history happened, and this will date me. Uh, but the Berlin Wall came down and so I pivoted and said, I don’t just want to study history, um, of the past because history is happening around us.

And so I pivoted to become a. I’d always been fairly international in my perspective. Speak a a few language.

Um, and so I always took a, a, a sort of more global perspective thing, so became a diplomat and had a wonderful 20 year career as a diplomat. Uh, and then had an opportunity to stay here in Boston. And I’m honored to be, uh, a senior lecturer at MIT’s management school. Um, having got a doctorate before going into diplomacy, I was nicknamed.

Dr. Phil, because there’s not many diplomats with doctorates and it seems to have stuck. And so, uh, I am not that Dr. Phil, I’m a different doctor Phil. Um, but that is how you find me at m i t now getting to teach great students like you. Oh,

Naji Gehchan: thanks. Thanks. Uh, Phil, uh, uh, uh, before going into, uh, where your focus is, uh, and what you worked on, you said I was an introvert, so I’m very interested with the past term.

And knowing you, I would have never said you are an introvert, so I, I’m, I’m like, I think we’re pretty similar. I’m an introvert too, so I, I’d love to hear mm-hmm. , why you said I was and did you work mm-hmm. on not becoming one, and it’s definitely not the perception that I think many of us have as your

Phil Budden: student.

That, that’s a great question. Now, Naji, I was and still am, uh, an introvert and it’s one of the things I’ve had to reckon with on my leadership journey when I was going to be an academic historian, it did ma did not matter that I was an introvert and loved research and study. , but through my diplomatic career, I had to, um, develop and evolve.

One of the misconceptions about introvert extrovert, um, comes down to that actually. They’re about the source of where we draw energy and we introverts draw our energy and recovery from stepping back from people and recovering and re. Uh, it doesn’t mean we’re any less sociable. Uh, you know, Naji, uh, and I are both very sociable people.

I’ve seen us at Ember parties, um, extroverts, however, get their energy from being around other people. And so for them it’s hard for them to be alone. So, yes, people are often surprised when I tell them I’m an introvert, but I think it’s important to do that because I think you can lead whether you recharge as an introvert.

By yourself or you recharge as an extrovert for some strange reason, wanting to be surrounded by people. Um, and that’s one of the things, uh, I’ve discovered. So I am, I, I reckon with my introversion, I can get up and I can teach, I can socialize, but then I need a chance to fall back. And often I will reach for a history book and just read about the world and recover in that way.

But I think it just shows that there’s a variety of ways of becoming a. . So true. And I think

Naji Gehchan: it it relates to if you love people, actually it doesn’t, you can be an introvert, love people. Mm-hmm. or extrovert love people. It’s just a matter that you need some time for yourself to recharge Exactly as you said.

Mm-hmm. . Exactly. But the key for, for leaders is obviously caring for others, right. As we’re gonna be discussing today. Yes. So you, you’ve seen and helped with the birth, uh, of several ideas. Uh, some of them turned into startup. Grew, uh mm-hmm. , what has been for you, the key for those who became successful ventures from all those that you’ve seen throughout the past years?

Mm.

Phil Budden: It, it has been fascinating. I, I worked on innovation when I was in government and at, ill teach about innovation, uh, here at, at m i t and one of the very humbling things is, Just the sheer volume of ideas that people have that they want to take forward. And this is not limited to young male coders in hoodies creating the next digital dance app.

It turns out that people, you know, mid-career, um, who have not had a background in technology can also be great innovators. In fact, often they can be. Because they know the challenges of the world. They know the problems that need to be fixed, and I love being at M I T because we’re not obsessed with just the purely web-based digital apps we have.

Doctors and medical professionals who want to make the world better through innovation in their areas of expertise. We have people from national security and defense who want to make the world a more secure space through deep technology and hard technology. We have people who are interested in the energy transition and achieving climate net zero.

Which you’re not gonna do with digital dance apps. You need people who are going to work on fusion energy and carbon capture. Uh, and so it’s a privilege to be at m I t and just see amazing people, professors, students, the broader ecosystem coming up with ideas about innovation that’s actually gonna have meaning for them, and they will lead that innovation through to impact.

So

Naji Gehchan: you, you mentioned several times ecosystems and you’re passionate about it and you actually work on it. So can you help us a little bit more understand and share your view about what do you mean by ecosystems that can foster innovation and entrepreneurship?

Phil Budden: Uh, that’s a great question, and I’m drawing on some fabulous m i t professors research in this area.

The ecosystem term helps us to answer a question, why is the world not. You know, Tom Friedman told us 20 years ago, the world is flat. Uh, anything can happen anywhere. And in terms of innovation, it’s not flat. In fact, it’s not fair. There are perfectly good places and perfectly good people that are left behind by innovation.

And so ecosystem is, uh, a model to try to understand why does the best innovation happen in certain places. , um, Silicon Valley, Boston, Cambridge, London, on a good day. Uh, why does it not happen in other places? Perfectly good Places like Nebraska, Kentucky, um, Scotland, Wales. And so the ecosystem becomes our way to both answer that empirical question, but also to give us a framework to take things forward.

And the thing about an ecosystem, rather, like in biology, it’s. There’s a variety of different players and species. There’s a des there’s a variety of different assets and and nutrients. Some of them are in collaborative relationships. Some are predatory. Some are parasitic. But this ecosystem, organic model is something we’ve now taught for a decade based on prior research and seems to help us explain why things happen in some places and not in others.

So can you in a

Naji Gehchan: nutshell tell us.

Phil Budden: Happen. I can give you the framework. So this is where my, his, this is where my history kicks in. Um, and so the ecosystem model helps explain why the industrial revolution and started in England, despite its many problems, why it spread the way it did. And this is relevant today for the 21st century.

And I think really important as we head into the, uh, economic turbulence ahead. So ecosystems, In the places on the planet that do best at innovation, there are five key stakeholders, one of which is the entrepreneur. Then there’s the traditional ones in the so-called triple helix of government, university, and big business.

Now, if a committee of government, university and big business was enough to solve problems, we’d all be rich. The challenge. That’s not enough to have a committee. You need to have the entrepreneur at the table because they’re the ones who are creating the enterprises of the future. And one of the things I’ve discovered in my corporate innovation research and teaching is sometimes big companies find it awfully hard to innovate, even if they came from an innovative startup.

So you do need entrepreneurs to keep refreshing that. Uh, and as you’ll have spotted, there’s a fifth one, and that is what we called risk. So venture capital is a form of that, but also angel investing, private equity, corporate venture capital, the ones who are willing to to fund the entrepreneurs. And so this five stakeholder model seems to apply around the world.

We’ve taught this in an M I T program called reap. We’ve now worked with 80 teams from all of the major continents, from most of the different political systems. The same five stakeholders seem to matter whether you are in Chile or China. Beirut or Paris. And so this is a model that is informed by our research, but also seems to be a framework for those who want to make a real difference and lead for impact in companies and communities that matter to them.

Thanks for

Naji Gehchan: sharing this framework. Uh, what is the role of leadership and all?

Phil Budden: Oh, leadership is key. So the word innovation, people when they hear this, they sometimes think it’s technology that all you need is a piece of technology, and M I t produces lots of technology. All you need is the app or access to the cloud or a fusion reactor.

Well, The M I T approach to innovation is the technology is important, but it’s not enough. You need to have leadership to go from the technology and the idea to impact, because the biggest challenge is not the technology, it’s usual, the people, the processes, and the systems. How do you bring the technology to bear?

Innovation does not happen spontaneously or sustainably without leadership. And so I spend a lot of my time working with executives saying, y Y. You may no longer feel that you are the most entrepreneurial tech savvy or innovative person in your organization, but if you are in a leadership role, Your leadership is crucial at empowering people around you, supporting them to, to spread the love about innovation and make it safe for people to, to innovate.

And so leadership really is the deciding factor within ecosystems, but also within companies and sectors. I love it.

Naji Gehchan: And how you frame that, leadership takes those innovative tech to

Phil Budden: impact Yeah. Out. They don’t get that by themselves. Well, a

Naji Gehchan: totally different question, uh, about diplomacy. I, I, do you miss being a

Phil Budden: diplomat?

Um, it was, that’s a great question. It was a great honor to be a British diplomat. Um, my final job was British Consult General to New England. Um, and especially to m i t. Uh, it was a great privilege to serve my country and my queen. Um, So I miss aspects of that. But the interesting thing is, I, I still find myself performing little d diplomacy.

Um, it turns out before diplomacy had become the action of of nation states, lots of people could be diplomatic. And so I actually think there are lessons from diplomacy, including in innovation ecosystems. You know, the way that an executive from a corporation engages the rest of the ecosystem requires a form of dis diploma.

Um, in the theory of diplomacy, it’s often regarded as the, uh, the mediation of estrangement, coping with differences, and so understanding the differences between a corporate leader at a startup venture between a government official and a university academic. So one of the things I find myself teaching some of the students, though not you yet Naji, is how to take these diplomatic approaches and to think like a diplomat, because it’s not the same as just command and control within a company if people still do that, uh, it’s not the same as, you know, between a professor and a student.

It really does require respect, understanding, and a realization that we sometimes speak different languages when we talk about innovation and technology, even if it’s all in some form of.

Naji Gehchan: That’s, that’s great to, to have this kind of how you’re transfer one part of diplomacy and I agree. Like we’re diplomats talking with people, managing relationship is super important in what we do.

Yeah. What, what, what is your view, uh, I don’t know if it’s a politically correct question, but I’d love your current view on global diplomacy in this ongoing craziness. I would say in the word and unfortunate things

Phil Budden: happening. Yes. , I think it just reminds us that diplomacy is even more important than than ever.

Land war has sadly returned to Europe. Um, and so there’s also a needed for hard edged defense, but diplomacy never stops. And so ultimately we’re still going to be living along alongside each other as nations. And so diplomacy as the way to mediate, estrangement, um, is going to be necessary. And diplomacy is not just with your friends and all.

It’s with your competitors and adversaries. And so I think it’s through diplomacy that we actually need to address these issues, that we need to come to some sort of halt in hostilities in the war that we need to manage the rise of other powers in Asia, respecting differences, but also coming up with some, some basics.

And so I actually think while the focus is on defense and the military, Diplomacy is going to be hugely important, uh, especially in the regions. I’m looking at more now, uh, the Middle Eastern Africa, where I think understandings, conflict prevention, shared prosperity are going to be really important. And I think some of the diplomatic tools, uh, respecting differences, acknowledging that we speak, uh, different languages, even if we’re.

Basically speaking, you know, English or Arabic or French or Spanish. Understanding those differences and managing those differences, I think is gonna be important. So, oddly, at the start of 2023, I think diplomacy is needed even more.

I’m gonna give you now

Naji Gehchan: one word and I would love your reaction to it. So the first word is

Phil Budden: leadership. Ah. Essential leadership is essential. Without it, we don’t make progress. And this is not just leadership. For those who are technically in leadership roles, loads of individuals can show leadership in loads of different ways.

What about entrepreneurship? Entrepreneurship is hugely important. It’s not the same as innovation. You can be entrepreneurial with a very low innovation, low tech venture. All of those people who are running corner stores or um, uh, Uh, bread stalls that I saw in Jordan in Egypt, or mum and pop stalls or pizza stores.

That’s a form of entrepreneurship and we should welcome people being brave to be entrepreneurial. We just shouldn’t confuse it with innovation and the real gamechanging changes that we need. The third word is

Naji Gehchan: console.

Phil Budden: Console. I was a console. Um, it means you are operating in a region. You are not the ambassador because the ambassador is the representative to the sovereign country.

Uh, so a console is a form of diplomat and it’s. It was my honor to be a consult for the late, uh, her Majesty the Queen, and it gave me a great opportunity to work with partners across New England, but also realize that I was just one small part of a global diplomatic network. And it was my job to show local leadership, but leadership in support of the wider network’s efforts.

The last word

Naji Gehchan: is thread love in

Phil Budden: organiz. Well, I, I’m British, so, and, and male, so it’s hard for me to talk about this love thing, but I love the initiative that you’ve shown Naji about spreading love because it reminds us that at the end of the day, , it’s about people. You know, we were talking about innovation.

Innovation is more than just technology. Uh, innovation can be of business models or processes and people. And as much as the pandemic had us thinking about technology and being remote and, and it’s great, you know, you and I get to chat and you get to record this, that is lovely, but at the end of the day, it’s about people.

And the diplomat in me thinks it’s about connecting people. And so you need to spread that love and joy and leadership can do. But so could pretty much any member of an organization, some of the most joyful people for me to work with are the ones I stroll in, uh, who greet me at the office and we chat about their lives and, you know, the challenges.

And so I think it’s really important to, to spread love, not least because it reminds us about leadership is about the people.

Naji Gehchan: Any final word of wisdom felt for leaders

Phil Budden: around the. . Um, it is with considerable modesty that I as a aging white middle class Brit, uh, offer advice in global contexts. Um, but leadership is really important.

Leadership is the only thing that’s really made a difference through history. And it’s not just leaders of countries who are elected or selected. It’s about leaders of companies, leaders of universities, leaders within communities, leaders of families. And so I think leadership is the thing that makes the difference.

So I encourage people to think what kind of leadership could they? Um, respect diversity. Uh, I am an introvert. My leadership is in small bursts, after which I need to recover. Uh, others will be able to show leadership in, in different ways, but be thoughtful about your leadership. Be respectful of the people.

Um, leadership without followership. Is just emptiness. So think about what is AU leadership authentically in your area, and think through to the impact. What, what are you leading towards? What difference are you going to make in the world? Um, how are you gonna make sure that all the right people are involved and that you’re having a positive impact?

Well, thank you

Naji Gehchan: so much Dr. Phil for being with me today. It was an incredible chat. Thanks for being.

Phil Budden: Naji, my pleasure. And I wish you lots, uh, of good luck with spread love. Keep up the good work. Thank you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Navin Goyal

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast joined today by Navin Goyal, a physician and entrepreneur who serves as CEO of LOUD Capital, an early-stage venture capital and alternative investment firm leveraging capital, entrepreneurship, and education to grow impactful companies across the globe. Bringing his physician training to do good for people, Navin strives to make venture capital more purpose-driven, inclusive, and accessible.  Before co-founding LOUD Capital, Navin practiced anesthesiology in a large hospital-based setting and was the Medical Director of a community hospital for several years. The beginning of his entrepreneurial journey was co-founding OFFOR Health (formerly SmileMD), a venture-backed mobile healthcare company that expands access to care across the United States with a dedicated focus on lower-income and rural communities. Navin is also author of the book Physician Underdog where he shares more about his story and impact that we will also hear more about today!

Navin – it is such a pleasure to have you with me today.

Navin Goyal: Naji, thank you for having me. I appreciate the kind introduction.

Naji Gehchan: I’m so intrigued by your story from med school to being a clinician and now venture capital. Can you share a little bit more with us about your personal story and what’s in between the lines of this incredible journey of impact you have in healthcare?

Navin Goyal: Yeah, so let’s see if I can do a relatively abridged version. Um, you know, wanted to be a physician, went to med school, became an anesthesiologist, and that was my goal.

And so like many things, when you reach your goal, you’re, you know, uh, it’s great, but it’s not necessarily everlasting. It’s, it’s like, what is the next goal for me? I thought that was it. I was in a great private practice, had great partner. Uh, it was very fulfilled, but over time, um, like many physicians nowadays pretty openly say, you know, there’s a little bit of boredom that happens because you are an expert in your field.

Your learning curve goes a little bit more flat. And we are so used to learning so much information that when that stops, unless you’re doing a lot of other things in your personal life or, um, extracurriculars, um, you still yearn to learn more. And I was no different. I just didn’t know what that looked like.

So I started reading at the age of 30, I started reading books, which my parents told me growing up, read, read, read. I never was that kid. I was like, no, I don’t think I don’t like books. I only will read what I need to for school. So I started leisure reading and the age of 30, I know this sounds funny, um, and I got lost into some fictional stuff, but really got veered into the non-fiction.

Entrepreneurship and inspirational stories about people pursuing a higher purpose, leaving their place of comfort because they felt so strongly about something. During that time, I’m started angel investing, you know, investing in some startups locally here in Columbus, Ohio, where the startup scene was really starting to to heat up, and I got inspired by these entrepreneurs that I was investing in.

So they not only were companies I invested in, they were also now relationships that. Was very curious about, and I was trying to learn as much as I could. So that really opened up the world of entrepreneurship to me. And then in 2014, had the opportunity to start a company with, uh, two other anesthesiologists.

Uh, called SMILE md, which is a mobile anesthesia company. So the anesthesia part, we knew all the business stuff, everything around it. We did not, but it was comfortable enough for us to move forward knowing that there was many unknowns, but we, we had each other. We knew anesthesia and we all figure it out.

And so what I just said is not knowing some things and we will figure it. Is what I have embraced. And I think it’s really hard for us physicians to say that statement and act on it because many of us have followed this rigorous path, but this path was known and by the end of it, you will be an expert if you pass these, if you have some experience, if you do all these things, you will be an expert.

There’s no guarantee in the entrepreneurial world, in fact, most of the world, there’s no guarantees like. So I think it was embracing a little bit of that discomfort, having people encourage each other, learning along the way. And guess what? Now today, the company employs about a hundred people. We’re in several states.

We have insurance companies as clients, and, and, and it’s been nine years, by the way. So this is not something that happened overnight. But how we look at entrepreneurship is we built something that’s now serving kids all over the country. So over 30,000 kids. We’ve, um, done anesthesia on in various practices around the country, and we’re serving kids that were not being served by the hospital or medical systems around.

They’re so backlogged with other types of procedures, so I’ll pause there, but that’s, that’s one way that’s really empowered me in the world of entrepreneurship.

Naji Gehchan: Wow. Thank you so much for sharing this. You know, I, as we chatted a little bit before, I relate so much to what you’re saying also in the entrepreneurial journey.

It’s, it’s funny, it’s kind of, you know, our company we, we founded some while ago is also nine years. Um, and the impact that you’ve done for those 30,000, uh, kids, as you said is, is really so powerful. So it’s not only entrepreneurship, entrepreneurship with impact, and I think this is something that you’re taking now.

In your new venture as, as a c e o of, of loud. So I, I would, I would like to start with this, you know, every, like those two letters. usually create a reaction. You know, I, I won’t say positive or negative, but VC always has a reaction with entrepreneurs. Yep. And you’re leading an early stage venture capital, uh, firm, really focusing on good for people as I read.

So it’s not usually how the VC word I would say is perceived. So I’m really intrigued about your vision. and what are you doing in, in this VC word and

Navin Goyal: how you’re doing it? Yeah, it’s, it’s a, it’s a great question. And so continuing my story, my lens of entrepreneurship started out with building an impactful company.

So I told you we take care of a lot of kids and these kids, um, Are on Medicaid. So these kids have long waits at hospital systems, nine to 12 months, sometimes 24 month wait to get dental extractions. Okay? And so what our company does is we get that done within a month. We get it done in their community and the office that they were diagnosed in, and we get it done without them leaving their community hours away to a medical system waiting months, months, months, even years.

And we get it done. So, We are saving money on the system. We’re saving progression of disease. We’re saving, uh, time. We’re saving discomfort from the families, and we’re making it all work. And it’s actually an alignment of stakeholders. Insurance companies, patients, providers, physicians, you name it, are aligned.

And so what that does is it creates a light bulb moment of, wait a second, you can create something for profit supported by all these stakeholders. That are in alignment while employing great people, working really hard, purp, it’s very purpose driven. We see the results. So wait, wh why don’t we continue to support companies that are doing this?

And so as I was building, uh, SMILE MD and um, really talking about this all the time, so I would go to work. All I could do was talk about it. And I was also an angel investing. You can imagine people are like, Navine, what are you? . Like we’re we’re, we’re at this practice here, but I couldn’t stop talking and thinking about it.

So then people were like, how do I get involved in your world? How do I get exposure to that? I wanna learn some stuff. I want some energy. Wait, I have some capital. How do I invest in this world? So that’s where in 2015 I started a fund. It was more of an angel fund to invest in these types of companies because again, my lens of entrepreneurship.

Impactful driven companies. And by the way, there are companies that are out there that don’t necessarily move the needle on people or productivity or really solving a problem. It’s, let’s say selling a product that’s a little better than this product. And we’re trying to, um, take market share from another company.

Okay. And there’s opportunity to make money off those. And so what clicked for me is like, Hey, I want to make money. I want people to make. , but let’s also feel really good about it. And that’s actually why I sleep well at night because I am supporting and investing in companies that are doing good things for people like our family and our friends, and people I know, and that just feels really good.

So I just consider it a higher standard that traditional venture capital looks at. How can we make money off these companies? My lens is how can we make money off these companies while. Further supporting the people around us. And it sounds really simple maybe, but it’s not. And it doesn’t happen enough.

And that’s where I think VC gets a really. Bad name because there’s a lot of fuel that goes behind companies that really aren’t adding value, and they might make a ton of money or they might go up bankrupt. But either way, there was no value to society outside of maybe some wealthy investors. And so I want investors to be wealthy, but I also want them to know that their money went towards pushing things that they care about for their own families or kids.

Naji Gehchan: I love this. This is so, you’re saying simple, but as you said, I think it’s really complex and obviously the word is not there yet. So I, I’m intrigued by, you talked about obviously the profit side of things. Yeah. So the timeframe I imagine for those type of investment might not be the same. The KPIs you are looking for might not be similar because it.

only about profit. You’re actually looking on impact, actually profit for stakeholders. So I’m interested, like how do you look at these

Navin Goyal: things? Yeah, actually the, we’re not looking at different metrics in the sense of time to exit or acquisition. So if you think about relevant companies today in 2023, people care now about the purpose behind a brand.

They care about who’s behind the brand, what they stand for, more than ever, right? And so, For me, it’s having a culture and leadership and solving a problem that is relevant to me as a consumer or a customer that doesn’t slow down the process of an acquisition. In fact, to me it elevates it. And so what we’ve seen is we have an accelerated, uh, kind of record.

We have a great track record. We’ve had exits. Our first exit came after, uh, a company of four years. And so investors got, you know, capital back and people are happy. Yeah, I, I no longer have to prove anything with just my words. It’s been the action that we’ve taken. And, you know, today also there’s a lot more of, uh, a movement of emerging fund managers.

You know, newer fund managers, even if they’re operationally experienced or have great entrepreneurial backgrounds, they’re now running funds with more of this thesis of impact. Now impact used a lot, but the way I described it deeply into problem solving, deeply into I, I, I believe in servant leadership.

You know, I believe in investing in people who are gonna treat their own people well, not just the problem they’re solving. So it’s like this whole comprehensive model of supporting good companies, good people that employ good people, that serve people. And there’s money to be made and there’s value to be created.

You’re, you’re

Naji Gehchan: touching on so many incredible aspects, you know, it is really this podcast that’s built on this. So I’m, I, I’m really so honored to have you here and talk about this. You talked about culture. You talked about servant leadership, um, and these are things you look at and the company is really based out of purpose, right?

Like purpose driven companies. Yeah. So how do you put all this into perspective and what are the key aspects? I would say when you’re looking at the founding team and you say like, yes, this is a founding team that has those. and you wanna invest in them. Like how, what, what are the key aspects? You’re looking in the founders and what is the culture Yeah.

Navin Goyal: You’re looking for. That’s, that’s great. And, and it’s taken some time over the years to really pin it down to answer this question. Um, and obviously there’s, there’s, there’s chemistry, there’s ability to work with, with a portfolio company cuz when you meet a team or founder, And you decide to move forward after your diligence process, et cetera.

There needs to be a healthy chemistry to say, we can work together. Cuz basically you’re committing to each other for several years at least to say, we’re gonna be working and building this business. And, and by the way, the, the name loud capital came from being loud and active investors. Not silent investors because even people who write large checks, they’re either very busy or they look at this as a, an investment financially, you know, mainly, , I look at it again as holistically as you’re solving a problem, how can we help and, and, you know, knock down some obstacles alongside you.

So our, our team and our culture is very entrepreneurial. Um, and that’s what’s exciting that we, we, we don’t look at it as just an investment business. Um, and so in doing so, there’s, there’s a chemistry. Um, there is a humility that needs to occur. So really, if you think about really, really ambitious, intelligent, and capable people, Right.

If they have all that without humility, then they, their learning journey will not be as great. Uh, they probably won’t attract, um, as many people as they can. They probably won’t attract the right people, I should say. Um, there’s something, that connection that we have in our team, the chemistry, keep talking about, we are attracted to that humility because no matter what we do, our team members, like I have partner.

Hear at Loud that are brilliant. Like they, I, I’m, they inspire me and they teach me so much every day, but they have a humility to them. And I think that is a necessary thing to have in founders and teams. And by the way, there’s been some groups or some teams who we’ve realized don’t have that level of humility and they’ve come into problems because of that.

And sometimes it’s really hard to, to, to pinpoint what it was. But my, you know, after processing a lot of things for a while and we have over 70 portfolio companies now, and, uh, I’ve co-founded three, uh, four now. Um, you just learn a lot and you learn a lot about the people that run into more problems than others.

Now, because of the market, now because of your industry, I really think there’s a level of humility that’s needed to really excel, um, really in life. But I’m talking specifically in this.

Naji Gehchan: Well, thanks for that. Um, I’d love to learn more about, you know, you’ve been a clinician, you’ve done med school, you told us your story, and now, now in vc, is there kind of a common thread or common learning that you took with you throughout your journey that you would never change, or it’s something that now is part of your signature as a leader?

Navin Goyal: That’s, that’s interesting you say that. I just had a discussion for an hour before this, um, before getting on a call with you. Um, I believe I’m an empowered individual and when I reflect on the things I’ve done and the things I’ve tried and put myself out there, um, I’m empowered and I. . I am privileged to have had that early, and right now I’m trying to figure out how to pass that on more to other people, including my own kids.

I think when you’re an empowered individual, whatever situation you’re in, you have this hat on that says, I’m gonna try to figure this out, and I’m, I’m the one that can do it. I’m not gonna rely on someone, Hey, I can use help. I can ask for help. I can do all these things, but I can. and imagine empowered kids around the world this moment if every kid was empowered.

Um, how really these small things can, you know, largely change the world. Lar largely change what we think of ourselves and what we can do in our capabilities. And even if we fall flat, right? Like, that’s okay. I learned that I’ve fall, I’ve fallen many times, but I feel like the pressure we put on ourselves to not fall.

Is is silly. It should really be the pressure of staying down, right? We’re gonna fall, but don’t put pressure on yourself of, you know, Hey, I just fell. Well, let’s not think about it. Just get up and let’s keep going. So, , I think empowered is the word that has been with me, and I am grateful for it, and it’s taken me a while to really process it.

Uh, but my goal and, and even doing these podcasts, to be frank, is, is to talk so people hear this and feel like they can do it too, whatever they want to do. Small or big.

Naji Gehchan: Thank you, Navine. This is, this is powerful and I think it’s inspiring for, uh, many of, uh, our listeners. I, I would give you now a word and I’d love your reaction to it.

The first one is leadership.

Navin Goyal: Yes. Serving is, is what it, what comes to mind. ,

Naji Gehchan: can you tell us a little bit more how you would define

Navin Goyal: servant leadership? Yeah, yeah, and it’s probably interesting to give the context of that’s a, that’s a changed attitude for me. I thought leader, especially when I was transitioning out of my medical job into running loud capital, I really thought I had to know.

more than everyone else. I had to kind of walk into a meeting and really set the tone. I like. I had this pressure on myself of a leader being more of a top-down approach. Now I look at leadership as it’s really now about me. What I know, it’s really about the people that are in the room, what they know, and trying to aggregate that or accumulate that into.

Common direction. And, and in order to do that, you have to listen more, speak less. You have to be able to accept that more people around the table might run the meeting and talk. And you are sometimes chiming in and learning. You’re constantly learning. So I think, and then the other thing is serving, which, which is going to each individual in your organization or your leadership team if you’re a larger company.

And ensuring that they have all the tools, they are empowered and that they’re being heard so they can be optimized, content and fulfilled. And if they are, that will, that will increase their obviously fulfillment, but productivity, right? They’re at your, let’s say company, then they were, they are optimized and that will optimize their teams under them or around them.

And what that does as a leader, It optimizes you. It fulfills you. It be makes you become more productive. So it doesn’t start with you. It actually ends with you. And so in a line, I’m not the front. I’m the last. That’s why I think about serving.

Naji Gehchan: This is, this is really so great, you know, and as you were talking about it, I’m thinking like this transformation, right?

And when you get to transformational leadership, uh, as, as, as we grow, and I love going back to physician, right? I think mm-hmm. , sometimes as a physician, everyone looks at you and say like, you should know, right? Like, you are making decisions, you’re diagnosing. And suddenly here as a leader, I love how you framed it.

It’s about. Not what you know, but rather what people in the room know and how you’re gonna foster this and empower them to, to a better outcome for, for the company and the group. The second word I have in mind is health equity.

Navin Goyal: Yes. Um, health equity, what comes to mind, um, is the opportunity to be healthy for all.

And so, What I’ve realized is how much of a kind of privileged situation that I’ve grown up in even the hospital system. Um, I’ve seen a lot of variety of cases. It’s a very large hospital system, but what I didn’t know is how many people weren’t able to reach even the hospital system I worked in. And so one of the things that opened my eyes, um, Two is is, is health equity, where when we were building SMILE MD and we’re serving a lot of kids on, on Medicaid, and I would hear about these long waits and at the same time my, my two girls who are now 14 and 12 were young.

Um, I have private insurance and if they, something happened dental wise, I could probably get that done within a week by making a few phone calls because I had private insurance. And I was like, wait a second. What are the parents thinking right now of that child that’s waiting 12 months of this kid being in pain?

And they can’t do this. They can’t do the same thing. They can’t call someone and say, let’s get them in. And so to me that’s what health equity is in a very real practical level. We’ve been in so many, um, meetings where we’re building this company and we have to remind ourselves what we’re doing for these kids.

And I constantly think about my own kids and I’m like, why me as a parent? Why do I have a different avenue and accelerated avenue than other people? And you know, you apply that to so many things. Access to care in general, access to basic fundamental things of, uh, a safe home, nutrition, all these things that, that are contribute to health, mental health.

Um, that’s what health equity means to me. And I’m. Grateful to be able to participate in some of the change, but obviously we need more people and more eyes and more knowledge, uh, that the health equity spectrum is so bad. I can’t

Naji Gehchan: agree more with you. The third word is

Navin Goyal: innovation. Innovation. So it’s kind of a funny word cuz it’s used so much now.

Um.

I would say what comes to mind is fearless, so not having fear of trying something new, not having fear of breaking down a system that’s not serving us or serving the people We initially. Started this system for, um, and not being afraid to listen to everyone, because I feel like sometimes when it comes to innovation, there’s a circle or panel of experts , and who determines that?

We probably do, okay, you’ve done this, you’ve done this. Like for example, there might be someone out there one day that calls me an expert on something. As soon as they plant that label on me, I’m screwed. That’s, that’s not true. Like I’ve learned a lot, but I’m still one person with a bunch of silly ideas.

But, so as a, a 10 year old kid with a bunch of silly ideas, let’s put it on the table and see what sticks and try it out. So, so those are some things that come, uh, to mind with innovation. The last one

Naji Gehchan: is spread glove and organiz.

Navin Goyal: Spread love in organizations. Ugh. I love it. Um, so I believe in leading with love.

And so when we’re talking about, um, the example I gave you where I’m talking to someone in my company and I’m listening and I’m, I’m seeing how can they be better? How can you know, how can they be fulfilled? Like that is love. And if you apply that to everything, to organizations, to people you work with, to your employee, To, to people at home when you come from work that is leading with love, so that that’s what comes to mind.

Naji Gehchan: Any final word of wisdom, David? For healthcare leaders around the world.

Navin Goyal: Yeah. So I think when we, um, talk about healthcare leaders, we immediately go to the vehicle of clinical and hospital systems. But when we talk about the health of people, right? There’s so many factors there. And I’m gonna give you one example and, um, you know, there was a, uh, a panel I did for a group of college student.

Um, and one of the things, uh, it was a, a great discussion and I was a young lady who came over to me, uh, she was a first or second year in college, and she said, you know, I really love your story. I want to be a doctor. Um, you know, I, I love, just would love some encouragement. And I said, oh, that’s great. I’m like, you know, why do you wanna be a doctor?

And she said, well, I grew up really poor and my parents didn’t have great access to. So I want to be a doctor because I wanna help my family and I wanna help people like my family. And I said, that’s amazing. I’m like, going down the route of becoming a physician is not easy. It takes a long time, but you want to help families like yourself, like what you grew up in.

You know, there’s other ways to help people. Right? What about being an entrepreneur and building companies where you. Uh, deliver services. Take great people in hospital systems and go to your home. Um, improve the quality of, I mean, let’s talk about, you know, wifi, right? The internet and because there’s so many houses that don’t have it, have an electronics to be able to access care, access Telehealth.

Right, so my, my point is there are so many ways to help the health of people. It doesn’t need to be in a clinical vehicle. And so I encourage healthcare leaders to think that way, where if you can get a leadership role that doesn’t necessarily have to do with only clinical, you can positively impact. A more holistic picture, and that’s kind of what I talk about with venture capital and all these other businesses.

It doesn’t have to be clinical and the fact that we went through medical school, or let’s say we’re talking healthcare leaders in general, the fact that you have some clinical background to take care of people, apply that in other vehicles, right? You have that intention, you have some experience. Now expand that application to a much broader, in to much broader industries and corporations and organizations.

Naji Gehchan: Well, thank you so much, Navin, for being with me today and empowering us through your great words and experience. Thanks.

Navin Goyal: Thank you so much for having me.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Semyon Dukach

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast joined today by Semyon Dukach, Managing Partner at One Way Ventures, the venture capital fund backing exceptional immigrant tech founders who are building great companies like Brex, Momentus Space, and Chipper Cash. Semyon is a refugee from the Soviet Union and formerly the Managing Director of Techstars (Boston). Prior to Techstars, he was a prolific angel investor and a friend of the startup community. Semyon has made over 100 angel investments, including early investments in Quanergy, SMTP.com, and Wanderu. Xconomy lists Semyon as a top angel investor in New England. His philosophy has been to focus on helping his founders at all costs. Prior to becoming a full-time angel, Semyon co-founded several technology companies including Vert and Fast Engines. Fast Engines was sold to Adero in 2000. Beyond startups, Semyon is known for leading one of the MIT blackjack teams in the early 90s to beat the casinos. Semyon earned his B.S. from Columbia University and M.S. from MIT, both in Computer Science.

Semyon – it is such an honor to have you with me today.

Semyon Dukach: Thanks for having me.

Naji Gehchan: We would love first to hear your incredible personal story from immigrating to MIT beating casinos in blackjack and now being a VC focused on impact investing in exceptional tech immigrants. It feels like a full circle, but we’d love to hear more about t from you.

Semyon Dukach: Yeah. You know, I, I started some companies and then I gravitated fairly early in my career towards investing. I realized, Uh, the customers I wanted to serve were the startup entrepreneurs and that I enjoyed being involved in multiple things in parallel, um, and was also fairly good at the, actually making money at it.

Uh, so, uh, I basically started gradually investing, um, more and more of whatever money I had. And as I started doing better as an investor, I had the exits and I rolled it all over. Um, to where, yeah, eventually, uh, maybe, um, 12 or 13 years after I started move, being an investor, I was like one of the most active people, uh, in the part of the world in New England.

But then actually I didn’t just immediately go to the venture fund. I was recruited to run the Techstars, uh, accelerator here in Boston. Um, uh, which at the time was quite early, but it was still already very successful. Had a great track record. It was a much stronger program than other programs like it.

and I was, you know, surprised cuz I’ve never, never had to work within any larger organization. But it was a little bit of a franchise and that, like the Boston group, uh, operated somewhat autonomously at the time. And, um, I took that on. And so that was actually my first kind of semi institutional investing experience we had.

I, I guess I ran four, uh, four groups, um, over three years. Um, A total of about 48 or 50 companies. Um, and those have done well as well. And there I really learned more about like, mentoring not just individuals, but doing groups of CEOs, working with the venture capital investors and connecting, you know, people making it more likely that they can tell a better story and raise money they need.

Um, and, uh, it was a little bit of a public facing role. Now there’s demo days, you know, it’s, it’s a large, large gathering of the whole community, uh, every year. Um, so, you know, it was fun. And that’s when I first dabbled a little bit with, uh, not just taking local companies, but bringing some companies over from Europe.

Um, which had mixed results, I would say. But after doing it for a few years, I, I felt it was a little too comfortable for me. It wasn’t as challenging, you know? Um, I wanted to do something of my own from scratch, something more global or something with a, with a mission and impact that I really cared about.

Cause I think, I think any kind of investing organization like any other startup needs to have some purpose other than how much money it’s gonna make. I think it’s really, it’s a good thing to, to have, it helps motivate your team. It helps keep people, you know, going through the hard times. . Um, and um, ultimately if you really believe in what you’re doing, you’re probably gonna do better than than folks who lack that belief, right?

You’re gonna work harder, you’ll be, you’ll have an easier time recruiting, you’ll have better deal flow. So, ended up, uh, picking this, uh, focus on immigrants because, I mean, I am, uh, an immigrant, or at least my parents were, you know, I was young when I came here. We were refugees. Um, I found most of like, um, most of my friends, but also a large number of the startups I invested in as an angel had immigrant founders.

Anyway. and, um, it just seemed like the right time. I mean, Donald Trump was just elected and, um, there was a bit of a backlash against people coming in. Right. So it, the time seemed right to, to make a stance and to say, you know what, we’re only gonna invest in immigrants cuz immigrants are more likely to build big unicorns than.

People ho born here, right? It’s a very strong filter. When you’ve gone through what you’ve gone through in order to move to another country, learn a cultural language, you know, rebuild your network. It’s predictive of resilience and future success. You’ve gone through more than someone in an equivalent position with an easier path who was already born here.

Um, in a sense, you know, immigration is almost like your first company. It’s like an entrepreneurial thing, right? Like getting yourself re-situated is, is quite a task. Um, and so yeah, we, we built the whole fund around that concept. We raised, I left Techstars, we raised, uh, first 28 million was the first fund, and we invested that and had a bunch of interesting outcomes and were able to raise a second fund that was twice as big as 57.

Um, and we are about halfway through investing that one at this point. So that, that’s what I did today. I, I typically, like the angel phase is long over. I, I don’t write angel checks. I’m full-time capital investor, uh, right now.

Naji Gehchan: Well, thank you so much, Samuel, for share sharing, uh, your story with us. Uh, I I’m gonna double click immediately on the VC impact and specifically for, um, for immigrant exceptional immigrants as you.

You shared a little bit about the philosophy behind it, so I’m interested if you can give a little bit more, uh, your, your words insight, how you ended up really thinking immigrants, and I can relate. Um, you know, I’ve been immigrant couple of times, so, uh, I’d love to get your insights on this. And really when you started and had this idea where you said, I’m gonna move and only invest on immigrant startups and entrepreneurs, Uh, you, you said you had good funds, uh, joining you.

Was it hard for people to believe it? I’m interested in the reaction about this, because you said you went through the stance in a moment of even like some tension, you know, politically or beyond, so I’m interested how you managed to convince people around

Semyon Dukach: it. I, I suspect it was probably easier because the, the people who didn’t.

What the administration were doing felt angry and they felt strongly and they, they, uh, knew that America was built on immigrants really. And what America’s success at attracting people from all over the world is largely, uh, related to, to how, how wealthy and successful America is today. Right. Um, people know that.

And so, They were frustrated and I think it was easier to get their attention. But at the end of the day, like we decided not to make an impact fund for the purpose of helping the people we invest in, right? Like of course we help because that’s what we do as investors. We help the companies, we give ’em money, you give add value, so they pick your money and not someone else’s.

But, um, and because that’s the fun part, but the act, the selection itself, the act of writing the. It’s fundamentally not a philanthropic exercise for us. Like we are not a fund that, uh, invests in people because. They’re under capitalized because they have trouble raising money from others. We’re not there to help people who struggle struggling with fund fundraising.

Right. Uh, on a contrary raising, think, you know, we have our beliefs, we have our passion. We love investing in immigrants. We wanna see a world that’s more open. We ideally want to see that any person, regardless of where, wherever they happen to be born, should be able to like switch their passports at will and join whatever country they want to be a part of.

And all countries should be open to everyone. Uh, I mean, obviously not the people who come and, you know, commit crime or whatnot, but you know, you could, you should be able to police crime the same way for new arrivals. As for existing, uh, people like it. I, I would like to believe. The random paperwork that you happen to have received when you were born is completely outside of your control.

Just like your, your race or gender is outside of your control. And so opportunities should be the same for everybody. And so, you know, we don’t like the idea of asking, uh, whether these tech immigrant founders are good for America because they create a lot of jobs. Just doesn’t interest me at all. Like, I, I, I don’t actually care about the fact.

These immigrants create a lot of jobs for America. I mean, it’s nice. It’s good that the jobs are created, but that’s not an argument for why we should allow them to enter the country. The reason we should allow them to enter the country, in my view, is because we believe in the quality of opportunity. We believe in human rights, and who the hell are we to ask whether the arrival of this person.

Gonna benefit us economically. It’s their right to come and do whatever the hell they want. As long as, you know, they’re not harming as long as they’re building, creating, you know, working like everyone should have the same rights. It shouldn’t matter where you’re born, right? Because that’s outside of your control.

That’s, that’s a core part of what we believe. And then we think globally, of course, in general, uh, we tend to, you know, our companies tend to have offshore development because they have come from a country where they understand the culture and it’s easier for them to set that up. Um, and there’s a lot of other, uh, advantages to it.

Um, but basically we have, you know, with our philosophy, uh, we were able to attract some really top immigrant, uh, talent, uh, like top founder. Uh, became part of our deal flow. Like the people sent us really interesting companies, even the ones, you know, the ones that maybe the immigration experience was some time ago and maybe they’ve already had a successful, uh, outcome and they’re like in hot demand and everybody wants to invest.

And often we get allocation in those rounds because we are the only fund who who is defined around this concept. And, you know, a strong immigrant founders just love, they remember how hard it was for them when they first. They love the idea that, that there’s a fund for immigrants, right? Like that they boldly state that like immigrants aren’t just as good.

They, they like better, they’re significantly better. They’re the single strongest group, right? Uh, for the purpose of determining your probability of building a unicorn, you know, really outside success, which is the only way to get good receiver returns is to invest in those unicorns, right? So, um, it’s, it’s been, you know, a really fun journey.

Um, Uh, you know, I’m sure some luck was involved as always, but, uh, I think, um, I think the mission has been really important. Like our founders are more likely to help each other because they all share this mission. We have a lot of limited partners. We, we didn’t go to institutions. We raised money from like, basically entrepreneurs who had exits, who had money because they sold their companies.

And we have 230 of ’em altogether. Um, . So that’s a pretty strong network of people who, many of whom, if not most of whom are pretty engaged. They wanna meet the founders, you know, they want to like us. They want to get excited about, you know, , high energy, younger people who are super smart, who are changing the world, who are very passionate, like doing something interesting.

Like it’s, it’s really fun to be around, uh, the kind of startup CEOs that could race sizeable rounds, right? Um, so it’s a fun job and it’s a fun community to be a part of. And so that’s, that’s what we do with one.

Naji Gehchan: and with high impact, and I really love how you framed that opportunity should be the same for everybody.

You know, like some would call it the genetic lottery, uh, actually where you get born and how, and, and what you’re trying to bring is really, really this equity or ac at least equitable access, uh, for people to be able to thrive wherever they were.

Semyon Dukach: Yeah, and you don’t do it, but like, just giving the VC check to every immigrant, obviously, like we, we look for extraordinary people who are building large in disruptive businesses.

Most of the companies we invest in, like their competitive rounds, and they could, they could get their money anyway from someone else. Uh, not all, but most of the time. Um, So

Naji Gehchan: I wanna, I wanna double click on this savian, because you, you talked about, uh, obviously, you know, immigrants, the grit. You talked a lot about resilience as an immigrant already, and this is kind of why, why you define those as your top, not top-notch entrepreneur.

Uh, I’m intrigued. What else do you look at and do you look for, in f in founding teams when you are ready to invest, uh, is there any key leadership trades capabilities within the founding team or the lead team of those companies that you really look for to

Semyon Dukach: make your final call? Well, of course, I mean, you know, there’s no shortage of immigrant at startups.

It’s just a, it’s just an initial filter for whether we’re gonna take the meeting, um, or even look at it. Like we don’t take, we only take one out and 50 meetings that come at us, even from immigrant founders. Right. And then we invest in one of 20 of those or whatever. Um, so one of the things we look for, it’s, it’s similar to what other investors look for, the seed.

We have seed investors. It’s usually the second round, like there’s a pre-seed round and then a seed round. Sometimes we do pre-seed. Um, at that stage, the, the CEOs, by far the most important factor, right? Like it needs to be a large market for sure has to be a large opportunity. Uh, hopefully in market that’s, it’s not too, too difficult to, to grow quickly in.

But then, uh, we really. The kind of, uh, leader who has a vision of the future, who has a thesis, has a belief, a strong belief about how to serve their customers, how the world will change, what their customers really need. They care about their customers, and they care about their team. and, uh, they’re able to articulate this belief, like explain it in a way that could make sense.

And, uh, when you challenge them, they listen pretty closely to your questions. They don’t agree with most of what you say, but they, uh, show you how they think. And how they take that stuff that you’re saying into account. Hopefully they, uh, usually they know much more about their business, their space than, than we do.

Just by definition, even the spaces we focus on, we still don’t know as much as a person, you know, spending all their time on one business. . Um, so we have these conversations we look at and then we look at the team, we look at who they’re able to recruit. Like we expect people to, to bring on like incredibly strong talent.

You know, the kind of people who could themselves be c e o and raise money from other VCs. Not the kind of people who just have like high paying jobs, but like really strong people. Um, and that those people wanna follow. This leader just for equity. Um, this usually minimal salaries in the beginning stages, you know, there’s some, but um, so this ability to inspire others right is, is really important.

And the ability to maintain a, a real vision while also like listening to skepticism and. And processing it and under, and like taking it into account, like not having a blind vision where you just don’t really want to hear anything where you think you know it all already. Like you have to be cognizant of what you know and what you don’t know.

So those, those kinds of characteristics. And then sometimes when it’s like a full sea round, sometimes there’s already some revenues, there’s always some customers. Even though there’s no products, no revenues, there has to be customers of course. So we talk to the customers when we are leading around and we, these days, we usually lead, we we wanna speak to the customers and try to understand, you know, how big this could be.

You know, how big a need is it? How many other people in the industry might need it in the way that they do. Uh, just get a sense for, is this gonna be a venture scale story cuz like, at the end of the day, right, like, uh, very few companies actually appropriate for, for significant venture capital. And while I found the small, the model is to, to back unicorns, which usually means that they’re gonna raise very large rounds from other people later.

So we do need it to, to be, you know, Defensible. Like ideally there should be some, some ip, some founder market fit, like the founder in addition to just being great has to be somehow a good fit for what they’re doing for the space that they’re in. Um, yeah, those are some of the, some of the factors look at.

Awesome.

Naji Gehchan: Thanks for that. Uh, I, I’m gonna take you back in time if, if we can talk for a couple of minutes about blackjack. Uh, I, I’m, I’m intrigued and interested. Uh, you know, it might have been like cut off your, one of the first entrepreneurship journey you had and you’ve built company yourself, uh, obviously as, uh, along the way.

Uh, is there like a common thread or key learnings from those experiences that you took with you? as you build companies and as a leader today within your

Semyon Dukach: vc. I mean, of course women Blackjack was my first company. It was also my first fund in a sense, cuz we, it was more like an investment fund, right? We had investors and then players who kind of managed that.

Uh, we had to keep track of stuff. We modeled probabilities, we generated results. Uh, we, we had. Pretty good, you know, returns, it was like around under 50% a year kind of returns in blackjack.

Naji Gehchan: Wow. Can, can you give maybe our audience who don’t know you much, like a little bit of a backstory of the blackjack we’re talking about?

Semyon Dukach: Yeah. I mean, it was the, that was part of this m I T team that figured out how to beat the casinos of the game and made a few million dollars around the world. I ended. Uh, leading one of the two teams who split off into a couple of groups. And I, I was sort of the defacto president of one of those groups.

Um, learned many, many things, uh, that applied to my later, later funds, uh, how to work with people, teams, how to keep people motivated, you know, how to think quantitatively for sure. Like, I think I have a pretty, pretty quantitative way of approaching most decision. For example, when we, usually, when our companies raise later stage rounds, we usually, you know, co-invest for our pro rat rates.

We’ll, you know, either out of fund reserves or we run PVS when it’s larger checks. But even though we usually invest, I always, every, every single time I actually consider selling rather than buying to me, it’s almost, you know, it’s almost like I should be doing rather than other, I rarely wanna maintain my position.

I either wanna buy the sell. So I’m trying to like, uh, be a little bit more, uh, objective and less emotional. , the initial decision is quite emotional cuz you have to decide if you trust the, the founder too. You have to decide, you know, uh, the gut. You often have to listen to a gut. Um, but, uh, over time, you know, uh, thinking Ally is very helpful I think.

And also I think blackjack taught me. You know, very few things are impossible. Like even if conventional wisdom says, you know, you can’t beat the casinos, obviously, like that’s a known fact. Well, we could, we could, if we, if we can prove why we can, if we can write a simulator and show that it could work well, it can actually work no matter what it is.

So when a founder tells me, um, uh, that’s something, you know, they can do something that everyone else says can’t be done, and I have some initial reference calls. , you know, this cannot work. It’s the physics, it’s not gonna work. It’s impossible. It’s bullshit. And then, you know, I’m like, are you sure? Why don’t you, why don’t you actually talk to the founder?

Like, just double check and then turns out that there is a way. Um, so just thinking that, that this first principles kind of thinking nothing is impossible unless you can prove it’s impossible, right? Actually the master will prove, um, and I’m sure many other things, um, Uh, we even had investors like it was a fund in the sense that there were investors who were just investing.

There were people who managed it. There were people who actually played. So it had all those attributes. And, um, yeah, I think, uh, what it didn’t have, like, it didn’t really create value. Like we, it was more of an arbitrage. Like, we beat money, we beat the casinos for money, and we spent the money and like it was our, like, we didn’t.

The casinos never thanked us for meeting them, right? We didn’t have customers for whom we created value, so we were more like, like traders or like some kind of hedge fund in or whatever in that sense than than tech investors. So it’s much more gratifying, of course to invest in companies where you can actually help ’em with advice.

So connections and whatnot, and you feel their gratitude and you feel a little bit. Of the responsibility for their success. Of course, 99% of it lies with the, with the team and not the investor. But still, um, you can make a meaningful impact sometimes, and that’s a very good feeling. Um, but yeah, it was my first, uh, my first company and my first fund.

And then, you know, I’ve done okay with my companies. I had like a pretty reasonable exit that got me started in invest. But, uh, I did way better as an investor than end of the day. And, uh, you know, basically when you all on all like 15 years of Angel, I was doing like, I dunno, 35, 30 8% per year returns in terms of actual exits, you know, like cash and cash returns, which for a long period of time, you know, was difficult to pull off.

And so far with Techstars, with the, with one way, I believe I’m maintaining that rough level, which, you know, it’s challenging. You can’t, you can’t take that for granted. Evaluations go up like crazy. Now you have wonder if it’s gonna work anymore. Well, now I’ve gone back down. So that concern is out of the way.

But, um, you know, it’s an, it’s more of an art in the science for sure. The venture capital. It’s a, it’s a craft and it does, I have to say, I got, I think I got pretty lucky a few times in the beginning because, um, it, it takes years and years to really know if you’re doing the right thing. Like, cuz the company can take, uh, more than a decade to actually.

Generate true value. Like there’s early indications, they might raise a bunch of money from someone else, but that could just be a fad. And you know, you only really know when you return capital to your investors or to yourself if you’re an angel. And that’s just with that delay, you sort of. You know, you gotta lose for 20 or 30 years to have a couple of cycles of feedback really.

So, I mean, I, I know some people are natural, some people are younger and they’re still able to have this amazing, uh, sense for it. Um, but generally it’s, uh, It’s a very long, it’s a long game. And building a venture capital brand, like one way, you know, it’s not, it’s not like a lifestyle kind of fund that’s like, me and my partners wanna run it, and then it’ll land when we get old.

That it’s really important to me that it succeeds, that it grows, that it becomes like a globally, like well known strong fund. Because I, I want, I want people to know that by investing in, I. we got, we were able to build a large fund, have above market returns because I think that could be an argument in, in discourse everywhere about, uh, how open should borders be about how welcoming countries should be, uh, to others, right?

Like, uh, I want our success in and of itself to, to, to make, uh, potentially apolitical point. Um, but yeah, meanwhile we are just focusing on, of course, generating the best possible returns for our investors and, you know, investing in, in the very, very, very best immigrants and not, not necessarily the ones who need our help, but also like, I guess I mentioned that a couple times now.

So I do wanna say that, uh, there’s a place in life for, for, for like helping people who need help. Specifically. Venture capital is not it, in my view. Um, I. Do have a, um, charitable foundation that, um, I’m a part of that, I’m on the board of that. My wife actually runs full-time and right now it’s focused on refugees, uh, outta Ukraine.

but in general, it’s gonna be refugees. I think in other parts of the world, people who fled from wars and, you know, people like that, they need help. You know, we don’t invest on them. You, you just give them money and, um, hopefully not for too long so they can get back on their feet. But, but there’s, there’s an aspect, there’s a place in the world for, for just philanthropy and, and helping people who need a hand.

And sometimes immigrants do need an extra hand, but one way ventures isn’t that it isn’t. Yeah. Well

Naji Gehchan: thanks for kind of separating and really differentiating both and, and what you’re doing with your, uh, VC and investment fund is really also, I, I love how you’re framing it towards this bigger purpose of, of really showing the word, this purpose that you have on, on immigration.

Um, and I love your leadership, how you’ve put things. Into contrast like quant, but also some, you know, gut taking decision, uh, some luck leadership vision, but also like going with the flow. You talked a lot about your, so it’s really great learning and I’ll, I’ll give you now one word and I would love actually your reaction to it.

And the first one

Semyon Dukach: is leadership.

Um, leader. Well, uh,

effective leader, someone who inspires people to be better than they otherwise would be. You know, the people want to follow a leader because following that person makes them be better people. Right? Um, people want us inspiration. Um,

I mean, a leader has to have strong views. They have to have vision, and they have to listen to the people. So for following them and stay in tune with ’em. And not lose them. What about equity?

Equity? Uh, like as in, in, in companies and, or you mean like equity, like fairness or equity? Like equity, like fair. , like kind of equity? Um, I think there should be equity of opportunity. I think people should, uh, be, shouldn’t be limited, uh, from doing whatever they can effectively achieve. They should be judged based on their.

They’re their results. Um, you know, there’s obviously other fault, prejudices of in the world, and generally I feel that, um, you know, we need to overcome them by, by letting people do what they want, not, uh, and not necessarily in other ways. Um, , you know, I’ve already spoken about, about borders. Uh, of course you have to come in peace, you know, having been very involved with the war in Ukraine.

The last thing I wanna suggest is that like Ukraine not have any borders. You know, with Russia, like clearly they need much stronger borders, but like much bigger walls, uh, you know, people are gonna come in and roll their tanks in and, and, you know, rape and murder people. But, um, but as long as people. Um, want to, uh, you know, interact peacefully, interact in a way, uh, that benefits everybody.

That’s, that’s based on freedom and, you know, voluntary contracts. Um, I really think everything should be, should be open. Um, And as far as equity, uh, the other equity, I don’t know. You didn’t ask about that one, but you know,

Naji Gehchan: as I was asking, I was sure your VC mind will, will go into equity, so I’d love to hear your thoughts

Semyon Dukach: also on it.

equity versus death. I mean, I think. . Um, the best part about when work, when it works well, the Capitalist Society allows for easy formation of new businesses and people who work with big companies and don’t really own them, they just get cash bonuses or whatever. At some point. There’s nothing like owning something, nothing like being ultimately responsible for success and getting the full benefit from its success.

it’s very motivating. I think generally people, uh, do best when they act as owners of whatever it is that they’re involved with. So I, I certainly believe that new companies should spread that ownership broadly, that like probably ev every serious employer of, of a company should have some equity, some stock options, some way to, to benefit from, from the real upside.

I think it’s very important. . The third

Naji Gehchan: one is Breaking

Semyon Dukach: Vegas.

Breaking Vegas. Well, I don’t know if we actually really broke it. You know, I think we just nibbled the edges a little bit. You know, I mean, we won a few million bucks, but like they make billions every year. Like it wasn’t that big a deal. Of course they hated us cuz they, it humiliates them to think that someone can actually beat.

But, um, did,

Naji Gehchan: did they do a good job relating it in the movie

Semyon Dukach: for you? No, the movie was, the Kevin Spacey movie was quite fictionalized, but there’s, uh, not other films in the history channel that are more accurate. But even the Kevin Spacey movie, well, the characters have all changed. You know, it captures the essence of what it felt like for.

It definitely captures, you know, the sense that we are doing impossible. We are a team, we are the good guys, they’re the bad guys. Like all of that was definitely part of it and I’m really glad I did it. It was an interesting experience. I. Kind of regret spending three or four years on it. I think it’s would’ve been a better three or four months experience in my life.

Just cuz you know, it was cool, it was neat, I learned something. But there’s more interesting things to do in the world, like built tremendous value for your customers, uh, than just, uh, you know, proof, proof that you was smarter than a bunch of casino people who are particularly smart, right? Like, yeah.

Naji Gehchan: And, and the team, like follow up question on this, I, the team has all ended up being successful entrepreneurs, right? Like there’s always this entrepreneurial spread within what

Semyon Dukach: you’ve been doing as a team. I, I wouldn’t say all of ’em, uh, but people are in different walks of life. You know, one woman is a tenure professor, one, a couple of people are still playing or whatever, like, but the, the number of like very, very successful entrepreneurs that came out of the team.

Is impressive. Like I’m not the most successful person that, you know, I’ve done really well, but like there’s people who’ve done better. Uh, there’s people like John Husick who started some very, very large successful companies like SolidWorks, like I don’t know Chen. There’s a few of these people who just built really big businesses.

Um, but I think, I don’t think any of ’em are really regret doing blackjack. I think they all felt like they learned a lot and had fun and, you know, it was teamwork. So. .

Naji Gehchan: Uh, and the last one is, uh, spread love in

Semyon Dukach: organizations.

No love makes the world go around. Uh, you know, uh, yeah. Organizations are to consist of like, you know, ties between people who deeply care about each other, who, who, um, you know, bond. Not indifferent if people shouldn’t be totally formal. I mean, yeah, you can keep your, your friends social circle separate from your work circle if you want.

But, but the work circle should also have, have, you know, real emotional, personal meaning to you should, you shouldn’t be indifferent to the people with when you spend much of your life, uh, and you got a love your customers, I mean, you’re not gonna really ever get anywhere if you don’t love your customers. They can feel.

Naji Gehchan: Any final word of wisdom for leaders around the world?

Semyon Dukach: The leaders don’t need any of my wisdom and the people who, who are hoping to get my wisdom to become leaders are unlikely to, to transform themselves into leaders. I think some of it just comes from then, um, I mean, there’s obvious advice. Like, you know, you don’t want the, the, in the, in the military, the, the leader is in the front, not in the back.

Right? Like the leader, the leader leads and, and inspires and does, doesn’t just stand behind and tell people what to do. But I think those, those little cliches at this point, um, so, you know, I think you have. Figure out what’s important to you and what you believe in and sort of run with it and, and sometimes the leadership just naturally happens.

Naji Gehchan: Thank you so much, Semyon, for being with me today and for this incredible chat.

Semyon Dukach: You’re welcome. It was nice being here. Thank you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Dave Noesges

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast joined today by Dave Noesges a retired pharmaceutical executive with Eli Lilly, where he spent 31 years in sales, marketing and general management roles in the US and abroad.  He spent much of his career leading sales organizations in both the Neuroscience and Diabetes therapeutic areas. His last role was to lead the Lilly Diabetes sales teams of nearly 2,000 people as Lilly reestablished market leadership in diabetes over a 10- year period, and launched several best in class medicines. Dave is a 1984 graduate of the United States Military Academy and served 5 years as a combat engineer in the US Army, most of that time in West Germany.  After the Army, he attended the Wharton School of Business where he graduated in 1991, joining Lilly immediately thereafter. Dave has been married for 35 years and has two grown children. He devotes his time now to caring for his 90 year-old father, spending as much time as possible with his wife and daughters and engages in many charitable endeavors through his church.  He and his wife also travel extensively working on a long bucket list of international destinations.

Dave – it is such a pleasure to have you with me today.

Dave Noesges: Thank you, Naji. It’s great to be here with you and kind of get reacquainted, uh, from our lily time together. .

Naji Gehchan: Yeah. I I wanted to start, uh, first by this, I’m biased here in this discussion as I had the privilege to be in your team, Dave, uh, in the US and really see the incredible impacts you have as a leader and the culture you’ve built.

Uh, so before going there and how you’ve, you’ve done, you’ve done the sculpture. Uh, I would really love to hear more about your personal story from serving in the US Army to business school and then pharma. Uh, what can you tell us a little bit more about this inspiring journey and how you ended up leading large teams in the pharma organization?

Dave Noesges: Sure. You know, it’s, um, probably like many of us, um, um, so much of who I am as a result of, uh, my family upbringing and my background. And I, I think it’s, um, um, both the, the, the strengths and the development area is probably a result of that. But I, I grew up really in, in a. Family of fairly humble means. My dad was, uh, the first in, um, and only person in his generation to be a college graduate.

And so it was a very blue collar environment. Almost everybody I knew was, um, in the family and friends and kind of the, my parents’ social circle were, um, um, steelworkers and working and working class people. And uh, um, and, uh, you know, my dad was a bit of an outlier. Every, everybody else, the college graduates I knew were all teachers as my dad was.

And so that was kind of, The environment I grew up in, and it was, um, uh, a very family oriented environment. It was kind of small town America in a, in a steel town in northwest Indiana. And, um, um, you know, people looked out for one another. It was a very strong community. Um, um, it was a very Christian-based community, and certainly that’s a big part of, um, uh, of what motivates me and guides me.

My faith is very important to me. It was to my parents. Um, but I, I, I think it. My parents taught me more than perhaps any other attribute, the importance of humility. And, uh, and, you know, we can talk some more about that as to how I, it’s influenced me and how I think about leadership. But, um, you know, I like to say, especially my mom was always proud of me, but never impressed because the only things that ever impressed my parents were if I was a good father and a good husband, and, uh, uh, and taking care of the things that were really important.

They were intrigued by, uh, My ambition and, uh, my, um, um, competitiveness from my career standpoint, but it wasn’t, uh, uh, wasn’t who they are and what was most important. Uh, and then, then I think, um, so that’s the background. So you said that doesn’t sound like somebody who’s, uh, with that background that’s gonna be ambitious and wanna grow and take on leadership roles.

That’s where I think West Point really began to, to shape me. And, um, um, I, you know, I saw. A big world out there with lots of opportunity and so much that I could do, and to be able to live overseas and to be on the east coast in college and to be probably the first person in my high school to have gone to West Point.

And so all, all of that kind of opened my eyes to all this opportunity that I wanted to be a part of. It just was exciting to me. And, uh, um, but I, west Point also was foundational to me in terms of, um, my leadership journey and, uh, I think that, You know, there’s probably a lot of baggage, especially in the business world about what comes with military leadership.

It’s seen as very, um, uh, very structured and top down and, uh, and there’s some truth to that. And then, you know, this, it goes back, um, almost 40 years when I went to West Point. So it was a, you know, it was a different generation and, uh, there was kind of a, a bit of chauvinistic kind of approach to leadership.

But, um, but when you. When you really, uh, immerse yourself in leadership as, and West Point was trying to transition at that time and what they were teaching, the, probably the fundamental, uh, principle that I took away was, uh, one of leading by example. Um, the best military leaders in spite of the command and control mindset in that, um, put their soldiers first.

Um, You know, it was kind of, um, drilled into us from our early days that the leaders eat last. And if you’re in the field or you’re in the most difficult circumstances, you feed everyone. You take care of everyone before you take care of yourself, which is probably not what people think of the military.

But, um, you know, when you’re preparing people to, to lead folks in combat, which I never had the. Fortunately, never had to do. It’s, uh, um, you know, the command and control starts to, you want the discipline, but people aren’t gonna follow a leader into dangerous space unless they really trust them. They think that you have their best interest at heart.

And so those were the most important things that I took away, um, from, uh, my experience, uh, at West Point. And I, I think over time, Came to learn some of the blind spots that military leaders had. We, um, um, it could be very structured. We kind of looked for a leadership model that looked like ourselves. And, you know, I, I think my time in business school started to open my eyes to, um, uh, to very different constructs of leadership that, uh, made me kind of rethink as there, you know, what probably was a kinda single-minded approach to leadership in the military that I needed to open my mind to, and that began to help me evolve.

But, um, uh, maybe one of the most important parts of my leadership journey though, was to meet my, uh, my, uh, now wife of, uh, of 35 years. We met in West Germany. She was a, an American expat working in the airline industry for twa. And then, and, uh, Just a completely different perspective on, uh, on, uh, she, she was my mentor in the business world.

She’s the one that suggested business goal to me. She was the one that helped me to figure out how to, how to adapt my military leadership in a business environment and to probably soften the rough edges a little bit. And that was a really important part too. But I, I think those are the, probably some of the milestones before I got to Lilly that really shaped who I am and how I think about leadership.

Uh,

Naji Gehchan: thank you so much Dave for sharing this and it’s, um, it’s already profound things that you shared that we will dig a little bit more into, uh, as we discussed. Uh, I would love to know why pharma. and how you started and you ended up staying for, for all your career in the

Dave Noesges: pharma world. Yeah, it’s a really, everybody asked me that Cause it’s not logical at, at, uh, first glance.

I mean, I was an engineer by training and a combat engineer. I was a civil engineer and you know, it, it. Um, um, and a lot of the career advisors when I was getting out of the military were suggesting that sales is, and marketing was not the right space for you to do something in operations. And, you know, that’s what a lot of my peers and colleagues did.

But, um, I, um, I didn’t know what I wanted to do. I knew that I wanted to, um, uh, you know, I had learned in my time in the military. I, I, I really, um, um, Leadership opportunities and having a team, uh, was really important to, to, um, to, uh, what motivated me and inspired me. But, uh, you know, how I was gonna accomplish that, uh, outside of the military, I mean, I knew nothing about the civilian world.

I, I didn’t, uh, understand how businesses worked. I hadn’t had a single business course at West Point. I had lots of other yeah, courses, but, uh, uh, you know, I didn’t understand the profit motive. I just didn’t know what the opportunities were. And that’s where Mimi, my wife, really guided me. Business school is a good place to ex where you could explore that, where you could figure out what you wanted to do.

And as I got to business school and started to see the opportunities, um, you know, I, being at Wharton, which is a finance institution and a lot of ties to Wall Street there, um, uh, there and, and Wall Street has, has. Had a strong pull for mil former military talent. I think they got part of it because it can make you cannon fodder.

You can, these are people that are used to uh, uh, sacrifice and hard work and long hours and doing whatever you’re told. Wall Street culture and uh, and I was intrigued by. Wall Street opportunities. But, um, I realized though, as I was exploring those opportunities that I just couldn’t get excited about.

And as important as Wall Street is, and I, I’m a capitalist, but I just couldn’t get excited about what, to me seemed, at its essence is buying and selling money. It just wasn’t, uh, the purpose I wanted. And I realized that what I was going to miss from my time in the military, uh, , uh, was the purpose driven culture.

We had a clear mission. It was important. We believed in it, we could all rally behind it, and I needed to to find that. And it was, um, probably, certainly somewhat cer serendipity that I found in the pharmaceutical industry. But I started to explore that because I thought that’s something I could get excited about.

Um, Breakthroughs that are gonna save lives and change lives. And, um, the serendipity was just that I happened, there happened to be a recruiter, uh, coming on campus for the summer internships at Lilly, who’s, uh, I learned later her dad was a retired, uh, colonel in the Army. And so my, uh, resume caught her attention in a way that it probably wouldn’t have most others.

And, uh, she encouraged me to think about Lily. I didn’t, you know, even though I’d grown up in northwest Indiana, I didn’t know much about Lily. And so I. Planning to come back home. My wife’s from Philadelphia. We figured our life would be on the East Coast. And, uh, but I came for a summer internship and I, I, it, uh, I knew this was, Lilly was where I wanted to be because I, I felt like every person I met believed in the mission.

They believed in what we were doing at Lilly. Uh, they were good people trying to make a difference in people’s lives. And that was really important to me. If I was gonna, um, you know, hopefully someday be a leader, was to have a mission that I could really get behind and. , and this is,

Naji Gehchan: uh, this is exactly what we do right?

In the healthcare and biopharma industry. Yes. And why I wake up every morning and you’ve touched so many lives by, by doing what you do with your teams. Uh, Dave, uh, so, and you have led team in different geographies, large organizations. Uh, as I shared la the latest team was more than 2000 people across the us.

Uh, what, what has been your recipe? for leading successfully, and I should say consistently high performing teams.

Dave Noesges: Well, I, you know, I, I, um, have reflected a lot on my leadership principles and what I think is really important, and I, I think that. I mentioned this from my West Point background. I think what is foundational to being able to be a successful leader is to have a, um, a, a belief in, but also to walk the talk around leading by example.

I, I think that, um, we spend way too much time as leaders talk, talking about what needs to happen and what our communication’s gonna be and, and not enough time about, um, How are we gonna lead from the front? How are we gonna show people, how are we gonna teach? How are we gonna, um, live the, um, um, the standards that we were ex expressing people to have?

So I, I think it’s really important to have a, a clear vision, uh, clear direction. I, I believe in, um, clear standards and accountability. But, um, um, but most important in that is that, um, the people who. who, who hopefully are gonna trust your leadership, know that, um, you’re not gonna ask them to do anything that you don’t do first, and you don’t step up from the front.

And it’s, you know, it’s probably cliche, but I, I really believe that, um, um, you know, leaders need to, to internalize and take the blame, but give the credit, uh, externally and to mean that when you do it. And, and that’s probably foundational. Uh, um, I also am not, I think that, um, one of my early. Earliest in lingering leadership learnings was, um, um, That I needed to be more humble and, uh, I think I’m generally a humble person, but the leadership construct, especially 20 or 25 years ago in the business world, was very much, um, confident leaders, strong.

That was the military ethos. And the, uh, extreme of that though is that you believe you have to have all the answers and you need to project that. And, um, you know, I found over time, and it sounds silly when in h. But, um, if I thought I had all the answers, I was the only person in the room that I thought I had all the answers, and I can stifle others kind of coming forward and stepping forward.

You have to admit ex mistakes. You have to be willing to, um, to admit to the people working for you that I don’t have the answer. And, and sometimes to say that I, I, I tru I believe you have the have, are more likely to have the answer, to have the innovation than I am because I know you and I know what you bring out and to pull that outta people.

But, um, you have to be humble to do. Uh, and, uh, exude that humility, I think. And, um, if you do, I people will rally behind you. Uh, uh, and I think that what many of us as leaders are afraid of is if we show humility and we kind of show our weakness and, and what we’re not good at, that people won’t trust us as leaders.

I don’t think that’s the case at all. Not have that has to be coupled, but confidence. But I, I think that’s the. Recipe for success, uh, for a leader is humility and confidence. Uh, I think more often than not run together. You show me a, a, um, an arrogant leader, and I’ll show you somebody who, um, uh, if you really get to know them, they have some deep-seated insecurities and the, the arrogance is trying to compensate for that.

And so I think humility. And then the last thing that. I think it’s really important if you’re gonna rally people behind you as you, you have to know them and you have to be able to help tie, um, their motivations and their beliefs to the broader organizational purpose. And that means you’ve gotta get really close to people.

You’ve gotta disclose to them, you’ve gotta open it up by. You know, back again to my early years of leadership, I got a, the worst advice I got from a lot of leaders in that generation where you can’t get too close to your people. You need to be able to hold ’em accountable and fire, and fire. And, um, and it created a leadership construct of distance between leader and people.

And, uh, I think that’s just exactly wrong. I, I do, there’s. You’re too close to your people. If you can’t make a tough decision and make a tough business decision, you can’t, um, um, that can include downsizing and, and hiring and firing and making those decisions, but, uh, as long as you, um, Can make the tough calls on behalf of the business.

I don’t think you can ever be, uh, um, I don’t think you can ever be, uh, too, too close, uh, to, uh, to your people and, uh, um, and, uh, um, you know, they’ll draw the line. There’s a place where everybody has, wants to be private and don’t want you involved, and I think you have to stop as a leader there and accept that.

And, uh, but up to that point, uh, we, uh, um, and we’re getting better in the business world and we’re comfortable with that. Uh, and I, I think it’s just so important. You, you

Naji Gehchan: really gave three key recipes, uh, living the standards that transfer people to have humility and confidence and get close to your people.

And as you were sharing, I’m, I’m intrigued to get more into how did this, how did you transform as a leader towards this? Because as you said, Military leadership potentially is different. Also, leading was kind of command and control top down, right? Like, it was not this type of organization we talk about today, like more, uh, you know, more inclusive, more degraded.

Mm-hmm. . So I, I’m intrigued as you grew, because there is some leaders still leading in command and control. They believe this, they believe leadership by fear. and you potentially came from this and totally transformed into servant leadership and leading with care and with love for people to deliver on the purpose.

So I’m, I’m really intrigued. Like, is there a story or an experience behind why you changed? How, how did, how did this happen? Yeah. It’s,

Dave Noesges: um, I’ve reflected a lot on this and I, I think there were three events that. That, and I won’t go into too much detail, but, uh, I’ll briefly describe that we’re really foundational and really kind of, um, caused me to, um, reflect more and to think more and to be open to growth in this area.

Um, and then a lot of it’s just incremental after that it’s experience. But the first one was, um, my first, um, Leadership role. I was a first line supervisor with 12 salespeople and an oncology Yep. District manager position. And I was going through that annual review process and um, I had a young woman who was about as different from me as, uh, somebody could possibly be who was on my team, but she was very confident.

She was, um, she’s what people would’ve described as a punk rocker in terms of her look. And she liked that kind of, From that time, and that was something that I could not relate to at all. But she was a great salesperson. Better than I could ever hope to be, I think. But we, I’d finished her performance review and she was really a good performer.

And at the end of that, I kinda asked what used to be the throwaway question, do you have any feedback for me? And especially in those days at Lilly, people tended to say, oh, I’m so lucky, so lucky to have you as a coach and , and it was kinda a formality and, and she said to me, there is one thing that I wanted to share with you.

And she said, I don’t, I know this isn’t your intent, but you are more comfortable with the men on the team than the women on the team. And it makes us feel excluded. And, um, and it’s mostly in a social setting. At dinner, you’re comfortable talking to the guys and that’s who, where your background is and, and, uh, um, I was devastated by the feedback, um, because it’s not who I wanted to be and half of my team were women.

And, uh, um, I went home and told my wife I got the feedback and she kinda laughed and said, well, yeah, no kidding. Duh, you up in the military yet. I mean, in the military it was a combat unit. At that time there were no women, so I had never led women, I hadn’t interacted with a lot of women in my professional life, and I had a huge blind spot.

Had she not shared with me, I never, I, you know, I, I look back on that sometimes and say, what, where would I be now? And I not gotten that feedback. I think that’s the single most important feedback anyone has ever given me, uh, in my professional life. And it, it, um, It’s not who I wanted to be, and it, it just opened my eyes to a blind spot.

And, and then I started to explore what, what my i, my other blind spots be and, um, and how can I grow from there? That was the first thing. The second thing was, it was the early days of Lilly trying to, uh, um, to be serious about diversity and inclusion, and we had started an African American foreign forum for our African American employees, and I, I was.

Invited by, uh, a colleague in Pier who was, uh, who was African American to come in. I was one of the first, uh, I think, and I was in middle management at the time, one of the first kind of white leaders to go to the forum because it started out as kind of a form of African Americans talking about how do we thrive at Lilly And um, It was a very uncomfortable experience because I was immersed for the first time in my life, probably in a culture that was different from mine, and I was the minority, at least in for a snapshot in time.

And, uh, um, I, I, I went, uh, every year after that for probably 25 years at Lilly to the African American Forum and just decided and realized then how much, if you wanna be an inclusive leader, you’ve gotta immerse yourself in. In other people’s world as much as you can to understand them and to be uncomfortable and ask uncomfortable questions that sometime are inadvertently offensive because you’re trying to understand and they will give you a lot of grace.

And it, um, uh, it gave me courage to say, I gotta try this again. And I’ve gotta get more comfortable and, and, uh, and learn and to, and to, to realize how much that must be getting in the way of me being able to connect with people and to be a leader. But, uh, the last thing was, After my first daughter was born, I had, um, Lily was reading this book called The One Minute Manager, which was, uh, the, I don’t know if you’ve ever read it, Naji, but it’s, it was an old throwaway book, but it was a guy who used these simple little anecdotes to talk about what coaching should be and how we’re getting it wrong in corporate America, but.

The one that got my attention because I had a young daughter, was he had this, uh, analogy that he shared about, uh, his, his assertion was that we are all at our very best, generally as coaches, uh, uh, in, in how we, uh, how we raise our children. And the best example of that, he said of what we should do, uh, whether you’re a parent or not, you think you can relate to this, is the experience of a child learning to take their first steps.

And it just had a profound impact on me and, and every instinct. Almost every parent, unless you’re just an awful parent or, uh, a cousin or an aunt or an uncle, or anyone else, when you see a kid, take that first step is to, uh, is to celebrate the victory, to be wildly enthusiastic. Um, and if, if you think about it in the context of, um, coaching in a corporate environment, those first steps are clumsy.

They’re, they usually end up in failure. They fall over and they land on their face and they wanna cry and they look up to see how mom and dad, uh, are reacting and. Almost in every case, a young child like that gets re positive reinforcement that says, oh, you’re the most special person in the world because you’re learning to walk.

And uh, and it has a profoundly positive impact, impact on a child’s, um, uh, confidence, uh, their wellbeing, uh, their self-confidence, and. You know, most kids who don’t have that environment, they’re going to learn to walk anyway because we’re pretty resilient, uh, as human beings. But I, it, it caused me to pause and think about a, a leadership construct that was pretty prevalent at that time and still lingers, I think.

And we spent an awful lot of time as leaders in corporate America. Criticizing people for their mistakes, fixing what’s broken, um, making sure they know that they got this wrong and they need to get better and they need to raise their standards. Um, and, you know, I, it’s, um, um, raising children. I mean, you know this n naji, you’ve got young children as well.

Um, you have very high expectations for your kids, probably higher than you have for just about anyone else because you love them. But it comes. Positive reinforcement and care and compassion and wanting them to do better. And, uh, it, it really caused me to realize how much that wasn’t what I was doing, and I needed to do more of that.

And I, I think I’ve gotten better and better at that, at realizing that this isn’t a Pollyanna, you need to be a cheerleader. You still hold people to a high standard. But, um, the vast majority of people who work with us, Are trying to be successful. They’re trying to deliver on the mission. They care a lot and, uh, uh, it makes no sense at all to spend so much time trying to fix what’s broken in them, but rather to take what they’re doing well and encourage them and, and help them believe that they can do more.

And so I, I think that that, uh, was really an important, uh, insight for me. That’s, uh, that’s guided me for the rest of my, uh, leadership.

Naji Gehchan: Those are incredible stories Dave. Thanks for sharing them. It’s, and it’s powerful and I can atest because I lift this leadership when I was, when I was in your team. And again, I think it shows really those stories shows your humidity, uh, and also your vulnerability.

Accepting them, living them, and, and transforming. So, thank you. My, my other questions was on something you really touched heavily on in those examples, which is diversity, equity, inclusion. Mm-hmm. , uh, I know you’re passionate about this. Uh, you’ve done a huge, uh, strives to, to make changes that matter. You know, not only leading by example, you led by example and you made sure.

Each of us is making, uh, you know, those moves for a more equitable, uh, teams internally and externally. Uh, and, and you, you’ve done it obviously across talent management across a very large organization. So I’m interested to know how did you make sure you create this caring culture throughout your leadership team and also across the all organization that I can say at some point became a community.

Really a community where we cared for one another and we had the sense of belonging. How, how did you do this and how did you make sure that it’s lived throughout the years you were there?

Dave Noesges: Yeah, it’s a good question. Naji and I, I think that, um, it’s, um, it starts with, um, real accountability. I think when I, when I, um, um, really got serious about having a more diverse and more equitable and inclusive organization, I, I think that the foundational step is to be very clear that, um, you’re going to build the diverse organization that we’re gonna break down barriers to that, um, If somebody claims they don’t have a blind spot or that, that, that we don’t have an unlevel playing field, that um, you know, I’m gonna show ’em the statistics that suggests otherwise and we’re not gonna accept that.

And it’s just, uh, there was a pretty kind of tough, clear accountability. And, um, when I really started with my team, uh, especially in the diabetes organization on this journey, it started. Um, with data that showed that we were falling short, that showed that, you know, minorities and others were, um, uh, were falling behind and were having the same level of success.

And even going back to, to look at resumes and say they had the same credentials, the same, uh, uh, they should be doing as well. And there’s the, if we’ve gotta look in the mirror and say we’re not doing well enough, but then to establish very. Milestones and accountability and to treat it, um, not like a kind of soft and squishy people issue, which is what we sometimes do in a corporation.

But, um, this is a business accountability and, uh, uh, and so that was the most important first step, I think. Uh, but I, I think you can only get to, uh, An equitable and inclusive organization if you, uh, uh, if you improve your representation, and it gets to the point where it really, where the, the leadership team looks like the, the, the population of people who are, uh, reporting to us and looks like the communities that, uh, in our case, in sales that we’re interacting with.

And so you’ve gotta get the representation right first. Um, but then you have to explicitly hold leaders accountable to, uh, And to measure it. And you know, I think we’ve had some good systems at Lilly that weren’t mine that I applied though that, um, uh, 360 feedback and concepts that are, you know, everybody tries to use, but you have to make it real.

It’s, uh, and you have to avoid, the temptation is very strong to, uh, forgive a leader who’s not very, Who delivers a couple of years of over, over, uh, uh, performance and kinda squeezes the results out of people, you know, they’re not gonna sustain that. But it’s, uh, it’s very easy for a company to reward that.

And then you lose credibility. And so you have to not accept that. And it means that you’re gonna, in some cases, uh, um, Not promote someone who’s got delivered great business results cuz they’re not developing people and they don’t have a, a track record. A track record of talent development. You’ve gotta couple it with that.

And so I, I think it um, um, and one of the things that I think is really important that, um, You know, for you and others who are in senior leadership positions now have to realize though, is that um, you need some longevity in a role to really change a culture. And in our construct, at least at Lilian, I think in many companies is a lot of rotations.

And, and, uh, you know, I spent the last 13 or 14 years and of my career in one role, which really allowed me to kind of shape a culture and build an organization. And I realized the degree to which. You know, for many years as a top talent, uh, by Lil’s standard, I was two or three years in one place, and you go to the next place that can create a temptation to, uh, take shortcuts and to have the overwhelming pressure to deliver a short term result and not be paying attention to the longer term of people development.

I, I think it’s a challenge that, um, um, you know, companies in healthcare and everywhere else have is how do you, how do you find that balance? Because I, I think it, it takes a, a sustained effort if you’re really gonna influence. Build a culture.

Naji Gehchan: Thanks a for that. And I, I love this concept that you brought and like always focusing on it.

Behavior is right, and recognizing behavior is even above results at some point. So if it’s good results, bad behaviors, you’ve always, and, and one of the behaviors and culture is obviously inclusion that you were focused on. I would give you now one word and I would love to get your first reaction to it.

What comes to mind. Okay. Okay. So the, the first one is leader.

Dave Noesges: I’d, I’d start with, um, humility. I, you know, I, I think that’s foundational to everything. Um, um, humility allows you to be a coach that people wanna follow. It allows you to make connections so people will trust you. It, it, um, allows you to, um, recognize mistakes so you can change course when you need to.

I, I think humility’s the, the most important, uh, and probably underappreciated attribute of, um, of leadership. , what about success? Success. I, that’s an, that’s an interesting one. It’s, um, you know, in the business world it tends to be, So we tend to bring it down to the essence of, um, of earnings and sales growth and, and quota achievement.

And those things, those are really important. I think you’ve got to have, um, and, um, and care about and have a central focus around, um, uh, around the specific business objective. Uh, I mean that’s, uh, what we’re about. But, um, but, um, if that’s, That’s the only definition. I think you’re gonna fall away short.

Nobody’s gonna wanna be a part of that team cuz you can deliver business results year in and year out and have a group of people who are dissatisfied and, and um, and uh, not rewarded in their careers. And so that, that’s why I think that success successes got to include. Helping people understand what really matters to them and what really motivates them, and being able to tie the business objectives and the success of the organization to what motivates individuals and motivates pe um, uh, teams.

And, um, you know, when I, I learned that about myself, that, um, The most important thing, what energizes me, what gets me up in the morning, what, uh, uh, makes me feel successful is to be a part of a successful team who have a shared purpose, who are attacking that purpose, who are working together, who have each other’s back, and, um, that feeling a team and being a part of that and wanting to accomplish the goals.

Um, that journey was way more important to me than actually the business result. But it was a means to an end and it got to the business result. And when I realized that, I knew that’s what was gonna drive me. And, uh, I think. Um, it’s gonna be a little different for other people, but I think most people wanna be a part.

Um, especially if you’re choosing a business, uh, career. You wanna be a part of a team that’s doing something that matters, uh, to you. And, and, uh, if you can, uh, if you can rally that together and define success that way, I think the business results will come. What about

Naji Gehchan: leaders eat last?

Dave Noesges: Yeah, it’s um, It’s the military’s, uh, way of describing servant leadership.

And, um, it, it, um, um, I, I think it’s so fundamental and so foundational. If, um, uh, if you wanna be a leader who people want to follow, um, you have to eat last. And it comes in every respect. They need to know that, um, you’re willing to make a sacrifice on their behalf, that you’re willing to go to bat for them if, uh, if they feel like they’ve been mistreated, um, that you’re gonna be an advocate for their career.

Delivered, um, that you’re gonna forgive them and help them overcome it if they’ve made a mistake, even if it’s a pretty significant mistake. And, um, that, um, if you’re giving someone really tough feedback. It’s, um, uh, it’s not because you’ve got a big ego and you wanna just be, you know, and prove who’s the boss, but it’s because you just wanna make them better, and they’ve gotta believe that.

So I, I think that, um, yeah, it, it’s, um, servant leadership means everything to people. I mean, I, you know, I’ve often, as I talk to young leaders and at Lilly and. and in other organizations now, um, now I always ask them, um, what do they want in a coach? And what, what may the think about the best coach, the best leader, the best mentor you ever had?

What were the attributes that they brought to, uh, to the table? And, uh, it’s, they may not say that Leader eight lasts, but they’re gonna describe all of those attributes that come from, um, putting others first and, and being a servant leader. And, uh, Uh, and caring about them and making them better. And often it’ll, it’ll include some really tough feedback and real challenge.

And they stretched me and sometimes I couldn’t stand them cause they just kept pushing me. But I always knew, uh, they were doing it because they wanted me to be better, not because they were trying to be better.

Naji Gehchan: The last one is spread love and organizations.

Dave Noesges: Yeah. It’s interesting. I, I, um, it, um, The idea of spreading love in an organization was uncomfortable for me.

Um, and, and probably, um, till very late in my career, if you’d said, how do you spread love? I would’ve been like, well, there’s, that’s not what we do here, Naji. This is work. And it’s, you know, it’s supposed to be tough and it’s, um, but you know, it, um, so much of what we’ve been talking about is about. Caring deeply for other people and people who are different from you and trying to help them be better and some self-sacrifice and, um, um, it, it’s, um, I, I think spread love in an organization is not about, uh, intimacy and the, the feelings that you have for a spouse or a family member, but it is about, Deep caring for other people and wanting to see them succeed and rallying behind them when they have, um, a difficult c circumstance, whether it’s in their, uh, in, in their business life or in their personal life, and caring enough about them to be there for them.

And, uh, you know, it, it, um, People will, um, will, will run toward a leader that, um, is there for them, uh, when they need them the most and when they didn’t expect it and run from a leader who’s not there for ’em, uh, under difficult circumstances. The challenge for organizations, uh, uh, and a healthcare company is how do you.

um, how do you as an organization demonstrate to people that, um, that you care for them and you, and you love them in, in that sense? And, uh, um, and, you know, organizations don’t love people, but, uh, I think the recipe there is you’ve gotta hire leaders at every level, and especially at the most senior level, who, um, lead by example in that way and really put their people first and.

um, and, and are willing to exemplify that in the most difficult circumstances. And, uh, um, there’s, uh, probably precious few companies that, that, uh, um, that most of their people feel like that’s what, what their leaders look like and how they operate. Well, thanks

Naji Gehchan: for that, Dave. What, what a great way to sum up and really.

Define what, what, what we mean by love. Also on this podcast, it’s really what, what you’ve shared throughout. So you are definitely spreading love in the organization as you’ve built those teams. Any final word of wisdom for healthcare leaders around the world?

Dave Noesges: You know, I, um, One is, uh, um, you know, as I see the political world now, an increasing challenge and there’s a lot of suspicion of, uh, of healthcare and, um, um, and, uh, y you know, a lot of, uh, I think, uh, public policy challenges that are, um, That have the potential to undermine innovation, it’s gonna take a lot of courage and a lot of, um, um, uh, just stay with it and tenacity to believe in the mission to, uh, to continue to innovate and what may not be the most innovation friendly, uh, environment from a.

Kind of geopolitical standpoint. And that just takes a lot of grit and a lot of tenacity and, and a lot of belief that we’re making a difference. Um, when you may have a lot of people telling you, and a lot of people telling your, your young people who have a, that, you know, this is a greedy or, um, um, Kind of, uh, institution and you can’t be trusted.

But, um, there’s so much good that’s coming outta biotech and healthcare. We’ve gotta believe in what we’re doing. We’ve gotta be humble about how we share that. We’ve gotta challenge ourselves and realize when, um, when our medicines truly are unaffordable and, uh, what we’re gonna do about that. But, um, it, it’s, uh, uh, if we’re gonna continue to have future generations that have longer life expectancies and we have, um, we, we’ve got to live our mission in, in healthcare, um, The other thing on a more personal note that I’ve, as I’m retired now and in a different phase of my life, that I’ve, um, um, wish I had.

Uh, been more thoughtful about when I was, uh, going through my career journey is to enjoy the journey. Um, the journey’s way more rewarding than the destination. I think so much of career steps were, when’s the next promotion, when’s the next success? Are we gonna make plan or not? And, um, I probably didn’t stop along the way and, uh, enjoy the moment enough and, uh, and enjoy that to what I.

Um, uh, was my why, which is with a great group of people pursuing a goal and the pursuit of the goal is much more exciting than achieving the goal and for me at least. And, and then the, the last thing is when you reach that retirement date and you look back on it, at least for me, I realize that, um, people to me, weren’t the most important thing.

They were the only thing that matters. When I look back at my Lilly career, the people that impacted me, the people that mentored me, people who I were, was able to mentor and grow and develop, and who I know appreciated that. Uh, it’s, uh, uh, all of my fond memories of, you know, 31 years at Lilly are about people.

Um, and that not about the business. And I think there’s a probably a lesson in that for all of us.

Naji Gehchan: Wow. Thank you so much again for those precious words of wisdom and, and incredible advice. Uh, again, it was an honor to be in your team and really honor to have you with me today. Thanks for joining me.

Dave Noesges: It’s my pleasure, Naji. Thank you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Dina Sherif

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I’m Naji your host for this podcast, joined today with Dina Sherif, senior lecturer at MIT Sloan, and executive Director of the MIT Legatum Center for Development and Entrepreneurship. Dina is also a founding partner of Cairo based, Ahead of the Curve, which is the Arab region’s leading firms on issues related to sustainable business growth and impact-driven entrepreneurship. Most recently, Dina joined Disrupt Tech, Egypt’s first FinTech focused venture capital fund as a partner, pursuing her passion and building a fund that will support technology being used as a critical tool in creating financial inclusion for a largely unbanked population, most specifically women. Formerly Dina was a senior advisor to Ashoka, helping them reimagine new ways to identify the world’s leading social innovators. She was also the founding director of the American University of Cairo Center of for Entrepreneurship. Gina has several publications, multiple recognitions and words, and is currently a member of the Special Presidential Advisory Council for Economic Development reporting to the President of Egypt, a global advisory board member, and the Eisenhower Fellowships, a member of the board of Kala, uh, holding a member of the Board of Smart Medical Services and a member of the Board of Educate. Beyond old. Dina is an incredible leader, an incredible human, and I am so honored to have her with me today.

Dina, it’s just a pleasure to see you again live from Cairo. I think today.

Dina Sherif: Yes, live from Cairo. Thank you Naji for reading out my full bio. It always makes me pause and feel very, very old. .

Naji Gehchan: No, and, and I didn’t, I didn’t treat all of it, actually.

It’s way longer, but I wanna hear all about it from you and so please, if we can have a little bit. You know, the, between the lines of your story, your personal jour, uh, journey, uh, would love to hear more about what brought you, where you are today and, um, the inspiring leader you became.

Dina Sherif: Hmm. Uh, I think what brought me to where I am today, um, is a general philosophy that I’ve had, uh, or that I applied to my life really, which is what I like to refer to as the law of two.

In other words, if I am, uh, doing work where I am adding value and extracting value, um, in a way that is feeding my soul and in a way that is really contributing to, um, the, the, the growth and development of a particular organization that I’m working with, then I keep my feet firmly there, but, I am no longer adding value in contributing to the growth and evolution of that organization.

And if I am, or if I am no longer receiving, um, value that is adding to my own personal growth and evolution, then I have a moral obligation to take my own two feet and walk elsewhere. And I think that has really served me well over the years, um, in terms of career decisions and. , uh, when I have moved from one place to the next in my professional career, um, you know, oddly enough, it’s also served me in my personal life.

I think, uh, I, I, I, I think that everything in life has an expiry date, and I think that that philosophy has really helped me, um, identify quicker when that expiry date has.

Naji Gehchan: I love this philosophy. Uh, um, it, it, you’re saying expirated, but it’s true, like knowing when you have to leave, you know, before actually you’re just. Have to leave, right? Like having this courage to go, having this also that of doing the things that you like. I, I love how you framed this philosophy. So tell, tell us more along the way and along the journey, uh, how, how did you move from, uh, I think you started studying, uh, political sciences.

You’ve done several other things and now you’re. I don’t know in how many different industries and how many different countries I’d, I’d love to learn a little bit like the common thread, uh, that took you into, um, all those different, um, yeah. All, all the different adventures and, and really focused on social entrepreneurship at the end on social impact.

Dina Sherif: Uh, yeah. I mean, I think when I, when I went to college, I went to the American University in Cairo, and I think, you know, one of the first. You know how in life you have all these defining moments, right? As you, as you go through your, the everyone goes through their individual journey. There are these moments that are just clearly defining moments that kind of dictate.

How the rest of your life will evolve. When I was studying at a U C I, I think one of those defining moments was, um, when a u C was still based smack in the center of Cairo and Tahari Square. Uh, I used to take either the metro I lived in, I lived in Hilo, so suburb in Cairo. I used to either take the metro or I would take, um, the, a public service bus because, you know, my father, even though I went to, you know, an elite private school, Believe that you have to use public transportation and find your own way around the city.

Um, uh, and so I, I, I used to, uh, interact with, with so many different kinds of people, um, as I was commuting from Hill, uh, to, to, and then one day. I don’t know what happened, but I ended up getting off a little earlier, um, on Ram in Ramsey Street, and I decided to like just walk the rest of the way to Tahari Square and I ended up in front of this church called St.

Andrews Church. And this is where I think, you know, fate tends to step in and I, I, I saw like there was a sign. Outside of the church that they were hosting refugees from different countries in Africa. And, and I walked in into the church and then I, I realized that the church was really, had really just been transformed into, um, More of a place for refugees from different countries, from all across Africa to come, uh, with their children, specifically mothers and children, um, where they could learn different, uh, skills that they needed so that when they were sent to, um, their final destination or final host country, they’d be.

Able to speak English or the children would be able to keep up with basic subjects like math and science and different things that would allow them to go to school. And it was kind of my first introduction to a politics and the reality that, you know, I think refu, all issues related to refugees are product of politics and poor policy.

Um, but also that the fate of these particular refugees, Uh, was really being determined by. Whatever anybody was willing to give to them out of the goodness of their heart, because the Egyptian government wasn’t really providing them with much. And so I walked away from that experience with a couple things.

One, um, you know, a desire to understand a lot more about Africa and why Africa is the way it is and what, what this whole economic development aid, um, industry looked like and, and why it was. There were so many refugees on the continent, how they ended up in Egypt, and why the Egyptian government was taking a particular stance and so forth and so on.

But I also walked away thinking that I as a citizen, had a moral obligation to also do something. If I could. And so I decided throughout the years of my university that I would volunteer my time there twice a week to work with the refugee children there. And I ended up over time bringing in a, a group of friends who also from from college, who also did the same.

And I think a lot of that, you know, really stemmed from the fact that, um, I always, my mom always taught me that if, if it’s in your ability to help and give back, then you have, you have to do that. But I think the entrepreneurial part of me was trying to figure out ways to, um, scale that help and mobilize other people and, and, and see how I could do that more efficiently and more effectively.

Right. . Um, so I think that was just the beginning, that that was the defining moment that led me to really, um, commit myself to, you know, what we wanna call, um, creating prosperity or sustainable development and so forth and so on. And so I graduated from college and I really, I said that’s, that’s the space I wanna work in.

And so I’d, over the course of the years, if you look at my resume, you’ll find that I have always, um, no matter. Which sector I’m in, whether it be public policy, civil society, private sector. The focus is how can I increase impact and prosperity for all. Um, I have firmly landed over the past 10 years in this 10 or over 10 years now, um, in this space of entrepreneurship and innovation because I have this deep belief that entrepreneurs have the ability to solve complex.

Challenges at scale in a way that, um, not-for-profits don’t. That’s not to say that we don’t need not-for-profits. And you, Naja and I have had this debate many times, , but I think we need not-for-profits, but I think. Innovation driven entrepreneurs, they have the ability to create business models at scale that can really, um, be financially sustainable and not dependent on, um, philanthropy and donor driven aid.

And I think also there’s something about entrepreneurship that really gives agency back to the citizen to create change and to solve their own problems. Um, and so that’s, Go ahead. Yeah. Yeah.

Naji Gehchan: And specifically this, because that, that was my my second question. And thank you for sharing, uh, this, this big, uh, experience that you had, uh, and powerful that led you to have so much impact across the world.

And, and now we work a lot with social impact and impact driven entrepreneurship. Like we, we are hearing a lot about it, but you are obviously super involved with, with those entrepreneurs. How do you define it? Like how do you define someone? Building a company that is an impact driven entrepreneurship organization.

Dina Sherif: I think, I think over the years, I’ve come to shy away now from the term social entrepreneurship or impact driven entrepreneurship. I think my position is if, uh, if somebody is coming to solve a. Complex challenge that impacts society. So whether it be education, um, transportation, healthcare, energy, you name it.

I mean, we, we don’t have a shortage of complex challenges in today’s world. You know, quite the contrary, we have a plethora. But if, if, if you have an individual and they. Coming in and they are coming up with a solution to this challenge that can be scaled and they’re, um, you creating a business model around that, that is scalable, then I think that is what impact is, right?

You’ll be solving a complex challen complex challenge at scale. You’re going to be creating jobs and generating wealth, so you’re creating multiple layers of value and I. For me when. When I talk about entrepreneurship, it’s always been important for me because of the different layers of impact that entrepreneurs have the power to create, right?

So if, if we take, you know, where we come, the Middle East, come from the Middle East, or if we take Africa larger, if we take Southeast Asia, if we take Latin America, you know, uh, Everyone talks about the need to create jobs, and we need entrepreneurship because we need to see economic growth and we need to create more jobs for the, for our local population.

For me, that’s just one aspect of it, that job creation, wealth creation piece of it. But the other part is that, you know, when you think about. Hal. For example, Mo Rahim, when he brought telecom uh, to Africa, he was the first person to start a telecom company in Sub-Saharan Africa. What he was doing is he was creating multiple new markets.

I think that is impact. that he was an impact driven entrepreneur because he knew the minute that he gave access to the, the majority of the population of Africa to a mobile phone, that this would unlock huge opportunity. Hmm. Uh, and it did. Right? Um, the same goes for example, um, you know, if you think about Uber or if you think about em, in the Middle East, and obviously these are companies that have done really, really well for themselves.

Em has done really well for themselves, but they’ve also created job opportunities for a lot of, uh, people who wouldn’t have had those job, job opportunities. But if you take that, that’s just a narrow scope of it. But if you think about the layers of value that they have created with that business model, , for example.

Um, in our, in our part of the world, you know, Uber solved a huge can. He solved a huge problem for women and mobility and getting from point A to point point B. Um, it, it, you know, it, I think, I think all of these different business models. Provided that they’re solving a real societal challenge, at the heart of it is going to be impact, and it will be.

And you will find many, many layers of impact that you can peel, peel back. I, I

Naji Gehchan: love, you know, this perspective and Yeah. Well you obviously work in this field. You’ve done research, you were part of a book, charity to social, uh, change. I’m, I’m feeling like there is a thin line right from. Being a company and saying we have a, an impact, right?

Like you gave example of great companies like Kareem Healthcare. Practically all of us in healthcare are trying to make life better for patients, right? And obviously having a social impact, but, but then you have like all. You know, other stories like, uh, shareholders value generating this. I’d love to get your views because I’m feeling like, and you can’t take rim as an example, as you said, like they made a lot of value for the, for the company and shareholders too, but yet they managed to impact socially.

So where do you, is there a line to be Joan or is it just Every company at the end of the day has a social responsibility? and they should

Dina Sherif: abide by it. No, I think it’s a really good question, and I think ultimately for me, the differentiating factor is always intentionality, right? What is the intention of the entrepreneur starting the venture?

Um, did that entrepreneur start that venture? with the sole purpose of solving a particular challenge in mind? Or was that entrepreneur starting a business because they wanna maximize profits and generate wealth? Because those are two very different things. And if we take, like, let’s take some examples.

When I think about, say for example, um, if you look at my country, Egypt, uh, healthcare is a massive problem. Access is a problem. Quality, uh, the quality of healthcare provided is a problem. You know, I would argue that healthcare overall, globally we’ve seen the, the, the. Extreme dysfunctionality of healthcare as a system.

Um, and I think the incredible misalignment of all the dis different stakeholders that exist in the health healthcare space around purpose hasn’t, has become extremely evident like during Covid and post covid. But if you say, for example, you know, in Egypt, public healthcare is. Extremely problematic. If you wanna get any, any kind of, I would say, semblance of quality healthcare, you have to go to a private healthcare provider, which is also very problematic because if you say, take one of our leading private hospitals, say Cle Cleopatra Holding, which, which is now like a group of private hospitals, well, the reality.

these hospitals are functioning to return maximum profits to their shareholders. Their purpose was never to deliver high quality healthcare to patients. If, if it was, they would be making decisions very differently. So the intention, right, was never about the patient or the end user or the quality of the healthcare provided.

And so, Decisions are made very differently. Now, if you think for example, um, about. Uh, an entrepreneur like amta who started smart medical, um, smart medical care, which is health insurance provided to at an affordable rate, to middle, middle income, to lower middle income citizens in Egypt. The intention behind starting that business was always how can we provide.

Health insurance at an affordable rate to those who don’t have access. Because if you look at small and medium enterprises in this country, it’s very hard for them to pay for, for the very acce, very expensive health insurance plans. And so this entrepreneur was trying to solve that problem and wanted to create better access and provide your average Egyptian citizen with the kind of infrastructure needed to.

And navigate the healthcare system. Now, the intentions behind that business were really to serve the end user and to make life better for the average Egyptian citizen. And so his decision making process is very different. Now, when people come and tell him, when his board comes and tells him, you know, you need to be, uh, generating more profit.

You need to be working on your exit. You need to be talking to, you know, this big health insurance company and find a way to get acquired. You know, his responses are always, um, no, no, no. Because that will take away from the overall intention of why I created this business. See what I’m saying?

I totally

Naji Gehchan: see it and I love it. And that was my second question that you partly answered. It’s because I love how you framed it into intentionality is the key, right? But then there is this piece where there’s funding and obviously you’re in impact investing too, where exactly what you said, the board at some point, or the company when the company scales, right?

Because there is the founder, but then when it scales, you know better than me. There is more than the founder, obviously, and sometimes even the founder, and ends up leaving the company at some point. So how, how do you combine this? Do you have any strong stories about The intentionality was here for the founders and it keeps on being here as, because I’m hearing like, this should be your true north.

If your true north is this, you, you should making long-term bets rather than saying, okay, I’m gonna make more profits on the immediate term. Yeah. And really stick to. .

Dina Sherif: I think this means this. This requires alignment around purpose, right? So if the entrepreneur is truly driven by particular intentions around a, a purpose or the desire to solve a very complex challenge that touches the lives of many people, that same entrepreneur has to go through the effort of aligning.

Shareholders around that purpose of aligning their board members around that purpose. Um, because if people are not constantly aligned and grounded in that purpose, then you’re going to, you’re gonna find yourself having to deal with kind of different. , I would say conflicting tensions of where our business should go.

And that’s where you start seeing people say, oh, where are the short-term gains? You know, the, the, the ability to wait to be a little bit patient for what is to come requires that all the different stakeholders involved be grounded in one purpose. You defined in one purpose when that alignment isn’t there, that’s where you start seeing.

I would say adrift. . Um, and I think truly, uh, I would say mission driven entrepreneurs or impact on driven entrepreneurs or social entrepreneurs. You choose whatever term you want, but those who are really deeply, um, grounded in that purpose, they will go to great lengths to align people around that purpose and the urgency of solving the problem.

Um, and I think anything that solves a real problem will inevitably make. for shareholders. There is no, no such thing as conditionality. I think if there is conditionality and you have to sacrifice purpose for, for, uh, social benefit, then maybe the problem wasn’t as relevant as we thought. But if you’re really solving a problem that is relevant to people, they will pay for that solution and you will generate wealth and solve the problem at the same time.

And there’s no need to s. . Yeah.

Naji Gehchan: Yeah. And, and certainly aligning this purpose with the people you’re hiring with, how you’re doing your bouncing team, your management team, and for the legacy to continue. Uh, I, I will move now to a section where I’ll give you word, uh, I’d love to reaction to it. Sounds good.

All right. . The first one is leadership.

Dina Sherif: I think leadership is an activity. I do not believe in leaders. So I do not identify as a leader. I think there are times where I step up and I exercise leadership, uh, and that’s when there, there’s no real known answer or known solution and it requires that somebody step up. But I do not believe that we are.

you know, just cause I hold the title of an executive director or a partner in a fund or a c e o, that that automatically makes me a leader and makes me somebody with authority, um, who has a title. But what identifies somebody as a leader is, is that moment where they have to step up and mobilize people to move into the unknown and really evolve and charter progress.

Yeah,

Naji Gehchan: it’s, uh, it’s my belief Two leaders are known for their actions and not their titles. Right. Titles, uh, is, is more authority or whatever, you know, it can gives you, but definitely not being a leader. The second one is inclusive society.

Dina Sherif: Wow. Naja, you really go for the triggering words. Um, I think for me, inclusion. Inclusion is a very, uh, has been a very important word for me as a woman. Um, a woman from the Arab world who really had to kind of fight and push forward to have a space here. But I think, um, and to have a career in the Arab region, but I.

inclusion has come to mean so much more living in America as being perceived as a woman of color. Um, and I think that has brought all kinds of, um, I think has just been a, brought a lot up for me when it comes to this idea of what it means to truly be inclusive and to create spaces where, Different viewpoints, different work styles, um, different, uh, different cultures.

Um, it’s so much more than color of skin, right? Color of skin for me is a very narrow, easy way to define inclusion or along the lines of ethnic ethnicity or religion. But it’s really so much more. It’s, I think it’s the, the willingness and the ability for. Uh, different opinions and styles to be allowed to be allowed to have a space to be accepted with love and kindness and compassion.

That’s not to say that we all have to agree, and it’s not to say that, you know, um, we can’t disagree. We absolutely have to disagree, right? That’s what diversity leads to. But I think there’s something very healthy when, when there’s a space that allows for the tension that can exist within differences to evolve into something more beautiful.

This, this is

Naji Gehchan: so powerful, uh, how you, you said something, you know, diversity leads to disagreement. I, I, I agree. And this is what you look for. obviously, and creating this space where disagreement is okay for us to grow and learn and innovate is, is really crucial. The third one is social

Dina Sherif: innovators.

Yeah. So like I said, I, I, I shy away now from using the word social because. , I think it has a lot of baggage. When we say social, you know, investors immediately switch off and they say, oh, okay. If you’re a show social innovator, then you’re not going to be rigorous about having a, um, financially viable business model.

And so, you know, your, your world is only to go to the philanthropists and, uh, I think, I think it’s led to a lot of kind of misunderstandings. Um, but for me, I think the world really genuinely needs innovators who are driven by the, the desire to create a more sustainable, inclusive, um, and prosperous world.

And I. Inevitably that is social because what is social? Social is everything that impacts us as humans and business. Every business will have some impact on us as a human, and if we don’t really. Own that and embrace that and stop shying away from it as being, you know, too soft or too fluffy. But the reality is, it’s not.

We all exist in this world as humans. Uh, we are built for human connection. Everything we consume and use and products that are offered are meant, uh, designed for the human. And so that is social. Um, and we need to have more innovators who are willing to step up and own the fact that innovation should, um, and can, uh, lead society to a better place.

And that better place has to be sustainable, and it has to be inclusive, and it has to have very much embedded at the very core, um, compassion and love and kindness. Right. ,

Naji Gehchan: you said it many times and it’s also a word we shy away from. So that’s my last one. Spread love in organizations, .

Dina Sherif: Yeah, I mean, you know, this has never become more important to me.

I, I think you and I had have had conversations about this since, since I met you. Um, but it’s become even more important to me because I think. In a post covid world than in a world where all of a sudden there are all these conversations around diversity and equity and inclusion and, uh, we see world, a world where there’s a lot of polarization and a lot of ugliness and a lot of, uh, othering and.

Um, words that have a lot of hate and unkindness in them. I, I think organizations, all organizations need a lot more love. And in that love needs a lot more patience and understanding and compassion and empathy and real, true kindness, right? Uh, kindness in the sense that. Really give people the benefit of the doubt and assume the best in people.

And that’s not to say that people are necessarily coming with the best of intentions, but I feel like when you create a space where, or a work culture where that assumption is there, you’re, you’re lifting up the bar and you’re asking people to show up as the best versions of themselves. Um, and I don’t think we.

Enough an organization. So I think we absolutely need to see, uh, I think now more than ever, just more love and kindness in, in how we show up for each other in a workplace. What

Naji Gehchan: an, an amazing way to sum it up. Uh, any final word of wisdom, you know, for leaders

Dina Sherif: around the. . Yeah. I don’t, I don’t know if I have words of wisdom, but I think what’s been top of my mind lately is that, um, we spent so much time, or we’ve spent so much time talking about employees and work-life balance and the wellbeing of employees throughout C O V D and the pandemic and, um, how, how can we create better workplaces for employees?

And I think. , we don’t spend enough time talking about what it’s like to be a person in a position of authority through very difficult times. And I think when times are uncertain, where times are difficult and decisions have to be made, and there’s a lot of pressure and you know, for a lot of people who have been in positions authority throughout the pandemic and now going into a global recession, life has been really hard.

And they’ve been, you know, I would say it’s been, it’s probably lonely. I don’t en envy anybody in a position of authority these days because they’re the first ones to be scapegoated. They’re the first ones to be blamed. They’re the first ones to not be at the receiving end of kindness and compassion and benefit of the doubt.

And I get that. That is the reality of what it means to be in a position of authority, but we just don’t spend enough time talking about. , the difficulties of that and the scars that people incur when they are forced to step up, forced stop forced, but when the circumstances dictate that they need to step up and lead.

And a lot of that puts, that’s a, puts you in a very vulnerable position because it really opens you up for a lot of, um, scapegoating and blame and undermining and alienation because nobody likes change. and when somebody is stepping up to create change, it’s going to be tough, and I hope that we can also talk about what it means to show up with love and kindness for people who are actually stepping up and having enough courage to lead people to a new or a different possibility.

Naji Gehchan: This is definitely another topic. I will, I will have someone, I’ll actually, because it touches so many different aspects for leaders and moments of crisis change. Uh, and, and exactly what you said, like it touches mental health for those leaders. Several times we just. Don’t even consider it. We don’t talk about it.

So I have someone where we will talk about this, who’s a specialist in mental health at some point also, and, and leadership, and we will talk about it. I, I love this opening. We can go on Dina as every single time. Uh, but again, thank you for being with me today. We probably will do another, another episode specific on leaders and, uh, and how they do, do, how much do they receive love.

Also as, as leaders, we can definitely do it. Uh, I would love that. Awesome. Thanks again for being with me, uh, today and looking forward to seeing you in person again in Cambridge.

Dina Sherif: Thank you for having me.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Cathy Nolan

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode joined today by Cathy Nolan, an experienced international business executive. Cathy has spent over 23 years in the pharma and biotech industry, including Eli Lilly, and more recently Aimmune Therapeutics. As a leader, Cathy consistently created value by building and developing diverse talents globally and delivering highly successful launches and growth strategies in Big Pharma, niche and non-conventional biotech. She has extensive experience across US, UK and Europe including multiple launches in Neuroscience, Oncology and Immunology. Cathy is from a large Irish family, and grew up on a farm in the west of Ireland. She likes to spend time with her family and friends, stay fit and active, read, and watch movies. 

Cathy – it is such a pleasure to have you with me today live from Twickenham, I believe? South West London.

Cathy Nolan: Thank you, Naji. Nice to see you, .

Naji Gehchan: Great. So first, Cathy, I would love to hear your story, your personal story from Ireland to leading global healthcare teams. What’s in between the lines of such an inspiring journey?

Cathy Nolan: Well, thanks, Naji. Um, yeah, I mean, I, I have a very humble story, I would say in some respects. I, I started off as a, you read out in the intro, I grew up in the west of Ireland on a farm, the oldest of five kids, um, four girls and a boy. Um, and then when I went to university, I studied business, um, and really had a.

You know, gained a passion for marketing, I think from the very beginning when I started to study marketing as part of my business degree. Um, and then I think what really drove me in terms of joining the pharmaceutical industry, um, in Dublin with Lilly was really that kind of passion for understanding people and patients and their experiences with conditions I joined.

Lily on the Schizophrenia Zyprexa brand team. And what fascinated me about Zyprexa and, and schizophrenia and bipolar disorder was the experience that patients go through. And I, I was really drawn to that, to understanding that in more detail and then understanding how medicines can, can make a difference and change the lives of, of people who are suffering with schizophrenia, bipolar disorder, and other mental health conditions.

So that started my journey and I joined. Eli Lilly in Dublin and spent five years there, um, really getting to know the pharmaceutical industry, I would say, and, and really loving and thriving in, in that industry. And then I took a career break for six months and went traveling by myself and. You know, took advantage of getting a career break from Lilly to really explore the world a little and then came back to Eli Lilly in the uk and then, um, was involved in various other brands, um, in psychiatry, um, and then moving on beyond that to Indianapolis, um, with my husband who I met at Lilly.

And so we headed off to Indianapolis and then had an amazing experience in the corporate center. I think from a career perspective. A real, uh, milestone moment going to the corporate headquarters and being part of, you know, the, the nerve engine, I would say, for the organization and really getting a sense of how great an organization Eli Lilly is and the, the different opportunities that there were to grow and stretch and develop both professionally and personally within the organization.

So I got many opportunities in, um, Lilly in Indianapolis, um, leading brands, global brand director roles, and then working with the chief marketing officer, Rob Brown at the time as his chief of staff, which really again, was an eye-opening, um, experience looking at the organization as a whole and working with some of the more senior leaders within the organization and addressing board questions, et cetera, and working with Rob on that.

Then, um, we had two boys, uh, Lakin and. They were both born in Indianapolis and we decided to move back to Europe to be near a family as we were raising our boys and wanted to be closer. So we moved back and then I was doing some leadership roles in Europe, um, in oncology, and then ultimately back to the UK business heading up.

Um, the business unit for the specialty portfolio and the chief marketing officer role, which where we worked together closely when you were in France. Um, I then, I loved Lilly and I had an amazing experience there and. You know, thrived, I would say, and grew up with the company. But after 19 years, I just wanted to try something new and different and challenge myself in other ways, and decided to move to another opportunity within a small organization.

So going from the big, big pharma to small pharma and joining a biotech called Immune Therapeutics. I had an opportunity to lead global marketing commercial capabilities from London. Um, the, the business was based in Brisbane, California, so it was a real unique opportunity to do that. So I took the opportunity and then we were acquired by Nestle a year later.

So we had another amazing experience of going through the acquisition and the integration and. Building the global organization and uh, and really learning so much across multiple areas and building my expertise and capabilities. So, yeah, and I’ve felt very fortunate Naji over the years. I’ve had lots of really strong mentors and advocates, to be honest, um, who really pushed me to kind of think bigger than, or go further than I thought.

I. Um, and with their backing, give me the confidence to just go for it and usually it, it ended up in success. So, so yeah, that’s kind of my journey thus far.

Naji Gehchan: tha thanks for sharing this. It, it certainly did go into success and yeah, we, we’ve worked, so I’m, I’m biased. We’ve worked together and, you know, I’m a big fan of yours, so, uh, be before jumping into the learnings, as you said, from, you know, different, different geographies.

You had different teams, you worked in different companies. I’d ask a more personal question, uh, about really juggling careers. You touched it a little bit, uh, having both of you and your husband both have careers, growing careers. You had kids living abroad, going to your country. Like, how have you thought through all this?

I know many of us go through it or are going through it, so how, how did you manage this? Um, uh, going. Any advice

Cathy Nolan: of us? Yeah, I mean I, and I think like many of us, you know, through all. Inspiring career opportunities we have. The biggest job we have is, as you know, the biggest role we play as, as a mom or a dad or as a partner and managing through life.

But yeah, it, it definitely comes with challenge, but I think, first of all, I’m fortunate to have a spouse that’s been very supportive all the way through, um, our relationship together, um, before kids and, and after kids. So he works in the pharmaceutical. As well. So to some degree we understand each other’s jobs as best we can.

And so we know where the give and take might need to be for each other at various times in our career. Um, with the kids, you know, it is about flexibility for me. I have the two boys are eight and 10, and flexibility is key to me now to be able. Do a good job in the way I know I can do a good job, but have the flexibility to be there for the kids as and when they might need it.

But we also have the support network around us. Um, you know, we do have some childcare support when we need it because otherwise it just doesn’t work. Somebody did once say to um, my husband, um, John Banford, I guess, you know, and, uh, a lot of people lil would know him, but he and his wife were, you know, big careers at Lilly and he gave John and I advice out when we started to have kids in Indianapolis.

And he said, you know, at some point you both will think you can’t do it. That one of you has to take a step back or one of you has to stop working because it’ll become too much. And at that moment you must put the resource around you that helps you continue on because you can. But you’ve gotta give yourself a break and understand you can’t do everything.

And you might need to have somebody look after the kids in on an evening or pick them up from school and you might need to get cleaners and you might need to do some of that support network, have that around you, but do it. You can both still achieve your ambition and your potential. You just have to not try and do it all.

So we’ve really embraced that advice. I would say and, and do kind of make sure that we’re giving ourselves the support to help us achieve that. But it’s an ongoing balance every day, every day. So, yeah, I haven’t got it fixed. .

Naji Gehchan: Yeah. Yeah. And, and it’s continuous, but, and it’s a great advice, uh, obviously, um, you’ve led diversity as you said, across the globe, uh, in different cultures, different geographies, and you brought innovative medications, uh, to patients.

Uh, do you have a secret recipe for doing that successfully?

Cathy Nolan: for doing launch or for managing diverse teams and geographies? Yeah. Leading,

Naji Gehchan: leading, uh, high performing teams. Um,

Cathy Nolan: I would probably, so one of my. Career highlights, I think was when we launched, uh, Laval in Europe. Now, Laval ultimately was a, a treatment for a soft tissue sarcoma that was approved on, um, conditionally on phase two.

And unfortunately, the phase three data didn’t pan out. But at the time, in phase two, we thought we really have an innovative treatment here for patients with sarcoma who’ve had no innovation for 40. And we built such a cool, dynamic, energized team across the different countries in Europe, Germany, France, uk, Italy, and Spain.

Um, and I was part of the lead team for Europe, pulling our team together. I think the secret recipe is to all understand what you’re trying to achieve together. So clarity of vision. Where are we? , what do we want to achieve? And does everyone understand that first and foremost? Secondly, giving everyone a voice on the team and a role on the team.

So we had different personalities on the team and some people brought different things and giving everybody a role in that team to bring their best self and fu fundamentally move the team forward. So that was a key part of our dynamic where. Knew each other enough to know who brought what to the table.

And thirdly, I think we had such fun , we laughed. We, we got together, we had some downtime together. We were, we were launching in very, very quick timeline. We had like nine months to get ready to launch, and often they say you need three years. And we didn’t have that. So we knew we were gonna have to work fast.

And it was gonna be manic and it was gonna be a lot of pressure, but actually we got a lot of energy from that. And we made sure we’re only gonna do what’s most important here. We’re not gonna do all the other stuff. We’re gonna focus on the fundamentals. We’re gonna do that well, and we’re gonna have each other’s back and support each other through that journey.

And so I think some of those things, just being human and having a bit of fun along the way made a big, big difference. So some of. Most, uh, fun times. I think we’re in that team, even though we were under a lot of pressure to get a lot done in a short space of time. But that’s some of, I think what I would

Naji Gehchan: aim.

And how so, so let me double click on this, uh, cuz I love it. You said curtail vision, giving everyone a voice and having fun as we go through it. Uh, how, how did you manage if there was some tensions to make sure. Because you’re touching, I think, to the trust also within the team. Like you were all, yeah.

You said everyone has the others back. How did you build this, uh, as you were going through it to make sure that it’s a team that trust one another to, to be able to deliver on, you know, the men’s task that you guys had? Well,

Cathy Nolan: I think we, we built trust because we helped each other. . You know, we, we weren’t, you know, Germany weren’t on their own getting ready to launch.

We were all getting ready to launch in Germany cuz they were the first market to go. And you know, we all, Stephan was the brand leader at the time. You know, the rest of the team, whether you’re in France or uk, so you’re Spain or the European team. We were all in it for Stephan and his team to get this right.

So I think demonstrating. We were there to support and be part. It was as much our success. The German launch as it was gonna be anybody else’s was really important. Any tension. You know, there are obviously going to, there’s obviously going to be tension when there is a lot to do in a short space of time, but I think it was about, you know, having those conversations if there was tension and not waiting and letting things fester.

You know, having side conversations but then, you know, being transparent and open and tackling them head on and not pretending everything is fine when it isn’t. Um, and then being able to move on and just being respectful for people. I think tension comes if people are suspicious of agendas or you know, people are in an environment where they’re not honestly being authentic and genuine, but we were all just being who we were.

Good, bad, and ugly. Bringing it to the table. We were, we liked people for their good things as well as their, you know, eccentricities. And, and that was just what, what you need to do to build that trust. This is who I am. I’m not trying to hide anything and we wanna just get the job done and do it well for patients.

So that was, that was the kind of real big piece that we needed to focus.

Naji Gehchan: I love it. This is super powerful. Uh, and you touched something like, my next question would be more about you and your leadership style. We talk, we talked a lot about it, both of us. Um, and you talk, you talked here about authentic leadership, uh, being who you are.

So how do you define your leadership signature?

Cathy Nolan: Yeah, a la large part of my leadership signature is, is, you know, I, uh, I may be a leader, but I’m still like everyone else. I would say . I don’t, I don’t lean into I hierarchy. I, I wanna support my team regardless of where they sit in the organization. Everyone deserves to be heard, um, and everyone’s as important as everyone else from the top to the bottom and back up again.

So, you know, fairness, equality. , um, listening. Being, um, empathetic to people’s situation, but I’m also, I also like to achieve. I like to achieve, well, I have high standards. I, I want us to be successful as a team because I think that’s where, you know, a team gels most when you’re, in good times and being successful and achieving good things together.

Um, but a big part of my leadership style is, is authenticity, I think. And also being direct and forthright. I mean, you know, again, no agenda. This is what I think , um, and this is why, and let’s, sometimes I’m right and sometimes I’m wrong and let’s have a chat about it. And I love to debate and discuss and be open in, in, in how we, we manage through, um, problems and, and, and build things.

Naji Gehchan: Did this evolve over time? Did your leadership evolve over time or, and was it the same, for example, leading global team in a large organization and then leading, you know, in a biotechs motor team?

Cathy Nolan: I would say that I was always started out as being pretty up. I mean, that’s just who I am, I think is more upfront, direct.

and authentic. I, I’m, you know, I, I am who I am is my kind of thing. I think as I became a leader midway through the last 23 years, at some point I started to doubt that. I started to say, well, as a leader, do I now have to put on a face? Do I now have to pretend that I’m something like, because this is the way a leader should behave.

And then I think through the last number of years, I’ve come out the other side to say, I am who I am. I’m here because of who I am and what I can bring. I sometimes get it right and sometimes get it wrong. . And, but that’s okay. And I, I now, I think, have come to a realization that authenticity is actually key.

So I would say I’ve, I’ve evolved, but come back to the point that I just wanna be who I am and be true to myself and to others, and do good work with good people. And, and that’s, that’s kind of, you know, as I see myself moving into the next phase of my career, what’s important to me. .

Naji Gehchan: Well, thanks for sharing this.

And I, I would add also vulnerability. You’re sharing vulnerably those things. And ma many of us, I think doubt, ask questions, you know, about ourselves as we go through it. Uh, and it’s, um, it, it’s super powerful as you’re sharing it with vulnerability and also authenticity. So thanks for that. Uh, Kathy, what is your, if you have one advice you would give yourself, , uh, as you were starting your career in healthcare and pharma, what would be that advice?

Cathy Nolan: Um, I mean, I would still give myself advice over, even 10 years ago, not even at the start, you know, the, the learnings trust yourself. Trust yourself. Have confidence and trust your instinct. That’s what I would say to to myself back then. You know, I, I believe I have good instinct, but I sometimes lack confidence in that, and that’s where mentors have been hugely helpful to me along the way in my career, and I can’t overemphasize that enough.

They’ve helped me. See beyond the limitations I may have placed on myself, because I may have lacked that confidence or didn’t trust my own gut instinct. So I would go back and say, just trust yourself. You know, stay true to who you are. Lean in, don’t be afraid. I mean, I’m not, and now I would say I’m not fearful and I will take on any challenge and what’s the worst that can happen, but I’ll give it my best.

Sometimes fear along the way can stop us, stop us doing things that we know we can do. We just don’t maybe have the confidence to kind of embrace that. And so I would say to my younger self, you know, be confident. Don’t be afraid. You know, go for it and you’ll learn something along the way, whether it works out or not.

So that’s what I would probably say to myself.

Naji Gehchan: I’d love now to move to a section where I will give you a word and get your reaction. Okay, . The first one is Leadership Powerful. What about diversity? Essential, I, I know you’re passionate about it, so you can say more than one word. For this one, I’d love to dig a little bit deeper.

Cathy Nolan: Ping pong. Yeah. Diversity. . Yeah. I mean, you know, group think and all same people have the same idea. It doesn’t get you to a better place. And I, I think diversity is what makes for amazing conversations and fascinating ideas. I think it’s. challenging sometimes to create diverse teams because you have to embrace difference.

And not everyone can embrace difference for various reasons. Either they don’t know how to, or they’re not in a place in their life career to be able to do so. So, you know, it takes openness of mind to be able to embrace diversity, but it is essential because it, it brings different perspectives to the table, um, and ultimately gets us to a better place.

Naji Gehchan: The third word is Chief

Cathy Nolan: LinkedIn,

Chief, uh, well, I’ve just joined as the founding member in the uk, an organization called Chief, which I’m super excited about actually. So it’s just a network of female leaders who, from all industries, um, who get together and support each other. Various professional and, uh, personal, I think challenges. I, it’s, I’m starting out on this journey, so I have my first core session next week with a group of female leaders, none of which are in the farming industry.

So I’m, I’m excited cuz sometimes. For me, I was in the one company for 19 years and then I’ve been in another company for the last three years. So, you know, I honestly feel like my, you know, my lens is kind of narrow and I wanna broaden that, and I’m really excited to do so with, with a group of powerful female leaders and learn.

Naji Gehchan: and there is still so much to be done, obviously for, for women in leadership. I, I’d love like your view about it, anything you’ve seen that has moved further better and things that you would really focus on, uh, now within this organization, or even in life as, as a, as really a role model for several women, uh, what would you do or what would you focus on?

Cathy Nolan: I think one of my, um, how do I say acknowledgements? Observations in the last number of years as I moved to a pretty senior position in the latter number of years when we were at Lilly, there was a a journey customer journey work done for female leaders within the organization. I dunno if you remember that, but when it got to VP or SVP level female leaders, that was the toughest phase of most female leaders careers.

Now you might expect that because they’re big roles, but you also would expect that that should be exhilarating and exciting to be at those senior leader, leader levels. But actually it was really, really challenging and I felt that myself. Um, I think you doubt yourself for some reason when you get to that level cuz you know, who am I to be at the senior level?

You don’t bring as much confidence again as you might see other male leaders have at that level for whatever reason. Plus, it’s demanding on time and some of the responsibilities at home With the best balance between partners and spouses, possible females still do tend to take slightly more of the burden of managing life at home, as well as then trying to manage a career.

So I’ve observed that dynamic that I saw and observed in this journey work years ago, and now I. I would say it in the last number of years. It’s tough. My advice, I mean, my reflection now is it’s okay that you can get overwhelmed in big roles, and that’s normal. And actually the biggest thing you can do for yourself in that moment is take a step back, just metaphorically.

Not necessarily leave, but take a step back. and gain perspective because you don’t have to be perfect . You don’t have to have it all sorted. There is a wealth of people around you to support you. , you can talk it out with somebody in the company, in the industry, in your team, in your mentor network or outside, such as a chief network, et cetera.

There are places to go to bounce things around, but also many other people are experiencing the same thing. And I sometimes it’s lonely in a really senior leader role, and you feel you can’t talk to anybody because you can’t show that vulnerability anymore, because now you’re really important and you have to have it together.

But, uh, I think, no, you don’t, everyone’s human no matter how senior you are. And you, you need to be able to say that and, and find the right support so that you can do your best work. Cuz you wouldn’t be in the role if you couldn’t do it. So that’s the other thing. You can do it. You just sometimes need to know that you’re not gonna be perfect all the time.

It’s okay to say that. I hope that makes sense.

Naji Gehchan: It does. And, and those are very powerful advices for sure. Uh, the last one is spread love in organizations.

Cathy Nolan: Uh, my, my reaction to that isn’t done enough. . Um, you know, I, when I was preparing for this discussion to some degree, I didn’t prepare too much. But when I prepare for the discussion, it is interesting the love in organizations, because some people would say love in work, , but it is important. It’s about kindness.

Empathy and making work a good place to be for people, cuz that’s when people do their best work. So I think it’s important to spread love in an appropriate way, , um, and, and make people feel safe and appreciated and rewarded and, you know, be transparent with people as well. And, you know, be open with what’s going well and what’s not going well.

And that’s spreading love too by being honest with people. You know, we’ve talked of late, sometimes just upfront, honest conversations about where people are at and where they’re going in an organization is key to giving people the transparency they want to need and, and I think more of it should happen.

Naji Gehchan: This is true love when you’re transparent and you tell people where they stand. And those are incredibly powerful words. Uh, Cathy, any final word of wisdom for leaders around the words?

Cathy Nolan: Um, you know, I, again, it comes back to, you know, trust your instinct. Know you’re good enough, you are good.

you just sometimes may need support, and it’s okay to look for that support. And I think finally, you know, you won’t always enjoy what you do or have fun every day. If you’re having fun in your role, relish it and build off that because that’s where the magic happens. I think when teams are having fun and enjoying being with each other and doing good work.

If you’re not having fun on a regular basis or have stopped having fun, be brave and make a change. . Um, I think that has been my learning, I think over the last number of years as well. Life’s too short. We’re all good at what we do and find our right spot. And I think if you’re not in the right spot, then bring that leadership talent and ability and, and go apply it somewhere else in the organization or outside or whatever.

But that would be, don’t let the chance go by or, and stay still where you don’t need.

Naji Gehchan: Thank you so much for, uh, this amazing informal chat and conversation. So many words of wisdom. Thanks for being with me, Cathy, today. Thank you so much.

Cathy Nolan: No problem, Naji. Thank you for the opportunity. I’ve enjoyed the chat.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Shahin Gharakhanian

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, having the pleasure to be joined by Dr. Shahin Gharakhanian, a physician and Pharmaceutical Executive with expertise in Pharmaceutical Medicine, Leadership/Management, and operational experience both in the US & in Europe. Shahin is specialized in HIV Medicine and Infectious Diseases has practiced clinical medicine for over 20 years in AP-HP Hospitals in Paris France. Shahin joined the pharmaceutical industry in 1991, progressing to Vice-President of Vertex Pharmaceuticals, with roles in 3 main areas: Clinical Development, Medical Affairs, Strategic Leadership including membership in the corporate Operating Council. Overall, within industry, he has held positions ranging from General Manager of a Contract Research Organization to Program Executive leading product development, regulatory approval/launch in multiple therapeutic areas across the world. Shahin has also founded, built, organized full functional departments/units for biotechnology companies and hospitals as well as two LLCs as an entrepreneur. He is a member of several international societies. His passion is Patient-focused programs for drug & vaccine development, approval, and launch.

Shahin – It is such an honor you with me today!

Shahin Gharakhanian: Thank you for having me in the program.

Naji Gehchan: I would love first to hear your personal story from being a clinician and friends to the pharma industry, and now back with several hearts, including being a clinician in infectious diseases during the Pandemic, entrepreneur, consultant, and many different, several roles that you, uh, you play today.

What’s in between the lines of your inspiring career?

Shahin Gharakhanian: Naji, I can, I can, um, say that probably the guiding. Uh, the red line, as you know, there’s a, uh, uh, uh, expression in French, or the guiding light, if you like. That expression has been, I consider myself as somebody who is in the helping professions, you know, whether, uh, in, as a medical doctor, this was really my initial and more.

The, the core, uh, value. And, uh, some of my colleagues, which I totally respect, they choose the medical profession, for example, because it’s scientifically very appealing. They, they are eminent researchers and they go, uh, through, uh, many phases of their lives discovering it’s, I love seeing, I loved and still love seeing patients.

Uh, I. Love the contact, the human contact, the fact of making a difference in one person’s life, I think it’s a huge, uh, it’s a huge accomplishment. I know there are wonderful, wonderful people who learn, uh, who run philanthropic organizations and through their money and through their efforts, they help hundreds and thousands.

Uh, I silting that when you make a difference in. Person’s life and that person remembers you, believe it or not. I haven’t. I’ve stopped practicing for a decade and some of my patients still write, um, and ask and tell me, you know, how they are doing and how I am doing . So this has been the guiding line at one point, um, in.

Career. I met a gentleman called, uh, professor Mark Tini. Maybe the name doesn’t resign to you. He is, uh, uh, he wa he is, he’s, uh, alive and, and doing well. Uh, elder, a more senior gentleman, a member of the French Academy of Medicine. He is a specialist in tropical medicine. And, uh, you know, there are two schools in tropical medicine, the British and the French, because.

Historical past, uh, they, they have the, they still have the, that knowledge. And he was the person who really, uh, told me, you know, are you interested in epidemiology? Are you interested? Computers were coming. Are you interested in, um, applic, uh, the applications of the computer Science to medicine? And he, uh, had a phrase it telling me, you know, there are people who work with their steth.

and there are people, the by people, he meant physicians. They’re physicians who work with their stethoscope and they’re physicians who work with their, uh, pen and their computer and their, their knowledge. Uh, so he suddenly opened, um, uh, an area of thinking that, you know, uh, sure you can, you can, we are trained, uh, to be, uh, at the bedside or, or to do.

but that’s not the only way. And that actually took me, uh, to pharma. Uh, and, uh, because you, uh, asked me what was the journey, uh, the comp, the, you mentioned in my biography, I was formed essentially in France. French medicine is excellent and, uh, but I have. Long years of, uh, continuing education at Harvard.

Uh, where, where, where the teachers are just extraordinary from my viewpoint. Uh, but, um, from a pharmaceutical base, you know, science and medicine, uh, I am very much, uh, uh, my, I lay learned a trait at Vertex Pharmaceuticals and. Uh, uh, it’s also how serendipity and chance can influence your life. Um, I got a phone call and somebody was looking for, um, uh, an MD for Vertex.

Uh, and I, uh, at that time, point in time, the company was totally unknown. In fact, the person told me, uh, they, they, you don’t know them, you know the name will, will not speak to you. I. Tell me who they are, and he said, vertex. Uh, it’s a company in US called Vertex. And I said, is it the vertex of the book? So there’s a book about Vertex called In Search of the 2 billion Molecule, uh, by, um, by a journalist of, uh, New York Times, I believe, and was, uh, in fact the best seller.

And I was in France, probably one of the three persons in the country, , uh, who had read the book. And I told her, you know, don’t move. I’m, I’m coming over . Uh, and I wa I discovered, uh, Dr. Joshua Boger, uh, um, the co-founder, an incredibly talented group of, um, Professionals and, uh, took me, uh, and, and I learned a lot, uh, and launched two drugs there, um, uh, with, with that wonderful team.

So, um, I would say, um, some of the dec some was some of the journey and who I am was decision making. You know, you you, you apply to medical school, right? You, you make the decision of. Uh, applying for something and, uh, going through, but a lot of it, uh, whether it was, um, H I V, uh, meeting the, the people who discovered H I V and later on got the Nobel Prize of, uh, medicine or meeting Vertex were all chances.

Um, and it’s, uh, it makes you think that, you know, um, how much are, are you really in control of your destiny? You know, you might be, you might not be. Who knows? you.

Naji Gehchan: Yeah, there’s a, that’s a big debate, right? Like, is exactly, is it truly chance, is it a chance that you practically created through your intention, uh, and where you wanna go?

So I, I, I love your humility and stating its chance and serendipity and other things. And I also loved how you said helping professions. Uh, I, I really think, you know, it’s kind of an underlining that you’re talking about. This is what you wanted. So I’m. Did you always wanted to become a physician? Was it something since your childhood?

Shahin Gharakhanian: Yes, I think I was, uh, it came to me, uh, perhaps, um, uh, we had in our family, uh, a family physician, uh, who was a wonderful man, and, um, uh, you know, the, the. The type you see in movies, um, uh, you know, coming, uh, to your house. At that time, physicians used to make house calls. , you’re too young maybe to remember, but, you know, he, these people became friends of the family, in fact.

And, um, um, I was very much inspired by his, um, uh, by his, uh, conduct the way he was. And in fact, I, I went to see, Um, to get advice on my choice. Um, and I, I perhaps, uh, there were, unlike many families, I, we did not have any physician in the family. Uh, so there was nobody, my parents were not, uh, in the medical profession, so there was nobody close I could get inspiration from.

Uh, I don’t, uh, I don’t remember seeing a lot of movies or TV series. I think it was probably this, this one person. That, um, that sort of inspired me. You, you talked

Naji Gehchan: about, uh, h I V and you’ve been part of, um, this, this first public health crisis, uh, through h I v, um, and you were, I think, clinician, but then you also were in pharma during that time.

So I’m interested, I would love to hear your thoughts about really your learning from that time as a leader in both sides as a

Shahin Gharakhanian: clinician and in the firm. Absolutely. In, uh, in the, uh, you, as you remember, in the mid eighties, um, uh, the Center for Disease Control reported several cases of a strange disease, uh, in, uh, young men, uh, in San Francisco, in, uh, Paris, France.

A young physician, uh, Dr. Willie Rosenbaum, uh, was. Uh, talk about chance, right? Was called, uh, from the emergency room saying that there was a young, uh, steward from a major EL airline, uh, flying between New York and Paris, who was very ill. Um, and they, uh, performed the, uh, bronchoscopic lavage on him, and there was, they had discovered pneumocystic screening pneumonia, which is extraordinarily rare.

In normal times. You can see it only in people who go under, who undergo, uh, transplantation. Uh, uh, Dr. Rosenbaum was one of the few peoples in Paris reading the journal of the C D c called M M W R, mortality Morbidity Weekly Reports. And suddenly the light bulb came on. He rushed to the emergency room and he told him, this is the disease that the CDC has just described.

And from there started the, the incredible adventure. Where he took the, um, uh, lymph node from this patient, uh, to the pastor in Paris. And, uh, professor Mont, uh, Paris and their teams discovered, uh, hiv. I met Willie in, um, summer of 85. Uh, he looked at me, uh, and he told me I was looking for a fellowship and said, you know, if you’re looking for a ordinary.

Fellowship. Um, you don’t come here if you are looking for something extraordinary in the true sense of the work. You can start tomorrow morning. He looked at me in the, Ima imagine this is August of 1985, where very few people were talking about this disease. He looked at me in the eyes and said, this is the biggest public health crisis of modern times.

So with that, um, I started working, uh, with H I V and to answer your question, uh, Naji directly, 2, 2, 2 things. One will interest you because I understand it’s the thematic of your podcast. You talk about love. Um, it is, uh, the love of patients and the love you get from patients, uh, was an extraordinary lesson of humility to me as a young.

Who was not prepared, A young physician who was not prepared to see a lot of people in his age range die, which h i v was, um, at the beginning a hundred percent mortality rate. But it also a, um, lesson in leadership in people who, um, pushed away, um, the discriminations. The stigmatizing, uh, for who said, you know, you can be from Haiti, Haiti from you can be, uh, gay, uh, et cetera.

It doesn’t make a difference. We are supposed to treat people and, uh, pushed away all of those taboos to show leadership and take charge of people. And I think, uh, those were things which.

Sort of were totally inspirational. Uh, and I learned, uh, how, and then of course there were, uh, leaders among patient advocacy groups. There were leaders among doctors in hospitals, among the nursing, um, staff. Very important. I think the women play the major. And in society. And that was, um, a fantastic, uh, uh, lesson, uh, for me that later on inspired me.

Um, inspired

Naji Gehchan: me a lot. Those are really super powerful, uh, learning in in leadership. Thanks for her.

Shahin Gharakhanian: Shane shapes you? Yeah, a lot. Uh, well,

Naji Gehchan: the, it’s, and it’s not over, right? H i v We’re way better now.

Shahin Gharakhanian: No, we are way better. Thanks. Thank you to the pharmaceutical industry who produced over 30 or probably the, the count is higher.

32 maybe drugs. Uh, and the formidable collabo. Between academia, industry, uh, public health authorities. I would’ve liked to see this more. During the Covid area, people started, uh, setting up barriers again, and this was a big deal, um, in those times. And of course, later on in Africa, uh, philanthropic organizations like the Gates Foundation, different funds, everything came together to, to beat, uh, this, uh, this incredible, um, pandemic.

Naji Gehchan: So, so that, that was my follow up question. Um, actually, did you feel we learned from this h i V era going through Covid and, and I’m interested also, you, you bring a very important point, which is, uh, really the stigma, uh, diversity include like, it touches really very social, social issues. Unfortunately, we saw resurface again in.

even though it was not a particular gender, race or nationality, whatever exactly you want. Right. So I, I’m intrigued. Like did you, were you frustrated?

Shahin Gharakhanian: How was that? Yes. And, uh, the, the no part is that, um, we didn’t see that sort of international collaboration. Every country started saying idu. Even the Europeans were, were supposed to have, um, uh, sort of a more uniform approach.

Of course, you remember, uh, you, if you’re coming from this country, you’re coming from that country. You need to test and you need not to test. And everybody started. I, I won’t go into ugly incidents like. People fighting over masks, uh, in international airports and things like that, uh, to, uh, in, uh, when, when there was a mask shortage, everybody was fighting over that.

Uh, what did carry over was, uh, I believe, um, I can cite, uh, uh, I, I remembered, uh, data I saw from Dr. Tony fci. Who said that roughly 50% of people engaged in Covid care and research are from the HIV background. So they brought, uh, and we brought, uh, all of that, um, more scientific knowledge, uh, on resistance on, um, uh, mutations on.

variance, uh, et cetera, the public health also knowledge. So yes and no. Yes, yes. In the terms that if the world mobilized because, uh, the experts were from that background, no. Uh, we would’ve liked to see more, uh, more empathy, more, uh, more solidarity between the countries, rather than people saying, you know, I’m, I’m shutting a down and don’t come and see me, and, you know, If you’re coming from, uh, from this country or that country, then you’re not really welcome.

Uh, which, uh, which, uh, which is not exactly, was not at all helpful, you know, uh, in, in fighting the epidemic.

Naji Gehchan: So do you feel, I, I have to ask you this question, I feel with, with, we’re, we’re seeing that pandemic, most probably experts like yourself are saying they will come at a faster pace potentially in the future.

Uh, what, what are your thoughts about our readiness as a human beings as humanity towards this? And

Shahin Gharakhanian: if you had asked me the same question a year or 14 months ago, or 18 months ago, I try to look at this scientifically and not with emotion. I would’ve been probably, uh, I would’ve sort of politely brushed away.

But, um, uh, I have seen during this past 18 months numerous publications and I can provide that to your, uh, auditors and, uh, to people who listen to your programs in major journals such as science, et cetera. Uh, uh, very well. Thought through experiments, um, explaining how, uh, virus, uh, viral diseases, uh, will and infectious diseases in general will spread, uh, because, um, of the, of the ecological DYS Caribbean that we currently have.

Let me give your auditors a. Relatively simple scenario that, uh, I witnessed, um, through the rep, uh, through the reporting of a, um, of a journalist. Uh, there has been massive, uh, um, forest cleaning. Uh, and, uh, cutting down of trees in the Congo. Congo is republic. Uh, areas which have been cleaned out were the sanctuary of a certain type of, uh, monkey.

Uh, the monkeys, uh, were therefore had no dwelling anymore, started going into villages. Uh, and, uh, because they were, uh, one can, I think one can put oneself in their situation. Uh, their homes were destroyed. They go into villages. You shouldn’t expect them to be very friendly. And, uh, by biting, uh, especially children, they have transmitted viral diseases to these.

So it’s, it’s a scary se scenario, but it’s, uh, this is from last year was, uh, reported by, um, uh, news reporters, not scientists, news reporters. Um, so, uh, it is just one of the examples of how, uh, we are, um, Ma man is facilitating. Yeah. And again, there is a mounting amount of evidence, uh, in this direction.

Hence, you see that certain organizations or startups are being created to be able to respond by producing antivirals more quickly and things

Naji Gehchan: like that. Yeah. Yeah. Unfortunately, as you’re saying it, it’s another, it shows us, again this system and system functioning and the system dynamics between, between things, right?

Like it’s, it’s an interconnected web, even though we exactly always wanted to think about it, like as we human being, and unfortunately some would think even some of us are better than others as human beings are like on the top of the, the. The other species, but unfortunately we are an interconnected web and it’s a great reminder.

Totally. It’s such a great

Shahin Gharakhanian: example. Totally. And travel, air travel, uh, interconnects us and we saw how efficiently during the Covid area air travel was a vehicle of transmission. In fact the c d C, uh, uh, in, in Atlanta, one of the, one of the data pieces that they look when there is an international outbreak, they look at connections, air connections between cities.

Cause you can almost predict , uh, what will happen, uh uh, and where it’ll happen. Yeah.

Naji Gehchan: Yeah. That was a great, that was a great article, uh, on Covid actually with the first, how, how flights out spread everyth Exactly. Everything. Exactly. You, you talked Jane, about, um, startups and, and I, I know you’ve been heavily involved in, um, the different biotech ventures at different stages and development.

Uh, I’m intrigued now more, uh, from this, What, what would be your advices for biotech companies starting up? You’ve been involved in companies starting, building, growing, scaling, uh, and you’ve been helping and consulting also some of the smaller biotechs and larger ones. Uh, I’d love to ha to hear your thoughts if you have one or two advice for those.

Uh, you know, the first

Shahin Gharakhanian: thing I would say is, you know, if you’re mo motivational, your, your motivation is uniquely to make money. Uh, very sophisticated financial, uh, people have explained to me that, you know, going into biotech business is probably not the best route. You can very quickly make money in.

other areas of economic activity in a shorter period of time, rather than go into a business where 10 years later you might or you might not , you know, uh, you might or you might not, uh, uh, make a lot of money. So, uh, great leaders, which I have observed, like Joshua Booger or hen tier me, or people who have been, um, at the helm, uh, of large companies, even, uh, the founder of.

Uh, had a famous saying, saying, doing, doing well, uh, by doing good. Uh, the, they have been consistently motivated by something which is above and beyond then. Um, I would say, you know, in, when, when you are leading, um, a biotech company, there are three facets you have to take into consideration. One is being a leader.

Where you need to inspire, you need to mobilize. You make people work long hours. You have to be able to get them the inspiration they need. You have to be a good administrator and you have to be a great manager. These are three dis distinct. Qualities. And then the question is, what is the right mix? You can take, uh, you know, 30%, 30%, 30%, but some companies may need.

um, 70% of management and just a little of the others. Some need a little at, at various times. Also, the needs change. The sometimes at one point you do need to be a great administrator because you have maybe things going on in that field, which are very important. At the end of the day, uh, you do need, um, it’s, it’s such a tough area where you need, um, a, a, a lot of inspirational leader.

by somebody who can just pull you because it’s, um, it’s, it’s, look at all these brave CEOs trying to raise money right now, uh, in the middle of an economic crisis in, in Europe at war. I mean, I, um, I really have a lot of admiration. You, you see them, they tell you they’ve done like 40 pitches in one month or, uh, 38.

They go to bio, they meet, I dunno hun, 120 meetings in five days, , you know, it’s, um, you have to have a lot of, um, stamina, uh, to be able to, to get there. I would love now to

Naji Gehchan: give you a. Sure. And get your reaction to it. I know you love this game. , .

Shahin Gharakhanian: If I have a blank, everybody will, excuse me. .

Naji Gehchan: So the first word is leadership

Shahin Gharakhanian: on anticipation.

Naji Gehchan: What about innovation?

Shahin Gharakhanian: Daring

Naji Gehchan: I. Okay. Can you say a little bit more about it? I love this, this

Shahin Gharakhanian: definition. You, you have, um, you have to have the guts to come out of your, um, uh, comfort zone and, uh, to be beaten, uh, on the head by stick because what you’re saying or what you’re trying to achieve, nobody else has done. Um, uh, I think, um, I think, uh, without getting into any cliche or but from public and personal, Personal, um, information.

I, I think, uh, the team at Moderna, uh, was, was able to innovate, um, because believe me, you know, um, every, the doors did not open at the first day . So, um, um, so you have to dare, uh, you have to dare.

Naji Gehchan: Uh, the third one is Boston Biotech Summit Collaboration. I, I’d love for you to pitch briefly to our audience cause it’s one of those great summits when you’re bridging Paris and Boston.

Shahin Gharakhanian: Um, Naji, I think we, a number of thanks to many, many people around the world. A number of medical problems have been resolved. Uh, with new drugs, new innovation, uh, vaccines, monoclonal antibodies, uh, new devices, everything you want. Now we are at the, you know, uh, a core of remaining problems. Uh, if I may, I can, uh, compare hepatitis C.

Hepatitis B, which is currently the, the target, hepatitis sees an easier disease. In many ways, the target finding the drugs was difficult, but Hep B, because it, it integrates, uh, it is an integrated virus. It’s much more difficult. Curing HIV is very difficult. Some cancers, we have progress, but other cancers are very tough.

To cure. And finally, uh, if you take, uh, rare disease of children, some of them there is, there are breakthroughs, but others remain psychiatric disease, which is a big unknown un un uh, unmet medical need. Uh, finding better treatments for tuberculosis. Number one infection in the world. It’s, it’s, it’s a shame, uh, on humanity that, you know, we are in 2022.

TB is still out there. Getting these problems solved, will need know-how from everywhere. No company, uh, not even the, the, the big ones. They notice, by the way, the Pfizers and, and the GSKs and the Sanofis, they notice. Uh, but I think even if you have a smaller biotech, you need to understand that you, you cannot do it.

This is the, uh, this is the idea behind the, the summit is to build bridges. Ours is across the Atlantic. Uh, but, but you can imagine all sorts of bridges between people, uh, between labs, between, and if we try to bring people together in a small scale meeting, We respect the big meetings. They’re, they’re essential, but ours is a artisans meeting, we call it.

Um, and so they, they can talk to each other and from there can come, uh, synergies because we are firm believers. Now I know we are swimming, um, against Tide. When you hear. Countries shutting down and telling, you know, stay out. I’m going to do my own thing. You know, um, uh, it’s, it’s not always easy, uh, but, um, but we’ve been, we’ve been doing this for six years and I think, uh, uh, we have data now showing that there is, uh, uh, there are projects that sparked up.

So your, your answer is on our website. It’s the bridges you can see on our website, which is, uh, symbolizes collaboration really.

Naji Gehchan: Yeah. And even if it’s against, you know, tide and current, uh, this is crucial. Collaboration is crucial, and we saw like the success we can

Shahin Gharakhanian: get from. Absolutely, absolutely.

Naji Gehchan: The last word is spread love in organizations.

Shahin Gharakhanian: I, I like your, uh, applying the word love in a corporate setting is not, uh, an easy task, but, uh, there is an word in English, which I like very much, which is, Uh, which is another way of saying love. Um, and, um, uh, I also, um, want to remind your, um, auditors, um, and I can, um, I can look up, uh, the exact references, but there is a, uh, there was a former, uh, Boston Scholar who’s now retired, uh, who has a whole theory, uh, around the big, uh, social movements.

and the, that their foundation is in, is a, is a sudden burst of love. He has written several books. I can try to find the references for you, but, uh, I hope we are entering an era where, um, our leaders, uh, whether they’re political or corporate, will understand that, uh, their, their teams have evolved. The population has.

And the more, uh, the world is now full of people like Ji, where, which are highly educated, highly motivated, come from different backgrounds, uh, are very autonomous in their thinking, and, uh, leading people of this phenotype is very different from the past. So you need to have that empathy, uh, built into your, uh, leadership model, I believe.

But of course, I’m sure it’s a big debate in management schools . Sure. . Well, well, you

Naji Gehchan: know, uh, first I would love all your reference and we’ll make sure we’ll have them for our audience on your, uh, on your page. Um, and yeah, obviously this is something that have been studied. It’s not always called love, genuine care, servant leader, psychological safety, empathy, as you said, compassion like.

Hundreds of words. And really what we’re trying to bring here is incredible leaders, thinkers like you, who actually have done it and believe in it. Uh, because we, we would never do enough, uh, to, uh, again, emphasize exactly what you said. We, we need this type of leadership for us to be able to collaborate, move forward, and actually deliver for the different, uh, uh, stakeholders in, in our organizations.

Any final word of wisdom shaheen for healthcare leaders around the world?

Shahin Gharakhanian: Um,

probably a plea, uh, to, to pay more attention to this interface between health and our environment. Uh, a plea that in order to, um, be able to contribute to he. Uh, it is better to have peace than war. Uh, war is extremely costly in, in many ways, human, uh, but also, uh, finite. It’s a huge, I’m very worried that, uh, conflicts a across the world will drain countries energies.

Uh, uh, and, uh, uh, you have to, I mean, you cannot. Print money indefinitely, you need to take from somewhere to give to somewhere else. Uh, it’s just as basic as that. Uh, but, uh, but taking this interface between, uh, uh, our natural environment and, uh, our health seems to be rising really to the top, um, of the agenda.

I mean, uh, just looking at from, from HIV. to Covid, to Monkey Parks with Ebola, Zika in the middle, uh, coming and going. Uh, uh, you know, uh, I, I, I hope the covid, um, the covid crisis will make everybody think twice, because here you have a disease where everything stopped, , cities emptied, everything stopped, life stopped, and we, we probably cannot have one another one of these crisis.

It’ll be very tough to manage. So, uh, uh, that also calls for more empathy and love, probably . Yeah. And it’s such

Naji Gehchan: a powerful, uh, please Shaneen, thanks for sharing this, and thank you again for being with me today.

Shahin Gharakhanian: Thank you, Naji, for having me on this program. Thank you. I appreciate it.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Cheerag Upadhyaya

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode joined today by Cheerag Upadhyaya, Clinical Associate Professor of Neurosurgery, and Chief Transformation & Business Strategy Officer. Cheerag completed neurosurgical residency at the University of Michigan, complex and minimally invasive spine fellowship at the University of California San Francisco, and research fellowships at the Howard Hughes Medical Institutes / National Institutes of Health and the Robert Wood Johnson Clinical Scholars Program resulting in a Masters in Science from the University of Michigan. He recently completed his MBA from MIT Sloan where we met as classmates and had fun negotiating a car in one of our classes. Cheerag is a member of the Executive Committee for the AANS/CNS Spine and Peripheral Nerve Section as well as a member of several associations. He has been awarded the Scoliosis Research Society Edgar Dawson Traveling Fellowship and AANS/CNS Spine and Peripheral Nerve Outcomes Committee Award. Cheerag was also elected to the Editorial Board of the Journal of Neurosurgery: Spine in 2021.

Cheerag, It is such an honor to have you with me today!

Cheerag Upadhyaya: Oh, thanks, Naji . It’s a very, uh, humbling, uh, intro.

Naji Gehchan: Well, every time we chatted about this podcast and this episode, you kept telling me with such humility that you have nothing interesting to tell, and I know you have a ton. So why don’t we start with your personal story. Can you tell us a little bit more what got you to where you are today?

Cheerag Upadhyaya: so I’m the, the son of, uh, immigrants, uh, from India. Um, they. , they came here. My father came here in the late 1960s, um, actually because he wanted to, to be a physician. So he did his medical education in India and then came to the United States for a residency, um, and then decided to stay here.

Um, and, uh, that experience I think, transfers a lot to me. Uh, you know, understanding what my father and my mother. Went through as they made that transition from India to the United States and the drive and determination that he had and my wo mom had about wanting to take care of patients really. And so that served as a very early inspiration in terms of just work ethic.

But also in terms of what I wanted to do with my life. And so I knew early on I wanted to become, um, a physician. Um, that was just a, a core part of who I was as I was growing up. I just didn’t know what I wanted to do. . That was the, that was the part I didn’t know what part. My dad is a ob, uh, G Y n. And so I, I saw a lot of, or heard about a lot of things that he did.

Um, so surgery was somewhat interesting to me at the time, but I really just didn’t know. Um, but I put my head down, worked, went to college and, and then went to med school. And as I. Went through medical school. I really enjoyed, um, surgery. I loved just working with my hands. I loved the clinical aspects of, uh, leading a team, right?

To, to be able to operate successfully and safely, you have to be able to help everybody around you perform at a certain level, right? Um, so that the patient is taken care of really well. And that really attracted me. There was something about that that just, um, Connected. Um, and so I pursued surgical training and ultimately, um, neurosurgical training, um, and then ultimately spine as you, as you already outlined.

Um, the other aspect though that I wanted to explore was, you know, inquiry. I wanted to understand, okay, how can you not only make an impact on our patients, Today, but how do you start impacting patients? Um, uh, in terms of future, right? Extend yourself, scale yourself up as a, uh, individual. And research is one avenue.

And I looked at basic science, but I realized that basic science. Which was the Howard Hughes, um, n i H program, um, wasn’t, didn’t connect with me. Um, and that’s where the clinical research came in, uh, with the Robert Wood Johnson Foundation Fellowship. And then the M B A actually was a way to sort of understand how to connect the dots when it comes to.

Clinical outcomes research, but how do you actually implement that Right. Within large health systems, right. Within organizations, it’s, uh, it’s actually a, something I’m seeing more and more of now that you and I finished the program, that there’s a disconnect between understanding the data. In understanding how to actually operationalize the data, implement it for best practices.

And so that, you know, brought me back to academics, um, here at U N C as a way of being able to function within a large health system and work with partners and neurosurgery, but within the larger health system as well. Thanks for sharing,

Naji Gehchan: uh, part of your story with us. Uh, ed, I know as we were just telling you, are we connecting, you told me you might be called for the operating room.

Uh, as we are recording, I’d love to get your thoughts actually about this. You talked about it, about this readiness, really constant readiness to deliver in high stress environment, not only you, but also the team around you. How, how do you. .

Cheerag Upadhyaya: Yeah. So it’s it, I learned this from my faculty at the University of Michigan.

Um, and there’s a few factors that I’ve always taken with me, right? So the first is you, you have to really be good at your job, right? Yourself, right? Uh, you always have to put the patient first. Um, and then the other thing that. Learned in that. I, I understood it from my faculty in terms of the training and, and I jokingly say as I grew up in, in, in medicine, um, but it was emphasized in everything we learned at M I t, which is you have to create.

Um, a safe space for folks, right? Um, and you also have to, um, empower folks, right? So let me give you a small example. Um, every time I do an operation, one of the things that I, when you’re doing a spine surgery, for example, is you have to check and make sure. You’re operating on the right level, right? Are you operating on what level of the spine?

Um, and the spine has a lot of vertebra. And so if you’re in a rush, it’s easy to get off one level. Um, and that is something that obviously you don’t wanna do, right? You wanna operate on the level where the patient has the pathology. And so when I check the level with an x-ray, I stop and ask everybody around the room before I say anything.

Look at the. Double check if that level matches the level that we thought we were going to do from the initial timeout consent process and so forth. And I do that for a couple of reasons. One is I wanna make sure that everybody’s engaged, everybody’s part of the team. The second thing is I want to convey to everybody that.

if you see something that you feel that we’re at the wrong level, speak up, say something, right? Um, I want you to say something, right? If I’m driving it completely all the time, then folks are gonna be passive part of the process. And I think you can’t get the best out of everybody when they’re passive in the process versus if you actively engage them in the process.

And I think that it makes a huge impact on patient care. And I gave an operative example, but I think the same. Is very true in the outpatient realm. The same is very true in the inpatient realm and frankly, from what you and I learned at m i t I think it’s true, you know, outside of healthcare, right. And, and, and business as a whole.

Yeah. You, you

Naji Gehchan: took me back in time to my residency and, and actually we had this issue in operating room and um, unfortunately after the operation, the. Told me that she knew, but she couldn’t say it because the, the head of department was operating actually. So, you know, going back to this, uh, how, how do you lead these teams efforts?

You talked about, uh, creating the safe space. How, how do you do this? How do you ensure there’s a safe space? And if I wanna challenge a little bit more, I don’t know if in your career you had this, did you build this safe space after a leader who, before you actually did not have this s culture and how you dealt with this?

Cheerag Upadhyaya: Uh, I think it was, it was a, it was the opposite. I, I was very fortunate in my career as I, as a trainee, as a medical student, as a resident, as a fellow to even in the research space, um, at the n I h, at the Robert Wood Johnson. Um, I think it was, I was very, very fortunate. I was surrounded by mentors who, um, Created this environment.

And so for me, and again, I couldn’t describe it right. I couldn’t describe it, you know, when you, when you talk about like, um, what we learned at school, right? Uh, with psychological safety and, you know, some of the work that was done at Harvard in terms of Amy Edmondson, it wasn’t, it wasn’t something that I could describe.

It was just the way that they led and. Created this environment where they had high standards, they had high standards, but it wasn’t about getting upset with people or, or, um, getting, um, mad at people or, or, or, or demeaning people. It was about helping folks setting very high expectations. I think it’s, you know, you, you, uh, you and I were talking about this, right?

Setting expectations, clearly articulating those expectations. so folks know where to go and what they need to do, but then giving people the support and then appropriate feedback, right? Um, and then being humble enough to know that it’s a team effort. Somebody has to lead the team, but ultimately you still need the team to work.

Um, and, and that humility was something that, um, also translated across many, many of the mentors that I’ve been fortunate to work with, uh, over the.

Can you share one of,

Naji Gehchan: uh, the stories, uh, potentially where things might have gone wrong, uh, and how you dealt with this. Uh, I’m really looking at, you know, those mistakes that can be life-threatening actually in your job. And as you’re saying, as you’re talking about creating this psychological, safe environment, how do you deal in mistake with mistakes in a, in a different, uh, ,

Cheerag Upadhyaya: you know, it, uh, that’s a great question.

I, I, dealing with mistakes I think is hard. I think the natural reaction that we all have, or the vast majority of us have is to ignore the mistake. Right. To, to put your head in the sand. To, to, to just not think about it. Right. And when I’ve worked with, um, residents, when I work with medical students, um, younger faculty, I try to explain to them that that’s been my initial reaction as well.

Right? There, something happens and you want to, to run away from it or hide it because it, it’s hurts, right? As a, as a clinician, as a surgeon, you always want the very best for your patient, and when things don’t go right, even if it is something that is within the profile of known complications and things like that, you, you take it personally.

One thing I’ve learned, and it requires work, it actually, it requires a tremendous amount of intentional effort, is that you have to just confront it, acknowledge it, talk about it with your colleagues. Not in a blaming sense, right? You know, of like, this person did this or this person did that. Cuz that goes against everything we talked about a minute ago.

You’ll create an environment that isn’t conducive to safety, but to talk about it in terms of how could I have done better? How could we have done better? Right? And frame it from that perspective. Um, the, the other thing is, own it, right? So for example, if I have a patient who does have a complication, Bring that patient back, talk to them more.

Um, you know, don’t distance yourself from that patient. Um, and I think this is true, whether it’s a patient or any problem or any challenge or any mistake if you will, um, anything like that in life is that distancing yourself from it is. I think a very natural reaction, but we have to sort of fight that reaction and, and, and work through that sort of dissonance in our head and say, no, let me bring it closer to me.

And if you do that, I think you can learn from those mistakes better. And you set an example to your team of, okay, this is a space where we can talk about it, right? Where, where if you make a mistake, this is how we’re gonna handle it. And I think that’s the other, again, going back to the idea is how do you model yourself, model yourself as a leader?

Folks need to see that, right? They need, if they don’t, if they see you getting defensive or they see you running away from things, then that’s what they’re, you know, going to probably do. If they see you owning it and acknowledging it, talking about it, bringing it closer, then they’re gonna start. And I, again, it goes back to what we started with.

I think you’ll improve processes and patients care and everything. Um, dramat. So much of what we is, uh, iterative. I mean, it’s, it, it’s iterative. I mean, we talk about it in medicine, it’s the practice of medicine, right? I’m, I’ll never stop practicing medicine until I stop, right? . Um, I’m always going to be just working to better myself.

Um, and I think that’s true for life and, and business as well. Totally,

Naji Gehchan: and I love it, as you said, do not ignore mistakes. Own them. You know, and, and you didn’t go until saying, uh, like kind of, sometimes you say it’s the others’ mistake too. And I think this is kind of the worst thing that can happen when you not only disowned them, but practically say, oh, it was the operating, uh, room schedule, or it was the nurse or so, so really owning them, even if it’s.

Your mistakes, but your team’s mistake for you to create the safe place and make it better the next time. I, I love what you shared. Sh you also have a key role within your organization now, which is business strategy. So I was very interested when I read, you know, for a physician business and strategy, uh, in, in their function.

So I’d love to, uh, understand from you, how do you define business and also how you define. Yeah, .

Cheerag Upadhyaya: So, uh, it, it’s an evolving idea for me, Ashley. Uh, as I’m, as I’m getting started, this has been something that I’m still learning in myself. Um, the way that I sort of think it’s, it’s hard you don’t, healthcare as you know, right?

Is, is a business, right? Um, so much of we, you know, if, if, if it’s. It goes back to what we talked about in the, in our program when it comes to nonprofits, right. A nonprofit still has to run like a business. Right. It just doesn’t have to pay taxes. Right. Like a for-profit business does. Right. Um, so in healthcare, many of us are in nonprofits.

Um, it’s still important to run the business and run it well. So the lens through which I. Thinking about this, right, is where, what I alluded to a little while ago, which is that I want to understand those best practices that we’ve studied, right? That even you company, right? Your, your company brings out best practices, right?

You use these medications, this is the patient population, this is the best data, et cetera, but the implementation of that, Has to be done in a large corporate environment, right? Multi-billion dollar health systems have to implement these processes of care. And so for me, that is where I’m sort of thinking about it as how do I help bring management approaches?

right, to improve patient care, improve operations, um, on multiple levels, right? Whether it’s at the individual clinic level or whether it’s at the, you know, departmental level or even at a programmatic, a multidisciplinary programmatic level in terms of strategy, part of what I’m thinking about is what is the core competency, right?

What is the competitive advantage of any health system, right? And, and then, so I’m just not a big believer in. You know that there’s a fixed pie, right? Uh, one thing you we’ve learned is that there’s, there’s space in the world for a lot of folks, right? Um, we learned that over and over again with, uh, businesses, right?

I think about the conversations we had and strategy when it came to, like Trader Joe’s versus other grocery stores, for example, right? And it seems like a mundane example, but it’s, no, it’s, it’s very. Applicable to our life, right? There’s room for different health systems in the same market. But I think a lot of times folks get into this idea that it’s a zero sum game, right?

We’re just competing over a fixed number of patients, and I think that there are ways of approaching and guiding programmatic development. Strategy right around that, whether it’s at the departmental level or at an institutional level, that allows the healthcare system to position itself for what it can do the very best.

Right? Um, and I think that’s my approach, at least as I’m thinking about it and as I’m getting started. .

Naji Gehchan: I love this. And yeah, you reminded me of the fixed buy bias because you talked about it and it’s one of the best biases I learned as a concept in negotiation, right? Like when, when we all fight for the same buy, who’s gonna take the bigger piece rather than thinking how to expand actually the buy and we can all benefit from it.

So thanks for sharing that. Uh, I, I would give you now one word and I would love your reaction to it. So the first word is leadership.

Cheerag Upadhyaya: My reaction to that word is, um, understanding your people, understanding who you’re leading and helping them become the best version of themselves within your capacity. Right. Um, that to me has always been sort of the way that I approach it. You know, when I interview. People, when I’m thinking about conversations that I’ve had with people, my first question or one of my early questions is, what, what do you aspire for yourself?

Right? I want to know that, um, because if I can help them achieve some of what they aspire or even better, Achieve more than what they believe they can aspire to. Right? Then I think you can really engage that person and you’re really leading them, and they’ll be with you right through the worst times. Um, but you have to be able to get them there.

I I, I learned this from. I learned this from a, a friend of mine, um, who, who recently passed, um, and, uh, at a young age, uh, she was, uh, one of my, um, early, early mentors as a resident. She was my chief resident and then faculty. Um, and I, you know, leaned on her for advice over the years. , um, uh, her name was, uh, uh, Linda Yang.

Um, and, uh, just an outstanding peripheral nerve neurosurgeon. Um, but I saw this with what she did. She would help people, everybody. Whether it was somebody in the office who, you know, wanted a nurse in the office who wanted to become a nurse practitioner but didn’t see it in themselves, and she did, and she would push them and again, support them.

And then suddenly they were like, oh my gosh, look, look what I did. Um, to, to others who, you know, no, I can’t do research. And no, I think you can. Right? You can help me with research and you’re not a medical student and you’re not a resident. You’re, you know, et cetera. But you can do research. Let me show you how you can do research, and this is the impact you can make.

Um, I think that’s when you, when you use that word, leadership, that’s what sort of pops into my head. Oh, thanks

Naji Gehchan: GaN. I, I’m sorry for your loss. And you, you’re touching a key point of mentorship, coaching, uh, which is also part of leadership. What about, uh,

Cheerag Upadhyaya: transformation, transformation.

I think the word transformation, um, the word that comes to my mind and the ideas that come to my mind are around empowerment, right? I think transformation is an opportunity to, to really empower people to move to the next level. , right. Um, to break the status quo, right? To, to, to rebuild, if you will, in a sense.

Um, I had a flavor of this, you know, in terms of some programmatic development where we were given the opportunity for transformation, right? How do you, how do you do this? Right? And, um, the way that it was most successful, the, the, the opportunities that we leveraged that were the most successful were those opportunities where we empowered people.

And allowed them to help lead the effort as well. Right. And then suddenly that transformation from the ground up was so much more powerful and so much more engaged when it came to the organization. What about health equity?

Uh, that one , that’s a challenging one. I actually, it’s, it’s near and dear to my heart now cuz I’m seeing, um, so much inequity, uh, frankly, in healthcare, um, for me. It’s, it’s a big challenge that we need to address, um, increasingly, not just in the United States, but around the world. Um, uh, but living in the United States, I, on some levels, you know, it seems like we’ve got, as we’ve talked about many times, wonderful healthcare, which we do have amazing, amazing healthcare.

But when you see the inequity, when you see patients who are not able to. Who are not able to afford care. Right. Um, and or who because of social, um, uh, determinants of health. Right. And the unrecognized aspects that social determinants of health, it’s improving, it’s getting better. We’re understanding it more.

But the impact of social determinants of health on health inequity or health equity, I think is another area. So for me, That is an area that actually I’m in very interested in, in trying to understand and explore. And it’s one of the things I’d like to understand over the next several years as part of, you know, a research, research effort when it comes to neurosurgery and spine surgery is, is exactly that, right?

When it comes to the social determinants of health and how that drives inequity in health outcomes. Um, I do think that there’s an opportunity to a, again, go back to management though, right? How does an organization. Interact and, and interface with other community stakeholders, right? As a way of helping build up capability when it comes to the resources that we can offer, the community, the environment, you know, our, the people around, um, to improve health inequity.

The last one

Naji Gehchan: is spread love and organizations.

Cheerag Upadhyaya: So , I. I think I, I was fortunate to participate in a, um, and I really love your podcast. I love your podcast because you unan unashamedly, I don’t even know if, if that’s the right word, I think, right. But just right there, you throw it out there, you use the word love, right?

And I think. I think that that is an important concept. I was fortunate to participate in, um, uh, physician leadership, or, sorry, a healthcare leadership forum, um, at Intermountain Healthcare. Um, and it was led by, uh, one of the former CEOs of Intermountain Healthcare. His name is Charles Sorenson. Wonderful gentleman, wonderful gentleman.

Very humble. Um, exemplified much of what you and I have talked about this morning. and one of the speakers that he had brought was another executive at, um, the, uh, Intermountain former executive Inter Intermountain Healthcare. And he exac he said that he, he emphasized that he’s like, you know, leadership is love.

As well, right? As all these other things we’ve talked about and that hit home, um, when I heard that a few, this was a few years ago before the, before all this pandemic and everything we’ve been living through it hit home. And, and he went through and he described, and I thought this was very insightful.

He went through and he described, you know, that we don’t, you know, we use the word love, but you know, you know, if you go back to certain culture, You know, for example, I think you talked about the Greek and the, uh, Greek culture and antiquity, right? They had. They, they put different words around different types of love, right?

And that I think is sometimes lost in our modern world. That you can love the people around you, and it doesn’t have to be all this other stuff. It can truly be a love of mission, a love of watching people grow and become the best versions of themselves. But I think that is an important part. That is something that is lost at times, I feel in the modern era.

And I really appreciate what you’re trying to do here, which is bring some of that back, you know, into the conversation, right? As a way of, um, helping improve business, but also frankly, improve people’s lives. Right? Because, you know, work is such an important part of everybody’s life. and if you feel good about going to work, right?

That’s, that’s a good thing, , when it comes to life in general, right? It shouldn’t be consuming, but it should be fun and enjoyable and, and, uh, and uh, and help you grow as an individual and feel like there’s dignity to that, right? That you’re coming home. And I think if you don’t have love in that conversation, and I think the type of love that we’re talking about, right?

It, it begins to, um, you lose some of.

Naji Gehchan: Thank you so much, uh, SHA for saying this. It means so much for me. And yeah, hopefully we’re bringing a little bit more of this love, you know, not the ro romantic love. We only think about when we hear the word love, but all the other pieces of love, of humanity, life, work, and humans.

Uh, any final word of wisdom for healthcare leaders around.

Cheerag Upadhyaya: Uh, you know, it’s one thing I’ve learned, um, again, I, going back to going back to our experience at m I t Naji, like, um, I build networks, um, you know, build networks, build friendships in healthcare, which I think sometimes comes naturally cuz that’s where we are.

But build networks of people outside of healthcare, right. In other industries. Um, I, you know, I mean we went through this pandemic. Right. As a, as a class , um, and, and learning from each other, um, I think it’s easy to get siloed right in, in what we do, but I think learning from each other, um, and finding and seeking out really good people like, like yourselves and so many other, other folks that we worked with as, as classmates.

Um, is, is something I’ve learned, um, has been very valuable and it actually gives perspective on the challenges that we’re all facing, right? Um, and uh, the other thing is taking the time to have good conversations. Um, I think, uh, You know, the fireside chats that we had as, um, as students, um, were probably some of the most impactful things for me personally.

Um, just to learn from each other, the humanity that people bring to the table, um, as well. And it gives perspective on, on, on our mission. So that, that’s just, uh, just my 2 cents in additional, obviously everything else we’ve talked about.

Naji Gehchan: Awesome. Thank you so much again, uh, for being with me.

Cheerag Upadhyaya: Thanks, Naji. It was a pleasure and I look forward to seeing you in person here in, uh, next month.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Stephanie Chen

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, having the pleasure to be joined by Stephanie Chen, ChenMed’s Chief Legal Officer and Culture Officer. Stephanie has been with ChenMed since 2006, and served as General Counsel prior to being named Chief Legal Officer in 2016.  A graduate of New York Law School, which she attended on a Harlan Scholarship, Stephanie was admitted to the Florida Bar in 2008. She graduated cum laude from Boston College with a degree in economics.

Stephanie and her husband, Dr. Chris Chen, the CEO of ChenMed, have four children together and live in Florida.

Stephanie – It is such a pleasure to have you with me today!

Stephanie Chen: It’s a pleasure to be here, Naji. Thank you so, so very much for the warm welcome.

Naji Gehchan: Uh, can you first please share with us a little bit more about your personal story from law to now being in healthcare as chief legal officer and culture officer, uh, in this industry?

Stephanie Chen: Definitely, um, you said with love. So I’ll start with, um, I married my high school sweetheart. Uh, Chris and I have been together since I was 15 years old. Um, we went to prom, my prom together and he came to my high school graduation. So we kind of have a, a funny story in that way. Um, I was married as a college sophomore.

Um, and so that’s kind of, if anyone’s been to Boston College in your audience, that’s not normal. at Boston College. Uh, and so most, most students live on campus there. And so I was off campus, married to a, uh, uh, Beth Israel Deacon as resident. But, um, we, we grew up together. Um, and, uh, I wouldn’t change any of it.

He’s a great guy. So that’s my, my my love story. Um, and then growing up in healthcare, um, to be honest, if you had asked me when I was maybe 12 or 13, , I don’t know if I would’ve said I’m gonna end up in healthcare. I, I loved caring for people, but I’ve never loved science. So what’s really wonderful about the health candu industry is that I get to care for patients and people and not be a physician or a nurse, or a nurse practitioner, or even a medical assistant.

None of those things appeal to me. Um, But I, but changing the world appeals to me and caring for people has always appealed to me. So healthcare, I think, um, has both of those things, an impact on the world and an impact, uh, and a chance to love on people in an individual way. Oh,

Naji Gehchan: for sure. This is, this is our why.

This is why we wake up every morning trying to make an impact and help patients live better. Uh, I, I’m really intrigued by Chen Med, uh, and specifically after I received from a friend who sent me an article about, uh, how you are transforming love into profits in healthcare. So I was very intrigued because my podcast talked about spreading love in organizations.

So I’d love to hear a little bit more about what you do and really the values, uh, that you bring in your in. I shouldn’t say company. It’s more in your organization, I should say.

Stephanie Chen: Yeah. Well, thank you for asking Naji. So, um, maybe like eight years ago, I remember being in a room where, um, Chris was presenting, um, to the family where family run.

Company, right? Family owned and operated. Um, but we have an executive team and we’ve got like 6,000 employees. So we’re not a mom and pop anymore, but it still very much feels like a momand pop. Um, he presented to the family the, the values that he wanted our company to have. And there were three, and I remember being so critical in my mind because the three were love accountability, and.

And I just spoke up and said, you know, love and passion in a workplace environment sounds so weird. It sounds like a, like a litigation waiting to happen, right? Like, we’re gonna get sexual, uh, harassment claims, , you know, like love and passion, you know, , um, sounds like something that should be on an e true Hollywood story.

Um, but he was really convicted and, um, and and really passionate about making those three our company values. And we have them as defined terms. You know, we have, um, like love is defined in four ways. Accountability is defined in five ways, and then passions defined in four ways. And we really are those three things at ChenMed.

Um, and we live. Love, um, for each other. That’s one of the things we, we value every human being as an incredible creation of God who brings value. And so that’s one of them. We also love people enough to tell them the truth. That’s one of our values of love. Um, and give them open and honest feedback. And so, and we invest in others as part of our love at Chen.

And help develop everyone to be the best they can be. Um, and then accountability obviously in healthcare is, there’s so much data, right? Um, and there’s just so much around results and obviously the results are bigger than profits. The results are changing people’s lives and keeping people healthier longer, and, and changing the healthcare statistics in the country, right around cancer survival rates.

Chen Med has done that, um, around, um, Like just, uh, life expectancy in, in the zip codes we serve. Um, there’s a 20 year age gap in the zip codes we serve versus in the zip code maybe, um, that you or I would live in Naji. And so like just really working at that, at that life expectancy, discrepancy and shipping away at that.

And so that accountability is huge. And then passion is just like our zest for what we do. And at ChenMed we really love what we do. Um, We wake up in the morning with inspiring energy. Um, and that’s how passions defined and we bring new energy to each day. And so when Chris said those three, I was like, this sounds like a nightmare, but I was really wrong because, um, they really are the best values to define what it’s like to live and work at Gen Med.

And I think because of those people are, are just confident in how they bring their passions and their zaniness and their love to work and even their accountability. .

Naji Gehchan: I love it. And I, I, you know, when I, when I came for the little story, when I came, uh, from France, uh, to the us so I, I’ve been spreading love in the organization where I work for some years now.

Uh, and when I moved here, the first thing they told me, don’t talk about love in the workplace. You’re gonna end up in a very bad situation as a French Lebanese guy, you know, talking about this . So when you said like, love and passion, You know, legally what you thought about it was the same for me, but at the end, as you said, like this is actually what can bring impact, caring for one another for us to, at the end, care for the customers and ultimately help patients live better.

So I, I love how you define it. Um, how do you build this culture daily? You know, in Chen, because there’s so much you’re doing. Um, so how, how, how daily do you build this within the team? For them to be focused truly on love for people for one another and love for the patients. ,

Stephanie Chen: you know, it’s one-on-one, which does not sound scalable, but it really is.

We have to hire for people who really want this in their own life as well. And then they have to, want to push it out because I can’t be in Detroit or Louisville or Atlanta or New Orleans or you know, Memphis. Right. And, and none of us can. And so we have to hire beautiful, loving people in Memphis and in Detroit and Atlanta, who, who want this in their lives as well.

and then that’s the first thing. So it’s people. You gotta get the right people. And then the second thing is it’s cultivated. So in our town halls, in our emails, in our meetings, we really do try to remind everyone of the beautiful purpose of why we’re here. One of my favorite books is Simon Cenek. Start With Why.

And he just hits the nail on the head with, with, we have to constantly be reminded of why we’re doing things, um, and, and why we’re here. And so I think just starting with why. And so our town halls are literally like a one hour love meeting, like a love fest to make that, you know, sound funny and inappropriate.

But it really is celebrating our team members who have gone above and beyond celebrating our, our patient victories and the data. Celebrating. We had an 87 year old patient get engaged cuz she wasn’t healthy, um, enough to even like leave her home. And then she became healthy enough to be social and then she became healthy enough to like find a fiance and she was just so happy.

And so that’s like a story we told on our Town Hall of Loneliness to Love and just celebrating those because we, we impact so many patients and we have to know and be reminded because our job is very hard, um, in healthcare everywhere. It’s a very hard job. So we have to constantly remember why we’re doing.

Naji Gehchan: So talking about this, that was actually my second question, right? If you work in a highly stressful environment, uh, these days with low staffing, uh, we, we read all over overworked healthcare professionals. Yeah. Uh, h how do you do to keep really love at the heart of what you do and actually support, support this mission?

Stephanie Chen: You know, I wish I could say we did it perfectly. I’m constantly striving to figure out how to do it better. Um, that’s like my full-time job because it’s, it’s understaffing triple masking, um, changing protocols, right? The stress is just so very high and it’s always like, do more and do better and do faster and do better quality in healthcare, right?

Like, and so, um, I would say,

Okay. I would say that, um, uh, we, we work on care teams. We say that we are all here to serve our physicians and our nurse practitioners. And so, um, it’s a team that, that really does help encapsulate with returning messages, looking at emails, getting scripts organized. Um, calling the day before and asking our patients, our senior patients, can you bring all the medications you’re on so we can see what you’re taking, what you’re out of.

Um, we really do try to have a one stop shop at ChenMed. I don’t know if you’re familiar with our model, but, um, it’s all encompassing care and we look at all the social determinants of health. We look at if they don’t have the money for their copay and they’re not taking their blood thinner, well, what does that look like for a hospitalization?

Right? and so, hey, how can we get that copay in a payment plan for you, even if it’s only five or $10? How can we help you pay just 50 cents or a dollar today so that you don’t stop taking an important medication? We make sure they have Uber health and and rides. , they’re specialists, and if their doctor, daughter, or son or brother or sister can’t take them to a specialist, we make sure they get there no matter what.

And so we really do try to have this care team that comes around, the physicians and the nurses and the staff to make sure that that load is, is. Co-labor and that the burden is carried together with others. We really do believe that it’s gotta be a team. It’s gotta be kind of like, I don’t know. Um, we have a strong Christian faith and so a lot of my analogies are from the Bible, but there’s this chord of three St.

Strands cannot easily be broken. And so it’s like, I think burnout comes when a physician feels alone. I think burnout comes when a nurse feels alone and that they have to carry the heavy weight of their panel. By themselves. And at ChenMed that’s not the case. They should be fully supported by our home office staff and by their care team.

Naji Gehchan: I, I’m intrigued since you’re talking about teams. Uh, are you, do you, for example, train your people? Do you have like leadership efficiency work together and what, what are the ones you are focused on since like, one of your values is love and passion so much

Stephanie Chen: training , so much training Naji. Um, we believe in lifelong.

um, at ChenMed. So, um, even our physicians, basically we realized that. In medical school, um, you’re not really totally trained on kind of like, um, the positive no. Or, um, even, uh, degrees of influence. Now, I didn’t go to medical school, and I don’t mean any slight, but I know in four years you’re learning a lot of other things more than kind of like family influence or.

Or, or things like that. And so at ChenMed we have so much physician training around, um, how to influence, how to provide for full care, how to ask different questions to get to the right answer, um, and, and things like that. So they can go through training here at ChenMed that we’ve spec specifically designed for our physicians and, and p c leaders.

Our PCP leadership train is amazing. Um, I was just at a partner’s weekend in Orlando. And, um, it’s just awesome to see people who’ve been employed here 20 years, um, you know, 15 years, 18 years, and just keep getting promoted, promoted, promoted, and so, and now are leading teams and markets and, and, and national, national groups.

Naji Gehchan: I, I would love now to go to a part where I will give you a word and I’d love to, your reaction to it.

Stephanie Chen: I am the most excited and nervous about this. Nudie, I knew you were gonna do this. And I kept thinking, what is he gonna

Naji Gehchan: say? ? So the fir, the first one is

Stephanie Chen: leadership. Okay. Um, oh, I think by example. I think, um, to be a good leader, you have to walk what you talk and the, you gotta be consistent and yeah.

What about health equity? Uh, That breaks my heart is the first thing I think about it, because it feels like a fundamental right, that we should all be the day we’re born. We should have the same chance as everyone else. Um, and, uh, the fact that that’s not the case here in the United States as a developed nation really should break everyone’s heart that what’s that, wakes me up in the morning and keeps me doing my job every day.

So,

Naji Gehchan: uh, I wanna double click on this because this is one of the focus areas that you work on, uh, in Chen. Can you tell us a little bit more what you’ve done and also the data that you’ve been able to deliver?

Stephanie Chen: Sure, sure. So, um, Started in Miami Gardens and um, that’s a, if you don’t know Miami well that’s a, a, a poorer neighborhood in Miami.

A beautiful neighborhood in Miami, but lower income and medically underserved, which means, um, the doctors to people who need doctors ratio is low. Um, there’s not enough doctors in that community and we just happened to start there. My father and mother-in-law had one office. Um, their story is incredible.

They’re, they’re two immigrants from China who came here. Um, went bankrupt in a restaurant business and, um, then they’re very brilliant. My father-in-law, PhD already in Wisconsin, moved to Miami, homeless with two children and, and op and went to medical school in two years cuz as a PhD they had that program and then became a physician in Miami Gardens, um, with these two sons, um, basically without a home.

But, um, the, in Miami Gardens, what he found was that so much of healthcare actually was just care and not even anything to do with medicine. And, and so he found that, you know what I said about missing a co-pay or missing a specialist appointment, or just using the emergency room as their only only form of, of healthcare instead of.

True prevention, right. With colonoscopies and mammograms and, and everything else. And, and blood work and, and staying, you know, staying healthy and diet and, and so, and loneliness and community. So they started this, this one center in Miami Gardens in a medically underserved neighborhood and realized the great need.

And so that became the model. Is, where else can we scale and go where there’s a need for doctors and let’s not move into like the, the county hospital where there’s already, you know, 700 doctors on the elevator list. Let’s go, um, in, into medically underserved neighborhoods and help the communities that need us most.

And so we’ve done that and, um, we’ve grown exponentially, mainly word of mouth. I mean, until very recently we didn’t have a marketing team. Um, you know, we don’t pay for Super Bowl commercials, , um, or anything like that. And so it’s very grassroots, word of mouth. Once one person in a church finds out about us, we end up having like 300 patients from that church and things like that.

And so, um, but really a heart to change the outcomes. And so if you check out our impact report, um, the data is all there, but we have, um, doubled cancer survivor rates in six months, which is just insane. If a drug could do that, I think it would be like multi-billion Naji. And, and ChenMed has done that through.

um, our care model, we see our patients frequently and often, and we have smaller physician panel sizes so that we can know our patients intimately well. Um, and I think that, that, that is kind of back to almost the old and days in our minds in the movies where a physician would come to your home with like the leather bag.

You know? I don’t know if you’re getting that. But, and they would know the brother and the son and the, you know, like the, the horse’s name. And so we don’t have horses. But , the, the thing is like, if you know someone really, really well, you know what’s off for them or what’s low for them or what’s high for them, and so then you can cater your medicine to them.

So that’s, that’s our model in a nutshell. There’s more data on the impact report. I didn’t give you that much, but I wanted you to check it out@chenmed.com.

Naji Gehchan: I will. And, uh, so one that might be related Modern healthcare. Hmm.

Stephanie Chen: Oh, the, well, I’m sorry. Mother

Naji Gehchan: Modern Healthcare. How do you Oh, modern healthcare, I’m sorry.

Reaction for this?

Stephanie Chen: Yes. Um, I think it’s disjointed. Um, and f and fractured, I think, um, you can get a lot of tests done. Um, and because of. I don’t know if it’s various electronic medical record systems or HIPAA or lack of communication, but a lot of, there’s like a lot of tea leaves, but no one reading all of them, if that makes sense.

Like, uh, especially if you have something you’re really trying to get to the bottom of, it can take a long time because of the disjointed and fractured system we have and physicians not speaking to physicians kind of all in a, in a, on a unified team, if that makes. What about spread? I don’t mean, I don’t mean that to sound overly critical.

Naji Gehchan: No, no, no. It’s, it’s your view on the challenges we are facing, which is, which is definitely, uh, data is definitely one of the biggest challenges and how they are interconnected and who owns them, and are we really looking into them for us to make, you know, intentional decisions about our health. Right.

The last one is spread love in organiz.

Stephanie Chen: Uh, um, with how you show up, um, like one human at a time. Uh, I think there’s something wonderful about being, uh, at scale. We’ve certainly grown exponentially at ChenMed, but, uh, the only thing I would say is. , um, you’ve gotta have like a playbook and a strategy around love.

You can’t forget about it. Um, I think people are so quick to make sure the model is scalable and the, and even us sometimes at Chen Med, and how do we figure out how to hire at scale and grow at scale. But you have to figure out how to love at scale and you have to figure out how to, um, uh, always look for a situation where, where everyone can win.

Like a win-win situation that’s part of. Mission statement at ChenMed. And I think, I think that’s loving others. If I’m looking for how you can benefit Naji and then you’re looking for how I can benefit, and then we’re both looking together at how our patients can benefit. That’s how we really spread love.

So

Naji Gehchan: yeah. Thank you for that. I, I love it. Love at scale. I love this. . Any final word of wisdom, Stephanie? For healthcare leaders specifically around the.

Stephanie Chen: Oh, do what you love. Don’t, don’t defer your life. Don’t have a deferred life plan. There’s kind of like we grow up, at least in America, I don’t know about in France or in Lebanon, but if you eat your peas, you get the pie, right?

Like if you do the hard thing, you get to do the good thing. And I think a lot of people live like, if I work hard now I can do what I love when I retire. And I think that that is a. So don’t buy into that lie. Um, I read that when I was like 18 years old in a book, the Monk in the Riddle, and I just ha, I try to live every day, waking up doing what I love, and there’s so much room in healthcare to do what you love.

You don’t have to switch jobs, you don’t have to retire. You don’t have to become an author. Um, stay a physician, but do what you love in a place that believes in you and, um, is for you and where you can do what you love. In healthcare, don’t leave healthcare to do what you love. You can do it in healthcare at the right spot.

Naji Gehchan: That’s such a great advice and word of wisdom. Uh, for sure. Life is too short to do things we don’t like.

Stephanie Chen: Too short. And what if you never get to retire? Right? Like, what if we we could, we could either of us have something horrible that happens tomorrow, so we gotta do what we love today.

Naji Gehchan: True. So true.

Thank you so much again, Stephanie, for being with me today.

Stephanie Chen: It was such incredible. What an honor and privilege. Have a great day.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Pravin Chaturvedi

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, having the pleasure to be joined by Dr Pravin Chaturvedi a veteran drug developer, serial biotech entrepreneur, and seasoned CEO/CSO, Board member of many life science ventures. Over his 30+ years in the biotech and pharmaceutical industry, he has participated and led the drug development teams for multiple drugs across the several therapeutic areas. He has participated in the successful drug approval and commercialization of seven drugs. Pravin serves as the Chairman of the Scientific Advisory Board and Chief Scientific Officer (CSO) for Napo Pharmaceuticals and Jaguar Health. He is also the cofounder and CEO of IndUS Pharmaceuticals and Oceanyx Pharmaceuticals. He is also the Executive Chairman of Cellanyx and Chair of the Board for Enlivity. He currently and previously served on the boards of several biotech too. Over his career, he has also been a part of multiple national and international strategic partnerships with large pharmaceutical companies as well as governments. Pravin also contributes significant time to teaching and serves as an adjunct faculty member at Georgetown Medical School. He holds a doctoral degree from West Virginia University and has an undergraduate degree in pharmacy from University of Bombay. I could go on and on introducing Pravin but let’s here from him here!

Pravin, it’s such a great pleasure to have you with me.

Pravin Chaturvedi: Thank you, Naji. It’s a pleasure for me to be here. Thank you.

Naji Gehchan: Can you first share with us your personal story and what is in between the line of your incredible journey bringing so much impact in healthcare?

Pravin Chaturvedi: I, a very deep question. Naji, , but, uh, thank you for asking.

I think, uh, from, uh, early days, I’ve always been about, Uh, not, uh, tolerating any oppression of human beings in any form. So, um, illness, uh, medicine was one my way of doing it, but other ways of that is poverty and disenfranchisement and underserved communities. So, over the early days of my life, I was fortunate enough, having been born in Bombay, I had seen both sides of the world, cuz it’s a very large city.

Um, where I could see that, you know, a lot of people do not even have the opportunity to do, um, uh, what they could do, uh, because of the way the systems are set up. So I think, uh, in that regard with my interest in medicine, um, I was fortunate to have. Great mentors through my life, you know, and the first, um, of them was, um, back in the eighties.

Early eighties, and he was a physician pharmacologist, which was what the reason is that I have an interest in pharmacology, uh, because he shaped my thinking about, um, he said something that I will never forget. Back then, I was probably in my high teens and he. Uh, life is really short when you’re happy, and life is really long when you have suffering.

You know, so alleviate that. And so kind of, you know, put me on a path to thinking about this in a way where I could make a difference. And it was not sort of, you know, just giving money here and there for charity, but really making an impact in that regard. So through that journey, I met my second mentor, uh, uh, in West Virginia, who was also a pharmacologist, , and, uh, brilliant man.

And, uh, a very, very authentic person who, uh, basically took me to the next, uh, level where, I had a philosophy that reason is a queen and mistress of all things, and which is normally oriental, people are considered to be fatalistic. And so, uh, his Peter, my mentor, then thought that that was quite oxidental of me, which, uh, basically was a challenge

So we, we had long discussions about it and we started making differences there. So everything comes from reason. And so by reasoning logically, I would start from the patient first, and I would, so, because what you get from the physicians is a perspective of what symptoms are presented. And so the physicians are first doing symptomatic management, but the patient’s journey is far bigger than that, you know, a lot, lot longer.

So I used to talk to the patients and I’d get completely different discussions, you know, uh, from what we were thinking in the ivory towers of academic institu. And so that, that was very telling for me. So that helped me a lot. And then, um, um, by, you know, I was surely going to be an academic na but um, I got plucked because I speak the way I sound right now to you, like a conversationalist.

And so I was giving a talk somewhere. And some executive at large pharma, uh, saw me speak and decided that I was gonna work for her. And that large pharma was called Park Davis at that time. Now it is Pfizer. And so as soon as I graduated, I was bought into New Jersey and thrust into the late stage development programs, uh, because I was trained in epilepsy on the CNS side, but also oncology.

And so from there, um, I, I got this, uh, intoxication , almost addiction for making medicine because it was very, um, satisfying naji to see a drug get approved by the fda. And to go to the pharmacy and see the shelf, the name over there, , even though it was not my name, it was a company’s name. So, so then I came to, uh, Boston.

From there I was recruited to Boston, uh, to early state startups. And then I met my third mentor over there. This third mentor of mine, John, he. Spent his entire career at Lilly, your place, you know, as along with Ray Fuller, pretty much the father of depression. These two gentle, and John and Ray, um, had developed the Hamilton scale and everything.

So he had developed Prozac and Zyprexa and all these drugs. John also pharmacologist. Imagine that . So John and I. We would talk about these chronic illnesses that would afflict human beings because we are living longer. So I come from a place where India, you know, we have more infectious diseases because it’s endemic.

But in us, you know, we were living longer, we were having different illnesses which were cardiometabolic and cancer and cns. And so with him, I learned about that. So got a couple more drugs, but in that journey we had HIV drugs that we were being developed because patients were dying. And that’s when I met this really ill population Naji, uh, who had T-cell counts of two who were unable to even drive by a Dunking donut sign without throwing up.

That’s how sick they were. That’s how grateful nausea they. And so by talking to them and finding out their journey, uh, we developed, uh, HIV drugs and we changed the face of aids, um, obviously as a community, you know, and, um, and so we, being a part of that 30 years ago was another, uh, learning curve for me.

And then, um, I left Vertex, uh, uh, and in 2001 started my first company, cion, which was a neuro company, neuroscience company, iron Channel company focused on neuropathic pain. And I met my fourth mentor there who was a worldwide head of r and d. At Ciba GGI Novartis, their gift is the entire field of kinase inhibitors, you know, uh, two aminos that they had been working on forever.

And so, George, uh, he was a chemist, so the first non pharmacologist mentor, at, uh, so many drugs in George’s, uh, uh, time. So he shaped me thinking about solving complex problem. Of diseases that we could not just apply, you know, because some of the parts is not the whole. And having been fortunate enough to be trained holistically treating the phenotype, I knew not to fall in the DNA RNA protein trap because then people try to add up one plus, one plus one.

One plus one plus one does not equal trillion cells, you know, which is what constitutes a living organism, a living human being. And so, um, tried to work backwards and, and, and George’s gift was, you know, how to analyze what was presented as symptoms and then try to work backwards and get drugs done. So that led me to, uh, starting many companies and I can never come back now, uh, to working for anyone unless there’s a real unmet need, a real patient and a patient who’s going to feel the benefit of what we do.

So that’s sort of a seven minute long answer to your question. Hope that’s. Oh, I, I love

Naji Gehchan: it. Thanks for sharing this, and obviously the impact, as you said, of what we do in, in the biotech pharma where is just massive. I, I feel the same joy when, you know, we work hard on a molecule and then we see it getting to patients hands and then benefiting from it.

I think it, that’s why we wake up every morning.

Pravin Chaturvedi: Yeah, I agree. Absolutely.

Naji Gehchan: You, you built companies, you participated in building, uh, several biotech companies now over the years and managed to bring, uh, to patients seven drugs. Uh, what are your key learnings and advice for those building their biotechs

Pravin Chaturvedi: today?

Yeah. Um, you know, so I, I think my advice is always what I follow, which is I. Um, make sure that we are solving a real problem. Um, so it is not a, you cannot fall in love with the technology or the latest, uh, trend that we read in science or cell or nature. It has to be a real patient that does not have any available therapies or diagnosis.

It can be any. On the entire continuum. It can be anything between diagnostics, treatments, management, doesn’t really matter. So that should be the first, uh, rule that you have to do. That. Second one is, um, um, I do not believe that a single person can solve 6 billion people’s problem. So it should always be

Your thesis has to be pressure tested. With, uh, at least a few people not related to you , so that because they want to please you, it has to be independent people. So if you think that you have an unfair advantage because you have some technology or some breakthrough that is going to make a difference, then you should be able to convince another human being about both the problem and the unfair advantage that you might get.

So that’s the second thing I look for is the unfair advantage. And if you have convinced, uh, one or two other people that that’s the correct unmet need and the unfair advantage, then those two or three people together, not the first person, but all of them together, need to then build the third thing, which is board of advisors and mentors.

Because, um, uh, you cannot know, you cannot predict the future, but you can certainly prepare for it better. If you have wise people to advise here, and the advice has to be related, The fiduciary responsibility of the organization, which is what is correct for that organization rather than this, uh, mechanical thinking about how much money to raise or what partnering to do or which forum to go and present at, or the go to market strategy and all that stuff that people hear about.

That’s not mentorship, that’s just process. Process is not knowledge. So the advisors can do that. And if you get those three, uh, things settled in, then you really have to think about and it. It takes about 40 years realistically to see the true impact of your innovation. And there are three legs to it.

Innovation, translation, commercialization until it’s, so if you’ve just innovat. And not translate it or commercialize. That’s just something, that’s what I call bench to bookshelf research, you know, and I believe in bench to bedside, which means you have to fulfill all three and one cannot do all of it, and one cannot live for 40 years and try to see this many drugs.

So you have to always understand what are value inflection milestones. So what is really going to be a disproportionate increase in value? And so focus on those. So with your advisors and your board members, if you’re lucky enough, you know, some wise investors talk about value inflection milestones, and then really build the budget to those milestones, keeping in mind that you have to have longer budgets as well.

But remember, time is the most precious commodity. It does not come back. So try to hit the short winds. On target, on budget and make the milestones be meaningful in terms of value inflection. So, so that’s what I’ve been able to do with those six points that I just told you. Those are

Naji Gehchan: great advice. I would love to continue on this and more from a leadership standpoint.

You as a leader, uh, have you, what, what are your key learning, uh, from a leadership

Pravin Chaturvedi: stand? Yeah, . So, you know, it’s, it’s a very lonely position. Naji, because, um, um, you’re supposed to do the right things as a leader. Managers do things right. They can, you know, jiggle the process and get it right, but leaders have to set the right vision and, uh, the right, uh, goals.

And so you have to really think about, you know, what are you going to. Um, um, in 10 years, what are you gonna do in five years? What are you gonna do in three years? What are you gonna do in one year? What you gonna do next quarter? So you kind of work backwards from your label, right? So as a leader, you have to always keep that in mind that, um, um, you have to think about what is the right thing to do when you have set that up.

Then the second thing is how are you going to basically, Your colleagues, because you know, all of us, the sun will set on all of us, right? It’s our descendants who will bring it forward, right? So, and our descendants can be our peers, our superiors, our our junior people. It doesn’t really matter. You have to inspire them.

So you have to win their hearts and minds. How do you win people’s hearts and minds is by basically telling them the truth. So you have to be honest, authentic, and truthful. So you should be able to say, you know, um, we are going to do. None of us have a blueprint. There is no roadmap. Uh, and it’s going to be, uh, sort of an expedition.

But, you know, come on the journey with me, right? Because think about the founding fathers of United States. Ji 12 people signed their names and there were death warrants issued on them in 1775, right in the Declaration of Independence here in Boston. And now we have a 19 trillion country from those 12 signatures, and the return on capital invested that time is infinite.

Nobody can calculate, right? Because if you do the right things, the right things will happen. So it has to be timelessness. So the third thing you have to be is remain relevant. So timelessness of your decisions are very important. You cannot make decisions to solve yesterday’s problem. You should make decisions that allow the future, your descendants to be able to solve the problems that therefore they have to encounter that you can’t think about right now.

So you have to give them that wisdom to recognize it. So as a leader, if you can do those three things, then the most important thing against people, cuz you’re inspiring people who are going to basically carry your baton and then, um, and, and if to, in order to do that, communication becomes very important.

You have to speak and, and, and not exchange long emails. Don’t send emails because the written word is harsher than the spoken word, you know, because when I speak, you can see my face, you can see my voice, you can see my hands. And you can see that I really believe in what it is. So when you inspire people and you communicate that, then they understand and they’re not afraid to tell you.

Cuz you can’t terrify them, right? You cannot tell them, don’t tell me any problems, just tell me good news. Right? No, I, I, I always tell them, you know, escalate bad news faster. That’s not a good bottle of wine, bad news. It doesn’t get better with time, it gets worse . So when things are not working, come and tell me, you know, and we’ll solve it together.

Don’t hide it. So those things become, you know, transparency becomes very important. And, and people, authentic people will get people to talk to them and, and they will have great convers. Yeah. Building

Naji Gehchan: the safe space, obviously for, for people to speak up. And when you talked about people, you obviously built teams, scaled companies, joined boards.

Uh, what are the key capabilities or traits that you look when you are hiring or growing a team in a biotech

Pravin Chaturvedi: company? Yeah. Um, it’s a good question. And so really ask them, you know, you know, what is the, uh, what is it that they know, right? Because I think people tell you their skills. Um, but for instance, if you woke me up at three in the morning and say, what is it that I know?

I’ll tell you, I know drug development. I’ll go back to sleep. So the more you know, the more succinct you are. You’re kind of very confident about what you know, and you don’t pretend to be anything else, right? So I want people to have that authenticity about them, that I’m, I’m good at this, you know, I can do this, you know, and, and not say I’ve done this, I’ve done that, I’ve done that.

Activities don’t make up residual intellect, which is what I look for. That’s the first one. Second thing I look for is why are these people really building an enterprise? Are they doing it because of their ego? Is an ex is an expression of their narcissism? You know? Or are they really caring about something?

Is there a significance to why they’re doing it? Because naji all, uh, entrepreneurs and medical scientists are narcissistic. They firmly believe they’re smart kids. They’ve always been top of their class wherever they were, they competitive. And arrogant. And, and, and so that is, and that is a price to pay.

I’m going to inherit those kind of people. So then I want to know the significance, what inspires this person. And if that person cares about someone other than themselves, , uh, then that’s an important character in them. And I will actually partner with them despite their, um, ego in arrogance. So that’s the second thing I look for.

And third thing is motivation. Yeah. You know, uh, 98% of success is from execution. Execution with discipline. And it is very hard to see progress when your nose is so close to the grindstone and, and board members can see that. And this person has to wake up every morning and go do the same thing over and over.

Inspire the people work the people run, and try to raise money, pay bills, , make sure that the rent is paid on time, electricity is not lost, and that that requires a daily grind and that person has to be motivated and a self starter. So I look for those three characters characteristic.

Naji Gehchan: Thanks for sharing, uh, from your broad experience.

And I know this question, uh, you kind of mentioned it in the beginning that you look for problems and how to solve them specific for patients, but I’m gonna try it. Mm. You have such a broad experience in different top science, uh, uh, companies today. Uh, what is for you the next best problem that we’re solving or the next.

You know, think in science that will come up when you’re looking at the biotech field.

Pravin Chaturvedi: Yeah. Um, it’s an excellent question. Naji. It’s unanswerable, honestly, but I think, um, um, there are, there are black swan events that I have experienced, uh, in my life, right? So, um, obviously HIV epidemic, uh, in the nineties was a Black swan event.

Um, unforeseen, unexpected. I didn’t know the first thing about biology. Right. Uh, but I didn’t need to know virology. I knew there were plenty of biological scientists. They were somewhere in the shadows. But with HIV and with retroviruses, um, it was completely antithetical. You know, DNA to RNA is what everybody knows.

RNA to dna, nobody knows, you know, and HIV is a retrovirus, you know? So, uh, so to, to think about it that way, uh, was, um, antithetical for people. So it’s a Black swan event. Um, when we, um, Sort of solve that, uh, epidemic over time. Took us over 25, 30 years to do that. But we did ultimately people became part of the workforce and became almost healthy.

Um, HIV patients today are not as sick as what they were in the eighties and seventies, eighties and nineties. Then, um, September 11th. Uh, and that was a Black Swan event because it changed the world. Um, uh, basically the geopolitical crisis that was created by September 11th, uh, created this whole infrastructure change and, and we got exposed to, um, everything from military.

Uh, department of Defense initiatives to what was, what was troubling the Middle East or what was troubling Africa, because now all of a sudden this coalition had gone to Afghanistan and, and done that. Uh, and, and, and it was all well and good from a military standpoint, but it changed the world forever.

So that was a Black Swan event. Um, the subprime mortgage crisis was the third Black swan event. Because basically wiped out 60% of the world’s economy, from that crisis, and everybody kind of went into, um, abject poverty. And illness and malnutrition. So then you, you did that. Natural disasters happen every year anyway, earthquakes and floods and everything, so you’re dealing with that as well.

And then the fourth one that I have witnessed in my life is covid And, uh, covid came unforeseen and, uh, without firing a single bullet changed the world forever. And so, um, uh, the pandemics, uh, naji are happening faster now than they used to in the previous century. And that’s because of globalization.

Bad luck, , that you get in contact and you travel more and more crowded because the population of the earth has grown, you know, to 6 billion. So I think we are living longer, but we are living more crowded, less resources. Climate change. All of these are having an effect on us, any, any living cell. So adaptive response.

So I’m not going to say that there is a technology today that’s gonna solve every problem tomorrow. So when I, you know, CRISPR came out in 93, gene editing became the, uh, flavor of the month. I’m completely unprecedented by that because that does not mean anything. Because by the time you edit the gene and put that back in to translate to a protein, the species has evolved or become extinct,

So you’ve gotta solve real problems in real. And not sell hope. And so one has to remember, hope is not a strategy, you know, to solve problems, you know? Yes. And people who sell hope are basically just interested in being narcissistic and talk on media circuits. We have to solve real problems. If there’s a chole outbreak in Haiti, we gotta really contain that.

Or if there’s a viral crisis, Ebola crisis in West Africa, we gotta solve that. So I don’t, um, somehow problems emerge. I don’t go looking for them. But when they emerge and they come in my, uh, eye line and I feel like we should do something about it, then I will collect a group of people who know more about it and then, and try to listen to them and say, what can we do about it?

And then try to influence everything. So policy influence is very important. Science alone cannot solve the problem policy and the market conditions have to be solved. So then you have to bring all those people into the equation. So that’s how I.

Naji Gehchan: Yeah, I’m, I’m with you. We, you know, so many times we hear that we wanna do things, but actually do not act and just fix the problem.

So this getting things done, I’m feeling is one of the toughest things, unfortunately, in, in today’s where a lot of people wanna do things, but actually those who really take a problem and fix it, or a few. I, I will go into giving you a word now and I would love your reaction to it. Uh, The first word is leadership.

Mm-hmm.

Pravin Chaturvedi: decisions.

What about impact value,

PowerPoint. Useless

Naji Gehchan: I manage the bet for you to speak more than three minutes. , can you tell us more? Can you tell us more about your philosophy on PowerPoint? I think

Pravin Chaturvedi: many will benefit from it. Well, I think, uh, I think PowerPoints are visual aids, right? So, uh, people use them as a way to, uh, create a, um, um, a monolog. Because, uh, you know, it’s like watching television or watching these, um, um, um, what do they call binge watching all these shows on Netflix.

You know, you get transfixed to the, uh, stimulus to your eye and your brain, and you basically are no longer thinking you suspend everything else. So what PowerPoints are meant to be is, you know, I have a 10, 20, 30 rule for PowerPoint. So if you work with me Naji, it’s 10 slides, 20 minutes, and 30 point font.

So not six point fonts with 9,900 words in a slide. You know, cannot have more than 10 slides. If you cannot speak to me in 20 minutes. What you want to talk about should be usually two minutes. But if you can do it in 20 minutes with 10 slides, with 30 point font, I will listen. But as soon as somebody comes in and there are so many words on the PowerPoints line, I stop reading and I basically either leave the room and get a cup of coffee.

Or I just go outside, you know? So that’s my philosophy on PowerPoint .

Naji Gehchan: What about spread love in organizations?

Pravin Chaturvedi: Well, I, I am fascinated by what you, uh, the preamble that you gave, uh, I think it’s a very interesting, um, um, way to present. Um, in our industry, which is a technical industry. Correct. So, so the way you have decided to spread love and you are making your point that we learn from each other, that human beings learn from each other and we grow and grow together.

Um, which is, you know, is my philosophy about mentorship. Right? That’s why I’m so grateful to my mentors. I’ve been lucky to. Many, obviously my parents and my friends and new friends, uh, such as you, Naji, you know, they’re all become my mentors because we learn from everyone, including our children. And so I, I feel like the way you, your thesis of, uh, spread love.

I, I loved it. Thank you for including me. Oh, thank you. It’s such,

Naji Gehchan: it’s such an honor Pravin hearing you say this and, and I know you’re passionate about it. I remember the first time we met you made sure that everyone connects humanly with others. Yes. And, and this is, I think you’re genuinely caring about people just talking to one another

Pravin Chaturvedi: for us to grow.

I think otherwise we would, you know, we can cannot, we live in isolations and we, we, we, we do not solve anything. Cause you know, it becomes an echo chamber if you only hear yourself all the time and there is no dialogue in it. You know, cuz the purpose of a talk and education for that matter, maji, is to provoke a response.

And so when I give a talk, I expect two responses. I expect you to either hate what I. Or love what I say, the people that I get upset by are the ones who are apathetic to it, who basically don’t listen, have no reaction to it. That bothers me a lot because that means that I did not influence them. I would, I would provoke an anger in you.

I would’ve influenced you because my purpose may well have been to annoy, you know, in my talk. You know? So I think that’s the purpose of human interaction. We get better when we actually provoke a reaction, you know?

Naji Gehchan: Any final words of wisdom, uh, Pravin to healthcare leaders around the world?

Pravin Chaturvedi: Um, they should always remember that they have to be mission oriented and the mission has to be about patient impact.

Unfortunately, our world has become, we have replaced the word impact with seven letter word called impress, and they try to impress you with wealth and their balance sheets and, and when you are a healthcare leader. Take that position with great responsibility because the patients rely on you to basically help them get better.

And a healthy society is a productive society. And just if 10 people have wealth, but 90 people are sick, that’s not a society that is going to be productive. So healthcare leadership take. Responsibility very, very seriously. Otherwise, they should not be healthcare leaders. They should be investment bankers, or they can be involved street, but they should not be running healthcare, biotech, leadership organizations, that is not their role.

And biotech companies should always be led by scientists, medical physician scientists, biological scientists, because it is a scientific game. And that has to, that’s the unfair advantage you have to bring the unfair advantages of people. Intellectual property is not a patent, it’s the people, you know. So that’s my advice to them.

Thank you

Naji Gehchan: so much. It’s such a crucial advice for us as healthcare leaders to make sure that it’s patient, as you said first, and being oriented to this, uh, to this mission, uh, and impact we bring to the world. It’s such a noble and responsible, um, purpose that we have.

Pravin Chaturvedi: Thank you, Naji.

Naji Gehchan: Thank you so much for being with me today.

Pravin Chaturvedi: a pleasure. Likewise. Thank you for inviting me.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Basima Tewfik

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, having the pleasure to be joined by Basima Tewfik Career Development Professor and Assistant Professor of Work and Organization Studies at the MIT Sloan. Basima main stream of research examines the psychology of the social self at work. In particular, she seeks to define new conversations around two underexplored phenomena in the organizational literature that implicate the social self: Workplace impostor thoughts (popularly known as impostor syndrome), and request-declining at work. In a secondary stream of work, she examines effective employee and workgroup functioning in the modern workplace, an increasingly important topic given the rising complexity of work. Basima’s work has received several recognitions and she was named by Poets & Quants as a “40 Under 40” Best Business School Professor in 2021 and by Thinkers50 as one of 30 thinkers to watch in 2022. Prior to her graduate studies, Basima worked in consulting.

Basima – It is such an honor you with me today!

Basima Tewfik: Thank you so much for having me, Naji. It’s great to be.

Naji Gehchan: I’d love first to hear your personal story from psychology to consulting and now being a professor, a thinker on work and organization studies. What, what’s in between the line of your incredible journey?

Basima Tewfik: Yeah, that’s a great question. Uh, so, uh, it looks a lot more linear than it actually is. Uh, so this started back when I was an undergraduate. I started doing some research with a professor of psychology who was also affiliated with the business school. His name was Richard Hackman. He’s a big sort of person in leadership and teams research.

While I was doing that as an undergraduate, I really, really enjoyed it, but I sort of looked around my peers and a lot of peers were going into finance or consulting, and so I naturally said, obviously that’s what I’m going to do too. So I ended up going into consulting. But it was really when I was in consulting that sort of, the idea of going back to school and potentially being a professor really came to light.

Um, and this was in part because I realized as I was going to client sites, uh, that I was much more interested in examining the dynamics. Of my own teams when we were at different, different states, um, and different countries, then I was actually helping the clients. Um, and so that indicated to me that I probably should be focusing my efforts on understanding workplace dynamics.

And so I ended up reaching back out to my undergraduate advisor, um, who was nice enough to write me a recommendation letter. And that sort of, uh, catapulted my journey back into Accu.

Naji Gehchan: I love it. So let’s dig into your research. What your thoughts or what’s known imposter syndrome. Uh, big topic, rarely discussed, I would say, but big topic in many of our minds.

Can you first help us maybe define it and why you talk about thoughts versus syndrome and your, your ideas around it.

Basima Tewfik: Yeah, let’s, let’s jump right into it. Uh, so the idea of studying this phenomenon came to me very early, uh, in my PhD exactly for the reason that you mentioned, which is this is something that we often hear about.

Maybe people aren’t actually necessarily sort of telling their supervisors or their, their subordinates that they’re experiencing this phenomenon. But it’s definitely something that many, many people think or feel. So I think statistics show that maybe up to 70% of people tend to have what I call workplace imposter thoughts.

Um, so what do I mean when I say workplace imposter thoughts? I basically mean that it captures the belief that others overestimate your talent or abilities at work. So specifically a sample sort of statement to really bring that to light, to make it concrete is this idea that I think other people think I’m smarter than I think I.

And as a result, this could lead to a number of emotions or thoughts or a sense of belonging, but really it’s about this discrepancy that I think people maybe think I’m a 10 when it comes to, uh, how competent I am at work. And it’s not necessarily that I think I’m bad at work, so it’s not like I think I’m a three, but maybe, I think I’m like an eight.

And so there’s this positive discrepancy where I think people are overestimating me. The reason I use the term thoughts and not syndrome. Or, or even phenomenon, uh, was actually something that was carefully thought through. So if you look at the academic literature, um, this was first introduced in 1978.

Uh, interestingly in that literature, they always refer to it as imposter phenomenon. But if you Google, um, you’re gonna see that the popular term is imposter syndrome. And syndrome implies that sort of, this is a medical diagnosis. Uh, you have a healthcare background, . Um, and one of the big things about this is it’s not a syndrome.

It’s not a medical diagnosis. This is not something that people always have. Um, and so it really became clear to me that we have to be much more precise with the terminology if we’re going to start a new conversation around this phenomenon. Hence my term of workplace imposter.

Naji Gehchan: Yeah. And I love how you framed it.

Uh, you know, and another thing, I obviously definitely have imposter thoughts, and frequent ones. And I’m always surprised we talked about it even within my team a couple of weeks ago, and many have it actually, and sometimes we don’t say it even in, and even more in technical jobs I feed, sometimes it can become a thing and people don’t really talk about it.

Um, you know, another, another sentence I’m sure you heard a lot is this fact. One day they’ll figure out, you know, that I’m the impostor and why they, you know, I’ll, I’ll, they will know. Uh, so I’m, I’m interested a little bit more from your research. You know, is it a bad thing? Is it a bad thing of having those thoughts?

Like how, how do you deal with it and what have you, uh, seen in the, the research you’ve done?

Basima Tewfik: Yeah, so, so the general sort of consensus or prevailing wisdom, I would say is that it’s a bad thing, and that’s really not surprising, right? So even if you think about the term imposter that conjures imagery of, you know, a bad, a person who’s trying to fake it or something like that, right?

So it has negative connotations. Um, and so most of the research, most most practitioners suggest that it’s a bad thing. Um, You know, there is some sort of research to support that in the sense that people who have these thoughts generally might have more anxiety or lower self-esteem. So there tends to be these correlations, right, with negative wellbeing outcomes.

Um, but my interest in the phenomenon actually came from the fact that most people who report having these thoughts or, or let’s say a lot of people who report having these thoughts are actually high. When we hear about this phenomenon, we hear about it happening in C-suites of top companies. Um, Albert Einstein is someone who’s claimed to have had these thoughts and, you know, he is synonymous with the word genius.

And so this sort of indicates, hey, maybe we don’t have a full perspective or a holistic picture of what this phenomenon is. And that’s sort of what kicked off my whole interest, uh, in trying to create this more holistic picture.

Naji Gehchan: So can you tell us more about it? Because you’ve done very serious randomized research, so obviously I’m in healthcare.

When I saw your research I was like, oh, like this is serious. So I’d love to hear more what, what, what was the outcome and the methodology of what you’ve done.

Basima Tewfik: Yeah. So let’s talk about, um, maybe one of my most recent papers that looks at how workplace imposter thoughts relates to the important workplace outcome of interpersonal effectiveness, um, while keeping sort of job performance in mind, right?

Because obviously we wanna make sure that there’s no downsides for competence related outcomes. So a lot of my research, just as at a high level, combines correlational studies in the field. So I actually go into organizations to try and find associations between imposter thoughts and outcomes of interest.

Um, and then I tend to pair these with causal experiments so that I can get at exactly what you were talking about earlier, which is this idea of making sure that you know it’s specifically imposter thoughts. It’s actually leading to the outcomes that I’m hypothe. So for one of my papers, I was really interested, uh, in trying to understand if and why, um, people with more imposter thoughts are actually gonna be rated as more interpersonally effective.

So I ran four studies. The first study was actually in a finance firm, and that was sort of a, you know, a simple test of this idea, right? Would I find people who have more imposter thoughts? Would, would I find that their supervisors would rate them as more interpersonally effective? And what was super interesting is at time one I had.

Finance employees rate their imposter thoughts using a measure that I created and then two months later I had their supervisors rate them on how interpersonally effective they were. I also had them rate their, their employees on how well they were doing at their job, right? Because we wanna make sure that this interpersonal effectiveness benefit doesn’t necessarily come at the cost of compete.

And so what I found there was, was really promising. So I found this really robust, significant positive effect between having imposter thoughts at time one and other people seeing us smart, interpersonally effective. And so this led me into a second study. Um, and this study I was, I was really excited about it because it was actually at a patient simulation.

So specifically I partnered with a medical school and they have these simulation centers where their physician trainees actually interact with actors who are stimulating as if they have a particular illness. Um, and they often video record these interactions. And what’s really, really cool about these, uh, interactions is they’re, they’re standardized.

So what I mean by that is all of these patients have gone through a training, they’re all making sure that they’re interacting with physicians in the exact same. And so it was this nice hybrid of, you know, very organizational in the field with a little bit more control over what was going on. And there, what I found is those physician trainees who said that they experienced imposter thoughts more frequently.

Actually ended up interacting with patients quite well. So specifically patients gave them higher interpersonal effectiveness ratings. So specifically they said things like, oh, I really felt that the physician was empathizing with me. I really thought they were listening. Well, I really thought they were sort of answering my questions Well.

Um, but what was also really cool is the fact that these were video recorded because it allowed me to see what exactly was going on. How were these patients suddenly deciding that the physicians with more frequent imposter thoughts were actually these more interpersonally skilled physicians. And so I ended up recruiting several coders and we watched, uh, these videos, which was approximately 5,000 minutes of video, where we would stop the video every minute to see what was going on.

Um, and basically what we found is those physicians who had more frequent imposter thoughts, Were also those physicians who noded a lot more. Uh, they sort of practiced more active listening skills. Um, they had better eye contact. They had a more sort of considerate tone as compared to those physicians with less frequent imposter thoughts.

And as a result, that was leading to, uh, higher ratings of interpersonal effectiveness. And they weren’t getting the diagnosis in. So we also wanted to make sure, okay, maybe these physicians are really interpersonally effective, but they’re really bad doctors. Like maybe you don’t want them cause they’re not actually gonna diagnose you.

And we didn’t find that to be the case. And then I followed up those two studies with some experiments to actually get at causality where I actually manipulated some people to have imposter thoughts and then looked at how other focus they were. Um, and then whether that explained essentially how interpersonally affected, and I found that to be.

Naji Gehchan: That, that’s great. So to to my question, is it a bad thing now that you’ve looked at this, you’ve seen the interpersonal, uh, effectiveness coming out? Like how, how, how do, would you answer this question? Should I be reassured?

Basima Tewfik: Yeah, so this is a great question because it gets at this idea, okay, what are the implications?

What are the takeaways here? And I actually think we have to be really subtle and precise with what the takeaway should be. So one thing I want to emphasize right off the bat is, although I didn’t find that, you know, in the finance sample, they ended up performing worse, or in the doctor sample, they ended up getting in correct diagnoses.

I wanna make sure that we’re not over. Um, so reading into non findings, right, it’s a non-significant finding. It doesn’t necessarily mean it’s always gonna be non-significant. Um, so for me it means a couple things. It means as a manager, um, you know, if I have an employee who has imposter thoughts, Um, you know, I want to assess the employee in its in their entirety.

So what I mean by that is I wanna think about three sets of outcomes. I wanna think about my employees wellbeing outcomes. I wanna think about their confidence outcomes, and I wanna think about their interpersonal outcomes. And so if my employee is in a setting, like the ones that I studied, so there were opportunities for interpersonal interaction.

Maybe their, you know, performance is a little bit more subjective, then maybe I might say, Hey, the takeaway shouldn’t be, get rid of your imposter thoughts. Cause actually, if you get rid of your imposter thoughts, maybe you won’t have this interpersonal benefit and it doesn’t necessarily hurt you from a competence perspective.

That being said, there’s the elephant in the room about wellbeing. Imposter thoughts still don’t make you feel really great when you have it. Um, and so this means to me of, okay, so let’s imagine a different employee, maybe an employee who’s working remotely and doesn’t interact a lot with other people.

Then we might wanna consider for that employee that maybe they, they should get rid of their imposter thoughts. Because for them there’s no way for them to get the interpersonal benefit. They’re probably gonna get the wellbeing, cost, and competence right now is a wash. It’s not necessarily gonna be good for your competence.

Um, and so what I’m hoping is that people have a lot more of a sort of tailored approach to managing this phenomenon. Now if we think about it from the perspective of the employee themselves, um, what I hope this research does is sort of indicates to those individuals who are experiencing the, these imposter thoughts that maybe they’re not so bad.

Maybe we can reappraise our thoughts so that we sort of downplay the negative emotions that comes with them so that we can focus on sort of the upsides that may also accompany.

Naji Gehchan: I love it. This is really super helpful tips and kind of situational, right, like situational managerial, uh, depending on, on people.

And I love how you framed also the wellbeing. It’s really a very important point in this hybrid virtual word. Um, that’s, that’s really super helpful. Uh, you know, one, one thing that keeps coming to mind, um, and you kind of mentioned it a little bit, uh, is those imposter thoughts. If, if we have this overachiever.

Someone who really is doing good and he wants to overachieve, are these imposter thoughts actually driving people to be at their best sometime. And my other kind of related question is, is it also kind of related or. Putting me a check from a humidity standpoint, like, did, did you look at kind of humidity?

And also, if we combine this with overachieving, then it’s really good because people are gonna keep on trying to be better on what they think. They’re not as good as they should be.

Basima Tewfik: Yeah. Nearly. It’s almost like you have a, a magnifying glass into my current research pipeline. . Um, so. Talk about your first, uh, statement, which is sort of connecting this phenomenon of imposter thoughts to ever, um, like do you work harder?

Uh, so what’s really interesting in the literature is there seems to be mixed intuitions about when people with imposter thoughts work harder or when they sort of procrastinate and withdraw. Um, one of my current projects is trying to understand under what conditions, so thinking about sort of job characteristics.

So, you know, do you have a lot of a high workload? Do you have a really complex job? Is it maybe when your role is particularly salient that would necessarily explain when you suddenly do well versus when you suddenly do not do well? Um, from an effort standpoint, I think it’s an open question. I think it’s a.

Uh, you know, a ripe, fertile ground to explore. Um, I’d love to tell you in about two months what the answer is. Um, but in general, my intuition is that people with imposter thoughts do, uh, exert a lot of effort. Now, the bigger question though, is again, with, with sort of painting this more holistic picture, it’s always really important to think at what costs right as and to ask that question.

And so if I’m telling you, Hey, my intuition is that people with imposter thoughts might work really hard, well, one question you may have is, well, does that lead to burnout? Um, some of my preliminary evidence suggests that the increased effort doesn’t necessarily lead to more burnout. But, um, there are always usually positive correlations between people who have imposter thoughts and their report of burnout.

Part of this might be due to halo effects, so if I’m someone who thinks or I have imposter thoughts, so I report, I have imposter thoughts, I’m probably much more likely to report also negative outcomes. I might be more likely to report that I’m also anxious, I might be more likely to report that I’m also exhausted at.

And so that’s why causal experiments are really important to start to tease, uh, these sort of concepts apart. Which also relates to your part two of your question. So you asked about the relationship between humility and imposter thoughts. Um, and this is, this is a fantastic question. So my paper is one of the sort of first papers, particularly in our top organizational journals, to really reco conceptualize this phenomenon.

And as part of that exercise, you really have to go through a, a sort of, um, a whole rigamarole, a very good rigorous rigamarole to start to say is imposter thoughts. This is it, this is it. This, to make sure that you’re not adding a construct that’s redundant with what we already know. So one that often comes up is this idea of humil.

So is our people who say, oh, I think other people think I’m smarter than I think I am. Are they just humble people? Um, so to this, I actually turned to Owens’s work. Uh, he is someone who studies humility in the organizational space. Um, and what’s really interesting about humility is it’s. A construct that captures much more than this idea of discrepancy between what other people think of me and what I think of myself.

So typically humility is wrapped up with things like, you know, your limits. So you sort of know your weaknesses and your strengths, and so you’re able to sort of make those assessments. Um, and so I do think that there’s probably a correlation between being humble and people have imposter thoughts, uh, but I do think they’re distinct things.

This also leads to another thing that that often comes up. So I mentioned to you at the beginning that 70% of people tend to experience these thoughts. So one question I often get is, well, who are the 30%? Um, I usually don’t like answering that question because the 30%. Uh, could be a number of different, uh, different types of people.

Um, so some might be people who are not particularly reflective. I don’t mean that in a negative way. It’s just people who aren’t necessarily thinking about what other people think of them. Um, and to them, I’m very proud of them and hope that they maintain that sense of self. Um, it could also be people who are over competent, confident, so people who are over competent.

Have the opposite problem. They’re, they’re, they’re not particularly humble. They think that they are better maybe than their actual performance or better, uh, than they think other people think they’re, and very

Naji Gehchan: quick question before we go into another subject. Uh, any differences in gender and cultural differences with imposter thought?

Basima Tewfik: Yes. Um, so the gendered question often comes up. So one of the big things around this phenomenon is that women tend to experience this more than men. What’s really interesting is that in my own data and also in a systematic review by, um, Dr. Bravada, that’s actually not the case. Um, so there are actually a number of studies to suggest that this is not necessarily more prevalent for one gender over another.

Um, it’s not necessarily more prevalent for one race over another. And so what I’m hoping is that we start to move the conversation from who’s experiencing this is one particular gender, experiencing this more to under what conditions might people of different genders maybe respond to these thoughts in different ways?

Um, so it’s definitely where I think the field is moving, but we’re still in the process of trying to dispel some myths that are, that are very popular. Right? Yeah. Which takes a lot of time to essentially bring them down. Um, from a culture perspective, it’s a really interesting question. This is something I want to explore further.

Um, there’s a couple things I can say. So, for example, if you look up this phenomenon on like Google Trends and you sort of map out who’s searching for this phenomenon, it tends to be primarily Western. So you tend to see the search, the searches happening in Western Europe, Canada, United States. Does this mean it’s not happening, uh, in other parts of the world?

Maybe. Um, I, I think that’s definitely something to explore. I definitely think it’s still happening, but what might be going on is people might refer it or see it in different ways, uh, potentially healthier ways, right? Maybe they’re not searching this concept because they actually think this is part of life, and so they’re not trying to figure out, how do I get over my imposter syndrome?

Thanks. Thanks

Naji Gehchan: for those. I, I’d love to go now to another feed you explore, which is effective employees and work group functioning, uh, especially in this new word that we are living in. Uh, and I’m gonna be very specific asking for maybe one or two advices that you would, uh, give us as leaders to ensure effectiveness and teamwork in our

Basima Tewfik: organiz.

Yeah, I think that the biggest thing for me, it’s probably just one, um, and actually very basic, but it’s really listening. Um, so part of, part of actually what I love about your podcast is this idea of spreading love and, and sort of paying attention to those in your environment. I think at the end of the day, work is about relat.

To the extent that you can sort of approach everything at work as relational relationship building, um, the better off you are. So for example, at Sloane, I teach a negotiations class to MBAs. And the biggest thing, and what I say on day one is that negotiations is about relationships. It’s not about winning.

It’s not about losing. I make a joke in Class six about how you can use everything that we’re teaching in this class to apply to romantic relationships at home. Um, because essentially it’s, it’s all the same. So I really want people to think about relationships and prioritize that because the rest will follow.

Naji Gehchan: Yeah. And, and it’s, it’s so true. And sometimes it’s tough for people to accept it, right? Like the more technical you are, the toughest it is to like, no, like, we don’t need to build relationship. We know exactly what you wanna do, right? So I, I love this advice. Um, I, I would love now to give you words and get your reaction to it.

Basima Tewfik: Okay. That sounds fun. I, I grateful to see these words or two,

these

Naji Gehchan: words. So the first word is leader.

Complicated. Oh, it’s the first time I get this reaction. Tell me

Basima Tewfik: more. Uh, so I think, uh, to be a really good leader, you probably don’t actually want to be a leader. So there’s some great research, um, that was done at dissertation work by a professor named Danielle Tess, um, on this idea of reluctant leaders.

And it’s really something that’s really resonated with me, which is I think the best leaders are often those who are most reluctant to take the mantle.

What about

Naji Gehchan: request decline?

Basima Tewfik: Can I use three words in response or does it have to be a one word reaction to reflect?

Naji Gehchan: No. Yeah. No. You can, you can, you can talk about it a little bit more. I was so intrigued with this research, so you can talk more .

Basima Tewfik: Uh, I would say my reaction to the phenomenon of request declining is it should be more prevalent.

So request declining is the idea. That you should say no to more requests that are on your plate. And the reason that I study this phenomenon is that a disproportionate amount of helping at work is actually done by a a few number of people. And so if they’re really going to be effective in giving help, they need to be able to prioritize among the requests that they have.

And so, and I think it’s really important that, and we should be more willing to say,

Naji Gehchan: This is definitely a big phenomena we, we all see. Right? Especially if you combine overachieving with people delivering. Uh, yeah. So one of the things, um, I stopped prioritizing, I don’t know if you agree with me on this. I stopped prioritizing and I started to make choices. Like I, I really push my, you know, my teams that make a choice that if you’re doing this, then you’re not doing something else.

Basima Tewfik: I, I think that sounds great. I think that’s, uh, if you can get there, I think that’s a bold, bold new frontier that more people should move into.

Naji Gehchan: Thank you. I’m trying. I’ll let you know. . Yeah, I

Basima Tewfik: was like, report back .

Naji Gehchan: What about social self?

Basima Tewfik: Uh, I think it’s under prioritized. Um, and it’s the same reason for what I was telling you earlier, that I think relationship building is really important.

I think when we think of the self, uh, we tend to think of, especially the self at work, we tend to really think about, you know, how smart we are, how well we’re doing our talks. Um, and we tend to downplay how we’re interacting with others or, um, what our relationships are like.

Naji Gehchan: The final one is Fred Love and organizations.

Basima Tewfik: I, so when I heard about this, uh, I think, uh, there would be a late professor, her name is Al Bar, who would be absolutely thrilled to hear that you’re doing this, um, this podcast she has, she passed away last year. She was fantastic. She’s at Wharton. Um, she has a paper on companion love in organiz.

So one of the big ideas that she’s left in the field, um, is sort of this idea that we need to have more love at work, um, and love, not romantic love, companion love this idea of affection and caring for others, um, and showing that that leads to really positive downstream outcomes at work. Uh, thank you so

Naji Gehchan: much for, for sharing this and honoring all her work.

Any final word of wisdom, uh, Basma for us leaders around the.

Basima Tewfik: I think it is, um, continued to aspire even if it is complicated. So I think being a leader, going back to what I said earlier, it’s a hard job. Uh, it’s not for the faint of heart. Um, and it’s a continuous learning process. So adopting a growth mindset as you sit in that position, uh, can be incredibly helpful, especially given the impact that you have on so many.

Naji Gehchan: Well, thank you so much. It was really an honor and a pleasure to talk to you and learn more, uh, about your research and all that you’ve done. Thanks so much for being with me today.

Basima Tewfik: Thank you so much for having me.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Deborah Ancona

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this episode joined by a distinguished Professor of Management and founder of the MIT Leadership Center Deborah Ancona.

Deborah’s research and work led to the creation of multiple powerful models, tools, practices and concepts, including X-Teams as a vehicle for driving innovation within large organizations, and also the concept of distributed leadership that enable organizations to foster creative leadership at every level.

She has also served as a consultant on leadership and innovation to several companies including healthcare. 

Deborah is the author of the book, X-Teams: How to Build Teams That Lead, Innovate, and Succeed along with several other publications and articles in prestigious reviews. One of my favorites is “Family Ghosts in the Executive Suite”, I had the privilege to hear it, and apply it directly in Deborah’s leadership class, and it did help me tremendously!

Deborah – I am thrilled to have you with me today!

Deborah Ancona: Well, I’m thrilled to be here. Thanks for the invitation

Naji Gehchan: From psychology to leadership and management, there might be some links, but would love to hear your story. And what’s in between the lines of your journey. And now being a distinguished professor at MIT, Sloan and founder of the leadership center.

Deborah Ancona: So my story, it’s interesting because I have all of the students in my classes tell their stories. And I don’t always think about, about my own. Uh, but one of the stories I do tell in the class is that, um, I come from a kind of an intellectual family. Um, my father was a professor, um, and. Everybody in the family had medical background.

So my dad was a doctor and my mother was a medical social worker. My brother was a doctor. It was just expected. That’s what I would do. But, um, I hated natural science. I hated physics. I hated chemistry. I hated all of those subjects. And, um, the good news was that I. Somehow had the wherewithal, cause I was a pretty gutsy, uh, gets a young lady, um, to say, no, this is not for me.

And, and that kind of led me, um, to ask the question, well, what did I really like? And, um, It’s funny because there was a bet with a, a friend of mine, uh, who was taking a management course and I was taking a psychology course and he said, oh, that’s so easy. I could get an, a easily. And I said, oh really well, I’ll take a management class and you take a psychology course and we’ll see who does better.

And that led me to really. Uh, liking that idea of taking the psychology that I had studied all about cognitions and how people think and why people are fearful and why people get depressed and lots of interesting questions from psychology, but applying them in business and managerial situations. So I found that very intriguing.

Um, so off I went to get my PhD and found that, um, One of the areas. Again was very intriguing to me. So I I’ve always kind of followed my nose to say, what’s a problem out there. That’s, that’s interesting. That kind of pulls my attention. And so, um, while I was working on my PhD, I was asked to come in and work at a telecommunications company.

To understand what made their teams effective. And, um, I was very lucky. My advisor got me into this company and we had lots of data collected of over a hundred teams and we took all of the. Literature that was known about teams. What makes teams effective? Um, so you looked at, uh, the right kinds of people, um, clear goals, clear roles, comradery, cohesion, uh, being able to synthesize everything good.

Decision-making, uh, the ability to create trusting relationships, all the things that are written up in the literature. And so we went out and we studied those things and. All of these dynamics were totally predictive of how satisfied members of the teams were. And predicted how well they thought their team was doing in selling communications equipment.

The only trouble was there was zero none, no relationship between what, how well those teams were operating. And their financial revenue, the revenue they brought into the organization. So this started the next, I don’t know, continues to this day. So 20 plus years of research on what makes teams effective.

And, and I love those kinds of puzzles. Why is it that what we think we know doesn’t really work and what does work? Um, and so I love that. Almost investigative process of interviewing people and observing them and collecting a lot more data and having people actually record what did they do? Um, studying highly effective teams and contrasting them to less effective teams.

What are the, what are the real differences? And it turned out that while all of the things that. Intrinsically think of as important in teams, the things I’ve just mentioned, clear goals and roles and cohesion, et cetera, those are important, but they’re only half the story. And if you get half the story wrong, you can still have a lot of failures.

So the other side of the equation, if you will, is what we term X teams, externally active teams. What differentiates high-performing teams from low performing teams, whether they’re hardware teams, software teams, top management teams, manufacturing teams, service teams. Is the ability to not just be good at interacting within their borders, but to be able to reach out, to understand the larger organization, the larger ecosystem, what are new trends?

How do I get my fingers on the pulse of new technologies in a, in an exponentially changing world, as we have seen. For the past 10 years and, and even more amplified with COVID is the B is the need to adapt. And if you aren’t monitoring the external environment, if you aren’t learning from that external environment, if you aren’t creating, um, allies and dealing with your adversaries, if you aren’t reaching out to really coordinate, then you are not as effective.

You are when you do engage in those activities. So anyway, that was, that was a whole long time of really having a great time working with teams, studying teams, watching them pretending I was a member of a communications team, uh, lots of, lots of fun things. Um, and then post that, um, I actually kind of diverge, um, into thinking, well, what about the individual?

Um, how do we help individuals to be able to develop so that they can become members of those kinds of teams so that they can deal with the uncertainty, uncertainty, and ambiguity. So that story. The creation of the course that you took, uh, which is how do you understand and develop your own unique way of leading, which we call your leadership signature.

Um, and, um, Again, lots and lots of talking to people about how they developed looking at it, the theory. So I engage in a lot of sense-making, which is one of the core attributes or capabilities that we look at in the leadership model. And I think, um, part of the power of that model is the idea of sense-making.

Leadership models don’t include it. And yet this ability to really dig deeply into the problem that you’re trying to solve, really try to understand your context, make sense of the context in which you are operating is, is critical. And I use that skill to really, um, pull together. This framework, um, that brought me right back to my psychology roots.

So I was a psychology major after throwing away the natural sciences, I became a psychology major. And, um, so that brought me back into, into those roots, which I’ve enjoyed. Um, I’ve enjoyed helping others to be able to. So on their journey as it were, I hate that word journey, but I use it, um, to develop, um, more fruitfully, uh, using the constructs and concepts that I’ve developed and that I borrowed from a lot of other people.

And the other side of the equation is. Working with teams and individuals and seeing the progress that they were all making. And yet they would go back into toxic environments or organizations that were so bureaucratic that they couldn’t use their new found skills and they become, they became frustrated.

Uh, and so that started a whole other kind of research, um, story, as it were to say, uh, What constitutes a nimble organization as opposed to a bureaucratic one and not only nimble and its ability to adapt, but also having a culture that was not toxic, that kind of embraced freedom and, and people’s ability to be full-fledged members.

Uh, of those organizations. Uh, and so that work with, um, Elaine Backman and. Isaacs by the way that X team was done with Henrik, Brisbane and David Caldwell to give credit where credit was due. Um, so Kate, Elaine and I did did a, oh, I don’t know, many years multi-year study to look at what constitutes nimble.

And so that’s been some of my more recent writing as well. And an HBR article 2019. So that’s a little bit, um, not so much my personal journey, but my personal research journey as it were. And oh, by the way, along the way, I had four kids. Um, so I, um, I have four great children who are grown up now and in launch mode.

And that was also just a. Lovely lovely part of my life. I, um, I never held a child before I had one, so I was woefully unprepared. Uh, but nonetheless, um, I, I just found the kids a joyful experience, watching them grow and develop and feeling like I had some, um, albeit small role to play in, in helping them navigate.

The complex world that we live in. So, um, so that’s my story.

Naji Gehchan: Thank you. Thank you for sharing that. The powerful story, and you summarized in some minutes, huge amount of research that actually helps businesses help us as leader to be better organizations and better leaders. I will go back to a couple of things you shared.

So first. Um, if, if we want to talk about X teams, I love how you frame it. What’s the difference between a high-performing team and our performing team and this internal and external lens. What would be for a leader leading this team? What would be the top one or two capabilities that you think the leader needs to have for them to foster this type of environment for the team?

Deborah Ancona: So I think. One of the things that leaders need to be able to do is to understand that they don’t know everything. Um, and therefore, uh, a big aspect of both X teams and nimble organizations is the idea of distributed leadership that you have to open up your mind to be. Able to receive an update your view of the world.

If the world is changing really, really quickly, then you need to be able to suspend your belief system to say, okay, what’s new, what’s different. And how do I engage? The members of my team and going out and updating our models of what does the customer need? How is technology changing? Uh, what’s different about the economic and political reality that we face right at this moment what’s going on in, in healthcare, uh, with the pandemic and all the different changes that are happening there.

Um, so there has to be an ability to be open. And to encourage many people, not just yourself to seek answers. Uh, and so that’s very necessary, um, uh, in terms of a leader being able to step into, uh, into that realm. Uh, the other thing is, I think. That that you have to be open, but it also requires an ability to step back and let other people lead and let other people come in.

Um, In interviewing leaders. I’ve, I’ve been so impressed with some of them in terms of this idea of stepping up and stepping back. You step up if there’s a need, if there’s something not happening, but the ability also to step back and for even the lowest, um, member on the totem pole, uh, to. Participate and to, um, engage, not that everybody is equal.

It doesn’t mean that everybody has equal participation, but there are things that other people can bring to the table that perhaps the single leader cannot. And we need people to do that more in this day and age.

Naji Gehchan: I love it. And so many different ideas and innovation comes sometimes from where leaders are, we think least expected.

Right? So being open and bringing everyone on the force of everyone on the table is so crucial

Deborah Ancona: and sending them out the ability to. Engage them, not just internally, but outside everybody next week, go interview a customer. What did we learn? What’s different. Go interview a competitor. What are they doing that we’re not doing?

Um, getting everybody engaged and involved, and then you all have when you report back in a better understanding of, of the context.

Naji Gehchan: So, so true. Sometimes it’s frightening. When you think the percentage of time focused on internal. Versus actually being out with customers or with, you know, face sheds or whatever, even looking around at the environment.

Yeah. I totally agree.

Deborah Ancona: The other thing, which I told you in class, I always quote John, John Reed, the former head of Citibank and the MIT corporation, um, is if your inbox equals your outbox, you’re not alone. That you have to do more than respond to what other people are asking you to do. Leadership requires aspirations to new things, to taking on new challenges.

And so that’s also a key thing.

Naji Gehchan: Uh, you, we hear it a lot. All organizations or companies now want to become nimble. So you are behind the nimble organizations and this idea and you’ve researched it. So I would two questions I would love to hear from you. What does nimble organization mean? Like the definition, if you can give it to us.

Um, and then after this one, how to create it and can we aspire towards, uh, what, what should we do as leaders to.

Deborah Ancona: Yeah. Um, well, so we’re not the only one in the space. Obviously. There are a lot of people who are looking at that now. So there are people who stay, we call it nimble, um, uh, McKinsey calls it agile.

Uh, other people call it learning organizations or, um, networked organizations. So implicit in. Is this external focus. You need to be networked and learning, um, uh, for a good period of time and nimble. You need to also be able to move. Uh, one of the reasons to employ X teams, X teams are a big part of nimble organizations is their ability to.

Put together resources very quickly and act in a changing environment. So the ability to both see problems and opportunities quickly and be able to respond to them, uh, is, is part of what nimble is, uh, as well as a culture, um, of being able to step out, being able to, uh, have flexible forms of organizing, um, a culture.

Uh, enables people to learn and celebrate learning or, um, Carol Dweck’s idea of, of a growth mindset, um, is, is quite pivotal to, to being nimble. Also respect, respect for individuals is, uh, is a core part of that. Um, and in terms of. How do you make it happen? Um, we teach in the nimble course, um, a case on such an Adela who has been hard at work actually to try to transform, uh, Microsoft, but we also studied organizations that were nimble from birth and there were several findings from that.

Um, so I’ll just go into, to. As quickly as I can. Uh, one is that we saw three different kinds of leaders in nimble organizations. The. Bottom, not the total bottom, but lower down in the organization. You have the entrepreneurial leaders. This is really the hub of a nimble organization is lots and lots of people who are innovating and coming up with new ideas.

They’re entrepreneur. So what’s a great new business model that we should be pursuing. What’s a new product that we should look at. What’s some new material we should use. What’s a better way to address customer needs. So you have this huge hub of innovation that goes on, um, at, so you want entrepreneurial leaders at every level of an organization, but in particular at the lower and middle ends and then in the middle.

As opposed to bureaucratic organizations where middle managers are all about directing and planning and providing incentives and so on. Um, the, the middle level, the more experienced leaders or what we call nibbling leaders. So they are helping those entrepreneurial leaders to navigate the organization to figure out how do you present this?

And what’s the best way to get people engaged. And how do you run some experiments to prove. Proof of concept, et cetera. And then. Top you have what we call the architecting leaders and the architecting leaders are architecting. What we call the game board, uh, on which the entrepreneurial leaders and enabling leaders play.

So they’re the ones who are architecting the culture of the organization and they’re, um, removing. Um, barriers to innovation. They’re also putting up guardrails because even though nimble gives people a lot more autonomy, um, leaders get scared. I don’t want to go there because autonomy means chaos and it’s going to be a big mess.

And I don’t want to do that. Um, but in fact, nimble organizations have a lot of guard rails and those guard rails are things like, um, uh, funneling. So not every idea that comes from an entrepreneurial, an entrepreneurial leader is a great idea. And so what you want to do is make sure there’s a funnel and everybody knows there’s a funnel.

Right? Okay. Not every idea is going to make it to the rest of the organization. Um, and so there’s, um, a choice committee or, um, you enter a con. And there are very clear rules. This is what kind of innovation we want. This is what it has to be able to do simple rules. It has to be able to make whatever 500 million in the marketplace, or we don’t, we don’t want it.

It has to work with these technologies. So we don’t so very simple rules that provide. Uh, a system by which you can evaluate those entrepreneurial ideas and decide which ones go forward. Um, so the architecting leaders create these systems and these guard rails and these simple rules that help people innovate, but innovate with within particular domains so that it’s not chaotic.

Naji Gehchan: Uh, within, within this, um, those organizations, you talked in the beginning about culture, too. You talked about adaptation change. There’s all this wealth practically for entrepreneurs who are coming with ideas and building them, uh, and culture obviously should be super important. So you framed nontoxic culture.

But I want to hear more about what do you mean by not only non-toxic, but what type of culture you need to have for people to keep on bringing ideas, understand that there are boundaries and not all ideas will go in, but it’s fine. Not being afraid of bringing even more ideas or crazy ideas that sometimes.

We hear it. I know it’s too crazy for a company to do so. What is the type of culture that you think is important? Uh,

Deborah Ancona: well, first of all, a culture of transparency, if people don’t know how decisions are made, they get very resentful. Why did that person get to go ahead? And I didn’t know if it’s too political or it’s too close door, then people cease to believe in the process.

So transparency is a core element. In fact,

Um, organization about moving to nimble, but the first step is building the reputation and the actual transparency that’s needed to operate in, in a nimble way. So, um, that’s an very important piece, um, respect for other people, um, because. If you are enabling autonomy, um, you need to provide, uh, respect for everybody and their ideas and their, um, Well, respect for them as individuals.

And yet, I mean, some of these nimble organizations are very tough on ideas. Um, so it’s not that you accept everything thing. You can be very tough on ideas, but you don’t shame the person who brings that idea. Everybody’s entitled to, to have a place and, and, um, and be heard or to get the opportunity to get other people on board.

Um, To, to make things happen. Uh, you have to be able to, uh, let go, um, of bureaucracy. So if there are too many rules, too many regulations, too many, you have to go through 15,000 forms, um, at WL gore, and one of the companies that we studied, um, They don’t have these manuals for new products. There is a one-page document that you create.

It’s called real win, worth a, is it a real product that we can create? We can actually do it with our technologies. Real win. Can we win in the market? Um, with this, with this new thing that we’re going to create and worth, can we actually make money? Because if we can’t make money, I mean, the organization needs to make money.

So. Prove to us that it’s real, that we can win and then it’s worthwhile to do, and then you get acceptance. Now there might be a lot of data collected for that, but it’s a one pager, um, rather than hours and hours and days and days, and months and months spent on. On putting those programs together. So it’s low bureaucracy, um, are part of what nimble organizational cultures have also not blaming people all the time for mistakes.

Uh, you have to have a mindset of how do we learn from what we just did not. Who do we punish? Okay. Let’s figure out who’s fault. Was it really? No. What you really want to do is say, okay, what have we learned from this? And how do we do it better next time. Now, obviously, if somebody fails over and over and over again, then that becomes a problem.

But you do want to Institute this, this learning mindset, uh, within the, within the organization.

Naji Gehchan: Great. Uh, now I want to move into a different section where I would give you a word and I would love your reaction to it. So the first word is leadership

Deborah Ancona: leadership. Uh, do you want like a word or just a, it can be an idea. Um, so. I tend to think of leadership more as in a bird formation. It’s not necessarily the bird in the front, it’s the bird in the back. That’s making sure that everything is operating smoothly. So it’s, it’s more the idea of the enabling and architecting, uh, leaders who help, uh, the entrepreneurial leaders to, to move forward.

Um, and I think that idea. Gets lost. When we think of the heroic. Um, here I am kind of leadership,

Naji Gehchan: good stories,

Deborah Ancona: stories. I think of stories as.

I want to say one of the most effective tools that leaders have, but just thinking about it as a tool, you think of a hammer or you think of, of a saw, and it’s not like that it’s a tool in that stories are a better way to communicate and that people remember stories more than data or more than lists of things, but also.

Stories engaged, not just the cognitions of other people, but their emotions as well. And so it brings an emotional, um,

Piece to, to an organization and to an audience. And so it helps people to connect to one another, uh, and it helps people to realize that, um, that we have to be, um, understanding of other people because there’s a lot behind the facade that they bring, that they bring to work. Um, But also is an important way of connecting people to one another so that they can more easily work together and do things together and have a good time doing it.

Naji Gehchan: What about family? Ghosts?

Deborah Ancona: Family goes well. No, I guess I’m a little bit surprised that not more people in the field have talked about the impact of your family because on your, on your leadership. So you, you know, you talked about ghosts, but ghosts are things that we, we take from our past. So from our actual own families, because those families have such an impact on us, on our, um, On our values and on the things that we believe in on the things that we think are right.

The things that we think are wrong, the things that we should do, the things that we shouldn’t do, that the expectations of. And who we should be in the world. Those are deep, deep, deep things we learned from our family and therapists worry about that in terms of our own mental wellbeing. But ghost is more about whoa.

Sometimes those dynamics are playing out in the workplace in ways that I haven’t really been aware. And so for me go, sorry. What are the dynamics that play out in what work that have to do with the way I was raised? What are the good ones? Because sometimes we tend to think of. The terrible demon goes.

So I can’t get over. I, I, I can’t delegate because I need to have the control because I had a very uncontrolled family life. And so I need control. Um, and so that can be a negative ghost. Um, at the same time, you could be really good at controlling and organizing and operating. So it’s important to recognize that these things we bring from the past.

Have an important impact on who we are right now, sometimes for the good and sometimes for the, for the ill and sometimes for both simultaneously,

Naji Gehchan: it’s a spread love and organizations.

Deborah Ancona: I’m sorry. W

Naji Gehchan: w what about spread, love and organization?

Deborah Ancona: Yeah. So, um, I’m not one who speaks about love very often in, in the work that I do.

Um,

so I think that’s a harder one for me. Um, I think. Love if you take it to mean care and concern for other people. Um, I think we probably need more of that in organizations because we tend to look a little bit too much at only numbers and, um, output, um, productivity and effective. Effectiveness and efficiency.

And we, we do need to also consider, um, our fellow human beings and how we treat them. And can we, can we actually help them? I don’t, I don’t know if that’s what you mean by love. Um, but I guess that’s where I would take the concept.

Naji Gehchan: Th th this is actually what we’ve been hearing quite, what I personally mean is really this genuine care and caring for your people, for them to thrive.

And this is constantly what we’ve been hearing from, uh, from thinkers and leaders, uh, around genuine care or servant-leadership with this word, uh, that isn’t too often the organization.

Deborah Ancona: Yeah, no, I think so. And I, I think for me, um, The the, the greatest joy really from my own work comes from that. Whether it’s, I wouldn’t consider that work from my children, as I said, um, being able to, to help them to grow and develop, but also the leaders that go through this course, I feel so.

Really grateful that they tell their stories to me and that they hopefully take some steps along their own developmental path, um, helping a team to be more effective, to come up with a great idea. That to me is just. So much fun. Oh, well, we came up with this idea. We never would have done it if we hadn’t operated in this way, uh, where we want to change.

Um, it’s just very fulfilling for people to send me notes. I’ve learned more in three weeks of sense-making than I have in 10 years being at this organization, or, uh, we were able to implement this plan faster and better than we ever could have before, or it was great to finally realize that. We didn’t have all the answers and we could go out and, and learn from other organizations.

These are, to me, if that’s what love is, then, then I’m a fan. Okay,

Naji Gehchan: great. Then I think I was going to tell you, you’re actually, you’re spreading love and how you’re doing things, right. It’s like being open outside, being open inside being this genuine leader and listening to your people. This is how I’m defining it as, as love.

And it’s part of all that you’ve been taking us and teaching us through, um, through not only this course, but also through many years of research.

Deborah Ancona: Um, the other thing I would bring to that is, um, I don’t think of love in that respect as being always supportive. Um, that is, um, I sometimes push people and I push people hard.

Okay. You could, you could do that better. What if you tried it this way? Um, what if you, um, implemented this in a different way? Um, so it’s not all, oh, everything is great. It’s also pushing people because of a core belief that the person can learn, that that person can take that input, that that person is capable of doing more and being more.

It’s not up to me to provide the motivation for that. But I do think if the person is motivated to do that, then, then I feel like part of love in a sense is feeling good enough about that person that you can push them, uh, and not just say, oh, whatever you do is fine.

Naji Gehchan: Yeah. And this is, this is one of the pieces in one of the interviews.

Sometimes we talk about tough love, right? If you think about your kids, as you mentioned to actually push them, they’re doing, you know, you help them, you coach them, you guide them. And sometimes there’s tough love. And I remember one of the great leaders we interviewed told me, it’s, it’s true now. It’s not tough love because if you generally care for your people, yeah.

You’re going to push them sometimes because you believe in them, you believe they can do better. So if they’re not. We are going to help them see it and see how they can do better. So definitely a great point. Again,

any final word of wisdom for leaders around the world?

Deborah Ancona: Well, I think the only thing that I would say is that leadership is a complex concept. And that I think part of where we sometimes fall down is taking one piece of that and saying, this is what leadership is. So yes, you need to improve your relating abilities, the ability to coach and mentor and care for others.

But. You also, um, per our model need to be able to sense, make about your environment so that you’re able to come up with new ways of, uh, meeting the demands of that environment. And you need to be at some point a visionary leader who is about where do we go in the future? What does the future look like?

What could we do together? So you have to be kind of motivated. As a leader by presenting a picture of the future that that could be achieved. And you have to be what we call an inventing leader who comes up with ways to both execute on what needs to be done. Keep the trains running, make them run better over time.

Keep on that and also creating an innovative environment because in this day and age, you need to innovate to, to kind of survive. Um, and that requires making decisions and, and coming up with new ways to, to do things and to include people. And so I think sometimes we get lost because. People talk about one part of that leadership model without really recognizing that great leaders do all of those things and also rely on other people for doing tasks that they can’t do.

Uh, and, and that’s a key part of, of what leadership is.

Naji Gehchan: Thank you so much for this inspiring discussion today.

Deborah Ancona: Uh, thank you again for having me. I appreciate it.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Daphne Haas-Kogan

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host today. So many times we hear about selfless leaders… Until you hear and meet Dr Daphne Haas Kogan, you obviously didn’t really see what selfless leadership is. Daphne is Professor and Chair of the Department of Radiation Oncology at Dana-Farber Cancer institute, Brigham and Women’s Hospital, Boston Children’s Hospital and Professor at Harvard Medical School.

After her Biochemistry and Molecular Biology degree from Harvard University, Daphne received her M.D. from the University of California where she served as Vice-Chair for Research and Educational Program Director. Daphne has been elected in 2019 to the National Academy of Medicine, considered one of the highest honors in the fields of health and medicine. She has been selected as one of the top physicians in the United States by several publications including Best Doctors in America.

Daphne, I am just so honored and thrilled to have you with me today.

Daphne Haas-Kogan: It’s entirely my honor, and my pleasure truly.

Naji Gehchan: Great. I would, I would love to start, uh, definitely with the very beginning, let’s say, what’s your personal story, who you are as a person on what got you to health care and being the leader or the physician and the healthcare provider that you are today.

Daphne Haas-Kogan: So I can, I recall from a very early in childhood wanting to treat children with cancer. I don’t recall the exact impetus to when I was young, but I had a sense that that was a time, of course, when children and their families were in great need, um, emotionally, psychologically, physically. And I got, I had a sense.

That would be a place where I could truly, uh, contribute. Um, I have a, an interesting family story that I think has always, uh, positioned me to have this drive, to make the world a better place. Um, both of my parents, my mom’s from Poland and my father’s from Holland and both of them are Holocaust survivors and they each have.

Interesting family and, and personal histories that highlight the fact that people who were strangers to them, uh, saved their lives and saved the lives of, of many. And I remember even from. Uh, from very early in my childhood, the sense that I really had an obligation to pay it forward or pay it back. Um, however one wants to, um, articulate it and that it was really, uh, on me to, um, spread love as your organization states and really do everything that I could to do right by others, even others that I had never met.

And, um, leave the earth a better place than when I arrived on it.

Naji Gehchan: Wow. Oh, and throw you, you, you taken this to, you know, to a different level, obviously you’re actually doing it and. Great children, patients at their toughest moments. How are you defining today, your purpose and how you, you take this and you do it with all the team that you have, you, you are in leadership positions.

So how do you do this? And you transfer all that you’re bringing to so many for, for your impact to be even brother.

Daphne Haas-Kogan: I, I think. Of myself as being part of a team and part of a, a path with patients and their families. Um, that’s honestly a more fulfilling for me personally than I could have ever imagined a career being. So when a, uh, a child and their family come. Come to me for my expertise or my support, or I’m in need of a path of a person who’s going to travel a very challenging path with them, holding their hand along the way, uh, having the background, having, having the expertise to education, to, to, to walk that journey with them is a privilege beyond what I could have ever imagined.

The fact that. Families in their greatest time of need, but their trust in me is, uh, so deeply rewarding to me. Uh, it’s really what propels me and what, what helps me get up each and every morning. Um, even when I’m wishing I had more sleep, um, more recently since I moved from the university of California, San Francisco to Harvard.

I’ve had more responsibility in administrative and leadership roles. And I find myself really transitioning from being, uh, being focused on my career to some extent, to being focused on, on other people’s careers. When people talk to me about, um, Becoming the chair of the department of radiation oncology.

I often reflect on the fact that I never actually recall having an aspiration to be a chair of a department. And in fact, I very often was very reluctant to, um, to think of myself in this role. I, I think because, um, I’m very conscious of the fact that. That, that at least in my opinion, um, power is a very, um, undermining and corrupting, um, forced.

And, and to me, actually not being in a position of leadership and power was a more impactful straight forward, um, way. To contribute to the world. So it was with some trepidation and uncertainty and kind of dubious thoughts that I did take on this position. And it was a little bit of a leap of faith, kind of jumping into the water to see what it would be like.

What’s, what’s turned out to be very. True for me personally is that, and now I harp back to the transition that I was talking about a few minutes ago. I think the transition to a leadership position has to be at a time and was at a time for me in my life where my career, my personal career mattered much, much less to me in the sense that there wasn’t that much more honestly, that I really wanted to accomplish.

Um, It was a transition in that I have, I have three children and my youngest was finishing high school. So I was going to be newly empty nested. Um, uh, I have a wonderful family that I thought was getting settled and I needed to worry a little bit less about them perhaps. And I didn’t really have. Very obvious Frank tangible career aspirations that I hadn’t achieved.

So it was a very, very natural point of transition for me to start focusing the turning away from a focus on my personal aspirations to supporting other others aspirations. So the transition from. Uh, less of a leadership position to more of a leadership position that came along with moving from San Francisco to Harvard was a very poignant time for me in terms of it was no longer about myself.

Um, really it can never be about me anymore, but it always now, uh, should be about supporting other people. Um, be it patients or their families or relatives or staff or colleagues. Uh, faculty members, um, colleagues, uh,

Naji Gehchan: other chairs on like I a definite how, how you’re framing, which is quite the opposite of usually being a manager or in a leader position, how people would think of it.

You’re literally seeing it at the surface of your people, right. Really the servant leadership and the caring about the others and developing them. I it’s, it’s amazing how you framed it. Like it’s this tipping point where you really wanted to focus on others that brought you to leadership or a leadership position.

And did you change your opinion about power now? That’s you are one of the most powerful in the institutions that.

Daphne Haas-Kogan: Well, that’s definitely not true, but have, um, have more responsibility and accountability. And then than I did before, I definitely have not changed my position and my feelings. I, in fact, the longer I’m in the position, the more I realized that it really cannot be, can never be about oneself when one leaves.

Um, a group, um, like this, that really one must focus on the, on those, that one leads and my conviction of anything has strengthened, uh, as, as it, as it relates to that. And I do really feel, and I often reflect on the fact that I do think that that power is a corrupting force. I mean, when. When one has has, uh, let’s say I have the it’s it’s under my purview to, to offer somebody a position.

Um, the, any kind of, what if I ever get a feeling of, um, um, you know, wow, I’m in charge here. I know that I need to look at myself and back. And be introspective and, um, and be clear with myself about what the driving force has to be on it. The can never be about power or control or any of those, uh, any of those synonyms.

Um, but it required for me at least. I mean, they’re probably people that are, that are. More selfless than I am, but for me, at least it requires constant reflection on, is my motivation at this moment on this day, um, as it should be, and, and, and, and constantly being aware, um, that my motivations can never be corrected.

And if they ever are, I need to move long time for something else.

Naji Gehchan: And you can create the example on this. Like how you, how you manage a self-reflection. Uh, if you take the recruitment, you talked about recruitment, any processes you’ve done as a leader to make sure that, you know, you bring diversity inclusion, like you’re aware of all the unconscious biases that we might have as we’re recruiting.

And any concrete example, you can get inspired and, and apply

Daphne Haas-Kogan: well on this time of very heightened awareness of inequities that we honestly should have been aware of for, for decades. Um, I find myself questioning myself very often. For example, if I’m. If I’m ever a part of a group where, um, let’s say I express a, uh, questions or doubts about whether we’re being as inclusive as, as we might be.

If I ever feel, if I ever have a sense of, wow, that was a good thing you said, or a sense of feeling. Part of myself for like, say you saying the right thing. I immediately, um, put the brakes on and questioned myself and the purity of my motive. Like, are you doing this because it’s the right thing, or are you doing this to make yourself feel better?

And I always, always tried to back it up and make sure I’m doing it because it’s the right thing and never to make myself feel better. I, you know, I. No, I’ve I went to, um, I went to school and I trained in San Francisco in the eighties and the nineties. And, um, it was at the height of the aids crisis in San Francisco.

And, um, at the time, you know, I had a pretty traditional, um, heterosexual marriage with. You know, cute little children and the, the education that I received from being from training in the, in healthcare at a time when there was so much bigotry, um, against, especially against gay men and looking back at my own bigotry, um, was very transforming.

For me. And I think because I grew up in a very, my, uh, family of origin and my community of origin is very conservative and very traditional. And I grew up with very kind of traditional family values and having to question those and look at myself in a very critical light, especially. During those, the early days of the aids crisis really taught me a lot about the room for growth and room for education and room for change.

And then, um, kind of the, my family’s history of basically being persecuted for who they were not having any control about whether they. You know, we’re born Jewish or not. Um, and then the fact that I was a woman in the sciences, which wasn’t the easiest thing, um, especially not, you know, 30, 40, I guess, not quite, yeah.

You know, decades ago. And then, um, almost 20 years ago when actually I came out as a lesbian or. Really, um, brought home to me, uh, how deep seated Frank bigotry. And also as you say, um, kind of implicit bias and explicit, explicit bias is that every single one of us has that in us. And if we don’t question ourselves every minute of every day, we will inadvertently act on those biases.

Um, I know that I make mistakes right. And left every day. And if I don’t have it in me to examine my own behaviors and my own thought process and my own inclinations and make sure that I as much as possible, um, and always fighting for, uh, for the underdog, um, Be it underrepresented minorities, disenfranchise communities, um, that, that, that’s, that’s an enormous component of my mission and leadership and requires attention a lot.

It’s not something I think that can be taken for granted or, or honestly that even comes naturally.

Naji Gehchan: Oh, thank you so much. Uh, definitely for, you know, for sharing, for sharing your story and sharing this, uh, the, this with me it’s, um, you know, building on, on this, we, we discussed it last time offline, you know, and how, how you manage from obviously all your beliefs, all your learning, uh, w with this genuine leadership, your teams, you also.

When during the last year and still ongoing this year with the pandemic and, and healthcare has been challenged, it’s been done for you for your teams on the front lines. Um, but, but still you, you lead them. They show up, you show up for them. Uh, so, you know, beyond thanking you and everyone saying how, how much we appreciate and the, the heroes that you are, the chili everyday, for all those patients that you serve, any leadership, key leadership lesson for you during those times, you know, with your team and with, with all, uh, with all that you learn throughout, uh, throughout the years.

And, um, and your personal.

Daphne Haas-Kogan: I think one of the most important lessons that I’ve probably learned, but it was brought home. So clearly to me was something that, again, I think I learned from my teachers and mentors when I was a student during the aids crisis, but now I had to really practice an exercise as a leader. And that is honesty and transparency.

And. And owning getting it wrong and being willing to admit mistakes and do better. So for example, very early on, within days of, um, the pandemic, we, because we treat cancer patients and that’s not. It’s not a, uh, it’s because it’s a necessary procedure. Um, we, we couldn’t stop treating our cancer patients.

It wasn’t like we could, they weren’t elective procedures or elective surgeries. So we had to continue treating our patients and our staff had to continue, uh, coming in to, to treat the patients in person. And I saw everybody around me, our staff. But the patients, um, the trainees, the students, the, the, every role group, the radiation therapists, the nurses, the medical assistants, the physics staff, the dosimetry staff, um, the child life specialists and, and, and, and so many more, I saw that they were terrified.

To a large extent because it was so, uh, unclear, um, how broad and how deep the dangers were. And we had, um, young people who were, um, who were caring for elderly parents at home or for small children or for themselves, or who were pregnant, um, or had other responsibilities. And here they were coming in to treat.

Sick cancer patients. And it wasn’t clear to what extent they were exposing themselves to risks. And it was really hard to assuage their anxieties because honestly, number one, they were putting themselves at risk and number two, it wasn’t really clear how big the risk was to them. And number three, we didn’t know how to mitigate those risks.

So, for example, at the beginning, not only did we not have any personal protection protect, protective equipment PPE, we didn’t even have masks. We had, we had nothing. And, uh, and what we heard was that because of the way this virus spread, um, it really wasn’t necessary to mask. That was the original. Um, that was the original message.

And of course that’s what I told my staff. And in fact, I distinctly recall one, uh, the might’ve been the first or second day, very early on after we went virtual. But of course going virtual was really hypothetical for most of us because we had to be there for the patients. And one of the trainees had a mask that they had gotten.

From the outside world. So they hadn’t gotten it from the hospital, but they had acquired it outside. They had access to masks. Um, at the same time, our young therapists that were actually treating were also at the front lines, treating patients, you know, every minute of every day didn’t have masks because they didn’t have access to masks outside the hospital.

And we didn’t have masks in the hospital to provide them. And I went to the trainee and I asked the, ask this trainee to take their mascot. And because, uh, I didn’t feel that it was right for somebody who might have been a little more privileged than had, had access to a mask outside to where one within the department, when others who were really, you know, face-to-face with an inches of a patient’s face not having access to masks.

And I think back at that now, and I’m sure. I am mortified and, uh,

Naji Gehchan: shame, right?

Daphne Haas-Kogan: Like how, how could I have said that? How could I have told somebody to take off their mask? They were, they had their own set of, um, fears and of course they were, um, also in danger of contracting COVID.

So it was, I mean, looking, it was painful then, but it’s a hundred times more painful now in some ways to look back and see how wrong I got it. Um, but I think when it became clear that masking was absolutely imperative and the right thing, um, then owning it and saying to the whole department, I really got this wrong and I’m really sorry.

Um, was, uh, very, very important stuff. And I harped back and thought, you know, this is something that I learned when I was a trainee, because I saw other people owning their mistakes, owning things. They got wrong, owning their fears, owning their insecurities, owing, what they did know, and also what they didn’t know.

And I realized that it was others who taught me, who put themselves out for me as a young person, as a young mother, as a trainee, as a young healthcare provider, that helped me be transparent, honest, um, Open and accountable now, um, as a leader, I reflect on the fact that it’s really not easy to feel so exposed and to feel so wrong.

I really have gotten it so, so wrong and in a way that feels very personal, but I also realize. If one is going to lead through our crisis, you know, that’s what I have to practice and, and try to keep doing better every, every day.

Naji Gehchan: Yeah. But, and, and just took accountability. Beyond any leader, right? So you took accountability on a decision, that’s it?

You made, but it was not only you, right? Like this, these were the guidance. You, you, well, you’re a physician. So you did by the state of the art and evidence at that time. So, but still coming back and taking the ownership and saying, yeah, I got it all wrong. Many of them would have said, that’s not me.

Whoever I’d like the CDC or someone else. Who’s got it wrong, but it’s, I think, again, it’s another, it’s another point of, um, you know, find her honesty for you and your leadership, you know, being transparent and, and owning whatever we do. Right, right. Or wrong.

Daphne Haas-Kogan: It was very offline when we talked before. Um, that’s one thing.

Even though we haven’t known each other for that long. That was one thing that I’ve found really inspiring about your and Zena stories. And I’m hearing so much from many of our colleagues about the goodness that U2 spread that has, has really, uh, inspired me to, um, really get engaged with this spread love and organizations.

Um, And. Well, why I feel so honored, typically speaking with, okay.

Naji Gehchan: Thank you. That’s what we’re. Yeah, I know. You’re you’re way too kind to know where I think a lot of us as, as a human being, you know, even before being either as a, whatever, you know, as a human beings, we all try and drink an inbox and, uh, we’re, we’re, we’re definitely.

Uh, to help people in where they need most. So we definitely share, you know, volumes and we share also the same purpose. So it’s, yeah, it’s just amazing to have you with us. I would love know to jump into the different sectors. Where I will be giving you one word and I promise there is one words here. You might smile.

I, because you said it many times, I wrote it before the interview. So let me give you this word and then tell me whatever you have top of mind.

Daphne Haas-Kogan: Okay. Sounds good. Great.

Naji Gehchan: So women in leadership,

Daphne Haas-Kogan: I think women have a very important role to play in. And leadership on the one hand, I think women have themselves experienced, um, inequities.

On the other hand, I think women are in more empowered positions than many other groups. So we’re in this sweet spot as women where we really, many of us have very much felt. What it’s like to be treated unfairly and not be given opportunities, perhaps to be judged prematurely about our abilities or our roles, but we’ve also come a long way.

So we’re empowered to help other groups that are tens, if not hundreds of year behind us, in terms of opportunities. So for, for me as, uh, as a woman and leadership, and I think for all women in leadership, um, there’s an enormous responsibility of taking the, the experience that experiences that we’ve had, both the unpleasant experiences, but also the experiences that we’ve had and in our mentors, our colleagues, um, Uh, our students empowering, empowering us and making sure that we pay it forward and, and empowering and assisting and mentoring and supporting those who have not had quite the opportunities that we have.

And of course there are many such groups.

Naji Gehchan: Yeah. What about, uh, innovation?

Daphne Haas-Kogan: Innovation is a very interesting word to follow women in leadership because, um, I’ve been reflecting very often on the fact that I find in general that many of my women, colleagues and leadership don’t think about innovation as a mission. And I think we should. I think we, we many women that I’ve encountered including myself,

At least I very much put one foot in front of the other and don’t actually think much about any innovative contributions that I could ever make. Um, but in some ways it’s not true. There are things that. Um, I think about ideas that I have that are innovative and I think it requires me and other women to step out of our comfort zone and to be brave and to think, yes, we can be innovative.

We have innovative ideas and we should, um, engage others. Hmm. Try to do something new, something outside the box. Something that doesn’t feel as comfortable and it might be, might be, might be different, but it’s worth taking the chance for,

Naji Gehchan: and do you have like a feeding of what might be holding, holding you or the women doc?

And what’s your advice?

Daphne Haas-Kogan: Yeah, I thought a lot about this. I don’t, I don’t have that much of a deep insight. I would say that women that I am exposed to on a professional level, um, many of them have been socialized to, um, to be very. Uh, to be very given and be motivated, uh, very much by benevolence. And sometimes for me, the concept of innovation, um, feels a little self-serving of course it isn’t.

Um, but sometimes it gets attached to feelings of being self-serving, um, which then. Honestly feels like a turnoff to me. I, I would myself and I think many women colleagues that I interact with, um, want to make sure that our mission is to do right by others, not ourselves. And so I don’t think we often think of ourselves as having, um, innovative, innovative ideas to.

Um, frankly, it’s, it’s a reason that I find myself and I find that many other women, uh, shying away from public speaking or speaking to groups because in a very similar way, I mean, I certainly feel like I don’t have very much to offer like a group of listeners let’s say. Um, but it’s

Naji Gehchan: probably, you’re

Daphne Haas-Kogan: so kind.

But I think, I think it takes just being brave with thinking about things a little bit differently. So maybe I don’t have as much to offer as somebody else who has more expertise than me, but you got to have my personal story to offer. And maybe my idea is a little bit more innovative than I than I think, I think it’s perhaps a little bit part of the socialization process of what motivates women or what women feel like should motivate them.

But beyond that, um, I’m sure there are other insights that others would have that I would be very interested to hear. Right?

Naji Gehchan: Yeah, definitely. It’s it’s part of also your, your humble leaders. I think your story is amazing. It’s so inspiring and can definitely inspire so many, so many people who are listening to all this, but you were such a humble and selfless leader that says this is what’s bringing those words.

Then the next word I have, I literally wrote it before. So it’s it’s questions or questioning.

Daphne Haas-Kogan: So, although I did say that I grew up in a very traditional household in a very traditional community and culture. The culture that I did grow up in was very, um, very much valued questioning and curiosity. So curiosity as in a life, a lifelong learner, um, but questioning in a way that steps beyond just lifelong learning and honestly questioning authority and questioning the status quo.

And that’s one thing that I very much enjoyed and I didn’t really understand how much I would enjoy this in my leadership position that I think because of the way I grew up, I’m not afraid to question. And, and when I’m with my team, I’m I find it. I find the role of questioning in a very open way. Very.

And I think it’s extremely important, um, in, in any organization, but in particular for leaders to be very comfortable with questioning and always question assumptions, questioned the process, question the conclusions very much, not in a judgemental way, but rather in a truly and deeply open and curious way.

But question nonetheless.

Naji Gehchan: Right. And, and I can attest that you have the best questions, always. The last one I heard you, well, you said it a little bit of it in the beginning, spread love and organizations.

Daphne Haas-Kogan: So of course you, you and Zena are the, the, the beacon of, of that and all that you do, how you think and how you execute.

Um, for me, honestly, Getting to talk to people like you is an enormous part of the inspiration. Um, and ultimately I think probably the most life altering experience I had was actually having children. And that really taught me, um, Uh, lesson that I, I think I really needed to learn and well, two lessons, um, the, the lesson of patience and the lesson of selflessness and, um, having children teaches you patience and selflessness very, very quickly to get a crash course.

And one night you get to practice at all and, uh, That the ability to practice, um, selfless selflessness and kind of very deeply dedicated divorce, devoted, unconditional love and child and child rearing and, um, and raising a family. Very much a guided my feelings of spreading love in my leadership position in my workplace.

I look back at times where I felt like I was, I felt so challenged. Um, so. Unworthy, uh, really like, I, I w I wasn’t gonna make it for, for one reason or the other. And I think of people who approached me with openness, curiosity, as we said, and honestly, just devotion and love. And that’s what got me to the next day and helped me move on and have more confidence in myself and, and, um, gained the strength.

In, in, in myself to then go and be able to give to others. And now it’s time for me to do for others. What, um, others did for me and continue to do for me. Um, I think even about coming to Harvard and how difficult that transition was for me, and there were people right and left that were there for me. Um, Whether it was by just inquiring how I was or, um, helping teach me or not making me feel silly when I asked and a question that wasn’t all that educated.

Um, I mean, it took so many. Forms and facets that, that the support and love that was, um, that I was afforded. Uh, and so in every stage of my, of my, of my life and my career, that the least I can do for my community and for the world is to pay it forward by spreading the love.

Naji Gehchan: Great. Thanks, Daphne. Do I’d love to hear a final word of wisdom for, you know, for your students to the other D there’s that’s your hub for our little kids growing, you know, and, and dreaming of changing the word then being the future either is in healthcare around, around the word.

Daphne Haas-Kogan: Well, we’ve talked about many of the themes that are really central to what makes me.

Maybe one thing that comes to mind that we didn’t talk about is, uh, one thing that’s been very, very helpful to me early in my career, but in particular in my leadership position is always, always to think how it feels, how a word, a sentence and experience feels to the other person, never to jump to conclusions and always the feel to, um, to think well of the.

I think relative my colleague think well of the organization. Um, any, any, uh, tendency that I might have to, um, to think that somebody is approaching me with ill will, or has a, uh, a poor motivation. It’s a feeling that I actively try to resist and I would advise others to constantly resist and the, the approach of always thinking well of others and making, making sure I think, what does this feel like to them?

Where are they coming from when they’re reacting to me? How did, um, how did the experience or the word I said, or my tone? How did that land with. Were they coming from and their reaction that’s really helped me be a more thoughtful and inclusive and effectively.

Naji Gehchan: Well, thank you so much. Let him inspiring leader, selfless either. You are definitely thank you for being with me today and for all that you do every single day, helping so many patients, I’m giving, giving back love, care, and compassion for all the people that 2d then for all the patients that.

Daphne Haas-Kogan: Well let’s people like you and Zena that inspire me.

So the gratitude goes from me to you. So thank you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Daena Giardella

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

In this episode, get ready to learn and be inspired as I have the honor to be with Daena Giardella, a Senior Lecturer at the MIT Sloan School of Management and a Faculty Affiliate of the MIT Leadership Center. Daena has been an organizational leadership consultant and executive coach as well as a media, communication, and presentation consultant for over twenty-five years. I have the privilege to learn from her as she’s been my executive coach for more than a year now and has definitely influenced me to start the Spreadlove in organization movement!  Before being a senior lecturer at MIT and teaching numerous amazing courses, Daena has enjoyed dual careers in business organizational development and in the performing arts. She combines these backgrounds to design innovative educational programs for numerous world-class companies, organizations, and academic institutions in the USA and abroad. A fact I learned recently, Daena is also a talented actor who received kudos in the USA and internationally, the Boston Globe has called her an “impressive talent” and she definitely is an impressive talent, an impressive leader, coach and an amazing person.

Daena – I am thrilled to have you with me today and so much looking forward to our chat!

Daena Giardella: Wow, what a generous introduction. That’s great. I’m looking forward to this conversation too.

Naji: Um, I’m eager to hear more about your personal story, your personal journey, a journey from acting to leadership, to lecture now at MIT and helping so many leaders around the world be at their best. What is between the lines of your personal.

Daena: Yes. Thank you, Natalie. Thank you again. Uh, I know it’s a, it’s a journey that for some people, they completely understand how it’s, uh, kind of integrated because in myself it feels like one path.

These two seemingly very different. You know, I grew up in a family where the conversation at the dinner table was often about the D the work that my parents were doing there. And during that day, they were leading people in different ways, in their different work. In my head, two parents who worked, it was very interesting.

And so this. Of leadership was always part of my outlook. How do you, how do you influence people? How do you get the best out of people? My own, uh, early migration into the arts was very simple because I was very interested in, in communicating the story. That need to be told in the world. So I went into theater, I was an actor.

I have been an actor and created many, one woman performances. My specialty was in the art of improvisation. It’s that aspect of him, of acting where you’re generating the script in the moment and it can be either comedy or drama. So the connection was that as I went through the process of learning about that art form, I was also.

From the very beginning, always working as a consultant in my work in organizations of all kinds, you know, and I very quickly observed that the same skillset that was needed for success in influencing people and leadership. In business was the same skillset that actors needed to learn, which has to be in the moment to be able to influence effectively, to be able to listen, to be adaptive and pivot in situations.

There were so many parallel skills, so it really inspired me when I would go from one world to the other to realize, wait a minute, I can bring some of what’s needed in each world. To the opposite world because obviously theater companies and actors, and I also work in, in, in the video production really needed to also understand leadership and business dimension.

So I feel comfortable in both worlds and that’s sort of how I began to make this cross fertilization between the two skills.

Naji: That’s a that’s awesome. Uh, and now that you actually, you cross both, you teach and coach, uh, many of the leaders. What is it? Because you’re talking about communicating the stories, uh, you know, in a, in theater and then other things as leaders it’s we hear it and you’ve told me also how to tell stories, right.

And leadership to be impactful. Any, any links beyond, well, the story piece, but also, are there things that you’ve taken from, from your actor learning into.

Daena: Absolutely nationally. I’m glad you’re asking that the, the most important thing that leaders need to know how to do is to make that personal connection, to make a connection on a human level, whether they’re dealing with people at their own level, in their team colleague experience, whether they’re dealing with people who report to them or clients or.

Toward the C-suite. If they’re interfacing with folks there, or if they’re in the C-suite, they’re dealing with a board, that connection on a human level is what allows the improvisation as it were of the, whatever the interaction is to happen. Actors understand that if you’re not really in a yes and.

Making connection with people, which is the core of what improvisational actor is that. Yes. And I want to embrace what you’ve just told me your whatever you’ve offered and add my own addition to that. And now we’re collaborating, that’s the core of acting improvisation, and really it is the core of great leadership because instead of trying to show I’m the smartest person in the room, I’m really there to try to build on the ideas to foster a collaborative, psychologically safe environment so that everybody has what is called voice efficacy, borrowing from what Amy Edmondson writes about in her work from Harvard.

This notion that I have confidence to speak up, to say what is on my mind. To navigate conflict. So that’s number one. And number two, the other thing a leader needs that is in common with an actor is the ability to deal with the unexpected, to pivot, to adapt according to what one encounters and often it’s friction.

Let’s face it. We’re in fast-paced business environments, whatever environment it might be, and things are happening that don’t always go along with what we had expected. So a really effective. Yeah, somebody who is, has the skill to understand how to respond to what is happening instead of. She thought or he thought should be happening or would be happening, uh, where we’re attached to our past conception, which might be from five minutes ago of what we thought we would encounter in the meeting.

We walk in all of a sudden the CEO says, we’re not going to deal with that agenda. We’re dealing with this and nausea. Would you please stand up and speak to us on this topic? And you didn’t go in prepared. Because there’s a crisis. And yet knowing how to meet the moment, instead of going into that resistance of wait a minute, I don’t have control or I don’t have my clan.

That’s a very important. And certainly in the times we’re living in with so much uncertainty and the ambiguity of the, now this is what leaders, I think this is the crucible that leaders are, are in right now to really separate who can really meet this moment with that efficacy and who might be finding it a little more.

Naji: This is two really very important points and advice as they’re giving us, I want to double click on the first one, because you, you link the connection piece with also, uh, how to improvise to be able to collaborate. I love how you frame that. My question to you, you know, because when we hear improvisation, we think like, You just show up, figure out, you know, and you’re smart enough to be able to manage whatever situation might pop up, but how you frame that.

I think it’s a little bit different. It’s it’s taking the time to build this connection. What is the role of, you know, bringing prepared the preparation in order to be able to manage better like uncertainty and those type of situations. I’d love to hear more from you on.

Daena: You know, that is a very profound and sophisticated question.

It’s actually, I think at the heart of the issue, because there is a misconception about improvisation that it means do whatever you want, just show up, you know, and that is what we call one half of the skillset, which has to do with being free, to have impulses, to, to have freedom with spontaneity.

There’s no question that when you learn improvisation, that’s one part of it. However, we only have to look to Jack. Which is of course, an improvisational form in many ways, if all you have is the ability to make random notes, you don’t, you’re not a jazz master. The ability to do that means you have to rely on music theory.

And there has to be a sense of understanding all the dimensions of music, same thing with improvisation and leadership. There is a struggle. That makes improvisation work. And there is when there is a lack of that structure, it falls apart. Some of it has to do with, uh, listening. There are rules of improvisation, which is, uh, don’t just, uh, ask questions because you are, I don’t want to really use your own imagination.

There, there are rules of improvisation that have to do with, you know, showing up with, uh, a clear sense of where you’re going, being very specific, identifying the who, what, where when, uh, don’t block, the other person don’t use a yes but mentality or, or try to upstage people. And one basic rule. Maybe if your listeners remember just one rule of improvisation, no matter what’s happening, always make the other actor.

And that means that no matter what’s going on, even if I fiercely disagree with you, my job as a leader is not to make you lose face. I need to know. Cause you to lose face or to make you look bad and need to find a way to persuade you to come over to another way of seeing things that also honors your respect, your dignity, and gives you a chance to pivot to maybe a better version of yourself, or maybe open-mindedness.

So those are, there is a structure and I remember actually, Uh, teaching. I did a couple of workshops in Argentina. I was in Buenos Aires and also in Santiago. And I remember when I was in that Latin American tour of doing workshops and I was using the word improvisation, they said to me, you know, Are you sure we have to use that word because here in Spanish, when we say a proposition, we mean in a bad way, you really aren’t prepared.

And they said, it’s kind of like you’re caught with your pants down and it’s cause a negative connotation. And I understood immediately because they were seeing the negative part, which of course is true. We don’t want to be. With our pants down. However, that is not necessarily what is meant by improvisational leadership.

In fact, it means prevent being caught in that state of your pants being down, because you know how to pivot in a way that will build the conversation most productively toward the next step that it needs to go to with the structure in mind.

Naji: That’s so powerful. And w when you’re coaching, I remember in the very first, uh, you know, coaching sessions, we had, we worked a lot on, um, you know, the, the purpose driven leadership, the authentic leadership.

And you mentioned, um, many of those already in the beginning around. Listening about around psychological safety, how to build effective, effective teams that I’m going to ask you a kind of a hard question. If there is only one piece that you definitely every single time you’re coaching an executive or at either that you would always try to push them to think of or to, you know, to get better at, as a skill or as a capability, what would be this one?

Daena: If I had to pick one and I had to be on that desert island with that one particular, uh, coaching skill or that leadership skill, I would definitely pick building strong relationships because within the. Are so many of the other skillsets in order to build strong relationships, we have to do everything you just mentioned.

And we have to be able to be open. We have to be listening. We have to pay attention to the other person, pick up on what their needs and wants are. And we have to be strong communicators because you don’t just build a good relationship in your mind. Right. So I probably would pick that one out. Within that there are many skills like learning humble inquiry, which helps build that relationship and helps people listen.

So that’s a, that’s a skill that people who are listening can decide to adopt starting tomorrow, which is I want to build strong relationships and everybody knows. What people respond to is peop other people taking an interest in them and, uh, wanting to learn more about who they are. This is the basic idea of sales.

I think it’s basic in pretty much every industry. So to use humble inquiry, which is ed Schein’s concept, the ability to. Inquire in a state of mind that is truly a learning state of mind where you suspend that, you know what the answer is because you’re truly want to learn. You’re curious, and to use those kinds of questions instead of the kind of interrogation questions that can sometimes happen in business or.

Questions where we already know the answer and we’re just seeking a confirmation of what we already know, which is kind of boring. And it pushes the other person away more than drawing them near to us. People really respond to that quality of humble inquiry. And

Naji: th they, you know, and when you, when you talk about, you know, building strong relationships, can you define it a little bit more and help help us as leaders understand what it means?

You know, and I know we’ve discussed this. Do you think it’s a skill that can be built? Uh, we hear it many times from either, oh, we don’t have time for the. Is it too intrusive or even some are not even interested right then in learning from their teams. Is it a skill that can be built? Sometimes? I feel like it’s better not to manage people.

If you don’t love people, you don’t enjoy being with people. But what are your thoughts as an executive coach?

Daena: I hear that all the time. Nashi also, I don’t have time. I, you know, I’m, I’m in a rush. Uh, many of the physicians that I’ve coached over the years and I’ve coached a lot of people from the medical profession, particularly physicians will say, I just, you know, I have to get from one room to the next.

I have 30 people. I have to see particularly people who are working as hospitalists, for example, or even people in cancer treatment environments where. Things are so fast paced, uh, studies are being conducted. I think that for sure it can be developed. I’ve seen this firsthand. It can be developed. It has to do with the culture that is fostering that development, which is why I’m so excited about the kind of work your doing, for example, because this doesn’t happen as an anomaly.

The situation, it has to be supported by a culture and the leaders can be drivers of that cultural change. And you asked me, well, how do I define it? It means, am I bringing empathic listening? Uh, it doesn’t take a long time. It can take a moment of, of connection of letting somebody know that what they just said really was meaningful to you.

It can be when we are in person. That moment of eye contact a nod. It can be a look on the face, but it’s empathy. Uh, strong relations. It has to begin with listening, listening somebody to somebody, and then paraphrasing, I’m trying to think of practical skills that you, the people listening can apply saying back to somebody.

What you’ve just heard is a way of signaling. I care about you. I care about the relationship more, most important. I care about what you just said. Uh, another way of building another dimension of strong relationship is that we’re giving space for the other person to speak. We’re not doing all the time.

Where we’re listening. We’re interested in their ideas as well. And there’s. We, we follow up with that person. If it’s a colleague who we work with, we, we touch base. When we find out that their daughter is ill. We, we circle back the next day house. How Sarah doing, you know, there’s a, there’s a sense of bringing in that human part of the story.

Uh, strong relationships I think are, are easier to build. When we ourselves bring a quality of transparency at times, and it doesn’t take a lot of time it’s touching base and being real. Yeah. This has been a long day. Um, you know, I’m, I’m, I’m feeling I really need to get home to my kids. I miss them just to say that now I, and you’ve signaled to me.

Who are you as a person? I you’re signaling to me that your family matters, for example. Um, so there are many dimensions to that in a work. Building strong relationships begins and ends with respect. There’s no question we have to respect each other. We have to value each other. And one very simple way to do that is to affirm people in the meeting that we’re in, whoever is speaking to give them affirmation for what they’ve just said, uh, to, to build that sense of trust.

Because now I feel much safer with you and much more of knowledged by you, and I’m going to offer more because you’re giving me more.

Naji: Okay. Yeah, they might be obvious, but these are so important. Small steps that you said, did I? And there’s, I can add to those. Whereas sometimes I feel like it’s, it’s just obvious and it comes with respect, but unfortunately, without even noticing, sometimes people will do a try to being in a one-on-one.

Checking your mate, or looking down with video now, these days that are on your phone, like these are all these small things that as leaders, we should be so aware of their impact on the people that we have.

Daena: Correct. And especially in the zoom world, we have to watch for things like multitasking, doing our email while we’re listening, I just put air quotes on that.

We have to really be present. We have to use our voices more. We have to really lean in with emotion to some of what’s being talked about, even if it’s a dry meeting about, you know, data, for example, deconstructing some data. There has to be either a check-in at the beginning, a checkup. At the end and you know, people, it is true.

I want to embrace what you said. People don’t have time. We don’t have time where we’re, we’re operating with the same brain that we’ve always had, but with so much more input and we’re rushed and we’re pressured and we’re, we’re dealing with a lot of stress. So we have to not necessarily rely on our abundance of time.

We have to make the most of our moment. And improvisation is the art of the moment. It’s the art of being completely present in the moment. So in that sense, it’s mindfulness in action. It’s I may not have time to build a long relationship with you, a deep, long one, but I, in that moment, I’m with you. You. I care because of the way I listened to you because of the way I responded, the way I affirmed you.

The question I asked that I made you feel that your input was essential. That’s the moment that matters, or I’m in the room with somebody I’m with a patient. If I’m in a healthcare center setting and I’m making it very clear. That I may not be able to stay for hours and hours to address everything, but I hear you.

I’m going to go and get that answer that I don’t know the answer to, or I’ll let me circle back that moment of eye contact. Very, very.

Naji: And something you mentioned I’d love your thoughts on, I’ve been thinking a lot about, we obviously discussed it both, but I’m still, yeah. I’m still a buzzer and sometimes kind of reflective of, and struggling with in this virtual hybrid environment.

Right. And I think it’s something that people still, unfortunately, or fortunately for some be living for a while. Um, I, lot of the connections would happen. And, you know, an in-person mode spontaneously. Right. And I know for example, if I take my example, I’m someone who loves people. I love walking meeting with people, chatting, you know, without events.

Having them on the calendar, you know, in a calendar word and we’re losing all this. So now being intentional is even we need to double down on this and really being intentional or for also for these spontaneous moments that a human being would have normally. So it’s something that I I’m still struggling with.

I’m still trying to figure out because with the best intent. Just the touch points decreased, right? Like you’re not seeing your team every day, 10 times in an office anymore. And maybe there’s days where you’re not even in contact with your full team. So any advice, any thoughts on this, how to, you know, how to make sure that we keep this human interaction in a virtual.

Daena: Wow. That’s such an important question, right? I mean, we’re all struggling with this and I really relate to what you said, because I’m the same way, those unexpected moments in the hall in between sessions, in between what I’m doing, you know, there’s that saying? That big deal start by bumping into somebody in the hall and you start off talking about the weather and pretty soon you find out you have this common.

Objective and you decide to do something or, you know, even sharing data. I work with a lot of people in stem who are telling me, you know, I’m a scientist and I want to share, you know, conversations and I’m losing these ad hoc moments. So what I’ve been focusing on a lot, because I’m teaching a lot on zoom as you know, a lot of workshops and trainings and organizations, and also at MIT.

I’ve been looking at how we need to preserve some of that spontaneity. Now, for some people who might hear this, they may think, oh, I could never do this. Well, I’ll tell you what I’m doing. And I’ll just share with you if maybe there are adaptations of this, I’m bringing in some of that spontaneity to the beginning of some of my classes, as much as I possibly can.

Uh, the chitchat at the beginning of. The conversation where conversation is not structured at the beginning. Where, how are you doing? You know, it’s not even necessarily a formal check-in CA if that’s how your organization whirls, then do it as a formal check-in. But sometimes it’s that spontaneity at the beginning.

That’s very, very important where a theme gets developed and the leader. We’re going to let this go for five or 10 minutes before we dive into what has to happen. There may be humor. There may be everybody’s in a group complaint session about something they don’t like, whatever it is. The fact that every time they want to go out, it’s raining could be something deeper.

You know, that people are dealing with some situations at home and reading. Uh, some people are using techniques, like, you know, just tell us on a scale of, you know, look, if you were the weather and your, your life was the weather, is it stormy? Is it, is it a clear sky? And then if somebody says stormy, you bring up, okay, well what’s going on?

Well, my. Israel, you know, and I’m struggling with that, which happens to be my situation at the moment. And you’re bringing in a particular story. Uh, I’m using movement truthfully. I don’t think we can sit and do our meetings without moving. So suggesting stretch breaks, uh, where we bring in some music for just a moment and let people stretch.

I know that might sound like wide in a fast paced organizational setting. Can I really do that? I’m having a tremendous success with that in. Organizations that do not usually do that sort of thing. You know, 60 seconds of listening to some music, letting people walk around the room and then coming back and there’s laughter there’s connection in some way.

Uh, and then to get to what you said, those moments of, of really learning more about each other. I try to encourage the, after the meeting, hangout and chat for awhile as well, or come early and chat because it’s kind of like creating a virtual version of running into somebody before the meeting or hanging out with them.

After we have to be disciplined about that, we have to be ready to hang out there for 10 minutes beforehand. And. I never ended my meetings by leaving. I always end by saying, Hey, I’m going to hang as anybody want to hang and talk for a second. And these are formal meetings that have had a content and agenda, uh, you know, a beginning, middle and end.

But it’s the only way I can think of to keep that going. I’m getting a lot of good feedback and I’m asking some of the professionals I’ve worked with to try it. And they’re telling me. They’re using different adaptations. I don’t know if that’s what you had in mind, is that,

Naji: yeah, that that’s, that’s great.

And I can attest, I’ve tried, uh, you know, the early, as we discussed, uh, 15 minutes before the official start of the meeting being, and getting together just to chat as if we were having coffee and it definitely works.

Daena: That’s great to hear. That’s great to hear. And I think as we go more hybrid, we’ll be catching up on a little bit more seeing people if we are intersecting in person to some extent, but at the moment there is, you know, with the Delta variant, I think we are still in this new format.

Many people are.

Naji: Yeah. Before jumping into a session or where I would love for you to react to a word. But just before that, you talked a little bit about health care. I know you’re passionate about it, and you’ve been obviously developing and coaching many leaders in healthcare. Any, any specific thoughts or advices for the healthcare leaders listening to.

Daena: Yes, I can talk to you. Not only as somebody who has been an executive coach with many people in healthcare and taught workshops for people in healthcare, but also as somebody who has been a patient care advocate. Because of family members who have gone through serious, very serious illness, because I tend to be the person in the role of interfacing with the, with the medical professionals.

And so what I’m going to say is basically an amalgam of some insights that I’ve drawn more than anything. Uh, I first have to. Give a tip of the hat of a strong thank you to healthcare workers, particularly in this time with what’s been happening with COVID. And in general, I think of healthcare workers on the front lines of so much that’s important in the human experience, obviously, especially when we’re facing pandemics and serious illnesses like cancer.

So the stress and the pressure is immense. And. W one of the things that I think is very important is people in healthcare don’t have a lot of time to reflect. Given all the stress that they’re dealing with, and that shows up sometimes in the way that their teams feel about the way they’re leading their teams, uh, from a patient standpoint, the patient can always tell when there’s hardly.

Or disharmony between the physician, let’s say that the healthcare leader and the team, and when there is that harmonious sense that the team feels valued by the physician and everybody’s working together. Wow. It communicates. And many physicians tell me that they don’t have the time to build their strong teams to, to put focus on that or that there’s a lot of turnover, especially right.

And changing of personnel, uh, w it’s very, very important to, again, go back to that, making strong relationships and imparting what your vision is. So that, that you can also get the rest of the team on board with that vision and build in their vision to somehow make it a shared vision. That’s a very, very important, and that takes reflection time.

It takes with my executive coaches. I say to them, you know, take 10 minutes. If you don’t have a whole day or half an hour, even just take 10, 15 minutes to reflect on what do you feel is needed. Right. For that connection with your team? Uh, the other part of it is practicing, uh, Uh, thinking about your thinking and how it’s affecting the way you’re communicating.

Uh, are you having your own confidence problems in terms of having to lead a team? Many people were brought up in science in some form in medicine, but really never learned anything about being a leader and need to understand how to do that. There can be integrated. Feelings that people feel or a feeling of confidence crisis.

So getting reflection on that, getting support from that from colleagues from coaches is very, very important because ultimately I think people in healthcare are having to emotionally self-regulate, which by the way, is a cornerstone. KA capability, the ability to emotionally self-regulate. And without that, we cannot flourish as leaders.

And how do we emotionally self-regulate when all of these emotions are flying around, uh, those are some of the things that come to my mind quickly and you know, how to balance that listening that has to be done with also being efficient. Right. That’s that’s very, I know that’s a big.

Naji: Yeah. And all the emotional as you have emotional self-regulation, which is so important, right?

The moment of constant stress and unknown as the system is husband going through for years, but even more the last year is with the pandemic. No one was expecting.

Daena: Yeah. I, I would have to highlight that. I, I want to just briefly say that it is, it is. Cruel to imagine that people in healthcare can continue at the pace that we’re in and with the demands of not only this pandemic, but so much that’s happening, the fast changing environment without.

Support without this love message that you’re bringing this self-love it has to start with self-love care, self care. If people need to translate the word love, because they’re not prepared for how to say that. I believe that your message is a message. It has to start with love, have to start with, look self care, and then realizing that my, my team members need that self care.

And if it’s, you know, encouraging them to. Take that self care time or to reflect, or even at the beginning of those meetings, just to acknowledge each other, how stressful it’s been very, very important right now.

Naji: Then I will move to the section I talked about. So one word, one reaction.

Daena: Okay. And what do you want me to react or, or in a sentence

Naji: if I were there sentence, top of mind idea, I’d say the first one is included.

Daena: Bias comes to my mind because that’s when that’s the obstacle to inclusion and how much we need to be conscious of our own unconscious bias.

Naji: Can you tell, I know you’re passionate about this and you’ve been teaching about around diversity inclusion. Uh, I’d love to hear like a small summary of, uh, of your advices on.

Daena: Right now what I encounter when I’m teaching this, as people say to me, you know, the really egregious aspects of bias, maybe we all know to avoid those.

I don’t know. As I look at the way Asian hate crimes have Asian American hate crime. So prison, particularly toward healthcare workers, but randomly in the COVID pandemic. I think that we have a lot of work to do there, but let’s just say we’re looking at the unconscious bias dimension. Most important is for us to realize we all have bias.

It will come in, not only in terms of ethnic cultural, racial, gender identity bias, it also comes in in terms of cognitive learning style. So to take a step back and to ask, am I an unconsciously making somebody in this meeting right now? Because I am quickly deciding they’re not, they’re not speaking clearly enough.

They’re not their cognitive style is making me impatient, uh, or, you know, well, they’re from that culture, but I’m not realizing I’m doing it unconsciously to always ask ourselves, how am I bringing potential bias to this moment? Very, very important to start with our. Instead of thinking that our jobs to go out and police other people’s bias, of course.

And when we do see bias to set a limit, to find a way to speak about it, that invites people to learn rather than coming down on them and making them feel bad about themselves, because remember it could be unconscious, they may not realizing they’re doing it, and they may need your help as a mirror to learn more about that.

If it’s a very egregious statement, of course, setting a limit. But inclusion is my favorite word right now, because if we don’t have inclusion, we can’t spread love. And in a way spreading love is about making sure we are including every person at the heart of the organization and making sure that every person feels welcome and psychologically safe.

Yes.

Naji: What about leadership?

Daena: Well, the first word that comes to me is interesting because of what your work is it’s love. Uh, I know that we could say courage and risk-taking and you know, daring to influence people and persuasion. Ultimately, if we’re not coming from a place of caring, deep caring about the mission. About the, the new cancer treatment that we care about, the people that can help, if we don’t care about the people in the meeting who are going to have to run off and do all the gritty work that has to happen to, to launch the study or to, uh, to deal with the people, because we have an overload of, of, uh, more people than staff, whatever it is, we have to care about one another.

And ultimately obviously in healthcare, We can lose sight of it in all of the industries. Ultimately we’re serving the people, the patients, the family members. So when I think of leading, I think of love, I think of caring, uh, finding ways to influence that inspire people, that lift people up and make people feel they can be the best version of themselves, which is really just another way of saying water, the garden with love instead of accusation, criticism, judgment, blame.

Naji: It’s going to make it hard with my, I always ask this word at the end, which has spread love and organizations, but I’m going to say it. That would talk about your reaction.

Daena: Oh, I love that spread love and organizations. Do you want my reaction to that? Connect up with Naji. First thing that come to me, if I give you my honest, spontaneous it’s connect up and spread what you’re doing, what you find in this work of this podcast.

And if the website, the other thing that comes to me is this second is I think we’re at an inflection point and there’s a generational dimension to this as well. That, and it’s a good thing. People in the generations that are coming up leading now, uh, have so much awareness about the psychological dimensions of life, of leadership, of what they can expect from work and really have no.

Desire to tolerate a psychologically unsafe environment that doesn’t care for people in my father’s day or in other generations, they would get a job and stay there for 40 years. Uh, even if they didn’t like it, because that was the way it world, the world doesn’t work. And we have. So when I think of spread love, I also think of retaining talent of cultivating talent of making people feel valued so they can help build an organization and feel that they are part of it, which doesn’t mean that the older generations don’t have a lot to offer.

It just means we can’t expect to treat people the way we did. Let’s say in the 1950s Madmen. To, to reference a popular culture, reference of a TV show about, you know, the way we used to conduct the top-down command control type of leadership that was insensitive and biased and so forth. So spread love to me is.

Literally moving organizations into the future so that the, the new generation of leaders feel we have a home for them here and that they don’t feel that somehow they have to conform to a way of treating people that leaves caring about your personal life at the door, or says, check your, your values are at the door or, or check, or you have to leave aside purpose and quality of life.

You know, I can quote studies where we see this is what people care about. They don’t just want to go to work and be a cog in a machine. So that’s what I think about when I think of spread.

Naji: This is awesome. And I, I can’t ever describe it in better words that hopefully with, with all this initiative and all that you’ve been giving us the day, we will be able to change, you know, the word changed leadership for a better word than for every single person as you start to feel.

T to be at their best and deliver on the bigger purpose within their organizations. Any final words of wisdom that enough for leaders and executives around the world.

Daena: Well, thank you. First of all, for what you said, and I feel such a simpatico with, with your mission in the work you’re doing a final word I would have is, uh, take the time you need for reflection and.

You know, I believe in executive coaching. So the heart of executive coaching is providing a space where somebody can have a thought companion to, to accompany them through their different conflicts or ideas that they’re trying to grapple with or missions. So even without coaching, we can be in a reflective mode, reflect.

Meetings before you go to them, reflect on what happened in your day, make notes on what you need to consider for tomorrow. If you had a conflictual or tense interaction reflect to see, well, how can I go in and improve that tomorrow? I think we in not reflecting, we often leave. Loose threads that then contribute to feeling not bad, not good about ourselves or not good about the way a meeting went, always try to do the repair, always try to repair the conversation that didn’t go well, or maybe even your own response that you’re not feeling good about find a way to reflect so that you can repair and also inspire because reflection is required for inspiration.

Otherwise we’d burn out, you know, even if everything seems to be going well, we want to reflect, you know, take that. To consider what we need and who we are.

Naji: Thank you so much for such an inspiring and genuine discussion. I will remember you said water, the garden with love. I will keep this. I love it. And I will keep many, many, many of the other great words of wisdom that you brought to us today.

Thank you so much.

Daena: Wonderful.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Amre Nouh

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, having the pleasure to be joined by Dr.Amre Nouh is a physician leader, healthcare executive, clinical researcher and innovator with a proven track record of developing and executing strategy, leading multidisciplinary teams and implementing system practices to improve patient outcomes. Amre joins Cleveland Clinic Florida as the Regional Chairman of Neurology, leading neurology care for the clinic’s neuroscience institute in the state of Florida and beyond. Amre Is a board certified neurologist and vascular neurologist. Over the past decade, Nouh has lead stroke care in CT in various roles at Hartford HealthCare, most recently as System Director of Stroke and Cerebrovascular disease. During his tenure he also served as core faculty at the University of Connecticut, Associate professor of neurology, vascular neurology fellowship director and currently is Chair of the Northeast Cerebrovascular consortium, an AHA sponsored consortium for stroke care encompassing 8 states. Amre is a fellow of the American heart and Stroke Association and has led statewide legislative efforts to improve regional stroke care focused on patient advocacy and recognition of stroke center designation for optimal patient care. Amre earned his executive MBA from MIT Sloan school of management where we first met and has served and a key opinion leader and consultant in neuroscience and stroke for various innovative projects within the neurologic care space. He is father, husband, son, brother and in his spare time a fisherman, musician, and avid reader.

Amre – It is such a pleasure to have you with me today!

Amre Nouh: Pleasure is mine Naji. I’m a big fan of your podcast and thank you so much for having me today.

Naji Gehchan: I would love first to hear about your personal story and really what brought you to become this incredible physician and specialist you are today.

Amre Nouh: Thank you, Naji. Well, I’ll first off start out by saying I’ve been very blessed. Um, you’ve shared a lot about my, uh, professional journey, but really I, uh, I was born in Vermont and, uh, grew up in the United States for several years. My parents are originally from Egypt, and, um, uh, we stayed in the US for, uh, many years in the beginning, um, in my elementary school years, and then, uh, moved actually quite a few times. I, I moved to Saudi Arabia for five years. Which was a very interesting transition. Um, this was, uh, uh, late eighties, early nineties, and then, um, moved then to Egypt.

And I stayed in Egypt for about 10 years. I actually finished my medical school there and then decided to return back to the US and started out as a, uh, clinical researcher, um, and did a, a neuroscience research, uh, tenure at Duke. And then, um, through that process, um, studied for my boards. Worked, uh, worked my way up to getting to residency training where I did that at the University of Illinois at Chicago and then went to Loyola for fellowship.

Um, and then, um, moved here, um, to Connecticut, um, where I am currently recording this and, um, about almost a decade here, I met my wife during my internship year in New York. And, um, I have to say that it’s, um, it’s been an amazing journey. I. I look back and reflect on all the things that you said while, while you were sharing them, and, uh, just a flurry of memories just rushed into my head about all the different steps and things that had to happen and things that didn’t happen that have made it possible for me to be where I am today. So I would say I’m very blessed and, and thankful, um, that, um, this is how things turned out so far.

Naji Gehchan: Thank you for sharing this,. You’re a neurologist and specifically specialized in stroke care. You manage patients in really ultimate urgencies. You have few hours, sometimes even minutes to save their lives and save their brains. I’m really interested to know how you manage this stress and responsibility personally before going to the team.

Amre Nouh: Absolutely. Um, yeah, I, I think, um, I think, uh, you know, neurology has, has evolved. I think, uh, over many years. Neurologists have always thought to be analytical thinkers. They have time to think and pontificate over things.

And as you know, um, it is a specialty that requires a lot of that. But stroke is indeed unique where you have to make quick decisions and you have. To manage that stress. Um, I found it, uh, I found it very calming to think of, um, to think of things in chunks of time and steps. So, uh, I think being disciplined with a process, uh, following a specific protocol that you have and uh, creating it out a habit out of managing your time while you’re thinking through the steps has been.

Um, every now and then you’ll encounter a patient that doesn’t follow the book and kind of throws you off track of your, your process and, uh, is trying to keep calm under that pressure and always remembering that you’re not alone. Thankfully, Um, no decisions are made in vacuums and there’s always someone around you.

So when things do kind of, um, present themselves unique or a challenge that you know is different than what I’ve seen, I tend to take a step back, take a deep breath. I think, um, there’s no shame at all in, uh, calling a friend or seeking some advice from a colleague. Um, I think that’s the most important part because ultimately, um, you know, you wanna do what’s best for the patient.

Naji Gehchan: So when you’re doing this, you’re obviously also managing a team, a cross-functional team, uh, with, with different tasks, different responsibilities. So how do you make this at this team level, ensuring coordination, agility, speed, and also continuous improvement in your patient care?

Amre Nouh: Yeah, I would, um, I would actually, uh, take that and, and maybe share with you sort of.

My strategy that’s helped me so far. Um, and what I’ve really learned over, over, uh, the past decade, uh, leading teams is really rallying everybody around the vision. You know, there’s, uh, two quotes that come to my mind, always want to talk about this, and the first one is, um, um, you know, a vision is not an idea because everyone who’s ever taken a shower has had an idea, right?

It’s the person who got out the shower, dried off and did something. That made a difference. And that’s a famous quote by Nolan Bushnell, which essentially means that you have to really, uh, be very communicative about your vision and, and you have to execute it. And to execute it, you have to have a, a pathway.

Uh, another thing that comes to mind is if you don’t know where you’re going, any road will take you there. And that’s a famous quote too by Louis Cornell. Um, so those two points together really, I would say provide a true north for the team. So on. Smaller scale of managing an acute care patient, it may not seem as as important, but on a larger scale of leading stroke teams and leading hospital divisions and leading healthcare, uh, at a larger level, everybody has to know what the true north is.

Um, and, uh, having a vision and having a plan about how that vision is, is going to, um, pull itself or evolve is really, is really key. So I think. Communicating, setting expectations and resetting expectations, um, very clearly about what it is we’re trying to achieve is really the way to go.

Naji Gehchan: I love that. So you definitely touch on, you know, my other question, which was, uh, how do you transfer the skills you learned in acute settings towards what you do now, which is leading large organization systems, improving those systems to, to better patient care? Any other learning than vision, executing on the vision, which is a key first step.

Do you have any other thoughts from a leadership skill stand?

Amre Nouh: Uh, absolutely. So, uh, you know, I, I would summarize leadership in two things. Uh, two really sentences. One is, um, for me, I felt leadership is the maturation of frameworks Plus influence and mentor maturity is a shift in frameworks nurtured by experience.

I believe that, um, any good leader needs three key characteristics. Uh, first and foremost, me. I mean, I, I’ve been blessed throughout my life so far with some really great mentors that I owe a lot of gratitude for, and I’ve been asked to mentor people, uh, as well. Um, everybody needs a coach. Um, and, um, um, I think that I’ve been, I’ve been helped to, you know, get, get out of trouble or avoid trouble.

I’ve been given some sound advice. Many times there’s a imperative action bias. We wanna jump in and do things and solve things. And, um, it’s like what Napole used to say, Don’t, don’t, uh, interrupt your enemy while they’re making a mistake. Sometimes you just have to sit back and watch and let things unfold.

And I have to say that, uh, a mentor who is not emotionally charged or is looking at things from the outside who genuinely cares about your wellbeing and your development is key. , Um, if you are even a mentor yourself, having a mentor keeps you humble and keeps you, uh, keeps you aware of what you need to do to mentor your teams.

So mentorship is almost, I mean, it’s invaluable. I know that many people talk about this. Um, but from my personal experience and what I can share is that especially as a physician, um, there’s a lot of experience and wisdom that we can gain. Uh, you know, lowering our ego levels to ask for help and to understand situations.

So that would be one of the first things. Naji, eager to hear the second . So, well, I, I, I think, um, the second one, um, which, um, which is an interesting, it’s not a novel concept at all and maybe we can spend a little time cuz I’m curious about what you think about this as well as a. As a fellow colleague, leader, and, uh, MIT alumni, um, being assertive.

I mean, um, I was reading recently a very, uh, the work by Emmanuel Smith and who kind of summarized, um, coping mechanisms, uh, into this very interesting framework and concept where we are all conditioned, um, by our design to have fight or flight responses. I mean, that’s what differentiates us from any other creatures on those ends of the spectrum.

In the center, we have verbal reason. You know, if you’re driving your car and someone cuts you off, you’re not gonna get out and, and, and fight them. Um, it’s because we have, you know, we have the, the verbal reasoning part, but over time what ends up happening because of the emotional load that is associated with a problem or a situation or an opportunity, we tend to treat things with the slider approach, where instead of the flight mode we’re in this, some people become passive aggressive and on the, um, on the flight mode, they become non confront.

And, um, you know that there’s a slider in the middle, and sometimes when you deal with a problem that’s you don’t wanna deal with, you just avoid it. You use some fancy words, you pass it on to someone else, but in reality, you really didn’t cope. You just became non-confrontational and avoidant. Or you get the passive aggressive behavior.

And we see it all the time, not only with leaders, but even with our team members and others. But true coping is being assertive and, and, and really calling things out for what they are and trying to avoid that. Either falling a victim to an abusive relationship where passive aggressiveness is the culture or the tone of the relationship, or non-confrontational, avoiding things where you can’t get anything done because people are indecisive.

I really like that and I felt that, you know, this kind of summarizes, um, really what assertiveness is very nicely. Um, and as I just said, it’s that maturity of frameworks and influence. So, you know, as we all evolve as leaders, Um, defining assertive is that way and understanding the differences and seeing it when people cope or not.

How they respond are they’re being avoidant and there’s usually some degree of emotional discomfort. So, um, I feel like that’s a under stressed area in an area that’s not really talked about amongst teams is calling out that type of behavior by reframing it in, in being assertive and avoiding those two negative trap.

Naji Gehchan: Yeah, this is, this is super important. I just said, Amber, I think you’re touching on different aspects, as you said around assertiveness. You have, making sure as a leader that you’re building this safe environment. Mm-hmm. , where people feel safe to say what they think to challenge and where, where, Honestly, honestly, confrontation is.

Like we have to confront ideas. For us to innovate, we have to say we don’t agree. We have sometimes like to go into those healthy small confrontations or fights or whatever we wanna call them within the team. But if, if we share, I think what you said in the very beginning vision, like if we know if we share the same purpose and the same values, but actually those small confrontation will help us be.

And move forward. And the risk is exactly what you said. If you’re building a culture where people will start escaping them or not sharing what they think while you cut. Lose all the value of having a diverse team or bringing new ideas. And ultimately, as a leader also, you said like, if you are not assertive and if you are starting to avoid those topic, it’s like it just ripples through your team.

So I, that’s really a great one, and I agree it’s rarely shared through this land, so I thank you for sharing it. I, I love how you framed it through assertive.

Amre Nouh: I will link it to, um, the concept that’s been discussed in many different formats. Uh, you know, being in the basement, uh, you know, like if you are, and we all, I mean, this is an area that I’ve, I’ve learned from experience that, um, you don’t have to solve this one.

All you have to do is get better by reducing the amount of time it takes you to get out of it, right? Uh, so you have a problem, or some you become emotionally charged or you become challenged and all of a sudden you’re in the basement, right? You’re panicking, you’re, you’re, you’re falling. On one side of that spectrum, you’re gonna either become avoidant or get angry, or become passive aggressive, and, uh, you need a mantra to get you outta that basement.

Many times it’s just time. Some people can meditate. Some people pick up a phone and call someone. Um, and I, I think that the lens that has always been looked at for this one is, you have to get out of this. You have to get out of this, you have to get out of this, but not focusing on, you just have to get out this sooner so you don’t dwell for days on a problem.

And really progress is measured by, you know what, This happened to me. I had this really bad experience, but only took me an hour or two and I feel like I’m back to myself versus the only, this would’ve been a week’s worth of moping. Um, and it does go back to the same concept. Links into this, uh, sort of, uh, spectrum of coping and, and being assertive.

So, um, I think that’s one thing as a leader as, as you kind of gauge your own sense or your mentors tell you you’re getting better or not, is really gauging how long you spend in the quote unquote basement and how you can get out of that sooner, um, and what mechanisms you have.

Naji Gehchan: I, I love this. How long do you spend in the basement?

Yeah. ,

Amre Nouh: I mean, I’ve spent, I, I’ve renovated my basement literally in figuratively, . I mean, it’s really, it’s a, it’s a tough one. It is. I mean, we’re human beings and we are, we are gonna, we’re gonna make mistakes and we’re gonna have these problems. And a lot of times it’s not just work, you know, it’s, it’s, uh, It’s the crushing reality of all the different, um, responsibilities we have and the work life synergies and all these other things we have to deal with.

Um, but it’s also an area where I think one of the three key characteristics that goes with hand in hand with assertiveness, um, and the mentorship piece.

Naji Gehchan: Yeah. And so, so you talked about two things I would like to, uh, kind of double click on. Um, obviously you’re, as you’re saying, it’s not only work, it’s all that goes around it.

And in, in your intro you also talked a little bit about this, like the things that happened. That made you not do things or that pushed you to do things not the way you wanted to do. So I’d love to hear more about, about this. Uh, and then I will go into, uh, you talked about mistakes. I’d also love to Yeah.

Talk about this. But let’s, let’s start with the first one. So,

Amre Nouh: um, I’ll start that off by talking about the, the, the, uh, the widely shared or widely taught, the widely believed notion of work life balance. And I feel like word work life balance gives a dis surface to both your life and your work. Because essentially when you say, when I say balance, or you say balance and you close your eyes, I think we envision a scale with two sides, kind of those old school scales.

And that the word balance automatically assumes that those things have to equal each other out. So sometimes you have to, you know, Rob Peter to pay Paul and you’re gonna, you know, do a little more with work, um, at the cost of family. Your other life or vice versa, but they’re never in sync. And, um, you’re always tugging on one side or the other.

And, and we’ve always been sort of taught that we have to perfect that. But a, a mentor , ironically, has, has shared with me a very important concept and said, never say work life balance. Always say work life synergy. And there’s two incredible lessons in that sentence alone. Number one. The choice of words matters.

Um, you know, it it, it goes back to framing. If it’s framed right, uh, it’s gonna, you’re gonna think, right? Um, and the second one is using the word synergy instead of balance. And naji, I mean, you are one of the busiest people I’ve ever met as well. Um, and, uh, you’re, you know, you’ve managed a lot of things and I think this resonates with you as well.

Um, it, it all has to make sense together. You have to find ways where your work is meaningful, um, and that it is not robbing you of the joys, uh, the focus, the the being in the moment with your family, um, outside of the confines of time. Because the reality is that’s the one variable that no one has any control over.

You’re gonna still have those 24 hours and make most of them, but it’s, um, it’s framing not just to yourself, but also to your. Get them involved in what you do. Uh, share the passion with them, even if they don’t feel passionate about it and understand where they’re coming from. Um, you know, um, the way a problem is posed, uh, influences really how, how, how you solve it and how you kind of address it.

And, um, and work life balance sounds like a problem. It doesn’t sound like, it doesn’t sound like a solution, but work life, synergy.

Naji Gehchan: Yeah, I, I love this frame. When you, when you said synergy, I’ve been more drastic about this. I say like, there’s no work life balance. There’s one life we live, and like, obviously, you know, that’s even better

But yeah, it’s, and as you said, I think like the, how you frame things and the power of how you ask the questions. Yeah. Make a whole difference. I really like this idea of balance versus synergy. So if you go to the mistake, Uh, in your word, obviously dealing with mistakes has practically to be like close to zero when you’re dealing in an acute setting with a patient.

Um, but yet you innovate. You improve patient care constantly with your teams. So even though unfortunately the stroke kind of framework, uh, and innovation with drugs, et cetera has not been as big as in other therapeutic areas, you obviously are treating better patients. Your passion is in hospital stroke, but also out outpatient care.

Yes. So I, I, I’m really interested to, to know how you deal. Zero mistakes and following the processes I choose, as you said, and at the same time trying novel ways to better treat patients. How do you, how do you deal with those two things, especially that as we’ve seen at MIT and as we many times hear, do mistake, learn from them, trial and error, but in such a high, high stake specialty, it has to be a little bit different.

So I’m eager to hear how you do this. Wow.

Amre Nouh: Um, that’s a lot. Naji. I’m going to try, I’m gonna attempt that one as best as I can. Um, it is, uh, it, it is, it is a very, um, uh, big responsibility to, uh, to, to manage, uh, patients and take care of them in any specialty. And you’re right, the tolerance level for mistakes is, is zero.

Um, you know, we always talk about the first rule of medicine is do no harm. Um, and I believe. Fullheartedly, I would say examples of, of mistakes that involve bad leaderships or bad decisions are around who was right versus what is right. Um, and the reality is that we are human beings taking care of human beings.

Um, so stakes are, are inevitable. Um, we do, you know, we try our best to avoid them by sticking to process, tricking to protocol. Um, I think what I found that helps with, with, um, learning from mistakes and, um, keeping that spirit going and, and really connecting with the human beings we are, and the ones we are caring for is emphasizing that relationship is making sure that, you know, we are, we are with best intent, going to do our best.

Um, we’re going to settle only for the. And if, and when something bad happens, an adverse outcome or something that wasn’t planned or there is some degree of error, uh, how we handle it is going to matter way more, in my opinion, over maybe nine enough time times than, than just getting to the outcome. Um, and, you know, um, I, I can, I can share with you that, um, being on both sides of that, um, a lot of times.

Um, and it goes back to this assertiveness a lot of times. Um, you know, you fall into that trap of either, you know, playing the blame game or, um, you know, which is passive aggressive, uh, and not owning the problem or being unavoiding that it wasn’t mean it was someone else, or, Oh, this only happened because someone didn’t do this part of that part.

Um, I mean, I, I could tell you that some of the best stories I’ve had with, with families and patient. Were those that did not have a good outcome. Ironically, and, and when I talk to many of my colleagues in neurosciences, we all have those heroic cases where it’s a great save. Someone was paralyzed and coming into a hospital going to be completely disabled and within hours have complete restoration of blood flow, and they literally walk out the hospital.

Those miracle cases that we see on the news and on tv, and we’re fortunate to be part of that many times. A lot of stories that I, I, I, I will never forget. And the ones that I think of often, and the ones that have helped teach me way more than the, the good outcomes were the ones that were bad outcomes.

And I actually have long, uh, you know, long standing, uh, family members, uh, patients passed away. And it was how we handled, how we handled that and how we handled the bad outcomes. So, um, I know. That’s a long answer for, for a long question, but that’s the reality of what neurosciences is sometimes. It’s such a unforgiving, uh, system, a nervous system.

And you’re right, we have made a lot of advances and what drives me, um, to continue to strive in this field is I think there’s a lot of potential still in advancing technologies and bridging the gap between good patient outcomes and, uh, the shortcomings. The human ability to, to care for these folks.

Naji Gehchan: Thank you so much. It’s not at all a long answer. It’s um, it. Pretty humbling and tough to transition to the next section. And you shared beautiful things. I love how you said who was right versus what is right, and we see it many times in medicine and, uh, everywhere, honestly, even on organizations, uh, and how to handle the, the outcome.

Thank you. Thank you Amery, for sharing this. Um, I’ll transition now to a phase where I will give you a word and I’d love your reaction to it. Okay. . So the first one we talked a lot about it’s leadership. Yes.

Amre Nouh: Um, yeah, I, I’m, I’m going to, uh, I’m going to reiterate what I said. I, I mean, leadership, you know, John Maxwell, uh, says leadership is influenced nothing more, nothing less.

I, I don’t disagree with that. I would just add that that leadership is a, is a, is a maturation of frameworks plus influence, and that maturation, uh, comes from being nurtured by experie. So that’s what comes to mind. Health equity. Health equity, um, what in my humble opinion, health equity is offering every patient the same care you would give to a family member or to anybody else.

Um, independent of who they are, what, what their background is, where they come from, and, uh, treating them like you treat your. Mentorship, mentorship. Mentorship is sharing these nuggets of wisdom. This type of conversation that you and I are having the pleasure of having is so valuable for the people that you mentor.

And, um, I think mentorship is gold. There’s no way that anybody in any position, at any rank does not need a coach. Everybody needs a.

Naji Gehchan: The last one is spread love in organizations .

Amre Nouh: So, you know, I love that. Um, and this is why I’m a big fan of, of what you do. Naji. Um, earlier I said there’s three main characteristics of a leader, and I think that the last one resonates with this word that I’ll tell you is empathy.

Um, you know, a little bit of empathy goes, goes a long. Um, you know, um, there’s a really great book that I read recently by Moga, which is, um, Solve For Happy, and there’s a lot of great nuggets of wisdom in that. One. One that really I liked was how, uh, the author frames how we perceive the world and says, We are all movie stars in our own movies, and everybody we interact with is a supporting actor.

So right now I’m the movie star of my movie, and you’re the supporting actor. And in your world it’s vice. Um, and a little bit of empathy will help us oversee, uh, you know, not oversee the fact that, that that separate reality exists and will allow us just enough to keep our eyes and our ears open, uh, to understanding where other people are coming from.

So, spreading love in organizations has to come from empathy has to come from that ability to recognize. Sure you are the movie star of your own movie, but you have to understand sometimes that the person sitting in front of you feels exactly the same. And maybe you should play a supporting role, um, for that love to spread. Because if everybody stays as the movie star, um, the team will fall apart.

Naji Gehchan: Any final word of wisdom for healthcare leaders around the world?

Amre Nouh: It’s a journey. Um, one of my mentors always says it’s about progress and not perfect. Um, you know, if I were to have this talk with you a few years ago, it would sound very different than it is today, and I hope that we could redo this in a few years, and I’m sure you and I will have a whole different host of things to talk about.

I think there are some core things that we, we talked about. Um, I think first and foremost, talking about vision for others, having your own value system is so I. Another, uh, mentor always told me, Write down your three core values on a piece of paper and carry them in your wallet. And when you’re in the basement, take out your wallet and take out that piece of paper and look at it.

Um, and it was very interesting. I mean, it’s, uh, I’ve done it a few times, but I’m gonna be honest with you, it’s hard to do that cuz you know, once you’re panicking, if you’re, if you’re panicking and reaching for something in your pocket, , that’s not a good thing to do all the time. But, um, I think. I think that’s a great nugget of wisdom.

Um, knowing your true north, um, and reminding yourself of your true north will help keep that work life synergy going, will help prioritize where you need to, uh, channel your energy and will help build a foundation and a growth mindset for you to continue to evolve as a leader. And, um, staying humble and staying true to yourself and understanding those shortcomings will, will only help perpetuate that.

Um, I, I, I, I’ll leave with this final piece of wisdom that’s not mine, But perpetual optimism is a force multiplier that’s, uh, one of Home Powell’s 13 Rules of Leadership. And it’s true, uh, you have to have a positive mindset. Everything we just talked about, you could see the half class empty, but the half class full is always better.

Naji Gehchan: Thank you so much. I, great. And I, I love your challenge. Let’s, uh, let’s put a date in five years to rerecord whether the podcast has still here or not, but I will do it with you again in five years and we’ll chat about it, . I

Amre Nouh: love it. I really look forward to it, and, and I think it’ll be awesome. Thank you, Naji, for everything you do.

I think spreading love is important and I, I hope to continue to, to hear all the great guests you have and learn from all the episodes and, and nuggets of wisdom that you get to share with the world through, your guests and through the discussions you have. Thank you for having me.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Jennifer Kherani

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, having the pleasure to be joined by Dr Jennifer Kherani. Jen received her M.D. from Duke and subsequently completed her residency training in emergency medicine in the combined Cornell/Columbia program at New York-Presbyterian Hospital, where she served as Chief Resident in her final year. Until August 2022, she served as Head of Clinical Safety at Loxo Oncology.  Jen is also a founder of Summus Global, a subscription-based healthcare advisory company aimed at restoring the human connection between patients and healthcare providers. Jen is currently serving on the Rye Country Day School (RCDS) Board of Directors and is a member of the Medical Committee, the Diversity, Equity and Inclusion (DEI) Committee, the Education Committee and the Marketing and Communications Committee. She also serves on the DukeNY Board of Directors, serving as Co-Chair of the Nominating Committee as well as member of the DEI Committee, the Women’s Impact Network (WIN) Leadership Counsel and as a mentor on the Reimagining Medicine course.

Jen, it is such a pleasure to have you with me today.

Jen Kherani: Naji. Thank you so much for having me. It’s a pleasure to be.

Naji Gehchan: Can you share with us first your personal story from med school to emergency medicine, then entrepreneurship, biotech, pharma. What’s, what’s in between the line of this incredible journey you had?

Jen Kherani: Yeah, it’s a little bit sinuous, admittedly. Um, I, you know, I was born on Long Island and in New York and had been local here pretty much throughout my entire life. Um, my parents, it’s funny, my, my dad was a policeman. My mom. Started a business when she was, you know, when I was five years old. So I remember it being, I was very little, um, and just remembered the dynamics there.

Like neither of them had had the opportunity to go to college afterwards. They had us very young. Um, so we lived a very fun life. My mom, I think she was 23 when she had me, and my dad was not much older and so I sort of started out. Just having fun with things and not really thinking about them too much.

And I think that, you know, came full circle later on. I do think that it has helped for me. Um, so I, I went through my education, not really taking it too seriously. I mean, I, I did, I did what I had to obviously to get through it, but, um, I didn’t think of things as probably deliberately when I was, when I was younger.

I just sort of, any endeavor that I did, I tried to do it very best I could. And. It sort of started working out. I mean, you know, at one of my first jobs it was working at a restaurant. I became a manager when I was 16, and then I, you know, went to to college in undergrad and joined the the Panhellenic and then became the president of the Panhellenic.

And most of the things that I did, I just tried to do what I enjoyed and. Threw myself into them. And when I graduated undergrad, I didn’t actually know that I wanted to be a doctor. I was not a pre-med undergrad. And then when I finished, I moved to New York City and I kind of flip flopped into a few different jobs.

And as I was doing it and trying to find my direction, I happenstance on a medical trip that went down to Guatemala and it was a trip that. It had multiple groups that traveled down together. One was a medical group and they would go out and create sort of a virtual clinic into in, in these communities that were local down there.

Another would go into the hospital and they were doing clef, lip and pallet repairs. And then the third group, which is how I ended up there, was it was a group that was going down for community service and just, Building an orphanage or building a playground or trying to do something for the community.

And as I went to this, um, I did get time to go into the hospital and into the clinic group and spend some time sort of crossing, you know, into, into the different subgroups that were there. And when I did, um, you know, I, I remember very vividly there was a young man who was about 18 years old and he came in with the bandana across his face, um, almost like, like a classic bank robber style and.

You could see when he took it down, he was, he just very, Malformed mouth and oral and, you know, his palate was also malformed and he life. But, um, ultimately they did the clef lip and palate surgery. And I just remember handing this gentleman a mirror at the end of it and the, the look in his face, I mean, you could tell that his whole life was going to turn around right there for him.

And, you know, in his mind and. I, I don’t know. That kind of captivated me to the point where I got home and I did the same thing. I said, Well, you know, that’s it. I wanna do medicine. And so I went and I took both back courses at Columbia and I worked in a lab during the day and ultimately ended up in medical school.

And I was that medical student that whatever rotation I did, I, that was what I was going to be. I wanted to do that. I wanted to be that, you know, it’s, I loved surgery, I loved pathology, I loved ob gyn. I loved everything. Um, and so when I got down to it, I, I sort of danced around and I, when I picked my specialty, um, I had taken, like I said, some time off in between undergrad and med school.

Um, I had met my husband, I got married in med school, and I knew that I wanted to have kids, and so I. Took everything. The fact that I loved everything and I, I had all this energy that I wanted to put towards things, and I also wanted to have a family. And so that spun into me choosing emergency medicine, you know, for so many reasons.

And I went into it and I, I loved it. It was fast paced, it was strong team building. I, you know, again, I could do what I loved, become a leader, teach, um, you know, teach both patients and med students and residents and that I absolutely loved. Um, And then I finished that and, and when I started practicing as an attending, I also simultaneously as planned, became a mom, which impacts everybody a bit differently.

But in those moments, I, I finally figured out that the only thing that I loved more than being a doctor was being a mom. And so my kids started to factor very heavily into my decisions. And so I was working part-time in the emergency room. Um, I started, like you said, Sumas with my husband and another friend of ours, and.

That company sort of took off on its own. It started off more slowly and as I was doing those two things, Locko sort of found me. Um, they had needed a physician to run their hotline to try and find patients and match them to their clinical trials. And so I took a chance, decided to try it, and pretty much never looked back.

So, Medicine, entrepreneurship, and, you know, industry sort of all found me at the same time. And I was fortunate and lucky enough to sort of grow all of those things at the same time. And again, because of the same, I, you know, passion to just do things well, uh, you know, if you love them, just throw yourself into them.

It sort of took off and went in the right directions and, and kind of led me to where I am.

Naji Gehchan: Thank you, Jen, for sharing your story and, uh, and how you, how you led and been there. Uh, it’s something you talked about as being a physician, how you lead team, how you develop leadership teaching, and also you have high pace.

So, um, you know, I, I kind of relate to this in my training and frequently we get this question about. What is it different? When you joined biotech, you obviously were dealing with life and death practically, really every day. Uh, so how did you. How did you think about this? Uh, did did it feel so different or was it a different stress?

But it’s still, patients can’t wait, obviously in our industry neither. Right. So I, I’m interested to get your perspective on it.

Jen Kherani: It was, you know, to your point, it was very different. And I think the reason that I had patients with the difference, because I didn’t leave clinical . I loved my patients, my time with them, my relationship with them.

Um, but I started to start, you know, I started to think about the fact that I wanted more longitudinal relationships with them. And so I, you know, there was a part of me that was kind of dancing and dabbling into looking for something else. And then, like I said, my kids came into it when I started industry.

I think because I s. You know, I was ready. I took the leap, but I did miss that patient interaction and I thought it was, it was more invisible to me at first when I started industry. And I think that was hard for me to adjust to. I enjoyed it. I knew what I was doing was making a difference in theory. Uh, you know, you’d start these trials.

Our philosophy, Naloxone was always to help every single patient. If there was a patient, legitimately, one of them was in the middle of Vietnam and we figured out how to get them drug and how to get them, you know, onto a, a single patient protocol. And we did that for every single patient. And sometimes you got the stories returned to you, but many times you didn’t.

And that was the hardest. Adjustment for me. Um, but I think my husband was very pivotal and he would always remind me of that. He would say, You know, it’s, it’s invisible, but your impact, what you’re doing, how you’re touching patients is not as tangible to you. Um, but it is nonetheless there. But it took some reminding and then honestly that.

I think what I, what also sort of landed me in this place of, of comfort that I really enjoyed and and loved about industry was all the people that I was surrounded with. Not that it’s not the same in, in medicine, it is, but so much of it was new to me at the very start. I was switching from emergency medicine to oncology, from, you know, clinical work to, to clinical trials and, you know, industry and all of it was so different and new to me, and I just loved the pursuit of learning.

And so I think that that kept me very captivated even through that for a rough patch of adjustment where I missed that clinical interaction with patient.

Naji Gehchan: Yeah, we definitely share this. And it’s, uh, you know, the impact that we bring in the industry, the scale. I’ve always talked about the scale, what you’ve managed to do throughout your career in the industry, obviously had a huge scale on the number of people you’ve touched.

Uh, any learning specifically from a leadership standpoint leading in emergency medicine? Like you read so many cross-functional groups and leading in the industry, did you take any, you know, key learning from, from one to the.

Jen Kherani: It. I think, yes, I’d say what carry over the most is the same philosophy, meaning, you know, I always, there’s a couple of quotes that sort of linger in my head whenever I’m doing something in life and, and one of them is always, you know, no job is too small for a big enough person.

And the idea of when you’re building a team, get in there with them. Lead by example, you know, sort of walk the walk that you are talking, um, and no matter where you are in life. That always served me in the emergency room. Everybody always knew that, you know, if they needed anything. It wasn’t that I was not going to do it or too busy, I would always find the time, make the time, and get in there with the team.

I think I carried that over to industry again because I had so much to learn. If anybody needed help, sort of my hand flew up because I needed to learn it anyway. Um, and I needed to meet them and I needed, and eventually that evolved into my foraying into a leadership position because I started to work with everybody and know them and, and be in it with them.

So I think that that skill translates to both. Um, and then having some energy. VR obviously brings on its own, um, but the personalities in industry bring it on as well in a different, you know, it’s a different flavor. Um, but everyone is working their hardest just to make, you know, to get the end goal accomplished.

Naji Gehchan: You also founded a startup, so you’re also an entrepreneur by heart. You love what you do with, with your energy too. Uh, and this startup has a big aim of restoring human connection. So I really picked up on these two words cuz I feel they are so powerful. And specifically between patients and healthcare providers.

Can you tell us a little bit more about it and what you’re, what you’re trying to do?

Jen Kherani: Yeah, so Sumas Global, I started that, um, along with my husband and like I said, a friend of ours, all of us had gone to Duke. Um, and it really started over a conversation about the state of healthcare. And again, it sort of spawned from one of my, my at least involvement.

It spawned from one of my interactions again with a patient where this. Elderly woman had come in at around two or three in the morning by the time I saw her. You know, the ER goes, I dunno how long she had waited. And her triage complaint was, she didn’t know what to take when, and she came in with these bags full of medicine and she had all these redundant pills.

Pills that were expired. She didn’t know what to do with them. She had no primary care doctor for a time. And it just sort of, to me, struck a chord as to how broken this system is, where you, it’s all breaking down. You don’t have a primary care physician to act as the hub and spoke, or you know, the hub for your wheel.

Um, and a lot of people are getting lost. I think they’re losing guidance. Everything is very sort of metric driven, and it is not, it’s not driven by that connection, that human connection that you have. Have with your, um, you know, your physicians and on the physician side, I think sometimes, you know, particularly with certain specialties, it’s, it’s sort of survival of the fittest because they have to make ends meet, they have to make enough to run their office and pay their office staff.

But what they’re gonna reimbursed is not, you know, they’re gonna reimbursed for tests that they run. They’re not getting reimbursed for their time that they’re educating their patients. And so their patients end up down these rabbit holes of not understanding. So anyway, our endeavor was to bring that back.

And so what it is, it’s membership based. Um, and we typically try to get employers to buy it as a service for their employees. And if you have a, it is not, we’re not necessarily treating patients. It is a medical education platform, you know, first and foremost. And so, If someone comes in with a new diagnosis, many times it’s cancer.

Just, you know, oncology tends to be one of the higher d types of diagnoses that patients have or, you know, members come in with, um, if they have a new diagnosis and they just want to understand it and they just want time with a physician, that is exactly what it is. So we have sim as physicians that are in-house and they curate the, the experience, meaning they collect all of the information that the patient has to date.

They walk them through it. They say, Have you gotten this test? That test? What results have you gotten? And not dissimilar to how it was in the er. Collate all this information and create a summary for the specialist. And then we have a specialist platform. Some of it is an entire hospital, like you can, you can pick any hospital at Duke or a couple of other institutions, Sinai and, and you can talk to any doctor in that network.

Other times it’s individual physicians who have. Signed up and it’s a glass marketplace, so there is a cost for that physician’s time. And that, you know, typically is covered by, if your employer offers this, um, it is covered by your membership up to a certain number of encounters a year. And you can use them for yourself, for your family members, friends.

You can gift them, give them away. And so if you come in with this new diagnosis, the specialist will sit with you. We’ll look at everything that has been, you know, collated in terms of information, and we’ll give you an A to Z interpretation. Your diagnosis where they can guide you what they think is coming, what are the big sort of mile markers that you will go through?

You know, so if it is an oncology diagnosis, okay, you are currently getting this regimen, these are the things that you should think about, these are the tests that I would think about getting for you. Um, and it is just meant to be a sort of holistic conversations so that the patient or member, whatnot, when they leave, knows exactly what they’re going through and what to.

Naji Gehchan: This is definitely a big need. So I’m, I’m really eager to see how you keep on growing this organization. Okay. I, I wanna factor this entrepreneurship journey in on top, you know, of the ER and being in biopharma. Like anything between these three, uh, that you felt kind of helped to one another, any trait of leadership you felt helped you out and you think anyone who wanna build today, companies from, from biotech, because you also.

You know, building a biotech from very early stage into kind of later stage and growing in a big company, any key threat you felt as a leader? So you had the one on being present with your team? Yeah, for sure. Anything, Anything else you have in

Jen Kherani: mind? I think. I think the greatest thing is to, to move with passion.

Meaning, you know, if it is something that bores you, it’s, you know, you can do it, but I don’t think it’s ever going to get you to a level where you’re going to engage to make it the success you wanna get it to. So choosing something that you’re passionate about and then being a yes person, you know.

Every single day. Like I said, you know, when I first showed up to Locko or to the, you know, biotech, every single thing that had to be done, every task, I never said no. And even if I didn’t know how to do it, I just said yes. And I sort of decided in my head that I was going to figure out who I had to ask, what I had to read, what resources I had to go to, um, to make it happen.

And that never let me down. It was. An endeavor that sometimes is quite frustrating, but always left me more enriched on the other side. And I think no matter what you’re endeavoring to do, be it industry, um, you know, entrepreneurship, when you throw yourself into it with that energy and with that sort of yes attitude, you’ll always come out enriched.

And sometimes it’s to learn what not to do , and that’s okay too. Um, but that has always served me well, uh, regardless of my, you know, my.

Naji Gehchan: I love that. Uh, I will move now to a section where I will give you a word and I’d love your reaction to it. Yeah. Okay. . The first one is leadership.

Jen Kherani: Hmm. My reaction has been, or is, um, something that, you know, I, I sort of still strive for at every.

Minute it, it’s something I never assume is going to happen. It’s something I always yearn for and I try to put my best foot forward. But, you know, leadership is something certainly to be earned. Um, and I hope that I can do it and respin it no matter where I go. But I do recognize that that sometimes takes some time and some listening and learning.

But I hope to always be someone who people can look to as a leader. What about d e and I? Hmm. It’s funny cuz you mentioned at the beginning during my bio, you know, I sit on the DEI committee for both Duke New York and for the Right Country Day Board. And I, when I first went into it, that was another thing that I accepted kind of out of nowhere saying, Well, I, I’m not entirely sure what this means, but I.

I have been stretched in so many ways for just learning what DEI means truly. Um, you know, there’s sort of become buzz words, but when you’re really learning how to create an environment that is inclusive, that is diverse, there are things that are subtle, uh, or there are subtleties to that. And a lot of it goes back to it’s almost the same organic roots as a yes attitude.

You kind of have to park all of your preconceived notions at the door when you walk in and be open to learning the smallest amount from whomever comes in. And even if your initial reaction is, No, I don’t believe that, or I don’t think that, or I don’t agree with that. It’s the process of letting it happen and listening because I think that, you know, if you start to craft, and the other P portion of that is learning how to craft.

Environments and meetings that truly do facilitate grabbing the right people in. You know, if you’re always putting the same ticker up for, for what’s going to be discussed, you’re always gonna get the same crowd organically. So it’s, it’s trying to break through that ceiling and, and getting the room to be a truly, um, all inclusive and equitable sit, you know, situation for people to be sitting and for them all to feel comfortable in their discomfort.

Um, and just listening to one another, um, you know, with a common task or I, we have found that, you know, having common tasks to start and spark discussions, um, is a good starting place. But it’s been, it’s been another learning journey for me, one that I am really, really enjoying. Can

Naji Gehchan: you share more about the last piece, the practice that you’re, uh, that you mentioned that’s gonna help.

Jen Kherani: Yes. I mean, one of them, I’ll talk, you know, very, um, uh, objectively about a meeting that’s coming up. This one’s for Duke, New York. But the tasks that are set forth are very objective, but it is meant to sort of spark and, and spawn ideas that bring people closer together and have each other sees perspectives.

So the task is to read the Constitution. It is. Unbelievably short as compared to what you would think, you know, you think it’s this long scrolling document. It’s not an apropo of what’s going on in the real world today. You know, we only have a limited number of amendments to it. Um, it’s structure and it’s utility is limited based on when it was written, which is hundreds of years ago.

And so the task is to read it, to get everybody in the room and to write an amendment that you think speaks to something. That is important to you that you feel was left out of the Constitution in its initial inception? It’s, I’m still in the middle of it. I haven’t written my amendment yet and I still haven’t actually finished it, reading it even.

Um, but it’s a fun, it’s a really fun task. Um, And the last one was a book read. So a lot of it is just to get people out of their comfort zones and to stretch them. So to go in there and listen to how other people feel the constitution fails them, should open a box. That’s very interesting. I think for, you know, for the broader group,

Naji Gehchan: sure. What about entrepreneurship?

Jen Kherani: That to me is kind of a synonym for fun. I I think that, you know, I don’t know where my career will take me in the, you know, both the, the more immediate future and even in the, the farther out future as my kids get older, as they leave and as I have more time to do it. But to me, entrepreneurship is just sort of this open horizon that you can have fun with, that you take your passions and drive with.

And I hope. I will return to that space where I can just run with it. ,

Naji Gehchan: what about spread love and organizations?

Jen Kherani: I love that one. I, when I saw your organization and it’s, you know, it’s, it’s objective. I find it to be such a heartwarming and welcoming concept. It’s, it kind of goes along with everything else where it’s just an open door and this, you know, Open couch to sit on and have a discussion and be open and honest and loving with everybody that comes into that, you know, virtual room, so to speak. So, I, I, I love it.

Naji Gehchan: Any final word of wisdom, Jen, for healthcare leaders around

Jen Kherani: the world? Oh gosh. I think, you know, we covered a ton. Um, but one thing that I don’t believe I’ve said throughout that I find to be, um, maybe one of my biggest tools and one of my hardest challenges is to constantly find ways, um, to find humility and to be humble.

I think, you know, as you are climbing these endeavors, tasks, you know, positions, whatever you’re going for, you sort of have this pie in the sky. That you wanna create the shortest distance between you and it. And you know, you sort of feel in certain moments, like you wanna move everything out of your path and sometimes that’s not the best way to get there.

I think that it kind of, Innocuously fold or, or invisibly folds into some of the other concepts of listening to who’s around you at the time, whether or not you think it’s going to be a valuable position, a valuable endeavor. Um, kind of tackling that with humility, because I think that the people you meet when you open your ears and your eyes and your heart and listen to them truly, they’ll challenge you to think about things a different way.

And then you sort of have to look inboard and think, Well, gosh, I, I didn’t. Think about that. You know, how do I need to change myself or how do I need to act? So I think that, you know, all the things that we’ve talked about, finding something that grounds you, that gives you humility throughout. Um, I know that people find it in different ways, but I think it’s so incredibly important slash imperative

Naji Gehchan: that’s powerful. Tackle problems with humidity. I love it. Jen, thank you so much for being with me today.

Jen Kherani: Naji, thank you so much again for having me. This is wonderful.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Clarissa Yang

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, joined by Dr Yang, a thought leader and clinician dedicated to delivering high-quality, compassionate, clinical care to her patients. She believes in constant improvement and re-evaluation of clinical care systems and in developing the next generation of doctors.

Clarissa is the President of Pratt Dermatology., Dermatologist-in-Chief at Tufts Medical Center, and the Chairman of Dermatology at Tufts University School of Medicine where she is responsible for the strategic clinical, educational and research success. She also serves on the Board of Trustees at Tufts Medical Center. Previously, she held leadership roles at Harvard Medical School and was the Outpatient Medical Director for the Department of Dermatology at Brigham and Women’s Hospital and helped expand the clinical footprint to 13 outpatient clinical facilities. Clarissa grew up in Canada and obtained her medical school training at McGill University. She focuses on operational efficiencies, integration of technology, and clinical care redesign. and has been awarded “Top Doctor” by Boston Magazine since 2018!

Welcome Clarissa! Honored to have you with me today!

Clarissa Yang: Great, thanks Naji for inviting me.

Naji: If there is, I would love to start as every time to hear a little bit more about what’s in between the line of your amazing career as a, as a clinician. What’s your personal story? What got you there?

Clarissa Yang: So I, you know, we always start from the beginning, right? I think my parents were first generation immigrants from Taiwan.

And they immigrated to Canada actually. Um, my father was a, um, nuclear physicist and there were only a few, um, Nuclear accelerators in the world. And one was a sketch one in Canada. And so, um, they came over and started a family and they moved east after I have an older sister. So when they moved east after that, but because they were, you know, the first generation here, They really didn’t have any money.

They really felt like they needed to build everything from scratch. So very much from childhood, they really instilled a sense of responsibility and, um, determination. And you know, how I probably landed in healthcare was, um, my grandmother came from Taiwan when I was much younger and, uh, she came over because she had metastatic breast cancer.

In her sixties. And I remember my mother taking her to all of her appointments and how challenging it was really for her, um, as an experience with a significant amount of lymphedema. And, you know, she, she lived about 10 years and then passed away, but it sort of left quite an impact on. On myself and how much healthcare, um, impacts others and their lives and the lives of their families as well.

And so I guess very early on because of those experiences, I always felt like I really wanted to become a physician and help make that impact. Um, and I always loved kids and always thought that I would end up, uh, as a pediatrician actually, But then once I got to medical school and then I had to take care of really sick kids, it was, it was hard, actually.

It was, um, I loved being able to be their advocate. I loved playing with them, but then when it came time to, you know, doing procedures and actually not having that kind of relationship with them, Uh, I started started thinking, is this the right thing? Um, and then one day when I was actually in the hospital, I was actually on a pediatric service.

Um, we had this child who had quite an unusual eruption on his lower leg. And for days, we really just didn’t know what was wrong with him. And, um, we finally decided to call a dermatology consult and the dermatologist that’s the time she just came in and she looked at him and said, this is clearly this diagnosis you should be doing.

You should have done this workup by. And I was sort of really amazed by that, that you could actually just look at something and know what was happening inside. And, you know, he turned out to have a bowel disorder and, and we figured it out. Um, so, you know, I was like, oh, this is really cool. I want to be that lady one day.

So, um, so that’s sort of how I thought about looking into dermatology and as. Explored it it’s really a window into what’s going on inside that not everybody gets a lot of training on. So, um, it was like this great expertise that sort of drew me to Durham. Um, and I couldn’t be happier. I love what I do and I love taking care of my patients.

Naji: The welfare, thank you for sharing, you know, your, your story and, and how you care every day for your patients and what drove you there. Uh, and on this piece, you know, if you’d talk a little bit about dermatology, we’re going to talk about, um, you know, uh, one of the things you’re passionate about, uh, as this clinical carry designs are reading sheet to learn a little bit more, but maybe before that, you know, dermatology, as you said, this really the skin that.

Somehow, like everyone sees it, right? Like it’s such a dizzy. Well, if there is a disease on the skin, uh, we can see, uh, there’s lot of discussions also in dermatology, obviously with innovation, like imagery, what that the medicine can bring, like all those scans and cancer that can transform this. So I’d love to hear before going into COVID and what.

Changed in medicine, uh, obviously, which is the most obvious piece. What are your thoughts about since you’re really into integration of technology? What are your thoughts about dermatology technology and all those changes?

Clarissa Yang: Gosh, I mean, I think it’s really exciting, right. Um, because I think a lot of. A lot of times when we go, at least as physicians go to medical school, we’re taught to take care of patients.

We’re taught diagnosis and treatment, but then outside of that, whether it is business innovation, Relationships with industry, um, working in a multidisciplinary fashion that is not necessarily outside of medicine, the traditional medicines, it’s actually more rare. Um, and you know, in most other industries, um, I would say healthcare sort of lags behind and its ability to deliver things efficient, efficiently, have everybody working at the top of their license, the ability to pivot and, uh, change with the times.

It seems to struggle. At least that’s what I’ve noticed in healthcare. Um, and so. I love that marriage of the two and thinking about how we do things better, but it’s not just technology that I care about. It’s it’s how do you just always look at something with fresh eyes? How do you think about the process?

It’s a very process-based and, um, and so I really think about process improvement and then how do you do things maybe differently than, than we’ve always done and not be scared of that kind of change? Um, I think some of the reasons why. Uh, I’ve always, I’ve always, if you go, if you always think back to, to sort of childhood, it was always, oh, well I see a problem, you know, why can’t we just do it this way?

Right. And, um, I used to laugh with my father actually, and he would do his things and I’d be like, okay, we can do this faster. Can you do it this way? And so, so I, I always knew that I liked, um, being able to create efficiencies in process. That’s also why I love care clinical care redesign.

Naji: So, so what is, what is your biggest challenge as it either, you know, and you talked about cross-functionality working with those different teams, try to talk.

Well, what is your biggest challenge to drive this efficiency in patient care?

Clarissa Yang: So I think some of the bigger challenges that I’ve noticed is because I’m an academic, uh, dermatologist. And so. When you work in larger systems, I think that sometimes there’s a lot of bureaucracy, right? There’s a lot of red tape where you have to get clearance in order to, uh, go to the next step and that sometimes stifles people’s drive to continue and keep pressing.

The other challenges I would say is that, um, when we don’t have time to think. Um, and sometimes, you know, that we talk a lot about healthcare and burnout, especially of physicians, staff. And if people are just moving all the time and they don’t have time to think they can’t really innovate. Um, and so I think that’s another big challenge is how do you create processes to give people back some of that time to innovate and think different.

Naji: Yeah, this, uh, well, the Headspace, right? The more we were able to create this test, that space for us to think and, and think different obviously. And you talked about health care and burnout, obviously what you’ve been living, all the work that you’ve been doing, also leading your team and as a clinician, uh, we can’t thank you enough.

Right? As a community, as patients with, with all that you’ve been going through with the pandemic. Uh, looking back, uh, at this, uh, I always feel like we never do enough, right. For the healthcare. We always say we got to do more, but then you’re on the frontline unfortunately, and, and suffering from this. So how, how have you led your team during those times for them to be able to keep on coming in, keep on, showing up, you know, with all the risks, right?

Like you’re, you’re literally. Uh, some of them are literally risking their lives right. Every day, coming in and going home. How have you dealt with this? Uh, during those times?

Clarissa Yang: Yeah. You know that, thanks for asking the question, because I think it was a really challenging time. The uncertainty it’s usually the uncertainty that creates the anxiety.

Um, and I have to speak for my team. They really, really rose to the occasion. Um, some of the most important things that both the leadership at my hospital and health system along with, uh, myself, was to increase the amount of communication, um, communicating all of the time, uh, multiple times a day, even anything we knew, um, creating.

Base, you know, we set up wellness committees in which we try to connect, um, because you know, part of it was, uh, the social distancing where people didn’t feel like they had any ties or, uh, places to, um, have discussions. And so we tried to create that kind of infrastructure and, um, And then check in and recognize and feel with others, right?

It’s the empathy, it’s the understanding where they’re coming from, arming them with the information, um, and then developing a common sense of purpose. Right? Um, why is it that we all come together in healthcare? Uh, why are we here, but also respecting what they have to say and trying to, to, to help them through.

Uh, the challenging time. So whatever fears they had, if I could address them, I would, if I could bring somebody in to talk to them about how they could be more safe, I would, if we could implement policies and procedures that would keep them more safe. We did. So. I know, you’re probably gonna ask me already about like some of the changes and healthcare, but at one point in time, our teams were worried.

There wasn’t enough PPE throughout the hospitals. We, you know, you think about dermatology. Maybe there are some people make there aren’t life-threatening complications, but we do, we have, we still see patients on the inpatient service that have. You know, disorders where their skin is sloughing or they have vasculitis.

And, and, um, so during those times we tried to leverage technology, right. We said, okay, how do we, how do we use tele on the inpatient service? Can we leverage. Different modalities to be HIPAA compliant for texting and photos, um, increase the communication. So, so that we could function and still deliver high quality of care while still preserving PPE and helping preserve some decreasing some anxiety for people.

Naji: Yeah, where you shared, you know, the common sense of purpose and really caring, obviously for, for each other, the wellness piece and, and all the work that you’ve done. So again, uh, I think all, all of us can take enough. Uh, all of, all of you who’s been here, uh, on the front lines, uh, taking care of ourselves during those times, um, Well, one of ’em, you know, as you were sharing about it and yeah, obviously I’ll, I will ask this question, right?

Like, is there one or two lessons that you took from what we’ve been going through and potentially innovations that you had, and you will keep on doing, uh, after this.

Clarissa Yang: So I think telemedicine is now here to stay. Right. Um, the adoption of telemedicine was actually quite. Slow at the beginning, because there was a lot of anxiety about quality of care. And, um, throughout the, um, COVID pandemic, we really, uh, tried to still deliver excellent care. And the things that we learned through that was the importance of.

I feel like we’ve always been doing, but even more so is the importance of reiterating a process. And so, you know, we had to, we talk about PTSA cycles, right? Plan, do study act, um, and then repeating them. And, you know, during the COVID pandemic, it was really hard because these cycles became really, really fast because you’re flying the plane and you’re, and you’re learning to do this at the same time.

And so we learned. Um, to actually really come together and set expectations that we would be constantly pivoting, um, and the amount of flexibility that we needed, um, during this time was substantial. And, you know, our team rose to the occasion. And so I do think that telemedicine is here to stay a lot of the challenges associated with delivering that is how much support staff do you need?

How can we deliver the same quality of care? Um, and what do we lose? Um, so we learned a lot of those pieces along the way. We’ve been able to improve the efficiency of care so we can increase volume, increased access, a lot of this. Challenges are still around, you know, governmental policy and, um, insurance, uh, reimbursements and things like that.

But we have found an amazing place, you know, amazing way to deliver care. That is really good for certain situations. So, um, So we did learn a lot about telemedicine. Um, Nigeria, what was your other part of your question? I feel like there was another card.

Naji: Yeah. It was like what you’re taking, obviously, this is why.

Well, one of the pieces you will be keeping, and I want to double click on something, you know, as a leader, you talked a lot about obviously, right? Like it’s always what you did for them. And, um, uh, how you led them in fact, to keep on being here, being themselves. Um, I’m also intrigued as a leader. Where did you.

Your resources from, how did you personally manage going through this? Right? Because many times we think about others and well, to, to care about others, we need to care about ourselves. So I’m, I’m intrigued how you manage to, um, yeah. Where, where was your sources of inspirations of, uh, comfort to be able to help your teams going through this?

Clarissa Yang: I think I’ve been lucky along the way, you know, I’ve had other leaders, um, Show me what is right. And what works well, um, even, you know, before COVID, um, where the importance of really taking care of your team, doing the right thing, um, doing the right thing for them, not for you, not for the organization and thinking about it through that those lenses, um, is, is, is really powerful.

And then. You know, I’m in a place, luckily that has very, very strong culture at the hospital level interpersonal culture where people care for each other. And so, um, the leaders within. The organization cared about the same things. They cared about. The people I cared about, the patients they cared about, the staff, uh, they cared about the physicians.

Um, so it makes it really easy when you’re in that kind of environment. Um, I will tell you it wasn’t always easy. You know, I, I, when I stepped into my job, um, it was a department. It was a turnaround situation that hadn’t been, um, that had, didn’t have a lot of leadership for a couple of years before I came on board.

And you know, that cultural revolution of like really caring team, um, thinking about others, uh, is something that I’ve really been trying to instill. Um, these last three years that I’ve been here, there. And it’s very contagious. Right. And when that becomes the norm, the new people who come in, you know, everybody wants to be internally consistent.

And so it becomes a much easier place to develop, continue that kind of culture. So both outside of COVID, but you know, even augmented through COVID, um,

Naji: And what is, what is, what is the one thing that made this happen? If you know our audience, because this is really about what we’re discussing and leaders coming in, always talking about this culture of care, this culture of what I call love, right?

Like spread love and organizations showing up for each other, being here for one another. It’s exactly the culture that you created throughout the years, but what is one thing? That’s who can advise the there’s to do for them to be successful as you were, as you were rebuilding this country and that same, or building it from scratch.

Clarissa Yang: I think it’s a lot of times too. Lead this you would like to be led, right? Like I would do anything from my team and they can see that, like, I work really hard. I’m there when they need me. I will, anytime when they need me. Um, and so stepping up to the plate, um, Doing the things that are necessary is sort of role modeling.

And then I think the other piece is believing in your team, um, believing in what they’re capable of and when you believe in what they’re capable of, they will always rise to the occasion. So I think that’s one thing I find, um, that I learned along the way. I didn’t always know.

Naji: Yeah. Powerful. Great, clear sentence.

Let’s play a little game now, so, okay. So the game is, I’m going to give you one or two words and then I’d love to hear your thoughts. Like something that’s gone, uh, comes top of mind when you’re here. Done. Okay, good. Great. So the first one is women and healthcare.

Clarissa Yang: To feel, to feel at a leadership positions.

That’s so there are a lot of women in healthcare and I think women have, uh, it’s challenging. Um, a lot of times women are expected to. Do there, they have multiple jobs. They usually are the primary caretaker. I won’t say always, but you know, for a good amount of time, they’re the primary caretakers. Um, especially when they’re having families or children.

Um, who are little. And so I do think that often they are spread more thin. I think it’s more challenging for them to continue to grow in a leadership position. Um, I think there’s still, unfortunately, a lot of disparity, um, at the higher ranks of, um, leadership. Um, I know, you know, our, our organization is really trying to change that, but for awhile I was the.

I was one of two chairs that was female and then became one chair. And now we have two again, but you know, our organizations, you know, going through bias training and things like that. But I think it’s tough, you know, and, and I think we need more women leaders. We know that when we have women at the table, um, different decisions get made, especially on boards and, um, Committees.

And so I’m hoping that, um, you know, that there’s, there’s just a lot, there’s just a lot more work that needs to be done. And, uh, I hope that there are more women who are empowered to grow within these work.

Naji: Uh, yeah, and, and the work is for each and all of us. We need to advocate for women, you know, as, as man.

And, and definitely this is something to continue that there’s long, long, long way still. Um, you leadership, I want to ask you this question, you know,

Clarissa Yang: Oh leadership. Oh yeah. This is the word leadership, I guess. It’s um, what comes to mind? I guess because we’re on this topic leadership, what comes to mind is my other, the P the other people who have role models for me. Right. Um, as soon as you say that I can actually think of, you know, a previous chair, uh, the CEO, certain CEOs and leadership.

Everybody has a different style to their leader. Um, and much like Edison and much like life, you go through life and you try to figure out, well, what parts of this leader do I love? And what parts of this leader do I love to sort of create your own personal signature? Um, and, and I think part of leadership is also being observant and listening and being able to sort of pull what works and what doesn’t work.

Um, From from your environment. Um, so that’s what I think of when I hear leadership.

Naji: What about the efficiency?

Clarissa Yang: like, uh, if, uh, as through my training, if you asked anybody, um, about me, they all know that I really care about. And it’s, it’s really just to get from a, to B faster, better, and still maintain quality so that we can do other things. Right. So there’s so much to enjoy so much to do in life. Like let’s just be let’s, let’s get, let’s get everything done when we can do it.

So that’s, that’s how I think about it.

Naji: Awesome. Uh, spread love and organization.

Clarissa Yang: Yeah, I love that concept. Spread love. Um, I think it’s contagious, you know, when people give of themselves to others, um, it, it builds it’s a butterfly effect, right? So, um, yeah, I, I think this, your, your title, your organization here, podcasts spread love is a wonderful notion that everybody should adopt.

Naji: Yeah. Um, so now if we look moving forward, what would you continue right in your organizations from all that you’ve been doing in the last four, four or five years, uh, as we discussed the culture you created, what the tough moments have been going through also as, uh, as it’s in, uh, w with, uh, with a pandemic.

Moving forward. What are the one or two things that you will be focusing on as a leader again, within your organization to keep on striving?

Clarissa Yang: Well, I mean, I think the culture part is somewhat never ending, right? It’s we’re, we’re not, we’re still not in the place that we needed to be. Um, even though we started, you know, three years ago, it’s, it’s a continuous process.

Um, so. A lot of the lessons that we learned around communication about the importance of hearing others. Um, Those are pieces that we will continue. Um, we have continued, uh, you know, question and answer boxes and now we’re well past COVID because that’s been really helpful. Um, we’re continuing our wellness events.

We’re trying to think about different ways to connect and celebrate. Um, and so if there’s anything that we learned, it was. Trying to figure out how to become more connected and continue to become more connected to our time.

Naji: Um, do you have beyond all the readings that we’re doing? I don’t know if you have recently a book that you read that inspires you or even a previous book that you would recommend all leaders listening to us, like go get this book, this, this one inspired.

Clarissa Yang: Oh, gosh, let me think about this. Um, for leadership, um,

Naji: not necessarily the leadership either set up innovation or even a story.

Clarissa Yang: Well, I do, you know, the one book that I had read relatively recently was the power of. Like why we do what we do in life and in business and how we can change habits, things that are incredibly ingrained with us. Um, so I think the book starts out talking about somebody who had a neurologic issue. And even with a neurologic deficit and where you think that they cannot create new habits, they can.

Um, and so when people say I can’t change, you know, I can’t do something differently. You can. It’s about, it’s a lot about practicing. It’s about, it’s about a mentality. Repeating a particular behavior until it becomes part of you. Um, and so, so that, I, I really love that book because it sort of teaches you about how to, how w why it is that we do what we do and how do we form these new habits that we’re, we’re striving for.

So I think that would be a good book.

Naji: Um, do you have any, you know, find a word of wisdom? Uh, I would, I would love to hear it oriented to the young generation of physicians as you’re, you’re also coaching them and developing them to be the next generation of physicians or even younger. Like I’m, uh, I’m thinking.

Uh, both of them, right? Like all, all those young girls who are dreaming of becoming doctors and we want them to become leaders, all the kids and anything about this, then some words of wisdom around that.

Clarissa Yang: So I think we always have a lot of external influences that push us to do certain things, whether it’s a societal values or.

Peer pressure, whatever it is. Um, but I think actually really sitting down and really thinking about what makes you happy, right? Like what do you really enjoy doing? Um, because. I know it took me a while to get there. Um, you know, I used to just do, because I was supposed to do. And then when I finally sat back and go, why do I make the decisions that I make and figure out where the, where that nugget comes from?

Like what drives you? That is like really powerful because at the end of the day, it’s that passion that. Define what it is that you do in life, whether there’s success, whether there’s, whatever that definition of success is, right? Like everybody’s definition is different, whether you have impact and whether you actually enjoy all the years that you spend on this, in this place.

And it’s usually that passion that helps you succeed, um, and, and, and grow. And so really figuring that out, um, It is I think really important in people’s career trajectories. And I try to foster that those faculty residents really thinking about those pieces.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Christi Shaw

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, having the pleasure and honor to have with me today Christi Shaw, Chief Executive Officer of Kyte.

Christi serves as CEO of Kite, Gilead’s cell therapy company. Based in Santa Monica, California, Kite is pursuing the ambitious goal of a cure for cancer with industry-leading pipeline and manufacturing capabilities. In her role, Christi is responsible for all cell therapy operations around the world.

Before joining Gilead in 2019, Christi held senior executive positions at Eli Lilly and Novartis. Her leadership has spanned a broad range of therapeutic areas. In 2016, Christi founded the More Moments More Memories Foundation, which assists patients with cancer and their families. Christi currently serves on the board of directors of the Biotechnology Innovation Organization, Avantor and the Healthcare Women’s Business Association.

I had the incredible chance to learn from Christi at many different levels, she’s definitely THE example of servant loving highly successful leadership.

Christi Shaw: Oh, and I’m so humbled by your recognition and having me on the podcast now.

Naji: Thank you Christi first, we would love to learn more about your personal story from business administration to now leading one of the most innovative companies, improving patients’ lives and oncology around the world.

What’s in between the lines of this inspiring journey,

Christi Shaw: uh, in between the lines, you know, We people talk a lot about making sure that you’re living your true north. And I feel so humbled and, um, so, so much self satisfaction and reward being every day able to come to work and help people and really help in a way that gives them the potential to live a longer life.

Having as our foundation’s name is creating more memories in their life, uh, with their loved ones, you know, my, a story. From I w when I was little, you know, I grew up in the Midwest, uh, for the most part. Between the ages of six and 12, we, we moved every year to two years. So I got to witness other ways of living in Canada.

Um, you know, the French speaking, Montreal, Quebec, and then other states in the United States, but, you know, from zero to five and also, you know, from 12 to 22, I was in Iowa. So very strong Midwest roots, which really grew up in the farming area. Uh, area where community’s extremely important. Family’s extremely important.

And moving around like that too, as well as, you know, it really makes the family close and really makes you understand when people say, uh, home is where the heart is, that it is not just about the physical place, where you go, but who, the people that you’re surrounded with having come into the pharmaceutical industry, it was an intentional on my, it was intentional on my part is.

Personally my family to go to college. And my father really wanted me to know what I was doing before I went to. So I, so I, you know, he was a very strong role model for me, and I really wanted to help people. My mom was very philanthropic. My dad was a businessman, which also intrigued me and it was really intentional.

I said, you know, I want to do something that, you know, takes the skills of business and also. You know, it gives, gives, gives help to so many people, as many people as possible. And then, you know, fast forward it both in my personal life and in my professional life, that desire and that true north and mission have only gotten stronger over time based on personal circumstances and professional.

So for me, between the lines is people are people. I was tried. Uh, I was coached by somebody early on. My job was to be respected, not liked and my first manager job. And I’ve never believed that I was, uh, uh, not responsive to that initially. And I’m not now we spend too many hours at work, not to like the people that we’re with, not to get the best out of them and to leverage their strengths for the whole, to, to create better in the world for more people.

And so, um, that’s been kind of my journey, if you will. I

Naji: thank you so much for C4 for sharing this with us. Uh, you talk about liking people, so let’s go immediately there. Um, is this your key learning as a leader through your journey? Or what would, what would it be like if you want to pick one key learning you had through your journey?

Christi Shaw: You know, I, I think it, it goes to when you’re at your best, um, and you can help other people be at their best and throughout through my journey, I’ve learned, you know, one hard lesson, which is my dad always taught me not to let success go to my head, but what he didn’t teach me that I’ve learned on my own is not to let failure go to your house.

And so one of the biggest things is knowing that you’re in control of your destiny, that this is a journey. And when you’re going through very difficult times, know that that’s a point in time in your journey. And if you can control. You can change your destiny and not to be scared to do that, um, that whatever lies on the other side, uh, can be better and most likely will be better than where you are now.

But at the same time, those moments of times are also so precious that the very, those very small moments that are good. How can you take advantage of it? So an example for me would, that was really big for me, was growing up. I was very close to my family and moving around, like I said, you know, it was always with my older sister, who’s two years older and my parents, and then, you know, my younger sister who was significantly younger than us.

And, uh, and she wasn’t born until later in that, in that journey. And so as my life progressed, I started losing family members. My mom died at 51 of breast cancer. My dad died at 67 of a rare infection. And then my sister passed away at age 51, um, of multiple myeloma. And through that journey, it only strengthened my desire to do more and more critically important work, to help more and more patients as possible.

Um, not to have to go through that pain, you know, at kite. Our goal at kite is to focus on the cure. That’s our mission. Um, but what we do is we, we have patients who are. Um, have non-Hodgkin’s lymphoma who are told they have on average six months to live and they’re in the last moments of their life. And we’re able, 50% of those patients are now to be specific.

43% of those patients at five years are still alive. And they’re having not only. More precious moments with their loved ones. Their loved ones are having more precious moments with them. Some of them are having children and grandchildren and are there for remarkable moments. And to know that we’re able to give that to people, uh, by what we do every day is, is so very motivating.

And it’s, it’s, it’s the love. I would say that love that we give and the love that we get back. The patients come to us, uh, remarkably the biggest and most powerful ambassadors of just wanting to help spread the word because so many people who are eligible for cell therapy don’t even know what exists and they’re sent to palliative care sent to hospice.

And not even knowing that they have a 50% chance to live. And so what we’re trying to do now is really spread the word cause why should only some people have access to this therapy? We now are a global company. We have two cell therapy labs, one in California, one in Amsterdam. One that will open in Maryland this year.

And we basically take a patient’s own immune system and they send us their T-cells and we help re-engineer them so that they can be put back in that patient’s body and really fight the cancer. Uh, and, and we’re continuing on that journey because now we’ve gotten. We have three indications now and he malignancies and three, three in hematology, I should say four lymphoma and one in leukemia and hematology.

So four indications in blood cancers, three in lymphoma, one in, uh, leukemia. And we’re looking to continue to figure out how do we get that 43% to a higher number to treat more patients. And how do we actually take this therapy to more types of cancers so that more patients can be. And I’m just, uh, just so humbled to be leading an organization like this and to be around people that I do.

Like, uh, I’m a big believer in leveraging people’s strengths. What are they good at? It’s what are they, what inspires them, motivates them. And just really triple down on that, because people like to do what they’re good at really focusing on what people are bad at and what they need. Work on. Sure. You need to do that.

Um, if it’s a derailer or people are doing things terribly wrong, but in general, I feel, you know, that loving spirit of leveraging people’s strengths and loving them enough to tell them when they’re doing something wrong. I think, you know, that’s just how we should be as human human beings. I just feel like the more I do that, the more reward comes back to.

Naji: Oh, Christie, uh, you, you shared, you know, we feel the passion and the purpose and the passion you have for the people. And it’s just impressive what you did with, um, with your teams and, uh, literally changing people’s lives and boxing them positively. And. Changing their lives, right? That w when I joined oncology, that was one of the pieces, you know, can we, can we have cure?

And, and it’s true. Even one additional day can mean so much. So thanks for sharing this. And I want to go there. You’ve done this. During moments of crisis, you brought a disruptive way of treating, uh, I with impressive results for those diseases. And on top of doing this and the complexity of the technology itself and manufacturing and all, uh, all those challenges that you were, that you knew you were facing, you had on top of the pandemic.

I I’d love to hear, you know, your key learnings. Uh, as a leader during those times of challenges. And if there is something that you would definitely keep from, from those learning after the pandemic, or if there’s something that you would definitely change.

Christi Shaw: Sure. You know, so w what I do for a living today is actually an experience that I went through as a caregiver with my sister.

So my sister actually had cell therapy, um, back in 2016. Um, I was her caregiver for a couple of months, uh, in Philadelphia at UPenn. Uh, we stayed at cancer hope lodge. Um, I don’t know if you know this or your audience knows this, but there’s, there’s approximately about 40 million people, almost 17% of the United States who are caregivers.

Uh, two other adults in the us and 60% of them are also employed on top of that caregiving. And so going through that experience, and now I actually gave up my job. I was, um, in a financial situation where my husband worked and I was very fortunate and most people can’t do that. Um, but being able to see this therapy, um, front and center and what it takes, um, from that, that was really my first glimpse of it.

I had heard about it. I was at Novartis working at Novartis when we did the acquisition, but, um, it wasn’t launched yet to the marketplace and, and my sister got it as a clinical trial patient. Unfortunately, she had the type of cancer. It did not work for. Um, and shortly after her death, I was asking. To become the leader of kite, the leading organization in cell therapy.

Now I’m on the other side looking at, um, delivering for patients and then the pandemic hit six months after I get here. So if you can imagine, um, a patient just to give you a story, a patient who’s in Europe who has, um, lymphoma, who this is their only hope at survival. Now all of the flights in the United States are grounded.

Um, international flights are grounded because of the pandemic. And we need to figure out how we’re going to get these patients. Um, from our California site back to that patients in Europe. And so going outside of just our company, just outside of healthcare, working with airlines, getting, um, on their top list of medical need, getting the government to allow us, uh, to ship, um, and to, to fly that overseas and, and having a plan a with, you know, the, the normal airlines, everyone flies in a plane.

Be with charter flights and a plan C with, you know, um, private airlines. And we did end up needing in Europe to fi to really, um, charter private jets to actually ship patients cells. And when these cells come in, a lot of people call them all your manufacturing site. I like to call themselves therapy labs because those patients, little red bag of cells comes into the facility.

Uh, It looks like our two D two goes in the elevator gets shipped up to, um, the floor where they’re re-engineered and they come back out hoping to give life to that patient. And we actually had, in one instance in Chicago, O’Hare airport now a total of nine cancellation of flights, one after the other.

And we had no way to store these cells, no cold storage in the area. Luckily the cells got there, but during the pandemic. A hundred percent of patients got their cells returned to them and it is absolutely remarkable. And in fact, there was a wall street journal article of one of our employees in Europe who used to, um, actually get, uh, supplies and the war torn countries.

And he was his expertise, but actually helped us with the logistics of how we could do that. And he really sprinted into action. And regardless of his title, which wasn’t. Uh, hi in the, on the wrong Healy, he led us into how to solve this problem. And so as I look at that, and I think about the pandemic, what I learned is this inclusive leadership leveraging the strengths of people who know, learning, uh, leveraging the expertise.

Variances strengths, intuition, uh, listening. Nobody had a title. We were on the call twice a week, um, who can remove what barrier? What is the problem? Um, from CEO down to the, um, you know, uh, manufacturing, uh, so. Uh, a chemist, a researcher, we were all on the same level working together. And at times it was daunting.

I mean, it was absolutely, you didn’t know if they were going to get there, you all, and having that caregiver experience of thinking about that patient as my sister’s. And needing the urgency that you have to get it there yet, sometimes feeling absolutely helpless that you have no control over it. Um, sometimes makes you crawl in bed and want to throw the covers over your head.

I have to be honest. Um, but in the end, uh, seeing, uh, seeing cell therapy now really coming to fruition has been so rewarding at the American society of hematology in December. We had probably the most. Transformative and a legacy leaving event in that we were able to show that five years patients who were going to die survive, 43% of them were able to show it’s working in multiple indications, and now we’re able to show as well that you can use it sooner.

You don’t have to wait till the end of the line, but if you actually, hopefully in April, So we’ll get approval. Um, but if you can use cell therapy earlier lines of earlier, like second, let’s say instead of third, fourth, fifth, or sixth, you can actually save a lot of hardship on the family going through a lot of different therapies that aren’t curative, but only give you a little more time.

And so I’m just so excited as I’m sure you can. Um, when I go, when I, when I talked to my employees just before the holidays, I said to them, could you imagine going to Christmas this year and think about a loved one that you’ve lost or everybody I know has lost someone. They love, whether it’s a close member of family, friend or a relative, but imagine them being there at Christmas when you thought there.

No, you’re told that they were supposed to, they only had six months to live and here it is a year later and they’re still here two years, three years, five years. And just the change. That that has on the family in such a positive and deep meaning way. And obviously for me, it’s rewarding and at the same time disappointing, unfortunately that, um, my mom, dad, and sister didn’t, uh, benefit from that, but so rewarding that hopefully for years and generations to come others, uh, we’ll see this become a chronic illness and not a death sentence.

I don’t know if I told you my learning’s dodgy, but I guess my big learning is, uh, is love at work is a good thing. Um, and really, um, you know, this new generation of titles don’t matter. I don’t, I, I want to be developed, I don’t want to be promoted. Somebody told me that the other day I got three promotions, Christian, and during COVID she worked for another company, but my, I want to be developed and I’m being developed every day, but I, everybody I work with and so.

This collaboration, inclusiveness and no hierarchy, I think is really something the lessons learned from COVID that we need to reduce the barriers to collaboration so that we can really see what we’re trying to do together to have the best outcome possible.

Naji: Th this is, this is so powerful and I, I believe in this as you know, and I think what you’re, what you’re doing is just impressive on why we wake up every morning at this industry and your.

But she can get even patient by patients, which is, which is great. I want Christie to react to a word that I will give yourself. I’m going to give you four words and I would love to have the reaction on each one of them. So the first one is leadership.

Christi Shaw: So the first thing that comes to mind for me in leadership is enabling. Uh, a lot of people think that leadership is about having all of the answers, being the smartest person in the room, telling people what to do. And that is, we’ve been talking about it for a long time, but unfortunately I haven’t seen it change too much in the C-suite at least not in our industry.

And I think that’s a problem for us moving forward leadership. Isn’t enabling. Th the whole organization to move forward, um, as fast as they can by leveraging the great gifts everybody brings to the table, nobody can know everything, nobody can experience everything and that inclusion and diversity that we talk about.

The equity that we talk about, all of those things are so important for us to not have labels. You know, you’d have to be able to lead without labels. You can’t just wait to get the title and start leading, or you don’t have to have a title to lead. Um, and just knowing that your influence is leadership, whether you’re, um, an individual contributor, a manager, or the CEO leadership, it is about enabling others and bringing your best self, uh, solve problems.

Naji: You mentioned my second word at, which is.

Christi Shaw: So equity to me doesn’t mean equal and it’s so easy for that to, um, to, to be wrongfully, um, interpreted because you know, being equal is not always fair, right? There are, there are times when, um, some people deserve more based on the effort, uh, given, and I think, uh, equity means opportunity who has, uh, Uh, giving the opportunities to everyone is everyone.

Um, uh, Equal in, in their ability to tap into their potential. And that’s what that means to me. Um, you know, it’s not about everybody paid the same, recognize the same. Everybody gets a trophy. It’s about everybody having the same opportunity. And, um, people think that everybody has the same opportunity, but as I’ve, you know, been, um, I was the.

ERG leader at Lilly for the African-American, um, employee resource group. And I’ve also, um, been reversed mentored by two people in the LGBTQ group individually at two different companies. And I think it really requires us to understand and learn other people’s journey to understand if they really have.

’cause I, I w from those learnings, I changed my behavior. I ask questions differently. I have, when we’re talking about succession planning, we don’t just talk about the, you know, the leaders in the room, because if the leaders in the room aren’t diverse in their experiences, diverse in their, um, you know, social, uh, and their experiences, we need to have people in the room that are making sure that we’re not.

How a lot of unconscious bias, uh, cause that that exists. And I try to make sure that transparently, we call that out. So equity to means equity and opportunity and ensuring that we all understand and know what that means. Um, diversity inclusion, equity. They’ll all three of those go together and you can’t, you can’t do one and think that you’re now solving the problem.

You can’t have diversity and think now you’ve solved the problem. You can’t. Um, you need to have the equity piece inclusiveness piece with it as well.

Naji: So true and going through the journey of reverse mentoring, as you shared, and also willingness to learn and be curious about the other, and it comes with your beliefs on loving other certain like of your team.

Christi Shaw: Exactly.

Naji: What about CEO?

Christi: Oh, um, that’s a, that’s a really great question. What do I think of when I think of CEO, you know,

I don’t know this, probably not an appropriate answer, but so far I CEO, I, the first thing I think of is change. I want the cut. I want the connotation of CEO, not to be what people assume. CEO today means to everybody, um, financially driven, profit oriented. Um, and, and that’s not a positive term. And so for me being a chief executive officer of kite, um, I, I, I prefer to say, um, you know, I’m a leader I’m leading the kite organization because I think we have a lot to learn and a lot farther to go.

I think we’re doing some good work, um, by holding, uh, CEOs and their boards accountable for ESG, the, you know, um, giving back to the community. I know Gilead does a great job of that, uh, with the HIV communities and in the communities where we work and where we have, um, sites and you know, everything to do with clean air, et cetera.

Um, But we need to do more of that without being told to do it. Uh, we need to bring more love into the C-suite. Uh, I love, I, you know, I think it’s very courageous of you Naji to actually have the word love and your podcast and to put love in the business. I think it’s extremely brave of you because, um, It can show to a lot of people.

Um, it could be perceived as a weakness when it actually is a huge strength to show vulnerability to say, here’s what I know. And here’s what I don’t know. Um, here’s, here’s what we’re working on. Here’s what we need to be working on. Here’s how we’re trying to give back to society, not just to the shareholders and profit and be okay.

Um, that we were looking at the long-term not a short term, quarterly profit. And what are we saying to the analyst on the next call? If you take a long-term view, I think that’s what makes you successful. If you put people first, um, if you have high expectations for the outcomes and the outcomes are focused on what’s best and making the world better and you thinking, they’re thinking long-term.

I don’t see, um, failure in that. Uh, I CA I see only winning in that, and I think we could, we could add a lot more love the C-suite. It’s a long answer to say that we don’t. When I think of CEO, I think of the lack of love, um, right now, as a connotation, which I’d like to change,

Naji: but a great honor to hear this new Christie as a segue.

My last word is spreading love and organization

Christi Shaw: spread love. Yeah. Oh, Yeah, I, I, I am so, so lucky every day to go to work. And because we talk about patients’ life and death every day, it’s so easy for us to be so personable with each other. It’s so easy for our organization to get around our mission. I don’t have to create a mission and a value statement, and it doesn’t take long for people to understand what it means to have a loved one living longer.

Um, or for me to know that, um, as an employee. Um, you’re working really hard and we care about the patient. But one thing I will tell you, I’ve learned in this role in the last three years, Naji is sometimes we’re so focused on saving patient’s lives that we forget to focus on employees that are actually doing it and showing them that we care about them.

As much as we care about the patient, the pandemic. Put our organization, as it did many in overdrive, you would think that working from home meant that we were working less hours when everybody was working so many more hours, there was a blur between work and personal and really burnout, um, occurring.

And I think we’ve seen that in the great resignation that’s happened. And that we’re going through now, uh, in the world of people really, um, taking a second look at am. I actually spending the time with my family, my loved ones, not just helping those patients live longer, helping patients and their families, but what about my family?

And so for me, spreading love at kite is a greater focus on loving our employees and showing them. It’s like recognition showing them appreciation, developing them, not just through promotions, but developing them, not just at work, but in their personal, what do they want to develop personally, socially that we can help them with.

So for me, that’s the next, um, thing to double down on his love for our employees.

Naji: Any final word of wisdom Christi for healthcare leaders around the word?

Christi Shaw: So I, I, you know, the, the biggest ones I’ve talked about is, you know, um, I know you won’t let success go to your head, but don’t let failure go to your heart. I’ve also talked a little bit about, you know, realizing that things are a point in time and. Knowing through my experience that sometimes I stayed in places or stayed in jobs or stayed personally I’m around people that you just, you felt like you needed to, you had to, you were scared to take a risk.

Um, that’s probably the biggest, second thing I’d say is in my journey. Actually making the decision to not stay and follow a different path has probably led to more success than having stayed. Um, and, and, and trying to, um, work through these. I’m not, I’m not saying quit, but I’m saying sometimes there’s a another path.

So for example, the saddest story for me, when I left my job at Novartis was. And having the announcement go out that I was leaving my job to care for my sister and my LinkedIn box exploded over the course of the next three, four weeks from then. And it, and it was sad because most of those emails were people who did not make that choice.

Who worked instead of taking care of a loved one or who didn’t move closer to being next to a loved one, or spend enough time with a loved one before they died. And that time was gone, it was extremely heartbreaking. So for me, it was a motivation for me. After my sister died to come back to show people that you can leave, you can leave the highest level job, and you don’t know what’s going to happen.

But it’s okay if you prioritize your loved ones, because you will find something else to me, I ended up finding the job that fulfilled in me and helped me grieve the loss of my sister by helping others survive. And I didn’t know what it was going to be, but if I’m any example, follow your heart, follow your loved ones, make those choices and it will be okay.

So that would be my advice.

Naji: Thank you so much, you’re such an inspiration and a real example for so many leaders, uh, around the word. Thank you so much.

Christi Shaw: Thank you so much Naji, and thank you for this podcast and for creating this, uh, for everyone it’s, it’s really exciting and, uh, uh, really, uh, a real, really great tool that I will pass along.

Naji: Thank you again. So, so honored and humbled to hear it from you.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Chinedu Echeruo

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this very special episode with Chinedu Echeruo, a serial entrepreneur, Dreamer and cofounder of Love and Magic Company!

Chinedu believes that individuals, empowered by imagination and inspiration, can solve virtually any problem. He dared to invent the future starting in 2005, when he founded HopStop, the pioneering travel app that helped millions of users navigate public transportation in major metropolitan areas around the world that Apple acquired in 2013. Chinedu also founded Tripology, a lead-generation and referral business for the travel industry. Tripology was acquired by Rand McNally and now owned by USA Today.
Prior to completing his M.B.A., Chinedu spent several years at J.P Morgan Chase where he was involved in a broad range of M&A, financing, and private equity transactions.
Chinedu has been featured in multiple media and is committed to making the world a better, more cohesive place through the free flow of information.

Chinedu – I am exited and honored to have you on this episode of a podcast striving to make the world of better through a loving leadership!

Chinedu Echeruo: So excited to have you with me. Thank you for inviting me. I’m looking forward to, uh, our company.

Naji: I’d love first to hear more about your personal story, your journey, your leadership journey behind your amazing achievements.

Chinedu Echeruo: Oh, well, thank you again for inviting me. Um, So I’m getting more and more courageous, um, and kind of sharing, um, some of the thoughts, um, and, and kind of my, uh, my story.

So thank you for, uh, making space, um, um, to share with you with your, with your community. Um, so I grew up in Nigeria. Nigeria is on the, uh, on the west coast of, uh, of Africa as I came in when I was 16, but before I got to the U S. I was always struck by, uh, by poverty and suffering. Uh, not because I experienced it personally, uh, just because I think I grew up in a very privileged Willy, but I saw it all around me and I remember.

That’s a kid. Uh, my, my grades plants and, uh, software in on the African continent was two breeds. Rabbits. You know, I had this idea that rabbits, if I read in a book somewhere, that if you, if you add rabbits had lots of children. So I figured then this is my nine year old mind. If I, if I go rapids and they breed it and they breed it and it will be like an infinite number.

Rabbits and that would, and, um, Africa’s a hundred Congo problem. So I actually ended up actually going into my mom, asking for my, my savings and investing in a rabbit cage and rabbits and experiments that didn’t work. Uh, but I think that that idea of using business, uh, to solve real business of real human problems has always, uh, uh, stayed with me then through.

Um, my years in investment banking and finance, I think I got a more, uh, newest, uh, understanding of what that bigger system, uh, looks like. And I think. I went, what I’m excited about now is how can we share that technology of creation of abundance in a way that is practical, but it’s also sustainable and in a way, in a very real way, true to like the human expert.

Naji: Thanks. Thanks for sharing your story. So you you’re, you’re talking about, you know, business for good. How, how do you define your purpose before going into your, the last company you co-founded?

Chinedu Echeruo: Yeah, so it’s actually an interesting question because in a way, the only way I can answer the question is to also answer it for myself.

Right? So you have this kind of like, Self reference in that loop in a way. And in a way that’s really been my goal with the past few years is try to really try and bring coherence, you know, really bring a coherent philosophy of life. Um, so to speak and understand what is the, what is the physics of value?

You know, Since the statistics have meaning in a very real way. And so this is the way I think I’ve been able to make sense of, of, of my own human journey. And, and that’s also a framework. I think other people can use, uh, to, to create value for themselves and hopefully value for their organizations or meaning for their organizations as well.

So it’s really, that’s what the simplest way of telling the story is to really think of human experience as the hero’s journey. That whoever you are, uh, whatever circumstances you have, your, and there’s something you strive for. There’s a set point of imagination or goal you seek, and between where you are now and, and that goal, uh, dragons of complexity, things that just stop you at least a fearful, right?

So what I think good is. Good at this, that remove the fare, remove the dragons, remove the obstacles to human subjective progress. Right. So, so in that way, um, so if I can do that for other people, then that’s value for other people. So. With the, with the, uh, with the teachings we have, and then, uh, in our services, we can help people conquer complexity, help them achieve their own imagination, then that, then that’s in a way that’s the most service I can, I can, I can bring to someone else’s life.

And so maybe let me make it more practical. So let’s say the healthcare industry, for example, There’s a human being. That’s in pain, real pain, mental pain, physical pain. And if you can ground your organization. In the transformation of that human being from where they are now in the states of suffering to where they aspire to be ease, lower anxiety, lack of pain, happiness.

If you can ground your organization in the transformation and the necessary transformation. Of that human experience from bad to good, then you, you would have really done the best you can do, right. Really to transform human life and enable that human being to be where they wants to be. Uh, so in a way, so that’s the way I frame my purpose is if I can build, um, um, systems that can help human beings.

Reach the goal they want to reach, then that will be my most service, uh, to the world. And it will be the most meaning I can create for myself. So that’s the way I’ve, I’ve tried to frame this question, but obviously this is something that’s taken me a while to think about. How can you create coherence through this, through the dimensions of work, personal life?

Um, there’s so many aspects that all need to, uh, to have coherent.

Naji: Wow. And this is ultimately having impact on leaders who are driving organizations and you’re multiplying your impact by thousands.

Chinedu Echeruo: Right. That’s so powerful. Yeah. Yeah. Well, thank you. Thank you for saying that. And, um, it’s one of those things where it’s also my hero’s journey, right?

Because the Herculean. Statement I made has to be backed up with lots of thoughts, lots of action, and lots of, um, storytelling to really, um, uh, tell, um, to, to kind of share the ideas in a way that’s palatable and understandable to people, uh, because you know, that’s, that’s the only real friction for us to share and truly communicate with each other.

Um, so, so thank you for saying. Sure

Naji: you have in your, um, in your latest company, you co-founded, um, love and magic. Well, I’m so interested, obviously with both words, you know, our podcast is focused on love and organizations and we share this word and magic is just such an amazing word. Innovation imagination and imagining a better word.

W how did you came up with those two words? And then if you can tell us a little bit more about, um, about your company and what

Chinedu Echeruo: you’re doing. Sure. Sure. Okay. So, um, I was in Nigeria, this was 2013. Um, at the, uh, my two sons were about, uh, my twin boys were about to be born and I was asking really God, that was really trying to find purpose and clarity of what the next part of my life would be.

Then all of a sudden, um, uh, apple, uh, approach, uh, the company I founded bought. And, um, and then literally in your three month periods, um, apple acquired a hub stuff. Okay. And at that point I realized looking, well, what just happened? And, um, and why can’t we have more of that? Right. What is, you know, really the question is how do I DIA’s turn to things?

Like how did I go from nuts where as a hedge fund analyst, I wasn’t sure about creating a story. And I went from that point. So having exited, um, HopStop right. So what was that process? And so what I, what I realized, and it’s like, if I could imagine the best life possible, the most adventurous life possible, then that would be it really trying to tame this, this process of how do people manifest?

How do ideas turns to Benz? How do you go from where you are now to where you aspire to be? So that was the challenge, but. Um, I didn’t, I didn’t know that there was an answer and to add to the question, um, but it’s really through, um, three intense thoughts and dedication to this question. Yes. With now emerge with some structure that we can now hopefully share with leaders, uh, to, to help them transform, uh, thoughts and idea of projects and opportunity into something that’s real.

That’s um, that’s in the world. That’s hopefully helping people, making money growing, and also growing financial goals. As a way of helping people, which is at the end of the day, the only real sustainable strategy you have. So in PR in practical terms, what we do at the love and magic company is we help people birth ecosystems, uh, per new concepts and help them put some structure, how they can go from an idea to something that’s alive, um, in, in the world.

Naji: That’s great. And you, you talk specifically, the first thing we see on your website is, um, go building beloved organization. Yeah. So what, what do you mean by business? I know the word love. We always have this reaction, like love organization. I have it constantly, right? Like how love can work in corporate

Chinedu Echeruo: world.

Yeah. So actually I realized I didn’t actually ask the specific question you asked. Okay. So what is love? Like how, where, where is space for long in the world of business? Okay. So, okay. So to answer that question, right, there’s a, there’s a whole field of science known as complexity science, right. And if you go deep into that, you’ll see.

All, all the world is interrelated and a really kind of spooky, uh, not spooky in some it’s it’s unmeasurable. It’s just that it’s, it’s it’s, uh, you can’t determine what those, what that correlation is. So the very most mathematical view of reality is this web of. Into real, into relatedness. So love it. Even though it might seem like a non-scientific non business world, it’s actually probably the most, um, accurate description of what reality is, is when, so that’s love, right?

That’s deep interconnectedness that one day. Of being right. So if you understand that, then it has huge implications from innovation, from a technology, from a storytelling, from a business perspective, that in a way, so you can also think of. As turning the potential into reality, right. Turning that potential right.

Of love that infinite possibility. How do you now manifest it? How do you bring it to the, how do you put structure in your imagination? How do you make it real? How do you, how do you make it like electricity, where it actually helps people in their daily lives? Right. So in a way it’s, it’s really, you can think of love and magic as that’s gold, like bringing it.

Uh, imagination and love and potential, but not just talking about it, but also bringing it into kind of reality in the form of a structure in the form of an organization in the form of an ecosystem. In the form of a startup, uh, as well.

Naji: So, you know, you obviously co-founded startup your exit, your successful entrepreneur, and you’re obviously built in right to be successful like performance, and now you’re helping other organizations, other D there is build their teams.

Is there like a common thread that you are seeing or that you believe in. For high-performing successful teams that leaders should have.

Chinedu Echeruo: Yeah. At a hundred percent. And it’s, it’s something that, um, as I, as, as we go on building these beloved organizations are understanding and nuances of that complexity becomes clearer and clearer.

So one aspect that’s I think in terms of, um, ways of, of, of all these frameworks, I think a leader can practically use to really try to harness. Potential is to do something that’s about matching the values of the people in the organizations and connecting our value to the values of the organization. So any company, any leader that can connect those two aspects has, has unleashed magic in the organization has unleashed innovation has unleashed a creative space.

Okay. Now, practically, how would you do that? So the first thing is really taking the time as a leader to have an inventory and have people get to their own levels of self inventory and self-assessment of what they value and a practical way to do that is to take a personality test as, so there’s a, there’s a, there’s a site called on the stand myself.

And so that has, uh, I think I’m not affiliated with the program, but that’s a, a simple test you can take. And that I think gives you clinical data on self, who are you at least statistically in instead of what kind of personality types you have then based on that you can then bubble up your value. So, let me give you an example.

So if you’re an introvert’s right, you probably value, um, one-on-one conversations. Um, you probably value, uh, Um, social gathering. So that has implications on the decisions you make. Uh, if your, if you score high on or low on or high on neuroticism, for example, your focus on peers are fearful. So in a team dynamics, you’re focused on what could go wrong.

Right. But until you, you understand that about yourself, right? You can really, um, be able to know what you value. So personality maps to value. So once you’ve done that, then you can cannot map those values to the organizational values is your match. Right? And if you can do that, then you’ve connected the true value things that people truly wanted there.

Right to giving them an opportunity to do that within your organizational context. Right? So that’s the key. And if you can frame the purpose of your organization as helping the heal another person’s hero’s journey, then you will have an incredible opportunity for people to connect the very real way to another human.

So the person in accounting, doesn’t just think of themselves in doing bills and medical records. They see themselves as removing the anxiety around what that patients will receive after the operation. Right? So if, if you frame your accountant, your challenge is this human being just came up through this incredibly difficult experience.

It’s been three months after their surgery. And as a human being, what can you send them to help that journey of transformation? Right? So once you frame it like that, then you have true empathy. You have a true unleashing of capacity within your organizations, right? And people can now reframe their work, not just as a thing they do, but as services to another human being.

And once you can do that as, as, as an organization, you’ve tapped into. Love right. You’ve tapped into a deep, deep phenomena in, in, in life. Right. Which is, which is what I just described.

Naji: I love this. Uh, and you know, I’m, I’m totally with you on it. And that’s what I trying at least to convey also at my level, with, with leadership and this loving and caring, genuinely caring for your people and their organization.

One of, one of the, you know, salts that come out, I would ask it from both sides. I would love to hear your thoughts since you’re working with teams on this, the first one is from a personal standpoint, do I want to share. Those, those type, you talked about psychology, right? And it’s, it might feel for some, some vulnerable pieces.

Like, you know, I’m an introvert. Do I want to share this with my manager? Who might be an extrovert? Right. So, yeah. And the same for managers. So what are your thoughts for people in the organization and then for. Who have people and who would say, for example? Yeah. And I, I’m not a psychologist. I’m not here to listen about like all my team’s problems, uh, w which I completely disagree with, but what ha what are your thoughts about, about these two

Chinedu Echeruo: aspects?

Sure. Okay. Yeah. So let me, yeah. So wonderful questions. So to start off with the team members themselves, so. So, uh, obviously one of the things that’s, um, um, um, I’m I deal with and I’m, and I’ve heard many people deal with that is this idea of imposter syndrome. If you think about it, why do, why would you ever have imposter syndrome?

Right. So the truth is you should have an imposter syndrome. If you’re being an imposter. The question is how are you being an impostor simple as that? I, you been unemployed. So what is not being an imposter and being an imposter is being true is being as you are or not judging yourself as you are. If you understand that every uniqueness is all part of the human tapestry, every in cultures that didn’t have aggressive, people were conquered.

You need aggressive people. To go and defend against the lions and against the enemies you need. Um, introverted people to look deep into the structure of phenomena. You need Einsteins to unravel truths about the world. We need everyone. So I think that’s the first, I think perhaps the normative culture of organizations to be a certain way in a way, deprives human beings of.

Benefits of the relaxation of being who they are. Right. And instead of trying to use energy to be somebody else, which is in a way a waste, why don’t we let people know what type of animals they are? I mean, personality wise, right. And not try to be, go from being Alliance, being a giraffe. Just try to figure out how you, how you could possibly be the best lion.

And if you’re introverted be introverted, if you’re neurotic, be neurotic, but be neurotic in a way that helps us win, helps that customer succeed helps that customer’s frustration. Um, go away and make their stew brewery come true. Right. So I think if you frame it that way, then we relax, then we’re not so judging of ourselves or whether we should be introverted or extroverted.

Right. Calm as you are bringing your superpower because you’re not, you’re not a, you’re not a throw away. You are uniquely your unique in your perspective. And so I think that’s a person on the team level then on the, on the, on the leadership. You’re the capacity of the team to discern these dynamics and actually have a fully is, is actually a prerequisite for a functioning team.

That team that doesn’t know what individually you value and doesn’t map that value to what the team values is. That is a team that isn’t, um, isn’t a high-performance team. So you have to find what is it truly? What’s the intrinsic. And again, this was a researcher and it was the intrinsic motivation of your team members.

And how can you tie that intrinsic there? And that intrinsic thing. An external thing. It’s a value. It’s a belief. It’s a it’s I, I am this type of person. So the keys, how can you bubble up, bubble it up and then, uh, connected to something the team needs to do so that, that other human beings life could be better.

Right? That’s you know, that could be a really simple way of framing it. So individual, so organizations and organizations to human life. Right. That could be the connections of value.

Naji: Great. I like this is, this is super powerful that I hope will hold off us as leaders. We’ll, uh, we’ll take this and are taking this.

I did daily basis to make our organizations better and the word better. I’d love now a teenager to jump into a section where I will give you one word and I want to get your first reaction to this word. So the first one is leadership.

Chinedu Echeruo: Oh, leadership insight, vision.

Naji: What about, uh, entrepreneurship

Chinedu Echeruo: fate? Would you want one word or more?

Naji: I feel you want to give more, tell me more than,

Chinedu Echeruo: okay. So can leadership, right? So leadership is about staring, right? And to stare, you know, like, uh, you’re pointing to something you’re telling people, look, there’s something there, come this way.

Good left. Go right. Go left. Right. So in a way, leadership is, is the capacity to discern. A location of value. Right. So that’s the, okay. And then, um, then you mentioned entrepreneurship and I said, fate, and the reason why I said that is, um, there’s no, there’s not, there is there’s no, there’s no such thing as matter.

Right. So everything is a belief. So entrepreneurship in a way is the most epic, uh, journey of belief. Right? So you’re going out on a limb and you’re trying to figure it out. Um, you, you have faith that this concept you’ve dreamed up in your head actually is real, and you’ve gone on this epic journey of faith to go find it.

So that’s why I said, um, uh, entrepreneurship and faith.

Naji: What about, uh, spread love and organizations

Chinedu Echeruo: spread love? I would say spread IntelliJ.

Yeah, spread intelligence. Um, because that’s, you know, think about it every time you look at any act of suffering, any injustice, right? At the end of the day, it’s really in a way you always think of it as an act of ignorance in some way, fundamentally. Right. So if we frame love as really just about enlightening, Right.

It’s just, you just, you just didn’t know. Right? You didn’t know that she was you, right. You didn’t know your customers. Where were you? You didn’t know that human beings were related to the environment. You just didn’t know. Right? So you, you polluted the environment. Oh. So in a way, love, in a way it’s like it’s a growing consciousness.

It’s a growing intelligence. Of this, uh, this kind of interrelatedness, right. And I think as human beings, we can move up levels of these of consciousness. Right. And, and, and in a way, love is this constant seeking of connection, right. Constantly all the time with all phenomena. Right. And seeing yourself in everything and seeing that kind of.

That, that fullness, that, that oneness of that interrelatedness of all things,

Naji: I love how you, you know, you go from love to this, as you said, deep interconnectedness, and then to this one straight, and this shared consciousness at the end that you can get to for us to be able to imagine better.

Chinedu Echeruo: Yeah. And it’s not just, um, um, uh, uh, talk because in many ways I am, I am my biggest skeptic.

Like I’m always, I always bring in my as well, try to have some sort of formulism that can really test the hypothesis. And, um, so, uh, so it’s just the truth that you need to, you need structure in, you know, everything has to have any symmetry, anything that’s beautiful. Has deep structure in it. So that point is, has, could tell you so much about, about what’s, uh, what beauty is.

So this idea is like, if sending anything that’s coherence has symmetry, right. And anything that, in a way you can think of symmetry as a, as, as a way of beauty, right? So description of beauty. So in a way, another way of maybe think of what you’re saying. Um, and in many ways, what I’m seeing as. Is that what is beautiful in the world?

What is coherence and what is coherence is something that in a way takes into, it takes in consideration of all things, right? Of all things is coherence. It doesn’t, it doesn’t leave anything out, it fits together. Right? So in a way, that’s another way of thinking about law in the business context is you want your team.

To be, to use the most amount of information to be most aware, to be most conscious right of the sessions they’re making you. ’cause when you do that, revenue goes up, customer satisfaction goes up, retention goes up, uh, cashflow goes up, uh, stock market valuations, go up, you get a raise, your parents and your children love you more.

Perfect. Everyone wins if you do that. So the question is how, how do you unlock that? And it brings back to what you were saying about imagination. Is that when, when leaders are looking for how to grow revenue, but hasn’t reduced margin increase margins. What they’re really looking for is how can they really tap into the problem solving skills of their employees and partners?

That’s the challenge? How do you unlock. The potential, the problem solving skills of your, of your team, because if you can do that, revenue will go up. Okay. So now, so what, so how do you, how do you do that practically? So the one insight I just want to share here is that the way you do that is by having your team members, dear, be brave enough to ask a question.

And the question is how, how do we grow? How do we help our customers succeed? How do we do that? And, uh, but when you do that, then you not have the possibility of imagination. So most of the time we go first with what is. And be bound by what is, but sometimes if we start off with a question, how can we do this?

Right? And you allow your team members to truly express their unique creativity and not be boxed up into the pain and the fear of your organization. You find. Imagination will flow. Ideas will come, right? And those ideas are the hypothesis for you to not experiment with good check. If that customer loves that, I did check if retention increased check, if your, uh, your customer service call rates declined, uh, when you did that, send a message to those employees, to those customers.

So that’s when we have pre making this practical. To think of creativity and imagination and love as an opportunity to let creativity lack imagination come through. And if you can let those things come through your team members, those will lead to the solving of the, of the bottlenecks of group. The bottlenecks of a customer metrics, the customer, the metrics of valuations, whatever it is that they have, your six of your sex is an act of imagination from your team members.

So if that’s true, invest in it, because you’ll find that that’s where you answered.

Naji: Totally and letting the team, as you said, be courageous to say how, and I would add one small thing is, and you’ve said it many times is receiving what they say and actually act upon it because many times, you know, we might go and say, well, this is the issue, and this is how you need to do it.

Right. Because we think we’re better, but like opening up and receiving the best of our people is so cool.

Chinedu Echeruo: Yeah. And, and again, all, again, all I’m saying is also, there’s a, there’s lots of formulism too, but another way of saying this there’s an, there’s a, there’s an economist named Hayak and he talked about the optimal use of information in society.

And so he basically said, So the everyone should optimize the information that the unique information they have. Right. And if we all did that, we would solve, we will create economic surplus. So in a very real way, when, at, when the leader tells their team to make a decision based on their own information, they’re being wasteful.

So what you want to do is to have either. Team member given their own unique situation, given their own unique experiences, they own insight into the customer pain, their own insight into that conversation they had on the phone with that. I read customer. Right. Take all that information and bring it in right to use, to optimize the use of information.

And so you do that on the local level, you don’t do it on the CEO, on the team leader level, you do it on you do it on the team level, right. Ring. Um, all the people who have different ideas and then, um, mind-meld and, and play around with those ideas. Right. And then test it. Okay. And, and, and, um, it’s true.

What you said, there’s a resistance to, um, test and I did, especially as a leader, if you don’t believe those ideas are good. Uh, that’s very understandable. So, um, to address that, what I would, um, advise is that, um, business leaders set up systems for rapid testing of ideas. Okay. So what I’ve found is that most of the clients we work with don’t have ways they can quickly test tonight.

So, if you don’t have a way you can quickly test and I did, then the costs of testing idea becomes extremely high and you don’t want to do it right? Because especially if you don’t think it will work. So if you, if you build systems that will quickly alight you test ideas, you will find that you’re more, you’re more, you’re more agreeable and you can let these ideas come out because one of them could be the idea you have, that you boast that you most needed to drive.

Um, business metric, um, and instead of holding onto those ideas and build systems to let those ideas be more quickly, um, tested as fast as possible.

Naji: Yes. Thanks again for those advices, that will be precious for all of our listeners. I want to ask you a last question, any final word of wisdom for, for those leaders across the globe, trying to make an impact from the.

Chinedu Echeruo: Oh, I didn’t, if I’m, if I’m at the point of wisdom to your, to your, to, to your audience. But I think I, all I have to do is maybe share what half bounds. So I’ve searched high and low, uh, for, um, for assets, uh, for myself. And, um, and, um, and what I have found is that at end of the day, it’s comes back to what we’ve always known.

That it’s about love and that, um, meaning. Comes from, um, our capacity to help another human being. Who’s. You know, in, in finding meaning and finding, um, and making that life story come true. And as the leader, we have the epic opportunity to, to do that and do it that skill and be thoughtful and intentional about, um, the kinds of organizations we’re building and having that there center of your organization.

Your true desire to help kill the dragons. That’s in the way of the, of the, of the human experience of your team members and your customers. I think that is a coherence, a way to create wealth for yourself, but also have a sustainable and, uh, and, and happy life. So thank you. Thank you very much for, um, uh, for this company.

Naji: Thank you so much before for such an inspiring, uh, discussion full of tips for the leaders, listening to us. Thank you.

Chinedu Echeruo: Thank you. Okay. Take care.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Brie Doyle

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this very special episode like no other with Brie Doyle, founder of She Glows Retreats and Author of the great book YOU SHOULD LEAD NOW: Going on Retreat to Find your Way Back to Yourself!

This episode is like no other, we will be hearing from Brie about how to take care about ourselves as leaders – a key subject, yet rarely seriously considered by many of us…

Brie hosts transformational wellness retreats throughout the US and across the globe and is the founder of She Glows Retreats. She specializes in curating mental and emotional wellness curriculum for groups, conscious companies, schools and individuals.  A yoga and meditation teacher for over twenty years, Brie is a leader in the health and wellness space who helps people heal their past and reclaim their power.  Her first book, comes out this July – be on the lookout! Brie lives in Boulder, Colorado, with her husband and three kids.

Brie Doyle: Thanks so much Naji. I’m so excited to be here,

Naji: Brie, before traveling with you on a retreat. If I might say it that way, I’d love to hear more about your personal story and your journey, founding your company and writing this very first

Brie Doyle: book.

Absolutely. Yeah. I’d love to share more. um, so I, so I grew up in, um, Boulder, Colorado, actually, and I live here now, so I moved away for a bit, but I, um, grew up, you know, both my parents, my parents were married. I had, um, I have two younger brothers and, um, I grew up, I was a really shy, quiet kid. I, um, you know, I was smaller and younger for my grade.

So I was, I was pretty quiet in class and I, I always knew I wanted to be a teacher. That was something I really, you know, I loved children at a young age. So that was something I pursued. And, um, you know, from there I taught, I taught in schools actually for quite a while before, um, before having my own kids.

So I kind of started there and then, um, going further into my, into my professional career. So I, so I taught in New York city for a while. That was a wild experience. um, and then I taught in, um, Boulder, Colorado. For 10 years. And then once I had my kids, I decided to stay home with my kiddos, cuz my husband has a big job and travels quite a lot.

Um, so that was when I started writing. Um, yeah, so it kind of started there.

Naji: awesome. And, and so from, from there, how did you, um, you know, went into this, your belief if around retreats and they’re, you know, they’re, well, I, I would say in, uh, for leaders, right. And how to thrive, uh, in your life?

Brie Doyle: So retreating became important for me for a lot of reasons. I actually, I studied abroad when I was in college. I lived in Nepal actually, and I met a Buddhist meditation teacher and I, you know, became really interested in and. Studied under him and read constantly about Buddhism.

And I started taking retreats that way. And I was, you know, in my twenties at that time. And, um, so I came home and I took, I continued to take regular retreats just as a practice, um, to, to kind of pull away from my daily life and meditate and relax. And. Dig deeper into kind of my inside life. And, um, but then I had kids and things changed a little bit.

It became harder to leave, um, as I’m sure many of, you know, uh, so, so I, you know, I had a few years where I hadn’t taken a retreat for a while and, and there was a point where I was really kind of struggling. I found myself, you know, just deplete did and exhausted and, um, Just, I, I was, I was feeling a little bit lost.

And so I said to my husband, I was like, you know, I think I need to take a retreat. I know we have three small kids. It’s a hard time for me to leave, but I, I think I need to go on a retreat. And thankfully he was, um, really understanding and I went on a retreat and what I realized is that, you know, there was nothing wrong with, with me.

There was, I was just exhausted. I just needed more of myself, you know, so stepping away was really important. And, and so going on that trip, and then I came home, I realized. Gosh, you know, I’m not the only one who feels like this. I know that other people, whether it’s from parenting or work or whatever it is, are dealing with exhaustion and burnout and, you know, feeling, feeling sad, heavy feelings like that.

So, so that’s where I started my business was from that point, just, just realizing that other people, you know, need some kind of container or, or motivation to step away themselves.

Naji: Yeah. This is social and for, you know, for many leaders, We always say, you, you have to, uh, take care of yourself to be able to take care of others, right?

Like the self-love and you even use this word in, uh, in your book around self-love, but many of us would see it as a little bit selfish. You know, if I, if I may use the word, you know, to go on a retreat or do this, um, and, and we, any times we say, yeah, we need to take care of about ourself, but. We don’t have time, you know, we always find excuses not to do it.

What, what would you, what would be your advice for, um, for many of us, uh, you know, who, who need it, but won’t do it.

Brie Doyle: Totally. I, and I, and I hear that all the time is that, gosh, it feels so indulgent, you know, and, and one of my beliefs is that, you know, if we’re really gonna take care of other people, it has to start with ourself and it’s a discipline.

You know, it seems like this really nice frivolous thing that, that people who have lots of money or lots of free time might do. But the thing is if, if we’re really leaders in our industry or in our homes, or we’re ever were leaders, you know, we have to model this kind of behavior because. When you’re, when you’re, when you’re modeling this for the people that work for you or the people that live with you, then they themselves feel permission to do the same sort of thing.

So, honestly, I see it as a sense of discipline, um, that a leader would take this kind of break because it’s not common and it’s not encouraged. You know, our society is like, go, go, go more, more, more push, push, push. And, and we’re, you know, Staggering numbers of mental health issues. You know, we think about health and we think it’s all related to our physical bodies.

You know, we have all kinds of like foods. We should be eating exercises we should be doing. But the only thing we hear about mental health are like the really horrifying statistics. You know, it’s like one in four, uh, adults right now has a diagnosable mental health, um, challenge, you know, and that’s really significant.

Um, I think it’s, I, this is in my book too, but I think it’s, um, oh, let’s see. Uh, Um, um, um, oh, 10.3 million adults have suicidal thoughts, you know, um, suicide is the third leading cause of death among 15 to 19 year olds. So this is, this is really significant, you know, it’s not any it’s, it’s not something that we can treat lightly anymore, like dealing and, and making space for our mental health is really significant.

If we’re gonna talk about health, we have to talk about the mental, emotional components, not just like what’s going on with our heart, what’s going on with our lungs. You know, it’s a lot deeper than that. Yeah. Yeah.

Naji: We, we, we don’t know. We, we never learned right in school, how to deal with emotions, how to talk about them.

Like how many times, you know, with my team, we, especially during, uh, this past year that we had, right. With the pandemic, starting to talk about emotions, how important it’s true. You know, technology connected us, but there’s myth of human warmth. Yeah. That is definitely bringing, uh, I, I hope we won’t get into a new pandemic.

With mental health, but it’s, it’s definitely a big issue that we will, uh, we will be facing. So, yeah, it’s, it’s great. What you’re doing and spreading this important, uh, notion about taking care of ourselves. Uh, Bria, how would you define we? We talked about retreat. I’d love to hear. What do you mean by retreat?

Brie Doyle: Yeah, of course. So for me, a retreat is really just taking time, a set period of time and pulling away from your day to day life, you know, pulling out of your daily duties, all the shoulds and the have tos and unplugging. I, I suggest on my retreats that all my participants, you know, they shut off their phones.

They send one final email to family and work say, Hey, you know, I’ll be back in touch. After the weekend or after the week or whatever duration you’ve decided and really kind of shutting out that world to focus on your inner world and really just to kind of realign realign yourself, you know, I mean, it starts with very basic things.

So like getting proper sleep. I mean, these are things we totally take for granted. And in our day to day life, we. We don’t value things like sleep or eating, nourishing food, or being out in nature. These things that are very basic and fundamental to our species, but we, this is not, again, these are not values that are honored in our society.

So it’s coming back to those really basic principles that seem like, oh, of course I do that. But over a lifetime, we start as. To slip away from some of those habits. So it’s bathing ourselves in those habits again. And that’s how retreating starts is really kind of allowing yourself to sleep. You know, allowing yourself really basic things and then, but it goes much deeper than that.

You know, I, I believe on retreat that it’s different than like a vacation it’s different than like a weekend away with friends. You go away for like a higher spiritual intent. So I always suggest that people bring either a podcast or a book or something that’s gonna challenge you or help you grow in a certain way.

Um, particularly if you’re going on your own, you know, you can either join an organized retreat or you can retreat by yourself. So it, it, you, my book kind of breaks down how to choose what is best for you, whether you should just go by yourself or to join a group. Um, there’s so many ways to retreat right now.

It’s. It’s wonderful. Um, but it’s worth considering, you know, what is best for you at a certain time. So it’s really just pulling away, um, shutting out your day to day duties and just allowing time for yourself

Naji: a and would this be something that you would do like once a year, once a semester, is there any advice around, you know, timing of those.

Brie Doyle: Yes. I, you know, I, my husband and I have this packed where we each go once a year, that right. We are kind of in the throes of life, you know, we both have big careers, we have kids. And so that feels reasonable. I mean, I, of course I’d love to go more, but that feels like a reasonable duration. If I can go more great.

But typically once a year, and that’s a pact, I keep with myself because one of the things that happens is once you say, okay, I’m gonna go on a retreat, then you easily start to talk yourself out of it. Like, oh, I don’t really actually have time for that. Or, oh, this is a bad weekend for me. So I suggest like committing to some duration or some or some, um, you know, every year, something like, like that, that feels reasonable and sticking with that because you will try to kind of weasel your way out of it.

Naji: and, and in between. Like this one year D which, uh, I, I definitely agree with you, like shutting down disconnecting is, is so important, right? At least, uh, we need it at least once a year. Right? Absolutely. What any advice on, in between those times? Right? Because our brain, uh, I’m also a big believer of, uh, the not only intensity, right, but more being consistent, uh, with, with what we do.

Yes. Uh, and our brain has always turned on with many different hats that we have. Yeah. Any advices or anything that you do personally, between those retreats to keep on reenergizing yourself, stepping back, being mindful, a any tips for, for us as leaders.

Brie Doyle: Sure. I mean, I, you know, I really think committing to some sort of daily practice.

I mean, we hear this all the time, but I appreciate that. You said, you know, consistency really matters. Cause I agree with you. I mean, I think it’s our habits that really determine who we become. So for me, my personal practice, I’m a morning person. I think you have to kind of. Consider am I morning person or a night person, but for me, I’m a morning person.

So I like to get up in the morning and I, you know, do yoga, do some meditation before the kids get up. And, um, you know, there’s so many different apps out there. There’s so many different supports to do meditation or yoga just from your living room. And that’s. Those are the things I do. And then also breathwork.

So I do those three every single morning and you know, occasionally here and there I’ll miss, like if we’re traveling or if I wake up, I don’t sleep well and I wake up late, then I’ll just do like just meditation or something like that. But I, I try to have a really firm, um, Practice for my internal, you know, wellspring, because I feel like, like you said, it’s, it’s a stacking effect.

It’s not something you do once, just like a retreat. I mean, it’s not something you do one time and say, okay, I’m, I’m good. , it’s a, it’s a regular practice. So again, finding the time of day that works for you and committing to that. And again, if you, if you commit really firmly to two weeks of that, then you’ll have a new pattern, you know?

So finding that, finding that time of day and. Honestly, I mean, 10 minutes makes a world of difference. It doesn’t have to be hours. It can be 10 minutes. And frankly, if you don’t have 10 minutes in your day, then, you know, I think it’s time to reprioritize.

Naji: yeah. Take a minute to plan for it, right. Exactly.

Brie Doyle: Exactly. Yeah.

Naji: Uh, brief from, uh, from your, uh, you should leave now. That is. That is going to be published very soon. July 13th, right? Yes. Awesome. Uh, you, you, uh, you share nine elements of a retreat. Uh, what would be the top two that, that you can share right now?

Brie Doyle: Yeah, the top two. So, um, you know, we spoke about one briefly, which is, um, disconnecting from work and home life.

So again, that’s just being really clear and I, and I again suggest sending an email or, um, some kind of communication. So there’s a hard line when you leave. Like, I love you all so much, unless there’s an emergency, we don’t need to be in touch. Um, because it’s hard, you know, we, and you get on retreat, you start to feel bored or you start to miss your people and then, or you start to think, gosh, I really should be working on that.

And that pulls you completely out of your. Phase. So really being firm about disconnecting from work and home life and another practice that this is a hard one for people, but I, I believe really firmly in this practice is using silence as a tool when you’re on retreat. So when you’re, when you’ve pulled away, this is easy to do when you’re by yourself, right?

Because you’re not interacting with lots of people, but if you join and program, it’s harder to find moments of silence. And the reason that I, that I feel this way is we. Been so much of our lives, just inundated with conversations and opinions and constantly bumping up against people, whether it’s via zoom or seeing people that drop off our kids’ playground, you know, at the school or friends or family, whatever it is, we’re constantly chatting.

And sometimes we lose that, that sense of like what we really, that felt sense that inner voice that we know is there. And so when you, when you take out that element of. Speaking all the time, then, you know, different, different, um, different things start to bubble up for you. Different ideas, different creative insights, different, um, synchronicities, all of these things start to come forward.

So using silence as a tool on your retreat, like for me, when I go by myself, but I’ll stay at, usually I’ll stay at a, a retreat center. I’ll have the morning be total silence. So even though people are having breakfast and some people are having conversations, I just sit by myself and stay silent. .

Naji: I, I love this.

I, I miss silence. So , I love that if we try it.

Brie Doyle: yeah. Sorry. When you have two, when you have kids at home, you realize it’s like, you really value it even more.

Naji: yeah. What is, if, if I were ask, like, what is your best learning or, you know, the best experience you had during a person? I retreated.

Brie Doyle: Yeah. Yeah, that’s a great question.

I, um, you know, so one of the was my idea for this book actually came as a result of a retreat and all the chapters, it was like, I had had two days of silence, you know, the first day is kind of hard. You’re kind of battling through like your old patterns of home and you’re feeling like bored and like you to be doing more.

But by the second day, you kind of start to drop down a little bit and settle down, calm down. . So after that second day, it was. The third day came and it was, I, you know, I was meditating and then I had gone for a hike. And on that hike, I had the idea for, for this book, that’s now being published and it was like, it all came to me in a matter of, you know, an hour.

And I couldn’t, I couldn’t get my pen to move fast enough. I mean, I was just joting down millions of ideas. And it’s funny because that’s that journal is the journal that I use to kind of reflect back on when I was writing the actual book. So to me, that was really a big moment because I, you know, I’ve always wanted to have, I’ve always wanted to be a writer and I’ve, I’ve always been a writer.

Um, and I’ve worked with fiction. I’ve done all kinds of different things. So, so this really came true as a result of, for me, pulling away for retreats.

Naji: That that is. That is great. Thanks. Um, re uh, you know, our podcast is called spread love in organizations. I have to ask you, what do you think about this?

So what is your reaction when you hear spread love in organizations?

Brie Doyle: Uh, I mean, I think it’s an amazing way to use your gifts because I think, you know, I know you personally have had so much experience with like in the medical world, but to spread love in organizations is such an important thing, because if you wanna be a leader, right, we have to model this work and to share it among the business world, I think is.

So, so critical because we kind of tend to separate, you know, like thinking spiritual or personal over here, business over here. But when you can bring those two things together, then you feel so fulfilled. You know, I think that’s, I think you’re doing something very important and to have these conversations with people that coming from the heart, I mean, that’s.

We’re all desperate for deep connection. You know, we spend too much time with like surface level garbage and we’re all yearning to have real meaningful connection. So I think, you know, to have these conversations with people is really important. And to hear other people’s stories is this is an awesome way to spread love.

So I really honor what you’re doing. Thank you.

Naji: Yeah. Uh, I, I know you had different mentions in your book, uh, from great leaders, uh, who inspired you, uh, personally, spiritually, uh, anyone specifically that, that, uh, you would mention today?

Brie Doyle: I mean, Eckhart tole is to me, one of the all time rates of ever, you know, I, I reread his book, a new earth just on repeat, because I think.

There’s so much profound wisdom in that book and it’s so grounding. And so to me, I read that book regularly and I think his, his work really informs a lot of my opinions and I can listen to it or read it a hundred times and come up with something new every time. So I think his. His bit about, you know, um, the importance of meditation.

I mean, that’s another, one of the elements of retreat is meditating. Again, having some kind of way to handle are constantly ruminating thoughts. And, and my, my view of how to handle that is through the practice of meditation. And he talks a lot about this, really just creating spaciousness with inside your internal life.

So I think Ekar whole lake to me really stands out.

Naji: Uh, and any, any app or advice, you know, for busy business people, as we always, as we always would say, uh, that, that you would recommend, or that you use, or even any dip, like a habit that I can bring. Starting

Brie Doyle: tomorrow morning. Yes. Um, so have you, there’s a, there’s an app called insight timer, which I find it’s a meditation app and I think it’s really easy to use.

It’s really manageable. So that’s a great setting, a timer for yourself when you’re starting a meditation practice, I think is really important because you, you kind of sit down and suddenly you’re like, I wanna do this, or I need to do this. Your mind starts going all the over the place. So I think setting a timer is a really great practice cuz then you know that like you don’t have to be constantly thinking about when is this over you can, you can kind of relax.

Into what you’re doing. So it doesn’t have to be inside timer. It can just be a timer, but there, there are guided meditations on inside timer. So if you’re someone who’s a very busy mind, sometimes listening to a meditation is a really helpful thing, you know, if, if you wanna experiment. So, so in my book I talk about, there are two kinds of meditation.

There’s form meditation, and there’s. Meditation. So form meditation is when you’re focusing on something like you’re listening to music like Ural beats, for instance, you know, these are those beats that, that have the theta brainwave vibration. So then your brain matches them. That’s a really great thing to listen to too.

So Ural beats is great, but this is a, this is a kind of form meditation, or maybe you’ve heard of walking meditation again, that’s for meditation. And then. Form less meditation is just where you’re sitting down. There’s no music, there’s no stimulation. You’re just allowing your thoughts to come in and allowing them to go out.

So. So, you know, choose which, which, which direction you wanna go, um, form or formless. And I would say, you know, if you have a very busy mind, you don’t have a lot of experience meditating. I would start with form meditation. I would start listening to meditations or listening to the Ural beats, something like that.

So it feels a little bit more manageable. And I would also say do it in bite size pieces. So maybe 10 minutes is a great goal. 10 minutes every morning for two weeks or 10 minutes every night before you go to bed for two weeks. Um, I think that’s a great starting point, you know, from there you can add on breathwork and different things like that.

Um, Or yoga or any other or prayer or whatever practice feels connective to you. But I think meditation is just such a foundational. It doesn’t have to have any religious connotation whatsoever. It’s just a really important practice to my meditation teacher talks about, he calls it, um, making friends with ourselves.

So I love which I love. I love the lightness of that. You know, there’s no, sometimes the Western mind comes in with such like aggressive tendencies. Like I’ve gotta be the best meditator in the room or something , you know, and I, and I love the idea of just like, Making friends with ourselves just kind of softening softening, you know?

So, so that would be one tip is, um, you know, using it a timer using insight timer and choosing, do I wanna do form meditation or form less meditation? Um, another tip that I have is to, to UN start to understand your state and what I mean by that is. You know, we have times when we, we have habitual behavior.

So sometimes we, we feel lots of energy during the day. Sometimes we feel really low and tired during the day. So starting to notice where our energy dips and taking responsibility for it, there are three things we can do to change our state. So, you know, sometimes for me, I’ll notice like after I’m kind of like, Ugh, you know, a bit of a, a bit of a dip, I feel tired.

So there are a couple things you can do. You can change your focus. Change what you’re focusing on. So if I’m working up and working on the same thing for a long time, and I feel that dip in my state, I need to change what I’m focusing on. So I need to try something different, work on something different, you know, get up, move, something like that.

So if change your focus, you can change your physiology. So like I said, you can get up and move. You can go outside, you can run up the stairs really quick. You can jump of up and down 10 times. so that’s another way to quickly change your energetic. State or you can change your language to me, this is the most nuanced one changing, noticing how we speak.

If you’re saying, if it’s after lunch and you’re jumping in a meeting and you’re like, oh, I’m so tired. I’m just so tired. I can’t believe how tired I am then it’s just this reaffirming thing. So kind of starting to pay attention to the Lang language that we use around everything around how we. Speak about our state, around how we speak about our partnerships, about our work, all of these things.

So those three ways, and starting to take notice in your own life of how you can manage your state. Because I think sometimes we think we’re just victims to like, well, I’m just tired. And it’s like, no, actually you can do something to shift that. So to, so managing those three things would be another, um, and noticing in your day, like where do I dip or where, when do I get really angry or when do I get really sad, you know, starting to take notice and then taking ownership of that.

Naji: That’s that’s really great, great tips. I will be adding, you know, I’m like to share with you the, the one thing, uh, I’m trying to make it a habit now is, uh, but, but I need to move to 10 minutes. I’m doing like the triple two. So it’s two minutes of mindfulness, two minutes of, you know, planning two minutes of prioritizing every morning and I feel it changed your day.

Yes. But I need to get more into the 10 days, uh, 10 minutes, your meditation. I’m I’m taking a lot of. Fits from you today. And thank you so much for that.

Brie Doyle: Of course, I’m, I’m honored and that’s, that’s amazing that you do that practice. I mean, clearly you’re a leader, so you have these things in place, which is awesome.

It’s, it’s so fun to talk to other people too, because then you start to get new ideas, like, oh, I might wanna try this or read this. And so I think that’s a fun thing too. Just sharing different ideas. Like what do you do for your mind for in this practice? You know, another thing I love is thinking and feeling gratitude.

So like, Adding that at the end of your 10 minutes and not just thinking like here, like writing a list, here’s what I’m grateful for, but like really feeling it in your body because the body is so amazing. As you know, it’s like, you don’t have to, you don’t have to go through an experience. You can actually just think about an experience and physiologically all the same hormones are gonna go off.

So if you’re remembering and you’re heart, like the moment you met your amazing wife, Or the moment that you had your first child, it’s like, I get chills just talking about it because, and then, and then you feel energized, you know, you’re like, gosh, I do have so much to be grateful for. So it’s not just making a list of things.

That’s a fantastic thing to do of gratitudes, but it’s like feeling it in your body. It’s a whole, it’s a physiological reaction. And so learning to feel. Those emotions and practicing them, right? Because the emotions that we feel over and over again are they become habitualize right. So if we’re constantly pissed off , then we get really comfortable being pissed off.

And then everything in our environment shows us like, well, that guy is awful and this work sucks. And I don’t like, you know, so it becomes this habitualize thing, but if you like. Oh, wow. Like, I feel, I feel so grateful right now to have rain. I mean, we don’t usually get a lot of rain in Boulder, but it’s like dumping outside and it feels like it’s really green right now.

And it’s, it’s a silly little thing, but like to start to look for little things, to feel grateful for and then feel it it’s a whole different experience.

Naji: and, and you find a word, uh, real of, uh, final word of wisdom for leaders, uh, around the words specifically in healthcare. I’d love to hear something from you to yeah.

Healthcare leaders. ,

Brie Doyle: you know, I, I hate to go back to this always, but I actually, I don’t hate to go back to this at all. I think, um, claiming fully like taking planning a retreat for yourself and putting it on your calendar well, in advance. So being really, really disciplined about when your retreat is like making this part of your regular practice.

So that you have it on the calendar, you have something to look forward to and that’s gonna come for you. I think that’s critical. Um, and I, and so the tips are the same, whether you’re in healthcare or anywhere. I mean, I think these are so valuable, no matter what you’re doing, but again, putting a retreat on the map I think is incredibly critical and then meditating that’s that, that would be the other tip.

I mean, those tips are, I just harp on them over and over, but I think they’re so important.

Naji: Thank you so much. Uh, yeah. Agree for such an amazing discussion and definitely in healthcare, uh, you know, people mainly on the frontline, even more, they I’m sure they need to, uh, step back disconnect recharge and all the tips that you gave us today, uh, are definitely needed for us to be able to continue on serving the word, uh, in the, from a healthcare standpoint.

Yeah. Thank you so much again for joining me today.

Brie Doyle: Thanks so much for having me. I’m great. Glad to be here.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Bridget Akinc

Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host for this podcast, having the honor to be joined today by Bridget Scott Akinc CEO at Building Impact. Passionate about innovation and finding new ways to work toward solving complex social challenges, Bridget leads Building Impact, a nonprofit organization that engages leading companies and brands in local communities through volunteering and capacity-building. Prior to this role, Bridget led dynamic teams focused on accelerating growth and innovation enabled by technology across multiple sectors including finance, retail, automotive, high-technology, and education. She led strategic consulting and marketing teams for high-growth Silicon-Valley based software companies like BEA Systems and Oracle, as well leading non-profit organizations like The New Teacher Project. Bridget also serves on the faculty of MIT Sloan, teaching the “Leading With Impact.” Course I had the privilege to be part of! Bridget is a marathon runner, youth soccer coach, and an avid visitor to national parks with her family.

Can, can you please share with us a little bit, a little bit more about your personal story from finance marketing consulting, to now leading an incredible nonprofit organization impacting lives of thousands in local communities.

Bridget Akinc: I think that if we think about it, my start was in education. Um, back in the days that I was in college, I trained to be a teacher. And, um, one of the things that I, I think was, you know, in, in the forefront of my mind at that point in time was that. This idea of systems change in a system is complex as an education system with so many different funding models, um, across charter schools, local schools, and then obviously private and independent schools.

Um, begged a question of what I, um, I hadn’t studied, which was to really understand the mechanics of business, to be able to make a systems level change in a, in a social system like education. And at the time that I was graduating from Princeton, Teach For America was a model that a lot of people thought about and pointed to as being a real, you know, um, turn things up, upside down, um, type of innovative model.

And at the same time it was running near bankruptcy. Now this of course, is the same time that Apple was running near bankruptcy. So if you think of these two organizations sort of simultaneously being, I think somewhat critical to the way in which we’ve thought about education reform and education innovation in this country, um, over the course of the last 25 years.

I think Apple has played a critical role in the way that it has enabled technology adoption and usage in, um, in, in the way that we think of education today and certainly made education possible during Covid and Teach For America, I think has fundamentally changed the way that we think about education, leadership, and education.

Um, uh, you know, the teaching profession, I would say. As a springboard into having informed discussions about education and its impact in our, in our world now more broadly even than Teach for America and Teach for All. Uh, and and so as I think about that from my mindset, one of the things that was sort of fundamentally, um, A fundamental belief that I had at the time that I was graduating college was that I wasn’t becoming a teacher so that I could just teach I was becoming a teacher so that I could think about systems change.

And I knew that there were lots of areas, the more that I delved into that, that I needed to learn about in order to be a credible leader, um, in that work. And I think that sitting at the intersection, Of education and for profit and nonprofit at the same time, as well as sort of the government policy work, uh, that I had studied was, to me the most fascinating place to sort of think about the, the role that a leader has, uh, in trying to actually influence systems change.

Naji Gehchan: I, I love this, so I will double click on it immediately. What, what is the role of a leader in influencing system chains for.

Bridget Akinc: So I think in the nonprofit sector we talk a lot about the importance of proximity. And I think that we are hearing that more and more as we think about impact investing. We talked during the Leading with Impact program with Dr.

Maba McClury, who’s leading this work in uh, many ways with leaders of color in the Commonwealth of Massachusetts, and thinking about impact investing. Relative to impact measures not designed, uh, or preordained by grant giving organizations, but rather by the leaders that are on the ground. Um, I think Ayanna Pressley speaks about this in on a public policy front in incredibly powerful ways.

Um, but also Gerald Churchian, who leads Europe up, um, speaks about the importance of proximity. Brian, um, Stevenson talks about this. I mean, I think this work is, um, you know, the work of systems change on a ground level for social systems, I think requires having proximity. And one of the goals that I have, you know, I think it, it’s interesting because I have a, um, a candidate who came, um, to interview with us, having come from.

Um, she had been in the Peace Corps. She was a part of the Harvard, um, Graduate School of Education before arriving at us. She had been at Georgetown, um, uh, as an undergrad. So like, clearly she had a lot of, um, both knowledge skills and really social justice awareness in terms of the work that she had done before.

But she sort of said, I don’t know, you know, this work around volunteering doesn’t really seem, it seems like a scratch the surface type of thing. And I said, For me, The first part of systems change begins by understanding the complexity of the systems that we’re working in. And oftentimes people think of volunteering as being sort of, oh, a tow dip into the water.

But if that volunteering experience can ignite in someone a deeper level of understanding, inquiry into why the root causes of these social challenges. If spending that day doing that activity as we do with leading with impact, um, can provide an on-ramp to an immersion, into a social impact area that you want to learn more about, vote more consciously about, um, and enact change through, you know, investing, um, and change in policies.

Then I believe that actually volunteering is the very first and critical step. For this intersection of corporate, nonprofit, and government work to be happening?

Naji Gehchan: Yeah. Well, I can’t agree more. I’ve been a volunteer, as you know, for years. Uh, and what really struck me about this, like even me being volunteer of large, uh, NGO with the Red Cross, um, you talked.

And you think about NGOs in a very different way, uh, about nonprofit organization. Um, and I would love if you can share with us here the perspective you have about nonprofits operations and also how they can sustain what they do at the long run. Uh, because I really think this is a critical point.

Sometimes we don’t think of it that way.

Bridget Akinc: Yeah. I think oftentimes we think about nonprofits in the context of. The mission that they hold, uh, sort of the problem that they’re trying to solve and the funding that will be needed to do it. And oftentimes we measure nonprofit leaders relative to the growth in that funding.

Um, and, and sort of outcomes remain a question, right? We certainly do this in, in the education sector. We wanna know how much, you know, how much have we, um, increased the funding associated for each student. But relative to the kind of things that we think about on, on an outcome measure, um, and thinking about whether or not our impact investment has been made in, in terms of the, you know, the outcomes that we’re designing.

I really think we need to be thinking about nonprofit work in much the same way that we think about it in the for profit sector, which is to really think about, uh, the context of the business model and. If our goal is to have a sustained system level change, then we have to have a sustainable model in which to build that work.

There is enormous value created by the nonprofit sector that is revenue worthy, revenue generating worthy, I should say. Which is to say that, um, you know, I don’t think that we should relegate the nonprofit sector. To fundraising. Uh, fundraising can be an important, you know, jump start in the same way that a kickstart or angel investment or any of the other, you know, sort of tools that we use in the for profit sector can be.

Um, but I think at the end of the day, a nonprofit endeavor to really close a gap or achieve a change. Requires an investment that is sustainable on a business model level. And so when we look at the kinds of changes that we’re trying to recommend and, and help our organizations on the ground implement through the Leading With Impact program, we’re really trying to look at how it is that we can build a sustained business model.

That doesn’t necessarily just mean fundraising , um, where it is that we can look at, you know, tranches of impact made, uh, through investment in a calculated and, and sort of time oriented way relative to the outcomes we’re trying to achieve.

Naji Gehchan: I want, uh, now to, uh, go through across the industries and the different experiences you had, profit and non-profit from a leadership standpoint, uh, do you see any common thread, uh, that you really took with you across all those experiences and that you think is really essential for leaders?

Bridget Akinc: Um, so I think that I would go back to this notion of communication as being one of the most critical elements. Um, when I started at bcg, uh, you know, back in the late nineties, I remember I was working on a project where we were doing, uh, basically a worldwide education program for all of the partners globally on.

What the internet really, you know, the dawn of the internet and what it really meant for these Fortune 500, Fortune 100 businesses that we were consulting to. And so in order to do that, my background in having done a little bit of coding and, and, and a little bit of teaching meant that I was, um, you know, the associate on the project that was meant to pull this, this curriculum together with a set of folks that had deep expertise.

In both our client base as CIOs, as well as in, in the, in the space as technologists and engineers. And for me, uh, you know, the most critical element that happened in, in that experience was to learn the power of education through really strong communication. Um, and I, it was really no different at some level to the kind of communication skills that we learned in becoming teachers, uh, fundamentally.

We have to begin by thinking that we’re communicating, not a subject matter, but we’re communicating to people. We’re not educating on a topic, We’re educating individuals. And I think in order to be able to, you know, meet folks, um, at a place where, you know, they’ve arrived, It’s communication beginning by listening.

I think we talk about this in the context of the, the work that we do with nonprofits, um, in the Leading With Impact program a lot. We talk about this at Building Impact a lot. You know, there’s a lot of programs that are designed to benefit communities that never, ever begin with listening to those communi leaders and those communities for what the need actually is.

Um, There’s a, a leader, um, who’s been, um, sort of a celebrated leader now within the innovation space, um, coming out of Africa. He’s Ghanaian, um, Sango. Who is now also on the board of receivers at Harvard and has, has done a number of things to really evangelize this model of listen first, whether it’s an impact investing or a nonprofit.

And he talks about his own journey in sort of coming to an understanding of really beginning with innovation by listening to community, um, need and to to community generation. And I think Sango hits this on the head. I think that it. The idea that we listen first in any context, , to understanding what it is that our audience is, is looking to, to learn, and to looking to, to know, and to look to utilize, um, that that is the foundation for the principle of of leadership.

And I think it is only in. In listening that we can then co-design and, and develop a solution and develop an idea of, of, of innovation to really achieve the goals that we hold, um, in working with, um, that, that constituency. So it was, it was an interesting, you know, thing to think about relative to the work that I was doing at bcg because I was told, you know, your, your ideas are fine.

Everything is there. But you talk like a Californian, like, can we, can we back this up because you sound like this, you know, kid from California. And I really appreciated the feedback at the time because what it meant for me was I was learning how to operate in a. Corporate sphere, whereas, you know, maybe my, uh, California child worked in a classroom with, with eighth graders, it was not gonna impress, uh, the C level executives that I was working with.

And so it was really this partner pulling me aside saying, you know, you gotta substitute a few of your filler words in a different kind of way. In order to be taken seriously. And you know, as much as the feedback was, um, difficult to hear at the time because I thought, Well, the ideas are all here. Look at my charts.

It was a really important ingredient into thinking about the investment that he was making in me relative to the way in which I would credibly be. Um, taken seriously in the, in the ideas of that were being conveyed and in the, uh, in, in the data that we had. And I think that that is something, um, both in developing in innately the confidence to be that.

Spokesperson for those ideas. Um, but also to be thinking about how it is that, you know, our, our presence is met , uh, when we, you know, when we show up. Um, that was a really important, uh, element for me in, in toggling between these sectors and something that was very effective for me when I hopped into, you know, boardrooms in Detroit or boardrooms on wall.

Naji Gehchan: Uh, thanks for that. And so I will go on this. Listening in crisis management, you, you’ve obviously been managing, you know, challenging time, uh, with Covid. Uh, we talked about it like short staffing, lack of resources, uh, but also, well, we’ve seen it in l wwi obviously every. Can be a challenge for nonprofits on a daily basis with the communities they serve and, and they have to deal with those uncertainties.

What is the place of listening in crisis management? Or is there something else that you think is crucial to, to lead teams? How have you led your teams during those times? And I think that they are not done though, You know, some of us wanna put all the pandemic behind us. Unfortunately, the consequences of this, you’re seeing them daily in the communities.

Bridget Akinc: Yeah, I mean, I think Naji for me, one of the most important ways that I’ve learned about listening in the course of the last two years has been around, um, leading a diverse team during a time of racial racketing in this country, but also in the world. And I think that for me, the. Element of listening that is, has been a really important element that I have been, uh, learned and learning in the process, um, from my team here and also in the organizations we work with.

Is how important it is to give space and validation for all of the feelings that people bring when they bring their whole selves into the work. Um, you know, there have been times where we just take a pause and we as, as an organization, um, take a pause so that folks have an opportunity to. Uh, be mindful of how they’re feeling at the time of doing this work.

Um, it can be, you know, time to be angry. It can be time to be sad. It can be time to, you know, be joyful about, you know, the work that we’re doing and the outcomes that we’re having. But it’s so important that we take time together collectively and also take time individually. Um, you know, it’s something that I talked about recently, uh, with.

Um, a group on a different, um, uh, topic, but it was around this de and i, um, work that I had said. You know, I think for us in the nonprofit sector, one of the things that we have to acknowledge is that the communities that we work with and the communities that we are in experienced on a statistical level, a much greater degree of loss during this time in terms of loss of life, loss of freedoms.

Loss of financial security, loss of housing, loss of jobs. Um, and if I come back to the loss of life for a minute, the, the gravity of that has been felt, There’s no question across the board globally, but it is not possible to move through an experience like that and be the same, not on an individual level, but certainly not on a, on a organizational level.

Um, when we were going through leaving with Impact during 2020, our TA found out during our, um, during one of our sessions that she had lost an aunt to covid in the middle of the session. Um, it’s earth shattering when you lose someone close to you and when you’re losing someone close to you with so much uncertainty and so much distance, how troubling it can be.

You know, I think for, for all of us, and I. This notion of really being able to give time and space to people as they need it, but also time and space to the team. When you are collectively experiencing a set of those, um, challenges is, is so important. And I think that there have been moments where I’ve called for it, but there’s moments where my team has called for it and said, Hey, like Bridget, we need to take a moment here.

Like we need to take a pause because look at what. Look at what, what has just transpired. Look at what you know our community is experiencing. And I think that there has been time and space where people have needed to really voice those feelings and that type of, um, creating that type of environment is oftentimes the thing that our team does for others.

When we’re doing volunteer projects, we ask people to take a moment to think about. Maybe some of those topics that we don’t discuss often in a work environment, like let’s take a moment during Pride Month here to acknowledge the loss of life that has existed in the trans community, even just over the course of the last year.

Let’s take a moment, because this project that we’re doing to support trans youth means that these are youth who are going through an experience of collective loss for a community. They call their. It’s important that we take that time to think about that loss in the context of. Helping to really make an experience for them of going to camp, joyful.

Um, but let’s be cognizant that when we enter this work, it’s not being entered, you know, sort of shallowly. And I think that that type of opportunity to have a discussion, oftentimes our facilitation will then elicit a conversation with the companies that we’re working with that they’ve never had before.

Oh, well, you know, my, my son experienced this, you know, when he was going to camp, or this is an experience that my brother had when, when, you know, he was in the midst of his transition or whatever. Those are kinds of conversations that just bring out the humanity in all of us, and I think that that notion of being able to connect on a much more human level is something hopefully that, you know, we can do more and more of in all of our circle.

Naji Gehchan: So, so sovereign and profound. Thanks for sharing, uh, this project. Project. It’s, uh, yeah, our role as leaders is really crucial to create those spaces, and as you said, for our team to sometimes also ask for them when needed, but we definitely, we all can do more on it. I, it’s tough to transition now, but I want to give you, uh, a word and then get a reaction to it, uh, in this next part.

Okay? . So the first word is leadership.

Bridget Akinc: A reaction to that, to that word. Um, I, I think that it’s earned, not designated.

Naji Gehchan: What about impact?

Bridget Akinc: Yeah. Um, I, I look for the little things, . Um, it, it begins step by step. So I think it’s so important that we, um, we think about it incrementally and not just on an aggregate level. Belong ink, the glue belong is the glue for, for, I think for every c. Can,

Naji Gehchan: can you say more about this? I, I, I loved how you framed it during also the discussions we had, the different, like the journey from DNI to belonging.

I think a lot of, uh, organizations focused on dni, well D first dni, then the eni, and I think this belonging just gives it such a powerful next step as a meaning. Yeah,

Bridget Akinc: I mean, I think the power of belonging is, or an understanding, belonging is the, is the power of, of, um, understanding being othered. We have all experienced a time and place in our lives where we have been othered, and that can be for so many different reasons.

Um, but the feeling of being othered, um, carries with it a certain weight to it, right? A a certain weight that oftentimes can be. Um, A, a loneliness, an isolation, a, a feeling that you’re not cared for. You know, that, that there is, there, there isn’t care there. And I think that can happen in a crowd as easy as it can happen.

When you’re alone. Um, and so one of the things that I think we try so hard to, to do in the, in the projects that we create, um, is to really attach a sense of community, um, to the work that allows for reflection in people being able to bring their full selves to that work that, um, allows for that empathy building to be built very organically.

Through that sense of their own introspection about a time when they’ve felt othered, um, or felt outside of it. And I think that that can be a very powerful, um, ingredient to, to really captivating people’s imagination about how they might actually enter that space differently if they, um, are cognizant of.

Um, it’s interesting to me because, you know, one of the people that I oftentimes talk about, um, as having a very influential role for me in my concept of this, um, uh, of othering and this concept of this work was Tony Morrison. So Tony Morrison was a professor of mine at Princeton when I was an undergrad.

And had written a book actually that was a non, uh, nonfiction book about the origins of othering, which is not as often read, um, honestly is, you know, beloved and jazz in a number of, of her, um, very, very popular novels, rightly so. But the origins of othering, um, you know, has a system level systematic policy basis calculated financial, aggregated, um, Uh, construct in our society, the origins of others, and when we recognize that there are, that, you know, the experience of being othered is one that we can all identify with, but there are also systems level othering that create that construct for others in the times that we, whether intended or not, at the times that we construct them.

Will force us to have, I think, a different level of scrutiny to the work that we do relative to how it does impact, um, those in the community that we, we think, that we, you know, are, are helping, um, or are supporting.

Naji Gehchan: The last word is spread love in organizations.

Bridget Akinc: So, Naji, you and I talked a little bit about this. I think that the, the concept of love inside of organizations has such a, um, new pervasive element because of this important work on belonging. I think. But also because I think it is now one very positive silver lining coming out of, I think the last couple of years, is that it is a part of the vernacular.

I think the challenge is how do we move love to action, and I think that there’s now a lot that is in the vernacular about. Love in the context. Maybe not love, but kindness and, um, and compassionate making. You know, organizations feel more like, um, a a place where, you know, a safe space where people can come.

But I think the challenge of now moving to action, what do we see in the actions that we, that we hold and that we challenge ourselves to do? Uh, that to me is, um, I think the important next. I

Naji Gehchan: hope with this, with this podcast and episodes like those, we’re giving some hints, some, you know, advices to, to build a more caring and kind workspace and that that will have a ripple effect on the community and the Yeah.

And the organization. Any final word of them, uh, Bridget, for the leaders around the.

Bridget Akinc: No, I just, I mean, my final word is really one of gratitude, I think, uh, to you for hosting, um, this and for hosting this conversation, uh, not only with, you know, your peers, but those that you know, you can, um, reach more broadly through, through a vehicle like this tool, um, of the podcast.

I think it is. Remarkable to be able to spend some time thinking about and reflecting with others, uh, on how it is that we can express love in organizations and spread love, um, in those ways. And I think it’s kind of the essence of, of everything, isn’t it, in terms of making, um, making it worth, um, all the work that we put in.

Um, so I think, uh, it’s, it’s just a joy to be a part of the discussion and it was certainly a joy to watch. That love manifest in the work that your classmates did in the Leading With Impact program. This. Um, I, if I, if I could just one little plug for your class. It is the first time that we have ever seen a 100% NPS score from the nonprofits that we have worked with.

Uh, so, um, you know, companies out there, brands out there, take note at the, uh, the amba class of, of MIT was able to get a hundred percent of the nonprofit organizations that they worked with to recommend this to others, which to me speaks volumes about the kind of impact, um, that you were able to have in that.

Naji Gehchan: Thank you so much, bridge, truly it means so much. Uh, your words, uh, what you said coming from you means so much. So thank you for this and I’ll make sure all my classmates know about the NPS we got. So thank you so much again for being with me today and for this incredible, insightful discussion.

Bridget Akinc: Absolutely. Thanks for having me.

Naji Gehchan: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Dominic Abrams

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I am Naji, your host, having the pleasure to be joined by Dr Dominic Abrams Associate Professor, Harvard Medical School, Cardiovascular genetics and cardiac electrophysiology expert. Dominic specializes in cardiovascular genetics and cardiac electrophysiology at Boston Children’s Hospital and Harvard Medical School, and he is active in both clinical medicine and scientific research. With his team, Dominic provides personalized, multidisciplinary care to individuals and families, and drives novel research strategies in varying aspects of cardiovascular genetic disease. He has developed clinical programs in both the UK and US, with attention focused on organizational culture, leadership, clinical innovation and maximizing value to multiple stakeholders. Dominic has developed excellent collaborative relationships with individuals and organizations within the wider healthcare ecosystem.

Dominic Abrams: Thank you so much. It’s really great to be here and thank you for the invitation.

Naji: I would love first to hear a little bit more about your personal story and really what brought you to become this amazing physician and specialist and leader you are today.

Dominic Abrams: Thank you. So I originally started, as you can tell, I’m from the uk. Uh, I grew up in England and then moved to London for medical school when I was 18 and went through the British training system in the. Way it was in those days, which if you look back, is rather chaotic. But actually at the time was fantastic cause I was able to experience lots of different areas of medicine and train and lots of different things, but ultimately settled on cardiology, uh, because it just generally really interested me.

And then over time evolved to how much of a, more of an interest in electrophysiology and then. Cardiovascular genetics, which sort of to some degree goes hand in hand with that because many of the heart rhythm disorders that we care for have a genetic background. Um, at the time I was training in pediatric cardiology, but really wanted to get a broader understanding of the, um, Specialty.

So I went to a hospital called Barts Hospital in London, uh, which is why I did most of my electric physiology training, which was just a fantastic experience. And I stayed there for, um, many years initially as, as a fellow, and then on fa on then on faculty. Um, and I was there for about four or five years before moving to the us.

So it’s sort of an opportunity that came up to come over to Boston, which has, uh, has been really exciting and challenging in many different ways, but in, in a, in a good way. Uh, it’s been a lot, a lot of fun to do and makes you look at yourself in a different way and sort of what you’ve done and what you’ve achieved and what you wanna do.

Uh, it’s always a good thing. Change is, is exciting. Um, so I’ve sort of been working here for some time now and really, Clinical work has evolved into doing much more cardiac genetics, uh, than electrophysiology. And we’ve sort of built a very exciting team and a program at Boston Children’s, which has been very re rewarding and very enjoyable.

And I get to work with many, many great people, and the patients and the families that we care for are fantastic. So it’s a great position to be in and I’m very lucky and honored to, uh, be able to do what. And

Naji: David, have you always wanted to do to become a physician? ?

Dominic Abrams: Have I? Yes, I have from, from quite a young age, but I couldn’t really tell you why.

Um, I remember as a, as a young kid, I always wanted to be a doctor. No one in my family was a medic. Uh, there was no sort of pressure for my parents to become a doctor, but it was just something I always wanted to do. And apart from a few sort of flirtations with other things that most kids go through, Yeah, it was always medicine, so something I’ve always wanted to.

That’s,

Naji: that’s awesome. And you’re doing, and you’re obviously helping so many, uh, so many patients today. And as, as you shared, this is something I would like to, to go first, um, and discuss with you. So you’re a cardiovascular expert. You manage very challenging, uh, situations. Uh, with, with families, um, while ensuring, uh, one of your passions is this personalized medicine, but also in a multidisciplinary way.

So really leading those cross-functional teams, uh, treating and caring for patients and families. So I’d love to hear how you combine both personal approach. While also working in it with large cross-functional, multidisciplinary disciplinary teams to keep it personal at the end of the day for the patients when you have so many different, uh, people

Dominic Abrams: managing them.

So I think, um, We have many different people in our team who all have a very different and complimentary role. So I think it’s about understanding what each person in the team delivers, what their specific function is in regards to any one particular patient or family that we see. And everyone does a slightly different thing.

And it’s very interesting to see the way that patients perceive the team and how we look after them and, and I think they sort of, Many have reported back to us. They really like this sort of wraparound care that different people provide, and I’m sure that different patients have a different. Um, or have different relationships with all of us in different ways and may particularly gravitate more towards one or towards the other.

Um, so we have sort of the clinical piece where we actually make the diagnosis. We look into the clinical findings on ECGs and cardiac imaging cetera. Then we have the genetic piece, which is again, different people coming in for that. Uh, we have a psych. Uh, team as well involved because the stress of having these diagnoses, often they’re made in people who are completely asymptomatic.

So it’s all of a sudden I was fine and now I have this dag diagnosis, this label that’s attached to me. And just coming to terms with that, understanding what it means is very, very important. So I think that yes, ultimately we all work in a slightly different way, but ultimately we’re kind trying to bring together.

A strategy for the patient that makes sense for them. And it’s not just about sort of this is what you have to do medically, that’s what you have to do medically, but all of a sudden many of these families are adjusting to a new normal, if you like, a new sort of state of their life. And so it’s about helping them adjust to that, coming to terms with that, but also not letting that dominate their life.

I think that’s really important and we sort of very much emphasize. Um, you know, many of these many things they were doing before should go on and can go on. So exercise is a classic example, but there are many other things as well. So it’s about helping them navigate this journey. And, you know, I always say to patients at the beginning, once we’ve made the, uh, once we’ve met ’em for the first time, now you will look back in six months and things will look very different and you will look back again in 12 months and things will be different again.

So it, it’s a process of evolution and I think it’s our job to sort of help guide them through that in different. Can

Naji: you share with us, uh, your leadership learning along, along the way, doing this and also with the, the, the word evolved, obviously, and as we discussed last time, uh, both of us, there’s, there’s so many.

New innovations coming for the patients. So I imagine the way you’re caring for them, as you said, this is your main focus as a care team. What are your leadership learning for you to be able to provide what you’re trying to provide for those patients, especially with those new innovations that they are dealing with

Dominic Abrams: too?

So I think from the leadership and team perspective, I was in a very lucky position that in 2016, a number of. Events, if you like, came together that allowed me to start to build this team, uh, and obviously be very much part of it, but to build it from scratch. And I think that’s a very exciting thing to be able to do.

Really. It was triggered by a wonderful philanthropic donation, um, that we got, which allowed us to build the program, uh, by someone who personally had to experience this, uh, a sudden death in a family member from a cardiovascular genetic disorder and his. Uh, fundamental request is that no other family should go through this.

So ultimately what we’re trying to do is get towards that point. We’re still some way from it, but I think we’re making progress in many different ways and trying to understand the condition, prevent these things happening, and, um, In some ways develop new treatment strategies that allow us to overcome these disorders.

So really, I had the sort of a mandate to create a team and without a team culture from scratch. And there were sort of many things that I look back on at that time in my life to sort of help myself understand. How I wanted to do that and what examples I could take from my own experiences. And in 2016, I started the MBA at mit.

So that gave me a really sort of rigid construct around which to think about this and actually sort of to put some of the academic principles of leadership, of organizational culture, these things into play and allowed me to write about it as well and, and, you know, have it sort of assessed and graded by the professors at mit, which was very interesting and exciting.

But it was actually a conversation with, um, Gail Grad, who I know we both know well. And she was talking to me and she sort of said to me, So what does life look like post mba? And I just started talking and I, which went on for about 25 minutes I think, and she stopped me and said at the end and said, halfway through that conversation, your face completely changed.

And that was when you spoke about your team. And I was completely unaware of this, but that’s, at that point, it’s sort of really made sense to me. This is what was really important to me and having these people around me and really building that and how valuable that is and how much I enjoy doing that, and how much I enjoy being part of that and belonging to that team.

So I sort of started to look back at my own training, and when I was a junior doctor in the uk, we had this concept or this, um, the way the medical system was structured. We had these things called firms, which was basically a team of doctors with one or two taken from each grade throughout the junior doctor, um, hierarchy, if you like.

And I was the real, I was at the bottom of this team, but, um, it was a, it was a really tight knit group. You know, you worked with these people day in, day out. You saw them every day. You were with them at three o’clock in the morning in the emergency department, seeing people who were really sick and ill, and then you were with them on Friday after the after work having a beer.

So you got this really tight team bond, and I think that was something I look back on and felt really was a very powerful way for me to learn about medicine in so many different ways. Not about the academic aspect of medicine, but about being a doctor and how we deliver the. For our patients and create that real sense of empathy.

And I’ll never forget, at one time, one of our team, we admitted this lovely gentleman, he was in his mid to late seventies and he was clearly dying. He had motor neuro disease and that was, you know, we, we knew he was gonna die by the end of the day. And we went to see him and his wife was sitting by his bed.

And this doctor just said to her, Tell me about him. Tell me about him as a man. And it just gave her this 20 minutes to just reflect on his life and to speak to him in front of him and tell us what a wonderful man he was and all the things he’d done. Uh, it was a really moving and very incredible experience for me to watch is a very junior doctor.

So learning that empathy, learning. Not the medicine, but learning about what it means to be a doctor. So I think that sort of sense of team, that sense of togetherness became very important to me. And again, I look back at different people who’d influenced me in my life in different ways. Um, both through medicine, through sport, through different team concepts, and started to read and think about this a great deal more and how I wanted to take different aspects of what I’d experienced and sort of build that into the team.

So it’s a real pleasure to be part of that. I, it’s something I really, really enjoy. And I think it’s very important. It’s like how do we function as physicians, as a a, a group of people in very complex situations to maximize our own performance, uh, both as individuals and as a team. And then how that translates into patient care.

Um, so. Can

Naji: you tell us a little bit more on, uh, the culture, because you’re passionate and this is how you look at things, developing this culture, uh, and the leadership in the culture. So can you tell us a little bit more what culture you try to build and how do you, how do you do

Dominic Abrams: this? I think one of, um, you know, I see my role in the team as.

Creating an environment where everyone can be their best, everyone can achieve the best that they can be and achieve what they wanna achieve. And I think that’s a sort of really important thing for me to try and create. Um, and people sense that people know it. And if you. Actually deliver on that. And you, you act that out and say, Well, how can I help you do this?

How can I help? What are the obstacles to stopping you doing what you wanna do? I think it’s really, really important and different people respond in very, very different ways. Um, you know, as I said, I’ve taken sort of experiences for my own life, some of which. Would come from very, very different contexts.

So wouldn’t necessarily work in a medical team, but did work in a sports team, for example. So how do you contextualize that? How do you take that and reframe it and change it? But I think that’s a really, really important thing to do, is to, um, create that sense of you are, you care about you, you know, the, the environment should be very caring.

You should really care about your team. You should get to know them professionally and personally, uh, and understand. And I think that’s really important. And we just have this amazing group of people who sort of come together and everyone was sort of, I think, thinking in a similar way about what they wanted, what culture they wanted to be part of.

And I think it’s understanding your own perspectives on it and helping to shape that. And then everyone helps to be part of that as well. So I think it’s one of great honesty, It’s openness. Um, you know, we have conversations. I think as a leader you need to. Humble. Um, you need to recognize that you’re never gonna have all the answers and that different people are gonna see things that I just don’t see, and that’s really important and valuable.

So I always, you know, I might have certain people in conversations cause I know they’re gonna pick up on different things from me, then they’re gonna see things differently and their perspective may be much more important and relevant than mine. So it’s understanding the value that each person brings and how you can sort of shape those together and mold those, uh, to, to get a team that where the performance is maximized.

But everyone feels that they’re gonna be their best every day and they have the opportunity to do that. So I think it’s a, it’s a fascinating thing and it’s. When you look back at great cultures I’ve been part of over my life, it’s often very difficult to say, Well, why was that great? But you just know it was.

But it’s been a sort of interesting process to try and through, think through that in a bit more depth and how can we reproduce that and how can you, um, adapt to that? Because the situations change all the time. So our situation change, our team grows, people come, people go. But you’ve gotta sort of keep that central culture there, uh, at the core because that’s ultimately what sort of shapes and drives the team.

I,

Naji: I love that. And obviously you’re a part of what you do is also to maximize value to multiple stakeholders. So I imagine your experience have shown, starting with this culture of care as, as you shared, is ultimately giving you those results.

Dominic Abrams: Yeah, absolutely. I think that’s, that’s front and center what we do as a group of healthcare providers.

But you know, everyone, as I said, everyone brings a very different component to. The patient experience and you know, one of our team who’s now our team manager, You know, every week in clinic we hear from patients, Oh, she’s so wonderful. Thank you. You know, just please say, Is she here? Can I meet her? Can you say thank you to her?

For us? And she’s never actually with the patients, but she does all the organization collecting data, collecting information, helping the patient. Get to the clinic or you know, where do they need to go? Everything. And people are so, so grateful for that. It’s really, really interesting. Um, but we hear all the time about her and in often in very difficult circumstances, people have stopped me to say.

This is the best experience I’ve had in 20 years with this individual because just of what she did and how she helped and organized and structured things. So it’s not just the sort of clinical patient facing time as well. It’s the whole team, often behind the scenes who make what we do possible, but also who drive the patient experience so forcefully.

Naji: And can you give us some practical examples? You said the team grow. It shifts, I’m sure during the pandemic Also, things were different. Like is there like a key piece that you always try to keep as a practical thing you do in a team to keep this caring culture, to keep the team, All the togetherness, as you said, towards your purpose to be able to serve patients is, is there a key learning of a practical practice that you do and we’ll keep on doing as you

Dominic Abrams: move forward?

Yeah, I think it’s really important to get to know the people that you work with and get to know them individually. So, for example, um, you know, when I was in, in the UK it was always about going for beer on a Friday night after work. And it was something that sort of, you know, oh, the Britt’s always popping down the pub after work.

But it was, it was a very culturally powerful experience. It was very level. You know, the senior people were having a chat with the person and who was there for their first week coming in at the, at, at the other end of the spectrum. So it was always a great, to me, a really great experience. And of course at the time you don’t realize that, but looking back, that’s exactly what it was.

So I’ve tried to replicate these kind of social, um, uh, events. So we always try to go to lunch together on Friday after clinic, you know, and, and have lunch and not really talk about work, but talk about other things. Talk about. You know, someone’s dog or you know, what, whatever it may be. But to have that personal connection between people, uh, and I think that’s really, really important.

And if you, if you like and care for the people that you work with, it really drives that cohesion. It drives that maximizing performance when you’re in the professional situation because you understand the people so much better. So that’s something that we’ve always really tried to do and it’s that social context as well.

We’re all humans and we all need that social contact and that was why the pandemic was so hard because we sort of lost that. And so, you know, it was great now that we’re all sort of back and it’s interesting speaking to people, you know, recently about really liking coming back and sort of being part of the team and being physically with people again.

I think that’s really important. So I think that social. However hard you work and however much the cohesion is in the professional setting. I think the social piece is really, really important to me as well, because it just allows you to get to know people on a completely different level and I think really enhances the culture and the collaboration between individuals.

Naji: Uh, can, can’t agree more, and, and it’s true. Pandemic was hard and at the same time showed us the importance of this human war, right? Like this human connection. Absolutely. So tha thanks for sharing this. Uh, I’d love not to give you a word and get a reaction to it. So the first word is leadership.

Dominic Abrams: So I think, um, when I think of leadership, I like to think of a, of three words that summarize that best in my mind, which is value, belonging, and purpose.

I think you have to value people that you’re with. There’s a great quote. From Ed Cat Capal, who was the CEO of Pixar, who says, Great ideas can and do come from anywhere. And so if you really value the people you work with, recognize that everyone brings something unique, an individual, um, and let them know that really, really value them.

Let them know you value them, and that people are there for a reason. They’ve been chosen to be part of that team for a reason, because they bring something special. You’ve gotta give people purpose. That’s really, really important. If people believe they have a purpose and they understand the purpose individually and as the team, then it really sort of helps drive things forward and people feel motivated and their performance undoubtedly goes up.

Another great quote I love is from Greg Dyke, who was Director General of the BBC at the time, and someone said to me, What, what? What do you see your job as being in charge of the bbc? And he said, very simply, my job is to give people a reason to get up in the morning and come to. So you have to give people purpose.

You have to make them feel that they’re really part of something that they’re helping towards improving that. And for that us, obviously that’s the patient care and people have to need to feel they belong. I mean, that is an incredibly powerful human. Emotion to belong. And I think that’s why I sort of went back to my early experience in London as a junior doctor, that sense of belonging to that firm of belonging to that team.

This was your people. And I think that’s really, really important. And Amy Edmondson’s done some wonderful research on this in. Uh, the medical set set setting, I think it was a big emergency department where people felt when they were in teams, they belonged in their performance. Measurable performance improved significantly.

So that sense of belonging to me is very, very important. And there’s a wonderful book by a guy called Owen Eastwood, uh, called Bonging, um, which I would recommend to anyone to read. It’s a really, really fantastic book, which goes to that in great detail. And of course it goes back. Many hundreds of thousands of years when if you didn’t belong to a tribe and you were on the outside, you were in trouble because whatever was gonna come along and you would do so because you are isolated and on your own.

So I think it’s a really, really important concept. So that’s how I like to think of it in those three words.

Naji: This is, this is great value, purpose, belonging. And you touched on so many important things. You know, when we talk diversity, inclusion, equity, belonging is now a big part of it. And I had the opportunity and pleasure to, uh, host Amy Edmondson where she shares her work on this.

Um, so thanks for that. Uh, the second word is innovation.

Dominic Abrams: I think innovation can, you know, be thought of in so many different ways, but I think sometimes it’s looking at things and just seeing things from a very different perspective sometimes and understanding that although certainly in medicine, we like to think of things. Being causal in a certain way or a certain mechanism, that’s not always the case.

And sometimes you can look at it from a completely different perspective, and that’s why I think that having multiple voices at the table, having multiple people who feel they can give their input. Is fascinating, uh, and really, really helpful to innovating because someone might say something as a bit of a joke or off the cuff and you think, Hang on a minute.

No, that actually is really important. That’s a really useful insight. So to me, innovation is just constantly bringing new ideas, constantly thinking of things in a different way, and driving our understanding of different situations forward. And that can be, you know, innovating from. How the patient gets into clinic to innovating a new therapy for a rare disease.

So it, it’s such a spectrum of different things, um, that it’s, uh, always exciting and it’s always something that’s present in our minds. Um, the, the gentleman who I spoke about earlier, who was the philanthropist who gave us that wonderful donation, that kickstarted everything used to come to meetings. And he would look at me and he’d say, How do you define.

And that was a great question because you can think of it in so many ways, and I think innovation can be thought of in many different ways as well. And it, it, it’s really interesting just to hear different people make different comments, uh, and just throw out different ideas that can, Sunny, yes, we need to think of it like that.

So that’s how I think of it. What about health equity?

I think we need to provide. Equal healthcare opportunities across the spectrum of human race, of human culture, all different ways that all, all the ways that we as human beings are different from each other. And I think it’s really important to understand what different things mean to different people and not just to draw.

The sort of traditional healthcare models of looking at one specific race, or one specific culture, or one specific, um, tree, if you like. A great example of that is the genetic. Makeup of, of us as human beings, what can be very relevant in one, um, ethnicity in terms of may cause a disease or a different disorder may be very, very different in another.

So that’s a sort of just a very simple example of thinking about how we need to understand everyone to provide the best treatment. And I think things are really improving now in terms of changing, um, how we think about things, not just perhaps from a medical and a genetic perspective, but also. What do these people actually really want?

What’s important to them? What are the meaningful outcomes to this group of individuals? Cause it may be very different to someone else. So I think it’s, it’s really important to understand what is important to our patients. What, what do they care about and what’s meaningful to them.

Naji: The last word is spread love in organizations

Dominic Abrams: Be. To be kind. It’s really two very simple words that can be thought of in so many different ways, but I think when you witness it, it’s so evident and it makes such a difference to people’s day. You know, it’s, it’s, um, really impactful and powerful in both ways when you are kind. It’s very empowering.

It’s very positive. It’s inspiring and uplifting, and. People are unkind. It has the opposite effect. So I think it’s really, um, that is a good way just to think about how to do it. Be kind.

Naji: Any final word of wisdom, Dominic for healthcare leaders around the world?

Dominic Abrams: I think,you know, I think it’s, it’s, I. Stress, the importance to me of team, of being part of a team, of being part of that, of understanding how that works and how we work together. It’s a very multifaceted, multidisciplinary specialty medicine, and you need all those different people at the table. You need different people bringing different ideas of interacting with patients and families in different ways.

Um, because. That ultimately is how you maximize their experience, how you improve their outcomes, uh, from doing in many, many different ways. So I think anyone who’s starting up and, and I think that’s a great way to think about things, is be part of a team. Understand that team, understand your own perspectives, what you are trying to do, and how that team comes together.

And then it’s about building that team and moving forward. But I think it’s a really. Important and key components of healthcare, uh, the people you work with and how you function as a group. And that’s been shown in many, many different situations. And I think it’s gonna get more and more important as we think about how we can improve both the experience and the outcomes of the patients that we serve.

Naji: Well, thank you so much for those, uh, great final words and for all this incredible chat we had together today. Thanks Dominic for being with me.

Dominic Abrams: Thank you. It’s been fantastic. Thank you very much!

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Lisa Matar

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji, your host for this podcast, having the pleasure to be joined today by Lisa Matar, a global life science senior executive with more than 25 years of experience leading organizations and driving significant impact across the globe. Lisa served as President and General Manager of Eli Lilly Canada for several years and was member of the North American Executive Committee. She served on the Board of Directors of Innovative Medicines Canada and chaired the ethics and compliance committee. Lisa currently serves on the boards of directors of Delphi Diagnostics and chares the Compensation and Governance Committee for them. She also serves on the BOD of Starpax Biopharma. Lisa earned her doctorate in pharmacy from University of St. Joseph in Lebanon. And I met Lisa a long time ago in France and she has definitely been an inspiration to me in so many different ways. Lisa, it’s so great to have you with me.

Lisa Matar: I’m really happy to be here with you today and, uh, I just wanna say like, congratulations on all the progress you made, uh, kind of from this mission of spreading love and compassion in organization. What you have done so far is simply amazing.

Naji: That means a lot. I would first love to hear your personal story from Lebanon to France to Canada and what healthcare, all that you’ve done in, uh, in this field too.Uh, what an, an incredibly inspiring career. I’d love to hear, uh, what’s in between the lines of this great career you had?

Lisa Matar: So I think we’re all shaped by our own experiences. Um, so I was born and raised in Lebanon. Um, and I spent most of my formative years, like in a war zone, uh, in bomb shelters. I’m sure you can relate to that.

Uh, naji uh, data has definitely shaped my identity. It has shaped me as a leader. It has shaped me as a, as a person. Um, and it made me no stranger to hardships. So during those. Very difficult times. Like we had really to work hard every day, not only to stay safe, but we had to work hard every day to bring a sense of like normalcy into our life.

So the word that I would use is determination. Um, it has always served me well. Uh, it has always pushed me to bring the best of me to the front. While under pressure, and it has fueled my success both professionally and and personally. So I’m, I had graduated from, uh, University of, uh, San Joseph, like pharma school, and after I, uh, graduated, I immediately joined Eli Lilly in Lebanon.

I was so lucky because I joined in a time where the whole, uh, regional hub, uh, was getting formed. So, I can say it was love at first sight. I immediately felt in love with Lilly, uh, with the people mainly and the culture. Second, I would say, uh, and I was so lucky early on in my career, uh, that I’ve met great mentors who really, really helped me, uh, not only in guiding me and coaching me, but I do believe that they saw a potential in me that I was unable to see.

And they took a bet by sending me as like, Talent from the Middle East to go on international assignments. So this is how I ended up after being area manager in Lebanon, I ended up in France, uh, on international assignment, uh, on the best adventure ever, which is launching Cialis. Uh, we both work on that product and my career took off from there.

Um, I wish I can tell you to be honest when I think about it, that I had a very clear outlined plan about how to grow my career. It wasn’t that at all. It was total freeze time. I simply kept saying yes to every job offer. Uh, and I ended up being, uh, Chief Medical Marketing Officer, business Unit, uh, like all different jobs.

That all prepared me to my last assignment with Lily. General manager, uh, of Lidian Canada. Um, like when I think about my whole career, like I moved a lot, changed therapeutical areas, changed geographies, but they are like, the whole career has been set on two major principles. One which is challenging the system, and second is challenging, uh, my own.

Uh, challenging the system. Um, I don’t know. Like I feel like I was not, the system was not set up for me to be successful. Uh, I should not get where I am today. I was a young female leader in the Middle East, uh, in a male dominated culture. So I didn’t have like a female role model to look up to. I didn’t have a modu operandi about how at the age of 23 you can manage a large team, a very seasoned sales rep, mainly male sales rep.

But I had to carve my own way. And later on, like years later, you would think that the system would have been probably more ready for like female ceo. When I became, uh, uh, CEO of Lillian Canada and I was elected to the board of, uh, in Medicine of Canada, uh, which is the industry association, I remember walking into the meeting and I just opened the door and I had like a view of probably like 20 male all in dark.

Like I used to call them, like the man in Black. And I was the, the only female CEO walking into this room. And I remember that I was, I kept saying to myself, You deserve to be here. You deserve to be here. Like all the way to this meeting room and. In reality, like when you condition yourself that you deserve to be in this room, that you have earned your right to be at the table, uh, you develop a confidence that other people will pick up on, and then it’ll give you all the legitimacy.

Fast forwarding, we, they have been incredible, the same men and black, they have been incredible, uh, uh, like war compan. Some of them, I kept them as great friends, and when I left the Boards of Innovative Medicine, Canada had 30% of female representation, which is an achievement. The second point is challenging my limits.

Um, I think we all have to work on a daily basis to challenge ourself. Like it’s easy to stay in a comfort zone, to be honest. I was just telling you like now I don’t know why I was, I, I had a little bit like of a nod in my stomach. Even on, on, on this podcast, like every time you try to do something new, like you have a kind of like a fear, which is really good.

Like it has always been my. And I have always said, I’d rather challenge my limits instead of limiting my challenges. And this is why, um, in my whole career, I don’t remember one position that I was comfortable with. By the time I was getting comfortable, it was time to move. And even now when, like after 25 years with Lily, uh, I was getting comfortable and I said, Yeah, it’s time for me to do something new.

And I took a leap and the unknown word of startup, which wasn’t easy by the way, it’s been 18 months. Um, it’s um, a lot of work every day, but I’m enjoying every minute.

Naji: Oh, thanks so much gi for sharing. Like, how can’t we be inspired by all that you shared and all that you’ve been doing and what you said.

Uh, you know, I, I really want to talk about a thing that you brought that made me think about this imposter thoughts that we might have. Um, and you’ve been vulnerable sharing those moments with us. Uh, here. So you said you deserve to be here. You deserve to be here. You kept saying it to yourself, and obviously you’ve been, definitely, the system is not helping even though we made improvements and you should be proud of what you’ve done having 30% female.

There’s still such a long road, uh, for us, and you touch on many different identities, right? Women, Middle East, going from other countries, et cetera. So my question to you, like, how do you. Do you have those imposer thoughts? How do you fight them? I frequently talk with people. I do have them, so I frequently talk with people who, uh, constantly have those i’d.

I’d love to know how do you live with them if you have them, and if you have any tips for us.

Lisa Matar: Like for me, like I said, we all have them. Like you all challenge. It doesn’t have to be only female only. Like you always question whether you’ve earned the right uh, to, to be at, at this spot. For me, it’s okay. I think we have to be okay with that, say, but don’t stay there for so long.

Um, it’s not about whether you have this imposter syndrome, it’s more about the image you portray. If I walk in and I feel like I’m extremely confident, That’s gonna be very communicative. It’s very contagious. People will see in you what you let them see. If you believe that you have an added value, if you work and demonstrating the value, that’s it.

That’s gonna be the end of imposter syndrome. But if you stay in the fear, Oh my God. I’m Lebanese. I’m a female. I don’t know how I’m gonna do it. If you stay in the why this is happening to me, and you stay into this self-doubt and victimization. This is like a negative place to be. If you very quickly move on to what’s next, What do I need to do for them to see my real value?

You’re already in the focus. You’re already in the projection. You’re already in the hope, and you convey the confidence that you need to convey for people to see exactly who you.

Naji: I love it. Use it practically. Use it for you to be even more confident and move forward. You, you let teams in so many different cultures, uh, we had those discussions between leading and, and Lebanon, France, Canada, and globally also, uh, teams.

Any, what, what are your key leadership learning, the leading in those different parts of the word?

Lisa Matar: Um, there is some tweaks from a culture to culture. But I have found, um, that people are the same. We are all the same, regardless from where we come. You may tweak the how you deliver the message, but at the end of the day, uh, human beings are very complex, uh, and they’re still different.

So it’s hard to say, This is the way you need to manage people in Lebanon. This is the way you need to manage Europe. Uh, this is said. There are some trends that you can see, like when. When I moved to Europe, I was so impressed by the technicality of people, like people really had in depth expertise. Um, and then I moved to Canada.

The culture of, Yeah, I wanna take on more, like give me more, and the, the, the whole loyalty to the company. So you, you can see some trends and the culture, but the leadership, I would say, style remain the same. What I struggled more with is when I got to Canada, it’s more about the title. Like, um, on my first week people were coming to me.

Okay, now you’re the GM of Canada. Uh, it’s a very big job. Watch out. Uh, like you have to get a certain posture of, of leader, uh, like the podium one, which is, which is okay. Uh, somehow they were encouraging me to be like, Touch kind of like the, the, to convey the image of strong leader. I didn’t know better at that time.

And for the first probably like 30 days, I was trying to be someone that I was not naturally, like I was kind of keeping my distance, uh, trying to give all the answer, like I know what’s going on, give the impression like, you mastered everything. But very, very quickly it drained me. Uh, I was so tired, that wasn’t me.

And I said, You know what? I’m gonna give it my try. I’m gonna be my. Uh, and, and see where it’s gonna take me. And the style, like leadership style that best worked for me across geographies is the authentic, imperfect leadership style. I am authentic and I’m far from being perfect. Uh, I know my shortcomings.

I know my flaws. I’m okay with my flaws. I am aware of those. I work on them. But I like, I, I feel like if people know that you’re authentic, they can. Accept your flaws, but they will never accept a phony leader. And that has always served me well. I believe authenticity, um, with imperfection, uh, kept me grounded, especially when you be, you get to a bigger job, like you can get fall victim of your own ego.

But acknowledging that my leadership studies far from being imperfect and being upfront and vocal about it, kept my ego in. Everyone knew, like I had some area was I was not really good at. And I kind of like pushed myself to, um, surround myself by people who are better than me in some areas. And, uh, the beauty of it, uh, people start coming to me with their own imperfection.

I didn’t have to dig a lot, dig deeper to know where I can. It was like an invitation. If my leader is not perfect, I can bring my true self to work so we can work on a better development plan. So it was a win-win. I spent less energy pretending to be someone else, and, uh, people felt much more comfortable, uh, talking to me, so I became more accessible and the conversation was very genuine.

Naji: I love it. I already heard, heard this before, authentic imperfect leadership style. It’s, it doesn’t t No, I . It’s yours. It’s yours. And I love it. Uh, a very personal question I have, you know, as, as you were talking about all those different countries, for full disclosure, I ask myself this question, I don’t have an answer, but I, I what, how so you always led in a different language than.

Own language. And you led in French, you led in English. Any, do you feel it’s different or is it harder, easier to do? So did you have to adapt some things? What, what are your thoughts about this? Um,

Lisa Matar: like, again, like if you’re not trying to be perfect, It’s okay. Like I’m not trying to speak with a perfect French accent or a perfect English accent cuz I’m not like, I’m Lebanese.

I speak like three languages. So that’s the beauty of it. If you accept it, you’re not, again, you, no one’s supposed, um, to see like the perfect leader. Then it’s, it’s, it’s fun. Uh, most of the people like I work with, they said because of the language and the accent, like we pay attention more to what you say.

And I always like, I all abused this to be honest, . Uh, so it’s fun. It’s part of your identity. Like if you see someone struggling in English, Goodest. To him, that means like he has another, um, he masters another language. So it’s all about accepting, being vulnerable and accepting to try and learn new things.

And this is exactly what we should like role model.

Naji: Uh, you, you mentored and coached so many people. Um, I was one of them. I still remember very well what you told me, uh, the first time we met. Uh, I, I, I won’t repeat it here, , but I would love to hear what’s, uh, the one advice that you’re giving today for, um, people you’re mentoring if they’re starting their careers in the healthcare sector.

Lisa Matar: First, like it’s not something that I say. I always check that they are in healthcare for the right reason. Like some people come to healthcare for. The money or they come to healthcare for, because they have a friends for people. But I always check that they are staying in healthcare for the right reason.

So my my first question is like, why you’re here. If your individual mission does not match with the company, you can do some tweaking. You can make some adjustment. Honestly, it’ll be a waste of time for them because they will do much better somewhere else. So I always like spend my first session if I wanna talk, like, why, why healthcare?

Why Lilly, why, uh, this startup? Like, that’s very, very important for me. Once you manage to get there, it’s very easy for, for, for them to say, Okay, how you can contribute? What’s the role that you wanna play? And like, and we’re not perfect again. Do you need to get from where you are to where you should be, But it’s all under the overarching umbrella that we are here to serve.

We all have a role to play. So what’s standing in the way of you doing a better role? I always take it from the mission and I will drag it from there,

starting

Naji: with with the purpose. Uh, I will give you a word now and I love your reaction to it. All right? Sure. . So the first one is leadership.

Lisa Matar: Uh, leadership. Like we were talking about it. For me, leadership is work in progress. Um, it’s not a sprint, it’s a marathon. And we leaders, we benefit from every mistake we make, every challenge we overcome.

Um, like I said, my style is totally about the imperfect, imperfect, genuine, uh, leadership. Um, and I really like hate the image that we draw about the leader who is completely like in total mastery. I don’t relate to that and I fight every day to bring this kind of like authenticity to the, to the leadership style.

What about resilience? Uh, hard not to talk about resilience. Um, especially from where we come both. We come, uh, I always, um, believe that succeeding is easy. If succeeding is the only option that you. Working hard is easy if working hard is the only option that you have. Look, when you always put your alternatives and you pick one, whatever path you choose, you put the resilience behind it because that’s the only option that you have.

And for us, like coming from, um, from Lebanon and having to go like on international career, definitely we had a lot of adversity, um, in, in our personal life and in our professional life. And I’m a great believer that adversity shapes identity, but because of the resilience, um, I’m not saying that a life with privilege is not fun, but I always say that people who lived with adversity, they appreciate life more than people.

Resilience. This is where I get there is a pride into it. I overcame all the obstacles and any resilience story is an excellent story to tell to your children.

Naji: Have you thought? So I’m, I’m going out of the, Yeah. The one word, but I wanna double click on this, uh, piece, resilience. And you shared in the beginning your, your childhood and bomb shelters. Um, have you reflected back on this and what it brought you or how it shaped you as a leader? So, I’m hearing a lot around, uh, resilience.

Great. Uh, having the only option is when is practically succeeding. Uh, anything else from, from those days that kind of you feel really shaped who you are as a leader when you are managing your teams?

Lisa Matar: Like I said, it’s the joy. Um, again, like when you have worked hard and you’ve been resilient, you start to appreciate things even more than when things come to you easily.

So I will add to everything that you spoke about, resilience, which is like you’re passionate about something, you focus about winning. You put all the efforts, the severance and the grid and the determination, but you take out of this bigger. There is a lot of pride of, of pride when you reach some something that was like, the past was not easy and now probably like more on, on, on this side of my career where I’m more enjoying this and said, Okay, look, from where I start, like 25 years ago.

Like this is, this is from where I come and look for everything that I have achieved. And I keep telling this story to my kids, to my boys. They’re no longer kids and they keep saying, Okay, mom, we got it. We got it, . But it’s something that you keep reminding yourself like it’s amazing. Like there’s a feeling of accomplishment that like no one can take it away.

Oh,

Naji: for sure. And yeah, you should, you should feel proud. And along the way, you impacted so many lives, whether by coaching them or helping them out with the, with the different drugs you, you managed to put on markets. Uh, what about diversity?

Lisa Matar: Um, like diversity by itself means nothing. It’s diversity, it’s equity, and it’s inclusion.

Like you need the three words for this to make sense and for you to reap the benefit of, of it. But I’m gonna try to be like, probably a little bit creative and, and this, uh, question with a small story. So, um, stay with. There once was a time in, not like a distant path, where penguins, they were ruling like a large lens in the sea of organization.

You know the story or not. Okay. I, I do not. So they were doing extremely well. The penguins were extremely, like, very successful until a point where they were struggling with one problem. They did everything they can. They brought their top talents, but they were unable to solve the problem. So they said, Oh, you know what?

We’re gonna leave the land of penguins and we’re gonna go and seek. Talents somewhere else. And this is where they had met Perry the peacock said, Oh my God, impressive. He is so charismatic, so fun. Um, he’s so loud. His feathers are so colorful, and they had to do the whole penguin dance for him to, for him to accept, to join them.

He finally accepted flattered by their offer and start working in the Land of Penguins. At the beginning, everyone was happy. They were all self congratulating themselves, saying, Oh my God, we have the best recruit, but very, very, very quickly as time passes. Um, the penguin started kind of like complaining about how loud Perry the pickup was that his colors were so bright, like it’s really like annoying that he is so creative, which is very much distracting them from doing their daily job.

So the top managements in the penguin called on for. Very, and said, We acknowledge that you are brilliant, that you have penguin potential, but we believe that you can benefit more if you, um, speak, like, turn the volume a little bit down, um, maybe you can go on wearing those distinctive suit like black and white and it’ll not even hurt if you start walking like a.

At the end of the day, to cut the long story short, bury the peacock. Said Thank you so much. Left the land of penguins and went to see his future and other lands. The land of opportunities. I always like tell this story because this is all about diversity and and inclusion. You can bring. Uh, people like you can have a diverse team, but if you do not create an environment of inclusion, you will not get the benefit of diversity.

And this story in particular make me like laugh and makes me sad because I have been the penguin so many times in my career where you go out, you try to bring people creativity, and then you stifle them by asking them to be conform to what we. So that’s my short answer to diversity, equity, and inclusion, ,

Naji: and it’s such a powerful example in how you ended it.

Yeah. The last one is spread love and organizations.

Lisa Matar: Okay, so we’re gonna be very honest here. When I first saw the Spread love in organizations, something didn’t sit well with me. I said like, Oh, Naji, what’s wrong with you? Like, why love? Like, no one’s gonna take you seriously. Um, I still struggle with the word love.

I think it’s very, very bold, but I have to give you the, the like put is to you because it has the merit of thought provoking. I am much more comfortable with a world like, Spread care in the organization. But put this aside, uh, the concept is phenomenal. Like seriously, it’s, it’s not only, I would say, um, um, moral imperative.

I do believe like morally we have to care and love each others. But I do believe in the bi it’s business imperative cuz if I care, I take care of my team, They. care of their customers, and then we will all benefit. But at the same time, I feel in my own experience, if people know that you care, they, they, they allow themself, like the masks are down and they allow themself to be like completely to bring their true self to work.

Um, I was reading two days ago, um, about. Experimentation that took place in some universities. To be honest, I don’t know which university, so apologies for that. Where a professor asked, uh, his students to inflate balloons and put their name into the balloons. Very, very simple task. And then he took all the balloons and then, uh, put them in the hallway way, mixed the balloons, and asked the students like, You have five minutes.

Find your own balloon. The balloon with your own name. Of course after, after hectic search, no one was able to find within five minutes their own balloon. And then he said, Okay, let’s change tactic. Um, now pick a balloon and give it to the person whose name isn’t. Of course, like within less than two minutes, everyone had their own balloon.

And I do believe that um, success in organization is very much like balloons. If we are all looking for hours, we will never find it. But if you really care and. Those, you will find yours as well.

Naji: What a great reaction to this, to this word. Yeah. And it is thought provoking as you said, and I totally believe that it’s, um, it’s, as you said, morally important, but also for business.

It’s, it’s key. Yeah. Any final word of wisdom visa for healthcare leaders around the world?

Lisa Matar: Um, it’s not, uh, words of wisdom. Um, it’s probably like a, uh, Like a call for all leaders, which is, um, the pay it forward. Uh, I don’t believe like any leader is where he is today. If it wasn’t because of the help of some individual or individuals who ha like gave him a hand along the way and pulled him up, uh, the ladder of success.

Um, I believe we should do more. Uh, we should be deliberate about paying it forward, whether through like coaching, whether mentoring or side conversations like pick whatever works for you, but we have really to do it. Um, if you’re only like leader with grit, you will run a successful business. But if you are a leader paying it forward, you will def definitely create a better legacy.

Naji: Thank you so much Lisa for this incredible chat and for being with me today. And also, again, I need to recognize the amazing inspiration you’ve been throughout my career. Thank you.

Lisa Matar: Oh my God, it was really my pleasure. Always, uh, a pleasure talking to you and, uh, to be honest, um, great job, what you’re doing.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Bogdana Coudsy

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji joined by Dr. Bogdana Coudsy, vice president, head of global medical franchise for vaccines, specifically at Sanofi Pasteur a medical director, uh, medical doctor by training and pharmaceutical marketing, uh, by trade.Bogdana has an impressive resume and career. She’s held consequential leadership roles across the globe at Johnson and Johnson, Procter and Gamble. And now leading the medical teams of influenza franchise for AOF pasta as a leader and expert in vaccine and immunology, she makes a daily population level impact on public health on the front. And, I can go on and on presenting and talking about Bogdana but I’m eager to hear it all from her. So I’ll stop here and Bogdana, please let me welcome you. Thank you so much for being with me today.

Bogdana Coudsy: Thank you, Naji. It’s a, it’s a real pleasure being with you and, uh, being able to add my voice to your collection of inspiring leaders.

Naji: Great. And let’s start with your story with your personal story. to, uh, to hear all that you will give us. I, I always like to start with amazing leaders like you by if you can tell us a little bit what’s in between the line of your impressive resume of your career, uh, who you are as, as a person, and what brought you to where you are today.

Bogdana Coudsy: Oh, thank you so much. Yeah. Yeah. What, what I can say, uh, I would say just that I’m, uh, a normal person, a person with, uh, a purpose in life that is not different from what other people are having. Um, I think I always wanted to make the difference to bring my contribution to, for a great purpose to impact positively the, the life of people around me.

So maybe. Maybe I build this in a different way than other people, because I started, uh, with a profession looking to help patients one at the time. Um, but finally, yeah, it felt maybe it was not enough. So. I did not follow my initial scenario and I wanted something different, um, a job that was giving me the possibility to contribute, not a patient at the time, but a group of patients and even population.

And, um, so entering in the pharma industry was an evidence for me. And, uh, I started my career having a vision, um, this vision and, uh, an ambition, but not really a plan because I, I was not knowing exactly where this path, uh, will bring me. So as many people, I, I build a career step by step, following this purpose, following the opportunity, um, to grow and, uh, to learn, uh, in my career.

And, um, yeah, I worked in, in big companies in different roles, uh, that each of them brought me a lot of learning opportunities, satisfactions, but especially, I would say true encounters with people that, uh, counted for me and are, and still count for me. And I would say that, um, finally my leadership journey was very much in influenced by the people I met and, um, It’s really something, uh, that I consider as luck.

Uh, I had, I had a lot of luck to, to meet great leaders, um, amazing people that, uh, inspired and that motivated me. And I, I, yeah, I can say that. Um, I follow their path, uh, uh, while trying to build mine and, um, to learn, to manage and to become a leader, uh, myself. Um, and again, the fact that, uh, I had opportunities in the career, uh, and I was building on, on this, I, I think was the, the key success factor here.

Um, I had opportunity to manage people, um, and I. Discover that I like that very much. Um, I like developing, uh, young talent and, uh, helping, uh, at their tone to find their past. And this is giving me a lot of satisfaction. And, uh, also a lot of positive energy that I will say is, uh, fueling my tank in order to continue this leadership journey.

Naji: Yeah. With all that you have to do, especially these days running the vaccine franchise for a. Specifically respiratory influenza’s. Yeah. I’m sure you have tons of things to do and inspire people. And what a better way. I, I love how you framed it from one patient at a time to now impacting the population and, and being part of the public health.

Um, how would you, uh, if, if we take this as you’re a purpose driven person and you were. As a physician, helping patients immediately, how are you driving this purpose across your team? Making sure that you’re telling me you were in a meeting with 50, with 5,000 people that before we were together today, how, how do you drive this passion for patients in their day to day jobs?

Where sometimes it’s, it might be child. We, we, this big picture and the no.

Bogdana Coudsy: Yeah, it’s a very, it’s a very, very good question. I, I think that, um, uh, you know, we, we don’t, uh, have to forget that, uh, the companies are made by people and all these people are having a purpose. And very often in the pharma industry, um, the, there are a lot of people with the same purpose that are searching, uh, to impact in a positive way.

The, the life of patients, the life of population, uh, So finally you are building on, on the same, um, common values. And when you are, um, considering the, the different activities, the different clinical trials that we are wishing to build the, the, the different, uh, I would say, ask. Of, uh, a better, uh, care for people that is, uh, at the core of everything we are doing, I would say everything is based, uh, you know, on, on this desire to, uh, to bring, uh, a better health for the people around us.

And, um, I would say it, it, it’s really easy to speak about this with the different colleagues from the different functions, because we are having this, uh, profound, um, belief and, uh, and sense of purpose that we are doing our job for that bringing new S or new vaccines to, to the population that are needing it.

Um, having a way to. Check, I would say also to, to, to do a research, to be sure all the time that, uh, what we are bringing to the markets as pharma, um, industry is really well used. And it’s in favor of the people that are using it. I think it’s at the core of everything we are doing, uh, in, in the different departments.

So, um, I would say it, it’s not difficult to be a, a physician in pharma industry because very often we are speaking the same language, uh, between the, the different departments between the R and D um, uh, with our colleagues from regulatory, et cetera, Pharmac vis, but also the others in marketing, et cetera.

Um, because at the end, we are all, uh, concern about the patient and we want to do what is the best. So I would say from that point of view, I, I, I found my place quite rapidly when

Naji: I and just added beautifully, right? Like sharing, sharing the same, uh, values and then being committed to the same purpose of helping patients live better is, is.

What you’re, how you’re uniting the teams cross-functionally towards it. Um, and , I, I can, but ask you the question with the pandemic. Like you’re in the vaccines. You’re. I imagine you and your team are relentlessly working to take the population and all of us out of this, um, of this pandemic and what’s going on, um, you know, without going into the details of, of what you’re doing, but, but I’d love to have the learning.

What, how you’re driving those teams. Obvious. Obviously the purpose here is even bigger. I it’s palpable. They can feel it live it every day. Uh, with ups and downs, I imagine. Also there is the complexity. I find the vaccines out, the resilience that you have to build as you are building, um, the different programs.

Is there any, you know, major learning that you had working in such a crucial team in a crucial time? I would say for humanity, is there any, any specific fake learning that you have.

Bogdana Coudsy: A lot of learnings, I would say, uh, really, uh, and I, I think that this is, uh, unprecedented era to live in. Uh, and, um, while working in, uh, in vaccines, uh, I would say, uh, as, uh, as a medical professional, you are feeling that you are having double responsibility.

Um, Everybody was feeling frustrated, uh, when this pandemic started and expanded so much. Uh, and, uh, you know, we were frustrated not to find a rapid solution because everybody was thinking that with the level of the techno the technological level that we are having today, it’ll be. Uh, rapidly, uh, possible to find a solution, uh, at least, uh, for several aspects for, and we learn finally that, um, we were not prepared really, uh, to face this kind of situation.

So even in if in, uh, the. Biggest countries you are having, um, organization that are looking to the pandemic prep partners. Um, it was more authority model that the people were taking. And, uh, when this is happening in real life, you understand that it’s so complex. There are several, um, important, very important aspects that you need to master that finally, um, you know, it’s, it’s not, um, possible to have, uh, a very rapid response and I’m.

I’m still very inspired, but what happened in front of this threat? The fact that, um, the big pharma started to create partnerships and alliances with the academia that, um, we, we had, uh, this, uh, really strong, uh, positive dynamic and, uh, energy that was put it in order to together in order to describe the virus rapidly.

To find, uh, solutions, uh, what are the antigens that, uh, will be needed to, to be using the vaccine? A lot of exchanges between the, on the scientific topics between the, the different partners and the, that are, uh, influencing the ecosystem that it’s around all the infectious diseases, uh, including the, the, the Pharmac companies.

And for me, this was a very good sign to, to show that when there is a major threat for the humanity would be. Find the power to go in the same direction to have a convergent, um, of a conversion vision to, to, to go on the same, uh, you know, over the same, uh, the same purpose, whatever, if, uh, you are a physician working in a, in a hospital or if a healthcare professional taking care of this.

People, um, also happy to give feedback and to inform, uh, what work, what didn’t work, uh, as in the beginning or not having any protocol, nobody was knowing how to manage these, these patients. So that was the second frustration. I would say, where as physician, you want to go there, you want to go to hospital and to help people.

And sometimes it’s quite frustrating to say, okay, you have to accept that. Um, There are processes, uh, for the development of new, new drugs, new, new vaccines. And this is taking time, uh, and in the same time to manage this inpatient and this need to do something rapidly to find, to, to be part of the solution for this pandemic.

Yeah. And I would say on, on the other hand, uh, when you are looking to the situation as leader of a team, as, as manager of the team, there is, uh, I would say a certain aspect of all this frustration that it’s it’s arriving is that a. The people are wishing, uh, you know, to continue to produce value, to, to bring their contribution to all this.

Um, but with the social distancing and the fact that we are not really having, uh, um, I would say the reflects to, to work a distance for. Long time, like, uh, like it happened now months and months not to see each other, uh, it’s creating a burden on, um, I would say really the, the wellbeing, the psychological wellbeing of people, because they’re having the frustration they want to do.

A lot of things, very fast to contribute more and the same time to be far away from the others and to have to accept, uh, this kind of engagement to be the others only via telephone or via zoom meetings. So that’s another aspect that I had to manage and I, I was trying to, um, add even more humanity and even, uh, warmer, uh, Words and, and kindness to my team in the exchanges we were having, having also moments where we were speaking person to person, not, um, only about, uh, the job, our activities, but, uh, what we have to do and how to track that.

But also about how you are doing, how your family is doing. Um, let’s have a moment together to, to, to laugh, to take things less seriously, because it’s important all this in order to continue to have this relation and to continue to build on the trust. Yeah. Uh, it,

Naji: it unfortunately took us a terrible.

Pandemic right. To get back to the human side of us at work as human beings. And, and what you’re saying is definitely one of the key pieces for us all as leaders and well, what, what you lived even on the front line as vaccines is, is really great to hear, right? Like the collaboration, how healthcare overall.

Pharma regulators, uh, patients, physicians, we, we tried at least to stand altogether to bring us a solution for humanities. So, yeah. Thank you so much for sharing, um, your experience with this. Uh and you know, one, if, if we talk about this leadership. Uh, spec in, in this specific moment, you talked about kindness.

You talked about how you are building relation virtually with your people, even at an individual, um, basis. Uh, can I imagine for you even more, as you are kind of on the front line of, of the vaccines, the pressure you’re getting, not only internally. Everyone is looking at me like all the companies, the government, uh, I meant, well, Sanofi is a French company.

Like we, we heard how many times even the president was talking about it. So how, how well I’m interested in twofolds first, you personally, as leading this team. How did you manage this? How did you get the energy for yourself? Making sure that you take care of yourself, you take your kind to yourself and then how you manage to get this kindness to your team.

Uh, you know, looking, looking backwards and forward. I don’t think those pressors stopped for you. So we would love to hear this.

Bogdana Coudsy: It’s a very good question. So I would say first of all, um, uh, you know, for me, people are counting very much. So I, as, as I was saying, this sense of purpose, uh, for me is what is driving, uh, driving me in all situation.

And, um, I, I. Care about people. So, uh, when, uh, you know, I, I know very well that, uh, all this, uh, situation, uh, is not, uh, easy to manage. Um, having my teams working in teleworking from home with small children, not having a space for them to, to, to work or, you know, we were, um, looking also from that point of view, how we can support them better.

And for me, You know, it was, um, really the challenge was to mix between my role as manager and my role as leader, because, um, to, to explain a little bit, first of all, as we are having the commitment, uh, a public health commitment to, to deliver what was needed, uh, you know, in terms of vaccines, everything around and the development that.

The, the, the program of development that we are running, it was important at the same time to check that the people can continue to work in an effective way. Uh, so this is a management part to say that you organize the work differently in order to allow to people, to, to, to continue to create value and to, to contribute.

To, uh, these objectives that we are having in terms of vaccine development, uh, clinical studies, communication, et cetera. But in the same time, I was needing also to, um, to balance with my leadership role, giving to people, uh, also, uh, moments, uh, where they were. Able to, to, to share, to, to say, yeah, it’s tough.

It’s a complex situation. Uh, it’s not only about delivering, but, uh, it’s, it’s also about how best to, um, deal to cope with the situation as people in order to, to stay in good healths, uh, in order to. Stay motivated and to, to be able to continue to produce, uh, value for, for our company, because the purpose is so important, as you were saying, the responsibility is so high.

Plus the visibility is so high that you cannot miss your target. You cannot, uh, do your work only at 50% cause it’s having a lot of consequences and you cannot afford that. So. You know, having the balance between these two roles, uh, continuing to, uh, lead people, to inspire them, to show the direction, even if, uh, sometimes was hard.

Uh, we were having, uh, to, to keep the people engaged and motivated, but the same time to recognize, to acknowledge that it’s hard for everybody to, to, to be able to organize their, uh, work life in order to allow a personal life. For me, it was very important. And again, I’m coming back to, uh, people are counting very much.

I, uh, you know, I have a style of management that I, I think it’s based on good sense and a lot on empathy and, um, I’m thinking about, uh, what the, the person in front of me is experiencing and, uh, having, uh, you know, all the time, this in mind, uh, in terms of how we do things and, uh, how we can. Support and have, uh, um, have all the en environment, allowing them to organize themself better, for example, to deliver the work that they were needing, uh, having, um, hours, for example, to let them have lunch, uh, with their families to take care of small kids, et cetera.

So this is not something that in the, I say normal conditions, uh, a leader is putting. You know, as high priority, but for me it was because it’s, it’s, you know, really so important to be able to, to, to keep, uh, our, our teams motivated and in good shape. Psychologically and physically that, uh, it’s, it’s really, you cannot miss that as manager.

It’s really, really important.

Naji: Yeah. And the, the first sentence you said was I care about people. I think this is this it’s really, we feel it as you’re talking, right? Like this balance of leadership management. I know you are also, we, I had the opportunity and chance to work with you, uh, for some time. And it’s you, you, you have it, we feel it, you care for people.

And, and as you said, like, this is how you drove it. And this is obviously what’s getting this balance and the results, uh, in your organization. Right. And keeping you move forward.

Bogdana Coudsy: Absolutely. And I haven’t, I, I have the chance to work in an organization where, you know, uh, this type of leadership and, uh, I would say, um, possibility to, to shape your leadership in a personal, authentic way.

It’s allowed. Because I think that this is important. I, I don’t have a lot of experience of, uh, other industries and, uh, how did this, uh, can happen in, in, in other companies? Um, but, uh, I think that in, in pharma companies, as we are having this. Uh, um, important purpose of, uh, human health and supporting human health.

First, I think also that, that there is, uh, more sensibility in terms of source of senior management to allow to people to bring this kind of management that is really, um, Influence by the humanity, by the empathy and where you are driving, uh, people in a direction that is, you know, really following the, the, the better good, the good of, uh, say the impact, the positive impact on a society and being kind once with the others, especially in periods like this one, for me, it was the only way and working the company that is allowing this was very important.

Because you need the same time to, to feel this support from your management that, uh, you know, it’s not considered that, uh, it’s a weakness, but it’s considered that it’s a strength because you ensure that the, the, the people you’re having in the team, you know, are continuing to live, uh, you know, the life of most normal possible, and to continue to be able to focus also in the work that is, uh, very important.

Naji: Yeah. And that’s a crucial point. And as you said, it’s, it’s a strength, not a weakness. And, and I, I think the fact that you’re saying it spontaneously, because many times we heard around genuine care or, you know, I, I, I call it spread love. Right. Which is really genuinely caring for one another. And being here for one another many times, you would hear, okay, Yeah, this is the soft, soft things, right?

Like it’s not what, what will work, where in fact, what I’m hearing from you and my personal beliefs is this is the core. Of how we make sure that we’re driving our shared purpose, we’re driving our people towards a bigger why, and it will bring amazing results. And, and, and again, you gave this concrete example, uh, a moment of crisis where the word needs you most, the first thing you said, I care about people and I’ve been leading people with genuine care for, for you to be able to deliver as a team on what the word is expecting from you.

Bogdana Coudsy: Yeah, absolutely very important moment. And I, I hope that, uh, after the pandemic will be controlled, we will still, uh, consider this kind of management more and more. And, uh, this kind of leadership allowing to spread it more. Cause unfortunately it’s not, uh, in the majority of the minds of leaders, Uh, there are some people that are, you know, not yet considering that this, this is maybe for me, it’ll be for sure the way in the future, we will be able to, uh, mix generation to work with millennials to, to, to be able to in the same time to work with seniors, because at the end, what we are having in common are our values and our humanity.

Wow. So yeah, from my side, I really, really hope, and I’m very optimistic about this, that there are profound changes in our society, but also in the, the way we are considering the leadership, uh, in, in the future that this will change. And, um, I think this authentic leadership will based on kindness and, um, recognition of the human being needs.

Because for me, that’s a need having, uh, you know, that that kind of approach it’s really important. So I think that this, this will be the future. You tell me if you are having the same vision

Naji: I, I definitely am. And it’s really the core of why this podcast even started and exists. It’s it’s really this, uh, I, I have the vision and I’m, I’m committed like you, uh, as a leader to make sure that we are, we’re changing the way we, we lead people and we manage with humanity and care, as you said, for, for a bigger purpose.

So I, I would love to play a game with you now. Uh, what, yeah, what I will do is saying one or two words, and I want your top of mind, uh, thought that would come. Sounds good.

Bogdana Coudsy: Yes, absolutely.

Naji: Right. So the first word, um, women in leadership,

Bogdana Coudsy: I didn’t catch it. Sorry. Can you repeat? Yes.

Naji: Women, women in leadership.

Bogdana Coudsy: Wow. Women in leadership. Wow. F for me, this have to be M in the future. I think that, uh, it’s something that we need to support, uh, to, to, to have more female leader. This is a lot of articles. A lot of books were written on this topic, but I’m convinced that, uh, this, uh, this is something that, uh, will happen.

And, uh, I I’m a really. Um, support for the young female leaders that I’m having in my team and my organization to help them to arrive these future leaders, to arrive, to become a true leader recognized in the, in the organization. And I think that it’s also part of the responsibility for, uh, professional like me, uh, that, uh, have already, uh, quite a, uh, quite a solid experience behind that is a responsibility to help the.

The future female talents to arrive to leadership positions.

Naji: Totally agree. And yeah, each of us, you know, as, as man leader being sure that we’re advocating for, for women and women in leadership, I don’t have you framed it. Synonyms. What about the word digital? I know you’re passionate about this.

Bogdana Coudsy: Yes, uh, digital for me.

Uh, it’s a chance. Uh, I, I think that, um, it was a real chance for all of us that the, the digital channels of communication were developed already that the internet and this connection was existing, uh, because I can even not imagine what would be a pandemic like this. Without being able to, to connect at all, to have the, uh, you know, the, the, the, all the tools that are need in order to continue to, to interact exchange with people.

Uh, so yeah, it’s a chance we now need to take advantage of the revolution that this pandemic make brought in same time in terms of the. Digitalization the interest of the companies and also the way we are considering the digital channels. Um, I, I think that, um, the progress will arrive. Thanks to the digitalization.

So let’s, let’s look to the future. I’m convinced that, uh, uh, it’s, we will learn a lot from this pandemic period and, uh, we will, we’ll continue to build on this, uh, you know, and I’m looking to the importance that took telemedicine, for example, uh, and, uh, how important, and it was when the people were, uh, in the first.

The wave of, uh, pandemic and, and we were having, uh, lockdowns everywhere, uh, being able to have physician that consulted in, in teleworking and doing, you know, telemedicine was really critical. It was the only way to, to have, um, uh, a medical support, uh, sometimes. So it’s one of the aspects, but there are so many that I don’t I will not take the time to, to go in all this, but I would say is the, the one that for me, I think it was, uh, for people, for some people it was life changing.

Naji: Yeah. Yeah. The, the third word is red queen

Bogdana Coudsy: red queen.

Naji: Yeah, I, I saw something mentioning red queen in your, in your studies, on your, your all on top of all you have, you’re currently you’re currently studying, which is again amazing. So, so I read red queen and I’m intrigued to hear it from you.

Bogdana Coudsy: Yes, it’s, uh, it’s I would say my metaphor of the year.

Uh, in fact, indeed, I’m, I’m, uh, following an executive MBA here in Paris, and I have a very inspiring professor that is called Jeremy gas and, and he. Uh, share with us, uh, this, uh, this metaphor of the red queen from Alice, uh, on, in Wonderland where this, um, Alice was wishing to meet the red queen, but the red queen was moving so fast that, uh, Alice was seeing her on the right and she was running there, but, uh, the queen already, uh, going in another direction in the left.

And when Alice was arriving in the first. Place. She was finding that the queen is already not there, but, uh, she already moved. And for me, this metaphor is really important. Why? Because it’s showing, uh, you know, how important is to adapt to the en environment. The only way for Alice to catch the, the, and to speak to the red queen was to anticipate and to look not what will be, uh, her first, her next direction, her next step.

But the one after. And to be all the time, uh, you know, open to, to listen from the on environment and to understand, to try to interpret, uh, what is happening in order to stay on the top. Because otherwise, if you don’t change, uh, at, at the, the, the right speed, you are staying behind, and this is. For me, uh, really, really showing how is the current period with the pandemic, with the amount of scientific information, for example, that is existing with the, you know, with everything it’s happening.

That it’s really, uh, a metaphor that is showing how important is to adapt, to anticipate and to be in change, to, to, to embrace the change and to try to anticipate, uh, you know, not the next move, but the, the, the one after. And this can be applicable for a lot of things. Yeah. Career science, whatever you want.

Naji: Yeah. I’ll, I’ll definitely remember thread queen, uh, the last, the last word spread love in organizations.

Bogdana Coudsy: Yes.

Um, Maybe in some organization, this is Anno. Um, I, I think that for the moment, um, uh, I would say is, is rare to, to, to speak about love in the organization because, um, Uh, love is more having, uh, a link with a personal life and, uh, where you are opening yourself to say what you love. I love arts. I love theater.

I’m I’m, you know, I’m a, I’m, I’m a person that is affecting emotions and, um, Building on, on all this and having, uh, you know, I would say this soft part on us that is more exposed in personal life, that in, in the organizations, so. I think that for the moment, um, in a lot of organization, it’s not something that you can say that it’s, uh, uh, it’s a concept that is not existing yet, but I would, uh, I would like very much to, to, to support as you are doing today, uh, to have this concept spreading around and, uh, you know, having this soft part in us, Uh, accepting, accepted even at work.

This is the way I’m interpreting it. When we are speaking about this is that to accept and for the leaders and for the employees, that we are all having the soft parts in us, um, you know, that, uh, everything related to our emotions and this, uh, and our in general, the, the sentiments that we are having, and this is part of human beings that we are.

So this have to be. Integrated, uh, with the work in order, not, uh, you know, to deny at work, what is the most beautiful in human being the possibility to have this emotion?

Naji: Yeah. Yeah. Well, we, with, with this, um, you know, I’d love to hear from you what you will be taking. You talked about genuine care. We just shared about how you perceive spread love, which is between genuine care emotions, hearing about the human side of us and, and being us at work.

How, how will you continue as you’re continuing this journey with vaccines and done, still to be done, how would you continue this, uh, in your organizing a stand.

Bogdana Coudsy: Oh, yeah. yes. I, I will say I will, um, especially continue what I started to do, uh, continue to, um, to show to my team, uh, empathy and understanding. Um, I hope that I will be able to find, uh, the words are resonating for them, for the people in order to feel that it’s a real. Um, you know, it’s a real care. I really care what is happening with them.

I really care. And, and I wish to help. Um, when, uh, you know, I, I want to, to bring this message inside is that we are stronger together and it’s not, uh, it’s not a political slogan. It’s something that we have, have to accept and to make it, uh, a strength, um, accepting that we are. Needing to connect the ones with the others to spend time, uh, in, uh, just Chi chatting, just, uh, uh, give a call to a person, even if you are having full of meetings, organize your time to have, uh, you know, also real exchanges about how you are doing genuinely, how it’s, what is happening in your country, where, what is happening in your environment, how you are coping with the lockdowns, you know, having being able to have this kind of mix between a.

Uh, I, I will say, delivering on the work and everything that’s expecting and, and, uh, yeah. Speaking, uh, from human to human about the emotion, about what is difficult to face for me, it’s important. So I hope really, as a leader that I can find the right words in order to give this message to, to, to my teams without being.

Blame and without, um, you know, having the impression that, uh, it’s more politics that, uh, that, uh, that anything. Yeah,

Naji: no, it you’re, you’re authentic and inspiring. Uh, Boga. It comes with authenticity. I think this is the main difference, you know, from yeah. Feeling it’s not genuine. The word it’s not politic.

Uh, you said you talked about leaders who inspire you. Uh, and also a professor who inspired you any specific leader or even a book potentially that you read recently that inspired you during those times and that you would recommend to our audience.

Bogdana Coudsy: Oh, yes. . There are a lot of, uh, there are a lot of, uh, good books and, and, uh, articles about management, about leadership that, uh, inspired me.

So I, I will maybe mention one that I, I really, I think that everybody already, uh, uh, had have this book, but anyway, uh, the is the Armenia Barr’s book, uh, think as a leader act as a leader, Um, for me, you know, this book and even his title be became after I, I, uh, I bought this book I read it. Uh, it become not only my motto, but also my everyday objectives.

Uh, you know, my everyday objective because what I want to, to do and to continue to build, uh, is a leadership that will allow me to, you know, to continue my part. And, uh, uh, have more impact, even more impact that now continue to grow, uh, in my career, continue to grow as a leader and bringing, um, this kind of leadership to be more recognized.

Um, so for me, this, uh, this book, uh, that was, um, yeah, that I, I had the chance to read was, uh, like an eye opener. Um, regarding inspiring people. Yeah. There are a lot now, as I’m, I’m doing this executive MBA, I’m, I’m having also the chance to, to meet very, very interesting personalities and, um, very clever people that are inspiring the others, uh, and the, the, the professor Jeremy guess is one of them.

But I would say at, uh, the last but not least, I, I have, uh, an amazing manager, uh, at work, uh, a woman leader that, um, I think, uh, shape, uh, what I am today because I’m working now with her for more than three years. And, um, I, I think that the fact that she’s trusting me and having the, the same values and the same, uh, giving the same support for this, uh, um, leadership that is an authentic and human, let me arrive at this stage where I consider myself a better leader.

That was three years ago.

Naji: Wow. With this. Do you have any final word of wisdom for the leaders in healthcare around the world?

Bogdana Coudsy: Um, yeah, I, I would say first of all, uh, trust yourself and, uh, in same time, uh, try to find around you, um, uh, role models. For me, it was very helpful, uh, to find role models, people that are inspiring you for this or that reason and learn from these people, uh, and be open to, uh, Taking, what is the, what is good in people?

Everybody is having something good and something you can learn from them, not only from the big inspiring leader, but also from your colleagues from also from your teams. And I have, yeah, I would say the, the, the lack to have, uh, an extraordinary team, uh, that have to live in order to go now on, on, on a new.

But, uh, you know, everything that I, uh, I experience with, uh, with my colleagues, with my team, uh, brought me where I’m here, where I’m now, uh, at, at the level where I found that I was inspired by all this, uh, People and I learn from them and I’m wishing to continue to learn from the other people that I will meet and to continue to inspire and to bring, uh, I would say again, uh, a positive dynamic and my, I would say my contribution.

For, for a better society, a better health. Uh, and, uh, yeah, this is what I would say to the young manager, trust yourself. And, uh, don’t forget to be authentic, to be the real you to be in line with your values, because it’s the only way this can function.

Naji: Thank you so much Bogdana again for being with me today, finding the time between studies work during a pandemic where your teams are relentlessly working to help us get out of it, uh, and, and sharing your story for, for us all, to continue leading with genuine care, with love for a better healthcare, around the world.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Bob Jones

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji, your host for this episode joined today by Bob Jones, serial healthcare industry, entrepreneur. Bob is founder and currently CEO of scientific nutrition products, a company addressing medical conditions by creating and selling nutrition based products. Bob was previously a principal at CIA advisors, a strategy consulting firm, where Bob led the nutrition and wellness practice. Prior to that, Bob was president and CEO of Viso USA.The nation’s largest marketer and manufacturer of tofu and the pioneer of soy milk in America, where he let successful turnaround before joining, uh, Bob launched three startups in the medical nutrition field, each company addressed chronic medical disorders, such as diabetes via specifically targeted nutrition products, all selling through retail pharmacy. Bob has also held executive positions at several other companies, including Abbot and Baxter. He has two awarded patents in the feed of nutrition. He’s an active mentor with MIT and several other organizations where I had the opportunity to learn from his wealth of experiences. He is also an incredible guitar player and part of a volunteer group that plays and sings in homeless shelters.

Bob, I am humble to have you with me today.

Bob Jones: Well, I’m flattered to be invited. Thanks for having me.

Naji: First I would love to hear your personal story from biology to serial entrepreneurship in, uh, in healthcare and nutrition. What’s in between the lines of this incredible journey.

Bob Jones:: Uh, it’s a long and winding road Naji.

Um, When I was studying biology and doing a research thesis in neuroendocrinology really what I cared about was behavior. I was trying to reconcile what the psychology professors were discussing with what the neurophysiology professors were. And of course that. That quest continues. Uh, but what I cared about was behavior and through an odd set of circumstances, my first job out of college was four years, uh, teaching school in the projects in west Philadelphia.

And. I walked in thinking, well, really what these kids need. They just need a friend, which of course was the height of naivete because that flatly didn’t work. Um, and I was required to dig a little deeper and. I would walk in and say, well, good morning kids today. We’re gonna learn how to find the area of a square.

And they would look me in the eye and say why we don’t care. And I had never thought about that. And, um, anyway, I had to dig a little deeper because I knew the material that I was being charged with teaching would make their lives better, but I had to sell it. I had to create the motivation because if they wanted to learn it badly enough, then even if my pedagogy, uh, was clumsy, they’d get it.

Anyway, on the other hand, even if I offered elegant explanations of stuff, they didn’t care about it was not gonna go anywhere. So, um, I. Had sort of a, a crisis rethought. All of this regrouped had at it just refused to quit. And, uh, discovered that I started having some real successes with these kids. They began accomplishing things.

You could see their self self-esteem go up. They moved up within this school hierarchies. Some of them got out of the gangs that they were in and actually ended up going off to college. Um, it was quite rewarding. but I left after a while, took a few more jobs and went to business school and, uh, was exposed to a completely different ethos.

We all were sort of told that we. Spring out into the world to become, uh, corporate leaders. And at that time, when I heard the word entrepreneur, I thought it was a French word. And I thought that it was a French word that meant unemployed and so, so I pursued the sort of traditional corporate, you know, command and control and all of that and discovered that.

It just, wasn’t a good fit for me. I didn’t enjoy it. I didn’t feel like I was having any kind impact that I wanted. I felt that the agendas were. Off access from, from my value structure. And so I began starting companies because I didn’t know what else to do. And so I ended up starting four companies in total with the docs out of Harvard med school.

I, I turned around a company that had lost money for a lot of years. I worked hard. I had some failures, I had a couple successes. It was much more fun, but then, um, Within a fairly short period of time. Two members of my family died and several of my friends died and all of them were younger than me. And I think we’re not well wired to lose people who are younger than we are.

And it brought home to me that one day the lights go out and I ended up thinking, I just don’t wanna waste any more of my time doing things that I don’t wanna. And it’s time to stop and think a little bit about, well, what do I want to do? And what I’ve found is that if I can help other people realize their dreams, that I find that quite gratifying.

And so I have ended up working rather. In the last few years, um, as a member of business advisory boards as a, a lecturer or workshop leader in various organizations that are associated with helping entrepreneurs, um, achieve their goals.

Naji: Thank you Bob, for, for sharing your story and, and your perspective, uh, also on, on life, I would say you, you founded startups, you started companies, you worked in, uh, the corporate world, uh, to, and now you’re advising so many different, uh, companies at different stages. What are your leadership lessons for, from really those diverse experiences you.

Bob Jones:: Well, I thought about your organization a little bit. NA and, um, and I think there’s a lot of merit in what you’re doing, but I may have a, a slightly different perhaps somewhat more constrained view of. Love Vivi, helping people realize their dreams. And, and that I found that sometimes the best way to show love is to tell people things that they don’t necessarily want to hear, but get ’em back on track.

And as an example of I’ve spent some time working with an excellent group called pipeline entrepreneurs that helps high growth entrepreneurs in the Midwest. And, uh, I lead a two and a half day workshop every February for the incoming group and a year or two ago at the end of the three days, couple of came up to me and said, Bob, Over the course of the past couple of days, you beat up every single one of us in this group.

And I said, yes. And they said, well, thank you. because our employees not always tell us the, the candid truth. They’re not always. Sagacious enough to know what they should tell us. They’re not always brave enough to tell us stuff we don’t want to hear. Um, but the net is, I think you transformed our businesses.

So in a potentially perverse sort of way, I was showing them love. And I was showing them a respect by helping them accelerate their path toward. The, the goals that really mattered to them. So I, I guess if, if there were a lesson in there, um, it would be candor if I were to summarize it in one word, and sometimes it’s not showing love to gloss over the gross mistakes that you see people making.

Sometimes you just have to tell ’em even if you think they, um, don’t want to hear it. But I also find that just spreading love universally is, is potentially a recipe for disaster because I’ve found that sometimes there are people in organizations who just don’t contribute. And if that’s because there are hurdles and I can remove the hurdles, then it’s a good thing.

If it’s because they’ve lost their motivation and I can help them find their motivation or help create some motivation. That’s a good thing. But I have run into people who just don’t wanna work. And I run into people who embezzle corporate funds. And, uh, and they have to go because on a professional basis, it would be a violation of showing love to those people in the organization who are motivated to create value.

If I put up with that kind of behavior beyond a certain point, and there have been times when I’ve. I have pulled aside the people after I fired them and said, look on a personal basis. I think you have a lot going for you. I think you could be very successful. I think you have a personality characteristic.

That’s a lot like having a pebble in your shoe. It may strike you as a small thing, but you’re never gonna sprint with a pebble in your shoot. You’ve got to address this and I don’t have the time to wait while you address it for us. And I haven’t seen any real commitment from you that you will address it.

So I have to fire you and I’m going to, but personally, I think if you could get this pebble out of your shoe, you could be a real runner. So, so as I said, I have to a constrained, maybe bounded view of.

Naji: Can I can I say I love it because it’s, , it’s not a thank you. It’s it’s not portrayed and it’s not bounded.

It’s, you know, it’s what I, when I think of love, this is true love. Right? You talked about candor, you, and this is when genuinely you care about someone. You need to tell them when things are going wrong. I, I don’t think people show up and wanna do it back job. And it’s our responsibility as leader. If we care.

To tell them that it’s going wrong and to, to, yeah. To help people go out of an organization, if it’s not where they’re getting at, where they’re being at their best. So you, you really touched upon two things that many times when we hear the word love, we think it’s. You know, like just love and it’s never those true discussions and those crucial conversations or taking some decisions sometimes on people.

It’s exactly this when it’s read off. So thank you for mentioning those. Um, yeah. I love how you framed it.

Bob Jones:: Well, you’re welcome. Um, as a, as a footnote, uh, you, uh, as a healthcare professional and I, as a healthcare entrepreneur know that though, this fact is tragic. There are people out there who simply have no interest in taking care of themselves, and you can do Mo motivational interviewing and you can salvage some of them.

But there are some that you simply can’t salvage. I’ve talked to many, a visiting nurse. Who’s told me terrible stories about calling on people who are stuck in a wheelchair with diabetes, with the oxygen in their nostrils. And they’re still smoking cigarettes. And of course, oxygen likes flame. And sometimes they blow the top of, of the building.

They live in. And so I had to conclude that I might have a lot of love, but I don’t have a limitless amount of love and that I should, I should love the people who have some interest in growing and living a fulfilled life.

Naji: That’s that’s awesome.

Bob Jones:: Call it conservation of resources. yeah.

Naji: Yeah. Limited amount of time and resources and, and yeah, it’s, there’s always this challenge, like.

Where you put your time and resources and love for people who generally care and what I would love to, uh, what would be your advices as a, now a serial founders and advising so many entrepreneurs. If we wanna boil it down to one or two advisors for those, uh, founders in the healthcare word, specifically, as you know about it, uh, in what.

Bob Jones:: Make sure that the need you have identified is genuinely unmet rather than you just being seduced by a really cool idea. Make sure that what you are offering is something that your clients or customers will think is better. Not that you will think is better, but that they will think is better. Make sure you’ve figured out a way to do this so that you can actually make enough money to continue sustaining your company.

Otherwise you don’t have a business. You have a really cool hobby or maybe a philanthropy. But, and, and for those who are interested in social entrepreneurship, I think the bar is even higher because if you wanna give away a pair of shoes for every pair of shoes you sell, you’ve got a lot of make a lot of money on the shoes that you sell in order to fund the ones that you give away.

And so your initial, no motivations might be noble. But they will founder and flop if you’re unable to make enough money to keep the lights on. So, um, look for that combination of creativity, maybe noble intentions and a practical, pragmatic view of, of how you’re actually gonna grow a business.

Naji: That’s great.

Noble and practical. I’ve I’ve heard about this word of pragmatic idealistic. I, I, and I think you’re summarizing it here, here, somehow. It’s

Bob Jones:: a tricky synthesis as you well know, there, there are people who genuinely want to be noble and they don’t know the first thing about making money. And there are people out there who genuinely want to make a lot of money and have zero interest in helping their fellow man.

Yeah. And what we’re looking for is the synthesis of those characteristics in some balanced fashion. Totally.

Naji: You led, uh, obviously your company through, uh, through those moment of crisis. I’d love to hear more first about your current company and what you’re doing, cuz you’re working on a noble, uh, purpose with, with your teams.

Uh, and also how you led through those those times. Uh, it’s always challenge in healthcare specifically with the pandemic and you’ve been working with, um, what, what, what your, the people, your company serve is also people who were. Highly touched during, uh, the pandemic. So how have you led through those, uh, those moments internally and externally?

If I may say.

Bob Jones:: Well, let me, uh, set the stage that I’m in the process of exiting the fourth business right now. And so there’s at least some of this that I probably should be discreet about. Um, having said that, I think it’s a very rare startup that doesn to encounter, uh, several crises along the way to stability.

In fact, this. Book that I’m in the process of writing has a whole chapter titled of don’t it right? The. And, and I have some remarkable stories from entrepreneurs that I’ve interviewed, fleshing that out back several of button hold me last week and said, put my picture up there next to that chapter title

So I think. Leadership through crisis is unavoidable. If you’re starting a company. And I, I think that the pandemic is a convenient heading, but maybe a more broad heading equally applicable is just growing pains. Because every company gets to the point where they’ve grown too fast and the quality assurance has gone to hell or they’ve hired a bunch of employees, some of whom they should not have hired and they don’t know how to fire ’em.

Um, they, they hired their relatives because they thought this would all be great. And then over that their relatives were a bad fit. And can’t figure out how to fire ’em without, uh, ruining family relationships. Um, there’s just all sorts of, um, hurdles that entrepreneurs inevitably have to clear. I think, keeping your team advise of what’s going on.

I mean, you can sell it a little bit, but there can’t be too much smoke. I, I think your employees almost always know the truth, even if you think they don’t. If you have an employee that is not performing, they probably know it before you do. And to try to pretend otherwise, uh, lowers your credibility as a leader, uh, damages your ability to lead the firm.

And so I think, I think you have to be candid. I think you have to be forthcoming and forthright. I also think. And this might seem counterintuitive. You have to make your employees go home. At the end of the day, spend time with their families, spend time on the things that recharge their batteries and take care of themselves because just driving them slavishly to comp, say for your management mistakes is.

Or a healthy way to lead a business. I think you have to tell, ’em go home, do something good for yourself, whether it’s exercise or play music or whatever it is, go home and, and recharge your battery. Step away from this. Come back in here tomorrow. Bring me your best act. You your be at the top of your game, but go home.

And, and as the leader, I think sometimes you have to exemplify that yourself, even though it’s sometimes hard to do to pack up at five or five 30 or whatever it is and say, well, goodnight, everybody. And I hope you’re not more than about five minutes behind me. I’m leaving. And it makes them realize that, okay.

It really is. It really is. Okay. He’s gone. maybe I can be home in time for dinner with my kids. So I, that is particularly important during times of crisis.

Naji: Yeah. Yeah. Uh, I wanna move now into, uh, a section where I would give you a word, oh God. And I wanna get the reaction so the first word is, uh, leadership.

Bob Jones:: Well, I think leadership requires courage. I don’t think I’ve ever been in an organization where. People did not criticize the leader. I think if you have a really high need to be liked, you are not well suited for a leadership position. I think you can be loved, but not liked. paradoxic though. That may sound, they may love you for your leadership qualities and not necessarily like you, when you hold them.

So I think I also think that.

Let me give you a better example than one that I would offer. I spent some time with the, uh, the top guy at about a $3 billion firm out there. We were having dinner one evening and he said, you know, Bob, I’ve got a whole squadron and very experienced executives working for me. And fact is I could probably leave the business for a month and they would do a great job of running the business.

What they need me for is to look over the horizon, see what’s coming. That could either be a great opportunity for us or a great threat to us and come back and make a risk, determination that we should address those things. That very few of us actually see. And sometimes I’m. It’s not easy, but that’s what I signed up for.

And I thought, wow, I should write this down. It’s brilliant.

Naji: What about entrepreneurship?

Bob Jones:: Uh, insanity, Lecy, character flaws, uh, psychosis and, um, Well, as, as I said, I’ve been interviewing fellow entrepreneurs, um, as part of cooking up this book, I’m writing, um, the startup starter kit and. I have to say it was a revelation that people that I already knew and thought of as having a lot of self confidence and a lot of swagger ended up saying things to me like this is excruciatingly difficult.

It’s absolutely not a life that’s for everyone. It challenged my. Self-esteem it, in some cases crushed my self respect. It did, uh, damage to some of my valuable and intimate relationships and, and entrepreneurship is over promoted and over glamorized and people, people should be told about entrepreneurship, but given enough information to make a eye decision.

And of course I couldn’t resist saying, well, would you do it again? And in every case they said,

yes,

And, and then of course I couldn’t resist saying well, given, um, that this was about as much fun as taking a hammer and hitting all your fingers. Why on earth would you do it again? And one of them said, well, I think an awful lot of people trade their dreams for security. And there’s two things wrong with that one.

If you think you’re gonna find security in a big company or delusional, it’s not there. And two, for me personally, Bob, I can’t think of anything that’s worth trading my dreams for. So I think entrepreneurship is creative. It’s exciting. It’s fulfilling, it’s exhilarating. It’s incredibly difficult. And when your business fails and as most of them do, it causes you to reevaluate a number of your personal full philosophies.

And I think that. Many of us take refuge in the analogy of the jockey and the horse. I’m a pretty good jockey. I happened to pick a horse that wasn’t gonna win the race. So the poor thing died in the middle of the race. So I guess I’ll mourn the loss of my horse. And then I’ll go find another horse. As opposed to thinking if the business fails, I’m a failure.

Everything I do from here forward will be a failure. I think that’s wrong. I think entrepreneurship incorporates failure that those who are successful view that failure as a learning event, rather than as a terminal event.

Naji: Love it. And I’m eager to get your book

Bob Jones:: out. well, uh, September and, uh, there’s a waiting list getting built at, uh, the startup starter kit.com.

So awesome. We’ll go there. Pedal the book co sign up. I’ll be glad to send you a personal.

Naji: Blues dogs

Bob Jones: well,

Working musician since before I was an adult and played a lot of different kinds of music, uh, thought I was pretty good until I started playing with people who made me realize I wasn’t any good. And at one point in my checkered past, I ended up playing in a seven piece fan on the south side, Chicago, where you had to go several miles to find anybody that looked like.

And I realized that I didn’t know how to play the blues either. And I had to really dig in, I, I learned the merit of space in your music that the next step in sophistication for me was learning when to not play and leave some room for everybody else, learn how to play and listen at at the same time, these were skills that I, as a hot dog, young guitar player, never assimilated.

And when I ended up with this group that I’m with now wonderful bunch, uh, we thought, well, we’re not actually playing at country clubs. We’re playing in some kind of down and dirty places along with the dogs. and the name blues dogs, uh, sort of evolved and that’s us.

Naji: That that’s awesome. And when, when you were talking about it, you talked about listen and play and give space.

I imagine you took some of those into your leadership style too, right? From the lessons of music.

Bob Jones:: Oh, absolutely. No. It’s profoundly affected my view of, of managing and. Employees on the Syrian site for a moment. One of the things we were taught in business school was concept called command and control, which was every bit as disagreeable as it sounds.

And it just didn’t work for me. I might lead the band, but I don’t know how to play saxophone. And I’m perfectly willing to suggest the direction to the sax player and get out of his way. And if we can do it in a way that is collaborative and there’s a creative synthesis that comes then sometimes a four piece band can sound like an eight piece band.

Because everything’s working and that’s a pretty good analogy in my view for how a small group of quality employees that are really in sync can move mountains.

[00:29:42] Naji: I love it. I’m a big fan of music, definitely worse than you playing guitar or piano, but , I’m, I’m a

Bob Jones:: big fan. Well, you must come see us.

Naji: uh, the last word is spread love and organizations.

Bob Jones:: Well, I’ve had a bit of a turnaround on that one, um, because. When I first, um, encountered you and the name of this organization, I thought, oh, I’m not gonna like this at all, because this is gonna be like one of those things where every kid that plays on the sports team gets a trophy just for being there.

When, in fact I’ve coached some of those teams and the kids don’t want that stuff. The kids wanna know, did we win or not? And, and independent of whether or not I’d push ’em. And coupled with some of my own insights is I really have caught employees embezzling from the company. And so I know that not everybody out there is a good person, most are, or I wouldn’t be doing all this volunteer work I’m doing, but not all.

So I was. And then I went to your website. I listened to a couple of your podcasts and thought, okay, I was wrong. That what you’re doing is shining the light on something that really will help people be effective. And.

I don’t know, maybe it sounds grandiose, but maybe leave the world a slightly better place than they found it by collaborating, working with supporting and sharing the love with, within the confines of who, uh, accept this gift and understand that it’s a gift.

Naji: Oh, thank you about this. It means so much what, what you just shared now, any final word of wisdom for leaders around the.

Bob Jones: You know, Naji I have hired people who were overqualified and making way more money than I, as the leader of a startup could afford to pay them. And when I asked them why they took the job. What boiled out of all, that was because I want to feel like I’m making a difference. I don’t want to be somewhere where I can sit all day long and shuffle paper from one side of the desk to the other, collect a fat paycheck and go home feeling like I didn’t make a contribute.

And, and I think. Is a kernel of real wisdom for leaders. If you can show people that what they are doing makes a difference and have them feel that what they’re doing is important and makes a difference. Then the next thing you have to do is just get out of their way. Sure. They understand where you’re trying to go and that they have an important in getting there.

And. Maybe step back in now and then, and help ’em clear a hurdle or something, but find out what it is that they think is important. Try and connect the dots to what your mission is, inspire ’em and get out of the way.

Naji: Love it. What a great advice. Thank you so much, Bob, for this genuine and straightforward discussion we had

Bob Jones: Thank you. Well, I’m flattered. Thank you for, uh, including me. It’s been a pleasure.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Elizabeth Sawin

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji your host for this episode joined by Elizabeth Sawin founder and director of the Multisolving Institute. Beth is an expert on solutions that address climate change while also improving health, wellbeing, equity, and economic fire fatality. She developed the idea of multisolving to help people see and create the conditions for such win-win solutions. Her work has been published widely. She has trained and mentored global sustainability leaders in the Donella Meadows fellows program and provided systems thinking training to both Ashoka and Delai Lama fellows since 2014. Beth has participated in the council of the uncertain human future. A continuing dialogue on issues of climate change and sustainability among a select group of humanities, scholars, writers, artists, and climate scientists, a biologist with a PhD from MIT, Beth co-founders climate interactive in 2010. She has two adult daughters and those in rural Vermont where she and her husband grow as much as their own food as they can manage.

Beth, I am so excited to have you with me today.

Beth Sawin: I’m excited as well.

Naji: First, I would love to hear your personal story from biology to climate change being part of the UN convention on the climate change. What’s what story behind this impressive work.

Beth Sawin: Yeah. Um,

I would, I guess, you know, it’s always a, a, a challenge to think where a story starts, but I would start it as a little kid who just played in nature a lot. You know, I was the kid with the rock collection and the, um, the seed collection and playing in the Brook. Um, and so that led me to an interest in science as an undergraduate.

I saw at a biology and chemistry. Um, and I, I followed those two threads to MIT where I studied neurobiology. Um, I worked on a small soil organism, a nematode called sea elegance. Um, this was in the late 1990s. And the research question we’re interested in was about learning and memory. And the fascinating thing about this organism, um, you know, is so beautiful.

It’s a transparent about a millimeter long worm. Um, it has. A limited number of cells a little bit more than a thousand. And they’re the same in every single elegans there is, and they have 302 neurons, very specific number. Each one had a name, um, that was worked by my PhD advisor and his colleagues to make this map of a nervous system.

Um, so I was, I had little tiny piece of that to try to understand. Learning and memory and how neurons connected, um, to, to enable this organism, to navigate its environment. And I loved the re I loved the organism. I loved the research. Um, a lot of it was very quiet actually, because I had to work in a dark room, um, at a cool temperature, like 45 or 50 degrees.

Um, I did lots of microscopy. Uh, one experiment I did was using a laser to kill single, no Iran, and try to understand how the behavior changed. Um, So in some ways, you know, that’s a big departure for where I, I sit now, um, 30, more, 30 plus years later, right. Leading an organization that works on sustainability health, climate change, equity and justice.

Um, but the, I think the threads are still there. Um, Because I was studying a system and I was really interested in the whole system. Um, how, how, how do you put 302 pieces together and get, um, emergent behavior? So that interest in systems, um, led me to start following the work of one of the most important mentors in my life, which is Danella Meadows.

Um, she was the, she was the, um, co-author of a book called the limits to growth, which is actually the 50th anniversary of that book. Um, just this we, uh, so that was the first real global modeling study that used. Systems theory and computer simulation to look at what at that point was, you know, something off in the future.

Um, it was, they were asking the question, the human economy is growing exponentially on a finite planet. Um, what are the scenarios for, for that? Like, Obviously it can’t keep growing forever. Are there pathways to fit within the, the economy within the earth system? And in 1972, there were all kinds of options.

Um, of course today we, we know that the advice of those authors didn’t really get taken by the world and we’re all living through some of the implications of that. So , um, While doing this research in biology, I got to know Janelle Meadows. I was interested in systems theory and she was starting a research Institute in 1997.

It was called the sustainability Institute. Um, and she needed a group of, of young researchers because there was more work she wanted to, to do in the world. Then she could accomplish as an individual. Um, the only problem was, you know, I knew a lot about biochemistry, genetics, and neurobiology, and she needed people who could make computer simulations of complex systems.

Um, and, and so this is one of those leaps of faith in a career. Uh, cuz she was, she said, well I never studied systems theory as a, you know, in a formal way. Um, her husband at the time, Dennis Meadows. Was a PhD student at MIT studying systems theory with Jay Forrester and Della taught herself systems theory at the kitchen table using Dennis’s books and notes.

She was like, I taught myself, you could teach yourself. I was like, oh, okay. I’ll teach myself. Um, You know, now I look back, she’s probably the most brilliant person I’ve known in my life. So the fact that she could teach herself something, uh, was not like a universal that anyone including me could just sit down and, and master that.

Um, So it was a very steep learning curve. I did take a few classes, um, and I learned the basics of the, um, of the math and the computer science to build, um, what we call system dynamics, computer simulations, which are ways, um, to use computers, to handle the complexity and the interconnection of world. Um, there’s, there’s more of it than we can mentally simulate, which is, is one of the reasons so often that our systems, whether they’re.

Families organizations, countries, um, uh, international relations, you know, things go off the rails because of that complexity because of especially feedback loops, where we make changes in the world and then they feed back in ways we don’t expect. Um, so that was a big leap for me from, from biology to sustainability and systems theory, um, that led to.

You know, so many other important things in my life. One is, um, where I ended up living and raising my family because Janelle MES was really committed to the theory of sustainability, but also the practice of it. And so she had a vision around that same time in the late 1990s of a, um, a community of people, um, living more cooperatively than most Americans sharing land and.

Resources and, um, practicing sustainability to the extent they could. So, um, my husband and I got inspired by that vision and we joined as the, some of the founding members of that community where, where I still live in Vermont. So it’s 23 families on 280 acres, um, that, uh, you know, far from perfect. But we, we practice and learn about, um, you know, Everything from sustainable energy to composting toilets, to energy efficiency and agriculture.

Um, so that’s been. Really important throughline of my life is the more grounded practice of what does sustainability mean. Um, and then of course this introduction into the wor world of systems has framed pretty much everything. I think about, you know, our, our work in the world, but also how we try to organize and participate in teams and collaborations with, with just this underlying belief that.

The world is actually, um, a unitary complex system. They’re the, uh, the boundaries, whether they’re between disciplines or nations are usually, uh, we call them mental models, things that, that human beings have made up, but they’re not. They’re not the physical substance of the world, you know, there’s between Russia and Ukraine, because we’re talking right now at this moment with the world’s attention, there there’s a line on a map, but in the ecology of that part of Europe, there’s, there’s no line.

Right. And of course, Anyone who’s, who’s been to space and come back and told the rest of us what that feels like. That’s one of the most pronounced things that those explorers of of space say is, you know, this, this small unitary earth that we all share. Um, so that, that journey through sustainability Institute eventually led to a project at sustainability Institute called climate interactive, um, which grew to the point where it became its own organization, um, where I was a co-founder along with Andrew Jones and co-director until.

Little more than a month ago. Um, and most of those years that climate are active, were focused on, uh, these same type of computer simulations, focused on climate change and what countries and, um, businesses and leaders could do to, um, meet climate targets. The. So we use computer simulations to help people ask really fast.

What if questions? What if, what if China rapidly decarbonized? What if the United States switched to all electric vehicles, questions like that? Um, and, and playing that out for the a hundred year future, what would, what would temperature and sea level rise and, um, droughts and air pollution look like under those different scenarios?

Which was F fascinating. Um, you know, just like I loved the biology and the, the intricacy of that one organism. Um, this was a different kind of in intricacy of trying to represent, you know, the whole global economy and the whole planetary climatology. Um, And that work led to so many fascinating places, um, including you mentioned the UN climate conferences, um, for a group of scientists, uh, you know, to find our way into advising some of the world’s governments and.

Civil society via, and also, you know, journalists who are telling the story of these, of these meetings. Um, one role that we ended up playing was, was saying if all the countries in the world accomplished what they’re promising, because in, in these negotiations countries, each say, you know, they’re gonna reduce their emissions by a certain percent, at a certain time.

And we became really good at. Um, asking if every country did what they said, what would that mean for the a hundred year climate future? Would we meet the goals that they said they were making these pledges for? Um, and year after year, our message, there was pretty much, um, you’re making progress and there’s further to go.

Um, and, and I are really frustrated to be honest, like saying that you year after year, cuz you know how urgent these issues are. Um, we don’t have. Time to just slowly make progress and have further to go. And every year of delay, um, means like losses and suffering, right. It means communities and ecosystems that we can’t recover.

Um, so, um, that, I guess that frustration gave birth to the old strand. I’ll tell you about which kind of leads up to, to the present moment. Which is this idea of multi solving, um, with, within the climate negotiations, um, there’s, there’s kind of a, laser-like focus on the greenhouse gases on, and particularly on CO2, um, which is.

In some ways as it should be like, that’s the source of global warming is CO2 and countries need to come up with ways to limit that. But, um, we’ve been talking about complex systems and interconnection and of course, CO2 doesn’t exist in a bubble it’s connected to, um, fossil fuels, which end up, you know, having other than just CO2.

And I know a lot of your audiences. Comes from health. So of course, people know about air pollution and all of the impacts, um, on, um, developing embryos on people’s, um, circulatory system, their respiratory system, their nervous system. Um, but, but in the space of talking about climate, all of that’s often ignored.

And so you have two problems that could be, um, improved at the same time by weaning countries and economies off of fossil fuels. Uh, But, um, and this is improving, but it’s still far from where it could be too much of the time. Those are two separate conversations with public health, thinking about air pollution and climate and energy leaders thinking about transportation and, um, the global climate.

and that’s really important because by bringing issues like that together, you bring together timescales. Um, the health impacts are often a lot quicker, you know, though, we’ve been talking about the a hundred year future when it comes to climate, but if you remove tail pipes or coal-fired power plants, the air in a community gets better in days to weeks.

Um, and incidents of things like asthma gets better on that same kind of time course. Um, so. Bringing these issues together, um, can can help with this problem of long term problems are hard to face. Um, politically they can be hard to get the energy for. You can combine that with short term short term benefits.

Um, and the other thing you start to pull together with more of a whole system view is the costs and the benefits. You know, we, we have to spend money, time and effort. To build a low carbon energy system, but what we would get on the health side, um, and the world health organization has been saying this since 2018, the health benefits outweigh the costs of the energy system transformation, um, expenses.

But when those two things are in silos, Then the net win overall for the whole system. It just stays out of reach. So, um, multi solving is this idea of solutions that tackle more than one problem at the same time. And as of a month ago, that work on multi solving, which was incubated at climate interactive.

Um, now is part of a freestanding organization called the multi solving Institute, which I’m the founder and director of. So that’s the long and winding story. Well,

Naji: it’s, it’s an amazing, inspiring story, Beth. Thanks for sharing part of your, your story and journey. Um, and you ended with the multi solving Institute.

So let’s double click on this. And I remember when we first discussed about it, uh, you, you gave an example of a simple town with bicycles. And then with system dynamics, the impact overall about it, and you kind of touched it and you really frame it as a win, win, win solutions. So can you tell us a little bit more this story or any other story where you think we can have immediate impact, in fact, and, and in the word.

Beth Sawin: Yeah, multi solving definitely, um, is best communicated through stories. So I’m glad that you asked that. Um, and one of the things that we do at the multi solving Institute is collect case studies that show the variety of possibilities. Um, so maybe I’ll just mention a few that my colleagues have researched that are some of my favorites.

Um, one is a project we learned about in New Zealand called warm up New Zealand. And it was a response to the, um, energy crisis or sorry, the economic crisis of 2008, 2009. So it was meant to be a jobs program for the construction industry in New Zealand to upgrade homes that were energy inefficient. And it, it was successful at that.

Um, homes got upgraded, there were good jobs. Um, and so that’s a win, right. But we’re talking about the win, win, win, as you said. So, one interesting thing that happened was, um, researchers from the health side looked at the residents in these homes that had been upgraded and they tracked things like ha um, emergency room visits, hospitalizations, and, um, the costs of medications.

And found really remarkable savings on the health side. Um, and that’s simply because people were living in more comfortable, less drafty, um, homes potentially with better air quality. And, and so there’s, you know, there’s the second win and they’ve, they’ve developed that now, so that they’ve included, um, you know, public health, health leaders and primary care physicians, people through this program, we understand can a doctor can.

Can refer, um, patients for home energy upgrades, right? So, you know, we laugh about, instead of taking aspirin and call me in the morning, it’s like, go get new windows and a new boiler. Um, and, and so that’s an example of this stretching across boundaries that we’re talking about. Um, and the, the power of these, uh, solutions, really the engine that drives them is people being able to connect across these sort of arbitrary made up.

Lines in the world, right. When we say this is the department of energy, and this is the department of health and they’re, they’re in different buildings and the people have different training and speak a different technical language and likely don’t know each other. Um, and so those are all hurdles that have to be overcome by people leading this type of work.

Um, do you have space for another example or is that, is that yeah, please? Um,

I’m well, one that has my, uh, my interest these days, uh, is happening, I think, around the world, in the United States, there’s 19 different states experimenting with electric school buses. Um, so the first real advantage of electric school buses is for the children who. You know, are, are waiting, um, at school or on their corner in their neighborhood and breathing in diesel exhaust fumes from traditional buses.

And, you know, kids are right at that level of where the air is the most polluted. Um, uh, so an electric school bus removes right away, some of that burden of air pollution, which has so many health impacts on people. But the other thing that can happen, um, is, uh, during the parts of the day, when the school buses aren’t in use, they can be charging, but they also can be connected to the grid as giant batteries.

And we know that part of getting a really clean energy grid is using these. Intermittent sources of power, like wind and solar. Um, and so there needs to be a smoothing process to balance out demand with the generation. So school buses or any kind of BA are, are also big battery, right. And they can be used to help smooth out those highs and lows.

And the other thing that they are is, um, mobile battery. And so in, um, instances where there’s. Impacts like climate impacts say a storm that takes out the power grid in a place. Um, you can send fleets of, uh, electric school buses, which are, which then can be used for people to charge their phones or keep their medicine cold or whatever is needed, um, in a community after a disaster.

So, you know, these are, these are pie pilots. People are trying to figure out the. So, you know, the budget, how to make it all happen. An electric school bus is more expensive right now than a diesel bus. Um, but it shows you how you can put these really different problems together. Like on the face of it.

You wouldn’t think kids with air pollution, getting to school is connected with making the electricity grid work better, but this is some of the just innovation that’s bubbling up all around us right now.

Naji: I love it. And you said the arbitrary lines in the word, I love how you framed it. When we start taking off those lines that we created, obviously we can imagine the possibilities and what we can do.

Beth Sawin: Yeah. What about, and you know, that’s, I mean, that’s the human element of multi solving, right? Because it’s you human beings who transcend those. Those boundaries agree.

Naji: So what about, uh, leadership as we were talking about human being, do you, do you see, uh, multi silver as a key capability for a leader in the 21st century?

Beth Sawin: Yeah, we, I mean, we’re really curious about this and, um, we, we think of our role as.

The, I think the contribution that we in our little Institute can make, or one contribution is to look across these examples of multi solving and really try to notice what are the attitudes and approaches that are enabling this way of working to happen. I mean, even from those two examples of home energy upgrades and electric school buses, you can start to see how the variety, you know, we haven’t talked about, um, agriculture projects and walkability and cycling and, um, you know, photovoltaic farms, like there’s, there’s endless variety in the what of multis, but the common threads seem to be about the way, um, that it happens.

And. And, and so that is. You know, of, of continuing interest to me is how is that way different than the sort of status quo way within our dominant culture and institutions. And I don’t feel like we have it, um, you know, a hundred percent understood yet, but, but some patterns, um, are emerging for us. Um, one of them.

I would say is that multi solving projects tend to start small and iterate and be, um, really led or driven by a learning approach and by curiosity. Um, and so you might think while there’s all these different players involved and there must be some giant vision, um, about how to put it all together and how to convene it all.

Um, and that’s not so much what we see, you know, we see, um, sometimes. Just a, a few people working together in a small way. Um, having some success sharing what they’re doing, which builds excitement, which pulls more partners in. And so they try a little bit more, um, they carefully measure and document the impacts they’re having.

And that’s part of the driving force that, um, allows projects to get kind of like a accrete, more and more energy and attention and collaborators. So I would highlight that as kind of, um, Both a learning, learning attitude and an openness to kind of reach out to others. Um, we, we also see, I’m trying to think how to turn this into a positive.

I don’t quite have it. So I’ll just say the, the reverse, um, people who are too attached to the identity of, of an spurt, um, is actually counter to multi solving. Um, You need expertise. Like there needs to be someone who understands the power grid in that school bus project I was talking about. Um, but you also need curiosity about the parts that you don’t know about.

Right? You need the transportation planner. Who’s like, tell me more about public health. I don’t really know what air pollution does to somebody’s lungs. Um, and you need the public health act expert being like, what are the obstacles to redesigning our streets? Um, so. Maybe you could, you could just really emphasize, I guess, the role of learner versus the role of expert and a certain kind of humility, um, that I think is really needed for these projects.

Um, so there’s think there’s more, but maybe those are the two that do really highlight, like learning organic iterative, curious and humble.

Naji: Thank you. Thank you for that. It’s these are so powerful and, you know, I love the framing within expertise, but also curiosity for the things you don’t know. So it touches the humidity side of things for us to be able to Multisolve in a, in a dynamic where

Beth Sawin: you were.

I think there’s, you know, there’s one more. Can I add, cuz I think it’s important. One more to add, um, all of these projects. Are playing out against a backdrop of a world with all different kinds of inequities. That’s just the nature of our world right now, whether it’s, um, racism and white supremacy or, uh, patriarchy and gender inequity and, and so on different places, the, the inequities are different, but.

They’re part of these systems we’re trying to transform. Um, and for multi solving to be effective, uh, leaders have to be willing to grapple with, um, those inequities and make disrupting those inequities part of their strategy. Um, Because multis solving is about healing fractures in, in this kind of way.

We’ve drawn lines and broken systems into parts, um, inequities of all sorts do that same thing. Um, and so the, um, the people who have historically been. Um, marginalized or disenfranchised from decisions about the infrastructure, say in their neighborhood, um, need to be included in a multi solving project.

And so right away you have, um, potentially, you know, experts with economic, political credential power, uh, needing to work together. Other with neighborhood residents say who might know the most about, um, you know, What the problems are and what the potential solutions are. And, and so people need, um, support and skills and patience, uh, for, for working together across those boundaries and, and dismantling them as they go.

Naji: You, you worked, uh, Beth closely with Donella Meadows and you, uh, shared in the beginning, her, uh, her book, the limits to growth. Uh, so she’s an incredible thinker teacher, researcher and, and leader. Um, I read one of her articles with a title. There are limits to growth, but no limits to love. So I was intrigued to hear from you about this, this title, and also love in system dynamics for a sustainable word.

Like what does love gets into this?

Beth Sawin: Yeah. Um, one thing that really interests me is. For sure. Danella Meadows, but other systems theorists too. I think of Gregory Batson, um, who wrote several articles about love, um, uh, who was also in that even, um, earlier than Danella Meadows and her colleague, one of the kind of founders of systems theory.

Um, and then for Dan or Dana, as we called her, um, you know, she was very forthright of talking about love, um, which was. Was, and is unusual, right? For, um, a highly credentialed scientist building computer simulations, very rigorous and analytical to also be talking about love, which is so often not in our scientific discourse.

Um, Danella died. Um, far too early, she, she died in her late fifties and I had only been working with her for, you know, a few years. I, I thought I would have a whole career to learn from her. So I never asked her why love was such a prominent thing, but for her, but you’re right. In addition into that article you name, um, uh, in.

In the follow on books to the limits to growth. One is called beyond the limits, which came out in 1992. Um, there’s a chapter that’s about, um, what, what do we need in order to, uh, address the sustainability crisis? And she named, I think it’s eight different things, um, vision and networking. Um, can’t give you the whole list, but one of those is love as well.

Um, another thing about her. Is, and I’ve only reflected on this in hindsight, but any email that she would send and it might be like, I question the parameters in equation, number 45 of your model. Would be love Dana, um, which is a, a countercultural thing to do, you know, certainly my MIT professors didn’t write emails, sign emails like that.

Um, but I, so all I have is my theory, I guess I would say I’ve thought about this a lot, like you, but I never got to ask her. So these aren’t, her are words of why love became such a, a force of her thinking. Um, but I have. Put myself in her shoes and you have to picture 1972. They were very young. These authors of the limits to growth.

I think they were in their early thirties, um, such important information for the world at a time where if they had been listened to the tragedies that we’re living through now, the flow floods, the fires, the diseases wouldn’t be happening. Right. We would be 50 years later. Coasting into an era of balance and sustainability.

It probably would’ve taken these five decades. Um, so knowing what was at stake, knowing that there was an alternative, uh, knowing to some extent the suffering that would happen by not being listened to, and you’re not listened to, you’re not listen to for decades. Right. Um, To keep going under those circumstances.

I can’t, um, you know, imagine the loneliness of that. Like those of us working in climate and sustainability today often I think feel lonely and feel like we’re not listened to. And yet our movement has millions of people. And this was the very planting, the very first seeds of that. So I think she was looking for what is the.

What is the force that can bring the human global society, you know, to safety. Um, and I, the other thing she wrote about a lot, you might know this is about worldviews and paradigms. Um, uh, because I think what they experienced was what they were saying at those scientists couldn’t connect because people couldn’t imagine that this life based on extraction from the planet, that they couldn’t even imagine alternatives to it.

Um, and so I think talking about love and talking about, um, being motivated by what matters most to us was. Was the best solution she could come to, you know, for the transformation that was needed. Um, and I think the reason love shows up so much in, in this discourse of, of systems theory, um, is that when you work with systems, you see the interconnections, you see there’s, there is no separation.

Um, and so, you know, whether it’s. Domination that happens in a workplace with an abusive boss or domination that happens between one ethnic group and another there’s no systems basis to justify that. Um, and so I think also this tension between how the world was and what her systems models were telling her, you know, the reality of the world was resolved itself somehow in this, this, uh, Through line that she U she used the word love to describe.

Naji: Thank you for that. Uh, I will move to a section where I want to give you a word and would love to get your reaction to it.

Beth Sawin: Sure. Sounds fun.

Naji: So the first word is leadership,

Beth Sawin Beth: uh,

open and available.

Naji: What about sustainability?

Beth Sawin: Um, join. Do you want just one word I’m having have trouble with one word? No, I would say you can re okay. It can be, uh, sustainability, I would say, uh, rejoining the flows and networks of the earth.

Naji: So I wanna double click on, on this one. What, what, what should we do as leaders personally, individually? Like what is the first step that I should be doing that you would push towards sustainability towards sustainability

and rejoining those forces?

Beth Sawin: Yeah. Well, the beautiful thing is that because sustainability touches everything. It’s literally, how are we on this planet and how are we with each other that, you know, whatever field we’re leaders in, there’s a connection, um, to sustainability, um, You can find all kinds of lists of, you know, flying less is more important than getting solar panels.

And so I’m gonna not go to that level of detail. And maybe because we’ve been talking about both love and paradigm, um, I’ll put forth a, a way that I think about it. Uh, right now I, I believe that among. Our societies, there’s two different worldviews that are battling each other. Um, one sees, sees humanity and the earth as a pyramid that has white men at the top of that pyramid and then white women, and then people of color with animals and plants somewhere down below.

And, um, that theory has of course, um, comes with colonization and empire and has been. Dominating, um, most of earth for 500 or so years. But it is, it is only a, a theory of how the world works. There’s another way to see how the world works. And, um, many wisdom traditions and indigenous cultures, um, are embedded in, in this world view and carry it forward and, and live it today.

Um, and I think of that as a, um, an inner connected web. Um, so there’s no, there’s nothing on top. Um, and it’s all connecting and flowing in all directions. Um, I attribute most of the crises we’re in as coming from the fact that that pyramid view doesn’t actually match reality very well at all. Cuz in fact, if you look at biochemistry or climatology or ecology, it, it is all this flow and interconnection that we’ve been talking about.

Um,

But whether it’s the extraction of natural resources or the extraction of labor from people that you somehow deem, you know, beneath you in that pyramid. And it could be literally slavery, um, at certain points in history, but just as well, you know, unfair labor practices. Um, so there’s this, this extraction from nature and people falls out of that pyramid view.

Um, it creates crises because. The world, isn’t a pyramid. The world is an interconnected flow and there is no other, and there is no away. Um, and so I am gonna, I am trying to work my way back to your question of what can leaders do. And what I would say is. Occupy that worldview of interconnection of a web.

Um, and the, the beauty of that is that you are gonna have a hundred times a day to do that. Um, maybe it is, you know, choices about your physical plant. Okay. So your physical plant is part of an interconnected web that includes all life and all flow of carbon oxygen nitrogen on earth. Um, If you’re thinking of it as an interconnected web, you’re gonna think about the circular economy.

You’re gonna think about, um, very, um, intentional use of energy and materials. So you’re brought to sustainability, um, but you might, your next meeting in the day might be staff meeting with your team. Um, and are you gonna conduct that as though your company is a peer or amid with you at the top, or you’re gonna conduct that as an interconnected.

Web of mutual mutuality and responsibilities to each other. Um, which doesn’t mean there’s not authority, right? Um, there’s there’s situational authority. If you are the. The founder or the director or the senior member, you have experience and responsibilities. So, you know, it doesn’t mean all decisions will be by consensus, but it means you’re thinking about that staff meeting in a way where all voices, um, And all, you know, there’s, there’s, um, a climate for all of the voices to be heard.

Um, even if the, in the dis and the decision may or may not be by consensus. I, I hope that makes sense. That that

Naji: is super powerful. See, stop, stop seeing the word through a pyramid lens and, and just distrac, as you said of labor from people nature, but more an interconnected web it’s. It makes more that sense?

I think it’s, uh, yeah, it’s a responsibility. We have to, to think that way as leaders. Thank you for sharing this, pat. Yeah. On, on a related topic that you also work on, the, the next word is equity.

Beth Sawin: Well, of course equity is. Completely related to, to what we’ve just been talking about a world ver of, of a pyramid versus a web. Um, uh, the inequities around us are justified by different, um, theories of supremacy that are, um, if, if you’ve been socialized is in the dominant culture as I have so white woman in the United States, um, uh, Two of the most important ideologies of supremacy are, are white supremacy and male supremacy are patriarchy.

Um, and.

Those have to be grappled with unlearned brought out into the light where we can see them. Um, because of course they’re not, they’re not justified by the web view of the world yet. All of our science from, you know, particle physics to ecology says, actually, you. The world is this web, um, all of the consequences, um, from climate change to lead and drinking water, to, um, you know, child labor in different parts of the world, all these horrors that we say we want to, you know, quote solve are justified by these ideologies of, of supremacy.

So, so equity is choosing, um, To reject those ideologies and to live in ideologies of gender equity of racial equity, of ethnic equity. Um, and in systems theory, we talk about the interplay of worldview and systemic structure by systemic structure. We mean physical things like how our city, these are constructed.

Um, but also, uh, Laws and rules and incentives and investments. Um, and so because we’re, we are at a point of 500 or more years of those ideologies. Everything we inhabit is shaped by those ideologies of supremacy. And just like one example in the United States, um, the urban heat island effect is when parts of the city are, are warmer because of all the buildings and pavement.

And that can be counteracted by greenery, especially by trees, which help cool the environment. It, so it’s an important climate change solution. And. Recently people have been looking at maps of urban tree cover and in city, after city, in the us, those maps super superimpose with a great amount of alignment over maps of historic red lining, which are, um, the places where especially via lending practices, African Americans were prevented from living in certain neighborhoods.

Those neighborhoods are the ones that today don’t have tree cover. So that’s just an example of how the structures. Um, you know, we may feel like, well, redlining doesn’t exist anymore. And it’s many of those policies are no longer on the books, but yet in the trees, in the structure of the city, that inequity is still there.

So if you’re gonna address climate change and adapt to climate change in a way that dismantles inequity, somehow you need to bring the community together or to grapple with that fact and look at that history and figure out how to make amends or reparations for it. Um, and. That’s still far too rare, you know, in our, in our discourse.

Um, and time is getting really short. The I PCC report that came out, um, last week, Monday, last week, uh, You know, ends with these lines about a, um, shrinking window of opportunity to preserve a livable climate. Like those are the words of the scientists shrinking window of opportunity, livable climate. Um, but when you start looking at it with this lens of a web and not a pyramid, then you can understand why so many, especially environmental justice leaders say that equity is inseparable from climate and.

From addressing climate change. And I think this one example with redlining, but we could look at, um, other studies that show that in the us people of color. Breathe in more air pollution than their economic activity produces. And white people breathe in less air pollution than their economic activity produces.

Or we could look at how, um, refineries for fossil fuels that produce all kinds of toxic chemicals like benzene, um, are predominantly situated in NA neighborhoods, um, of people of color. So these things are tangled together and like any systems problem, you, you can’t separate them and you have to. You have to zoom out enough to see how they all fit together.

Naji: Yeah. And those are, you know, the systemic, uh, type of inequities. We can see it in healthcare also, as you mentioned, like from pollution to also health, uh, health problems. So yeah, definitely something to keep in mind as leaders as we move forward and start with.

Beth Sawin: Yeah, and we should name that pandemic as well.

Right. Which just has revealed again and again, the inequities, um, that tie all of these problems together.

Naji: Yeah. The last word is spread love and organizations.

Beth Sawin: Well, one it’s interesting question for someone who’s one month into starting a new organization. Um, one of our aspirations, uh, is to not instruct the world to do anything we’re not willing to do ourselves. Um, right now ourselves as a team of three, me and two colleagues and we have, I have plans to, to grow.

And so we’re also thinking about welcoming new people. We’re thinking about setting the patterns that we want to have as we welcome new people in, and our touchstone, um, kind of goes back to the beginning of our conversation of these attitudes that we, we are seeing promote multi solving. Um, and so. Be a learner was one of them, uh, bring your expertise, but not your identity as an expert, uh, is another way to say that, um, uh, I’m creating a white led organization, at least for now.

I’m the, I’m the director and I’m white and middle class. And I’m talking about multi solving, only being effective when you’re conscious about equity. Um, But we also know about systems and worldviews that it’s really hard to see, um, worldviews, especially if, um, you’re more a beneficiary of them than someone who’s, who’s felt the sting of them.

So, um, I’m thinking a lot about. Um, creating the conditions where my own worldview and blind spots don’t hamper, um, our, our effectiveness as an organization, um, that don’t create, you know, uh, for lack of a better word, white culture in an organization that hopes to, um, have a, have a, to that matches the diversity of the country.

Um, So I don’t have answers to most of these. Most of them are, uh, you know, questions to discuss more at our retreat or, um, uh, things that I know I need other people to help me with. But I think the lucky thing for us is that by learning from multi solvers, we have at least some amount of focus on, uh, you know, what we need to pay attention to and be deliberate about.

Naji: Yeah. And I’m eager to see how your organization will, will grow. It’s such an important topic and capability or even leadership, uh, principle to work on. So I’m, I’m eager to see how your organization will grow and help the word be a better place. Any final word of a final word of wisdom, best for the leaders around the world.

Beth Sawin: Maybe only just to beep across a, a little bit, because healthcare is a, a focus of your work and, and your podcast. Um, I think there’s. There’s a lot. I have learned from your field. When I think about social determinants of health and the phrase creating a culture of health, um, in some ways I feel like, uh, health, health, thinkers, thought leaders are a bit ahead of the climate space in understanding the.

The ways in which the conditions in our system create outcomes like health, um, and, and maybe more of a whole system view sometimes. So I don’t know if that’s a word of wisdom or more, just a shout out to say that, um,

I see a lot of potential from the climate movement to learn from some of, of that thinking. And, uh, and for me, myself to learn more from it too.

Naji: Yeah. And I, you know, as we discussed before, I think we also have a lot to, to learn and, and contribute to what you’re doing. Because as you said, when you think of it from an interconnected web, every single example that you gave today, touches health.

At some point somehow, right. And touches, you know, climate and E everything we, we talked about. So, so yeah, looking forward to, uh, to your work, and I’m sure you will be, uh, working closely with healthcare leaders to, um, thank you so much again, Beth, for being with me today and for having this amazing discussion.

Beth Sawin: Yeah. Thank you.  

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Ben Shields

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji your host for this episode, joined today by Ben Shields, senior lecturer in managerial communication at the MIT. Ben studies the multibillion dollar sports industry to identify broadly transferable management lessons in areas such as leadership, communication, data driven, decision making and innovation. Ben teaches a number of courses. And I had the privilege to be in one of those where he’s the faculty and he’s faculty director of two programs, the formula one extreme innovation series and the global executive academy. His other sports work at MIT included co-hosting counterparts podcasts from MIT, Sloan management, but also other podcasts that he built before that. Prior to MIT. Ben served as the director of social media and marketing at ESPN. He oversaw social media strategy and also worked on marketing strategy for several ESPN brands and sub-brands including the sports center, da da da campaign, an Emmy award winning: It’s not crazy. It’s sport brand campaign.

Ben. I am thrilled to have you with me today

Ben Shields: Naji. It’s such a pleasure to be with you. On your podcast. I am a big fan of what you’re building with this podcast and honored to be included.

Naji: Oh, thank you so much, Ben. Uh, I would love to hear first your personal story from communication to sports to now being, uh, senior lecture and professor at MIT.

What, what’s the common thread what’s in between the line of this amazing journey you had?

Ben Shields: well, I’d say there’s probably three common threads. One is passion. Two is hard work and three is luck along the way. I have been so fortunate throughout my career to be working on interesting projects with interesting people and doing very rewarding work, I guess, just to foreground a little bit for your audience.

This is my eighth academic year. At MIT Sloan. And as you mentioned, my work largely focuses on the impact of digital technologies on the sports media and entertainment industries. And I also have a soft spot for leadership and communication. It is what makes the world go round being effective at both leadership and communication.

So that’s another key area for me prior to my life, as an academic at MIT, as you mentioned, I was at ESPN, the sports media firm of the Walt Disney company and had an credible opportunity there. To help them build and implement their social media strategy in the earlier days of that space. And prior to that, I had a life changing experience at Northwestern university where I was an undergrad and as part of my finance aid package, I had a work study obligation.

And my freshman year, I got a job through the work study program at the gym. I love sports. I might as well work at the gym, but then there was a staff member within one of the schools of communication at Northwestern. And she said, Hey, there’s this professor Irv rain who is looking for a research assistant.

And he can pay you through the work study program. I said, sign me up. He’s interested in sports. He’s interested in media. He’s interested in entertainment. Sounds great to me. And I signed up as a work study student for him, ended up going on to do my master’s and PhD at Northwestern, with Irv as my, my advisor.

And that changed my life. And that’s because of the, the chance that he gave me. And I’ve just been so grateful for that throughout the entire ride that I’ve had. And we’ll never forget it for as long as I live.

Naji: Thank you, Ben, for sharing, uh, this part of your, uh, your story. Uh, I I’d love to go into your research on the sports industry.

And as you said, your, uh, you, you have a, a passion for leadership and coming, uh, what are the transferable. Management lessons that you think we should all learn from, from what you’ve seen and what you’ve researched more broadly as leaders. But if you have any idea also for the healthcare leaders, is there any transferable skill that you think we should focus on?

Ben Shields: You know, Naji? It’s a really interesting question. I enjoy studying sports because I do think there’s so much that can be learned from the. Other industries about how successful teams operate. You know, there’s a couple things that come to mind. The first that’s really interesting about sports is performance is measurable and there is a common goal for teams and that is to win.

Win enough games to win the division, win enough games to win the championship, whatever the case may be. But the goal is to win and every single person on the team, whether they play the game or on the coaching staff, or are in the back office, they’re all aligned on that singular clear goal. And the way it’s very easy to.

Put in place performance measurements to understand how people are contributing to that overall goal, that type of performance measurement, as it relates to an overall goal, seems like such a simple concept, but it’s really hard sometimes to apply in context outside of sports. You know, often when I’ve worked with other organizations, they, I think rightly so push back and say, look, you know, we’re not playing a zero sum game here.

We don’t have a competitor, like a sports team would have on the other end of the court, but there are still ways that you can create sense of what a win or a loss can be and rally people around achieving that common win. And measuring people’s performance along the way. So I think that’s the first thing that I would say that’s really inspirational in sports is having that clear goal and measuring performance as it relates to achieving that goal.

The second is less data focused and I think a little bit more on the soft component, which is around creating and maintaining, uh, winning culture and. What I appreciate most about studying sports teams is that the culture doesn’t necessarily just start and end with some words that are plastered up against a wall, right?

In the locker room. It is the collective set of actions. On a daily basis, even minute by minute basis that the coaches, the players, the trainers all take that form, the culture and the best teams we’ve seen over and over again are almost obsessive about ensuring that the culture is sustainable and that all the little actions ladder up to.

What the team wants to be and how it relates to their efforts to win going forward. So those are the two things that stand out to me about studying sports teams and, and how they do their business. One is that measurable performance and relation to a overall goal. And the second is the creation of culture.

And then the mainten and instance sustaining of that culture on a minute to minute, minute to minute basis with daily actions, behaviors.

Naji: I love it. And it’s definitely relatable to what we do, having this common, the shared purpose, right? As, as a company and also building those small steps, we talked about how each one contributes towards this shared purpose or this common goal, right.

For, for getting, for getting there and performance management and on the winning cut. Um, do you have like specific examples? Right? We hear a lot and we’re seeing today and I’m personally convinced what’s going on with great resignation and all other things that there’s been a bunch of research showing that toxic cultures in fact are the first, the first reason.

And it’s always. Linked to management somehow, right. There is definitely a culture environment that you can build overall in a team. Uh, but then there’s really the management. Who’s the first line with his people. And what is the culture being built inside the culture? Have you seen this in. In sports team.

Any thoughts about this? When you say winning culture, how this is built and is there subcultures that sometimes can ruin this winning culture?

Ben Shields: Sure, sure. Well, Naji, I’m so glad you brought that up. There is a culture that I’m been following for a long time, and that is the Miami heat NBA team. And if you are an NBA fan, You have probably heard about heat culture, some of you that are NBA fans may have great respect for it.

O others may. Be tired of hearing about the heat culture, but the reason why you might be tired of hearing about the heat culture is because it consistently has produced results. And the heat culture is I think almost become institutionalized as a team and a place where certain types of players that are focused on hard work.

Team play physical, mental strength, sacrificing yourself for the betterment of the overall team. Those are the types of values that have been almost inculcated into heat culture over time to the point where. The team has developed at least externally this competitive advantage where they now have a reputation for finding undeveloped talent, bringing them to the team and to, into the heat culture and taking that undeveloped talent and turning it into.

A highly capable NBA player. Even this year’s team has a number of different players like max STR Y. Before them people like Duncan Robinson. And for those of you that aren’t NBA fans, I apologize for dropping those names, but what’s really interesting is that that the, the culture has produced results.

And then it is almost a virtuous cycle where people come get better. And the team gets better and then more people come, they get better as a result. And I think that’s the combination of both having the structure in place. And then also making very clear to the players that if you buy in, you’re going to get results.

So the benefit is on their side too. What’s in it for them is they’re gonna get better or two. And so that’s a, I think a really interesting model. Clearly there are other examples in other sports. Winning is very hard. And the, the through line of winning teams often is the culture and the leadership as stabilizing forces as players come and go.

Naji: That’s a, that’s a great example. Uh, you shared with us Ben, um, you should, you said in the beginning around leadership communication, and this is practically what keeps the word going, uh, in those, in those days, crisis after crisis tensions, war, uh, unfortunately these days, um, where do you think leadership communi is?

And as a, as someone who teaches this, where do you think we should take it?

Ben Shields: Well, that’s a very big question. NA and I appreciate you asking it look fundamental to effective communication. At least in my view is mutual understanding. And I think part of the challenge that we face as a society. Is

there, isn’t the mutual understanding between differing groups sometimes. And when you don’t have mutual understanding, then everything else crumbles, right. By the way, mutual understanding doesn’t mean you have to agree with the other person.

But in some of the communication challenges that we have as a global society today, party a and party B aren’t even operating from the same set of information. They’re not even operating from the same mutual understanding of the issues. They, and so when we get in that type of situation, That foundation of mutual understanding.

If that’s broken, then that’s going to set off a whole host of other challenges. So from my standpoint, it is absolutely critical whether it’s in our teams or organizations or other parts of our society, that we prioritize immune mutual understanding because if we understand one another. Then we might have a little bit more empathy or even more respect for one another’s opinions and we can engage in a dialogue to productively move things forward.

But without that foundation of mutual understanding, that’s gonna be a real challenge.

Naji: I love this. And so agree with you, Ben I’m, you know, I talk a lot with, uh, with my teams and even through MIT with the class about healthy debates as leaders, creating those safe places for us to share what we think, our experiences, our, our biases, because we all have different lenses right through this and have those healthy debates.

So I love how you framed it into mutual understanding as a beginning.

Ben Shields: Yeah, well, I’m, I, I applaud you for, for focusing on that, you know, there’s, there’s just so much value in creating a safe space for debates. I mean, you know this as well as anybody, when someone can share a different point of view that might lead to a, an idea that no one else was thinking about, right.

If someone can share a different point of view and also be heard. Well, then that’s just gonna encourage the person to share the next time. They’ve got an interesting idea. And so, so much of our work is relationship based and we’ve gotta create those conditions for people to feel comfortable sharing their points of view and being open to those points of view as well within our teams.

It’s critical. Indeed.

Naji: Uh, if we talk about data now, everyone wants to take data driven decision and you’re one of the experts helping the word and leaders look at data differently, but yet we see. So many decisions being made and critical decisions around the word, really out of opinions, misinformation, personal judgment.

I’m not gonna go into examples. Like there’s bunch of those that everyone is seeing these days. Uh, so as you see this kind of constantly happening in the word and being a teacher about those, what is what’s, what are your thoughts and how do you think as leaders we can improve this?

Ben Shields: Sure. Well, just by way of background, you know, I’ve always loved data.

When I was a kid, I would play fantasy basketball with my dad and I would calculate the scores just from the, the, the, the box scores in the newspaper. And, you know, we didn’t have the online fantasy sports that we have now when I was a kid. And then, you know, I, I continued to do a lot of fantasy. Did some graduate.

Research on the topic. Then when I went to ESPN, when we were working in social media, the amount of data that we got back on our content instantaneously was really exciting. We could start to make some data driven decisions as well, just based on the amount of information that we had. And so I, I love data and evidence based decision making.

is more often than not going to lead to a better decision. Right? I think we can all accept that. I think my main reflection, especially when working with executives and other leaders that are trying to grapple with how to incorporate data into their decision making, what I try to say is, look, it’s not an either or proposition.

It’s not either you use data or you don’t, it is both. And meaning the world is complex. I have a friend Ben Amar who often says that data can help you be less wrong in your decisions. I, and I also try to recognize in executives that look. There’s a reason why you’ve been as successful as you have been as a decision maker.

Right? You’ve got expertise, you’ve got intuition. And so we can’t necessarily completely shut that away either. So what I try to. Work with students or, or executives on is striking the right balance between what data you’re incorporating into the decision making process, as well as your intuition and being super clear about, you know, what, with this particular decision I’m going to follow what the probability says and being very clear on the times where, you know, what.

With this particular decision. I see what the probability is, but I’ve got a, an instinct here based on a lot of other external factors that are not measurable, and I’m gonna go in that direction. And I think if we could just be upfront about that and be transparent about what is the logic and reason and rationale for the decisions that you’re making.

Sometimes it’s going to be re really reliant on data other times. Look, intuition is still powerful. Right. Um, and just being upfront and transparent about that. I think we’re gonna, as, as decision makers be much better off going forward. And by the way, that’s I think I, you know, Naji, I’m sorry. I think what I would, what I would say is to me, I’m a very PR I try to be very pragmatic in my work.

That is just a pragmatic way of looking at it. It’s not either, or you it’s either you use data or you use your intuition. It’s both and, and you’ve gotta negotiate the appropriate balance.

Naji: Yeah, and this is, this is so powerful as an advice like it’s both of them and I love, uh, how you share it being upfront on how you’re making decisions.

This is, this is really powerful. Yeah.

Ben Shields: And then the great thing is that, you know, you and I both have been in plenty organizations. Now you can go back and see how effective that decision was. That’s that’s always possible. Right. You know, you can, you can have a, you can have 10, 10 possible decisions and you can say, you know what, I’m following the probabilities on six of them and following my instinct and tuition on four of them.

And by the way, you know, six months later, when you do an after action report, you see how you did versus what the analytics show.

Naji: Yeah. Totally Ben. I would go now, uh, on a section where I will give you one word and yeah, I want your reaction to it. What’s top off mind to you. So the first word is leadership

Ben Shields: I have my own way of thinking about leadership. I should say my own sort of, um, Definition, which is not mine. Um, this definition is, is from a mentor and friend of mine. Um, and it is leaders, great leaders make those around them better. Great leaders make those around them better. And as a teacher, as a and an organization, That is my north star.

Like I want, if any student comes and works with me or, you know, thinking back on, on my days in, in the corporate world, if anyone came and worked with me and spent some time with me, I, I want them to be better as a result of that interaction. That’s that’s my north star. There are other technical definitions of leadership.

There’s lots of great work and research on it, but for me, that’s what it comes down to make others better.

Naji: What about innovation?

Ben Shields: Excitement wonder the art of what’s possible.

The part of our work that gets me outta bed in the morning. It is hard and yet incredibly rewarding when you come up with a new idea and it moves things forward. I encourage anyone. And this is similar to I’ll. Just throw another big word out there to you. If you don’t mind. I don’t mean to, to go word for word, but I also, when I hear innovation, I also think creativity.

And one thing that I work with a lot on with my students is, yeah, you may think you’re more technical. You might not be traditionally creative or you might not be traditionally innovative, but everyone can be, everyone can be innovative. Right. Everyone can be creative. So I think that that’s, um, I think that’s a reality and something that I, I try to get everyone to think about.

Naji: What about influencer?

Ben Shields: I think about the fact that people connect with other people fundamentally on social media. I think that if you are truly influential, Then what you post or what your message is, should actually leave to some sort of action or behavior change. Right? Oftentimes we see quote, unquote influencers with millions upon millions of followers, but may not actually an action.

And there’s. Interesting work a few years back from a colleague at MIT Sloans and on all on that question too. So it’s a bit of a problematic term. I think that’s why the industry has impart gravitated a little bit toward the creator terminology versus influencer, but it’s an exciting space and I monitor and do research on it very closely.

Naji: Yeah. Well, I learned a lot through the creator economy that, that you teach us on how to look at this and the responsibility we have as leaders. If at some point we’re influential or we’re creating, uh, some, some content and ideas.

Ben Shields: Yeah.

Naji: What about spread, love and organizations?

Ben Shields: Ooh, I, first of all, I. I respond very positively to it.

You know, I was thinking about your podcast, you know, in preparation for this conversation and you know, what, what comes to mind? There are a number of things that, what comes to mind when, when I hear spread love and organizations. One thing that I thought would be interesting to talk about is feedback within organizations.

And I think that. Feedback often can be construed very negatively, right. Especially when it comes to constructive feedback, like how could you possibly spread love in organizations and also give people constructive feedback? You know, it seems like those two ideas could be op in, in opposition, but I actually think that if you have very strong relationships with your.

Employees and your teams where there is mutual understanding in place, where there is trust and crucially, where your employees know that you as a manager have their best interest in mind, then constructive feedback is not about putting the other person some down constructive feedback is not about demonstrating your superiority.

Constructive feedback is to go back to the leadership definition from a friend and mentor constructive feedback is making those around you better. And so I think it is possible to spread love in organizations while also providing constructive feedback in a way that makes others better. I don’t know.

How does that resonate with you Naji it?

Naji: Yeah. I, I love that you’re bringing this because it’s something I think people we always have in mind as leaders and for me, it’s it spread love an organization is exactly this, you know, if you genuinely care about someone. You will tell them the truth you will get, you will help them outgrow you will, you will be here for them.

Right. So I think you summarized it beautifully around this trust about, uh, yeah, really this caring culture that will help you go there. Right. And I’m sure you’ve had. Mentors. And usually the toughest feedback are from people who loves you most, and it can be tough, but you know that they are doing it for you and for you to be able to be at your best.

So, yeah, it’s spread love is really about this is having this level of care mm-hmm for, for us to be able to be at our best and for us to be able to deliver on our shared purpose. So I think,

Ben Shields: yeah, I, I, I think that’s outstanding. I see that very clearly. And you know, the other thing that I would say is that the, the other side of that constructive feedback coin is around positivity and optimism.

And thanks to my mom, I am built as a positive and optimistic person , but that doesn’t mean that. You know, you mistake my kindness for weakness, right? That doesn’t mean that because I look at things optimistically. I can’t offer. Critical point of view or a piece of feedback that’s going to help you as an individual and us as a team.

And so I, I think it’s possible for both optimism and positivity to coexist with, uh, a, a, a strong pension for, for constructive feedback and, and the ability to do so, again, with, with some love and some caring. Yeah.

Naji: Yeah. I’m I’m I totally agree with you. You know, I reflected a lot about feedback in organizations because some would give and some others would just, you know, go through processes and we don’t even give this feedback.

Right. And at the end we cheer, we cheer up. Like it was great, even though it’s not. And it took me back to my humanitarian work know in moments of war and tension. And one of the aspects we always did. Every single urgency, every single. Every single time we went out in an ambulance, we would come back after, regardless how it went.

We would do a session of debrief and we will literally tell each other the truth. Positive or negative, but we will, like we debrief. And, and again, it might sound obvious because we had people’s lives in hands, but actually this discipline on doing this built out of a culture where we, we cared for one another and we were all here for the same purpose, which was helping people build this.

Amazing culture of being always at our best and saying, okay. Yeah, like it was a hard discussion in the ambulance, but this is where it happened and it helped me grow. And next time I’m not, you know, I’m gonna learn of it. And if something was positive, well, great. Like let’s all learn from this and move forward.

So I try to Institute this, you know, positive feedback group, not all, only when things go bad in, in companies, but constantly for us to be able to grow and learn.

Ben Shields: That’s right. And it builds trust too. NA yeah. I mean, I just think about people that have given you valuable, constructive feedback in the past, you know, you’re probably more likely to trust them and then go back to them in the future.

You know, if you’re really, at least I could just say with, with my own life and my mentors and the people that have had an impact me, you know, I’ll pick up the phone and call them, Hey, I’m working through this issue. I know. That I’m going to get an unvarnished point of view. I may not agree with it. I may not follow the advice, but there’s that trust there based on the, the numerous of, of, of more difficult topics that we’ve, we’ve covered in the past.

Yeah,

Naji: totally agree. Any final word of wisdom, Ben, for leaders around the.

Ben Shields: Well, I’m not necessarily in the business of being able to provide wisdom or advice. I would only say that reflecting on. What you are doing, the message of your podcast is just to remember that in the day to day hustle and all the different deliverables and all the data and all the communication, all the messages, information, overload, everything that we deal with on a day to day basis.

Our work as leaders is about connecting with other people. Building trusting relationships based on mutual understanding. And if we can do that, whether it’s in the sports context or in the academic context or in healthcare or whatever it may be, then we’re gonna have more fulfilling organizations and reward more rewarding lives.

Naji: Thank you so much, Ben for this inspiring discussion today.

Ben Shields: Thank you, Naji, it’s a pleasure. I appreciate you having me.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Angelique Adams

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji your host for this episode joined today by Dr. Angelique Adams, an author speaker, and executive coach focusing on leadership development for scientists and engineers. Angelique is an engineer with 25 years of experience in operations strategy and innovation. She was director of R and D. At aluminum, giant OAA and chief innovation officer at multibillion dollar steel maker, ARA after leading hundreds of scientists and engineers around the word, she discovered her true passion is developing people, not products.

Following the successful publication of her first book for women in stem in 2021, she launched Angelique Adams media solutions, a distribution platform for her books, online courses and coaching programs. Her second book be be on the lookout for women executives in college. Athletics will be out this summer Angelique lives in Knoxville with her husband and two children.

She serves on the board of several local nonprofits and volunteers, her time to mentor entrepreneurs. I am so thrilled to have you with me today.

Angelique Adams: Thrilled to be here. NA thank you

Naji: first. I would love to hear your personal story from engineering leadership and now author and executive coach what’s in between the lines of this incredible, uh, journey.

Angelique Adams: Thank you. Well, let’s see. So maybe I’ll start with, uh, a little bit about how I got into engineering, um, which is very much a story about wanting to improve my financial situation. You know, I grew up as a char as a child from the military. My father was in the us army. And so we moved around every three years, um, in all over the United States and in, in Germany twice.

And, uh, money was tight. In fact, I, I, I attribute my math skills to, uh, helping my mom at the grocery store and sort of rounding up the sum of each of the, the. Things that she bought so that when she went to the counter to pay for the groceries, we always had enough money to pay for everything. Um, and I knew I went to go to college because I figured that would improve my financial situation, but I had no idea what I wanted to study because everybody around me was soldiers.

My doctor, my dentist, you know, everybody was, was a soldier because we lived on all the military bases, went to school on military bases, et cetera. And when I went to a college just for a visit, they said, if you’re good at math and science, we have scholarships for minorities in engineering. And I said, okay, uh, I’ll apply.

And I got in. And so I be decided I was gonna study engineering, even though I had no idea what an engineer was, what they did, um, or anything like that. But. I went to Penn state and studied chemical engineering. I picked chemical engineering simply because at that time there were these, uh, magazines that would tell you like the top salary.

And that was the top salary in engineering. So, I mean, it was . So I started and I say all of that, just to say that I. Started my career journey, not be of a, because of, of a necessarily an engineering mission or a love of the science, but a purpose to improve my own financial situation. And, um, and then I, you know, I studied engineering.

I had an internship, I was starting to do a little bit of undergraduate church and it just so happened that, um, There was a, you know, lots of times at universities, uh, companies will come and take students out to dinner. And a company OAA took a group of us out to dinner, and I was telling them about my undergraduate research.

And they said, if you would be interested in pursuing that. At the graduate level, we would be interested in having you come and work for us and we’ll pay for your graduate education. So of course I said yes to that, to that offer. And that’s how I started my 20 year journey with OAA. They paid for my PhD.

Um, And then, you know, I started to work with work for them pretty early on. I raised my hand and said, I think I wanna be a manager. And I’m honestly not really sure exactly how I thought of that, but I just felt like this was something I wanted to try. I felt like I was pretty good with people and it’s something that I wanted to try.

And of course I it’s a, and my father manage, you know, as a Sergeant in the military manage teams of people that way. So I thought I wanna try it. And I was hooked immediately. I really enjoyed the process of trying to get the best out of people trying to deliver results that we couldn’t do as individuals, we had to work together collectively.

And I also. Really got a sense for what managers and leaders really do is care for the whole person. And I had two really shocking experiences early on. So the first thing was one of my, I had a very small team of just three people, one person, their home burned down and they had to run out of their home with only the clothes on their back.

And so, you know, as that this person’s leader, I. Realize. Okay. I have to try to help this person, you know, financially, but also make sure they’re safe. Um, make sure that they, you know, have what they need in order for them to, when they’re ready to return, to work, to be able to, to work in the best cap capacity that they could.

I have to really help help them manage their whole life. I had another person who was trying desperately to, to get extra vacation because he was managing his sister. Who had a mental health illness in Europe and we were in the us. So here’s somebody who again, was bringing his whole life to work. And he said, you know, I need help Angelique as my leader, how can you help me?

And both of those two experiences really shaped my kind of view of leadership as being much more than just getting business results, but really how. People to, to be their best, um, throughout their whole lives so that they can bring their best to work. And then I just continued to grow. My leadership got bigger and bigger teams went from three people to eventually 150 people.

And, um, then went back to school to, uh, MIT to get my executive MBA. Use that as an opportunity to do some product development work found a job in Europe to do some product development work. And I thought that product development was really my true passion, but I realized that leading the team and really helping them to advance in their careers, um, was much more into interesting to me.

And so at that same time, I happened to be working on a book. It was something that my MIT classmates inspired me to do. And so when the book. Was published and did well. I thought, well, maybe I’ll use this as an opportunity to actually pivot my entire career to focus on the, the thing I love the most, which is developing people.

And so that’s what I do now.

Naji: Well, thank you so much for sharing part of, uh, your story and those incredible stories along the way, uh, as you were, as you were developing others and growing in your leadership, uh, and, and you said, you know, you define management and leadership as caring for the whole person.

Few people do this. So I wanna recognize the fact that you lead with, um, with genuine care and, and love. This is, this is the way I believe leaders should, should lead. So, um, but it’s not that disseminated. Let’s say it in the word.

Angelique Adams: Yes. We have some work to do to spread that. to spread that mindset, Don, we, yeah.

Naji: so you’ve been, you’ve been in highly technical, uh, engineering environment, leading experts, right? And many times we hear this differences, right? When you are a leader and when you’re an expert and also leading experts, uh what’s what’s your leadership learning along the way. Cause you’ve had different experiences in different organizations and even leading different functions, um, at some point, so.

Anything specific you feel as a leader when you’re in this high technical environment, you should be focused on.

Angelique Adams: Yeah, that’s a great question. I think you made the, one of the first ones to ask me that. So I do, I do think that, you know, experts leading a bunch of PhDs. They’re very demanding of their leader.

They, you know, really want to make sure that they clearly underst. Stand the direction, the policies they’re very often gonna challenge things because of their level of expertise and, and, and wanting to feel like, you know, this, it makes sense to them. So that’s one thing I would say about, um, about managing technical experts.

and my approach has been. To one, make sure I take that into consideration. So make sure that as I am perhaps sharing new policy changes or sharing my vision and direction, that I’m very clear to one think in advance about objections. They may have through the lens of their technical expertise and be prepared to answer those questions, but also to be patient and to expect that, okay, even though.

I’m a technical expert in one area. I’m not a technical expert across every discipline. And so be patient in expecting additional challenges to come. So to not get frustrated, um, when it may be a challenge to onboard and get buy in, um, particularly on change with technical experts. The other thing that that I have found is that oftentimes when you’re in, in the organizations that I’ve been in big manufacturing firms, Technical experts were just one piece of it, right?

It’s a multi it’s a multidisciplinary business. And oftentimes the technical experts are a little bit, um, pigeonholed from the view of management. The. Oftentimes it’s because of our communication skills. We wanna talk in technical expertise and we talk over the heads of, you know, finance leaders and business leaders.

And, you know, they don’t have a lot of patience for us, but that has been because I’m aware of that fact, that’s actually been one of the ways that I’ve been very effective at gaining support of my team, because I’m able to help them TA learn to tailor their messages, such that leaders actually wanna talk with them.

And so, and that’s. So that’s, we can go from really feeling like we’re left out of some of the business conversations to now being, having a seat at the table, because we’re able to bring our technical expertise, but communicate it in a way that the rest of the organiza, it resonates with the rest of the organization.

And when you do that, when somebody goes from, nobody cares about me to, oh, the CEO wants to have a meeting with me now that you know, that’s a huge leadership. Win for, for the whole team.

Naji: Love it. Uh you’re you defined your passion as developing people, and you said, uh, purpose, you know, at the beginning, as you started, you discovered this, uh, right where along the way, uh, is this how you define now your purpose?

Angelique Adams: Absolutely. My purpose now is to develop actually, what I’d really love to do is to put 10,000 diverse stem professionals into leadership positions, partially because I think that really the way we’re gonna improve the diversity and inclusion piece of, of, uh, science and, and engineering, which is, is still very few women, very few underrepresented minorities.

Is to put people into leadership roles and have them change the culture of the organizations from within. So I really feel like because I’ve gotten myself to the C-suite and because I have a passion for, for this and, and some skills in terms of communication, in my own areas of expertise, I think that I’m well poised to really help develop diverse stem leaders.

So that’s really my, my ultimate purpose. Yeah,

Naji: you, you definitely are. So let’s double click on the subject, women and stem. Um, it’s such, you know, there is still such a long way as you shared for women and minority group in, uh, in stem, you have researched this domain, published a great book. What’s your vision on this important topic?

How can we close the dream gap for are our daughters for women really across the world?

Angelique Adams: Yeah, that’s a great question. So I think there’s, this’s a multicomponent challenge. I think there’s a lot of great work being done to get young girls and underrepresented minorities, even aware and interested in stem to begin with there’s a lot going on in universities to sort of keep the pipeline going.

And my own personal expertise is more around mid-career professionals. That transition from being an entry level person to being considered for leadership and management roles. And that’s where, whether you call it the leaky pipeline or whatever you wanna call it, that’s where a lot of things. Happen, uh, in the case of women in particular, oftentimes that’s when women are interested in having children.

And so that can cause a challenge, the work life balance issue, um, then because there’s so few role models, there are challenges about how do I actually navigate this. This type of space, this type of career as somebody who’s different from my peers or the senior managers that I’m working with. There’s lots of questions and uncertainty and, and feelings of self doubt around that.

And that’s really what I focus on. I focus on teaching leadership skills. I focus on. Helping people with their mindset around imposter syndrome and self doubt, of course, by being who I am, I’m automatically a role model. And I think I finally sort of embraced that as, okay. , there’s no way around that, which for me means really being much more comfortable being.

Out front. So I’m used to being behind the scenes in large organizations. And now I have, you know, I’m the face, obviously the face of my own small organization, but I have to be out there talking about my message, like I’m doing right now, which, which has taken me a while to get used to. Um, but those are the things that, that I think will, will help individuals.

So I focus on really helping individuals. The other area I focus on is talking to organizations and being, um, Being sharing. First of all, what I’m learning from all the women I’ve interviewed kind of the insider’s perspective of the barriers that they’re facing and the challenges that they’re having and what organizations can do to help.

And also maybe bringing a, a little bit of a different perspective because I’m not a diversity and inclusion professional. I don’t see through the, at lens I see through the lens of large organizational leader and what. People want for recruitment and, and retention. And also as somebody who has been the only, you know, the only person in the room, what, what, what that experience is actually like.

So I’m willing to talk about that to leaders and per perhaps offer them some different tools from what they were considering.

Naji: What, what about, uh, me as a man? You know, as an ally, how, what can I do? What should I do? Uh, I, I should frame it that way for, to, uh, to reinforce what you’re trying to do.

Angelique Adams: Yeah, I think that men can, there’s a couple of things, you know, that men can do. I think that men can, first of all, really help reinforce the challenges that they’re having in their own careers.

Because one of the things that often surprises organizational leaders is when I say. If you really wanna help women in under underrepresented minorities in their career, be very clear and intentional about career path opportunities, make sure that people understand how they can progress and grow and that you provide tools to help them get there.

And they say, oh, well, doesn’t everyone want that? And I was like, yeah, actually everybody does want that, but you, but many or organizations don’t provide that. So what I feel like one thing that men can do is to be vocal about. Where they’re struggling in their own career. And that may help organizations realize, okay, we have some systemic issues that if we fix we’re actually gonna improve our entire organization, which will include women in underrepresented minorities.

The second thing I think men can do is decide what level of, of comfort they have with, with raising issues. So, um, one of the things that I. Like to, to say, is that, you know, it’s actually, I think, okay. To not necessarily want to be confrontational or to, um, call people out. I, I know that. That, that is one important way of allyship, but I also think it’s, it’s okay to not feel comfortable doing those things also, uh, because a lot of people don’t feel comfortable doing those things.

So think about what you do feel comfortable doing. And my one of my favorite tech techniques, it’s a very simple thing. Is to help manage interruptions. When you talk to women, they, one of their biggest frustrations is being interrupted in meetings. And what I tell leaders in general, but including as including men is to say, can you just develop the practice of saying good point after somebody gives a comment?

In a meeting, you don’t have to, you don’t have to, um, necessarily stop the meeting and say, Hey, you interrupted this person. Stop doing that because it’s disruptive. You don’t have to do that. What about if you, if you’re proactively after somebody makes a comment, say, oh, that was a good point Angelique, then that person’s affirmed.

They’re heard they weren’t interrupted and that person’s gonna have a much better day than they otherwise would have if they tried to talk 20 times and got interrupted each time. So for me, that’s a way to both be an Allo, but also acknowledge that maybe you’re not comfortable stopping a meeting and say, Hey, Quinn interrupting everybody.

Um, but you’re still doing other things that, that are working in the, in the, in the direction that we want things to go with.

Naji: I love it. This is such, uh, simple and I think powerful technique for us to do, uh, what, you know, one of the pieces we are hearing. And I, can’t not ask you this question about steam, right?

Like what about art in stem? Any thoughts about this?

Angelique Adams: Yeah. Yeah. I, I think that it’s fine to add art to, to steam. I mean, I, to stem, I think that there are. There are some values to doing that from an educational perspective. And I think when you get to the business world and really focusing on, um, recruitment and retention of different fields, they obviously start to, it starts to starts to diverge.

And when you’re talking at a, about a big manufac extra firm, you’re talking about scientists and engineers that you need, not necessarily people in art. So. I think in some places it makes a lot of sense to add, to add art. And in other places, you know, it will naturally maybe, maybe fall out, um, of being something to focus on.

But I, I don’t have a strong sort of objection. .

Naji: Great. And there’s all this topic I’m sure you’re, you know, about, uh, on epoch, like how to develop all those smart skills, right? Like empathy, all the others to add on stem. So, so this is also another big topic. Uh, I would want, uh, now to move into a section where I will be your reaction.

Angelique Adams: Leadership to me means focusing simultaneously on people and their entire wellbeing and results and the best leaders can do those two things simultaneously

Naji: innovation.

Angelique Adams: Innovation to me is the application of new ideas. Whether those ideas are completely new or whether they’re a, uh, reorientation or a co um, combination of different ideas. I’m less concerned about where the idea comes from, but it’s a new way to actually do something out in the world.

Naji: What about spread love and organizations

Angelique Adams: spread love in organizations. I’d like to see organizations celebrate more. That’s one of the things that I talk a lot about when I talk about leading innovation is how important it is to celebrate wins. I think that it’s often a misconception that celebrating leads to complacency or people feel like they don’t have time for it.

I think the opposite is true. And not only should you celebrate the big wins, like the major milestones, but I think good leaders actually. Are constantly on the lookout for even small wins both individually and as a team that they can celebrate. And that, that positivity will radiate within the company and lead to good things.

Naji: Love it. Any final word of wisdom, Angelique for the leaders around the.

Angelique Adams: I think that that’s one topic we haven’t talked, talked a lot about yet. Maybe is this topic, you mentioned it, but is this topic of empathy? Um, and it’s a huge topic today in leadership. And, and I think that it is a little bit nebulous, particularly for, you know, the type of people that I typically work with scientists and engineers.

It like, what do you like, what are you talking about? It’s this abstract idea. And I think a way to kind of start towards empathy is actually to be a little bit more open about our own challenges and struggles as leaders. Because when we start to talk a little bit more about those people start having empathy for us and say, oh, this is a real person.

Oh, they’re normal. Like they’ve, they’ve had struggles, they’ve had failures, they’re having a bad day and that will then in turn. Allow our staff to feel a little bit more comfortable sharing those things with us. And once we start doing that, that’s how we’re starting to really UN uh, reveal our whole selves to everyone.

And then we can start taking care of those whole selves. But until we start to, to have that level of conversation, it’s really a challenge and we’re still only focused on the business results. So. I would encourage leaders to, to be the ones to take the very first step and provide a little bit of sharing of some of their own challenges.

Naji: This is super powerful, like bringing back humanity right into our leadership. Mm-hmm being just human as we beat people. Thank you so much Angelique for this inspiring discussion we had.

Angelique Adams: Thank you for having me.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Angel Perez

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love.

I’m Naji and in this episode, get ready to have your mind challenged with what social impact really means. We’ll dive in a leader’s passion that became now his company’s purpose to build a better word. Angel Perez is founder and managing partner at transcendent, a business impact consulting firm. He has an extensive experience in the pharmaceutical industry, leading commercial organizations as a general manager and marketing leader before founding his company. He served as the senior director marketing capabilities, commercial operations and AI, heading different transformations, including marketing automation and creating closer collaborations with startups and public bodies. Angel was named one of the 2015 internationalists of the year by the internationalists. He lives now in Spain. And I’m just super excited to have you Angel with me today and so much looking forward for our conversation.

Angel Perez: My pleasure, Nancy. Thanks for having me here.

Naji: So I help between all these, you know, lines of your career, the great success that you had, both in pharma and now actually starting a business and growing business.

Can you tell us a little bit about your story? What, what got you into healthcare and now even a broader impact, uh, in the world?

Angel Perez: Sure. Thanks a lot. Um, well I guess that my, my journey within business, I. Had degree economics. I had an MBA at Chester business school and straight from that, I joined MI Eli Lilly, uh, fantastic company to grow, uh, as an individual.

And luckily in my case, as a leader, uh, having marketing a sales experience in Spain, I very quickly been promoted into opportunity and challenges. Uh, I think that I’ve been extremely blessed by the people, uh, leading or having ahead of me. Um, My career with inform and Lilly went quickly, uh, being a managing director in Denmark.

Uh, well, we might talk about this later, but most probably not being ready, uh, to perform at the age of 34 leading a country. Uh, but with plenty of people around who wanted to help and, and we were lucky in some cases and also through hard. To, to manage, to, to achieve the performance that was respected and then getting into regional positions, uh, with the need of leveraging different skills to lead or to make things happen.

And we can double click into that later as well. Um, I was having a fantastic, um, multinational C career path. And, and quickly while something happened in, in 2014. And for me, that was my aha moment. Um, we were with a group of marketers, uh, of, uh, between Australia, Canada, and Europe, uh, spending a few days in London, uh, visiting companies, trying to open our minds on the commercial side.

And how could things be done differently within, in pharma, uh, with the program organized by wavelength and well, the last visit, uh, on that trip. Was, uh, to a creative agency called Liberty based in Briston, in, in London. Um, and that company was the first time I, I came across a social enterprise. Very, um, well profitable company, but at the same time, with a huge effort on helping kids and adolescents within the neighborhood to go back to the proper path on education and going to school or university and using their insights even to, to have to win context and doing basically pitches on their, on their business.

And, and despite being in pharma and knowing that within pharma already, we were making an impact for me, that was the big aha moment, what I consider, uh, doing something else and, and not only pharma, um, coming back to Spain, uh, I, I, I very often say that that trigger curiosity, uh, for the first time, So when I came back to Spain, um, I started to know to try to know more about the, the social enterprise ecosystem in Spain.

Um, luckily thanks to the leadership in the Spanish affiliate and in the region we managed to put together the first program in Spain to support social entrepreneurs in health, uh, called them branding health, which is up. And, and this is this fifth year running in Spain. Um, well, and, and that was not enough.

And then, well, the, the big moment in my career was in 2017 when the, the decision, uh, thanks to the support of my wife was to leave almost 20 years successful career in Lilly and, and put together transcendent, which as you said, is a, is a consulting film, helping companies to leverage impact the, uh, as a, as, as a, as a platform to improve performance.

Um, Four years ago, uh, corporate social responsibility was. Somehow, um, knowledge, uh, but nothing about impact, not even ESG. Um, well, those topics that today, uh, we can, uh, know and, and, and are wider know than, than before, uh, were not concepts. Um, so, so much used in, in, in management as such. Uh, but the reality is that.

But maybe, uh, unfortunately due to COVID, but the reality is that today we are, um, growing, as you said, a company, a small service firm, helping businesses to do better and to improve their top line through impact. Uh, and that is what is driving basically when, what, what I found as my, why, uh, after being, uh, many years in pharma.

And now, now here,

Naji: Wow. Yeah. That that’s amazing. You know, how, how you’re defining your why and how you’re helping. Obviously companies get into performance through impact be before. And I want us to discuss about, you know, you talked about CSR impact. You’re seeing this trend of companies changing now finally, into getting into social impact rather than, uh, just respond to.

As we had it. Um, but before that you talked about being very early on 34 years, I think you said taking a leadership position, uh, having to drive as a general manager in Denmark, I think at that time, you know, your teams, your business, uh, tell us a little bit more about this as we were seeing more and more leaders getting into leadership position early in their career, even earlier, uh, sometimes.

And what, what are your learnings or. Words that you would tell them, uh, from what you got.

Angel Perez: I, I, I usually get the feeling that I, I had some experiences too early in my life and I didn’t make the most out of them. And this is probably one, but at the same time, something that is, I, I, another topic that I always consider, or I I’m usually quite optimistic.

And I see the, the, the last half a full always, I was. Clearly not at my best to deal, uh, with the situation in Denmark, but I was blessed and lucky with the people I had around. Uh, there was a, a leadership team in Denmark already up and running, and that helped a lot. And I was, and, and this is just not by chance, probably the, among the very good leaders I had within my career in Lilly.

If, if I come pick just one, I would pick Patrick Johnson. Um, who was the, the leader of the Scandinavian cluster on those days and was my boss. And he’s for me, the, the clear role model on how to balance, uh, being strong with operations and management and smart and soft and close to people, uh, on the, on the people’s side.

Uh, and I learned a hell of a lot looking at team, um, competencies when you are a young leader. Well, I think that the ones I’m going to name are. Maybe especially important when you are young, but probably are the ones that I try to still use these days when I’m not that young. Um, I, I think that trying to be humble when you don’t know things, um, has been useful and powerful in my case, um, I think that cultivating empathy, eh, when you’re talking with people is key, especially when you don’t know about your business yet.

Um, I was lucky or, or blessed us again, uh, to attend plenty of training courses, but there is one that I, I use and I still use very often, uh, related with a book, the mood and with a, a single line that I keep very close. In fact, I have it in my, in my, in my office. Um, be here now, uh, when you are talking with someone you have to be, or that person has to be the most.

Important personally in the world when you’re talking with him or her. Um, and, and then the other two, that again is not only when you’re young, I guess that probably they are forever is if you are able to lead by example, most probably people will be following you. Um, clearly when I was 34 or 35, I was not able to articulate this the way I have said it now, but probably those were the things that at that point with a mix of intuition and, and knowledge were the ones that allowed me together with many people around to be somehow successful.

Naji: Yeah. This is so powerful, really. So, so powerful. Insights. And you know, many times I say you set it combining two things that for me are, are really crucial for, for leaders. I, I usually say love and discipline, right? Like this is, this is what makes leaders successful and, and you shared it. So you, you then led throughout different countries.

You led globally Canada, Europe in moment of transformations, as you said, in marketing and. Anything from a leadership learning, you know, as you went there and didn’t, cross-function cross operationally cross-functionally and cross country also culturally mm-hmm and anything that, that stood out for you as a leadership, did anything change from those early learnings about, you know, genuine care and, and making sure operationally things are done.

Do you think it’s the same recipes, but that you just need to adopt them?

Angel Perez: Probably it is the same base. I mean, it’s like, uh, olive oil for any dish you cook in Spain, you start with olive oil and garlic, maybe. So the, the, the main, the main ingredients are the same, but then you need to use some other, uh, tactics to, to put it that way.

Um, when I move into a regional role, and again, what I’m going to say in the now sounds very natural to every one of us now with COVID, but again, back in 2009, uh, excelling your skills. And how to lead, uh, from the distance that was not so common. Uh, at a point, I mean, I was based in Spain only with one diary report next to me, Madrid and the group of 15 people reporting and then longer groups, uh, were spread all over the place.

Uh, so for instance, I might only go three times a year to Canada, uh, because of the functional structure. I was not the owner of their budget. So how on earth can you be leading a group from the distance, not controlling the OPEX, but making things happen. And, and I think that the, the, the key recommendation or advice on that situation is you, you need to make sure that you try to lead by influencing and the, the time you spend with people face to face that you try to, to deliver, or to provide some kind of lasting, um, trusting experience.

And then you keep building on that while you are not there anymore. So going back to this, be here now, and that you can do it virtually as well. And that the last year we are excelling on that because there is no choice, but if you could only talk over the phone with someone in Australia every month, how do you make sure that that half an hour, that you are linking previous conversation, that you are keeping an eye on the loft side, as you said to then get deeper into the discipline piece and to try to keep some.

Cannons or momentum despite being far away geographically. And, and during the time as well, on, on during the, the daily work, I, I think that the, by cultivating this trust in the distance and this sense of, eh, feeling that the one who’s talking with you is really important for, for you really was a relevant bond that made.

The ongoing, uh, managing and, and business discussions successful.

Naji: Great. Uh, and, and I want to switch now into, you know, you, you shared about CSR social impact. Uh, and I, I wanna double click on this. And you said in the beginning in healthcare, it’s sometimes so obvious, but we don’t look at it that way.

Right? Like our social responsibility, the impact that we bring with medicines with, with care devices, whatever. And out here we are is so massive. But then there’s always, you know, the CSR that feels a little bit disconnected, right? Like this corporate social responsibility, you took it to a different level, right?

With, with you being curious in the beginning and now actually helping companies to, to have a social impact. Uh, tell us a little bit about your journey here. How would you separate CSR from social impact? Uh, I, I, I saw you, you shared this and, and I agree with you, you say like only companies that include social impact in their core business would exist to more.

It’s a very provocative way to saying it. So, so help us understand and how we as leaders can, can bring this social impact to our, our

Angel Perez: companies. Very good. So first of all, disclaimer, I’m clearly positively biased to pharma industry because that is home. So, uh and, and, and I guess that despite these bias, I think it’s fair to say that the healthcare sector and the pharma industry does deliver a strong, positive impact in social society full stop.

Now, whether that is being properly perceived, whether that is considered as it should. Whether the companies that are perceived to be changing the world are pharma companies or others. And it should be the other way that is another debate. I guess that’s another podcast, um, going to your question and, and trying to not to get very techy or, or sophisticated on the wording, the, the, we talk very often not transcendent on the business impact journey.

And this is agnostic of sectors, basically saying companies. From the very beginning, imagine that a company has different boats or ships, right. And there is one sip, which is the, the business, the core business ship with the best, um, boat, the best, um, uh, crew. With plenty of OPEX and resources and they need to do better on the business side.

They go that way. Then there is smaller boats that are the ones with corporate resource and responsibility that are trying to get some impact in society, but it’s far away from the core of the business. Okay. So when talking about CSR, this is like the, what do you do that is far away from your business?

That is good for society. And that, that was like the bread and butter until. I’m making, I mean, nobody statement five years ago now, as you move into the next territory or island, many times companies realize that, wait a minute, we might be doing better business by monitoring what our people in corporate social responsibility or in sustainability as such too, and suddenly they start getting together.

And that is the next step. And that is what is starting to happen this day. So saying. If we are a smarter with our, these, these letters that are like best letters lately, this if for environment is for social and G for governance, this ESG, and you realize if we as a company, not only report because it’s mandatory to do this, non-financial reporting, but we manage our ES the output properly.

This is good for business. And that is the point when I go back to pharma and say, come on. I mean, the essence of pharma is the good. Um, and it’s not only to do better on the environment. It’s the impact you have on society by having better molecules, better products, I’m providing better lives for the people who benefit from us.

And that is what I, we want to believe that we help companies together at that point to understand putting the core of your business. Close to the effect you have on the environment on the society and how you do governance is good for your business in terms of output as such. And that is the next step.

The, the, the, the, the promise land, I mean, the, the purpose island, and that is next is when you realize that is not only about the output about the outcome, where is the effect of your action on the people and on the planet out there? And that is one instead of measuring output, you measure the outcome of what are you doing there.

So it’s not only how many, um, pills, how many treatments you have, what is the impact on the patients on their lives? What is the impact you start building process to put into well, to value all the effect that you’re doing in the case of pharma. I, and it’s the same across sectors. So. From CSR out of business to ESG where suddenly business look at these outputs as an opportunity to perform better.

And to finally think about what is the impact I want to proactive. I want ask, I want to make proactively in. So with society and, and, and basically the planet, if you look about, uh, environmental topics, those are the three stages of this business impact journey that we see, um, in a very quickly. And I don’t know if an organized way.

Um, happening with companies and that’s what we are trying to do. We try to accelerate their journey to understand that the farther or the closer they get to their purpose, to this territory of purpose, the better it will be not only for society, but clearly for their own business.

Naji: Yeah, that’s that that’s powerful.

And I’m gonna do the link. You talked about social entrepreneurship and health that, that you, you built. And, and I know you’ve been always very active with, you know, startups and building things differently and really an adapt of like small experiments and then you can grow it. So how, how do you see this?

Because the transformation you are helping companies to get to is obviously really, as you said, this, this promised

Angel Perez: island, right?

Naji: And. I’m not gonna go into politics, what we’re seeing globally, but obviously a lot of movements are not going there. So how, how are you helping people get there? Are you really looking at small things as you’ve done that have a big impact, right?

Like with small entrepreneurship, within a company and then building on this for people to get there, or, or do you think at some point policies will change for us to get there? Like, like how, how are you naing this down for you to be able to work with companies? Very good.

Angel Perez: Great question. Not, not easy to answer, because if I, I, I will try to, it is, it should be different company by company, but I guess that there are at least four, um, driving forces out there suggesting, or even obliging companies to move.

As you said, one is clearly regulation. I mean, I mean, in the case of Europe, we were farther ahead now in the us, it’s moving, moving forward quickly. Um, companies do see now their obligation to report properly on this. And this is great because even the, the laggards are feeling that they need to raise the bar.

That is one thing. Uh, peer pressure. Luckily we start to have champions almost in every sector of companies leading the way. And you don’t want to be a Lagar, as I said, so you want to do that as well. Mm. Society, customers, clients, I mean, very clear, even, even if we don’t do what we say in surveys, that we will always go for the super environmental, uh, opportunity and product.

But the reality is that that rent is irreversible and, and not last clearly not least, um, money itself. So today we see that investors are looking for opportunities to invest on ESG related, uh, companies or opportunities or even opportunities where you can measure the impact. So those external forces, we want to believe that I are making the positive, perfect storm for companies for the smart business leaders to realize, wait a minute.

This is not lateral. This is not CSR. This is not a cost center. This this could be profit center. And, and that is a time when you can engage on a pure management business conversation with the C-suite, uh, not talking about funding, which is fantastic and NGO it on improving your performance based on impact now.

How do you make that happen? How do you get the spark in different companies? Well, depending on their reality, their sensitivities, the challenge from the competitors and going to your, to your first point, in some cases that you might, uh, align the fire with the opportunity to put together companies with social entrepreneurs.

And that’s what we did at really starting in 2016 with this program where basically. Lilly together with unlimited Spain, an NGO, uh, that is, uh, which expert has the expertise to accelerate social entrepreneurs. Um, healthcare, uh, social entrepreneurs were incubated by Lilly and unlimited Spain for six or eight months.

So that. These, uh, guys with fantastic concepts, uh, at the very early states, got all the knowledge from Lilly employees in Spain to know about the sector. And, and that was a great time when you realize, you know, a lot about the sector, how many people don’t and then Lilly was able, I always put the, the analogy of like opening the windows to get a there, um, no fear to failure, uh, being far more curious, And looking at opportunities within pharma that potentially were unknown or non explored by traditional pharma companies, so that you could truly get into some kind of cell value concept, uh, on, on leverage team from social entrepreneurs in big pharma and help, and truly helping these guys to move up next, accelerate their businesses.

Naji: that’s a that’s that’s powerful, uh, example. Thanks. Uh, and for sharing this, uh, I want us to jump into, uh, kind of a different section, a game. If you wanna call it, uh, I’m gonna give you one word, uh, and you will give me top of mind idea that you, uh, that you will have sounds good. Yes. So, so the first one is startup.

Opportunity

the, the second one, uh, is, um, transformation,

Angel Perez: mandatory to survive.

Naji: You you’ve led many of those, tell us a little bit more. It’s mandatory to survive, but it’s usually tough to, to, to implement, right?

Angel Perez: I mean, these, these days, um, no one on earth is going to have a successful business without two levers. In my view, one is, uh, technology and the, the other one is impact.

Uh, and, and not many companies are there yet. Unless you truly transform and understand that those are the new peak levers, uh, of success in the future. You will not, will not even be successful. You will not survive as a business. I’m convinced.

Naji: Yeah. The, the third one is responsible business.

Angel Perez: Uh, I mean, in one word, I would say mandatory.

We have a couple of analogies we use quite often here at transcendent. Um, one is some, I mean, I’m older than you Naji. Uh, not many years ago. People could smoke in the airplanes and not many years ago. I mean, our parents put at, at the back of the car without a safe belt. Um, and they were not doing it because they didn’t want us.

It was because that was not the time for it. Um, we are very close to go back and look in five, six years ago, look back to 2021 and say, wait a minute, this, these guys allow business to run, not having their business with a minimum check of being responsible. I mean, well, that is, that is my big bet on, on, on what we are doing these days, but that will come.

Um, and, and luckily due to. Technology that is allowing us to have businesses being extremely more transparent than ever. You. We will be able to see who, which businesses are being responsible, which ones are not. And the ones that are not, they will need to evolve or transform, or they will not have a chance.

Uh, because, because this will be a mass, I mean, going back to labor conditions, going back to those topics that are already luckily, already a part of our. Routinely way of doing business very soon. We’ll have a minimum check to be responsible business, or you are out of here.

Naji: Yeah. Yeah. So try I’m so needed, right?

It’s we, we can’t, we won’t be able to survive as a humanity if we, if we don’t deal with this. Immediately, you know, there there’s some I’ve read something like it’s even already too late. I’m not gonna give I’m, I’m an optimistic like you, but it’s, it means that really we need to, we need to ramp up our capabilities on, on social impact for sure.

The, the last one is spread love and organizations.

Angel Perez: Yeah. I mean, I was expecting this one, not the other ones. It’s, it’s funny. Because very early in my career, I met someone who was joining my team and, and she was asking me, so what, what do you want to, to do, I mean, with your business career? And I was very naive, but I said, well, I want people to, to, to be enjoying what they are doing.

I want them to enjoy being at work. And I probably, that was a very naive statement. Or at least I was not able to support it as properly as I think I can do to today. Um, at this stage of my career. I struggle to see successful companies, not spreading somehow love in their organizations or to put it in another way.

Successful companies that do not spread love are missing great opportunities or being of being even better by taking care of this as, uh, very true, um, business and managing tool. Um, I’ve seen, um, very successful business, very successful teams and very, uh, productive teams, uh, working with and without love and care, uh, the ones where you can install and cultivate and work, because this is something that you can make happen.

Uh, this, this handle and love and care between each other. They perform better. I think that the, the, there is evidence and empirical evidence that that is, that should be there now far is easier to say than to do. Unfortunately, the current circumstances with COVID, uh, I was talking this morning with a big multinational saying, we, we need to go back to finance more than we used to be a year and two months ago.

Of course. I mean, again, dealing with a big company is not easy, but, um, not forgetting this. As a, as a nice managing management level. I think that, um, I, I, I think that spreading love in organizations, uh, is a, is an opportunity and a key success factor. If you can do it properly. Yeah. And again, I mean, sorry, and I can be biased because I was blessed by, by having my development as a, as in my professional career in Lilly.

And, and it is a culture where I would say spread a love is part of the culture. So I’m, I’m again, positively maybe biased on that, but I strongly feel it.

Naji: Yeah. And, and as you said, I think, you know, during those times it’s, uh, you link it to performance, right? And there are bunch of things out there that show perfor high winning, performing teams have the genuine care.

Right. And. And I love that you’re sharing. You’ve experienced that you’ve done it with, with your teams very early on, uh, as a GM and then growing into organization, you kept on doing it. And, and I imagine now with, with your company, you kind of do it daily and you help others kind of build it.

Angel Perez: And, and if, if I may, and then, I mean, and suddenly you, you see that spreading love somehow can link fully with any company’s purpose.

I mean, why are you as a company? Why do you exist? And this is not, and it cannot be making money because you want to do something better, uh, than, than, and, and if you are not here, what the world or society miss, there is an element of care, uh, within any company. Um, and, and even the ones that are there just for the money, well, they will not last for long and, and looking into the future, they will last even less because all of them, at some point, whether it is genuinely or because they are forced again, going back to peer pressure, this is an element that needs to be embraced as a core competency in any business.

Naji: That’s strong core compet competency. I, this is strong. I like that. Uh, tell you, you shared about, I know you’re a big fan of, uh, reading things. You’re so curious. I, I follow your curiosity and the things you look and as you’re courageous to change things, Anything you’re reading these days or anything that you would advise us to have a look at or to follow for us to get into this transformational leadership and, and the social impact that that you’re at?

Angel Perez: Yes. If, if one book, uh, by Sarah Ronald coin impact, um, I’m not going to spoil the outstanding story of, of Ronald going, uh, a book that is. Easy to read outstanding, at least for me, effects on how do you look at business? Um, another author, he has three books that for me has also been very influential Mohammed jus uh, the father of micro loans, um, uh, Nobel this no prize, outstanding, uh, writer.

The last book is like the three, uh, zero sum effect, something like that. Um, those two books for me are key. Another one that I enjoyed reading last year is reimagining capitalism, uh, by a professor at Harvard business school called Rebecca Henderson.

Angel Perez: and, and then, I don’t know. I mean, I already mentioned it, another one.

Um, I mean, I we’ve been talking a lot about, um, aspiration and, and wishes and the like, but at the end we are here to perform and we need to deliver right. And, and a book. And, uh, that has been, and I, you still have a very, and I use very often is called the four disciplines of execution, uh, because at the end, This is about executing

Uh, so I mean, don’t get me wrong. Uh, I’m not becoming more naive as I get older. Um, after we talk about all the things we’ve been talking, this is about making a business successful and for disciplines of execution is something that I’ve been, uh, using for more than eight years. And at least for me, it, it works,

Naji: but yeah.

Great, great, great books. Uh, and yeah, you said it many times is how you combine both, right. Little care, love and discipline about the, how, uh, well, any final word of wisdom and how for all those leaders and executive around the word, and maybe on the social impact that you need to have. Any, any advice, any word of wisdom

Angel Perez: is been a, it’s been a pleasure talking with you Naji. First of all, the, the not, not only about impact or, or business impact. Um, probably the biggest learning for me and that I’m trying still to keep it as alive as, as possible is you can foster and cultivate and everything in my career over the last seven years or so has been based on building my career city.

Of reading different books of following different people. Um, whether it’s tweeted, whether it’s LinkedIn, whether it’s, uh, looking at the book reviews. Um, my, my, my stay curious is the, the name of the game. Um, and as a business leader, I, I think that you cannot afford not being curious. Unless you have a team of curious people around you, which is a good plan B, but it’s less fun.

So, um, find something that is not your core. Again, it can be impact. It can be technology. It can be both, but keep your brain, uh, fresh by cultivating your C that be my well advice. My suggestion.

Naji: Well, uh, thanks again for this great conversation. I’m sure you use part of this curiosity for all of us to go and look more into what social impact means, uh, for us to, um, really make the word a better place for, for ourselves today and for the future generations.

Naji: Thank you so much Angel for your insights and, and this great conversation.

Angel Perez: My pleasure. Thanks a lot for inviting me to talking with you Naji.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Andrew Bunton

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I’m Naji your host for this podcast, joined today by Andrew Bunton Vice President of Omnichannel customer experience and at CVS Health, Andrew leads the efforts to create a differentiated, frictionless pharmacy experience leveraging cvs, digital and physical assets. He has worked at CVS Health for 10 years, including leading the retail pharmacies, development, and management of clinical services, retail health services strategy, and new product development. Prior to CVS, Andrew worked at Bain and Company and also as Vice President in the corporate and investment banking group at Bank of America. Andrew, I am so excited and honored to have you with me today.

Andrew Bunton: Thank you so much for having me. I’m excited about this.

Naji: First, I would love to hear your personal story. What’s in between the lines of your journey from purely business to banking and now leading in the healthcare industry?

Andrew Bunton: Yeah, I’ve, I’ve always been driven by wanting to make an impact and, and it’s, uh, and it’s interesting cuz I think even when I was in college, you know, flirted with maybe going into ministry and kind of thought, thought some about that.

Um, but ended up seeing that that was not my, my calling. Um, but, um, but then, uh, had an experience, um, had an experience at the Tuck Business Bridge program that kind of opened my eyes to. You know, just how invigorating and, and exciting the business world, you know, really was. And that’s what kind of lit my fire and desire for going into business.

Um, but along the way had always been looking for, you know, how can I make sure I’m making as big an impact as as possible, um, you know, through, um, you know, through business. Um, and that’s, and that’s really. Brought me to, you know, to focus on the healthcare space where I, I feel like I can kind of give back using the talents that, that, that I, you know, that I have, you know, leadership, you know, analytic, capability, strategy, toolkit, Um, you know, but, but, you know, make a difference, make a difference for, for folks.

Um, and, and so, uh, that that’s really, you know, been, been part of, part of that journey.

Naji: You definitely are doing a huge difference leading such a, such a large organization. So with CVS Health, uh, and specifically you’re using, and you talked a little bit about it, uh, data analytics, omnichannel, We hear a lot about omnichannel and all, you know, all of us in a healthcare want to get and become an omnichannel company.

So you’re reading those efforts. Uh, can you, can you tell me a little bit your definition of what omnichannel means?

Andrew Bunton: Yeah. At at, at the end of the day, for us, it’s really, you know, how do we meet our customers where, where they’re at. Um, and, and if, if a patient really wants to get their, say their medications delivered, um, you know, at, at, at at home, making that as easy as possible, if they want to come into the pharmacy, that’s great as well.

But how do we take a lot of the friction that’s historically existed within the pharmacy industry, you know, out and, and. You know, give, give the patient more power, you know, right at their fingertips to, to control their, you know, their medication and their overall, you know, health, health regimen. Um, it’s interesting and, and healthcare, you know, so much comes down to the little micro barriers, um, in terms of, you know, taking the right steps.

Um, and so what, what we’ve seen is, is if we can really focus on making things as easy as possible, you remove a lot of those micro barriers. And really help help patients to, you know, to stay on their medication therapies and live, you know, healthier, more active lives. So when

Naji: you started this transformation or this journey around omnichannel, I imagine those are large changes for the teams, especially when you have physical retail stories and, and now moving into digital, we face the same in the corporate word with, uh, with pharma.

Uh, obviously how, what is the key capability in your leadership style and the way you led those teams to be able to deliver, uh, on the omnichannel strategy?

Andrew Bunton: I think a lot comes down to, um, really, you know, energizing, exciting the, uh, the team around, you know, the, the, the art, the art of possible, you know, what, what could actually be, you know, delivered at the end of the day if, if we really get this right.

Um, and so a lot of it’s kind of starting with the patient and kind of grounding it in the. What is the, what is the patient looking for? What are some of the pain points that exist for our patients today? Um, and then how can we, how can we work to close, to close all of those gaps and getting folks excited about a world in which we really could deliver, uh, a frictionless pharmacy.

Um, and then, and then as we go, um, you know, it’s great to have some, some quick wins to really, you know, start to energize folks and, and get folks excited about, you know, about what, what is, uh, what is possible as we also work on some things that, that take a little bit longer, um, and, and, and are gonna require more persistence to, to chase after.

Naji: I love it. The art, uh, the art of possible. And you share, starting with the patients, and you, you said in the beginning, your purpose driven, uh, leader, and this is what made you ca come to healthcare. Uh, also, so how do you make sure that the patient is alive? When you’re leading large organizations for your teams, many time we get into, you know, our operational things into our, uh, the weed of what we need to deliver, like the website, how it’s looking, what, what we need to do a little bit more, a little bit less.

And we forget that actually at the end of the day, we are helping a patient live better. Do you, do you have any tips for leaders in healthcare on how to make sure that the patient is alive? Whatever we are doing, uh, in, in our work daily.

Andrew Bunton: It’s a great, uh, it’s a great question. Um, and I think that, that there’s a lot of things that, that can be done.

Of course, it starts with grounding it in the consumer, the consumer research and kind of keeping that, that front and center, like what are the jobs to be done, what are the, the real things that we need to be working on? Um, but one, one thing that’s really helped. Thus along the way is making sure that we have some, um, some design thinking, you know, experts who are in charge of really monitoring and tracking the overall customer, you know, customer experience as we go.

What, what if, what sometimes can happen is, um, is when you have folks who are pushing on certain features or certain innovations, um, you know, that might be a great success, but it might conflict with something. That, that’s being worked on. So, so at the end of the day, making sure that there’s some folks who are really tracking the overall customer experience and how everything is kind of coming together at once.

And then as, as we go really, you know, testing, testing out innovations on, on patients. And so, Not, not working all the way until something is fully developed and then launching it and seeing what happens instead. Um, you know, ex exposing, exposing, you know, customers to, to prototypes, um, and, and, and really getting there, getting their feedback and, and what, what they use it and what do they like about it, what don’t they like about it, Cetera, et cetera.

To make sure that we’re kind of staying grounded and really what are our patients looking for and what’s gonna resonate with.

Naji: I love that you’re, you’re talking really about those iteration and innovation that you can go fast with, you know, like MVP and test and improve. Uh, I’m, I’m interested to know how in a large organization you manage to.

Push those ideas in and more from a leadership standpoint. Right. It’s, uh, because usually large, the, I’m feeling the larger the organization is, the less nimble sometimes it becomes. So how did you manage to get this, uh, culture or mindset in your team?

Andrew Bunton: Yeah. Um, I, I love, I love continuous improvement. I love thinking about kind of iterative, iterative design.

Um, and, and at the end of the day, I mean, I think the, the, the nice thing with it is it, it really aligns incentives as, as well. Um, you know, if, if you, um, it’s very difficult to, to fund something when you don’t have a proven business case. Um, but if you can, if you can go test something out, even if it’s in a very scrappy manner.

And show that patients are really interested, um, and, and show some of the potential benefits that can come from it. Um, then it becomes much easier to kind of gain the, the, the capital, the operating, um, the operating expense that, that you’re looking for to actually fund something. Um, so it’s nice. Is it, it’s actually kind of aligned with.

You know, doing kind of quick snap tests, doing mini tests to, to then build out a business case. Well, you’re also making sure that it’s grounded in, you know, in the customer and what they’re looking for. Um, and then, and then keeping, keeping the team focused, you know, focused on, you know, on that. And, and what I’ve found is, uh, is generally.

Teams love to test. Um, it’s really invigorating and it’s, it’s fun to be, you know, on, on the front lines actually executing, you know, executing something at a, at a super small scale. Um, so, so I found actually teams, teams generally embrace that and, and, and would, would prefer to test things and, and then of course the solution is so much better for having done it anyway.

Naji: Andrew, I, I wanna look a little bit, The last two years, I imagine the challenges for you has been even more, even bigger than the normal transformation that you were leading. Like ha having to immediately move into practically digital, the vaccine, the platform, all that you have done with appointments, scheduling.

I, I, I just like being. Customer, I imagine all that you had to deal with at a national level, uh, to make, uh, to make this happen. Uh, how, how, how did you really reinvent those things and be able to serve patients more? Your personal, uh, experience, I would say as a leader to make sure that, uh, your teams are delivering.

Andrew Bunton: First I would just say, you know, I think the, the real, the real heroes at the end of the day are, you know, our, our pharmacists, our technicians, our front store staff that were kind of on, on the front lines, you know, throughout, you know, throughout the Covid, the Covid pandemic, Um, you know, because, uh, because they, they, they, uh, they were the ones who, you know, who actually.

Stood up so many of the, the things that we brought to life, whether it was the, you know, the covid testing or the, or the Covid vaccine or, um, you know, uh, providing people access to, um, to, you know, p, p and E. Um, and so at the end of the day, they, they, they were the true, you know, they were the true heroes at, at the end of the day.

Um, I think it, um, we were, we were challenged. I mean, I think that it was a. Period of, of unprecedented, um, transformation, whether it is the, you know, the ability to, um, you know, to, to really quickly, um, ramp up our delivery capabilities, um, to make sure in those early days of the pandemic we could, you know, deliver, uh, you know, patients their prescriptions for those that didn’t feel comfortable coming in to, to pick it up.

Um, you know, making sure that we were. You know, um, you know, sending out new kind of cleaning protocol and things like that. Um, changing our, our hours of operation to make sure that we were, you know, reflecting the needs of, of the community. Um, standing up the, you know, the, the testing, you know, the testing and vaccine.

Um, I think at the end of the day, um, a lot of it came, came to really making sure, um, that, that for our, you know, for our colleagues, for our teams, we were keeping, you know, front and center, the real purpose behind it all. Um, you would think that that was easy to do, you know, in the pandemic, but sometimes it could be challenging when, when folks are working really long hours and, and having to invest, you know, so much.

Um, but at the end of the day, you know, really constant reminders and celebrations of, of just the magnitude of the, of. You know, of the, uh, the purpose of the, of the work and where, where it was all, you know, heading, you know, heading.

Naji: Sure. Thank you for that. And definitely we, we celebrated them in the beginning of the pandemic and we should never forget to celebrate all the frontline workers, pharmacists, physicians, technicians, all of those all the time. Um, looking back at those experiences, uh, would you have done something different when you look back at.

And what is the one thing that you wanna make sure that you’re gonna keep on doing moving forward?

Andrew Bunton: I think. I think one thing that, that it’s definitely opened my my eyes to is, is kind of the, the, the importance of work life balance. And of course, you know, we’ve all, we all talk about that a great, a great deal, but I think it, it helped reinforce for me, um, you know, the, the, the import of, of, you know, you can’t just.

Talk about it. You need to be very mindful. You need to be watching out for, you know, for colleagues that, um, that, that you, you know, uh, to make sure that there is no, no burnout and being much more kind of proactive, um, you know, proactive and kind of managing and managing through it. Um, because I, I, I would say, um, you know, it was a, it was a challenge.

It was a challenge throughout the period, just where I think throughout, throughout the, throughout the pandemic, um, at every, at every turn, you’d think like, Okay, we’re gonna push through. For the next month, and then it’s gonna be better. And, but then it would be another twist in turn, you know, within the pandemic, uh, a as as we went.

So it ended up being a long time running for a lot of folks. And I, and I think that’s the, that’s the piece that it kind of helped open my eyes to is just the, the, the importance of, of being, you know, of being much more proactive and having, and having a lot of dialogue with patient, with our, you know, with our colleagues in terms of how.

How they’re feeling, how they’re managing and encouraging folks to take, to take time off. It was also in a period to remember where a lot of folks weren’t taking vacation because, you know, because they, they’re used to vacation being someplace that you, that you travel to. And so, and in the pandemic that wasn’t happening.

But, uh, you know, making sure that folks are even taking staycations and things like that. I think that that’s definitely, you know, been much more of a priority for me, you know, and it was a big learning coming, you know, coming through, through the experience.

Naji: Are you able to, uh, to maintain this now moving forward?

Because it’s definitely something that we’ve seen in all organizations and a lot of organization. Talked about wellness, talked about life, uh, life work balance. But now after two years being in the pandemic, we see those kind of. Pointing down and, And now it’s, Yeah. Yeah. It’s worth life balance, but maybe not as we expected it or as we said about it, like how you make sure, how are you making sure that this is truly now embedded since that was one of the big learnings for you

Andrew Bunton: Yeah, I, it’s, it’s interesting. I think one of the things that, that I’ve, that I’ve worked on and tried to do is, is having, you know, the, the shadow of a leader. I mean, a lot of it starts for your team. It all starts with you a, a as a leader. And so, um, you know, making sure that, that I’m, I’m practicing the things that, um, You know, the, the, the things that, that, that, that I preach.

And so, um, taking, taking, you know, pto, um, you know, um, being okay with kind of, um, you know, stopping work at, at, at 5, 5 30 in the evening when I can, like the things, things like that. I actually had an experience with a, um, with someone on my team who I respect, uh, greatly, who, who gave me the feedback on.

Um, I know that you’re sincere about work life balance, um, but if you, if you stay at work until six 30 every night, then everyone else is gonna stay at until at work until six 30 as well. And so, you know, being mindful of, uh, of, you know, of the actions that, that, that you take as a leader. Um, and also having, like I mentioned before, proactive conversations with folks and making sure that, that where you see a little smoke, where you think that, that they’re, that they’re, you know, perhaps working too hard.

How can you do something about that?

Naji: I love it. Leading by example and yeah, actually kind of walking the talk , this is, this is really crucial. I, I will now give you one word and I would love to get your reaction to this word. So the first, the first word is leadership

Andrew Bunton:. Hmm. Um, I, I’d say servant leadership, um, for, for me it is, it, it is, you know, how, how can you as a leader, um, really, you know, empower, empower, um, your, your colleagues, you know, invest, invest in them.

Something I’m passionate about is, is like really making sure that you have an eye on what’s important for the colleague. Um, really what are they working toward? Where do they wanna get in their career? What’s, you know, what is it that really drives them? Um, so that then you can be structuring the work, you know, around, you know, around that.

Um, and, and, and making sure that, that, at the end of the day, it’s not just the output, it’s the, it’s the journey. The journey as well, and that they’re gaining from, from that, you know, from that journey. What about in. Ooh. I, I, I’d say, uh, I’d say mini test. I, I mentioned it before. I, I love, I, I love to, you know, to test out, you know, to test out new, you know, new concepts, challenge, you know, challenge the status, you know, the status quo.

Um, I’d also say, Diversity, um, you know, diversity brings, you know, brings innovation, you know, innovation to it. And so, um, you know, it’s, I always strive to have a, a diverse team and, and that, that of course means, you know, racial, ethnic, uh, diversity, but also like diversity of background as, as well. Um, we’ve had a lot of success in, in kind of having our, our teams be comprised not just of folks who have, you know, MBAs say, but also we have, you know, pharmacists on the team, technicians on the team.

People from more of a public health background, kind of all, all collaborating, you know, together to bring, um, to bring, you know, innovations, you know, innovations to, to the.

Naji: Can I double click on this one?

Andrew Bunton: Uh, well, you know about it, right? Like diversity comes inclusion, uh, especially when you’re talking about a lot of diverse backgrounds and diverse thoughts and innovation.

How are you making sure in a large organization this is actually happening and those who have a totally different experience, different plans, that worst things, their ideas are being heard and. It, it’s a great, it’s a great question. Um, and, and something that that, that, um, that you do have to be really, really mindful of in terms of how are we, and, and it’s interesting.

It’s not with that, it also brings into, into account like diversity of personalities, you know, And so a lot of times like. How are we making sure that we are pulling insights out of folks who might be more introverted or, or, you know, and, and making sure it’s not just the extroverts who are kind of dominating, dominating the, the, uh, the conversation as well.

Um, At the end of the day, a lot of it is, you know, is, is again, getting to making sure that you’re setting that right culture and that it is one where, where everybody’s voice, you know, you know, can and, and should be heard is making sure people feel safe and feel, you know, and feel that, that, that sense of, of belonging to.

Um, I often refer to it as kind of a work family, you know, that, that at the end of the day we’re, we’re a work family. Like how everyone plays, you know, plays a role as part, you know, as part of that, of that family and everyone belongs. And then hopefully that’s kind of empowering folks to be confident in kind of having their, their, their message, their message heard

Naji: Customer experience. As a marketer, I had to ask you your lens on this .

Andrew Bunton: Yeah. Uh, customer, customer experience. It, um, I guess I’ll say feedback channels. Like what are all of the ways in which we are truly listening for, you know, for what that customer experience is. Um, and so that’s something that’s definitely been, you know, I’ve learned a.

Through, through time and, and that you have to have a lot of different listening channels. Um, and so, you know, whether it’s, um, how are we making sure that we’re getting, you know, great customer feedback in as near real time as possible? How are we making sure that we’re listening to what our frontline colleagues have to say and kind of taking their recommendations and hearing from them, uh, how we can help them better, you know, better serve our customers, you know, as it as, uh, as well.

Um, how are we doing cons? A lot of consumer research, making sure that we’re staying ahead of, uh, not just like, what’s the feedback on what we have now, but what are the, what else are, are our patients looking for? How else can we, you know, really be, be helping them as as we go.

Naji: The last one is Spread Love in Organizations.

Andrew Bunton: Yeah, I’m, I, I’m passionate, I’m passionate about spreading love. At, at, I mentioned before that, um, at one point I had thought about even, even going into the ministry. Um, I think for me, what I’ve kind of realized is that you can minister in most any role that, that, that you are in. Um, and so for, for me, it’s, it, it is, you know, how, how do I make sure that.

um, you know, whether it’s a, a, you know, peer peers, whether it’s leaders, whether it’s my, my team, um, that I’m treating people as a a as people, as people first and as, and as colleagues, and as colleagues second, um, and really investing and really investing in people and sometimes it. It takes forms in the most, in the smallest things like I, I’d say, you know, even though I’ve, even though I lead a large team, it’s important to me that I have, uh, touch bases with, with everyone on the team at, at, at least, you know, at least, and some periodic basis to make sure I’m really getting to know folks and kind of hearing from them.

What they’re, what they’re looking for in their career and kind of, and engaging and kind of that, that, that level of, of dialogue. Um, so yeah, I, I’m, I hope, I hope that I’m bringing love to, uh, you know, to, to CBS and other places that I work every day. I love

Naji: that. Uh, any final word of wisdom, Andrew, for healthcare ideas around the world.

Andrew Bunton: Um, what I always tell people is, you know, is, is find, find your passion. You know, fi find your passion. Um, and um, and I think what I’ve been, what I’ve been impressed by is if, if you find your passion, you can identify it. Um, In most any role, you can start steering more and more of your day toward, toward that, uh, toward that passion.

And if you find your passion, then, then chances are you’re gonna be working alongside people who share a very similar passion. And, and, and that’s what helps with kind of bringing together that, that, that, that work family, because you, you’re, you know, you’re together, you know, driving toward, you know, you know, big audacious goals, you know, together.

Naji: Thank you so much again, uh, for being with me today, Andrew.

Andrew Bunton: Yeah, this has been great. Na said, Thank you so much for having me. Thank you.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Alon Shklarek

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership and love. I’m Naji your host for this episode, joined today by Alon Shklarek serial entrepreneur investor, and a serial entrepreneur. Alon has founded co-founded and invested in over 25 businesses across 16 countries. Whether it is duct plexus, the largest Indian doctors platform that solves thousands of patient cases every day, or sky plastics, a leading European recycling company that recycles over 100,000 tons of plastic waste every year. All his companies are focused around leading with purpose and impact as active impact investor. Alon directly supports and mentors selected social entrepreneurs and is an ASN member of Ashoka. The words leading social entrepreneurship organization. Besides a teaches leadership and entrepreneurship as guest lecturer at MIT. I am so humbled to have you with me today, live from Vienna.

Alon Shklarek: Well, actually live from Boston. We’re actually not far away. I’m actually, oh, you here. yeah. I’m I’m at MIT. Well, I’m, I’m really pleased to be here. We’ve been working on that date for quite some months now. So it feels like finally we’re, we’re getting together.

Naji: Alan, I would love to hear your personal story. Uh, what took you from to Syria, entrepreneurship, and more specifically your passion for healthcare and social entrepreneurs

Alon Shklarek: Well, you know, so, uh, I, I guess I’ll start by saying, I, I made it a whole three months as employee, uh, many years old and luckily realized very quickly that this wasn’t the right path for me.

Right. And mainly. It was because I predominantly had to do stuff that I thought to be wrong, uh, and that went against my beliefs. And, um, I think when I reflect on that, I was lucky to have had a mentor back then that asked me a really interesting question. And, you know, remember I was really young, like 20 years old and the mental.

Asked me a question that had a very deep influence on my life, which I realized only later. And the question was what makes you tick? And he told me that I can take as many days or weeks or month that I needed to answer this question, but the only guideline was the answer could only be one single word.

Um, and you know, if you think about that, what makes you ticket? Like, what is it that gets you up in the morning and makes you excited and, and what is the energy really that fuels your life? And, uh, you know, one word is really hard, you know, is it harmony or independence or love, you know, speaking about your, uh, your, your podcast.

Uh, and so it, it took me really quite some time. Um, But I understood that what really makes me tick is, um, freedom and that in order to get that freedom, I would have to be able to, um, follow my passions and my purpose. And I can’t. Follow someone else’s passion and purpose. Um, and that is really what got me into starting my first company, because I, I really felt this is what I wanna do.

And this would give me the freedom of, um, you know, turning my passion into, into a business that really, uh, would improve the world. And, um, So 30 years later when we, you know, we’re sitting here, I’ve founded co-founded and later on invested in quite a number of businesses. And I guess I, I, I should put a full disclosure here that I do enjoy making profits, but not in isolation.

And I always try to focus on businesses that do some good in the world. Uh, although I have to say, I never had a word for that. Um, it, it, you know, and. That’s why I really love the fact that in the past few years, the word impact has become mainstream has been coined and then become mainstream. For me, it was a little like, uh, you know, loving a avocados just for the way they taste.

And then, uh, um, basically learning they’re actually called super foods. And, uh, so my super, my entrepreneurial superfood is impact. And that is at the core of, of really, uh, everything I do. And I. Also interesting is looking back is my most dismal failures are actually with businesses that didn’t focus on purpose and impact.

So it’s really no purpose, no passion, no passion, no success. Obviously no impact, and it sounds like a tourism, but it it’s one that I hold very dear.

Naji: I, I would love to hear a little bit more stories about the different companies that you co-founded and the massive impact you actually have through each one of them.

How, how did you end up in having social impact in healthcare specifically? You built one in, uh, in India. We talked about last time. Yeah. Can you tell us a little bit the stories and kind of the common thread of all the companies you’ve built or you helped build, uh, across the word.

Alon Shklarek: Yeah, so , so first of all, uh, it’s never alone.

It’s never me alone. It’s not the story of a guy that of, uh, has all, all it himself. It’s always with people it’s the co-creation of impact and, and, you know, coming back to that purpose. Element. This is so important because when you find people with a shared purpose, it’s like compounding your energy.

It’s not one plus one is two. It’s actually much more than that. But back to your question on, uh, you know, we, it really, and I’m sorry to, uh, disappoint you. There is no strategy in my entrepreneurial journey. Really? There is none. Uh, it’s not like a fund that has a focus. Okay. We are a healthcare fund. It’s really.

I guess the best way to describe it is when I see a problem, I start a business period. Like when I, when I see a problem that really touches me or I care about, I really want it solved, I think about, okay, how can, the only thing I know is building businesses, how can I actually use that knowledge and that, uh, uh, power that I.

To actually address that problem. And it’s, it’s, I think it’s coincidental, uh, to be very honest, like I, I, I get to some kind of, um, you know, problem and I dig into it and I I’d love to get into the detail and double click on it. And, and that’s something leads to the other, uh, specifically about healthcare, like 12 years ago.

And we started, um, in Germany, we’ve actually built the largest Germans, uh, German, uh, doctors network. And then we went on to India and actually a few years ago we started in Latin America, uh, which goes very well. And the, the idea was that it’s, you know, It is really interesting if you look at, uh, doctors are the, at the heart of a healthcare system and every single dollar that exchange, uh, hands in the healthcare system is because of either a therapeutic or a diagnostic decision of a doctor at the core really that’ll simplified, but still, and.

You as a patient. And we all know that ourselves or family member, someone that we love when they have a problem, it, there is a lot of luck involved, whether you get to the right doctor, even if it’s a specialist and very well known, you really need. Uh, to, uh, you know, be lucky to get to the right person that knows exactly, uh, how to, how to diagnose the right thing.

And I’m sure you, I mean, you come from that field, you, we all know these stories. Like it took three years to finally find something or in more, you know, sad cases where you don’t find the right approach. Uh, and on the other side, you have that collective knowledge of all doctors. Around the world. And if we could actually link that together, Wouldn’t that be wonderful.

So that was the problem I tried to address. There is a patient with a problem and it’s absolutely coincident whether he sees a doctor that actually can help him or not. But for sure, out of the 10 million doctors we have in the world, that will be someone that we would have seen that already or whatever.

So how can we get that together? That was the idea. And, uh, what I love about that idea really is that what we. Achieve this to make it free for, uh, patients free for doctors it’s completely free. And the only way actually that business is monetizing is by aggregating and anonymizing, all the data that we generate on a daily basis, through all these conversations and actually making meaningful insights for the healthcare community out of that.

And I think that’s great. It’s win. Win-win.

Naji: Oh, that’s that’s great. Uh, and as a founder and investor, you know, of several other companies, what are the key capabilities or traits you look for in leaders you recruit or interpreters who invest in?

Alon Shklarek: Hmm. Uh, well, they they’re quite some, but I think authenticities is probably the first thing. I, I, you know, I, I look for. Because, um, you know, we, we live in the world where everybody tries to. Make us be something else than we really are. I mean, it starts with all due respect to all the parents out there and my parents and everyone, the parents have a very clear view of what their kids should do very often.

And then the teachers. And then if you join a company, I mean, there’s the whole world constantly tries to make something out of you that you’re maybe not. And that you. Focusing on, on what you really want and what your purpose is when coming back to that purpose. Uh, part that is something I really look for first.

I’m not sure it’s a capability really. Uh, but, but that, that would be one. And then one thing that I really, uh, specifically look for and I try to. You know, also train myself all the time is, is listening and it may sound super simple. Uh, you know, okay. That’s clear everybody is listening, but I, I, I talk about a specific way of listening.

It’s listening to understand rather than to reply. And, and that requires a lot of training. If, if we think about it very often, it’s, we’re in a convers. The moment someone opens his mouth and starts to talk to us. We already think about what want to reply in training yourself to really listen, like until the end, and really try to get to the bottom of what others are saying.

That’s a really important leadership capability because it helps you to make sense of the world around you. It helps you to build relationships. Uh, it helps you find new ways to address problems. It helps you to drive diversity and differences of perspectives. It helps you actually bring out the best in others because you give them time and space.

Uh, so I, I guess if I have to choose one, that’s like my core, uh, key that I would look. Those are great.

Naji: I, I so agree with the listening, right? Like taking this offer the yes. And, and really looking at how you can build on someone else’s, uh, proposal every single time. Yeah. Uh, I, I also remember, um, in the, in the class I had the privilege to be in where you, you gave us, uh, a talk, um, on entrepreneurship, the framework you shared with us.

I still remember it had teams in the center and you talked a lot about the purpose. First for this team. Uh, and it was really intriguing for me because many times we’re focused on the product on the problem. We want to fix the solution, the, you know, the invention that we have, but really focused on teams and purpose.

Can you detail a little bit more, your thoughts on this?

Alon Shklarek: Well, you know, Of course they’re, you know, a great team with a really bad idea will also not be successful. Let’s be clear about that. So, you know, level playing field, we are talking about comparing good or okay. Ideas with potential. With other good or okay.

Ideas with potential. And then the team is really what makes or breaks it, uh, very obviously. And, and the connection between team and purpose relates a little bit back to, uh, what I, what I, um, a few minutes ago is around understanding. And compounding the energy that is created by really, um, focusing on what makes you tick.

So if you know, a team of founders meet at MIT where we met too, and, uh, um, you know, the dorm room type of startup, but then one, one of them really. Pursues that startup idea, because he deeply cares about for example, healthcare and improving patient outcomes and the other one really. Um, and, and I I’ll I’ll use that kind of little extreme example really just wants to, uh, join that startup because he wants to get rich really fast.

Now, if. If these, if the purpose or if the drive and the motivation behind why people are doing it are not compatible very, very quickly. Those teams usually, uh, you know, just fall apart, uh, or in even worse cases, you know, when it falls apart quickly, that’s actually good because then you can move on, but very often it’s kept together and it’s under the surface.

It actually, uh, you know, explodes at the wrong worst possible, uh, uh, time. But I think having alignment around purpose is, is so important because building a startup is so hard and you have so many, uh, setbacks and, you know, you take two steps, forwards, three steps backwards, and you always need to. You know, take hold problems every single day and only having that glue between the people that you really understand why you’re doing that.

You can remind yourself about it. That is really what, what will get you, uh, to the finish line really?

Naji: Any story about a social startup you want to highlight today,

Alon Shklarek: Yeah, there there’s so many, I, I don’t even know where to, uh, honestly, that’s it. It’s like, you know, I have three kids, um, it’s like asking me, you know, you have to pick one.

I, I can’t , you know, there there’s so many incredible, uh, incredible social entrepreneurs now. And yeah, it starts with what is really a social. Social business. And may, maybe I’ll use that even though it’s not a real answer to your question, but it, I really believe, um, social business is not about not making, making profit.

It’s it’s really about, uh, because profits are not bad, you know, if you think about money, The question about it is where does it come from and for what are you using it once you have it? So as long as your business model is focusing on, uh, uh, you know, on, on, on revenue streams that are actually not, uh, not having giving any concern, social, uh, um, concern and you’re using the money wisely, I think you can think about being a, uh, a social business.

I actually think every single. Company, every single one, uh, can have a social fo social impact, focus, or impact focus, whatever you do. Let me give you an idea of, uh, an example of one company, uh, that, that, that, that I built in the additive manufacturing space. So it, it really. We, we took that company from a more or less bankruptcy situation and they were, um, building, uh, projectors for a movie theater.

There, there is no, there’s not a lot of social impact there. Right. And we transformed the company because it’s the same technology that is at the core for, uh, 3d printing technology. So if you think about a projector for a movie, it is a light source that goes through an electronical system and then the light hits a screen.

And that’s what you see in the movie theater, 3d printing, same principle. You have a light source, goes through an electronical system. And then it hits liquid polymer and where liquid polymer, oxygen and light meat, the polymer cures. And this is how you 3d print. Uh, and so. The interesting thing was switching kind of the whole company’s idea to a more Futureproof, uh, industry than movie theaters.

And then again, no impact there, but then using our competence in really high precision 3d printing to look at organ printing. Uh, and I’m not sure if I used that example in our class, but just for, because I think it’s so interesting today, if you think talk and it’s healthcare related. So if you think about lung transplants, for example, it’s done by, uh, growing lungs in special pigs.

And then when you need the lung, you kill the pig. You need to chemically wash the lung, uh, because it is animal DNA. Of course, then you’re enriched with human DNA and then you’re actually implanted, uh, into the patient’s body. Of course, many complications, et cetera. It’s not humane obviously for the pig.

I mean, it’s not nice to kill animals, et cetera, et cetera. What we are looking at is trying to actually. Uh, lungs for transplants, uh, and we are pretty close to, to, to getting there. And this is J just, if you think about it, if any single business, I think that you have, you can think hard. Okay. How can I impact the world and how can I use what we do best in this company to actually make the world a better place.

Now is jokingly. Maybe you can’t do that. If your idea is. Build Tinder for cats. Um, but for any other business, I think you can have impact.

Naji: I love it. This is such a powerful example. I, I will give you now one word and I’d love to get your reaction. First is leadership.

Alon Shklarek: Um, well, my reaction to one word, it’s kind of it’s it’s, uh, I. My first reaction to it is that it, there is a myth that good leaders are super humans. That is, that is my first reaction. You know, there is, uh, Very often. And I think it changes, but especially if you look a few years back, we always had that.

Or a lot of people had that feeling that leaders know, have all the answers and, you know, they know everything best. It’s actually the opposite. If anything, the advantage great leaders have over others is that they know that they don’t have it all figured out. But, uh, They actually, um, see the advantage in having others around them that are better and more diverse.

And that leadership is a team sport. Maybe that’s the answer. My, my, my reaction to the leadership is leadership is a team sport. What about entrepreneurship? Um, yeah. Entrepreneurship is about turning your passion, uh, into businesses that improve the world. And entrepreneurship is definitely not, uh, owning a business that, that, you know, And a lot of people think about it this way.

Uh, you know, being an owner is okay, that, that you own a business entrepreneurship is about really understanding what you care about. Uh, you know, showing up, standing up, speaking up for what you care about, inspiring others to follow you on that path and turning your passion into, uh, into a business. And you could do that as an entrepreneur, too.

That’s for me, all the Impact impact, uh, making the world a better place, very simple. And, and, and it needs to be measured as a side comment. All of our, uh, companies we have actually, we, we define. What the actual impact is and whether it is, you know, uh, number of people that have access to, uh, uh, medical, uh, medical information or whether it is the millions of pounds of recycled plastics.

I mean, whatever it is, we actually measure that on a day by day basis on the dashboard. And we always look at how are we doing in creating that.

Naji: And that’s super powerful. I imagine for, for all the stakeholders you have, right. Your employees who wake up and see the impact that they are having on the word, but also all the different stakeholders, the customers, patients, et cetera,

Alon Shklarek: it it’s really, it’s really help.

It’s really powerful. And you know, that, that, you know, management quote, what, what gets measured gets done? Uh, uh, I mean, that’s not for me. I think it’s Peter drer if I’m mistaken, obviously, but, uh, it’s not only about getting. That purpose piece, it helps you align and curate the right people around that.

Cause you know, if, if it, if it’s so clear, what is the center of your universe? The stars that rotate around that center usually gravitate towards that thing. And that’s why it’s so powerful.

Naji: The last word is spread love in organizations

Alon Shklarek: Well, I, I, I’m not judge. I’m not judge Clooney, but my answer is what.

You know, what else would you wanna spread? You know, stress, anger. I mean, of course we need to spread love. Uh, what else really? I mean, if you think about that, you know, what makes you tick and the energy that you have really that gets, gets started in the morning and, and excited for what you can achieve.

And that day. The, so the, like the, the common ground for all of these are love because without love, you know, uh, you’re not touching the hearts, uh, of people and you’re, you’re not going anywhere without love.

Naji: This is so powerful. I, I love it. What else? any final word of wisdom for healthcare leaders around the word?

Alon Shklarek: I think a great leader, uh, is. Someone that is barely noticed. You could say where like, if, when things are done, the team actually is proud to have done it themselves. Uh, a little bit about like poor leaders, I would say 10 and average leader explain and. Good leaders demonstrate that great leaders inspire and they do that, not by being super humans, but by helping all others around them to be the best versions of themselves.

Naji: Thank you so much, Alon, for being with me today and having such an amazing and inspiring discussion.

Alon Shklarek: Thank you. Well, I thank you. It was really, I enjoyed it. The love.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Aden Eyob

Naji: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership and love. I’m Naji your host for this episode and I have the pleasure to be with Aden Eyob, a leader in mindset. Aden is a clinical neuroscientist and author of the book on mind training, the secret of positive living. She is the founder and CEO of mind medication. A fusion of neuroscience, psychology and SP spirituality based mindset consulting and speaker service that helps uncover people’s why unlock potential and free limiting beliefs to achieve the impossible. Her customers include CEOs, entrepreneurs, and celebrities. Aden’s mission is a word free from limiting belief. I’m sure you’re eager like me to hear from Aiden and learn more from what she does. Aden, I am excited to have you with me today.

Aden Eyob: Thank you for having me here. I’m very excited to be here

Naji: first. I’d love to hear your personal story, Aiden, how, how you became leader in mindset.

Aden Eyob: Yes. So it’s a bit of a whirlwind journey. Um, I think for me, honestly, I started when I was young, six year old self I’ve always had visions and dreams of, uh, being in leadership, taking control of my circumstances. I remember having arguments with my grandmother about the house rules and challenging her.

And she’s like, don’t question me. This is how things are done. I’m like, but you don’t know why you’re doing it. So I will continue to question you. So obviously naturally that got me in a lot of trouble, but I was willing to sort of, uh, challenge the state of school, starting with my grandmother, and then also led into school and also at, in the workplace challenging.

The status in terms of what a leadership looks like. Um, there’s diversity in leadership, but you know, the typical way to lead for me was always something that if I don’t understand the why, then I’m gonna be the one to ask those questions. Um, even if, if it does. Come with a little bit of a blow back because that’s how change, um, begins.

And so really I started my journey in academia. You know, I studied neuroscience and psychology, so I, I worked within the, the space of, uh, academic research, but I found that it was a little bit too stagnant for, for my form of leadership. And so. I moved into business. I went into pharmaceuticals. I spent a great deal of time doing clinical trial management and, you know, working with pharma, there’s a lot of, uh, mindset shifts that must happen.

And so I found that as an opportunity was more of a challenge, but an opportunity to lead better because what I was seeing in my, in my role as a clinical trial manager was. Ideas that I’ve had, but there were stagnant and very stale ways of doing things. And so there was a conflict in, in how I could lead and, and really do my best.

And so there were opportunities in that, that I created so that I was able to bring different perspectives into the organization, but ultimately my vision was a little bit too much more than, uh, for that space. And so I found myself going down the entrepreneurial path to really explore how far. I can take my vision and, and, and really lead, but most importantly, lead myself.

So then I can lead others better. Right. Uh, leaders are learners. Leaders are ones who know how to lead themselves first. So in doing so, that’s how I found myself in, in the maze of entrepreneurship. And, um, navigating that the ups and downs of, of, you know, uh, building a business, but also bringing others along in that process and journey and, and managing people’s different, um, mindset and, and change states.

And so I think for me, the mindset element really stemmed from my childhood. I grew up in a rather chaotic environment. I, you know, my mother was mentally unwell. I’ve had various family members who suffered from mental illness. And so I was just very curious about. Why they were thinking that way and how they were, I guess, in that sense, unable to really lead themselves because of, of the mental illnesses that they had.

And so that’s really where the mindset element came. But in, in all my studies, I then also realized the power of the mind and in terms of even leadership, a lot of times we make such emotive based decisions. And so. My journey down the mindset realm really stemmed from the fact of really wanting to understand how we think and how our thoughts and emotions and behaviors are all really correlated and how that really plays out into how we lead ourselves and, and lead others.

Naji: Thank you so much, uh, Aiden for sharing your journey and how you, how you got there. There’s different pieces. We will discuss, obviously between entrepreneurship, your, your work in the pharma and in development, uh, and clinical trials. But I can’t, but start ask about the secret for positive living. This is, this is the title of your book.

So can you share with us. The secret.

Aden Eyob: So the, the secret really the formula is, um, is the thought plus emotion equals behavior. And so oftentimes when faced. With challenges, it’s actually an opportunity to grow and, and adapt and learn. So the environment that we’re placed in is for a reason, there’s a purpose to it.

And so when you, when you understand the formula, that really the seed is the thought that you’re thinking about that environment. That’s gonna play the emotion and then play the behavior. That’s. That’s what’s gonna happen. And so even if the environment is not conducive for growth or for a healthy form of leadership, you have the ability to apply the growth mindset by applying that principle of thoughtless emotion equals behavior.

So when you change the thought to be positive intentionally, that’s how you change the emotions and then behavior, because oftentimes, um, in terms of neuroscience, our brain is really hardwired. To have a negative T bias. And so we’re more four times more likely to hold onto bat situations and that plays out into our leadership.

And so when you apply the secret formula of adapting that negative bias into a positive by intentional, um, Thoughts of positivity. And that comes with practicing mindfulness, which isn’t something that’s typically associated with leadership, but is really relevant and pertinent. Um, what that happens is then it frees up that negativity bias so that it’s positive.

And then the emotions will correlate with that and then so forth the behavior. And so the, the, the POS the, the part of being positive is a choice. And, and. As resilient leaders, the choices, do you wanna stay stagnant or do you wanna take this stagnant opportunity and turn it into an opportunity to bring light into a situation, a broad perspective, a new horizon for yourself and for others?

Naji: So you talk about mindfulness, uh, right in this idea of bringing positivity, uh, to the thought. So I love how you framed it. Thoughts, emotions, equal behavior, um, you know, in, in this word of constant change movement and unfortunately sad news, right? We, we can’t, but think of the tensions and the word wars around the word happening and, and people suffering.

How, how are you helping out leaders? Think positively. So, and if you have like a specific example or exercise, you can, you can give us for also people listening to us today, uh, on how they can foster this positive thinking. Yeah,

Aden Eyob: absolutely. So, um, the framework that I really apply, all these principles is called the calm mindset system.

So it stands for clarity. Accountability. It’s your goals, love and motivation. So the, the clarity element is really digging into your why, why are you here? What is your purpose? Right? It’s it’s not money. Money’s just the tool. What, what is it that you are gifted to do? So we, we do a lot of reflective exercises.

Um, to really dig deep in a bit of mind mapping to get to the why. So oftentimes it’s just the what and the, how that people get stuck on and really don’t understand the why. So the clarity comes with really understanding your why the accountability of goals is actually applying measurable ways of, of testing your why and your desire.

So it really it’s about understanding what your desires are and then breaking them down into goals because the goals are just the vehicles that. The why, which is the desire. And so there’s a system and a process, um, that I’ve developed that basically allows you to push forward with getting your desires, but in a very strategic and tangible way.

And then. Motive love is really about self care because especially as leaders, we’re often last to take care of ourselves, cuz we’re busy taking care of everybody else and, and fighting fired. But in order to be a really effective leader and resilient in times of chaos, it’s really important to take care of yourself first.

So we look at ways in which we can bring holistic. He, um, mindfulness practices, mind, body spirit. So that looks like, for example, one of my clients has. Decision fatigue constantly because being pulled in different directions. And, and what that did over time was that they were just not able to make any more decisions.

They were tapped out, they were burnt out. And so by really focusing on the self care element that looked like setting healthy boundaries, saying no to things that they may look like good opportunities, but long term, when we strategize it, it doesn’t work in terms of where their, why is. Um, it also looks like setting, um, Nighttime routine.

So I call them power habits. So morning and nighttime routines creating these buffers that help them to stay in a calm mindset. So in the morning, the first thing that they’re doing is taking care of themselves. And then. The the chaos of the day or, or leading the day, and then at night taking care of themselves and I call this like the calm, calm sandwich.

So when you’re in ability that the first thing you’re doing is taking care of yourself. You’re in a better position to take care of others. But when the first thing you’re doing is social media or so forth, that puts the mind at a state of sort of anxiety. It puts us in high beta state. And so with, with the calm mindset system and particularly the love element of the component, what we’re doing is creating bespoke.

Rituals so that they’re able to stay in that alpha theta state of mindset and then be able to really make better decisions and really take care of themselves. And then for motivation is really identifying their motivators. Are they intrinsically motivated, extrinsically motivated and how that will play into their, their self leadership, but then leading their teens as well and understanding their teams better.

So if somebody else is. Different to them. It’s not an opposition, but an opportunity to, to work together and understand that. But that only comes first when they understand how they operate as a leader.

Naji: I love it. And you know, it seems simple as you’re saying it, but many times, I’m sure you’re hearing from readers.

Uh, like we don’t have time for this like seriously mindfulness in a busy day. Like how can I do this? And sadly, many times it happens as you, you talked about one of the leaders you’re, you’re helping. It happens too late. Mm-hmm right. So any small habits or tricks that you think as leaders, we can cut off, put in our schedule for us to be intentional about it and, and be better with

Aden Eyob: Yeah, absolutely. One of the things I say is like the box breathing, the Navy seals use it. So if it’s good enough for them and they’re in high stress environments, it’s definitely good enough for most leaders. So it’s a very simple box breathing exercise. You imagine yourself as a box, you breathe in for four count.

You breathe out for four count, you breathe in for four count. You breathe out for count and there’s apps that can do it for you. If you don’t really wanna like breathe and time up the same time. um, but what that does is it instantly takes the mind from. Alert down to being calm. And so you’re going within a span of five minutes, which I think we can all say we have in our, in our schedule from, from that state of hi beta to alpha theta.

And so, especially when you’re in a situation where you’re having to make decisions on the snap, this is a great tool. That’s gonna help you to make that decision a little bit more strategically and with a broader perspective, as opposed to just. That’s emotive based. Okay. I’m just gonna make a decision, cuz this is where I’m at in terms of my feelings.

So less emotions, more logic and

Naji: wisdom. Love it, the, the box pretty I’ve been, I’ve been using the 2, 2, 2. I don’t know if you’re familiar with it, like two minute of mindfulness, two minute of, uh, yeah. Of planning and, and prioritizing. So it’s yeah, it’s, it’s an additional one. I’ll try to use the box breeding.

Aden Eyob: Yeah. And I think just generally pause, it sounds so basic, but when you’re pausing, think about your brain. It’s, it’s like a Google server. It’s constantly churn out data, right? The minute you pause, it’s almost like a refresh. So if you know that you’re feeling your body’s a great signal, it tells you where it’s at.

If you’re struggling. There’s a reason for that. So when you pause, take five minutes out to just breathe in, breathe out. What happens is then your mind is then able to see a situation that you may be mulling over in a different angle, but also asking yourself open ended question. Like wh why am I feeling this way?

Is this true? Challenging, your own thought processes will oftentimes also help you to come up with a better, um, answer.

Naji: So, so this was the L part, like the love part of your club framework that I really, I really like, um, I wanted to go to the clarity of the why. So, and this is part that you’ve, you know, your research you worked on and obviously your coaching, uh, people on it.

And as you shared also in your experience in healthcare, I’d love also to understand. Is this why still kind of interlinked between healthcare and what you’re doing today. Uh, and really what I, what I’m interested to hear your thoughts on, um, is we all know the important of this why and how it will unlock the potential, right.

And what we can do and the possibilities for ourselves, but also for the teams we’re leading. Uh, but many times. It’s limited, right? Like people keep on doing their jobs without thinking of it. What for you is kind of this limiting factor. Why aren’t we taking it to the next level a little bit more broadly, uh, for, for leaders?

Aden Eyob: Yeah. So it’s, it’s down to, um, fear of the unknown uncertainty. So as a lot of the leaders I’ve worked with. It’s all for them. It’s become more mitigating risks, right? So less of the uncertainty, but as leaders, that’s exactly what we’re supposed to do is go forward. When there are seasons of uncertainty, just like the pandemic we’ve we’ve endured.

Right? And so a lot of the times when a process isn’t working, it’s not being changed because of the effort that it will bring in, in actually changing that at an energetic level, at a strategic level at implementation level, but deep down, it’s that fear of what if it doesn’t work? And then the blame is gonna go back on the leader.

Right? So it’s that real internal fear. Is this now gonna be a reflection of me as a person and my identity and I I’m no longer a qualified leader because I’ve set this new process. It didn’t work and the backlash is too much. So I’d rather just maintain the status quo even though it’s not working. And so it’s, it’s often down to fear of the unknown, but also perfectionism.

So if I’m gonna, if you’re gonna start something new, it’s gonna come with a lot of unknowns. It’s gonna come with a lot of imperfect methodologies. And so for someone who is a leader that borders on having that perfectionist tendencies and high standards, it’s gonna be a clash because they’re gonna have to not face leading teams who may not perform to the standard that they’re accustomed to because of the new processes that have been implemented.

So a lot of it is perfectionism, um, fear of the unknown, but also procrastination plays a big role as well. There there’s so much. As leaders we’re having to do. Oftentimes the, the, the stuff that we’re not certain becomes low on, on the, on the level of priorities, but they’re the ones that actually will push us further into our purpose driven leadership.

Naji: I love it and really agree with you. I’m I’m in one of, uh, I’m in a great sessions on improv improvisation in leadership, and really boils down to, as you said, like this fear of the unknown, and in fact, the importance of embracing uncertainty, because this is. This is usually where leadership is needed at most.

Aden Eyob: Well, that’s the thing we’re leading, right? If you’re a leader you are leading, so what are you leading? You’re creating a new path. And so, and I think COVID was a really great opportunity for leadership to really show itself. Right. There’s many as. Various types of leadership. And, and the one I tend to ascribe to is more on the resilient type of leadership, just because of the life I’ve led.

There’s been a series of challenges of having to overcome, but as leaders, the common core of us is that we’re paving a new path. You can’t pave a new path. If you’re still on the same path that has already been paved by someone else.

Naji: So in, uh, talking about the why and the purpose, uh, you worked in pharma and usually many of us in the industry, healthcare industry, uh, even larger than only the biotech or the pharma industry, we are really driven by this purpose of making life better for patients and trying hard to improve patients’ lives by bringing you know, novel medications or services for, for the communities.

Um, have you. Sense this. And how would you describe, you know, what you’ve experienced in the pharma? Where is it different from now being an entrepreneur and working with leaders across different industries? Uh, what are your thoughts about this?

Aden Eyob: Yeah. So I think, you know, health, the healthcare, um, industry, and, and so the leaders I’ve experienced it.

They have great intentions. They definitely do wanna help. But what I have also seen is that somewhere down the line, it gets lost with all the, the logistics of it, uh, uh, with all the bureaucracy and all the egos. Go into that. And, and also the bottom line. So unfortunately, people, you know, a lot of the people I’ve worked with, they start off with that intention of I’m gonna lead.

I’m gonna bring change healthcare equality into this, and then they get up the career ladder. And as they’re getting there, it’s almost like a little piece of them dies along the process. And then their leadership starts to dim. And by the time they’re there, they’re no longer leading from their heart.

They’re no longer leading from purpose. It’s pre pretty much. Let’s just make bottom line work for us, as opposed to why they were really there to begin with was to really create opportunity for, um, for the masses who can’t get the healthcare that they need to have that. And so it’s, and then when I look at it from, you know, Entrepreneurs.

They’re very much driven on the passion, right? They’re, they’re fueled by that, that why, and that’s why they’re, they’re still able to, to keep pushing forward. And so, um, a lot of the times when I’ve worked with various different leaders, what I’m seeing is that there’s a gap between their why and what they’re doing currently.

It there’s there’s. They’ve sort of lost that passion or they’ve lost the, the desire to continue to pursue that because of the external challenges presented, whether that’s the systems and structures of, of healthcare, where there’s so many regulations as well. So how do, how do they stay on track and, and be authentic leaders while still navigating the terrains of all the different regulations that come with the healthcare space?

Naji: Yeah, this is definitely the focus of this podcast and my personal fo uh, focus. It’s we, we are fortunate enough to work in an industry that can literally change people lives, uh, for the better. We should never forget about it. And I totally agree with you sometimes, you know, down the lines and with things happening, operations, et cetera, we forget actually why we wake up every morning, which is trying to make life better for one patient at a time.

So, yeah, definitely. It’s definitely my journey to making sure that as leaders, we constantly keep this in mind throughout all our decision process. Aiden. I, I want to go now into a se uh, into a part of the podcast where I will give you a word and I want your reaction to it. Okay. So the first word is leadership

Aden Eyob: taking care of others for the greater good.

Naji: Love it. What about diversity

Aden Eyob: embracing? The parts of you that you have not been aware accustomed to.

Naji: Oh, wow. I love this framing. Can, can you share more?

Aden Eyob: Yes. So for me, when I think of diversity, so when I see people who come from different walks of life, that means there’s a part of me that needs to learn embrace, but is, is a projection.

So if I am reacting in a positive or negative way, it’s oftentimes because there’s a part of me that resonates with that person, either in a, in a positive way or a negative way, but then it’s also an opportunity to embrace it because what you resist persist. So if I, if there’s somebody with a different thought than I.

And I resisted I’m I’m now finding myself in a stuck state, but when I actually take the time to listen and hear what they’re saying, oftentimes I’ll hear part of me that may have been resisting to them. And then it’s also creating an opportunity to create harmony. So that’s an opportunity to embrace a new perspective that they’ve brought into my life will then help me to lead better.

Naji: Love it, mind medication.

Aden Eyob: Bringing a state of calm into a chaotic environment.

Naji: What about spread love in organizations

Aden Eyob: leading from heart rather than ego?

Naji: Thank you so much, Aiden, for, for those reactions, any final word of wisdom, uh, you have for leaders generally, but also healthcare leaders, specifically as you, uh, you’ve been in this industry before your entrepreneurship journey. Yes.

Aden Eyob: Around the word. Yes. I think, you know, isn’t not an easy space to, to bring change and healing, um, to patients and, and I think with leadership, it’s also giving us, give yourself grace.

You don’t have to figure everything out in one day, you don’t have to get everything. Right. What matters is the patient? Think of the patient first, if you can heal one person that’s leadership, right there, leadership, isn’t all about taking care of the world once one person at a time. So whenever you find yourself in situations of, of uncertainty, think about the effect you’re gonna have impact with just one person.

And then that will be the ripple effect. You will. With a mess.

Naji: Thank you so much. Uh, Aiden for being with me today and for this great inspirational chat.

Aden Eyob: My pleasure. Thank you for having me here. Such a great time.

Naji: Thank you all for listening to spread love and organization’s podcast. Drop us a review on your preferred podcast platform

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Loredana Padurean

Naji: Hello, leaders of the word. Welcome to spread love in organizations, the podcast for purpose driven healthcare leaders, striving to make lives better around the words by leading their teams with genuine care, servant leadership and love. I’m Naji, your host for this episode, we’re joined by Professor Loredana Padurean, associate dean at the all new Asia School of Business, the collaboration between the central bank of Malaysia, MIT Sloan, and the international faculty fellow at MIT, Sloan.

Loredana is the faculty director for action learning and innovation and entrepreneurship at ASB. She has been an energizing force behind the establishment of the school. Under her leadership, the action learning program at ASB was recognized repeatedly as one of the most innovative program in the world.

She is an international keynote speaker and TEDx speaker. She has taught in various MIT Sloan exec programs, at AMD as well as in major companies. Professor Loredana has a MA in communication and economics and a PhD in management from USI, Switzerland.

And I am just so thrilled to have you Loredana with me today and looking forward for our chat.

Loredana Padurean: Thank you. I’m very excited to do this with you Naji. Thank you for having me.

Naji: Loredana, I would love to learn more about your personal story from Romania to Malaysia, economics, management, three known international leader and professor now, what’s in between the lines of this amazing journey.

Loredana Padurean: So, I always say that I’m an accidental professor.

I actually never really wanted to be a professor and before I became an academic, I had 19 different jobs anywhere from working in life insurance, to hospitality, transportation, construction, sales, marketing, media. I used to have a TV show called Fashion Police, where I used to arrest people on the street for bad taste and give them a make-over life on camera.

So, I’m purely an accidental professor. So I was born in Romania and I was born in Romania during communism, towards the end of communism. And I actually spent most of my early, and mid twenties in Romania. And I had a couple of attempts to try to figure out what do I want to do with my life.

And, I had a startup, right after college because it turns out nobody would hire me. So I decided to hire myself. That’s what entrepreneurs do. And I learned very quickly that I’m really, really good at marketing and I’m very creative, but I was terrible at accounting and finance. So the business failed.

And with that realization in mind, I applied for a masters in economics and communication in Switzerland. I got in and while I was there, I was one of the first generations. It was a brand new university, and I was one of the first generations and the program needed some hands-on management. And as a student, I decided that I’m going to be the leader everybody’s waiting for. So I became the manager of the program and that’s how I got involved with the academic life.

But even so, I didn’t think, or I never considered that I wanted to be a professor. I wanted to be an entrepreneur, so I wanted to graduate and start my own business. But before graduation,  I was actually offered a scholarship from the Swiss National Foundation. I had to compete for a scholarship and the scholarship covered about two years of a PhD program, during which I got exposed to MIT and especially MIT Sloan. And I have to say, I have met a few people at MIT that changed the way I thought professors were. So I don’t know about you Naji, but I grew up with pretty conventional professors, you know the kind of old men, mostly white, at least in my culture who would sit down at the teacher’s desk at the professor’s desk and read from a book in the most boring monotone voice ever and they would expect you to get excited about the subject. And even during my master’s program, I had a majority of them were like that. I had a few exceptions, but there were so few and there were no women, especially when I lived in Switzerland, we only had one woman professor.

And, when I came to MIT just as a visitor, I remember sitting in Charlie Fine’s class and Roberto Rigobon and Roberto Fernandez, three outstanding professors at MIT who I worship. And I thought, Whoa, people can be like, this teachers can be like this. Professors can be like this. Well, then I decided that, I mean, I didn’t even decide. I realized that, you know what, I actually, I can actually be whomever I want. And I think this is why role models and representation is so important because I never, ever, ever imagined that somebody like me, I’m very boisterous, I’m very outgoing, I’m extremely unconventional on academic terms, could be an academic. And then I saw Roberto Rigobon through, I don’t know, through a puppet, somebody, and he started speaking in Spanish and then he started singing a song and it was like the most entertaining thing that I’ve ever seen. And I thought I can be like that.

So, I did my PhD, but I also got very excited about the MIT culture of action learning and action research. So I decided to do my PhD, but I did a PhD in action research because I’m very entrepreneurial. And instead of just writing a thesis, I actually took over a bankrupted ski resort in Switzerland and I spent two and a half years in the middle of the mountain, recovering the resort and writing my thesis. And then after that, I got my PhD. I moved to Boston where I taught for a while at Brandeis University, and then I continue my relationship with MIT by teaching for MIT at the Indian school of business in India.

And that’s how I got recruited for Asia school of business. I was in India, and they were looking for somebody crazy enough to start, to join the startup in Malaysia. And, I thought, I don’t even know where Malaysia is, but it must be interesting and it must be fun to start a business from scratch. So in a nutshell, that’s the story.

Naji: Wow, amazing. And you know, you gave so many topics. I’d love to go to the first one. You said unconventional, and I know even on your personal page, you say unapologetically unconventional, and you’ve talked about being, you know, different, being yourself. This is one of the hardest thing I feel for leaders. Like, be yourself, everyone say it, but it’s so hard, you know, in the society.

So why unconventional? What are conventions that can probably even harm us sometimes right? And how to fight those and be yourself? I’d love to have your reactions on this.

Loredana Padurean: So my handler is the unconventional professor and unapologetically unconventional. And I have to say, I didn’t think of myself as unconventional. I didn’t use this word, but it was very much my audience, the market, the people that met me that said that I was unconventional. I think because I didn’t plan to be an academic and I didn’t have role models from the academic traditional world. When I joined the academia, I joined us myself.

And my self is a pretty colorful, very open, very direct, very straightforward, Easter European woman with a big mouth. And it turns out that it’s not a typical model, is not a conventional model that you see in, especially once I started living in Asia, but even in the US, I was pretty out of the box.

And for a while, every time somebody would say, oh my God, you are a professor, but you don’t look like a professor or, oh my God, you are a professor, but you don’t act like a professor. I would always say, what is your expectation? How do you want me to act? How do you want me to behave? What is the model that you have in your mind that I’m challenging? And is it me that I’m the challenger or easy view that maybe you should open your models? And you say that it’s hard to be unconventional in general, imagine how hard it is to be a woman in a leadership position. So let’s not forget about that.

And, so I had this interesting relationship with how people would perceive me and how I had to make not only peace with being perceived as a very different than unconventional person, but to own it, to embrace it and to make it into my own brand. I didn’t start as a branded professor quite the opposite, but at some point I said, you know what? Everybody else thinks that I’m so unconventional, and I think once you see me teach, you realize that I’m pretty theatrical. I think of my classes upstage, I’m a performer, but once people sort of branded me as unconventional. I took it, I owned it and I literally ran with it. And, we actually built ASB with unconventional as one of our attributes.

So ASB stands for two attributes. It’s a school of business, extraordinary and unconventional, because I realized that I have to be other people like us out there who are crazy enough to join a brand new startup in Malaysia. Other than association with MIT Sloan, but it’s still a brand new school. You have to be a little bit unconventional.

You have to have a little bit more of a crazy streak, right?

Naji: I love it. Moving from unconventional to owning it, embracing it and running with it. I think it’s a great inspiration for many women and leaders that are listening to us.

One of the things, you know, I’d love to jump into a key topic we both discussed, soft and hard skills, right. So outdated, type of definition. And the podcast here, our podcast is all about love, all about caring for one another. And many times I hear these are the soft skills while it’s, I’m convinced, these are the core skills, right, for any business to succeed. And then I heard what you say, smart and chart. So this is it. Tell us more about it.

Loredana Padurean: So, since this is very much a podcast about healthcare, I’m sure you know, but if you don’t know, the concept of soft and hard was actually invented by a US army doctor in 1972, who noticed that different troops have different type of skills. There are people in the battalions were very good at machines, guns, you know, the technology, I guess, shooting people, I don’t know. And he called this the real skills, the hard skills. And for everything else that he didn’t know how to name, he called them the soft skills, like dealing with people, paperwork administration, et cetera. So this was in 1972 Naji, and if you think about it, this is a 50 year old concept, which served us well for a while, but as society has evolved as values evolve, as the way we interact with each other, and we think about our values evolve.

When I started ASB, I was thinking, you know, I’m so fed up with hearing that, oh, this is soft skills. And I remember when I moved to ASB, I left Boston and I went to my previous boss who I adored. Her name is Nancy Waldron, she’s a professor at LaSalle College and, I told Nancy, I said Nancy, I’m really worried about this job, it’s a big job, I’ve never done anything like this, I don’t understand much about financial statements and I’m not sure that I even know how to balance the books even today. And Nancy looked at me and she smiled a little bit, like the way you smile at the dumb child. And she said, oh, Loredana don’t worry, the job is easy, the people are not. And boy, was she right? Because it turns out that it was not the hard skills that I needed to master, but it was the soft skills that made my job and myself very difficult to work with and work with others.

So everyday I would hear about a conflict or be part of a conflict or experienced somebody who would have a conflict about managing that, about keeping their emotions into check because of stress, about dealing with diversity, about dealing with their board and all of this came from the soft skills, so-called. So I started thinking, why do we call this skill soft? I mean, there’s nothing soft about it. The dictionary defines soft as gentle, tender, fragile, and there’s nothing fragile about this skills. There’s also feminine association to soft skills. Oh, women are very good and soft, because they are soft. Well, you haven’t met me, honey, because not all women are soft.  And then, I also did not like the way we think of hard skills as hard. So you’re obviously MIT, right? MIT is the godfather, the godmother of hard skills, right? It’s all about engineering and math and finance and chemistry and astronomy and et cetera. But as a child, as a young person growing up, I would always hear that, oh, these are the hard skills. And there was such, you know, implication that they were difficult. They were challenging. They were more, you know, more, tasking then the other skills. And there was an implication that they were also rigid, that once you know them, you know them, right?

So I said, no, no, no, no. I don’t like this, enough for the soft and hard skills. Let’s get smart in sharping stuff because the truth is, in the absence of smart skills, you’re actually dumber, right? Somebody who doesn’t know how to work with other people, somebody who doesn’t know how to navigate multiple cultures, somebody who doesn’t know how to deal with stress, that doesn’t make you, you know, harder. It just makes you dumber. And then sharp skills, we call them sharp skills, and this is the idea of my co-author Professor Charles Fine from MIT, who is the president of ASB. Charlie said, you know, the truth is that this technical skills today, especially, are not static, which the word hard implies, but they actually have to constantly be updated. You can’t really say, oh, Naji, congratulations, you learned a software language, you good for life. Probably in two years, it’s going to be obsolete. So you constantly have to sharpen them, constantly have to update them. So enough with soft and hard, people, get smart and sharp instead. That’s what I’m doing.

Naji: I love it. That’s what I will be doing too. I think, you know, for the 50th anniversary next year, we should like stop using soft and hard. It’s all about smart and sharp. Let’s do it.

Loredana Padurean: Yay, I love that!

Naji: It started in healthcare. So that’s make sure that healthcare disrupted too. You know, we got started here. I know each one of the letters has a meaning and has a specific skill or capability within smart and sharp, and I will definitely put them, you know, on the page and people can look at them and look at the great work you’re doing at ASB.

I have maybe a challenging question for you on this. If there is only one, between those that you would definitely think a leader should invest and, or half, you know, I don’t know if it’s something that’s can be built or if it’s something that, you know, can be nurtured, what would be this one skill?

Loredana Padurean: Yeah. So believe it or not, I get this question all the time because people want to know what’s the number one. So I came up with top 10 for each category, and now you asked me to choose one. I would say for smart skills, probably the most challenging and comprehensive inclusive skill is cognitive readiness.

And for sharp skill, I’m going to choose an MIT sharp skills, which is a system dynamics. And believe it or not, this two feed off each other, they co-exist, they have a ying and yang relationship.

So let me start with cognitive readiness. I used to only be a professor of management and my life was very easy, and then I got promoted and I became a manager and my life became very hard. So warning to people listening, if you get promoted, it’s not always for the better. So,  one of the things that I heard a lot as a manager, as a leader, as a director, et cetera, was that I always had to be mentally ready, for no matter what. And I kept thinking, how does one stay always mentally ready? I mean, I know when Olympians train for the Olympics and they managed, probably working in two Olympics or even three, if they’re super humans, they train all the time. How do we train our brain all the time to be cognitively ready? And the more I started to learn about this skill cognitive readiness, which is defined as the ability to be mentally ready, no matter when, no matter what in any kind of circumstance. I realized that it’s actually a little bit of balancing of system one and system two, which is slow thinking versus fast thinking. On one hand, I need to slow thing, new problems, new challenges. So thinking fast and slow by Daniel Kahneman, I’m quoting now, but you’re on one hand you have to slow things that you see for the first time that you face for the first time, or they’re too complicated to go into your automatic processor.

But at the same time, you have to practice fast thinking. So it’s almost like you’re driving on two lanes at two different speeds at all time. So your brain has to co-exist in this two dimensions, and I think Professor Kahneman was talking about the fact that slow thinking is something that requires a lot of energy, you know, requires a lot of mental space, it’s very taxing. And you tend to do it when you learn things for the first time, when you approach a problem for the first time when you face something for the first time. Versus, you know, fast thinking is thinking about driving. If you know how to drive or, you know, even walking, if you think about it, when you were a baby, you don’t think about those things.

So cognitive readiness, the way I understand, it is balancing fast and slow thinking, but doing it simultaneously, which is very hard. And that’s why, and I’m sure as a medical expert, you probably heard this a lot in the past 18 months that people accused very high levels of mental fatigue during the pandemic.

We are actually a lot more mentally tired in the past almost two years, because we exist in this two lanes. We are constantly in this two lanes and the transition in between the two lanes is very fast and also these two lanes are running at the same time. So that’s cognitive readiness as my number one smart skill.

If you want to know more about the sharp scale, like I said, system dynamics for me is probably one of the sharpest skills in the toolbox. And Professor Nelson Repenning at MIT, he’s extraordinary at teaching system dynamics, and Professor John Sterman as well, and system dynamics is just teaches you how to think, in function of systems and how to understand the different parts of a system co-exist, co-relate, co influence each other. And it’s so interesting I’ve noticed that during the pandemic, a lot of great leaders who sort of were ready, cognitively ready, they were ready because they applied the system thinking. They said, all right, if we’re going to have a pandemic, the first thing is going to get affected is travel. If trackable got affected, supply chains will get effected. If supply chains will get affected, production will get affected. Consumptions will got affected. Retail will get affected. Banking will get affected. So I noticed that true successful leaders during this 18 months of pandemic or two years almost by now were great because they applied both cognitive readiness and system dynamics.

Naji: Those are great insights and yeah, definitely being a student of system dynamics, I think that, everything changed in my view around the world, like it’s all interrelated with the loop. So I am definitely conquered.

So you talked a little bit about the pandemic efforts, that we’re still going through. Did you see, or did you rethink any of those smart and sharp skills relative to the virtual world or the pandemic itself?

Loredana Padurean: I did. I actually, so I’m about to release a white paper in December. So whenever we’re gonna feature this podcast, I will share with you the link to the white paper and I’m also working on a book called The job is easy, the people are not: top 10 smart skills to help people become better. And one of the skills that I learned, actually, I don’t know if I learned, but it was definitely validated by the pandemic was emotional maturity and validation. So emotional maturity, which is very different than emotional intelligence, emotional maturity is defined as the capacity to understand, manage your own emotions and emotions about those around you, and, actually for the the book I interviewed Professor Roberto Fernandez from MIT, Sloan, and Roberto talks about emotional awareness as well, not just emotional maturity. So why am I saying this? The workforce during pandemic accused very, very high levels of stress because of all the changes that we were going through and like I said, because of this constant state of being alert, of being cognitively ready. And when you are in very stressful situations and you know, your doctors are not going to tell you about adrenal glands and cortisol, and you know, all the hormones that get released during negative situations, but during very stressful times, you either fight or flight or run, right?

And most people started to lose the shields that made them nice to work with, easy to work with, great colleagues because you go sort of like in survival mode. So emotional maturity became very, very important during the pandemic because you have to practice a lot more self-awareness about what your emotional state, how would that impact or affect the meeting? What kind of energy do you bring in a meeting and how it will, that energy can teach others? And then another skill that I learned, and I have to say if there’s one smart skill next to next to cognitive readiness that I worship, and I pray to is validation. So I used to think that validation was just another way of giving a person a compliment Naji, great job with a podcast. I listened to three episodes, I was in Prague. Great job. That is not validation. That actually is just cheering, right? It’s trying to provide a compliment. Validation is saying, you know Naji, I listened to this podcast with Dr. Adam and I learned about the importance of having medical equity and medical information as a patient. And once I learned that, it made me realize how important it is for me to be properly educated as a patient. And I could go on and on. So validation is evidence-based affirmation, evidence-based detailed description of the value that you provided. Now, why is that even more important during the pandemic?

Before pandemic, we had body language, right? I can see you now on the screen. I can see that you’re smiling. I hope that you’re smiling because of what I’m saying, you could be smiling because you have a cat under your table, I don’t know. Because of the Zoom environment, we make assumptions on how the other person perceives us, reacts to us, engages with us, thinks about us, but we are very much in the dark. Validation becomes a massive positive management tool to help people understand what is it about their job that creates value. What about their job helps you and helps others. And because it’s evidence-based, right, it’s specific I’m telling you what I like about Dr. Adam’s observations about medical equity. You also understand how to further build your next step. So I’ll end here. But before that, I’ll say I learned about validation from Oprah, Oprah Winfrey. Oprah interviewed, I don’t know how many over 2000 top celebrities in the world and she said that she realized that if there’s one person that, if there’s one thing that every person she interviewed has in common is the need for validation. I saw her in an interview saying that Beyoncé was on her show and at the end of a song, she sang a song for the small audience in her studio. Beyoncé sort of looked at Oprah and she said, how was it? Was it good? And Oprah was shocked. You’re Beyoncé, why do you even bother asking? And then in that moment, it clicked for her that it doesn’t matter who you are. If you’re Queen Elizabeth or Queen B validation is equally important because we want to know through evidence-based affirmation, that what we do creates value.

Naji: Wow, I love it. Well, thanks for the validation first, I have to thank you for it.

Loredana Padurean: Very well deserved.

Naji: And it’s so powerful. Yeah, I think it’s just all that you said, this really is a managerial powerful too, but even a human too, right? For all of human. Yes.

Loredana Padurean: Yeah, by the way, guys, if you’re listening, when your wife is asking, does this dress make me look fat? The answer is never, I don’t know, right? She’s not looking for feedback. She’s looking for validation. Very good for relationship too.

Naji:  I will give you a couple of words, now one word, and I would love to get your reaction to this word. So the first one is leadership.

Loredana Padurean: Hassle. You want me to expand?

Naji: Yes, that’s unconventional.

Loredana Padurean: Well, like I said, I had the best job in the world. I was a professor of management and then I got promoted and I became a manager and the director and the leader. Maybe it is because as a professor, you feel like you have a lot of freedom and a lot of oh, you have a lot of responsibility, but you have a lot of autonomy. Whereas a leader, one of the smart skills that a leader must practice is followership.

So followership is top 10 of my smart skills and followership doesn’t mean that I’m following my boss because as a leader, assuming that I don’t have that many bosses. Followership followership means that I have to follow my vision, my mission, my standards, my stakeholders, my community, people that invested in me and let me just say that leadership comes with a pain of the job is easy, but the people are not. I am an executive education,  professor as well, both at MIT Sloan and at ASB. And I talked to a lot of much more accomplished leaders than I am. And they all say I spent 80% of my job, the higher I go in my career, the higher the percentage dealing with people, and most of the time, is related to validation, emotional maturity, humility, the lack of it, conflict, etcetera.

So, hassle. I don’t want to get promoted anymore, by the way, if anybody’s listening.

Naji: What about jungle?

Loredana Padurean: Oh, so now you’re coming very close to my second favorite child, which is entrepreneurship. And it’s not second favorite child, I have twins. I think of my research as my twins and, for the past six years I’ve been developing a new entrepreneurship concept called Nail it, Scale it, Sail it, which I’ve been teaching at MIT and the days before a few years, very successfully, if I can say so. And it’s it defines a roadmap for how companies evolve. I believe very much in evolution and the first stage, the nailing stage, the startup stage feels very much like going through the jungle with nothing but a machete.

So the startup world is very much a jungle world where you have to carry as little as possible, but choose that little bit care. You have to realize that the jungle is a very dynamic, very animated and very dangerous, constantly changing environment. And only the very few agile, brave and highly entrepreneurial survived.

Naji: Yeah, you talked beautifully about it. So, I recommend listeners to go and watch your TEDx about the jungle and, that it’s really great.

 Another word: lazy.

Loredana Padurean: Oh, my comfort zone. I’m a person who enjoys being lazy. When I think of laziness, I think of myself as a couch potato. I love myself a really good couch and 10 hours of uninterrupted Netflix and YouTube prime. But I have to tell you Naji, I used to feel very guilty for, you know, pretty much being lazy. And then one day, I was on my iPhone and it was running out of battery because I don’t know if you realize, but the latest generations of iPhones are crap, ever since Steve jobs died, excellence is not the baseline anymore. But anyway, so I got very frustrated with my iPhone and I was like, God damn it. You ran out of battery again. You know, I can’t rely on you. Then I put it in the charger and then I stopped for a second and I was like, Huh. So isn’t that interesting that even my phone needs time to recharge. And when it has to recharge, it has to recharge it. No matter how much I scold the phone or I motivate the phone, like, come on, I know you’re only 2%, but give it some more. Let’s go, let’s do it 110%. And I thought, you know what? This is a bunch of idiots because we expect humans to have unlimited capacity, unlimited energy. We expect this energy to be expandable. And what I realized that my laziness, and by the way, I’m extremely introverted. Like I did a bunch of tests and I’m like 98% introverted. I realized that my laziness is my charging time. When I’m lazy, it is my productive time, it is the time that allows my brain to go into charging mode.

And, another thing that I hate, absolutely hate when people say, what’s your guilty pleasure. And I say, honey, if it’s a pleasure, I’m not going to feel guilty about it. If I watch six hours of YouTube, and I enjoy it and he helps my recharging process. I’m not going to feel guilty about it. I don’t care if it’s the Real Housewives of Boston or whatever that is.

Naji: Yeah, you know, it made me reflect so much when we discuss this. Yeah, I’m proud to be lazy too, now.

What about spread love in organizations?

Loredana Padurean: So, I used to tell people all the time, that I really don’t like people very much. And most of my talks start with saying, I have to admit that I hate people. If there’s one thing I learned about management is that I hate people. The truth is that I don’t hate people, but the job is easy and the people are not. Unless, unless you treat them like people.

I think organizations that treat people like sort of mining machines or, you know, heartless and soulless entities are the ones that make you think the job is easy, the people are not because I worked for an organization where, I mean, I think I like about 95% of the people I work with those 5%, you know, everybody has an admissions failure.

But it’s about how you contribute to an organization, and how that organization contributes back to you. I teach the Ritz-Carlton case study, which you also learned at MIT Sloan in service organization, in the service organizations course. And one of the things that I learned from the Ritz-Carlton case is that during a seven day training program, the first two days are all about love. They teach you about the vision, the mission, the values of the company. They validate you. They validate themselves. They make you fall in love with the organization. And then the rest is technical training. And why do they make you fall in love? Because you cannot give 110%, because humans do actually give more than the iPhone does. You cannot give 110% when you’re not in love. And then one more thing that I do when I teach, when I teach service management and I teach about service excellence, I always say, before you reach into my bank account, reach into my emotional account. Make me love you as a company, and once, I love you, and I feel that love back, I will find ways to justify the most irrational behavior like paying $3,000 for a pair of Prada shoes that are killing me. It’s all about love Naji. That’s why I love the title of your podcast. It is all about love and love justifies irrational behavior. Love justifies 12, 16 hours a day. Love justifies, you know, when the job gets hard, why do we push through? And as a doctor, I think, you know that better than anybody.

Naji: Wow, I won’t comment. It’s just beautiful. Any final word? Any final words of wisdom to all those leaders listening to you today?

Loredana Padurean: I don’t, I’m still trying to find wisdom to be honest. So far, all I’m learning is that the more I know, the less I know, which is why humility is one of my top 10 smart skills. I would say that love should also come with a massive pill of humility because if you don’t, that’s why I’m saying, I don’t have any wisdom in me because I still don’t know a lot. The more I know, the less I know. And I think that’s why we’re both in education because you know, the more we know, the less we know and learning is fun.

Naji: It definitely is. Thank you so much, Loredanna, for an amazing, incredible inspiring chat we had today.

Loredana Padurean: Thank you, so very much. And, I will share with you the upcoming title, the upcoming book title, The job is easy, the people are not, and the white paper. Thank you so very much. Get smart and sharp, get smart and sharp. Remember that.

Naji: So much looking forward to reading it.

Thank you all for listening to Spread Love in Organizations podcast.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Barry Stein

Naji: Hello leaders of the world. Welcome to spread love in organizations, a podcast for purpose driven healthcare leaders, striving to make life better around the world, by leading their teams with genuine care, servant leadership and love. I’m Naji, your host today, honored to be with Dr. Barry Stein, chief clinical innovation officer and chief medical informatics officer for Hartford Healthcare.

He also practices as a vascular and interventional radiologist. Dr. Stein is also an assistant clinical professor at the University of Connecticut school of medicine and has held numerous prestigious leadership positions at Hartford Hospital. Barry graduated with his executive MBA from MIT Sloan school of management, where he received also his postgraduate medical training at Massachusetts General Hospital, Harvard medical school and his medical degree from the University of Stellenbosch in Cape town, South Africa.

Dr. Stein is a recognized and expert in cardiovascular MRI and CT, and was one of the pioneers in magnetic resonance and geography. Barry continues to remain engaged at MIT participating as an invited lecturer in courses on innovation. He’s also mentor for LinQ programs in the MIT Institute for medical engineering and science, a host to students from the MIT initiative for health system innovation, as well as co-principal investigator conducting clinical and operational health systems analytics research in collaboration with Sloan faculty at HHC. He is currently focused on leveraging technology and building a differentiated healthcare innovation ecosystem at Hartford Healthcare to accelerate clinical transformation.

I can go on and on about Barry, and I’m delighted and excited to have you with me today on this podcast.

Barry Stein: Hi Naji. Thank you very much. I’m very honored and looking forward to our discussion today. 

Naji: Barry, I’m eager to hear more about your personal story and what’s in between the line that took you from South Africa to now leading one of the biggest health institutions in new England.

Barry Stein: So Naji, thanks for that question.

 I grew up in South Africa during the apartheid era, a horrible time in South Africa. A time where oppression was the law of the land and, just a lot of injustice. I grew up in a wonderful,  family with parents that were both immigrants, one of which who fled Nazi, Germany and the other from Russia, and grew up in a very modest home with a lot of love, a lot of caring with a lot of focus around education and, serving our community at the same times. Our parents,  always role modeled that was the only thing to do, the right thing to do.

We felt it and lived at every day. I was one of three boys, and always had a passion to become a medical doctor from the age of four. Again, just with an absolute sort of drive to want to serve others, to heal others, to impact others, in a selfless way as possible.

I went to medical school in South Africa and that in of itself was very sensitizing to the atrocities of oppression, apartheid, and I can remember very vividly being at a medical school and one of the hospitals in South Africa, of close to 2,000 beds. And, the hospital was literally splitting off, mirror image, one for whites and the other for everybody that wasn’t white. Duplicated services, different class of services, but an absolute distinct difference between the two.

I also grew up when Nelson Mandela, who is, I believe one of the greatest human beings that ever lived was imprisoned on Robin island. And actually, an island that we could see in Cape Town, seven miles from the coast, very easily visible, but at a time where someone was not able to have a book written by Mandela, a picture by Mandela, without being worried about police repercussions. So it was really a very, very intense time. And then I remember right at the end of medical school, when I was doing my internship at a really famous hospital where they did the first heart transplant hospital. And I remember taking care of a patient without mentioning names, a very famous patient, a very famous prisoner together with Nelson Mandela in the hospital, shackled to a bed for one reason only: because he was fighting apartheid. He was deemed a criminal, a terrorist because he was fighting apartheid.

And I think that backdrop really lives with me every day. And, it was really difficult to live in that country for that long. And as soon as I could, I left the country before military conscription, I left the country and didn’t really have much money. I had a few hundred of dollars in my pockets. I had two suitcases. I had just gotten married a few weeks and immigrated to, or left to go and work in Canada, in Saskatchewan, the boonies of Canada. And think about Cape Town being an absolutely spectacular country, with climate, with beaches, 80, 90 degrees F, no humidity in the summer. And then immigrating to Canada as a general practitioner, family practitioner earning some money before immigrating to the United States.

And I remember very clearly arriving new in Saskatchewan, it was minus 78 within a winter. And I remember as a young person just being stocky aware of the privilege that I had in South Africa, of having amazing experiences around me, good and bad, in a beautiful climate. And then sort of going to another part of the world where people were equally happy or unhappy, living in a very, very, very extreme kind of environment, but sort of functioning in the same ways as all of us. So it was just really difficult to reconcile, and this is a young, I was a young physician.

I then went off to Philadelphia to do some research, two years of research, not necessarily because I absolutely had a passion to do so, but it was a way for me to get my immigration,  status correct. And actually that was a really fantastic time, where I got off the wheel of having to work 18 hours a day and do research and actually reflect on what I really wanted to do and, enjoyed the academic rigor of the research. And then decided I’d go into radiology because of the lifestyle at the time, appealed to me. And very quickly, once I started radiology at Mass General, realized how much I missed direct patient impact, really serving others, helping vulnerable people.

And as soon as I could, then went in to do interventional radiology, which is procedurally based angioplasty, stents, biopsies, embolizations really making a difference every day to every patient in a very, very impactful way. Now, because of that specialty being such a cutting edge specialty I developed and always had an interesting technology. And when I discovered using the wonderful privilege of my education, both in South Africa, as well as at Mass General at Hartford, really wanted to make a difference. And I used technology as well as my training to help develop a technology, magnetic resonance angiography, so that you could visualize blood vessels in a non-invasive way, as opposed to an invasive way.

And what I learned at that time was, it wasn’t just about taking your education. It wasn’t just about caring, but it was really having to develop a capability of change management, leadership. How do you change paradigms that are fixed in mindsets, not just regionally, not just nationally, but globally? And quickly realized that you either get lucky, like I may have been, but to be able to do it in a sustainable, repetitive way in a bigger organization.

In the years to come, some of the skill sets that I was lacking, I wanted to go and immerse myself in to crew to get. And that sort of led me to MIT, where I realized it was important to do big change management, to make huge impact in a sustainable organized way. There were a lot of capabilities as a physician I never developed. I didn’t understand strategy in an immersive way. I did understand it, but could never sort of articulate it or execute upon it in a meaningful way that others could understand, rather than instinctual, I wanted immersive marketing, finance, accounting. But the real reasons why I wanted to go to MIT was to understand innovation, entrepreneurship, which I believe was the catalyst, the frameworks, to be able to take technology and solve real recalcitrant problems in healthcare in a way that perhaps here to four was not possible or difficult to do.

I wanted to understand how to accelerate new ideas, matching new ideas to problems and accelerating them to impact. I also understood that one of the fundamental fuels for innovation and entrepreneurship and transformation in healthcare was next generation analytics, understanding how to apply predictive and prescriptive and optimization analysis to do so.

So I went off to MIT and I was very honored and privileged to be able to go there, and of course learn a ton of frameworks. And then came back to Hartford Healthcare to start an innovation ecosystem as the chief clinical innovation officer, to be able to develop an environment, where larges amount of people, organization is 33,000 plus, understood what it meant to be innovative, to be entrepreneurial and to be able to accelerate good ideas to impact. 

I’ll stop there. I mean, I could go on and on and on, but I think the most important thing for me was the privilege of education, the privilege of wonderful mentorship and colleagues and the influence that those folks had on how I developed over time as a leader. .

Naji: Wow, that’s powerful, inspiring, Barry. Thank you so much for sharing your story. 

Barry Stein: Yeah, and there’s one other thing that I wanted to mention that I’m married to somebody who really with her guidance, her support, her teaching me right from wrong, Reagan, a marriage and family therapist, an executive coach. Those are the privileges. Those are the fortunes that someone like myself has being surrounded by persons like that. That can guide you, support you and show you the north star. 

Naji: Thanks Barry. And I can’t agree more. My wife is also my coach since many years. I’m totally with you. It’s definitely the support system, it’is super important.

During your leadership journey, all that you learned, you know, coming from South Africa and in those moments of tension. I’d love to hear from you and potentially I’m sure last year, without going through the pandemic, even though, you know, we all wanna forget it, but I think there are so many important lessons that I hope the word will not forget.

What is the one leadership trait or one leadership piece that you really take with you throughout all those experiences globally? And now as you’re leading your teams?

Barry Stein: You know, I’ll go. And that’s such a wonderful question, because obviously there are many, there are many, many different pieces, but I think at the core of this, it’s combining something that crystallized with impact for me at MIT, together with my experience since South Africa and this was it. Growing up, as I said, one of my idols, a folks, person that I looked up to was Nelson Mandala. How somebody like that, who had every reason to be angry when he was liberated, it was never about him. It was never about spinning the rest of his life with paybacks, good and bad. It was solving the most difficult problems it had, collectively. And when I think, I didn’t realize when I was young, but as I got older and as I started to be more and more blessed with more and more incredible people around me, certainly like MIT, I realized one thing and understanding the problem to solve is key, and then surrounding yourself with folks that have different talents.

And some of those folks, you may not agree with. In fact, some of those folks, you may not even like, some of those folks, you may actually even have a reason to want to have resentment towards for all the reasons. But the magic happens when you forget about the persona, that’s sitting around the table and you can focus on a team of people that are very different. That’s a lot of interpersonal potential tension and conflict, and focusing them on a problem, a vision that excites them all. And it may sound cliche, but it proved out last year, over and over and over again, when we had to rapidly create solutions for problems that we had never confronted before. And we could either do it in silos and with the exclusion, or we could bring everybody in with that talent, focused on actually solving a meaningful, impactful problem, and it just simplifies it and sort of distilled to that essence. Forget about yourself, forget about all your interpersonal issues, focus on a mission and a vision that is meaningful, not just the group you’re working with, but your community, your region, the world. And extraordinary things can happen.

Naji: Can you share with us? Can you share with us one of the examples, I’m sure you’ve done amazing things, obviously, you know, before the pandemic hit and the pandemic, as you said, well, I know that you have done really impressive things for the communities you serve and even more globally.

Can you share with us one of those example where, in moment of tension, how you manage to get your people together, to be able to deliver on those. Especially in healthcare, where you guys were really on the front line all the time with, with tough moments for the healthcare system. But yet, you manage to overcome and serve us all and be able to take us through it the best you could. Any example that you can share with us on this?

Barry Stein: Sure. You know, there’s so many and it’s not me. It’s the environment that you work. It’s the people that you work with and then certainly the opportunities that arise. And I’ll give you a few examples that may sort of reflect on what at least I believe servant leadership can do, and all the possibilities available. And I remember very clearly, let me give you some of the anti-scene history to this. For years and years and years, we all, all of us believed that virtual delivery of care had a very significant purpose, and potential of removing a lot of friction to get access to healthcare. And by that, I mean is why do I have to get into a car to go to a doctor’s appointment for her or him to tell me something that I could easily have done in a virtual way? Why does it take me to block off an entire afternoon from my work, weeks and weeks ahead of time to go and visit a provider, a clinician for something that I could do in my car, from my house, from my vacation, from my work, wherever. Simple stuff. Why was that the incredible friction in the system to maintain status quo? and in a self righteous way, in a way, and I’m just bringing that up. The payers, oh, it’ll cost too much money. The providers, well, how do we support our bricks and mortar? All the different things. And as you can imagine before, COVID just moving that concept through a system that had business models that were hardwired, created enormous friction on itself. Incredible antibodies, incredible resistance. And those discussions created animosity and sometimes ill feelings and ill world, not just in our organization, and I am not saying it happened in our organization. No ill world, just tension, but that played over and over and over again around the world.

We have an existential threat that comes upon us in a second, without the virtual ability to take care of patients, there was no connection between patients and clinicians. That’s an existential threat. We understood the problem to solve, which was very clear: connect our clinicians to our patients, so that they can remain healthy. That was the singular problem that everybody, no matter what walk of life they came from was super focused on solving. So something that would ordinarily take five years of change management, simply took within 10 days, we were doing thousands of visits a day and within three weeks, tens of thousands.

That was done by a very clear focus, bringing the right people to the table to solve a problem. Here’s another example. Analytics in healthcare. I would argue that healthcare has been way behind other industries in using analytics. What can it do? What does it mean? We can’t change this, we don’t believe this, et cetera, et cetera.

Pandemic hits. How many patients are gonna get infected? How many patients are gonna be coming into your hospital tomorrow? How many patients are gonna need an ICU? How many patients are gonna need a ventilator? Where are your ventilators? You’ve got eight hospitals, seven hospitals. How do you plan your PPE? No one knew. How can you operate a huge multi billion dollar company providing healthcare without knowing any of that?

So we were very fortunate. And again, this is relationships, caring, having community that coalesced around solving a problem. We had a wonderful relationship with MIT Sloan Professor Dimitri Bertsimas and in his team. We had been working on lots of different analytics before, but this was the moment where the resistance, the sort of trepidation disappeared. The operational folks in our organization, the clinical folks in our organization, the ITS teams in the organization all came together to convert the data that we all know exists into clinical intelligence, into operational intelligence that allowed us very quickly to be able to plan ahead and be equipped, to be able to take care of the patients that we predicted that would come in, the number of patients that would need ventilators, our PPE inventory, we were able to really manage more effectively than we’ve ever ever before. And what happened in that moment was the resistance, the black box kind of what is this? All of a sudden disappeared. The animosity just disappeared because we were focused on solving a problem, the same people that were at log ahead, sometimes with one another. All of that disappeared. And we were all able to collectively with all the talent around the table, solve that problem.

I can go on and on and on about how important it was to make sure that everybody thought that the problem we were trying to solve was impactful. Then everybody wanted to get up 18 hours a day, 19 hours a day in the middle of the night to work on this, to solve it, and to forget about the interpersonal disagreements. .

Naji: Yeah. It’s this laser focus, as you’re saying on the purpose that is beyond individuals. You know, as I reflected on now, we’re feeling in some places in the world,  we are starting to get back to normal, somehow.  I’m always afraid that all the energy that we’ve seen, all that you’ve shared, my question to you is how you gonna make sure that we keep it? Like it took us so many years to get into those transformations that might have been crucial to your eyes, but as you said, many barriers didn’t let us go there. So now that we’ve seen the power of being together, to actually act and change radically things, how are you going to make sure that it’s maintained in your organization?

Barry Stein: Great question. I’m sure you ask many great questions. And I think that the most important piece is first of all, to name it. We went through a lot of change last year, because there was an existential threat. We had no choice and we managed to do amazing things, and we had to change. So change was not an option.

What I’m hearing you ask is now that change could be an option, how do we guard against the strong gravitational pull to go back to the way we used to work? Because that’s our comfort zone. The way, and I can give you an example. It’s first of all, name it. Say last year, look at the amazing things we did, look at the impact we had, and actually describe how we did it. Not to say we did great things, but actually use examples. We had a clear problem statement and rather than sequential kind of activity, we got around the table once a day, three times a day, once a week, depending on the cadence necessary to talk about number one, agreeing on the problem, and number two, clearing up ambiguity, to be able to rapidly translate the task.

What we’ve learned at MIT, from also repenting and team, is dynamic work design. Understanding the problem, and creating teams to solve the problem, cross-functional multidisciplinary teams. And to make sure that’s the norm, rather than the exception and the exception is working in silos, not really understanding what the others lens is appreciating, generating multiple emails, amping up the friction and the misunderstanding, not understanding the elective goals. And I can give you many examples, but just in my world of innovation and clinical transformation using technology, what we are in the process of doing is number one, we all recognize the magic of being able to work as teams and respecting one another ideas.

And again, going back to understanding the problem, not bringing solutions until we understand the problem and everybody on the team being excited to solve that problem to impact. And what we’ve done now is rather than the exception of using that model of getting together, listening to one and other it’s become the norm, of work groups that understand the problem, multiple lenses, take off your hats of which silo and which function you’re in there as a team to solve a problem. And you’re there because you have the talent and the lens, and you leave everything behind and it does require reinforcement around that model. And here’s the wonderful thing, Naji. It’s not abstract anymore. I believe many organizations, most organizations that thrived during the pandemic, meaning they were able to continue to impact have many, many examples of how they worked to call on, to support a different way of working, to support a different kind of purpose, a different kind of meaning to the work and the gratification on being able to impact others in that way.

So it’s naming it, we can’t go back, naming an alternative, and having last year with many examples to support the alternative. Before COVID, I would’ve say before the crisis, the alternative was somewhat abstract. I think our job and our opportunity is much easier now because we’ve got multiple rich examples of impact working differently.

Naji: Yeah. I love it. You know, I will take it even for myself, for my work, you know, what you’re bringing is actually we’ve seen what we can do. So, how we frame it, we frame the problem. We see actually what we did with examples. And I love your idea of actually practically building in the process we’ve done to get to this solution and making it now part of the way we operate.

So great, thank you so much for those advisors, Barry.

I’m gonna switch to a session that is a little bit different. I will give you one word. So I have three words. I’m gonna give you, and every time I give you a word, I would love to have your first reaction to it.

So the first word is innovation.

Barry Stein: Taking new ideas that solve real problems and executing upon those ideas so that they have impact. Matching new ideas to real problems and taking those ideas and translating them to impact.

Naji: That’s a great frame for innovation. What about LQ2?

Barry Stein: Oh, Qualitative, and quantitative leadership. Left brain and right brain. Harmonizing, leadership, emotional quotient, sensing how people are feeling, wanting to help one another, inspire one another, that’s leadership. That’s the qualitative part. The quantitative part is the data that helps you drive in the direction that you’re trying to get to, and making sure that both are harmonized. Using the quantitative and the qualitative in a harmonized way has a force multiplying effect.

And I would you argue that one without the other is not even additive. That you really need both. And without either one, you’re not gonna get too far anytime soon.

Naji: Thanks. And, that was where we met. I had the pleasure to listen to you during the lecture, and it’s such a powerful lesson for me, this Q squared, in fact, right? Quantitative and qualitative, as you shared. The last word is spread love in organizations

Barry Stein: And I couldn’t think of a more powerful few words, that opened up the doors of opportunity. And I think to spread love is probably the most important thing that we as leaders in an organization can attempt to do. And I believe the way we can express love and feel loved, is by feeling heard. When somebody’s in pain, really understand where that pain’s coming from and how we can help them. And vice versa, it’s really feeling heard to me is another way of expressing love. Having deep interest in what matters most to the person that you’re working with, and being sensitive to that, as often as you can, whenever you interacting with that person.

And that is what my wife taught me, how important making the other person feel heard. That doesn’t mean you have to agree with them, that you hear them and understand them.

Naji: Yeah. You know, I think many times of each of those interactions you have, as you’re saying, it’s the person you’re interacting with, they should be on the scene, right? Like you’re here for them and they are heard.

Barry Stein:  Yeah. And much like our kids. Those of us who are privileged to have kids and I do too, two beautiful young men. To teach me about the importance of making them feel heard, and often we forget. We use the word love, but love means making somebody else feel heard.

So thank you for asking that and thank you for your leadership and your beautiful wife’s leadership in spreading that word and that concept. 

Naji: Thanks Barry. Any final word of wisdom for leaders in healthcare around the world?

Barry Stein: Remain curious, remain curious, ask as many questions as you can, and assume that, you know, very little relative to the richness around you.

Naji: Thank you so much Barry for such an inspiring discussion.

Barry Stein: Thank you very much. Looking forward to the journey that you are and supporting and helping. Thank you. Thanks. A special person you are.

Naji: Thanks Barry. Thank you all for listening to spread love in organization’s podcast. Follow us on social media and connect with us on spreadloveio.com. We’re looking forward to reading your feedback and reviews on your favorite podcast app, and most importantly, spread love in your organization for people to feel safe to thrive and reimagine the world.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Amer Kaissi

Naji: Hello leaders of the word. Welcome to spread love in organizations, a podcast for purpose driven healthcare leaders, striving to make life better around the world, by leading their teams with genuine care, servant leadership and love. I’m Naji, your host, having the pleasure to chat today with Professor Amer Kaissi and discuss his most recent book Humbitious: The Power of Low-Ego, High-Drive Leadership. Amer is an award winning professor of healthcare administration at Trinity university, the top 15 program. His previous book Intangibles: The Unexpected Traits of High-performing Healthcare Leaders won the 2019 ACHE book of the year award. He is a national speaker and a faculty member with ACHE, the university of Colorado, Denver and Boston college.

Amer is the director of the executive program at Trinity university, where he teaches courses in leadership, professional development and public speaking. Amer works with MEDI, a division of Navis, and with the leadership development group as an executive coach and consults with hospitals and other organizations in their strategic planning efforts. Amer is also a certified executive and physician coach.

He lives in San Antonio, Texas with his wife and their two teenagers. Amer, I’m so honored to have you with me today.

Amer Kaissi: Oh, thank you, Naji. Thanks for having me. It’s a pleasure.

Naji: I would love to learn more about your personal story. What took you to research healthcare specifically and your current leadership philosophy?

Amer Kaissi: Wow. We’ll start from the beginning then. So, as you know, I grew up in Beirut in Lebanon and, you know, went to the American university of Beirut for my undergrad, but didn’t really know what I wanted to do with my life and with my career, you know, ended up doing an undergraduate degree in, in public health, which I enjoyed, but it wasn’t something that I’ve always planned for or dreamt about until I took a course in healthcare administration.

That was almost the last course I took in my undergraduate degree and really enjoyed healthcare administration, loved the material, loved the fact that as an administrator, as a healthcare leader, you know, the decisions that you make impact thousands, if not hundreds of thousands of patients, you know, on the provider side, you’re a provider yourself, you know, your actions are very important obviously, and impact one patient at a time. But what administrators can do is make decisions that can hopefully positively impact patients in large numbers. So that’s what appealed to me in the field of healthcare administration, so I went on and I got a master’s in healthcare administration.

I worked at the hospital that is associated with the American of Beirut and really enjoyed my work in hospitals, in healthcare. At the same time, I started feeling that I had a passion for teaching, that teaching was gonna be my calling in this life and I wanted to teach.

So I started looking for ways where I can marry my love for healthcare administration, with my passion for teaching and I decided to pursue a PhD in healthcare administration. So I left Lebanon and that was back in 99. So, you know, I came here just after Columbus came and, you know, started a PhD program at the university of Minnesota and really enjoyed the research in healthcare administration. And part of my focus was on the patient safety part and the medical errors part, but also I had a huge interest in leadership and started looking into leadership issues within healthcare organizations, as well as at large.

Now, when I finished that degree, I took a job at, Trinity university in a healthcare administration program, you know, to two each future healthcare leaders. And as I started working with the graduate students, you know, I start realizing that, we kind of have a way of penalizing the individuals that are more humble, the individuals that are more compassionate, more empathetic, we tend to reward the loud students. We tend to reward, you know, the self-centered students. Organizational practices also favor the student, the applicants that are more focused on themselves and that brag and that, you know, talk about themselves. So all of these things started planting seeds in my head that I wanted to understand this better. I wanna figure out what are the best traits of leaders, especially the leaders in healthcare, because that’s my field.

So a few years after I got, you know, tenure here, I took a sabbatical and I wanted to read everything I can read about leadership traits, which obviously is a lot, you know, you can, you can’t read it all, but I read as much as I could and what started emerging from that research is that the traits that are responsible for high performance, especially in healthcare are totally unexpected ones.

You would expect that the leaders who are the most successful will be the confident, decisive my way or the highway kind of leaders, but it turned out, it’s actually the opposite that the research showed very clearly that, the traits that lead to high performance are empathy, compassion, generosity, and humility.

So that’s when, you know, I wrote that book that you mentioned in the introduction called intangibles, and I showed how the research supports that thesis. However, these traits are not enough by themselves. They have to be complimented with accountability, with competence, as well as with ambition.

Now, when I took that book on the road and spoke to different organizations, especially in healthcare, the one trait that was the most intriguing to people and that I felt was the least understood was the humility one. A lot of people were one wondering about humility and really questioning the research and saying really humility can lead to high performance? I’ve always thought of humility as a weakness. I always thought of humility, as you know, if you’re humble, you lack assertiveness or you’re not confident in your own abilities. So I felt that there was a need to do a deep dive on humility to better understand how is it a strength for health for leaders, but also to understand what else should be in there in addition to humility and what the research pointed to is that you need to have ambition. And that’s where that term Humbitious came from. Another thing that I realized, is that this doesn’t just apply to healthcare leaders. These two traits together can lead to high performance for any kind of leader in any industry.

Naji: Thank you so much, Amer for sharing part of your story and you know, one of the questions I usually like to ask leaders and thinkers, I have the opportunity to have here on spreadlove is the traits, the common traits are for successful leaders and high performing teams. But I think you smarized it in a new word called Humbitious. So if we take this work and start with humility, as you said, many times it’s perceived negatively. Sometimes people, you know, and we’ll talk later on different cultures and what it means also from your point of view in different cultures. I personally believe it’s one of the most important ones and obviously you just shared it, that it keeps us at check. It help us even continuously learn as leaders, and reinvent ourselves for our people. But how do you define it yourself?

Amer Kaissi: Sure. Let us start with defining humility at three different levels.

So the research points us to the direction that, you know, we can understand humility in terms of our relationship with ourselves, that’s the first level. Our relationship with others, that’s the second level. And then our relationship with the world, which is the third level. So starting with humility in terms of our relationship with ourselves, the first building block there is self-awareness, is understanding yourself really well in terms of your strengths, but also in terms of your limitations or areas for improvement, and that can only happen through self-reflection. So it’s very important for humble leaders to take the time, to think about their strengths, but also their areas for improvement, to think what the impact that they are having on others.

You know, when we talk about misperceptions about humility, it’s important to understand that humility is not thinking less of yourself. It’s not underestimating your, you know, skills and abilities. It’s just about looking at them as accurately as possible. So that’s the first level, which is humility with ourselves.

And then we have humility in terms of our relationships with others. And here we talk about our generosity as leaders, we talk about whether we’re willing to give from our time and our effort, to grow others and develop, develop them. We also talk about our appreciation and gratitude towards others. When you realize that you are not always the smartest person in the room, then you have a newfound appreciation to the intelligence of the group and to the skills that every individual brings in. And then another aspect of that humility in terms of relationship with others is what we call open-mindedness or teachability.

That is the ability to go into every conversation and every interaction with curiosity, with the mindset that says I’m gonna learn from you something new, regardless whether you are the CEO of the organization or a junior intern that just started. I’m gonna go into every one of these conversations with the assumption that I’m gonna learn something new. And in order to do that, I’m gonna ask good questions and then I’m gonna listen to understand your answer. So, that’s the second level, which is humility in terms of relationship with others.

And then we have the last level. Which is a humility in relationship to the world or the universe, which is a little bit deeper, understanding of humility, and it mainly relates to our understanding of our own insignificance in the world. And, this is a tricky concept. So I wanna make sure that I explain that well. We’re saying we are insignificant, not in terms of the work that we’re doing right now in our efforts, but in relationship to larger concepts, such as the universe or history or nature, or God, if you’re a believer, right? So when you take the time as a leader to ponder these larger concepts, you realize that no matter how important the work you’re doing right now in the grand scheme of things, it’s insignificant. And when you do that kind of pondering, you get another level of humility and a better understanding of how things stand.

Naji: Wow, on this level, I imagine you’re touching spirituality at some point, right?

Amer Kaissi: A lot of experts, you know, go to that part of it, which is the spiritual aspect of it. Others like to take it more on the religious side. I think both are valid depending on what your beliefs are. So a lot of people would like to, you know, compare how they, as a creature, relate to the creator, which, you know, they believe in God, right? But others maybe don’t go to the religious part, but more the spiritual side, which can be found in terms of contemplation in terms of relationship to nature. So there is this great research study that was done in Australia, where the researcher himself was a nature tour guide.

So he took a group of participants on a full week trip down a large river in Australia, and what he asked them to do was during that trip while they were rafting in the river, after every day to record their thoughts, and then he interviewed them at the end and what most of them described their feelings as they were immersed in this beautiful nature. They had, you know, they start having these spiritual feelings of realizing how small you are, and one of the participants described it as ego dissolving. When you see how grand nature is, you realize how small you are. So you’re absolutely right. This is a deeper, a little bit more spiritual side of humility. In my conversations with leaders, when I talk about this aspect of it, it’s especially the seasoned leaders that resonate a lot with that aspect of humility, you know, what we call transcendence or humility in relationship to the universe.

Naji: So let’s take ambition and then we can discuss the word, right, Humbitious. So from the ambition side, it’s also obviously very different, right? From a culture to another, it can be perceived differently, I imagine from a culture to another. But also when I think about even gender biases, right? An ambition women and ambition men, and how we perceive those things.

So I would love to hear your thoughts about how do you define ambition, but have you seen different reaction depending on different cultures or different settings?

Amer Kaissi: Yeah, let’s start with defining ambition first. So the way I understand ambition as part of this concept of Humbitious is that ambition is about not accepting the status quo, not settling, right? It’s about setting audacious goals and executing on them. It really is about believing in your own greatness and in your teams and organizational greatness. And what that translates to in terms of the day to day behaviors is having the confidence to speak up, having the confidence, to confront difficult situations, having the ability to have crucial conversations and to hold other people accountable when appropriate.

Now, your question is very insightful about the different applications of this concept to gender, but also to culture. So let’s start with, with the gender issue. And as you know, this is a very, very wide topic. And a lot of research has been done on that. So I’m gonna try to summarize, you know, 20 years of research in two minutes by saying that yes, there are definitely double standards when it come to ambitious men and ambitious women, especially in leadership. Ambition in men is appreciated and rewarded because look at him, he’s a leader he’s so ambitious, right? Whereas in many different organizations and organizational cultures, it’s not that appreciated when it comes to women. I interviewed a lot of male and female leaders for Humbitious as well as for intangibles, and one of the common themes I heard was when you are a female leader, it’s almost like you’re in a double bind. On the one hand, you have to act like a leader, which means you have to show ambition. But on the other hand, there is a gender stereotype that you should be more accommodating, that you should be more nurturing, you know, these kind of words that people refer to female leaders.

So, female leaders find themselves in this double bind. Do I act like a leader, which means like a male leader and show that you know, extreme ambition so that I can be taken seriously. But then risk being perceived as too aggressive, or, you know, some, some of the terminology that is used, like the B word or whatever, right, versus acting like how a female is supposed to act or how they want female to act in this culture and being perceived as someone who is, you know, more accommodating, more empathetic and so on and so forth, but maybe not what people think about when they think of a leader. So it is a very difficult situation in some organizational cultures, obviously it’s not everywhere.

And, we have a lot of research on that. And here I would mention a great book called Why do so many incompetent men become leaders and, it’s a great research basebook, and it’s not an attack on men, obviously, it’s just shows through research how much easier it is for a male leader to get into a high leadership position and how much harder that is for a female leader with the same capabilities.

Now, the last aspect of your question I believe was about the culture, right? And, you know, both you and me understand other cultures because we grew up in different cultures. So for example, in our culture back home, you know, in Lebanon, but in general, in the middle east, you have this perception of humility as not being something that you want to portray to other people, right. I remember growing up in Lebanon, you know, people would say, oh, haram matwadei, kalbo tayeb, right. And I’ll translate that, you know, God bless his heart, he’s so humble, you know, he’s so nice with other people, so that’s not always seen as a positive thing. So, trying to translate some of these concepts to different cultures is a little bit hard.

And then we have the whole aspect of, for example, the Asian culture, which, you know, while overgeneralizing is more appreciative of humility, because it’s less focused on the self and more focused on serving others and other centeredness. And by the way, a lot of the research that we have on humility and leadership comes to us from a lot of research done in Asian countries, especially in China and Singapore.

So it really is very interesting to start thinking about this concept of humility. Now, when we bring it back to the Western world, sometimes it’s also not that appreciated as we started with because many people are taught since early on, that you have to brag, you have to show self-confidence so you can stand out. So you can get chosen for sports teams and, for you know, plays. And then later on to be promoted for leadership positions.

Naji: and this is definitely true, right? When we, as you’re stating on this ambitious, and we see it, right, and incorporate sometimes from your stars where you’re good at and how to brag about it, right? So when is it too much, right? Like when do you think ambitious get in the way and what is the right equilibrium and what I liked and how you were framing it also for it to be clear, it’s not only ambitious for yourself, you talked about being ambitious for your team and how you drive your teams.

So any thought on, you know, this balance between it’s too much or is it not enough?

Amer Kaissi: Yeah, you’re right. I mean, if we think about it in terms of a continuum, right, and the continuum starts with being passive on one hand and then being aggressive on the other end, right. The sweet spot right there in the middle is to be appropriately assertive.

And you’re being appropriately assertive for yourself, but also for your team and for your organization. So that appropriate assertiveness shows up in terms of standing up for what’s right. Standing up for yourself when appropriate. Standing up for your team in terms of making sure your team has the appropriate resources, so it can achieve its goals and its tasks.

So we start seeing that aspect of ambition, as being appropriately assertive and also in terms of holding others accountable, when you need to do that, right, it’s about not shying away from difficult conversations. It’s about making sure that when there is one of these conversations to have with someone who, for example, is not pulling their own weight or not performing well, you don’t just let it slide, but you address it appropriately.

You know, as Brené brown said: kind is clear, right? When you are clear what your team members, you are being kind with them, you are showing that humility that we we’re talking about. So, you know, your question was about when is ambition too much? I’d say ambition is too much when it starts showing up as being too aggressive and the kind of leaders that I talked to, and I coached when that starts showing up, you see it in their interactions with others, as someone who is always talking and never listening. Someone who is always making statements, and not asking enough questions. You know, sometimes as an executive coach, the first thing that I do is I go and observe a leader in their natural habitat right, in the organization when they’re holding their staff meetings. And the only thing that I do in those meetings when they’re talking with their staff members is I count the number of statements that they make versus the questions, and I also count how many times they say I versus we.

Those two ratios Naji, by themselves can give you a great understanding of the leadership style of a certain individual right away.

Naji: I love it, and I love this idea appropriately assertive. Can you share with us a story of Humbitious leaders, and their impact on their organization?

Amer Kaissi: Absolutely, Absolutely. You know the one that I wanna share is maybe a little bit better known outside the us than maybe audiences in the us. But, given that your audience is global, I think it’ll be an appropriate one. So this is a leader that I have been fascinated with for the last few years ever since she became prime minister of New Zealand.

So we’re talking about just in the order and here again, you see, related to connections to what we talked about earlier with the gender aspect of it. So she became prime minister of New Zealand and thus becoming the youngest female leader in the world. Now, when that happens, when you have a junior leader, especially a female leader, there are a lot of cynics. There are a lot of skeptics out there. Oh, what is she gonna do? She’s probably all talk. She’s not gonna achieve anything. And, all of that negativity.

As soon as she became prime minister, she faced one of the biggest challenges that New Zealand was facing when they had the terrorist attacks in the town of Christchurch. Her response to that crisis was textbook Humbitious leadership. The first thing that she did was to take time, to go and be with the families of the victims. And if you see pictures of that time, pictures of her of that time, she wasn’t doing what politicians do in these situations, which is pretend to be there for the victims while getting attention for themselves. She was there really to feel with people, to mourn with them, to empathize with them and to tell them that she’s gonna do everything that she can to make sure this never happens again. So first stage was all humility and empathy. And then right after that, it was all decisiveness, it was all action, it was all ambition.

One of the first things that she did was to go to the parliament in New Zealand and make them pass gun control laws that they’ve been trying to pass for a long time in New Zealand, never been able to pass. Right away, they passed gun control laws that severely limited the availability of guns and, you know, people here in the us can debate whether that is a good policy or not. I’m not interested in that. I’m not interested in the politics. I’m just interested in the decisiveness, in the leadership lessons that we can take from that. So that’s how she dealt with that Christchurch and that terrorist attack and how she combined the humility and ambition.

A few months after that COVID 19 hit, and just like any other leader in the world, she had to deal with that in her country. And here again, we see this perfect combination of empathy and compassion on one hand, but also decisiveness and action and results on the other hand. One of the first things that they did in New Zealand was they closed the border right away, when no one was even talking about closing borders. And then they did an immediately a lockdown. Again, you can debate whether these are good policies or not in general, but for them that’s what they felt was the right thing to do. While she was doing that, she was doing daily interactions with her citizens on social media. So every day she would have a Facebook live or a LinkedIn live event where she would be talking with regular citizens off the country about how the government is going to be helping them, especially the small business owners. What are the programs that they’re putting in place to make sure that, you know, they’re not losing money and so on and so forth. You know, in June of 2020, we’re not talking about June of last year. We’re talking June of 2020, they had zero active cases of COVID 19 in New Zealand, zero! Sure, it’s a smaller country. It’s, you know, it’s an island and all of that, but I mean to talk about that kind of results with that leadership style, I just feel it is very impressive. So when I think of Humbitious leaders, she’s probably one of the few that come to mind.

Naji: It makes me think about something. We talk about women, men, right, and, and those type of leadership. Another question is generation that comes to mind. Do you think there’s a generational difference? And we might be seeing more Humbitious leaders? Or no, like any leader can be Humbitious and can work to become Humbitious regardless of a generational gap.

Amer Kaissi:  I certainly agree with those last, you know, last statements that you made there Naji about it can be any generation that embraces ambitiousness or not, right. However, what we are seeing, what the data shows us is that there is more appetite for this kind of leadership among the younger generation.

So the latest surveys that were done by, you know, divided and slice and dice the data by generation showed that it’s especially the younger generation, you know, people under 40 or even under 30 in their twenties, they have a very strong appetite for the leaders who are in touch with their followers, for the lead who are available, who are accessible, who are open-minded and there is much, much less tolerance for the leader that leads through my way or the highway.

Naji: Yeah. You know, and the more I see all those topics on the great resignation, the more I think, you know, what you’re proposing is what maybe the first solution for organizations to have Humbitious leaders and leaders who lead from a place of love.

Amer Kaissi: Absolutely, absolutely. You know, leading from a place of love, like you call it, I think is probably the most important factor in impacting employee engagement and employee innovation in our organizations these days. And this is not just touchy, feely stuff. This is not just, oh, let’s just hold hands and love each other. There is tons of research. There is tons of data that shows that this is the right way to lead. If you want your employees to go above and beyond, if you want your employees to generate new ideas and solve problems in creative and innovative ways, you know, this is not your opinion or my opinion. This is based on research that has been done in the last 10, 15 years, all over the world that shows that when the leader is inclusive, when the leader listens to inputs, when the leader asks questions, when the leader makes development, something legitimate in the organization, professional development, you know, when the leader admits and say Hey, I’m work in progress here, I’m not perfect as a leader. When you have that kind of leader that just rubs off the whole team and then everyone starts feeling like Hey, it’s okay to be work in progress in this organization, it’s okay to develop, it’s okay to learn, it’s okay to admit mistakes and limitations. And when that happens, the magic happens in teams and in organizations. Burnout is reduced. Engagement is increased and all of a sudden you have innovation and creativity that is unleashed throughout teams and throughout organizations.

So I agree with you a hundred percent about this could be one of the best ways that we fight the great resignation, that we fight burnout and, and chronic stress in our organizations.

Naji: Amer, I’m gonna go to a session now where I’m gonna give you a word and I would love your reaction to it.

The first word is leadership

Amer Kaissi: Leadership, I’d say misunderstood by a lot of people. There is this misconception about leadership being someone who is loud, someone who bangs on the table, someone who brags and yells at people, someone who overestimate their own abilities and underestimate others’ abilities.

And I’ll say all of these are misconceptions, misperceptions about leadership. So when I try to understand leadership, I always try to go back to that data and see what the science shows and what the research shows and the science is very clear. These kind of leaders that I just described do not get results in the long term.

Yes. They may be able to come in and change things in short term and do a turnaround what have you, but if we really want leaders that achieve a long-lasting impact, then we have to look for things such as love as you talk about, empathy, compassion, humility.

Naji: What about narcissism?

Amer Kaissi: Hmm. That’s a really good one. So narcissism is very interesting in leadership because again, if we look at the research, the research shows that narcissists tend to be chosen more for leadership positions. So if you and I are interviewing an applicant today and that, you know, we have two applicants, one is narcissist, and one is humble, chances are, even if we’re aware of the research, we’re gonna choose the narcissist because the narcissists tend to be more entertaining, more charming. They interview better.

However, and this is what I was just touching on a minute ago in the long run, narcissists are not effective leaders because they are poor team players. They’re lousy managers. They’re so self-centered, they’re not gonna get results in the long run. So when we think about narcissists, it’s very important to make a distinction between leadership, emergence and leadership effectiveness. Yes, they can emerge as leaders, but all of the indicators are there that they’re not gonna achieve long term success for their organizations.

Naji: The last word is spread love in organizations

Amer Kaissi: Spreading love in organizations, the way that I understand that, is that there are two levels of doing that.

There is first the superficial level that most people get stuck on, which is to be nice to say, please, and say, thank you. And you know, you’re standing in line in the cafeteria and you pay for the person behind you and all of that. Now all of that is good. You know, I’m not against any of that, but I think the real love being spread in organizations is done by being generous with others, by mentoring the young comers by taking time from your busy schedule, to sit down with someone and help them work through a problem or listen to their personal situation and being empathetic and being compassionate with them.

So the first level of spreading love, you know, we can call that confetti kindness. We can call that superficial kindness because it really doesn’t take a lot of time and energy and it’s very convenient, right? But the real work of spreading love in my opinion is the type that takes time, takes energy, takes commitment, and is sometimes inconvenient, but you still do it because it’s the right thing to do.

And as we just explained in terms of the research, it’s the only way to do it going forward with the challenges that every organization is facing right now. I truly believe that no organization is gonna be able to survive this, you know, COVID pandemic that we’re going through and burnout on all of that without love being one of its values.

Naji: Wow. That’s super powerful.

Any final word of wisdom for leaders around the world and even more specifically healthcare since this is also where you’re passionate is.

Amer Kaissi: You know, on the healthcare side, I’d say everything that we just discussed is amplified times hundred, right? I mean, if you think about it, healthcare is really the business of compassion. It’s the business of empathy. So, if you don’t mind, I’d like to end with a little story that a doctor friend of mine shared. Okay. So let’s call him Dr. Lee. So Dr. Lee shared this story with me. So Dr. Lee is an endocrinologist and he had a diabetic patient, come see him one day for a foot exam, okay. Now that patient is severely obese. So after the foot exam was over, Dr. Lee was, you know, was done with the examination. The patient was trying to put back his socks and his shoes on, but he couldn’t do it on his own because of his large size. So, what Dr. Lee did is he noticed that the patient was struggling, so he went straight and he knelt on his knees and helped the patient put his shoes on and his socks on. Now in that moment, the patient was embarrassed, but at the same time, he was deeply appreciative of this amazing act of kindness. Here’s this prestigious doctor down on his knees, you know, helping me put my socks on and put my shoes on.

Six months later, that same patient came back to Dr. Lee having lost 60 pounds, and he told him, he said I lost 60 pounds because of that one act of compassion and love that you showed me. I’ve been trying to lose weight all of my life, and I’ve never been able to lose more than five pounds at a time. But because of what you did, I started showing love to myself and that’s how I lost the weight. And not only that he told him, he said, I promise you Dr. Lee in six months, I’m gonna come back and. I’m going to have lost another 60 pounds. Now, I like to tell this story because it shows that in healthcare, we are in the business of love and compassion and empathy.

But my advice to leaders in healthcare is that it is not enough for us to show that love and compassion to our patients. Yes, of course that’s required. That’s great. But we need to show that same level of love and compassion and empathy to each other, within the healthcare team, within the leadership team, between leaders and clinicians, that is the kind of culture that we need to create in our healthcare organizations, otherwise we’re not gonna make it.

Naji: Thank you so much Amer, for such an inspiring and transformational chat, and definitely healthcare is a need of love as many organizations. But I agree with you. Healthcare is definitely in this need. Thank you.

Amer Kaissi:  Oh, it’s it’s been a pleasure. Naji, thank you for having me.

Naji: Thank you all for listening to spread love in organization’s podcast.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Adam Brown

Naji: Hello leaders of the world. Welcome to spread love in organizations, a podcast for purpose driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership and love. I’m Naji your host for this episode. And I am thrilled to be joined by an outstanding communicator, a visionary leader, a healthcare thought leader, and one of the most amazing frontline emergency physicians.

Dr. Adam Brown, Adam began as a frontline emergency physician with progressive clinical and administrative roles throughout the Mid-Atlantic and Midwest becoming the president of the nation’s largest emergency medicine practice at envision healthcare. During the first waves of the COVID pandemic, he continued to serve as president of emergency medicine and was named chair of the COVID taskforce for all specialties at envision.

That year, the CEO also appointed him to the role as an executive sponsor of diversity equity and inclusion in 2021, he assume the role of a newly created position at envision as the chief impact officer and has continued in his role in the pandemic response at D&I.

As an emergency physician and healthcare executive, Adam has a driving passion to improve the lives of patients using all his skills and influence he’s gained as a healthcare business leader and physician. He has expanded his reach and is imparting and improving the health of millions of lives. Adam, it is such an honor to have you with me today.

Adam Brown: Hey, it’s so great to be with you today.

Naji: From frontline physician, Adam, to now chief impact officer. And I’d love afterwards to, for your vision about this title. But before that your constant thread around improving patient’s lives, I want to know what’s behind this. What’s your personal story for you to do this journey and what you are today as a leader, and who you are.

Adam Brown: Yeah, I think that’s a really great question. You know, I’ll first start with a simple answer is that, I saw that as I was working as an emergency physician in different areas around the country, that there is an opportunity to take some of the things that I was learning. Some of the best practices around clinical medicine, the operational practices around how you take care of patients in an ER, or even in the inpatient units.

How to export that to other hospitals and by extension, as you start to export education and best practices, and you really start to scale that I started recognizing the opportunity there was to impact patient’s lives. And so I think, you know, as I’m looking at where I sit right now, one of the things that gives me a lot of energy and, gives me a lot about, of joy in the work that I’m doing is knowing that many of the things that I am doing really has the potential, either directly or indirectly to impact millions of patient’s lives.

But the question about the personal story, you know, I’m from Eastern North Carolina. I grew up at the beach, going to out on the water on Saturdays with my dad and a flat bottom kind of looks like a swamp boat almost, fishing and, fairly humble beginnings. My dad and mom are both amazing people.

They grew up in Eastern North Carolina in, what we called the country, in the country part of the state. And, my dad was the son of a sharecropper. He actually didn’t have running water to he was 18 years old and my dad’s only 68. So he did not come from wealthy means by any stretch of the imagination.

My mom, my grandmother was a school teacher, English school teacher. I think that’s where a lot of my communication interests came from. My granddad still to this day at 87 years old runs a barbecue restaurant in Eastern North Carolina. And so, you know, my background was definitely not one in medicine, but where I think is very important to me and how it’s shaped and informed my decisions along the way is the importance of people and really the importance of making an impact in people’s lives, no matter what you did whether it’s making really good barbecue that people wanna wake up for on a Saturday morning to drive an hour, to get to, to see people smiles as they’re coming to get that barbecue, or to hear the stories from my grandma talking about in her very Southern drawl about kids that have come back, who are now adults to thank miss blizzard. My grandmother’s last name was blizzard, to thank her for the education that she provided. And so I think that’s some of the pieces and parts of what kind of shaped who I am today.

Naji: Well, thank you so much for sharing this part of you. And I love how you framed it, right? You had it early on and you’ve seen it how to help people, right? How to make people happy. So it will take me to this idea of chief impact officer. And I think it’s coming again from the millions of patients who are impacting and helping, but also your teams, right? You’re passionate about D&I, you’re running today one of the largest teams in the us and emergency medicine and beyond. So tell us a little bit more about why chief impact officer, what do you put behind this as a daily job?

Adam Brown: Well, this actually goes back to during the pandemic and at the beginning of the pandemic. So in 2020, I was named president of emergency medicine for envision how healthcare and, just to give folks a little bit of idea of what and who envision is we’re a large medical group, one of the leading medical groups in the country, and we have clinicians over 25,000 of them taking care of patients in 45 states across the country. And actually now, even across the world, as we have medical type mission trips that we’re going actually going to Dominican Republic on Saturday. But we are an organization with very different types of skills, whether it’s emergency medicine, pediatrics, neonatology, anesthesia surgery, OBGYN. Those are just a few of the areas where our clinicians work. And so at the beginning of the pandemic, I was president of emergency medicine, but I could see what was I thought was about to happen, that we were going to be heading into a pandemic. And so there was a lot of concern that I had about that. It would not take long for that virus to come onto our shores as well, and was probably already here. And so at that point in time, our CEO, asked me, you know, I’m an emergency physician, emergency physicians deal with that type of training crisis training, even pandemic training. I had done some work of course in the us when we were worried about Ebola coming around.

So I had an idea about what we would need from a personal protective equipment, how we would need to have, you know, information control, crisis control, et cetera. So he asked me to start working on the pandemic response. And I think what was a really big challenge at the time was I was not just now helping the response of emergency medicine, I was having to think through how do we take care of our clinicians in the hospitalist inpatient unit? How do we take care of our clinicians in the anesthesia, in the operating room suite? How do we get them to the protective equipment that they need, but also how do we get them the educational information that they’ll need to take care of patients? So folks, remember back to March and April of 2020, all that we knew was that, there was a virus that was coming. It could be respiratory, it could be droplet. It could be, we were wiping down our Amazon packages. We were doing all these things to protect ourselves. So there’s a lot of unknowns that now we know today. And so a part of my job was to identify best ways to take care of patients, best ways to protect our clinicians best ways to distribute information and really to become the trusted voice. So that’s a long answer to get to how we got to the chief impact officer.

We recognized by the end of the year, there were so many societal changes, social changes, changes that needed to happen within patients and even within our own clinicians that keeping me siloed in a single service line, like emergency medicine did make a lot of sense. And so I wanted to lean into, the reason why I went and got my MBA. The reason why I went to get become a doctor is I wanna impact a lot alive. So it was a title that I said “Hey, what are your thoughts about this?” to our CEO, here’s the reason in the rationale. We already had decided what work I would be doing, and it seemed to make a lot of sense. And so that was the reason why we got to chief impact officer.

Naji: When you’re talking obviously you went back to the pandemic, you led the team in one of the most challenging times, right? And cross-functional teams caring for patients, but also as you mentioned, right? Caring for the healthcare providers, you guys were on the frontline, risking your lives to save others lives. So there’s a couple of things I would love to hear your thoughts about. The first one you said you wanted to become the trusted voice and I think in those moment of tensions, being also an emergency physician, as you know, like being able to be the trusted voice for the people to trust you right? To risk their lives and do practically what you’re asking is something big, right? So we’d love to hear your thoughts about the learning around this. And then I will go to the other part, which is more the silos also that you talked about. But let’s start with this one first.

Adam Brown: Yeah. I will never forget a good friend told me at the beginning of the pandemic, when I told her that I would be leading the response and she was so right. She said, Adam, your most important thing you can do is be trusted. That’ll be the most important thing for you, to lead the organization, to lead the team, is trust. There’s other pieces there too. You have to be trusted. You also have to deliver, which also kind of filters into being trusted. But you need to be a trusted voice. And so everything that I did laddered back up to being that trusted voice.

So it made me critically think about what information I was trying to get out to our clinicians. What would need, what was the research there? What were the proof points for that information getting out? Being honest with them about good news and bad news and becoming that person at the organization that when people said, Adam is speaking about something, we can trust what he says. But we are an organization of not just clinicians, we have 35,000 employees that work for us and so we have our teammates that work for us. And so many of them are not clinicians. And so not only being that trusted voice for the clinical persons, also being that trusted voice for our clinical support teammates that are helping our clinicians with everything, from their schedules, their paperwork, their credentialing at hospitals to our business development teams and our managed care type teams. Those also too were looking to me at times for answers on how they interact, how they should interact with their family at Halloween. This was before the vaccine, you know, in 2020, what type of information was available and how to try to help them search through all the disparate information that was coming out there because I knew that just as much information that was scientific that could be trusted, was out there. There’s a lot of information that was out there was untrusted. So I felt like the big piece and I’m gonna use a marketing term, but the big piece of my personal brand was be trusted.

But not only be trusted, but choose wisely on activities that I get involved in, because anything that could potentially corrupt that trust had a far greater concern of then me not being able to carry certain messages about how to protect yourself, how to protect your family, how to take care of patients in a certain way.

Naji: So any key learning you had, because obviously we all faced and you faced it at a totally different level. And everyone listening today knows potentially all those questions we all asked ourselves, right? But you guys being on the front line, it’s multiplied by hundreds of times. Any key learning as a leader, trying to be trusted? So I love the idea of choosing the activities being involved, making sure that you’re bringing the data that can be trusted and being the voice of this data. But many time, you gave the example of Halloween, for example, before the vaccines, many time we do not have answers as leaders. That’s right. How did you handle this, right? And brought back this voice to keep the trust but also many time people will look up other leaders and well, tell me what I need to do, right? So how did you coach our people towards those moments of uncertainties? Because we face them also in the business word in a daily life, to a minor extent.

Adam Brown: Well, I think a part about being trustworthy is also being honest about what you know, and what you don’t know. And so I think when you can say things sometimes with caveats, but sometimes you say things like, for example, let’s take Halloween. Based upon the best information that we have available, the way that you can protect your family the most is by X, Y, Z, A, B and C.

That’s based upon what we know now. And we’re early in this pandemic. But as we move forward, we’ll learn more. And as there, as that adjusts, I’m gonna give you that information to the best of my knowledge. So that was one of the ways that I think I built trust, by being honest with people about what we did and didn’t know.

But I think the other piece here and you had asked specifically about learnings is the power and importance of communication effectively. I’ve heard people say things like communicate, communicate often, overcommunicate, when you think you haven’t communicated enough, do it again. And I agree, but I disagree.

I agree that’s the right thing to do if you’re communicating effectively. And so this goes to the second piece that I learned. When you’re a healthcare company, every person that you are working with, whether they are an anesthesiologist, whether they are an anesthesia business leader, whether they are a scheduler or someone working in security at one of your operations offices, they all come with very different levels of understanding of healthcare.

They have different levels of understanding about their life experiences. Meaning some have been always in healthcare. Some have not. And so you really have to think through when you’re communicating the different segments of your audience. And so the questions I would ask, Naji, oftentimes were, who is this message going to? Is this going to my ER docs? Is this going to my nurse practitioners and PAs that are in the emergency department? Is this going to my clinical support non-clinician teammates? Because the message needed to adjust and change and so even though the old maximum of communicate over communicate and continue to communicate is true, but bad communication is sometimes worse than not communicating at all.

And so really, really thinking granularly about what are the experiences of the audience that you’re trying to communicate to? What is the level of understanding? What type of biases may they have? What type of information may they might be receiving at home or online or on television? And so crafting a message in such a way that can get to your ultimate goal, i.e protect people, give people the right information, stay the trusted voice, that sort of thing. It was an important, important piece to how we communicated and continue to communicate through this pandemic.

Naji: Yeah, so really adopting it, listening, knowing who they are. And I think it goes back to your very first words that you said, your passion for people. Like you can only do this if you’re literally, and genuinely want to understand what they’re going through and try to help them and be empathetic with them. So a lot of credits for you to be able to run those things with your teams.

Adam Brown: I think, let me explain it this way. When I talk to my mom and dad and they have had questions throughout the pandemic, of course, you know, and they have seen me at times as their son, they continue to see me as their son, despite being a healthcare executive and a doctor, sometimes they forget that but then they see me at times as the doctor and the trusted boy with them as well. And the way that I explain, a new story that may have come out, or the way that I explain the guidelines for say vaccines for them, or the way that I’ve talked to them about incoming potential risks, is very different than of course the way that I would talk to you or I would talk to someone who is a, a healthcare provider. And that seems really simple, but a lot of times, and I’ve seen the traps of this, whether it’s within the hospital or when clinicians are talking to patients, is that many times we start to get overly reductive in the way that we try to communicate. We either drop our communication down to a sixth or an eighth grade level because that’s what generally, newspapers are written on or we try to do things like make things overly simplistic without really understanding the driver of the anxiety of why someone may be asking a question that they’re asking. And so that stakeholder engagement that back and forth in the piece of the communication is so critical in crafting your message during a crisis, so that you can get that other individual to not only hear you, but also understand, absorb and take that information in.

That’s a really important thing. And I hope if we talk a little bit more about it, because I think it’s an important piece for us as healthcare executives or business executives, period.

Naji: Yeah, I totally agree. And how many times, like we come with the same message, as you said, we’ve heard it many times over communicate and it’s missing this tailoring piece to who you’re communicating and how you’re communicating, what you’re communicating.

I do wanna go into COVID questions. I can, I have bunch of questions. I love to ask you about it, but I don’t wanna get there. We’re talking about, you know, leadership and what we can learn from you as you have done and still doing this. Anything you would have done differently, during those times or earlier, if you would have known and not related to the virus more from a leadership standpoint.

Adam Brown: Yeah. I think there’s probably two things that I would’ve done, you know, as much as I felt that it was important for people to trust me, I needed to learn to trust others as well. And I think what I mean by that is, is that when you are crisis or even when you’re not in crisis, when you are dealing with a business challenge or you’re dealing with a challenge with engagement with employees or choose the problem you’re trying to solve, really quickly assessing the skillset of those around you, but also identifying those other persons that you can trust and start to anchor over to them because you can’t do it all. And I think that is, has been a bit of a, something that I realized really early on, is that engagement back and forth with, again, your stakeholders, your employees within your organization, your direct reports, your colleagues, those that you report to identifying who you can trust. And I don’t mean trust, like there’s someone that’s not a good person. I’m talking about someone who’s skilled, who knows their information, who can get what you need to get done, done so that you can depend on them.

And I think early on, I was trying to do everything. And I remember my husband saying to me, at one point, he said, Adam, this was probably in April of 2020. And this was around COVID, but I can apply it to other things too. He’s like, Adam you’re not gonna be able to get everything done and sleep and have a life. He’s like, you’re gonna have to identify other people that are going to be able to help you accomplish the goals that you need to accomplish and so I quickly had to figure out a rubric and my mind of how do I learn about, identify the skillset of another individual and then, trust them.

Naji: That’s definitely replicable and a great, great point and joining. What’s next, do you think in the healthcare leadership, you know, the pandemic is still ongoing, we are all hearing about, you know, the mental health issues, unfortunately, within our healthcare teams, but also across the globe and in the us. Any thought from your side on the next challenges as we continue on having, well, luckily with vaccines, less of, you know, the kind of the catastrophic situation we were with so many patients suffering and dying unfortunately, but it’s continuing right and isolation, people having more and more suffering from mental health and we seeing it in healthcare also being impacted way more, I would say, from outside healthcare, because of all the challenges you’re facing, obviously. Any thoughts about this and how as leaders we can help out.

Adam Brown: Yeah, I actually think there’s a couple things that kind of converge into this. I’ll say it’s not post pandemic because, you know, we just recently had a hundred thousand people die within a relatively short period of time, just here in the United States.

And the virus is continuing to spread, pretty significantly in Eastern Europe and in Europe right now. And that said, I think the first big issue that’s going to be facing healthcare and clinician wellbeing and clinical wellness and burnout are an issue and I’ll talk about that in a second, but I think there’s something higher level that we are going to be dealing with and that is misinformation and disinformation within healthcare because it transcends the pandemic. It has, we’ve seen now with this pandemic, this has been an opportunity for us and although a negative one, that for people that have anchored to misinformation or disinformation about the vaccine, the last hundred thousand people to have died from this virus, a large majority of them were unvaccinated, which means could have prevented their death.

So think about that for a minute. Think about how individuals chose to listen to something other than the prevailing science, trusted voices. Those voices to them became distrustful and they made decisions that affected their lives and that’s just the people who died. There’s people that have had other type of long COVID symptoms or will continue to have sadly some long COVID symptoms, at least to what we’re seeing.

So here’s my point to this COVID is an example of a broader problem that we have around misinformation. And why is that a big problem? Well, if there’s so much distrust where people are not believing physician or people are not believing organizations that are trying to protect the public, then what are they not going to believe when there’s new cancer treatments, when there’s new other emerging pathogens, when there’s other diseases that we want to treat?

What happens when patients are coming to a hospital and their loved ones in the ICU for a different type of infection and the family members are coming with an inherent distrust of the clinicians because of information that they have seen that has been mis or disinformation. I see that as one of the biggest emerging and continual problems that we have.

So that’s the high level problem that I see that we are going to be facing with healthcare. And I think that the answers to that come back to a marketing and influence answer of identifying segments of the population, identifying what influences and drives decision making in those populations and how can we do what we need to do to address the needs of those individuals. Now diving into the healthcare sector specifically. Yeah. You were gonna ask something.

Naji: Yeah. Just before diving, because I love this point. When you’re saying we,  who do you see around the table being able to get back to this trusted information because there’s many actors, right? Like I’m in the pharma industry, you’re on the front line. There’s regulators, agencies, authorities, you know, patient advocacy group. Like when you say we do see us getting together and doing this, how do you see things?

Adam Brown: Well, I think you have to take a step back and even look for, to answer that question.

You have to take a step back. What drives your decision making for anything right now? What drives informs your decision about why you make a decision for whatever product you want to buy, where you wanna go on vacation? Why you like one thing over another, or why you believe one health type food is better than another health type food?

I believe that healthcare decisions. and any decisions for that matter are really, really complex. And I think that we’ve made the, the grievous error and I learned it in medical school that you have to talk to your patients in such a way that they can understand. Well that’s right. But I think what’s wrong is that you’re not the only one talking to that patient.

It’s their person at their church. It’s their Facebook group. It’s, you know, a celebrity, someone from the green bay Packers. There’s someone that is talking to that individual in such a way that is triggering in their mind connection and influence and driving decisions. And so I think what we have done wrong in, and when I say we, I say the healthcare community in general, is we have assumed that there’s health literacy and then by contrast health illiteracy, meaning that you either know healthcare or you don’t. And I think that’s the wrong setup because every single individual believes or knows something about their healthcare. Let me, let me just tell you a personal story. So I’m from Eastern North Carolina. I started working in an ER when I was 19 years old.

I was a tech in the ER. And I remember one day sitting with the nurse in triage, that’s the area where patients come in, the intake process and a guy had a burn on his arm. I’m probably gonna slip into a Southern accident a little bit, cuz I’m being a little nostalgia. And so anyway, guy comes in with his arm, he sits and I’m like, what happened to your arm?

He’s like, well, I burned it. And I’m like, well, why is it so shiny? He goes, oh, I put Crisco and butter all over my arms. I did, I just put it all over it. And I’m like, why? You’re not trying to make biscuits. Like, why are you putting this on your arm? And his response was, well, that’s what I’ve always been told.

Now, this a guy who worked at a farm, he was not a healthcare professional, but he had knowledge of healthcare in his mind. That he was doing what was right for him for his healthcare. So I think it’s wrong to believe that people are illiterate. It’s just their understanding of healthcare and their personal healthcare is very different. Now, clearly he’s wrong and I’m encouraging anyone who’s listening to never do that because that’s not the right thing to do. But the point here is that people are not empty vessels just waiting for information to be poured. People have made up in their minds stories and, stuff from their grandma and their granddad and their aunt and their uncles of what you do.

I mean, I remember one day working on a tobacco field and yes, I did this, when I was, my dad made me do it, when I was like eight or nine years old. So that I would ever A, want the smoke or chew tobacco, or B ever that I would want to do something other than work in tobacco field. But I got stung by a bee or a wasp or something and I remember someone saying here, let me chew up some tobacco in my mouth and put it on your bite because that sucks out the sting. Now kind of look, and that was accepted and thought it would be a really great thing and a really wonderful thing to do or take like raw meat and put on your arm. I mean, these are the things that I grew up with knowing.

They’re clearly really bad things to do. They’re not good things to do to protect your skin from infection and all the other stuff. So the point here is that those individuals believe fervently, and that is the way you treat a condition. So what we have to do is we have to not make the assumption that people are just quote illiterate.

I find that offensive. We have to make the assumption that people do come with certain levels of information, albeit wrong at times, but identify how then to communicate. So to your early question about who’s the we? The we is not just doctors. We have to think, or clinicians or healthcare providers, we have to think like a marketer.

We have to think like a disinformant. We have to think about what are the drivers of influence, the complex drivers of influence for people in their decision making to get them to understand truth in medicine.

Naji: What an amazing perspective Adam really, really great, great different perspective. And as you were talking, I was thinking about all those different beliefs patients can come with and me included, right? As you said. Yeah. And it’s, yeah, it’s definitely a different perspective and a challenging one, right? Like to unlearn and relearn, and make sure we trust people to be able to listen. 

I would love now to give you one word and get the reaction to it. So the first word I have in mind for you is leadership.

Adam Brown: Ooh, one word I’m gonna give you a second one back, challenging, but opportunity. I see that being a leader is a challenging job. Being the leader of people is not easy and nor should it be. But I also see great opportunity in the job. And that’s been such a driver for me.

Naji: What about equity in healthcare? If you want even broader

Adam Brown: Misunderstood. I think that what people have understood as equity means access, just because you have access to something doesn’t mean you can use it. You know, I could have access to tons of cars, but if I don’t know how to drive the car, or if my legs are short and I can’t reach the pedals, or if I can’t see over the steering wheel, then the car’s kind of meaningless.

So I may have access to it. So I think people, and this is something we’re kind of grappling with a bit here is there’s an assumption that there is equitable access to vaccines, equitable access to hospitals. But there’s not, it’s not because when you look in rural, there are multiple areas in the country that are well over an hour to your closest hospital.

There are areas in the country where there’s very disparate skill sets in the type of clinicians that are in various hospitals. There are areas of the country where you have some people that have access to primary healthcare clinics and some that don’t, that only have critical access hospitals. It’s not just rural though versus urban, even within urban environments.

Like I live here in Washington, DC, there are parts of the city that have better access to care, better public transportation. So, equity and healthcare is not just simply about the ability of, of saying that there’s something close by or not close by. It’s like, can people actually truly access it? And is there equity in ensuring that all parties and all persons can get there?

The other thing with equity and healthcare is that if we are looking at the future of healthcare. we have got to start addressing the issue of equity in healthcare. And where do those issues come from? They come from social determinants of health. If we don’t address those, we aren’t accomplishing the goals of improving the population’s health across the board.

And so that means identifying ways to improve education in our communities, improve infrastructure in certain areas, clean water, getting people the access they need. There’s direct correlations, between those type of big infrastructure things, those social determinants of health, it’s in the title, it’s a determinant of health. That, we have to address those issues to truly ensure, and we have to address racism before we can start to get to equity.

Naji: Can I double click on this one, cuz it’s such an important topic and you’re obviously within your organization leading diversity, equity and inclusion efforts.

What should we do? Where are you starting? So I know a lot of things we’re a little bit, I don’t wanna say way better, right? Like at least there’s light on it and we’re taking actions, right, to improve diversity.

There’s a still long way I think, into inclusion, because something is to have a diverse team, it’s a different thing to make sure that everyone is included and equity is also another step as you just shared. And I love this idea about difference between access and usage. Where are you starting and what can we, and should we do, as leaders on this topic?

Adam Brown: Well, I think you started hitting on it right there. You know, diversity is not the full answer to equality. Inclusion is not the full answer to equality. You really have to take all three of them together, right? You have to have diversity, you have to have inclusion, you have to have equity. And the three pieces of those parts have to be a part of your solution in tackling the problem.

So let’s take, for example, just a few issues with social determinants of health and healthcare. Sometimes when we say health inequity, or I said racism earlier, that can be triggering of course, to people meaning that, oh my God, I’m not a racist. There’s no way in the world that I’m a doctor. I care for everyone. And there’s an immediate defense that can kind of come up.

So what I believe you have to do is you have to recognize that let’s start talking about number one. Do we have a problem? Let’s start educating populations within our own sphere of influence about the problem. Like there should not be a reason that if you live in Dallas, Texas in one part of the city that your life expected sees 30 years different than someone in another part of the city.

So when we look at that, we have to start asking a question of then why? Now as clinicians and as healthcare professionals, many of us, and even as business professionals, we’re analytical individuals, we’re intellectual individuals. We should start asking the questions to why is that? And you keep peeling back that onion and digging to the why, why, why.

Why did this happen? Why did that happen? Why is this happening? And so for us, when we started looking at how do we start to improve? Not only diversity in our organization, I can get to that, some tactics there. How do we create a sense of belonging and inclusion, but how do we get to equity?

We start to look at the reasons and the drivers for inequity, meaning what are the drivers for those social determinants health? So whether it’s education, whether it’s systemic racism, whether it’s, I mentioned education like childhood education, but are there even other types of education that we need to focus on? Targeted education, housing, food insecurity.

Those are some of the issues that we start looking at. And then we, once we identify those five or six domain, then we look tactically, or what are the things that we can do? As a large healthcare organization to make improvements in those areas so that we can ensure that patients are getting better healthcare, more access to healthcare, more equitable healthcare.

This is a long, long, long journey though. This is not something that will change in a day. So that’s the first thing is I think we first are diagnosing the showing that there is a problem we’re educating our teams, that there is a problem. And sometimes it’s not so much an issue as a new problem. It’s a Hey, we’re all into this together. And we need to recognize that there’s a broad, broad problem here, and we need to do something to to affect it. And then once you identify the domains and the areas that are creating the inequity, then you start to address tactically the issues that are supporting that inequity and turning those around.

So it’s a multi-year journey, multi-prong type of approach.

Naji: Yeah, totally agree. And yeah, we have to start it and it’s great that Envision has you as a leader and then impact that you can have across the country. That’s really great. My last word is spread love in organizations. Thoughts?

Adam Brown: I love it. I mean, I love spread love. I think that makes a lot of sense. You know, we talk about as, you know, you’re a physician, I’m a physician, you know, we kind of jokingly said, oh, we did this cuz we want to help people. And when I say that jokingly, I remember someone saying to me back in medical school don’t answer that way on a question when someone asks why you want to go into medicine, because everybody says that, but I think it’s true. I think the reason why I’m doing what I’m doing is because I wanna impact people’s lives positively. I wanna make sure that my nephew whose eight years old has the same and the other that six, has the same ability as the kid across the street, the African American kid, has a life expectancy. I hope the African American kid has the same life expectancy as my nephew who’s Caucasian. There’s love there, right, that I want to make sure that there’s equitable access, that there’s fulfilled life. It’s because the color of our skin or where we grew up or the political leanings that we had, or the religion that we had, all of those different things should not be the driving force behind how our lives look, how long we have lives, the quality of life that we should have in the negative, it should all be positive. And so I love this idea that you have of spreading love, beause it goes back to your impact. What impact do we have as business leaders of improving the lives of other individuals around the world.

Naji: Well, it’s really an amazing way to sum it up. And I think you bring love and we can feel the passion you have behind it. This is why you’re moving lines within your organization and across all the US with what you’re doing, Adam, this is amazing. Any final word of wisdom for healthcare leaders around the world?

Adam Brown: Yeah, I think the final thing actually goes back to the thing that I’ve learned earlier. You know, I do believe that we are are still very much in this pandemic as much as many of us don’t want to be in the middle of the pandemic. And there is going to be a piece as we are starting to hopefully see the ends of some of the hard, hard pieces of the pandemic, where there’s not a vaccine, but where there is a vaccine now.

But we are going to have to reestablish our trust as leaders. And I think that’s important not only when we start to think through the lens of how do we protect the patients that we see, but how do we protect the clinicians that are caring for those patients?

Because as I’ve talked to many of my colleagues, many of us are hurting, and many of us have seen things that we never thought we would have seen, something that we did not prepare for. People say, oh Adam, yeah, yeah, in emergency medicine, you prepared for crises. Yep. But we didn’t prepare for crises that would go on at this long with this amount of stress and strain. And so as leaders, business leaders, as healthcare leaders, a way for us to establish that trust is start to become very empathic and understand the challenges of the patient, the challenges of our clinicians, so that we can reestablish ourselves as the trusted leaders and many of many folks who are listening are the trusted leaders. But that trust can be lost. And so as we go through challenges through the end of the pandemic, hopefully coming out of it sometimes soon there will be new issues. And so I believe we still have to understand our audience and make sure that we stay that trusted voice.

Naji: Thank you so much, Adam again for your time, generosity and such an inspiring discussion. Thank you.

Adam Brown: Thanks again for having me.

Naji: Thank you all for listening to spreadlove in organization’s podcast.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Ahmed Mady

Naji: Hello leaders of the world. Welcome to spread love in organizations, a podcast for purpose driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership and love. I am Naji your host for today’s episode joined by Dr. Mady a physician scientist, healthcare consultant, serial entrepreneur, and a brilliant innovator.

Ahmed Mady is currently pursuing his executive MBA at MITs Sloan in Boston. While serving as the managing director of his family, textile business in Egypt. Prior to this role, he worked as the senior director of business development at an innovative Boston based diabetes management, startup, Healthy Nation, and as a senior consultant at Navigant Consulting, where he led nerous global life sciences and healthcare projects for pharmaceutical companies Medtech and biotech space. In addition, Dr. Maji has experience conducting translational research at the cardiovascular research center at Harvard medical school, Mass General Hospital. His lab research is focused on stem cell applications in heart diseases and diabetes, where he created han cardiac tissue engineering models.

He earned his medical degree from Alexandria University in Egypt with several rotations in the United States. Ahmed has over 14 years of experience in healthcare business, manufacturing, medical research, and technology management. Welcome Ahmed. I am thrilled to have you with me today.

Ahmed Mady: Thank you so much Naji for the introduction, and it’s my pleasure to be with you on your great podcast.

Naji: Well, I would love to start by knowing you a little bit, more, more about your personal story. What took you from, you know, your childhood in Egypt to medicine to now becoming a serial entrepreneur and a student at MIT. What’s your personal story behind it?

Ahmed Mady: Well, I can tell you it all started back in when I was, 40 years old, when my father wanted to teach me the tricks of a trade. My father owns a textile factory in Egypt and, he wants actually to just make me get involved with him in the factory. So I used to go to the factory and just play as a kid. And when I was 10 years old, he made me work on the factory floor before moving me to the cushy desk, managing the entire business with him when I was 16.

During that time, I had a great experience with the workers and employees of the factory and, I can tell you this great experience with the 500 workers had a profound impact on my life, teaching me many lessons in medicine, in consulting and, in manufacturing and mostly, recently startups. So, when I was working at the factory, everybody was expected that I’m gonna just follow my father’s footsteps and I will enter business school. I will be managing the factory after him. And, when I was working with a factory, just, I felt that all the underprivileged workers and people, they really needed something in healthcare. And, one of the biggest challenges we were facing is the lack of adequate healthcare in the country that made me become more interested in medicine, become more interested in science and I just decided to enter medicine. So during that time, I was working the factory during the first couple of years of medical school while also going to medical school and studying medicine and I decided that I really wanted to focus on the healthcare sector and I finished medical school and got a scholarship to go to the United States to do my internship year. And I would say the rest was history, just continuing my healthcare career for more than 12 years until, I got a call from my father in 2018, telling me that he wasn’t feeling very well.

And he was thinking about closing, shutting down the business. Unless I’m willing to go back and help out. There was lot of mounting losses because of the market and from health perspective, he wasn’t feeling very well to continue managing all the employees. It was a really tough call at that point that I had to make a decision whether I should continue my healthcare period, the United States, or go back to help out and save the business.

Naji: Wow. And obviously you went back and you are working now and you’re leading, right, the textile business of the family, right?

Ahmed Mady: That’s correct. It was a very tough call. I had to discuss with my wife during that time how we would make it work. We have two beautiful kids. We were in school in Boston. My wife was working in Boston and it’s very hard to really do the transition and come back to the middle east, after we established our careers. So she was very supportive and we made the decision that I’ll be spending two weeks in Boston, two weeks in the us until I can figure out a model that the factory can be managed remotely.

So since 2018, I’ve been traveling between Egypt and the United States until COVID happened. And that made me get back in Boston for a couple of months, until the oponing of airports.

Naji: And now you’re back, right? Like you’re between Egypt and Boston. Again, like we’re talking together, you’re in Egypt.

Ahmed Mady: That’s correct. So during that time, I just wanted to strengthen my business acumen and learn more about the business fundamentals. And I made a decision that during my two weeks of staying in Boston, why not just get an executive MBA out of it and learn more how to really do what I’m as aspiring to do, which is how to put a system in my factory that can that I can manage remotely while going back to the us and focus on my other endeavors.

Naji: It’s awesome. And how did, you know, like I feel this healthcare never left you. I know you even, co-founded two startups during the pandemic so that are somehow touching the textile. You’ve done the masks to heroes. You have another startup potentially you wanna talk about also for sanitizing, like you’ve, you know, there is something around this entrepreneurship that you have in your, you know I dunno if it’s in your DNA in your blood, but you have this while also having this healthcare in back of your mind.

Tell us a little bit more about this journey is, and what you’ve done is impressive last year’s and building companies. Now that answers, and again, it helps. Obviously you shared the employees in the beginning, the society where you felt healthcare needs a little bit more of support in that region and globally. So tell us a little bit more like this common thread that you have in all the different adventures that you’re on.

Ahmed Mady: So for my entrepreneurship journey I would say it all started when I was very young and I really liked the business. I wanted to start something, but starting a startup is not an easy thing to do, especially if you have family, if you have commitments. You really need to have some sort of security, to be able to put some foot on the table. So when I made a decision to go back to my father’s factory, I still have this huge interest in healthcare and coming up with ideas, but I can tell you honestly, that the moment I went back and I moved from this steady job to become, to managing the business, I just felt freedom.

You know, I really don’t really need to report to somebody. I don’t need to go back and and work towards promotion or make sure that my review will come, you know, pretty great. So I can get a raise on my salary. I just felt freedom on my end. And this freedom gave me the option to rethink out of the box and made me think about what else do we need, you know, during the pandemic when we were faced by huge shortage of medical supplies and masks. I put two production lines from my factory to produce masks. And when we faced shortage of chemical sanitizers, I came up with a small device, you can attach to the back of sanitizer utilizing some technology that I used during my lab work at Harvard utilizing ultraviolet C technology to kill viruses and bacteria within seconds.

So I can tell you that the main thing in order to really tackle problems is to free your mind and make yourself think out of the box without any limitation, thinking that you really need to report to somebody or work towards the promotion or keep put on the table.

Naji: Ahmed, It sounds so simple when you say it, it’s just so impressive.

Like you found a problem that was a public health problem with face masks. You found a solution and it’s not only business. I know for each mask that you were, you are producing, you were giving back a mask for healthcare providers and, the sanitizer, like this is such a great idea that can help us all say, so it’s, it’s just amazing how you’re, you know, you have always this healthcare with business ,so with good also behind it’s really great to hear this. 

I wanna double down on something you shared in the beginning you know, 16 years old working with 500 employees, you said you had life learning, managerial and leadership experiences that you took. I’d love to hear more about this and how you took this in a startup world in healthcare while leading today in manufacturing textile business with again, more than 500 people working for you.

What are those things that as a teenager, you learned that you are definitely keep on doing it as an executive today in the healthcare world?

Ahmed Mady: That’s a great question. I would say that it really came down to my father’s philosophy when he wanted me to learn about business. He put me on the factory floor and working with the employees, eating with them, talking to them, understanding their language was this huge, you know, has this huge impact on how I learned to do things.

When we learn things in business school, we learn how to really put strategies, how to execute on a strategy, how to do some operational management. But what’s, I would say more important and before even learning all of this, is understanding the language of who you are working with, understanding their culture, their thoughts, and understanding what they think about, you know, the place and why they are here.

And just by being around all these workers, that taught me a lot of things that I kept forward. When I was, you know, when I started managing the business with my father, so forming this great and strong relationship with the workers when I was super young, you know, when I was 10 or 11 made them feel that I’m not a manager. I’m not I’m not somebody different than them. It just happened that I’m the son of the owner. And now we are working together to achieve great things for all of us. And instead of thinking that, yes, you are a manager and I’m an employee, or I’m a worker. No, we are here for just one goal, is to do something great that will make all of us happy, that we can make that can make us feel that yes, we accomplished what we are working towards at the same time, there’s some return that will make our life better. And just understanding this, you know, very simple things will make people really work with you as great team players instead of looking at you as a manager and an employee.

Naji: Creating this culture, right, of care, of you’re all together, working, you said words common purpose, obviously making things great.

Ahmed Mady: And, understanding their pain. So when you work with somebody for example, like when you are working on understanding that there’s a huge need for healthcare and you start talking to them about, okay, let’s secure some healthcare, good healthcare insurance companies that can really help, you know, if any of you or your family members, you know, get any into any issue. Do you really understand that you are not here to make them work harder so you can get richer or, you know, make more money. You are here that for a purpose that we are all working towards better living. And when you work in a textile factory or textile business, it’s very hard to tell somebody, yes, we are here for great cause because you are just doing a product. It’s an economy scale thing, you know, where you are manufacture some goods, you’re selling these for X amount of dollars. You’re paying the salaries and it’s very hard, you know, when you explain to somebody why you are doing this. It’s just a very simple, you know, business comparing this to healthcare or to vaccines or to do something where you can really inspire people that we are doing this to save the world.

So understanding their pain points, just feel these pain points, be good human being, you know, just the empathy, you know, being empathetic with them, that can really carries a long way in managing a business and, just doing great things for people.

Naji: And, we shared what we were discussing before one, you know, there was the pandemic, there was also a moment, an unfortunate moment, recently in your in your plant that you lived with with your people.

And I’d love to go into this concrete example because it really shows what you’re talking about, how you cared about people and where you drove them towards this bigger purpose as an organization. Even though yes, sometimes in healthcare is easier, right? Like we’re living to save lives or to make people’s lives better, but you too, like, you’re managing them with care to where it’s this purpose that you created, this culture of purpose that you created.

So I I’d love, if you can tell us a little bit more this concrete story and how as a leader, you went through it and you’re back into an amazing continuous growing successes.

Ahmed Mady: Sure. So during COVID, let me start by COVID. COVID was a very challenging time, that when COVID happened we started getting cancellations for the majority of our orders. You know, stores were closed. Our clients said that we are not working and they start canceling orders. We start seeing all the factors around us, pretty much the majority of them, fleeing of people saying that we don’t have work, we need to shut down, or we need to put a pause, you know, until things will go back on track. And the way we thought about it is how we can actually go through this challenge all together as one team without affecting anybody. And from a medical background, I realized that there would be huge need for PPEs, you know, and masks and patient gowns and doctor scrubs. So I start pitching actually the first idea to my classmates at MIT saying that I’m thinking about making mask outta fabric, and that was a even before, you know people were like, just thinking about, you know, these fabric mask as a normal thing. I was thinking about two ways, two things. The first one, there would be huge shortage for medical supplies, and they’d love to help out, in this the second, how can actually make my workers, you know, continue to work.

How can I afford them? How can I make the factory, keep the factory open during this pandemic? And that helped a lot, you know, we manage to really make thousands of these masks and sell them and keep everybody’s job, we didn’t lay any layoff, any single employee. And that thing, you know, when workers felt that, oh, we have been working in this factory for years and other workers in other factors were laid off or they lost their jobs while we still keep our jobs that made them feel that we are literally working as one family and not just as, you know, as a business. It’s a family business who literally, we are dealing with everybody as a family.

Then, you know, COVID happens. We were going through COVID and then we were faced by another big challenge. And I would say this was the biggest challenge of my life where back in January, in the morning at 11 o’clock in the morning, we had huge explosion erupted on the top floor and a huge fire happened in our printing house. During that time I was actually at the nearby bank, I got a call from one of the employees screaming over the phone saying that I had to really go back immediately to the factory because the factory was on fire. And during that time, you know, I tried calling many people in the factory. Nobody was picking up. I tried calling my dad, he wasn’t answering my phone, so I had to rush to the factory. And during that time I just found five trucks standing in front of the factory, hundreds of our employees outside of the gates and were saying that we still have a dozen employees on the top word that are still trapped. I just couldn’t feel myself. I just ran, you know, towards the tough floor. And I asked the firemen if they were able to really rescue them, they said that they were facing some challenges getting, you know, knowing the weight. So I just had to go up with them and figure out, you know, how I can help.

I showed them, you know, the shortcuts and I like, we spend pretty much the next 20 minutes putting down the fire and we were successful in getting everybody out except one employee that we unfortunately lost during that fire.

Naji: oh, I’m sorry.

Ahmed Mady: It was a huge tragedy on everybody and it was just shocking experience that we had to deal with. The next day, there were a lot of things that we had to do to really bring back the team together and get that production up and running. One of them is just allow people, you know, to mourn, to listen to all of them and, and see what they wanna do and there are a lot of details here, I don’t wanna, you know, continue the details, but I would say to summarize the experience, having a huge shocking experience like that will test people’s internal motivation and people’s morale and morals. And I can tell you that the majority of our employees really did an amazing and understanding job in just working together and and getting the whole factory back into production very, very fast.

I was surprised to see our workers working 15 consecutive days without one single day off. I was also surprised to see that nobody was asking for any, you know, work and not asking for any overtime or anything like that. Despite the fact that at the end, you know, I got all their full salaries and with over time, but I felt that people were really acting as one family and instead of just taking advantage of the situation.

Naji: Ahmed, you led the way, like, it’s impressive. You went in, you were in the fire, you went with the firefighters, you went there. They saw you, right? Like, I think you’re such a genuine caring leader that this is why they are showing up. Like, it’s really this culture as you shared in the beginning, and thank you for sharing, again, this painful experience by showing again, this genuine care and leading with your heart makes people, you know, strive for whatever purpose they are on and for the company they work for. Thanks, thanks Ahmed again for sharing this with us.

Ahmed Mady: Thank you for the nice words, but I really want to give the credit to all the team. It’s not me. I just acted, you know, as a human being, not as a leader, you know, or as I would say, like, not as a manager and just everybody was working towards, you know, getting this whole factory. They felt, they told me this is our second home and we can’t let our second home go like that and it was a very humbling experience.

Naji: Well, with this, I’d love to jump into another section, where we are going to play some sort of a game. I will giving you a one word and I’d love to hear your top of mind thoughts.

So the first word for you is entrepreneurship

Ahmed Mady: Freedom.

Naji: Tell me more, you shared a little bit in the beginning, but I’d love to hear what you call freedom.

Ahmed Mady: Freedom, freedom, innovation, leaving your impact on the world. Creating jobs, coming up with something very new and making it happen, turning ideas into reality.

Naji: Great. What about disruption?

Ahmed Mady: disruption? Thinking differently. Moving, advancing the world and leaving a dent in this universe.

Naji: I’m gonna say OP.

Ahmed Mady: Okay. It’s actually, it’s very important. Organization process is very important. Having the three lenses where you have the strategic political and culture lens is a great way of leading your organization.

It’s very true that a lot of lessons that we learned in op, you can apply practically and not theoretically on the ground and see if there effects pretty quickly, including having a buy-in from your team to change an organization behavior, including anchoring an idea in somebody’s mind, or in the team’s, you know your team and making them work towards this idea, just working with your team and, trying to lobby for a specific goal or specific action. So, it’s OP all the way. If you really wanna create a good culture and lead the organization in a great effective way.

Naji: And, to finish this section what about spread love in organizations?

Ahmed Mady: It’s very important. Spreading love. Love is humanity, you know, being a human is what it takes to really have a great organization.

Naji: Great. And I wanna end this with you know, a shout out for your work with mask to heroes as the pandemic is still here and we’re still living it every day. So a shout out for everyone hearing us to go and get masks and help out also the community to give back also for the community and, for so many healthcare workers who are on the frontlines.

Ahmed Mady: I wanna actually give a shout out to all the MIT and the colleagues who made this idea happen without their help, you know, masks would just be an idea, but everybody jumped on the board and we turned an idea into a reality in two weeks, we start selling thousands of these masks in two weeks and, that was because of the help of all the whole class of the executive MBA at MIT.

Naji: Very nice. Ahmed, moving forward with you know, from the 16 year, and even you said 10 years old to, healthcare being a physician working in care and then leading now the organization and different companies how, like, how would you continue, you know, spreading love in organizations, as you said, this is the key point of a human being, right? How looking forward, what would you take from all your learning and now that you that you’re here and you wanna keep on growing, I’m sure, the different businesses that you have.

Ahmed Mady: Sure. Outside, by continually learning, you know, from your colleagues and from employees and clients in any organization, and to learn, you need to listen.

You really need to have active listening, not just listen and learn about what makes people happy in an organization. What makes them love this organization? How can you increase you know, spreading this love and most importantly, just showing empathy being good human being always, always care for the people and people will care for you.

Naji: You know, you talked about a lot about leadership, about the impact of your father, who told you very early on, any leader, you know, in around you that inspires you and that you look up to and help during this leadership journey that you’re on.

Ahmed Mady: Many leaders. The first one I would say my father, is my role model.

There are lots of leaders that he actually takes. So every leader has actually a great strength in one point. And I love reading about all entrepreneurs, you know, from the famous entrepreneurs who are currently among us, in basis, Elon Musk and all those people, they’re great and specific things, you know, where they made their organization tremendously successful.

And there are other leaders like you know, Tony Shay, of Zappos, you know, who created a great culture and Bill Gates, you know, and all these great names. So it’s a learning experience and they continue to learn every day from all of them.

Naji: The patchwork of different strength that you have, right. You talked about reading, any type of mind book you have for our audience to read these days.

Ahmed Mady: I really like, I would say how to make habits, the power of habits. And when you really try to understand the social normal and and the market norm, there is a great book called predictably irrational. It’s it’s a great one about understanding how people think and how people can help each other. Ut’s it’s a great one.

Naji: Great. Any final word of wisdom that you have for the students you know around you, or the entrepreneur in healthcare, specifically, any final word from you?

Ahmed Mady: Well, I continue to learn from all our colleagues and from you, Naji, and from all amazing colleagues. And, I consider myself a student, you know, of life, continue to learn every day. The only thing I can share, you know, here is final words just being a good human, you know, is a shortcut to great leader. That’s one thing. The second, I would say that when you work with people and and you talk to them, people will always remember how you make them feel, not what you tell them. So be mindful of your words and how people can, you know, how people feel after you talk to them and there is a lot of humbling lessons that I learned during this, you know Fire crisis, and I continue to learn from every day from our employees and from everybody around around me.

Naji: Be a good human is a shortcut to be a great leader, it’s so powerful.

I wanna end with this sentence and thank you so much again, Ahmed for being with me today and for this genuine discussion, You shared such inspiring stories for us all to continue leading with genuine care and love for a better healthcare around the word.

Thank you all for tuning in today. Follow our podcasts for more inspiring stories from global leaders in healthcare. New episodes are released every other week, beyond the lookout and stay connected. Follow subscribe, leave a review on apple, Google, or Spotify.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.

EPISODE TRANSCRIPT: Amy Edmondson

Naji: Hello leaders of the world. Welcome to SpreadLove in Organizations, a podcast for purpose-driven healthcare leaders, striving to make life better around the world, by leading their teams with genuine care, servant leadership, and love. I’m Naji, your host for this exciting episode from our new series focused on us, as leaders.

I still can’t believe with who I’ll be chatting today and not sure if I even need to introduce my guest, Amy Edmondson. Amy is the Novartis Professor of leadership and management at the Harvard business school. She teaches rights and “ruminates”, as she says, on organizational learnings, psychological safety, leadership, and teaming.

Amy is one of the most renowned thought leaders who won multiple awards and published the best books I’ve read. Her most recent book, The Fearless Organization, creating psychological safety in the workplace for learning innovation and growth is a must not only read, but a must learn and do in our organizations.

I can spend hours sharing my admiration for Amy and praising her impact on many of us leaders, trying to make the world we all inhabit a better place, but I’ll stop here. 

Amy, I am beyond thrilled having you with me on this podcast. 

Amy Edmondson: Well, you’re very kind, I’m very happy to be here. 

Naji: Amy, before diving in your incredible word of leadership, I’m eager to hear more about your personal journey from engineering to organizational behavior, and now being professor at Harvard and an influential self leader.

Can we hear more about your personal story? 

Amy Edmondson: I don’t think we have enough time to tell my whole story and I’m not sure it would be that interesting either, but I did have the great joy of working as an engineer, right out of college, working for Buckminster fuller, who was a remarkable inventor and designer and educator. And my job, during those three years was to do the hands on engineering drawings and, model building and, the calculations for some of the new geodesic domes. It was a great job. It was a great experience. And it was unique. It certainly helped me understand that I wasn’t going to be an engineer in the sense that I loved what I was doing, but it was very special, very special case.

And it was related more to making the world a better place. That was sort of the mission, the purpose, if you will, of the organization. And so my job then was to figure out where do I go from here? What is it that I’m uniquely able and drawn to do that might make a difference? And, so I wrote a book about Fuller’s mathematical work, that taught me that I enjoyed the process of writing and teaching, but I still didn’t have a field. And so I was fortunate to meet an entrepreneur who had a consulting business in organizational development. And, that was what ultimately opened the door to me, to studying organizations, to studying people at work, working in teams, trying to make their work better, ultimately trying to do the right thing for customers and communities.

And that was a great job,  as well. And it’s the job that led me to realize I needed more school. I didn’t have a business background. I didn’t have a psychology background. And that was the work I was doing. So I applied to a PhD program and I don’t think I fully appreciated that that’s a job that that’s a entry level job in an academic career, rather than a way to get smarter, and, come back out and make things happen in the world. So, I went to do a PhD. It was tough going at first, but I got through it and managed to get a faculty job at Harvard business school where I’ve been ever since for 25 years. 

Naji: Wow, and, this transition, you always mentioned kind of like the same thread of having an impact and making the word better.

 When did you discover the threat, your impact and the purpose that now you are doing every single day? 

Amy Edmondson: Well, I think it was you know, it’s emergent, it’s gradual, there isn’t a single moment of discovery. I. Just kept following my nose, I guess. And in the PhD program, some things didn’t seem like the kind of work I should do, and other things did seem like the kind of work I wanted to do. So as long as I stayed true to the questions that both seem to me to be important and, answerable and, especially answerable with the particular skills and methods I had developed, then I was okay, right? Then, things seemed to go well.

Naji: if we want to jump now in all the work that you have been leading, the research that you’ve been doing on leadership and the experiences that you’ve had, I wanna start with a high level question. If there is one trait for leaders that you believe is the most important one in the 21st century, what would that be?

Amy Edmondson: No question about it. Humility and, I don’t mean false modesty. I mean, the humility to understand you don’t have all the answers to stop and recognize that what lies ahead is complex, uncertain, novel, and it will take a lot of learning and a lot of engagement and help and input from other people to make progress.

So we and leaders have humility, they’re more able and willing to inspire and engage others, right? Because others feel that their input is needed, that they matter. And they do of course,  matter. So it’s the opposite of arrogance, leaders who have arrogance tend to put forward the message that it’s all about them and, I don’t think that’s a terribly effective leadership quality in today’s world. 

Naji: And, this is a great you segue to the fearless organizations, obviously as a leader and how you developed this. So the first question I had, because I’m a big obviously fan of all your work of the Fearless Organizations.

How did Fearless Organizations came to you and how do you define it specifically? 

Amy Edmondson: Well, I use that title for the book, the Fearless Organizations, because I don’t think psychological safety would be a very good title for the book. People would say, well, what is that? and, I’m not interested in that, but fearless organization sounds like something you might wanna learn more about, but what I mean is an organization that is very low in interpersonal fear. Meaning people feel quite able and willing to speak up with their ideas, their questions, their concerns. They get to admit mistakes. They get to experiment to, to learn on the fly. And they’re able to team up with each other because they’re able to be interpersonally fearless.And I don’t mean reckless, but I mean, just it’s not about me. It’s about us and I’ve got to be open. I’ve gotta be candid. I’ve gotta be willing to go for it, to play to win, if you will. 

And I got interested in this, I mean, I discovered the sort of importance of this kind of interpersonal climate by studying healthcare teams, by studying those teams and those clinicians who do such challenging and such high stakes work and where that willingness to speak up, to report a mistake or that willingness to speak up to ask for help when you’re not quite sure what to do is mission critical to the quality of care. And, so it was in studying healthcare organizations that I got interested in this. And then I found that it really was true in all sorts of other kinds of workplaces, too.

Naji: You brought the psychological safety to the business world, right? And we hear it more and more luckily in many different organizations. And it’s crucial, but yet, so many leaders try to do it, try to foster it. And I consistently see how many don’t even realize how fast you can destroy it, in fact, right? One simple meeting, one simple word, and suddenly people can, you know, shut down, stop speaking up. Any advice, for us as leaders on how to not only build, but sustain psychological safety within our teams?

Amy Edmondson: You know, I think we have to not, you know, not emphasize that you can destroy it, right? And then it’s gone, it’s blown up, right? Because I think that’s too strong. It is a more fallible human beings, all of us. And so we will at times do things that don’t work, right? We’ll inadvertently get upset or we’ll use a term or a phrase that is very counterproductive and, has a negative impact on others.

It’s all reparable, right? These are not life and death. They can feel like it. They can feel like life and death interactions, but they’re not, right? So I think the first thing one has to realize is that you can always repair a situation, right? When you make a mistake, interpersonally or otherwise own it, apologize, resolve to do better and, move forward, and that sets a good example, right? That’s modeling the behavior that helps other people, as well as yourself.  Continue to feel safe enough to be candid and that, and that’s what it’s all about. So we’re going to make mistakes. We need to do our best to keep learning and keep improving.

Naji: Yeah, recognizing it, and, as you’re saying apologizing for it, if it happens, but really bouncing back as a team. You know, one of the things I’ve always, we always hear, right? When we are trying to build such a culture and environment for people to feel safe to thrive, is this speed, the base of in a innovation, the base of how the word is going, and sometimes it’s put into contradiction with trying to build this trust, this psychological safe environment.  

So any thought on this, between this fast moving environment? 

Amy Edmondson: Yeah, I mean, I actually think we can get up to speed and to connect with each other and work relationships very quickly, right? And in a productive way. I mean, if, if I don’t know you and yet we have to do something together. I think I need to know three things and I think they can be conveyed in less than three minutes, right? One, I need to know what you are trying to do, right? What’s your goal? Two, I need to know what you bring, what skills, what resources, right? What experience? And three, I need to know what you are up against, right? What constraints are you aware of? You know, maybe your boss needs something from you by tomorrow. Maybe you have, you know, a daycare pickup at six. I mean, I just, so that’s it, right? Your goals, your resources and your constraints.

And then I need to tell you that in return, it’s a kind of strangely intimate thing to know. I mean, I think the first one goal that’s easy, but for me to tell you my skills, that’s a little harder for me to tell you my worries, my constraints, that’s a little harder still, but they’re all relevant, right? These aren’t personal in the sense of personal life. They’re work relevant, right? So, I think we want to not overplay the need for long slow deep explorations to feel comfortable with each other, but just enough, enough knowledge on the task relevant things that we can team up. 

Naji: I love this framework because, you know, one of the things as I was also reading all your research, was this hybrid world I wanted to get your reaction on, but the framework you just gave actually can do even virtually, to be better team player and to build our team.

But have you seen any challenges with the hybrid world and building cultures obviously totally virtually, right? Like there is no more this informal interactions, no small things that really build a culture sometimes, especially when you’re new in a team or as a leader leading a new organization.

Have you seen this in the virtual world? And have you seen some good ways for us?

Amy Edmondson: Yes. I think it’s a great deal more challenging. I think, in fact, we have a growing amount of data to show that this is challenging for us. We’re social creatures. We work virtually well, when we know each other a little bit, we can get to know each other. You and I are doing that right now, in a non face to face environment, but in a mediated communication setting.  But I think there’s no way around the recognition that some of the warmth isn’t there, some of the connection isn’t there, and so we need to find new ways to build that safety and to build that candor, we need to use rituals and tools to kind of make sure that we hear from each other and, share especially the most relevant information that we have.

Naji: And from those learning and you obviously also are an expert in teaming,  with the first research and book that you’ve done, and I remember one of the examples you gave and you gave it today again on healthcare emergency room. You know, it reminded me of some of my past life experiences. With the pandemic, actually, when I think of, it was a great example in some of the sectors of real teaming up, right? And we’ve seen what real teaming can do to humanity. 

Are you hopeful now that leaders have learned this lesson of how we should team up and changed the world? What are your thoughts or reflection about this? 

Amy Edmondson: I’m gonna be cautiously hopeful, because one of the things that was striking, I think for so many people, including me, was how quickly we could change and set up new systems and new ways of working, you know, virtually overnight, and in ways that we would’ve thought weren’t possible, right? But we had to do it. So we did it. And then we got better at it. We got better at not trying to talk when we’re on mute, we got better at sort of setting meetings up and maybe figuring out the right length for meetings and at engaging the students from a distance and, all of the rest.

So yes, it was a giant problem solving teaming opportunity. And I think it continues today. I think we continue to figure out to solve the problem of what works, what works best in this remote context and what doesn’t work well in a remote context. And then how do you solve the, you know, how do you design going forward the right mix, the right hybrid mix.

But I don’t think we know the answer yet. Right? I don’t think that those plans, those blueprints exist, I think we need to do a great deal more experimenting and testing and iterating. 

Naji: That would’ve been my question. Do you have any sense of how the future, you know, of work and building this culture would be, but it seems we need somewhere experimenting.

Amy Edmondson: Yeah, I think we have a lot more learning to do. I think we’re in danger of concluding too much from the last 18 months, but the last 18 months were very special. They were, first of all, it was new. Second of all, we didn’t have any choice. I mean, at least for large portions of that period, we had to be socially distant. We had to stay home and I think we were less sensitive to what we were missing. I think we will be going forward, right? I think again, we are social creatures and I think we need to be together some portion of the time or we lose our relationships. And if, you know, we were able to maintain many of them, maybe a good way to say this is that the Zoom happy hour phenomenon got old quickly, right? It was fun at first, you sort of saw your friends, you know, you had a beer, but after a little while, it was like, no, it’s just not, you really don’t wanna do it. And I think an implication of that was that, we realized this isn’t really socializing, right? This isn’t the same, the same is true for work, right? There’s some aspects of the workplace that really, it’s just really nice to be together. We laugh, we talk about the weekend. We feel a sense of camaraderie and connection. 

Naji: Yeah. We speak one over the other, in real happy hours. Yeah. You know, I thought a lot about it and I’ve been asked the questions with my, you know, childhood and, really, I kind of summed up in human works, right? Something that we really miss and we learned is that we missed this human warmths, right? So as you’re saying, we’re social, you know, very social at the end as a human being, which is good.  

Amy, I would love to get your first reaction on some words I will tell you, if you’re fine with this game. So the first one is leadership.

Amy Edmondson: Purpose. I mean, to leadership is about influencing others, to achieve important aims that one could not do oneself.

So leadership is about purpose.

Naji: What about team? 

Amy Edmondson: More than the sum of the parts, right. The team is about synergy, the team is about bringing different expertise and talent and strengths together to get more done than one could ever do alone

Naji: Innovation.

Amy Edmondson: Potential. It’s what we need. We need innovation to make a better world that works for everyone.

Naji: And the last one is spread love in organizations.

Amy Edmondson: Love, Buckminster Fuller said is metaphysical gravity, right? So gravity is a scientific, a physical force that makes two objects of mass attracted to each other. You know, fortunately, I’m very stuck on this earth right now because of gravity. It’s a wonderful thing instead of floating off, here I am. Love is metaphysical gravity, love is that the very real, but often under acknowledged connections that we all have with each other.

Naji: And do you see a place where it is in corporations and organizations? 

Amy Edmondson: Yes. And I see how people could misunderstand that, right? I think we love our, I mean, I think when we are fortunate, we love our work. We love our colleagues. But most importantly, we feel connected to both. We feel connected to the organization, we feel connected to our colleagues. We feel connected to the work. And that’s an invisible force that keeps us going.

Naji: And finally, I would love to have a final word of wisdom to all of us leaders around the world, in healthcare and, in any industry, 

Amy Edmondson: I don’t know if I have a word of wisdom, but I will say when I think about leadership, the most important thing that comes to mind is, remember it’s not about you, right?

I think when one falls into that trap of being self-centered, self-absorbed, self-protective, leadership is less effective, right? And, sort of remind, get it back to front and center of your mind that it’s about out the purpose and about other people being available for present for other people, then things tend to go well.

Naji: Great, that’s an amazing definition for leadership. Purpose, and then being here for others. 

Thank you so much, Amy, for your time, generosity and such an inspiring discussion. Thank you. 

Amy Edmondson: You’re very welcome. It’s great to be with you. 

Naji: Thank you all for listening to SpreadLove in Organizations’ podcast.

Follow us on LinkedIn and connect with us on spreadloveio.com. We’re eager to hear your thoughts and feedback. Most importantly, spread love in your organizations and spread the word around you to inspire others and amplify this movement, our world so desperately needs.